<SEC-DOCUMENT>0001193125-19-271052.txt : 20191022
<SEC-HEADER>0001193125-19-271052.hdr.sgml : 20191022
<ACCEPTANCE-DATETIME>20191021212026
ACCESSION NUMBER:		0001193125-19-271052
CONFORMED SUBMISSION TYPE:	S-1/A
PUBLIC DOCUMENT COUNT:		48
FILED AS OF DATE:		20191022
DATE AS OF CHANGE:		20191021

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			RAPT Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001673772
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				473313701
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		S-1/A
		SEC ACT:		1933 Act
		SEC FILE NUMBER:	333-232572
		FILM NUMBER:		191160466

	BUSINESS ADDRESS:	
		STREET 1:		561 ECCLES AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080
		BUSINESS PHONE:		(650) 489-9000

	MAIL ADDRESS:	
		STREET 1:		561 ECCLES AVENUE
		CITY:			SOUTH SAN FRANCISCO
		STATE:			CA
		ZIP:			94080

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	FLX Bio, Inc.
		DATE OF NAME CHANGE:	20160504
</SEC-HEADER>
<DOCUMENT>
<TYPE>S-1/A
<SEQUENCE>1
<FILENAME>d723949ds1a.htm
<DESCRIPTION>AMENDMENT NO. 3 TO FORM S-1
<TEXT>
<HTML><HEAD>
<TITLE>Amendment No. 3 to Form S-1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As filed with the Securities and Exchange Commission on October&nbsp;21, 2019 </B></P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="right"><B>Registration No.&nbsp;333-232572 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="margin-top:2pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>UNITED STATES </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>SECURITIES
AND EXCHANGE COMMISSION </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B>Washington, D.C. 20549 </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>  <P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>AMENDMENT
NO.&nbsp;3 </B></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>TO </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>FORM <FONT STYLE="white-space:nowrap">S-1</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>REGISTRATION STATEMENT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><I>UNDER </I></B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:9pt; font-family:Times New Roman" ALIGN="center"><B><I>THE
SECURITIES ACT OF 1933 </I></B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:20pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">(Exact name of registrant as specified in its charter) </P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="32%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="32%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"><B>Delaware</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>2834</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B><FONT STYLE="white-space:nowrap">47-3313701</FONT></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(State or other jurisdiction of</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>incorporation or organization)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Primary Standard Industrial</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Classification Code Number)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(I.R.S. Employer</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Identification Number)</B></P></TD></TR>
</TABLE> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>561 Eccles Avenue </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>South San Francisco, California 94080 </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">489-9000</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Address, including zip code, and telephone number, including area code, of registrant&#146;s principal executive offices) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Brian Wong, M.D., Ph.D. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>President and Chief Executive Officer </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>RAPT Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>561 Eccles Avenue </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>South
San Francisco, California 94080 </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">489-9000</FONT> </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(Name, address, including zip code, and telephone number, including area code, of agent for service) </B></P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><I>Copies to: </I></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Michael Tenta</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Sale Kwon</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Ryan
James</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Cooley LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>3175 Hanover Street</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Palo
Alto,&nbsp;California&nbsp;94304</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">(650)&nbsp;843-5000</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Bruce K. Dallas<BR>Stephen Salmon<BR>Davis Polk&nbsp;&amp; Wardwell LLP</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>1600 El Camino Real</B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Menlo
Park, California 94025</B></P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(650) <FONT STYLE="white-space:nowrap">752-2000</FONT></B></P></TD></TR>
</TABLE> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:8%; font-size:8pt; font-family:Times New Roman"><B>Approximate date of commencement of proposed sale to the public:</B> As soon as practicable after this Registration Statement is declared
effective. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:8pt; font-family:Times New Roman">If any of the securities being registered on this form are to be offered on a delayed or continuous basis pursuant to Rule 415
under the Securities Act of 1933, as amended, check the following box.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:8pt; font-family:Times New Roman">If this Form is filed to register additional
securities for an offering pursuant to Rule 462(b) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744;
</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:8pt; font-family:Times New Roman">If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the
Securities Act registration statement number of the earlier effective registration statement for the same offering.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:8pt; font-family:Times New Roman">If
this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same
offering.&nbsp;&nbsp;&#9744; </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:8pt; font-family:Times New Roman">Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a <FONT
STYLE="white-space:nowrap">non-accelerated</FONT> filer, a smaller reporting company or an emerging growth company. See the definitions of &#147;large accelerated filer,&#148; &#147;accelerated filer,&#148; &#147;smaller reporting company&#148; and
&#147;emerging growth company&#148; in Rule <FONT STYLE="white-space:nowrap">12b-2</FONT> of the Exchange Act. </P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="14%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="63%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="18%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="2%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Large&nbsp;accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Accelerated&nbsp;filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">Non-accelerated filer</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Smaller&nbsp;reporting&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9744;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Emerging&nbsp;growth&nbsp;company</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&#9746;</TD></TR>
</TABLE> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:8pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended
transition period for complying with any new or revised financial accounting standards provided pursuant to Section&nbsp;7(a)(2)(B) of the Securities Act.&nbsp;&nbsp;&#9744; </P>
<P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>CALCULATION OF REGISTRATION FEE </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:7pt" ALIGN="center">


<TR>

<TD WIDTH="66%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>


<TR STYLE="font-size:1px; ">
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:7pt">
<TD VALIGN="bottom" ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Title&nbsp;of&nbsp;Each&nbsp;Class&nbsp;of<BR>Securities&nbsp;To&nbsp;Be&nbsp;Registered</B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Proposed&nbsp;Maximum<BR>Aggregate&nbsp;Offering<BR>Price<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></B></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000"><B>Amount&nbsp;of<BR>Registration&nbsp;Fee<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></B></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="top" STYLE="BORDER-TOP:1px solid #000000"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:8pt; font-family:Times New Roman">Common Stock, $0.0001 par value per share</P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$92,000,000</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000; BORDER-TOP:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center" STYLE="BORDER-TOP:1px solid #000000">$11,941.60</TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
<TR STYLE="font-size:1px; ">
<TD COLSPAN="5" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD></TR>
</TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Estimated solely for the purpose of calculating the registration fee pursuant to Rule 457(o) under the
Securities Act of 1933, as amended. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Includes the aggregate offering price of additional shares that the underwriters have the option to purchase to
cover over-allotments, if any. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Calculated pursuant to Rule 457(o) under the Securities Act of 1933, as amended, based on an estimate of the
proposed maximum aggregate offering price. Of this amount, $11,941.60 was previously paid. </P></TD></TR></TABLE>  <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center> <P STYLE="margin-top:3pt; margin-bottom:0pt; text-indent:8%; font-size:8pt; font-family:Times New Roman"><B>The Registrant
hereby amends this Registration Statement on such date or dates as may be necessary to delay its effective date until the Registrant shall file a further amendment which specifically states that this Registration Statement shall thereafter become
effective in accordance with Section&nbsp;8(a) of the Securities Act of 1933, as amended, or until the Registration Statement shall become effective on such date as the Securities and Exchange Commission, acting pursuant to said Section&nbsp;8(a),
may determine. </B></P> <P STYLE="font-size:3pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><FONT COLOR="#cc062a">The information in this preliminary prospectus is not complete and may be changed. We
may not sell these securities until the registration statement filed with the Securities and Exchange Commission is effective. This prospectus is not an offer to sell these securities and we are not soliciting offers to buy these securities in any
jurisdiction where the offer or sale is not permitted. </FONT></P> <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT
 COLOR="#cc062a">Subject to Completion </FONT></P>  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><FONT COLOR="#cc062a">Preliminary Prospectus dated October&nbsp;21, 2019 </FONT></P>
<P STYLE="margin-top:3pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>PROSPECTUS </U></P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Shares </B></P>
<P STYLE="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g00v03.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:8pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This is RAPT
Therapeutics, Inc<I>.</I>&#146;s initial public offering. We are selling &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect the initial public offering price to be between $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. Currently, no public market exists for the shares of our common stock. After pricing of the offering, we expect that the shares will trade on the Nasdaq Global
Market under the symbol &#147;RAPT.&#148; </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148; as defined under the U.S. federal securities
laws and, as such, may elect to comply with certain reduced public company reporting requirements for this and future filings. See &#147;Prospectus Summary&#151;Implications of Being an Emerging Growth Company.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:12pt; font-family:Times New Roman"><B>Investing in our common stock involves risks that are described in the &#147;<A HREF="#toc723949_2">Risk&nbsp;Factors</A>&#148; section
beginning on page 14 of this prospectus. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="19%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Per&nbsp;Share</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Total</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Initial public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discount<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See &#147;Underwriting&#148; beginning on page 187 for additional information regarding underwriting
compensation. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The underwriters may also exercise their option to purchase up to an additional
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock from us, at the initial public offering price, less the underwriting discount, for 30 days after the date of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Certain existing stockholders have indicated an interest in purchasing up to approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of shares of our common stock in this offering at the initial public offering price. However, because these indications of interest are not binding agreements or commitments
to purchase, the underwriters may determine to sell more, less or no shares in this offering to any or all of these stockholders, or any or all of these stockholders may determine to purchase more, less or no shares in this offering. The
underwriters will receive the same underwriting discount on any shares purchased by these stockholders as they will on any other shares sold to the public in this offering. Substantial purchases of common stock by existing stockholders could reduce
the liquidity of the trading market for our common stock and increase price volatility. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Neither the Securities and Exchange
Commission nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The shares of common stock will be ready for delivery on or about
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:11pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="38%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="31%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:11pt">
<TD VALIGN="top"><B>BMO&nbsp;Capital&nbsp;Markets</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"><B>Wells&nbsp;Fargo&nbsp;Securities</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right"><B>UBS&nbsp;Investment&nbsp;Bank</B></TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">The date of this prospectus is
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc"></A>TABLE OF CONTENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Prospectus </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Page</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_1">Prospectus Summary</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_2">Risk Factors</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_3">Special Note Regarding Forward-Looking Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_4">Market, Industry and Other Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_5">Use of Proceeds</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">64</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_6">Dividend Policy</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_7">Capitalization</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">66</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_8">Dilution</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_9">Selected Consolidated Financial Data</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_10">Management&#146;s Discussion and Analysis of Financial Condition and Results
 of Operations</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_11">Business</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">87</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_12">Management</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">145</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_13">Executive Compensation</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">154</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_14">Certain Relationships and Related Party Transactions</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">168</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_15">Principal Stockholders</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">172</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_16">Description of Capital Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_17">Shares Eligible for Future Sale</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_18">Material U.S. Federal Income Tax Consequences to <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holders of our Common Stock</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_19">Underwriting</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">187</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_20">Legal Matters</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_21">Experts</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_22">Where You Can Find Additional Information</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">195</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#toc723949_23">Index to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-1</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>Through and including&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019 (25 days after
the date of this prospectus), all dealers effecting transactions in our common stock, whether or not participating in this offering, may be required to deliver a prospectus. This is in addition to a dealer&#146;s obligation to deliver a prospectus
when acting as an underwriter and with respect to unsold allotments or subscriptions. </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have not and
the underwriters have not authorized anyone to provide you with any information or to make any representations other than those contained in this prospectus or in any free writing prospectuses we have prepared. We and the underwriters take no
responsibility for, and can provide no assurance as to the reliability of, any other information that others may give you. We are offering to sell, and seeking offers to buy, shares of our common stock only in jurisdictions where offers and sales
are permitted. The information contained in this prospectus is accurate only as of the date of this prospectus, regardless of the time of delivery of this prospectus or of any sale of our common stock. Our business, financial condition, results of
operations and future growth prospects may have changed since that date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For investors outside the United States: Neither we nor any of
the underwriters have done anything that would permit this offering or possession or distribution of this prospectus in any jurisdiction where action for that purpose is required, other than in the United States. Persons outside of the United States
who come into possession of this prospectus must inform themselves about, and observe any restrictions relating to, the offering of the shares of our common stock and the distribution of this prospectus outside of the United States. </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_1"></A>PROSPECTUS SUMMARY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>This summary highlights selected information, presented in greater detail elsewhere in this prospectus. This summary does not contain all
of the information you should consider before investing in our common stock. You should read this entire prospectus carefully, including the sections titled &#147;Risk Factors&#148; and &#147;Management&#146;s Discussion and Analysis of Financial
Condition and Results of Operations&#148; and our consolidated financial statements and the related notes included elsewhere in this prospectus, before making an investment decision. Unless the context otherwise requires, all references in this
prospectus to &#147;we,&#148; &#147;us,&#148; &#147;our,&#148; &#147;the company&#148; and &#147;RAPT&#148; refer to RAPT Therapeutics, Inc. </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage
immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing our proprietary drug discovery
and development engine, we are developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases. In our first four years since inception, we have discovered and advanced two unique drug
candidates each targeting <FONT STYLE="white-space:nowrap">C-C</FONT> motif chemokine receptor 4 (&#147;CCR4&#148;). Our lead oncology drug candidate, FLX475, reached the clinic in just two and a half years and our lead inflammation drug candidate,
RPT193, entered the clinic in August 2019. We are also pursuing a range of targets, including general control nonderepressible 2 (&#147;GCN2&#148;) and hematopoietic progenitor kinase&nbsp;1 (&#147;HPK1&#148;), that are in the discovery stage of
development. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following chart summarizes the status of the drug candidates in our current pipeline. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Our Pipeline: Highly Selective Oral Compounds Targeting </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Critical Immune Drivers </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g723949g27z46.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:4pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Investigational New Drug application (&#147;IND&#148;) submitted in May 2018 to treat multiple
&#147;charged&#148; tumor types including non-small cell lung cancer, triple negative breast cancer, head and neck squamous cell carcinoma, nasopharyngeal cancer, gastric cancer, certain Hodgkin and non-Hodgkin lymphomas and cervical cancer.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Initial Phase 1 study in healthy volunteers and patients with atopic dermatitis initiated in August 2019. Our
Clinical Trial Application (&#147;CTA&#148;) in Europe was accepted in July 2019. Subject to acceptance of an IND or CTA, subsequent Phase 2 studies may include additional allergic diseases beyond atopic dermatitis, including asthma, chronic
urticaria (skin rash), allergic conjunctivitis, chronic rhinosinusitis and eosinophilic esophagitis (inflammation of the esophagus). </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

   <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our CCR4 Franchise </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our proprietary drug discovery and development engine has identified the cell surface receptor CCR4 as a drug target that potentially has
broad applicability in oncology and inflammatory diseases. Receptors such as CCR4 bind to chemoattractant molecules called chemokines that orchestrate migration and homing of immune cells to specific tissues throughout the body. Chemokines specific
for CCR4 are secreted from tumors and from allergically-inflamed tissues, but are not highly expressed in healthy tissues. Our approach is designed to enable selective restoration of the immune response within tumor and allergically inflamed tissues
without systemically depleting immune cells and broadly suppressing the immune system. Each of our two unique drug candidates, FLX475 and RPT193, target CCR4 in a manner we believe is well suited for cancer and inflammatory disease, respectively.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CCR4 Antagonist for Oncology: FLX475 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are developing FLX475 for the treatment of a broad range of &#147;charged&#148; tumors, which represent cancer types we believe are most
likely to respond to FLX475. In cancer, the secretion of certain chemokines from tumor cells and tumor-resident immune cells is responsible for recruitment of immunosuppressive regulatory T cells (&#147;T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB>&#148;) to tumor sites. T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> represent a dominant pathway for downregulating the immune response, and thus may limit the effectiveness of
currently available therapies such as checkpoint inhibitors. Therefore, blocking the migration of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> has the potential to restore naturally-occurring antitumor immunity as well as to
synergize with a variety of both conventional and immune-based therapies, such as radiation, chemotherapy, checkpoint inhibitors, immune stimulators and adoptive T cell therapy. We believe that the inhibition of CCR4 has the potential to bring
therapeutic benefit to patients across a wide spectrum of tumors in a manner similar to other immuno-oncology therapies that have been shown to be effective against multiple tumor types, while also potentially deepening or broadening clinical
responses to these therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our proprietary drug discovery and development engine has identified certain tumors in which the abundance
of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> is likely to be a cause of immune suppression. We refer to these tumors as &#147;charged,&#148; as defined by high levels of (i)&nbsp;CCR4 ligands, (ii)&nbsp;T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> and (iii)&nbsp;CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> effector cells. These &#147;charged&#148; tumors include tumor types such as
<FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer, triple negative breast cancer, head and neck squamous cell carcinoma, nasopharyngeal cancer, gastric cancer, certain Hodgkin and non-Hodgkin lymphomas, and cervical cancer.
Additionally, we have discovered that the presence of oncogenic viruses, such as Epstein-Barr virus and human papillomavirus, is associated with tumors that are highly &#147;charged&#148; and allows prospective patient selection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">FLX475 is a small molecule CCR4 antagonist designed to block the migration of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>
specifically into tumors, but not healthy tissues, without depleting T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> throughout the body, which we believe may decrease the likelihood of side effects. We have completed a
placebo-controlled, double-blinded dose-escalating Phase 1 clinical trial of FLX475 in 104 healthy volunteers. FLX475 was well tolerated and demonstrated dose-dependent inhibition of CCR4 with no observed immune-related adverse events or significant
clinical adverse events. Daily dosing within the single dose arm ranged between 5 mg and 1,000 mg and in the multiple dose arm between 25 mg and 150 mg a day for 14 days. At the 75 mg daily dose, FLX475 exceeded the targeted receptor occupancy in
six out of six healthy volunteers, which, in our preclinical studies, corresponded with a 90% inhibition of in vitro T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and the highest level of inhibition of in vivo T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and antitumor activity. We are currently enrolling a Phase&nbsp;1/2 trial of FLX475 as a monotherapy, and in combination with pembrolizumab (marketed as Keytruda), in patients with
&#147;charged&#148; tumors and anticipate results from the Phase&nbsp;2 portion of the trial could provide clinical proof-of-concept (&#147;PoC&#148;) data in the first half of 2020. While Phase 1 dose escalation is ongoing and a maximum tolerated
dose (&#147;MTD&#148;) has not yet been identified for either monotherapy or combination therapy, a patient with NSCLC in the 50 mg FLX475 and Keytruda<SUP STYLE="font-size:85%; vertical-align:top"><FONT
STYLE="font-family:Times New Roman; font-size:6.5pt">&reg;</FONT></SUP> (pembrolizumab) cohort that had failed prior treatment with anti-PD-L1 therapy (atezolizumab) has had a confirmed partial response (&#147;PR&#148;)
</P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
under RECIST 1.1 criteria, based on radiological analysis performed at the clinical investigator site, with a 37.5% reduction in target lesion measurement at 8 weeks and a 47% reduction at 14
weeks. The patient remains on study. We intend to present topline data from the Phase 1/2 trial in the first half of 2020. For more information regarding the risks associated with our Phase 1/2 clinical trial for FLX475, please see &#147;Risk
Factors&#151;Risks Related to Our Business&#151;FLX475 and PRT193 are in clinical development, which may fail or suffer delays that materially and adversely affect their commercial viability.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In preclinical studies, FLX475 caused a 56-78% reduction in T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> recruitment into
tumors in two out of two experiments in mice. In contrast, CCR4 antagonism did not cause T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> reductions in skin, blood, or lymphoid organs in seven out of seven mice in two out of two
experiments. This reduction of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> recruitment by tumors in mice was sufficient to increase effector immune cells (CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>) by an average of 3
fold (ranging from 1.7 to 4.1 fold in individual mice). In addition, in preclinical tumor models, use of our CCR4 antagonist as a single agent resulted in tumor growth inhibition comparable to an immune checkpoint inhibitor in three out of four
experiments. In combination with checkpoint inhibitors, our CCR4 antagonist led to tumor reduction and eradication greater than checkpoint inhibitors alone and did not appear to negatively impact effector immune cells. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We hold worldwide rights to FLX475 and own an issued U.S. composition of matter patent with respect to FLX475 that is scheduled to expire in
2037. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>CCR4 Antagonist for Allergic Inflammatory Disease: RPT193 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">RPT193 is a small molecule CCR4 antagonist that blocks the recruitment of inflammatory immune cells, known as type&nbsp;2 T helper cells
(&#147;Th2 cells&#148;), which are clinically implicated in allergic inflammatory diseases. We are developing RPT193 for the treatment of a broad range of allergic inflammatory diseases, the first of which is atopic dermatitis (&#147;AD&#148;), a
chronic, inflammatory skin disease characterized by skin barrier disruption and immune dysregulation. We have initiated a first-in-human trial in August 2019 starting with Phase&nbsp;1a single and multiple dose escalation cohorts in healthy
volunteers, to be followed by placebo-controlled Phase&nbsp;1b testing in patients with moderate to severe AD. We refer to this trial design as &#147;seamless&#148; given it will start with healthy volunteers and then transition directly into a
cohort of patients with AD. Preliminary safety, pharmacokinetic, and pharmacodynamic data from the initial single dose cohorts support once-daily oral dosing with RPT193 and dose escalation continues as planned. We anticipate PoC clinical results
from the Phase 1b portion of this study by mid-2020. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">While there are marketed injectable products for the treatment of AD, as well
as oral and injectable drug candidates in development, we believe there is an unmet need for a safe and effective oral treatment. In preclinical studies, oral administration of RPT193 resulted consistently in statistically significant (p &lt; 0.05)
reduction of inflammation in allergic skin (nine out of nine experiments) and airway inflammation models (two out of two experiments). In five of five preclinical experiments in mice, in a head-to-head comparison, we observed that the activity of
oral RPT193 was similar to that observed with an anti-IL13 antibody. We believe based on our preclinical pharmacology and Good Laboratory Practice (&#147;GLP&#148;) toxicology results, if confirmed in clinical trials, combined with the convenience
of once daily oral dosing, RPT193, if approved by the FDA, could fill an unmet medical need for the treatment of allergic disorders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">CCR4
is highly expressed on Th2 cells. In allergic inflammatory diseases, including AD, chemokines recruit Th2 cells via CCR4 into inflamed tissues. Once Th2 cells enter tissues such as the skin or the airways in the lung, they secrete proteins known to
drive the inflammatory response. The role of Th2 cells has been clinically validated by, among others, dupilumab, an injectable biologic targeting this pathway. Further evidence of CCR4&#146;s role in AD includes the observation of higher levels of
CCR4 ligands in AD patients compared with healthy humans; these ligands also correlate with the severity of disease. We believe that by inhibiting CCR4, </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
RPT193 has the potential to bring therapeutic benefit to patients across a broad spectrum of additional allergic inflammatory diseases, including asthma, chronic urticaria (skin rash), allergic
conjunctivitis, chronic rhinosinusitis and eosinophilic esophagitis (inflammation of the esophagus). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are developing RPT193 initially
in AD because there is: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an unmet need for a safe and effective oral treatment; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a potentially efficient path to PoC, due to high prevalence of disease and short time to clinically relevant
endpoints; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a well-defined set of clinical endpoints that have historically been accepted for regulatory approval, which are
usable for PoC as well as for subsequent pivotal studies; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">easy access to patient samples, such as skin biopsies, to interrogate mechanisms of action and clinical
biomarkers of efficacy; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a precedent that PoC in AD has translated to other Th2 driven allergic inflammatory diseases.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We hold worldwide rights to RPT193 and have pending patent applications with respect to RPT193 that, if issued, would
be scheduled to expire in 2039. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>GCN2 and HPK1 Programs for Oncology </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">GCN2 is a fundamental driver of immune suppression and the survival of tumor cells under the conditions of metabolic stress typically seen in
the tumor microenvironment. Preclinical studies have shown that the inhibition of GCN2 can result in tumor cell death in vitro and restoration of immune function under these stress conditions. The GCN2 pathway is generally not active in healthy
tissue suggesting the potential for a favorable therapeutic index for drugs targeting GCN2. Preclinical in vitro studies have demonstrated that a potential inhibitor of GCN2 (an &#147;RPT-GCN2i&#148;) has the ability to increase T cell proliferation
and function in nutrient-deprived conditions to levels comparable to T cells cultured in non-nutrient-deprived conditions (six out of six studies). An RPT-GCN2i also reduced immune suppression induced by myeloid-derived suppressor cells as measured
by an increase in T cell proliferation (by 80-148% of control in immune cells from five out of five human donors). Preclinical in vivo studies demonstrated that oral administration of an RPT-GCN2i elicited consistent (four out of four experiments)
antitumor responses in animal models. We are developing an RPT-GCN2i with the intent of filing an IND with the FDA in 2020. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">HPK1 is a
negative regulator of T cell activation, and the inhibition of HPK1 has the potential to enhance T&nbsp;cell function and antitumor activity. HPK1 was identified in a RAPT computational screen, which also identified clinically validated targets
including <FONT STYLE="white-space:nowrap">PD-1,</FONT> as well as CCR4. We are refining the chemical structure of our lead HPK1 compounds utilizing high resolution crystal structures and demonstrated that inhibition of HPK1 enhanced activation of
primary mouse and human T&nbsp;cells in vitro, as well as antigen-specific CD8+ T&nbsp;cell effector function in vivo. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Proprietary Drug
Discovery and Development Engine </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Through the deep expertise of our team in immunology and drug discovery, supported by advanced
computational biology, we are developing the ability to exploit difficult targets, including through proprietary </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
know-how. We refer to this as our &#147;proprietary drug discovery and development engine.&#148; This engine is built upon the following four key pillars: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">computationally-driven disease target and biomarker identification; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">efficient design of small molecule drug properties; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">data-driven patient selection; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">nimble clinical execution. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We believe that the drug candidates generated from this engine, if approved, will significantly improve the treatment paradigms and outcomes
for patients by fundamentally modulating the immune responses in a range of cancers and inflammatory diseases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Team and Investors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our management and scientific teams and scientific advisory board have substantial expertise in three areas key to our success: immunology,
small molecule drug discovery and development and computational biology. Collectively, our executives have contributed to the research and development of multiple drugs, including Gazyva, Venclexta, Tavalisse, Actemra, Provenge and Xgeva. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have assembled a leadership team and advisory group with a proven track record of success, and a team of scientists with substantial
knowledge and expertise especially in human immune biology and also in the drug discovery and development and translational areas essential to execute on this approach. Our President and Chief Executive Officer, Brian Wong, M.D., Ph.D., previously
served as Senior Vice President, Research, and Head of Immuno-Oncology at Five Prime Therapeutics and Director of Research in the Inflammation Disease Biology Area at Roche. William Ho, M.D., Ph.D., our Chief Medical Officer, previously led clinical
development at Igenica Biotherapeutics and the development of multiple products at Genentech including Gazyva and Venclexta. Our Chief Scientific Officer, Dirk Brockstedt, Ph.D., previously served as Executive Vice President of Research and
Development at Aduro Biotech. Our Vice President, Quantitative and Computational Biology, Paul Kassner, Ph.D., previously served as Director of Research and Head of the Genome Analysis Unit at Amgen. Before joining RAPT, our Senior Vice President of
Drug Discovery and Preclinical Development, David Wustrow, Ph.D., most recently served as Vice President, Chemical and Pharmaceutical Sciences at Cleave Biosciences. Our Vice President, Finance and Corporate Controller, Karen&nbsp;C. Lam, previously
served as Senior Director, Controller of True North Therapeutics and Director, Controller at iPierian and Ms.&nbsp;Lam is a Certified Public Accountant (inactive). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our management team is supported by a scientific advisory board comprised of leading clinicians and scientific researchers, including
Alexander Rudensky, Ph.D. (Memorial Sloan Kettering Cancer Center); Antoni Ribas, M.D., Ph.D. (UCLA); Scott Antonia, M.D., Ph.D. (Duke University); Drew Pardoll, M.D., Ph.D. (Johns Hopkins University); Philip Greenberg, M.D., Ph.D. (Fred Hutchinson
Cancer Research Center); Robert Zamboni, Ph.D. (McGill University); Emma Guttman-Yassky, M.D., Ph.D. (Mt. Sinai) and David Goeddel, Ph.D. (The Column Group). Our clinical advisors also include Jasmina Jankicevic, M.D. (Premier Research); Thomas
Bieber, M.D. (University of Bonn, Germany); and Andrew Blauvelt, M.D., M.B.A. (Oregon Medical Research Center). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are backed by
leading corporate and institutional investors, including The Column Group, GV, Kleiner Perkins, Topspin Partners, Hartford Healthcare, Celgene Corporation and funds and accounts managed by T. Rowe Price Associates, Inc. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Advance our lead candidate, FLX475, through clinical development to commercialization in &#147;charged&#148;
tumor types, which represent cancer types we believe are most likely to respond to FLX475.</B> We expect to rapidly evaluate FLX475&#146;s efficacy in multiple tumor types both as a single agent and in combination with other immuno-oncology agents
such as programmed cell death 1 (&#147;PD-1&#148;) checkpoint inhibitor. Our goal is to expeditiously progress into registration trials to ultimately enable treatment of cancer patients for whom current treatments are inadequate.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Enhance the impact of RPT193 by expanding development across multiple allergic diseases.</B> We are initially
developing RPT193 for AD because the characteristics of the disease present an opportunity to rapidly demonstrate RPT193&#146;s anti-inflammatory effect. We believe this anti-inflammatory effect, along with its convenient oral administration and
good preclinical safety profile, has potential clinical translatability in a variety of allergic diseases beyond AD. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Develop and advance a preclinical GCN2 inhibitor into clinical trials. </B>We view our preclinical programs as
important drivers of long-term growth and stability of our company. Our goal is to rapidly advance our programs to generate validating preclinical data that warrant clinical development. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Expand our pipeline by leveraging our proprietary drug discovery and development engine and small molecule
expertise.</B> We believe there are additional identifiable targets that will be important to fundamentally modulate the immune response in the treatment of cancer and inflammatory diseases. We will continue to invest in our proprietary drug
discovery and development engine and investigate several of our identified targets as well as generate additional target and drug candidates, including a future HPK1 drug candidate. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Utilize collaborations in support of our long-term goals.</B> We plan to selectively use collaborations and
partnerships as strategic tools to maximize the value of our drug candidates. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Associated with Our Business </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have performed preclinical studies in mouse models to examine the potential mechanism of action, toxicity and therapeutic activity of our
drug candidates. By the nature of such experiments, there is variability in the degree and ranges of results observed, and the statistical significance of the findings from each experiment. For specific details on how the studies were conducted,
ranges of results observed and statistical significance of the findings, see the section titled &#147;Business.&#148; Data from preclinical studies should always be interpreted with caution, as results in preclinical studies do not necessarily
predict the results in clinical studies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our business is subject to numerous risks and uncertainties, including those highlighted in the
section titled &#147;Risk Factors&#148; immediately following this prospectus summary. These risks include, among others, the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We are a clinical stage biopharmaceutical company with a history of losses. We expect to continue to incur
significant losses for the foreseeable future and may never achieve or maintain profitability, which could result in a decline in the market value of our common stock. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FLX475 and RPT193 are in clinical development, which may fail in development or suffer delays that materially and
adversely affect their commercial viability. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">


<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FLX475, RPT193 or an RPT-GCN2i or other future drug candidates may not demonstrate the safety and efficacy
necessary to support further development or commercial viability. </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may not be successful in our efforts to use and expand our proprietary drug discovery and development engine
to build a pipeline of drug candidates, and as an organization we have no history of successfully developing drugs. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we or others later identify undesirable side effects caused by FLX475 or RPT193, our ability to market and
derive revenue from the drug candidate could be compromised. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Even if we consummate this offering, we will need substantial additional funds to advance development of drug
candidates and our proprietary drug discovery and development engine, and we cannot guarantee that we will have sufficient funds available in the future to develop and commercialize our current or potential future drug candidates.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could
be delayed or otherwise adversely affected. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We face intense competition from entities that have developed or may develop drug candidates for the treatment of
the diseases that we are currently targeting or may target in the future. If these companies develop technologies or drug candidates more rapidly than we do, or if their technologies or drug candidates are more effective than our candidates, our
ability to develop and successfully commercialize drug candidates may be adversely affected. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If third parties on which we rely to conduct certain preclinical studies and clinical trials do not perform as
contractually required, fail to satisfy regulatory or legal requirements or miss expected deadlines, our development program could be delayed with material and adverse impacts on our business and financial condition. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may experience difficulties in managing our growth and expanding our operations. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">We may not be able to enter into collaborations or strategic transactions on acceptable terms, if at all, which
could adversely affect our ability to develop and commercialize current and potential future drug candidates, impact our cash position and increase our expenses. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">If we are unable to obtain, maintain, enforce or defend intellectual property rights related to our technology
and current or future drug candidates, or if our intellectual property rights are inadequate, we may not be able to compete effectively. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Clinical development includes a lengthy and expensive process with an uncertain outcome, and results of earlier
studies and trials may not be predictive of future trial results. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">An active trading market for our common stock may not develop. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Corporate Information </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We were
incorporated under the laws of the state of Delaware in March 2015 under the name FLX Bio, Inc. In April 2015, Flexus Biosciences, Inc. (&#147;Flexus&#148;) contributed and assigned to us the assets and rights relating primarily to its <FONT
STYLE="white-space:nowrap">fms-like</FONT> tyrosine kinase receptor 3, cyclin-dependent kinase 4/6 inhibitor and small molecule T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> cancer immunotherapy in exchange for shares of our
convertible preferred stock, which were </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
immediately distributed to the preferred stockholders of Flexus. In May 2019, we changed our name to RAPT Therapeutics, Inc.&nbsp;Our principal executive offices are located at 561&nbsp;Eccles
Avenue, South San Francisco, California 94080. Our telephone number is (650) <FONT STYLE="white-space:nowrap">489-9000.</FONT> Our website address is www.rapt.com. Information contained on, or that can be accessed through, our website is not
incorporated by reference into this prospectus, and you should not consider information contained on, or that can be accessed through, our website to be part of this prospectus or in deciding whether to purchase our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">RAPT, the RAPT logo and our other registered or common law trade names, trademarks or service marks appearing in this prospectus are the
property of RAPT Therapeutics, Inc. Trade names, trademarks and service marks of other companies appearing in this prospectus are the property of their respective owners. Solely for convenience, trademarks and trade names referred to in this
prospectus may appear without the &reg; or <SUP STYLE="font-size:85%; vertical-align:top">&#153;</SUP> symbols. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Implications of Being an Emerging
Growth Company </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As a company with less than $1.07&nbsp;billion in revenues during our last fiscal year, we qualify as an
&#147;emerging growth company&#148; as defined in the Jumpstart Our Business Startups Act (the &#147;JOBS Act&#148;), enacted in April 2012. An emerging growth company may take advantage of reduced reporting requirements that are otherwise
applicable to public companies. These provisions include, but are not limited to: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">not being required to comply for a certain period of time with the auditor attestation requirements of
Section&nbsp;404 of the Sarbanes-Oxley Act of 2002, as amended (the &#147;Sarbanes-Oxley Act&#148;); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reduced disclosure obligations regarding executive compensation in our periodic reports, proxy statements and
registration statements; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exemptions from the requirements of holding a stockholder advisory vote on executive compensation and any golden
parachute payments not previously approved. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have elected to take advantage of certain of the reduced disclosure
obligations in the registration statement of which this prospectus is a part and may elect to take advantage of other reduced reporting requirements in future filings. As a result, the information that we provide to our stockholders may be different
than you might receive from other public reporting companies in which you hold equity interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, pursuant to the JOBS Act,
as an &#147;emerging growth company&#148; we have elected to take advantage of an extended transition period for complying with new or revised accounting standards. As a result, we will not be subject to the same new or revised accounting standards
as other public companies that comply with the public company effective dates, including but not limited to the new lease accounting standard. This effectively permits us to delay adoption of certain accounting standards until those standards would
otherwise apply to private companies. As a result, our consolidated financial statements may not be comparable to the financial statements of issuers who are required to comply with the effective dates for new or revised accounting standards that
are applicable to public companies, which may make our common stock less attractive to investors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may take advantage of these
provisions until the last day of our fiscal year following the fifth anniversary of the date of the first sale of our common stock in this offering. However, if certain events occur prior to the end of such five-year period, including if (i)&nbsp;we
become a &#147;large accelerated filer,&#148; with at least $700&nbsp;million of equity securities held by <FONT STYLE="white-space:nowrap">non-affiliates;</FONT> (ii)&nbsp;our annual gross revenues exceed $1.07&nbsp;billion; or (iii)&nbsp;we issue
more than $1.0&nbsp;billion of <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt in any three-year period, we will cease to be an &#147;emerging growth company&#148; prior to the end of such five-year period. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>The Offering </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock offered by us </P></TD>
<TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Common stock to be outstanding after this offering </P></TD>
<TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Underwriters&#146; option to purchase additional shares of common stock </P></TD>
<TD>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Use of proceeds </P></TD>
<TD>We estimate that the net proceeds from the sale of our common stock in this offering will be approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (or approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if the underwriters exercise their over-allotment option in full), based on the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by us. </TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">We currently expect to use the net proceeds from this offering, together with our existing cash and cash equivalents, as follows: </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="40%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to fund the development
of FLX475 beyond PoC results from our Phase 1/2 clinical trial; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="40%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to fund the development
of RPT193 beyond our Phase 1 trial in healthy volunteers and patients with AD; and </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="40%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="right">&#149;</TD>
<TD WIDTH="2%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The remaining proceeds for continued development of our GCN2 and HPK1 programs, continued refinement of our
proprietary drug discovery and development engine, hiring of additional personnel, capital expenditures, costs of operating as a public company and other general corporate purposes. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR>
<TD WIDTH="38%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">See &#147;Use of Proceeds&#148; for additional information. </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Risk factors </P></TD>
<TD>See &#147;Risk Factors&#148; for additional information and a discussion of factors you should carefully consider before deciding to invest in our common stock. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Reserved share program </P></TD>
<TD>At our request, the underwriters have reserved up to 5% of the shares offered by this prospectus, for sale at the initial public offering price in a reserved share program, to our directors, officers, employees, consultants and related persons.
See Underwriting&#151;Reserved Shares.&#148; </TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR VALIGN="TOP">
<TD WIDTH="38%"> <P STYLE=" margin-top:0pt; margin-bottom:1pt; margin-left:2%; text-indent:-2%; font-size:10pt; font-family:Times New Roman">Proposed trading symbol on the Nasdaq Global Market </P></TD>
<TD>&#147;RAPT&#148; </TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The number of shares of our common stock that will be outstanding after this offering is
based on 18,279,943&nbsp;shares of our common stock (including shares of our convertible preferred stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) outstanding as of June&nbsp;30, 2019, and excludes: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,049,976 shares of our common stock issuable upon the exercise of options to purchase shares of our common stock
issued under our 2015 Stock Plan, as amended (&#147;2015 Plan&#148;), and outstanding as of June&nbsp;30, 2019, with a weighted-average exercise price of $6.11&nbsp;per share; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">63,652 shares of our common stock issuable upon the exercise of stock options granted after June&nbsp;30, 2019,
with an exercise price of $13.62 per share, and an additional 164,745&nbsp;shares of our common stock issuable upon the exercise of stock options granted after June&nbsp;30, 2019, with an exercise price equal to the public offering price set forth
on the cover page of this prospectus; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,481,819&nbsp;shares of our common stock reserved for future issuance under our 2019 Equity Incentive Plan
(&#147;2019 Plan&#148;) (including 617,194 shares of our common stock reserved for issuance as of July&nbsp;15, 2019, under our 2015 Plan that will be added to our 2019 Plan reserve upon its effectiveness), which includes an annual evergreen
increase and will become effective in connection with this offering; and </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">240,336 shares of our common stock reserved for future issuance under our 2019 Employee Stock Purchase Plan
(&#147;ESPP&#148;), which includes an annual evergreen increase and will become effective in connection with this offering. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, the information in this prospectus reflects and assumes the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, which is the midpoint of the estimated offering price range set forth on the cover page of this prospectus; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the one-for-six reverse stock split for our common stock and a proportional adjustment to the conversion ratio of
our convertible preferred stock effected on July 19, 2019; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise of the outstanding options described above; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">no exercise of the underwriters&#146; option to purchase up to an additional
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock to cover over-allotments; and </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the filing and effectiveness of our amended and restated certificate of incorporation in Delaware and the
adoption of our amended and restated bylaws, each of which will occur upon the closing of this offering. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Certain
existing stockholders have indicated an interest in purchasing up to approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of shares of our common stock in this offering at the initial public offering price.
However, because these indications of interest are not binding agreements or commitments to purchase, the underwriters may determine to sell more, less or no shares in this offering to any or all of these stockholders, or any or all of these
stockholders may determine to purchase more, less or no shares in this offering. The underwriters will receive the same underwriting discount on any shares purchased by these stockholders as they will on any other shares sold to the public in this
offering. Substantial purchases of common stock by existing stockholders could reduce the liquidity of the trading market for our common stock and increase price volatility. Based on the beneficial ownership of our capital stock as of
September&nbsp;15, 2019, our executive officers and directors, together with holders of 5% or more of our capital stock before this offering and their respective affiliates, will beneficially </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
own approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;% of our common stock immediately after the closing of this offering without giving effect to any additional purchases by these
holders in the offering and assuming no exercise of the underwriters option to purchase additional shares. Of this $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in indications of interest, approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; was received from our executive officers, directors and holders of 5% or more of our capital stock before this offering, and their respective affiliates, whose beneficial
ownership immediately after the closing of this offering would increase to &nbsp;&nbsp;&nbsp;&nbsp;% if these holders purchase the full amount for which they have expressed non-binding indications of interest, based on an assumed initial public
offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. </P>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Summary Consolidated Financial Data </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following tables set forth a summary of our historical consolidated financial data as of, and for the periods ended on, the dates
indicated. The consolidated statements of operations data for the fiscal years ended December&nbsp;31, 2017 and 2018, and the consolidated balance sheet data as of December&nbsp;31, 2017 and 2018, are derived from our audited consolidated financial
statements and related notes included elsewhere in this prospectus. The consolidated statements of operations data for the six months ended June&nbsp;30, 2018 and 2019 and the consolidated balance sheet data as of June&nbsp;30, 2019 are derived from
our unaudited condensed consolidated financial statements and related notes included elsewhere in this prospectus. You should read this data together with our consolidated financial statements and related notes appearing elsewhere in this prospectus
and the information in &#147;Selected Consolidated Financial Data&#148; and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations.&#148; Our historical results are not necessarily indicative of the results
to be expected in the future, and the results for the six months ended June&nbsp;30, 2019 are not necessarily indicative of the results to be expected for the full year or any other period. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year
ended<BR>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;December&nbsp;31,&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Six Months
Ended<BR>June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating costs and expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 31,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 14,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">36,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and
diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">67.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">58.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average number of shares used in computing net loss per share, basic and diluted</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">431,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">574,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and
diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average number of shares used in computing pro forma net loss per share, basic and
diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,461,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,328,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<div style ="BORDER-BOTTOM:1.00pt solid #000000;BORDER-LEFT:1.00pt solid #000000;BORDER-RIGHT:1.00pt solid #000000;BORDER-TOP:1.00pt solid #000000;MARGIN-LEFT:0px; MARGIN-RIGHT:0px;max-width:100%"><div style="width:97%; margin-top:1.5%; margin-left:1.5%; margin-right:-1.25%">

 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:16%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note&nbsp;13 to our audited consolidated financial statements and Note&nbsp;11 to our unaudited interim
condensed consolidated financial statements for an explanation of the method used to calculate historical and pro forma basic and diluted net loss per share. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>As of June&nbsp;30, 2019</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Actual</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Pro<BR>Forma<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Pro Forma<BR>as<BR>Adjusted<SUP
STYLE="font-size:85%; vertical-align:top">(2)(3)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="10" ALIGN="center"><B>(in thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(115,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,006</TD>
<TD NOWRAP VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;margin-left:8%;border-bottom:1px solid #000000; width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The pro forma column in the consolidated balance sheet data above gives effect to the automatic conversion of
all outstanding shares of our convertible preferred stock into an aggregate of 17,467,184 shares of common stock as of June&nbsp;30, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The pro forma as adjusted column gives effect to the adjustment described in footnote (1)&nbsp;above and the
receipt of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; in net proceeds from the sale by us of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock in this offering at an
assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after deducting
underwriting discounts and commissions and estimated offering expenses payable by us. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each $1.00 increase (decrease) in the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common stock, the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as
adjusted amount of each of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit) equity by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming that the number of
shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. We may also increase (decrease) the number
of shares we are offering. An increase (decrease) of 1,000,000 shares in the number of shares offered by us would increase (decrease) the amount of cash and cash equivalents, working capital, total assets and total stockholders&#146; (deficit)
equity by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming the assumed initial public offering price per share, as set forth on the cover page of this prospectus, remains the same. The pro forma as
adjusted information above is illustrative only and will change based on the actual initial public offering price and other terms of this offering determined at pricing. </P></TD></TR></TABLE>
</div><br clear="All"></div><br clear="All">

 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_2"></A>RISK FACTORS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Investing in our common stock involves a high degree of risk. You should consider and read carefully all of the risks and uncertainties
described below, as well as other information included in this prospectus, including our consolidated financial statements and related notes appearing at the end of this prospectus and our &#147;Management&#146;s Discussion and Analysis of Financial
Conditions and Results of Operations,&#148; before making an investment decision. The risks described below are not the only ones facing us. The occurrence of any of the following risks or additional risks and uncertainties not presently known to us
or that we currently believe to be immaterial could materially and adversely affect our business, financial condition or results of operations. In such case, the trading price of our common stock could decline, and you may lose all or part of your
original investment. This prospectus also contains forward-looking statements and estimates that involve risks and uncertainties. Our actual results could differ materially from those anticipated in the forward-looking statements as a result of a
number of specific factors, including the risks and uncertainties described below. </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Business </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are a clinical stage biopharmaceutical company with a history of losses. We expect to continue to incur significant losses for the foreseeable future
and may never achieve or maintain profitability, which could result in a decline in the market value of our common stock. </I></B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We
are a clinical stage biopharmaceutical company with a history of losses. Since our inception, we have devoted substantially all of our resources to research and development, including our drug discovery and development engine, preclinical studies,
clinical trials, raising capital, building our management team and our intellectual property portfolio. Our net loss was $19.8&nbsp;million and $36.1&nbsp;million for the six months ended June&nbsp;30, 2019 and for the year ended December&nbsp;31,
2018, respectively. As of June&nbsp;30, 2019, we had an accumulated deficit of $138.8&nbsp;million. Substantially all of our losses have resulted from expenses incurred in connection with our research and development programs and from general and
administrative costs associated with our operations. To date, we have not generated any revenue. Furthermore, we do not expect to generate any revenue from product sales for the foreseeable future, and we expect to continue to incur significant
operating losses for the foreseeable future due to the cost of research and development, preclinical studies, clinical trials and the regulatory approval process for our current and potential future drug candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect our net losses to increase substantially as we advance the clinical development of our lead drug candidates, FLX475 and RPT193.
However, the amount of our future losses is uncertain. Our ability to generate revenue from product sales and achieve or sustain profitability, if ever, will depend on, among other things, successfully developing drug candidates, obtaining
regulatory approvals to market and commercialize drug candidates, manufacturing any approved products on commercially reasonable terms, entering into any future collaborations or other partnerships, establishing a sales and marketing organization or
suitable third-party alternatives for any approved product and raising sufficient capital to finance our operations. If we, or any of our future partners, are unable to develop and commercialize one or more of our drug candidates, or if sales
revenue from any drug candidate that receives regulatory approval is insufficient, we will not achieve or sustain profitability, which would have a material and adverse effect on our business, financial condition, results of operations and
prospects. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>FLX475 and RPT193 are in clinical development, which may fail or suffer delays that materially and adversely affect their commercial
viability. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have no products on the market or that have gained regulatory approval. Other than FLX475 and RPT193, none of our
drug candidates has ever been tested in humans. None of our drug candidates has advanced into late-stage development or a pivotal clinical trial and it may be years before any such trial is initiated, if at all. Our ability to achieve and sustain
profitability depends on us developing, obtaining regulatory approval for and successfully commercializing one or more drug candidates, either alone or with partners. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Before obtaining regulatory approval for any of our drug candidates, we must conduct
extensive preclinical studies and clinical trials to demonstrate the safety and efficacy of our drug candidates in humans. Although we have successfully completed preclinical studies and a Phase 1 clinical trial with healthy volunteers for FLX475,
and are conducting a Phase 1/2 clinical trial investigating FLX475 as a single agent and in combination with pembrolizumab in a broad range of tumors, and have initiated a seamless Phase&nbsp;1 trial of RPT193 comprised initially of Phase&nbsp;1a
single and multiple dose escalation cohorts of healthy volunteers, more clinical trials are needed and there is no guarantee that the FDA will permit us to conduct additional clinical trials for FLX475, RPT193 or any other potential drug candidates.
Further, we cannot be certain of the timely completion or outcome of our clinical trials and cannot predict if the FDA or other regulatory authorities will accept our proposed clinical programs, or if the outcome of our preclinical studies or
clinical trials will ultimately support the further development of FLX475, RPT193 or any other potential drug candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">FLX475 and
RPT193 are in clinical development, and we are subject to the risks of failure inherent in the development of drug candidates based on novel approaches, targets and mechanisms of action. Although FLX475 is currently in a Phase 1/2 clinical trial,
there is no guarantee that FLX475 will benefit patients. In the ongoing Phase 1/2 clinical trial of FLX475, a partial response has been observed in one NSCLC patient in the 50 mg FLX475 and pembrolizumab cohort. It is possible that no response will
be observed in other patients or that the observed partial response was caused solely by the pembrolizumab administered to the patient, and not by FLX475, or that the partial response was spontaneous, and unrelated to either FLX475 or pembrolizumab.
Additionally, although RPT193 has shown activity in several preclinical models, and we have initiated a seamless Phase&nbsp;1 trial of RPT193 comprised initially of Phase&nbsp;1a single and multiple dose escalation cohorts of healthy volunteers,
there is no guarantee that we will be able to proceed with its clinical development or that it will benefit patients. Even though we have designed and selected our drug candidates to achieve an intended biological effect and to avoid certain others,
and even if we have demonstrated this effect in preclinical models, there can be no assurance that the effect will be observed or avoided, as the case may be, in clinical trials or that the drug candidate will offer any significant clinical benefit
to humans. Results in preclinical studies do not necessarily predict the results of clinical studies. Additionally, even though our drug candidates are designed to address the same indications as existing drugs and therapies, we have not conducted
head-to-head clinical trials comparing our drug candidates with such existing drugs and therapies. Accordingly, you should consider our prospects in light of the costs, uncertainties, delays and difficulties frequently encountered by clinical and
preclinical stage biopharmaceutical companies such as ours. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">FLX475 is currently undergoing clinical development and testing as a
single agent and in combination with pembrolizumab, which is supplied to us by Merck under our collaboration agreement with Merck.&nbsp;If Merck were to terminate our collaboration agreement, we may be forced to purchase pembrolizumab to continue
our current and planned clinical trials or to pursue another <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> therapy for <FONT STYLE="white-space:nowrap">co-administration</FONT> with FLX475 in place of
pembrolizumab, which may require us to restart preclinical studies or clinical trials, any of which could result in a change to our business plan and materially harm our business, financial condition, results of operations and prospects. In
addition, if FLX475 is approved as a treatment in combination with pembrolizumab, then the availability of pembrolizumab for administration with FLX475 will affect our ability to commercialize FLX475. For example, if supply of pembrolizumab were
constrained for any reason it could have the effect of limiting the commercial uptake of FLX475, if approved for commercial sale. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may
not have the financial resources to continue development of, or to enter into new collaborations for, FLX475 and RPT193 or any potential future drug candidates. Our position may be exacerbated if we experience any issues that delay or prevent
regulatory approval of, or our ability to commercialize, a drug candidate, such as: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">negative or inconclusive results from our clinical trials or the clinical trials of others for drug candidates
similar to ours, leading to a decision or requirement to conduct additional preclinical studies or clinical trials or abandon a program; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product-related side effects experienced by participants in our clinical trials or by individuals using drugs or
therapeutics similar to ours; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in submitting INDs or comparable foreign applications, or delays or failure in obtaining the necessary
approvals from regulators to commence a clinical trial, or a suspension or termination of a clinical trial once commenced; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">conditions imposed by the FDA, or other regulatory authorities regarding the scope or design of our clinical
trials; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays in enrolling research subjects in clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">high <FONT STYLE="white-space:nowrap">drop-out</FONT> rates of research subjects; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">inadequate supply or quality of drug candidate components or materials or other supplies necessary for the
conduct of our clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">greater-than-anticipated clinical trial costs; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">poor effectiveness of our drug candidates during clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unfavorable FDA or other regulatory agency inspection and review of a clinical trial or manufacturing site;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure of our third-party contractors or investigators to comply with regulatory requirements or otherwise meet
their contractual obligations in a timely manner, or at all; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delays and changes in regulatory requirements, policies and guidelines; or </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or other regulatory agencies&#146; data interpretation. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Further, we and our potential future partners may never receive approval to market and commercialize any drug candidate. Even if we or a
potential future partner obtains regulatory approval, the approval may be for targets, disease indications or patient populations that are not as broad as we intended or desired or may require labeling that includes significant use or distribution
restrictions or safety warnings. We or a potential future partner may be subject to post-marketing testing requirements to maintain regulatory approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>FLX475, RPT193 or an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> or other future drug candidates may not demonstrate the safety and efficacy
necessary to support further clinical development or commercial viability. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have completed a Phase 1 clinical trial with
healthy volunteers for FLX475 and are conducting a Phase 1/2 clinical trial investigating FLX475 as a single agent and in combination with pembrolizumab. In addition, we have initiated a seamless Phase 1 trial of RPT193 comprised initially of Phase
1a single and multiple dose escalation cohorts of healthy volunteers in August 2019. An <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> candidate has never been tested in humans. We may ultimately discover that neither FLX475, RPT193 nor an <FONT
STYLE="white-space:nowrap">RPT-GCN2i</FONT> candidate possesses certain properties that we currently believe are therapeutically effective or safe. For example, although RPT193 has exhibited encouraging results in preclinical models of AD and
allergic asthma, it may not demonstrate the same properties in humans and may interact with human biological systems in unforeseen, ineffective or harmful ways. As a result, we may never succeed in developing a marketable product based on RPT193. If
FLX475, RPT193 or any of our potential future drug candidates prove to be ineffective, unsafe or commercially unviable, our entire pipeline could have little, if any, value, which could require us to change our focus and approach to small molecule
discovery and development, which would have a material and adverse effect on our business, financial condition, results of operations and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful in our efforts to use and expand our proprietary drug discovery and
development engine to build a pipeline of drug candidates, and as an organization we have no history of successfully developing drugs. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">A key element of our strategy is to use and expand our proprietary drug discovery and development engine to build a pipeline of potential drug
candidates and advance these drug candidates through preclinical studies and clinical development for the treatment of various diseases. As an organization, we have never developed a drug candidate through to commercialization nor have we ever
conducted a pivotal clinical trial. Although our research and development efforts to date have resulted in our identification and development of FLX475, RPT193 and other potential future drug candidates, neither our proprietary drug discovery and
development engine nor our organization has a track record of success. Our current drug candidates may not be safe or effective therapeutics and we may not be able to develop any successful drug candidates. Our proprietary drug discovery and
development engine is evolving and may not reach a state at which building a pipeline of drug candidates is possible. Even if we are successful in building our pipeline of drug candidates, the potential drug candidates that we identify may not be
suitable for clinical development or generate acceptable clinical data, including unacceptable toxicity or other characteristics that indicate that the drug candidates are unlikely to be products that will receive marketing approval from the FDA or
other regulatory authorities or achieve market acceptance. Even if the drug candidates we identify are suitable for clinical development, our lack of experience as an organization at developing drugs may cause us to fail in successfully developing
the drug candidate through to commercialization. If we do not successfully develop and commercialize drug candidates, we will not be able to generate product revenue in the future. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Failure to successfully validate, develop and obtain regulatory approval for companion diagnostics for our drug candidates could harm our drug
development strategy and operational results. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As one of the elements of our clinical development approach, we may seek to screen
and identify subsets of patients who are more likely to benefit from our drug candidates. To achieve this, we may seek to develop and commercialize companion diagnostics by us or by third-party collaborators. Companion diagnostics are sometimes
developed in conjunction with clinical programs for an associated product. The approval of a companion diagnostic as part of the product label would limit the use of the drug candidate to those patients who are more likely to benefit from our drug
candidate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Companion diagnostics are subject to regulation by the FDA and other regulatory authorities as medical devices and require
separate clearance or approval prior to their commercialization. To date, the FDA has required premarket approval of all companion diagnostics for oncology therapies. We may encounter difficulties in developing and obtaining approval for these
companion diagnostics. Any delay or failure by us or third-party collaborators to develop or obtain regulatory approval of a companion diagnostic could delay or prevent approval of our related drug candidates. The time and cost associated with
developing a companion diagnostic may not prove to have been necessary in order to successfully market the product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>The market may not be receptive
to our current or potential future drug candidates, and we may not generate any revenue from the sale or licensing of our drug candidates. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Even if regulatory approval is obtained for a drug candidate, including FLX475 or RPT193, we may not generate or sustain revenue from sales of
such products. Market acceptance of our current and potential future drug candidates will depend on, among other factors: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing of our receipt of any marketing and commercialization approvals; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the terms of any approvals and the countries in which approvals are obtained; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the safety and efficacy of our drug candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the prevalence and severity of any adverse side effects associated with our drug candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limitations or warnings contained in any labeling approved by the FDA or other regulatory authority;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">relative convenience and ease of administration of our drug candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which physicians recommend our products to their patients; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of coverage and adequate government and third-party payor reimbursement; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the pricing of our products, particularly as compared to alternative treatments; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the availability of alternative effective treatments for the disease indications our drug candidates are intended
to treat and the relative risks, benefits and costs of those treatments. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If any drug candidate we commercialize fails
to achieve market acceptance, it could have a material and adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful in our efforts to expand indications for approved drug candidates </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Part of our drug development strategy is to clinically test and seek regulatory approval for our drug candidates in indications in which we
believe there is the most evidence that we will be able to quickly generate PoC data. We then intend to expand clinical testing and seek regulatory approvals in other indications within oncology and inflammatory diseases. Conducting clinical trials
for additional indications for our drug candidates requires substantial technical, financial and human resources and is prone to the risks of failure inherent in drug development. We cannot provide you any assurance that we will be successful in our
effort to obtain regulatory approval for our drug candidates for additional indications even if we obtain approval for an initial indication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we
or others later identify undesirable side effects caused by FLX475 or RPT193, our ability to market and derive revenue from the drug candidate could be compromised. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Undesirable side effects caused by FLX475, RPT193 or any other potential future drug candidate could cause regulatory authorities to
interrupt, delay or halt clinical trials and could result in a more restrictive label or the delay or denial of regulatory approval by the FDA or other regulatory authorities. While we have not discovered any adverse side effects of FLX475 or RPT193
in healthy subjects that have limited our ability to test FLX475 or RPT193 in humans, and only initiated clinical trials for RPT193 in healthy volunteers in August 2019 and have not yet initiated clinical trials of an
<FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> candidate, it is possible that there will be undesirable side effects associated with their use. Results of our clinical trials could reveal a high and unacceptable severity and prevalence of these
side effects. In such an event, our trials could be suspended or terminated, and the FDA or other regulatory authorities could order us to cease further development of or deny approval of a drug candidate for any or all targeted indications. Such
side effects could also affect patient recruitment or the ability of enrolled patients to complete the trial or result in potential product liability claims. Any of these occurrences may materially and adversely affect our business and financial
condition and impair our ability to generate revenues. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Further, clinical trials by their nature utilize a sample of the potential
patient population. With a limited number of patients and limited duration of exposure, rare and severe side effects of a drug candidate may only be uncovered when a significantly larger number of patients are exposed to the drug candidate or when
patients are exposed for a longer period of time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If any of our current or potential future drug candidates receive regulatory approval
and we or others identify undesirable side effects caused by one of these products, any of the following adverse events could </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
occur, which could result in the loss of significant revenue to us and materially and adversely affect our results of operations and business: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may withdraw their approval of the product or seize the product; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be required to recall the product or change the way the product is administered to patients;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additional restrictions may be imposed on the marketing of the particular product or the manufacturing processes
for the product or any component thereof; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be subject to fines, injunctions or the imposition of civil or criminal penalties; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory authorities may require the addition of labeling statements, such as a &#147;black box&#148; warning
or a contraindication; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may be required to create a Medication Guide outlining the risks of such side effects for distribution to
patients; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we could be sued and held liable for harm caused to patients; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the product may become less competitive; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our reputation may suffer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if we consummate this offering, we will need substantial additional funds to advance development of drug candidates and our drug discovery and
development engine, and we cannot guarantee that we will have sufficient funds available in the future to develop and commercialize our current or potential future drug candidates. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Since our inception, we have used substantial amounts of cash to fund our operations and expect our expenses to increase substantially in the
foreseeable future. Developing our drug candidates and conducting clinical trials for the treatment of cancer and any other indications which we may pursue in the future will require substantial amounts of capital. We will also require a significant
additional amount of capital to commercialize any approved products. Accordingly, we expect our expenses to increase in connection with our ongoing activities, particularly as we continue the research and development of, initiate clinical trials of,
and seek marketing approval for, our drug candidates. In addition, if we obtain marketing approval for any of our drug candidates, we expect to incur significant commercialization expenses related to product sales, marketing, manufacturing and
distribution. Furthermore, upon the closing of this offering, we expect to incur additional costs associated with operating as a public company. Accordingly, we will need to obtain substantial additional funding in connection with our continuing
operations. If we are unable to raise capital when needed or on attractive terms, we would be forced to delay, reduce or eliminate our research and development programs or future commercialization efforts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Based on current business plans and assuming no financing, we believe that our existing cash and cash equivalents will be not be sufficient to
fund our cash requirements through at least October 31, 2020, and therefore, we believe there is substantial doubt about our ability to continue as a going concern. We have based this estimate on assumptions that may prove to be incorrect or require
adjustment as a result of business decisions, and we could utilize our available capital resources sooner than we currently expect. The timing and amount of our operating expenditures will depend largely on: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and progress of preclinical and clinical development activities; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the timing and progress of our advancement of our drug discovery and development engine; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the price and pricing structure that we are able to obtain from our third-party contract manufacturers to
manufacture our preclinical study and clinical trial materials and supplies; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and scope of preclinical and clinical programs we decide to pursue; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to maintain our current licenses, collaboration and research and development programs, including the
continued agreement of Merck to supply pembrolizumab to us for use in our clinical trials; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to establish new collaborations; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the progress of the development efforts of parties with whom we may in the future enter into collaboration and
research and development agreements; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs involved in obtaining, maintaining, enforcing and defending patents and other intellectual property
rights; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost and timing of regulatory approvals; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our efforts to enhance operational systems, secure sufficient laboratory space and hire additional personnel,
including personnel to support development of our drug candidates and satisfy our obligations as a public company. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">To
date, we have primarily financed our operations through the sale of equity securities. We may seek to raise any necessary additional capital through a combination of public or private equity offerings, debt financings, collaborations, strategic
alliances, licensing arrangements and other marketing and distribution arrangements. We cannot assure you that we will be successful in acquiring additional funding at levels sufficient to fund our operations or on terms favorable to us. If we are
unable to obtain adequate financing when needed, we may have to delay, reduce the scope of or suspend one or more of our preclinical studies, clinical trials, research and development programs or commercialization efforts. To the extent that we
raise additional capital through collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable rights to our current and potential future drug candidates, future revenue streams or research
programs or to grant licenses on terms that may not be favorable to us. If we do raise additional capital through public or private equity or convertible debt offerings, the ownership interest of our existing stockholders will be diluted and the
terms of these securities may include liquidation preferences or other rights that adversely affect our and our stockholders&#146; rights. If we raise additional capital through debt financing, we may be subject to covenants limiting or restricting
our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We do not
expect to realize revenue from product sales in the foreseeable future, if at all, and unless and until our current and potential future drug candidates are clinically tested, approved for commercialization and successfully marketed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may expend our limited resources to pursue a particular drug candidate and fail to capitalize on drug candidates that may be more profitable or for
which there is a greater likelihood of success. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Because we have limited financial and managerial resources, we intend to
prioritize our efforts on specific research and development programs, including clinical development of FLX475, RPT193 and an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> or other future drug candidates. As a result, we may forgo or delay
pursuit of other opportunities, including with potential future drug candidates that later prove to have greater commercial potential. Our resource allocation decisions may cause us to fail to capitalize on viable commercial products or profitable
market opportunities. Our spending on current and future research and development programs and drug </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
candidates for specific indications may not yield any commercially viable drug candidates. If we do not accurately evaluate the commercial potential or target market for a particular drug
candidate, we may relinquish valuable rights to that drug candidate through partnership, licensing or other royalty arrangements in cases in which it would have been more advantageous for us to retain sole development and commercialization rights to
such drug candidate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to enter into collaborations or strategic transactions on acceptable terms, if at all, which could
adversely affect our ability to develop and commercialize current and potential future drug candidates, impact our cash position and increase our expense. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">From time to time, we may consider strategic transactions, such as collaborations, acquisitions of companies, asset purchases, joint ventures
and <FONT STYLE="white-space:nowrap">out-</FONT> or <FONT STYLE="white-space:nowrap">in-licensing</FONT> of drug candidates or technologies. For example, we will evaluate and, if strategically attractive, seek to enter into collaborations, including
with biotechnology or pharmaceutical companies, hospitals or other third parties. The competition for partners is intense, and the negotiation process may be time-consuming and complex. If we are not able to enter into collaborations or other
strategic transactions, or continue our existing collaboration, we may not have access to required liquidity or expertise to further develop our potential future drug candidates or our drug discovery and development engine. Any such collaboration,
or other strategic transaction, may require us to incur <FONT STYLE="white-space:nowrap">non-recurring</FONT> or other charges, increase our near- and long-term expenditures and pose significant integration or implementation challenges or disrupt
our management or business. We may acquire additional technologies and assets, form strategic alliances or create joint ventures with third parties that we believe will complement or augment our existing business, but we may not be able to realize
the benefit of acquiring such assets. Conversely, any new collaboration that we do enter into may be on terms that are not optimal for us. These transactions would entail numerous operational and financial risks, including: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">exposure to unknown liabilities; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">disruption of our business and diversion of our management&#146;s time and attention in order to manage a
collaboration or develop acquired products, drug candidates or technologies; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">incurrence of substantial debt or dilutive issuances of equity securities to pay transaction consideration or
costs; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">higher-than-expected collaboration, acquisition or integration costs, write-downs of assets or goodwill or
impairment charges, increased amortization expenses; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulty and cost in facilitating the collaboration or combining the operations and personnel of any acquired
business; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">impairment of relationships with key suppliers, manufacturers or customers of any acquired business due to
changes in management and ownership; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the inability to retain key employees of any acquired business. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Accordingly, although there can be no assurance that we will undertake or successfully complete any collaborations or other strategic
transactions of the nature described above, any transactions that we do complete may be subject to the foregoing or other risks and our business could be materially harmed by such transactions. Conversely, any failure to enter any collaboration or
other strategic transaction that would be beneficial to us could delay the development and potential commercialization of our drug candidates and have a negative impact on the competitiveness of any drug candidate that reaches market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, to the extent that any of our current or future partners were to terminate a collaboration agreement, we may be forced to seek
additional partnerships, which may be less favorable to us, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
independently develop our current and future drug candidates, including funding preclinical studies or clinical trials, assuming marketing and distribution costs and obtaining, maintaining,
enforcing and defending intellectual property rights, or, in certain instances, abandon drug candidates altogether, any of which could result in a change to our business plan and materially harm our business, financial condition, results of
operations and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If third parties on which we rely to conduct certain preclinical studies and clinical trials do not perform as
contractually required, fail to satisfy regulatory or legal requirements or miss expected deadlines, our development program could be delayed with material and adverse impacts on our business and financial condition. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We rely on third-party clinical investigators, contract research organizations (&#147;CROs&#148;), clinical data management organizations and
consultants to design, conduct, supervise and monitor certain preclinical studies and any clinical trials. Because we intend to rely on these third parties and will not have the ability to conduct certain preclinical studies or clinical trials
independently, we will have less control over the timing, quality and other aspects of such preclinical studies and clinical trials than if we would have had we conducted them on our own. These investigators, CROs and consultants will not be our
employees and we will have limited control over the amount of time and resources that they dedicate to our programs. These third parties may have contractual relationships with other entities, some of which may be our competitors, which may draw
time and resources from our programs. The third parties with which we may contract might not be diligent, careful or timely in conducting our preclinical studies or clinical trials, resulting in the preclinical studies or clinical trials being
delayed or unsuccessful. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If we cannot contract with acceptable third parties on commercially reasonable terms, or at all, or if these
third parties do not carry out their contractual duties, satisfy legal and regulatory requirements for the conduct of preclinical studies or clinical trials or meet expected deadlines, our clinical development programs could be delayed and otherwise
adversely affected. In all events, we will be responsible for ensuring that each of our preclinical studies and clinical trials are conducted in accordance with the general investigational plan and protocols for the trial. The FDA may require
preclinical studies to be conducted in accordance with good laboratory practices and clinical trials to be conducted in accordance with good clinical practices, including for designing, conducting, recording and reporting the results of preclinical
studies and clinical trials to ensure that data and reported results are credible and accurate and that the rights, integrity and confidentiality of clinical trial participants are protected. Our reliance on third parties that we do not control will
not relieve us of these responsibilities and requirements. Any adverse development or delay in our clinical trials could have a material and adverse impact on our commercial prospects and may impair our ability to generate revenue. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we encounter difficulties enrolling patients in our clinical trials, our clinical development activities could be delayed or otherwise adversely
affected. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may not be able to initiate or continue clinical trials for our current or potential future drug candidates if we
are unable to locate and enroll a sufficient number of eligible patients to participate in these trials as required by the FDA or other regulatory authorities. In particular, we are conducting a Phase 1/2 clinical trial investigating FLX475 as a
single agent and in combination with pembrolizumab in a broad range of tumors. We cannot predict how difficult it will be to enroll patients for trials in these indications. We may experience difficulties in patient enrollment in our clinical trials
for a variety of reasons. The enrollment of patients depends on many factors, including: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the severity of the disease under investigation; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patient eligibility criteria defined in the clinical trial protocol; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the size of the patient population required for analysis of the trial&#146;s primary endpoints;
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the proximity and availability of clinical trial sites for prospective patients; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patient referral practices of physicians; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to recruit clinical trial investigators with the appropriate competencies and experience;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinicians&#146; and patients&#146; perceptions as to the potential advantages of the drug candidate being
studied in relation to other available therapies, including any new drugs that may be approved for the indications we are investigating; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain and maintain patient consents; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the risk that patients enrolled in clinical trials will drop out of the trials before completion.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, our future clinical trials will compete with other clinical trials for drug candidates that are in the
same therapeutic areas as our drug candidates, and this competition will reduce the number and types of patients available to us, because some patients who might have opted to enroll in our trials may instead opt to enroll in a trial being conducted
by one of our competitors. Since the number of qualified clinical investigators is limited, we expect to conduct some of our clinical trials at the same clinical trial sites that some of our competitors use, which will reduce the number of patients
who are available for our clinical trials at such clinical trial sites. Additionally, because some of our clinical trials will be conducted in patients with advanced solid tumors, the patients are typically in the late stages of the disease and may
experience disease progression or adverse events independent from our drug candidates, making them unevaluable for purposes of the trial and requiring additional enrollment. Delays in patient enrollment may result in increased costs or may affect
the timing or outcome of the planned clinical trials, which could prevent completion of these trials and adversely affect our ability to advance the development of our drug candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to conduct, or contract others to conduct, animal testing in the future, which could harm our research and development activities.
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Certain laws and regulations relating to drug development require us to test our drug candidates on animals before initiating
clinical trials involving humans. Animal testing activities have been the subject of controversy and adverse publicity. Animal rights groups and other organizations and individuals have attempted to stop animal testing activities by pressing for
legislation and regulation in these areas and by disrupting these activities through protests and other means. To the extent the activities of these groups are successful, our research and development activities may be interrupted or delayed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because we may rely on third parties for manufacturing and supply of our drug candidates, some of which are or may be sole source vendors, for
preclinical and clinical development materials and commercial supplies, our supply may become limited or interrupted or may not be of satisfactory quantity or quality. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We currently rely on third-party contract manufacturers for our current and future clinical trial product materials and supplies. We do not
produce any meaningful quantity of our drug candidates for clinical development, and we do not currently own manufacturing facilities for producing such supplies. Furthermore, some of our manufacturers represent our sole source of supplies of
current and future clinical development materials, including our source for the manufacture of FLX475 and RPT193. We cannot assure you that our preclinical or current or future clinical development product supplies and commercial supplies will not
be limited or interrupted, especially with respect to our sole source third-party manufacturing and supply partners, or will be of satisfactory quality or continue to be available at acceptable prices. In particular, any replacement of our
manufacturers could require significant effort and expertise because there may be a limited number of qualified replacements. For our current and future sole source third-party manufacturing and supply partners, we may be unable to negotiate binding
agreements with them or find replacement manufacturers to support our preclinical </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and current and future clinical activities at commercially reasonable terms in the event that their services to us becomes interrupted for any reason. We do not always have arrangements in place
for a redundant or second-source supply for our sole source vendors in the event they cease to provide their products or services to us or do not timely provide sufficient quantities to us. Establishing additional or replacement sole source vendors,
if required, may not be accomplished quickly. Any delays resulting from manufacturing or supply interruptions associated with our reliance on third-party manufacturing and supply partners, including those that are sole source, could impede, delay,
limit or prevent our drug development efforts, which could harm our business, result of operations, financial condition and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The manufacturing process for a drug candidate is subject to FDA and other regulatory authority review. Suppliers and manufacturers must meet
applicable manufacturing requirements and undergo rigorous facility and process validation tests required by regulatory authorities in order to comply with regulatory standards, such as current Good Manufacturing Practices (&#147;cGMP&#148;). If any
of our manufacturers fails to comply with such requirements or to perform its obligations to us in relation to quality, timing or otherwise, or if our supply of components or other materials becomes limited or interrupted for other reasons, we may
be forced to manufacture the materials ourselves, for which we currently do not have the capabilities or resources, or enter into an agreement with another third party, which we may not be able to do on reasonable terms, or at all. In some cases,
the technical skills or technology required to manufacture our current and future drug candidates may be unique or proprietary to the original manufacturer and we may have difficulty transferring such skills or technology to another third party and
a feasible alternative may not exist. These factors would increase our reliance on such manufacturer or require us to obtain a license from such manufacturer in order to have another third-party manufacture our drug candidates. If we are required to
change manufacturers for any reason, we will be required to verify that the new manufacturer maintains facilities and procedures that comply with quality standards and with all applicable regulations and guidelines. The delays associated with the
verification of a new manufacturer could negatively affect our ability to develop drug candidates in a timely manner or within budget. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We
also expect to rely on third-party manufacturers if we receive regulatory approval for any drug candidate. We have existing, and may enter into future, manufacturing arrangements with third parties. We will depend on these third parties to perform
their obligations in a timely manner consistent with contractual and regulatory requirements, including those related to quality control and assurance. If we are unable to obtain or maintain third-party manufacturing for any drug candidate, or to do
so on commercially reasonable terms, we may not be able to develop and commercialize our drug candidates successfully. Our or a third party&#146;s failure to execute on our manufacturing requirements and comply with cGMP could adversely affect our
business in a number of ways, including: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an inability to initiate or continue clinical trials of drug candidates under development; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">delay in submitting regulatory applications, or receiving regulatory approvals, for drug candidates;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">loss of the cooperation of a potential future partner; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">subjecting third-party manufacturing facilities or our potential future manufacturing facilities to additional
inspections by regulatory authorities; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">requirements to cease distribution or to recall batches of drug candidates; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">in the event of approval to market and commercialize a drug candidate, an inability to meet commercial demands
for our products. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our third-party manufacturers may be unable to successfully scale manufacturing of FLX475, RPT193 or
potential future drug candidates in sufficient quality and quantity, which would delay or prevent us from developing drug candidates and commercializing approved products, if any. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In order to conduct further clinical trials for FLX475 and RPT193 as well as any potential future drug candidates, we will need to manufacture
large quantities of these drug candidates. We may continue to use third parties for our manufacturing needs. Our manufacturing partners may be unable to successfully increase the manufacturing capacity for any current or potential future drug
candidate in a timely or cost-effective manner, or at all. In addition, quality issues may arise during <FONT STYLE="white-space:nowrap">scale-up</FONT> activities. If our manufacturing partners are unable to successfully scale the manufacture of
any current or potential future drug candidate in sufficient quality and quantity, the development, testing and clinical trials of that drug candidate may be delayed or infeasible, and regulatory approval or commercial launch of any potential
resulting product may be delayed or not obtained, which could significantly harm our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If the market opportunities for our current and
potential future drug candidates, including FLX475 and RPT193, are smaller than we believe they are, our ability to generate product revenues may be adversely affected and our business may suffer. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our understanding of the number of people who suffer from certain types of cancers and allergic inflammatory diseases that FLX475 and RPT193,
respectively, may have the potential to treat is based on estimates. These estimates may prove to be incorrect, and new studies may demonstrate or suggest a lower estimated incidence or prevalence of these diseases. The number of patients in the
United States or elsewhere may turn out to be lower than expected, may not be otherwise amenable to treatment with our current or potential future drug candidates or patients may become increasingly difficult to identify and access, all of which
would adversely affect our business prospects and financial condition. In particular, the treatable population for our candidates may further be reduced if our estimates of addressable populations are erroneous or
<FONT STYLE="white-space:nowrap">sub-populations</FONT> of patients do not derive benefit from FLX475 or RPT193. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Further, there are
several factors that could contribute to making the actual number of patients who receive our current or potential future drug candidates less than the potentially addressable market, including the lack of widespread limited reimbursement for new
therapies in many markets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We face intense competition from entities that have developed or may develop drug candidates for the treatment of the
diseases that we are currently targeting or may target in the future. If these companies develop technologies or drug candidates more rapidly than we do, or if their technologies or drug candidates are more effective, our ability to develop and
successfully commercialize drug candidates may be adversely affected. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The development and commercialization of drugs and
therapeutic biologics is highly competitive. We compete with a variety of large pharmaceutical companies, multinational biopharmaceutical companies, other biopharmaceutical companies and specialized biotechnology companies, as well as technology
being developed at universities and other research institutions. Our competitors are often larger and better funded than we are. Our competitors have developed, are developing or will develop drug candidates and processes competitive with ours.
Competitive therapeutic treatments include those that have already been approved and accepted by the medical community and any new treatments that are currently in development or that enter the market. We believe that a significant number of
products are currently under development, and may become commercially available in the future, for the treatment of conditions for which we are developing or may try to develop drug candidates. There is intense and rapidly evolving competition in
the biotechnology, biopharmaceutical, immuno-oncology and inflammation fields. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are aware of a number of companies that are developing
biologics and small molecule drugs for the treatment of cancer and inflammatory diseases. Many of these companies are well-capitalized and, in contrast to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
us, have significant clinical experience, and may include our future partners. In addition, these companies compete with us in recruiting scientific and managerial talent. Our success will
partially depend on our ability to obtain, maintain, enforce and defend patents and other intellectual property rights with respect to small molecule drugs or biologics that are safer and more effective than competing products. Our commercial
opportunity and success will be reduced or eliminated if competing products that are safer, more effective, or less expensive than the drugs we develop are or become available. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect to compete with small molecule, biologics and other therapeutic platforms and development companies, including, but not limited to,
companies such as ChemoCentryx, Tusk/Roche and Agenus/Gilead for oncology, and Dermira and AnaptysBio for inflammatory diseases. In addition, we expect to compete with large, multinational pharmaceutical companies that discover, develop and
commercialize small molecule drugs and other therapeutics for use in treating cancer and inflammatory diseases such as AbbVie, Amgen, AstraZeneca plc, Bristol-Myers Squibb, GlaxoSmithKline, Incyte, Kyowa Hakko Kirin, Merck, Novartis, Pfizer,
Roche/Genentech and Sanofi/Regeneron. If FLX475, RPT193 or an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> or other future drug candidate is eventually approved, it will compete with a range of treatments that are either in development or
currently marketed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Many of our competitors have significantly greater financial, technical, manufacturing, marketing, sales and supply
resources or experience than we do. If we successfully obtain approval for any drug candidate, we will face competition based on many different factors, including the safety and effectiveness of our products, the ease with which our products can be
administered, the timing and scope of regulatory approvals for these products, the availability and cost of manufacturing, marketing and sales capabilities, price, reimbursement coverage and patent position. Competing products could present superior
treatment alternatives, including by being more effective, safer, less expensive or marketed and sold more effectively than any products we may develop. Competitive products may make any product we develop obsolete or noncompetitive before we
recover the expense of developing and commercializing such product. Such competitors could also recruit our employees, which could negatively impact our level of expertise and our ability to execute our business plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Any inability to attract and retain qualified key management, technical personnel and employees would impair our ability to implement our business plan.
</I></B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our success largely depends on the continued service of key management, advisors and other specialized personnel, including
Brian Wong, M.D., Ph.D., our President and Chief Executive Officer, William Ho, M.D., Ph.D., our Chief Medical Officer, Dirk Brockstedt, Ph.D., our Chief Scientific Officer, David Wustrow, Ph.D., our Senior Vice President of Drug Discovery and
Preclinical Development, Paul Kassner, Ph.D., our Vice President, Quantitative and Computational Biology, and Karen C. Lam, our Vice President, Finance and Corporate Controller, as well as our ability to attract and retain other highly qualified
personnel. We have a written employment agreement with each of Dr.&nbsp;Wong, Dr.&nbsp;Ho, Dr.&nbsp;Brockstedt, Dr.&nbsp;Wustrow, Dr.&nbsp;Kassner, and Ms.&nbsp;Lam. The loss of one or more members of our executive team, management team or other key
employees or advisors could delay our research and development programs and have a material and adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The relationships that our key managers have cultivated within our industry make us particularly dependent upon their continued employment
with us. We are dependent on the continued service of our technical personnel because of the highly technical nature of our drug candidates and technologies and the specialized nature of the regulatory approval process. Because our management team
and key employees are not obligated to provide us with continued service, they could terminate their employment with us at any time without penalty. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our future success will also depend in large part on our ability to attract and retain other highly qualified scientific, technical and
management personnel, as well as personnel with expertise in clinical testing, manufacturing, governmental regulation and commercialization. We face significant competition for personnel from other companies, universities, public and private
research institutions, government entities and other organizations. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of September 15, 2019, we had 64 full-time employees. Our focus on the development of
FLX475, RPT193 and an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> and other potential future drug candidates will require adequate staffing. We may need to hire and retain new employees to execute our future clinical development and
manufacturing plans. We cannot provide assurance that we will be able to hire or retain adequate staffing levels to develop our current and potential future drug candidates or to run our operations or to accomplish all of our objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may experience difficulties in managing our growth and expanding our operations. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have limited experience in product development. As our current and potential future drug candidates enter and advance through preclinical
studies and any clinical trials, we will need to expand our development, regulatory and manufacturing capabilities or contract with other organizations to provide these capabilities for us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may also experience difficulties in the discovery and development of potential future drug candidates using our drug discovery and
development engine if we are unable to meet demand as we grow our operations. In the future, we also expect to have to manage additional relationships with collaborators, suppliers and other organizations. Our ability to manage our operations and
future growth will require us to continue to improve our operational, financial and management controls, reporting systems and procedures and secure adequate facilities for our operational needs. We may not be able to implement improvements to our
management information and control systems in an efficient or timely manner and may discover deficiencies in existing systems and controls. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If any
of our drug candidates is approved for marketing and commercialization in the future and we are unable to develop sales, marketing and distribution capabilities on our own or enter into agreements with third parties to perform these functions on
acceptable terms, we will be unable to successfully commercialize any such future products. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We currently have no sales, marketing
or distribution capabilities or experience. We will need to develop internal sales, marketing and distribution capabilities to commercialize each current and potential future drug candidate that gains FDA approval, which would be expensive and
time-consuming, or enter into partnerships with third parties to perform these services. If we decide to market any approved products directly, we will need to commit significant financial and managerial resources to develop a marketing and sales
force with technical expertise and supporting distribution, administration and compliance capabilities. If we rely on third parties with such capabilities to market any approved products or decide to
<FONT STYLE="white-space:nowrap">co-promote</FONT> products with partners, we will need to establish and maintain marketing and distribution arrangements with third parties, and there can be no assurance that we will be able to enter into such
arrangements on acceptable terms or at all. In entering into third-party marketing or distribution arrangements, any revenue we receive will depend upon the efforts of the third parties and we cannot assure you that such third parties will establish
adequate sales and distribution capabilities or be successful in gaining market acceptance for any approved product. If we are not successful in commercializing any product approved in the future, either on our own or through third parties, our
business and results of operations could be materially and adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our present and potential future international operations may expose
us to business, political, operational, and financial risks associated with doing business outside of the United States. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our
business is subject to risks associated with conducting business internationally. Some of our suppliers and clinical trial centers are located outside of the United States. Furthermore, if we or any future collaborator succeeds in developing any
products, we anticipate marketing them in the European Union and other jurisdictions in addition to the United States. If approved, we or our collaborator may hire sales representatives and conduct physician and patient association outreach
activities outside of the United States. Doing business internationally involves a number of risks, including but not limited to: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">multiple, conflicting and changing laws and regulations such as privacy regulations, tax laws, export and import
restrictions, employment laws, regulatory requirements, and other governmental approvals, permits and licenses; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">failure by us to obtain and maintain regulatory approvals for the use of our products in various countries;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">rejection or qualification of foreign clinical trial data by the competent authorities of other countries;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additional potentially relevant third-party patent and other intellectual property rights that may be necessary
to develop and commercialize our products and drug candidates; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">complexities and difficulties in obtaining, maintaining, enforcing and defending our patent and other
intellectual property rights; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">difficulties in staffing and managing foreign operations; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">complexities associated with managing multiple payor reimbursement regimes, government payors or <FONT
STYLE="white-space:nowrap">patient&nbsp;self-pay&nbsp;systems;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">limits in our ability to penetrate international markets; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">financial risks, such as longer payment cycles, difficulty collecting accounts receivable, the impact of local
and regional financial crises on demand and payment for our products and exposure to foreign currency exchange rate fluctuations; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">natural disasters, political and economic instability, including wars, terrorism and political unrest, outbreak
of disease, boycotts, curtailment of trade and other business restrictions, implementation of tariffs; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">certain expenses including, among others, expenses for travel, translation and insurance; and
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory and compliance risks that relate to anti-corruption compliance and record-keeping that may fall within
the purview of the U.S. Foreign Corrupt Practices Act, its accounting provisions or its anti-bribery provisions or provisions of anti-corruption or anti-bribery laws in other countries. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any of these factors could harm our ongoing international clinical operations and supply chain, as well as any future international expansion
and operations and, consequently, our business, financial condition, prospects and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our future growth may depend, in part, on
our ability to operate in foreign markets, where we would be subject to additional regulatory burdens and other risks and uncertainties. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our future growth may depend, in part, on our ability to develop and commercialize drug candidates in foreign markets for which we may rely on
partnering with third parties. We will not be permitted to market or promote any drug candidate before we receive regulatory approval from the applicable regulatory authority in a foreign market, and we may never receive such regulatory approval for
any drug candidate. To obtain separate regulatory approval in foreign countries, we generally must comply with numerous and varying regulatory requirements of such countries regarding safety and efficacy and governing, among other things, clinical
trials and commercial sales, pricing and distribution of a drug candidate, and we cannot predict success in these jurisdictions. If we obtain approval of any of our current or potential future drug candidates and ultimately commercialize any such
drug candidate in foreign markets, we would be subject to risks and uncertainties, including the burden of complying with complex and changing foreign regulatory, tax, accounting and legal requirements and the reduced protection of intellectual
property rights in some foreign countries. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Price controls imposed in foreign markets may adversely affect our future profitability. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In some countries, particularly member states of the European Union, the pricing of prescription drugs is subject to governmental control. In
these countries, pricing negotiations with governmental authorities can take considerable time after receipt of marketing approval for a product. In addition, there can be considerable pressure exerted by governments and other stakeholders on prices
and reimbursement levels, including as part of cost-containment measures. Political, economic and regulatory developments, in the United States or internationally, may further complicate pricing negotiations, and pricing negotiations may continue
after reimbursement has been obtained. Reference pricing used by various European Union member states and parallel distribution, or arbitrage between <FONT STYLE="white-space:nowrap">low-priced</FONT> and high-priced member states, can further
reduce prices. In some countries, we or future partners may be required to conduct clinical trials or other studies that compare the cost-effectiveness of a drug candidate to other available therapies in order to obtain or maintain reimbursement or
pricing approval. Publication of discounts by third-party payors or authorities may lead to further pressure on the prices or reimbursement levels within the country of publication and other countries. If reimbursement of any current or potential
future drug candidate that is approved for marketing in the future is unavailable or limited in scope or amount, or if pricing is set at unsatisfactory levels, our business and results of operations or prospects could be materially and adversely
affected and our ability to commercialize such drug candidate could be materially impaired. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our business entails a significant risk of product
liability, and our inability to obtain sufficient insurance coverage could have a material and adverse effect on our business, financial condition, results of operations and prospects. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As we conduct clinical trials of FLX475 and RPT193, we will be exposed to significant product liability risks inherent in the development,
testing, manufacturing and marketing of cancer and inflammatory disease treatments. Product liability claims could delay or prevent completion of our development programs. If we succeed in marketing products, such claims could result in an FDA
investigation of the safety and effectiveness of our products, our manufacturing processes and facilities or our marketing programs and potentially a recall of our products or more serious enforcement action, limitations on the approved indications
for which they may be used or suspension or withdrawal of approvals. Regardless of the merits or eventual outcome, liability claims may also result in decreased demand for our products, injury to our reputation, costs to defend the related
litigation, a diversion of management&#146;s time and our resources, substantial monetary awards to trial participants or patients and a decline in our stock price. Any insurance we have or may obtain may not provide sufficient coverage against
potential liabilities. Furthermore, clinical trial and product liability insurance is becoming increasingly expensive. As a result, our partners or we may be unable to obtain sufficient insurance at a reasonable cost to protect us against losses
caused by product liability claims that could have a material and adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our employees, principal investigators, consultants and commercial partners may engage in misconduct or other improper activities, including
noncompliance with regulatory standards and requirements. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are exposed to the risk of fraud or other misconduct by our
employees, principal investigators, consultants and commercial partners. Misconduct by employees could include intentional failures to comply with FDA regulations, provide accurate information to the FDA, comply with manufacturing standards we may
establish, comply with federal and state healthcare fraud and abuse laws and regulations, report financial information or data accurately or disclose unauthorized activities to us. In particular, sales, marketing and business arrangements in the
healthcare industry are subject to extensive laws and regulations intended to prevent fraud, kickbacks, self-dealing and other abusive practices. These laws and regulations may restrict or prohibit a wide range of pricing, discounting, marketing and
promotion, sales commission, customer incentive programs and other business arrangements. Such misconduct could also involve the improper use of information obtained in the course of clinical trials, which could result in regulatory sanctions and
serious harm to our reputation. It is not always possible to identify and deter misconduct, and the precautions we take to detect and prevent this </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
activity may not be effective in controlling unknown or unmanaged risks or losses or in protecting us from governmental investigations or other actions or lawsuits stemming from a failure to be
in compliance with such laws or regulations. If any such actions are instituted against us, and we are not successful in defending ourselves or asserting our rights, those actions could have a material and adverse effect on our business and
financial condition, including the imposition of significant criminal, civil, and administrative fines or other sanctions, such as monetary penalties, damages, fines, disgorgement, imprisonment, exclusion from participation in government-funded
healthcare programs, such as Medicare and Medicaid, integrity obligations, reputational harm and the curtailment or restructuring of our operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Failure to comply with health and data protection laws and regulations could lead to government enforcement actions (which could include civil or
criminal penalties), private litigation or adverse publicity and could negatively affect our operating results and business. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We
and our current and any of our future collaborators may be subject to federal, state and foreign data protection laws and regulations (i.e., laws and regulations that address privacy and data security). In the United States, numerous federal and
state laws and regulations, including federal health information privacy laws (e.g., the Health Insurance Portability and Accountability Act (&#147;HIPAA&#148;), as amended by the Health Information Technology for Economic and Clinical Health Act
(&#147;HITECH&#148;)), state data breach notification laws, state health information privacy laws and federal and state consumer protection laws (e.g., Section&nbsp;5 of the Federal Trade Commission Act), that govern the collection, use, disclosure
and protection of health-related and other personal information could apply to our operations or the operations of our collaborators. In addition, we may obtain health information from third parties (including research institutions from which we
obtain clinical trial data) that are subject to privacy and security requirements under HIPAA, as amended by HITECH, or other privacy and data security laws. Depending on the facts and circumstances, we could be subject to criminal penalties if we
knowingly obtain, use, or disclose individually identifiable health information maintained by a HIPAA-covered entity in a manner that is not authorized or permitted by HIPAA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">International data protection laws, including Regulation 2016/679, known as the General Data Protection Regulation (&#147;GDPR&#148;) may also
apply to health-related and other personal information obtained outside of the United States. The GDPR went into effect on May&nbsp;25, 2018. The GDPR introduced new data protection requirements in the European Union, as well as potential fines for
noncompliant companies of up to the greater of &#128;20&nbsp;million or 4% of annual global revenue. The regulation imposes numerous new requirements for the collection, use, storage and disclosure of personal information, including more stringent
requirements relating to consent and the information that must be shared with data subjects about how their personal information is used, the obligation to notify regulators and affected individuals of personal data breaches, extensive new internal
privacy governance obligations and obligations to honor expanded rights of individuals in relation to their personal information (e.g., the right to access, correct and delete their data). In addition, the GDPR includes restrictions on cross-border
data transfers. The GDPR increased our responsibility and liability in relation to personal data that we process where such processing is subject to the GDPR, and we may be required to put in place additional mechanisms to ensure compliance with the
GDPR, including as implemented by individual countries. Further, the United Kingdom&#146;s vote in favor of exiting the EU, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. In
particular, it is unclear how data transfers to and from the United Kingdom will be regulated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, California recently enacted
the California Consumer Privacy Act (&#147;CCPA&#148;), which creates new individual privacy rights for California consumers (as defined in the law) and places increased privacy and security obligations on entities handling personal data of
consumers or households. The CCPA will require covered companies to provide new disclosure to consumers about such companies&#146; data collection, use and sharing practices, provide such consumers new ways to
<FONT STYLE="white-space:nowrap">opt-out</FONT> of certain sales or transfers of personal information, and provide consumers with additional causes of action. The CCPA goes into effect on January&nbsp;1, 2020, and the California Attorney General may
bring enforcement actions for violations beginning July&nbsp;1, 2020. The CCPA was amended on September&nbsp;23, 2018, and it remains unclear what, if any, further modifications will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
be made to this legislation or how it will be interpreted. As currently written, the CCPA may impact our business activities and exemplifies the vulnerability of our business to the evolving
regulatory environment related to personal data and protected health information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Compliance with U.S. and international data protection
laws and regulations could require us to take on more onerous obligations in our contracts, restrict our ability to collect, use and disclose data, or in some cases, impact our ability to operate in certain jurisdictions. Failure to comply with U.S.
and international data protection laws and regulations could result in government enforcement actions (which could include civil or criminal penalties), private litigation or adverse publicity and could negatively affect our operating results and
business. Moreover, clinical trial subjects about whom we or any of our potential collaborators obtain information, as well as the providers who share this information with us, may contractually limit our ability to use and disclose the information.
Claims that we have violated individuals&#146; privacy rights, failed to comply with data protection laws, or breached our contractual obligations, even if we are not found liable, could be expensive and time consuming to defend and could result in
adverse publicity that could harm our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we, our CROs or our IT vendors experience security or data privacy breaches or other
unauthorized or improper access to, use of, or destruction of personal data, we may face costs, significant liabilities, harm to our brand and business disruption. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In connection with our drug discovery and development engine and efforts, we or our CROs may collect and use a variety of personal data, such
as name, mailing address, email addresses, phone number and clinical trial information. Although we have extensive measures in place to prevent the sharing and loss of patient data in our sample collection process associated with our drug discovery
and development engine, any failure to prevent or mitigate security breaches or improper access to, use of, or disclosure of our clinical data or patients&#146; personal data could result in significant liability under state (e.g., state breach
notification laws), federal (e.g., HIPAA, as amended by HITECH), and international law (e.g., the GDPR). Any failure to prevent or mitigate security breaches or improper access to, use of, or disclosure of our clinical data or patients&#146;
personal data may cause a material adverse impact to our reputation, affect our ability to conduct new studies and potentially disrupt our business. We may also rely on third-party IT vendors to host or otherwise process some of our data and that of
users, and any failure by such IT vendor to prevent or mitigate security breaches or improper access to or disclosure of such information could have similarly adverse consequences for us. If we are unable to prevent or mitigate the impact of such
security or data privacy breaches, we could be exposed to litigation and governmental investigations, which could lead to a potential disruption to our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We depend on sophisticated information technology systems to operate our business and a cyber-attack or other breach of these systems could have a
material adverse effect on our business. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We rely on information technology systems that we or our CROs or other vendors,
contractors or consultants operate to process, transmit and store electronic information in our or their <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">day-to-day</FONT></FONT> operations. The size and complexity of such
information technology systems makes them vulnerable to a cyber-attack, malicious intrusion, breakdown, destruction, loss of data privacy or other significant disruption. A successful attack could result in the theft or destruction of intellectual
property, data, or other misappropriation of assets, or otherwise compromise our confidential or proprietary information and disrupt our operations. Cyber-attacks are becoming more sophisticated and frequent. We have invested in our systems and the
protection and recoverability of our data to reduce the risk of an intrusion or interruption, and we monitor and test our systems on an ongoing basis for any current or potential threats. There can be no assurance that these measures and efforts
will prevent future interruptions or breakdowns. If we or our CROs or other vendors, contractors or consultants fail to maintain or protect our information technology systems and data integrity effectively or fail to anticipate, plan for or manage
significant disruptions to these systems, we or they could have difficulty preventing, detecting and controlling such cyber-attacks and any such attacks could result in losses described above as well as disputes with physicians, patients and our
partners, regulatory sanctions or penalties, increases in operating expenses, expenses or lost revenues or other adverse consequences, any of which could have a material adverse effect on our business, results of operations, financial condition,
prospects and cash flows. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our information technology and other internal infrastructure systems, including corporate
firewalls, servers, leased lines and connection to the internet, face the risk of systemic failure that could disrupt our operations. A significant disruption in the availability of our information technology and other internal infrastructure
systems could cause interruptions and delays in our research and development work. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we do not comply with laws regulating the protection of the
environment and health and human safety, our business could be adversely affected. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our research, development and manufacturing
involves the use of hazardous materials and various chemicals. We maintain quantities of various flammable and toxic chemicals in our facilities that are required for our research, development and manufacturing activities. We are subject to federal,
state and local laws and regulations governing the use, manufacture, storage, handling and disposal of these hazardous materials. We believe our procedures for storing, handling and disposing of these materials in our facilities comply with the
relevant guidelines of the state of California and the Occupational Safety and Health Administration of the U.S. Department of Labor. Although we believe that our safety procedures for handling and disposing of these materials comply with the
standards mandated by applicable regulations, the risk of accidental contamination or injury from these materials cannot be eliminated. If an accident occurs, we could be held liable for resulting damages, which could be substantial. We are also
subject to numerous environmental, health and workplace safety laws and regulations, including those governing laboratory procedures, exposure to blood-borne pathogens and the handling of animals and biohazardous materials. Although we maintain
workers&#146; compensation insurance to cover us for costs and expenses we may incur due to injuries to our employees resulting from the use of these materials, this insurance may not provide adequate coverage against potential liabilities. Although
we have some environmental liability insurance covering certain of our facilities, we may not maintain adequate insurance for all environmental liability or toxic tort claims that may be asserted against us in connection with our storage or disposal
of biological or hazardous materials. Additional federal, state and local laws and regulations affecting our operations may be adopted in the future. We may incur substantial costs to comply with, and substantial fines or penalties if we violate,
any of these laws or regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our current operations are concentrated in one location, and we or the third parties upon whom we depend may be
adversely affected by natural or other disasters and our business continuity and disaster recovery plans may not adequately protect us from a serious disaster. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our current operations are concentrated in the San Francisco Bay Area. Any unplanned event, such as earthquake, flood, fire, explosion,
extreme weather, medical epidemic, power shortage, telecommunication failure or other natural or manmade accidents or incidents that result in us being unable to fully utilize our facilities or the manufacturing facilities of our third-party
contract manufacturers, or lose our repository of preclinical and clinical human samples and other valuable laboratory samples, may have a material and adverse effect on our ability to operate our business, particularly on a daily basis, and have
significant negative consequences on our financial and operating conditions. Loss of access to these facilities may result in increased costs, delays in the development of our drug candidates or interruption of our business operations. Natural
disasters such as earthquakes or wildfires, both of which are prevalent in Northern California, floods or tsunamis could further disrupt our operations, and have a material negative impact on our business, financial condition, results of operations
and prospects. If a natural disaster, power outage or other event occurred that prevented us from using all or a significant portion of our headquarters, that damaged critical infrastructure, such as our research facilities or the manufacturing
facilities of our third-party contract manufacturers, or that otherwise disrupted operations, it may be difficult or, in certain cases, impossible, for us to continue our business for a substantial period of time. The disaster recovery and business
continuity plans we have in place may prove inadequate in the event of a serious disaster or similar event. We may incur substantial expenses as a result of the limited nature of our disaster recovery and business continuity plans, which could have
a material adverse effect on our business. As part of our risk management policy, we maintain insurance coverage at levels that we believe are appropriate for our business. However, in the event of an accident or incident at these facilities, we
cannot assure you that the amounts of insurance will be sufficient to satisfy any damages and losses. If our facilities, or </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the manufacturing facilities of our third-party contract manufacturers, are unable to operate because of an accident or incident or for any other reason, even for a short period of time, any or
all of our research and development programs may be harmed. Any business interruption may have a material and adverse effect on our business and financial condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Our Intellectual Property </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we
are unable to obtain, maintain, enforce or defend intellectual property rights related to our technology and current or future drug candidates, or if our intellectual property rights are inadequate, we may not be able to compete effectively.
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our success depends in large part on our ability to obtain and maintain protection in the United States and other countries for
our intellectual property rights and proprietary technology. We rely on patents and other forms of intellectual property rights to protect our current or future drug discovery and development engine, drug candidates, methods used to manufacture our
current or future drug candidates, and methods for treating patients using our current or future drug candidates. We do not currently own any patents or patent applications relating to our proprietary drug discovery and development engine. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The patent prosecution process is expensive, complex and time-consuming. Patent license negotiations also can be complex and protracted, with
uncertain results. We may not be able to file, prosecute, maintain, enforce or license all necessary or desirable patents and patent applications at a reasonable cost or in a timely manner. It is also possible that we will fail to identify
patentable aspects of our research and development output before it is too late to obtain patent protection. Although we enter into <FONT STYLE="white-space:nowrap">non-disclosure</FONT> and confidentiality agreements with parties who have access to
confidential or patentable aspects of our research and development output, such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors, and other third parties, any of these
parties may breach the agreements and disclose such output before a patent application is filed, thereby jeopardizing our ability to seek patent protection. The patent applications that we own or may
<FONT STYLE="white-space:nowrap">in-license</FONT> may fail to result in issued patents, and, even if they do issue as patents, such patents may not cover our current or future technologies or drug candidates in the United States or in other
countries or provide sufficient protection from competitors. In addition, the coverage claimed in a patent application can be significantly reduced before the patent is issued and its scope can be reinterpreted after issuance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Further, although we make reasonable efforts to ensure patentability of our inventions, we cannot guarantee that all of the potentially
relevant prior art relating to our patent applications and any issued patents we obtain has been found. For example, publications of discoveries in scientific literature often lag behind the actual discoveries, and patent applications in the United
States and other jurisdictions are typically not published until 18 months after filing, and in some cases not at all. Additionally, pending patent applications that have been published can, subject to certain limitations, be later amended in a
manner that could cover our drug discovery and development engine, our drug candidates or the use of our technologies. We thus cannot know with certainty whether we or any of our future licensors were the first to make the inventions claimed in our
pending patent applications or any issued patents we obtain, or that we or our any of our future licensors were the first to file for patent protection of such inventions. For this reason, and because there is no guarantee that any prior art search
is absolutely correct and comprehensive, we may be unaware of prior art that could be used to invalidate an issued patent or to prevent our pending patent applications from issuing as patents. Invalidation of any of our patent rights, including <FONT
STYLE="white-space:nowrap">in-licensed</FONT> patent rights, could materially harm our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Moreover, the patent positions of biopharmaceutical companies are generally uncertain because they may involve complex legal and factual
considerations that have, in recent years, been the subject of legal development and change. As a result, the issuance, scope, validity, enforceability and commercial value of our pending patent rights is uncertain. The standards applied by the
United States Patent and Trademark Office </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(&#147;USPTO&#148;), and foreign patent offices in granting patents are not always certain and moreover, are not always applied uniformly or predictably. For example, there is no uniform
worldwide policy regarding patentable subject matter or the scope of claims allowable in patents. Changes in either the patent laws or interpretation of the patent laws in the United States and other countries may diminish the value of our patent
rights or narrow the scope of our patent protection. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Even if patents do successfully issue and even if such patents cover our current or
any future technologies or drug candidates, third parties may challenge their validity, enforceability or scope, which may result in such patents being narrowed, invalidated, or held unenforceable. Any successful challenge to any patents we own or
may in-license could deprive us of rights necessary for the successful commercialization of any current or future technologies or drug candidates that we may develop. Likewise, if patent applications we own or may
<FONT STYLE="white-space:nowrap">in-license</FONT> with respect to our development programs and current or future technologies or drug candidates fail to issue, if their breadth or strength is threatened, or if they fail to provide meaningful
exclusivity, other companies could be dissuaded from collaborating with us to develop current or future technologies or drug candidates. Lack of valid and enforceable patent protection could threaten our ability to commercialize current or future
products and could prevent us from maintaining exclusivity with respect to the invention or feature claimed in the patent applications. Any failure to obtain or any loss of patent protection could have a material adverse impact on our business and
ability to achieve profitability. We may be unable to prevent competitors from entering the market with a product that is similar to or the same as FLX475, RPT193 or an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> or other future drug
candidates that emerge from our discovery program. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The filing of a patent application or the issuance of a patent is not conclusive as to
its ownership, inventorship, scope, patentability, validity or enforceability. Issued patents and patent applications may be challenged in the courts and in the patent office in the United States and abroad. For example, our patent applications or
patent applications filed by any of our future licensors may be challenged through third-party submissions, opposition or derivation proceedings. By further example, issued patents may be challenged through reexamination, inter partes review or
post-grant review proceedings before the USPTO or patent offices in other jurisdictions, or in declaratory judgment actions or counterclaims. An adverse determination in any such submission, proceeding or litigation could prevent the issuance of,
reduce the scope of, invalidate or render unenforceable our patent rights; limit our ability to stop others from using or commercializing similar or identical products; allow third parties to compete directly with us without payment to us; or result
in our inability to manufacture or commercialize products without infringing third-party patent rights. In addition, if the breadth or strength of protection provided by our patent rights is threatened, it could dissuade companies from collaborating
with us to license, develop or commercialize current or future drug candidates. Any of the foregoing could have a material adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Moreover, some of our intellectual property, including patents and patent applications, are or may in the future be <FONT
STYLE="white-space:nowrap">co-owned</FONT> with third parties. If we are unable to obtain an exclusive license to any such third-party <FONT STYLE="white-space:nowrap">co-owners&#146;</FONT> interest in such intellectual property, including patents
or patent applications, such <FONT STYLE="white-space:nowrap">co-owners</FONT> may be able to license their rights to other third parties, including our competitors, and our competitors could market competing products and technology. We may need the
cooperation of any such <FONT STYLE="white-space:nowrap">co-owners</FONT> of our patent rights to enforce such patent rights against third parties, and such cooperation may not be provided to us. Any of the foregoing could have a material adverse
effect on our competitive position, business prospects and financial conditions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with our obligations under any license,
collaboration or other intellectual property-related agreements, we may be required to pay damages and could lose intellectual property rights that may be necessary for developing, commercializing and protecting our current or future technologies or
drug candidates or we could lose certain rights to grant sublicenses.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any
license, collaboration or other intellectual property-related agreements impose, and any future license, collaboration or other intellectual property-related agreements we enter into are likely to impose, various
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
development, commercialization, funding, milestone, royalty, diligence, sublicensing, insurance, patent prosecution and enforcement or other obligations on us. If we breach any of these
obligations, or use the intellectual property licensed to us in an unauthorized manner, we may be required to pay damages and the licensor may have the right to terminate the license. In spite of our best efforts, any of our future licensors might
conclude that we have materially breached our license agreements and might therefore terminate the license agreements, thereby removing our ability to develop and commercialize products and technologies covered by these license agreements. Any
license agreements we enter into may be complex, and certain provisions in such agreements may be susceptible to multiple interpretations. The resolution of any contract interpretation disagreement that may arise could narrow what we believe to be
the scope our rights to the relevant intellectual property or technology, or increase what we believe to be our financial or other obligations under the relevant agreement, either of which could have a material adverse effect on our business,
financial condition, results of operations, and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may seek to obtain licenses from licensors in the future, however, we may
be unable to obtain any such licenses at a reasonable cost or on reasonable terms, if at all. In addition, any of our future licensors terminate any such license agreements, such license termination could result in our inability to develop,
manufacture and sell products that are covered by the licensed technology or could enable a competitor to gain access to the licensed technology. Any of these events could have a material adverse effect on our competitive position, business,
financial conditions, results of operations, and ability to achieve profitability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Furthermore, we may not have the right to control the
preparation, filing, prosecution, maintenance, enforcement and defense of patents and patent applications that we license from third parties. Therefore, we cannot be certain that these patents and patent applications will be prepared, filed,
prosecuted, maintained, enforced and defended in a manner consistent with the best interests of our business. If our future licensors fail to prosecute, maintain, enforce and defend patents we may in-license, or lose rights to licensed patents or
patent applications, our license rights may be reduced or eliminated. In such circumstances, our right to develop and commercialize any of our products or drug candidates that is the subject of such licensed rights could be materially adversely
affected. In certain circumstances, our licensed patent rights are subject to our reimbursing our licensors for their patent prosecution and maintenance costs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Moreover, our licensors may own or control intellectual property that has not been licensed to us and, as a result, we may be subject to
claims, regardless of their merit, that we are infringing, misappropriating or otherwise violating the licensor&#146;s intellectual property rights and the amount of any damages or future royalty obligations that would result if any such claims were
successful would depend on the technology and intellectual property we use in products that we successfully develop and commercialize, if any. Therefore, even if we successfully develop and commercialize products, we may be unable to achieve or
maintain profitability. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Patent terms may not be able to protect our competitive position for an adequate period of time with respect to our current
or future technologies or drug candidates. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Patents have a limited lifespan. In the United States, the standard patent term is
typically 20 years after filing. Various extensions may be available. Even so, the life of a patent and the protection it affords are limited. As a result, our patent portfolio provides us with limited rights that may not last for a sufficient
period of time to exclude others from commercializing products similar or identical to ours. For example, given the large amount of time required for the research, development, testing and regulatory review of new drug candidates, patents protecting
such candidates might expire before or shortly after such candidates are commercialized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Extensions of patent term may be available, but
there is no guarantee that we would succeed in obtaining any particular extension&#151;and no guarantee any such extension would confer patent term for a sufficient period of time to exclude others from commercializing products similar or identical
to ours. In the United States, the Drug Price Competition and Patent Term Restoration Act of 1984 permits a patent term extension of up to five years beyond the normal expiration of the patent, which is limited to the approved
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indication (or any additional indications approved during the period of extension). A patent term extension cannot extend the remaining term of a patent beyond 14 years from the date of product
approval; only one patent may be extended; and extension is available for only those claims covering the approved drug, a method for using it, or a method for manufacturing it. The applicable authorities, including the FDA and the USPTO in the
United States, and any equivalent regulatory authority in other countries, may not agree with our assessment of whether such extensions are available, and may refuse to grant extensions to any patents we obtain, or may grant more limited extensions
than we request. An extension may not be granted or may be limited where there is, for example, a failure to exercise due diligence during the testing phase or regulatory review process, failure to apply within applicable deadlines, failure to apply
before expiration of relevant patents, or some other failure to satisfy applicable requirements. If this occurs, our competitors may be able to launch their products earlier by taking advantage of our investment in development and clinical trials
along with our clinical and preclinical data. This could have a material adverse effect on our business and ability to achieve profitability. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Changes in U.S. patent law or the patent law of other countries or jurisdictions could diminish the value of patents in general, thereby impairing our
ability to protect our current or any future technologies or drug candidates.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Changes in either the patent laws or interpretation of the patent laws in the United States or elsewhere could increase the uncertainties and
costs surrounding the prosecution of patent applications and the enforcement or defense of issued patents. The United States has enacted and implemented wide-ranging patent reform legislation. On September&nbsp;16, 2011, the Leahy-Smith America
Invents Act (the &#147;Leahy-Smith Act&#148;), was signed into law, which could increase the uncertainties and costs surrounding the prosecution of our patent applications and the enforcement or defense of any issued patents we obtain. The
Leahy-Smith Act includes a number of significant changes to U.S. patent law. These include provisions that affect the way patent applications are prosecuted, redefine prior art, may affect patent litigation and switch the U.S. patent system from a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-invent&#148;</FONT></FONT> system to a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;first-to-file&#148;</FONT></FONT> system. Under a <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-to-file</FONT></FONT> system, assuming the other requirements for patentability are met, the first inventor to file a patent application generally will be entitled to the patent on an
invention regardless of whether another inventor had made the invention earlier. These provisions also allow third-party submission of prior art to the USPTO during patent prosecution and set forth additional procedures to challenge the validity of
a patent by the USPTO administered post grant proceedings, including derivation, reexamination, inter partes review, post-grant review and interference proceedings. The USPTO developed additional regulations and procedures to govern administration
of the Leahy-Smith Act, and many of the substantive changes to patent law associated with the Leahy-Smith Act, and, in particular, the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-to-file</FONT></FONT> provisions, became
effective on March&nbsp;16, 2013. Accordingly, it is not clear what, if any, impact the Leahy-Smith Act will have on the operation of our business. The Leahy-Smith Act and its implementation could increase the uncertainties and costs surrounding the
prosecution of our patent applications and the enforcement or defense of any issued patents we obtain, all of which could have a material adverse impact on our business prospects and financial condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As referenced above, for example, courts in the U.S. continue to refine the heavily <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">fact-and-circumstance-dependent</FONT></FONT> jurisprudence defining the scope of patent protection available for therapeutics, narrowing the scope of patent protection available in certain circumstances or weakening the
rights of patent owners in certain situations. This creates uncertainty about our ability to obtain patents in the future and the value of such patents. We cannot provide assurance that future developments in U.S. Congress, the federal courts and
the USPTO will not adversely impact our patent rights. The laws and regulations governing patents could change in unpredictable ways that could weaken our and our licensors&#146; ability to obtain new patents or to enforce our existing patent rights
or patent rights that we might obtain or <FONT STYLE="white-space:nowrap">in-license</FONT> in the future. Similarly, changes in patent law and regulations in other countries or jurisdictions or changes in the governmental bodies that enforce them
or changes in how the relevant governmental authority enforces patent laws or regulations may have a material adverse effect on our and our licensors&#146; ability to obtain new patents or to protect and enforce our owned or <FONT
STYLE="white-space:nowrap">in-licensed</FONT> patent rights or patent rights that we may obtain or <FONT STYLE="white-space:nowrap">in-license</FONT> in the future. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other companies or organizations may challenge our patent rights or may assert patent rights that
prevent us from developing and commercializing our current or future products. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Third parties may attempt to invalidate our
intellectual property rights. Even if such rights are not directly challenged, disputes could lead to the weakening of our intellectual property rights. Our defense against any attempt by third parties to circumvent or invalidate our intellectual
property rights could be costly to us, could require significant time and attention of our management, and could have a material and adverse impact on our profitability, financial condition and prospects or ability to successfully compete. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Further, we cannot guarantee that we are aware of all patents and patent applications potentially relevant to our technology or products.
There may be issued and pending patents that claim aspects of our current or potential future drug candidates and modifications that we may need for our current or potential future drug candidates. We may not be aware of potentially relevant
third-party patents or applications for several reasons. For example, U.S. applications filed before November&nbsp;29, 2000, and certain U.S. applications filed after that date that will not be filed outside the U.S. remain confidential until
patents issue. Patent applications in the United States and elsewhere are published approximately 18 months after the earliest filing for which priority is claimed, with such earliest filing date being commonly referred to as the priority date.
Therefore, patent applications covering our drug candidates or technologies could have been filed by others without our knowledge. Additionally, pending patent applications that have been published can, subject to certain limitations, be later
amended in a manner that could cover our drug candidates or the use of our technologies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may be subject to priority disputes,
inventorship disputes and similar proceedings that could, if resolved unfavorably, narrow the scope of our intellectual property protection. We cannot provide any assurances that third-party patents do not exist which might be enforced against our
drug candidates or technologies or future methods or products, resulting in either an injunction prohibiting our manufacture or sales, or, with respect to our sales, an obligation on our part to pay royalties or other forms of compensation to third
parties, which could be significant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Thus, it is possible that one or more third parties will hold patent rights to which we will need a
license, which may not be available on reasonable terms or at all. If such third parties refuse to grant us a license to such patent rights on reasonable terms or at all, we may be required to expend significant time and resources to redesign our
technology, drug candidates or the methods for manufacturing our drug candidates, or to develop or license replacement technology, all of which may not be commercially or technically feasible. In such case, we may not be able to market such
technology or drug candidates and may not be able to perform research and development or other activities covered by these patents. This could have a material adverse effect on our ability to commercialize our drug candidates and our business and
financial condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be able to protect our intellectual property rights throughout the world, which could negatively impact our
business. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Filing, prosecuting and defending patents on current or future technologies or drug candidates in all countries
throughout the world would be prohibitively expensive. Competitors or other third parties may use our technologies in jurisdictions where we have not obtained patent protection to develop their own products and, further, may export infringing
products to territories where we have patent protection or licenses but enforcement is not as strong as that in the United States. These products may compete with our products, and our patent or other intellectual property rights may not be
effective or sufficient to prevent them from competing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Additionally, the laws of some foreign jurisdictions do not protect intellectual
property rights to the same extent as the laws in the United States. Consequently, we may not be able to prevent third parties from practicing our inventions in all countries outside the United States, or from selling or importing products made
using our inventions in and into the United States or other jurisdictions. Many companies have encountered significant difficulties in protecting and defending intellectual property rights in such foreign jurisdictions. The
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
legal systems of certain countries, including certain developing countries, do not favor the enforcement of patents, trade secrets and other intellectual property protection, particularly those
relating to biotechnology, which could make it difficult for us to stop the infringement of our patent rights or the marketing of competing products in violation of our intellectual property and proprietary rights generally. Proceedings to enforce
our intellectual property and proprietary rights in foreign jurisdictions could result in substantial costs and could divert our efforts and attention from other aspects of our business. Such proceedings could also put our patent rights at risk of
being invalidated or interpreted narrowly, could put our patent applications at risk of not issuing, and could provoke third parties to assert claims against us or any of our future licensors. We may not prevail in any lawsuits or other adversarial
proceedings that we initiate, and the damages or other remedies awarded, if any, may not be commercially meaningful. Accordingly, our efforts to enforce such intellectual property and proprietary rights around the world may be inadequate to obtain a
significant commercial advantage from the intellectual property that we develop or <FONT STYLE="white-space:nowrap">in-license.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Further, many countries have compulsory licensing laws under which a patent owner may be compelled to grant licenses to third parties. In
addition, many countries limit the enforceability of patents against government agencies or government contractors. In these countries, the patent owner may have limited remedies, which could materially diminish the value of its patents. If we or
any of our licensors are forced to grant a license to third parties with respect to any patents relevant to our business, our competitive position in the relevant jurisdiction may be impaired and our business prospects, financial condition and
results of operations may be materially adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Third parties may initiate legal proceedings alleging that we are infringing,
misappropriating or otherwise violating their intellectual property rights, the outcome of which would be uncertain and could have a material adverse impact on the success of our business. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our commercial success depends, in part, upon our ability or the ability of any of our future collaborators to develop, manufacture, market
and sell our current or any future drug candidates and to use our proprietary technologies without infringing, misappropriating or otherwise violating the proprietary and intellectual property rights of third parties. The biotechnology and
pharmaceutical industries are characterized by extensive and complex litigation regarding patents and other intellectual property rights. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We or any of our future licensors or strategic partners, may be party to, or be threatened with, adversarial proceedings or litigation
regarding intellectual property rights with respect to our current or any potential future drug candidates and technologies, including derivation, reexamination, inter partes review, post-grant review or interference proceedings before the USPTO and
similar proceedings in jurisdictions outside of the United States such as opposition proceedings. If we or our licensors or strategic partners are unsuccessful in any interference proceedings or other priority or validity disputes (including through
any patent oppositions) to which we or they are subject, we may lose valuable intellectual property rights through the loss of one or more patents or our patent claims may be narrowed, invalidated, or held unenforceable. In some instances, we may be
required to indemnify our licensors or strategic partners for the costs associated with any such adversarial proceedings or litigation. Third parties may also assert infringement, misappropriation or other claims against us, our licensors or our
strategic partners based on existing patents or patents that may be granted in the future, as well as other intellectual property rights, regardless of their merit. There is a risk that third parties may choose to engage in litigation or other
adversarial proceedings with us, our licensors or our strategic partners to enforce or otherwise assert their patent rights or other intellectual property rights. Even if we believe such claims are without merit, a court of competent jurisdiction
could hold that these third-party patents and other intellectual property rights are valid, enforceable and infringed, which could have a material adverse impact on our ability to utilize our drug discovery and development engine or to commercialize
our current or any future drug candidates. In order to successfully challenge the validity of any such U.S. patent in federal court, we would need to overcome a presumption of validity by presenting clear and convincing evidence of invalidity. There
is no assurance that a court of competent jurisdiction, even if presented with evidence we believe to be clear and convincing, would invalidate the claims of any such U.S. patent. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Further, we cannot guarantee that we will be able to successfully settle or otherwise
resolve such adversarial proceedings or litigation. If we are unable to successfully settle future claims on terms acceptable to us, we may be required to engage in or to continue costly, unpredictable and time-consuming litigation and may be
prevented from or experience substantial delays in marketing our drug candidates. If we or any of our licensors or strategic partners are found to infringe, misappropriate or violate a third-party patent or other intellectual property rights, we
could be required to pay damages, including treble damages and attorney&#146;s fees, if we are found to have willfully infringed. In addition, we, or any of our licensors or strategic partners may choose to seek, or be required to seek, a license
from a third party, which may not be available on commercially reasonable terms, if at all. Even if a license can be obtained on commercially reasonable terms, the rights may be <FONT STYLE="white-space:nowrap">non-exclusive,</FONT> which could give
our competitors access to the same technology or intellectual property rights licensed to us, and we could be required to make substantial licensing and royalty payments. We also could be forced, including by court order, to cease utilizing,
developing, manufacturing and commercializing our drug discovery and development engine or drug candidates deemed to be infringing. We may be forced to redesign current or future technologies or products. Any of the foregoing could have a material
adverse effect on our ability to generate revenue or achieve profitability and possibly prevent us from generating revenue sufficient to sustain our operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, we or our licensors or strategic partners may find it necessary to pursue claims or to initiate lawsuits to protect or enforce
our patent or other intellectual property rights. If we or our licensors or strategic partners were to initiate legal proceedings against a third party to enforce a patent covering one of our drug candidates or our technology, the defendant could
counterclaim that such patent is invalid or unenforceable. In patent litigation in the United States, defendant counterclaims alleging invalidity or unenforceability are commonplace. Grounds for a validity challenge could be an alleged failure to
meet any of several statutory requirements, for example, claiming patent-ineligible subject matter, lack of novelty, indefiniteness, lack of written description, <FONT STYLE="white-space:nowrap">non-enablement,</FONT> anticipation or obviousness.
Grounds for an unenforceability assertion could be an allegation that someone connected with prosecution of the patent withheld relevant information from the USPTO or made a misleading statement during prosecution. The outcome of such invalidity and
unenforceability claims is unpredictable. With respect to the validity question, for example, we cannot be certain that there is no invalidating prior art of which we or our licensors or strategic partners and the patent examiner were unaware during
prosecution. If a defendant were to prevail on a legal assertion of invalidity or unenforceability, we could lose at least part, and perhaps all, of the patent protection for one or more of our drug candidates. The narrowing or loss of our owned and
licensed patent claims could limit our ability to stop others from using or commercializing similar or identical technology and products. All of these events could have a material adverse effect on our business, financial condition, results of
operations and prospects. Patent and other intellectual property rights also will not protect our drug candidates and technologies if competitors or third parties design around such drug candidates and technologies without legally infringing,
misappropriating or violating our patent or other intellectual property rights. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The cost to us in defending or initiating any litigation
or other proceeding relating to our patent or other intellectual property rights, even if resolved in our favor, could be substantial, and any litigation or other proceeding would divert our management&#146;s attention and distract our personnel
from their normal responsibilities. Such litigation or proceedings could materially increase our operating losses and reduce the resources available for development activities or any future sales, marketing or distribution activities. We may not
have sufficient financial or other resources to conduct such litigation or proceedings adequately. Some of our competitors may be able to more effectively to sustain the costs of complex patent litigation because they have substantially greater
resources. Uncertainties resulting from the initiation and continuation of patent litigation or other proceedings could delay our research and development efforts and materially limit our ability to continue our operations. Furthermore, because of
the substantial amount of discovery required in connection with certain such proceedings, there is a risk that some of our confidential information could be compromised by disclosure. In addition, there could be public announcements of the results
of hearings, motions or other interim proceedings or developments and if securities analysts or investors perceive these results to be negative, such announcements could have a material adverse effect on the price of our common stock. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">39 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual property rights of third parties could adversely affect our ability to commercialize our
current or future technologies or drug candidates, and we might be required to litigate or obtain licenses from third parties to develop or market our current or future technologies or drug candidates, which may not be available on commercially
reasonable terms or at all. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Because the immuno-oncology and inflammation disease landscapes are still evolving, it is difficult
to conclusively assess our freedom to operate. Thus, we may unknowingly pursue development of a product or technology that infringes, misappropriates or otherwise violates third-party rights. There are numerous companies that have pending patent
applications and issued patents broadly covering immune-therapies generally or covering small molecules directed against the same targets as, or targets similar to, those we are pursuing. Our competitive position may materially suffer if patents
issued to third parties or other third-party intellectual property rights cover our current or future technologies drug candidates or elements thereof or our manufacture or uses relevant to our development plans. In such cases, we may not be in a
position to develop or commercialize current or future technologies, drug candidates unless we successfully pursue litigation to nullify or invalidate the third-party intellectual property right concerned, or enter into a license agreement with the
intellectual property right holder, if available on commercially reasonable terms. There may be issued patents of which we are not aware, held by third parties that, if found to be valid and enforceable, could be alleged to be infringed by our
current or future technologies or drug candidates. There also may be pending patent applications of which we are not aware that may result in issued patents, which could be alleged to be infringed by our current or future technologies or drug
candidates. Should such an infringement claim be successfully brought, we may be required to pay substantial damages or be forced to abandon our current or future technologies or drug candidates or to seek a license from any patent holders. No
assurances can be given that a license will be available on commercially reasonable terms, if at all. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Third-party intellectual property
right holders may also actively bring infringement, misappropriation or other claims alleging violations of intellectual property rights against us. We cannot guarantee that we will be able to successfully settle or otherwise resolve such claims. If
we are unable to successfully settle future claims on terms acceptable to us, we may be required to engage in or to continue costly, unpredictable and time-consuming litigation and may be prevented from or experience substantial delays in marketing
our drug candidates. If we fail in any such dispute, in addition to being forced to pay damages, we may be temporarily or permanently prohibited from commercializing any of our current or future technologies or drug candidates that are held to be
infringing, misappropriating or otherwise violating third-party intellectual property rights. We might, if possible, also be forced to redesign current or future technologies or drug candidates so that we no longer infringe, misappropriate or
violate the third-party intellectual property rights. Any of these events, even if we were ultimately to prevail, could require us to divert substantial financial and management resources that we would otherwise be able to devote to our business,
which could have a material adverse effect on our financial condition and results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may not be successful in obtaining necessary or
exclusive rights to any drug candidates or products we may develop through acquisitions and <FONT STYLE="white-space:nowrap">in-licensing.</FONT> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may be unable to acquire or otherwise <FONT STYLE="white-space:nowrap">in-license</FONT> any compositions, methods of use, processes, or
other intellectual property rights from third parties that we identify as necessary for drug candidates that we may wish to develop. The licensing or acquisition of third-party intellectual property rights is a competitive area, and several more
established companies may pursue strategies to license or acquire third-party intellectual property rights that we may consider attractive or necessary. These established companies may have a competitive advantage over us due to their size, capital
resources and greater clinical development and commercialization capabilities. In addition, companies that perceive us to be a competitor may be unwilling to assign or license rights to us. We may be unable to license or acquire third-party
intellectual property rights on terms that would allow us to make an appropriate return on our investment or at all. If we are unable to successfully obtain rights to required third-party intellectual property rights or maintain the existing
intellectual property rights we have, we may have to abandon development of the relevant program or drug candidates, which could have a material adverse effect on our business, financial condition, results of operations, and prospects. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">40 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Patent rights we may <FONT STYLE="white-space:nowrap">in-license</FONT> in the future may be
subject to a reservation of rights by one or more third parties. For example, the research resulting in any <FONT STYLE="white-space:nowrap">in-licensed</FONT> patent rights and technology may be funded in part by the U.S. government. As a result,
the government may have certain rights, or <FONT STYLE="white-space:nowrap">march-in</FONT> rights, to such patent rights and technology. When new technologies are developed with government funding, the government generally obtains certain rights in
any resulting patents, including a <FONT STYLE="white-space:nowrap">non-exclusive</FONT> license authorizing the government to use the invention for <FONT STYLE="white-space:nowrap">non-commercial</FONT> purposes. These rights may permit the
government to disclose our confidential information to third parties and to exercise <FONT STYLE="white-space:nowrap">march-in</FONT> rights to use or allow third parties to use our licensed technology. The government can exercise its <FONT
STYLE="white-space:nowrap">march-in</FONT> rights if it determines that action is necessary because we fail to achieve practical application of the government-funded technology, because action is necessary to alleviate health or safety needs, to
meet requirements of federal regulations, or to give preference to U.S. industry. In addition, our rights in such inventions may be subject to certain requirements to manufacture products embodying such inventions in the United States. Any exercise
by the U.S. government of such rights could harm our competitive position, business, financial condition, results of operations and prospects. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If
we are unable to protect the confidentiality of our trade secrets, our business and competitive position would be harmed. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As
referenced above, in addition to seeking patent protection for certain aspects of our current or future technologies and drug candidates, we also consider trade secrets, including confidential and unpatented
<FONT STYLE="white-space:nowrap">know-how,</FONT> important to the maintenance of our competitive position. However, trade secrets and <FONT STYLE="white-space:nowrap">know-how</FONT> can be difficult to protect. We protect and plan to protect trade
secrets and confidential and unpatented <FONT STYLE="white-space:nowrap">know-how,</FONT> in part, by entering into <FONT STYLE="white-space:nowrap">non-disclosure</FONT> and confidentiality agreements with parties who have access to such knowledge,
such as our employees, corporate collaborators, outside scientific collaborators, CROs, contract manufacturers, consultants, advisors and other third parties. We also enter into confidentiality and invention or patent assignment agreements with our
employees and consultants under which they are obligated to maintain confidentiality and to assign their inventions to us. Despite these efforts, we may not obtain these agreements in all circumstances and we cannot guarantee that we have entered
into such agreements with each party that may have or have had access to our trade secrets or proprietary information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Moreover,
individuals with whom we have such agreements may not comply with their terms. Any of these parties may breach such agreements and disclose our proprietary information, including our trade secrets, and we may not be able to obtain adequate remedies
for any such breaches. We may be forced to bring claims against third parties, including current or former employees or consultants, or defend claims that they may bring against us, to determine the ownership of what we regard as our intellectual
property, including our patent rights. Enforcing a claim that a party illegally disclosed or misappropriated a trade secret, or securing title to an employee- or consultant-developed invention if a dispute arises, is difficult, expensive and
time-consuming, and the outcome is unpredictable. If we are unsuccessful in any inventorship disputes to which we are subject, we may lose valuable intellectual property rights, such as ownership of our patent rights. In addition, some courts in the
United States and certain foreign jurisdictions disfavor or are unwilling to protect trade secrets. Further, if any of our trade secrets were to be lawfully obtained or independently developed by a competitor, we would have no right to prevent that
competitor from using the technology or information to compete with us. If any of our trade secrets were to be disclosed to or independently developed by a competitor, our competitive position would be materially and adversely harmed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be subject to claims that we or our employees or consultants have wrongfully used or disclosed alleged trade secrets or other proprietary
information of our employees&#146; or consultants&#146; former employers or their clients. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Many of our employees or consultants
and our licensors&#146; employees or consultants were previously employed at universities or biotechnology or biopharmaceutical companies, including our competitors or potential competitors. Although we try to ensure that our employees and
consultants do not use the proprietary information or <FONT STYLE="white-space:nowrap">know-how</FONT> of others in their work for us, we may be subject to claims that one or more of these </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">41 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
employees or consultants or we have inadvertently or otherwise used or disclosed intellectual property, including trade secrets or other proprietary information of any such individual&#146;s
current or former employers. Litigation or arbitration may be necessary to defend against these claims. If we fail in defending such claims, in addition to paying monetary damages, we may lose valuable intellectual property rights or personnel or
may be enjoined from using such intellectual property. Any such proceedings and possible aftermath would likely divert significant resources from our core business, including distracting our technical and management personnel from their normal
responsibilities. A loss of key research personnel or their work product could limit our ability to commercialize, or prevent us from commercializing, our current or future technologies or drug candidates, which could materially harm our business.
Even if we are successful in defending against any such claims, litigation or arbitration could result in substantial costs and could be a distraction to management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Obtaining and maintaining our patent protection depends on compliance with various procedural, document submission, fee payment and other requirements
imposed by government patent agencies, and our patent protection could be reduced or eliminated for <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these requirements. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Periodic maintenance fees, renewal fees, annuity fees and various other government fees on patents or applications will be due to be paid to
the USPTO and various government patent agencies outside of the United States over the lifetime of our patent rights and any patent rights we may own or <FONT STYLE="white-space:nowrap">in-license</FONT> in the future. The USPTO and various <FONT
STYLE="white-space:nowrap">non-U.S.</FONT> government patent agencies require compliance with several procedural, documentary, fee payment and other similar provisions during the patent application process. We employ reputable law firms and other
professionals to help us comply with these requirements, and we may also be dependent on our licensors to take the necessary action to comply with these requirements with respect to our <FONT STYLE="white-space:nowrap">in-licensed</FONT>
intellectual property. In many cases, an inadvertent lapse can be cured by payment of a late fee or by other means in accordance with the applicable rules. There are situations, however, in which
<FONT STYLE="white-space:nowrap">non-compliance</FONT> can result in abandonment or lapse of the patent or patent application, resulting in partial or complete loss of patent rights in the relevant jurisdiction. In such an event, potential
competitors might be able to enter the market with similar or identical products, which could have a material adverse effect on our business prospects and financial condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If our trademarks and trade names are not adequately protected, then we may not be able to build name recognition in our markets of interest and our
business may be adversely affected. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our trademarks or trade names may be challenged, infringed, circumvented, declared generic or
determined to be infringing on other marks. We own a pending U.S. trademark application, but do not yet own a U.S. registered trademark, for our corporate name, &#147;RAPT.&#148; We may not be able to protect our rights to these trademarks and trade
names or may be forced to stop using these names, which we use for name recognition by potential partners or customers in our markets of interest. If we are unable to establish name recognition based on our trademarks and trade names, we may not be
able to compete effectively and our business may be materially adversely affected. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Intellectual property rights do not necessarily address all
potential threats to our business. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The degree of future protection afforded by our intellectual property rights is uncertain
because intellectual property rights have limitations and may not adequately protect our business. The following examples are illustrative: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may be able to make small molecule drugs, inhibitors or formulations that are similar to our drug
candidates, but that are not covered by the claims of any patents that we own, license or control; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or any strategic partners might not have been the first to make the inventions covered by the patent rights
that we own, license or control; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">42 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we or our licensors might not have been the first to file patent applications covering certain of our owned and <FONT
STYLE="white-space:nowrap">in-licensed</FONT> inventions; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">others may independently develop the same, similar, or alternative technologies without infringing,
misappropriating or violating our intellectual property rights; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">it is possible that our pending patent applications will not lead to issued patents; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">issued patents that we may own, <FONT STYLE="white-space:nowrap">in-license,</FONT> or control may not provide us
with any competitive advantages, or may be narrowed or held invalid or unenforceable, including as a result of legal challenges; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our competitors might conduct research and development activities in the United States and other countries that
provide a safe harbor from patent infringement claims for certain research and development activities, as well as in countries where we do not have patent rights, and may then use the information learned from such activities to develop competitive
products for sale in our major commercial markets; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we may choose not to file a patent in order to maintain certain trade secrets or
<FONT STYLE="white-space:nowrap">know-how,</FONT> and a third party may subsequently file a patent covering such trade secrets or <FONT STYLE="white-space:nowrap">know-how;</FONT> and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the patents of others may have an adverse effect on our business. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Should any of these events occur, they could have a material adverse impact on our business and financial condition. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related to Government Regulation </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Clinical
development includes a lengthy and expensive process with an uncertain outcome, and results of earlier studies and trials may not be predictive of future trial results. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our drug candidates FLX475 and RPT193 are in clinical development, and their risk of failure is high. It is impossible to predict when or if
our candidates or any potential future drug candidates will prove effective in humans or will receive regulatory approval. Before obtaining marketing approval from regulatory authorities for the sale of any drug candidate, we must complete
preclinical studies and then conduct extensive clinical trials to demonstrate the safety and efficacy of a drug candidate in humans. Clinical testing is expensive and can take many years to complete, and its outcome is inherently uncertain. Failure
can occur at any time during the development process. The results of preclinical studies and clinical trials of any of our current or potential future drug candidates may not be predictive of the results of later-stage clinical trials. Drug
candidates in later stages of clinical trials may fail to show the desired safety and efficacy traits despite having progressed through preclinical studies and initial clinical trials. A number of companies in the pharmaceutical industry have
suffered significant setbacks in advanced clinical trials due to lack of efficacy or safety profiles, notwithstanding promising results in earlier trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are conducting a Phase 1/2 clinical trial investigating FLX475 as a single agent and in combination with pembrolizumab in a broad range of
tumors and we anticipate that initial data from this trial will be available by the first half of 2020. Further, we have initiated a seamless Phase 1 trial of RPT193 comprised initially of Phase 1a single and multiple dose escalation cohorts of
healthy volunteers in August 2019 with PoC data expected by <FONT STYLE="white-space:nowrap">mid-2020.</FONT> Despite these plans, we may experience delays in initiating or completing our clinical trials. We do not know whether planned clinical
trials will be completed on schedule or at all, or whether planned </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">43 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
clinical trials will begin on time, need to be redesigned, enroll patients on time or be completed on schedule, if at all. Our development programs may be delayed for a variety of reasons,
including delays related to: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the FDA or other regulatory authorities requiring us to submit additional data or imposing other requirements
before permitting us to initiate a clinical trial; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtaining regulatory approval to commence a clinical trial; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reaching agreement on acceptable terms with prospective CROs and clinical trial sites, the terms of which can be
subject to extensive negotiation and may vary significantly among different CROs and clinical trial sites; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">obtaining institutional review board (&#147;IRB&#148;), approval at each clinical trial site;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">recruiting suitable patients to participate in a clinical trial; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">having patients complete a clinical trial or return for post-treatment
<FONT STYLE="white-space:nowrap">follow-up;</FONT> </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">clinical trial sites deviating from trial protocol or dropping out of a trial; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">adding new clinical trial sites; or </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">manufacturing sufficient quantities of our drug candidates for use in clinical trials. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Furthermore, we expect to rely on our CROs and clinical trial sites to ensure the proper and timely conduct of our clinical trials and, while
we expect to enter into agreements governing their committed activities, we have limited influence over their actual performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We
could encounter delays if prescribing physicians encounter unresolved ethical issues associated with enrolling patients in clinical trials of our current or potential future drug candidates in lieu of prescribing existing treatments that have
established safety and efficacy profiles. Further, a clinical trial may be suspended or terminated by us, our partners, the IRBs of the institutions in which such trials are being conducted, the Data Safety Monitoring Board for such trial or by the
FDA or other regulatory authorities due to a number of factors, including failure to conduct the clinical trial in accordance with regulatory requirements or our clinical protocols, inspection of the clinical trial operations or trial site by the
FDA or other regulatory authorities resulting in the imposition of a clinical hold, unforeseen safety issues or adverse side effects, failure to demonstrate a benefit from using a drug or therapeutic biologic, changes in governmental regulations or
administrative actions or lack of adequate funding to continue the clinical trial. If we experience delays in the completion of, or termination of, any clinical trial of any of our current or potential future drug candidates, the commercial
prospects of such drug candidate will be harmed, and our ability to generate product revenue from such drug candidates will be delayed. In addition, any delays in completing our clinical trials will increase our costs, slow our product development
and approval process and jeopardize our ability to commence product sales and generate revenue. Any of these occurrences may materially and adversely affect our business, financial condition, results of operations and prospects. In addition, many of
the factors that cause, or lead to, a delay in the commencement or completion of clinical trials may also ultimately lead to the denial of regulatory approval of our current or potential future drug candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may be unable to obtain U.S. or foreign regulatory approval and, as a result, be unable to commercialize FLX475, RPT193 or an RPT-GCN2i or other
future drug candidate. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">FLX475, RPT193, an RPT-GCN2i and other future drug candidates are and will be subject to extensive
governmental regulations relating to, among other things, research, testing, development, manufacturing, safety, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">44 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
efficacy, approval, recordkeeping, reporting, labeling, storage, packaging, advertising and promotion, pricing, marketing and distribution of drugs and therapeutic biologics. Rigorous preclinical
testing and clinical trials and an extensive regulatory approval process are required to be successfully completed in the U.S. and in many foreign jurisdictions before a new drug, therapeutic or biologic can be marketed. Satisfaction of these and
other regulatory requirements is costly, time-consuming, uncertain and subject to unanticipated delays. It is possible that none of the drug candidates we may develop will obtain the regulatory approvals necessary for us or our potential future
partners to begin selling them. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have very limited experience in conducting and managing the clinical trials necessary to obtain
regulatory approvals, including approval by the FDA. The time required to obtain FDA and other approvals is unpredictable but typically takes many years following the commencement of clinical trials, depending upon the type, complexity and novelty
of the drug candidate. The standards that the FDA and its foreign counterparts use when regulating us require judgment and can change, which makes it difficult to predict with certainty how they will be applied. Any analysis we perform of data from
preclinical and clinical activities is subject to confirmation and interpretation by regulatory authorities, which could delay, limit or prevent regulatory approval. We may also encounter unexpected delays or increased costs due to new government
regulations, for example, from future legislation or administrative action, or from changes in FDA policy during the period of product development, clinical trials and FDA regulatory review. It is impossible to predict whether legislative changes
will be enacted, or whether FDA or foreign regulations, guidance or interpretations will be changed, or what the impact of such changes, if any, may be. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any delay or failure in obtaining required approvals could have a material and adverse effect on our ability to generate revenue from the
particular drug candidate for which we are seeking approval. Further, we and our potential future partners may never receive approval to market and commercialize any drug candidate. Even if we or a potential future partner obtains regulatory
approval, the approval may be for targets, disease indications or patient populations that are not as broad as we intended or desired or may require labeling that includes significant use or distribution restrictions or safety warnings. We or a
potential future partner may be subject to post-marketing testing requirements to maintain regulatory approval. If any of our drug candidates prove to be ineffective, unsafe or commercially unviable, we may have to
<FONT STYLE="white-space:nowrap">re-engineer</FONT> FLX475, RPT193 or an RPT-GCN2i or other future drug candidate, and our entire pipeline could have little, if any, value, which could require us to change our focus and approach to small molecule
discovery and development, which would have a material and adverse effect on our business, financial condition, results of operations and prospects. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are also subject to numerous foreign regulatory requirements governing, among other things, the conduct of clinical trials, manufacturing
and marketing authorization, pricing and third-party reimbursement. The foreign regulatory approval process varies among countries and may include all of the risks associated with FDA approval described above as well as risks attributable to the
satisfaction of local regulations in foreign jurisdictions. Moreover, the time required to obtain approval may differ from that required to obtain FDA approval. Approval by the FDA does not ensure approval by regulatory authorities outside the
United States and vice versa. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if we receive regulatory approval for any of our current or potential future drug candidates, we will be subject
to ongoing regulatory obligations and continued regulatory review, which may result in significant additional expense. Additionally, our current or potential future drug candidates, if approved, could be subject to labeling and other restrictions
and market withdrawal and we may be subject to penalties if we fail to comply with regulatory requirements or experience unanticipated problems with our products. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any regulatory approvals that we or potential future partners obtain for FLX475, RPT193 or an
<FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> or other future drug candidate may also be subject to limitations on the approved indicated uses for which a product may be marketed or to the conditions of approval, or contain requirements for
potentially costly post-marketing testing, including &#147;Phase&nbsp;4&#148; clinical trials, and surveillance to monitor the safety and efficacy of such drug candidate. In addition, if the FDA or other regulatory authority approves FLX475, RPT193
or an </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">45 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
<FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> or other future drug candidate, the manufacturing processes, labeling, packaging, distribution, adverse event reporting, storage, import, export,
advertising, promotion and recordkeeping for such product will be subject to extensive and ongoing regulatory requirements. These requirements include submissions of safety and other post-marketing information and reports, registration, as well as
continued compliance with cGMP and good clinical practices for any clinical trials that we conduct post-approval. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with
our third-party manufacturers or manufacturing processes, or failure to comply with regulatory requirements, may result in, among other things: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of the product, withdrawal of the product from the market or
voluntary or mandatory product recalls; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning letters or holds on clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal by the FDA to approve pending applications or supplements to approved applications filed by us or our
strategic partners; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">suspension or revocation of product license approvals; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention or refusal to permit the import or export of products; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The FDA&#146;s policies may change and additional government regulations may be enacted that could prevent, limit or delay regulatory approval
of our drug candidates. We cannot predict the likelihood, nature or extent of government regulation that may arise from future legislation or administrative action, either in the United States or abroad. If we are slow or unable to adapt to changes
in existing requirements or the adoption of new requirements or policies, or if we are not able to maintain regulatory compliance, we may lose any marketing approval that we may have obtained and we may not achieve or sustain profitability, which
would adversely affect our business. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Healthcare legislative reform measures may have a material adverse effect on our business and results of
operations. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the United States, there have been and continue to be a number of legislative initiatives to contain healthcare
costs. For example, in March 2010, the Patient Protection and Affordable Care Act (the &#147;ACA&#148;), was enacted, which substantially changed the way healthcare is financed by both governmental and private insurers, and significantly impacted
the U.S. pharmaceutical industry. Among the provisions of the ACA, of greatest importance to the pharmaceutical and biotechnology industry are the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an annual, nondeductible fee on any entity that manufactures or imports certain specified branded prescription
drugs and biologic agents apportioned among these entities according to their market share in some government healthcare programs; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an increase in the statutory minimum rebates a manufacturer must pay under the Medicaid Drug Rebate Program to
23.1% and 13% of the average manufacturer price for most branded and generic drugs, respectively, and capped the total rebate amount for innovator drugs at 100% of the Average Manufacturer Price (&#147;AMP&#148;); </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated
for certain drugs and biologics that are inhaled, infused, instilled, implanted or injected; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">46 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">extension of manufacturers&#146; Medicaid rebate liability to covered drugs dispensed to individuals who are
enrolled in Medicaid managed care organizations; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expansion of eligibility criteria for Medicaid programs by, among other things, allowing states to offer Medicaid
coverage to additional individuals and by adding new mandatory eligibility categories for individuals with income at or below 133% of the federal poverty level, thereby potentially increasing manufacturers&#146; Medicaid rebate liability;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a new Medicare Part D coverage gap discount program, in which manufacturers must agree to offer 50% (and 70% as
of January&nbsp;1, 2019) <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discounts off negotiated prices of applicable brand drugs to eligible beneficiaries during their coverage gap period, as a
condition for the manufacturer&#146;s outpatient drugs to be covered under Medicare Part D; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expansion of the entities eligible for discounts under the Public Health program; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a new Patient-Centered Outcomes Research Institute to oversee, identify priorities in, and conduct comparative
clinical effectiveness research, along with funding for such research; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishment of a Center for Medicare Innovation at CMS to test innovative payment and service delivery models
to lower Medicare and Medicaid spending; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">implementation of the federal physician payment transparency requirements, sometimes referred to as the
&#147;Physician Payments Sunshine Act&#148;. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Some of the provisions of the ACA have yet to be fully implemented, and
there have been legal and political challenges to certain aspects of the ACA. Since January 2017, President Trump has signed two executive orders and other directives designed to delay, circumvent, or loosen certain requirements mandated by the ACA.
Concurrently, Congress has considered legislation that would repeal or repeal and replace all or part of the ACA. While Congress has not passed comprehensive repeal legislation, two bills affecting the implementation of certain taxes under the ACA
have been signed into law. The Tax Cuts and Jobs Act of 2017 (the &#147;Tax Act&#148;), includes a provision that repealed, effective January&nbsp;1, 2019, the <FONT STYLE="white-space:nowrap">tax-based</FONT> shared responsibility payment imposed
by the ACA on certain individuals who fail to maintain qualifying health coverage for all or part of a year, that is commonly referred to as the &#147;individual mandate.&#148; Additionally, on January&nbsp;22, 2018, President Trump signed a
continuing resolution on appropriations for fiscal year 2018 that delayed the implementation of certain <FONT STYLE="white-space:nowrap">ACA-mandated</FONT> fees, including the <FONT STYLE="white-space:nowrap">so-called</FONT> &#147;Cadillac&#148;
tax on certain high cost employer-sponsored insurance plans, the annual fee imposed on certain health insurance providers based on market share, and the medical device excise tax on <FONT STYLE="white-space:nowrap">non-exempt</FONT> medical devices.
Further, the Bipartisan Budget Act of 2018 (&#147;BBA&#148;), among other things, amended the ACA, effective January&nbsp;1, 2019, to close the coverage gap in most Medicare drug plans, commonly referred to as the &#147;donut hole.&#148; In July
2018, CMS published a final rule permitting further collections and payments to and from certain ACA qualified health plans and health insurance issuers under the ACA risk adjustment program in response to the outcome of federal district court
litigation regarding the method CMS uses to determine this risk adjustment. On December&nbsp;14, 2018, a U.S. District Court Judge in the Northern District of Texas ruled that the individual mandate is an inseverable feature of the ACA, and
therefore, because it was repealed as part of the Tax Act, the remaining provisions of the ACA are invalid as well. While the Texas U.S. District Court Judge, as well as the Trump Administration and CMS have stated that the ruling will have no
immediate effect, it is unclear how this decision, subsequent appeals, and other efforts to repeal and replace the ACA will impact the ACA and our business. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. On August&nbsp;2, 2011,
the Budget Control Act of 2011 among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years
2013 through 2021, was unable to reach required </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">47 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
goals, thereby triggering the legislation&#146;s automatic reduction to several government programs. This includes aggregate reductions of Medicare payments to providers of 2% per fiscal year.
These reductions went into effect on April&nbsp;1, 2013 and, due to subsequent legislative amendments to the statute, will remain in effect through 2027 unless additional Congressional action is taken. On January&nbsp;2, 2013, the American Taxpayer
Relief Act of 2012 was signed into law, which, among other things, further reduced Medicare payments to several types of providers. Additionally, there has been heightened governmental scrutiny recently over the manner in which manufacturers set
prices for their marketed products. For example, there have been several recent Congressional inquiries and proposed and enacted federal and state legislation designed to, among other things, bring more transparency to drug pricing, review the
relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. At the federal level, the Trump administration&#146;s budget proposal for fiscal year 2019 contains further
drug price control measures that could be enacted during the 2019 budget process or in other future legislation, including, for example, measures to permit Medicare Part D plans to negotiate the price of certain drugs under Medicare Part B, to allow
some states to negotiate drug prices under Medicaid, and to eliminate cost sharing for generic drugs for <FONT STYLE="white-space:nowrap">low-income</FONT> patients. Further, the Trump administration released a &#147;Blueprint&#148; to lower drug
prices and reduce out of pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal healthcare programs, incentivize manufacturers to lower the list price of their
products and reduce the out of pocket costs of drug products paid by consumers. In addition, on January&nbsp;31, 2019, the HHS Office of Inspector General, proposed modifications to the federal Anti-Kickback Statute discount safe harbor for the
purpose of reducing the cost of drug products to consumers which, among other things, if finalized, will affect discounts paid by manufacturers to Medicare Part D plans, Medicaid managed care organizations and pharmacy benefit managers working with
these organizations. Although a number of these, and other potential, proposals will require additional authorization to become effective, Congress and the executive branch have each indicated that it will continue to seek new legislative or
administrative measures to control drug costs. At the state level, legislatures have increasingly passed legislation and implemented regulations designed to control pharmaceutical and biological product pricing, including price or patient
reimbursement constraints, discounts, restrictions on certain product access and marketing cost disclosure and transparency measures and, in some cases, designed to encourage importation from other countries and bulk purchasing. These new laws and
initiatives may result in additional reductions in Medicare and other healthcare funding, which could have a material adverse effect on our future customers and accordingly, our financial operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect that additional state and federal healthcare reform measures will be adopted in the future, any of which could limit the amounts
that federal and state governments will pay for healthcare products and services, which could result in reduced demand for our drug candidates or additional pricing pressures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we or potential future partners, manufacturers or service providers fail to comply with healthcare laws and regulations, we or they could be subject
to enforcement actions, which could affect our ability to develop, market and sell our products and may harm our reputation. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Healthcare providers, physicians and third-party payors, among others, will play a primary role in the prescription and recommendation of any
drug candidates for which we obtain marketing approval. Our current and future arrangements with third-party payors, providers and customers, among others, may expose us to broadly applicable fraud and abuse and other healthcare laws and regulations
that may constrain the business or financial arrangements and relationships through which we market, sell and distribute our drug candidates for which we obtain marketing approval. Restrictions under applicable federal and state healthcare laws and
regulations, include the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal Anti-Kickback Statute, which prohibits, among other things, a person or entity from knowingly and
willfully soliciting, offering, paying, receiving or providing remuneration, directly or indirectly, in cash or in kind, to induce or reward either the referral of an individual for, or the purchase, lease order, arranging for or recommendation of,
any good, facility, item or service, for which payment may be made, in whole or in part, by a federal healthcare program, such as </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">48 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">
Medicare or Medicaid. A person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation. In addition, a violation of
the Anti-Kickback Statute can form the basis for a violation of the federal False Claims Act (discussed below); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">federal civil and criminal false claims laws and civil monetary penalties laws, including the federal False
Claims Act, which provides for civil whistleblower or qui tam actions, that impose penalties against individuals or entities for knowingly presenting, or causing to be presented, to the federal government, claims for payment that are false or
fraudulent or making a false statement to avoid, decrease or conceal an obligation to pay money to the federal government. In addition, the government may assert that a claim including items and services resulting from a referral made in violation
of the federal Anti-Kickback Statute constitutes a false or fraudulent claim for purposes of the False Claims Act; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, which imposes criminal and civil liability for executing a scheme to defraud any healthcare benefit
program, or knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal
Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in order to have committed a violation; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">HIPAA, as amended by HITECH, and its implementing regulations, including the Final Omnibus Rule published in
January 2013, which impose obligations on certain covered entity healthcare providers, health plans, and healthcare clearinghouses as well as their business associates that perform certain services involving the use or disclosure of individually
identifiable health information, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information, and require notification to affected individuals and
regulatory authorities of certain breaches of security of individually identifiable health information; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal false statements statute, which prohibits knowingly and willfully falsifying, concealing or covering
up a material fact or making any materially false statement in connection with the delivery of or payment for healthcare benefits, items or services; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the federal transparency requirements known as the federal Physician Payments Sunshine Act, created as part of
ACA, which requires certain manufacturers of drugs, devices, biologics and medical supplies for which payment is available under Medicare, Medicaid or the Children&#146;s Health Insurance Program to report annually to CMS information related to
payments and other transfers of value made by that entity to physicians and teaching hospitals, as well as ownership and investment interests held by physicians and their immediate family members; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">analogous local, state and foreign laws and regulations, such as state anti-kickback and false claims laws that
may apply to healthcare items or services reimbursed by third-party payors, including private insurers; local, state and foreign transparency laws that require manufacturers to report information related to payments and transfers of value to other
healthcare providers and healthcare entities, marketing expenditures, or drug pricing; state laws that require pharmaceutical companies to register certain employees engaged in marketing activities in the location and comply with the pharmaceutical
industry&#146;s voluntary compliance guidelines and the relevant compliance guidance promulgated by the federal government; and state and foreign laws governing the privacy and security of health information in certain circumstances, many of which
differ from each other in significant ways and often are not preempted by HIPAA, thus complicating compliance efforts. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">49 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Ensuring that our future business arrangements with third parties comply with applicable
healthcare laws and regulations could involve substantial costs. If our operations are found to be in violation of any such requirements, we may be subject to penalties, including criminal and significant civil monetary penalties, damages, fines,
individual imprisonment, disgorgement, contractual damages, reputational harm, exclusion from participation in government healthcare programs, integrity obligations, injunctions, recall or seizure of products, total or partial suspension of
production, denial or withdrawal of <FONT STYLE="white-space:nowrap">pre-marketing</FONT> product approvals, private qui tam actions brought by individual whistleblowers in the name of the government, refusal to allow us to enter into supply
contracts, including government contracts, additional reporting requirements and oversight if subject to a corporate integrity agreement or similar agreement to resolve allegations of <FONT STYLE="white-space:nowrap">non-compliance</FONT> with these
laws, and the curtailment or restructuring of our operations, any of which could adversely affect our ability to operate our business and our results of operations. Although effective compliance programs can mitigate the risk of investigation and
prosecution for violations of these laws, these risks cannot be entirely eliminated. Any action against us for an alleged or suspected violation could cause us to incur significant legal expenses and could divert our management&#146;s attention from
the operation of our business, even if our defense is successful. In addition, achieving and sustaining compliance with applicable laws and regulations may be costly to us in terms of money, time and resources. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If we fail to comply with U.S. and foreign regulatory requirements, regulatory authorities could limit or withdraw any marketing or commercialization
approvals we may receive and subject us to other penalties that could materially harm our business. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Even if we receive marketing
and commercialization approval of a drug candidate, we will be subject to continuing regulatory requirements, including in relation to adverse patient experiences with the product and clinical results that are reported after a product is made
commercially available, both in the United States and any foreign jurisdiction in which we seek regulatory approval. The FDA has significant post-market authority, including the authority to require labeling changes based on new safety information
and to require post-market studies or clinical trials to evaluate safety risks related to the use of a product or to require withdrawal of the product from the market. The FDA also has the authority to require a Risk Evaluation and Mitigation
Strategy (&#147;REMS&#148;), after approval, which may impose further requirements or restrictions on the distribution or use of an approved drug or therapeutic biologic. The manufacturer and manufacturing facilities we use to make a future product,
if any, will also be subject to periodic review and inspection by the FDA and other regulatory agencies, including for continued compliance with cGMP requirements. The discovery of any new or previously unknown problems with our third-party
manufacturers, manufacturing processes or facilities may result in restrictions on the product, manufacturer or facility, including withdrawal of the product from the market. We intend to rely on third-party manufacturers and we will not have
control over compliance with applicable rules and regulations by such manufacturers. Any product promotion and advertising will also be subject to regulatory requirements and continuing regulatory review. If we or our existing or future partners,
manufacturers or service providers fail to comply with applicable continuing regulatory requirements in the U.S. or foreign jurisdictions in which we seek to market our products, we or they may be subject to, among other things, fines, warning
letters, holds on clinical trials, delay of approval or refusal by the FDA to approve pending applications or supplements to approved applications, suspension or withdrawal of regulatory approval, product recalls and seizures, administrative
detention of products, refusal to permit the import or export of products, operating restrictions, injunction, civil penalties and criminal prosecution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Even if we are able to commercialize any drug candidate, such drug candidate may become subject to unfavorable pricing regulations or third-party
coverage and reimbursement policies, which would harm our business. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our ability to commercialize any products successfully will
depend, in part, on the extent to which coverage and adequate reimbursement for these products and related treatments will be available from third-party payors, such as government authorities, private health insurers and health maintenance
organizations. Patients who are prescribed medications for the treatment of their conditions generally rely on third-party payors to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">50 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reimburse all or part of the costs associated with their prescription drugs. Coverage and adequate reimbursement from government healthcare programs, such as Medicare and Medicaid, and private
health insurers are critical to new product acceptance. Patients are unlikely to use our future products, if any, unless coverage is provided and reimbursement is adequate to cover a significant portion of the cost. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Cost-containment is a priority in the U.S. healthcare industry and elsewhere. As a result, government authorities and other third-party payors
have attempted to control costs by limiting coverage and the amount of reimbursement for particular medications. Increasingly, third-party payors are requiring that drug companies provide them with predetermined discounts from list prices and are
challenging the prices charged for medical products. Third-party payors also may request additional clinical evidence beyond the data required to obtain marketing approval, requiring a company to conduct expensive pharmacoeconomic studies in order
to demonstrate the medical necessity and cost-effectiveness of its product. Commercial third-party payors often rely upon Medicare coverage policy and payment limitations in setting their reimbursement rates, but also have their own methods and
approval process apart from Medicare determinations. Therefore, coverage and reimbursement for pharmaceutical products in the U.S. can differ significantly from payor to payor. We cannot be sure that coverage and adequate reimbursement will be
available for any product that we commercialize and, if reimbursement is available, that the level of reimbursement will be adequate. Coverage and reimbursement may impact the demand for, or the price of, any drug candidate for which we obtain
marketing approval. If coverage and reimbursement are not available or are available only at limited levels, we may not be able to successfully commercialize any drug candidate for which we obtain marketing approval. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Additionally, the regulations that govern regulatory approvals, pricing and reimbursement for new drugs and therapeutic biologics vary widely
from country to country. Some countries require approval of the sale price of a drug or therapeutic biologic before it can be marketed. In many countries, the pricing review period begins after marketing approval is granted. In some foreign markets,
prescription pharmaceutical pricing remains subject to continuing governmental control even after initial approval is granted. As a result, we might obtain regulatory approval for a product in a particular country, but then be subject to price
regulations that delay our commercial launch of the product, possibly for lengthy time periods, and negatively impact the revenues we are able to generate from the sale of the product in that country. Adverse pricing limitations may hinder our
ability to recoup our investment in one or more drug candidates, even if our drug candidates obtain regulatory approval. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are subject to U.S. and
foreign anti-corruption and anti-money laundering laws with respect to our operations and <FONT STYLE="white-space:nowrap">non-compliance</FONT> with such laws can subject us to criminal or civil liability and harm our business. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are subject to the U.S. Foreign Corrupt Practices Act of 1977, as amended (&#147;the FCPA&#148;), the U.S. domestic bribery statute
contained in 18 U.S.C. &#167; 201, the U.S. Travel Act, the USA PATRIOT Act, and possibly other state and national anti-bribery and anti-money laundering laws in countries in which we conduct activities. Anti-corruption laws are interpreted broadly
and prohibit companies and their employees, agents, third-party intermediaries, joint venture partners and collaborators from authorizing, promising, offering or providing, directly or indirectly, improper payments or benefits to recipients in the
public or private sector. We interact with officials and employees of government agencies and government-affiliated hospitals, universities and other organizations. In addition, we may engage third-party intermediaries to promote our clinical
research activities abroad or to obtain necessary permits, licenses and other regulatory approvals. We can be held liable for the corrupt or other illegal activities of these third-party intermediaries, our employees, representatives, contractors,
partners and agents, even if we do not explicitly authorize or have actual knowledge of such activities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In connection with this
offering, we will adopt a Code of Business Conduct and Ethics that will be effective upon the closing of this offering and we expect to prepare and implement policies and procedures to ensure compliance with such code. The Code of Business Conduct
and Ethics mandates compliance with the FCPA and other anti-corruption laws applicable to our business throughout the world. However, we cannot assure you that our employees and third-party intermediaries will comply with this code or such
anti-corruption </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">51 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
laws. Noncompliance with anti-corruption and anti-money laundering laws could subject us to whistleblower complaints, investigations, sanctions, settlements, prosecution, other enforcement
actions, disgorgement of profits, significant fines, damages, other civil and criminal penalties or injunctions, suspension or debarment from contracting with certain persons, the loss of export privileges, reputational harm, adverse media coverage
and other collateral consequences. If any subpoenas, investigations or other enforcement actions are launched, or governmental or other sanctions are imposed, or if we do not prevail in any possible civil or criminal litigation, our business,
results of operations and financial condition could be materially harmed. In addition, responding to any action will likely result in a materially significant diversion of management&#146;s attention and resources and significant defense and
compliance costs and other professional fees. In certain cases, enforcement authorities may even cause us to appoint an independent compliance monitor which can result in added costs and administrative burdens. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comprehensive tax reform bills could adversely affect our business and financial condition. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">On December&nbsp;20, 2017, the U.S. Congress passed the Tax Act, enacting comprehensive tax legislation that includes significant changes to
the taxation of business entities. These changes include, among others: a permanent reduction to the corporate income tax rate; a partial limitation on the deductibility of business interest expense; a shift of the U.S. taxation of multinational
corporations from a tax on worldwide income to a territorial system (along with certain rules designed to prevent erosion of the U.S. income tax base); and a <FONT STYLE="white-space:nowrap">one-time</FONT> tax on accumulated offshore earnings held
in cash and illiquid assets, with the latter taxed at a lower rate. Notwithstanding the reduction in the corporate income tax rate, the overall impact of this tax reform remains uncertain, and our business and financial condition could be adversely
affected. This prospectus does not provide an <FONT STYLE="white-space:nowrap">in-depth</FONT> discussion of any such tax legislation or the manner in which it might affect purchasers of our common stock. We urge our stockholders to consult with
their legal and tax advisors with respect to any such legislation and the potential tax consequences of investing in our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Risks Related
to Our Common Stock and this Offering </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our quarterly operating results may fluctuate significantly or may fall below the expectations of
investors or securities analysts, each of which may cause our stock price to fluctuate or decline. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect our operating
results to be subject to quarterly fluctuations. Our net loss and other operating results will be affected by numerous factors, including: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">variations in the level of expense related to the ongoing development of our drug candidates or future
development programs; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results of clinical trials, or the addition or termination of clinical trials or funding support by us or
potential future partners; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our execution of any collaboration, licensing or similar arrangements, and the timing of payments we may make or
receive under potential future arrangements or the termination or modification of any such potential future arrangements; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any intellectual property infringement, misappropriation or violation lawsuit or opposition, interference or
cancellation proceeding in which we may become involved; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">additions and departures of key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">strategic decisions by us or our competitors, such as acquisitions, divestitures, spin-offs, joint ventures,
strategic investments or changes in business strategy; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">52 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">if any of our drug candidates receives regulatory approval, the terms of such approval and market acceptance and
demand for such drug candidates; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments affecting our drug candidates or those of our competitors; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in general market and economic conditions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If our quarterly operating results fall below the expectations of investors or securities analysts, the price of our common stock could
decline substantially. Furthermore, any quarterly fluctuations in our operating results may, in turn, cause the price of our stock to fluctuate substantially. We believe that quarterly comparisons of our financial results are not necessarily
meaningful and should not be relied upon as an indication of our future performance. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our stock price may be volatile and purchasers of our common
stock could incur substantial losses. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our stock price is likely to be volatile. As a result of this volatility, investors may not
be able to sell their common stock at or above the initial public offering price. The market price for our common stock may be influenced by many factors, including the other risks described in this section of the prospectus titled &#147;Risk
Factors&#148; and the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to advance FLX475, RPT193 or other potential future drug candidates in the clinic;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">results of our preclinical studies, non-clinical studies and clinical trials for our current and future drug
candidates or those of our competitors or potential future partners; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory or legal developments in the United States and other countries, especially changes in laws or
regulations applicable to our products; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of competitive products or technologies; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">introductions and announcements of new products by us, our future commercialization partners, or our competitors,
and the timing of these introductions or announcements; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actions taken by regulatory agencies with respect to our products, clinical trials, manufacturing process or
sales and marketing terms; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actual or anticipated variations in our financial results or those of companies that are perceived to be similar
to us; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the success of our efforts to acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> additional
technologies, products or drug candidates; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments concerning any future collaborations, including, but not limited to, those with our sources of
manufacturing supply and our commercialization partners; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">market conditions in the pharmaceutical and biotechnology sectors; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcements by us or our competitors of significant acquisitions, strategic partnerships, joint ventures or
capital commitments; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developments, disputes or litigation matters concerning patents or other intellectual property rights, and our
ability to obtain and maintain patent protection for our products; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">53 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability or inability to raise additional capital and the terms on which we raise it; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the recruitment or departure of key personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in the structure of healthcare payment systems; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">actual or anticipated changes in earnings estimates or changes in stock market analyst recommendations regarding
our common stock, other comparable companies or our industry generally; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our failure or the failure of our competitors to meet analysts&#146; projections or guidance that we or our
competitors may give to the market; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fluctuations in the valuation of companies perceived by investors to be comparable to us; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">announcement and expectation of additional financing efforts; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">speculation in the press or investment community; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">trading volume of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sales of our common stock by us or our stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the concentrated ownership of our common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">changes in accounting principles; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">terrorist acts, acts of war or periods of widespread civil unrest; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">natural disasters and other calamities; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">general economic, industry and market conditions. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, the stock markets in general, and the markets for pharmaceutical, biopharmaceutical and biotechnology stocks in particular, have
experienced extreme volatility that has been often unrelated to the operating performance of the issuer. These broad market and industry factors may seriously harm the market price of our common stock, regardless of our operating performance.
Substantial purchases of common stock by existing stockholders could reduce the liquidity of the trading market for our common stock and increase price volatility. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>You will experience immediate and substantial dilution as a result of this offering and may experience additional dilution in the future. </I></B></P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If you purchase common stock in this offering, assuming a public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, the midpoint of the range set forth on the cover of this prospectus, you will incur immediate and substantial dilution of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share, representing the difference between the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;per share and our pro forma net tangible book value per share as of June&nbsp;30, 2019 after giving effect to this offering and the conversion of all outstanding shares
of our Series A, Series B, Series C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock into common stock immediately upon the closing of this offering. Moreover, we issued options in the past to acquire common stock
and securities convertible into common stock at prices significantly below the assumed initial public offering price. As of June&nbsp;30, 2019, there were 1,049,976&nbsp;shares of our common stock subject to outstanding options at a weighted average
purchase price of $6.11 per share. To the extent that any of these outstanding securities are ultimately exercised or settled, you will incur further dilution. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">54 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Raising additional capital may cause dilution to our stockholders, including purchasers of common
stock in this offering, restrict our operations or require us to relinquish rights to our technologies or drug candidates. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Until
such time, if ever, as we can generate substantial product revenues, we expect to finance our cash needs through a combination of equity offerings, debt financings, collaborations, strategic alliances and licensing arrangements. To the extent that
we raise additional capital through the sale of equity or convertible debt securities, your ownership interest will be diluted and the terms of these securities may include liquidation or other preferences that adversely affect your rights as a
common stockholder. Debt financing, if available, may involve agreements that include covenants limiting or restricting our ability to take specific actions, such as incurring additional debt, making capital expenditures or declaring dividends. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If we raise funds through collaborations, strategic alliances or licensing arrangements with third parties, we may have to relinquish valuable
rights to our technologies, future revenue streams, research programs or drug candidates or to grant licenses on terms that may not be favorable to us. If we are unable to raise additional funds through equity or debt financings when needed, we may
be required to delay, limit, reduce or terminate our product development or future commercialization efforts or grant rights to develop and market drug candidates that we would otherwise prefer to develop and market ourselves. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>An active trading market for our common stock may not develop. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has been no public market for our common stock. The initial public offering price for our common stock will be
determined through negotiations with the underwriters. Although we have applied to list our common stock on the Nasdaq Global Market, an active trading market for our shares may never develop or be sustained following this offering. If an active
market for our common stock does not develop, it may be difficult for you to sell shares you purchase in this offering without depressing the market price for the shares or at all. Substantial purchases of common stock by existing stockholders could
reduce the liquidity of the trading market for our common stock and increase price volatility. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because our management will have flexibility in
allocating the net proceeds from this offering, you may not agree with how we use them and the proceeds may not be invested successfully. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We intend to use the net proceeds from this offering to fund preclinical and clinical development activities for FLX475, RPT193 and an <FONT
STYLE="white-space:nowrap">RPT-GCN2i</FONT> or other future drug candidates, further development of our drug discovery and development engine and additional drug candidates, hiring of additional personnel, capital expenditures, costs of operating as
a public company and for other general purposes. We may also use a portion of the net proceeds from this offering to <FONT STYLE="white-space:nowrap">in-license,</FONT> acquire or invest in complementary businesses, technologies, products or assets.
However, we have no current commitments or obligations to do so. Therefore, our management will have flexibility in allocating the net proceeds from this offering. Accordingly, you will be relying on the judgment of our management with regard to the
allocation of these net proceeds, and you will not have the opportunity, as part of your investment decision, to assess whether the proceeds are being allocated appropriately. It is possible that the proceeds will be invested in a way that does not
yield a favorable, or any, return for our company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>If securities or industry analysts do not publish research or reports about our company, or if
they issue an adverse or misleading opinion regarding our stock, our stock price and trading volume could decline. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The trading
market for our common stock will be influenced by the research and reports that industry or securities analysts publish about us or our business. We do not currently have and may never obtain research coverage by securities and industry analysts. If
no or few securities or industry analysts commence coverage of our company, the trading price for our common stock would be negatively impacted. In the event we obtain securities or industry analyst coverage, if any of the analysts who cover us
issue an adverse or misleading opinion regarding us, our business model, our intellectual property rights or our common stock performance, or if our target studies and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">55 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
operating results fail to meet the expectations of the analysts, our stock price would likely decline. If one or more of these analysts cease coverage of our company or fail to publish reports on
us regularly, we could lose visibility in the financial markets, which in turn could cause our stock price or trading volume to decline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our
principal stockholders and management own a significant percentage of our stock and will be able to exert significant control over matters subject to stockholder approval. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Based on the beneficial ownership of our capital stock as of September&nbsp;15, 2019, our executive officers and directors, together with
holders of 5% or more of our capital stock before this offering and their respective affiliates, will beneficially own approximately &nbsp;&nbsp;&nbsp;&nbsp;% of our common stock immediately after the closing of this offering without giving effect
to any additional purchases by these holders in the offering and assuming no exercise of the underwriters option to purchase additional shares. Certain of our executive officers, directors and holders of 5% or more of our capital stock before this
offering, and their respective affiliates, have expressed indications of interest to purchase up to approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of our common stock in this offering and, if these holders
purchase the full amount for which they have expressed non-binding indications of interest, their beneficial ownership immediately after the closing of this offering would increase to &nbsp;&nbsp;&nbsp;&nbsp;%, based on an assumed initial public
offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. As a result, these stockholders, if acting together, will continue to have significant influence over the outcome of corporate actions requiring
stockholder approval, including the election of directors, any merger, consolidation or sale of all or substantially all of our assets and any other significant corporate transaction. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The interests of these stockholders may not be the same as, and may even conflict with, your interests. For example, these stockholders could
delay or prevent a change of control of our company, even if such a change of control would benefit our other stockholders, which could deprive our stockholders of an opportunity to receive a premium for their common stock as part of a sale of our
company or our assets and might affect the prevailing market price of our common stock. The significant concentration of stock ownership may adversely affect the trading price of our common stock due to investors&#146; perception that conflicts of
interest may exist or arise. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sales of a substantial number of shares of our common stock by our existing stockholders in the public market could
cause our stock price to fall. </I></B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If our existing stockholders sell, or indicate an intention to sell, substantial amounts of
our common stock in the public market after the <FONT STYLE="white-space:nowrap">lock-up</FONT> and other legal restrictions on resale discussed in this prospectus lapse, the trading price of our common stock could decline. Based on
812,759&nbsp;shares of common stock outstanding at June&nbsp;30, 2019, and after giving effect to the conversion of our outstanding Series A, Series B, Series C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock,
immediately upon the closing of this offering we will have outstanding a total of 18,279,943&nbsp;shares of common stock. Of these shares, only the shares of common stock sold in this offering by us, plus any shares sold upon exercise of the
underwriters&#146; option to purchase additional shares, will be freely tradable without restriction in the public market immediately following this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect that the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements pertaining to this offering will expire after 180 days from the
date of this prospectus. BMO Capital Markets Corp., Wells Fargo Securities, LLC and UBS Securities LLC, however, may, in their sole discretion, permit our officers, directors and other stockholders who are subject to these <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements to sell shares prior to the expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. In addition, shares of common stock that are either subject to outstanding options or
reserved for future issuance under our 2019 Equity Incentive Plan (&#147;2019 Plan&#148;), will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, the
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreements and Rule 144 and Rule 701 under the Securities Act. If these additional shares of common stock are sold, or if it is perceived that they will be sold, in the public market, the trading price
of our common stock could decline. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">After this offering, the holders of 17,467,184&nbsp;shares of our common stock issuable upon
conversion of our convertible preferred stock at June&nbsp;30, 2019 will be entitled to rights with respect to the registration of their </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">56 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
shares under the Securities Act, subject to the <FONT STYLE="white-space:nowrap">180-day</FONT> <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above, as applicable. See
&#147;Description of Capital Stock&#151;Registration Rights&#148;. Registration of these shares under the Securities Act would result in the shares becoming freely tradable without restriction under the Securities Act, except for shares held by
affiliates, as defined in Rule 144 under the Securities Act. Any sales of securities by these stockholders could have a material adverse effect on the trading price of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Future sales and issuances of our common stock or rights to purchase common stock, including pursuant to our 2019 Equity Incentive Plan, could result in
additional dilution of the percentage ownership of our stockholders and could cause our stock price to fall. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect that
significant additional capital may be needed in the future to continue our planned operations, including further development of our drug discovery and development engine, preparing IND filings, conducting clinical trials, commercialization efforts,
expanded research and development activities and costs associated with operating a public company. To raise capital, we may sell common stock, convertible securities or other equity securities in one or more transactions at prices and in a manner we
determine from time to time. If we sell common stock, convertible securities or other equity securities, investors may be materially diluted by subsequent sales. Such sales may also result in material dilution to our existing stockholders, and new
investors could gain rights, preferences and privileges senior to the holders of our common stock, including shares of common stock sold in this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to our 2019 Plan, our management is authorized to grant stock options to our employees, directors and consultants. Initially, the
aggregate number of shares of our common stock that may be issued pursuant to stock awards under our 2019 Plan is 3,481,819 shares. Additionally, the number of shares of our common stock reserved for issuance under our 2019 Plan will automatically
increase on January&nbsp;1 of each year, beginning on January&nbsp;1, 2020 and continuing through and including January&nbsp;1, 2030, by 4% of the total number of shares of our capital stock outstanding on December&nbsp;31 of the preceding calendar
year, or a lesser number of shares determined by our board of directors. Unless our board of directors elects not to increase the number of shares available for future grant each year, our stockholders may experience additional dilution, which could
cause our stock price to fall. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We are an &#147;emerging growth company&#148; and our election of reduced reporting requirements applicable to
emerging growth companies may make our common stock less attractive to investors. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are an &#147;emerging growth company&#148;
as defined in the Jumpstart Our Business Startups Act, or JOBS Act. For as long as we continue to be an emerging growth company, we may take advantage of exemptions from various reporting requirements that are applicable to other public companies
that are not emerging growth companies, including not being required to comply with the auditor attestation requirements of Section&nbsp;404 of the Sarbanes-Oxley Act, or Section&nbsp;404, reduced disclosure obligations regarding executive
compensation in this prospectus and our periodic reports and proxy statements and exemptions from the requirements of holding a nonbinding advisory vote on executive compensation and stockholder approval of any golden parachute payments not
previously approved. In addition, as an emerging growth company, we are only required to provide two years of audited financial statements and two years of selected financial data in this prospectus. We could be an emerging growth company for up to
five years following the completion of this offering, although circumstances could cause us to lose that status earlier, including if we are deemed to be a &#147;large accelerated filer,&#148; which occurs when the market value of our common stock
that is held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700&nbsp;million as of the prior June&nbsp;30, or if we have total annual gross revenue of $1.07&nbsp;billion or more during any fiscal year before that time, in which
cases we would no longer be an emerging growth company as of the following December&nbsp;31, or if we issue more than $1.0&nbsp;billion in <FONT STYLE="white-space:nowrap">non-convertible</FONT> debt during any three-year period before that time, in
which case we would no longer be an emerging growth company immediately. Even after we no longer qualify as an emerging growth company, we could still qualify as a &#147;smaller reporting company,&#148; which would allow us to take advantage of many
of the same exemptions from disclosure requirements including not being required to comply with the auditor attestation requirements of Section&nbsp;404 and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">57 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
reduced disclosure obligations regarding executive compensation in this prospectus and our periodic reports and proxy statements. We cannot predict if investors will find our common stock less
attractive because we may rely on these exemptions. If some investors find our common stock less attractive as a result, there may be a less active trading market for our common stock and our share price may be more volatile. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Under the JOBS Act, emerging growth companies can also delay adopting new or revised accounting standards until such time as those standards
apply to private companies. We have elected to avail ourselves of an exemption that allows us to delay adopting new or revised accounting standards until such time as those standards apply to private companies. As a result, we will not be subject to
the same new or revised accounting standards as other public companies that comply with the public company effective dates, including but not limited to the new lease accounting standard. We have also elected to take advantage of certain of the
reduced disclosure obligations in the registration statement of which this prospectus is a part and may elect to take advantage of other reduced reporting requirements in future filings. As a result of these elections, the information that we
provide to our stockholders may be different than you might receive from other public reporting companies. However, if we later decide to opt out of the extended period for adopting new accounting standards, we would need to disclose such decision
and it would be irrevocable. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We will incur increased costs as a result of operating as a public company, and our management will be required to
devote substantial time to new compliance initiatives and corporate governance practices. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As a public company, and particularly
after we are no longer an emerging growth company, we will incur significant legal, accounting and other expenses that we did not incur as a private company. The Sarbanes-Oxley Act, the Dodd-Frank Wall Street Reform and Consumer Protection Act, the
listing requirements of the Nasdaq Global Market and other applicable securities rules and regulations impose various requirements on public companies, including establishment and maintenance of effective disclosure and financial controls and
corporate governance practices. Our management and other personnel will need to devote a substantial amount of time to these compliance initiatives. Moreover, these rules and regulations will increase our legal and financial compliance costs and
will make some activities more time-consuming and costly. For example, we expect that these rules and regulations may make it more difficult and more expensive for us to obtain director and officer liability insurance, which in turn could make it
more difficult for us to attract and retain qualified members of our board of directors. However, these rules and regulations are often subject to varying interpretations, in many cases due to their lack of specificity, and, as a result, their
application in practice may evolve over time as new guidance is provided by regulatory and governing bodies. This could result in continuing uncertainty regarding compliance matters and higher costs necessitated by ongoing revisions to disclosure
and governance practices. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our ability to use net operating losses to offset future taxable income may be subject to certain limitations.
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In general, under Section&nbsp;382 of the Internal Revenue Code of 1986, as amended, or the Code, a corporation that undergoes an
&#147;ownership change&#148; is subject to limitations on its ability to utilize its <FONT STYLE="white-space:nowrap">pre-change</FONT> net operating loss (&#147;NOL&#148;) or tax credits to offset future taxable income. Our existing NOLs or credits
may be subject to substantial limitations arising from previous ownership changes, and if we undergo an ownership change our ability to utilize NOLs or credits could be further limited by Section&nbsp;382 of the Code. In addition, future changes in
our stock ownership, many of which are outside of our control, could result in an ownership change under Section&nbsp;382 of the Code. Our NOLs or credits may also be impaired under state law. Accordingly, we may not be able to utilize a material
portion of our NOLs or credits. Furthermore, our ability to utilize our NOLs or credits is conditioned upon our attaining profitability and generating U.S. federal and state taxable income. As described above under &#147;&#151;Risks Related to
Business,&#148; we have incurred significant net losses since our inception and anticipate that we will continue to incur significant losses for the foreseeable future; thus, we do not know whether or when we will generate the U.S. federal or state
taxable income necessary to utilize our NOLs or credits. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">58 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Because we do not anticipate paying any cash dividends on our capital stock in the foreseeable future,
capital appreciation, if any, will be your sole source of gain. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have never declared or paid cash dividends on our capital
stock. We currently intend to retain all of our future earnings, if any, to finance the growth and development of our business. As a result, capital appreciation, if any, of our common stock will be your sole source of gain for the foreseeable
future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>We may incur significant costs from class action litigation due to our expected stock volatility. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our stock price may fluctuate for many reasons, including as a result of public announcements regarding the progress of our development
efforts for our drug discovery and development engine and our drug candidates, the development efforts of future partners or competitors, the addition or departure of our key personnel, variations in our quarterly operating results and changes in
market valuations of biopharmaceutical and biotechnology companies. This risk is especially relevant to us because biopharmaceutical and biotechnology companies have experienced significant stock price volatility in recent years. When the market
price of a stock has been volatile as our stock price may be, holders of that stock have occasionally brought securities class action litigation against the company that issued the stock. If any of our stockholders were to bring a lawsuit of this
type against us, even if the lawsuit is without merit, we could incur substantial costs defending the lawsuit. The lawsuit could also divert the time and attention of our management. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Anti-takeover provisions in our charter documents and under Delaware law could make an acquisition of our company, which may be beneficial to our
stockholders, more difficult and may prevent attempts by our stockholders to replace or remove our current management. </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Provisions
in our amended and restated certificate of incorporation and our amended and restated bylaws may delay or prevent an acquisition of our company or a change in our management. In addition, these provisions may frustrate or prevent any attempts by our
stockholders to replace or remove our current management by making it more difficult for stockholders to replace members of our board of directors. Because our board of directors is responsible for appointing the members of our management team,
these provisions could in turn affect any attempt by our stockholders to replace current members of our management team. These provisions include: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a prohibition on actions by our stockholders by written consent; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a requirement that special meetings of stockholders, which our company is not obligated to call more than once
per calendar year, be called only by the chair of our board of directors, our chief executive officer, or our board of directors pursuant to a resolution adopted by a majority of the total number of authorized directors; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">advance notice requirements for election to our board of directors and for proposing matters that can be acted
upon at stockholder meetings; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">division of our board of directors into three classes, serving staggered terms of three years each; and
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the authority of the board of directors to issue preferred stock with such terms as the board of directors may
determine. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Moreover, because we are incorporated in Delaware, we are governed by the provisions of Section&nbsp;203 of
the Delaware General Corporation Law, as amended, which prohibits a person who owns in excess of 15% of our outstanding voting stock from merging or combining with us for a period of three years after the date of the transaction in which the person
acquired in excess of 15% of our outstanding voting stock, unless the merger or combination is approved in a prescribed manner. These provisions would apply even if the proposed merger or acquisition could be considered beneficial by some
stockholders. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">59 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our amended and restated certificate of incorporation that will be in effect upon the closing of this
offering will provide that the Court of Chancery of the State of Delaware and the federal district courts of the United States will be the exclusive forums for substantially all disputes between us and our stockholders, which could limit our
stockholders&#146; ability to obtain a favorable judicial forum for disputes with us or our directors, officers, or employees. </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation that will be in effect upon the closing of this offering will provide that the Court of
Chancery of the State of Delaware is the exclusive forum for the following types of actions or proceedings under Delaware statutory or common law: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any derivative action or proceeding brought on our behalf; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any action asserting a breach of fiduciary duty owed by any of our directors, officers, employees or agents to
us or our stockholders; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any action asserting a claim against us or any of our directors, officers or other employees arising under any
provisions of the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">any action asserting a claim against us or any of our directors, officers or other employees governed by the
internal affairs doctrine. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">These provisions would not apply to suits brought to enforce a duty or liability created by
the Exchange Act or the rules and regulations thereunder. However, these provisions apply to Securities Act claims and Section&nbsp;22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to
enforce a duty or liability created by the Securities Act or the rules and regulations thereunder. Accordingly, there is uncertainty as to whether a court would enforce such provisions, and our stockholders will not be deemed to have waived our
compliance with the federal securities laws and the rules and regulations thereunder. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of
incorporation that will be in effect upon the closing of this offering will further provide that the federal district courts of the United States will be the exclusive forum for resolving any complaint asserting a cause of action arising under the
Securities Act, subject to and contingent upon a final adjudication in the State of Delaware of the enforceability of such exclusive forum provision. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">These exclusive-forum provisions may limit a stockholder&#146;s ability to bring a claim in a judicial forum that it finds favorable for
disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other employees. If a court were to find the exclusive-forum provisions in our amended and restated certificate
of incorporation that will be in effect upon the closing of this offering to be inapplicable or unenforceable, we may incur additional costs associated with resolving the dispute in other jurisdictions, which could seriously harm our business. For
example, the Court of Chancery of the State of Delaware recently determined that a provision stating that U.S. federal district courts are the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act
is not enforceable. However, this decision may be reviewed and ultimately overturned by the Delaware Supreme Court. If the Court of Chancery&#146;s decision were to be overturned, we would seek to enforce the federal district court exclusive forum
provision in our amended and restated certificate of incorporation. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">60 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_3"></A>SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This prospectus contains forward-looking statements about us and our industry that involve substantial risks and uncertainties. All statements
other than statements of historical facts contained in this prospectus, including statements regarding our future results of operations or financial condition, business strategy and plans and objectives of management for future operations and
statements that are necessarily dependent upon future events are forward-looking statements. In some cases, you can identify forward-looking statements because they contain words such as &#147;anticipate,&#148; &#147;believe,&#148;
&#147;contemplate,&#148; &#147;continue,&#148; &#147;could,&#148; &#147;estimate,&#148; &#147;expect,&#148; &#147;intend,&#148; &#147;may,&#148; &#147;plan,&#148; &#147;potential,&#148; &#147;predict,&#148; &#147;project,&#148; &#147;should,&#148;
&#147;target,&#148; &#147;will&#148; or &#147;would&#148; or the negative of these words or other similar terms or expressions. Forward-looking statements in this prospectus include, but are not limited to, statements about: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">estimates of our total addressable market, future revenue, expenses, capital requirements and our needs for
additional financing; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the initiation, cost, timing, progress and results of research and development activities, preclinical or and
clinical trials with respect to FLX475, RPT193, our <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> program and potential future drug candidates; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to identify, develop and commercialize drug candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to advance FLX475, RPT193 or an RPT-GCN2i or other future drug candidates into, and successfully
complete, preclinical studies and clinical or field trials; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain and maintain regulatory approval of FLX475, RPT193 or an
<FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> or other future drug candidates, and any related restrictions, limitations and/or warnings in the label of an approved drug candidate; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to develop and expand our drug discovery and development engine; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to identify drug candidates using our drug discovery and development engine; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain funding for our operations; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to obtain and maintain intellectual property protection for our technology and any of our drug
candidates; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to successfully commercialize any of our drug candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the rate and degree of market acceptance of any of our drug candidates; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">regulatory developments in the United States and international jurisdictions; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential liability lawsuits and penalties related to our technology, our drug candidates and our current and
future relationships with third parties; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to attract and retain key scientific and management personnel; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to effectively manage the growth of our operations; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to contract with third-party suppliers and manufacturers and their ability to perform adequately
under those arrangements; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">61 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to compete effectively with existing competitors and new market entrants; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectations regarding uses of proceeds from this offering; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">potential effects of extensive government regulation; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial performance; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our expectation regarding the time during which we will be an emerging growth company under the JOBS Act; and
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the volatility of the trading price of our common stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">You should not rely on forward-looking statements as predictions of future events. We have based the forward-looking statements contained in
this prospectus primarily on our current expectations and projections about future events and trends that we believe may affect our business, financial condition, results of operation, business strategy and financial needs. The outcome of the events
described in these forward-looking statements is subject to risks, uncertainties and other factors described in the section titled &#147;Risk Factors&#148; and elsewhere in this prospectus. Moreover, we operate in a very competitive and rapidly
changing environment. New risks and uncertainties emerge from time to time, and it is not possible for us to predict all risks and uncertainties that could have an impact on us. The results, events and circumstances reflected in the forward-looking
statements may not be achieved or occur, and actual results, events or circumstances could differ materially from those described in the forward-looking statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, statements that &#147;we believe&#148; and similar statements reflect our beliefs and opinions on the relevant subject. These
statements are based on information available to us as of the date of this prospectus. While we believe that information provides a reasonable basis for these statements, that information may be limited or incomplete. Our statements should not be
read to indicate that we have conducted an exhaustive inquiry into, or review of, all relevant information. These statements are inherently uncertain, and investors are cautioned not to unduly rely on these statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The forward-looking statements made in this prospectus relate only to events as of the date on which the statements are made. We undertake no
obligation to update any forward-looking statements made in this prospectus to reflect events or circumstances after the date of this prospectus or to reflect new information or the occurrence of unanticipated events, except as required by law. We
may not actually achieve the plans, intentions or expectations disclosed in our forward-looking statements, and you should not place undue reliance on our forward-looking statements. Our forward-looking statements do not reflect the potential impact
of any future acquisitions, mergers, dispositions, joint ventures or investments. We qualify all of our forward-looking statements by these cautionary statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">62 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_4"></A>MARKET, INDUSTRY AND OTHER DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This prospectus contains estimates and information concerning our industry, including market size and growth rates of the markets in which we
participate, which are based on industry publications and reports. This information involves a number of assumptions and limitations, and you are cautioned not to give undue weight to this information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have not independently verified the accuracy or completeness of the data contained in industry publications and reports. While we believe
that each of these studies and publications is reliable, the industry in which we operate is subject to a high degree of uncertainty and risk due to a variety of factors, including those described in the section titled &#147;Risk Factors.&#148;
These and other factors could cause results to differ materially from those expressed in these publications and reports. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">63 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_5"></A>USE OF PROCEEDS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We estimate that we will receive net proceeds from this offering of approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; (or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; if the underwriters exercise their over-allotment option in full) based on the
assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common stock, the midpoint of the estimated offering price range set forth on the cover page of this prospectus, after
deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">A $1.00 increase (decrease) in
the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common stock would increase (decrease) the net proceeds to us from this offering by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming the number of shares offered by us, as set forth on the cover page of this prospectus, remains the same, and after deducting estimated underwriting discounts and
commissions and estimated offering expenses payable by us. We may also increase or decrease the number of shares we are offering. Similarly, each increase (decrease) of 1,000,000 shares in the number of shares of common stock offered by us would
increase (decrease) the net proceeds to us from this offering by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common stock remains the same, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The principal purposes of this offering are to increase our capitalization and financial flexibility and create a public market for our common
stock. We currently expect to use the net proceeds from this offering, together with our existing cash and cash equivalents, as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to fund the development
of FLX475 beyond PoC results from our Phase 1/2 clinical trial; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; to fund the development
of RPT193 beyond our Phase 1 trial in healthy volunteers and patients with AD; and </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">The remaining proceeds for continued development of an RPT-GCN2i or other future drug candidate, continued
refinement of our proprietary drug discovery and development engine, hiring of additional personnel, capital expenditures, costs of operating as a public company and other general corporate purposes. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We also may use a portion of the net proceeds from this offering to <FONT STYLE="white-space:nowrap">in-license,</FONT> acquire or invest in
complementary businesses, technologies, products or assets. We, however, have no current commitments or obligations to do so. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We cannot
specify with certainty all of the particular uses for the remaining net proceeds to us from this offering. The expected net proceeds from this offering, together with our existing cash and cash equivalents will not be sufficient for us to fund any
of our drug candidates through regulatory approval, and we will need to raise additional capital to advance the development of our drug candidates. We will have broad discretion over how to use the net proceeds to us from this offering. Pending
their use, we intend to invest the net proceeds to us from this offering in board-approved investments including U.S. treasuries, U.S. government agencies, A-1/P-1 commercial paper, bank repurchase agreements, CDs from investment grade banks and
money market funds. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">64 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_6"></A>DIVIDEND POLICY </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have never declared or paid any dividends on our capital stock. We currently intend to retain all available funds and future earnings, if
any, to fund the development and expansion of our business, and we do not anticipate paying any cash dividends in the foreseeable future. Any future determination regarding the declaration and payment of dividends will be at the discretion of our
board of directors and will depend on then-existing conditions, including our financial condition, operating results, contractual restrictions, capital requirements, business prospects and other factors our board of directors may deem relevant. In
addition, we may enter into agreements in the future that could contain restrictions on payments of cash dividends. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">65 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_7"></A>CAPITALIZATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table sets forth our cash and cash equivalents, and our capitalization as of June&nbsp;30, 2019 as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on an actual basis; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma basis, giving effect to (i)&nbsp;the automatic conversion of all outstanding shares of our
convertible preferred stock as of June&nbsp;30, 2019 into 17,467,184&nbsp;shares of common stock immediately prior to the closing of this offering and (ii)&nbsp;the filing and effectiveness of our amended and restated certificate of incorporation
that will be in effect upon the closing of this offering; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">on a pro forma as adjusted basis, giving effect to (i)&nbsp;the pro forma adjustments set forth above and
(ii)&nbsp;the issuance and sale of shares of common stock in this offering at the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the estimated offering
price range set forth on the cover page of this prospectus, after deducting estimated the underwriting discounts and commissions and estimated offering expenses payable by us. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The pro forma and pro forma as adjusted information below is illustrative only, and our capitalization following the closing of this offering
will be adjusted based on the actual initial public offering price and other terms of this offering determined at pricing. You should read this information in conjunction with our consolidated financial statements and the related notes included in
this prospectus and &#147;Management&#146;s Discussion and Analysis of Financial Condition and Results of Operations&#148; and &#147;Selected Consolidated Financial Data&#148; and other financial information contained in this prospectus. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>As of June&nbsp;30,
2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Actual</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Pro&nbsp;Forma<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>(in&nbsp;thousands,&nbsp;except&nbsp;share</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>and&nbsp;per&nbsp;share&nbsp;data)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock, $0.0001 par value per share: 117,889,475&nbsp;shares authorized,
actual, no shares pro forma and pro forma as adjusted; 104,803,325&nbsp;shares issued and outstanding, actual; no shares issued and outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">175,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; (deficit) equity:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Preferred stock, $0.0001 par value per share: no shares authorized, issued or outstanding, actual;
50,000,000&nbsp;shares authorized and no shares issued and outstanding, pro forma and pro forma as adjusted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value per share: 133,071,007&nbsp;shares authorized, 812,759&nbsp;shares
issued and outstanding, actual; 500,000,000&nbsp;shares authorized, &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares issued and outstanding, pro forma</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">198,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(115,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,758</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total capitalization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each $1.00 increase (decrease) in the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common stock, the midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as
adjusted amount of each of cash and cash equivalents, total stockholders&#146; (deficit) equity and total capitalization by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming that the number
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">66 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
of shares offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated underwriting discounts and commissions and estimated offering expenses.
Similarly, each increase (decrease) of 1,000,000 shares in the number of shares offered by us at the assumed initial public offering price per share, the midpoint of the estimated offering price range set forth on the cover page of this prospectus,
would increase (decrease) the pro forma as adjusted amount of each of cash and cash equivalents, total stockholders&#146; (deficit) equity and total capitalization by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share of common stock remains the same,
and after deducting estimated underwriting discounts and commissions and estimated offering expenses. The pro forma and pro forma as adjusted information discussed above is illustrative only and will change based on the actual initial public
offering price and other terms of this offering determined at pricing. </TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The outstanding share information in the table above
is based on 18,279,943&nbsp;shares of our common stock (including shares of our convertible preferred stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) outstanding as of June&nbsp;30, 2019, and excludes: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,049,976&nbsp;shares of our common stock issuable upon the exercise of options to purchase shares of our common
stock issued under our 2015 Stock Plan (&#147;2015 Plan&#148;) and outstanding as of June&nbsp;30, 2019, with a weighted-average exercise price of $6.11 per share; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">63,652&nbsp;shares of our common stock issuable upon the exercise of stock options granted after June&nbsp;30,
2019, with an exercise price of $13.62 per share, and an additional 164,745&nbsp;shares of our common stock issuable upon the exercise of stock options granted after June&nbsp;30, 2019, with an exercise price equal to the price per share to the
public in this offering; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,481,819 shares of our common stock reserved for future issuance under our 2019 Equity Incentive Plan
(&#147;2019 Plan&#148;), (including 617,194&nbsp;shares of our common stock reserved for issuance as of July&nbsp;15, 2019, under our 2015 Plan that will be added to our 2019 Plan reserve upon its effectiveness) which includes an annual evergreen
increase and will become effective in connection with this offering; and </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">240,336 shares of our common stock reserved for future issuance under our 2019 Employee Stock Purchase Plan
(&#147;ESPP&#148;), which includes an annual evergreen increase and will become effective in connection with this offering. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">67 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_8"></A>DILUTION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If you invest in our common stock in this offering, your ownership interest will be immediately diluted to the extent of the difference
between the initial public offering price per share and the pro forma as adjusted net tangible book value per share of our common stock immediately after the completion of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2019, we had a pro forma net tangible book value of approximately $60.0&nbsp;million, or $3.28&nbsp;per share. Pro forma
net tangible book value per share represents the amount of our total tangible assets less our total liabilities, divided by the number of shares of our common stock outstanding as of June&nbsp;30, 2019, after giving effect to the automatic
conversion of all shares of our convertible preferred stock outstanding as of June&nbsp;30, 2019 into 17,467,184&nbsp;shares of our common stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">After giving further effect to the sale of &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock
that we are offering at the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the estimated offering price range set forth on the cover page of this
prospectus, and after deducting estimated underwriting discounts and commissions and estimated offering expenses payable by us, our pro forma as adjusted net tangible book value as of June&nbsp;30, 2019 would have been approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, or approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. This amount represents an immediate increase in pro forma as adjusted
net tangible book value of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to our existing stockholders and an immediate dilution in pro forma as adjusted net tangible book value per share of approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share to new investors purchasing shares of common stock in this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Dilution per share to new investors purchasing our common stock is determined by subtracting pro forma as adjusted net tangible book value per
share after this offering from the assumed initial public offering price per share paid by new investors. The following table illustrates this dilution (without giving effect to any exercise by the underwriters of their over-allotment option) on a
per share basis: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed initial public offering price per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net tangible book value per share as of June&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3.28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Increase in pro forma net tangible book value per share attributable to this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma as adjusted net tangible book value per share after this offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dilution in pro forma as adjusted net tangible book value per share to new investors in this
offering</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The dilution information above is illustrative only and will change based on the actual initial
public offering price and other terms of this offering determined at pricing. Each $1.00 increase (decrease) in the assumed initial public offering price of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the
midpoint of the estimated offering price range set forth on the cover page of this prospectus, would increase (decrease) the pro forma as adjusted net tangible book value per share after this offering by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, and dilution in pro forma as adjusted net tangible book value per share to new investors by approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, assuming that the number of shares of common stock offered by us, as set forth on the cover page of this prospectus, remains the same and after deducting estimated
underwriting discounts and commissions and estimated offering expenses. Each increase (decrease) of 1,000,000 shares in the number of shares of common stock offered by us would increase (decrease) our pro forma as adjusted net tangible book value
per share after this offering by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share and decrease (increase) the dilution in pro forma as adjusted net tangible book vale per share to investors
participating in this offering by approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, assuming that the assumed initial public offering price remains the same, and after deducting estimated underwriting
discounts, commissions and estimated offering expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If the underwriters exercise their over-allotment option in full, the pro forma
as adjusted net tangible book value after the offering would be $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the increase in pro forma net tangible book value per share to existing stockholders would be
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share and the dilution per share to new investors would be </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">68 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, in each case assuming an initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the estimated offering price set forth on the cover page of this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table summarizes, on the pro forma as adjusted basis described above, as of June&nbsp;30, 2019, the differences between the
number of shares of common stock purchased from us by our existing stockholders and common stock by new investors purchasing shares in this offering, the total consideration paid to us in cash and the average price per share paid by existing
stockholders for shares of common stock issued prior to this offering and the price to be paid by new investors for shares of common stock in this offering. The calculation below is based on the assumed initial public offering price of
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share, the midpoint of the estimated offering price range set forth on the cover page of this prospectus, before deducting estimated underwriting discounts and commissions and estimated offering
expenses. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="6" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="6" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="3" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Average<BR>Price&nbsp;Per<BR>Share</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="3">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD ROWSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares Purchased</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total Consideration</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Percent</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Amount</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Percent</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"><B>(in thousands, except share, per share and percentages)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Existing stockholders</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,279,943</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">176,380</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">9.65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">New investors</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The outstanding share information in the table above is based on 18,279,943&nbsp;shares of our common
stock (including shares of our convertible preferred stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) outstanding as of June&nbsp;30, 2019, and excludes: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1,049,976&nbsp;shares of our common stock issuable upon the exercise of options to purchase shares of our common
stock issued under our 2015 Plan and outstanding as of June&nbsp;30, 2019, with a weighted-average exercise price of $6.11&nbsp;per share; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">63,652 shares of our common stock issuable upon the exercise of stock options granted after June&nbsp;30, 2019,
with an exercise price of $13.62 per share, and an additional 164,745&nbsp;shares of our common stock issuable upon the exercise of stock options granted after June&nbsp;30, 2019, with an exercise price equal to the price per share to the public in
this offering; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">3,481,819 shares of our common stock reserved for future issuance under our 2019 Plan, (including
617,194&nbsp;shares of our common stock reserved for issuance as of July&nbsp;15, 2019, under our 2015 Plan that will be added to our 2019 Plan reserve upon its effectiveness) which includes an annual evergreen increase and will become effective in
connection with this offering; and </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">240,336 shares of our common stock reserved for future issuance under our ESPP, which includes an annual
evergreen increase and will become effective in connection with this offering. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If the underwriters exercise their
over-allotment option in full, our existing stockholders would own &nbsp;&nbsp;&nbsp;&nbsp;% and the investors purchasing shares of our common stock in this offering would own &nbsp;&nbsp;&nbsp;&nbsp;% of the total number of shares of our common
stock outstanding immediately after closing of this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">69 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_9"></A>SELECTED CONSOLIDATED FINANCIAL DATA </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following selected consolidated financial data should be read in conjunction with &#147;Management&#146;s Discussion and Analysis of
Financial Condition and Results of Operations&#148; and the consolidated financial statements and related notes included elsewhere in this prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The consolidated statements of operations data for the years ended December&nbsp;31, 2017 and 2018, and the balance sheet data as of
December&nbsp;31, 2017 and 2018, are derived from our audited consolidated financial statements and related notes included elsewhere in this prospectus. The condensed consolidated statements of operations data for the six months ended June&nbsp;30,
2018 and 2019 and the condensed consolidated balance sheet data as of June&nbsp;30, 2019 are derived from our unaudited interim condensed consolidated financial statements and related notes included elsewhere in this prospectus. We have prepared the
unaudited interim condensed consolidated financial statements on a basis consistent with our audited consolidated financial statements and, in the opinion of management, such unaudited interim condensed consolidated financial statements reflect all
adjustments, consisting only of normal recurring adjustments, that are necessary for the fair presentation of our unaudited interim condensed consolidated financial statements. Our historical results are not necessarily indicative of the results to
be expected in the future, and the results for the six months ended June&nbsp;30, 2019 are not necessarily indicative of the results to be expected for the full year or any other period. The selected financial data in this section are not intended
to replace our consolidated financial statements and the related notes and are qualified in their entirety by the consolidated financial statements and related notes included elsewhere in this prospectus. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year
ended<BR>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Six months
ended<BR>June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"><B>(in thousands, except share and per share data)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Statements of Operations Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating costs and expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 31,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 14,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 16,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 29,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 36,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 16,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 19,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and
diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 67.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">58.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 28.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 28.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average number of shares used in computing net loss per share, basic and diluted</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">431,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">574,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and
diluted<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average number of shares used in computing pro forma net loss per share, basic and
diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,461,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,328,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">70 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">See Note 13 to our audited consolidated financial statements and Note 11 to our unaudited interim condensed
consolidated financial statements for an explanation of the method used to calculate historical and pro forma basic and diluted net loss per share. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="61%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Consolidated Balance Sheet Data:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">47,517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">63,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">44,994</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">56,161</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">69,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">161,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,806</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(62,405</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(97,113</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(115,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">71 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_10"></A>MANAGEMENT&#146;S DISCUSSION AND ANALYSIS OF </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>FINANCIAL CONDITION AND RESULTS OF OPERATIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>The following discussion and analysis of our financial condition and results of operations should be read together with the section titled
&#147;Selected Condensed and Consolidated Financial Data&#148; and our condensed and consolidated financial statements and accompanying notes included elsewhere within this prospectus. This discussion includes both historical information and
forward-looking statements that involve risk, uncertainties and assumptions. Our actual results may differ materially from management&#146;s expectations as a result of various factors, including, but not limited to, those discussed in the section
titled &#147;Risk Factors.&#148; </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule
therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing our proprietary drug discovery and development engine, we are developing highly selective small molecules that are designed to modulate the critical
immune responses underlying these diseases. In our first four years since inception, we have discovered and advanced two unique drug candidates each targeting CCR4. Our lead oncology drug candidate, FLX475, reached the clinic in just two and a half
years and our lead inflammation drug candidate, RPT193, entered the clinic in August 2019. We are also pursuing a range of targets, including GCN2 and HPK1, that are in the discovery stage of development. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our lead oncology drug candidate, FLX475, is designed to selectively inhibit the migration of immunosuppressive T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> into tumors. In a Phase 1 clinical trial in 104 healthy volunteers, FLX475 was well tolerated and demonstrated favorable drug-like properties with a level of target engagement that, in our
preclinical studies, corresponded with 90% inhibition of in vitro T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and the highest level of inhibition of in vivo T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>
migration and antitumor activity. FLX475 has also demonstrated single agent and combination activity in preclinical tumor models associated with the inhibition of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration into the tumor
and an increase in the CD8 : T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> ratio. We are currently conducting a Phase 1/2 clinical trial investigating FLX475 as a single agent and in combination with pembrolizumab in patients with
&#147;charged&#148; tumors, who we believe have the greatest probability of clinical benefit, in order to study the safety and potential clinical activity of FLX475 in patients with advanced cancer. We anticipate results from the Phase&nbsp;2
portion of the trial could provide clinical PoC data in the first half of 2020. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our lead inflammation drug candidate, RPT193, is
designed to selectively inhibit the migration of Th2 cells into allergically-inflamed tissues. Th2 cells are clinically validated drivers of allergic diseases along the &#147;atopic march&#148; such as AD, asthma, chronic urticaria (skin rash),
allergic conjunctivitis, chronic rhinosinusitis and eosinophilic esophagitis (inflammation of the esophagus). We believe based on our preclinical pharmacology and GLP toxicology results, if confirmed in clinical trials, combined with the convenience
of once-daily oral dosing, RPT193, if approved by the FDA, could fill an unmet medical need for the treatment of allergic disorders. We have initiated a seamless Phase&nbsp;1 trial of RPT193 comprised of Phase&nbsp;1a single- and multiple-dose
escalation cohorts of healthy volunteers in August 2019, to be followed by placebo-controlled Phase 1b testing in patients with moderate to severe AD. Preliminary safety, pharmacokinetic, and pharmacodynamic data from the initial single dose cohorts
support once-daily oral dosing with RPT193 and dose escalation continues as planned. We anticipate PoC clinical results from the Phase&nbsp;1b portion of this study by <FONT STYLE="white-space:nowrap">mid-2020.</FONT> Thereafter, we intend to expand
clinical development into additional <FONT STYLE="white-space:nowrap">Th2-driven</FONT> allergic indications. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, we are
identifying lead compounds that inhibit GCN2, which we believe is a fundamental regulator of antitumor immunity and tumor cell survival. Preclinical studies have demonstrated that an RPT-GCN2i has the ability to increase in vitro T cell
proliferation and function in nutrient-deprived conditions, enhance tumor cell death and elicit antitumor responses in preclinical tumor models. We are developing an RPT-GCN2i with the intent of filing an IND with the FDA in 2020. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">72 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We will continue to invest in our proprietary discovery and development engine and
investigate several of our identified targets as well as generate additional target and drug candidates, including a future HPK1 drug candidate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Financial Overview </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Since commencing
operations in 2015, we have devoted substantially all of our efforts and financial resources to building our research and development capabilities and establishing our corporate infrastructure. As a result, we have incurred net losses since
inception. As of June&nbsp;30, 2019, we had an accumulated deficit of $138.8&nbsp;million. We have incurred net losses of $29.1&nbsp;million, $36.1&nbsp;million, $16.4&nbsp;million and $19.8&nbsp;million for the years ended December&nbsp;31, 2017
and 2018, and for the six months ended June&nbsp;30, 2018 and 2019, respectively. We do not expect to generate product revenue unless and until we obtain approval for the commercialization of a drug candidate, and we cannot assure you that we will
ever generate significant revenue or profits. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Since inception, we have financed our operations primarily through the private placements
of convertible preferred stock with net proceeds of $175.5&nbsp;million. As of September 30, 2019, we had cash and cash equivalents of $48.3 million. The September 30, 2019 information is preliminary and subject to adjustment and has not been
reviewed or audited by our independent registered public accounting firm. We believe that our existing cash and cash equivalents will not be sufficient to fund our planned operations for at least the next 12 months from the date of this prospectus
without the proceeds from this offering. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect to incur substantial expenditures in the foreseeable future as we expand our
pipeline and advance our drug candidates through clinical development, undergo the regulatory approval process and, if approved, launch commercial activities. Specifically, in the near term we expect to incur substantial expenses relating to our
ongoing and planned clinical trials, the development and validation of our manufacturing processes, and other development activities. Furthermore, upon the completion of this offering, we expect to incur additional costs associated with operating as
a public company, including significant legal, accounting, investor relations and other expenses that we did not incur as a private company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We will need substantial additional funding to support our continuing operations and pursue our development strategy. Until such time as we
can generate significant revenue from sales of our drug candidates, if ever, we expect to finance our operations through the sale of equity, debt financings or other capital sources, including potential collaborations with other companies or other
strategic transactions. Adequate funding may not be available to us on acceptable terms, or at all. If we fail to raise capital or enter into such agreements as, and when, needed, we may have to significantly delay, scale back, or discontinue the
development and commercialization of our drug candidates or delay our efforts to expand our product pipeline. We may also be required to sell or license to other parties rights to develop or commercialize our drug candidates that we would prefer to
retain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clinical Trial Collaboration and Supply Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In November 2018, we entered into a clinical trial collaboration and supply agreement with MSD International GmbH, an affiliate of Merck
(known as MSD outside the United States and Canada), under which we will conduct a clinical trial evaluating FLX475 as a monotherapy and in combination with KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (pembrolizumab),
Merck&#146;s anti-PD-1 therapy, in patients with advanced cancers. We are the sponsor of the clinical trial and are responsible for the costs of conducting it, and Merck will supply KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>
for use in the clinical trial at no charge to us except that we may be required to reimburse Merck&#146;s manufacturing costs upon certain early termination events. Neither party will have any other obligations to reimburse any costs or expenses
incurred by the other party. We retain ownership of the quantities of FLX475 used in the clinical trial and we will own the quantities of KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> supplied to us by Merck for use in the
clinical trial. The agreement provides for joint ownership of any inventions, clinical data and results generated in the clinical trial </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">73 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
that relate to the combined use of the two drugs. Merck will solely own any inventions generated in the clinical trial that relate solely to
KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and all data resulting from testing performed by or on behalf of Merck upon samples collected during the clinical trial. We will solely own any inventions generated in the clinical
trial that relate solely to FLX475, clinical data resulting from the use of FLX475 as a monotherapy, and from all data resulting from testing performed by or on behalf of us upon samples collected during the clinical trial. The term of the agreement
will continue until delivery of the final report for the clinical trial, provided that either party may terminate the agreement due to the other party&#146;s uncured material breach, a violation of anti-corruption obligations, patient safety
concerns, regulatory action that prevents supply of such party&#146;s compound, or such party&#146;s termination of its compound&#146;s development or withdrawal of its compound&#146;s regulatory approval. Merck may also terminate the agreement if
we fail to make any changes to the clinical trial protocol regarding the use of KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> that are reasonably requested by Merck to address any concern raised by Merck that KEYTRUDA<SUP
STYLE="font-size:85%; vertical-align:top">&reg;</SUP> is being used in the clinical trial in an unsafe manner. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Components of Operating Results
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expense both internal and external research and development expenses to operations as they are incurred. We track the external research and
development costs incurred for each of our drug candidates. We do not track our internal research and development costs by drug candidate, as the related efforts and their costs are typically spread across multiple drug candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We account for <FONT STYLE="white-space:nowrap">non-refundable&nbsp;advance</FONT> payments for goods or services that will be used in future
research and development activities as expenses when the goods have been received or when the service has been performed rather than when the payment is made. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Clinical trial costs are a component of research and development expenses. We expense costs for our clinical trial activities performed by
third parties, including clinical research organizations (&#147;CROs&#148;) and other service providers, as they are incurred, based upon estimates of the work completed over the life of the individual study in accordance with the associated
agreements. We use information received from internal personnel and outside service providers to estimate the clinical trial costs incurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">External research and development expenses consist primarily of costs incurred for the development of our drug candidates and include: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">expenses incurred under agreements with CROs, investigative sites, and consultants to conduct our clinical trials
and preclinical and <FONT STYLE="white-space:nowrap">non-clinical</FONT> studies; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs to acquire, develop and manufacture supplies for clinical trials and other studies, including fees paid to
contract manufacturing organizations, or CMOs; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs related to compliance with drug development regulatory requirements. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Internal research and development costs include: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">salaries and related costs, including stock-based compensation and travel expenses, for personnel in our research
and development functions; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">costs for consultants who advise us on multiple drug candidates; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">depreciation and other allocated facility-related and overhead expenses. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">74 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect our research and development expenses to increase substantially during the next
few years as we seek to complete existing and initiate additional clinical trials, pursue regulatory approval of FLX475 and RPT193, and advance other programs into the clinic. Over the next few years, we expect our preclinical, clinical, and
contract manufacturing expenses to increase significantly relative to what we have incurred to date. Predicting the timing or the final cost to complete our clinical program or validation of our manufacturing and supply processes is difficult and
delays may occur because of many factors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>General and Administrative Expenses </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">General and administrative expenses consist principally of personnel-related costs including payroll and stock-based compensation for
personnel in executive, finance, human resources, business and corporate development, and other administrative functions; professional fees for legal, consulting, and accounting services; rent and other facilities costs, depreciation, and other
general operating expenses not otherwise classified as research and development expenses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We anticipate that our general and
administrative expenses will increase substantially during the next few years as a result of staff expansion and additional occupancy costs, as well as costs associated with being a public company, including higher professional fees for legal,
consulting, and accounting services, investor relations costs, higher insurance premiums and other compliance costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Income, Net </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Other income, net, consists primarily of interest earned on our cash and cash equivalents and also includes interest we earn on promissory
notes we executed with our president and chief executive officer and former chief operating officer. The promissory note with our former chief operating officer was extinguished in May 2019, and the promissory note with our president and chief
executive officer was forgiven in June 2019. Our cash and cash equivalents are invested in money market funds. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Critical Accounting Policies,
Significant Judgments and Use of Estimates </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our consolidated financial statements have been prepared in accordance with U.S. generally
accepted accounting principles (&#147;GAAP&#148;). The preparation of these consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent
assets and liabilities at the date of the consolidated financial statements, as well as the reported expenses incurred during the reporting periods. Our estimates are based on our historical experience and on various other factors that we believe
are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates
under different assumptions or conditions. We believe that the accounting policies discussed below are critical to understanding our historical and future performance, as these policies relate to the more significant areas involving
management&#146;s judgments and estimates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">While our significant accounting policies are described in the notes to our consolidated
financial statements, we believe that the following critical accounting policies are most important to understanding and evaluating our reported financial results. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Expenses </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Research and development costs are charged to expense as incurred. Research and development costs consist primarily of salaries and benefits
of research and development personnel, costs related to research activities, preclinical studies, clinical trials, drug manufacturing and allocated overhead and facility-related costs. We account
<FONT STYLE="white-space:nowrap">for&nbsp;non-refundable&nbsp;advance</FONT> payments for goods or services that will be used in future research and development activities as expenses when the related goods have been received or when the service has
been performed rather than when the payment is made. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">75 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Clinical trial costs are a component of research and development expenses. We expense costs
for our clinical trial activities performed by third parties, including CROs and other service providers, as they are incurred, based upon estimates of the work completed over the life of the individual study in accordance with associated
agreements. We use information we receive from internal personnel and outside service providers to estimate the progress of services performed and the associated clinical trial costs incurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation Expense </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We account for stock-based compensation arrangements with employees in accordance with ASC 718, <I>Stock Compensation</I>. Stock-based awards
issued by the Company have been primarily stock options with time-based vesting and performance-based options. ASC 718 requires the recognition of compensation expense, using a fair value-based method, for costs related to all stock-based awards.
Our determination of the grant-date fair value of stock options with time-based vesting utilizes the Black-Scholes option-pricing model, and is impacted by the fair value of our common stock as well as other variables including, but not limited to,
expected term that options will remain outstanding, expected common stock price volatility over the term of the option awards, risk-free interest rates and expected dividends. There has been no public market for our common stock to date. As such,
the estimated fair value of our common stock and underlying stock options has been determined at each grant date by our board of directors, with input from management, based on the information known to us on the grant date and upon a review of any
recent events and their potential impact on the estimated per share fair value of our common stock. Our valuations of our common stock were prepared by a third-party valuation firm in accordance with the guidance outlined in the American Institute
of Certified Public Accountants Technical Practice Aid, <I>Valuation of Privately Held Company Equity Securities Issued as Compensation</I> (the &#147;Practice Aid&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For awards with time-based vesting, stock-based compensation is recognized over the period during which an optionee is required to provide
services in exchange for the option award, known as the requisite service period (usually the vesting period) on a straight-line basis. For awards with performance-based vesting, the fair value of the award is recognized as expense when the
performance criteria are probable of being achieved, using an accelerated attribution method. In both cases, stock-based compensation expense is recognized based on the fair value determined on the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Equity instruments issued to <FONT STYLE="white-space:nowrap">non-employees</FONT> are accounted for in accordance with ASC <FONT
STYLE="white-space:nowrap">505-50,</FONT> <I>Equity Based Payments</I> <I>to <FONT STYLE="white-space:nowrap">Non-Employees</FONT></I>, and are recorded at their fair value on the measurement date and are subject to periodic adjustments as the
underlying equity instruments vest. The fair value of options granted to consultants is expensed when vested. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Estimating the fair value
of equity-settled awards as of the grant date using the Black-Scholes option pricing model, is affected by assumptions regarding a number of complex variables. Changes in the assumptions can materially affect the fair value and ultimately how much
stock-based compensation expense is recognized. These inputs are subjective and generally require significant analysis and judgment to develop. These inputs are: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Expected term &#150; </I>The expected term represents the period that our options granted are expected to be outstanding and is determined
using the simplified method (based on the <FONT STYLE="white-space:nowrap">mid-point</FONT> between the vesting date and the end of the contractual term). We have very limited historical information to develop reasonable expectations about future
exercise patterns and post-vesting employment termination behavior for our stock option grants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Expected volatility &#150; </I>Since
we are a privately-held Company and do not have any trading history for our common stock, the expected volatility was estimated based on the average volatility for comparable publicly traded biopharmaceutical companies over a period, where
available, equal to the expected term of the stock option grants.&nbsp;The comparable companies were chosen based on their similar size, life cycle stage, or area of specialty. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">76 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Risk-Free Interest Rate</I> <I>&#150; </I>The risk-free interest rate is based on the
U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the expected term of the options. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Expected Dividend &#150; </I>We have never paid dividends on our common stock and has no plans to pay dividends on our common
stock.&nbsp;Therefore, we used an expected dividend yield of zero. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We will continue to use judgment in evaluating the expected
volatility, expected terms, and interest rates utilized for our stock-based compensation expense calculations on a prospective basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense for employees and <FONT STYLE="white-space:nowrap">non-employees</FONT> is reflected in the consolidated and
condensed consolidated statements of operations and comprehensive loss as follows (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="54%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year
Ended<BR>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>For&nbsp;the&nbsp;Six<BR>Months&nbsp;Ended</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;399</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">628</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;1,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Common Stock Valuations </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I></I><I></I>The grant date fair value of the Company&#146;s common stock has been determined by the Company&#146;s Board of Directors with
the assistance of management and an independent third-party valuation specialist. The grant date fair value of the Company&#146;s common stock was determined using valuation methodologies which utilizes certain assumptions including probability
weighting of events, volatility, time to liquidation, a risk-free interest rate and an assumption for a discount for lack of marketability (Level 3 inputs). In determining the fair value of the Company&#146;s common stock, the methodologies used to
estimate the enterprise value of the Company were performed using methodologies, approaches, and assumptions consistent with the Practice Aid. The methodology to determine the fair value of our common stock included estimating the fair value of the
enterprise using a market approach, which estimates the fair value of the Company by including an estimation of the value of the business based on guideline public companies under a number of different scenarios. The assumptions used to determine
the estimated fair value of our common stock are based on numerous objective and subjective factors, combined with management judgment, including external market conditions affecting the pharmaceutical and biotechnology industry and trends within
the industry; our stage of development; the rights, preferences and privileges of our convertible preferred stock relative to those of our common stock; the prices at which we sold shares of our convertible preferred stock; our financial condition
and operating results, including our levels of available capital resources; the progress of our research and development efforts, our stage of development and business strategy; equity market conditions affecting comparable public companies; general
U.S. market conditions and the lack of marketability of our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Practice Aid identifies various available methods for
allocating enterprise value across classes and series of capital stock to determine the estimated fair value of common stock at each valuation date. In accordance with the Practice Aid, we considered the following methods: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Option Pricing Method</I>. Under the option pricing method (&#147;OPM&#148;), shares are valued by creating a
series of call options with exercise prices based on the liquidation preferences and conversion terms of each equity class. The estimated fair values of the preferred and common stock are inferred by analyzing these options. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">77 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Probability-Weighted Expected Return Method</I>. The probability-weighted expected return method
(&#147;PWERM&#148;) is a scenario-based analysis that estimates value per share based on the probability-weighted present value of expected future investment returns, considering each of the possible outcomes available to us, as well as the economic
and control rights of each share class. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Based on our early stage of development and other relevant factors, we
determined that an OPM was the most appropriate method for allocating our enterprise value to determine the estimated fair value of our common stock for valuations during 2017 and 2018. For the first six months of 2019, we used the PWERM method to
determine the estimated fair value of our common stock. The PWERM is appropriate for a company expecting a near term liquidity event. In determining the estimated fair value of our common stock, we considered the fact that our stockholders could not
freely trade our common stock in the public markets. Accordingly, we applied discounts to reflect the lack of marketability of our common stock based on the weighted-average expected time to liquidity. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Following the completion of this offering, our board of directors intends to determine the fair value of our common stock based on the closing
price of our common stock on the date of grant. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We provide for income taxes under the asset and liability method. Current income tax expense or benefit represents the amount of income taxes
expected to be payable or refundable for the current year. Deferred income tax assets and liabilities are determined based on differences between the financial statement reporting and tax bases of assets and liabilities and net operating loss and
credit carryforwards, and are measured using the enacted tax rates and laws that will be in effect when such items are expected to reverse. Deferred income tax assets are reduced, as necessary, by a valuation allowance when management determines it
is more likely than not that some or all of the tax benefits will not be realized. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We account for uncertain tax positions in accordance
with ASC <FONT STYLE="white-space:nowrap">740-10,</FONT> <I>Accounting for Uncertainty in Income Taxes</I>. We assess all material positions taken in any income tax return, including all significant uncertain positions, in all tax years that are
still subject to assessment or challenge by relevant taxing authorities. Assessing an uncertain tax position begins with the initial determination of the position&#146;s sustainability and is measured at the largest amount of benefit that is greater
than fifty percent likely of being realized upon ultimate settlement. As of each balance sheet date, unresolved uncertain tax positions must be reassessed, and we will determine whether (i)&nbsp;the factors underlying the sustainability assertion
have changed and (ii)&nbsp;the amount of the recognized tax benefit is still appropriate. The recognition and measurement of tax benefits requires significant judgment. Judgments concerning the recognition and measurement of a tax benefit might
change as new information becomes available. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2018, our total deferred tax assets were $24.8&nbsp;million. Due to
our lack of earnings history and uncertainties surrounding our ability to generate future taxable income, the net deferred tax assets have been fully offset by a valuation allowance. The deferred tax assets were primarily comprised of federal and
state tax net operating losses (&#147;NOLs&#148;). Utilization of NOLs may be limited by the &#147;ownership change&#148; rules, as defined in Section&nbsp;382 of the Internal Revenue Code. Similar rules may apply under state tax laws. Our ability
to use our remaining NOLs may be further limited if we experience an ownership change in connection with this offering, future offerings or as a result of future changes in our stock ownership. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">78 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Results of Operations </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Years Ended December&nbsp;31, 2017 and 2018 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table summarizes our results of operations for the periods indicated (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="55%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year
Ended<BR>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>$&nbsp;Change</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>%&nbsp;Change</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;25,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;31,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;6,149</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,467</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">40</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,616</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(584</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(270</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 29,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 36,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 7,032</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">24</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased $6.1&nbsp;million, or 24%, from $25.6&nbsp;million for the year ended December&nbsp;31, 2017 to
$31.8&nbsp;million for the year ended December&nbsp;31, 2018. The increase in research and development expenses was primarily due to an increase of $2.4&nbsp;million in clinical trial expenses to support our lead clinical candidates, an increase of
$1.5&nbsp;million in outsourced research and development consultants, an increase in laboratory supplies of $1.4&nbsp;million to support our preclinical programs and an increase in personnel and other costs of $0.8&nbsp;million as a result of an
increase in employee headcount. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following is a comparison of research and development expenses for the years ended December&nbsp;31,
2017 and 2018 (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year
Ended<BR>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">External development expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FLX475</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2,910</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,941</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RPT193</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,324</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Programs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,596</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,204</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,112</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,298</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;25,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;31,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As previously noted, we do not track our own internal research and development costs by drug candidate, as the
related efforts and their costs are typically spread across multiple drug candidates. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased $1.5&nbsp;million, or 40%, from $3.7&nbsp;million for the year ended December&nbsp;31, 2017 to
$5.2&nbsp;million for the year ended December&nbsp;31, 2018. The increase in general and administrative expenses was primarily due to an increase of $0.7&nbsp;million in personnel costs as a result of an increase in employee headcount, an increase
of $0.4&nbsp;million in legal and accounting fees, an increase of $0.2&nbsp;million in investor relations expense and an increase of $0.1&nbsp;million in other administrative expenses to support our infrastructure growth. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">79 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Other Income, Net </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Other income, net increased $0.6&nbsp;million, from $0.2&nbsp;million for the year ended December&nbsp;31, 2017 to $0.8&nbsp;million for the
year ended December&nbsp;31, 2018. The increase was due to an increase in interest income of $0.6&nbsp;million primarily as a result of a higher average cash and cash equivalents balances in 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comparison of the Six Months Ended June&nbsp;30, 2019 and 2018 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table summarizes our results of operations for the periods indicated (in thousands): </P>
<P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Six&nbsp;Months&nbsp;Ended<BR>June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>$&nbsp;Change</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>%&nbsp;Change</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"><B>(unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating costs and expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,931</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,841</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,772</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(393</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">133</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,379</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Research and Development Expenses </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Research and development expenses increased $1.9 million, or 14%, from $14.2 million for the six months ended June 30, 2018 to $16.1 million
for the six months ended June 30, 2019. The increase was primarily due to an increase in development expenses relating to RPT193 of $1.4 million, an increase in clinical costs relating to FLX475 of $0.6 million, an increase in facility related costs
of $0.9 million and an increase in personnel and consultants costs of $0.6 million. These increases are partially offset by a reduction in laboratory supplies of $0.9 million and outsourced research and development costs for other programs of $0.7
million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following is a comparison of research and development expenses for the six months ended June&nbsp;30, 2018 and 2019 (in
thousands): </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Six&nbsp;Months&nbsp;Ended</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">External development expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FLX475</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,323</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,874</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">RPT193</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">685</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,082</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other Programs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">231</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Internal research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11,029</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,950</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total research and development expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;14,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;16,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>General and Administrative Expenses </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">General and administrative expenses increased $1.8 million, or 73%, from $2.5 million for the six months ended June 30, 2018 to $4.4 million
for the six months ended June 30, 2019. The increase was primarily due to an increase in personnel and consultant costs of $0.8 million, accounting and audit related costs of $0.8&nbsp;million, facility-related costs of $0.1 million and
travel-related costs of $0.1 million. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">80 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As previously noted, we do not track our own internal research and development costs by drug
candidate, as the related efforts and their costs are typically spread across multiple drug candidates. </P>   <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Other Income, Net
</I></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Other income, net increased $0.4&nbsp;million from $0.3&nbsp;million for the six months ended June&nbsp;30, 2018 to
$0.7&nbsp;million for the six months ended June&nbsp;30, 2019. The increase was as a result of a higher average cash and cash equivalents balances in 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Capital Resources; Plan of Operations </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June 30, 2019, we had cash and cash equivalents of $59.9 million and as of September 30, 2019 we had cash and cash equivalents of $48.3
million. The September 30, 2019 information is preliminary and subject to adjustment. Our cash and cash equivalents are held in money market funds. Since inception, we have incurred net losses and negative cash flows from operations. At June 30,
2019, we had an accumulated deficit of $138.8 million, and working capital of $56.1 million. In addition, we expect to incur substantial costs in order to conduct research and development activities necessary to develop a commercialized product.
Additional capital will be needed to undertake these activities and commercialization efforts, and, therefore, we intend to raise such capital through the issuance of additional equity, borrowings, and potentially strategic alliances with other
companies. However, if such financing is not available at adequate levels or on acceptable terms, the Company could be required to significantly reduce operating expenses and delay, reduce the scope of or eliminate some of its development programs
or its commercialization efforts, out-license intellectual property rights to its drug candidates and sell unsecured assets, or a combination of the above, any of which may have a material adverse effect on the Company&#146;s business, results of
operations, financial condition and/or its ability to fund its scheduled obligations on a timely basis or at all. The ability of the Company to continue as a going concern is dependent upon our ability to successfully accomplish these plans and
secure sources of financing and ultimately attain profitable operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As a result of these conditions, management has concluded that
substantial doubt about the Company&#146;s ability to continue as a going concern exists as conditions and events, considered in the aggregate, indicate that it is&nbsp;probable that the Company will be unable to meet our obligations as they become
due within one year after the date that the&nbsp;financial statements are issued. The financial information throughout this registration statement and the financial statements included elsewhere in this registration statement have been prepared on a
basis that assumes that we will continue as a going concern, which contemplates the realization of assets and the satisfaction of liabilities and commitments in the normal course of business. This financial information and these financial statements
do not include any adjustments that may result from an unfavorable outcome of this uncertainty. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our failure to raise capital as and
when needed could have a negative impact on our financial condition and our ability to pursue our business strategies. We anticipate that we will need to raise substantial additional capital, the requirements of which will depend on many factors,
including: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope, rate of progress and costs of our drug discovery, preclinical development activities, laboratory
testing and clinical trials for our drug candidates; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the number and scope of clinical programs we decide to pursue; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the scope and costs of manufacturing development and commercial manufacturing activities; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the extent to which we acquire or <FONT STYLE="white-space:nowrap">in-license</FONT> other drug candidates and
technologies; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost, timing and outcome of regulatory review of our drug candidates; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">81 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost and timing of establishing sales and marketing capabilities, if any of our drug candidates receive
marketing approval; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs of preparing, filing and prosecuting patent applications, obtaining, maintaining and enforcing our
intellectual property rights and defending intellectual property-related claims; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our ability to establish and maintain collaborations on favorable terms, if at all; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our efforts to enhance operational systems and our ability to attract, hire and retain qualified personnel,
including personnel to support the development of our drug candidates; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the costs associated with being a public company; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the cost associated with commercializing our drug candidates, if they receive marketing approval.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If we raise additional funds by issuing equity securities, our stockholders may experience dilution. Any future debt
financing into which we enter may impose upon us additional covenants that restrict our operations, including limitations on our ability to incur liens or additional debt, pay dividends, repurchase our common stock, make certain investments and
engage in certain merger, consolidation or asset sale transactions. Any debt financing or additional equity that we raise may contain terms that are not favorable to us or our stockholders. If we are unable to raise additional funds when needed, we
may be required to delay, reduce, or terminate some or all of our development programs and clinical trials. We may also be required to sell or license to other parties rights to develop or commercialize our drug candidates that we would prefer to
retain. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">See &#147;Risk Factors&#148; for additional risks associated with our substantial capital requirements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Summary Consolidated Statement of Cash Flows </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table sets forth the primary sources and uses of cash and cash equivalents for each of the periods presented below (in
thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="53%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year Ended
December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Six Months
Ended<BR>June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash (used in) provided by:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;(27,123</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;(32,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;(14,879</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">&nbsp;(17,647</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,124</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,050</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(787</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,734</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase (decrease) in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 16,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(3,936)</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Cash Used in Operating Activities </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $27.1&nbsp;million for the year ended December&nbsp;31, 2017, reflecting a net loss of
$29.1&nbsp;million, net changes in operating assets and liabilities of $0.1&nbsp;million, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges for depreciation, amortization and stock-based compensation expense&nbsp;of
$2.1&nbsp;million. Net cash used in operating activities was $33.0&nbsp;million for the year ended December&nbsp;31, 2018, reflecting a net loss of $36.1&nbsp;million, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges for
depreciation, amortization and stock-based compensation expense&nbsp;of $2.4&nbsp;million, and net decreases in operating assets and liabilities of $0.7&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities was $14.9&nbsp;million for the six months ended June&nbsp;30, 2018, reflecting a net loss of
$16.4&nbsp;million, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges for depreciation, amortization and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">82 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
stock-based compensation expense&nbsp;of $1.2&nbsp;million and net increases in operating assets and liabilities of $0.3&nbsp;million. Net cash used in operating activities was $17.6&nbsp;million
for the six months ended June&nbsp;30, 2019, reflecting a net loss of $19.8&nbsp;million, partially offset by <FONT STYLE="white-space:nowrap">non-cash</FONT> charges for depreciation, amortization and stock-based compensation expense&nbsp;of
$1.4&nbsp;million and net increases in operating assets and liabilities of $0.8&nbsp;million. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Cash Used in Investing Activities
</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Cash used in investing activities was $1.1&nbsp;million and $3.5&nbsp;million for years ended December&nbsp;31, 2017 and 2018,
respectively, and primarily resulted from the purchase of laboratory equipment and leasehold improvements. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Cash used in investing
activities was $1.1&nbsp;million and $0.8&nbsp;million for the six months ended June&nbsp;30, 2018 and 2019, respectively, and primarily resulted from the purchase of laboratory equipment and leasehold improvements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Cash Provided by Financing Activities </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities was $30.1&nbsp;million and $52.7&nbsp;million for the years ended December&nbsp;31, 2017 and 2018,
respectively, resulting from the receipt of net proceeds from the issuance of our convertible preferred stock. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Net cash provided by
financing activities was $30.1&nbsp;million and $14.4&nbsp;million for the six months ended June&nbsp;30, 2018 and 2019, respectively, resulting from the receipt of net proceeds from the issuance of our convertible preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Contractual Obligations and Commitments </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table summarizes our contractual obligations as of June&nbsp;30, 2019 (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" ALIGN="center">


<TR>

<TD WIDTH="64%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="18" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Payment due by
Period</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Less&nbsp;than<BR>1
year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B><FONT STYLE="white-space:nowrap">2-3</FONT></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>4 to 5</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>After 5</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating Lease obligations</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,429</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">3,712</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,219</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,491</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,851</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2019, our commitments consisted of operating leases for our operating facilities
for approximately 36,754 square feet. Under the terms of the agreements, we will have lease obligations, net of sublease income, consisting of $14.9&nbsp;million in payments from 2019 through 2026. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We enter into contracts in the normal course of business with third-party contract organizations for clinical trials, <FONT
STYLE="white-space:nowrap">non-clinical</FONT> studies and testing, and other services and products for operating purposes. These contracts generally provide for termination following a certain period after notice, and therefore we believe that our <FONT
STYLE="white-space:nowrap">non-cancelable</FONT> obligations under these agreements are not material and they are not included in the table above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT
STYLE="white-space:nowrap">Off-Balance</FONT> Sheet Arrangements </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Since our inception, we have not engaged in any <FONT
STYLE="white-space:nowrap">off-balance</FONT> sheet arrangements, as defined in the rules and regulations of the SEC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As permitted under Delaware law and in accordance with our bylaws, we indemnify our officers and directors for certain events or occurrences
while the officer or director is or was serving in such capacity. We are </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">83 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
also party to indemnification agreements with our officers and directors. We believe the fair value of the indemnification rights and agreements is minimal. Accordingly, we have not recorded any
liabilities for these indemnification rights and agreements as of December&nbsp;31, 2017 and December&nbsp;31, 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>JOBS Act Accounting Election
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Jumpstart Our Business Startups Act of 2012 (the &#147;JOBS Act&#148;), permits an &#147;emerging growth company&#148; such as us
to take advantage of an extended transition period to comply with new or revised accounting standards applicable to public companies. We are choosing to elect the extended transition period for complying with new or revised accounting standards
pursuant to Section&nbsp;107(b) of the JOBS Act until the earlier of the date we (i)&nbsp;are no longer an emerging growth company or (ii)&nbsp;affirmatively and irrevocably opt out of the extended transition period provided in the JOBS Act. As a
result, our financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We elected to use this extended transition period for complying with new or revised accounting standards, including but not limited to the new
lease accounting standard, that have different effective dates for public and private companies until the earlier of the date that we (i)&nbsp;are no longer an emerging growth company or (ii)&nbsp;affirmatively and irrevocably opt out of the
extended transition period provided in the JOBS Act. As a result, these financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. We early adopted
Accounting Standards Update <FONT STYLE="white-space:nowrap">2014-09,</FONT> <I>Revenue from Contracts with Customers</I> (Accounting Standards Codification Topic 606), and Accounting Standards Update <FONT STYLE="white-space:nowrap">2018-07,</FONT>
<I>Improvements to Nonemployee Share-Based Payment Accounting</I> (Accounting Standards Codification Topic 718), as the JOBS Act does not preclude an emerging growth company from early adopting a new or revised accounting standard earlier than the
time that such standard applies to private companies. We expect to use the extended transition period for any other new or revised accounting standards during the period in which we remain an emerging growth company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We will remain an emerging growth company until the earliest of (1)&nbsp;the last day of our first fiscal year (a)&nbsp;following the fifth
anniversary of the completion of this offering, (b)&nbsp;in which we have total annual gross revenue of at least $1.07&nbsp;billion, or (ii)&nbsp;in which we are deemed to be a large accelerated filer, which means the market value of our common
stock that is held by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> exceeds $700.0&nbsp;million of the prior June 30th and (2)&nbsp;the date on which we have issued more than $1.0&nbsp;billion in
<FONT STYLE="white-space:nowrap">non-convertible</FONT> debt securities during the prior three-year period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Adopted Accounting Pronouncements
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In May 2014, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2014-09,</FONT> <I>Revenue from Contracts with
Customers</I> (Topic 606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. This standard is based on the principle that revenue is recognized to depict the transfer of goods or services to customers in an
amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash flows
arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The standard is effective for annual periods beginning after December&nbsp;15, 2018
using one of two retrospective application methods. Early adoption is permitted, but not before annual periods beginning after December&nbsp;15, 2016. We have elected to adopt this standard as of January&nbsp;1, 2018. The adoption of ASU <FONT
STYLE="white-space:nowrap">No.&nbsp;2014-09</FONT> did not have any impact on our consolidated financial statements and related disclosures. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In August 2018, the SEC issued a final rule to simplify certain disclosure requirements. In addition, the amendments expanded the disclosure
requirements on the analysis of stockholders&#146; equity for interim financial statements. In August and September 2018, further amendments were issued to provide implementation guidance on adoption of the SEC rule and transition guidance for the
new interim stockholders&#146; equity disclosure. We adopted these requirements in the first quarter of 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">84 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In May 2017, the FASB issued
<FONT STYLE="white-space:nowrap">ASU&nbsp;No.&nbsp;2017-09,</FONT> <I>Compensation&#151;Stock Compensation</I> (Topic 718), Scope of Modification Accounting. This pronouncement provides guidance about which changes to the terms or conditions of a
share-based payment award may require an entity to apply modification accounting under Topic 718. This guidance is effective for annual reporting periods beginning after December&nbsp;15, 2017, including interim periods within that reporting period,
with early adoption permitted. We adopted this standard on January&nbsp;1, 2018. The adoption of ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2017-09</FONT> did not have a significant impact on our consolidated financial statements and related
disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In August 2016, the FASB issued&nbsp;ASU No. <FONT STYLE="white-space:nowrap">2016-15,&nbsp;Statement</FONT> of Cash Flows
(Topic 230), which provides greater clarity to preparers on the treatment of certain items within an entity&#146;s statement of cash flows. The new guidance is intended to reduce diversity in practice in how certain transactions are classified in
the statement of cash flows.&nbsp;The guidance becomes effective on January&nbsp;1, 2019 and early adoption is permitted. We adopted this standard on January 1, 2019. The adoption of ASU No. 2016-15 did not have a significant impact on our interim
condensed consolidated financial statements and related disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Recent Accounting Pronouncements Not Yet Adopted </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Under the JOBS Act, we meet the definition of an emerging growth company, and have elected the extended transition period for complying with
new or revised accounting standards pursuant to Section&nbsp;107(b) of the JOBS Act. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In May 2019, ASU 2019-05, <I>Financial
Instruments&#151;Credit Losses (Topic 326): Targeted Transition Relief</I>, was issued to provide entities with an option to irrevocably elect the fair value option in Subtopic 825-10, applied on an instrument-by-instrument basis for eligible
instruments, that are within the scope of Subtopic <FONT STYLE="white-space:nowrap">326-20,</FONT> upon adoption of Topic 326. The fair value option election does not apply to held-to-maturity debt securities. This targeted transition relief is
intended to increase comparability of financial statement information for some entities that otherwise would have measured similar financial instruments using different measuring methodologies. The effective date of this ASU for the Company is the
same as ASU No. 2016-13, which is January 1, 2021. We are currently assessing the impact of this ASU on our consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In April 2019, the FASB issued ASU 2019-04, <I>Codification Improvements to Topic 326, Financial Instruments&#151;Credit Losses, Topic 815,
Derivatives and Hedging, and Topic 825, Financial Instruments</I>, to clarify and address certain items related to the amendments in ASU 2016-13, <I>Financial Instruments&#151;Credit Losses (Topic 326): Measurement of Credit Losses on Financial
Instruments</I>. The effective date of this ASU for the Company is the same as ASU No. 2016-13, which is January 1, 2021. We are currently assessing the impact of this ASU on our consolidated financial statements. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In August 2018, the FASB issued ASU No. <FONT STYLE="white-space:nowrap">2018-13,</FONT> <I>Fair Value Measurements (Topic 820): Disclosure
Framework&#151;Changes to the Disclosure Requirements for Fair Value Measurement</I> as part of the FASB&#146;s disclosure framework project. This ASU modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value
Measurement by removing the requirement to disclose amounts of and reasons for transfers between Level&nbsp;1 and Level&nbsp;2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation process for Level&nbsp;3
fair value measurements. This ASU also modifies existing disclosure requirements by clarifying that the measurement uncertainty disclosure is to communicate information about the uncertainty in measurement as of the reporting date, and it adds
required disclosures for the changes in unrealized gains and losses for the period included in other comprehensive income for recurring Level&nbsp;3 fair value measurements held at the end of the reporting period, and the range and weighted average
of significant unobservable inputs used to develop Level&nbsp;3 fair value measurements. This ASU will be effective for the Company for fiscal years and interim periods within those fiscal years, beginning after December&nbsp;15, 2019. We are
currently assessing the impact of this ASU on our consolidated financial statements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In June 2018, the FASB issued <FONT
STYLE="white-space:nowrap">ASU&nbsp;No.&nbsp;2018-07,</FONT> <I>Compensation&#151;Stock Compensation (Topic&nbsp;718): Improvements to <FONT STYLE="white-space:nowrap">Non-Employee</FONT> Share-Based Payment Accounting</I> as part of the FASB
simplification initiative. The </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">85 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
new standard expands the scope of Topic 718, allowing us to apply the requirements of Topic 718 to <FONT STYLE="white-space:nowrap">certain&nbsp;non-employee&nbsp;awards</FONT> to acquire goods
and services <FONT STYLE="white-space:nowrap">from&nbsp;non-employees.&nbsp;This</FONT> ASU will be effective for the Company for fiscal years beginning after December&nbsp;15, 2019, and interim periods within fiscal years beginning after
December&nbsp;15, 2020, with early adoption permitted. We are currently assessing the timing of adoption and the impact that the adoption of ASU <FONT STYLE="white-space:nowrap">2018-07</FONT> will have on our consolidated financial statements and
related disclosures. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In June 2016, the FASB issued ASU No. 2016-13, <I>Financial Instruments&#151;Credit Losses (Topic 326):
Measurement of Credit Losses on Financial Instruments</I>. The new standard changes the impairment model for most financial assets and certain other instruments. Under the new standard, entities holding financial assets and net investment in leases
that are not accounted for at fair value through net income are to be presented at the net amount expected to be collected. An allowance for credit losses will be a valuation account that will be deducted from the amortized cost basis of the
financial asset to present the net carrying value at the amount expected to be collected on the financial asset. The new standard will be effective for the Company on January 1, 2021. The Company is currently evaluating the impact of this new
guidance. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In February 2016, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02,</FONT> <I>Leases</I>. ASU <FONT
STYLE="white-space:nowrap">2016-02</FONT> requires lessees to put most leases on their balance sheet while recognizing expense in a manner similar to existing accounting. ASU <FONT STYLE="white-space:nowrap">2016-02</FONT> states that a lessee would
recognize a lease liability for the obligation to make lease payments and a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-to-use</FONT></FONT> asset for the right to use the underlying asset for the lease term. The new
accounting guidance is effective for fiscal periods beginning after December&nbsp;15, 2019 and early adoption is permitted. The Company plans to adopt this standard on January&nbsp;1, 2020 and is currently evaluating the impact that the adoption of <FONT
STYLE="white-space:nowrap">ASU&nbsp;2016-02</FONT> will have on our consolidated financial statements and related disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Quantitative and
Qualitative Disclosures about Market Risk </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The market risk inherent in our financial instruments and in our financial position
represents the potential loss arising from adverse changes in interest rates or exchange rates. As of June&nbsp;30, 2019, we had cash and cash equivalents of $59.9&nbsp;million and as of September 30, we had cash and cash equivalents of $48.3
million, consisting of interest-bearing money market accounts for which the fair market value would be affected by changes in the general level of United States interest rates. However, due to the short-term maturities and the <FONT
STYLE="white-space:nowrap">low-risk</FONT> profile of our investments, an immediate 10% change in interest rates would not have a material effect on the fair market value of our cash, cash equivalents and investments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We do not believe that inflation, interest rate changes, or exchange rate fluctuations had a significant impact on our results of operations
for any periods presented herein. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">86 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_11"></A>BUSINESS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Overview </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are a clinical-stage
immunology-based biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing our proprietary drug discovery
and development engine, we are developing highly selective small molecules designed to modulate the critical immune responses underlying these diseases. In our first four years since inception, we have discovered and advanced two unique drug
candidates each targeting <FONT STYLE="white-space:nowrap">C-C</FONT> motif chemokine receptor 4 (&#147;CCR4&#148;). Our lead oncology drug candidate, FLX475, reached the clinic in just two and a half years and our lead inflammation drug candidate,
RPT193, entered the clinic in August 2019. We are also pursuing a range of targets, including general control nonderepressible 2 (&#147;GCN2&#148;) and hematopoietic progenitor kinase 1 (&#147;HPK1&#148;), that are in the discovery stage of
development. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our lead oncology drug candidate, FLX475, is designed to selectively inhibit the migration of immunosuppressive
regulatory T cells (&#147;T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>&#148;) into tumors. In a Phase 1 clinical trial in 104 healthy volunteers, FLX475 was well tolerated and demonstrated favorable drug-like properties with a level
of target engagement that, in our preclinical studies, corresponded with 90% inhibition of in vitro T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and the highest level of inhibition of in vivo T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and antitumor activity. FLX475 has also demonstrated single agent and combination activity in preclinical tumor models associated with the inhibition of T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration into the tumor and an increase in the CD8 : T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> ratio. We are currently conducting a Phase 1/2 clinical trial investigating
FLX475 as a single agent and in combination with pembrolizumab (marketed as Keytruda) in patients with &#147;charged&#148; tumors who we believe have the greatest probability of clinical benefit, in order to study the safety and potential clinical
activity of FLX475 in patients with advanced cancer. We anticipate results from the Phase 2 portion of the trial could provide clinical <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT>
(&#147;PoC&#148;) data in the first half of 2020. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our lead inflammation drug candidate, RPT193, is designed to selectively inhibit
the migration of type 2 T helper cells (&#147;Th2 cells&#148;), into allergically-inflamed tissues. Th2 cells are clinically validated drivers of allergic diseases along the &#147;atopic march&#148; such as atopic dermatitis (&#147;AD&#148;),
asthma, chronic urticaria (skin rash), allergic conjunctivitis, chronic rhinosinusitis and eosinophilic esophagitis (inflammation of the esophagus). We believe based on our preclinical pharmacology and Good Laboratory Practice (&#147;GLP&#148;)
toxicology results, if confirmed in clinical trials, combined with the convenience of once-daily oral dosing, RPT193, if approved by the FDA, could fill an unmet medical need for the treatment of allergic disorders. We have initiated a seamless
Phase 1 trial of RPT193 comprised initially of Phase 1a single and multiple dose escalation cohorts of healthy volunteers in August 2019, to be followed by placebo-controlled Phase 1b testing in patients with moderate to severe AD. Preliminary
safety, pharmacokinetic, and pharmacodynamic data from the initial single dose cohorts support once-daily oral dosing with RPT193 and dose escalation continues as planned. Thereafter, we intend to expand clinical development into additional <FONT
STYLE="white-space:nowrap">Th2-driven</FONT> allergic indications. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, we are identifying lead compounds that inhibit GCN2,
which we believe is a fundamental regulator of antitumor immunity and tumor cell survival. Preclinical studies have demonstrated that a potential inhibitor of GCN2 (an &#147;RPT-GCN2i&#148;), has the ability to restore in vitro T&nbsp;cell
proliferation and function in nutrient-deprived conditions, enhance tumor cell death and elicit antitumor responses in preclinical tumor models. We are developing an RPT-GCN2i with the intent of filing an IND with the FDA in 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We will continue to invest in our proprietary discovery and development engine and investigate several of our identified targets as well as
generate additional target and drug candidates, including a future HPK1 drug candidate. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We internally discovered and designed all of our
drug candidates. We hold worldwide rights to each of our drug candidates. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">87 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Our Pipeline: Highly Selective Oral Compounds Targeting Critical Immune Drivers </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g723949g27z46.jpg" ALT="LOGO">
 </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">IND submitted in May 2018 to treat multiple &#147;charged&#148; tumor types including non-small cell lung
cancer, triple negative breast cancer, head and neck squamous cell carcinoma, nasopharyngeal cancer, gastric cancer, certain Hodgkin and non-Hodgkin lymphomas and cervical cancer. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Initial Phase 1 study in healthy volunteers and patients with atopic dermatitis initiated in August 2019. Our
CTA in Europe was accepted in July 2019. Subject to acceptance of an IND or CTA, subsequent Phase 2 studies may include additional allergic diseases beyond atopic dermatitis, including asthma, chronic urticaria (skin rash), allergic conjunctivitis,
chronic rhinosinusitis and eosinophilic esophagitis (inflammation of the esophagus). </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Key Upcoming Milestones </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g40n70.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our CCR4 Franchise </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our proprietary drug discovery and development engine has identified the cell surface receptor CCR4 as a drug target that potentially has
broad applicability in oncology and inflammatory diseases. Receptors such as CCR4 bind to chemoattractant molecules called chemokines that orchestrate migration and homing of immune cells to specific tissues throughout the body. Chemokines specific
for CCR4 are secreted from tumors and from allergically-inflamed tissues, but are not highly expressed in healthy tissues. Our approach is designed to enable selective restoration of the immune response within the tumor and allergically-inflamed
tissues without </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">88 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
systemically depleting immune cells and broadly suppressing the immune system. Each of our two unique drug candidates, FLX475 and RPT193, target CCR4 in a manner we believe is well suited for
cancer and inflammatory disease, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>CCR4 Antagonist for Oncology: FLX475 </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are developing FLX475 for the treatment of a broad range of &#147;charged&#148; tumors, which represent cancer types we believe are most
likely to respond to FLX475. In cancer, the secretion of certain chemokines from tumor cells and tumor-resident immune cells is responsible for recruitment of immunosuppressive T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> to tumor
sites. T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> represent a dominant pathway for downregulating the immune response, and thus may limit the effectiveness of currently available therapies such as checkpoint inhibitors. Therefore,
blocking the migration of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> has the potential to restore naturally-occurring antitumor immunity as well as to synergize with a variety of both conventional and immune-based therapies, such
as radiation, chemotherapy, checkpoint inhibitors, immune stimulators and adoptive T cell therapy. We believe that the inhibition of CCR4 has the potential to bring therapeutic benefit to patients across a wide spectrum of tumors in a manner similar
to other immuno-oncology therapies that have been shown to be effective against multiple tumor types, while also potentially deepening or broadening clinical responses to these therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>FLX475: Highly Selective Approach for Targeting Tumor T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> </B></P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g14k32.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our proprietary drug discovery and development engine has identified certain tumors in which the abundance
of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> is likely to be a cause of immune suppression. We refer to these tumors as &#147;charged,&#148; as defined by their expression of high levels of (i)&nbsp;CCR4 ligands, (ii)&nbsp;T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> and (iii)&nbsp;CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> effector cells. These &#147;charged&#148; tumors include tumor types such as
<FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer (&#147;NSCLC&#148;), triple negative breast cancer (&#147;TNBC&#148;), head and neck squamous cell carcinoma (&#147;HNSCC&#148;), nasopharyngeal cancer (&#147;NPC&#148;), gastric
cancer, certain Hodgkin (&#147;HL&#148;) and <FONT STYLE="white-space:nowrap">non-Hodgkin</FONT> lymphomas (&#147;NHL&#148;), and cervical cancer. Additionally, we have discovered that the presence of oncogenic viruses, such as Epstein-Barr virus
(&#147;EBV&#148;) and human papillomavirus (&#147;HPV&#148;), is associated with tumors that are highly &#147;charged&#148; and allows prospective patient selection. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">FLX475 is a small molecule CCR4 antagonist that is designed to block the migration of
T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> specifically into tumors, but not healthy tissues, without depleting T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> throughout the body, which we believe may decrease the
likelihood of side effects. In preclinical tumor models, FLX475 appears to selectively bind to CCR4 and inhibit the migration of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> into tumors without affecting healthy tissue such as skin,
blood or lymphoid organs, increase the number of CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> effector T cells in the tumor and, as a single agent or in combination with checkpoint inhibitors, lead to tumor reduction or eradication. In
addition, in preclinical tumor models, inhibition of CCR4 with FLX475 did not appear to negatively impact effector immune cells. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">89 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have completed a placebo-controlled, double-blinded dose-escalating Phase 1 clinical
trial of FLX475 in 104 healthy volunteers. The objectives of the trial were to evaluate the safety and tolerability, pharmacokinetics, and pharmacodynamics of single and repeat doses of FLX475 in human subjects. FLX475 was well tolerated and
demonstrated dose-dependent inhibition of CCR4 with no observed immune-related adverse events or significant clinical adverse events. Daily dosing within the single dose arm ranged between 5 mg and 1,000 mg and in the multiple dose arm between 25 mg
and 150 mg a day for 14 days. At the 75 mg daily dose, FLX475 exceeded the targeted receptor occupancy in six out of six healthy volunteers, which, in our preclinical studies, corresponded with a 90% inhibition of in vitro<I> </I>T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and the highest level of inhibition of in vivo T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and antitumor activity. We are currently enrolling a Phase 1/2
trial of FLX475 as a monotherapy, and in combination with pembrolizumab, in patients with &#147;charged&#148; tumors and anticipate results from the Phase 2 portion of the trial could provide clinical PoC data in the first half of 2020. While Phase
1 dose escalation is ongoing and a maximum tolerated dose (&#147;MTD&#148;) has not yet been identified for either monotherapy or combination therapy, a patient with NSCLC in the 50 mg FLX475 and
Keytruda<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (pembrolizumab) cohort that had failed prior treatment with anti-PD-L1 therapy (atezolizumab) has had a confirmed partial response (&#147;PR&#148;) under RECIST 1.1 criteria, based
on radiological analysis performed at the clinical investigator site, with a 37.5% reduction in target lesion measurement at 8 weeks and a 47% reduction at 14 weeks. The patient remains on study. We intend to present topline data from the Phase 1/2
trial in the first half of 2020. For more information regarding the risks associated with our Phase 1/2 clinical trial for FLX475, please see &#147;Risk Factors&#151;Risks Related to Our Business&#151;FLX475 and PRT193 are in clinical development,
which may fail or suffer delays that materially and adversely affect their commercial viability.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Confirmed Partial Response in a Checkpoint
Inhibitor-Refractory NSCLC Patient Treated with 50&nbsp;mg FLX475+Keytruda<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>* </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g70u81.jpg" ALT="LOGO">
 </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Based on radiological analysis conducted at the clinical investigator site. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We hold worldwide rights to FLX475 and own an issued U.S. composition of matter patent with respect to FLX475 that is scheduled to expire in
2037. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>CCR4 Antagonist for Allergic Inflammatory Disease: RPT193 </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">RPT193 is a small molecule CCR4 antagonist that blocks the recruitment of inflammatory immune cells, known as Th2 cells, which are clinically
implicated in allergic inflammatory diseases. We are developing RPT193 for the treatment of a broad range of allergic inflammatory diseases, the first of which is AD, a chronic, inflammatory skin disease characterized by skin barrier disruption and
immune dysregulation. We have initiated </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">90 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
a seamless first in human trial in August 2019 starting with Phase 1a single and multiple dose escalation cohorts in healthy volunteers, to be followed by placebo-controlled Phase 1b testing in
patients with moderate to severe AD. Preliminary safety, pharmacokinetic, and pharmacodynamic data from the initial single dose cohorts support once-daily oral dosing with RPT193 and dose escalation continues as planned. We anticipate PoC clinical
results from the Phase 1b portion of this study by mid-2020. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">While there are marketed injectable products for the treatment of AD,
as well as oral and injectable drug candidates in development, we believe there is an unmet need for a safe and effective oral treatment. We believe based on our preclinical pharmacology and GLP toxicology results, if confirmed in clinical trials,
combined with the convenience of once-daily oral dosing, RPT193, if approved by the FDA, could fill an unmet medical need for the treatment of allergic disorders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">CCR4 is highly expressed on Th2 cells. In allergic inflammatory diseases, including AD, chemokines recruit Th2 cells via CCR4 into inflamed
tissues. Once Th2 cells enter tissues such as the skin or the airways in the lung, they secrete proteins known to drive the inflammatory response. The role of Th2 cells has been clinically validated by, among others, dupilumab, an injectable
biologic targeting this pathway. Further evidence of CCR4&#146;s role in AD includes the observation of higher levels of CCR4 ligands in AD patients compared with healthy humans; these ligands also correlate with the severity of disease. We believe
that by inhibiting CCR4, RPT193 has the potential to bring therapeutic benefit to patients across a broad spectrum of additional allergic inflammatory diseases, including asthma, chronic urticaria, allergic conjunctivitis, chronic rhinosinusitis and
eosinophilic esophagitis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>RPT193 Acts on a Well-Validated Pathway in AD and Asthma </B></P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g84h44.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are developing RPT193 initially in AD because there is: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an unmet need for a safe and effective oral treatment; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a potentially efficient path to PoC, due to high prevalence of disease and short time to clinically relevant
endpoints; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a well-defined set of clinical endpoints that have historically been accepted for regulatory approval, which are
usable for PoC as well as for subsequent pivotal studies; </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">91 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">easy access to patient samples, such as skin biopsies, to interrogate mechanisms of action and clinical
biomarkers of efficacy; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a precedent that PoC in AD has translated to other <FONT STYLE="white-space:nowrap">Th2-driven</FONT> allergic
inflammatory diseases. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We hold worldwide rights to RPT193 and have pending patent applications with respect to RPT193
that, if issued, would be scheduled to expire in 2039. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>GCN2 and HPK1 for Oncology </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">GCN2 is a fundamental driver of immune suppression and the survival of tumor cells under the conditions of metabolic stress typically seen in
the tumor microenvironment (&#147;TME&#148;). Preclinical studies have shown that the inhibition of GCN2 can result in tumor cell death in vitro and restoration of immune function under these stress conditions. The GCN2 pathway is generally not
active in healthy tissue suggesting the potential for a favorable therapeutic index for drugs targeting GCN2. Preclinical in vitro and in vivo studies have demonstrated that an RPT-GCN2i has the ability to increase T cell proliferation and function
in nutrient-deprived conditions, to overcome immune suppression induced by myeloid-derived suppressor cells (&#147;MDSC&#148;), and to elicit antitumor responses in animal models. We are developing an RPT-GCN2i with the intent of filing an IND with
the FDA in 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>GCN2: Key Driver of Immunosuppression in the TME </B></P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g41j36.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">HPK1 is a negative regulator of T cell activation, and the inhibition of HPK1 has the potential to
enhance T cell function and antitumor activity. HPK1 was identified in a RAPT computational screen, which also identified clinically validated targets including PD-1, as well as CCR4. We are refining the chemical structure of
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">92 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
our lead HPK1 compounds utilizing high resolution crystal structures and demonstrated that inhibition of HPK1 enhanced activation of primary mouse and human T&nbsp;cells in vitro, as well as
antigen-specific CD8+ T&nbsp;cell effector function in vivo. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>HPK1: Negative Regulator of T Cell Activation </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g53j78.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Proprietary Drug Discovery and Development Engine </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Through our team&#146;s deep expertise in immunology and drug discovery, supported by advanced computational biology, we are developing the
ability to exploit difficult targets, including through proprietary know-how. We refer to this as our &#147;proprietary drug discovery and development engine.&#148; This engine is built upon the following four key pillars: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>computationally-driven disease target and biomarker identification; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>efficient design of small molecule drug properties; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>data-driven patient selection; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B></B>nimble clinical execution. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We believe that the drug candidates generated from this engine, if approved, will significantly improve the treatment paradigms and outcomes
for patients by fundamentally modulating the immune responses in a range of cancers and inflammatory diseases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Team and Investors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our management and scientific teams and scientific advisory board have substantial expertise in three areas key to our success: immunology,
small molecule drug discovery and development and computational biology. Collectively, our executives have contributed to the research and development of multiple approved drugs, including Gazyva, Venclexta, Tavalisse, Actemra, Provenge and Xgeva.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have assembled a leadership team and advisory group with a proven track record of success, and a team of scientists with substantial
knowledge and expertise especially in human immune biology and also in the drug discovery and development and translational areas essential to execute on this approach. Our President and Chief Executive Officer, Brian Wong, M.D., Ph.D., previously
served as Senior Vice President, Research, and Head of Immuno-Oncology at Five Prime Therapeutics and Director of Research in the Inflammation Disease Biology Area at Roche. William Ho, M.D., Ph.D., our Chief Medical Officer, previously led clinical
development at Igenica Biotherapeutics and the development of multiple products at Genentech including Gazyva and Venclexta. Our Chief Scientific Officer, Dirk Brockstedt, Ph.D., previously served as Executive Vice President of Research and
Development at Aduro Biotech. Our Vice President, Quantitative and Computational Biology, Paul Kassner, Ph.D., previously served as Director of Research and Head of the Genome </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">93 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Analysis Unit at Amgen. Before joining RAPT, our Senior Vice President of Drug Discovery and Preclinical Development, David Wustrow, Ph.D., most recently served as Vice President, Chemical and
Pharmaceutical Sciences at Cleave Biosciences. Our Vice President, Finance and Corporate Controller, Karen&nbsp;C.&nbsp;Lam, previously served as Senior Director, Controller of True North Therapeutics and Director, Controller at iPierian and
Ms.&nbsp;Lam is a Certified Public Accountant (inactive). </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our management team is supported by a scientific advisory board comprised
of leading clinicians and scientific researchers, including Alexander Rudensky, Ph.D. (Memorial Sloan Kettering Cancer Center); Antoni Ribas, M.D., Ph.D. (UCLA); Scott Antonia, M.D., Ph.D. (Duke University); Drew Pardoll, M.D., Ph.D. (Johns Hopkins
University); Philip Greenberg, M.D., Ph.D. (Fred Hutchinson Cancer Research Center); Robert Zamboni, Ph.D. (McGill University); Emma Guttman-Yassky, M.D., Ph.D. (Mt. Sinai); and David Goeddel, Ph.D. (The Column Group). Our clinical advisors also
include Jasmina Jankicevic, M.D. (Premier Research); Thomas Bieber, M.D. (University of Bonn, Germany); and Andrew Blauvelt, M.D., M.B.A. (Oregon Medical Research Center). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are backed by leading corporate and institutional investors, including The Column Group, GV, Kleiner Perkins, Topspin Partners, Hartford
Healthcare, Celgene Corporation and funds and accounts managed by T. Rowe Price Associates, Inc. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Strategy </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Advance our lead candidate, FLX475, through clinical development to commercialization in &#147;charged&#148;
tumor types, which represent cancer types we believe are most likely to respond to</B> <B>FLX475</B>. We expect to rapidly evaluate FLX475&#146;s efficacy in multiple tumor types both as a single agent and in combination with other immuno-oncology
agents such as programmed cell death 1 (&#147;PD-1&#148;) checkpoint inhibitor. Our goal is to expeditiously progress into registration trials to ultimately enable treatment of cancer patients for whom current treatments are inadequate.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Enhance the impact of RPT193 by expanding development across multiple allergic diseases.</B> We are initially
developing RPT193 for AD because the characteristics of the disease present an opportunity to rapidly demonstrate RPT193&#146;s anti-inflammatory effect. We believe this anti-inflammatory effect, along with its convenient oral administration and
good preclinical safety profile, has potential clinical translatability in a variety of allergic diseases beyond AD, including allergic asthma, chronic urticaria, chronic rhinosinusitis, allergic conjunctivitis and eosinophilic esophagitis.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Develop and advance a preclinical <FONT STYLE="white-space:nowrap">RPT-GCN2</FONT> inhibitor into clinical
trials. </B>We view our preclinical programs as important drivers of long-term growth and stability of our company. Our goal is to rapidly advance our programs to generate validating preclinical data that warrant clinical development.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Expand our pipeline by leveraging our proprietary drug discovery and development engine and small molecule
expertise.</B> We believe there are additional identifiable targets that will be important to fundamentally modulating the immune response in the treatment of cancer and inflammatory diseases. We will continue to invest in our proprietary discovery
and development engine and investigate several of our identified targets as well as generate additional target and drug candidates, including a future HPK1 drug candidate. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><B>Utilize collaborations in support of our long-term goals.</B> We plan to selectively use collaborations and
partnerships as strategic tools to maximize the value of our drug candidates. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Drug Discovery and Development Engine </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We credit our rapid identification of therapeutic targets and drug candidate selection to our proprietary drug discovery and development
engine, which relies on our team&#146;s deep expertise in immunology and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">94 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
chemistry, supported by strong computational biology and the ability to exploit difficult targets through our advanced discovery engine. The key pillars of our proprietary drug discovery and
development engine are as follows. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Our Integrated Drug Discovery and Development Engine is Designed to Improve Probability of and Speed to
Clinical Success </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g93u91.jpg" ALT="LOGO">
 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>1)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Computationally-Driven Disease Target and Biomarker Identification. </B>We use proprietary methods to
identify targets that we believe have a high propensity to drive the immune response in disease states such as in oncology and inflammatory diseases by computationally screening a combination of proprietary and public databases. Through this process
we also identify biomarkers that can guide our clinical development strategy and increase the probability of clinical success. A computational screen we designed to seek tumor-infiltrating lymphocyte modulating genes identified CCR4 and HPK1 as
potential targets. In addition to well-known and clinically validated targets such as <FONT STYLE="white-space:nowrap">PD-1</FONT> and cytotoxic T-lymphocyte associated protein 4 <FONT STYLE="white-space:nowrap">(&#147;CTLA-4&#148;),</FONT> our
target identification approach has also uncovered what we believe are key immune drivers of pathology that have not been fully explored but which may offer significant therapeutic potential. We have designed additional screens that have identified
potential targets controlling (i)&nbsp;tumor and immune metabolism, (ii)&nbsp;resistance to checkpoint therapy and (iii)&nbsp;suppressive myeloid cells. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>2)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Efficient Design of Small Molecule Drug Properties. </B>Key to our rapid discovery of small molecules
is our use of structure and pharmacophore-based drug design strategies, and machine-learning assisted structure-activity-relationships to improve potency, selectivity and pharmacokinetic (&#147;PK&#148;) properties, along with early testing in
physiologically-relevant immune assays to rapidly identify highly selective, orally-administered small molecules. This seamless integration of biology, chemistry and pharmacokinetic disciplines allows for rapid cycle times and quick iterations
between hypothesis and compound selection. An example is our lead CCR4 program that moved from concept to <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">first-in-human</FONT></FONT> testing in two and a half years. Using
pharmacophore modeling we identified novel templates which selectively inhibit the CCR4 receptor. These were then rapidly refined for biological activity and robust oral bioavailability. Once lead candidates are identified, strong <FONT
STYLE="white-space:nowrap">in-house</FONT> synthetic expertise quickly develops improved synthetic methodologies that facilitates large scale synthesis needed for broader testing. Employing
</P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">95 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
these techniques allowed us to assess a variety of novel chemical structures to derive our clinical candidates FLX475 and RPT193, which have favorable potency and PK properties. We are now
utilizing similar strategies and leveraging novel structure-based drug design techniques to improve potency, selectivity and pharmacokinetic properties to identify leads in our GCN2 and HPK1 programs. </TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>3)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Data-Driven Patient Selection. </B>A key strategy for every program is to identify a patient
selection and enrichment approach. Our proprietary drug discovery and development engine enables enrichment and prospective selection of patients in our early clinical trials that we believe increase the probability of clinical success. Using
proprietary and public databases, we can mine contextually-rich molecular and clinical data from disease tissues to identify tumor types and inflammatory disease indications that we believe will be most likely to respond to our therapeutic agents.
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left"><B>4)</B></TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"><B></B><B>Nimble Clinical Execution. </B>We believe our precision medicine approach enables a rapid path to PoC
and the potential for accelerated regulatory approval. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have leveraged this engine to identify and target CCR4, a
key driver of the immune response in both oncology and allergic inflammatory disease. For FLX475, we achieved a rapid pace from concept to the clinic in only two and a half years, with RPT193 having entered the clinic in August 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Background on CCR4 in Oncology and Allergic Inflammatory Disease </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>CCR4: A Key Modulator Across the Immunological Continuum </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The immune system is a series of complex interactions between different types of white blood cells. T cells are one category of these cells
that play crucial roles in immunological memory, regulation and responses. One subset of these T cells that are characterized by the cluster of differentiation 4 (&#147;CD4&#148;) glycoprotein on their cell surfaces, the CD4 T cells, are paramount
in directing immune responses and immune tolerance. Two main CCR4-expressing CD4 T cells of clinical interest are called T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> and Th2 cells.
T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> and Th2 cells both express CCR4, which is a receptor that binds to chemokines that orchestrate cell migration and homing throughout the body. The two chemokines that bind to this receptor,
<FONT STYLE="white-space:nowrap">C-C</FONT> motif chemokine ligand 17 (&#147;CCL17&#148;) and <FONT STYLE="white-space:nowrap">C-C</FONT> motif chemokine ligand 22 (&#147;CCL22&#148;), are over expressed and secreted by tumors and allergically
inflamed tissues. This over expression allows for the theoretical manipulation of CCR4 and, consequently, its two CD4 T cell subtypes to address diseases across the immunological continuum spanning underactive to overactive immune responses in
oncology and allergic inflammatory disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>CCR4 Drives Tumor Progression and Allergic Inflammation </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g02t00.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">96 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>CCR4: Modulating Underactive Immune Activity in Oncology </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In cancer, the secretion of certain chemokines from tumor cells and tumor-resident immune cells recruits immunosuppressive T cells called T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> to tumor sites. T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> represent a dominant pathway for downregulating the immune response. Blocking the migration of T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> has been shown to have both the potential to unleash naturally-occurring antitumor immunity and to synergize with a variety of both conventional and immune-based therapies, such as radiation,
chemotherapy, checkpoint inhibitors and adoptive T cell therapy. T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> recruitment into tumors is dependent on CCR4, whose ligands are produced by tumor cells themselves or by tumor-associated
macrophages. CCR4 is highly expressed on T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> and not highly expressed or used by effector or cytotoxic T cells, suggesting that targeting CCR4 may selectively block T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration into tumors. We believe that a therapeutic drug that specifically inhibits T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration into tumors has the potential to
specifically enhance immuno-oncology efficacy without the serious risks associated with current CCR4 approaches that systemically deplete T cells and broadly suppress the immune system. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>CCR4: Modulating Overactive Immune Activity in Inflammation </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In allergic inflammatory diseases, such as AD and asthma, CCR4 chemokines recruit Th2 cells to inflamed tissues. Once these cells enter
certain tissues, such as the skin or the airways in the lung, they secrete products known to drive the inflammatory response. In allergic asthma, Th2 cells have been demonstrated to play a pivotal role in airway inflammatory response and airway
remodeling. CCR4 is essential in recruiting Th2 cells to asthmatic airways. Similarly, murine models and ex vivo studies strongly suggest that CCR4 plays a critical role in allergic inflammation in AD. Blocking the migration of Th2 cells has been
shown to reduce allergic inflammation in the skin and the lung. We believe that CCR4 antagonists have the potential to suppress allergic inflammation in patients in a clinically meaningful manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Lead Oncology Drug Candidate&#151;FLX475 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our lead oncology drug candidate, FLX475, is designed to selectively inhibit the migration of immunosuppressive T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> into tumors. In a Phase 1 clinical trial in 104 healthy volunteers, FLX475 was well tolerated and demonstrated favorable drug-like properties and target engagement. FLX475 has also demonstrated
single agent and combination activity in preclinical tumor models associated with the inhibition of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration into the tumor and an increase in the CD8 : T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> ratio. We are currently conducting a Phase 1/2 clinical trial investigating FLX475 as a single agent and in combination with pembrolizumab in &#147;charged&#148; tumors where we believe it has
the greatest probability of clinical benefit. We anticipate results from the Phase 2 portion of the trial could provide PoC data in the first half of 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We hold worldwide rights to FLX475 and own an issued U.S. composition of matter patent with respect to FLX475 that is scheduled to expire in
2037. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>CCR4 in Charged Tumors </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our proprietary drug discovery and development engine has identified certain tumors where we believe FLX475 has the greatest probability of
demonstrating clinical benefit. We refer to these tumors as &#147;charged&#148; as defined by (i)&nbsp;their expression of high levels of CCR4 ligands, (ii)&nbsp;their enrichment for T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> and
(iii)&nbsp;their enrichment for CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> effector cells. Tumors with high levels of these three parameters imply they have the necessary components to generate a potent immune response; however, the
presence of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> dampens this response. As shown in the diagram below, we have identified numerous tumors as being charged, including NSCLC, TNBC, HNSCC, NPC, gastric cancer, EBV<SUP
STYLE="font-size:85%; vertical-align:top">+</SUP> HLs and NHLs and cervical cancer. The data presented in the diagram below was derived from an in-house analysis of The Cancer Genome Atlas Database and additional published sources and confirmed by
us through in situ hybridization of over 400 tumor microarray samples. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">97 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Identification and Characterization of &#147;Charged&#148; Tumors </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g72t68.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">The graph above reflects a logarithmic scale on each axis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Additionally, we have discovered that the presence of oncogenic viruses, such as EBV, (as shown in the diagram below) and HPV, is associated
with tumors that are highly &#147;charged&#148; and can be prospectively selected. In preclinical studies, we have demonstrated an association between EBV and CCR4 ligand expression, which is believed to be causal to T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration. These studies are further validated by scientific publications linking EBV to T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> tumor infiltration in HL, gastric cancer and
NPC. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">98 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>&#147;Charged&#148; Tumors Include EBV-Associated Tumors </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g45v24.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">EBER1 = EBV-encoded RNA1 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Oncology Market Overview </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Significant progress in cancer treatment has been made recently with the development of highly targeted and immuno-oncology-based therapies.
Remarkable clinical response rates have been observed with targeted therapies in selective patient populations, while in a subset of a broad range of tumors, immuno-oncology products have demonstrated durable responses and possible cures. Although
true breakthroughs have been achieved, often only a very narrow segment of the patient population can be treated or are responsive to these novel therapies. Hence, there remains a significant unmet medical need for a majority of tumor types
including &#147;charged&#148; tumors in which we intend to develop FLX475 either as single agent or in combination with immune checkpoint inhibitors such as pembrolizumab or other agents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">99 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>&#147;Charged&#148; Tumor Prevalence </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g41e02.jpg" ALT="LOGO">
 </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Based on 2012 Globocan registries 5-year prevalence (2008-2012 estimates) </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">**</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Data from in-house analysis </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">***</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Worldwide prevalence </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">****</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Based on 2018 Globocan registries 5-year prevalence (2013-2018 estimates) </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-Small</FONT> Cell Lung Cancer </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">NSCLC is the most common type of lung cancer, representing 84% of all lung cancer cases in the United States. Squamous cell carcinoma
(&#147;NSCLC Sq.&#148;), adenocarcinoma (&#147;NSCLC Ad.&#148;), and large cell carcinoma are all subtypes of NSCLC. Lung cancer is the leading cause of cancer death for both men and women. In 2019, an estimated 142,670 people in the United States
will die from lung cancer. There are approximately 228,000 diagnoses of lung cancer annually in the United States. Despite the availability of numerous available therapies, the prognosis remains poor, with an overall five-year survival rate for all
patients diagnosed with NSCLC as low as 19.4%. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Standard therapies include surgery, chemotherapy and radiation therapy. Up to a third of
NSCLC patients have tumors with mutations in genes (such as epidermal growth factor receptor and anaplastic lymphoma kinase) for which molecularly-targeted therapies have been approved (such as erlotinib, gefitinib or crizotinib).<SUP
STYLE="font-size:85%; vertical-align:top"> </SUP>However, these treatments usually do not result in long-term remissions, and the tumors generally return and become resistant to therapy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Immunotherapies that target <FONT STYLE="white-space:nowrap">PD-1</FONT> or the PD-1 ligand (&#147;PD-L1&#148;) (e.g. pembrolizumab, nivolumab
and atezolizumab) have recently been approved for the treatment of patients with advanced or metastatic NSCLC either alone (for previously untreated or treated patients), or in combination with chemotherapy (for previously untreated patients). While
treatment with these immunotherapy agents in NSCLC has resulted in promising activity ranging from approximately <FONT STYLE="white-space:nowrap">15-30%</FONT> overall response rates in previously treated patients to approximately <FONT
STYLE="white-space:nowrap">40-60%</FONT> response rates in combination with chemotherapy in previously untreated patients. However, approximately <FONT STYLE="white-space:nowrap">50-80%</FONT> of patients do not respond to these therapies,
indicating significant unmet medical need remains. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Triple-Negative Breast Cancer </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Breast cancer is the most common type of invasive cancer among women and the second leading cause of cancer death. The Centers for Disease
Control and Prevention (&#147;CDC&#148;) estimates that there are approximately one million women in the United States living with breast cancer that has been diagnosed within the past five </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">100 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
years. In 2019 there will be an estimated 271,270 new diagnoses and 42,260 breast cancer deaths in the United States each year and 12.4% of women will develop breast cancer in their lifetime.
Effective therapies have been developed that target tumors containing at least one of three protein receptors: estrogen receptor, progesterone receptor and human epidermal growth factor receptor 2 (&#147;HER2&#148;). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Approximately 15% to 20% of breast cancers, however, do not express any of these three receptors and are referred to as triple-negative breast
cancer (&#147;TNBC&#148;). These tumors have a more aggressive phenotype and a poorer prognosis due to the high propensity for metastatic progression and absence of specific targeted treatments. Prior to the recent anti-PD-L1 approval, the only
approved targeted therapy for TNBC was olaparib (marketed as Lynparza) for the small minority of patients with mutations in the BRCA1 or BRCA2 genes. The five-year survival rate for TNBC has been reported to be 62.1%. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">However, there is also potential for immuno-oncology agents in TNBC based on its high tumor mutation burden and the finding of elevated levels
of <FONT STYLE="white-space:nowrap">PD-L1</FONT> in up to 26% of primary TNBCs. Treatment of previously untreated metastatic TNBC patients can result in approximately <FONT STYLE="white-space:nowrap">20-25%</FONT> response to PD-(L)1 checkpoint
inhibitors. The <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-L1</FONT></FONT> antibody atezolizumab (marketed as Tecentriq) was recently granted accelerated approval in combination with chemotherapy for the initial
treatment of women with advanced TNBC expressing <FONT STYLE="white-space:nowrap">PD-L1.</FONT> However, in previously treated TNBC, response rates to anti-PD-L1 agents alone have generally been less than 10%, representing substantial need for novel
and improved therapies for advanced or metastatic TNBC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Head and Neck Squamous Cell Carcinoma </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">HNSCC represent a broad category of cancers that arise from different tissues that have been grouped anatomically in the head and neck region.
HNSCC accounts for about 4% of all cancers in the United States with an estimated 53,000 new cases and 10,860 deaths in 2019. The five-year survival rate for people with head and neck cancer varies and depends on several factors making an overall
five-year survival rate difficult to track accurately. Most cases of HNSCC are considered to be related to use of tobacco, alcohol, or to the exposure to HPV. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Treatment for HNSCC can include surgery, radiation therapy, chemotherapy, targeted therapy or a combination of treatments. These tumors are
believed to express a fair number of tumor-specific antigens, making them attractive targets for immunotherapies. Nivolumab and pembrolizumab have been approved for recurrent and metastatic HNSCC based on their ability to shrink tumors and increase
median survival. However, treatment with either agent led to partial or complete tumor shrinkage in approximately 15% of treated HNSCC patients, indicating that over 80% of patients do not respond to therapy and that a significant unmet clinical
need remains. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Nasopharyngeal Cancer </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">NPC is a cancer that forms in the tissues of the nasopharynx which is the upper part of the throat behind the nose. It is estimated that
approximately 129,000 NPC patients worldwide were diagnosed and 72,900 NPC patients died in 2018. Approximately 39% of patients are diagnosed with late stage NPC, in which the five-year survival rate is 38%. While there is no known cause of NPC, EBV
is associated with a vast majority of cases. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Standard treatment for NPC involves radiation therapy, chemotherapy and surgery. There is
some evidence that NPC can be treated with immuno-oncology agents. A Phase 1b trial in patients with recurrent or metastatic NPC found an objective response rate of 26% with a <FONT STYLE="white-space:nowrap">PD-1</FONT> inhibitor pembrolizumab.
While promising, novel therapies for NPC are still needed to improve overall responses and prolong survival. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Hodgkin Lymphoma </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Hodgkin lymphoma, formerly called Hodgkin&#146;s disease, is a cancer of the lymphatic system that arises in immune cells called B cells. HL
accounts for approximately 10% of all lymphomas and approximately 0.6% </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">101 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of all cancers diagnosed in the developed world annually. Approximately 8,100 people in the United States are estimated to be diagnosed with HL in 2019, with an estimated 1,000 deaths. EBV has
been associated with approximately 30% to 50% of HL. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">While approximately 75% of patients can be cured with standard therapies including
combination chemotherapy, radiation therapy, high-dose chemotherapy and stem cell transplantation, novel therapies are being developed to further improve clinical outcomes. The CD30-directed antibody-drug conjugate brentuximab vedotin (marketed as
Adcetris) has been approved for certain adult patients with classical HL (&#147;cHL&#148;). Nivolumab and pembrolizumab are immunotherapies that have been granted accelerated approval for the treatment of patients with cHL that has recurred or
progressed after multiple previous treatments, including autologous transplantation and post-transplant treatment with brentuximab vedotin. For both pembrolizumab and nivolumab, the overall response rate in these relapsed and refractory cHL was
approximately 69%. However, the average duration of response to these <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-1</FONT></FONT> therapies is less than a year, signifying the need for continued advances. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">Non-Hodgkin</FONT> Lymphoma </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">NHL, another cancer of the lymphatic system, is not a single disease but rather a group of cancers affecting cells of the immune system.
Although the various types of NHL have common elements, they differ in other areas, including their appearance under the microscope, their molecular features, their growth patterns, their impact on the body, and treatment. According to the National
Cancer Institute, in the United States approximately 74,200 patients were diagnosed with NHL in 2018 and 19,910 patients died as a result of NHL in 2018. The five-year survival rate is 71.4%. While there is no direct cause of NHL, it is generally
linked to a weakened immune system and begins when the body produces too many abnormal lymphocytes. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">There is a wide range of therapies
available for the treatment of NHL depending on the subtype of the disease, its aggressiveness and the patient&#146;s overall health. These include chemotherapy; radiation therapy; immunotherapy such as monoclonal antibodies; checkpoint inhibitors
and chimeric antigen receptor T&nbsp;cells (&#147;CAR-T cells&#148;); targeted therapies; and stem cell transplantation. Depending upon the analysis and subtype, EBV has been associated anywhere from less than 10% to greater than 90%, or
approximately 12% of NHL, on average. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Cervical Cancer </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Cervical cancer begins with abnormal changes in the cervical tissue. In the United States, 13,170 patients are estimated to be diagnosed with
cervical cancer in 2019 with cervical cancer leading to 4,250 deaths. The five-year survival rate is 65.8%. It is almost always associated with the presence of HPV. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Advanced cervical cancer is treated by chemotherapy or radiation therapy. Pembrolizumab has been approved in those patients that express <FONT
STYLE="white-space:nowrap">PD-L1</FONT> based on a Phase 2 trial in which the response rate was 14.3%. While the approval of pembrolizumab has been an advance in the treatment of cervical cancer, over 80% of patients do not respond to this therapy,
indicating significant room for improvement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Oncology Solution: FLX475 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> represent a dominant pathway for downregulating the immune response. Many current
approaches to deplete T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> in the tumor have resulted in systemic T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> depletion, and such approaches been associated with serious safety
issues (such as autoimmunity). In addition, these approaches have been associated with the depletion of effector immune cells, which has the potential to limit their efficacy. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">FLX475 is an oral small molecule that is designed to selectively inhibit the migration of immunosuppressive T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> into tumors while sparing T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> in healthy tissues and without negatively impacting </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">102 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effector immune cells. We will initially develop FLX475 in &#147;charged&#148; tumors, in which we believe there remains significant unmet medical need. In preclinical studies, our drug candidate
appears to selectively restore the immune response within the TME without systemically depleting T cells. We believe FLX475 has attractive characteristics for use as a single agent and in combination regimens with a variety of both conventional and
immune-based therapies given its favorable safety profile observed to date in preclinical studies and in healthy volunteers, as well as the synergistic nature of its mechanism of action as demonstrated in preclinical mouse models. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In a Phase 1 clinical trial in 104 healthy volunteers, FLX475 was well tolerated and demonstrated dose-dependent inhibition of CCR4 with no
observed immune-related adverse events or significant clinical adverse events. We are currently conducting a Phase 1/2 clinical trial investigating FLX475 as a single agent and in combination with pembrolizumab in patients with tumors that are
likely to be &#147;charged&#148; where we believe FLX475 has the greatest probability of clinical benefit. We anticipate PoC data from the Phase 2 portion of the trial in the first half of 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>FLX475 Preclinical Data </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We evaluated the mechanism of action as well as the antitumor activity of FLX475 (or a preclinical tool CCR4 antagonist) in two kinds of
preclinical mouse tumor models representing the human equivalent of (i)&nbsp;a &#147;charged&#148; tumor and (ii)&nbsp;tumors that accumulated T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> in the TME following checkpoint inhibitor
treatment. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>FLX475 Inhibition of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> in a Mouse Model of a &#147;Charged&#148;
Tumor </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Immunosuppressive CCR4<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>
T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migrate towards CCL17 and CCL22 which are often found to be elevated in the TME. FLX475 inhibited in a dose-dependent manner CCL22- and CCL17-induced migration of T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg </SUB>in cellular in vitro migration assays. Dosing of FLX475 prevented migration of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> into established tumors expressing high levels of CCR4
ligand at baseline (&#147;charged&#148; tumor), as represented by a Pan02 mouse tumor model. In this model, mice with established tumors were dosed with FLX475, then injected with labeled T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>.
The migration of these modified T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> into tumors could then be easily followed and quantified. In two independent experiments with seven mice per experimental arm, FLX475 inhibited this
migration in a statistically significant and dose-dependent manner (p &lt; 0.01). In these studies a dose of 10 mg/kg reduced T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration by averages of 56% and 78% in the two studies, with
individual animals ranging from 42% to 85% reduction. Blocking the migration of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> into tumors also enhanced the activation and increased the number of CD8<SUP
STYLE="font-size:85%; vertical-align:top">+</SUP> effector cells in a dose-dependent manner with a 3-fold increase at the 10 mg/kg dose level (range from 1.7 to 4.1 fold in individual animals in one experiment). The highest level of inhibition of T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and increase in CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> effector cells was observed in our preclinical studies at 10 mg/kg given once daily, which achieves
concentrations that inhibit 90% of in vitro T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration (&#147;IC<SUB STYLE="font-size:85%; vertical-align:bottom">90</SUB>&#148;) throughout the dosing period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Blocking CCR4 with FLX475 Inhibits T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> Migration into the Tumor<SUB
STYLE="font-size:85%; vertical-align:bottom"></SUB> </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g723949g40x04.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">103 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>CCR4 Antagonist Single Agent Antitumor Activity in a Mouse Model of a &#147;Charged&#148;
Tumor </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The antitumor activity of a CCR4 antagonist closely related to FLX475 was assessed in the Pan02 mouse tumor model, which
represents a &#147;charged&#148; tumor. In three independent experiments with ten mice per experimental arm, oral administration of the CCR4 antagonist demonstrated single agent reduction in tumor growth which was statistically significantly
different from mice who received vehicle control (p &lt; 0.05). The observed antitumor activity was similar to an immune checkpoint inhibitor in three of four experiments. Importantly, the combination of our CCR4 antagonist with the checkpoint
inhibitor resulted in enhanced antitumor activity. Analysis of the TME of seven to eight mice per experimental arm treated with our CCR4 antagonist showed a statistically significant increase in the CD8 : T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> ratio compared to vehicle control and similar activity compared to the checkpoint inhibitor. Consistent with the antitumor activity, combination of our CCR4 antagonist with the immune checkpoint
inhibitor further increased this ratio. The increase of this ratio demonstrates a shift from an immune-suppressive to an immune-stimulatory environment. The CD8 : T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> ratio is a
well-established biomarker in human clinical trials and has been demonstrated to correlate with clinical outcome. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>CCR4 Antagonist: Single Agent
Activity in a Mouse Model of a &#147;Charged&#148; Tumor </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g65p26.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>CCR4 Antagonism of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> Migration Following
Checkpoint Inhibitor Treatment in Mouse Model of a <FONT STYLE="white-space:nowrap">Non-&#147;Charged&#148;</FONT> Tumor </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Clinical
studies have demonstrated the accumulation of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> in the TME following treatment with conventional therapies such as chemotherapy and radiation, as well as immune-based therapies such as CAR-T
cell and checkpoint inhibitor therapies. The figure below shows several examples of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> accumulation in the TME of patients who underwent treatment with CAR-T cell or anti-CTLA-4 immune
checkpoint inhibitor therapies. FoxP3 is a marker used to identify T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>. Ipilimub (Ipi) and Tremelimumab (Treme) are both anti-CTLA-4 antibodies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">104 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Accumulation of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> in the TME is a General
Adaptive Immune Resistance Mechanism to Treatment </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g75n05.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Accumulation of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> has also been observed in
both post anti-PD-1 and after conventional therapies such as radiation or chemotherapy </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">To mimic this in a preclinical tumor model, we
evaluated FLX475 in a mouse tumor model that does not express high levels of CCR4 ligands, exemplified by the CT26 mouse tumor model. We observed in four independent experiments with five mice per experimental arm that the treatment with checkpoint
inhibitors led to a statistically significant (p &lt; 0.05) increase in the expression of CCR4 ligands with an average increase of 2.9 fold over vehicle control and a range from 1.6 to 4.3 fold. In two independent experiments with eight mice per
treatment cohort we observed a 1.6-fold (range 0.8 to 2.4) increase in the number of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> that infiltrate the tumor, recapitulating the clinical observations mentioned above. We believe that
the increase in the infiltration of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> upon treatment with the checkpoint inhibitor is representative of one mechanism of resistance seen in patients treated with these inhibitors.
Importantly, in these two independent experiments with eight mice per experimental arm we observed that the addition of FLX475 to the checkpoint inhibitor reduced the number of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migrating
into the TME in a statistically significant manner. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">105 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>FLX475 Inhibition of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> Migration
Following Checkpoint Inhibitor Treatment in a </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Mouse Model of a <FONT STYLE="white-space:nowrap">Non-&#147;Charged&#148;</FONT> Tumor </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g09y11.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Antitumor Activity of the Combination of a CCR4 Antagonist and Checkpoint Inhibitor in a Mouse Tumor
Model </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The antitumor activity of a CCR4 antagonist closely related to FLX475 in combination with an immune checkpoint inhibitor was
evaluated in the CT26 mouse tumor model in five independent experiments with ten mice per experimental cohort. Single agent activity of an immune checkpoint inhibitor results in modest antitumor activity and almost no cures. However, the combination
of a CCR4 antagonist and an immune checkpoint inhibitor resulted in statistically significant (p &lt; 0.05) synergistic antitumor activity with 50% of all mice showing complete tumor regression in the experiment shown. In multiple experiments, an
average of 39% experienced tumor regression (0%-70% across studies). Mice treated with the combination approach were completely resistant to rechallenge with the same tumor, confirming that the antitumor effect observed during the treatment phase
was immune-mediated and associated with long-term immune memory. The combination of inhibition of T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> by a CCR4 antagonist with an immune checkpoint inhibitor in three independent experiments
with eight mice per experimental cohort demonstrated an increase in the ratio of CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> effector T cells to T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>. Previous studies have shown
that this ratio is an indicator of prognosis in many cancers. Patients with low effector T cell to T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> ratios have worse prognoses in cancers that include ovarian cancer, pancreatic cancer,
lung cancer, glioblastoma, NHL and melanoma. We believe that the ability of a CCR4 antagonist to increase this ratio and provide therapeutic benefit will not be limited to a few select cancers, but may have broad implications across many tumor
types. The ability of a CCR4 antagonist to prevent T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration suggests that combining FLX475 with a checkpoint inhibitor may provide highly effective antitumor activity by potentially
deepening or broadening responses compared to checkpoint inhibitor alone. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">106 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Antitumor Activity of Our CCR4 Antagonist and Checkpoint Inhibitor </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>in Combination in a Mouse Tumor Model </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g26v56.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Our CCR4 Antagonist Selectively Inhibits T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>
Migration into Tumors but not Healthy Tissues </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The impact of CCR4 inhibition by a CCR4 antagonist was compared to a depleting CCR4
antibody on T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration into the tumor and healthy tissue in a mouse tumor model, which included two independent experiments with seven mice per experimental arm. Mice with established
tumors were dosed with either our CCR4 antagonist or a depleting CCR4 antibody, then injected with fluorescently labeled T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> to assess the level of T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration into the tumor and healthy tissues. Both our CCR4 antagonist and the antibody led to statistically significant (p&lt;0.05) reductions in T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> that were able to infiltrate the tumor compared to untreated controls. However, in contrast to the antibody, our CCR4 antagonist did not result in depletion or inhibition of migration of T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> in the blood or skin (demonstrated in two separate experiments). We believe that the tumor-selective activity of our FLX475 will enable reductions in tumor T<SUB
STYLE="font-size:85%; vertical-align:bottom">reg</SUB> with a decreased likelihood of deleterious adverse events that may result from systemic depletion of all T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Our CCR4 Antagonist Selectively Inhibits T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> Migration into Tumors but Not Healthy Tissues
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g10n01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>FLX475: Clinical Trials </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">FLX475-01:</FONT> A Phase 1 Clinical Trial of FLX475 in Healthy Volunteers </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We completed a placebo-controlled, double-blind dose-escalation Phase 1 clinical trial of FLX475 in 104 healthy volunteers. We designed and
conducted the healthy volunteer study in order to (i)&nbsp;rapidly generate PK and receptor occupancy data that allow us to identify a therapeutic dose, (ii)&nbsp;corroborate in humans our observed favorable preclinical safety profile and
(iii)&nbsp;potentially allow us to accelerate the dose-escalation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">107 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
portion of our Phase 1/2 oncology study and drive efficiencies in our clinical development going forward. FLX475 was well tolerated and demonstrated dose-dependent inhibition of CCR4 with no
observed immune-related adverse events or significant clinical adverse events. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Oral dosing of FLX475 led to linear PK and a clear
dose-related inhibition of CCR4 with low <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">subject-to-subject</FONT></FONT> variability. Based on analysis of the multiple dose data, at the 75 mg once-daily dose, 75% receptor
occupancy was achieved in six out of six healthy volunteers, which, in our preclinical studies, corresponded with 90% inhibition of in vitro T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and the highest level of inhibition
of in vivo T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> migration and antitumor activity. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>FLX475: Favorable Exposure in Healthy
Volunteer Study </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g26g87.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>CCR4 Target Coverage Exceeded at 75 mg Once Daily Dosing with FLX475 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g20q57.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">FLX475 was well tolerated, with no significant lab abnormalities, serious adverse events or dose-limiting
clinical adverse events. There was no evidence of autoimmunity or changes in peripheral blood immune cell populations. Sporadic Grade 1 corrected Q-T interval (&#147;QTc&#148;) prolongation was observed in nearly every cohort (including placebo). No
QTc prolongation greater than Grade 1 was observed in 14-day multiple ascending dose cohort doses through 300/100 mg (300 mg Day 1 loading dose followed by 100 mg once daily), including the projected efficacious dose of 75 mg once daily. At the
highest dose (300/150 mg) correlating with exposures three to five times that needed to achieve efficacious exposure, two subjects (out of six dosed with FLX475) met QTc stopping criteria (greater than 60 msec prolongation from baseline, one of whom
also exhibited a transient Grade 2 QTc prolongation), which were asymptomatic and not associated with arrhythmia or any other adverse event. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">108 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I><FONT STYLE="white-space:nowrap">FLX475-02:</FONT> A Phase 1/2 Dose Escalation and
Expansion Study of FLX475 Alone and in Combination with Pembrolizumab in Advanced Cancer </I></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are currently conducting a
Phase&nbsp;1/2 clinical trial of FLX475 as monotherapy and in combination with pembrolizumab in patients with EBV or HPV and other &#147;charged&#148; tumors. We are currently in the Phase&nbsp;1 arm of this trial in which the PK and safety of
FLX475 are being investigated as monotherapy and in combination with pembrolizumab. One dose-limiting clinical adverse event of asymptomatic QTc prolongation (&gt; 500 ms and &gt; 60 ms prolongation from baseline) has been observed in the 75 mg
monotherapy cohort in one subject with confounding factors (including an elevated and increasing QTc at baseline), with no dose-limiting clinical adverse events observed in the three subjects dosed to date in the 100 mg monotherapy cohort.
Phase&nbsp;1 dose escalation is ongoing and a MTD has not yet been identified for either monotherapy or combination therapy, a patient with NSCLC in the 50&nbsp;mg FLX475 and pembrolizumab cohort that had failed prior treatment with <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-PD-L1</FONT></FONT> therapy (atezolizumab) has had a confirmed PR under RECIST 1.1 criteria, based on radiological analysis performed at the clinical investigator site, with a 37.5%
reduction in target lesion measurement at 8 weeks and a 47% reduction at 14&nbsp;weeks. The patient remains on study. We intend to present topline data from the Phase&nbsp;1/2 trial in the first half of 2020. For more information regarding the risks
associated with our Phase 1/2 clinical trial for FLX475, please see &#147;Risk Factors&#151;Risks Related to Our Business&#151;FLX475 and PRT193 are in clinical development, which may fail or suffer delays that materially and adversely affect their
commercial viability.&#148; </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the first stage of the Phase 2 arm of this trial, FLX475 cohorts of ten patients grouped by
indication will be dosed with FLX475 as monotherapy or in combination with pembrolizumab. Monotherapy patients will either have NPC or lymphoma confirmed to be EBV<SUP STYLE="font-size:85%; vertical-align:top">+</SUP>, cervical cancer that is HPV<SUP
STYLE="font-size:85%; vertical-align:top">+</SUP> or HNSCC that is na&iuml;ve to checkpoint therapy. NSCLC or HNSCC patients who are relapsed or refractory to checkpoint inhibitors or TNBC or HNSCC patients na&iuml;ve to checkpoint inhibitors will
be dosed with FLX475 in combination with pembrolizumab. We anticipate obtaining data on overall response rates in the Phase&nbsp;2 arm of this trial throughout the first half of 2020. Cohorts in which promising activity is observed will then proceed
into Stage 2, enrolling an additional 19&nbsp;patients. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>FLX475 Phase 1 Dose Escalation </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g03z39.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">109 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>FLX475 Phase 2 Trial: Rapid Path to PoC in 1H 2020 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g65i17.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:9pt; font-family:Times New Roman">Gated 2-stage design: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">First stage enrollment (10 patients/cohort) expected by YE 2019 </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="12%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:8pt">Second stage: if positive ORR in a cohort, enroll additional 19 patients </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Accumulating results from the <FONT STYLE="white-space:nowrap">FLX475-02</FONT> Phase 1/2 study will inform available clinical development
options that can be leveraged in near real time. For example, if we observe promising clinical data with FLX475 monotherapy in a specific Phase&nbsp;2 expansion cohort (such as a high overall response rate), we could then initiate planning for a
potential pivotal trial. Examples of such a trial include a <FONT STYLE="white-space:nowrap">single-arm</FONT> study in a patient population with high unmet need (e.g.&nbsp;either a single disease, or &#147;basket&#148; of virally-associated tumors,
with no available standard therapy options), and in a randomized trial against standard therapy(ies). Similarly, data from a particular Phase 2 combination cohort could be considered promising enough to plan for a randomized Phase 2 or 3 study
comparing FLX475/pembrolizumab combination therapy against pembrolizumab alone. Based on historical examples, it may be possible to modify the current Phase 1/2 trial to seamlessly proceed into one or more pivotal trials, thus saving significant
clinical development time to potential regulatory submission and approval. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, biomarker data obtained from the patients in
the ongoing Phase 1/2 trial may inform the generation of a companion diagnostic that could potentially be used to prospectively select for patients who may be more likely to respond to FLX475 therapy in a future study, thus increasing the chances of
a positive trial result and regulatory approval. Our comprehensive biomarker plan includes analysis of the TME in paired biopsies collected before and on treatment. Key biomarkers include (i) CD8 :
T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB> ratio as detected by immunohistochemistry, (ii) expression of CCL17 and CCL22 as detected by in situ hybridization (iii) receptor occupancy, (iv) peripheral blood analysis for CCL17 and
CCL22 and (v) exploratory analysis, including immune phenotyping, transcriptomics and T cell clonality. An example of the multiplexed immunohistochemistry analysis of the TME derived from a commercially-available tumor sample is shown in the figure
below. For more information regarding the risks associated with our Phase 1/2 clinical trial for FLX475, please see &#147;Risk Factors - Risks Related to Our Business.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">110 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Multiplexed Immunohistochemistry Analysis of the TME </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g70e01.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Lead Inflammation Drug Candidate&#151;RPT193 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our lead inflammation drug candidate, RPT193, selectively inhibits the migration of Th2 cells into allergically-inflamed tissues. Th2 cells
are clinically validated drivers of allergic diseases such as AD, asthma, chronic urticaria, allergic conjunctivitis, chronic rhinosinusitis and eosinophilic esophagitis. The current standard of care for AD, the first indication for which we are
pursuing clinical development, includes topical creams and steroids as well as the injectable biologic, dupilumab. Dupilumab was approved for moderate to severe AD in 2017 as well as in moderate to severe asthma in late 2018, achieving
$922&nbsp;million of worldwide net sales in 2018. Despite recent progress in the treatment of inflammatory diseases, including AD, we believe there remains a significant unmet need for a safe, oral treatment with an attractive efficacy profile. </P>
 <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We believe based on our preclinical pharmacology and GLP toxicology results, if confirmed in clinical trials, combined with the
convenience of once-daily oral dosing, RPT193, if approved by the FDA, could fill an unmet medical need for treatment of allergic disorders. We have initiated a seamless Phase 1 trial of RPT193 comprised of Phase 1a single- and multiple-dose
escalation cohorts in healthy volunteers in August 2019, to be followed by placebo-controlled Phase 1b testing in patients with moderate to severe AD. Preliminary safety, pharmacokinetic, and pharmacodynamic data from the initial single dose cohorts
support once-daily oral dosing with RPT193 and dose escalation continues as planned. We anticipate PoC clinical results from the Phase 1b portion of this trial in AD patients by <FONT STYLE="white-space:nowrap">mid-2020.</FONT> Thereafter, we intend
to expand clinical development into additional <FONT STYLE="white-space:nowrap">Th2-driven</FONT> allergic diseases. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">RPT193 is
chemically distinct from FLX475, our CCR4 antagonist for oncology, and has demonstrated a unique pharmaceutical profile in preclinical experiments, that we believe will be favorable for use in <FONT STYLE="white-space:nowrap">non-oncology</FONT>
indications. Our data have shown that RPT193 has a lower PK parameter known as the volume of distribution relative to that of FLX475. Compounds with a lower volume of distribution, such as RPT193, are more likely to spare key organ systems from
extensive drug exposure. Limited tissue exposure has the potential to contribute to a safety advantage for RPT193. Consistent with this, RPT193 has demonstrated a preclinical safety profile that suggests it would be well tolerated for chronic dosing
in <FONT STYLE="white-space:nowrap">non-oncology</FONT> indications. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We hold worldwide rights to RPT193 and have submitted patent
applications with respect to RPT193 that, if issued, would be scheduled to expire in 2039. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">111 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Background&#151;Th2 Cells and Allergic Disease </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Th2 cells express high levels of CCR4 and are clinically validated drivers of allergic diseases along the atopic march, which includes AD,
asthma, chronic urticaria, allergic conjunctivitis, rhinosinusitis and eosinophilic esophagitis. When a pathogen comes into contact with the skin or mucosal lining of the nose or lungs, an immune response is triggered. It is believed that innate
immune cells and antibodies that recognize the pathogen initiate a release of inflammatory cytokines, leading to the recruitment of other immune system components, including Th2 cells. Th2 cells secrete inflammatory cytokines, such as interleukin 4 <FONT
STYLE="white-space:nowrap">(&#147;IL-4&#148;),</FONT> interleukin 5 <FONT STYLE="white-space:nowrap">(&#147;IL-5&#148;)</FONT> and interleukin 13 <FONT STYLE="white-space:nowrap">(&#147;IL-13&#148;).</FONT> While this Th2 response may be highly
effective against foreign pathogens, particularly parasites, sometimes the body overreacts to benign substances in this way, resulting in a significant and presumably unnecessary influx of Th2 cells, leading to conditions along the atopic march.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">At a cellular and molecular level, the Th2 response is initiated and sustained when Th2 cells are recruited to the site of inflammation
by the binding of CCL17 and CCL22 to CCR4. Patients suffering from AD and other allergic diseases have significantly elevated levels of both CCL17 and CCL22, suggesting that inhibiting the ability of these chemokines to bind to CCR4 may prevent
migration of Th2 cells into these inflamed sites, thus reducing inflammation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>CCR4 Ligands (CCL17 and CCL22) are Significantly Elevated in AD
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g37k35.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center">Thijs et al. Journal of Allergy and Clinical Immunology, 2018, supplemental data </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">112 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">CCL17 and CCL22 levels have been found to strongly correlate with the severity of many
allergic diseases, including AD. Dupilumab works by blocking the receptor for <FONT STYLE="white-space:nowrap">IL-4</FONT> and <FONT STYLE="white-space:nowrap">IL-13,</FONT> two of the cytokines produced by Th2 cells, leading to a reduction in the
level of inflammation. Dupilumab also indirectly leads to reductions in the level of CCL17, thus breaking the <FONT STYLE="white-space:nowrap">Th2-driven</FONT> inflammatory cycle. We believe that inhibition of the CCR4 receptor will block the
migration of Th2 cells into these inflammatory sites, leading to reductions in inflammation thereby blocking the secretion of <FONT STYLE="white-space:nowrap">IL-4,</FONT> <FONT STYLE="white-space:nowrap">IL-5</FONT> and <FONT
STYLE="white-space:nowrap">IL-13</FONT> before they can induce tissue damage. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>CCL17 Is a Good Marker for Response to AD Therapy (Dupilumab)
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g11r70.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">Guttman-Yassky et al. Journal of Allergy and Clinical Immunology, 2019, supplementary figures </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">EASI = Eczema Area and Severity Index </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">qw = Weekly dosing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">113 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Atopic Dermatitis Overview </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">AD is a chronic, inflammatory skin disease characterized by skin barrier disruption and immune dysregulation. Patients with AD have
chronically inflamed skin lesions that cause, among other disabilities, debilitating pruritus (itch), which can severely impair quality of life. Onset of AD often occurs during childhood and can persist into adulthood. The estimated U.S. adult
prevalence of AD is approximately 19&nbsp;million individuals, of which approximately 50% are diagnosed. An estimated 60% of these adults have disease characterized as moderate to severe. Furthermore, an estimated 9&nbsp;million children have AD, of
which approximately 30% experience moderate to severe disease. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Atopic Dermatitis (AD) U.S. Prevalence* </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g19v15.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:8pt; font-family:Times New Roman">*2018 Data, Decision Resources </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>AD Historical Standard of Care </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Creams, ointments and topical steroids, or other topical or systemic anti-inflammatory agents, are routinely used to manage skin health and
reduce skin inflammation in patients with mild to moderate AD. Patients who do not achieve sustained alleviation of symptoms with topical treatments have historically been prescribed systemic steroids or other systemic immunosuppressive agents such
as cyclosporine. While these are effective as temporary treatments of <FONT STYLE="white-space:nowrap">flare-ups,</FONT> extended use has been associated with many potential side effects or adverse events. Systemic steroids, such as prednisone, can
lead to temporary symptom relief but their use is not recommended to induce stable remission due to numerous side effects and the propensity of severe disease flares upon treatment cessation. Cyclosporine is also not suitable for long-term use as it
has been associated with renal toxicity, hirsutism, nausea and lymphoma, and patients must discontinue use after one to two years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We
believe that topical immunosuppressive agents inadequately address the systemic nature of AD. Furthermore, safety issues associated with systemic immunosuppressants such as steroids and cyclosporine make them inappropriate for chronic
administration. The treatment paradigm in AD is evolving given these inadequacies of the historical standard of care agents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>AD
Emerging Standard of Care </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">There are two key recent developments within the AD treatment landscape that will shape the standard of
care in the future: (i)&nbsp;the approval of the biologic agent dupilumab for moderate to severe AD in 2017 and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">114 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(ii)&nbsp;the clinical progress of the class of oral Janus kinase (&#147;JAK&#148;) inhibitors, which are in late stage clinical development and are anticipated to reach the market by 2021. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Dupilumab is a recently approved biologic for AD targeting the Th2 pathway. Dupilumab prevents T&nbsp;cell activation and amplification of
proinflammatory signaling pathways by blocking the IL-4 receptor alpha, <FONT STYLE="white-space:nowrap">(&#147;IL-4R</FONT><FONT STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT>&#148;), preventing <FONT STYLE="white-space:nowrap">IL-4</FONT> and <FONT
STYLE="white-space:nowrap">IL-13</FONT> binding. Approximately 36% of patients receiving weekly or biweekly injections of dupilumab achieved significant improvement in disease symptoms. Dupilumab was approved for moderate to severe AD in the United
States in March 2017 and in Europe in September 2017. Net sales of dupilumab were $257&nbsp;million in 2017 and $922&nbsp;million in 2018, highlighting the growing demand for safe and effective systemic treatments of AD. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Among the orally administered JAK inhibitors in development for AD, there are three in Phase 3 development: upadacitinib, baricitinib and
abrocitinib.&nbsp;JAK inhibitors block the signaling pathway to multiple proinflammatory cytokines, including <FONT STYLE="white-space:nowrap">IL-4</FONT> and <FONT STYLE="white-space:nowrap">IL-13,</FONT> thereby preventing the downstream signaling
of Th2 cells at the sites of inflammation.&nbsp;While JAK inhibitors have demonstrated comparable clinical efficacy to that of dupilumab and offer the advantage of oral dosing, these inhibitors are broadly immunosuppressive and therefore may not be
suitable for long-term dosing.&nbsp;Additionally, the FDA has placed black box warnings for JAK inhibitors approved in other indications due to the potential for serious infections, malignancies and thromboembolic events. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Despite these recent developments, we believe that there is significant unmet medical need and market potential for a safe and efficacious
agent for the treatment of AD. We believe that preventing the migration of Th2 cells into inflamed tissues with an oral CCR4 antagonist represents a highly differentiated approach. We further believe that an oral agent with a favorable safety and
efficacy profile would offer an attractive alternative for patients compared to the biweekly injections associated with dupilumab. While the JAK inhibitor agents are orally administered, they are broadly immunosuppressive and therefore may not be
suitable for long-term dosing. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Overview of Other Diseases Along the Atopic March </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition to AD, a number of allergic diseases are characterized by an inflammatory response to cytokines produced by Th2 cells. These
diseases include allergic asthma, chronic urticaria, chronic rhinosinusitis, allergic conjunctivitis and eosinophilic esophagitis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Asthma </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Asthma is a
chronic inflammatory disease of the airways characterized by intermittent airway obstruction, swelling and mucus hyperproduction, which can result in coughing, wheezing and difficulty breathing. Allergic asthma is triggered by the inhalation of
allergens including dust, pollen and dander. An estimated 25.2&nbsp;million individuals in the United States have asthma, with allergic asthma as the most common subtype, constituting approximately 80% of asthmatic children and approximately 60% of
asthmatic adults. Asthma is driven by both Th2 allergic and Th17 autoimmune mechanisms. An estimated 40% to 50% of patients with asthma fall within the <FONT STYLE="white-space:nowrap">Th2-high</FONT> subtype characterized by elevated levels of <FONT
STYLE="white-space:nowrap">IL-13</FONT> and <FONT STYLE="white-space:nowrap">IL-5.</FONT> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Standard treatment of asthma includes inhaled
rapid-acting beta<SUB STYLE="font-size:85%; vertical-align:bottom">2</SUB>-agonists for the treatment of acute symptoms and daily<SUB STYLE="font-size:85%; vertical-align:bottom"> </SUB><FONT STYLE="white-space:nowrap">low-dose</FONT> inhaled
corticosteroid (&#147;ICS&#148;) monotherapy as a first-line maintenance treatment. Anti-immunoglobin E <FONT STYLE="white-space:nowrap">(&#147;Anti-IgE&#148;)</FONT> monoclonal antibody omalizumab and <FONT STYLE="white-space:nowrap">IL-4R</FONT><FONT
STYLE="FONT-FAMILY:SYMBOL">&#097;</FONT> antagonist dupilumab can be prescribed for individuals with asthma who are uncontrolled on ICS therapy. While these therapies are generally effective, they are administered via injection and their targets are
downstream of CCR4, presenting a market opportunity for an oral, upstream alternative. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Chronic Urticaria </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Chronic urticarias (&#147;CUs&#148;) are a group of skin conditions including chronic spontaneous urticaria (&#147;CSU&#148;), cholinergic
urticaria (&#147;CLU&#148;) and symptomatic dermographism that are characterized by hives, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">115 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
redness, itching and swelling, lasting for greater than six weeks. The trigger for CSU is unknown; however, CLU is triggered by increases in body temperature and symptomatic dermographism by
physical contact with the skin by exogenous mechanical stimuli. Symptoms result from the degranulation of dermal mast cells, and IgE signaling likely contributes to inappropriate mast cell activation. Urticaria affects
<FONT STYLE="white-space:nowrap">15-20%</FONT> of the population at some point during their lifetime, with approximately 30% of urticaria patients experiencing recurring episodes. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Current treatment guidelines for CU recommend the use of oral <FONT STYLE="white-space:nowrap">H1-antihistamines</FONT> as a first-line
therapy, with dose escalation of up to four times the standard dose in lower responders. Up to 50% of patients with CSU do not respond to <FONT STYLE="white-space:nowrap">H1-antihistamines</FONT> and can be prescribed omalizumab, an injected
monoclonal antibody, which maintains an approximately 65% response rate as a second-line treatment. Given these response rates from approved biologic drugs, there remains an unmet need for a safe, efficacious therapy with a favorable oral dosing
profile. CCL17 and CCL22 are elevated in chronic urticaria, supporting the potential use of RPT193 in this indication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Chronic
Rhinosinusitis </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Chronic rhinosinusitis (&#147;CRS&#148;) is a disease characterized by sinonasal mucosal inflammation, which results
in facial pain/pressure, nasal drainage, nasal obstruction and reduction or loss of smell, for at least <FONT STYLE="white-space:nowrap">8-12</FONT> consecutive weeks. Confirmation of the disease is required using an objective measure such as a
nasal endoscopy or CT scan, given lack of symptom specificity. It is believed that approximately <FONT STYLE="white-space:nowrap">5-15%</FONT> of the general population experiences CRS, however, the prevalence of doctor-diagnosed CRS was found to be
<FONT STYLE="white-space:nowrap">2-4%.</FONT> There is wide belief that CRS is a heterogeneous condition and that the causes of inflammation are diverse and multifactorial, involving overlap between both host and environmental triggers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Standard treatment of CRS utilizes topical and oral steroids, antibiotics and ultimately surgical intervention if symptoms are not adequately
controlled by available therapies. IgE antibodies may play a role in CRS, with total IgE levels correlating with disease severity, as assessed by CT scan. As a result, <FONT STYLE="white-space:nowrap">anti-IgE</FONT> antibody omalizumab and <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-IL-5</FONT></FONT> antibodies reslizumab and mepolizumab have been evaluated as treatment alternatives for CRS, with reslizumab and mepolizumab now considered a recommended treatment
for CRS patients with nasal polyps. Dupilumab has also demonstrated activity in CRS in Phase 3 trials. Compared to these widely used injectable biologics, we believe that an orally dosed therapy with comparable safety and efficacy results would have
a competitive profile. Given the activity of the <FONT STYLE="white-space:nowrap">Th2-targeted</FONT> biologics, we believe that RPT193 represents a potential oral treatment for this indication. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Allergic Conjunctivitis </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Allergic conjunctivitis<I> </I>is an ocular disease in which the conjunctiva&#151;the transparent tissue lining the eyelid and covering the
white part of the eye&#151;is inflamed as a result of exposure to allergens. Simple allergic conjunctivitis, vernal keratoconjunctivitis, atopic keratoconjunctivitis and giant papillary conjunctivitis are the four main types of allergic
conjunctivitis.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>These different manifestations of conjunctivitis differ in their affected population and etiology.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>The majority of
conjunctivitis patients have simple allergic conjunctivitis and this predominantly affects patients who are younger than 20 years old. Diagnosis is difficult to estimate given that patients often fail to report symptoms and do not seek medical
attention, but it is estimated that between <FONT STYLE="white-space:nowrap">10-30%</FONT> of the general population suffers from this inflammation of the eye. In fact, more than 60% of individuals suffering from allergies are believed to have
allergic conjunctivitis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The current treatment paradigm for severe forms of simple allergic conjunctivitis has a combination of
antihistamine and mast cell-stabilizing drops as the first-line of treatment. The second-line treatment is providing patients with topical nonsteroidal anti-inflammatory drops. Refractory patients are given corticosteroid drops for no more than two
weeks, and clinicians may also opt to give patients systemic antihistamines.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>We believe there is an unmet need in the tolerability and safety profiles of patients with severe refractory cases of
simple allergic conjunctivitis given the adverse events resulting from the long-term use of corticosteroids and antihistamines. CCL17 and CCL22 are elevated in allergic conjunctivitis, supporting the potential use of RPT193 in this indication. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">116 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Eosinophilic Esophagitis </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Eosinophilic esophagitis is a chronic, allergic inflammatory disease of the esophagus. It is estimated that eosinophilic esophagitis affects
at least 150,000 people in the United States. Studies from Western Europe, Australia and North America estimate prevalence to be <FONT STYLE="white-space:nowrap">50-100</FONT> cases per 100,000 persons.&nbsp;Eosinophilic esophagitis is caused by the
presence of a large number of eosinophils in the esophagus, which stems from many factors such as immune hypersensitivity, environmental proteins and genetics. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Standard treatment for eosinophilic esophagitis includes diet modification, esophageal dilation and drugs with topical corticosteroids as a
first-line medication. It is estimated that there is at least a partial symptomatic response seen in 60% to 75% of adults with eosinophilic esophagitis who take topical steroids. While steroids offer symptomatic relief once treated, patients are
required to continue maintenance regimens as disease recurrence is common after discontinuation of treatment. Dupilumab has demonstrated activity in eosinophilic esophagitis in clinical trials, supporting the potential use of RPT193 in this
indication. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Allergic Disease Solution: RPT193 </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">While there are marketed injectable biologics, as well as oral drug candidates and injectable biologics in clinical development, we believe
there is an unmet need in the treatment landscape for a safe and efficacious oral therapy for the long-term treatment of AD. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g26k67.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">RPT193 is an oral, small molecule CCR4 antagonist designed to block the migration of inflammatory Th2 cells
into allergically inflamed tissues. In an in vitro chemotaxis assay, RPT193 was shown to block CCL22-induced chemotaxis of human Th2 cells with an IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> of ~370 nM. For comparison, two CCR4
antagonists from the published literature, AZD2098 and GSK2239633, both exhibited chemotaxis IC<SUB STYLE="font-size:85%; vertical-align:bottom">50</SUB> of &gt;3&micro;M when assayed head to head in the same in vitro experiment.</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">117 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CCL22-Induced Th2 Chemotaxis </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g74x93.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In preclinical studies, oral administration of RPT193 resulted consistently in statistically significant
(p&nbsp;&lt;&nbsp;0.05) reduction of inflammation in allergic skin (nine out of nine experiments) and airway inflammation models (two&nbsp;out of two experiments). We believe based on our preclinical pharmacology and GLP toxicology results, if
confirmed in clinical trials, combined with the convenience of once daily oral dosing, RPT193 could fill an unmet medical need for the treatment of allergic disorders. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>RPT193 Preclinical Data </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">RPT193 has demonstrated the ability to block the migration of mouse and human Th2 cells in vitro and has demonstrated activity in multiple
preclinical mouse models of AD and asthma. The observed activity in preclinical mouse models was similar to that of a commercially available anti-mouse <FONT STYLE="white-space:nowrap">IL-13</FONT> antibody, which we believe is representative of the
class of biologics such as dupilumab, lebrikizumab and others targeting <FONT STYLE="white-space:nowrap">Th2-derived</FONT> cytokines such as <FONT STYLE="white-space:nowrap">IL-4,</FONT> <FONT STYLE="white-space:nowrap">IL-5</FONT> and <FONT
STYLE="white-space:nowrap">IL-13.</FONT> We believe that the results observed in these models, individually and in the aggregate, demonstrate the clinical potential to treat a number of <FONT STYLE="white-space:nowrap">Th2-driven</FONT> diseases
along the atopic march in humans. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>RPT193 Activity in Preclinical Model of AD </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In a mouse model of AD, repeated systemic sensitization to ovalbumin (&#147;OVA&#148;) induces a Th2 response leading to increased expression
of Th2 cytokines <FONT STYLE="white-space:nowrap">IL-4,</FONT> <FONT STYLE="white-space:nowrap">IL-5</FONT> and <FONT STYLE="white-space:nowrap">IL-13</FONT> in the allergen-exposed skin. This leads to broad inflammation, deposition of collagen and
skin thickening. Oral treatment of RPT193 in mice that have been sensitized to OVA results in two independent experiments with five mice per experimental arm demonstrated a significant decrease in inflammation, as measured by skin thickness of the
allergen-challenged ear. The treatment effect with RPT193 was comparable to the systemic treatment with the corticosteroid dexamethasone (&#147;Dex&#148;) which is used as a positive control in these models. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The figure below shows the experimental outline and results as measured by the change in (&#147;delta&#148;) ear thickness, determined by the
difference in ear thickness between the challenged ear and the unchallenged control ear. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">118 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>RPT193 Reduces Skin Inflammation in an OVA-Induced AD Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g84x74.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The activity observed with RPT193 was not only seen in the <FONT STYLE="white-space:nowrap">OVA-AD</FONT>
model, but was also seen in an alternative allergen-induced model of AD. In this model, five mice per experimental arm are sensitized using fluorescein isothiocyanate (&#147;FITC&#148;), which induces a strong Th2 cell-mediated response. Sensitized
mice are then challenged on the ear with FITC, which leads to inflammation resulting in swelling and is easily measured as ear thickness. In six of six independent experiments, we observed that mice treated with RPT193 one day prior to FITC
challenge had a significant reduction in thickness (p &lt; 0.05 with average reduction ranging from 20% to 42% compared to vehicle group). In a head-to-head experiment in this preclinical mouse model, oral RPT193 showed similar activity to a
neutralizing anti-IL-13 antibody (&#147;anti-IL13&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>RPT193 Reduces Skin Inflammation in a FITC-Induced AD Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g36g59.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The treatment effect with RPT193 was also observed in a therapeutic model of the <FONT
STYLE="white-space:nowrap">Th2-driven</FONT> FITC AD model. In contrast to the model described above, five to ten mice per experimental arm received treatment 24 hours following the allergen challenge when significant ear inflammation was already
observed. Oral administration of RPT193 in three of three independent experiments resulted in a statistically significant reduction in ear thickness compared to treatment control (p &lt; 0.05 with average reduction ranging from 42% to 54%). When
comparing to the respective vehicle or isotype control, RPT193 and anti-IL-13 antibody had similar effects (RPT193 vs. anti-IL-13: 45% vs. 46%, 54% vs. 40% and 42% vs. 28% reduction in ear thickness at Day 12 in the three separate experiments).
Therefore, the treatment effect was comparable to that observed with the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">anti-IL-13.</FONT></FONT> </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">119 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>RPT193 Reduces Skin Inflammation in a Therapeutic Th2-Driven AD Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g98a14.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>RPT193 Efficacy in a Preclinical Model of Allergic Asthma </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In a mouse model of allergic asthma induced by the allergen OVA, treatment with RPT193 in two independent experiments with ten mice per
experimental arm significantly reduced immune cell migration into the lungs and <FONT STYLE="white-space:nowrap">Th2-derived</FONT> cytokines such as <FONT STYLE="white-space:nowrap">IL-5</FONT> and <FONT STYLE="white-space:nowrap">IL-13,</FONT>
which are drivers of the disease as determined by analysis of fluid collected by washing a small portion of the lung. This fluid, called bronchoalveolar lavage fluid (&#147;BALF&#148;), was found to contain dose-dependent decreases in both <FONT
STYLE="white-space:nowrap">IL-5</FONT> and <FONT STYLE="white-space:nowrap">IL-13.</FONT> Not unexpectedly, <FONT STYLE="white-space:nowrap">anti-IL-13</FONT> had no effect on levels of <FONT STYLE="white-space:nowrap">IL-5</FONT> in the BALF. The
reduction of the cellular infiltrate and the level of <FONT STYLE="white-space:nowrap">Th2-derived</FONT> cytokines in the BALF supports the hypothesis that RPT193 was effective in reducing migration of Th2 cells into the lungs as evidenced by
lowered overall allergic inflammation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>RPT193 Shows Evidence of Broader Activity than Anti-IL-13 </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g08p42.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">120 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>RPT193 Reduces Levels of CCL17 and CCL22 in the BALF in a Preclinical Model of Allergic
Asthma </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In this OVA model of allergic asthma, treatment with RPT193 in two of two independent experiments with ten mice per
experimental arm also led to statistically significant decreases in the levels of CCL17 and CCL22 (p&lt;0.05 at high dose of RPT193, 24 hours after challenge), chemokines that are secreted by inflamed cells that serve to recruit Th2 cells. This
observation suggests that RPT193 is not only able to directly block Th2 cell recruitment, but that by doing so, the level of overall inflammation is decreased, reducing the secretion of these cytokines and the further recruitment of Th2 cells.
Reduction of the CCR4 ligands, CCL17 and CCL22, has also been observed in patients treated with other <FONT STYLE="white-space:nowrap">Th2-targeting</FONT> approaches, such as dupilumab, demonstrating the clinical relevance of our preclinical
findings with RPT193. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>RPT193 Reduces CCR4 Ligands in the BALF </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g86n48.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>RPT193 Reduces the Immune Cell Infiltrate in the BALF in a Preclinical Model of Allergic Asthma
</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Treatment of mice in an allergic asthma model with RPT193 in two independent experiments with ten mice per experimental cohort led to
reduction in multiple classes of immune cells in the BALF, including eosinophils, neutrophils and lymphocytes. These reductions are all consistent with the broad anti-inflammatory action that RPT193 can induce by blocking Th2 cell migration. This
prevents one of the earliest steps in the inflammatory cascade resulting in profound effects on multiple downstream components of the immune system and inflammatory response. The reduction of eosinophils in the BALF was comparable to the <FONT
STYLE="white-space:nowrap">anti-IL-13</FONT> antibody. However, deeper reduction in neutrophil and lymphocyte counts were observed with RPT193, suggesting a potentially greater impact on the disease compared to other
<FONT STYLE="white-space:nowrap">Th2-targeting</FONT> approaches. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">121 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>RPT193 Shows Evidence of Broader Activity than Anti-IL-13: </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Neutrophil and Lymphocytic Infiltration </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g36g08.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, we believe the overall activity of RPT193 in this
<FONT STYLE="white-space:nowrap">OVA-induced</FONT> asthma model if confirmed in clinical trials and approved by the FDA could fill an unmet medical need for the treatment of allergic disorders. We believe that the ability to achieve this level of
activity with an orally available therapy, if confirmed in clinical trials, would represent a significant advantage over biologics, which require regular injections. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>RPT193: Clinical Plans </I></B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We
have initiated a seamless Phase 1 trial of RPT193 comprised of Phase 1a single and multiple dose escalation (&#147;SAD/MAD&#148;) cohorts in healthy volunteers in August 2019, to be followed by placebo-controlled Phase 1b testing in patients with
moderate to severe AD. Preliminary safety, pharmacokinetic, and pharmacodynamic data from the initial single dose cohorts support once-daily oral dosing with RPT193 and dose escalation continues as planned. We anticipate PoC clinical results from
the Phase&nbsp;1b portion of this study by <FONT STYLE="white-space:nowrap">mid-2020.</FONT> Thereafter, we intend to expand clinical development into additional <FONT STYLE="white-space:nowrap">Th2-driven</FONT> allergic indications. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following graphic outlines the design for our proposed Phase 1a/1b trial and proposed Phase 2a/2b trials. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>RPT193: Seamless Clinical Trial Design to PoC </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g27t37.jpg" ALT="LOGO">
 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">122 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following graphic illustrates preliminary pharmacokinetic and pharmacodynamic data
from the initial single dose cohorts for the RPT193 Phase 1a SAD study. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>Preliminary Phase 1a SAD Data* Supports Once-Daily Dose </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g20u48.jpg" ALT="LOGO">
 </P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:8pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman; " ALIGN="left">Data from 18 dosed healthy volunteers. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following graphic outlines the design of our proposed Phase 2b trial in AD to be conducted subsequent to the successful completion of the
Phase 1a/1b trial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>RPT193: Future Phase 2b Double-Blind, Placebo-Controlled Trial for AD </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g36k80.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">BSA = Body Surface Area </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman">IGA =
Investigator Global Assessment </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">123 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> Program </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are developing a small molecule inhibitor of GCN2 as an agent targeting the dysregulated metabolism in the TME that results in immune
suppression and consequently in tumor progression. We believe this target has been validated by our proprietary drug discovery and development engine and that inhibition of GCN2 can lead to direct antitumor effects by addressing altered metabolic
pathways in tumors as well as relieving the immunosuppressive effects exerted by the TME through nutrient starvation and other stresses such as hypoxia. Preclinical in vitro and in vivo studies have demonstrated that an RPT-GCN2i has the ability to
increase T&nbsp;cell proliferation and function in nutrient-deprived conditions, to overcome MDSC-dependent immune suppression, to decrease tumor growth in vitro and to generate antitumor responses in animal tumor models. We are developing an
RPT-GCN2i with the intent of filing an IND with the FDA in 2020. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Role of GCN2 in Tumor Cell Proliferation and Immunosuppression </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">GCN2, or general control nonderepressible 2, is a stress response kinase that regulates the immune system and survival of tumor cells in the
TME. Due to the aberrant vasculature of the tumor, the limited blood supply results in a lack of oxygen and deprivation of nutrients, including amino acids. Activation of the GCN2 pathway has been demonstrated in human tumors and importantly,
deficiency in GCN2 limits tumor growth in preclinical tumor models. Activation of T cells is highly dependent on the availability of amino acids and other nutrients. GCN2 is a key cellular sensor in T cells for amino acid and glucose starvation. Low
levels of amino acids such as tryptophan, arginine and other amino acids lead to activation of GCN2. This triggers a cascade of cell signaling events in T cells leading to the inhibition of effector cell function and growth. GCN2, through this
regulatory pathway, prevents effector cells from mounting an immune response when amino acid levels are in limited supply. Inactivation of GCN2 removes this regulatory block and allows effector cell proliferation and activation even under conditions
of amino acid starvation similar to what may exist in tumors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our Solution, <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are developing an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> with the intent of filing an IND with the FDA in 2020. We believe that
the computational analysis of proprietary and public databases will allow us to identify tumor types or a subset of patients with a greater potential to benefit from GCN2 inhibition. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">124 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> Preclinical Data </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>An <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> Restores T Cell Proliferation and Function in Amino-Acid-Limited Conditions </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Low levels of tryptophan in the TME can be immunosuppressive by blocking the activation and proliferation of effector cells. In six
independent cell culture experiments with various human donors, an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> statistically significantly (p &lt; 0.05) increased effector T&nbsp;cell proliferation and function under nutrient starvation
conditions in a dose-dependent manner to levels comparable to T cell proliferation and function in non-nutrient-deprived conditions. The ability of an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> to recover effector cell proliferation was not
limited to a single amino acid or nutrient. We have shown that GCN2 inhibition can relieve the immunosuppressive effects of tryptophan (shown below), arginine and glucose deprivation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>An RPT-GCN2i Restores Human CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> T Cell Proliferation and Function Under Conditions of Nutrient
Starvation </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="font-size:0pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g17g41.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>An <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> Inhibits MDSC Immunosuppressive Function In Vitro
</I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">MDSCs are heterogeneous cells found in multiple cancer types that can cause immunosuppression through multiple pathways including the
expression of enzymes, such as indoleamine <FONT STYLE="white-space:nowrap">2,3-dioxygenase</FONT> that metabolizes tryptophan. Incubation of activated CD8<SUP STYLE="font-size:85%; vertical-align:top">+</SUP> T cells with MDSCs isolated from four
healthy volunteers as well as from one cancer patient leads to a statistically significant (p &lt; 0.05) inhibition of T cell proliferation, an effect that is reversed by an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> in a dose-dependent
manner with T cell proliferation comparable to T cells cultured without MDSC (range 80 to 148% of control). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">125 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>An RPT-GCN2i Reverses Suppressive Function of Healthy Donor and Cancer Patient-Derived MDSCs
</B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>  <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g99b72.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>An <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> Demonstrates Single Agent Activity in the CT26
Mouse Tumor Model </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In a CT26 mouse tumor model, oral administration of an <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> in four
independent experiments with ten mice per experimental arm led to a statistically significant (p &lt; 0.05) reductions in tumor volume (at the last day of measurement) when dosed as a single agent. We believe an
<FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> has the potential to have broad activity in stimulating the immune system in multiple tumor types either as a single agent or in combination with conventional or immune-based therapies. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:ARIAL" ALIGN="center"><B>An RPT-GCN2i Demonstrates Single Agent Activity in a CT26 Mouse Tumor Model </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g64u12.jpg" ALT="LOGO">
 </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our HPK1 Program </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">HPK1 is a negative regulator of T cell activation, and the inhibition of HPK1 has the potential to enhance T cell function and antitumor
activity. HPK1 was identified in a RAPT computational screen, which also identified clinically validated targets including PD-1, as well as CCR4. We are refining the chemical structure of our lead HPK1 compounds utilizing high resolution crystal
structures and demonstrated that inhibition of HPK1 enhanced activation of primary mouse and human T cells in vitro, as well as antigen-specific CD8+ T cell effector function in vivo. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">126 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Intellectual Property </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We strive to protect the proprietary technology, inventions and improvements that are commercially important to our business, including
obtaining, maintaining, enforcing and defending our intellectual property rights, including patent rights, whether developed internally or licensed from third parties. We rely, in part, on trade secrets
<FONT STYLE="white-space:nowrap">and&nbsp;know-how&nbsp;relating</FONT> to our proprietary technology and drug candidates and continuing innovation to develop, strengthen and maintain our proprietary position. We also plan to rely, in part, on data
exclusivity, market exclusivity and patent term extensions if and when available. Our commercial success will depend in part on our ability to obtain and maintain patent and other intellectual property protection for our technology, inventions and
improvements; to preserve the confidentiality of our trade secrets; to defend and enforce our proprietary rights, including any patents that we own or may obtain in the future; and to operate without infringing, misappropriating or otherwise
violating the valid and enforceable patents and other intellectual property rights of third parties. Intellectual property rights may not address all potential threats to our competitive advantage. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>C-C Chemokine Receptor 4 (CCR4) Antagonist Franchise </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June 30, 2019, our patent portfolio includes five patent families directed to CCR4 inhibiting compounds and their therapeutic uses, one
of which is directed to FLX475 and another of which is directed to RPT193, as discussed in more depth below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>FLX475</I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June 30, 2019, with respect to FLX475, we own one issued U.S. patent directed to FLX475 and other related compounds, pharmaceutical
compositions comprising the same and therapeutic methods of using the same for the treatment of diseases including cancers, one corresponding pending patent application in the U.S. and 15 corresponding pending patent applications in Australia,
Brazil, Canada, China, the European Patent Convention, India, Israel, Japan, South Korea, Mexico, New Zealand, Russia, Singapore, South Africa and Taiwan. Our issued U.S. patent, and any patents that may issue from our pending applications
worldwide, are scheduled to expire in 2037, excluding any additional term for patent term adjustment(s) or extension(s), and assuming payment of all applicable maintenance or annuity fees. In addition to the composition of matter patent and patent
applications described above, as of June 30, 2019, we own one pending U.S. patent application, one pending Patent Cooperation Treaty (&#147;PCT&#148;) patent application and one pending Taiwan patent application directed to the use of CCR4
antagonists generally, including FLX475 specifically, in therapeutic methods of treating EBV positive cancers. Any patents that may issue from these pending applications, in the United States and worldwide, are scheduled to expire in 2038, excluding
any additional term for patent term adjustment(s) or extension(s), and assuming national phase entries are timely made based upon the pending PCT application and payment of all applicable maintenance or annuity fees. Our pending PCT patent
application is not eligible to become an issued patent until, among other things, we file a national stage patent application(s) within 30 months in the countries in which we seek patent protection. If we do not timely file any national stage patent
applications, we may lose our priority date with respect to our PCT patent application and any patent protection on the inventions disclosed in such PCT patent application. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>RPT193</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June 30, 2019, with
respect to RPT193, we own one pending U.S. patent application, one pending PCT patent application and one pending Taiwan patent application directed to RPT193 and other related compounds, pharmaceutical compositions comprising the same and
therapeutic methods of using the same for the treatment of diseases such as immune, inflammatory, metabolic diseases or cancers. Any patents that may issue from these pending applications, in the United States and worldwide, are scheduled to expire
in 2039, excluding any additional term for patent term adjustment(s) or extension(s), and assuming national phase entries are timely made based upon the pending PCT application and payment of all applicable maintenance or annuity
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">127 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fees. Our pending PCT patent application is not eligible to become an issued patent until, among other things, we file a national stage patent application(s) within 30 months in the countries in
which we seek patent protection. If we do not timely file any national stage patent applications, we may lose our priority date with respect to our PCT patent application and any patent protection on the inventions disclosed in such PCT patent
application. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Our <FONT STYLE="white-space:nowrap">RPT-GCN2i</FONT> Program </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June 30, 2019, with respect to RPT-GCN2i product development, we own one pending U.S. provisional patent application, one pending U.S.
non-provisional patent application, one pending PCT patent application and one pending Taiwan patent application, all directed to certain compounds in development, pharmaceutical compositions of the same and therapeutic methods of using the same.
Any patents that may issue from these pending patent applications are scheduled to expire in 2039, excluding any additional term for patent term adjustment or extension, and assuming national phase entries are timely made based upon the pending PCT
application and payment of all applicable maintenance or annuity fees. Our pending PCT patent application is not eligible to become an issued patent until, among other things, we file a national stage patent application(s) within 30 months in the
countries in which we seek patent protection. If we do not timely file any national stage patent applications, we may lose our priority date with respect to our PCT patent application and any patent protection on the inventions disclosed in such PCT
patent application. Our provisional patent application is not eligible to become an issued patent until, among other things, we file a non-provisional patent application within 12 months of filing the related provisional patent application. If we do
not timely file any nonprovisional patent application, we may lose our priority date with respect to our provisional patent application and any patent protection on the inventions disclosed in our provisional patent application. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">With respect to our drug candidates, we intend to develop and commercialize in the normal course of business, we intend to pursue patent
protection covering, when possible, compositions, methods of use, dosing and formulations. We may also pursue patent protection with respect to manufacturing and drug development processes and technologies. We do not currently own any patents or
patent applications relating to our proprietary discovery and development engine. Obtaining and maintaining patent protection depends on compliance with various procedural, document submission, fee payment, and other requirements imposed by
governmental patent agencies. We may not be able to obtain patent protections for our compositions, methods of use, dosing and formulations, manufacturing and drug development processes and technologies throughout the world. Issued patents can
provide protection for varying periods of time, depending upon the date of filing of the patent application, the date of patent issuance and the legal term of patents in the countries in which they are obtained. In general, patents issued for
applications filed in the United States expire 20 years after the earliest effective filing date. In addition, in certain instances, the term of an issued U.S. patent that covers or claims an FDA approved product can be extended to recapture a
portion of the term effectively lost as a result of the FDA regulatory review period, which is called patent term extension. The restoration period cannot be longer than five years and the total patent term, including the restoration period, must
not exceed 14 years following FDA approval. For more information regarding patent term extensions, please see &#147;Business&#151;U.S. Patent Term Restoration and Marketing Exclusivity&#148; below. The term of patents outside of the United States
varies in accordance with the laws of the foreign jurisdiction, but typically is also 20 years from the earliest effective filing date. However, the actual protection afforded by a patent varies on <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">a&nbsp;product-by-product&nbsp;basis,</FONT></FONT> <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">from&nbsp;country-to-country,&nbsp;and</FONT></FONT> depends upon many factors, including the type of
patent, the scope of its coverage, the availability of regulatory-related extensions, the availability of legal remedies in a particular country and the validity and enforceability of the patent. The patent term may be inadequate to protect our
competitive position on our products for an adequate amount of time. For more information regarding the risks related to our intellectual property, please see &#147;Risk Factors&#151;Risks Related to Our Intellectual Property.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The patent positions of companies like ours are generally uncertain and involve complex legal and factual questions. No consistent policy
regarding the scope of claims allowable in patents in the field of biopharmaceuticals has emerged in the United States. The relevant patent laws and their interpretation outside of the United States is also uncertain. Changes in either the patent
laws or their interpretation in the United States </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">128 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
and other countries may diminish our ability to protect our technology or drug candidates and could affect the value of such intellectual property. In particular, our ability to stop third
parties from making, using, selling, offering to sell or importing products that infringe our intellectual property will depend in part on our success in obtaining, maintaining, enforcing and defending patent claims that cover our technology,
inventions and improvements. We cannot guarantee that patents will be granted with respect to any of our pending patent applications or with respect to any patent applications we may file in the future, nor can we ensure that any patents that may be
granted to us in the future will be commercially useful in protecting our products, the methods of use or manufacture of those products. Moreover, any issued patents we obtain do not guarantee us the right to practice our technology in relation to
the commercialization of our products. Patent and other intellectual property rights in the pharmaceutical and biotechnology space are evolving and involve many risks and uncertainties. For example, third parties may have blocking patents that could
be used to prevent us from commercializing our drug candidates and practicing our proprietary technology, and our patent rights may be challenged, invalidated or circumvented, which could limit our ability to stop competitors from marketing related
products or could limit the term of patent protection that otherwise may exist for our drug candidates. In addition, the scope of the rights granted under any issued patent that we own or license, now or in the future, may not provide us with
protection or competitive advantages against competitors with similar technology. Furthermore, our competitors may independently develop similar technologies that are outside the scope of the rights granted under any issued patents we obtain. For
these reasons, we may face competition with respect to our drug candidates. Moreover, because of the extensive time required for development, testing and regulatory review of a potential product, it is possible that, before any particular drug
candidate can be commercialized, any patent protection for such product may expire or remain in force for only a short period following commercialization, thereby reducing the commercial advantage the patent provides. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition to patent protection, we rely upon unpatented trade secrets and confidential know-how and continuing technological innovation to
develop and maintain our competitive position. However, trade secrets and confidential information are difficult to protect. We seek to protect our proprietary information, in part, using confidentiality agreements with any future collaborators,
scientific advisors, employees and consultants, and invention assignment agreement with our employees. We also have agreements requiring assignment of inventions with selected consultants, scientific advisors and collaborators. These agreements may
not provide meaningful protection. These agreements may also be breached, and we may not have an adequate remedy for any such breach. In addition, our trade secrets and/or confidential know-how may become known or be independently developed by a
third party, or misused by any collaborator to whom we disclose such information. Despite any measures taken to protect our intellectual property, unauthorized parties may attempt to copy aspects of our products or drug candidates or obtain or use
information that we regard as proprietary. Although we take steps to protect our proprietary information, third parties may independently develop the same or similar proprietary information or may otherwise gain access to our proprietary
information. As a result, we may be unable to meaningfully protect our trade secrets and proprietary information. For more information regarding the risks related to our intellectual property, please see &#147;Risk Factors&#151;Risks Related to Our
Intellectual Property.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clinical Trial Collaboration and Supply Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In November 2018, we entered into a clinical trial collaboration and supply agreement with MSD International GmbH, an affiliate of Merck
(known as MSD outside the United States and Canada), under which we will conduct a clinical trial evaluating FLX475 as a monotherapy and in combination with KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> (pembrolizumab),
Merck&#146;s anti-PD-1 therapy, in patients with advanced cancers. We are the sponsor of the clinical trial and are responsible for the costs of conducting it, and Merck will supply KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP>
for use in the clinical trial at no charge to us except that we may be required to reimburse Merck&#146;s manufacturing costs upon certain early termination events. Neither party will have any other obligations to reimburse any costs or expenses
incurred by the other party. We retain ownership of the quantities of FLX475 used in the clinical trial and we will own the quantities of KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> supplied to us by Merck for use in the
clinical trial. The agreement provides for joint ownership of any inventions, clinical data and results generated in the clinical trial that relate to the combined use of the two drugs. Merck will solely own any inventions generated in the clinical
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">129 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
trial that relate solely to KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> and all data resulting from testing performed by or on behalf of Merck upon samples collected during
the clinical trial. We will solely own any inventions generated in the clinical trial that relate solely to FLX475, clinical data resulting from the use of FLX475 as a monotherapy, and from all data resulting from testing performed by or on behalf
of us upon samples collected during the clinical trial. The term of the agreement will continue until delivery of the final report for the clinical trial, provided that either party may terminate the agreement due to the other party&#146;s uncured
material breach, a violation of anti-corruption obligations, patient safety concerns, regulatory action that prevents supply of such party&#146;s compound, or such party&#146;s termination of its compound&#146;s development or withdrawal of its
compound&#146;s regulatory approval. Merck may also terminate the agreement if we fail to make any changes to the clinical trial protocol regarding the use of KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> that are reasonably
requested by Merck to address any concern raised by Merck that KEYTRUDA<SUP STYLE="font-size:85%; vertical-align:top">&reg;</SUP> is being used in the clinical trial in an unsafe manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Competition </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The biotechnology and
pharmaceutical industries, including the oncology and inflammatory disease fields, are characterized by rapidly advancing technologies, strong competition and an emphasis on intellectual property protection. We face substantial competition from many
different sources, including large and specialty pharmaceutical and biotechnology companies, academic research institutions, governmental agencies and public and private research institutions. We believe that the key competitive factors affecting
the success of any of our drug candidates will include patient selection strategies, efficacy (single and combination strategies), safety profile, method of administration, cost, level of promotional activity and intellectual property protection.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If approved, FLX475 will compete with current therapies approved for the treatment of cancer, particularly immuno-oncology. Potential
immuno-oncology therapeutics are being developed or marketed by many large and specialty pharmaceutical and biotechnology companies such as Merck, Bristol-Myers Squibb, Novartis, AstraZeneca, Pfizer and Roche/Genentech. Additionally, there is one
approved CCR4-targeting T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>-depleting antibody, mogamulizumab developed by Kyowa Hakko Kirin, as well as other T<SUB STYLE="font-size:85%; vertical-align:bottom">reg</SUB>-targeting agents
currently in early development by companies such as ChemoCentryx, Tusk/Roche and Agenus/Gilead. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">RPT193 is a CCR4 antagonist intended to
treat allergic disease, including AD and other diseases along the atopic march. If approved for AD, we will face branded competition from dupilumab (marketed by Regeneron Pharmaceuticals, Inc. and Sanofi S.A. as Dupixent), a biologic recently
approved. In addition, there are several companies developing treatments that may be approved for AD, including large pharmaceutical and biotechnology companies such as Pfizer, Lilly/Incyte, AbbVie, AnaptysBio, Dermira and Amgen/AstraZeneca. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">There are several large and specialty pharmaceutical companies, as well as biotechnology companies with marketed or late stage assets
targeting the Th2 pathway along the atopic march, which includes Amgen, AstraZeneca, Chiesi Farmaceutici, GSK, Novartis, Roche, Sanofi and Teva Pharmaceuticals. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Many of the companies against which we may compete have significantly greater financial resources and expertise in research and development,
manufacturing, preclinical testing, conducting clinical trials, obtaining regulatory approvals and marketing approved products than we do. Smaller or early-stage companies may also prove to be significant competitors, particularly through
collaborative arrangements with large and established companies. These competitors also compete with us in recruiting and retaining qualified scientific and management personnel and establishing clinical trials sites and patient registration for
clinical trials, as well as in acquiring technologies complementary to, or necessary for, our programs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Government Regulation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The FDA and other regulatory authorities at federal, state, and local levels, as well as in foreign countries, extensively regulate, among
other things, the research, development, testing, manufacture, quality control, import, export, safety, effectiveness, labeling, packaging, storage, distribution, record keeping, approval, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">130 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
advertising, promotion, marketing, post-approval monitoring, and post-approval reporting of drug products such as those we are developing. We, along with third-party contractors, will be required
to navigate the various preclinical, clinical and commercial approval requirements of the governing regulatory agencies of the countries in which we wish to conduct studies or seek approval or licensure of our drug candidates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The process required by the FDA before drug candidates may be marketed in the United States generally involves the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">completion of preclinical laboratory tests and animal studies performed in accordance with the FDA&#146;s current
Good Laboratory Practices (&#147;GLP&#148;), regulation; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">submission to the FDA of an IND, which must become effective before clinical trials may begin and must be updated
annually or when significant changes are made; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">approval by an independent Institutional Review Board (&#147;IRB&#148;), or ethics committee at each clinical
site before the trial is commenced; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">performance of adequate and well-controlled human clinical trials to establish the safety and efficacy of the
proposed drug candidate for its intended purpose; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">preparation of and submission to the FDA of an NDA after completion of all pivotal clinical trials;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of an FDA Advisory Committee review, if applicable; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a determination by the FDA within 60 days of its receipt of an NDA to file the application for review;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">satisfactory completion of an FDA <FONT STYLE="white-space:nowrap">pre-approval</FONT> inspection of the
manufacturing facility or facilities at which the proposed product is produced to assess compliance with cGMP, and of selected clinical investigation sites to assess compliance with Good Clinical Practices (&#147;GCP&#148;); and
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">FDA review and approval of the NDA to permit commercial marketing of the product for particular indications for
use in the United States. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Preclinical and Clinical Development </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Prior to beginning the first clinical trial with a drug candidate, we must submit an IND to the FDA. An IND is a request for authorization
from the FDA to administer an investigational new drug product to humans. The central focus of an IND submission is on the general investigational plan and the protocol(s) for clinical trials. The IND also includes results of animal and in vitro
studies assessing the toxicology, pharmacokinetics, pharmacology, and pharmacodynamic characteristics of the product; chemistry, manufacturing, and controls information; and any available human data or literature to support the use of the
investigational product. An IND must become effective before human clinical trials may begin. The IND automatically becomes effective 30 days after receipt by the FDA, unless the FDA, within the <FONT STYLE="white-space:nowrap">30-day</FONT> time
period, raises safety concerns or questions about the proposed clinical trial. In such a case, the IND may be placed on clinical hold and the IND sponsor and the FDA must resolve any outstanding concerns or questions before the clinical trial can
begin. Submission of an IND therefore may or may not result in FDA authorization to begin a clinical trial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Clinical trials involve the
administration of the investigational product to human subjects under the supervision of qualified investigators in accordance with GCPs, which include the requirement that all research subjects provide their informed consent for their participation
in any clinical trial. Clinical trials are conducted under protocols detailing, among other things, the objectives of the study, the parameters to be used in </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">131 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
monitoring safety and the effectiveness criteria to be evaluated. A separate submission to the existing IND must be made for each successive clinical trial conducted during product development
and for any subsequent protocol amendments. Furthermore, an independent IRB for each site proposing to conduct the clinical trial must review and approve the plan for any clinical trial and its informed consent form before the clinical trial begins
at that site, and must monitor the study until completed. Regulatory authorities, the IRB or the sponsor may suspend a clinical trial at any time on various grounds, including a finding that the subjects are being exposed to an unacceptable health
risk or that the trial is unlikely to meet its stated objectives. Some studies also include oversight by an independent group of qualified experts organized by the clinical trial sponsor, known as a data safety monitoring board, which provides
authorization for whether or not a study may move forward at designated check points based on access to certain data from the study and may halt the clinical trial if it determines that there is an unacceptable safety risk for subjects or other
grounds, such as no demonstration of efficacy. There are also requirements governing the reporting of ongoing clinical trials and clinical trial results to public registries. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For purposes of NDA approval, human clinical trials are typically conducted in three sequential phases that may overlap. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase 1&#151;</I>The investigational product is initially introduced into healthy human subjects or patients
with the target disease or condition. These studies are designed to test the safety, dosage tolerance, absorption, metabolism and distribution of the investigational product in humans, the side effects associated with increasing doses, and, if
possible, to gain early evidence on effectiveness. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase 2&#151;</I>The investigational product is administered to a limited patient population with a specified
disease or condition to evaluate the preliminary efficacy, optimal dosages and dosing schedule and to identify possible adverse side effects and safety risks. Multiple Phase 2 clinical trials may be conducted to obtain information prior to beginning
larger and more expensive Phase 3 clinical trials. Some trials may combine aspects of Phase 1 and Phase 2 into a single clinical trial, which we refer to as a &#147;seamless&#148; study that can examine both safety in healthy volunteers and safety
and preliminary efficacy in patients with a specific disease. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Phase 3&#151;</I>The investigational product is administered to an expanded patient population to further
evaluate dosage, to provide statistically significant evidence of clinical efficacy and to further test for safety, generally at multiple geographically dispersed clinical trial sites. These clinical trials are intended to establish the overall
risk/benefit ratio of the investigational product and to provide an adequate basis for product approval. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">A
registrational trial is a clinical trial that adequately meets regulatory agency requirements for the evaluation of a drug candidate&#146;s efficacy and safety such that it can be used to justify the approval of the drug. Generally, registrational
trials are Phase 3 trials but may be Phase 2 trials if the trial design provides a reliable assessment of clinical benefit, particularly in situations where there is an unmet medical need. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In some cases, the FDA may require, or companies may voluntarily pursue, additional clinical trials after a product is approved to gain more
information about the product. These <FONT STYLE="white-space:nowrap">so-called</FONT> Phase 4 studies may be made a condition to approval of the NDA. Concurrent with clinical trials, companies may complete additional animal studies and develop
additional information about the characteristics of the drug candidate, and must finalize a process for manufacturing the product in commercial quantities in accordance with cGMP requirements. The manufacturing process must be capable of
consistently producing quality batches of the drug candidate and, among other things, must develop methods for testing the final product. Additionally, appropriate packaging must be selected and tested and stability studies must be conducted to
demonstrate that the drug candidate does not undergo unacceptable deterioration over its shelf life. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">132 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>NDA Submission and Review </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Assuming successful completion of all required testing in accordance with all applicable regulatory requirements, the results of product
development, nonclinical studies and clinical trials are submitted to the FDA as part of an NDA requesting approval to market the product for one or more indications. The NDA must include all relevant data available from pertinent preclinical and
clinical trials, including negative or ambiguous results as well as positive findings, together with detailed information relating to the product&#146;s chemistry, manufacturing, controls, and proposed labeling, among other things. A determination
by the FDA within 60 days of the receipt of an NDA to file the application for review for its completeness is initiated at the time of submission. If the FDA determines there is significance to the missing or incomplete information in the context of
the proposed drug product, the proposed indication(s), and the amount of time needed to address any given deficiency, it can issue a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">refusal-to-file</FONT></FONT> letter. The
submission of an NDA requires payment of a substantial application user fee to FDA, unless a waiver or exemption applies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Once an NDA has
been submitted, the FDA&#146;s goal is to review standard applications within ten months after it accepts the application for filing, or, if the application qualifies for priority review, six months after the FDA accepts the application for filing.
In both standard and priority reviews, the review process is often significantly extended by FDA requests for additional information or clarification. The FDA reviews an NDA to determine, among other things, whether a product is safe and effective.
The FDA may convene an advisory committee to provide clinical insight on application review questions. Before approving an NDA, the FDA will typically inspect the facility or facilities where the product is manufactured. The FDA will not approve an
application unless it determines that the manufacturing processes and facilities are in compliance with cGMP requirements and adequate to assure consistent production of the product within required specifications. Additionally, before approving an
NDA, the FDA will typically inspect one or more clinical sites to assure compliance with GCP. If the FDA determines that the application, manufacturing process or manufacturing facilities are not acceptable, it will outline the deficiencies in the
submission and often will request additional testing or information. Notwithstanding the submission of any requested additional information, the FDA ultimately may decide that the application does not satisfy the regulatory criteria for approval.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">After the FDA evaluates an NDA and conducts inspections of manufacturing facilities where the product will be produced, the FDA may issue
an approval letter or a Complete Response letter. An approval letter authorizes commercial marketing of the product with specific prescribing information for specific indications. A Complete Response letter will describe all of the deficiencies that
the FDA has identified in the NDA. In issuing the Complete Response letter, the FDA may recommend actions that the applicant might take to place the NDA in condition for approval, including requests for additional information or clarification. The
FDA may delay or refuse approval of an NDA if applicable regulatory criteria are not satisfied, require additional testing or information and/or require post-marketing testing and surveillance to monitor safety or efficacy of a product. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If regulatory approval of a product is granted, such approval will be granted for particular indications and may entail limitations on the
indicated uses for which such product may be marketed. For example, the FDA may approve the NDA with a Risk Evaluation and Mitigation Strategy (&#147;REMS&#148;), to ensure the benefits of the product outweigh its risks. A REMS is a safety strategy
to manage a known or potential serious risk associated with a product and to enable patients to have continued access to such medicines by managing their safe use, and could include medication guides, physician communication plans, or elements to
assure safe use, such as restricted distribution methods, patient registries and other risk minimization tools. The FDA also may condition approval on, among other things, changes to proposed labeling or the development of adequate controls and
specifications. Once approved, the FDA may withdraw the product approval if compliance with <FONT STYLE="white-space:nowrap">pre-</FONT> and post-marketing requirements is not maintained or if problems occur after the product reaches the
marketplace. The FDA may require one or more Phase 4 post-market studies and surveillance to further assess and monitor the product&#146;s safety and effectiveness after commercialization, and may limit further marketing of the product based on the
results of these post-marketing studies. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">133 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Expedited Development and Review Programs </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The FDA offers a number of expedited development and review programs for qualifying drug candidates. The fast track program is intended to
expedite or facilitate the process for reviewing new products that meet certain criteria. Specifically, new products are eligible for fast track designation if they are intended to treat a serious or life-threatening disease or condition and
demonstrate the potential to address unmet medical needs for the disease or condition. Fast track designation applies to the combination of the product and the specific indication for which it is being studied. The sponsor of a fast track product
has opportunities for frequent interactions with the review team during product development and, once an NDA is submitted, the product may be eligible for priority review. A fast track product may also be eligible for rolling review, where the FDA
may consider for review sections of the NDA on a rolling basis before the complete application is submitted, if the sponsor provides a schedule for the submission of the sections of the NDA, the FDA agrees to accept sections of the NDA and
determines that the schedule is acceptable, and the sponsor pays any required user fees upon submission of the first section of the NDA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">A product intended to treat a serious or life-threatening disease or condition may also be eligible for breakthrough therapy designation to
expedite its development and review. A product can receive breakthrough therapy designation if preliminary clinical evidence indicates that the product may demonstrate substantial improvement over existing therapies on one or more clinically
significant endpoints, such as substantial treatment effects observed early in clinical development. The designation includes all of the fast track program features, as well as more intensive FDA interaction and guidance beginning as early as Phase
1 and an organizational commitment to expedite the development and review of the product, including involvement of senior managers. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any
product is eligible for priority review if it has the potential to provide a significant improvement in the treatment, diagnosis or prevention of a serious disease or condition compared to marketed products. For products containing new molecular
entities, priority review designation means the FDA&#146;s goal is to take action on the marketing application within six months of the <FONT STYLE="white-space:nowrap">60-day</FONT> filing date (compared with ten months under standard review). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Additionally, products studied for their safety and effectiveness in treating serious or life-threatening diseases or conditions may receive
accelerated approval upon a determination that the product has an effect on a surrogate endpoint that is reasonably likely to predict clinical benefit, or on a clinical endpoint that can be measured earlier than irreversible morbidity or mortality,
that is reasonably likely to predict an effect on irreversible morbidity or mortality or other clinical benefit, taking into account the severity, rarity, or prevalence of the condition and the availability or lack of alternative treatments. As a
condition of accelerated approval, the FDA will generally require the sponsor to perform adequate and well-controlled post-marketing clinical trials to verify and describe the anticipated effect on irreversible morbidity or mortality or other
clinical benefit. In addition, the FDA currently requires, as a condition for accelerated approval, <FONT STYLE="white-space:nowrap">pre-approval</FONT> of promotional materials, which could adversely impact the timing of the commercial launch of
the product. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Orphan Drug Designation </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Under the Orphan Drug Act, the FDA may grant orphan designation to a drug or biologic intended to treat a rare disease or condition, which is
a disease or condition that affects fewer than 200,000 individuals in the United States, or more than 200,000 individuals in the United States for which there is no reasonable expectation that the cost of developing and making available in the
United States a drug or biologic for this type of disease or condition will be recovered from sales in the United States for that drug or biologic. Orphan drug designation must be requested before submitting an NDA. After the FDA grants orphan drug
designation, the generic identity of the therapeutic agent and its potential orphan use are disclosed publicly by the FDA. The orphan drug designation does not convey any advantage in, or shorten the duration of, the regulatory review or approval
process. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">134 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If a product that has orphan drug designation subsequently receives the first FDA approval
for the disease for which it has such designation, the product is entitled to orphan drug exclusive approval (or exclusivity), which means that the FDA may not approve any other applications, including a full NDA, to market the same drug for the
same indication for seven years, except in limited circumstances, such as a showing of clinical superiority to the product with orphan drug exclusivity. Orphan drug exclusivity does not prevent the FDA from approving a different drug or biologic for
the same disease or condition, or the same drug or biologic for a different disease or condition. Among the other benefits of orphan drug designation are tax credits for certain research and a waiver of the application user fee. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">A designated orphan drug may not receive orphan drug exclusivity if it is approved for a use that is broader than the indication for which it
received orphan designation. In addition, exclusive marketing rights in the United States may be lost if the FDA later determines that the request for designation was materially defective or if the manufacturer is unable to assure sufficient
quantities of the product to meet the needs of patients with the rare disease or condition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Post-Approval Requirements </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any products manufactured or distributed by us pursuant to FDA approvals are subject to pervasive and continuing regulation by the FDA,
including, among other things, requirements relating to record-keeping, reporting of adverse experiences, periodic reporting, product sampling and distribution, and advertising and promotion of the product. After approval, most changes to the
approved product, such as adding new indications or other labeling claims, are subject to prior FDA review and approval. There also are continuing user fee requirements, under which FDA assesses an annual program fee for each product identified in
an approved NDA. Drug manufacturers and their subcontractors are required to register their establishments with the FDA and certain state agencies, and are subject to periodic unannounced inspections by the FDA and certain state agencies for
compliance with cGMP, which impose certain procedural and documentation requirements upon us and our third-party manufacturers. Changes to the manufacturing process are strictly regulated, and, depending on the significance of the change, may
require prior FDA approval before being implemented. FDA regulations also require investigation and correction of any deviations from cGMP and impose reporting requirements upon us and any third-party manufacturers that we may decide to use.
Accordingly, manufacturers must continue to expend time, money and effort in the area of production and quality control to maintain compliance with cGMP and other aspects of regulatory compliance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The FDA may withdraw approval if compliance with regulatory requirements and standards is not maintained or if problems occur after the
product reaches the market. Later discovery of previously unknown problems with a product, including adverse events of unanticipated severity or frequency, or with manufacturing processes, or failure to comply with regulatory requirements, may
result in revisions to the approved labeling to add new safety information; imposition of post-market studies or clinical trials to assess new safety risks; or imposition of distribution restrictions or other restrictions under an REMS program.
Other potential consequences include, among other things: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">restrictions on the marketing or manufacturing of a product, complete withdrawal of the product from the market
or product recalls; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">fines, warning letters or holds on post-approval clinical trials; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">refusal of the FDA to approve pending applications or supplements to approved applications, or suspension or
revocation of existing product approvals; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">product seizure or detention, or refusal of the FDA to permit the import or export of products; or
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">injunctions or the imposition of civil or criminal penalties. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">135 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The FDA closely regulates the marketing, labeling, advertising and promotion of biologics
and drugs. A company can make only those claims relating to safety and efficacy, purity and potency that are approved by the FDA and in accordance with the provisions of the approved label. However, companies may share truthful and not misleading
information that is otherwise consistent with a product&#146;s FDA approved labeling. The FDA and other agencies actively enforce the laws and regulations prohibiting the promotion of <FONT STYLE="white-space:nowrap">off-label</FONT> uses. Failure
to comply with these requirements can result in, among other things, adverse publicity, warning letters, corrective advertising and potential civil and criminal penalties. Physicians may prescribe legally available products for uses that are not
described in the product&#146;s labeling and that differ from those tested by us and approved by the FDA. Such <FONT STYLE="white-space:nowrap">off-label</FONT> uses are common across medical specialties. Physicians may believe that such <FONT
STYLE="white-space:nowrap">off-label</FONT> uses are the best treatment for patients in varied circumstances. The FDA does not regulate the behavior of physicians in their choice of treatments. The FDA does, however, restrict manufacturer&#146;s
communications on the subject of <FONT STYLE="white-space:nowrap">off-label</FONT> use of their products. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>FDA Regulation of Companion Diagnostics
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">A therapeutic product may rely upon an in vitro companion diagnostic for use in selecting the patients that will be more likely
to respond to that therapy. If an in vitro diagnostic is essential to the safe and effective use of the therapeutic product, then the FDA generally will require approval or clearance of the diagnostic at the same time that the FDA approves the
therapeutic product. According to FDA guidance, a companion diagnostic device used to make treatment decisions in clinical trials of a drug generally will be considered an investigational device unless it is employed for an intended use for which
the device is already approved or cleared. If used to make critical treatment decisions, such as patient selection, the diagnostic device generally will be considered a significant risk device under the FDA&#146;s Investigational Device Exemption
(&#147;IDE&#148;), regulations. Thus, the sponsor of the diagnostic device will be required to comply with the IDE regulations. According to the guidance, if a diagnostic device and a drug are to be studied together to support their respective
approvals, both products can be studied in the same investigational trial, if the trial meets both the requirements of the IDE regulations and the IND regulations. The guidance provides that depending on the details of the trial plan and subjects, a
sponsor may seek to submit an IND alone, or both an IND and an IDE. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuing FDA approval of an in vitro companion diagnostic would
require either a <FONT STYLE="white-space:nowrap">pre-market</FONT> notification, also called 510(k) clearance, or a <FONT STYLE="white-space:nowrap">pre-market</FONT> approval (&#147;PMA&#148;), for that diagnostic. The review of companion
diagnostics involves coordination of review with the FDA&#146;s Center for Devices and Radiological Health. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The PMA process, including
the gathering of clinical and nonclinical data and the submission to and review by the FDA, can take several years or longer. The applicant must prepare and provide the FDA with reasonable assurance of the device&#146;s safety and effectiveness,
including information about the device and its components regarding, among other things, device design, manufacturing and labeling. PMA applications are subject to an application fee. In addition, PMAs for devices must generally include the results
from extensive preclinical and adequate and well-controlled clinical trials to establish the safety and effectiveness of the device for each indication for which FDA approval is sought. In particular, for a diagnostic, the applicant must demonstrate
that the diagnostic produces reproducible results. As part of the PMA review, the FDA will typically inspect the manufacturer&#146;s facilities for compliance with the Quality System Regulation (&#147;QSR&#148;), which imposes elaborate testing,
control, documentation and other quality assurance requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>U.S. Patent Term Restoration and Marketing Exclusivity </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The term of a patent depends upon the laws of the country in which it is issued. In most jurisdictions, a patent term is 20 years from the
earliest filing date of a <FONT STYLE="white-space:nowrap">non-provisional</FONT> patent application. Depending upon the timing, duration and specifics of the FDA approval of our drug candidates, one or more issued U.S. patents we obtain may be
eligible for limited patent term extension under the Drug Price Competition and Patent Term Restoration Act of 1984, commonly referred to as the Hatch-Waxman Amendments. The Hatch-Waxman Amendments permit a patent restoration term of up to five
years beyond the normal expiration of the patent, limited to the approved indication (or any additional indications approved during the period of extension), as compensation for patent term lost during the
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">136 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
FDA regulatory review process. The patent term restoration period granted on a patent covering a product is generally <FONT STYLE="white-space:nowrap">one-half</FONT> the time between the
effective date of an IND and the submission date of an NDA, plus the time between the submission date of an NDA and the ultimate approval date of that application. However, patent term restoration cannot extend the remaining term of a patent beyond
a total of 14 years from the product&#146;s approval date. Only one patent applicable to an approved product is eligible for extension and only those claims covering the approved product, a method for using it, or a method for manufacturing it may
be extended. Additionally, the application for the extension must be submitted prior to the expiration of the patent in question. A patent that covers multiple products for which approval is sought can only be extended in connection with one of the
approvals. The USPTO, in consultation with the FDA, reviews and approves the application for any patent term extension or restoration. In the future, we intend to apply for restoration of patent term for an issued patent we own, and if eligible for
such restoration, to add patent term beyond its current expiration date, depending on the expected length of the clinical trials and other factors involved in the filing of the relevant NDA. There can be no assurance that any of our pending patent
applications will be issued or that we will benefit from any patent term extension. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Marketing exclusivity provisions under the United
States Federal Food, Drug, and Cosmetic Act (&#147;FDCA&#148;) can also delay the submission or the approval of certain marketing applications for competing products. The FDCA provides a five-year period of
<FONT STYLE="white-space:nowrap">non-patent</FONT> marketing exclusivity within the United States to the first applicant to obtain approval of an NDA for a new chemical entity. A drug is a new chemical entity if the FDA has not previously approved
any other new drug containing the same active moiety, which is the molecule or ion responsible for the action of the drug substance. During the exclusivity period, the FDA may not accept for review an abbreviated new drug application
(&#147;ANDA&#148;), or a 505(b)(2) NDA submitted by another company for another drug based on the same active moiety, regardless of whether the drug is intended for the same indication as the original innovator drug or for another indication.
However, an application may be submitted after four years if it contains a certification of patent invalidity or <FONT STYLE="white-space:nowrap">non-infringement</FONT> to one of the patents listed with the FDA by the innovator NDA holder. The FDCA
also provides three years of marketing exclusivity for an NDA, or supplement to an existing NDA, if new clinical investigations, other than bioavailability studies, that were conducted or sponsored by the applicant are deemed by the FDA to be
essential to the approval of the application, for example new indications, dosages or strengths of an existing drug. This three-year exclusivity covers only the modification for which the drug received approval on the basis of the new clinical
investigations and does not prohibit the FDA from approving ANDAs or 505(b)(2) applications for drugs containing the active agent for the original indication or condition of use. Five-year and three-year exclusivity will not delay the submission or
approval of a full NDA. However, an applicant submitting a full NDA would be required to conduct or obtain a right of reference to all of the preclinical studies and adequate and well-controlled clinical trials necessary to demonstrate safety and
effectiveness. Orphan drug exclusivity, as described below, may offer a seven-year period of marketing exclusivity, except in certain circumstances. Pediatric exclusivity is another type of regulatory market exclusivity in the United States.
Pediatric exclusivity, if granted, adds six months to existing exclusivity periods and patent terms. This <FONT STYLE="white-space:nowrap">six-month</FONT> exclusivity, which runs from the end of other exclusivity protection or patent term, may be
granted based on the voluntary completion of a pediatric trial in accordance with an <FONT STYLE="white-space:nowrap">FDA-issued</FONT> &#147;Written Request&#148; for such a trial. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Drug Development </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In
Europe, our future drugs may also be subject to extensive regulatory requirements. As in the United States, medicinal products can only be marketed if a marketing authorization from the competent regulatory agencies has been obtained. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Similar to the United States, the various phases of preclinical and clinical research in Europe are subject to significant regulatory
controls. Although the EU Clinical Trials Directive 2001/20/EC has sought to harmonize the European Union clinical trials regulatory framework, setting out common rules for the control and authorization of clinical trials in the European Union, the
European Union Member States have transposed and applied the provisions of the Directive differently. This has led to significant variations in the member state </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">137 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
regimes. Under the current regime, before a clinical trial can be initiated it must be approved in each of the European Union countries where the trial is to be conducted by two distinct bodies:
the National Competent Authority (&#147;NCA&#148;), and one or more Ethics Committees (&#147;ECs&#148;). Under the current regime, all suspected unexpected serious adverse reactions to the investigated drug that occur during the clinical trial have
to be reported to the NCA and ECs of the Member State where they occurred. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In 2014, a new Clinical Trials Regulation 536/2014, replacing
the current Directive, was adopted. The new Regulation will become directly applicable in all EU Member States (without national implementation) once the EU Portal and Database are fully functional. It is expected that the Regulation will apply in
2019. The new Regulation seeks to simplify and streamline the approval of clinical trials in the European Union. For example, the sponsor shall submit a single application for approval of a clinical trial via the EU Portal. As part of the
application process, the sponsor shall propose a reporting Member State, who will coordinate the validation and evaluation of the application. The reporting Member State shall consult and coordinate with the other concerned Member States. If an
application is rejected, it can be amended and resubmitted through the EU Portal. If an approval is issued, the sponsor can start the clinical trial in all concerned Member States. However, a concerned Member State can in limited circumstances
declare an <FONT STYLE="white-space:nowrap">&#147;opt-out&#148;</FONT> from an approval. In such a case, the clinical trial cannot be conducted in that Member State. The Regulation also aims to streamline and simplify the rules on safety reporting
and introduces enhanced transparency requirements such as mandatory submission of a summary of the clinical trial results to the EU Database. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Drug Review and Approval </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the European Economic Area (&#147;EEA&#148;), which is comprised of the 28 Member States of the European Union plus Norway, Iceland and
Liechtenstein, medicinal products can only be commercialized after obtaining a Marketing Authorization (&#147;MA&#148;). There are two types of marketing authorizations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Community MA, which is issued by the European Commission through the Centralized Procedure, based on the opinion of the Committee for
Medicinal Products for Human Use (&#147;CHMP&#148;), of the EMA and which is valid throughout the entire territory of the EEA. The Centralized Procedure is mandatory for certain types of drugs, such as biotechnology medicinal drugs, orphan medicinal
drugs, and medicinal drugs containing a new active substance indicated for the treatment of AIDS, cancer, neurodegenerative disorders, diabetes, autoimmune and viral diseases. The Centralized Procedure is optional for drugs containing a new active
substance not yet authorized in the EEA, or for drugs that constitute a significant therapeutic, scientific or technical innovation or which are in the interest of public health in the European Union. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">National MAs, which are issued by the competent authorities of the Member States of the EEA and only cover their respective territory, are
available for drugs not falling within the mandatory scope of the Centralized Procedure. Where a drug has already been authorized for marketing in a Member State of the EEA, this National MA can be recognized in other Member States through the
Mutual Recognition Procedure. If the drug has not received a National MA in any Member State at the time of application, it can be approved simultaneously in various Member States through the Decentralized Procedure. Under the Decentralized
Procedure, an identical dossier is submitted to the competent authorities of each of the Member States in which the MA is sought, one of which is selected by the applicant as the Reference Member State (&#147;RMS&#148;). The competent authority of
the RMS prepares a draft assessment report, a draft summary of the drug characteristics (&#147;SPC&#148;), and a draft of the labeling and package leaflet, which are sent to the other Member States (&#147;Member States Concerned&#148;) for their
approval. If the Member States Concerned raise no objections, based on a potential serious risk to public health, to the assessment, SPC, labeling, or packaging proposed by the RMS, the drug is subsequently granted a national MA in all the Member
States (i.e. in the RMS and the Member States Concerned). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Under the above-described procedures, before granting the MA, the EMA or the
competent authorities of the Member States of the EEA make an assessment of the risk-benefit balance of the drug on the basis of scientific criteria concerning its quality, safety and efficacy. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">138 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Chemical Entity Exclusivity </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In Europe, new chemical entities, sometimes referred to as new active substances, qualify for eight years of data exclusivity upon marketing
authorization and an additional two years of market exclusivity. This data exclusivity, if granted, prevents regulatory authorities in the European Union from referencing the innovator&#146;s data to assess a generic application for eight years,
after which generic marketing authorization can be submitted, and the innovator&#146;s data may be referenced, but not approved for two years. The overall <FONT STYLE="white-space:nowrap">ten-year</FONT> period will be extended to a maximum of 11
years if, during the first eight years of those ten years, the marketing authorization holder obtains an authorization for one or more new therapeutic indications which, during the scientific evaluation prior to their authorization, are held to
bring a significant clinical benefit in comparison with existing therapies. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>European Union General Data Protection Regulation </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition to EU regulations related to the approval and commercialization of our products, we may be subject to the EU&#146;s General Data
Protection Regulation (&#147;GDPR&#148;). The GDPR went into effect on May&nbsp;25, 2018. The GDPR introduced new data protection requirements in the European Union, as well as potential fines for noncompliant companies of up to the greater of
&#128;20&nbsp;million or 4% of annual global revenue. The regulation imposes numerous new requirements for the collection, use, storage and disclosure of personal information, including more stringent requirements relating to consent and the
information that must be shared with data subjects about how their personal information is used, the obligation to notify regulators and affected individuals of personal data breaches, extensive new internal privacy governance obligations and
obligations to honor expanded rights of individuals in relation to their personal information (e.g., the right to access, correct and delete their data). In addition, the GDPR includes restrictions on cross-border data transfers. The GDPR increased
our responsibility and liability in relation to personal data that we process, and we may be required to put in place additional mechanisms to ensure compliance with the new EU data protection rules. Further, the United Kingdom&#146;s vote in favor
of exiting the EU, often referred to as Brexit, has created uncertainty with regard to data protection regulation in the United Kingdom. In particular, it is unclear whether the United Kingdom will enact data protection legislation equivalent to the
GDPR and how data transfers to and from the United Kingdom will be regulated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rest of the World Regulation </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For other countries outside of the European Union and the United States, such as countries in Eastern Europe, Latin America or Asia, the
requirements governing the conduct of clinical trials, drug licensing, pricing and reimbursement vary from country to country. In all cases the clinical trials must be conducted in accordance with GCP requirements and the applicable regulatory
requirements and the ethical principles that have their origin in the Declaration of Helsinki. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If we fail to comply with applicable
foreign regulatory requirements, we may be subject to, among other things, fines, suspension or withdrawal of regulatory approvals, product recalls, seizure of products, operating restrictions and criminal prosecution. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Coverage and Reimbursement </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Sales
of our drugs will depend, in part, on the extent to which our drugs will be covered by third-party payors, such as government health programs, commercial insurance and managed healthcare organizations. These third-party payors are increasingly
reducing reimbursements for medical drugs and services. Additionally, the containment of healthcare costs has become a priority of federal and state governments, and the prices of drugs have been a focus in this effort. The U.S. government, state
legislatures and foreign governments have shown significant interest in implementing cost-containment programs, including price controls, restrictions on reimbursement and requirements for substitution of generic drugs. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">139 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">There may be significant delays in obtaining coverage and reimbursement for newly approved
drugs, and coverage may be more limited than the purposes for which the drug is approved by the FDA or similar regulatory authorities outside of the United States. Moreover, eligibility for coverage and reimbursement does not imply that a drug will
be paid for in all cases or at a rate that covers our costs, including research, development, intellectual property protection, manufacture, sale and distribution expenses. Interim reimbursement levels for new drugs, if applicable, may also not be
sufficient to cover our costs and may not be made permanent. Reimbursement rates may vary according to the use of the drug and the clinical setting in which it is used, may be based on reimbursement levels already set for lower-cost drugs and may be
incorporated into existing payments for other services. Net prices for drugs may be reduced by mandatory discounts or rebates required by government healthcare programs or private payors and by any future relaxation of laws that presently restrict
imports of drugs from countries where they may be sold at lower prices than in the United States. Third-party payors often rely upon Medicare coverage policy and payment limitations in setting their own reimbursement policies, but also have their
own methods and approval process apart from Medicare determinations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We plan to develop, either by ourselves or with collaborators, in
vitro companion diagnostic tests for our drug candidates for certain indications. We, or our collaborators, will be required to obtain coverage and reimbursement for these tests separate and apart from the coverage and reimbursement we seek for our
drug candidates, once approved. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, in some foreign countries, the proposed pricing for a drug must be approved before it may be
lawfully marketed. The requirements governing drug pricing vary widely from country to country. For example, the European Union provides options for its member states to restrict the range of medicinal drugs for which their national health insurance
systems provide reimbursement and to control the prices of medicinal drugs for human use. A member state may approve a specific price for the medicinal drug or it may instead adopt a system of direct or indirect controls on the profitability of the
company placing the medicinal drug on the market. There can be no assurance that any country that has price controls or reimbursement limitations for pharmaceutical drugs will allow favorable reimbursement and pricing arrangements for any of our
drugs. Historically, drugs launched in the European Union do not follow price structures of the United States and generally tend to be significantly lower. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Healthcare Reform </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the United
States and some foreign jurisdictions, there have been a number of legislative and regulatory changes and proposed changes regarding the healthcare system that could prevent or delay marketing approval of drug candidates, restrict or regulate
post-approval activities and affect a biopharmaceutical company&#146;s ability to profitably sell any approved drugs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Medicare
Prescription Drug, Improvement, and Modernization Act of 2003 (&#147;MMA&#148;) established the Medicare Part D program to provide a voluntary prescription drug benefit to Medicare beneficiaries. Under Part D, Medicare beneficiaries may enroll in
prescription drug plans offered by private entities that provide coverage of outpatient prescription drugs. Unlike Medicare Parts A and B, Part D coverage is not standardized. Part D prescription drug plan sponsors are not required to pay for all
covered Part D drugs, and each drug plan can develop its own drug formulary that identifies which drugs it will cover and at what tier or level. However, Part D prescription drug formularies must include drugs within each therapeutic category and
class of covered Part D drugs, though not necessarily all the drugs in each category or class. Any formulary used by a Part D prescription drug plan must be developed and reviewed by a pharmacy and therapeutic committee. Government payment for some
of the costs of prescription drugs may increase demand for drugs for which we obtain marketing approval. However, any negotiated prices for our drugs covered by a Part D prescription drug plan will likely be lower than the prices we might otherwise
obtain. Moreover, while the MMA applies only to drug benefits for Medicare beneficiaries, private third-party payors often follow Medicare coverage policy and payment limitations in setting their own payment rates. Any reduction in payment that
results from the MMA may result in a similar reduction in payments from <FONT STYLE="white-space:nowrap">non-governmental</FONT> third-party payors. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">140 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The American Recovery and Reinvestment Act of 2009 provides funding for the federal
government to compare the effectiveness of different treatments for the same illness. The plan for the research was published in 2012 by the U.S. Department of Health and Human Services (&#147;HHS&#148;), the Agency for Healthcare Research and
Quality and the National Institutes for Health, and periodic reports on the status of the research and related expenditures are made to Congress. Although the results of the comparative effectiveness studies are not intended to mandate coverage
policies for public or private third-party payors, it is not clear what effect, if any, the research will have on the sales of our drug candidates, if any such drug or the condition that they are intended to treat are the subject of a trial. It is
also possible that comparative effectiveness research demonstrating benefits in a competitor&#146;s drug could adversely affect the sales of our drug candidate. If third-party payors do not consider our drugs to be cost-effective compared to other
available therapies, they may not cover our drugs after approval as a benefit under their plans or, if they do, the level of payment may not be sufficient to allow us to sell our drugs on a profitable basis. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Patient Protection and Affordable Care Act, as amended by the Health Care and Education Reconciliation Act of 2010 (&#147;ACA&#148;)
enacted in March 2010, has had a significant impact on the healthcare industry. The ACA expanded coverage for the uninsured while at the same time containing overall healthcare costs. With regard to pharmaceutical products, the ACA, among other
things, addressed a new methodology by which rebates owed by manufacturers under the Medicaid Drug Rebate Program are calculated for drugs that are inhaled, infused, instilled, implanted or injected, increased the minimum Medicaid rebates owed by
manufacturers under the Medicaid Drug Rebate Program and extended the rebate program to individuals enrolled in Medicaid managed care organizations, established annual fees and taxes on manufacturers of certain branded prescription drugs, and a new
Medicare Part D coverage gap discount program, in which manufacturers must now agree to offer 70% <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discounts off negotiated prices of applicable brand drugs
to eligible beneficiaries during their coverage gap period, as a condition for the manufacturer&#146;s outpatient drugs to be covered under Medicare Part D. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Some of the provisions of the ACA have yet to be fully implemented, while certain provisions have been subject to judicial and Congressional
challenges as well as recent efforts by the current U.S. President&#146;s administration to repeal or replace certain aspects of the ACA. Since January 2017, the current U.S. President has signed two Executive Orders and other directives designed to
delay the implementation of certain provisions of the ACA or otherwise circumvent some of the requirements for health insurance mandated by the ACA. Concurrently, Congress has considered legislation that would repeal or repeal and replace all or
part of the ACA. While Congress has not passed comprehensive repeal legislation, it has enacted laws that modify certain provisions of the ACA such as removing penalties, starting January&nbsp;1, 2019, for not complying with the ACA&#146;s
individual mandate to carry health insurance, delaying the implementation of certain <FONT STYLE="white-space:nowrap">ACA-mandated</FONT> fees, and increasing the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">point-of-sale</FONT></FONT> discount that is owed by pharmaceutical manufacturers who participate in Medicare Part D. On December&nbsp;14, 2018, a U.S. District Court Judge in the
Northern District of Texas (Texas District Court Judge), ruled that the individual mandate is a critical and inseverable feature of the ACA, and therefore, because it was repealed as part of the Tax Cuts and Jobs Act, the remaining provisions of the
ACA are invalid as well. While the Texas District Court Judge, as well as the current U.S. President&#146;s administration and the Centers for Medicare&nbsp;&amp; Medicaid Services (&#147;CMS&#148;), have stated that the ruling will have no
immediate effect, it is unclear how this decision, subsequent appeals, and other efforts to repeal and replace the ACA will impact the ACA. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, other legislative changes have been proposed and adopted in the United States since the ACA was enacted. On August&nbsp;2, 2011,
the Budget Control Act of 2011, among other things, created measures for spending reductions by Congress. A Joint Select Committee on Deficit Reduction, tasked with recommending a targeted deficit reduction of at least $1.2 trillion for the years
2013 through 2021, was unable to reach required goals, thereby triggering the legislation&#146;s automatic reduction to several government programs. This includes aggregate reductions to Medicare payments to providers of up to 2% per fiscal year,
started in April 2013, and, due to subsequent legislative amendments, will stay in effect through 2027 unless additional congressional action is taken. On January&nbsp;2, 2013, the <FONT STYLE="white-space:nowrap">then-U.S.</FONT> President signed
into law the American Taxpayer Relief Act of 2012 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">141 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
(&#147;ATRA&#148;), which, among other things, also reduced Medicare payments to several providers, including hospitals, imaging centers and cancer treatment centers, and increased the statute of
limitations period for the government to recover overpayments to providers from three to five years. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Further, there has been heightened
governmental scrutiny recently over the manner in which drug manufacturers set prices for their marketed products, which has resulted in several congressional inquiries and proposed and enacted federal and state legislation designed to, among other
things, bring more transparency to product pricing, review the relationship between pricing and manufacturer patient programs, and reform government program reimbursement methodologies for drug products. For example, the current U.S.
President&#146;s administration released a &#147;Blueprint&#148; to lower drug prices and reduce out-of-pocket costs of drugs that contains additional proposals to increase manufacturer competition, increase the negotiating power of certain federal
healthcare programs, incentivize manufacturers to lower the list price of their products and reduce the out-of-pocket costs of drug products paid by consumers. For example, in October 2018, CMS proposed a new rule that would require <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">direct-to-consumer</FONT></FONT> television advertisements of prescription drugs and biological products, for which payment is available through or under Medicare or Medicaid, to include in
the advertisement the Wholesale Acquisition Cost, or list price, of that drug or biological product. On January&nbsp;31, 2019, the HHS Office of Inspector General, proposed modifications to the federal Anti-Kickback Statute discount safe harbor for
the purpose of reducing the cost of drug products to consumers which, among other things, if finalized, will affect discounts paid by manufacturers to Medicare Part D plans, Medicaid managed care organizations and pharmacy benefit managers working
with these organizations. Although some of these and other proposed measures may require additional authorization to become effective, Congress and the current U.S. President&#146;s administration has each indicated that it will continue to seek new
legislative and/or administrative measures to control drug costs. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Additionally, on May&nbsp;30, 2018, the Trickett Wendler, Frank
Mongiello, Jordan McLinn, and Matthew Bellina Right to Try Act of 2017 (&#147;Right to Try Act&#148;) was signed into law. The law, among other things, provides a federal framework for certain patients to access certain investigational new drug
products that have completed a Phase&nbsp;1 clinical trial and that are undergoing investigation for FDA approval. Under certain circumstances, eligible patients can seek treatment without enrolling in clinical trials and without obtaining FDA
permission under the FDA expanded access program. There is no obligation for a pharmaceutical manufacturer to make its drug products available to eligible patients as a result of the Right to Try Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Other Healthcare Laws </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may
also be subject to healthcare regulation and enforcement by the federal government and the states and foreign governments where we may market our drug candidates, if approved. These laws include, without limitation, state and federal anti-kickback,
fraud and abuse, false claims, privacy and security and physician sunshine laws and regulations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The federal Anti-Kickback Statute
prohibits, among other things, any person from knowingly and willfully offering, soliciting, receiving or paying remuneration, directly or indirectly, to induce either the referral of an individual, for an item or service or the purchasing or
ordering of a good or service, for which payment may be made under federal healthcare programs such as the Medicare and Medicaid programs. The federal Anti-Kickback Statute is subject to evolving interpretations. In the past, the government has
enforced the federal Anti-Kickback Statute to reach large settlements with healthcare companies based on sham consulting and other financial arrangements with physicians. A person or entity does not need to have actual knowledge of the statute or
specific intent to violate it in order to have committed a violation. In addition, the government may assert that a claim including items or services resulting from a violation of the federal Anti-Kickback Statute constitutes a false or fraudulent
claim for purposes of the False Claims Act. The majority of states also have anti-kickback laws, which establish similar prohibitions and in some cases may apply to items or services reimbursed by any third-party payor, including commercial
insurers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">142 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Additionally, the federal civil and criminal false claims laws, including the False Claims
Act, and civil monetary penalties law, prohibits knowingly presenting or causing the presentation of a false, fictitious or fraudulent claim for payment to the U.S. government. Actions under the False Claims Act may be brought by the Attorney
General or as a qui tam action by a private individual in the name of the government. The federal government is using the False Claims Act, and the accompanying threat of significant liability, in its investigation and prosecution of pharmaceutical
and biotechnology companies throughout the United States, for example, in connection with the promotion of products for unapproved uses and other sales and marketing practices. The government has obtained multi-million and multi-billion dollar
settlements under the False Claims Act in addition to individual criminal convictions under applicable criminal statutes. Given the significant size of actual and potential settlements, it is expected that the government will continue to devote
substantial resources to investigating healthcare providers&#146; and manufacturers&#146; compliance with applicable fraud and abuse laws. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The federal Health Insurance Portability and Accountability Act of 1996 (&#147;HIPAA&#148;) also created additional federal civil and criminal
penalties for, among other actions, knowingly and willfully executing, or attempting to execute, a scheme to defraud any healthcare benefit program, including private third-party payors, knowingly and willfully embezzling or stealing from a
healthcare benefit program, willfully obstructing a criminal investigation of a healthcare offense, and knowingly and willfully falsifying, concealing or covering up a material fact or making any materially false, fictitious or fraudulent statement
in connection with the delivery of or payment for healthcare benefits, items or services. Similar to the federal Anti-Kickback Statute, a person or entity does not need to have actual knowledge of the statute or specific intent to violate it in
order to have committed a violation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">There has also been a recent trend of increased federal and state regulation of payments made to
physicians and other healthcare providers. The ACA, through the Physician Payments Sunshine Act, imposes new reporting requirements on drug manufacturers for payments made by them to physicians and teaching hospitals, as well as ownership and
investment interests held by physicians and their immediate family members. Drug manufacturers are required to submit annual reports to the government and these reports are posted on a website maintained by CMS. Certain states also mandate
implementation of compliance programs, impose restrictions on drug manufacturer marketing practices and/or require the tracking and reporting of gifts, compensation and other remuneration to physicians. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may also be subject to data privacy and security requirements that may impact the way in which we conduct research and operate our
business. HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act (&#147;HITECH&#148;), and their respective implementing regulations, including the final omnibus rule published on January&nbsp;25, 2013, impose
obligations, including mandatory contractual terms, with respect to safeguarding the privacy, security and transmission of individually identifiable health information on covered entities, including certain healthcare providers, health plans, and
healthcare clearinghouses, as well as individuals and entities that provide services on behalf of a covered entity that involve individually identifiable health information, known as business associates. In addition, we may be directly subject to
certain state laws concerning data privacy and security. For example, California recently enacted the California Consumer Privacy Act (&#147;CPPA&#148;), which creates new individual privacy rights for California consumers (as defined in the law)
and places increased privacy and security obligations on entities handling certain personal data of consumers or households. The CCPA will require covered companies to provide new disclosure to consumers about such companies&#146; data collection,
use and sharing practices, provide such consumers new ways to <FONT STYLE="white-space:nowrap">opt-out</FONT> of certain sales or transfers of personal information, and provide consumers with additional causes of action. The CCPA goes into effect on
January&nbsp;1, 2020, and the California Attorney General may bring enforcement actions for violations beginning July&nbsp;1, 2020. The CCPA was amended on September&nbsp;23, 2018, and it remains unclear what, if any, further modifications will be
made to this legislation or how it will be interpreted. As currently written, the CCPA may impact our business activities and exemplifies the vulnerability of our business to the evolving regulatory environment related to personal data and protected
health information. Existing state laws governing the privacy and security of personally identifiable information, and, in some states, health information, impose differing requirements, thus complicating our compliance efforts. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">143 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Legal Proceedings </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">From time to time, we are involved in various legal proceedings arising from the normal course of business activities. We are not presently a
party to any litigation the outcome of which, we believe, if determined adversely to us, would individually or taken together have a material adverse effect on our business, operating results, cash flows, or financial condition. Defending such
proceedings is costly and can impose a significant burden on management and employees, we may receive unfavorable preliminary or interim rulings in the course of litigation, and there can be no assurances that favorable final outcomes will be
obtained. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Employees </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of
September 15, 2019, we had 64 full-time employees, with 54 in research and development and 10 in general and administrative functions. As of June 30, 2019, 28 of our full-time employees had completed a Ph.D. or other advanced science or medical
degree. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">None of our employees is represented by a labor union or covered by collective bargaining agreements, and we have not
experienced any work stoppages. We consider our relations with our employees to be good. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Our Facilities </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our corporate headquarters are located in South San Francisco, California, and comprise approximately 36,754 square feet of space, pursuant to
an operating lease that expires in November 2026. This lease includes an option to extend for a further eight years, at market rates that prevail at the time of our election to extend. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We believe that these facilities are sufficient to meet our current needs. We also believe we will be able to obtain additional space, as
needed, on commercially reasonable terms. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">144 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_12"></A>MANAGEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table sets forth information for our executive officers and directors as of September 15, 2019: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="33%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="63%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Age</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Position</B></P></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Executive Officers</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Wong, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">President, Chief Executive Officer and Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">54</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Medical Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dirk Brockstedt, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chief Scientific Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Eric Hall, CFA</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Interim Chief Financial Officer and Secretary</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Key Employees</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David Wustrow, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Senior Vice President, Drug Discovery and Preclinical Development</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paul Kassner, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">53</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President, Quantitative and Computational Biology</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Karen C. Lam</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">46</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Vice President, Finance and Corporate Controller</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Rieflin<SUP STYLE="font-size:85%; vertical-align:top">(1)(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Chair of the Board of Directors</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael F. Giordano, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David V. Goeddel, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Linda Kozick<SUP STYLE="font-size:85%; vertical-align:top">(1)(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wendye Robbins, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(1)(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">58</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">Director</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the audit committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the compensation committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Member of the nominating and corporate governance committee. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In September 2019, Dr. Robbins was designated as a member of the board of directors and replaced
Dr.&nbsp;Giordano on the audit committee. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Officers </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>Brian Wong, M.D., Ph.D. </I></B>has served as a member of our board of directors and as our Chief Executive Officer since August 2015
and as our President since June 2019. From January 2009 to August 2015, he served as Vice President of Immunology and Discovery Research and most recently as Senior Vice President, Research and Head of Immuno-Oncology at Five Prime Therapeutics,
Inc., a biopharmaceutical company. From 2005 to 2009, he served as Director of Research in the Inflammation Disease Biology Area at F. <FONT STYLE="white-space:nowrap">Hoffmann-La</FONT> Roche Ltd., a pharmaceutical company. Dr.&nbsp;Wong received
an M.D. from Weill Cornell Medical College and a Ph.D. in Immunology from Rockefeller University. Dr.&nbsp;Wong obtained a B.A. in Chemistry and Biochemistry from Oberlin College. We believe that Dr.&nbsp;Wong&#146;s extensive experience in the life
sciences industry and his medical and scientific training provide him with the qualifications and skills to serve on our board of directors and as our President and Chief Executive Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>William Ho, M.D., Ph.D. </I></B>has served as our Chief Medical Officer since May 2015. From October 2012 to June 2016, he served as the
Vice President of Clinical Development at Igenica Biotherapeutics, Inc., a pharmaceutical company. From September 2005 to September 2012, he served in several positions up to Senior Medical Director in the Exploratory Clinical Development
(BioOncology) group at Genentech, Inc., a biotechnology company. Dr. Ho completed his internship and residency in Internal Medicine at the University of California, San Francisco, and received his fellowship training in Medical Oncology at the
University of Washington and Fred Hutchinson Cancer Research Center. Dr.&nbsp;Ho received an M.D. and a Ph.D. in Microbiology and Immunology from Stanford University and an A.B. in Molecular Biology from Princeton University. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">145 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>Dirk Brockstedt, Ph.D. </I></B>has served as our Chief Scientific Officer since June
2019. Prior to that he served as our Senior Vice President, Biology from January 2018 to June 2019. Since October 2017, he has also served as Executive in Residence at ShangPharma Innovation Inc., a healthcare investment company. From September 2011
to December 2017, he served as Senior Vice President of Research and Development and most recently as Executive Vice President of Research and Development at Aduro Biotech, Inc., a biopharmaceutical company. Dr. Brockstedt served as Director of
Research at Anza Therapeutics, Inc. from 2007 to 2009, Director of Immunology at Cerus Corporation from 2002 to 2007 and Senior Research Scientist at Aventis Pharmaceuticals, Inc. from 1999 to 2002, each a biopharmaceutical company. Prior to that he
was a post-doctoral fellow at the Stanford School of Medicine in the Department of Pathology. Dr.&nbsp;Brockstedt received a Ph.D. in Microbiology from the University of Kiel (graduate work performed at Stanford University) and an M.S. in
Microbiology from the University of Kiel. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>Eric Hall, CFA</I></B> has served as our interim Chief Financial Officer and Secretary
since March 2019 through his capacity as a partner at FLG Partners, LLC (&#147;FLG Partners&#148;), a Silicon Valley chief financial officer services firm. Mr.&nbsp;Hall has served as a partner at FLG Partners since 2004. In his capacity as a
partner at FLG Partners, Mr.&nbsp;Hall has served as Chief Financial Officer at ALX Oncology Inc., a biotechnology company, since October 2018, and at 4Info, Inc., an advertising company, since April 2018. He served as Chief Financial Officer at
uBiome, Inc. (&#147;uBiome&#148;), a biotechnology company, from September 2018 to December 2018. Prior to uBiome, Mr.&nbsp;Hall served as Chief Financial Officer at Peninsula Clean Energy from August 2018 to October&nbsp;2018. He served as Chief
Financial Officer at Lightning Bolt Solutions, Inc., a software company, from May 2018 to January 2019. He served as Chief Financial Officer at E2 Consulting Engineers, Inc., an engineering services company, from August 2017 to March 2018.
Mr.&nbsp;Hall served as Chief Financial Officer at Singulex, Inc., a medical equipment company, from February 2016 to December 2017. He served as Chief Financial Officer at Xambala Incorporated (&#147;Xambala&#148;), a financial technology company,
from June 2015 to November 2015. Prior to Xambala, he served as Chief Financial Officer at Visionnaire Ventures, LLC, an investment firm, from March 2014 to August 2015. Mr.&nbsp;Hall has been a Chartered Financial Analyst (CFA) charterholder since
1990. Mr.&nbsp;Hall obtained an M.B.A. in Finance from Vanderbilt University and an A.B. in Economics from the University of California, Davis. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Key
Employees </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>David Wustrow, Ph.D. </I></B>has served as our Senior Vice President of Drug Discovery and Preclinical Development
since January 2019. Prior to that, he served as our Vice President, Drug Discovery from February 2016 to January 2019. From June 2012 to February 2016, he served as Vice President of Chemical and Pharmaceutical Sciences at Cleave Biosciences, Inc.,
a biopharmaceutical company. Previously, he held several escalating positions at biotechnology and pharmaceutical companies, including XenoPort Inc., where he served as Vice President, Medicinal Chemistry from 2008 to 2011 and as Executive Director
of Scientific Assessment and Licensing in 2012, Neurogen Technologies, Inc., where he served as Executive Director of Chemistry from 2005 to 2008, and Pfizer Inc., where he served as Senior Director of Neuroscience Chemistry from 2003 to 2005. Prior
to that, Dr. Wustrow held positions of increasing responsibility at Pfizer Inc. and Parke Davis-Warner Lambert. Dr.&nbsp;Wustrow received an M.S. in Chemistry and a Ph.D. in Organic Synthesis from the University of Rochester. Dr.&nbsp;Wustrow
obtained a B.S. in Chemistry from Pennsylvania State University. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>Paul Kassner, Ph.D. </I></B>has served as our Vice President of
Quantitative and Computational Biology since January 2016. From January 2003 to December 2015 he served at Amgen, Inc., a biopharmaceutical company, most recently as Director of Research and Head of the Genome Analysis Unit. Dr.&nbsp;Kassner held
positions of increasing responsibility at multiple biotechnology companies from 1997 to 2003, including Selective Genetics, Inc., Zyomyx, Inc., Pointilliste, Inc. and Tularik Inc. Dr.&nbsp;Kassner completed his postdoctoral training at UC San Diego,
and received a Ph.D. in Immunology from Harvard University and a B.S. in Genetics and Development from the University of Illinois at Champaign-Urbana. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>Karen C. Lam </I></B>has served as our Vice President, Finance and Corporate Controller since June 2019. Prior to that, she was our
Senior Director, Finance and Corporate Controller from September 2017 to June 2019. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">146 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
From August 2013 to September 2017, Ms. Lam was Senior Director, Controller of True North Therapeutics, Inc., a biotechnology company. From September 2009 to August 2013, she was Director,
Controller at iPierian Inc., a development stage biotechnology company. Ms. Lam is a Certified Public Accountant (inactive) and received a B.S. in Business Administration from San Francisco State University. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>William J. Rieflin, J.D. </I></B>has served on our board of directors since April 2016 and as the chair of our board of directors since
June 2019. From September 2010 to September 2018, he served as the Chief Executive Officer of NGM Biopharmaceuticals. From 2004 until 2010, Mr. Rieflin served as President of XenoPort, Inc., a biotechnology company. Mr. Rieflin also serves as
Executive Chairman of the board of directors of NGM Biopharmaceuticals. Mr. Rieflin previously served on the board of directors of Anacor Pharmaceuticals, Inc., a pharmaceutical company, from April 2011 to June 2016 and of XenoPort, Inc. from
September 2010 to July 2016. Mr.&nbsp;Rieflin obtained a J.D. from Stanford Law School and an M.B.A. from the University of Chicago. Mr.&nbsp;Rieflin received a B.S. in Industrial and Labor Relations from Cornell University. We believe that Mr.
Rieflin&#146;s extensive experience in the biopharmaceutical industry, his industry expertise and financial knowledge, and his experience as a member of the board of directors of other public companies provide him with the qualifications and skills
to serve as a director of our company. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>Michael F. Giordano, M.D. </I></B>has served on our board of directors since January
2018. From 1999 to 2017, Dr.&nbsp;Giordano worked at Bristol-Myers Squibb Co., a pharmaceutical company, most recently serving as Senior Vice President and Head of Development of Oncology and Immuno-Oncology. Dr.&nbsp;Giordano also serves on the
board of directors of Epizyme, Inc., a biopharmaceutical company. He received an M.D. from Weil Cornell Medical College and a B.A. in Natural Science from Johns Hopkins University. We believe that Dr.&nbsp;Giordano&#146;s extensive experience in
oncology and immuno-oncology provide him with the qualifications and skills to serve as a director of our company. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>David V.
Goeddel, Ph.D. </I></B>has served on our board of directors since April 2015. Dr.&nbsp;Goeddel has been a Managing Partner of The Column Group, LLC, a venture capital partnership, since 2007. Prior to that, he served as Amgen&#146;s first Senior
Scientific Vice President until May 2006. Dr.&nbsp;Goeddel <FONT STYLE="white-space:nowrap">co-founded</FONT> Tularik Inc., a biotechnology company, in November 1991 and served as Vice President of Research there until 1996 and Chief Executive
Officer from 1996 through 2004. Dr.&nbsp;Goeddel also serves on the board of directors of NGM Biopharmaceuticals, Inc. and Peloton Therapeutics, Inc., both biopharmaceutical companies. Dr.&nbsp;Goeddel obtained a Ph.D. in Biochemistry from the
University of Colorado, Boulder and a B.A. in Chemistry from the University of California, San Diego. We believe that Dr.&nbsp;Goeddel&#146;s scientific training and experience as a director of other publicly traded and privately held
biopharmaceutical companies provide him with the qualifications and skills to serve as a director of our company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>Linda Kozick
</I></B>has served on our board of directors since December 2016. From January 2011 to July 2015, Ms.&nbsp;Kozick served as Head of Immuno-Oncology, Oncology Product and Portfolio Strategy for Opdivo and Yervoy Life Cycle Management at Bristol-Myers
Squibb Co. Ms.&nbsp;Kozick obtained an M.B.A. from Chapman University. Ms.&nbsp;Kozick also received an M.S. in Molecular Immunology and a B.S. in Medical Technology from SUNY Upstate Medical University. We believe that Ms.&nbsp;Kozick&#146;s
experience in the biopharmaceutical industry and her technical training provide her with the qualifications and skills to serve as a director of our company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B><I>Wendye Robbins</I></B>, <B><I>M.D. </I></B>has served on our board of directors since September 2019. She has served as President and
CEO of Blade Therapeutics since August 2016 (and previously held the title of Interim CEO from May 2015 to July 2016). Dr. Robbins has also served as an independent consultant to venture investors in company formation and translational biology. Dr.
Robbins has also served on the faculty at Stanford University School of Medicine in the Department of Anesthesia, Perioperative Care, and Pain Medicine since 2004. Dr.&nbsp;Robbins completed her residency in Anesthesiology at Johns Hopkins
University School of Medicine, her internship in Internal Medicine at the University of Pennsylvania School of Medicine, and received her </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">147 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
fellowship training in Pain Medicine from John Hopkins University School of Medicine. Dr. Robbins received an M.D. from The Medical College of Pennsylvania and a B.S. in Business Administration
from the Haas School of Business at the University of California, Berkeley. We believe that Dr. Robbins&#146; extensive experience in the biopharmaceutical industry, her industry expertise and financial knowledge provide her with the qualifications
and skills to serve as a director of our company. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Family Relationships </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">There are no family relationships among any of our executive officers or directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Composition of Our Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our business and affairs are managed under the direction of our board of directors. We currently have six directors. After the closing of this
offering, the number of directors will be fixed by our board of directors, subject to the terms of our amended and restated certificate of incorporation and amended and restated bylaws that will become effective upon the closing of this offering.
Each of our current directors will continue to serve as a director until the election and qualification of his or her successor, or until his or her earlier death, resignation or removal. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our board of directors may establish the authorized number of directors from time to time by resolution. In accordance with our amended and
restated certificate of incorporation that will be in effect upon the closing of this offering, immediately after this offering our board of directors will be divided into three classes with staggered three-year terms. At each annual general meeting
of stockholders, the successors to directors whose terms then expire will be elected to serve from the time of election and qualification until the third annual meeting following election. Our directors will be divided among the three classes as
follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Class&nbsp;I directors will be Dr. Wong and Dr. Goeddel, and their terms will expire at our first annual
meeting of stockholders following this offering; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Class&nbsp;II directors will be Mr. Rieflin and Ms. Kozick, and their terms will expire at our second annual
meeting of stockholders following this offering; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the Class&nbsp;III directors will be Dr. Giordano and Dr. Robbins, and their terms will expire at our third
annual meeting of stockholders following this offering. </P></TD></TR></TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect that any additional directorships resulting from
an increase in the number of directors will be distributed among the three classes so that, as nearly as possible, each class will consist of one-third of the directors. The division of our board of directors into three classes with staggered
three-year terms may delay or prevent a change of our management or a change in control. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Director Independence </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our board of directors has undertaken a review of the independence of each director. Based on information provided by each director concerning
his or her background, employment and affiliations, our board of directors has determined that Dr.&nbsp;Giordano, Dr. Goeddel, Ms.&nbsp;Kozick, Mr.&nbsp;Rieflin and Dr. Robbins do not have relationships that would interfere with the exercise of
independent judgment in carrying out the responsibilities of a director and that each of these directors is &#147;independent&#148; as that term is defined under the applicable listing standards. In making these determinations, our board of
directors considered the current and prior relationships that each <FONT STYLE="white-space:nowrap">non-employee</FONT> director has with our company and all other facts and circumstances our board of directors deemed relevant in determining their
independence, including the beneficial ownership of our shares held by each <FONT STYLE="white-space:nowrap">non-employee</FONT> director and the transactions described in the section titled &#147;Certain Relationships and Related Party
Transactions.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">148 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Committees of Our Board of Directors </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our board of directors has established an audit committee, a compensation committee, and a nominating and corporate governance committee. The
composition and responsibilities of each of the committees of our board of directors are described below. Members serve on these committees until their resignation or until otherwise determined by our board of directors. Our board of directors may
establish other committees as it deems necessary or appropriate from time to time. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Audit Committee </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our audit committee consists of William Rieflin, Linda Kozick and Dr. Wendye Robbins. Our board of directors has determined that each member
of the audit committee satisfies the independence requirements under the Nasdaq listing standards and Rule <FONT STYLE="white-space:nowrap">10A-3(b)(1)</FONT> of the Exchange Act. The chair of our audit committee is Dr. Robbins. Our board of
directors has determined that Mr. Rieflin and Dr. Robbins are &#147;audit committee financial experts&#148; within the meaning of SEC regulations. Each member of our audit committee can read and understand fundamental financial statements in
accordance with applicable listing standards. In arriving at these determinations, our board of directors has examined each audit committee member&#146;s scope of experience and the nature of his or her employment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The primary purpose of the audit committee is to discharge the responsibilities of our board of directors with respect to our corporate
accounting and financial reporting processes, systems of internal control and financial statement audits, and to oversee our independent registered public accounting firm. Specific responsibilities of our audit committee include: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">helping our board of directors oversee our corporate accounting and financial reporting processes;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">managing and/or assessing the selection, engagement, qualifications, independence and performance of a qualified
firm to serve as the independent registered public accounting firm to audit our financial statements; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">discussing the scope and results of the audit with the independent registered public accounting firm, and
reviewing, with management and the independent accountants, our interim and <FONT STYLE="white-space:nowrap">year-end</FONT> operating results; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing procedures for employees to submit concerns anonymously about questionable accounting or audit
matters; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing related party transactions; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing our policies on risk assessment and risk management; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing, with our independent registered public accounting firm, our internal quality control procedures, any
material issues with such procedures and any steps taken to deal with such issues; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><FONT STYLE="white-space:nowrap">pre-approving</FONT> audit and permissible
<FONT STYLE="white-space:nowrap">non-audit</FONT> services to be performed by the independent registered public accounting firm. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our audit committee will operate under a written charter, to be effective prior to the closing of this offering, that satisfies the applicable
listing standards of Nasdaq. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">149 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Compensation Committee </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our compensation committee consists of Michael Giordano and William Rieflin. The chair of our compensation committee is Dr. Giordano. Our
board of directors has determined that each member of the compensation committee satisfies the independence requirements under the listing standards of Nasdaq, and is a <FONT STYLE="white-space:nowrap">&#147;non-employee</FONT> director&#148; as
defined in Rule <FONT STYLE="white-space:nowrap">16b-3</FONT> promulgated under the Exchange Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The primary purpose of our compensation
committee is to discharge the responsibilities of our board of directors in overseeing our compensation policies, plans and programs and to review and determine the compensation to be paid to our executive officers, directors and other senior
management, as appropriate. Specific responsibilities of our compensation committee include: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending to our board of directors the compensation of our chief executive officer and other
executive officers; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and recommending to our board of directors the compensation of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">administering our equity incentive plans and other benefit programs; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing, adopting, amending and terminating incentive compensation and equity plans, severance agreements,
profit sharing plans, bonus plans, <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">change-of-control</FONT></FONT> protections and any other compensatory arrangements for our executive officers and other senior management; and
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing and establishing general policies relating to compensation and benefits of our employees, including our
overall compensation philosophy. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our compensation committee will operate under a written charter, to be effective prior
to the closing of this offering, that satisfies the applicable listing standards of Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Nominating and Corporate Governance Committee
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our nominating and corporate governance committee consists of Linda Kozick and Michael Giordano. The chair of our nominating and
corporate governance committee is Ms. Kozick. Our board of directors has determined that each member of the nominating and corporate governance committee satisfies the independence requirements under the listing standards of Nasdaq. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Specific responsibilities of our nominating and corporate governance committee include: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">identifying and evaluating candidates, including the nomination of incumbent directors for reelection and
nominees recommended by stockholders, to serve on our board of directors; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">considering and making recommendations to our board of directors regarding the composition and chairs of the
board of directors and committees of our board of directors; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">reviewing developments in corporate governance practices; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">developing and making recommendations to our board of directors regarding corporate governance guidelines and
matters; and </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">overseeing periodic evaluations of the board of directors&#146; performance, including committees of the board of
directors. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">150 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our nominating and corporate governance committee operates under a written charter, to be
effective prior to the closing of this offering, that satisfies the applicable listing standards of Nasdaq. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Code of Business Conduct and Ethics
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have adopted a code of business conduct and ethics (the &#147;Code of Conduct&#148;) that applies to our directors, officers and
employees, including our principal executive officer, principal financial officer, principal accounting officer or controller, or persons performing similar functions. Upon the closing of this offering, our code of business conduct and ethics will
be available under the Corporate Governance section of our website at www.rapt.com. In addition, we intend to post on our website all disclosures that are required by law or the listing standards of Nasdaq concerning any amendments to, or waivers
from, any provision of the Code of Conduct. The reference to our website address does not constitute incorporation by reference of the information contained at or available through our website, and you should not consider it to be a part of this
prospectus. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Compensation Committee Interlocks and Insider Participation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">None of the members of the compensation committee is currently or has been at any time one of our officers or employees. None of our executive
officers currently serves, or has served during the last year, as a member of the board of directors or compensation committee of any entity that has one or more executive officers serving as a member of our board of directors or compensation
committee. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee</FONT> Director Compensation </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In March 2018, the board of directors granted a stock option to purchase 16,666 shares of our common stock to Dr.&nbsp;Giordano and stock
options to purchase 4,166 shares of our common stock each to Ms.&nbsp;Kozick and Mr.&nbsp;Rieflin, in each case, at an exercise price per share of $6.18. The shares underlying Dr.&nbsp;Giordano&#146;s option vest in 48 equal monthly installments
measured from January&nbsp;12, 2018, subject to Dr.&nbsp;Giordano&#146;s continuous service with us as of each such vesting date. Upon a change in control, the vesting of Dr.&nbsp;Giordano&#146;s option shall accelerate in full. The shares
underlying Mr.&nbsp;Rieflin&#146;s option vest in 48 equal monthly installments measured from June&nbsp;23, 2017, subject to Mr.&nbsp;Rieflin&#146;s continuous service with us as of each such vesting date. The shares underlying
Ms.&nbsp;Kozick&#146;s option vest in 48 equal monthly installments measured from November&nbsp;15, 2017, subject to Ms.&nbsp;Kozick&#146;s continuous service with us as of each such vesting date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, we reimburse all of our <FONT STYLE="white-space:nowrap">non-employee</FONT> directors for their reasonable <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses incurred in attending board of directors and committee meetings. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table sets forth information regarding the compensation earned by or paid to our
<FONT STYLE="white-space:nowrap">non-employee</FONT> directors during fiscal 2018, other than Dr. Robbins who joined as a member of our board of directors in September 2019. The compensation earned by or paid to Dr.&nbsp;Wong as a named executive
officer for fiscal 2018 is set forth below under &#147;Executive Compensation&#151;Summary Compensation Table.&#148; </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Fees&nbsp;Earned<BR>or Paid in<BR>Cash</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Option<BR>Awards<BR>($)<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total<BR>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Beth Seidenberg, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael F. Giordano, M.D.<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">92,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David V. Goeddel, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Linda Kozick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Rieflin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts reported represent the aggregate grant date fair value of the stock options granted during fiscal
2018 under our 2015 Plan, computed in accordance with Financial Accounting Standard Board Accounting </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">151 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Standards Codification, Topic 718 (&#147;ASC Topic 718&#148;). The assumptions used in calculating the grant-date fair value of the stock options reported in this column are set forth in the
notes to our consolidated financial statements included elsewhere in this prospectus. This amount does not reflect the actual economic value that may be realized by the <FONT STYLE="white-space:nowrap">non-employee</FONT> director. As of
December&nbsp;31, 2018, the aggregate number of option awards outstanding to each of our directors was 16,666 for Dr.&nbsp;Giordano, 20,832 for Ms.&nbsp;Kozick and 9,721 for Mr.&nbsp;Rieflin (including 1,389 shares early exercised but not yet
vested). </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr. Seidenberg resigned from our board in June 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Giordano joined our board in January 2018. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts in this column represent fees for service on the Board of Directors. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">On June&nbsp;27, 2019, the board of directors granted, contingent upon the completion of this offering, stock options to purchase
7,500&nbsp;shares of our common stock each to Mr. Rieflin and Ms. Kozick, in each case, at a per share exercise price equal to the initial public offering price of our common stock. One-twelfth of the shares subject to each option will vest each
month measured from April&nbsp;7, 2019 (or December&nbsp;9, 2018 in the case of Ms.&nbsp;Kozick), subject to the applicable non-employee director&#146;s continuous service as of each such vesting date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">On September 26, 2019, the board of directors granted stock options to purchase 4,166 shares of our common stock, and an additional 3,333
shares of common stock contingent on completion of this offering, each to Mr. Rieflin and Ms. Kozick, in each case, at a per share exercise price of $13.62. One-twelfth of the shares subject to each option will vest each month measured from April 7,
2019, in the case of Mr. Rieflin, or December&nbsp;9, 2018, in the case of Ms. Kozick, subject to the applicable non-employee director&#146;s continuous service as of each such vesting date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Non-Employee&nbsp;Director&nbsp;Compensation</FONT> Policy </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have adopted <FONT STYLE="white-space:nowrap">a&nbsp;non-employee&nbsp;director</FONT> compensation policy that will become effective upon
the execution of an underwriting agreement related to this offering, pursuant to which <FONT STYLE="white-space:nowrap">our&nbsp;non-employee&nbsp;directors</FONT> will be eligible to receive compensation for service on our board of directors and
committees of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Equity Compensation </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Initial Grant </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Each <FONT
STYLE="white-space:nowrap">new&nbsp;non-employee&nbsp;director</FONT> who joins our board of directors after our initial public offering will automatically receive a nonstatutory stock option to purchase 22,500 shares of common stock under our 2019
Plan. Each initial grant will vest in a series of three successive equal annual installments over the three-year period measured from the date of grant, subject to the <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s continuous
service (as defined in our 2019 Plan) through each applicable vesting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Annual Grant </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">On the date of each annual meeting of our stockholders, each
<FONT STYLE="white-space:nowrap">continuing&nbsp;non-employee&nbsp;director</FONT> will automatically receive a nonstatutory stock option to purchase 7,500 shares of common stock under our 2019 Plan. Each annual grant will vest on the earlier of the
one year anniversary of the grant date or the day prior to the Company&#146;s next annual meeting occurring after the grant date, subject to the <FONT STYLE="white-space:nowrap">non-employee</FONT> director&#146;s continuous service through the
vesting date. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Vesting Acceleration </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event of a change of control (as defined in our 2019 Plan), any unvested portion of an equity award granted under the policy will fully
vest immediately prior to the closing of such change of control, subject to <FONT STYLE="white-space:nowrap">the&nbsp;non-employee&nbsp;director&#146;s</FONT> continuous service immediately prior to the closing of the change of control. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">152 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash Compensation </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Commencing with the first calendar quarter following our initial public offering,
<FONT STYLE="white-space:nowrap">each&nbsp;non-employee&nbsp;director</FONT> will receive an annual cash retainer of $35,000 for serving on our board of directors. The chair of our board of directors will receive an additional annual cash retainer
of $30,000. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The chairs and members of the three committees of our board of directors will be entitled to the following additional annual
cash retainers: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="55.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="62%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Board Committee</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Chair<BR>Fee</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Member<BR>Fee</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Audit Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">12,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Compensation Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">10,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Nominating and Corporate Governance Committee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">All annual cash compensation amounts will be payable in equal quarterly installments, in arrears no later than
30 days following the end of each fiscal quarter in which the service occurred,&nbsp;prorated&nbsp;for any partial quarter of service. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">153 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_13"></A>EXECUTIVE COMPENSATION </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our named executive officers for fiscal 2018, consisting of our principal executive officer and the next two most highly compensated executive
officers, were: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Brian Wong, M.D., Ph.D., our President and Chief Executive Officer; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Rekha Hemrajani, our former Chief Operating Officer; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">William Ho, M.D., Ph.D., our Chief Medical Officer. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Summary Compensation Table </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The
following table presents all of the compensation awarded to our named executive officers during fiscal 2018. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="41%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name and Principal Position</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Salary<BR>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Bonus</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Option<BR>Awards</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>($)<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B><FONT
STYLE="white-space:nowrap">Non-Equity</FONT><BR>Incentive Plan<BR>Compensation<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP><BR>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>All
Other<BR>Compensation<BR>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Wong, M.D., Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>President and Chief Executive Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">425,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">&#151;<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">865,920</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">119,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">1,409,920</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rekha Hemrajani <I></I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>former</I> <I>Chief Operating Officer</I><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">326,510</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="top" ALIGN="right">&#151;<BR></TD>
<TD NOWRAP VALIGN="top">&nbsp;<BR></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">72,160</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">75,914</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">474,584</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho, M.D., Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman"><I>Chief Medical Officer</I></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">2018</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">350,000</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">72,160</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">81,375</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD NOWRAP VALIGN="top" ALIGN="right">&#151;</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">503,535</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amounts disclosed represent the aggregate grant date fair value of the stock options granted to our named
executive officers during fiscal 2018 under our 2015 Plan, computed in accordance with ASC Topic 718. The assumptions used in calculating the grant date fair value of the stock options are set forth in the notes to our audited consolidated financial
statements included elsewhere in this prospectus. This amount does not reflect the actual economic value that may be realized by the named executive officer. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The amount disclosed represents the executive officer&#146;s total performance bonus earned for fiscal 2018 as
described below under &#147;&#151;Annual Performance-Based Bonus Opportunity.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Ms.&nbsp;Hemrajani resigned as our Chief Operating Officer as of March&nbsp;19, 2019. Pursuant to the Hemrajani
Separation Agreement with us dated March&nbsp;19, 2019 and amended April&nbsp;30, 2019, she will provide certain consulting services to us through a business entity that she owns jointly with her husband until June&nbsp;20, 2019 (unless the
consulting arrangement is earlier terminated by her or us). </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Annual Performance-Based Bonus Opportunity </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our executive officers are eligible to receive performance-based cash bonuses, which are designed to provide appropriate incentives to our
executives to achieve defined performance goals and to reward our executives for individual achievement towards these goals. The performance-based bonus each executive officer is eligible to receive is generally based on the extent to which we
achieve the corporate goals that our board or compensation committee establishes and is paid annually. Annually, the compensation committee of our board of directors reviews the company&#146;s performance and determines the actual bonus payout to be
awarded to each of our eligible executive officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">154 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Employment Arrangements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Brian Wong </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We entered into an
employment letter agreement with Dr.&nbsp;Wong, our President and Chief Executive Officer, in July 2019. His employment letter agreement has no specific term and provides that Dr.&nbsp;Wong is an <FONT STYLE="white-space:nowrap">at-will</FONT>
employee. His employment letter agreement also provides that his annual base salary is $440,000 (or $484,000 following the completion of this offering), and that he is eligible for an annual discretionary target bonus equal to 40% (or 50% following
the completion of this offering) of his annual base salary, based on the achievement of individual and corporate performance objectives. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to the employment letter agreement with Dr.&nbsp;Wong, if Dr.&nbsp;Wong&#146;s employment is terminated outside the 12 month period
following a &#147;change in control&#148; either (1)&nbsp;by us without &#147;cause&#148; (and not due to Dr.&nbsp;Wong&#146;s death or disability) or (2)&nbsp;by Dr.&nbsp;Wong for &#147;good reason&#148; (as such terms are defined in
Dr.&nbsp;Wong&#146;s employment letter agreement), then, subject to the preconditions described below, Dr.&nbsp;Wong will be entitled to receive the following payments and benefits: (i)&nbsp;continuing payments of his then-current base salary (or
the level in effect before any reduction in base salary that constitutes good reason) for a period of 12 months and (ii)&nbsp;reimbursement of premiums for coverage under the Consolidated Omnibus Budget Reconciliation Act of 1985, as amended, or
COBRA, for Dr.&nbsp;Wong and his eligible dependents, if any, for up to 12 months, or taxable monthly payments for the equivalent period in the event payment of the COBRA premiums would violate applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If Dr.&nbsp;Wong&#146;s employment is terminated during the 12 month period following a change in control either (1)&nbsp;by us without cause
(and not due to Dr.&nbsp;Wong&#146;s death or disability) or (2)&nbsp;by Dr.&nbsp;Wong for good reason, then, subject to the preconditions described below, Dr.&nbsp;Wong will be entitled to receive the following payments and benefits:
(i)&nbsp;continuing payments of his then-current base salary (or the level in effect before any reduction in base salary that constitutes good reason) for a period of 18 months; (ii)&nbsp;a lump sum cash payment equal to Dr.&nbsp;Wong&#146;s annual
discretionary target bonus; (iii)&nbsp;reimbursement of premiums for coverage under COBRA, for Dr.&nbsp;Wong and his eligible dependents, if any, for up to 18 months, or taxable monthly payments for the equivalent period in the event payment of the
COBRA premiums would violate applicable law; and (iv)&nbsp;accelerated vesting and exercisability of all outstanding equity awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The
receipt of the severance payments and benefits described above is conditioned on Dr.&nbsp;Wong timely signing and not revoking a release of claims in a form acceptable to us, as well as remaining in compliance with all continuing obligations he owes
to us, including those under the confidential information and inventions assignment agreement applicable to Dr.&nbsp;Wong. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Rekha Hemrajani
</I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Ms.&nbsp;Hemrajani&#146;s employment with us terminated on March&nbsp;19, 2019. In connection with Ms.&nbsp;Hemrajani&#146;s
termination of employment, we entered into a separation agreement with her dated March&nbsp;19, 2019. Pursuant to the separation agreement, Ms.&nbsp;Hemrajani provided certain consulting services to us through a business entity that she owns jointly
with her husband until June&nbsp;20, 2019 in exchange for consulting fees paid at a rate of $425 per hour. Pursuant to the separation agreement, the options granted to Ms.&nbsp;Hemrajani did not vest during the period she provided consulting
services to us; however, the period following her termination of employment to exercise the vested shares subject to her options was extended to June&nbsp;20, 2020. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>William Ho </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We entered into an
employment letter agreement with Dr.&nbsp;Ho, our Chief Medical Officer, in July 2019. His employment letter agreement has no specific term and provides that Dr.&nbsp;Ho is an <FONT STYLE="white-space:nowrap">at-will</FONT> employee. His employment
letter agreement also provides that his annual base salary is $360,500 (or $385,000 following the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">155 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
completion of this offering), and that he is eligible for an annual discretionary target bonus equal to 30% (or 40% following the completion of this offering) of his annual base salary, based on
the achievement of individual and corporate performance objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to the employment letter agreement with Dr.&nbsp;Ho, if
Dr.&nbsp;Ho&#146;s employment is terminated outside the 12&nbsp;month period following a &#147;change in control&#148; either (1)&nbsp;by us without &#147;cause&#148; (and not due to Dr.&nbsp;Ho&#146;s death or disability) or (2)&nbsp;by Dr.&nbsp;Ho
for &#147;good reason&#148; (as such terms are defined in Dr.&nbsp;Ho&#146;s employment letter agreement), then, subject to the preconditions described below, Dr.&nbsp;Ho will be entitled to receive the following payments and benefits:
(i)&nbsp;continuing payments of his then-current base salary (or the level in effect before any reduction in base salary that constitutes good reason) for a period of 9&nbsp;months and (ii)&nbsp;reimbursement of premiums for coverage under COBRA,
for Dr.&nbsp;Ho and his eligible dependents, if any, for up to 9&nbsp;months, or taxable monthly payments for the equivalent period in the event payment of the COBRA premiums would violate applicable law. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If Dr.&nbsp;Ho&#146;s employment is terminated during the 12&nbsp;month period following a change in control either (1)&nbsp;by us without
cause (and not due to Dr.&nbsp;Ho&#146;s death or disability) or (2)&nbsp;by Dr.&nbsp;Ho for good reason, then, subject to the preconditions described below, Dr.&nbsp;Ho will be entitled to receive the following payments and benefits:
(i)&nbsp;continuing payments of his then-current base salary (or the level in effect before any reduction in base salary that constitutes good reason) for a period of 12&nbsp;months; (ii)&nbsp;a lump sum cash payment equal to Dr.&nbsp;Ho&#146;s
annual discretionary target bonus; (iii)&nbsp;reimbursement of premiums for coverage under COBRA, for Dr.&nbsp;Ho and his eligible dependents, if any, for up to 12 months, or taxable monthly payments for the equivalent period in the event payment of
the COBRA premiums would violate applicable law; and (iv)&nbsp;accelerated vesting and exercisability of all outstanding equity awards. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The receipt of the severance payments and benefits described above is conditioned on Dr.&nbsp;Ho timely signing and not revoking a release of
claims in a form acceptable to us, as well as remaining in compliance with all continuing obligations he owes to us, including those under the confidential information and inventions assignment agreement applicable to Dr.&nbsp;Ho. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Potential Payments upon Termination or Change in Control </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Regardless of the manner in which a named executive officer&#146;s service terminates, each named executive officer is entitled to receive
amounts earned during his or her term of service, including unpaid salary and unused vacation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Wong and Dr.&nbsp;Ho are eligible
to receive potential termination or change of control payments pursuant to their employment letter agreements, as described in &#147;&#151;Executive Employment Arrangements&#151;Brian Wong&#148; and &#147;&#151;Executive Employment
Arrangements&#151;Dr.&nbsp;Ho.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">156 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Outstanding Equity Awards as of December&nbsp;31, 2018 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table presents the outstanding equity incentive plan awards held by each named executive officer as of December&nbsp;31, 2018.
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="34%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="14" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Option Awards<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Stock Awards<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Grant Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Exercisable</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number
of<BR>Securities<BR>Underlying<BR>Unexercised<BR>Options<BR>Unexercisable</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Option<BR>Exercise<BR>Price&nbsp;Per<BR>Share<BR>($)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Option<BR>Expiration<BR>Date</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number<BR>of
Shares<BR>that<BR>Have Not<BR>Vested(#)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Market<BR>Value
of<BR>Shares<BR>that<BR>Have Not<BR>Vested<BR>($)<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Wong, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">8/27/2015<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3/8/2017</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></P></TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">39,583</P></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></P></TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">52,083</P></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"><SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP>&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></P></TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">2.04</P></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman"></P></TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">3/7/2027</P></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR> <P STYLE="margin-bottom:1pt; margin-top:0pt; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">55,000</TD>
<TD NOWRAP VALIGN="top"><SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">&nbsp;</TD>
<TD VALIGN="top" ALIGN="right">346,500</TD>
<TD NOWRAP VALIGN="top">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3/28/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/27/2028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rekha Hemrajani</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6/15/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34,375</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">216,563</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">6/15/2016</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">157,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3/28/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,666</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/27/2028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5/13/2015</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,774</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,076</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">7/21/2015</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">972</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,124</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1/18/2017</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,456</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,018</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(11)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.04</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1/17/2027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">3/28/2018</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,666</TD>
<TD NOWRAP VALIGN="bottom"><SUP STYLE="font-size:85%; vertical-align:top">(12)</SUP>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3/27/2028</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Each of the equity awards was granted under the 2015 Plan, the terms of which plan is described below under
&#147;&#151;Equity Incentive Plans.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">This amount reflects the fair value of our common stock of $6.30 as of December&nbsp;31, 2018 (the
determination of the fair value by our board of directors as of the most proximate date) multiplied by the amount shown in the column &#147;Stock Awards&#151;Number of Shares that Have Not Vested.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On August&nbsp;27, 2015, Dr.&nbsp;Wong was granted an option to purchase 330,000 shares of our common stock at
a per share exercise price of $1.02. Dr.&nbsp;Wong immediately exercised the option as to all 330,000 shares subject to the option before they became vested, and such shares are subject to a repurchase right in favor of us. 25% of the shares were
released from our repurchase right on August&nbsp;27, 2016, and 1/48th of the shares will be released from our repurchase right each month thereafter, subject to Dr.&nbsp;Wong&#146;s continuous service with us. This award is subject to vesting
acceleration on the terms described in &#147;&#151;Executive Employment Arrangements&#151;Brian Wong.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of the shares subject to the option vested on January&nbsp;1, 2018, the first anniversary of the vesting
commencement date, and the remainder will vest in 36 equal monthly installments thereafter, subject to Dr.&nbsp;Wong&#146;s continuous service as of each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of the shares subject to the option vested on January&nbsp;1, 2019, the first anniversary of the vesting
commencement date, and the remainder will vest in 36 equal monthly installments thereafter, subject to Dr.&nbsp;Wong&#146;s continuous service as of each such vesting date. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On June&nbsp;15, 2016, Ms.&nbsp;Hemrajani was granted an option to purchase 91,666 shares of our common stock
at a per share exercise price of $2.04. Ms.&nbsp;Hemrajani immediately exercised the option as to all 91,666 shares subject to the option before they became vested, and such shares are subject to a repurchase right in favor of us. 25% of the shares
were released from our repurchase right on June&nbsp;15, 2017, and 1/48th of the shares will be released from our repurchase right each month thereafter, subject to Ms.&nbsp;Hemrajani&#146;s continuous service with us. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On June&nbsp;15, 2016, Ms.&nbsp;Hemrajani was granted an option to purchase 33,333 shares of our common stock
at a per share exercise price of $2.04. Ms.&nbsp;Hemrajani immediately exercised the option as to all 33,333 shares subject to the option before they became vested, and such shares are subject to a repurchase right in favor of us. On
February&nbsp;28, 2018, we repurchased 8,333 of these shares. Of the remaining 25,000 shares, 25% of the shares shall be released from our repurchase right on the satisfaction of certain performance milestones, and 1/48th of the shares will be
released from our repurchase right each month thereafter, subject to </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">157 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
Ms.&nbsp;Hemrajani&#146;s continuous service with us. As of December&nbsp;31, 2018, the performance milestones were not achieved. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of the shares subject to the option vested on January&nbsp;1, 2019, the first anniversary of the vesting
commencement date, and the remainder were scheduled to vest in 36 equal monthly installments thereafter, subject to Ms.&nbsp;Hemrajani&#146;s continuous service as of each such vesting date. However, pursuant to the separation agreement between us
and Ms.&nbsp;Hemrajani, the option ceased vesting as of March&nbsp;19, 2019, the date Ms.&nbsp;Hemrajani&#146;s employment with us terminated. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On May&nbsp;13, 2015, Dr.&nbsp;Ho was granted an option to purchase 45,833&nbsp;shares of our common stock at a
per share exercise price of $1.02. Dr.&nbsp;Ho exercised the option as to all 45,833&nbsp;shares subject to the option on July&nbsp;8, 2015, before they became vested, and such shares are subject to a repurchase right in favor of us. 25% of the
shares were released from our repurchase right on May&nbsp;15, 2016, and 1/48th of the shares will be released from our repurchase right each month thereafter, subject to Dr.&nbsp;Ho&#146;s continuous service with us. This award is subject to
vesting acceleration on the terms described in &#147;&#151;Executive Employment Arrangements&#151;William Ho.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">On July&nbsp;21, 2015, Dr.&nbsp;Ho was granted an option to purchase 6,666 shares of our common stock at a per
share exercise price of $1.02. Dr.&nbsp;Ho exercised the option as to all 6,666 shares subject to the option on July&nbsp;25, 2015, before they became vested, and such shares are subject to a repurchase right in favor of us. 25% of the shares were
released from our repurchase right on July&nbsp;14, 2016, and 1/48th of the shares will be released from our repurchase right each month thereafter, subject to Dr.&nbsp;Ho&#146;s continuous service with us. This award is subject to vesting
acceleration on the terms described in &#147;&#151;Executive Employment Arrangements&#151;William Ho.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of the shares subject to the option vested on January&nbsp;1, 2018, the first anniversary of the vesting
commencement date, and the remainder will vest in 36 equal monthly installments thereafter, subject to Dr.&nbsp;Ho&#146;s continuous service as of each such vesting date. This option is subject to vesting acceleration on the applicable terms
described in &#147;&#151;Potential Payments upon Termination or Change in Control.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(12)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">25% of the shares subject to the option vested on January&nbsp;1, 2019, the first anniversary of the vesting
commencement date, and the remainder will vest in 36 equal monthly installments thereafter, subject to Dr.&nbsp;Ho&#146;s continuous service as of each such vesting date. This option is subject to vesting acceleration on the applicable terms
described in &#147;&#151;Potential Payments upon Termination or Change in Control.&#148; </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">On June&nbsp;27, 2019, the
board of directors granted, contingent upon the completion of this offering, a stock option to purchase 83,333 shares of our common stock to Dr.&nbsp;Wong at a per share exercise price equal to the initial public offering price of our common stock.
Twenty-five percent of the shares subject to the option vest on June&nbsp;27, 2020, the first anniversary of the vesting commencement date, and the remainder will vest in 36 equal monthly installments thereafter, subject to Dr.&nbsp;Wong&#146;s
continuous service as of each such vesting date. This option is subject to vesting acceleration on the applicable terms described in &#147;&#151;Executive Employment Arrangements&#151;Brian Wong.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">On June&nbsp;27, 2019, the board of directors granted, contingent upon the completion of this offering, a stock option to purchase 22,083
shares of our common stock to Dr.&nbsp;Ho at a per share exercise price equal to the initial public offering price of our common stock. Twenty-five percent of the shares subject to the option vest on June&nbsp;27, 2020, the first anniversary of the
vesting commencement date, and the remainder will vest in 36 equal monthly installments thereafter, subject to Dr.&nbsp;Ho&#146;s continuous service as of each such vesting date. This option is subject to vesting acceleration on the applicable terms
described in &#147;&#151;Executive Employment Arrangements&#151;William Ho.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Compensation and Benefits </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Dr.&nbsp;Wong and Dr.&nbsp;Ho are eligible to participate in our employee benefit plans, including our medical, dental, vision, life,
disability and accidental death and dismemberment insurance plans, in each case on the same basis as all of our other employees. We pay the premiums for the life, disability, accidental death and dismemberment insurance for all of our employees,
including Dr.&nbsp;Wong and Dr.&nbsp;Ho. We generally do not provide perquisites or personal benefits to our named executive officers. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">158 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our named executive officers did not participate in, or earn any benefits under, any
nonqualified deferred compensation plan sponsored by us during the fiscal year ended December&nbsp;31, 2018. Our board of directors may elect to provide our officers and other employees with nonqualified deferred compensation benefits in the future
if it determines that doing so is in our best interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our named executive officers did not participate in, or otherwise receive any
benefits under, any pension or retirement plan sponsored by us during fiscal 2018. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Employee Benefit and Stock Plans </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The principal features of our equity incentive plans and 401(k) plan are summarized below. These summaries are qualified in their entirety by
reference to the actual text of the plans, which, other than the 401(k) plan, are filed as exhibits to the registration statement of which this prospectus is a part. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2019 Equity Incentive Plan </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our
board of directors adopted and our stockholders approved our 2019 Plan, on June 27, 2019, and July&nbsp;18, 2019, respectively. The 2019 Plan will become effective, and no stock awards may be granted under the 2019 Plan until immediately prior to
the execution of the underwriting agreement related to this offering. Once the 2019 Plan is effective, no further grants will be made under the 2015 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Stock Awards.</I> The 2019 Plan provides for the grant of incentive stock options (&#147;ISOs&#148;), within the meaning of
Section&nbsp;422 of the Code, nonstatutory stock options (&#147;NSOs&#148;), stock appreciation rights, restricted stock awards, restricted stock unit awards, performance-based stock awards, and other forms of equity compensation, which are
collectively referred to as stock awards. Additionally, the 2019 Plan provides for the grant of performance cash awards. ISOs may be granted only to our employees and to any of our parent or subsidiary corporation&#146;s employees. All other awards
may be granted to employees, including officers, and to <FONT STYLE="white-space:nowrap">non-employee</FONT> directors and consultants of ours and any of our affiliates. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Share Reserve.</I> Initially, the aggregate number of shares of our common stock that may be issued pursuant to stock awards under the 2019
Plan is the sum of (i) 1,786,166 new shares plus (ii)&nbsp;the number of shares reserved, and remaining available for issuance, under our 2015 Plan at the time our 2019 Plan became effective and (iii)&nbsp;the number of shares subject to stock
options or other stock awards granted under our 2015 Plan that would have otherwise returned to our 2015 Plan (such as upon the expiration or termination of a stock award prior to vesting). The number of shares of our common stock reserved for
issuance under our 2019 Plan will automatically increase on January&nbsp;1 of each year, beginning on January&nbsp;1, 2020 and continuing through and including January&nbsp;1, 2029, by 4% of the total number of shares of our capital stock
outstanding on December&nbsp;31 of the preceding calendar year, or a lesser number of shares determined by our board of directors. The maximum number of shares that may be issued upon the exercise of ISOs under our 2019 Plan is 10,445,457 shares.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If a stock award granted under the 2019 Plan expires or otherwise terminates without being exercised in full, or is settled in cash, the
shares of our common stock not acquired pursuant to the stock award again will become available for subsequent issuance under the 2019 Plan. In addition, the following types of shares under the 2019 Plan may become available for the grant of new
stock awards under the 2019 Plan: (1)&nbsp;shares that are forfeited to or repurchased by us prior to becoming fully vested; (2)&nbsp;shares withheld to satisfy income or employment withholding taxes; or (3)&nbsp;shares used to pay the exercise or
purchase price of a stock award. Shares issued under the 2019 Plan may be previously unissued shares or reacquired shares bought by us on the open market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The maximum number of shares of common stock subject to stock awards granted under the 2019 Plan or otherwise during any one calendar year to
any <FONT STYLE="white-space:nowrap">non-employee</FONT> director, taken together with any cash fees paid by us to such <FONT STYLE="white-space:nowrap">non-employee</FONT> director during such calendar year for service on the board of directors,
will not </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">159 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
exceed $750,000 in total value (calculating the value of any such stock awards based on the grant date fair value of such stock awards for financial reporting purposes), or, with respect to the
calendar year in which a <FONT STYLE="white-space:nowrap">non-employee</FONT> director is first appointed or elected to our board of directors, $1,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Administration.</I> Our board of directors, or a duly authorized committee thereof, has the authority to administer the 2019 Plan. Our
board of directors may also delegate to one or more of our officers the authority to (1)&nbsp;designate employees (other than other officers) to be recipients of certain stock awards, (2)&nbsp;determine the number of shares of common stock to be
subject to such stock awards and (3)&nbsp;specify the other terms and conditions, including the strike price or purchase price and vesting schedule, applicable to such awards. Subject to the terms of the 2019 Plan, our board of directors or the
authorized committee, referred to as the plan administrator, determines recipients, dates of grant, the numbers and types of stock awards to be granted and the terms and conditions of the stock awards, including the period of their exercisability
and the vesting schedule applicable to a stock award. Subject to the limitations set forth below, the plan administrator will also determine the exercise price, strike price or purchase price of stock awards granted and the types of consideration to
be paid for the stock award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The plan administrator has the authority to modify outstanding stock awards under our 2019 Plan. Subject to
the terms of our 2019 Plan, the plan administrator has the authority, without stockholder approval, to reduce the exercise, purchase or strike price of any outstanding stock award, cancel any outstanding stock award in exchange for new stock awards,
cash or other consideration, or take any other action that is treated as a repricing under generally accepted accounting principles, with the consent of any adversely affected participant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Stock Options.</I> ISOs and NSOs are evidenced by stock option agreements adopted by the plan administrator. The plan administrator
determines the exercise price for a stock option, within the terms and conditions of the 2019 Plan, provided that the exercise price of a stock option generally cannot be less than 100% of the fair market value of our common stock on the date of
grant. Options granted under the 2019 Plan vest at the rate specified by the plan administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The plan administrator determines the
term of stock options granted under the 2019 Plan, up to a maximum of 10 years. Unless the terms of an option holder&#146;s stock option agreement provide otherwise, if an option holder&#146;s service relationship with us, or any of our affiliates,
ceases for any reason other than disability, death or cause, the option holder may generally exercise any vested options for a period of three months following the cessation of service. The option term will automatically be extended in the event
that exercise of the option following such a termination of service is prohibited by applicable securities laws or our insider trading policy. If an option holder&#146;s service relationship with us or any of our affiliates ceases due to disability
or death, or an option holder dies within a certain period following cessation of service, the option holder or a beneficiary may generally exercise any vested options for a period of 12 months in the event of disability and 18 months in the event
of death. In the event of a termination for cause, options generally terminate immediately. In no event may an option be exercised beyond the expiration of its term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Acceptable consideration for the purchase of common stock issued upon the exercise of a stock option will be determined by the plan
administrator and may include (1)&nbsp;cash, check, bank draft or money order, (2)&nbsp;a broker-assisted cashless exercise, (3)&nbsp;the tender of shares of our common stock previously owned by the option holder, (4)&nbsp;a net exercise of the
option if it is an NSO and (5)&nbsp;other legal consideration approved by the plan administrator. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Unless the plan administrator provides
otherwise, options generally are not transferable except by will, the laws of descent and distribution, or pursuant to a domestic relations order. An option holder may designate a beneficiary, however, who may exercise the option following the
option holder&#146;s death. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Tax Limitations on ISOs.</I> The aggregate fair market value, determined at the time of grant, of our
common stock with respect to ISOs that are exercisable for the first time by an option holder during any calendar year under </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">160 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
all of our stock plans may not exceed $100,000. Options or portions thereof that exceed such limit will be treated as NSOs. No ISOs may be granted to any person who, at the time of the grant,
owns or is deemed to own stock possessing more than 10% of our total combined voting power or that of any of our parent or subsidiary corporations unless (1)&nbsp;the option exercise price is at least 110% of the fair market value of the stock
subject to the option on the date of grant and (2)&nbsp;the term of the ISO does not exceed five years from the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Awards.</I> Restricted stock awards are evidenced by restricted stock award agreements adopted by the plan administrator.
Restricted stock awards may be granted in consideration for (1)&nbsp;cash, check, bank draft or money order, (2)&nbsp;services rendered to us or our affiliates or (3)&nbsp;any other form of legal consideration. Common stock acquired under a
restricted stock award may, but need not, be subject to a share repurchase option in our favor in accordance with a vesting schedule as determined by the plan administrator. Rights to acquire shares under a restricted stock award may be transferred
only upon such terms and conditions as set by the plan administrator. Except as otherwise provided in the applicable award agreement, restricted stock awards that have not vested will be forfeited upon the participant&#146;s cessation of continuous
service for any reason. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Restricted Stock Unit Awards.</I> Restricted stock unit awards are evidenced by restricted stock unit award
agreements adopted by the plan administrator. Restricted stock unit awards may be granted in consideration for any form of legal consideration or for no consideration. A restricted stock unit award may be settled by cash, delivery of stock, a
combination of cash and stock as deemed appropriate by the plan administrator, or in any other form of consideration set forth in the restricted stock unit award agreement. Additionally, dividend equivalents may be credited in respect of shares
covered by a restricted stock unit award. Rights under a restricted stock unit award may be transferred only upon such terms and conditions as set by the plan administrator. Restricted stock unit awards may be subject to vesting as determined by the
plan administrator. Except as otherwise provided in the applicable award agreement, restricted stock units that have not vested will be forfeited upon the participant&#146;s cessation of continuous service for any reason. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Stock Appreciation Rights.</I> Stock appreciation rights are evidenced by stock appreciation grant agreements adopted by the plan
administrator. The plan administrator determines the strike price for a stock appreciation right, which generally cannot be less than 100% of the fair market value of our common stock on the date of grant. Upon the exercise of a stock appreciation
right, we will pay the participant an amount in cash or stock equal to (1)&nbsp;the excess of the per share fair market value of our common stock on the date of exercise over the strike price, multiplied by (2)&nbsp;the number of shares of common
stock with respect to which the stock appreciation right is exercised. A stock appreciation right granted under the 2019 Plan vests at the rate specified in the stock appreciation right agreement as determined by the plan administrator. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The plan administrator determines the term of stock appreciation rights granted under the 2019 Plan, up to a maximum of 10 years. Unless the
terms of a participant&#146;s stock appreciation right agreement provides otherwise, if a participant&#146;s service relationship with us or any of our affiliates ceases for any reason other than cause, disability or death, the participant may
generally exercise any vested stock appreciation right for a period of three months following the cessation of service. The stock appreciation right term will be further extended in the event that exercise of the stock appreciation right following
such a termination of service is prohibited by applicable securities laws. If a participant&#146;s service relationship with us, or any of our affiliates, ceases due to disability or death, or a participant dies within a certain period following
cessation of service, the participant or a beneficiary may generally exercise any vested stock appreciation right for a period of 12 months in the event of disability and 18 months in the event of death. In the event of a termination for cause,
stock appreciation rights generally terminate immediately upon the occurrence of the event giving rise to the termination of the individual for cause. In no event may a stock appreciation right be exercised beyond the expiration of its term. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Unless the plan administrator provides otherwise, stock appreciation rights generally are not transferable except by will, the laws of descent
and distribution, or pursuant to a domestic relations order. A stock appreciation right holder may designate a beneficiary, however, who may exercise the stock appreciation right following the holder&#146;s death. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">161 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Performance Awards.</I> Our 2019 Plan permits the grant of performance-based stock and
cash awards. The performance goals that may be selected include one or more of the following: (1)&nbsp;earnings (including earnings per share and net earnings); (2) earnings before interest, taxes and depreciation; (3)&nbsp;earnings before interest,
taxes, depreciation and amortization; (4)&nbsp;earnings before interest, taxes, depreciation, amortization and legal settlements; (5)&nbsp;earnings before interest, taxes, depreciation, amortization, legal settlements and other income (expense); (6)
earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense) and stock-based compensation; (7)&nbsp;earnings before interest, taxes, depreciation, amortization, legal settlements, other income (expense),
stock-based compensation and changes in deferred revenue; (8)&nbsp;total stockholder return; (9)&nbsp;return on equity or average stockholder&#146;s equity; (10)&nbsp;return on assets, investment, or capital employed; (11)&nbsp;stock price;
(12)&nbsp;margin (including gross margin); (13) income (before or after taxes); (14) operating income; (15)&nbsp;operating income after taxes; <FONT STYLE="white-space:nowrap">(16)&nbsp;pre-tax</FONT> profit; (17)&nbsp;operating cash flow;
(18)&nbsp;sales or revenue targets; (19)&nbsp;increases in revenue or product revenue; (20)&nbsp;expenses and cost reduction goals; (21)&nbsp;improvement in or attainment of working capital levels; (22)&nbsp;economic value added (or an equivalent
metric); (23) market share; (24)&nbsp;cash flow; (25)&nbsp;cash flow per share; (26)&nbsp;share price performance; (27)&nbsp;debt reduction; (28)&nbsp;implementation or completion of projects or processes; (29)&nbsp;stockholders&#146; equity;
(30)&nbsp;capital expenditures; (31)&nbsp;debt levels; (32)&nbsp;operating profit or net operating profit; (33)&nbsp;workforce diversity; (34)&nbsp;growth of net income or operating income; (35)&nbsp;billings; (36) bookings; (37)&nbsp;employee
retention; (38)&nbsp;user satisfaction; (39)&nbsp;the number of users, including unique users; (40)&nbsp;budget management; (41)&nbsp;partner satisfaction; (42)&nbsp;entry into or completion of strategic partnerships or transactions (including <FONT
STYLE="white-space:nowrap">in-licensing</FONT> and <FONT STYLE="white-space:nowrap">out-licensing</FONT> of intellectual property); and (43)&nbsp;other measures of performance selected by our board of directors or a committee thereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The performance goals may be based on company-wide performance or performance of one or more business units, divisions, affiliates, or
business segments, and may be either absolute or relative to the performance of one or more comparable companies or the performance of one or more relevant indices. Unless specified otherwise in the award agreement at the time the award is granted
or in such other document setting forth the performance goals at the time the goals are established, we will appropriately make adjustments in the method of calculating the attainment of performance goals as follows: (1)&nbsp;to exclude
restructuring and/or other nonrecurring charges; (2)&nbsp;to exclude exchange rate effects; (3)&nbsp;to exclude the effects of changes to generally accepted accounting principles; (4)&nbsp;to exclude the effects of any statutory adjustments to
corporate tax rates; (5)&nbsp;to exclude the effects of any items that are unusual in nature or occur infrequently as determined under generally accepted accounting principles; (6)&nbsp;to exclude the dilutive effects of acquisitions or joint
ventures; (7)&nbsp;to assume that any business divested by us achieved performance objectives at targeted levels during the balance of a performance period following such divestiture; (8)&nbsp;to exclude the effect of any change in the outstanding
shares of our common stock by reason of any stock dividend or split, stock repurchase, reorganization, recapitalization, merger, consolidation, <FONT STYLE="white-space:nowrap">spin-off,</FONT> combination or exchange of shares or other similar
corporate change, or any distributions to common stockholders other than regular cash dividends; (9)&nbsp;to exclude the effects of stock-based compensation and the award of bonuses under our bonus plans; (10)&nbsp;to exclude costs incurred in
connection with potential acquisitions or divestitures that are required to be expensed under generally accepted accounting principles; (11)&nbsp;to exclude the goodwill and intangible asset impairment charges that are required to be recorded under
generally accepted accounting principles; and (12)&nbsp;to exclude the effect of any other unusual, nonrecurring gain or loss or other extraordinary item. In addition, we retain the discretion to adjust or eliminate the compensation or economic
benefit due upon attainment of the goals. The performance goals may differ from participant to participant and from award to award. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Other Stock Awards.</I> The plan administrator may grant other awards based in whole or in part by reference to our common stock. The plan
administrator will set the number of shares under the stock award and all other terms and conditions of such awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Changes to
Capital Structure.</I> If there is a specified type of change in our capital structure, such as a stock split or recapitalization, appropriate adjustments will be made to (1)&nbsp;the class and maximum number of shares reserved for issuance under
the 2019 Plan, (2)&nbsp;the class and maximum number of shares by which the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">162 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
share reserve may increase automatically each year, (3)&nbsp;the class and number of shares that may be issued upon the exercise of ISOs and (4)&nbsp;the class and number of shares and exercise
price, strike price, or purchase price, if applicable, of all outstanding stock awards. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Corporate Transactions.</I> In the event of
certain specified significant corporate transactions, the plan administrator has the discretion to take any of the following actions with respect to stock awards: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">arrange for the assumption, continuation or substitution of a stock award by a surviving or acquiring entity or
parent company; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">arrange for the assignment of any reacquisition or repurchase rights held by us to the surviving or acquiring
entity or parent company; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">accelerate the vesting of the stock award and provide for its termination prior to the effective time of the
corporate transaction; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">arrange for the lapse of any reacquisition or repurchase right held by us; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cancel or arrange for the cancellation of the stock award in exchange for such cash consideration, if any, as our
board of directors may deem appropriate; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">make a payment equal to the excess of (1)&nbsp;the value of the property the participant would have received upon
exercise of the stock award over (2)&nbsp;the exercise price or strike price otherwise payable in connection with the stock award. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our plan administrator is not obligated to treat all stock awards, even those that are of the same type, in the same manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Under the 2019 Plan, a significant corporate transaction is generally the consummation of (1)&nbsp;a sale or other disposition of all or
substantially all of our consolidated assets, (2)&nbsp;a sale or other disposition of at least 50% of our outstanding securities, (3)&nbsp;a merger, consolidation or similar transaction following which we are not the surviving corporation or
(4)&nbsp;a merger, consolidation or similar transaction following which we are the surviving corporation but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of
the transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Change in Control.</I> The plan administrator may provide, in an individual award agreement or in any other written
agreement between a participant and us that the stock award will be subject to additional acceleration of vesting and exercisability or settlement in the event of a change in control. Under the 2019 Plan, a change in control is generally
(1)&nbsp;the acquisition by a person or entity of more than 50% of our combined voting power other than by merger, consolidation or similar transaction, (2)&nbsp;a consummated merger, consolidation or similar transaction immediately after which our
stockholders do not own more than 50% of the combined voting power of the surviving entity (or its parent company), (3) a consummated sale, lease or exclusive license or other disposition of all or substantially all of our consolidated assets and
(4)&nbsp;certain dissolutions, liquidations and changes in the board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Amendment and Termination.</I> Our board of
directors has the authority to amend, suspend or terminate our 2019 Plan, provided that such action does not materially impair the existing rights of any participant without such participant&#146;s written consent and provided further that certain
types of amendments will require the approval of our stockholders. No ISOs may be granted after the tenth anniversary of the date our board of directors adopts our 2019 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">163 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2019 Employee Stock Purchase Plan </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our board of directors adopted the ESPP on June 27, 2019 and our stockholders approved the ESPP on July 18, 2019. The ESPP will become
effective immediately prior to and contingent upon the date of the underwriting agreement related to this offering. The purpose of the ESPP is to secure the services of new employees, to retain the services of existing employees and to provide
incentives for such individuals to exert maximum efforts toward our success and that of our affiliates. The ESPP is intended to qualify as an &#147;employee stock purchase plan&#148; within the meaning of Section&nbsp;423 of the Code. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Share Reserve</I>. Following this offering, the ESPP will authorize the issuance of 240,336 shares of our common stock pursuant to purchase
rights granted to our employees or to employees of any of our designated affiliates. The number of shares of our common stock reserved for issuance will automatically increase on January&nbsp;1 of each calendar year, from January&nbsp;1, 2020
(assuming the ESPP becomes effective in 2019) through January&nbsp;1, 2029, by the lesser of (1) 1% of the total number of shares of our common stock outstanding on December&nbsp;31 of the preceding calendar year, and (2) 240,336 shares; provided,
that prior to the date of any such increase, our board of directors may determine that such increase will be less than the amount set forth in clauses (1)&nbsp;and (2). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Administration</I>. Our board of directors intends to delegate concurrent authority to administer the ESPP to our compensation committee.
The ESPP is implemented through a series of offerings under which eligible employees are granted purchase rights to purchase shares of our common stock on specified dates during such offerings. Under the ESPP, we may specify offerings with durations
of not more than 27 months and may specify shorter purchase periods within each offering. Each offering will have one or more purchase dates on which shares of our common stock will be purchased for employees participating in the offering. An
offering under the ESPP may be terminated under certain circumstances. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Payroll Deductions</I>. Generally, all regular employees,
including executive officers, employed by us or by any of our designated affiliates, may participate in the ESPP and may contribute, normally through payroll deductions, up to 15% of their earnings (as defined in the ESPP) for the purchase of our
common stock under the ESPP. Unless otherwise determined by our board of directors, common stock will be purchased for the accounts of employees participating in the ESPP at a price per share equal to the lower of (a)&nbsp;85% of the fair market
value of a share of our common stock on the first trading date of an offering or (b)&nbsp;85% of the fair market value of a share of our common stock on the date of purchase. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Limitations.</I> Employees may have to satisfy one or more of the following service requirements before participating in the ESPP, as
determined by our board of directors, including: (1)&nbsp;being customarily employed for more than 20 hours per week; (2)&nbsp;being customarily employed for more than five months per calendar year; or (3)&nbsp;continuous employment with us or one
of our affiliates for a period of time (not to exceed two years). No employee may purchase shares under the ESPP at a rate in excess of $25,000 worth of our common stock based on the fair market value per share of our common stock at the beginning
of an offering for each year such a purchase right is outstanding. Finally, no employee will be eligible for the grant of any purchase rights under the ESPP if immediately after such rights are granted, such employee has voting power over 5% or more
of our outstanding capital stock measured by vote or value pursuant to Section&nbsp;424(d) of the Code. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Changes to Capital
Structure</I>. If there occurs a change in our capital structure through such actions as a stock split, merger, consolidation, reorganization, recapitalization, reincorporation, stock dividend, dividend in property other than cash, large
nonrecurring cash dividend, liquidating dividend, combination of shares, exchange of shares, change in corporate structure or similar transaction, the board of directors will make appropriate adjustments to (1)&nbsp;the number of shares reserved
under the ESPP, (2)&nbsp;the maximum number of shares by which the share reserve may increase automatically each year, (3)&nbsp;the number of shares and purchase price of all outstanding purchase rights and (4)&nbsp;the number of shares that are
subject to purchase limits under ongoing offerings. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">164 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Corporate Transactions</I>. In the event of certain significant corporate transactions,
including (1)&nbsp;a sale of all or substantially all of our assets, (2)&nbsp;the sale or disposition of 50% of our outstanding securities, (3)&nbsp;the consummation of a merger or consolidation where we do not survive the transactions and
(4)&nbsp;the consummation of a merger or consolidation where we do survive the transaction but the shares of our common stock outstanding immediately prior to such transaction are converted or exchanged into other property by virtue of the
transaction, any then-outstanding rights to purchase our stock under the ESPP may be assumed, continued or substituted for by any surviving or acquiring entity (or its parent company). If the surviving or acquiring entity (or its parent company)
elects not to assume, continue or substitute for such purchase rights, then the participants&#146; accumulated payroll contributions will be used to purchase shares of our common stock within ten business days prior to such corporate transaction,
and such purchase rights will terminate immediately. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>ESPP Amendments, Termination</I>. Our board of directors has the authority to
amend or terminate our ESPP, provided that except in certain circumstances such amendment or termination may not materially impair any outstanding purchase rights without the holder&#146;s consent. We will obtain stockholder approval of any
amendment to our ESPP, as required by applicable law or listing requirements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>2015 Stock Plan </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our board of directors adopted and our stockholders approved our 2015 Plan in April 2015. Our 2015 Plan has been periodically amended, most
recently in December 2018. Our 2015 Plan will be terminated prior to the closing of this offering, and thereafter we will not grant any additional awards under our 2015 Plan. However, our 2015 Plan will continue to govern the terms and conditions of
the outstanding awards previously granted thereunder. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2019, stock options covering 1,049,976 shares of our common
stock with a weighted-average exercise price of $6.11 per share were outstanding, and 477,758 shares of our common stock remained available for the future grant of awards under our 2015 Plan. Any shares of our common stock remaining available for
issuance under our 2015 Plan when our 2019 Plan becomes effective will become available for issuance under our 2019 Plan. In addition, after the effective date of our 2019 Plan, any shares subject to options granted under our 2015 Plan that expire
or terminate prior to exercise or are withheld to satisfy tax withholding obligations related to the option or the exercise price of the option, will be added to the number of shares then available for issuance under our 2019 Plan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Administration</I>. Our board of directors or a committee delegated by our board of directors administers our 2015 Plan. Subject to the
terms of our 2015 Plan, the administrator has the authority and discretion to take any actions it deems necessary or advisable for the administration of our 2015 Plan, including modifying outstanding options or cancelling outstanding options in
return for a new option or a different type of award for the same or a different number of shares and at the same or a different exercise price (if applicable). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Options</I>. The exercise price per share of all options granted under our 2015 Plan must be at least 100% of the fair market value per
share of our common stock on the grant date. The term of an option may not exceed ten years. An incentive stock option to be granted to an employee who owns more than 10% of the total combined voting power of all classes of our stock or any of our
parent or subsidiary corporations may not have a term exceeding five years and must have a per share exercise price of at least 110% of the fair market value per share of our common stock on the grant date. After the termination of service of an
employee, director or consultant, he or she may exercise his or her option for the period of time stated in his or her option agreement. In the absence of a specified time in an option agreement, if termination is due to death or disability, the
option will remain exercisable for twelve months or six months, respectively. In all other cases, in the absence of a specified time in an option agreement, the option will remain exercisable for three months following the termination of service. An
option may not be exercised later than the expiration of its term. Subject to the provisions of our 2015 Plan, the administrator determines the other terms of options, including any vesting and exercisability requirements and the method of payment
of the option exercise price. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">165 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Changes to Capital Structure. </I>In the event there is a specified type of change in our
capital structure, such as a subdivision, combination or consolidation of our outstanding stock, appropriate adjustments will be made to (i)&nbsp;the number and kind of shares available for issuance under our 2015 Plan and (ii)&nbsp;the number and
kind of shares covered by and the exercise price of each outstanding option granted under our 2015 Plan. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Corporate Transactions.</I>
In the event we are a party to a merger or consolidation, or in the event of a sale of all or substantially all of our stock or assets, each outstanding option will be treated as our board of directors determines, which treatment may include one or
more of the following: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">continuation, assumption, or substitution of the option by the surviving corporation or the parent of the
surviving corporation; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cancellation of the option and a payment to the optionholder with respect to each share subject to the vested
portion of the option as of the transaction date equal to the excess of (i)&nbsp;the value, as determined by our board of directors, of the property (including cash) received by the holder of a share of our common stock as a result of the
transaction over (ii)&nbsp;the per share exercise price of the option; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">cancellation of the option without the payment of any consideration, provided the optionholder must be notified
of such treatment and given at least five business days preceding the effective date of the transaction to exercise his or her option to the extent vested (unless a shorter period is required to permit a timely closing of the transaction and such
shorter period still offers the optionholder a reasonable opportunity to exercise his or her option); </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">suspension of the optionholder&#146;s right to exercise his or her option during a limited period of time
preceding the closing of the transaction if such suspension is administratively necessary to permit the closing of the transaction; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">termination of any right the optionholder has to exercise the option prior to vesting in the shares subject to
the option; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">acceleration of the vesting and exercisability of the option. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our board of directors is not obligated to treat all options in the same manner. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><I>Plan Amendment or Termination</I>. Our board of directors may amend, suspend or terminate our 2015 Plan at any time. To the extent required
by applicable law, any amendment to our 2015 Plan will be subject to stockholder approval. The termination or amendment of our 2015 Plan may not affect any option previously granted under our 2015 Plan. As discussed above, we will terminate our 2015
Plan prior to the closing of this offering and no new awards will be granted thereunder following such termination. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>401(k) Plan </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We maintain a 401(k) plan that provides eligible U.S. employees with an opportunity to save for retirement on a tax advantaged basis. Eligible
employees are able to defer eligible compensation up to certain Code limits, which are updated annually. We have the ability to make matching and discretionary contributions to the 401(k) plan. Currently, we do not make matching contributions or
discretionary contributions to the 401(k) plan. The 401(k) plan is intended to be qualified under Section&nbsp;401(a) of the Code, with the related trust intended to be tax exempt under Section&nbsp;501(a) of the Code. As a <FONT
STYLE="white-space:nowrap">tax-qualified</FONT> retirement plan, contributions to the 401(k) plan are deductible by us when made, and contributions and earnings on those amounts are not generally taxable to the employees until withdrawn or
distributed from the 401(k) plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">166 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Limitations of Liability and Indemnification Matters </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Upon the closing of this offering, our amended and restated certificate of incorporation will contain provisions that limit the liability of
our current and former directors for monetary damages to the fullest extent permitted by Delaware law. Delaware law provides that directors of a corporation will not be personally liable for monetary damages for any breach of fiduciary duties as
directors, except liability for: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any breach of the director&#146;s duty of loyalty to the corporation or its stockholders; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any act or omission not in good faith or that involves intentional misconduct or a knowing violation of law;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">unlawful payments of dividends or unlawful stock repurchases or redemptions; or </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any transaction from which the director derived an improper personal benefit. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Such limitation of liability does not apply to liabilities arising under federal securities laws and does not affect the availability of
equitable remedies such as injunctive relief or rescission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation that will be in effect
upon the closing of this offering will authorize us to indemnify our directors, officers, employees and other agents to the fullest extent permitted by Delaware law. Our amended and restated bylaws that will be in effect on the closing of this
offering will provide that we are required to indemnify our directors and officers to the fullest extent permitted by Delaware law and may indemnify our other employees and agents. Our amended and restated bylaws that will be in effect on the
closing of this offering will also provide that, on satisfaction of certain conditions, we will advance expenses incurred by a director or officer in advance of the final disposition of any action or proceeding, and permit us to secure insurance on
behalf of any officer, director, employee or other agent for any liability arising out of his or her actions in that capacity regardless of whether we would otherwise be permitted to indemnify him or her under the provisions of Delaware law. We have
entered and expect to continue to enter into agreements to indemnify our directors and executive officers. With certain exceptions, these agreements provide for indemnification for related expenses including attorneys&#146; fees, judgments, fines
and settlement amounts incurred by any of these individuals in connection with any action, proceeding or investigation. We believe that these amended and restated certificate of incorporation and amended and restated bylaw provisions and
indemnification agreements are necessary to attract and retain qualified persons as directors and officers. We also maintain customary directors&#146; and officers&#146; liability insurance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The limitation of liability and indemnification provisions in our amended and restated certificate of incorporation and amended and restated
bylaws may discourage stockholders from bringing a lawsuit against our directors for breach of their fiduciary duty. They may also reduce the likelihood of derivative litigation against our directors and officers, even though an action, if
successful, might benefit us and other stockholders. Further, a stockholder&#146;s investment may be adversely affected to the extent that we pay the costs of settlement and damage awards against directors and officers as required by these
indemnification provisions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted for directors,
executive officers or persons controlling us, we have been informed that, in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is therefore unenforceable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">167 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_14"></A>CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Other than compensation arrangements for our directors and executive officers, which are described elsewhere in this prospectus, below we
describe transactions since January&nbsp;1, 2016 and each currently proposed transaction in which: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">we have been or are to be a participant; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the amounts involved exceeded or will exceed $120,000; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">any of our directors, executive officers or holders of more than 5% of our outstanding capital stock, or any
immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Equity and other compensation, termination, change in control and other arrangements are described in the section titled &#147;Executive
compensation.&#148; We also describe below certain other transactions with our directors, executive officers and stockholders. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock
Financings </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series B Convertible Preferred Stock Financing </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In April 2016, we issued and sold to investors in a private placement 25,000,000 shares of our Series&nbsp;B convertible preferred stock at a
price per share of $2.00, for aggregate consideration of $50&nbsp;million. Each six shares of Series&nbsp;B convertible preferred stock will automatically convert into one share of our common stock upon completion of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series&nbsp;B convertible preferred stock purchased by directors, executive officers, beneficial owners of
more than 5% of our capital stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) or any member of the immediate family of any of the foregoing persons. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="79%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Participants</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Series B</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>preferred<BR>stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total<BR>purchase</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>price</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5% or greater stockholders and
directors</B><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Topspin Fund,
LP<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,850,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,700,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with The Column Group,
LLC<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Regents of the University of California</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">10,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KPCB Holdings, Inc., as nominee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Wong Family Trust Dated February&nbsp;4,
2008<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">150,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">300,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rieflin Family Trust u/a dtd 4/3/00, William J. Rieflin and Prudence H. Rieflin, Trustees<SUP
STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">200,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Additional details regarding these stockholders and their equity holdings are provided in this prospectus under
the caption &#147;Principal Stockholders.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Entities affiliated with Topspin Fund, LP holding our securities whose shares are aggregated for purposes of
reporting share ownership information include Topspin Fund, LP and Topspin Biotech Fund II, LP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Entities affiliated with The Column Group, LLC holding our securities whose shares are aggregated for purposes
of reporting share ownership information include The Column Group, LP and The Column Group II. David V. Goeddel, a member of our board of directors, is a Managing Partner at The Column Group, LLC. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Brian Wong, our President and Chief Executive Officer and a member of our board of directors, is a trustee of
The Wong Family Trust Dated February&nbsp;4, 2008. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">168 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">William Rieflin, a member of our board of directors, is a trustee of Rieflin Family Trust u/a dtd 4/3/00,
William J. Rieflin and Prudence H. Rieflin, Trustees. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series C Convertible Preferred Stock Financing </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In December 2017, we issued and sold to investors in a private placement 13,054,679 shares of our Series&nbsp;C convertible preferred stock at
a purchase price of $2.2925 per share for aggregate gross proceeds of approximately $30&nbsp;million. In June 2018, we sold an additional 13,054,684 shares of Series&nbsp;C convertible preferred stock at a purchase price of $2.2925 per share for
aggregate gross proceeds of approximately $30&nbsp;million. Each six shares of Series&nbsp;C convertible preferred stock will automatically convert into one share of our common stock upon completion of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series&nbsp;C convertible preferred stock purchased by directors, executive officers, beneficial owners of
more than 5% of our capital stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) or any member of the immediate family of any of the foregoing persons. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="67%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Participants</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Series C</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>preferred&nbsp;stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total&nbsp;purchase</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>price</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5% or greater stockholders and
directors</B><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with The Column Group,
LLC<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,086,150</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">30,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Topspin Fund,
LP<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,181,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KPCB Holdings, Inc., as nominee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,181,025</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">5,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Regents of the University of California</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,085,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,781,009</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE> <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Additional details regarding these stockholders and their equity holdings are provided in this prospectus under
the caption &#147;Principal Stockholders.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Entities affiliated with The Column Group, LLC holding our securities whose shares are aggregated for purposes
of reporting share ownership information include The Column Group, LP, The Column Group II, LP, Ponoi Capital, LP and Ponoi Capital II, LP. David V. Goeddel, a member of our board of directors, is a Managing Partner at The Column Group, LLC and a
managing member of Ponoi Management, LLC, general partner of Ponoi Capital, LP, and a managing member of Ponoi&nbsp;II Management, LLC, general partner of Ponoi Capital&nbsp;II, LP. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Entities affiliated with Topspin Fund, LP holding our securities whose shares are aggregated for purposes of
reporting share ownership information include Topspin Fund, LP and Topspin Biotech Fund II, LP. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Series <FONT
STYLE="white-space:nowrap">C-2</FONT> Convertible Preferred Stock Financing </I></B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In December 2018, we issued and sold to investors
in a private placement 9,873,412 shares of our <FONT STYLE="white-space:nowrap">Series&nbsp;C-2</FONT> convertible preferred stock at a purchase price of $2.2925 per share for aggregate gross proceeds of approximately $22.6&nbsp;million. Between
January 2019 and June 2019, we sold additional 6,311,445 shares of Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock at a purchase price of $2.2925 per share for aggregate gross proceeds of approximately $14.5 million.
Each six shares of Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock will automatically convert into one share of our common stock upon completion of this offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table summarizes the Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock purchased by directors,
executive officers, beneficial owners of more than 5% of our capital stock (on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) or any member of the immediate family of any of the foregoing persons. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="68%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Participants</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B><FONT STYLE="white-space:nowrap">Series&nbsp;C-2</FONT></B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>preferred&nbsp;stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Total&nbsp;purchase</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>price</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>5% or greater stockholders and
directors</B><SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Regents of the University of California</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">967,935</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,218,991</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KPCB Holdings, Inc., as nominee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">872,410</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with The Column
Group,&nbsp;LLC<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,744,820</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">169 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Additional details regarding these stockholders and their equity holdings are provided in this prospectus under
the caption &#147;Principal Stockholders.&#148; </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Entities affiliated with The Column Group, LLC holding our securities whose shares are aggregated for purposes
of reporting share ownership information include The Column Group, LP, The Column Group II, LP, Ponoi Capital, LP and Ponoi Capital II, LP. David V. Goeddel, a member of our board of directors, is a Managing Partner at The Column Group, LLC and a
managing member of Ponoi Management, LLC, general partner of Ponoi Capital, LP, and a managing member of Ponoi II Management, LLC, general partner of Ponoi Capital II, LP. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Rights Agreement </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are
party to an amended and restated investor rights agreement (&#147;IRA&#148;) with certain holders of our capital stock, including the holders of more than 5% of our outstanding capital stock, such as entities affiliated with KPCB Holdings, Inc., as
nominee, entities affiliated with The Column Group, LLC, entities affiliated with Topspin Fund, LP, and The Regents of the University of California. The IRA provides the holders of our convertible preferred stock with certain registration rights,
including the right to demand that we file a registration statement or request that their shares be covered by a registration statement that we are otherwise filing. The IRA also provides these stockholders with information rights, which will
terminate on the closing of this offering, and a right of first refusal with regard to certain issuances of our capital stock, which will not apply to the shares issued pursuant to this offering and which will terminate on the closing of this
offering. In connection with this offering, the holders of up to 17,467,184 shares of our common stock issuable on conversion of outstanding preferred stock, as of June 30, 2019, will be entitled to rights with respect to the registration of their
shares under the Securities Act under this agreement. For a description of these registration rights, see the section titled &#147;Description of Capital Stock&#151;Registration Rights.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Voting Agreement </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are party to an
amended and restated voting agreement under which certain holders of our capital stock, including the holders of more than 5% of our outstanding capital stock, such as entities affiliated with KPCB Holdings, Inc., as nominee, entities affiliated
with The Column Group, LLC, entities affiliated with Topspin Fund, LP, and The Regents of the University of California, have agreed as to the manner in which they will vote their shares of our capital stock on certain matters, including with respect
to the election of directors. Upon the closing of this offering, the amended and restated voting agreement will terminate, and none of our stockholders will have any special rights regarding the election or designation of members of our board of
directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Participation in this Offering </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Certain existing stockholders have indicated an interest in purchasing up to approximately
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; of shares of our common stock in this offering at the initial public offering price. However, because these indications of interest are not binding agreements or commitments
to purchase, the underwriters may determine to sell more, less or no shares in this offering to any or all of these stockholders, or any or all of these stockholders may determine to purchase more, less or no shares in this offering. The
underwriters will receive the same underwriting discount on any shares purchased by these stockholders as they will on any other shares sold to the public in this offering. Substantial purchases of common stock by existing stockholders could reduce
the liquidity of the trading market for our common stock and increase price volatility. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reserved Share Program </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">At our request, the underwriters have reserved up to 5% of the shares offered by this prospectus, for sale at the initial public offering
price in a reserved share program, to our directors, officers, employees, consultants and related persons. See &#147;Underwriting&#151;Reserved Shares.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">170 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Indemnification Agreements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation that will be in effect upon the closing of this offering will contain provisions
limiting the liability of directors, and our amended and restated bylaws that will be in effect on the closing of this offering will provide that we will indemnify each of our directors and officers to the fullest extent permitted under Delaware
law. Our amended and restated certificate of incorporation and amended and restated bylaws that will be in effect upon the closing of this offering will also provide our board of directors with discretion to indemnify our employees and other agents
when determined appropriate by the board. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, we have entered into an indemnification agreement with each of our directors and
executive officers, which requires us to indemnify them. For more information regarding these agreements, see the section titled &#147;Executive Compensation&#151;Limitations of Liability and Indemnification Matters.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Stock Option Grants to Directors and Executive Officers </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have granted stock options to our directors and executive officers, as more fully described in the section titled &#147;Executive
Compensation.&#148; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Executive Loans </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In August 2015, we loaned Dr.&nbsp;Wong, our President and Chief Executive Officer, $336,600 in connection with his exercise of options to
purchase 330,000 shares of our common stock. The loan was evidenced by a limited recourse promissory note, which accrued interest at the rate of 1.82% per annum and was secured by a pledge of such exercised shares. In June 2019, the Company forgave
$353,951, which was the entire amount of principal and accrued interest due on the note, from Dr. Wong. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In June 2016, we loaned
Ms.&nbsp;Hemrajani, our then Chief Operating Officer, $255,000 in connection with her exercise of options to purchase 124,999 shares of our common stock. The loan was evidenced by a limited recourse promissory note, which accrued interest at the
rate of 1.41% per annum and was secured by a pledge of such exercised shares. $17,000 of the note was repaid in connection with our repurchase of 8,333 shares of common stock from her trust in February 2018, and an additional $109,437.84 of the note
was repaid in connection with our repurchase of 53,649 shares of common stock from her trust in March 2019. In June 2019, the Company repurchased 29,686 vested shares from Ms. Hemrajani in exchange for canceling $65,230 of principal and interest on
the promissory note. The Company received cash proceeds of $73,005 for the remaining 33,333 vested shares issued to Ms. Hemrajani. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Policies and
Procedures for Related Person Transactions </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Prior to the closing of this offering, our board of directors will adopt a related person
transaction policy setting forth the policies and procedures for the identification, review and approval or ratification of related person transactions. This policy covers, with certain exceptions set forth in Item 404 of Regulation <FONT
STYLE="white-space:nowrap">S-K</FONT> under the Securities Act, any transaction, arrangement or relationship, or any series of similar transactions, arrangements or relationships, in which we and a related person were or will be participants and the
amount involved exceeds $120,000, including purchases of goods or services by or from the related person or entities in which the related person has a material interest, indebtedness and guarantees of indebtedness. In reviewing and approving any
such transactions, our audit committee will consider all relevant facts and circumstances as appropriate, such as the purpose of the transaction, the availability of other sources of comparable products or services, whether the transaction is on
terms comparable to those that could be obtained in an arm&#146;s length transaction, management&#146;s recommendation with respect to the proposed related person transaction, and the extent of the related person&#146;s interest in the transaction.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">171 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_15"></A>PRINCIPAL STOCKHOLDERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table sets forth information with respect to the beneficial ownership of our capital stock as of September&nbsp;15, 2019, as
adjusted to reflect the sale of our common stock offered by us in this offering assuming no exercise of the underwriters&#146; option to purchase additional shares, for: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our named executive officers; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each of our directors; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">all of our executive officers and directors as a group; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">each person or group of affiliated persons known by us to beneficially own more than 5% of our common stock.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have determined beneficial ownership in accordance with the rules and regulations of the SEC, and the information is
not necessarily indicative of beneficial ownership for any other purpose. Except as indicated by the footnotes below, we believe, based on information furnished to us, that the persons and entities named in the table below have sole voting and sole
investment power with respect to all shares that they beneficially own, subject to applicable community property laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">At our request,
the underwriters have reserved up to 5% of the shares offered by this prospectus, for sale at the initial public offering price in a reserved share program, to our directors, officers, employees, consultants and related persons. See
&#147;Underwriting&#151;Reserved Shares.&#148; The following table does not reflect any purchases pursuant to the reserved share program, which purchases, if any, will increase the percentage of shares owned after the offering by such directors,
officers, employees, consultants and related persons from that set forth in the table below. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Certain existing stockholders have
indicated an interest in purchasing up to approximately $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of our common stock in this offering at the initial public offering price. However, because these indications of
interest are not binding agreements or commitments to purchase, the underwriters may determine to sell more, less or no shares in this offering to any or all of these stockholders, or any or all of these stockholders may determine to purchase more,
less or no shares in this offering. The underwriters will receive the same underwriting discount on any shares purchased by these stockholders as they will on any other shares sold to the public in this offering. Substantial purchases of common
stock by existing stockholders could reduce the liquidity of the trading market for our common stock and increase price volatility. The following table does not reflect any potential purchases by these stockholders, which purchases, if any, will
increase the percentage of shares owned after the offering of such stockholders from that set forth in the table below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Applicable
percentage ownership before the offering is based on 18,401,391 shares of common stock outstanding as of September&nbsp;15, 2019, assuming the automatic conversion of all outstanding shares of our convertible preferred stock into shares of common
stock upon the closing of this offering. Applicable percentage ownership after the offering is based on &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of common stock outstanding immediately after the closing of this
offering, assuming no exercise by the underwriters of their over-allotment option. In computing the number of shares beneficially owned by a person and the percentage ownership of such person, we deemed to be outstanding all shares subject to
options held by the person that are currently exercisable, or exercisable within 60 days of September&nbsp;15, 2019. However, except as described above, we did not deem such shares outstanding for the purpose of computing the percentage ownership of
any other person. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Unless otherwise indicated, the address of each beneficial owner listed below is c/o RAPT Therapeutics, Inc., 561
Eccles Avenue, South San Francisco, California 94080. We believe, based on information provided to us, that each of the stockholders listed below has sole voting and investment power with respect to the shares
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">172 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
beneficially owned by the stockholder unless noted otherwise, subject to community property laws where applicable. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares Beneficially<BR>Owned Prior
to<BR>Offering</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Name of Beneficial Owner</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Percentage</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>5% Stockholders</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with The Column Group,
LLC<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,152,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">KPCB Holdings, Inc., as nominee<SUP STYLE="font-size:85%; vertical-align:top">(2)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,547,063</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Entities affiliated with Topspin Fund,
LP<SUP STYLE="font-size:85%; vertical-align:top">(3)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,160,371</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">11.7</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">The Regents of the University of
California<SUP STYLE="font-size:85%; vertical-align:top">(4)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,342,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.3</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B><I>Directors and Named Executive Officers</I></B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Brian Wong<SUP STYLE="font-size:85%; vertical-align:top">(5)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">546,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Rekha Hemrajani<SUP STYLE="font-size:85%; vertical-align:top">(6)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">38,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Ho<SUP STYLE="font-size:85%; vertical-align:top">(7)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73,612</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">David V. Goeddel<SUP STYLE="font-size:85%; vertical-align:top">(1)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,152,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">33.4</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Linda Kozick<SUP STYLE="font-size:85%; vertical-align:top">(8)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,184</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Michael F. Giordano<SUP STYLE="font-size:85%; vertical-align:top">(9)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">William Rieflin<SUP STYLE="font-size:85%; vertical-align:top">(10)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">82,189</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wendye Robbins, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">All directors and executive officers as a group (9 persons)<SUP
STYLE="font-size:85%; vertical-align:top">(11)</SUP></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,950,500</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37.44</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Represents beneficial ownership of less than 1%. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 50,000 shares held of record by The Column Group II Management, LP, (ii)&nbsp;4,357,333 shares
held of record by The Column Group II, LP, (iii)&nbsp;145,401 shares held of record by Ponoi Capital&nbsp;II, LP, and (iv) 1,599,417 shares held of record by Ponoi Capital, LP. David Goeddel is a Managing Partner of The Column Group, LLC, which is
the general partner of The Column Group II GP, LP, which is the general partner of The Column Group II, LP. Dr.&nbsp;Goeddel is also a managing member of The Column Group II Management, LP. Dr.&nbsp;Goeddel is also a managing member of Ponoi
Management, LLC, general partner of Ponoi Capital, LP., and a managing member of Ponoi II Management, LLC, general partner of Ponoi Capital II, LP. Dr.&nbsp;Goeddel may be deemed to share voting and investment power with respect to the shares
reported herein and disclaims beneficial ownership of the shares except to the extent of his pecuniary interests therein. The address for the entities listed herein is 1700 Owens Street, Suite 500, San Francisco, CA 94158. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The shares held for convenience in the name of KPCB Holdings, Inc., as nominee for the accounts of the
following entities as follows: 3,444,199 shares held for the account of Kleiner Perkins Caufield&nbsp;&amp; Byers XV, LLC (&#147;KPCB XV&#148;) and 102,864 shares held for the account of KPCB XV Founders Fund, LLC (&#147;KPCB XV FF&#148;). The
managing member of KPCB XV and KPCB XV FF is KPCB XV Associates, LLC (&#147;KPCB XV Associates&#148;). Beth Seidenberg, L. John Doerr, Randy Komisar, Theodore E. Schlein, Wen Hsieh and William &#147;Bing&#148; Gordon, the managing members of KPCB XV
Associates, exercise shared voting and dispositive control over the shares held by KPCB Holdings, Inc. as nominee for the accounts of KPCB XV and KPCB XV FF. The address for KPCB Holdings, Inc., as nominee, is 2750 Sand Hill Road, Menlo Park, CA
94025. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 1,641,666 shares held of record by Topspin Biotech Fund II, LP, and (ii) 518,705 shares held of
record by Topspin Fund, LP. LG Management, LLC, the general partner of Topspin Fund, LP and Topspin Biotech Fund II, LP, may be deemed to have shared voting control and investment discretion over the shares of common stock held by Topspin Fund, LP
and Topspin Biotech Fund II, LP. The address for each entity is 3 Expressway Plaza, Roslyn Heights, NY 11577. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Dr.&nbsp;Goeddel disclaims beneficial ownership of the shares except to the extent of his pecuniary interests
therein. The address for each entity is 1700 Owens Street, Suite 500, San Francisco, CA 94158. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(4)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">The address for The Regents of the University of California is 1111 Broadway Avenue, Oakland, CA 94607.
</P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(5)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 100,000 shares held by Dr.&nbsp;Wong (of which 29,175 shares were issued pursuant to options
that were early exercised and are subject to repurchase within 60 days of September 15, 2019), (ii) 355,000 </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">173 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top">
shares held by The Wong Family Trust Dated February&nbsp;4, 2008, for which Dr.&nbsp;Wong is a trustee , and (iii)&nbsp;91,666 shares issuable pursuant to stock options exercisable within 60 days
of September&nbsp;15, 2019. </TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(6)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 33,333 shares held by The Sanjay Popli&nbsp;&amp; Rekha Hemrajani Revocable Living Trust, for
which Ms.&nbsp;Hemrajani is a trustee, and (ii) 4,861 shares issuable pursuant to stock options exercisable within 60 days of September&nbsp;15, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(7)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 72,223 shares held by Dr.&nbsp;Ho (of which 3,934 shares were issued pursuant to options that
were early exercised and are subject to repurchase within 60 days of September 15, 2019), and (ii) 1,389 shares issuable pursuant to stock options exercisable within 60 days of September&nbsp;15, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(8)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 14,148 shares issuable pursuant to stock options exercisable within 60 days of September&nbsp;15,
2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(9)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of 7,638 shares issuable pursuant to stock options exercisable within 60 days of September&nbsp;15,
2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(10)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 76,722 shares held by Rieflin Family Trust u/a dtd 4/3/00, William J. Rieflin and Prudence H.
Rieflin, Trustees, for which Mr.&nbsp;Rieflin is <FONT STYLE="white-space:nowrap">co-Trustee,</FONT> and (ii) 5,467 shares issuable pursuant to stock options exercisable within 60 days of September&nbsp;15, 2019. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(11)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Consists of (i) 6,789,429 shares beneficially owned by our directors (or their affiliated entities) and
executive officers and (ii) 161,071 shares issuable pursuant to stock options exercisable within 60 days of September&nbsp;15, 2019. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">174 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_16"></A>DESCRIPTION OF CAPITAL STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following is a summary of
the rights of our common and preferred stock and some of the provisions of our amended and restated certificate of incorporation and amended and restated bylaws, which will each become effective upon the closing of this offering, our investor rights
agreement and relevant provisions of the Delaware General Corporation Law (&#147;DGCL&#148;). The descriptions herein are qualified in their entirety by our amended and restated certificate of incorporation, amended and restated bylaws and investor
rights agreement, copies of which have been filed as exhibits to the registration statement of which this prospectus is a part, as well as the relevant provisions of the DGCL. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Upon the closing of this offering and the filing of our amended and restated certificate of incorporation, our authorized capital stock will
consist of 550,000,000 shares, all with a par value of $0.0001 per share, of which: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">500,000,000 shares are designated as common stock; and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">50,000,000 shares are designated as preferred stock. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Common Stock </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30,
2019, there were 18,279,943 shares of our common stock outstanding and held of record by 138 stockholders, assuming the automatic conversion of all outstanding shares of our convertible preferred stock into shares of common stock, which will
automatically occur immediately prior to the closing of this offering. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Holders of our common stock are entitled to one vote for each
share held on all matters submitted to a vote of stockholders, including the election of directors, and do not have cumulative voting rights. Accordingly, the holders of a majority of the outstanding shares of common stock entitled to vote in any
election of directors can elect all of the directors standing for election, if they so choose, other than any directors that holders of any preferred stock we may issue may be entitled to elect. Subject to preferences that may be applicable to any
then outstanding preferred stock, holders of common stock are entitled to receive ratably those dividends, if any, as may be declared by the board of directors out of legally available funds. In the event of our liquidation, dissolution or winding
up, the holders of common stock will be entitled to share ratably in the assets legally available for distribution to stockholders after the payment of or provision for all of our debts and other liabilities, subject to the prior rights of any
preferred stock then outstanding. Holders of common stock have no preemptive or conversion rights or other subscription rights and there are no redemption or sinking funds provisions applicable to the common stock. All outstanding shares of common
stock are, and the common stock to be outstanding upon the closing of this offering will be, duly authorized, validly issued, fully paid and nonassessable. All authorized but unissued shares of our common stock will be available for issuance by our
board of directors without any further stockholder action, except as required by the listing standards of Nasdaq. The rights, preferences and privileges of holders of common stock are subject to and may be adversely affected by the rights of the
holders of shares of any series of preferred stock that we may designate and issue in the future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Preferred Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2019, there were 17,467,184 shares of convertible preferred stock outstanding. Immediately upon the closing of this
offering, each outstanding share of convertible preferred stock will automatically convert into one share of common stock, and no shares of preferred stock will be outstanding. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">175 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Upon the closing of this offering, our board of directors may, without further action by our
stockholders, fix the rights, preferences, privileges and restrictions of up to an aggregate of 50,000,000 shares of convertible preferred stock in one or more series and authorize their issuance. These rights, preferences and privileges could
include dividend rights, conversion rights, voting rights, terms of redemption, liquidation preferences, sinking fund terms and the number of shares constituting any series or the designation of such series, any or all of which may be greater than
the rights of our common stock. The issuance of our convertible preferred stock could adversely affect the voting power of holders of our common stock, and the likelihood that such holders will receive dividend payments and payments upon
liquidation. In addition, the issuance of preferred stock could have the effect of delaying, deferring or preventing a change of control or other corporate action. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Options </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2019,
we had outstanding options under our equity compensation plans to purchase an aggregate of 1,049,976 shares of our common stock with a weighted-average exercise price of $6.11 per share. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are party to an
amended and restated investor rights agreement that provides that certain stockholders, including certain holders of common stock issuable upon the conversion of our convertible preferred stock, including certain holders of at least 5% of our
outstanding capital stock, have certain registration rights as set forth below. The registration of shares of our common stock by the exercise of registration rights described below would enable the holders to sell these shares without restriction
under the Securities Act when the applicable registration statement is declared effective. We will pay the registration expenses, other than underwriting discounts and commissions, of the shares registered pursuant to the demand, piggyback and Form <FONT
STYLE="white-space:nowrap">S-3</FONT> registration rights described below. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Generally, in an underwritten offering, the managing
underwriter, if any, has the right, subject to specified conditions, to limit the number of shares such holders may include. The demand, piggyback and Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration rights described below will expire
three years after the closing of this offering, of which this prospectus is a part, or with respect to any particular stockholder, such time after the closing of this offering that such stockholder holds less than 1% of our outstanding common stock
(including all shares of preferred stock on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis) and such stockholder can sell all of its shares entitled to registration rights under Rule 144 of the Securities Act during any <FONT
STYLE="white-space:nowrap">90-day</FONT> period. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Demand Registration Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The holders of an aggregate of 17,467,184 shares of our common stock as of June 30, 2019, including shares of common stock issuable upon the
conversion of our convertible preferred stock, will be entitled to certain demand registration rights. At any time beginning the six months after the effective date of this offering, the holders of at least 30% of these shares may request that we
register all or a portion of their shares. We are obligated to effect only two such registrations. Such request for registration must cover shares with an anticipated aggregate offering price, net of underwriting discounts and commissions, of at
least $20&nbsp;million. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Piggyback Registration Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In connection with this offering, the holders of an aggregate of 17,467,184 shares of our common stock as of June 30, 2019, including shares
of common stock issuable upon the conversion of our convertible preferred stock, were entitled to, and the necessary percentage of holders waived, their rights to notice of this offering and to include their shares of registrable securities in this
offering. After this offering, in the event that we propose to register any of our securities under the Securities Act, either for our own account or for the account of other security holders, the holders of these shares will be entitled to certain
piggyback registration rights allowing the holders to include their shares in such registration, subject to certain marketing and other limitations. As a result, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">176 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
whenever we propose to file a registration statement under the Securities Act, other than with respect to (i)&nbsp;a registration statement relating to any employee benefit plans, (ii)&nbsp;a
registration relating to a corporate reorganization or other Rule 145 transaction, (iii)&nbsp;a registration relating to stock issued upon conversion of debt securities, or (iv)&nbsp;a registration on any registration form that does not permit
secondary sales, the holders of these shares are entitled to notice of the registration and have the right to include their shares in the registration, subject to limitations that the underwriters may impose on the number of shares included in the
offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Form <FONT STYLE="white-space:nowrap">S-3</FONT> Registration Rights </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The holders of an aggregate of 17,467,184 shares of common stock as of June 30, 2019, including shares of common stock issuable upon the
conversion of our convertible preferred stock, will be entitled to certain Form <FONT STYLE="white-space:nowrap">S-3</FONT> registration rights. The holders of these shares can make a request that we register their shares on Form <FONT
STYLE="white-space:nowrap">S-3</FONT> if we are qualified to file a registration statement on Form <FONT STYLE="white-space:nowrap">S-3</FONT> and if the reasonably anticipated aggregate gross proceeds of the shares offered would equal or exceed
$5&nbsp;million. We will not be required to effect more than two registrations on Form <FONT STYLE="white-space:nowrap">S-3</FONT> within any <FONT STYLE="white-space:nowrap">12-month</FONT> period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Anti-Takeover Effects of Delaware Law and Our Certificate of Incorporation and Bylaws </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Some provisions of Delaware law, our amended and restated certificate of incorporation and our amended and restated bylaws contain or will
contain provisions that could make the following transactions more difficult: an acquisition of us by means of a tender offer; an acquisition of us by means of a proxy contest or otherwise; or the removal of our incumbent officers and directors. It
is possible that these provisions could make it more difficult to accomplish or could deter transactions that stockholders may otherwise consider to be in their best interest or in our best interests, including transactions which provide for payment
of a premium over the market price for our shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">These provisions, summarized below, are intended to discourage coercive takeover
practices and inadequate takeover bids. These provisions are also designed to encourage persons seeking to acquire control of us to first negotiate with our board of directors. We believe that the benefits of the increased protection of our
potential ability to negotiate with the proponent of an unfriendly or unsolicited proposal to acquire or restructure us outweigh the disadvantages of discouraging these proposals because negotiation of these proposals could result in an improvement
of their terms. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholder Meetings </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws will provide that a special meeting of stockholders may be called only by our chair of the board, chief
executive officer or president, or by a resolution adopted by a majority of our board of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Requirements for Advance Notification of
Stockholder Nominations and Proposals </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and restated bylaws will establish advance notice procedures with respect to
stockholder proposals to be brought before a stockholder meeting and the nomination of candidates for election as directors, other than nominations made by or at the direction of the board of directors or a committee of the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Elimination of Stockholder Action by Written Consent </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation and amended and restated bylaws will eliminate the right of stockholders to act by
written consent without a meeting. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">177 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Staggered Board </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our board of directors will be divided into three classes. The directors in each class will serve for a three-year term, one class being
elected each year by our stockholders. For more information on the classified board, see &#147;Management&#151;Board Composition and Election of Directors.&#148; This system of electing and removing directors may tend to discourage a third party
from making a tender offer or otherwise attempting to obtain control of us, because it generally makes it more difficult for stockholders to replace a majority of the directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Removal of Directors </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended
and restated certificate of incorporation will provide that no member of our board of directors may be removed from office by our stockholders except for cause and, in addition to any other vote required by law, upon the approval of not less than
two thirds of the total voting power of all of our outstanding voting stock then entitled to vote in the election of directors. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stockholders Not
Entitled to Cumulative Voting </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation will not permit stockholders to cumulate
their votes in the election of directors. Accordingly, the holders of a majority of the outstanding shares of our common stock entitled to vote in any election of directors can elect all of the directors standing for election, if they choose, other
than any directors that holders of our preferred stock may be entitled to elect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Delaware Anti-Takeover Statute </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We are subject to Section&nbsp;203 of the DGCL, which prohibits persons deemed to be &#147;interested stockholders&#148; from engaging in a
&#147;business combination&#148; with a publicly held Delaware corporation for three years following the date these persons become interested stockholders unless the business combination is, or the transaction in which the person became an
interested stockholder was, approved in a prescribed manner or another prescribed exception applies. Generally, an &#147;interested stockholder&#148; is a person who, together with affiliates and associates, owns, or within three years prior to the
determination of interested stockholder status did own, 15% or more of a corporation&#146;s voting stock. Generally, a &#147;business combination&#148; includes a merger, asset or stock sale, or other transaction resulting in a financial benefit to
the interested stockholder. The existence of this provision may have an anti-takeover effect with respect to transactions not approved in advance by the board of directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Choice of Forum </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and
restated certificate of incorporation to be in effect upon the completion of this offering will provide that the Court of Chancery of the State of Delaware will be the exclusive forum for the following types of actions or proceedings under Delaware
statutory or common law: (1) any derivative action or proceeding brought on our behalf; (2) any action asserting a breach of fiduciary duty owed by any of our directors, officers, employees or agents to us or our stockholders; (3) any action
asserting a claim against us or any of our directors, officers or other employees arising pursuant to any provisions of the Delaware General Corporation Law, our amended and restated certificate of incorporation or our amended and restated bylaws;
or (4)&nbsp;any action asserting a claim against us or any of our directors, officers or other employees that is governed by the internal affairs doctrine. These provisions would not apply to suits brought to enforce a duty or liability created by
the Exchange Act or the rules and regulations thereunder. However, these provisions apply to Securities Act claims and Section 22 of the Securities Act creates concurrent jurisdiction for federal and state courts over all suits brought to enforce a
duty or liability created by the Securities Act or the rules and regulations thereunder. Accordingly, there is uncertainty as to whether a court would enforce such provisions, and our stockholders will not be deemed to have waived our compliance
with the federal securities laws and the rules and regulations thereunder. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">178 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our amended and restated certificate of incorporation to be in effect upon the completion of
this offering will further provide that the federal district courts of the United States of America will be the exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act, subject to and contingent upon
a final adjudication in the State of Delaware of the enforceability of such exclusive forum provision. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">These exclusive-forum provisions
may limit a stockholder&#146;s ability to bring a claim in a judicial forum that it finds favorable for disputes with us or our directors, officers or other employees, which may discourage lawsuits against us and our directors, officers and other
employees. If a court were to find the exclusive-forum provisions in our amended and restated certificate of incorporation that will be in effect upon the closing of this offering to be inapplicable or unenforceable, we may incur additional costs
associated with resolving the dispute in other jurisdictions, which could seriously harm our business. For example, the Court of Chancery of the State of Delaware recently determined that a provision stating that U.S. federal district courts are the
exclusive forum for resolving any complaint asserting a cause of action arising under the Securities Act is not enforceable. However, this decision may be reviewed and ultimately overturned by the Delaware Supreme Court. If the Court of
Chancery&#146;s decision were to be overturned, we would seek to enforce the federal district court exclusive forum provision in our amended and restated certificate of incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Amendment of Charter Provisions </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The amendment of any of the above provisions, except for the provision making it possible for our board of directors to issue preferred stock,
would require approval by holders of at least <FONT STYLE="white-space:nowrap">two-thirds</FONT> of the total voting power of all of our outstanding voting stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The provisions of Delaware law, our amended and restated certificate of incorporation and our amended and restated bylaws could have the
effect of discouraging others from attempting hostile takeovers and, as a consequence, they may also inhibit temporary fluctuations in the market price of our common stock that often result from actual or rumored hostile takeover attempts. These
provisions may also have the effect of preventing changes in the composition of our board and management. It is possible that these provisions could make it more difficult to accomplish transactions that stockholders may otherwise deem to be in
their best interests. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Transfer Agent and Registrar </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The transfer agent and registrar for our common stock upon the closing of this offering will be American Stock Transfer &amp; Trust Company,
LLC. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Exchange Listing </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our common
stock is currently not listed on any securities exchange. We have applied to have our common stock listed on the Nasdaq Global Market (&#147;Nasdaq&#148;), under the symbol &#147;RAPT.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">179 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_17"></A>SHARES ELIGIBLE FOR FUTURE SALE </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Prior to this offering, there has been no public market for our common stock. Future sales of substantial amounts of common stock in the
public market, or the perception that such sales may occur, could adversely affect the market price of our common stock. Although we have applied to have our common stock listed on Nasdaq, we cannot assure you that there will be an active public
market for our common stock. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Following the closing of this offering, based on the number of shares of our common stock outstanding as
of June&nbsp;30, 2019 and assuming (1)&nbsp;the issuance of shares of common stock in this offering, (2)&nbsp;the conversion of all outstanding shares of our convertible preferred stock into shares of our common stock, which will automatically occur
immediately prior to the closing of the offering, and (3)&nbsp;no exercise of the underwriters&#146; over-allotment option, we will have an aggregate of approximately &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; shares of
common stock outstanding. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Of these shares, all shares of common stock sold in this offering will be freely tradable without
restriction or further registration under the Securities Act, except for any shares of common stock purchased by our &#147;affiliates,&#148; as that term is defined in Rule 144 under the Securities Act or any shares subject to <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements. Shares purchased by our affiliates would be subject to the Rule 144 resale restrictions described below, other than the holding period requirement. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The remaining shares of common stock outstanding after this offering will be &#147;restricted securities,&#148; as that term is defined in
Rule 144 under the Securities Act. These restricted securities are eligible for public sale only if they are registered under the Securities Act or if they qualify for an exemption from registration under Rule 144 or Rule 701 under the Securities
Act, each of which is summarized below. We expect that all of these shares will be subject to a <FONT STYLE="white-space:nowrap">180-day</FONT> <FONT STYLE="white-space:nowrap">lock-up</FONT> period under the
<FONT STYLE="white-space:nowrap">lock-up</FONT> and market <FONT STYLE="white-space:nowrap">stand-off</FONT> agreements described below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We may issue shares of common stock from time to time as consideration for future acquisitions, investments or other corporate purposes. In
the event any such acquisition, investment or other transaction is significant, the number of shares of common stock that we may issue may also be significant. We may also grant registration rights covering those shares of common stock issued in
connection with any such acquisition, investment or other transaction. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, shares of common stock that are either subject to
outstanding options or warrants or reserved for future issuance under our equity incentive plans will become eligible for sale in the public market to the extent permitted by the provisions of various vesting schedules, the <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements described below and Rules 144 and 701 under the Securities Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><FONT STYLE="white-space:nowrap">Lock-Up</FONT> Agreements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We, along with our directors, executive officers and substantially all of our other stockholders and optionholders, have agreed with the
underwriters that for a period of 180 days after the date of this prospectus, subject to specified exceptions as detailed further in &#147;Underwriters&#148; below, we or they will not, except with the prior written consent of the representatives,
offer, pledge, sell or contract to sell; sell any option or contract to purchase; purchase any option or contract to sell; grant any option, right or warrant to purchase; or otherwise dispose of or transfer any shares our common stock or any
securities convertible into or exercisable for shares of our common stock; request or demand that we file or make a confidential submission of a registration statement related to our common stock; or enter into any swap or other agreement or
transaction that transfers to another, in whole or in part, directly or indirectly, the economic consequence of ownership of our common stock. All of our stockholders are subject to a market <FONT STYLE="white-space:nowrap">stand-off</FONT>
agreement with us which imposes similar restrictions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Upon expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> period,
certain of our stockholders will have the right to require us to register their shares under the Securities Act. See &#147;&#151;Registration Rights&#148; below and &#147;Description of Capital Stock&#151;Registration Rights.&#148; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">180 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Upon the expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> period,
substantially all of the shares subject to such <FONT STYLE="white-space:nowrap">lock-up</FONT> restrictions will become eligible for sale, subject to the limitations discussed above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 144 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In general, under Rule 144 as
currently in effect, once we have been subject to public company reporting requirements of Section&nbsp;13 or Section&nbsp;15(d) of the Exchange Act for at least 90 days, an eligible stockholder is entitled to sell such shares without complying with
the manner of sale, volume limitation or notice provisions of Rule 144, subject to compliance with the public information requirements of Rule 144. To be an eligible stockholder under Rule 144, such stockholder must not be deemed to have been one of
our affiliates for purposes of the Securities Act at any time during the 90 days preceding a sale and must have beneficially owned the shares proposed to be sold for at least six months, including the holding period of any prior owner other than our
affiliates. If such a person has beneficially owned the shares proposed to be sold for at least one year, including the holding period of any prior owner other than our affiliates, then such person is entitled to sell such shares without complying
with any of the requirements of Rule 144, subject to the expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In general, under Rule 144, as currently in effect, our affiliates or persons selling shares on behalf of our affiliates are entitled to sell
shares on expiration of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements described above. Beginning 90 days after the date of this prospectus, within any three-month period, such stockholders may sell a number of shares that does not
exceed the greater of: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">1% of the number of shares of our common stock then outstanding, which will equal approximately
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;shares immediately after this offering; or </P></TD></TR></TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the average weekly trading volume in our common stock on&nbsp;Nasdaq&nbsp;during the four calendar weeks
preceding the filing of a notice on Form 144 with respect to such sale. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Sales under Rule 144 by our affiliates or
persons selling shares on behalf of our affiliates are also subject to certain manner of sale provisions and notice requirements and to the availability of current public information about us. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Rule 701 </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Rule 701 generally allows a
stockholder who was issued shares under a written compensatory plan or contract and who is not deemed to have been an affiliate of our company during the immediately preceding 90&nbsp;days, to sell these shares in reliance on Rule 144, but without
being required to comply with the public information, holding period, volume limitation or notice provisions of Rule 144. Rule 701 also permits affiliates of our company to sell their Rule 701 shares under Rule 144 without complying with the holding
period requirements of Rule 144. All holders of Rule 701 shares, however, are required by that rule to wait until 90 days after the date of this prospectus before selling those shares under Rule 701, subject to the expiration of the <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreements described above. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Form <FONT STYLE="white-space:nowrap">S-8</FONT> Registration Statement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We intend to file one or more registration statements on Form <FONT STYLE="white-space:nowrap">S-8</FONT> under the Securities Act to register
all shares of common stock subject to outstanding stock options and common stock issued or issuable under the 2015 Plan, the 2019 Plan and the ESPP. We expect to file the registration statement covering shares offered pursuant to these stock plans
shortly after the date of this prospectus, permitting the resale of such shares by <FONT STYLE="white-space:nowrap">non-affiliates</FONT> in the public market without restriction under the Securities Act and the sale by affiliates in the public
market subject to compliance with the resale provisions of Rule 144. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">181 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Registration Rights </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June&nbsp;30, 2019, holders of up to 17,467,184 shares of our common stock, which includes all of the shares of common stock issuable
upon the automatic conversion of our convertible preferred stock immediately prior to the closing of this offering, or their transferees, will be entitled to various rights with respect to the registration of these shares under the Securities Act
upon the closing of this offering and the expiration of <FONT STYLE="white-space:nowrap">lock-up</FONT> agreements. Registration of these shares under the Securities Act would result in these shares becoming fully tradable without restriction under
the Securities Act immediately upon the effectiveness of the registration, except for shares purchased by affiliates. See &#147;Description of Capital Stock&#151;Registration Rights&#148; for additional information. Shares covered by a registration
statement will be eligible for sale in the public market upon the expiration or release from the terms of the <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">182 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_18"></A>MATERIAL U.S. FEDERAL INCOME TAX CONSEQUENCES TO <FONT
STYLE="white-space:nowrap">NON-U.S.</FONT> HOLDERS OF OUR </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>COMMON STOCK </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following summary describes the material U.S. federal income tax consequences of the acquisition, ownership and disposition of our common
stock acquired in this offering by <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders (as defined below).&nbsp;This discussion is not a complete analysis of all potential U.S. federal income tax consequences relating thereto, and does not deal
with foreign, state and local consequences that may be relevant to <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders in light of their particular circumstances, nor does it address U.S. federal tax consequences (such as gift and estate taxes)
other than income taxes.&nbsp;Special rules different from those described below may apply to certain <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders that are subject to special treatment under the Internal Revenue Code of 1986, as amended
(the &#147;Code&#148;), such as financial institutions, insurance companies, <FONT STYLE="white-space:nowrap">tax-exempt</FONT> organizations, broker-dealers and traders in securities, U.S. expatriates, &#147;controlled foreign corporations,&#148;
&#147;passive foreign investment companies,&#148; corporations that accumulate earnings to avoid U.S. federal income tax, corporations organized outside of the United States, any state thereof or the District of Columbia that are nonetheless treated
as U.S. taxpayers for U.S. federal income tax purposes, persons that hold our common stock as part of a &#147;straddle,&#148; &#147;hedge,&#148; &#147;conversion transaction,&#148; &#147;synthetic security&#148; or integrated investment or other
risk reduction strategy, persons who acquire our common stock through the exercise of an option or otherwise as compensation, persons subject to the alternative minimum tax or federal Medicare contribution tax on net investment income, persons
subject to special tax accounting rules under Section&nbsp;451(b) of the Code, &#147;qualified foreign pension funds&#148; as defined in Section&nbsp;897(l)(2) of the Code and entities all of the interests of which are held by qualified foreign
pension funds, partnerships and other pass-through entities or arrangements, and investors in such pass-through entities or arrangements. Such <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders are urged to consult their own tax advisors to
determine the U.S. federal, state, local and other tax consequences that may be relevant to them.&nbsp;Furthermore, the discussion below is based upon the provisions of the Code, and Treasury Regulations, rulings and judicial decisions thereunder as
of the date hereof, and such authorities may be repealed, revoked or modified, perhaps retroactively, so as to result in U.S. federal income tax consequences different from those discussed below.&nbsp;We have not requested a ruling from the U.S.
Internal Revenue Service (the &#147;IRS&#148;) with respect to the statements made and the conclusions reached in the following summary, and there can be no assurance that the IRS will agree with such statements and conclusions.&nbsp;This discussion
assumes that the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder holds our common stock as a &#147;capital asset&#148; within the meaning of Section&nbsp;1221 of the Code (generally, property held for investment). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This discussion is for informational purposes only and is not tax advice. Persons considering the purchase of our common stock pursuant to
this offering should consult their own tax advisors concerning the U.S. federal income, estate and other tax consequences of acquiring, owning and disposing of our common stock in light of their particular situations as well as any consequences
arising under the laws of any other taxing jurisdiction, including any state, local or foreign tax consequences. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For the purposes of this
discussion, a <FONT STYLE="white-space:nowrap">&#147;Non-U.S.</FONT> Holder&#148; is, for U.S. federal income tax purposes, a beneficial owner of common stock that is neither a U.S. Holder, nor a partnership (or other entity treated as a partnership
for U.S. federal income tax purposes regardless of its place of organization or formation).&nbsp;A &#147;U.S. Holder&#148; means a beneficial owner of our common stock that is for U.S. federal income tax purposes any of the following: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an individual who is a citizen or resident of the United States; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a corporation or other entity treated as a corporation for U.S. federal income tax purposes created or organized
in or under the laws of the U.S., any state thereof or the District of Columbia; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an estate the income of which is subject to U.S. federal income taxation regardless of its source; or
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">a trust if it (1)&nbsp;is subject to the primary supervision of a court within the U.S. and one or more U.S.
persons have the authority to control all substantial decisions of the trust or (2)&nbsp;has a valid election in effect under applicable U.S. Treasury regulations to be treated as a U.S. person. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">183 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Distributions </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Distributions, if any, made on our common stock to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder to the extent made out of our
current or accumulated earnings and profits (as determined under U.S. federal income tax principles) generally will constitute dividends for U.S. tax purposes and will be subject to withholding tax at a 30% rate or such lower rate as may be
specified by an applicable income tax treaty, subject to the discussions below regarding effectively connected income, backup withholding and foreign accounts.&nbsp;To obtain a reduced rate of withholding under a treaty, a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder generally will be required to provide us or our paying agent with a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> (in the case of individuals) or IRS Form <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> (in the case of entities), or other appropriate form, certifying the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s entitlement to benefits under that
treaty. This certification must be provided to us or our paying agent prior to the payment of dividends and must be updated periodically. In the case of a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that is an entity, Treasury
Regulations and the relevant tax treaty provide rules to determine whether, for purposes of determining the applicability of a tax treaty, dividends will be treated as paid to the entity or to those holding an interest in that entity.&nbsp;If a <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder holds stock through a financial institution or other agent acting on the holder&#146;s behalf, the holder will be required to provide appropriate documentation to such agent.&nbsp;The holder&#146;s
agent will then be required to provide certification to us or our paying agent, either directly or through other intermediaries.&nbsp;If you are eligible for a reduced rate of U.S. federal withholding tax under an income tax treaty and you do not
timely file the required certification, you may be able to obtain a refund or credit of any excess amounts withheld by timely filing an appropriate claim for a refund with the IRS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We generally are not required to withhold tax on dividends paid to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder that are
effectively connected with the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s conduct of a trade or business within the United States (and, if required by an applicable income tax treaty, are attributable to a permanent establishment
or fixed base that such holder maintains in the United States) if a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8ECI,</FONT> stating that the dividends are so connected, is furnished to us or our paying agent (or, if stock is
held through a financial institution or other agent, to such agent).&nbsp;In general, such effectively connected dividends will be subject to U.S. federal income tax, on a net income basis at the regular rates applicable to U.S. residents.&nbsp;A
corporate <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder receiving effectively connected dividends may also be subject to an additional &#147;branch profits tax,&#148; which is imposed, under certain circumstances, at a rate of 30% (or such
lower rate as may be specified by an applicable treaty) on the corporate <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s effectively connected earnings and profits, subject to certain adjustments.
<FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders should consult their tax advisors regarding any applicable income tax treaties that may provide for different rules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">To the extent distributions on our common stock, if any, exceed our current and accumulated earnings and profits, they will first reduce the <FONT
STYLE="white-space:nowrap">Non-U.S.</FONT> Holder&#146;s adjusted basis in our common stock, but not below zero, and then will be treated as gain to the extent of any excess amount distributed, and taxed in the same manner as gain realized from a
sale or other disposition of common stock as described in the next section. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Gain on Disposition of Our Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Subject to the discussions below regarding backup withholding and foreign accounts, a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder
generally will not be subject to U.S. federal income tax with respect to gain realized on a sale or other disposition of our common stock unless (a)&nbsp;the gain is effectively connected with a trade or business of such holder in the United States
(and, if required by an applicable income tax treaty, is attributable to a permanent establishment or fixed base that such holder maintains in the United States), (b)&nbsp;the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder is a nonresident
alien individual and is present in the United States for 183 or more days in the taxable year of the disposition and certain other conditions are met or (c)&nbsp;we are or have been a &#147;United States real property holding corporation&#148;
within the meaning of Code Section&nbsp;897(c)(2) at any time within the shorter of the five-year period preceding such disposition or such holder&#146;s holding period.&nbsp;In general, we would be a United States real property holding corporation
if our interests in U.S. real estate comprise (by fair market value) at least half of our business assets.&nbsp;We believe that we have not been and we are not, and do not anticipate becoming, a United States real
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">184 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
property holding corporation.&nbsp;Even if we are treated as a United States real property holding corporation, gain realized by a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder on a
disposition of our common stock will not be subject to U.S. federal income tax so long as (1)&nbsp;the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder owned, directly, indirectly and constructively, no more than 5% of our common stock at all
times within the shorter of (i)&nbsp;the five-year period preceding the disposition or (ii)&nbsp;the holder&#146;s holding period and (2)&nbsp;our common stock is regularly traded on an established securities market. There can be no assurance that
our common stock will continue to qualify as regularly traded on an established securities market. If any gain on your disposition is taxable because we are a United States real property holding corporation and your ownership of our common stock
exceeds 5%, you will be taxed on such disposition generally in the manner as gain that is effectively connected with the conduct of a U.S. trade or business (subject to the provisions under an applicable income tax treaty), except that the branch
profits tax generally will not apply. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">If you are a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder described in (a)&nbsp;above,
you will be required to pay tax on the net gain derived from the sale at regular U.S. federal income tax rates, and corporate <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holders described in (a)&nbsp;above may be subject to the additional
branch profits tax at a 30% rate or such lower rate as may be specified by an applicable income tax treaty.&nbsp;Gain described in (b)&nbsp;above will be subject to U.S. federal income tax at a flat 30% rate or such lower rate as may be specified by
an applicable income tax treaty, which gain may be offset by certain U.S.-source capital losses (even though you are not considered a resident of the United States), provided that the <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder has
timely filed U.S. federal income tax returns with respect to such losses. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Information Reporting Requirements and Backup Withholding </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Generally, we must report information to the IRS with respect to any dividends we pay on our common stock (even if the payments are exempt
from withholding), including the amount of any such dividends, the name and address of the recipient, and the amount, if any, of tax withheld.&nbsp;A similar report is sent to the holder to whom any such dividends are paid.&nbsp;Pursuant to tax
treaties or certain other agreements, the IRS may make its reports available to tax authorities in the recipient&#146;s country of residence. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Dividends paid by us (or our paying agents) to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder may also be subject to U.S. backup
withholding.&nbsp;U.S. backup withholding generally will not apply to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder who provides a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN,</FONT> IRS Form <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or IRS Form <FONT STYLE="white-space:nowrap">W-ECI,</FONT> or otherwise establishes an exemption. Notwithstanding the foregoing, backup withholding may apply if the
payor has actual knowledge, or reason to know, that the holder is a U.S. person who is not an exempt recipient. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">U.S. information
reporting and backup withholding requirements generally will apply to the proceeds of a disposition of our common stock effected by or through a U.S. office of any broker, U.S. or foreign, except that information reporting and such requirements may
be avoided if the holder provides a properly executed IRS <FONT STYLE="white-space:nowrap">Form&nbsp;W-8BEN</FONT> or IRS Form <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">W-8BEN-E</FONT></FONT> or otherwise meets documentary
evidence requirements for establishing <FONT STYLE="white-space:nowrap">non-U.S.</FONT> person status or otherwise establishes an exemption.&nbsp;Generally, U.S. information reporting and backup withholding requirements will not apply to a payment
of disposition proceeds to a <FONT STYLE="white-space:nowrap">Non-U.S.</FONT> Holder where the transaction is effected outside the United States through a <FONT STYLE="white-space:nowrap">non-U.S.</FONT> office of a
<FONT STYLE="white-space:nowrap">non-U.S.</FONT> broker.&nbsp;Information reporting and backup withholding requirements may, however, apply to a payment of disposition proceeds if the broker has actual knowledge, or reason to know, that the holder
is, in fact, a U.S. person.&nbsp;For information reporting purposes, certain brokers with substantial U.S. ownership or operations will generally be treated in a manner similar to U.S. brokers. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Backup withholding is not an additional tax. Any amounts withheld under the backup withholding rules may be credited against the tax liability
of persons subject to backup withholding, provided that the required information is timely furnished to the IRS. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Foreign Accounts </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Sections 1471 through 1474 of the Code (commonly referred to as FATCA) impose a U.S. federal withholding tax of 30% on certain payments,
including dividends paid on and the gross proceeds of a disposition </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">185 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
of our common stock paid to a foreign financial institution (as specifically defined by applicable rules) unless such institution enters into an agreement with the U.S. government to withhold on
certain payments and to collect and provide to the U.S. tax authorities substantial information regarding U.S. account holders of such institution (which includes certain equity holders of such institution, as well as certain account holders that
are foreign entities with U.S. owners).&nbsp;FATCA also generally imposes a federal withholding tax of 30% on certain payments, including dividends paid on and the gross proceeds of a disposition of our common stock to a <FONT
STYLE="white-space:nowrap">non-financial</FONT> foreign entity unless such entity provides the withholding agent with either a certification that it does not have any substantial direct or indirect U.S. owners or provides information regarding
substantial direct and indirect U.S. owners of the entity.&nbsp;An intergovernmental agreement between the United States and an applicable foreign country may modify those requirements. The withholding tax described above will not apply if the
foreign financial institution or <FONT STYLE="white-space:nowrap">non-financial</FONT> foreign entity otherwise qualifies for an exemption from the rules.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The withholding provisions described above currently apply to payments of dividends, and, subject to the recently released proposed Treasury
Regulations described below, will apply to payments of gross proceeds from a sale or other disposition of common stock on or after January&nbsp;1, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The U.S. Treasury Department recently released proposed regulations which, if finalized in their present form, would eliminate the federal
withholding tax of 30% applicable to the gross proceeds of a disposition of our common stock. In its preamble to such proposed regulations, the U.S. Treasury Department stated that taxpayers may generally rely on the proposed regulations until final
regulations are issued. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Holders are encouraged to consult with their own tax advisors regarding the possible implications of FATCA on
their investment in our common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman"><B>EACH PROSPECTIVE INVESTOR SHOULD CONSULT ITS OWN TAX ADVISOR REGARDING THE TAX CONSEQUENCES OF
PURCHASING, HOLDING AND DISPOSING OF OUR COMMON STOCK, INCLUDING THE CONSEQUENCES OF ANY RECENT OR PROPOSED CHANGE IN APPLICABLE LAW. </B></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">186 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_19"></A>UNDERWRITING </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">BMO Capital Markets Corp., Wells Fargo Securities, LLC and UBS Securities LLC are acting as representatives of each of the underwriters named
below. Subject to the terms and conditions set forth in an underwriting agreement among us and the underwriters, we have agreed to sell to the underwriters, and each of the underwriters has agreed, severally and not jointly, to purchase from us, the
number of shares of common stock set forth opposite its name below. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="87%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" ROWSPAN="2" NOWRAP><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<U>Underwriter</U></B></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>Number&nbsp;of<BR>Shares</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BMO Capital Markets Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UBS Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Subject to the terms and conditions set forth in the underwriting agreement, the underwriters have
agreed, severally and not jointly, to purchase all of the shares sold under the underwriting agreement if any of these shares are purchased. If an underwriter defaults, the underwriting agreement provides that the purchase commitments of the
nondefaulting underwriters may be increased or the underwriting agreement may be terminated. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have agreed to indemnify the underwriters
against certain liabilities, including liabilities under the Securities Act, or to contribute to payments the underwriters may be required to make in respect of those liabilities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The underwriters are offering the shares, subject to prior sale, when, as and if issued to and accepted by them, subject to approval of legal
matters by their counsel, including the validity of the shares, and other conditions contained in the underwriting agreement, such as the receipt by the underwriters of officer&#146;s certificates and legal opinions. The underwriters reserve the
right to withdraw, cancel or modify offers to the public and to reject orders in whole or in part. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Commissions and Discounts </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The representatives have advised us that the underwriters propose initially to offer the shares to the public at the public offering price set
forth on the cover page of this prospectus and to dealers at that price less a concession not in excess of $&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; per share. After the initial offering, the public offering price, concession or any other
term of the offering may be changed. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table shows the public offering price, underwriting discount and proceeds before
expenses to us. The information assumes either no exercise or full exercise by the underwriters of their option to purchase additional shares. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="13%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Per&nbsp;Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Without&nbsp;Option</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>With&nbsp;Option</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Public offering price</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Underwriting discount</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds, before expenses, to us</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The expenses of the offering, not including the underwriting discount, are estimated at
$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; and are payable by us.<SUP STYLE="font-size:85%; vertical-align:top"> </SUP>We have agreed to reimburse the underwriters for expenses relating to clearance of this offering
with the Financial Industry Regulatory Authority up to $50,000. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">187 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Option to Purchase Additional Shares </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have granted an option to the underwriters, exercisable for 30 days after the date of this prospectus, to purchase up to
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; additional shares of our common stock at the public offering price, less the underwriting discount. If the underwriters exercise this option, each will be obligated, subject to
conditions contained in the underwriting agreement, to purchase a number of additional shares proportionate to that underwriter&#146;s initial amount reflected in the above table. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Reserved Share Program </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">At our request,
the underwriters have reserved up to 5% of the shares offered by this prospectus, for sale at the initial public offering price in a reserved share program, to our directors, officers, employees, consultants and related persons. If these persons
purchase reserved shares, this will reduce the number of shares available for sale to the general public. Any reserved shares that are not so purchased will be offered by the underwriters to the general public on the same terms as the other shares
offered by this prospectus. Participants in the reserved share program will not be subject to lockup or market standoff restrictions with the underwriters or with us with respect to any shares purchased through the reserved share program, except in
the case of shares purchased by any director or executive officer. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>No Sales of Similar Securities </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We, our executive officers and directors and our other existing security holders have agreed not to sell or transfer any common stock or
securities convertible into, exchangeable for, exercisable for, or repayable with common stock, for the period ending 180 days after the date of this prospectus without first obtaining the written consent of the representatives. Specifically, we and
these other persons have agreed, with certain limited exceptions, not to directly or indirectly: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">offer, pledge, sell or contract to sell any common stock, </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell any option or contract to purchase any common stock, </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">purchase any option or contract to sell any common stock, </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">grant any option, right or warrant to purchase any common stock, </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">otherwise dispose of or transfer any common stock, </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">request or demand that we file or make a confidential submission of a registration statement related to the
common stock or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">enter into any swap or other agreement or any transaction that transfers in whole or in part, directly or
indirectly, the economic consequence of ownership of any common stock whether any such swap or transaction is to be settled by delivery of shares or other securities, in cash or otherwise. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The exceptions permit our executive officers and directors and other existing security holders, subject to certain restrictions, to: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfer the common stock (i)&nbsp;as a bona fide gift or gifts, (ii)&nbsp;to the person&#146;s immediate family
or any trust for the direct or indirect benefit of the person or their immediate family, (iii)&nbsp;as a distribution to the person&#146;s limited partners or stockholders, (iv)&nbsp;to the person&#146;s affiliates or any investment fund or other
entity controlled or managed by the person, or (v) by will of intestate successor. </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">188 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfer the common stock to us upon exercise of any option granted under our incentive plans described in this
prospectus, including the surrender of shares of common stock to us in &#147;net&#148; or &#147;cashless&#148; exercise of any option; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfer the common stock to us in connection with our repurchase of shares of common stock pursuant to a
repurchase right arising upon the termination of the person&#146;s employment with us; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">convert our preferred stock into shares of common stock; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">transfer the common stock pursuant to an order of a court of competent jurisdiction or in connection with a
qualified domestic order or divorce settlement; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">establishing a trading plan pursuant to Rule 10b5-1 under the Exchange Act, provided that no sales of common
stock are made under such plans during the restricted period; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">sell shares of our common stock purchased in the initial public offering or on the open market following the
initial public offering. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This <FONT STYLE="white-space:nowrap">lock-up</FONT> provision applies to common stock and to
securities convertible into or exchangeable or exercisable for or repayable with common stock. It also applies to common stock owned now or acquired later by the person executing the agreement or for which the person executing the agreement later
acquires the power of disposition. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Nasdaq Global Market Listing </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We expect the shares to be approved for listing on the Nasdaq Global Market, subject to notice of issuance, under the symbol &#147;RAPT.&#148;
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Before this offering, there has been no public market for our common stock. The initial public offering price will be determined through
negotiations among us and the representatives. In addition to prevailing market conditions, the factors to be considered in determining the initial public offering price are: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the valuation multiples of publicly traded companies that the representatives believe to be comparable to us,
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">our financial information, </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the history of, and the prospects for, our company and the industry in which we compete, </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">an assessment of our management, its past and present operations, and the prospects for, and timing of, our
future revenues, </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the present state of our development, and </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="9%">&nbsp;</TD>
<TD WIDTH="2%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">the above factors in relation to market values and various valuation measures of other companies engaged in
activities similar to ours. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">An active trading market for the shares may not develop. It is also possible that after the
offering the shares will not trade in the public market at or above the initial public offering price. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The underwriters do not expect to
sell more than 5% of the shares in the aggregate to accounts over which they exercise discretionary authority. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">189 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Price Stabilization, Short Positions and Penalty Bids </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Until the distribution of the shares is completed, SEC rules may limit underwriters from bidding for and purchasing our common stock. However,
the representatives may engage in transactions that stabilize the price of the common stock, such as bids or purchases to peg, fix or maintain that price. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In connection with the offering, the underwriters may purchase and sell our common stock in the open market. These transactions may include
short sales, purchases on the open market to cover positions created by short sales and stabilizing transactions. Short sales involve the sale by the underwriters of a greater number of shares than they are required to purchase in the offering.
&#147;Covered&#148; short sales are sales made in an amount not greater than the underwriters&#146; option to purchase additional shares described above. The underwriters may close out any covered short position by either exercising their option to
purchase additional shares or purchasing shares in the open market. In determining the source of shares to close out the covered short position, the underwriters will consider, among other things, the price of shares available for purchase in the
open market as compared to the price at which they may purchase shares through the option granted to them. &#147;Naked&#148; short sales are sales in excess of such option. The underwriters must close out any naked short position by purchasing
shares in the open market. A naked short position is more likely to be created if the underwriters are concerned that there may be downward pressure on the price of our common stock in the open market after pricing that could adversely affect
investors who purchase in the offering. Stabilizing transactions consist of various bids for or purchases of shares of common stock made by the underwriters in the open market prior to the completion of the offering. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The underwriters may also impose a penalty bid. This occurs when a particular underwriter repays to the underwriters a portion of the
underwriting discount received by it because the representatives have repurchased shares sold by or for the account of such underwriter in stabilizing or short covering transactions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Similar to other purchase transactions, the underwriters&#146; purchases to cover the syndicate short sales may have the effect of raising or
maintaining the market price of our common stock or preventing or retarding a decline in the market price of our common stock. As a result, the price of our common stock may be higher than the price that might otherwise exist in the open market. The
underwriters may conduct these transactions on the Nasdaq Global Market, in the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">over-the-counter</FONT></FONT> market or otherwise. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Neither we nor any of the underwriters make any representation or prediction as to the direction or magnitude of any effect that the
transactions described above may have on the price of our common stock. In addition, neither we nor any of the underwriters make any representation that the representatives will engage in these transactions or that these transactions, once
commenced, will not be discontinued without notice. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Electronic Distribution </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In connection with the offering, certain of the underwriters or securities dealers may distribute prospectuses by electronic means, such as
email. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Other Relationships </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Some of
the underwriters and their affiliates have engaged in, and may in the future engage in, investment banking and other commercial dealings in the ordinary course of business with us or our affiliates. They have received, or may in the future receive,
customary fees and commissions for these transactions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, in the ordinary course of their business activities, the underwriters
and their affiliates may make or hold a broad array of investments and actively trade debt and equity securities (or related derivative securities) and financial instruments (including bank loans) for their own account and for the accounts of their
customers. Such investments and securities activities may involve securities and/or instruments of ours or our affiliates. The underwriters and their affiliates may also make investment recommendations and/or publish or express independent research
views in respect of such securities or financial instruments and may hold, or recommend to clients that they acquire, long and/or short positions in such securities and instruments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">190 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>European Economic Area </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In relation to each member state of the European Economic Area (each a &#147;Member State&#148;), no shares have been offered or will be
offered pursuant to the offering to the public in that Member State prior to the publication of a prospectus in relation to the shares which has been approved by the competent authority in that Member State or, where appropriate, approved in another
Member State and notified to the competent authority in that Member State, all in accordance with the Prospectus Regulation, except that offers of shares may be made to the public in that Member State at any time under the following exemptions under
the Prospectus Regulation: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to any legal entity which is a qualified investor as defined in the Prospectus Regulation;
</P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to fewer than 150 natural or legal persons (other than qualified investors as defined in the Prospectus
Regulation), subject to obtaining the prior consent of the representatives for any such offer; or </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">in any other circumstances falling within Article 1(4) of the Prospectus Regulation, </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><I>provided</I> that no such offer of shares shall require the Company or any representative to publish a prospectus pursuant to Article 3 of the Prospectus
Regulation or supplement a prospectus pursuant to Article 23 of the Prospectus Regulation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For the purposes of this provision, the
expression an &#147;offer to the public&#148; in relation to any shares in any Member State means the communication in any form and by any means of sufficient information on the terms of the offer and any shares to be offered so as to enable an
investor to decide to purchase or subscribe for any shares, and the expression &#147;Prospectus Regulation&#148; means Regulation (EU) 2017/1129. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The above selling restriction is in addition to any other selling restrictions set out below. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in the United Kingdom </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In addition, in the United Kingdom, this document is being distributed only to, and is directed only at, and any offer subsequently made may
only be directed at persons who are &#147;qualified investors&#148; (as defined in the Prospectus Directive)&nbsp;(i) who have professional experience in matters relating to investments falling within Article 19 (5) of the Financial Services and
Markets Act 2000 (Financial Promotion) Order 2005, as amended (the &#147;Order&#148;) and/or (ii)&nbsp;who are high net worth companies (or persons to whom it may otherwise be lawfully communicated) falling within Article 49(2)(a) to (d)&nbsp;of the
Order (all such persons together being referred to as &#147;relevant persons&#148;). This document must not be acted on or relied on in the United Kingdom by persons who are not relevant persons. In the United Kingdom, any investment or investment
activity to which this document relates is only available to, and will be engaged in with, relevant persons. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in
Switzerland </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The shares may not be publicly offered in Switzerland and will not be listed on the SIX Swiss Exchange (&#147;SIX&#148;)
or on any other stock exchange or regulated trading facility in Switzerland. This document has been prepared without regard to the disclosure standards for issuance prospectuses under art. 652a or art. 1156 of the Swiss Code of Obligations or the
disclosure standards for listing prospectuses under art. 27 ff. of the SIX Listing Rules or the listing rules of any other stock exchange or regulated trading facility in Switzerland. Neither this document nor any other offering or marketing
material relating to the shares or the offering may be publicly distributed or otherwise made publicly available in Switzerland. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Neither
this document nor any other offering or marketing material relating to the offering, the Company, nor the shares have been or will be filed with or approved by any Swiss regulatory authority. In </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">191 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
particular, this document will not be filed with, and the offer of shares will not be supervised by, the Swiss Financial Market Supervisory Authority FINMA (FINMA), and the offer of shares has
not been and will not be authorized under the Swiss Federal Act on Collective Investment Schemes (&#147;CISA&#148;). The investor protection afforded to acquirers of interests in collective investment schemes under the CISA does not extend to
acquirers of shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in the Dubai International Financial Centre </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This prospectus relates to an Exempt Offer in accordance with the Offered Securities Rules of the Dubai Financial Services Authority
(&#147;DFSA&#148;). This prospectus is intended for distribution only to persons of a type specified in the Offered Securities Rules of the DFSA. It must not be delivered to, or relied on by, any other person. The DFSA has no responsibility for
reviewing or verifying any documents in connection with Exempt Offers. The DFSA has not approved this prospectus nor taken steps to verify the information set forth herein and has no responsibility for the prospectus. The shares to which this
prospectus relates may be illiquid and/or subject to restrictions on their resale. Prospective purchasers of the shares offered should conduct their own due diligence on the shares. If you do not understand the contents of this prospectus you should
consult an authorized financial advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Australia </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">No placement document, prospectus, product disclosure statement or other disclosure document has been lodged with the Australian Securities
and Investments Commission (&#147;ASIC&#148;), in relation to the offering. This prospectus does not constitute a prospectus, product disclosure statement or other disclosure document under the Corporations Act 2001 (the &#147;Corporations
Act&#148;), and does not purport to include the information required for a prospectus, product disclosure statement or other disclosure document under the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Any offer in Australia of the shares may only be made to persons (the &#147;Exempt Investors&#148;) who are &#147;sophisticated
investors&#148; (within the meaning of section 708(8) of the Corporations Act), &#147;professional investors&#148; (within the meaning of section 708(11) of the Corporations Act) or otherwise pursuant to one or more exemptions contained in section
708 of the Corporations Act so that it is lawful to offer the shares without disclosure to investors under Chapter 6D of the Corporations Act. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The shares applied for by Exempt Investors in Australia must not be offered for sale in Australia in the period of 12 months after the date of
allotment under the offering, except in circumstances where disclosure to investors under Chapter 6D of the Corporations Act would not be required pursuant to an exemption under section 708 of the Corporations Act or otherwise or where the offer is
pursuant to a disclosure document which complies with Chapter 6D of the Corporations Act. Any person acquiring shares must observe such Australian <FONT STYLE="white-space:nowrap">on-sale</FONT> restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This prospectus contains general information only and does not take account of the investment objectives, financial situation or particular
needs of any particular person. It does not contain any securities recommendations or financial product advice. Before making an investment decision, investors need to consider whether the information in this prospectus is appropriate to their
needs, objectives and circumstances, and, if necessary, seek expert advice on those matters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Hong Kong </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The securities have not been offered or sold and will not be offered or sold in Hong Kong, by means of any document, other than (a)&nbsp;to
&#147;professional investors&#148; as defined in the Securities and Futures Ordinance (Cap. 571) of Hong Kong and any rules made under that Ordinance; or (b)&nbsp;in other circumstances which do not result in the document being a
&#147;prospectus&#148; as defined in the Companies Ordinance (Cap. 32) of Hong Kong or which do not constitute an offer to the public within the meaning of that Ordinance. No advertisement, invitation or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">192 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
document relating to the securities has been or may be issued or has been or may be in the possession of any person for the purposes of issue, whether in Hong Kong or elsewhere, which is directed
at, or the contents of which are likely to be accessed or read by, the public of Hong Kong (except if permitted to do so under the securities laws of Hong Kong) other than with respect to securities which are or are intended to be disposed of only
to persons outside Hong Kong or only to &#147;professional investors&#148; as defined in the Securities and Futures Ordinance and any rules made under that Ordinance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Japan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The securities have not been and will not be registered under the Financial Instruments and Exchange Law of Japan (Law No.&nbsp;25 of 1948, as
amended) and, accordingly, will not be offered or sold, directly or indirectly, in Japan, or for the benefit of any Japanese Person or to others for <FONT STYLE="white-space:nowrap">re-offering</FONT> or resale, directly or indirectly, in Japan or
to any Japanese Person, except in compliance with all applicable laws, regulations and ministerial guidelines promulgated by relevant Japanese governmental or regulatory authorities in effect at the relevant time. For the purposes of this paragraph,
&#147;Japanese Person&#148; shall mean any person resident in Japan, including any corporation or other entity organized under the laws of Japan. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Singapore </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">This prospectus has not been registered as a prospectus with the Monetary Authority of Singapore. Accordingly, this prospectus and any other
document or material in connection with the offer or sale, or invitation for subscription or purchase, of securities may not be circulated or distributed, nor may the securities be offered or sold, or be made the subject of an invitation for
subscription or purchase, whether directly or indirectly, to persons in Singapore other than (i)&nbsp;to an institutional investor under Section&nbsp;274 of the Securities and Futures Act, Chapter 289 of Singapore (the &#147;SFA&#148;), (ii) to a
relevant person pursuant to Section&nbsp;275(1), or any person pursuant to Section&nbsp;275(1A), and in accordance with the conditions specified in Section&nbsp;275, of the SFA, or (iii)&nbsp;otherwise pursuant to, and in accordance with the
conditions of, any other applicable provision of the SFA. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Where the securities are subscribed or purchased under Section&nbsp;275 of the
SFA by a relevant person which is: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(a)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a corporation (which is not an accredited investor (as defined in Section&nbsp;4A of the SFA)) the sole
business of which is to hold investments and the entire share capital of which is owned by one or more individuals, each of whom is an accredited investor; or </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(b)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">a trust (where the trustee is not an accredited investor) whose sole purpose is to hold investments and each
beneficiary of the trust is an individual who is an accredited investor, </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">securities (as defined in Section&nbsp;239(1) of the SFA) of
that corporation or the beneficiaries&#146; rights and interest (howsoever described) in that trust shall not be transferred within six months after that corporation or that trust has acquired the securities pursuant to an offer made under
Section&nbsp;275 of the SFA except: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(c)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to an institutional investor or to a relevant person defined in Section&nbsp;275(2) of the SFA, or to any
person arising from an offer referred to in Section&nbsp;275(1A) or Section&nbsp;276(4)(i)(B) of the SFA; </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(d)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where no consideration is or will be given for the transfer; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(e)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">where the transfer is by operation of law; </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(f)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Section&nbsp;276(7) of the SFA; or </P></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">193 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(g)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as specified in Regulation 32 of the Securities and Futures (Offers of Investments) (Shares and Debentures)
Regulations 2005 of Singapore. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Notice to Prospective Investors in Canada </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The securities may be sold only to purchasers purchasing, or deemed to be purchasing, as principal that are accredited investors, as defined
in National Instrument <FONT STYLE="white-space:nowrap">45-106</FONT> <I>Prospectus Exemptions</I> or subsection 73.3(1) of the <I>Securities Act</I> (Ontario), and are permitted clients, as defined in National Instrument <FONT
STYLE="white-space:nowrap">31-103</FONT> <I>Registration Requirements, Exemptions and Ongoing Registrant Obligations</I>. Any resale of the securities must be made in accordance with an exemption from, or in a transaction not subject to, the
prospectus requirements of applicable securities laws. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Securities legislation in certain provinces or territories of Canada may provide a
purchaser with remedies for rescission or damages if this prospectus (including any amendment thereto) contains a misrepresentation, provided that the remedies for rescission or damages are exercised by the purchaser within the time limit prescribed
by the securities legislation of the purchaser&#146;s province or territory. The purchaser should refer to any applicable provisions of the securities legislation of the purchaser&#146;s province or territory for particulars of these rights or
consult with a legal advisor. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to section 3A.3 (or, in the case of securities issued or guaranteed by the government of a <FONT
STYLE="white-space:nowrap">non-Canadian</FONT> jurisdiction, section 3A.4) of National Instrument <FONT STYLE="white-space:nowrap">33-105</FONT> <I>Underwriting Conflicts</I> (NI <FONT STYLE="white-space:nowrap">33-105),</FONT> the underwriters are
not required to comply with the disclosure requirements of NI <FONT STYLE="white-space:nowrap">33-105</FONT> regarding underwriter conflicts of interest in connection with this offering. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">194 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_20"></A>LEGAL MATTERS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The validity of the shares of common stock being offered by this prospectus will be passed upon for us by Cooley LLP, Palo Alto, California.
The underwriters are being represented by Davis Polk&nbsp;&amp; Wardwell LLP, Menlo Park, California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_21"></A>EXPERTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Ernst&nbsp;&amp; Young LLP, independent registered public accounting firm, has audited our consolidated financial statements at
December&nbsp;31, 2017 and 2018, and for the years then ended, as set forth in their report. We have included our financial statements in this prospectus and elsewhere in the registration statement in reliance on Ernst&nbsp;&amp; Young LLP&#146;s
report, given on their authority as experts in accounting and auditing. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_22"></A>WHERE YOU CAN FIND MORE
INFORMATION </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have filed with the SEC a registration statement on Form <FONT STYLE="white-space:nowrap">S-1,</FONT> including
exhibits and schedules, under the Securities Act, with respect to the shares of common stock being offered by this prospectus. This prospectus, which constitutes part of the registration statement, does not contain all of the information in the
registration statement and its exhibits. For further information with respect to us and the common stock offered by this prospectus, we refer you to the registration statement and its exhibits. Statements contained in this prospectus as to the
contents of any contract or any other document referred to are not necessarily complete, and in each instance, we refer you to the copy of the contract or other document filed as an exhibit to the registration statement. Each of these statements is
qualified in all respects by this reference. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">You can read our SEC filings, including the registration statement, over the internet at the
SEC&#146;s website at www.sec.gov. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Upon the closing of this offering, we will be subject to the information reporting requirements of the
Securities Exchange Act of 1934 and we will file reports, proxy statements and other information with the SEC. These reports, proxy statements and other information will be available for inspection at the website of the SEC referred to above. We
also maintain a website at www.rapt.com, at which, following the closing of this offering, you may access these materials free of charge as soon as reasonably practicable after they are electronically filed with, or furnished to, the SEC.
Information contained on or accessible through our website is not a part of this prospectus, and the inclusion of our website address in this prospectus is an inactive textual reference only. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">195 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="toc723949_23"></A>INDEX TO CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="95%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Years ended December&nbsp;31, 2017 and 2018</B></P>
<P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Page</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_1">Report of Independent Registered Public Accounting Firm </A></P>
<P STYLE="font-size:4pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-2</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Consolidated Financial Statements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_2">Consolidated Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-3</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_3">Consolidated Statements of Operations and Comprehensive Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-4</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_4">Consolidated Statements of Convertible Preferred Stock and Stockholders&#146;
 Deficit</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-5</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_5">Consolidated Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-6</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_6">Notes to Consolidated Financial Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-7</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Six Months Ended June 30,
2018 and 2019</B></P> <P STYLE="font-size:12pt; margin-top:0pt; margin-bottom:1pt">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Condensed Consolidated Financial Statements (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_7">Condensed Consolidated Balance Sheets</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-26</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_8">Condensed Consolidated Statements of Operations and Comprehensive
Loss</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-27</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_9">Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders&#146;
 Deficit</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-28</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_10">Condensed Consolidated Statements of Cash Flows</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-29</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><A HREF="#fin723949_11">Notes to Unaudited Interim Condensed Consolidated Financial
Statements</A></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><FONT STYLE="white-space:nowrap">F-30</FONT></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_1"></A>REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">To the Stockholders and the Board of Directors of </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">RAPT
Therapeutics, Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Opinion on the Financial Statements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have audited the accompanying consolidated balance sheets of RAPT Therapeutics, Inc. (f/k/a FLX, Bio, Inc.) (the Company) as of
December&nbsp;31, 2017 and 2018, the related consolidated statements of operations and comprehensive loss, convertible preferred stock and stockholders&#146; deficit, and cash flows for the years then ended, and the related notes (collectively
referred to as the &#147;consolidated financial statements&#148;). In our opinion, the consolidated financial statements present fairly, in all material respects, the financial position of the Company at December&nbsp;31, 2017 and 2018, and the
results of its operations and its cash flows for the years then ended in conformity with U.S. generally accepted accounting principles. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Basis for
Opinion </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">These financial statements are the responsibility of the Company&#146;s management. Our responsibility is to express an
opinion on the Company&#146;s financial statements based on our audits. We are a public accounting firm registered with the Public Company Accounting Oversight Board (United&nbsp;States) (PCAOB) and are required to be independent with respect to the
Company in accordance with the U.S. federal securities laws and the applicable rules and regulations of the Securities and Exchange Commission and the PCAOB. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We conducted our audits in accordance with the standards of the PCAOB. Those standards require that we plan and perform the audit to obtain
reasonable assurance about whether the financial statements are free of material misstatement, whether due to error or fraud. The Company is not required to have, nor were we engaged to perform, an audit of its internal control over financial
reporting. As part of our audits we are required to obtain an understanding of internal control over financial reporting but not for the purpose of expressing an opinion on the effectiveness of the Company&#146;s internal control over financial
reporting. Accordingly, we express no such opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Our audits included performing procedures to assess the risks of material
misstatement of the financial statements, whether due to error or fraud, and performing procedures that respond to those risks. Such procedures included examining, on a test basis, evidence regarding the amounts and disclosures in the financial
statements. Our audits also included evaluating the accounting principles used and significant estimates made by management, as well as evaluating the overall presentation of the financial statements. We believe that our audits provide a reasonable
basis for our opinion. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">/s/ Ernst&nbsp;&amp; Young LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We
have served as the Company&#146;s auditor since 2017. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redwood City, California </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">May&nbsp;24, 2019 </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">except for the retroactive effect of the
1-for-6 reverse stock split as described in Note 2, as to which the date is July&nbsp;22, 2019 </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_2"></A>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED BALANCE SHEETS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except share and per share data) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Pro
forma<BR>Stockholders&#146;<BR>Equity as of<BR>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(Unaudited)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 47,517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 63,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">725</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,264</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">48,242</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,913</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">236</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 50,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 69,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities, Convertible Preferred Stock and Stockholders&#146; Deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,106</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,771</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">650</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,248</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">905</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commitments (See Note 6)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Convertible preferred stock, $0.0001 par value:</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">104,018,468 shares authorized; 75,563,784 and 98,491,880 shares issued and outstanding at December&nbsp;31, 2017 and 2018, respectively;
aggregate liquidation preference of $170,000 at December&nbsp;31, 2018; no shares issued and outstanding, pro forma (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">161,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; Deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value:</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">119,200,000 shares authorized; 880,191 and 878,413 shares issued and outstanding at December&nbsp;31, 2017 and 2018, respectively;
17,293,694 shares issued and outstanding as of December&nbsp;31, 2018, pro forma (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">183,551</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party promissory note for the purchase of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(605</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(598</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(598</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,806</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity </P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(62,405</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(97,113</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 63,998</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities, convertible preferred stock and stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 50,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 69,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>See accompanying notes to consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_3"></A>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except share and per share data) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year Ended
December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 25,618</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 31,767</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,713</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,180</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,331</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,947</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income), net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(216</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(800</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 29,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 36,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 29,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 36,151</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 67.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">58.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average number of shares used in computing net loss per share, basic and diluted</P></TD>

<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">431,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 2.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average number of shares used in computing pro forma net loss per share, basic and
diluted (unaudited)</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,461,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>See accompanying notes to consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_4"></A>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#146; DEFICIT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except share amounts) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="7%"></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="4" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Convertible&nbsp;Preferred</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Stock</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Common Stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Additional<BR><FONT
STYLE="white-space:nowrap">Paid-In</FONT><BR>Capital</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Related&nbsp;Party<BR>Promissory Notes<BR>for the
Purchase<BR>of&nbsp;Common&nbsp;Stock</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Accumulated<BR>Deficit</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Accumulated<BR>Other<BR>Comprehensive<BR>Loss</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total<BR>Stockholders&#146;<BR>Deficit</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Amount</B></P></TD>
<TD VALIGN="bottom" STYLE=" BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Amount</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,509,105</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 78,787</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">868,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">20,043</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(596</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(53,691</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(34,243</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series C convertible preferred stock, net of issuance cost</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,054,679</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,856</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock upon exercise of stock options, net of repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,135</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest on promissory notes from related parties for purchase of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,115</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(29,115</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,563,784</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">108,643</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">880,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(605</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(82,806</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(62,405</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series C convertible preferred stock, net of issuance cost</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,054,684</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,914</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock, net of
issuance cost</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,873,412</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,554</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock upon exercise of stock options, net of repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase of common stock from related party</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest on promissory notes from related parties for purchase of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(10</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency translation adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,147</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(36,147</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,491,880</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">161,111</TD>
<TD NOWRAP VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878,413</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(598</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(118,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(97,113</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom" STYLE="BORDER-RIGHT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>See accompanying notes to consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_5"></A>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONSOLIDATED STATEMENTS OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,115</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(36,147</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss on disposal of capital equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other noncash income (loss), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(9</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other long-term assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(34</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(691</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(80</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27,123</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(32,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,124</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,124</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,500</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from the sale of convertible preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of common stock, net of repurchases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">246</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">266</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,102</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,734</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,855</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at beginning of year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">45,662</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at end of year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 47,517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 63,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental Disclosures of <FONT STYLE="white-space:nowrap">Non-Cash</FONT> Investing and
Financing Information</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment purchases included in accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 753</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>See accompanying notes to consolidated financial statements. </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_6"></A>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Organization and Liquidity Risks </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Description
of the Business </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">RAPT Therapeutics, Inc. (&#147;RAPT&#148; or the &#147;Company&#148;), is a clinical-stage, immunology-based
biopharmaceutical company focused on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary drug discovery and development
engine, the Company develops highly selective small molecules that are designed to modulate the critical immune responses underlying these diseases. In May 2019, the Company changed its name from FLX Bio, Inc. (&#147;FLX&#148;) to RAPT Therapeutics,
Inc. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company is located in South San Francisco, California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Liquidity and Management Plans </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. Since
inception, the Company has incurred net losses and negative cash flows from operations. During the year ended December&nbsp;31, 2018, the Company incurred a net loss of $36.1&nbsp;million and used $33.0&nbsp;million of cash in operations. At
December&nbsp;31, 2018, the Company had cash and cash equivalents of $63.8&nbsp;million and an accumulated deficit of $119.0&nbsp;million. Management expects losses to continue for the next several years and does not expect positive cash flows in
the foreseeable future. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company has historically financed its operations through the sale of convertible preferred stock. The Company
has evaluated and concluded there are no conditions or events, considered in the aggregate, that raise substantial doubt about the Company&#146;s ability to continue as a going concern for a period of at least one year following the date that these
consolidated financial statements were issued. Management expects operating losses to continue for the foreseeable future. As a result, the Company will need to raise additional capital. If sufficient funds on acceptable terms are not available when
needed, the Company could be required to significantly reduce its operating expenses and delay, reduce the scope of or eliminate one or more of its development programs. Failure to manage discretionary spending or raise additional financing, as
needed, may adversely impact the Company&#146;s ability to achieve its intended business objectives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of Significant Accounting Policies
</B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis of Presentation </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The accompanying consolidated financial statements have been prepared in accordance with U.S. generally accepted accounting principles
(&#147;U.S. GAAP&#148;) and include the consolidated accounts of the Company and its wholly-owned subsidiary, RAPT Therapeutics Australia Pty Ltd. which was established in 2018. All intercompany balances and transactions have been eliminated in
consolidation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Split </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">On July&nbsp;19, 2019, the Company filed an amendment to the Company&#146;s amended and restated certificate of incorporation to effect a
reverse split of shares of the Company&#146;s common stock on a one-for-six basis (the Reverse Stock Split). In connection with the Reverse Stock Split, the conversion ratio for the Company&#146;s outstanding convertible preferred stock was
proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was decreased in proportion to the Reverse Stock Split. The par value of the common stock was not adjusted as a result of the Reverse Stock Split.
All references to common stock, options to </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
purchase common stock, early exercised options, share data, per share data, convertible preferred stock (to the extent presented on an as-converted to common stock basis) and related information
contained in these consolidated financial statements have been retrospectively adjusted to reflect the effect of the Reverse Stock Split for all periods presented. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unaudited Pro Forma Financial Information </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma consolidated stockholders&#146; equity as of December&nbsp;31, 2018, assumes the conversion of all outstanding shares
of convertible preferred stock into 98,491,880&nbsp;shares of common stock immediately prior to the completion of the Company&#146;s planned initial public offering (&#147;IPO&#148;). The shares of common stock issuable and the proceeds expected to
be received in the IPO are excluded from such pro forma financial information. Pro forma basic and diluted net loss per share has been computed to give effect to the conversion of all outstanding convertible preferred stock into shares of common
stock. The unaudited pro forma net loss per share for the year ended December&nbsp;31, 2018, was computed using the weighted-average number of shares of common stock outstanding, including the pro forma effect of the conversion of all outstanding
shares of convertible preferred stock into shares of common stock, as if such conversion had occurred at the beginning of the period, or their issuance dates, if later. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Use of Estimates </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The preparation
of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. The Company bases its estimates on historical experience
and market-specific or other relevant assumptions that it believes are reasonable under the circumstances. The amounts of assets and liabilities reported in the Company&#146;s balance sheets and the amount of expenses and income reported for each of
the periods presented are affected by estimates and assumptions, which are used for, but are not limited to, determining the fair value of assets and liabilities, common stock valuation and stock-based compensation. Actual results could differ from
such estimates or assumptions. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Segments </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company operates as a single operating segment. The Company&#146;s chief operating decision maker, its President and Chief Executive
Officer, manages the Company&#146;s operations on a consolidated basis for the purposes of allocating resources, making operating decisions and evaluating financial performance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Fair Value of Financial Instruments </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The carrying amount of the Company&#146;s financial instruments, including certain prepaid and accrued expenses, approximates fair value due
to their short-term maturities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Cash and Cash Equivalents </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Cash equivalents are financial instruments that potentially subject the Company to concentrations of credit risk. The Company considers all
highly liquid investments with original maturities of 90 days or less from the date of purchase to be cash equivalents. The Company invests its cash and cash equivalents in money market funds. The Company limits its credit risk associated with cash
and cash equivalents by placing its cash with banks and institutions it believes are highly credit worthy and in highly-rated investments. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Property and Equipment </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Property and equipment consist of computer equipment, laboratory equipment, leasehold improvements and furniture and fixtures, and is recorded
at cost, less accumulated depreciation and amortization. Depreciation and amortization are calculated using the straight-line method over the estimated useful lives of the respective assets, generally three to five years. Leasehold improvements are
amortized over the shorter of the lease term or the estimated useful life of the improvements. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization begin at the
time the asset is placed in service. Maintenance and repairs are charged to expense as incurred. Upon sale or retirement of assets, the cost and related accumulated depreciation and amortization are removed from the balance sheet and the resulting
gain or loss is reflected in the results of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Impairment of Long-Lived Assets </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company evaluates its long-lived assets for impairment annually or more frequently whenever events or changes in circumstances indicate
that the carrying value of these assets may not be recoverable. Recoverability of these assets is measured by comparing the carrying amount of each asset to the future undiscounted cash flows the asset is expected to generate over its remaining
life. If the asset is considered to be impaired, the amount of any impairment is measured as the difference between the carrying value and the fair value of the impaired asset. As of December&nbsp;31, 2017 and 2018, the Company has not recorded any
impairment losses on long-lived assets. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Leases </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company leases office space and laboratory facilities under <FONT STYLE="white-space:nowrap">non-cancelable</FONT> operating lease
agreements and recognizes related rent expense on a straight-line basis over the term of the lease. Funding of leasehold improvements by the Company&#146;s landlord is accounted for as a tenant improvement allowance and recorded as current and <FONT
STYLE="white-space:nowrap">non-current</FONT> deferred rent liabilities and amortized on a straight-line basis as a reduction of rent expense over the term of the lease. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Convertible Preferred Stock </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The
Company records all shares of convertible preferred stock at their respective fair values on the dates of issuance, less issuance costs. In the event of a change of control of the Company, proceeds received from the sale of such shares will be
distributed in accordance with the liquidation preferences set forth in the Company&#146;s Amended and Restated Certificate of Incorporation unless the holders of the convertible preferred stock have converted their shares of convertible preferred
stock into shares of common stock. Convertible preferred stock is classified outside of stockholders&#146; deficit on the balance sheet as events triggering redemption are not solely within the Company&#146;s control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company has not adjusted the carrying values of its convertible preferred stock to the liquidation preferences of such shares because of
the uncertainty of whether or when such an event would occur. As of December&nbsp;31, 2018, it was not probable that such a redemption would occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Research and Development Costs </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Research and development costs are charged to expense as incurred. Research and development costs consist primarily of salaries and benefits
of research and development personnel, costs related to research </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
activities, preclinical studies, clinical trials, drug manufacturing and allocated overhead and facility-related expenses. The Company accounts
<FONT STYLE="white-space:nowrap">for&nbsp;non-refundable&nbsp;advance</FONT> payments for goods or services that will be used in future research and development activities as expenses when the goods have been received or when the service has been
performed rather than when the payment is made. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Clinical trial costs are a component of research and development expenses. The Company
expenses costs for its clinical trial activities performed by third parties, including clinical research organizations (&#147;CROs&#148;) and other service providers, as they are incurred, based upon estimates of the work completed over the life of
the individual study in accordance with associated agreements. The Company uses information it receives from internal personnel and outside service providers to estimate the clinical trial costs incurred. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-Based Compensation </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The
Company measures employee and director stock-based compensation expense for all stock-based awards based on their grant date fair value using the Black-Scholes option-pricing model. For stock-based awards with service conditions only, stock-based
compensation expense is recognized over the requisite service period using the straight-line method. For awards with performance conditions, the Company evaluates the probability of achieving performance conditions at each reporting date. The
Company begins to recognize stock-based compensation expense using an accelerated attribution method when it is deemed probable that the performance condition will be met. Forfeitures are recognized as they occur. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense for nonemployee stock-based awards is measured at fair value using the Black-Scholes option-pricing
model.&nbsp;The Company recognizes stock-based compensation expense for the estimated fair value of the vested portion of nonemployee awards in its consolidated statements of operations and comprehensive loss. Stock-based compensation expense
related to stock option grants to nonemployees is subject to <FONT STYLE="white-space:nowrap">re-measurement</FONT> over the service period, which approximates the vesting period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense related to restricted stock awards is determined using the estimated fair value of the Company&#146;s common
stock on the date of grant. The estimated fair value is amortized as compensation expense over the service period of the award. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Foreign Currency
Transactions </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The functional currency of RAPT Therapeutics Australia Pty Ltd., our wholly-owned subsidiary, is the Australian
dollar. Accordingly, all monetary assets and liabilities of the subsidiary are translated into U.S. dollars at the <FONT STYLE="white-space:nowrap">current&nbsp;period-end&nbsp;exchange</FONT> rates
<FONT STYLE="white-space:nowrap">and&nbsp;non-monetary&nbsp;assets</FONT> are translated using historical exchange rates. Income and expense elements are remeasured to U.S. dollars using the average exchange rates in effect during the period.
Remeasurement gains and losses are recorded as other income (expense). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company is subject to foreign currency risk with respect to
its clinical contracts denominated in currencies other than the U.S. dollar. Payments on contracts denominated in foreign currencies are made at the spot rate on the day of payment. Changes in the exchange rate between billing dates and payment
dates are recorded to other (income), net on the consolidated statements of operations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Income Taxes </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Income taxes are accounted for under the asset and liability method. Deferred tax assets and liabilities are recognized for the future tax
consequences attributable to differences between the financial statement carrying amounts of existing assets and liabilities and their respective tax bases and operating loss and tax credit </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
carryforwards.&nbsp;Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to
be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period such tax rate changes are enacted. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company recognizes the effect of income tax positions only if those positions are more likely than not to be sustained. Recognized income
tax positions are measured at the largest amount that is greater than 50% likely to be realized. Changes in recognition or measurement are reflected in the period in which the change in judgment occurs. Valuation allowances are established when
necessary to reduce deferred tax assets to amounts more likely than not to be realized. Interest and penalties related to unrecognized tax benefits are recognized as a component of income tax expense. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Comprehensive Loss </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Comprehensive
loss includes net loss and certain changes in stockholders&#146; deficit that are excluded from net loss, primarily unrealized losses from foreign currency translation adjustments. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss Per Share </I></B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Basic net
loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period, without consideration of potential dilutive securities. Diluted net loss per share is computed by dividing the net
loss by the sum of the weighted average number of common shares outstanding during the period plus the potential dilutive effects of potential dilutive shares outstanding during the period. Potential dilutive securities include stock options,
warrants and convertible preferred stock. The dilutive effect of stock options and warrants is computed using the treasury stock method and the dilutive effect of convertible preferred stock is calculated using the &#147;if-converted method&#148;.
For all periods presented, diluted net loss per share is the same as basic net loss per share since the effect of including potential common shares is anti-dilutive. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recent Accounting Pronouncements </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">From time to time, new accounting pronouncements are issued by the Financial Accounting Standards Board (&#147;FASB&#148;) or other standard
setting bodies and adopted by us as of the specified effective date. Under the Jumpstart Our Business Startups Act of 2012, as amended (the &#147;JOBS Act&#148;), we meet the definition of an emerging growth company, and have elected the extended
transition period for complying with new or revised accounting standards pursuant to Section&nbsp;107(b) of the JOBS Act. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recently Adopted
Accounting Pronouncements </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In May 2014, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2014-09,</FONT> Revenue from
Contracts with Customers (Topic 606), which supersedes the revenue recognition requirements in ASC 605, Revenue Recognition. This standard is based on the principle that revenue is recognized to depict the transfer of goods or services to customers
in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. The standard also requires additional disclosure about the nature, amount, timing and uncertainty of revenue and cash
flows arising from customer contracts, including significant judgments and changes in judgments and assets recognized from costs incurred to obtain or fulfill a contract. The standard is effective for annual periods beginning after December&nbsp;15,
2018 using one of two retrospective application methods. The Company has elected to adopt this standard as of January&nbsp;1, 2018. The adoption of ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2014-09</FONT> did not have any impact on the
Company&#146;s consolidated financial statements and related disclosures. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In May 2017, the FASB issued
<FONT STYLE="white-space:nowrap">ASU&nbsp;No.&nbsp;2017-09,&nbsp;Compensation&#151;Stock</FONT> Compensation (Topic 718), Scope of Modification Accounting. This pronouncement provides guidance about which changes to the terms or conditions of a
share-based payment award may require an entity to apply modification accounting under Topic&nbsp;718. This guidance is effective for the Company for annual reporting periods beginning after December&nbsp;15, 2017, including interim periods within
that reporting period, with early adoption permitted. The Company adopted this standard on January&nbsp;1, 2018. The adoption of ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2017-09</FONT> did not have a significant impact on the Company&#146;s
consolidated financial statements and related disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recently Issued Accounting Pronouncements </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In February 2016, the FASB issued ASU <FONT STYLE="white-space:nowrap">No.&nbsp;2016-02,</FONT> Leases. ASU
<FONT STYLE="white-space:nowrap">2016-02</FONT> requires lessees to put most leases on their balance sheet while recognizing expense in a manner similar to existing accounting. ASU <FONT STYLE="white-space:nowrap">2016-02</FONT> states that a lessee
would recognize a lease liability for the obligation to make lease payments and a <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-to-use</FONT></FONT> asset for the right to use the underlying asset for the lease term. The
new accounting guidance is effective for the Company for fiscal periods beginning after December&nbsp;15, 2019 and early adoption is permitted. The Company is currently assessing the timing of adoption and the impact that the adoption will have on
its consolidated financial statements and related disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In August 2016, the FASB issued&nbsp;ASU No. <FONT
STYLE="white-space:nowrap">2016-15,&nbsp;Statement</FONT> of Cash Flows (Topic 230), which provides greater clarity to preparers on the treatment of certain items within an entity&#146;s statement of cash flows. The new guidance is intended to
reduce diversity in practice in how certain transactions are classified in the statement of cash flows.&nbsp;The guidance is effective for the Company on January&nbsp;1, 2019, and the Company is currently evaluating the impact that the adoption of <FONT
STYLE="white-space:nowrap">ASU&nbsp;2016-15</FONT> will have on its consolidated financial statements and related disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In June
2018, the FASB issued <FONT STYLE="white-space:nowrap">ASU&nbsp;No.&nbsp;2018-07,&nbsp;Compensation&#151;Stock</FONT> Compensation (Topic&nbsp;718): Improvements <FONT STYLE="white-space:nowrap">to&nbsp;Non-Employee&nbsp;Share-Based</FONT> Payment
Accounting&nbsp;as part of the FASB simplification initiative. The new standard expands the scope of Topic 718, allowing the Company to apply the requirements of Topic 718 to
<FONT STYLE="white-space:nowrap">certain&nbsp;non-employee&nbsp;awards</FONT> to acquire goods and services <FONT STYLE="white-space:nowrap">from&nbsp;non-employees.&nbsp;This</FONT> ASU will be effective for the Company for fiscal years beginning
after December&nbsp;15, 2019, and interim periods within fiscal years beginning after December&nbsp;15, 2020, with early adoption permitted. The Company is currently assessing the timing of adoption and the impact that the adoption of ASU <FONT
STYLE="white-space:nowrap">2018-07</FONT> will have on its consolidated financial statements and related disclosures. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In August 2018, the
FASB issued ASU No. <FONT STYLE="white-space:nowrap">2018-13,&nbsp;Fair</FONT> Value Measurements (Topic 820):&nbsp;Disclosure Framework&#151;Changes to the Disclosure Requirements for Fair Value Measurement&nbsp;as part of the FASB&#146;s
disclosure framework project. This ASU modifies the disclosure requirements on fair value measurements in Topic 820, Fair Value Measurement by removing the requirement to disclose amounts of and reasons for transfers between Level&nbsp;1 and
Level&nbsp;2 of the fair value hierarchy, the policy for timing of transfers between levels, and the valuation process for Level&nbsp;3 fair value measurements. This ASU also modifies existing disclosure requirements by clarifying that the
measurement uncertainty disclosure is to communicate information about the uncertainty in measurement as of the reporting date, and it adds required disclosures for the changes in unrealized gains and losses for the period included in other
comprehensive income for recurring Level&nbsp;3 fair value measurements held at the end of the reporting period, and the range and weighted average of significant unobservable inputs used to develop Level&nbsp;3 fair value measurements. This ASU
will be effective for the Company for fiscal years and interim periods within those fiscal years, beginning after December&nbsp;15, 2019. The Company is currently assessing the impact of this ASU on its consolidated financial statements. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Fair Value Measurements </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Fair value accounting is applied for all financial assets and liabilities that are recognized or disclosed at fair value in the financial
statements on a recurring basis (at least annually). Financial instruments include cash and cash equivalents, accounts payable and accrued liabilities that approximate fair value due to their relatively short maturities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Assets and liabilities recorded at fair value on a recurring basis in the balance sheet are categorized based upon the level of judgment
associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an exit price that would be paid to transfer a liability in the principal or most advantageous market
for the asset or liability in an orderly transaction between market participants on the measurement date. The authoritative guidance on fair value measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements
as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Level&nbsp;1&#151;Inputs are unadjusted, quoted prices in active markets for identical assets or liabilities at the
measurement date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Level&nbsp;2&#151;Inputs are observable, unadjusted quoted prices in active markets for similar assets or liabilities,
unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the related assets or
liabilities; and </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Level&nbsp;3&#151;Unobservable inputs that are significant to the measurement of the fair value of the assets or
liabilities that are supported by little or no market data. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Financial assets subject to fair value measurements on a recurring basis
comprise money market funds that are measured using Level&nbsp;1 inputs. The money market funds subject to fair value measurements at December&nbsp;31, 2017 and 2018 were $47.5 million and $63.7 million, respectively, and are included in cash and
cash equivalents. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Property and Equipment </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Property and equipment consists of the following (in&nbsp;thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 4,603</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 5,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">598</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">244</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">237</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,682</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,769</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,969</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,913</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 4,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expenses were $1.4&nbsp;million and $1.2&nbsp;million for the years ended
December&nbsp;31, 2017 and 2018, respectively. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Accrued Expenses </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Accrued expenses consist of the following (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued clinical expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,019</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued professional and consulting services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">317</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued lab supplies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">70</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,492</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Commitments </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company enters into contracts in the normal course of business with CROs for preclinical studies and clinical trials.&nbsp;These
agreements provide for notice of termination by either party and are, therefore, cancelable contracts. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In May 2015, the Company entered
into an operating lease for 30,376 square feet of laboratory and office facilities in South San Francisco, California, which expires in May 2022 and provides for tenant improvement allowances of $0.8&nbsp;million. In April 2018, the Company amended
the lease agreement to include an additional 6,378 square feet of laboratory and office space increasing the total leased premises to 36,754 square feet. The lease amendment extended the lease term to November 2026, and contains scheduled rent
increases over the lease term and an option for the Company to extend the lease for an additional five-year term. The lease amendment contains a tenant improvement allowance of $1.4&nbsp;million that the Company used in 2018 toward $2.4&nbsp;million
in total leasehold improvements, which is amortized over the remaining lease term. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In February 2019, the Company entered into an
agreement to sublease its facility lease of 6,378 square feet of laboratory and office space with a related party. See Note&nbsp;14 for further discussion. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2018, future minimum <FONT STYLE="white-space:nowrap">non-cancelable</FONT> lease payments, net of sublease rental
income, are as follows (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="55.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="81%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Year ending December 31:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1,432</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2020</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,639</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2021</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">2022</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,038</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Thereafter</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8,687</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total minimum lease payments</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">15,765</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The terms of the lease agreement provide for rental payments on a monthly basis and on a graduated scale. The
Company recognizes rent expense on a straight-line basis over the lease period and has accrued for rent expense incurred but not paid. Rent expense includes certain monthly charges that do not represent
<FONT STYLE="white-space:nowrap">non-cancelable</FONT> obligations, as defined. These costs are determined based on actual charges incurred. In addition, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
tenant improvement allowances recorded are amortized as a reduction to rent expense on a straight-line basis over the lease term. Rent expense was $1.6&nbsp;million and $1.8&nbsp;million in the
years ended December&nbsp;31, 2017 and 2018, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">From time to time, the Company may be subject to various legal proceedings and
claims arising in the ordinary course of business. The Company assesses contingencies to determine the degree of probability and range of possible loss for potential accrual in its financial statements. An estimated loss contingency is accrued in
the financial statements if it is probable that a liability has been incurred and the amount of the loss can be reasonably estimated. The Company is not subject to any current pending legal matters or claims and no contingency loss had been accrued.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Clinical Trial Collaboration and Supply Agreement </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In November 2018, the Company entered into a clinical trial collaboration and supply agreement with Merck (known as MSD outside the United
States and Canada), through an affiliate, under which the Company will conduct a clinical trial evaluating FLX475 in combination with KEYTRUDA&reg; (pembrolizumab), Merck&#146;s anti-PD-1 therapy, in patients with advanced cancers. The Company is
the sponsor of the clinical trial, and Merck will supply KEYTRUDA&reg; for use in the clinical trial. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Related-Party Promissory Notes </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In August&nbsp;2015 and June 2016, the Company entered into limited recourse promissory notes with the Company&#146;s chief executive officer
and chief operating officer for the purchase of restricted common stock. The principal amount of the loans was $0.3&nbsp;million and $0.3&nbsp;million, respectively. The loans are secured by the shares of common stock of the Company held by the
individuals. The loans accrue interest at a rate of 1.82% and 1.41% per annum, respectively, and are due upon the earlier of voluntary termination of services to the Company, filing by the Company of its first registration statement with the
Securities and Exchange Commission under the Securities Act of 1933 or sale of substantially all of the Company&#146;s assets. As of December&nbsp;31, 2017 and 2018, the total outstanding balance under these notes, including accrued interest, was
approximately $0.6&nbsp;million and $0.6&nbsp;million, respectively. The notes are recorded within stockholders&#146; deficit. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Convertible
Preferred Stock and Stockholders&#146; Deficit </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Convertible preferred stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In June 2018, the Company completed a subsequent closing of Series C convertible preferred stock financing at $2.2925 per share for
$29.9&nbsp;million in gross proceeds. Additionally, in December 2018, the Company completed a $22.6&nbsp;million Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock financing at $2.2925 per share, and between January 2019
and March 2019, the Company completed subsequent closings of Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock financing at $2.2925 per share for $7.0&nbsp;million. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2017, convertible preferred stock consisted of the following (in thousands, except share amounts): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="58%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares<BR>Authorized</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares<BR>Issued
and<BR>Outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Net<BR>Carrying<BR>Value</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Aggregate<BR>Liquidation<BR>Preference</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,509,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,509,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,240,224</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,054,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,928</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,749,329</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,563,784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">108,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">117,437</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2018, convertible preferred stock consisted of the following (in
thousands, except share amounts): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="57%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares<BR>Authorized</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares<BR>Issued
and<BR>Outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Net<BR>Carrying<BR>Value</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Aggregate<BR>Liquidation<BR>Preference</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,509,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,509,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28,861</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">37,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,109,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,109,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">C-2</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">15,400,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,873,412</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,018,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,491,880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">161,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">170,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The rights, privileges, and preferences of the convertible preferred stock are as follows: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Conversion </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Each share
of Series A, Series B, Series C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock are initially convertible, at the option of the holder at any time, into shares of common stock as determined by dividing the
applicable original issue price for such series by the applicable conversion price for such series, subject to adjustment in the event of any stock splits, stock dividends, combinations, subdivisions or similar recapitalization affecting such
shares, and subject also to adjustment for certain dilutive issuances. Conversion of all outstanding convertible stock is automatic upon (i)&nbsp;the closing of a firm commitment underwritten public offering resulting in at least $30,000,000 in
gross proceeds to the Company, prior to underwriting commissions and expenses, provided that the public offering price is at least $13.7550 per share, as adjusted for any stock dividends, combinations, splits, recapitalizations and the like or
(ii)&nbsp;the election of the holders of 55% or more of the then outstanding shares of preferred stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Dividends </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The holders of shares of Series A, Series B, Series C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock shall
be entitled to receive dividends, when, as and if declared by the Board of Directors, at the rate per annum of $0.08, $0.16, $0.18, $0.18 per share, respectively, subject to adjustment in the event of any stock splits, stock dividends, combinations,
subdivisions or similar recapitalization affecting such shares. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Accrued dividends are payable when, as and if declared by the Board of
Directors, and are not cumulative. After payment of the above dividend, any additional dividends shall be distributed among all holders of common and preferred stock in proportion to the number of shares of common stock into which the representative
shares are convertible. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Voting </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Each holder of shares of Series A, Series B, Series C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock is
entitled to one vote for each share of common stock into which such shares of preferred stock are convertible, has voting rights and powers equal to the voting rights and powers of the common stock and shall vote together with the common stock on
all matters as to which holders of common stock have the right to vote, in each case, except as provided by law or by other provisions of the Company&#146;s Restated Certificate of Incorporation. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Election of board of directors </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As long as at least 6,000,000 shares of preferred stock are outstanding, as adjusted for any stock dividends, combinations, splits,
recapitalizations and the like, the holders of shares of Series A, Series B, Series </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock, voting as a separate class, are entitled to elect two members of the Board of Directors. The holders of
shares of common stock, voting as a separate class, are entitled to elect two members of the Board of Directors. The holders of the shares of preferred stock and common stock, voting together as a single class, and on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis, are entitled to elect all remaining members of the Board of Directors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Protective provisions </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As long as at least 6,000,000 shares of preferred stock are outstanding, as adjusted for any stock dividends, combinations, splits,
recapitalizations and the like, the Company shall first obtain the approval by vote or written consent of the holders of at least 65% of the then outstanding shares of preferred stock, voting together as a single class and not as a separate series,
and on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis with respect to: (i)&nbsp;consummation of liquidation event or effect any other merger or consolidation, (ii)&nbsp;amend, alter or repeal any provision of the Company&#146;s
certificate of incorporation of bylaws, (iii)&nbsp;increase or decrease the total number of authorized shares of common stock or preferred stock or designated shares of any series of preferred stock, (iv)&nbsp;authorize, issue or obligate the
Company to issue any equity security having preference over any series of preferred stock, (v)&nbsp;redeem, purchase or otherwise acquire any share or shares of preferred stock or common stock, (vi)&nbsp;change the authorized number of directors of
the Company, (vii)&nbsp;increase the number of shares of common stock reserved under any employee equity incentive plan, (viii)&nbsp;permit any subsidiary to sell or issue equity securities, (ix)&nbsp;pay or declare any dividend on any shares of
capital stock and (x)&nbsp;authorize, issue or obligate the Company to issue any debt security if the aggregate indebtedness exceeds $5,000,000. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Liquidation preferences </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In the event of any voluntary or involuntary liquidation, dissolution or <FONT STYLE="white-space:nowrap">winding-up</FONT> of the Company or
other &#147;Liquidation Event&#148; (as defined in the Company&#146;s Restated Certificate of Incorporation), the holders of shares of Series A, Series B, Series C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock
shall be entitled to be paid an amount equal to the original issue price per share, subject to adjustment in the event of any stock splits, stock dividends, combinations, subdivisions or similar recapitalization affecting such shares together with
any dividends declared but unpaid, prior to the payment of any distributions to the holders of common stock. If, upon the occurrence of such event, the assets and funds distributed among the holders of the Series A, Series B, Series C and Series <FONT
STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock are insufficient to permit the payment to such holders of the full aforesaid preferential amounts, then the entire assets and funds of the Company legally available for distribution
are to be distributed ratably among the holders of the Series A, Series B, Series C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">All holders of Series A, Series B, Series C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock shall be deemed
to have converted if, as a result of an actual conversion, such holder would receive, in the aggregate, a greater amount than the amount that would be distributed to such holder if such holder did not convert such shares of Series A, Series B,
Series C and Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock into common stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Classification </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company has classified the convertible preferred stock outside of permanent equity on the balance sheet as these shares can be redeemed
upon the occurrence of certain change in control events that are outside of the Company&#146;s control, including liquidation, sale or transfer of the Company. The Company has not adjusted the carrying values of the convertible preferred stock to
the liquidation preferences of such shares because it is uncertain whether or when an event would occur that would obligate the Company to pay the liquidation preferences to holders of shares of redeemable convertible preferred stock, and at the
balance sheet dates these </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
circumstances were not probable. Subsequent adjustments to the carrying values of the liquidation preferences will be made only when it becomes probable that such a liquidation event will occur.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Common Stock </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The holders of
the Company&#146;s common stock have one vote for each share of common stock held by them. Holders of shares of the Company&#146;s common stock are entitled to dividends when, as, and if declared by the Board of Directors, subject to the prior
rights of the holders of convertible preferred stock. As of December&nbsp;31, 2017 and 2018, no dividends had been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of
December&nbsp;31, 2018, the Company had reserved the following shares of common stock, on an <FONT STYLE="white-space:nowrap">as-converted</FONT> basis, for future issuance as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A convertible preferred stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,251,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B convertible preferred stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,166,663</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C convertible preferred stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,351,554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock
outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,566,666</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options issued and outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">768,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options available for future grants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">693,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,798,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Stock Option Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In 2015, the Company adopted the FLX Bio, Inc. 2015 Stock Plan (the 2015 Plan) for eligible employees, officers, directors, advisors, and
consultants, which provides for the grant of incentive and <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock options and restricted shares of common stock. Terms of the stock option agreements, including vesting requirements, are
determined by the Board of Directors, subject to the provisions of the 2015 Plan. Options granted generally vest over four years and expire no later than ten years from the date of grant. The estimated fair value of the underlying common stock is
determined by the Board of Directors. The exercise price of the incentive stock options must be equal to or greater than the estimated fair value of the underlying common stock on the date of grant. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following summarizes option activity under the 2015 Plan: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="47%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares<BR>Available</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Number of<BR>Shares</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Weighted<BR>Average<BR>Exercise&nbsp;Price<BR>Per Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Weighted<BR>Average</B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Remaining<BR>Contractual</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Term&nbsp;(Years)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00px solid #000000"><B>Aggregate<BR>Intrinsic<BR>Value</B><br><B>(in&nbsp;thousands)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balances at December&nbsp;31, 2016</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">539,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">142,037</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.56</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.47</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 426</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options authorized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">540,554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(306,804</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">306,804</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,034</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.91</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested common shares repurchased</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.06</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(50,147</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balances at December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">861,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">348,660</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 526</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options authorized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">250,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(497,417</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">497,417</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6.18</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,390</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.93</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested common shares repurchased</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19,158</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1.39</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60,448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(60,448</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balances at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">693,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">768,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and expected to vest at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">768,223</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercisable at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">7.99</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The aggregate intrinsic values of options outstanding, exercisable, vested and expected to vest were
calculated as the difference between the exercise price of the options and the estimated fair value of the Company&#146;s common stock, as determined by the Board of Directors, as of December&nbsp;31, 2017 and 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">During the year ended December&nbsp;31, 2017, the Company granted 0.3&nbsp;million stock options to purchase shares of common stock with a
weighted-average grant date fair value of $3.60 per share and a weighted-average exercise price of $1.99 per share. The weighted average grant date fair value of the common stock was $4.38 per share. The grant date fair value of those awards was
$1.2&nbsp;million. During the year ended December&nbsp;31, 2018, the Company granted 0.5&nbsp;million stock options to purchase shares of common stock with a weighted-average grant date fair value of $4.32 per share and a weighted-average exercise
price of $6.18 per share. The grant date fair value of those awards was $2.1&nbsp;million. The intrinsic value of options exercised for the years ended December&nbsp;31, 2017 and 2018 was $0.2&nbsp;million and $0.1&nbsp;million, respectively. The
fair value of the 0.3&nbsp;million and 0.3&nbsp;million stock options vested during 2017 and 2018 was $0.6&nbsp;million and $0.9&nbsp;million, respectively. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company had 33,333 shares and 25,000 shares of performance-based stock options outstanding as of December&nbsp;31, 2017 and 2018,
respectively. The grant date fair value of the award was $0.2&nbsp;million. As of December&nbsp;31, 2017 and 2018, the Company has not recognized any of the related stock-based compensation expense, as vesting of the awards was not determined to be
probable. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Employee stock option valuation </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The assumptions used to value employee and director stock option awards granted under the 2015 Plan during the years ended December&nbsp;31,
2017 and 2018, using the Black-Scholes option pricing model, were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="22%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year Ended
December&nbsp;31,</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$3.84&nbsp;-&nbsp;$6.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">$6.18&nbsp;-&nbsp;$6.30</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.96&nbsp;-6.07</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.67&nbsp;-&nbsp;6.08</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">81.50%&nbsp;-&nbsp;83.06%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">80.69%&nbsp;-&nbsp;81.48%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">1.75%&nbsp;-&nbsp;2.22%</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">2.62%&nbsp;-2.88%</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The fair value of the shares of common stock underlying stock options has historically been determined by the
Company&#146;s Board of Directors. Because there has been no public market for the Company&#146;s common stock, the Board of Directors has determined fair value of the common stock at the time of grant of the option by considering a number of
objective and subjective factors including important developments in the Company&#146;s operations, valuations performed by independent third parties, sales of convertible preferred stock, actual operating results and financial performance, the
conditions in the biotechnology industry and the economy in general, the stock price performance and volatility of comparable public companies and the lack of liquidity of the Company&#146;s common stock, among other factors. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In determining the fair value of the options granted, the Company uses the Black-Scholes option-pricing model and assumptions discussed below.
Each of these inputs is subjective and generally requires significant judgment to determine. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Expected term </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The expected term represents the period that the Company&#146;s options granted are expected to be outstanding and is determined using the
simplified method (based on the <FONT STYLE="white-space:nowrap">mid-point</FONT> between the vesting date and the end of the contractual term). The Company has very limited historical information to develop reasonable expectations about future
exercise patterns and post-vesting employment termination behavior for its stock option grants. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Expected volatility </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Since the Company is privately held and does not have any trading history for its common stock, the expected volatility was estimated based on
the average volatility for comparable publicly traded biopharmaceutical companies over a period, where available, equal to the expected term of the stock option grants.&nbsp;The comparable companies were chosen based on their similar size, life
cycle stage or area of specialty. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Risk-free interest rate </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The risk-free interest rate is based on the U.S. Treasury zero coupon issues in effect at the time of grant for periods corresponding with the
expected term of the options. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Expected dividend </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company has never paid dividends on its common stock and has no plans to pay dividends on its common stock.&nbsp;Therefore, the Company
used an expected dividend yield of zero. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Stock options granted to nonemployees </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Stock-based compensation related to stock options granted to <FONT STYLE="white-space:nowrap">non-employees</FONT> is recognized as the
services are rendered. The assumptions used to value <FONT STYLE="white-space:nowrap">non-employee</FONT> stock option awards granted under the 2015 Plan during the years ended December&nbsp;31, 2017 and 2018, using the Black-Scholes option pricing
model, were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="22%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year Ended
December&nbsp;31,</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">7.34&nbsp;-&nbsp;10.00</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">6.34&nbsp;-&nbsp;10.00</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">78.92%&nbsp;-&nbsp;86.03%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">78.29%&nbsp;-&nbsp;85.47%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">1.32%&nbsp;-&nbsp;2.57%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">1.32%&nbsp;-&nbsp;3.19%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">During the years ended December&nbsp;31, 2017 and 2018, the Company granted 33,332 and 4,166 options to
nonemployee consultants and recognized related expense of $0.1&nbsp;million and $0.1&nbsp;million, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Early exercise of
stock options </I></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The terms of the 2015 Plan permit option holders to exercise stock options before they are vested, subject to certain
limitations. Such unvested shares are subject to repurchase by the Company at the original exercise price in the event the option holder&#146;s service to the Company is terminated either voluntarily or involuntarily.&nbsp;As a result of early
exercises under the 2015 Plan, approximately 0.4&nbsp;million and 0.2&nbsp;million shares were subject to repurchase as of December&nbsp;31, 2017 and 2018, respectively. The Company treats cash received from the exercise of unvested options as a
refundable deposit and classifies such amounts as a liability in its balance sheet. As of December&nbsp;31, 2017 and 2018, the Company included cash received for the early exercise of unvested options of $0.5&nbsp;million and $0.2&nbsp;million,
respectively, in other current liabilities. Amounts included in liabilities are transferred into common stock and additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital as the shares vest, which is generally over a period of 48 months
and may include a <FONT STYLE="white-space:nowrap">one-year</FONT> cliff. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman"><I>Stock-based compensation expense </I></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Total stock-based compensation recognized for both employees and <FONT STYLE="white-space:nowrap">non-employees</FONT> was as follows (in
thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year&nbsp;Ended&nbsp;December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">394</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">542</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">322</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">628</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">716</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,170</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2018, unrecognized stock-based compensation cost related to outstanding unvested stock
options that are expected to vest was $1.3&nbsp;million. This unrecognized stock-based compensation cost is expected to be recognized over 1.72 years. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Income Taxes </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table presents domestic and foreign components of income (loss) before income taxes for the periods presented (in thousands):
</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="55.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="60%"></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="9%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">United States</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,114</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(36,033</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(113</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(29,114</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(36,146</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">A reconciliation of the statutory U.S. federal rate and effective rate is as follows: </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December 31<SUP
STYLE="font-size:85%; vertical-align:top">(1)</SUP></B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal tax</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">34.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">21.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">State, net of federal benefit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(0.6</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">R&amp;D credit</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2.0</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3.68</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Change in valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24.13</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.05</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap">Re-measurement</FONT> of deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(27.0</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Income tax expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">0.0</TD>
<TD NOWRAP VALIGN="bottom">%&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">Note:</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left"></P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">For the year ended December&nbsp;31, 2017, the statutory tax rate was 34%. For the year ended December&nbsp;31,
2018, as a result of Tax Reform, the statutory tax rate was decreased to 21%. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company has not recorded income tax
expense or benefit through December&nbsp;31, 2018 because of the Company&#146;s history of operating losses.&nbsp;The Company has incurred net operating losses for all periods since inception. The Company has not reflected any benefit of such net
operating loss carryforwards in the accompanying financial statements. The Company has established a full valuation allowance against its deferred tax assets due to the uncertainty surrounding the realization of such assets. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Tax Cuts and Job Act (the &#147;Act&#148;) was enacted on December&nbsp;22, 2017. The Act reduces the top U.S. federal corporate tax rate
from 34% to 21%, requires companies to pay a <FONT STYLE="white-space:nowrap">one-time</FONT> transition tax on earnings of certain foreign subsidiaries that were previously tax deferred, changes the rules related to uses and limitations of net
operating loss carryforwards created in tax years beginning after December&nbsp;31, 2017, allows for immediate expensing of fixed asset additions beginning after September&nbsp;27, 2017 and creates new taxes on certain foreign-sourced earnings. In
2017, the Company was not subject to a <FONT STYLE="white-space:nowrap">one-time</FONT> transition tax as no foreign accumulated earnings and profits existed. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Tax Act created a new requirement that global intangible <FONT STYLE="white-space:nowrap">low-taxed</FONT> income (&#147;GILTI&#148;)
earned by the Company&#146;s foreign wholly-owned subsidiary must be included in gross U.S. taxable income. While the Tax Act provides for a modified territorial tax system, beginning in 2018, GILTI provisions will be applied providing an
incremental tax on low taxed foreign income. The GILTI provisions require the Company to include in its U.S. income tax return foreign subsidiary earnings in excess of an allowable return on the foreign subsidiary&#146;s tangible assets. During
2018, the Company made an accounting policy election to treat taxes related to GILTI as a current period expense when incurred. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We applied the guidance in Staff Accounting Bulletin No.&nbsp;118 to reasonably estimate the
effects of the 2017 Act and recorded provisional amounts in our financial statements as of December&nbsp;31, 2017. In 2017, as a result of the signing of the Act, the Company recorded a $7.9&nbsp;million reduction in our deferred tax assets due to
the decrease in the Federal rate along with a corresponding reduction of our valuation allowance. In 2018, we completed our determination of the accounting implications of the 2017 Act and recorded no adjustments to the provisional amounts. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The components of the Company&#146;s deferred tax assets are as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net operating loss carryforwards</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 13,635</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 20,810</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Federal and state tax credits</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,035</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,378</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued liabilities and reserves</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">313</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">448</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gross deferred tax assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 16,068</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 24,791</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Valuation allowance</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,068</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(24,791</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net deferred taxes</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Realization of deferred tax assets is dependent upon future taxable income, if any. The Company has
established a valuation allowance to offset deferred tax assets as of December&nbsp;31, 2017 and 2018, due to the uncertainty of realizing future tax benefits from its net operating loss carryforwards and other deferred tax assets.&nbsp;The
valuation allowance increased by approximately $2.4&nbsp;million and $8.7&nbsp;million during the years ended December&nbsp;31, 2017 and 2018, respectively. The increase in the valuation allowance is mainly related to the increase in net operating
loss carryforwards incurred during the respective taxable years </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of December&nbsp;31, 2017, and 2018, the Company had federal net
operating loss carryforwards of approximately $60.9&nbsp;million and $95.0&nbsp;million, respectively. The federal NOL carryforwards generated during and after fiscal 2018 totaling $34.1&nbsp;million are carried forward indefinitely, while all
others along with the federal tax credit carryforwards, expire in years beginning in 2035. As of December&nbsp;31, 2017 and 2018, the Company had approximately $12.1&nbsp;million and $12.1 million of state net operating loss carryforwards,
respectively, which begin to expire in 2035 and are available to offset future taxable income. As of December&nbsp;31, 2017, and 2018, the Company had research and development tax credit carryforwards of approximately $1.7&nbsp;million and
$2.7&nbsp;million, and approximately $1.4&nbsp;million and $2.3&nbsp;million, available to reduce future federal and state income taxes, respectively. Moreover, as of December&nbsp;31, 2017 and 2018, the Company recorded federal and state reserves
of $0.4&nbsp;million and $0.7&nbsp;million and approximately $0.3 and $0.6&nbsp;million, respectively, as uncertain tax positions as of December&nbsp;31, 2018. If not utilized, the federal credit carryforwards will begin expiring in 2035. The state
credits carry forward indefinitely. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Federal and state laws impose substantial restrictions on the utilization of net operating loss and
tax credit carryforwards in the event of an ownership change for tax purposes, as defined in Section&nbsp;382 of the Internal Revenue Code. As a result of such ownership changes, the Company&#146;s ability to realize the potential future benefit of
tax losses and tax credits that existed at the time of the ownership change may be significantly reduced. The Company&#146;s deferred tax asset and related valuation allowance would be reduced as a result. The Company has not yet performed a
Section&nbsp;382 study to determine the amount of reduction, if any. The annual limitation may result in the expiration of net operating losses and credits before utilization. Under the new enacted law, the carryforward period of net operating
losses generated from 2018 forward is indefinite; however, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
the carryforward period for net operating losses generated prior to 2018 remains the same. Therefore, the annual limitation may still result in the expiration of certain net operating losses and
tax credit carryforwards before their utilization. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">A reconciliation of the beginning and ending amounts of unrecognized tax benefits for
the years ended December 31, 2017 and 2018 resulting primarily from research and development tax credits claimed on the Company&#146;s annual tax returns were as follows (in thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="77%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at beginning of year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">360</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions on tax positions related to prior years</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">19</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additions on tax positions related to current year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">406</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">473</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at end of year</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">789</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company does not expect that its uncertain tax positions will materially change in the next twelve months.
The reversal of uncertain tax benefits would not impact the Company&#146;s effective tax rate as the Company continues to maintain a full valuation allowance against its deferred tax assets. In accordance with ASC 740, the Company would classify
interest and penalties related to uncertain tax positions in income tax expense, if applicable. There was no interest expense or penalties related to unrecognized tax benefits through December&nbsp;31, 2018. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company files income tax returns in the United States, the State of California and the State of Colorado. The Company is not currently
under examination by income tax authorities in federal, state or other jurisdictions. All tax returns remain open for examination by federal and state authorities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>13. Net Loss Per Share </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Historical net loss per
share </I></B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the basic and diluted net loss per share of the years ended
December&nbsp;31, 2017 and 2018 (in thousands, except share and per share data): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Year Ended
December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">29,115</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">36,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average common shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">856,451</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">866,348</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: weighted-average unvested restricted common stock subject to repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(250,269</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(137,691</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: weighted-average unvested early exercised common shares subject to repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(174,504</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(106,368</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to compute net loss per common share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">431,679</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">67.45</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">58.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONSOLIDATED FINANCIAL STATEMENTS </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Potentially dilutive securities that were not included in the diluted per share calculations
because they would be anti-dilutive were as follows: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2017</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">12,593,942</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,415,281</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock options issued and outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">861,690</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">693,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,455,632</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,109,160</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unaudited pro forma net loss per share </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table presents the computation of pro forma basic and diluted net loss per share (in thousands, except share and per share
data): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>For the
Year<BR>Ended<BR>December&nbsp;31,<BR>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">36,147</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to compute net loss per common share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">622,289</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma adjustments to reflect:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed conversion of convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,838,797</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to compute net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,461,086</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2.50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>14. Subsequent Events </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In February 2019, the Company entered into an agreement to sublease its facility lease of 6,378 square feet of laboratory and office space
with a related party. The sublease has an initial term of eighteen months, expiring August 2020, with an option to extend by an additional six months. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In March 2019, the Company completed a subsequent closing of Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock
financing at $2.2925 per share with gross proceeds of $7.0&nbsp;million. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Management has reviewed and evaluated subsequent events through
May&nbsp;24, 2019, the date the audited financial statements were available to be issued. No subsequent events have been identified for disclosure, other than the subsequent events noted above. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_7"></A>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED CONSOLIDATED BALANCE SHEETS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except share and per share data) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="70%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD VALIGN="bottom" WIDTH="2%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,<BR>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>June 30,<BR>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Pro
forma<BR>Stockholders&#146;<BR>Equity as of<BR>June 30,<BR>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"><B>(Note 2)</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Assets</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current assets:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">63,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,264</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,194</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">65,062</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">62,056</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">389</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,776</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">69,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">68,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Liabilities, Convertible Preferred Stock and Stockholders&#146; Deficit</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Current liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,771</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,604</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other current liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">384</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">459</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total current liabilties</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">5,895</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Deferred rent, net of current portion</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">969</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,208</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Commitments</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock, $0.0001 par value:</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:2.00em; font-size:10pt; font-family:Times New Roman">117,889,475 shares authorized; 98,491,880 and 104,803,325 shares issued and outstanding at December 31, 2018 and June
30, 2019, respectively; aggregate liquidation preference of $170,000 and $184,469 at December 31, 2018 and June 30, 2019, respectively; no shares issued and and outstanding, pro forma</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">161,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">175,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stockholders&#146; equity (deficit):</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock, $0.0001 par value;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:4.00em; font-size:10pt; font-family:Times New Roman">133,071,007 shares authorized; 878,413 and 812,759 shares issued and outstanding at December 31, 2018 and June 30,
2019, respectively; 18,279,943 shares issued and outstanding as of June 30, 2019, pro forma</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Additional paid-in capital</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">22,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">23,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">198,773</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Related party promissory note for the purchase of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(598</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated other comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accumulated deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(118,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(138,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; (deficit) equity</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(97,113</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(115,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">60,006</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total liabilities, convertible preferred stock and stockholders&#146; deficit</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">69,610</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">68,109</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed consolidated financial statements.
</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_8"></A>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except share and per share data) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;Six Months Ended </B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>June 30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating expenses:</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">14,206</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,525</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,731</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">20,503</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income):</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other (income), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(296</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other comprehensive income</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total comprehensive loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,812</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average number of shares used in computing net loss per share, basic and diluted</P></TD>

<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">574,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.14</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average number of shares used in computing pro forma net loss per share, basic and
diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,328,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed consolidated financial statements.
</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_9"></A>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED CONSOLIDATED STATEMENTS OF CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS&#146; DEFICIT </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands, except share amounts) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="46%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Convertible&nbsp;Preferred<BR>Stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Common Stock</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Additional<BR><FONT
STYLE="white-space:nowrap">Paid-In</FONT><BR>Capital</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Related&nbsp;Party<BR>Promissory&nbsp;Notes<BR>for the
Purchase<BR>of&nbsp;Common&nbsp;Stock</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Accumulated<BR>Deficit</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Accumulated<BR>Other<BR>Comprehensive<BR>(Loss)</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ROWSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Total<BR>Stockholders&#146;<BR>Deficit</B></P></TD>
<TD VALIGN="bottom" ROWSPAN="2">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Amount</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD COLSPAN="2" VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Amount</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2017</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">75,563,784</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">108,643</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">880,191</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,005</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(605</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(82,806</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(62,405</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series C convertible preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">13,054,684</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock upon exercise of stock options, net of repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(689</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">137</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase of common stock from related party</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(8,333</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest on promissory notes from related parties for purchase of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(16,436</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at June&nbsp;30, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,618,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">138,557</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">871,169</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">21,722</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(593</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(99,243</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(78,112</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at December&nbsp;31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">98,491,880</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">161,111</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">878,413</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">22,441</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(598</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(118,953</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(4</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(97,113</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock, net of
issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,311,445</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Issuance of common stock upon exercise of stock options, net of repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,681</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Repurchase of common stock from related party</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(83,335</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">174</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Paydown of promissory notes from related parties for purchase of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">73</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Forgiveness of promissory notes from related party for purchase of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">351</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Foreign currency translation adjustment</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,814</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,814</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balance at June&nbsp;30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,803,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">175,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">812,759</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 1</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">23,265</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right"> &#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(138,767</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(115,503</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom" STYLE=" BORDER-LEFT:1px solid #000000">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these condensed consolidated financial statements.
</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_10"></A>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(In thousands) </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>Six Months Ended </B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>June 30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Operating activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(16,435</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19,814</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Adjustments to reconcile net loss to net cash used in operating activities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">634</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">669</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Gain on foreign currency translation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Noncash interest income (loss), net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:5.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Changes in operating assets and liabilities:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Prepaid expenses and other long-term assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">543</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(2,317</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:7.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accounts payable and accrued liabilities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(196</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,091</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in operating activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(14,879</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(17,647</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Investing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Purchase of property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,050</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(787</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash used in investing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(1,050</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(787</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Financing activities</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from the sale of convertible preferred stock, net of issuance costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,914</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,398</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Proceeds from issuance of common stock, net of repurchases</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">136</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net cash provided by financing activities</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">30,050</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,498</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net increase in cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,121</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(3,936</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at beginning of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">47,517</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">63,798</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents at end of period</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61,638</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">59,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD>
<TD HEIGHT="8" COLSPAN="4"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><B>Supplemental Disclosures of Non-Cash Investing and Financing Information</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment included in accounts payable</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>    <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>The accompanying notes are an integral part of these consolidated financial statements.
</I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B><A NAME="fin723949_11"></A>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>1. Organization and
Liquidity Risks </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Description of the Business </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">RAPT Therapeutics, Inc. (&#147;RAPT&#148; or the &#147;Company&#148;), is a clinical-stage, immunology-based biopharmaceutical company focused
on discovering, developing and commercializing oral small molecule therapies for patients with significant unmet needs in oncology and inflammatory diseases. Utilizing its proprietary drug discovery and development engine, the Company develops
highly selective small molecules that are designed to modulate the critical immune responses underlying these diseases. The Company changed its name from FLX Bio, Inc. to RAPT Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company is located in South San Francisco, California. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Liquidity and Management Plans </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The
accompanying condensed consolidated financial statements have been prepared assuming that the Company will continue as a going concern. However, since inception, the Company has incurred net losses and negative cash flows from operations and such
losses are expected to continue for the foreseeable future. As of June&nbsp;30, 2019, the Company had an accumulated deficit of $138.8 million, cash and cash equivalents of $59.9 million and working capital of $56.2 million. The Company believes
that its cash and cash equivalents as of June&nbsp;30, 2019 will not be sufficient for the Company to continue as a going concern for at least one year from the issuance date of its condensed consolidated financial statements and, therefore, there
is substantial doubt about the Company&#146;s ability to continue as a going concern. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Management plans to continue to incur substantial
costs in order to conduct research and development activities and additional capital will be needed to undertake these activities. The Company intends to raise such capital through the issuance of additional equity, borrowings, and potentially
strategic alliances with other companies. However, if such arrangements are not available at adequate levels or on acceptable terms, the Company would be required to significantly reduce operating expenses and delay or reduce the scope of or
eliminate some of its development programs. A combination of any of the above may have a material adverse effect on the Company&#146;s business, results of operations and/or financial condition. The ability of the Company to continue as a going
concern is dependent upon its ability to successfully accomplish these plans and secure sources of financing and ultimately attain profitable operations. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The accompanying condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable
to continue as a going concern. This basis of accounting contemplates the recovery of the Company&#146;s assets and the satisfaction of the Company&#146;s liabilities and commitments in the normal course of business and does not include any
adjustments to reflect the possible future effects of the recoverability and classification of recorded asset amounts or amounts and classification of liabilities that might be necessary should the Company be unable to continue as a going concern.
If the Company is unable to obtain adequate capital, it could be forced to cease operations. </P>    <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>2. Summary of Significant Accounting
Policies </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Basis of Presentation </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with U.S. generally accepted
accounting principles (&#147;U.S. GAAP&#148;) for interim financial information and pursuant to Article 10 of Regulation <FONT STYLE="white-space:nowrap">S-X</FONT> of the Securities Act of 1933, as amended (Securities Act).
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-30 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
Accordingly, they do not include all of the information and notes required by U.S. GAAP for complete financial statements. These unaudited condensed consolidated financial statements include only
normal and recurring adjustments that the Company believes are necessary to fairly state the Company&#146;s financial position and the results of its operations and cash flows. Interim-period results are not necessarily indicative of results of
operations or cash flows for a full year or any subsequent interim period. The condensed balance sheet at December&nbsp;31, 2018 has been derived from audited financial statements at that date but does not include all disclosures required by U.S.
GAAP for complete financial statements. Because all of the disclosures required by U.S. GAAP for complete financial statements are not included herein, these unaudited condensed consolidated financial statements and the notes accompanying them
should be read in conjunction with our audited consolidated financial statements included elsewhere in this registration statement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock Split
</I></B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">On July&nbsp;19, 2019, the Company filed an amendment to the Company&#146;s amended and restated certificate of incorporation to
effect a reverse split of shares of the Company&#146;s common stock on a one-for-six basis (the Reverse Stock Split). In connection with the Reverse Stock Split, the conversion ratio for the Company&#146;s outstanding convertible preferred stock was
proportionately adjusted such that the common stock issuable upon conversion of such preferred stock was decreased in proportion to the Reverse Stock Split. The par value of the common stock was not adjusted as a result of the Reverse Stock Split.
All references to common stock, options to purchase common stock, early exercised options, share data, per share data, convertible preferred stock (to the extent presented on an as-converted to common stock basis) and related information contained
in these consolidated financial statements have been retrospectively adjusted to reflect the effect of the Reverse Stock Split for all periods presented. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unaudited Pro Forma Financial Information </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The unaudited pro forma condensed consolidated stockholders&#146; equity as of June 30, 2019 assumes the conversion of all outstanding shares
of convertible preferred stock into 17,467,184&nbsp;shares of common stock immediately prior to the completion of the Company&#146;s planned initial public offering (&#147;IPO&#148;). The shares of common stock issuable and the proceeds expected to
be received in the IPO are excluded from such pro forma financial information. Pro forma basic and diluted net loss per share has been computed to give effect to the conversion of all outstanding convertible preferred stock into shares of common
stock. The unaudited pro forma net loss per share does not include the shares expected to be sold and related proceeds to be received from the initial public offering. The unaudited pro forma net loss per share for the six months ended June 30, 2019
was computed using the weighted-average number of shares of common stock outstanding, including the pro forma effect of the conversion of all outstanding shares of convertible preferred stock into shares of common stock, as if such conversion had
occurred at the beginning of the period, or their issuance dates, if later. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Deferred Offering Costs </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Deferred offering costs consisting of direct legal, accounting, printing and other fees and costs directly attributable to the Company&#146;s
planned IPO will be offset against IPO proceeds upon the consummation of the offering. In the event the planned IPO is terminated, all of the deferred offering costs will be expensed. As of June 30, 2019, $1.4 million of deferred offering costs were
capitalized. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Net Loss Per Share </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Basic net loss per share is computed by dividing the net loss by the weighted average number of common shares outstanding during the period,
without consideration of potential dilutive securities. Diluted net </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-31 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
loss per common share is computed by dividing the net loss by the sum of the weighted average number of common shares outstanding during the period plus the potential dilutive effects of
potential dilutive securities outstanding during the period calculated in accordance with the treasury stock method. Diluted net loss per share is the same as basic net loss per share since the effect of potentially dilutive securities is
anti-dilutive. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Recent Accounting Pronouncements </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company has reviewed recent accounting pronouncements and concluded that, other than those presented in the audited financial statements
included in this registration statement, the pronouncements are either not applicable to the business or no material impact is expected on the financial statements as a result of adoption at the effective date. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>3. Fair Value Measurements </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Fair value
accounting is applied for all financial assets and liabilities that are recognized or disclosed at fair value in the financial statements on a recurring basis (at least annually). Financial instruments include cash and cash equivalents, accounts
payable and accrued liabilities that approximate fair value due to their relatively short maturities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Assets and liabilities recorded at
fair value on a recurring basis in the balance sheet are categorized based upon the level of judgment associated with the inputs used to measure their fair values. Fair value is defined as the exchange price that would be received for an asset or an
exit price that would be paid to transfer a liability in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The authoritative guidance on fair value
measurements establishes a three-tier fair value hierarchy for disclosure of fair value measurements as follows: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Level&nbsp;1&#151;Inputs
are unadjusted, quoted prices in active markets for identical assets or liabilities at the measurement date; </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Level&nbsp;2&#151;Inputs are
observable, unadjusted quoted prices in active markets for similar assets or liabilities, unadjusted quoted prices for identical or similar assets or liabilities in markets that are not active, or other inputs that are observable or can be
corroborated by observable market data for substantially the full term of the related assets or liabilities; and </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:8%; font-size:10pt; font-family:Times New Roman">Level&nbsp;3&#151;Unobservable inputs that are significant to the measurement of the fair value of the assets or liabilities that are
supported by little or no market data. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Financial assets subject to fair value measurements on a recurring basis comprise money market
funds that are measured using Level&nbsp;1 inputs. The money market funds subject to fair value measurements at December&nbsp;31, 2018 and June&nbsp;30, 2019 were $63.8&nbsp;million and $59.9&nbsp;million, respectively, and are included in cash and
cash equivalents. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-32 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>4. Property and Equipment </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Property and equipment consisted of the following (in&nbsp;thousands): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="74%"></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="7%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,<BR>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>June&nbsp;30,<BR>2019</B></P></TD>

<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Laboratory equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 5,466</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 5,912</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Leasehold improvements</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,989</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">3,294</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Computer equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">308</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">309</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Furniture and fixtures</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">365</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">374</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,128</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">9,889</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less accumulated depreciation and amortization</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(4,969</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(5,612</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 4,159</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 4,277</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Depreciation and amortization expense were $0.6 million and $0.7 million for the six months ended
June 30, 2018 and 2019, respectively. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>5. Accrued Expenses </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Accrued expenses consist of the following (in thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>December&nbsp;31,<BR>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>June&nbsp;30,<BR>2019</B></P></TD>

<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued clinical expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 519</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">288</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued compensation</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,433</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,100</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued professional and consulting services</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">182</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,366</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued property and equipment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">202</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accrued lab supplies</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">28</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">72</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total accrued expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,488</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,832</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>6. Related-Party Promissory Notes </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In August&nbsp;2015 and June 2016, the Company entered into limited recourse promissory notes with the Company&#146;s chief executive officer
and chief operating officer for the purchase of restricted common stock. The principal amount of the loan with the Company&#146;s chief executive officer was $0.3&nbsp;million. The principal amount of the loan with the Company&#146;s chief operating
officer was $0.3&nbsp;million. The loans were secured by the shares of common stock of the Company held by the individuals. The loans accrued interest at a rate of 1.82% and 1.41% per annum, respectively, and were due upon the earlier of voluntary
termination of services to the Company, filing by the Company of its first registration statement with the Securities and Exchange Commission under the Securities Act of 1933, or sale of substantially all of the Company&#146;s assets. In March 2018,
the Board of Directors reduced the number of performance based options of its former chief operating officer by 8,333 shares resulting in a $17,000 reduction to the promissory note. As part of the separation agreement resulting from the chief
operating officer&#146;s resignation in March 2019, there were 63,019 vested shares and 28,645 unvested shares subject to repurchase. As of December 31, 2018, the total outstanding balances under these notes, including accrued interest, were
approximately $0.6 million. In March 2019, the Company reduced $0.1&nbsp;million of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-33 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
  <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
principal on the promissory note, relating to the unvested shares, which were cancelled and returned to the option pool. Subsequent to June 30, 2019, the Company repurchased 29,686 vested shares
from the chief operating officer in exchange for canceling $0.1&nbsp;million of principal and interest on the promissory note. The Company received cash proceeds of $0.1&nbsp;million for the remaining 33,333 vested shares issued to the chief
operating officer. In June 2019, the Company also forgave $0.4 million, which was the entire amount of principal and accrued interest due on the note from its president and chief executive officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>7. Convertible Preferred Stock and Stockholders&#146; Deficit </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Convertible preferred stock </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In June 2018, the Company completed a subsequent closing of the Series C convertible preferred stock financing at $2.2925 per share for
$29.9&nbsp;million in gross proceeds. Additionally, in December 2018, the Company completed a Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock financing at $2.2925 per share for $22.6&nbsp;million in gross proceeds, and
between January 2019 and June 2019, the Company completed subsequent closings of Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock financing at $2.2925 per share for $14.5 million in gross proceeds. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June 30, 2019, convertible preferred stock consisted of the following (in thousands, except share amounts): </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="56%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares<BR>Authorized</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Shares
Issued<BR>and<BR>Outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Net<BR>Carrying<BR>Value</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Aggregate<BR>Liquidation<BR>Preference</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,509,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,509,105</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 28,862</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right"> 37,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">25,000,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">49,926</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">50,000</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,109,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">26,109,363</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,770</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">59,856</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">C-2</FONT></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">29,271,007</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,184,857</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">36,952</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">37,104</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">117,889,475</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,803,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">175,509</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">184,469</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>8. Common Stock </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The holders of the Company&#146;s common stock have one vote for each share of common stock held by them. Holders of shares of the
Company&#146;s common stock are entitled to dividends when, as and if declared by the Board of Directors, subject to the prior rights of the holders of convertible preferred stock. As of December&nbsp;31, 2018 and June 30, 2019, no dividends had
been declared. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June 30,&nbsp;2019, the Company had reserved the following shares of common stock, on an <FONT
STYLE="white-space:nowrap">as-converted</FONT> basis, for future issuance as follows: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="85%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series A convertible preferred stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">6,251,502</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series B convertible preferred stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,166,663</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series C convertible preferred stock outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">4,351,554</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock
outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">2,697,465</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options issued and outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,049,976</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Options available for future grants</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">477,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">18,994,924</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-34 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>9. Stock Option Plan </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">In 2015, the Company adopted the FLX Bio, Inc. 2015 Stock Plan (the 2015 Plan) for eligible employees, officers, directors, advisors and
consultants, which provides for the grant of incentive and <FONT STYLE="white-space:nowrap">non-statutory</FONT> stock options and restricted shares of common stock. Terms of the stock option agreements, including vesting requirements, are
determined by the Board of Directors, subject to the provisions of the 2015 Plan. Options granted generally vest over four years and expire no later than ten years from the date of grant. The estimated fair value of the underlying common stock is
determined by the Board of Directors. The exercise price of the incentive stock options must be equal to or greater than the estimated fair value of the underlying common stock on the date of grant. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following summarizes option activity under the 2015 Plan: </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="50%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Options<BR>Available</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Number
of<BR>Options<BR>Outstanding</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Weighted<BR>Average<BR>Exercise<BR>Price Per<BR>Share</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Weighted<BR>Average<BR>Remaining<BR>Contractual<BR>Term<BR>(Years)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Aggregate<BR>Intrinsic<BR>Value<BR>(in&nbsp;thousands)</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balances at December 31, 2018</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">693,879</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">768,239</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.62</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.84</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1,291</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options authorized</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options granted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(353,267</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">353,267</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7.74</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options exercised</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(19,377</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.09</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Unvested common shares repurchased</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">85,027</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">1.02</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Stock options forfeited</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">52,125</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(52,153</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">4.26</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Balances at June 30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">477,764</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,049,976</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">6.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vested and expected to vest at June 30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,049,976</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.85</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">7,882</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exercisable at June 30, 2019</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">298,768</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">8.11</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">2,871</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The aggregate intrinsic values of options outstanding, exercisable, vested and expected to vest were
calculated as the difference between the exercise price of the options and the estimated fair value of the Company&#146;s common stock, as determined by the Board of Directors, as of December&nbsp;31, 2018 and June 30, 2019. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">During the six months ended June 30, 2018, the Company granted 0.4 million stock options to purchase shares of common stock with a
weighted-average grant date fair value of $4.34 per share and a weighted-average exercise price of $6.19&nbsp;per share. The grant date fair value of those awards was $1.9 million. During the six months ended June 30, 2019, the Company granted 0.3
million stock options to purchase shares of common stock with a weighted-average grant date fair value of $6.13 per share and a weighted-average exercise price of $8.62 per share. The grant date fair value of those awards was $1.9 million. The
intrinsic value of options exercised during the six months ended June 30, 2018 and 2019 was $25,000 and $0.2 million, respectively. The fair value of the 0.3 million and 0.3 million stock options vested during the six months ended June 30, 2018 and
2019 was $0.9&nbsp;million and $1.2 million, respectively. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company had 25,000&nbsp;shares of performance-based stock options to its
chief operating officer outstanding as of December&nbsp;31, 2018. As of December&nbsp;31, 2018, the Company had not recognized any of the related stock-based compensation expense, as vesting of the awards was not determined to be probable. As a
result of the chief operating officer&#146;s resignation in March 2019, these performance-based stock options were forfeited and returned to the 2015 Plan. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-35 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Employee stock option valuation </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The assumptions used to value employee and director stock option awards granted under the 2015 Plan during the six months ended June 30, 2019
and 2018, using the Black-Scholes option pricing model, were as follows: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="22%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>&nbsp;&nbsp;For the Six Months
Ended&nbsp;&nbsp;&nbsp;&nbsp;<BR>June&nbsp;30,</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Fair value of common stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$6.18</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">$13.62</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.67 - 6.08</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">5.96 - 6.08</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">80.69%&nbsp;-&nbsp;81.07%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">83.00%&nbsp;-&nbsp;83.60%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">2.62%&nbsp;-&nbsp;2.84%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">1.81%&nbsp;-&nbsp;2.23%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
</TABLE>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock options granted to nonemployees </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Stock-based compensation related to stock options granted to <FONT STYLE="white-space:nowrap">non-employees</FONT> is recognized as the
services are rendered. The assumptions used to value <FONT STYLE="white-space:nowrap">non-employee</FONT> stock option awards granted under the 2015 Plan during the six months ended June 30, 2018 and 2019, using the Black-Scholes option pricing
model, were as follows: </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="72%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="48%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="22%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD WIDTH="22%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="3" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>&nbsp;&nbsp;For the Six Months
Ended&nbsp;&nbsp;&nbsp;&nbsp;<BR>June&nbsp;30,</B></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Expected term (in years)</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">6.85-&nbsp;9.95</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">5.85-&nbsp;9.99</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Volatility</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">80.02%&nbsp;-&nbsp;82.32%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">81.43%&nbsp;-&nbsp;83.65%</FONT></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Risk-free interest rate</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">2.39%&nbsp;-&nbsp;2.96%</FONT></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"><FONT STYLE="white-space:nowrap">1.80%&nbsp;-&nbsp;2.67%</FONT></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Dividend yield</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">&#151;&nbsp;&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">During the six months ended June 30, 2018 and 2019, the Company granted 4,166 and 30,832 options to
nonemployee consultants and recognized expenses of $0.1 million and $0.1 million for previous option grants, respectively. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Early exercise of
stock options </I></B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The terms of the 2015 Plan permit option holders to exercise stock options before they are vested, subject to
certain limitations. Such unvested shares are subject to repurchase by the Company at the original exercise price in the event the option holder&#146;s service to the Company is terminated either voluntarily or involuntarily.&nbsp;As a result of
early exercises under the 2015 Plan, approximately 0.2&nbsp;million and 30,000 shares were subject to repurchase as of December 31, 2018 and June 30, 2019, respectively. The Company treats cash received from the exercise of unvested options as a
refundable deposit and classifies such amounts as a liability in its balance sheet. As of December&nbsp;31, 2018 and June&nbsp;30, 2019, the Company included cash received for the early exercise of unvested options of $0.2&nbsp;million and $39,000,
respectively, in other current liabilities. Amounts included in liabilities are transferred into common stock and additional <FONT STYLE="white-space:nowrap">paid-in</FONT> capital as the shares vest, which is generally over a period of 48 months
and may include a <FONT STYLE="white-space:nowrap">one-year</FONT> cliff. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-36 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Stock-based compensation expense </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Total stock-based compensation recognized for both employees and <FONT STYLE="white-space:nowrap">non-employees</FONT> was as follows (in
thousands): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="72%"></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="10%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>For the Six Months Ended<BR>June
30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">278</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">399</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">302</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stock-based compensation expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">580</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">724</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>   <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">As of June 30, 2019, unrecognized stock-based compensation cost related to outstanding unvested stock
options that are expected to vest was $2.7 million. This unrecognized stock-based compensation cost is expected to be recognized over 1.84 years. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>10. Income Taxes </B></P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The Company did
not record a provision for income taxes for the six months ended June 30, 2019, because all of our taxable income is expected to be fully offset by net operating losses generated in prior years. In addition, the deferred tax assets continue to be
subject to a full valuation allowance. </P>  <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>11. Net Loss Per Share </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Historical net loss per share </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the basic and diluted net loss per share for the six months ended June 30, 2018 and 2019 (in
thousands, except share and per share data): </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="80%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Six Months
Ended<BR>June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">16,435</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">19,814</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average common shares outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">870,355</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">789,777</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: weighted-average unvested restricted common stock subject to repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(164,045</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(58,628</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Less: weighted-average unvested common shares subject to repurchase</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(131,919</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">(43,279</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to compute net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">574,391</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.61</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">28.80</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-37 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>RAPT THERAPEUTICS, INC. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>(Unaudited) </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
 <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Potentially dilutive
securities that were not included in the diluted per share calculations because they would be anti-dilutive were as follows: <B></B> </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="85.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="69%"></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman" ALIGN="center"><B>As of </B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>June&nbsp;30,</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2018</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">88,618,468</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">104,803,325</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Common stock options issued and outstanding</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">754,221</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">1,049,976</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">89,372,689</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">105,853,301</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>    <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Unaudited pro forma net loss per share </I></B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table sets forth the computation of the unaudited pro forma basic and diluted net loss per share (in thousands, except share and
per share data): </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="88%"></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>For the
Six<BR>Months&nbsp;Ended<BR>June&nbsp;30,&nbsp;2019</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Numerator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(19,814</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Denominator:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to compute net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">687,870</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma adjustments to reflect:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Assumed conversion of convertible preferred stock</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">16,640,760</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted-average shares used to compute net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">17,328,630</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Pro forma net loss per share, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">(1.14</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>    <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>12. Subsequent Events </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">For purposes of the condensed consolidated financial statements as of June&nbsp;30, 2019 and the six months then ended, the Company has
evaluated subsequent events through October 21, 2019. No subsequent events other than the above have been identified for disclosure. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">F-38 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="line-height:2.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
<P STYLE="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Through and
including&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019, (the 25th day after the date of this prospectus), all dealers effecting transactions in the common stock, whether or not participating
in this offering, may be required to deliver a prospectus. This delivery requirement is in addition to a dealer&#146;s obligation to deliver a prospectus when acting as an underwriter and with respect to an unsold allotment or subscription. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Shares </B></P>
<P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="margin-top:0pt;margin-bottom:0pt" ALIGN="center">


<IMG SRC="g723949g00v03.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:14pt; font-family:Times New Roman" ALIGN="center"><B>Common Stock </B></P> <P STYLE="font-size:24pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><center>
<P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>P R O S P E C T U
S </B></P><center> <P STYLE="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:20%">&nbsp;</P></center>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>BMO Capital Markets </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>Wells Fargo Securities </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:16pt; font-family:Times New Roman" ALIGN="center"><B>UBS Investment Bank </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;, 2019 </B></P>
<P STYLE="font-size:30pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="line-height:4.5pt;margin-top:0pt;margin-bottom:2pt;border-bottom:2.00pt solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>PART II </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>INFORMATION NOT REQUIRED IN PROSPECTUS </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;13. Other Expenses of Issuance and Distribution. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The following table indicates the expenses to be incurred in connection with the offering described in this registration statement, other than
underwriting discounts and commissions, all of which will be paid by us. All amounts are estimated except the SEC registration fee, the Financial Industry Regulatory Authority, Inc. (&#147;FINRA&#148;) filing fee and the exchange listing fee. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="55.5%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="76%"></TD>

<TD VALIGN="bottom" WIDTH="8%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Amount</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">SEC registration fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">11,941.60</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">FINRA filing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">14,300</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Exchange listing fee</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Accountants&#146; fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Legal fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;<BR></TD>
<TD VALIGN="bottom" ALIGN="right">*<BR></TD>
<TD NOWRAP VALIGN="bottom">&nbsp;<BR></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Transfer agent&#146;s fees and expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Printing and engraving expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Miscellaneous</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">$</TD>
<TD VALIGN="bottom" ALIGN="right">*</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="2%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be provided by amendment. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;14. Indemnification of Directors and Officers. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Section&nbsp;145 of the Delaware General Corporation Law authorizes a court to award, or a corporation&#146;s board of directors to grant,
indemnity to directors and officers in terms sufficiently broad to permit such indemnification under certain circumstances for liabilities, including reimbursement for expenses incurred, arising under the Securities Act. Our amended and restated
certificate of incorporation that will be in effect upon the closing of this offering permits indemnification of our directors, officers, employees and other agents to the maximum extent permitted by the Delaware General Corporation Law, and our
amended and restated bylaws that will be in effect on the closing of this offering provide that we will indemnify our directors and officers and permit us to indemnify our employees and other agents, in each case to the maximum extent permitted by
the Delaware General Corporation Law. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We have entered into indemnification agreements with our directors and officers, whereby we have
agreed to indemnify our directors and officers to the fullest extent permitted by law, including indemnification against expenses and liabilities incurred in legal proceedings to which the director or officer was, or is threatened to be made, a
party by reason of the fact that such director or officer is or was a director, officer, employee or agent of RAPT Therapeutics, Inc., provided that such director or officer acted in good faith and in a manner that the director or officer reasonably
believed to be in, or not opposed to, the best interest of RAPT Therapeutics, Inc. At present, there is no pending litigation or proceeding involving a director or officer of RAPT Therapeutics, Inc. regarding which indemnification is sought, nor is
the registrant aware of any threatened litigation that may result in claims for indemnification. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">We maintain insurance policies that
indemnify our directors and officers against various liabilities arising under the Securities Act and the Exchange Act that might be incurred by any director or officer in his or her capacity as such. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;15. Recent Sales of Unregistered Securities. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Since January&nbsp;1, 2016, we have issued the following unregistered securities: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Sales of Preferred Stock </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In April 2016, we sold an aggregate of 25,000,000 shares of Series B preferred stock to a total of 9 accredited
investors at a purchase price per share of $2.00 for an aggregate purchase price of $50&nbsp;million. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In December 2017 and June 2018, we sold an aggregate of 26,109,363 shares of Series C preferred stock to a
total of 10 accredited investors at a purchase price per share of $2.2925 for an aggregate purchase price of approximately $59.9&nbsp;million. </P></TD></TR></TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(3)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">In December 2018, from January through March 2019 and in June 2019, we sold an aggregate of 16,184,857 shares
of Series <FONT STYLE="white-space:nowrap">C-2</FONT> convertible preferred stock to a total of 24 accredited investors at a purchase price per share of $2.2925 for an aggregate purchase price of approximately $37.1&nbsp;million.
</P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><I>Option and Common Stock Issuances </I></B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(1)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">From January 1, 2016 through September&nbsp;15, 2019, we granted to certain employees, consultants and
directors options to purchase an aggregate of 1,489,362&nbsp;shares of our common stock under our 2015 Plan at exercise prices ranging from $1.02 to $13.62 per share. In addition, as of September&nbsp;15, 2019, we granted to certain employees,
consultants and directors options to purchase an aggregate of 164,745&nbsp;shares, with an exercise price equal to the price per share to the public in this offering. </P></TD></TR></TABLE>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="8%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(2)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">From January&nbsp;1, 2016 through September&nbsp;15, 2019, we issued an aggregate of 414,648&nbsp;shares of our
common stock upon the exercise of options granted under our 2015 Plan, at exercise prices ranging from $1.02 to $6.18 per share, for an aggregate exercise price of $0.8&nbsp;million. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">None of the foregoing transactions involved any underwriters, underwriting discounts or commissions, or any public offering. Unless otherwise
stated, the sales of the above securities were deemed to be exempt from registration under the Securities Act in reliance on Section&nbsp;4(a)(2) of the Securities Act (and Regulation D or Regulation S promulgated thereunder) or Rule 701 promulgated
under Section&nbsp;3(b) of the Securities Act as transactions by an issuer not involving any public offering or pursuant to benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of the securities in each of
these transactions represented their intentions to acquire the securities for investment only and not with a view to, or for sale in connection with, any distribution thereof, and appropriate legends were placed on the share certificates issued in
these transactions. All recipients had adequate access, through their relationships with us, to information about us. The sales of these securities were made without any general solicitation or advertising. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;16. Exhibits and Financial Statement Schedules. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(a) Exhibits. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="5%"></TD>
<TD WIDTH="90%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description&nbsp;of&nbsp;Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;1.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d723949dex11.htm">Form of Underwriting Agreement. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex31.htm">Amended and Restated Certificate of Incorporation of RAPT Therapeutics, Inc., as currently in effect. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.2&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex32.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of RAPT Therapeutics, Inc., dated May 20, 2019, as currently
 in effect. </A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description&nbsp;of&nbsp;Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.3&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex33.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of RAPT Therapeutics, Inc., dated June 6, 2019, as currently
 in effect. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.4&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex34.htm">Certificate of Amendment to the Amended and Restated Certificate of Incorporation of RAPT Therapeutics, Inc., dated July&nbsp;
19, 2019, as currently in effect. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.5&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex34.htm">Form of Amended and Restated Certificate of Incorporation of RAPT Therapeutics, Inc., to be effective upon the completion of this offering.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.6&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex35.htm">Bylaws of RAPT Therapeutics, Inc., as currently in effect. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;3.7&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex37.htm">Form of Amended and Restated Bylaws of RAPT Therapeutics, Inc., to be effective on the completion of this offering.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;4.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex41.htm">Form of common stock certificate of RAPT Therapeutics, Inc. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>&nbsp;&nbsp;5.1*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Opinion of Cooley LLP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex101.htm">Amended and Restated Investors&#146; Rights Agreement by and among RAPT Therapeutics, Inc. and certain of its stockholders, dated December&nbsp;18,
 2018. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.2+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex102.htm">RAPT Therapeutics, Inc. 2015 Stock Plan, as amended. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.3+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex103.htm">Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Stock Option Exercise under the 2015 Stock Plan.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.4+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex104.htm">RAPT Therapeutics, Inc. 2019 Equity Incentive Plan. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.5+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex105.htm">Forms of Stock Option Agreement, Notice of Stock Option Grant and Notice of Stock Option Exercise under the 2019 Equity Incentive Plan.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.6+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex106.htm">Form of Restricted Stock Unit Award Agreement and Restricted Stock Unit Grant Notice under the 2019 Equity Incentive Plan.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.7+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex107.htm">RAPT Therapeutics, Inc. 2019 Employee Stock Purchase Plan. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.8+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex108.htm">Form of Indemnification Agreement by and between RAPT Therapeutics, Inc. and each of its directors and executive officers.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.9+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex109.htm">Amended and Restated Employee Offer Letter, by and between Brian Wong and RAPT Therapeutics, Inc., dated July&nbsp;20, 2019.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.10+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1010.htm">Amended and Restated Employee Offer Letter, by and between William Ho and RAPT Therapeutics, Inc., dated July&nbsp;20, 2019.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.11+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1011.htm">Amended and Restated Employee Offer Letter, by and between Dirk Brockstedt and RAPT Therapeutics, Inc., dated July&nbsp;20, 2019.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.12+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1012.htm">Employee Offer Letter, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated March&nbsp;17, 2016. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.13+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1013.htm">Separation and Consulting Agreement, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated March&nbsp;19, 2019.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.14+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1014.htm">Amendment to the Separation and Consulting Agreement, by and between Rekha Hemrajani and RAPT Therapeutics, Inc., dated April&nbsp;
30, 2019. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.15+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1015.htm">Board of Directors Agreement, by and between Linda Kozick and RAPT Therapeutics, Inc., dated November&nbsp;15, 2016. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.16+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1016.htm">Board of Directors Agreement, by and between Michael F. Giordano and RAPT Therapeutics, Inc., dated January&nbsp;12, 2018.
</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.17+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1017.htm">Board of Directors Agreement, by and between William Rieflin and RAPT Therapeutics, Inc., dated June&nbsp;23, 2015.
</A></TD></TR></TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD></TD>

<TD VALIGN="bottom" WIDTH="3%"></TD>
<TD WIDTH="90%"></TD></TR>

<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman"><B>Exhibit</B></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; "><B>Number</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Description&nbsp;of&nbsp;Exhibit</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.18&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex1021.htm">Lease, by and between HCP, Inc. and Flexus Biosciences, Inc., dated October&nbsp;10, 2014. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.19&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex1022.htm">First Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated April&nbsp;29, 2015. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.20&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex1023.htm">Second Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated April&nbsp;16, 2018. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.21&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949dex1024.htm">Third Amendment to Lease, by and between HCP, Inc. and RAPT Therapeutics, Inc., dated December&nbsp;13, 2018. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.22#&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1022.htm">Clinical Trial Collaboration and Supply Agreement, dated as of November&nbsp;
1, 2018, by and between MSD International GmbH and RAPT Therapeutics, Inc.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.23+&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/0001673772/000119312519198410/d723949dex1023.htm">Non-Employee Director Compensation Policy </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>10.24+</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d723949dex1024.htm">Board of Directors Agreement, by and between Wendye Robbins and RAPT Therapeutics, Inc., dated October&nbsp;11, 2019. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.1</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d723949dex231.htm">Consent of independent registered public accounting firm.</A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>23.2*</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top">Consent of Cooley LLP (included in Exhibit 5.1).</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.1&#134;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="http://www.sec.gov/Archives/edgar/data/1673772/000119312519189775/d723949ds1.htm#poa">Power of Attorney. </A></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="8"></TD>
<TD HEIGHT="8" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" NOWRAP>24.2</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top"><A HREF="d723949dex242.htm">Power of Attorney of Wendye Robbins. </A></TD></TR>
</TABLE>  <P STYLE="line-height:8.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000;width:11%">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">&#134;</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Previously filed. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">*</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">To be filed by amendment. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">+</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Indicates management contract or compensatory plan. </P></TD></TR></TABLE>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%" VALIGN="top" ALIGN="left">#</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">Portions of this exhibit (indicated by asterisks) have been omitted as the registrant has determined that
(i)&nbsp;the omitted information is not material and (ii)&nbsp;the omitted information would likely cause competitive harm to the registrant if publicly disclosed. </P></TD></TR></TABLE>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(b) Financial Statement Schedules. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">All financial statement schedules are omitted because the information required to be set forth therein is not applicable or is shown in the
consolidated financial statements or the notes thereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Item&nbsp;17. Undertakings. </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes to provide to the underwriters at the closing specified in the underwriting agreement
certificates in such denominations and registered in such names as required by the underwriters to permit prompt delivery to each purchaser. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of
the registrant under the foregoing provisions or otherwise, the registrant has been advised that in the opinion of the SEC, such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. If a claim
for indemnification against such liabilities (other than the payment by the registrant of expenses incurred or paid by a director, officer or controlling person of the registrant in the successful defense of any action, suit or proceeding) is
asserted by such director, officer or controlling person in connection with the securities being registered, the registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of
appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">The undersigned registrant hereby undertakes that: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(1) For purposes of determining any liability under the Securities Act, the information omitted from the form of prospectus filed as part of
this registration statement in reliance upon Rule 430A and contained in a form of prospectus filed by the registrant under Rule 424(b)(1) or (4)&nbsp;or 497(h) under the Securities Act shall be deemed to be part of this registration statement as of
the time it was declared effective. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">(2) For the purpose of determining any liability under the Securities Act, each post-effective
amendment that contains a form of prospectus shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering
thereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>SIGNATURES </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its
behalf by the undersigned, thereunto duly authorized, in the City of South San Francisco, State of California, on October&nbsp;21, 2019. </P>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"><B>RAPT THERAPEUTICS, INC.</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="24"></TD>
<TD HEIGHT="24" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian Wong, M.D., Ph.D.</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Brian Wong, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">President and Chief Executive Officer</TD></TR>
</TABLE></DIV>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">
<h5 align="left"><a href="#toc">Table of Contents</a></h5>


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:8%; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Act of 1933, this registration statement has
been signed by the following persons in the capacities and on the dates indicated. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="31%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD>

<TD VALIGN="bottom" WIDTH="2%"></TD>
<TD WIDTH="18%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00px solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Brian Wong, M.D., Ph.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Brian Wong, M.D., Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">President, Chief Executive Officer and Director <I></I></P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>(Principal Executive Officer) </I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;21, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Eric Hall</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Eric Hall</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interim Chief Financial Officer and Secretary</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman"><I>(Principal Financial Officer) </I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;21, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Karen C. Lam</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Karen C. Lam</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Vice President, Finance and Corporate Controller</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman"><I>(Principal Accounting Officer)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;21, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">William Rieflin</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Chair of the Board of Directors</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;21, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Michael F. Giordano, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;21, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">David V. Goeddel, Ph.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;21, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Linda Kozick</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;21, 2019</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">*</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Wendye Robbins, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="middle"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October&nbsp;21, 2019</TD></TR>
</TABLE>  <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">* Pursuant to the Power of Attorney</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom" STYLE=" BORDER-BOTTOM:1px solid #000000">&nbsp;</TD>
<TD VALIGN="top" STYLE="BORDER-BOTTOM:1px solid #000000">/s/ Brian Wong, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Brian Wong, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Attorney-in-Fact</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">II-7 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-1.1
<SEQUENCE>2
<FILENAME>d723949dex11.htm
<DESCRIPTION>EX-1.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-1.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 1.1 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RAPT Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(a Delaware corporation) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[&#9679;] Shares of Common Stock </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>UNDERWRITING AGREEMENT </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dated: [&#9679;],
2019 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P> <P STYLE="line-height:1.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&nbsp;</P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">RAPT Therapeutics, Inc. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(A Delaware corporation) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[&#9679;] Shares of Common Stock </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>UNDERWRITING AGREEMENT </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">[&#9679;], 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BMO Capital Markets Corp. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UBS Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as Representatives of the several Underwriters </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>c/o&nbsp;&nbsp;&nbsp;&nbsp;BMO Capital Markets Corp. </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3
Times Square, 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP>&nbsp;Floor </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10036 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>c/o&nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo Securities, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">375 Park Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, NY 10152 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>c/o&nbsp;&nbsp;&nbsp;&nbsp;UBS Securities LLC </B></P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1285
Avenue of the Americas </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Ladies and
Gentlemen: </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">RAPT Therapeutics, Inc., a Delaware corporation (the &#147;Company&#148;), confirms its agreement with BMO Capital Markets
Corp. (&#147;BMO&#148;) and each of the other Underwriters named in Schedule A hereto (collectively, the &#147;Underwriters,&#148; which term shall also include any underwriter substituted as hereinafter provided in Section&nbsp;10 hereof), for whom
BMO, Wells Fargo Securities, LLC, and UBS Securities LLC are acting as representatives (in such capacity, the &#147;Representatives&#148;), with respect to (i)&nbsp;the sale by the Company and the purchase by the Underwriters, acting severally and
not jointly, of the respective numbers of shares of Common Stock, par value $0.0001 per share, of the Company (&#147;Common Stock&#148;) set forth in Schedule&nbsp;A hereto and (ii)&nbsp;the grant by the Company to the Underwriters, acting severally
and not jointly, of the option described in Section&nbsp;2(b) hereof to purchase all or any part of [&#9679;] additional shares of Common Stock. The aforesaid [&#9679;] shares of Common Stock (the &#147;Initial Securities&#148;) to be purchased by
the Underwriters and all or any part of the [&#9679;] shares of Common Stock subject to the option described in Section&nbsp;2(b) hereof (the &#147;Option Securities&#148;) are herein called, collectively, the &#147;Securities.&#148; </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company understands that the Underwriters propose to make a public offering of the
Securities as soon as the Representatives deem advisable after this Agreement has been executed and delivered. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and the
Underwriters agree that up to [&#9679;] shares of the Initial Securities to be purchased by the Underwriters (the &#147;Reserved Securities&#148;) shall be reserved for sale to certain persons designated by the Company (the &#147;Invitees&#148;), as
part of the distribution of the Securities by the Underwriters, subject to the terms of this Agreement, the applicable rules, regulations and interpretations of the Financial Industry Regulatory Authority, Inc. (&#147;FINRA&#148;) and all other
applicable laws, rules and regulations. The Company solely determined, without any direct or indirect participation by the Underwriters, the Invitees who will purchase Reserved Securities (including the amount to be purchased by such persons). To
the extent that such Reserved Securities are not orally confirmed for purchase by Invitees by 11:59 P.M. (New York City time) on the date of this Agreement, such Reserved Securities may be offered to the public as part of the public offering
contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company has filed with the Securities and Exchange Commission (the &#147;Commission&#148;) a registration
statement on <FONT STYLE="white-space:nowrap">Form&nbsp;S-1</FONT> (No. <FONT STYLE="white-space:nowrap">333-232572),</FONT> including the related preliminary prospectus or prospectuses, covering the registration of the sale of the Securities under
the Securities Act of 1933, as amended (the &#147;1933 Act&#148;). Promptly after execution and delivery of this Agreement, the Company will prepare and file a prospectus in accordance with the provisions of Rule 430A (&#147;Rule 430A&#148;) of the
rules and regulations of the Commission under the 1933 Act (the &#147;1933 Act Regulations&#148;) and Rule 424(b) (&#147;Rule 424(b)&#148;) of the 1933 Act Regulations. The information included in such prospectus that was omitted from such
registration statement at the time it became effective but that is deemed to be part of such registration statement at the time it became effective pursuant to Rule 430A(b) is herein called the &#147;Rule 430A Information.&#148; Such registration
statement, including the amendments thereto, the exhibits thereto and any schedules thereto, at the time it became effective, and including the Rule 430A Information, is herein called the &#147;Registration Statement.&#148; Any registration
statement filed pursuant to Rule 462(b) of the 1933 Act Regulations is herein called the &#147;Rule 462(b) Registration Statement&#148; and, after such filing, the term &#147;Registration Statement&#148; shall include the Rule 462(b) Registration
Statement. Each prospectus used prior to the effectiveness of the Registration Statement, and each prospectus that omitted the Rule 430A Information that was used after such effectiveness and prior to the execution and delivery of this Agreement, is
herein called a &#147;preliminary prospectus.&#148; The final prospectus, in the form first furnished to the Underwriters for use in connection with the offering of the Securities, is herein called the &#147;Prospectus.&#148; For purposes of this
Agreement, all references to the Registration Statement, any preliminary prospectus, the Prospectus or any amendment or supplement to any of the foregoing shall be deemed to include the copy filed with the Commission pursuant to its Electronic Data
Gathering, Analysis and Retrieval system or any successor system (&#147;EDGAR&#148;). <B></B> </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As used in this Agreement: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Applicable Time&#148; means [<U>&nbsp;&nbsp;&nbsp;&nbsp;</U>:00 P./A.M.], New York City time, on [INSERT DATE] or such
other time as agreed by the Company and the Representatives. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;General Disclosure Package&#148; means any Issuer
General Use Free Writing Prospectuses issued at or prior to the Applicable Time, the most recent preliminary prospectus that is distributed to investors prior to the Applicable Time and the information included on Schedule <FONT
STYLE="white-space:nowrap">B-1</FONT> hereto, all considered together. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Issuer Free Writing Prospectus&#148; means
any &#147;issuer free writing prospectus,&#148; as defined in Rule 433 of the 1933 Act Regulations (&#147;Rule&nbsp;433&#148;), including without limitation any &#147;free writing </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
prospectus&#148; (as defined in Rule 405 of the 1933 Act Regulations (&#147;Rule 405&#148;)) relating to the Securities that is (i)&nbsp;required to be filed with the Commission by the Company,
(ii)&nbsp;a &#147;road show that is a written communication&#148; within the meaning of Rule 433(d)(8)(i), whether or not required to be filed with the Commission, or (iii)&nbsp;exempt from filing with the Commission pursuant to Rule 433(d)(5)(i)
because it contains a description of the Securities or of the offering that does not reflect the final terms, in each case in the form filed or required to be filed with the Commission or, if not required to be filed, in the form retained in the
Company&#146;s records pursuant to Rule 433(g). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Issuer General Use Free Writing Prospectus&#148; means any Issuer
Free Writing Prospectus that is intended for general distribution to prospective investors (other than a &#147;<I>bona fide</I> electronic road show,&#148; as defined in Rule 433 (the &#147;Bona Fide Electronic Road Show&#148;)), as evidenced by its
being specified in Schedule <FONT STYLE="white-space:nowrap">B-2</FONT> hereto. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Issuer Limited Use Free Writing
Prospectus&#148; means any Issuer Free Writing Prospectus that is not an Issuer General Use Free Writing Prospectus. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; margin-right:2%; text-indent:4%; font-size:10pt; font-family:Times New Roman"><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">&#147;Testing-the-Waters</FONT></FONT>
Communication&#148; means any oral or written communication with potential investors undertaken in reliance on Section&nbsp;5(d) of the 1933 Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">&#147;Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT>
Communication&#148; means any <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication that is a written communication within the meaning of Rule 405 under the 1933 Act. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 1.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations and Warranties</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<I>Representations and Warranties by the Company</I>. The Company represents and warrants to each Underwriter as of
the date hereof, the Applicable Time, the Closing Time (as defined below) and any Date of Delivery (as defined below), and agrees with each Underwriter, as follows: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Statement</U><U> and Prospectuses</U>. Each of the Registration Statement and any
amendment thereto has become effective under the 1933 Act. No stop order suspending the effectiveness of the Registration Statement or any post-effective amendment thereto has been issued under the 1933 Act, no order preventing or suspending the use
of any preliminary prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or, to the Company&#146;s knowledge, contemplated. The Company has complied with each request (if any)
from the Commission for additional information. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">Each of the Registration Statement and any post-effective amendment
thereto, at the time it became effective, the Applicable Time, the Closing Time and any Date of Delivery complied and will comply in all material respects with the requirements of the 1933 Act and the 1933 Act Regulations. Each preliminary
prospectus, the Prospectus and any amendment or supplement thereto, at the time each was filed with the Commission, and, in each case, at the Applicable Time, the Closing Time and any Date of Delivery complied and will comply in all material
respects with the requirements of the 1933 Act and the 1933 Act Regulations. Each preliminary prospectus delivered to the Underwriters for use in connection with this offering and the Prospectus was or will be identical to the electronically
transmitted copies thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by Regulation <FONT STYLE="white-space:nowrap">S-T.</FONT> </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Accurate Disclosure</U>. Neither the Registration Statement nor any amendment thereto, at its
effective time, on the date hereof, at the Closing Time or at any Date of Delivery, contained, contains or will contain an untrue statement of a material fact or omitted, omits or will </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
omit to state a material fact required to be stated therein or necessary to make the statements therein not misleading. At the Applicable Time and any Date of Delivery, none of (A)&nbsp;the
General Disclosure Package, (B)&nbsp;any individual Issuer Limited Use Free Writing Prospectus, when considered together with the General Disclosure Package and (C)&nbsp;any individual Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, when considered together with the General Disclosure Package, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to
state a material fact necessary in order to make the statements therein, in the light of the circumstances under which they were made, not misleading. Neither the Prospectus nor any amendment or supplement thereto, as of its issue date, at the time
of any filing with the Commission pursuant to Rule 424(b), at the Closing Time or at any Date of Delivery, included, includes or will include an untrue statement of a material fact or omitted, omits or will omit to state a material fact necessary in
order to make the statements therein, in the light of the circumstances under which they were made, not misleading. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">The
representations and warranties in this subsection shall not apply to statements in or omissions from the Registration Statement (or any amendment thereto), the General Disclosure Package or the Prospectus (or any amendment or supplement thereto)
made in reliance upon and in conformity with written information furnished to the Company by any Underwriter through the Representatives expressly for use therein. For purposes of this Agreement, the only information so furnished shall be the
information in the first paragraph under the heading &#147;Underwriting&#150;Commissions and Discounts,&#148; the information in the second, third and fourth paragraphs under the heading &#147;Underwriting&#150;Price Stabilization, Short Positions
and Penalty Bids&#148; and the information under the heading &#147;Underwriting&#150;Electronic Distribution&#148; in each case contained in the Prospectus (collectively, the &#147;Underwriter Information&#148;). </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Issuer Free Writing Prospectuses</U>. No Issuer Free Writing Prospectus conflicts or will
conflict with the information contained in the Registration Statement or the Prospectus, and any preliminary or other prospectus deemed to be a part thereof that has not been superseded or modified. The Company has made available a Bona Fide
Electronic Road Show in compliance with Rule 433(d)(8)(ii) such that no filing of any &#147;road show&#148; (as defined in Rule 433(h)) is required in connection with the offering of the Securities. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(iv)&nbsp;&nbsp;&nbsp;&nbsp;
<U><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Materials</U>. The Company (A)&nbsp;has not engaged in any
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication other than <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications with the
consent of the Representatives with entities that are qualified institutional buyers within the meaning of Rule 144A under the 1933 Act or institutions that are accredited investors within the meaning of Rule 501 under the 1933 Act and (B)&nbsp;has
not authorized anyone other than the Representatives to engage in <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. The Company reconfirms that the Representatives have been authorized
to act on its behalf in undertaking <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications. The Company has not distributed any Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communications other than those listed on Schedule <FONT STYLE="white-space:nowrap">B-2</FONT> hereto. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;<U>Company Not Ineligible Issuer</U>. At the time of filing the Registration Statement and any
post-effective amendment thereto, at the earliest time thereafter that the Company or another offering participant made a <I>bona fide</I> offer (within the meaning of Rule 164(h)(2) of the 1933 Act Regulations) of the Securities and at the date
hereof, the Company was not and is not an &#147;ineligible issuer,&#148; as defined in Rule 405, without taking account of any determination by the Commission pursuant to Rule 405 that it is not necessary that the Company be considered an ineligible
issuer. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;<U>Emerging Growth Company Status.</U> From the
time of the initial confidential submission of the Registration Statement to the Commission (or, if earlier, the first date on which the Company engaged directly or through any Person authorized to act on its behalf in any <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication) through the date hereof, the Company has been and is an &#147;emerging growth company,&#148; as defined in Section&nbsp;2(a) of the 1933 Act
(an &#147;Emerging Growth Company&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(vii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Independent Accountants</U>. The accountants who
certified the financial statements and supporting schedules included in the Registration Statement, the General Disclosure Package and the Prospectus are independent public accountants as required by the 1933 Act, the 1933 Act Regulations and the
Public Company Accounting Oversight Board. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(viii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Financial Statements</U>. The financial
statements included in the Registration Statement, the General Disclosure Package and the Prospectus, together with the related schedules and notes, present fairly in all material respects the financial position of the Company and its consolidated
subsidiaries at the dates indicated and the statement of operations, stockholders&#146; equity and cash flows of the Company and its consolidated subsidiaries for the periods specified; said financial statements have been prepared in conformity with
U.S. generally accepted accounting principles (&#147;GAAP&#148;) applied on a consistent basis throughout the periods involved. The supporting schedules, if any, present fairly in accordance with GAAP the information required to be stated therein in
all material respects. The selected financial data and the summary financial information included in the Registration Statement, the General Disclosure Package and the Prospectus present fairly in all material respects the information shown therein
and have been compiled on a basis consistent with that of the audited financial statements included therein.&nbsp;&nbsp;&nbsp;&nbsp;Except as included therein, no historical or pro forma financial statements or supporting schedules are required to
be included or incorporated by reference in the Registration Statement, the General Disclosure Package or the Prospectus under the 1933 Act or the 1933 Act Regulations. The interactive data in eXtensible Business Reporting Language included in the
Registration Statement, the General Disclosure Package and the Prospectus fairly presents the information called for in all material respects and has been prepared in accordance with the Commission&#146;s rules and guidelines applicable thereto.
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(ix)&nbsp;&nbsp;&nbsp;&nbsp;<U>No Material Adverse Change in Business</U>. Except as otherwise stated therein, since the
respective dates as of which information is given in the Registration Statement, the General Disclosure Package or the Prospectus, (A)&nbsp;there has been no material adverse change in the condition, financial or otherwise, or in the earnings,
business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business (a &#147;Material Adverse Effect&#148;), (B)&nbsp;there have been no transactions
entered into by the Company or any of its subsidiaries, other than those in the ordinary course of business, which are material with respect to the Company and its subsidiaries considered as one enterprise, and (C)&nbsp;there has been no dividend or
distribution of any kind declared, paid or made by the Company on any class of its capital stock. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(x)&nbsp;&nbsp;&nbsp;&nbsp;<U>Good Standing of the Company</U>. The Company has been duly organized and is validly existing as
a corporation in good standing under the laws of the State of Delaware and has corporate power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the General Disclosure
Package and the Prospectus and to enter into and perform its obligations under this Agreement; and the Company is duly qualified as a foreign corporation to transact business and is in good standing in each other jurisdiction in which such
qualification is required, whether by reason of the ownership or leasing of property or the conduct of business, except where the failure so to qualify or to be in good standing would not, individually or in the aggregate, reasonably be expected to
result in a Material Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">5 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xi)&nbsp;&nbsp;&nbsp;&nbsp;<U>Good Standing of Subsidiaries</U>. Each
subsidiary (each, a &#147;Subsidiary&#148; and, collectively, the &#147;Subsidiaries&#148;) has been duly organized and is validly existing in good standing under the laws of the jurisdiction of its incorporation or organization (to the extent the
concept of &#147;good standing&#148; is applicable in each such jurisdiction), has corporate or similar power and authority to own, lease and operate its properties and to conduct its business as described in the Registration Statement, the General
Disclosure Package and the Prospectus and is duly qualified to transact business and is in good standing in each jurisdiction in which such qualification is required (to the extent the concepts of &#147;qualification to transact business&#148; and
&#147;good standing&#148; are applicable in each such jurisdiction), whether by reason of the ownership or leasing of property or the conduct of business, except where the failure to so qualify or to be in good standing would not, individually or in
the aggregate, reasonably be expected to result in a Material Adverse Effect. Except as otherwise disclosed in the Registration Statement, the General Disclosure Package and the Prospectus, all of the issued and outstanding capital stock of each
Subsidiary has been duly authorized and validly issued, is fully paid and <FONT STYLE="white-space:nowrap">non-assessable</FONT> (to the extent such concepts are applicable in each such jurisdiction) and is owned by the Company, directly or through
subsidiaries, free and clear of any security interest, mortgage, pledge, lien, encumbrance, claim or equity. None of the outstanding shares of capital stock of any Subsidiary were issued in violation of the preemptive or similar rights of any
securityholder of such Subsidiary. The only subsidiaries of the Company are the subsidiaries listed on Exhibit 21 to the Registration Statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Capitalization</U>. The authorized, issued and outstanding shares of capital stock of the
Company are as set forth in the Registration Statement, the General Disclosure Package and the Prospectus in the column entitled &#147;Actual&#148; under the caption &#147;Capitalization&#148; (except for subsequent issuances, if any, pursuant to
this Agreement, pursuant to reservations, agreements or employee benefit plans referred to in the Registration Statement, the General Disclosure Package and the Prospectus or pursuant to the exercise of convertible securities or options referred to
in the Registration Statement, the General Disclosure Package and the Prospectus). The outstanding shares of capital stock of the Company have been duly authorized and validly issued and are fully paid and
<FONT STYLE="white-space:nowrap">non-assessable.</FONT> None of the outstanding shares of capital stock of the Company were issued in violation of the preemptive or other similar rights of any securityholder of the Company. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization of Agreement</U>. This Agreement has been duly authorized, executed and
delivered by the Company. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xiv)&nbsp;&nbsp;&nbsp;&nbsp;<U>Authorization and Description of Securities</U>. The Securities
to be purchased by the Underwriters from the Company have been duly authorized for issuance and sale to the Underwriters pursuant to this Agreement and, when issued and delivered by the Company pursuant to this Agreement against payment of the
consideration set forth herein, will be validly issued and fully paid and <FONT STYLE="white-space:nowrap">non-assessable;</FONT> and the issuance of the Securities is not subject to the preemptive or other similar rights of any securityholder of
the Company, except as have been duly and validly waived in writing as of the date of this Agreement. The Common Stock conforms to all statements relating thereto contained in the Registration Statement, the General Disclosure Package and the
Prospectus and such description conforms in all material respects to the rights set forth in the instruments defining the same. No holder of Securities will be subject to personal liability solely by reason of being such a holder. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xv)&nbsp;&nbsp;&nbsp;&nbsp;<U>Registration Rights</U>. There are no persons with registration rights or other similar rights
to have any securities registered for sale pursuant to the Registration Statement or otherwise registered for sale or sold by the Company under the 1933 Act pursuant to this Agreement, other than those rights that have been disclosed in the
Registration Statement, the General Disclosure Package and the Prospectus and have been waived. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">6 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvi)&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Violations, Defaults and
Conflicts</U>. Neither the Company nor any of its subsidiaries is (A)&nbsp;in violation of its charter, <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar organizational document, (B)&nbsp;in default in the performance or observance of any
obligation, agreement, covenant or condition contained in any contract, indenture, mortgage, deed of trust, loan or credit agreement, note, lease or other agreement or instrument to which the Company or any of its subsidiaries is a party or by which
it or any of them is bound or to which any of the properties or assets of the Company or any subsidiary is subject (collectively, &#147;Agreements and Instruments&#148;), except for such defaults that would not, singly or in the aggregate, result in
a Material Adverse Effect, or (C)&nbsp;in violation of any law, statute, rule, regulation, judgment, order, writ or decree of any arbitrator, court, governmental body, regulatory body, administrative agency or other authority, body or agency having
jurisdiction over the Company or any of its subsidiaries or any of their respective properties, assets or operations (each, a &#147;Governmental Entity&#148;), except for such violations that would not, singly or in the aggregate, result in a
Material Adverse Effect. The execution, delivery and performance of this Agreement and the consummation of the transactions contemplated herein and in the Registration Statement, the General Disclosure Package and the Prospectus (including the
issuance and sale of the Securities and the use of the proceeds from the sale of the Securities as described therein under the caption &#147;Use of Proceeds&#148;) and compliance by the Company with its obligations hereunder have been duly
authorized by all necessary corporate action and do not and will not, whether with or without the giving of notice or passage of time or both, conflict with or constitute a breach of, or default or Repayment Event (as defined below) under, or result
in the creation or imposition of any lien, charge or encumbrance upon any properties or assets of the Company or any subsidiary pursuant to, the Agreements and Instruments (except for such conflicts, breaches, defaults or Repayment Events or liens,
charges or encumbrances that would not, singly or in the aggregate, result in a Material Adverse Effect), nor will such action result in any violation of the provisions of the charter, <FONT STYLE="white-space:nowrap">by-laws</FONT> or similar
organizational document of the Company or any of its subsidiaries or any law, statute, rule, regulation, judgment, order, writ or decree of any Governmental Entity. As used herein, a &#147;Repayment Event&#148; means any event or condition which
gives the holder of any note, debenture or other evidence of indebtedness (or any person acting on such holder&#146;s behalf) the right to require the repurchase, redemption or repayment of all or a portion of such indebtedness by the Company or any
of its subsidiaries. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xvii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Labor Dispute</U>. No labor dispute with the employees of
the Company or any of its subsidiaries exists or, to the knowledge of the Company, is imminent, and the Company is not aware of any existing or imminent labor disturbance by the employees of any of its or any subsidiary&#146;s principal suppliers,
manufacturers, customers or contractors, which, in either case, would result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xviii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Proceedings</U>. Except as disclosed in the Registration Statement, the General
Disclosure Package and the Prospectus, there is no action, suit, proceeding, inquiry or investigation before or brought by any Governmental Entity now pending or, to the knowledge of the Company, threatened, against or affecting the Company or any
of its subsidiaries, which would reasonably be expected to result in a Material Adverse Effect, or which would reasonably be expected to materially and adversely affect their respective properties or assets or the consummation of the transactions
contemplated in this Agreement or the performance by the Company of its obligations hereunder; and the aggregate of all pending legal or governmental proceedings to which the Company or any such subsidiary is a party or of which any of their
respective properties or assets is the subject which are not described in the Registration Statement, the General Disclosure Package and the Prospectus, including ordinary routine litigation incidental to the business, could not result in a Material
Adverse Effect. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">7 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xix)&nbsp;&nbsp;&nbsp;&nbsp;<U>Accuracy of Exhibits</U>. There are no
contracts or documents which are required to be described in the Registration Statement, the General Disclosure Package or the Prospectus or to be filed as exhibits to the Registration Statement which have not been so described and filed as
required. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xx)&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence of Further Requirements</U>. No filing with, or authorization, approval,
consent, license, order, registration, qualification or decree of, any Governmental Entity is necessary or required for the performance by the Company of its obligations hereunder, in connection with the offering, issuance or sale of the Securities
hereunder or the consummation of the transactions contemplated by this Agreement, except (A)&nbsp;such as have been already obtained or as may be required under the 1933 Act, the 1933 Act Regulations, the rules of the Nasdaq Global Market, state
securities laws or the rules of FINRA and (B)&nbsp;such as have been obtained under the laws and regulations of jurisdictions outside the United States in which the Reserved Securities were offered. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxi)&nbsp;&nbsp;&nbsp;&nbsp;<U>Possession of Licenses and Permits</U>. The Company and its subsidiaries possess such permits,
licenses, approvals, consents and other authorizations (collectively, &#147;Governmental Licenses&#148;) issued by the appropriate Governmental Entities necessary to conduct the business now operated by them, except where the failure so to possess
would not, singly or in the aggregate, result in a Material Adverse Effect. The Company and its subsidiaries are in compliance with the terms and conditions of all Governmental Licenses, except where the failure so to comply would not, singly or in
the aggregate, result in a Material Adverse Effect. All of the Governmental Licenses are valid and in full force and effect, except when the invalidity of such Governmental Licenses or the failure of such Governmental Licenses to be in full force
and effect would not, singly or in the aggregate, result in a Material Adverse Effect. Neither the Company nor any of its subsidiaries has received any notice of proceedings relating to the revocation or modification of any Governmental Licenses
which, singly or in the aggregate, if the subject of an unfavorable decision, ruling or finding, would result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Title to Property</U>. The Company and its subsidiaries have good and marketable title to all
real property owned by them and good title to all other properties owned by them, in each case, free and clear of all mortgages, pledges, liens, security interests, claims, restrictions or encumbrances of any kind except such as (A)&nbsp;are
described in the Registration Statement, the General Disclosure Package and the Prospectus or, (B)&nbsp;do not, singly or in the aggregate, materially affect the value of such property and do not interfere with the use made and proposed to be made
of such property by the Company or any of its subsidiaries; and all of the leases and subleases material to the business of the Company and its subsidiaries, considered as one enterprise, and under which the Company or any of its subsidiaries holds
properties described in the Registration Statement, the General Disclosure Package or the Prospectus, are in full force and effect, and neither the Company nor any such subsidiary has any notice of any claim of any sort that has been asserted by
anyone adverse to the rights of the Company or any subsidiary under any of the leases or subleases mentioned above, or affecting or questioning the rights of the Company or such subsidiary to the continued possession of the leased or subleased
premises under any such lease or sublease, except to the extent that any such failure to be in full force and effect or any such claim could not reasonably be expected, individually or in the aggregate, to result in a Material Adverse Effect. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxiii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Possession of Intellectual Property</U>. Except as described in the Registration Statement,
the General Disclosure Package and the Prospectus or would not, singly or in the aggregate, result in a Material Adverse Effect, (i)&nbsp;the Company and its subsidiaries own, possess or can promptly obtain on commercially reasonable terms a valid
and enforceable license to use, </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">8 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
all patents, patent rights, licenses, inventions, copyrights, technology, software, databases, <FONT STYLE="white-space:nowrap">know-how</FONT> (including any trade secrets and any other
unpatented and/or unpatentable proprietary or confidential information, systems or procedures), trademarks, service marks, trade names, trade dress, domain names and other source identifiers, and any other similar intellectual property or
proprietary rights in any jurisdiction throughout the world (including any and all issuances and registrations and applications for issuance or registration of,and all goodwill associated with, any of the foregoing, as applicable) (collectively,
&#147;Intellectual Property&#148;) used or held for use in, or otherwise necessary to, the conduct of the business as now operated by them and as proposed to be operated in the Registration Statement, the General Disclosure Package and the
Prospectus; (ii)&nbsp;to the knowledge of the Company, the Company&#146;s and its subsidiaries&#146; conduct of their business does not infringe, misappropriate or otherwise violate, and has not infringed, misappropriated or otherwise violated,
asserted rights of any others with respect to any Intellectual Property (it being understood that the foregoing representation and warranty is made without giving effect to any exemption under applicable law to which the Company may be entitled
(e.g., 35 U.S.C. Section&nbsp;271(e)(1)); (iii) neither the Company nor any of its subsidiaries has received any notice or is otherwise aware of, (A)&nbsp;any pending or threatened action, suit, proceeding or claim by any third party against the
Company or any of its subsidiaries (x)&nbsp;alleging that the Company or any of its subsidiaries has infringed, misappropriated or otherwise violated any Intellectual Property, (y)&nbsp;challenging the ownership, validity, enforceability or scope of
any Intellectual Property owned by or licensed to the Company or any of its subsidiaries or (z)&nbsp;challenging the Company&#146;s or any of its subsidiaries&#146; rights in or to any of the Intellectual Property or (B)&nbsp;any facts that would
form a reasonable basis for any such action, suit, proceeding or claim; (iv)&nbsp;to the knowledge of the Company, the Intellectual Property of the Company and its subsidiaries has not been infringed, misappropriated or otherwise violated by any
third party; (v)&nbsp;all Intellectual Property owned by the Company or any of its subsidiaries is owned solely and exclusively by the Company or such subsidiaries and the Company and its subsidiaries own such Intellectual Property and hold all of
their rights under all Intellectual Property licensed to them, in each case, free and clear of all liens, encumbrances, defects or other restrictions; and (vi)&nbsp;the Company and its subsidiaries have taken reasonable steps in accordance with
normal industry standards and practices to maintain the confidentiality of all Intellectual Property of the Company and its subsidiaries the value of which to the Company or any of its subsidiaries is contingent upon maintaining the confidentiality
thereof and, to the knowledge of the Company, no such Intellectual Property has been disclosed other than to employees, representatives and agents of the Company or any of its subsidiaries, all of whom are bound by written and enforceable
confidentiality agreements. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxiv)&nbsp;&nbsp;&nbsp;&nbsp;<U>Environmental Laws</U>. Except as described in the
Registration Statement, the General Disclosure Package and the Prospectus or would not, singly or in the aggregate, result in a Material Adverse Effect, (A)&nbsp;neither the Company nor any of its subsidiaries is in violation of any federal, state,
local or foreign statute, law, rule, regulation, ordinance, code, policy or rule of common law or any judicial or administrative interpretation thereof, including any judicial or administrative order, consent, decree or judgment, relating to
pollution or protection of human health, the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface strata) or wildlife, including, without limitation, laws and regulations relating to the
release or threatened release of chemicals, pollutants, contaminants, wastes, toxic substances, hazardous substances, petroleum or petroleum products, asbestos-containing materials or mold (collectively, &#147;Hazardous Materials&#148;) or to the
manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of Hazardous Materials (collectively, &#147;Environmental Laws&#148;), (B) the Company and its subsidiaries have all permits, authorizations and
approvals required under any applicable Environmental Laws and are each in compliance with their requirements, (C)&nbsp;there are no pending or, to the Company&#146;s knowledge, threatened administrative, regulatory or judicial actions, suits,
demands, demand letters, claims, liens, notices of </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">9 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
noncompliance or violation, investigations or proceedings relating to any Environmental Law against the Company or any of its subsidiaries and (D)&nbsp;to the Company&#146;s knowledge, there are
no events or circumstances that would reasonably be expected to form the basis of an order for <FONT STYLE="white-space:nowrap">clean-up</FONT> or remediation, or an action, suit or proceeding by any private party or Governmental Entity, against or
affecting the Company or any of its subsidiaries relating to Hazardous Materials or any Environmental Laws. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxv)&nbsp;&nbsp;&nbsp;&nbsp;<U>Healthcare Laws</U>. The Company has operated at all times and is currently in compliance in
all material respects with all applicable statutes, rules and regulations of the U.S. Food and Drug Administration and applicable foreign regulatory authorities, including the European Medicines Agency and the UK Medicines and Healthcare products
Regulatory Agency, including, without limitation, (A)&nbsp;the Federal Food, Drug, and Cosmetic Act (21 U.S.C. &#167;&#167; 301 et seq.) and the regulations promulgated thereunder; (B)&nbsp;all healthcare related fraud and abuse laws, including,
without limitation, the federal Anti-kickback Statute (42 U.S.C. <FONT STYLE="white-space:nowrap">&#167;1320a-7b(b));</FONT> the civil False Claims Act (31 U.S.C. &#167;&#167; 3729 et seq.); the criminal False Claims Law (42 U.S.C. <FONT
STYLE="white-space:nowrap">&#167;1320a-7b(a));</FONT> the civil monetary penalties law (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7a);</FONT> the exclusion law (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7);</FONT> the
Physician Payments Sunshine Act (42 U.S.C. &#167; <FONT STYLE="white-space:nowrap">1320a-7h);</FONT> all criminal laws relating to healthcare fraud and abuse, including, but not limited to 18 U.S.C. Sections 286, 287, 1035, 1347 and 1349; the
healthcare fraud criminal provisions under the U.S. Health Insurance Portability and Accountability Act of 1996 (&#147;HIPAA&#148;) (42 U.S.C. &#167;&#167;1320d et seq.), the Medicare statute (Title XVIII of the Social Security Act) and the Medicaid
statute (Title XIX of the Social Security Act); (C) the patient privacy, data security and breach notification provisions under HIPAA, as amended by the Health Information Technology for Economic and Clinical Health Act of 2009 (42 U.S.C.
&#167;&#167;17921 et seq.); and (D)&nbsp;licensure, quality, safety and accreditation requirements under applicable federal, state, local or foreign laws or regulatory bodies (collectively, as amended, the &#147;Healthcare Laws&#148;). The Company
is not a party to and does not have any ongoing reporting obligations pursuant to any corporate integrity agreement, deferred prosecution agreement, monitoring agreement, consent decree, settlement order, plan of correction or similar agreement with
or imposed by any Governmental Entity. Additionally, neither the Company, nor any of its employees, officers, directors or agents, is or has been excluded, suspended, debarred or is otherwise ineligible from participation in any U.S. state or
federal healthcare program or human clinical research, or is subject to a governmental inquiry, investigation, proceeding or other similar action that could reasonably be expected to result in such exclusion, suspension or debarment. Except as
described in the Registration Statement, the General Disclosure Package and the Prospectus, the Company (x)&nbsp;has not received any Form 483, notice of adverse finding, warning letter, untitled letter or other written correspondence, or any other
notice from any Governmental Entity alleging or asserting noncompliance with any Healthcare Laws or the terms of any Governmental Licenses; (y)&nbsp;has not received notice of any claim, action, suit, proceeding, hearing, enforcement, investigation
or arbitration from any Governmental Entity or third party alleging that any product operation or activity is in violation of any Healthcare Laws or Governmental Licenses and (z)&nbsp;has no knowledge that any such Governmental Entity or third party
is considering any such claim, action, suit, proceeding, hearing, enforcement, investigation or arbitration. The Company has filed, obtained, maintained or submitted all material reports, documents, forms, notices, applications, records, claims,
submissions and supplements or amendments required by any Healthcare Laws or Governmental Licenses; all such reports, documents, forms, notices, applications, records, claims, submissions and supplements or amendments were complete and correct and
not misleading on the date filed; and the Company is not aware of any reasonable basis for any material liability with respect thereto. The Company and the Company&#146;s officers, employees and agents have not made any untrue statement of material
fact or fraudulent statement to any Governmental Entity or failed to disclose a material fact required to be disclosed to any Governmental Entity. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">10 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxvi)&nbsp;&nbsp;&nbsp;&nbsp;<U>Clinical Data and Regulatory
Compliance</U>. All clinical and <FONT STYLE="white-space:nowrap">pre-clinical</FONT> tests and trials conducted by or on behalf of the Company, including any such studies and trials that are described in or referred to in the Registration
Statement, the General Disclosure Package and the Prospectus (the &#147;Company Trials&#148;) were and, if still pending, are being conducted in accordance with standard medical and scientific research standards and procedures; current Good Clinical
Practices and Good Laboratory Practices; and all applicable laws, rules, and regulations of any applicable regulatory authority, including without limitation the Federal Food, Drug, and Cosmetic Act and the regulations set forth at 21 C.F.R. Parts
50, 54, 56, 58 and 312. The descriptions of the results of the Company Trials contained in the Registration Statement, the General Disclosure Package and the Prospectus are accurate and complete in all material respects and fairly present the data
derived therefrom. The Company has no knowledge of any other tests the results of which are inconsistent with or otherwise call into question the results described or referred to in the Registration Statement, the General Disclosure Package and the
Prospectus. The Company has not received any written notices or other correspondence from any regulatory authority requiring the termination, suspension or material modification of any preclinical tests or clinical trials. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxvii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Accounting Controls</U>. The Company and its subsidiaries, on a consolidated basis, maintain
a system of effective internal control over financial reporting (as defined under Rule <FONT STYLE="white-space:nowrap">13-a15</FONT> and <FONT STYLE="white-space:nowrap">15d-15</FONT> under the 1934 Act Regulations) and a system of internal
accounting controls each designed to provide reasonable assurances that (A)&nbsp;transactions are executed in accordance with management&#146;s general or specific authorization; (B)&nbsp;transactions are recorded as necessary to permit preparation
of financial statements in conformity with GAAP and to maintain accountability for assets; (C)&nbsp;access to assets is permitted only in accordance with management&#146;s general or specific authorization; and (D)&nbsp;the recorded accountability
for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect to any differences. Except as described in the Registration Statement, the General Disclosure Package and the Prospectus, since the
end of the Company&#146;s most recent audited fiscal year, there has been (1)&nbsp;no material weakness in the Company&#146;s internal control over financial reporting (whether or not remediated) and (2)&nbsp;no change in the Company&#146;s internal
control over financial reporting that has materially affected, or is reasonably likely to materially and adversely affect, the Company&#146;s internal control over financial reporting. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxviii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Compliance with the Sarbanes-Oxley Act.</U> The Company has taken all necessary actions to
ensure that, upon the effectiveness of the Registration Statement, it will be in compliance with all provisions of the Sarbanes-Oxley Act of 2002 and all rules and regulations promulgated thereunder or implementing the provisions thereof (the
&#147;Sarbanes-Oxley Act&#148;) that are then in effect and with which the Company is required to comply as of the effectiveness of the Registration Statement, and is, or will be, actively taking steps to ensure that it will be in compliance with
other provisions of the Sarbanes-Oxley Act not currently in effect, upon the effectiveness of such provisions, or which will become applicable to the Company at all times after the effectiveness of the Registration Statement. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxix)&nbsp;&nbsp;&nbsp;&nbsp; <U>Payment of Taxes</U>. All United States federal income tax returns of the Company and its
subsidiaries required by law to be filed by them (taking into account any timely requested extensions thereof) have been filed and all taxes shown by such returns or otherwise assessed, which are due and payable, have been paid, except assessments
against which appeals have been or will be promptly taken and as to which adequate reserves have been provided. The United States federal income tax returns of the Company through the fiscal year ended December&nbsp;31, 2018 have been settled and no
assessment in connection therewith has been made against the Company. The Company and its subsidiaries have filed all other tax returns that are required to have been filed by them pursuant to applicable foreign, state, local or other law except
insofar as the failure to file </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">11 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
such returns would not result in a Material Adverse Effect, and has paid all taxes due pursuant to such returns or pursuant to any assessment received by the Company and its subsidiaries, except
for such taxes, if any, as are being contested in good faith and as to which adequate reserves have been established by the Company. The charges, accruals and reserves on the books of the Company in respect of any income and corporation tax
liability for any years not finally determined are adequate to meet any assessments or <FONT STYLE="white-space:nowrap">re-assessments</FONT> for additional income tax for any years not finally determined, except to the extent of any inadequacy that
would not result in a Material Adverse Effect. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxx)&nbsp;&nbsp;&nbsp;&nbsp;<U>Insurance</U>. The Company and its
subsidiaries carry or are entitled to the benefits of insurance, with financially sound and reputable insurers, in such amounts and covering such risks as is generally maintained by companies of established repute engaged in the same or similar
business, and all such insurance is in full force and effect. The Company has no reason to believe that it or any of its subsidiaries will not be able (A)&nbsp;to renew its existing insurance coverage as and when such policies expire or (B)&nbsp;to
obtain comparable coverage from similar institutions as may be necessary or appropriate to conduct its business as now conducted and at a cost that would not result in a Material Adverse Effect. Neither of the Company nor any of its subsidiaries has
been denied any insurance coverage which it has sought or for which it has applied. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxi)&nbsp;&nbsp;&nbsp;&nbsp;<U>Investment Company Act</U>. The Company is not required, and upon the issuance and sale of the
Securities as herein contemplated and the application of the net proceeds therefrom as described in the Registration Statement, the General Disclosure Package and the Prospectus will not be required, to register as an &#147;investment company&#148;
under the Investment Company Act of 1940, as amended (the &#147;1940 Act&#148;). </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Absence
of Manipulation</U>. Neither the Company nor any affiliate of the Company has taken, nor will the Company or any subsidiary of the Company take, directly or indirectly, any action which is designed, or would reasonably be expected, to cause or
result in, or which constitutes, the stabilization or manipulation of the price of any security of the Company to facilitate the sale or resale of the Securities or to result in a violation of Regulation M under the 1934 Act. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxiii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Foreign Corrupt Practices Act</U>. None of the Company, any of its subsidiaries or, to the
knowledge of the Company, any director, officer, agent, employee, affiliate or other person acting on behalf of the Company or any of its subsidiaries is aware of or has taken any action, directly or indirectly, that would result in a violation by
such persons of the Foreign Corrupt Practices Act of 1977, as amended, and the rules and regulations thereunder (the &#147;FCPA&#148;), including, without limitation, making use of the mails or any means or instrumentality of interstate commerce
corruptly in furtherance of an offer, payment, promise to pay or authorization of the payment of any money, or other property, gift, promise to give, or authorization of the giving of anything of value to any &#147;foreign official&#148; (as such
term is defined in the FCPA) or any foreign political party or official thereof or any candidate for foreign political office, in contravention of the FCPA and the Company and, to the knowledge of the Company, its affiliates have conducted their
businesses in compliance with the FCPA and have instituted and maintain policies and procedures designed to ensure, and which are reasonably expected to continue to ensure, continued compliance therewith. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxiv)&nbsp;&nbsp;&nbsp;&nbsp; <U>Money Laundering Laws</U>. The operations of the Company and its subsidiaries are and have
been conducted at all times in compliance with applicable financial recordkeeping and reporting requirements of the Currency and Foreign Transactions Reporting Act of 1970, as amended, the money laundering statutes of all jurisdictions, the rules
and regulations thereunder </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">12 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
and any related or similar rules, regulations or guidelines, issued, administered or enforced by any Governmental Entity (collectively, the &#147;Money Laundering Laws&#148;); and no action, suit
or proceeding by or before any Governmental Entity involving the Company or any of its subsidiaries with respect to the Money Laundering Laws is pending or, to the best knowledge of the Company, threatened. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxv)&nbsp;&nbsp;&nbsp;&nbsp;<U>OFAC</U>. None of the Company, any of its subsidiaries or, to the knowledge of the Company,
any director, officer, agent, employee, affiliate or representative of the Company or any of its subsidiaries is an individual or entity (&#147;Person&#148;) currently the subject or target of any sanctions administered or enforced by the United
States Government, including, without limitation, the U.S. Department of the Treasury&#146;s Office of Foreign Assets Control (&#147;OFAC&#148;), the United Nations Security Council (&#147;UNSC&#148;), the European Union, Her Majesty&#146;s Treasury
(&#147;HMT&#148;), or other relevant sanctions authority (collectively, &#147;Sanctions&#148;), nor is the Company located, organized or resident in a country or territory that is the subject of Sanctions; and the Company will not directly or
indirectly use the proceeds of the sale of the Securities, or lend, contribute or otherwise make available such proceeds to any subsidiaries, joint venture partners or other Person, to fund or facilitate any activities of or business with any
Person, or in any country or territory, that, at the time of such funding or faciliating, is the subject of Sanctions or in any other manner that will result in a violation by any Person (including any Person participating in the transaction,
whether as underwriter, advisor, investor or otherwise) of Sanctions. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxvi)&nbsp;&nbsp;&nbsp;&nbsp; <U>Sales of Reserved
Securities</U>. In connection with any offer and sale of Reserved Securities outside the United States, each preliminary prospectus, the Prospectus and any amendment or supplement thereto, at the time it was filed, complied and will comply in all
material respects with any applicable laws or regulations of foreign jurisdictions in which the same is distributed. The Company has not offered, or caused the Representatives to offer, Reserved Securities to any person with the specific intent to
unlawfully influence (i)&nbsp;a customer or supplier of the Company or any of its affiliates to alter the customer&#146;s or supplier&#146;s level or type of business with any such entity or (ii)&nbsp;a trade journalist or publication to write or
publish favorable information about the Company or any of its affiliates, or their respective businesses or products. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxvii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Lending Relationship</U><I>. </I>Except as disclosed in the Registration Statement, the
General Disclosure Package and the Prospectus, the Company (i)&nbsp;does not have any&nbsp;material lending or other relationship with any bank or lending affiliate of any Underwriter and (ii)&nbsp;does not intend to use any of the proceeds from the
sale of the Securities to repay any outstanding debt owed to any affiliate of any Underwriter. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxviii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Statistical and Market-Related Data</U>. Any statistical and market-related data included
in the Registration Statement, the General Disclosure Package or the Prospectus are based on or derived from sources that the Company believes, after reasonable inquiry, to be reliable and accurate and, to the extent required, the Company has
obtained the written consent to the use of such data from such sources. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(xxxix)&nbsp;&nbsp;&nbsp;&nbsp;<U>Cybersecurity</U>. Except as described in the Registration Statement, the General Disclosure
Package and the Prospectus, (A)&nbsp;to the Company&#146;s knowledge, there has been no security breach or incident, unauthorized access or disclosure, or other compromise of or relating to the Company or its subsidiaries&#146; information
technology assets and equipment and computers, systems, networks, hardware, software, websites, applications, data and databases (including all data and information of their respective customers, employees, suppliers, vendors and any third party
data collected, maintained, processed or stored by the Company and its subsidiaries, and any such data collected, maintained, processed or stored by third parties on behalf of the Company and </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">13 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">
its subsidiaries), equipment or technology (collectively, &#147;IT Systems and Data&#148;); (B) the Company&#146;s IT Systems and Data are adequate for, and operate and perform in all material
respects as required in connection with the operation of the business of the Company and its subsidiaries as currently conducted, free and clear of all material bugs, errors, defects, Trojan horses, time bombs, malware and other corruptants;
(C)&nbsp;neither the Company nor its subsidiaries have been notified of, and each of them have no knowledge of any event or condition that could result in, any security breach or incident, unauthorized access or disclosure or other compromise to
their IT Systems and Data; (D)&nbsp;the Company and its subsidiaries have implemented and maintained appropriate controls, policies, procedures, and technological safeguards, including backup and disaster recovery technology, to maintain and protect
their material confidential information and the integrity, continuous operation, redundancy and security of their IT Systems and Data reasonably consistent with industry standards and practices or as required by applicable regulatory standards and
(E)&nbsp;the Company and its subsidiaries are presently, and have been, in material compliance with all applicable laws and statutes and all judgments, orders, rules and regulations of any court or arbitrator or governmental or regulatory authority,
internal policies and contractual obligations relating to the privacy and security of their IT Systems and Data and to the protection of such IT Systems and Data from unauthorized use, access, misappropriation or modification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<I>&nbsp;&nbsp;&nbsp;&nbsp;Officer&#146;s Certificates</I>. Any certificate signed by any officer of the Company or
any of its subsidiaries delivered to the Representatives or to counsel for the Underwriters shall be deemed a representation and warranty by the Company to each Underwriter as to the matters covered thereby. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 2.&nbsp;&nbsp;&nbsp;&nbsp;<U>Sale and Delivery to Underwriters; Closing</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;<I>&nbsp;&nbsp;&nbsp;&nbsp;Initial Securities</I>. On the basis of the representations and warranties herein
contained and subject to the terms and conditions herein set forth, the Company agrees to sell to each Underwriter, severally and not jointly, and each Underwriter, severally and not jointly, agrees to purchase from the Company, at the price per
share set forth in Schedule A, that number of Initial Securities set forth in Schedule A opposite the name of such Underwriter, plus any additional number of Initial Securities which such Underwriter may become obligated to purchase pursuant to the
provisions of Section&nbsp;10 hereof, subject, in each case, to such adjustments among the Underwriters as the Representatives in their sole discretion shall make to eliminate any sales or purchases of fractional shares. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;<I>&nbsp;&nbsp;&nbsp;&nbsp;Option Securities</I>. In addition, on the basis of the representations and warranties
herein contained and subject to the terms and conditions herein set forth, the Company hereby grant(s) an option to the Underwriters, severally and not jointly, to purchase up to an additional [&#9679;] shares of Common Stock, at the price per share
set forth in Schedule A, less an amount per share equal to any dividends or distributions declared by the Company and payable on the Initial Securities but not payable on the Option Securities. The option hereby granted may be exercised for
30&nbsp;days after the date hereof and may be exercised in whole or in part at any time from time to time upon notice by the Representatives to the Company setting forth the number of Option Securities as to which the several Underwriters are then
exercising the option and the time and date of payment and delivery for such Option Securities. Any such time and date of delivery (a &#147;Date of Delivery&#148;) shall be determined by the Representatives, but shall not be later than seven full
business days after the exercise of said option, nor in any event prior to the Closing Time. If the option is exercised as to all or any portion of the Option Securities, each of the Underwriters, acting severally and not jointly, will purchase that
proportion of the total number of Option Securities then being purchased which the number of Initial Securities set forth in Schedule A opposite the name of such Underwriter bears to the total number of Initial Securities, subject, in each case, to
such adjustments as the Representatives in their sole discretion shall make to eliminate any sales or purchases of fractional shares. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">14 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Payment</I>. Payment of the purchase
price for, and delivery of certificates or security entitlements for, the Initial Securities shall be made at the offices of Davis Polk&nbsp;&amp; Wardwell LLP, 1600 El Camino Real, Menlo Park, California 94025, or at such other place as shall be
agreed upon by the Representatives and the Company, at 9:00&nbsp;A.M. (New York City time) on the second (third, if the pricing occurs after 4:30 P.M. (New York City time) on any given day) business day after the date hereof (unless postponed in
accordance with the provisions of Section&nbsp;10), or such other time not later than ten business days after such date as shall be agreed upon by the Representatives and the Company (such time and date of payment and delivery being herein called
&#147;Closing Time&#148;). </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In addition, in the event that any or all of the Option Securities are purchased by the Underwriters, payment
of the purchase price for, and delivery of certificates or security entitlements for, such Option Securities shall be made at the <FONT STYLE="white-space:nowrap">above-mentioned</FONT> offices, or at such other place as shall be agreed upon by the
Representatives and the Company, on each Date of Delivery as specified in the notice from the Representatives to the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Payment
shall be made to the Company by wire transfer of immediately available funds to a bank account designated by the Company against delivery to the Representatives for the respective accounts of the Underwriters of certificates or security entitlements
for the Securities to be purchased by them. It is understood that each Underwriter has authorized the Representatives, for its account, to accept delivery of, receipt for, and make payment of the purchase price for, the Initial Securities and the
Option Securities, if any, which it has agreed to purchase. Each Representative, individually and not as representative of the Underwriters, may (but shall not be obligated to) make payment of the purchase price for the Initial Securities or the
Option Securities, if any, to be purchased by any Underwriter whose funds have not been received by the Closing Time or the relevant Date of Delivery, as the case may be, but such payment shall not relieve such Underwriter from its obligations
hereunder. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 3.&nbsp;&nbsp;&nbsp;&nbsp;<U>Covenants of the Company</U>. The Company covenants with each Underwriter as follows:
</P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-right:2%; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance with Securities Regulations and Commission Requests</I>.
The Company, subject to Section&nbsp;3(b), will comply with the requirements of Rule 430A, and will notify the Representatives immediately, and confirm the notice in writing, (i)&nbsp;when any post-effective amendment to the Registration Statement
shall become effective or any amendment or supplement to the Prospectus shall have been filed, (ii)&nbsp;of the receipt of any comments from the Commission, (iii)&nbsp;of any request by the Commission for any amendment to the Registration Statement
or any amendment or supplement to the Prospectus or for additional information, (iv)&nbsp;of the issuance by the Commission of any stop order suspending the effectiveness of the Registration Statement or any post-effective amendment or of any order
preventing or suspending the use of any preliminary prospectus or the Prospectus, or of the suspension of the qualification of the Securities for offering or sale in any jurisdiction, or of the initiation or threatening of any proceedings for any of
such purposes or of any examination pursuant to Section&nbsp;8(d) or 8(e) of the 1933 Act concerning the Registration Statement and (v)&nbsp;if the Company becomes the subject of a proceeding under Section&nbsp;8A of the 1933 Act in connection with
the offering of the Securities. The Company will effect all filings required under Rule 424(b), in the manner and within the time period required by Rule&nbsp;424(b) (without reliance on Rule 424(b)(8)), and will take such steps as it deems
necessary to ascertain promptly whether the form of prospectus transmitted for filing under Rule 424(b) was received for filing by the Commission and, in the event that it was not, it will promptly file such prospectus. The Company will make every
reasonable effort to prevent the issuance of any stop order, prevention or suspension and, if any such order is issued, to obtain the lifting thereof at the earliest possible moment. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Continued Compliance with Securities Laws</I>. The Company will comply with the 1933 Act
and the 1933 Act Regulations so as to permit the completion of the distribution of the Securities as </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">15 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
contemplated in this Agreement and in the Registration Statement, the General Disclosure Package and the Prospectus. If at any time when a prospectus relating to the Securities is (or, but for
the exception afforded by Rule 172 of the 1933 Act Regulations (&#147;Rule 172&#148;), would be) required by the 1933 Act to be delivered in connection with sales of the Securities, any event shall occur or condition shall exist as a result of which
it is necessary, in the opinion of counsel for the Underwriters or for the Company, to (i)&nbsp;amend the Registration Statement in order that the Registration Statement will not include an untrue statement of a material fact or omit to state a
material fact required to be stated therein or necessary to make the statements therein not misleading, (ii)&nbsp;amend or supplement the General Disclosure Package or the Prospectus in order that the General Disclosure Package or the Prospectus, as
the case may be, will not include any untrue statement of a material fact or omit to state a material fact necessary in order to make the statements therein not misleading in the light of the circumstances existing at the time it is delivered to a
purchaser or (iii)&nbsp;amend the Registration Statement or amend or supplement the General Disclosure Package or the Prospectus, as the case may be, in order to comply with the requirements of the 1933 Act or the 1933 Act Regulations, the Company
will promptly (A)&nbsp;give the Representatives notice of such event, (B)&nbsp;prepare any amendment or supplement as may be necessary to correct such statement or omission or to make the Registration Statement, the General Disclosure Package or the
Prospectus comply with such requirements and, a reasonable amount of time prior to any proposed filing or use, furnish the Representatives with copies of any such amendment or supplement and (C)&nbsp;file with the Commission any such amendment or
supplement; provided that the Company shall not file or use any such amendment or supplement to which the Representatives or counsel for the Underwriters shall reasonably object. The Company will furnish to the Underwriters such number of copies of
such amendment or supplement as the Underwriters may reasonably request. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Delivery
of Registration Statements</I>. The Company has furnished or will deliver to the Representatives and counsel for the Underwriters, without charge, conformed copies of the Registration Statement as originally filed and each amendment thereto
(including exhibits filed therewith) and of all consents and certificates of experts. The copies of the Registration Statement and each amendment thereto furnished to the Underwriters will be identical to the electronically transmitted copies
thereof filed with the Commission pursuant to EDGAR, except to the extent permitted by <FONT STYLE="white-space:nowrap">Regulation&nbsp;S-T.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Delivery of Prospectuses</I>. The Company has delivered to each Underwriter, without
charge, as many copies of each preliminary prospectus as such Underwriter reasonably requested, and the Company hereby consents to the use of such copies for purposes permitted by the 1933 Act. The Company will furnish to each Underwriter, without
charge, during the period when a prospectus relating to the Securities is (or, but for the exception afforded by Rule 172, would be) required to be delivered under the 1933 Act, such number of copies of the Prospectus (as amended or supplemented) as
such Underwriter may reasonably request. The Prospectus and any amendments or supplements thereto furnished to the Underwriters will be identical to the electronically transmitted copies thereof filed with the Commission pursuant to EDGAR, except to
the extent permitted by Regulation <FONT STYLE="white-space:nowrap">S-T.</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Blue Sky Qualifications</I>. The Company will use its reasonable best efforts, in
cooperation with the Underwriters, to qualify the Securities for offering and sale under the applicable securities laws of such states and other jurisdictions (domestic or foreign) as the Representatives may designate and to maintain such
qualifications in effect so long as required to complete the distribution of the Securities; provided, however, that the Company shall not be obligated to file any general consent to service of process or to qualify as a foreign corporation or as a
dealer in securities in any jurisdiction in which it is not so qualified or to subject itself to taxation in respect of doing business in any jurisdiction in which it is not otherwise so subject. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Rule 158</I>. The Company will timely file such reports pursuant to the Securities
Exchange Act of 1934, as amended (the &#147;1934 Act&#148;) as are necessary in order to make generally available to its securityholders as soon as practicable an earnings statement for the purposes of, and to provide to the Underwriters the
benefits contemplated by, the last paragraph of Section&nbsp;11(a) of the 1933 Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">16 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Use of Proceeds</I>. The Company will
use the net proceeds received by it from the sale of the Securities in the manner specified in the Registration Statement, the General Disclosure Package and the Prospectus under &#147;Use of Proceeds.&#148; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Listing</I>. The Company will use its reasonable best efforts to effect and maintain the
listing of the Common Stock (including the Securities) on the Nasdaq Global Market. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Restriction on Sale of Securities</I>. During a period of 180 days from the date of the
Prospectus, the Company will not, without the prior written consent of [&#9679;], (i) directly or indirectly, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option,
right or warrant to purchase or otherwise transfer or dispose of any shares of Common Stock or any securities convertible into or exercisable or exchangeable for Common Stock or file or confidentially submit any registration statement under the 1933
Act with respect to any of the foregoing or (ii)&nbsp;enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or indirectly, the economic consequence of ownership of the Common Stock, whether any
such swap or transaction described in clause (i)&nbsp;or (ii) above is to be settled by delivery of Common Stock or other securities, in cash or otherwise. The foregoing sentence shall not apply to (A)&nbsp;the Securities to be sold hereunder,
(B)&nbsp;any shares of Common Stock issued by the Company upon the exercise (including any net exercise or exercise by delivery of already-owned shares of Common Stock) of an option or warrant or the conversion of a security outstanding on the date
hereof and referred to in the Registration Statement, the General Disclosure Package and the Prospectus, (C)&nbsp;any shares of Common Stock issued or options to purchase Common Stock or restricted stock units covering shares of Common Stock granted
pursuant to existing employee benefit plans of the Company referred to in the Registration Statement, the General Disclosure Package and the Prospectus, (D)&nbsp;any shares of Common Stock issued or options to purchase Common Stock granted pursuant
to any <FONT STYLE="white-space:nowrap">non-employee</FONT> director stock plan referred to in the Registration Statement, the General Disclosure Package and the Prospectus; (E)&nbsp;the filing by the Company of any registration statement on Form <FONT
STYLE="white-space:nowrap">S-8</FONT> or a successor form thereto with respect to the registration of securities to be offered under any employee benefit or equity incentive plan referred to in the Registration Statement, the General Disclosure
Package and the Prospectus and (F)&nbsp;shares of Common Stock or other securities issued in connection with a transaction that includes a commercial relationship (including strategic alliances, commercial lending relationships, joint ventures, and
strategic acquisitions), provided that (i)&nbsp;the aggregate number of shares issued pursuant to this clause (F)&nbsp;shall not exceed 5.0% of the total number of outstanding shares of Common Stock immediately following the issuance and sale of the
Securities and (ii)&nbsp;the recipient of any such shares of Common Stock or securities issued pursuant to this clause (F)&nbsp;during the <FONT STYLE="white-space:nowrap">180-day</FONT> restricted period shall enter into an agreement substantially
in the form of Exhibit A hereto. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;If, in the sole discretion of [&#9679;], [&#9679;]
agree to release or waive the restrictions set forth in a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement described in Section&nbsp;5(i) hereof for an officer or director of the Company and provide the Company with notice of the impending
release or waiver at least three business days before the effective date of the release or waiver, the Company agrees to announce the impending release or waiver by a press release substantially in the form of Exhibit C hereto through a major news
service at least two business days before the effective date of the release or waiver. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Reporting Requirements</I>. The Company, during the period when a Prospectus relating to
the Securities is (or, but for the exception afforded by Rule 172, would be) required to be delivered under the 1933 Act, will file all documents required to be filed with the Commission pursuant to the 1934 Act within the time periods required by
the 1934 Act and 1934 Act Regulations. Additionally, the Company shall report the use of proceeds from the issuance of the Shares as may be required under Rule 463 under the 1933 Act. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">17 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Issuer Free Writing Prospectuses</I>.
The Company agrees that, unless it obtains the prior written consent of the Representatives, it will not make any offer relating to the Securities that would constitute an Issuer Free Writing Prospectus or that would otherwise constitute a
&#147;free writing prospectus,&#148; or a portion thereof, required to be filed by the Company with the Commission or retained by the Company under Rule 433; provided that the Representatives will be deemed to have consented to the Issuer Free
Writing Prospectuses listed on Schedule <FONT STYLE="white-space:nowrap">B-2</FONT> hereto and any &#147;road show that is a written communication&#148; within the meaning of Rule 433(d)(8)(i) that has been reviewed by the Representatives. The
Company represents that it has treated or agrees that it will treat each such free writing prospectus consented to, or deemed consented to, by the Representatives as an &#147;issuer free writing prospectus,&#148; as defined in Rule 433, and that it
has complied and will comply with the applicable requirements of Rule 433 with respect thereto, including timely filing with the Commission where required, legending and record keeping. If at any time following issuance of an Issuer Free Writing
Prospectus there occurred or occurs an event or development as a result of which such Issuer Free Writing Prospectus conflicted or would conflict with the information contained in the Registration Statement, any preliminary prospectus or the
Prospectus or included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the light of the circumstances existing at that subsequent time,
not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement, at its own expense, such Issuer Free Writing Prospectus to eliminate or correct such conflict, untrue statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Certification Regarding Beneficial Owners</I>. The Company will deliver to the
Representatives, on the date of execution of this Agreement, a properly completed and executed Certification Regarding Beneficial Owners of Legal Entity Customers, together with copies of identifying documentation, and the Company undertakes to
provide such additional supporting documentation as the Representatives may reasonably request in connection with the verification of the foregoing certification. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(o)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Compliance with FINRA Rules</I>. The Company hereby agrees that it will ensure that the
Reserved Securities will be restricted as required by FINRA or the FINRA rules from sale, transfer, assignment, pledge or hypothecation for a period of three months following the date of this Agreement.
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; will notify the Company as to which persons will need to be so restricted. At the request of the Underwriters, the Company will
direct the transfer agent to place a stop transfer restriction upon such securities for such period of time. Should the Company release, or seek to release, from such restrictions any of the Reserved Securities, the Company agrees to reimburse the
Underwriters for any reasonable expenses (including, without limitation, legal expenses) they incur in connection with such release. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(p)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
<I><FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Materials</I>. If at any time following the distribution of any Written
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication there occurred or occurs an event or development as a result of which such Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication included or would include an untrue statement of a material fact or omitted or would omit to state a material fact necessary in order to make the statements therein, in the
light of the circumstances existing at that subsequent time, not misleading, the Company will promptly notify the Representatives and will promptly amend or supplement, at its own expense, such Written <FONT STYLE="white-space:nowrap"><FONT
STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication to eliminate or correct such untrue statement or omission. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(q)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Emerging Growth Company Status</I>. The Company will promptly notify the Representatives
if the Company ceases to be an Emerging Growth Company at any time prior to the later of (i)&nbsp;completion of the distribution of the Securities within the meaning of the Securities Act and (ii)&nbsp;completion of the <FONT
STYLE="white-space:nowrap">180-day</FONT> restricted period referred to in Section&nbsp;3(i). </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">18 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 4.&nbsp;&nbsp;&nbsp;&nbsp;<U>Payment of Expenses</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Expenses</I>. The Company will pay or cause to be paid all expenses incident to the
performance of its obligations under this Agreement (excluding taxes, other than taxes described in clause (iii)&nbsp;below), including (i)&nbsp;the preparation, printing and filing of the Registration Statement (including financial statements and
exhibits) as originally filed and each amendment thereto, (ii)&nbsp;the preparation, printing and delivery to the Underwriters of copies of each preliminary prospectus, each Issuer Free Writing Prospectus and the Prospectus and any amendments or
supplements thereto and reasonable costs associated with electronic delivery of any of the foregoing by the Underwriters to investors, (iii)&nbsp;the preparation, issuance and delivery of the certificates or security entitlements for the Securities
to the Underwriters, including any stock or other transfer taxes and any stamp or other similar taxes, in each case payable upon the sale, issuance or delivery of the Securities to the Underwriters in the manner contemplated by this Agreement and
the Prospectus, (iv)&nbsp;the fees and disbursements of the Company&#146;s counsel, accountants and other advisors, (v)&nbsp;the qualification of the Securities under securities laws in accordance with the provisions of Section&nbsp;3(e) hereof,
including filing fees and the reasonable fees and disbursements of counsel for the Underwriters in connection therewith and in connection with the preparation of the Blue Sky Survey and any supplement thereto, (vi)&nbsp;the fees and expenses of any
transfer agent or registrar for the Securities, (vii)&nbsp;the costs and expenses of the Company relating to investor presentations on any &#147;road show&#148; undertaken in connection with the marketing of the Securities, including without
limitation, expenses associated with the production of road show slides and graphics, fees and expenses of any consultants engaged by the Company or with the Company&#146;s prior written consent in connection with the road show presentations, travel
and lodging expenses of the representatives and officers of the Company and any such consultants (provided that the travel, lodging and any car travel expenses of representatives of the Underwriters shall be paid for by the Underwriters), and fifty
percent (50%) of the cost of any aircraft chartered in connection with the road show (with the Underwriters agreeing to pay for the other fifty percent (50%) of the cost of the aircraft, as well as any other travel and lodging expenses of the
Underwriters in connection with the road show), (viii) the filing fees incident to, and the reasonable fees and disbursements of counsel to the Underwriters in connection with, the review by FINRA of the terms of the sale of the Securities,
(ix)&nbsp;the fees and expenses incurred in connection with the listing of the Securities on the Nasdaq Global Market and (x)&nbsp;the costs and expenses (including, without limitation, any damages or other amounts payable in connection with legal
or contractual liability) associated with the reforming of any contracts for sale of the Securities made by the Underwriters caused by a breach of the representation contained in the third sentence of Section&nbsp;1(a)(ii) and (xi)&nbsp;all
reasonable costs and expenses of the Underwriters, including the reasonable fees and disbursements of counsel for the Underwriters, in connection with matters related to the Reserved Securities which are designated by the Company for sale to
Invitees; provided, however, that the amount of fees and disbursements of counsel payable by the Company pursuant to clauses (v), (viii) and (xi)&nbsp;shall not exceed $50,000 in the aggregate. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Termination of Agreement</I>. If this Agreement is terminated by the Representatives in
accordance with the provisions of Section&nbsp;5, Section&nbsp;9(a)(i) or (iii)&nbsp;or Section&nbsp;10 hereof, the Company shall reimburse the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters for all of their reasonable <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">out-of-pocket</FONT></FONT> expenses, including the reasonable fees and disbursements of counsel for the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 5.&nbsp;&nbsp;&nbsp;&nbsp;<U>Conditions of Underwriters&#146; Obligations</U>. The obligations of the several Underwriters hereunder
are subject to the accuracy of the representations and warranties of the Company contained herein or in certificates of any officer of the Company or any of its subsidiaries delivered pursuant to the provisions hereof, to the performance by the
Company of its covenants and other obligations hereunder, and to the following further conditions: </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">19 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Effectiveness of Registration
Statement; Rule 430A Information</I>. The Registration Statement, including any Rule 462(b) Registration Statement, has become effective and, at the Closing Time, no stop order suspending the effectiveness of the Registration Statement or any
post-effective amendment thereto has been issued under the 1933 Act, no order preventing or suspending the use of any preliminary prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are
pending or, to the Company&#146;s knowledge, contemplated; and the Company has complied with each request (if any) from the Commission for additional information. A prospectus containing the Rule 430A Information shall have been filed with the
Commission in the manner and within the time frame required by Rule 424(b) without reliance on Rule 424(b)(8) or a post-effective amendment providing such information shall have been filed with, and declared effective by, the Commission in
accordance with the requirements of Rule 430A. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinions and Negative Assurance
Letter of Counsel for Company</I>. At the Closing Time, the Representatives shall have received the favorable opinion and negative assurance letter, dated the Closing Time, of Cooley LLP, counsel for the Company, and an opinion, dated the Closing
Time, of Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C., intellectual property counsel for the Company (&#147;Mintz Levin&#148;), each in form and substance as previously agreed upon by the Representatives and such counsel, together with signed
or reproduced copies of such letters for each of the other Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Opinion of
Counsel for Underwriters</I>. At the Closing Time, the Representatives shall have received the favorable opinion, dated the Closing Time, of Davis Polk and Wardwell LLP, counsel for the Underwriters, together with signed or reproduced copies of such
letter for each of the other Underwriters. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Officers&#146; Certificate</I>. At the
Closing Time, there shall not have been, since the date hereof or since the respective dates as of which information is given in the Registration Statement, the General Disclosure Package or the Prospectus, any material adverse change in the
condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries considered as one enterprise, whether or not arising in the ordinary course of business, and the Representatives shall
have received a certificate of the Chief Executive Officer or the President of the Company and of the chief financial or chief accounting officer of the Company, dated the Closing Time, to the effect that (i)&nbsp;there has been no such material
adverse change, (ii)&nbsp;the representations and warranties of the Company in this Agreement are true and correct with the same force and effect as though expressly made at and as of the Closing Time, (iii)&nbsp;the Company has complied with all
agreements and satisfied all conditions on its part to be performed or satisfied at or prior to the Closing Time, and (iv)&nbsp;no stop order suspending the effectiveness of the Registration Statement under the 1933 Act has been issued, no order
preventing or suspending the use of any preliminary prospectus or the Prospectus has been issued and no proceedings for any of those purposes have been instituted or are pending or, to their knowledge, contemplated. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Accountant&#146;s Comfort Letter</I>. At the time of the execution of this Agreement,
the Representatives shall have received from Ernst&nbsp;&amp; Young LLP, independent public accountants (&#147;Ernst&nbsp;&amp; Young&#148;), a letter, dated such date, in form and substance satisfactory to the Representatives, together with signed
or reproduced copies of such letter for each of the other Underwriters containing statements and information of the type ordinarily included in accountants&#146; &#147;comfort letters&#148; to underwriters with respect to the financial statements
and certain financial information contained in the Registration Statement, the General Disclosure Package and the Prospectus. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(f)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>CFO Certificate</I>. At the Closing Time, the Company shall have furnished to the
Representatives a certificate, dated the Closing Time and addressed to the Underwriters, of the Company&#146;s chief financial officer, on behalf of the Company and not in his individual capacity, with respect to certain financial data, contained in
the Registration Statement (or any amendment thereto), the General Disclosure Package or the Prospectus (or any amendment or supplement thereto), providing &#147;management comfort&#148; with respect to such information, in form and substance
reasonably satisfactory to the Representatives. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">20 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(g)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Bring-down Comfort Letter</I>. At the
Closing Time, the Representatives shall have received from Ernst&nbsp;&amp; Young a letter, dated as of the Closing Time, to the effect that they reaffirm the statements made in the letter furnished pursuant to subsection (e)&nbsp;of this Section,
except that the specified date referred to shall be a date not more than three business days prior to the Closing Time. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(h)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Approval of Listing</I>. At the Closing Time, the Securities shall have been approved
for listing on the Nasdaq Global Market, subject only to official notice of issuance. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>No Objection</I>. FINRA has confirmed that it has not raised any objection with respect
to the fairness and reasonableness of the underwriting terms and arrangements relating to the offering of the Securities. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(j)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I><FONT STYLE="white-space:nowrap">Lock-up</FONT> Agreements</I>. At the date of this
Agreement, the Representatives shall have received an agreement substantially in the form of Exhibit&nbsp;B hereto signed by the persons listed on Schedule C hereto. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(k)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Absence of Rated Securities</I>. Neither the Company nor its subsidiaries have any debt
securities or preferred stock that are rated by any &#147;nationally recognized statistical rating agency&#148; (as defined in Section&nbsp;3(a)(62) of the 1934 Act). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(l)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Conditions to Purchase of Option Securities</I>. In the event that the Underwriters
exercise their option provided in Section&nbsp;2(b) hereof to purchase all or any portion of the Option Securities, the representations and warranties of the Company contained herein and the statements in any certificates furnished by the Company
and any of its subsidiaries hereunder shall be true and correct as of each Date of Delivery and, at the relevant Date of Delivery, the Representatives shall have received: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;<U>Officers&#146; Certificate</U>. A certificate, dated such Date of Delivery, of the President or a
Vice President of the Company and of the chief financial or chief accounting officer of the Company confirming that the certificate delivered at the Closing Time pursuant to Section&nbsp;5(d) hereof remains true and correct as of such Date of
Delivery. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinions of Counsels for Company</U>. If requested by the Representatives, the
favorable opinion and negative assurance letter of Cooley LLP, counsel for the Company, together with the opinion of Mintz Levin, each in form and substance as previously agreed upon by the Representatives and such counsel for the Underwriters,
dated such Date of Delivery, relating to the Option Securities to be purchased on such Date of Delivery and otherwise to the same effect as the opinion required by Section&nbsp;5(b) hereof. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;<U>Opinion of Counsel for Underwriters</U>. If requested by the Representatives, the favorable
opinion of Davis Polk&nbsp;&amp; Wardwell LLP, counsel for the Underwriters, dated such Date of Delivery, relating to the Option Securities to be purchased on such Date of Delivery and otherwise to the same effect as the opinion required by
Section&nbsp;5(c) hereof. </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(v)&nbsp;&nbsp;&nbsp;&nbsp;<U>Bring-down Comfort Letter</U>. If requested by the
Representatives, a letter from Ernst&nbsp;&amp; Young, in form and substance satisfactory to the Representatives and dated such Date of Delivery, substantially in the same form and substance as the letter furnished to the Representatives pursuant to
Section&nbsp;5(e) hereof, except that the &#147;specified date&#148; in the letter furnished pursuant to this paragraph shall be a date not more than three business days prior to such Date of Delivery. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">21 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(vi)&nbsp;&nbsp;&nbsp;&nbsp;A certificate, dated such Date of Delivery, of
the chief financial officer of the Company confirming that the certificate delivered at the Closing Time pursuant to Section&nbsp;5(f) hereof remains true and correct as of such Date of Delivery. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(m)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Additional Documents</I>. At the Closing Time and at each Date of Delivery (if any)
counsel for the Underwriters shall have been furnished with such documents and opinions as they may reasonably require for the purpose of enabling them to pass upon the issuance and sale of the Securities as herein contemplated, or in order to
evidence the accuracy of any of the representations or warranties, or the fulfillment of any of the conditions, herein contained; and all proceedings taken by the Company in connection with the issuance and sale of the Securities as herein
contemplated shall be reasonably satisfactory in form and substance to the Representatives and counsel for the Underwriters. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(n)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Termination of Agreement</I>. If any condition specified in this Section shall not have
been fulfilled when and as required to be fulfilled, this Agreement, or, in the case of any condition to the purchase of Option Securities on a Date of Delivery which is after the Closing Time, the obligations of the several Underwriters to purchase
the relevant Option Securities, may be terminated by the Representatives by notice to the Company at any time at or prior to Closing Time or such Date of Delivery, as the case may be, and such termination shall be without liability of any party to
any other party except as provided in Section&nbsp;4 and except that Sections 1, 6, 7, 8, 14, 15, 16 and 17 shall survive any such termination and remain in full force and effect. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 6.&nbsp;&nbsp;&nbsp;&nbsp;<U>Indemnification</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification of Underwriters</I>. The Company agrees to indemnify and hold harmless
each Underwriter, its affiliates (as such term is defined in Rule 501(b) under the 1933 Act (each, an &#147;Affiliate&#148;)), its selling agents and each person, if any, who controls any Underwriter within the meaning of Section&nbsp;15 of the 1933
Act or Section&nbsp;20 of the 1934 Act as follows: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;against any and all loss, liability, claim,
damage and expense whatsoever, as incurred, arising out of any untrue statement or alleged untrue statement of a material fact contained in the Registration Statement (or any amendment thereto), including the Rule 430A Information, or the omission
or alleged omission therefrom of a material fact required to be stated therein or necessary to make the statements therein not misleading or arising out of any untrue statement or alleged untrue statement of a material fact included (A)&nbsp;in any
preliminary prospectus, any Issuer Free Writing Prospectus, any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, the General Disclosure Package or the Prospectus (or any
amendment or supplement thereto), or (B)&nbsp;in any materials or information provided to investors by, or with the approval of, the Company in connection with the marketing of the offering of the Securities (&#147;Marketing Materials&#148;),
including any roadshow or investor presentations made to investors by the Company (whether in person or electronically), or the omission or alleged omission in any preliminary prospectus, Issuer Free Writing Prospectus, any Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, Prospectus or in any Marketing Materials of a material fact necessary in order to make the statements therein, in the light of the
circumstances under which they were made, not misleading; </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;against any and all loss, liability,
claim, damage and expense whatsoever, as incurred, to the extent of the aggregate amount paid in settlement of any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or of any claim whatsoever
based upon any such untrue statement or omission, or any such alleged untrue statement or omission; provided that (subject to Section&nbsp;6(d) below) any such settlement is effected with the written consent of the Company; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">22 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(iii)&nbsp;&nbsp;&nbsp;&nbsp;against any and all expense whatsoever, as
incurred (including the fees and disbursements of counsel chosen by the Representatives), reasonably incurred in investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body,
commenced or threatened, or any claim whatsoever based upon any such untrue statement or omission, or any such alleged untrue statement or omission, to the extent that any such expense is not paid under (i)&nbsp;or (ii) above; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">provided, however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue
statement or omission or alleged untrue statement or omission made in the Registration Statement (or any amendment thereto), including the Rule 430A Information, the General Disclosure Package, any preliminary prospectus, any Issuer Free Writing
Prospectus, any Written <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, any Marketing Materials or the Prospectus (or any amendment or supplement thereto) in reliance upon and in
conformity with the Underwriter Information. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification of Company, Directors
and Officers</I>. Each Underwriter severally agrees to indemnify and hold harmless the Company, its directors, each of its officers who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of
Section&nbsp;15 of the 1933 Act or Section&nbsp;20 of the 1934 Act, against any and all loss, liability, claim, damage and expense described in the indemnity contained in subsection (a)&nbsp;of this Section, as incurred, but only with respect to
untrue statements or omissions, or alleged untrue statements or omissions, made in the Registration Statement (or any amendment thereto), including the Rule 430A Information, the General Disclosure Package or the Prospectus (or any amendment or
supplement thereto) in reliance upon and in conformity with the Underwriter Information. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Actions against Parties; Notification</I>. Each indemnified party shall give notice as
promptly as reasonably practicable to each indemnifying party of any action commenced against it in respect of which indemnity may be sought hereunder, but failure to so notify an indemnifying party shall not relieve such indemnifying party from any
liability hereunder to the extent it is not materially prejudiced as a result thereof and in any event shall not relieve it from any liability which it may have otherwise than on account of this indemnity agreement. In the case of parties
indemnified pursuant to Section&nbsp;6(a) above, counsel to the indemnified parties shall be selected by the Representatives, and, in the case of parties indemnified pursuant to Section&nbsp;6(b) above, counsel to the indemnified parties shall be
selected by the Company. An indemnifying party may participate at its own expense in the defense of any such action; provided, however, that counsel to the indemnifying party shall not (except with the consent of the indemnified party) also be
counsel to the indemnified party. In no event shall the indemnifying parties be liable for fees and expenses of more than one counsel (in addition to any local counsel) separate from their own counsel for all indemnified parties in connection with
any one action or separate but similar or related actions in the same jurisdiction arising out of the same general allegations or circumstances. No indemnifying party shall, without the prior written consent of the indemnified parties, settle or
compromise or consent to the entry of any judgment with respect to any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever in respect of which indemnification or
contribution could be sought under this Section&nbsp;6 or Section&nbsp;7 hereof (whether or not the indemnified parties are actual or potential parties thereto), unless such settlement, compromise or consent (i)&nbsp;includes an unconditional
release of each indemnified party from all liability arising out of such litigation, investigation, proceeding or claim and (ii)&nbsp;does not include a statement as to or an admission of fault, culpability or a failure to act by or on behalf of any
indemnified party. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Settlement without Consent if Failure to Reimburse</I>. If at
any time an indemnified party shall have requested an indemnifying party to reimburse the indemnified party for fees and expenses of counsel, such indemnifying party agrees that it shall be liable for any settlement of the nature contemplated by
Section&nbsp;6(a)(ii) or settlement of any claim in connection with any violation referred to in Section&nbsp;6(e) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">23 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
effected without its written consent if (i)&nbsp;such settlement is entered into more than 45 days after receipt by such indemnifying party of the aforesaid request, (ii)&nbsp;such indemnifying
party shall have received notice of the terms of such settlement at least 30 days prior to such settlement being entered into and (iii)&nbsp;such indemnifying party shall not have reimbursed such indemnified party in accordance with such request
prior to the date of such settlement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Indemnification for Reserved Securities</I>.
In connection with the offer and sale of the Reserved Securities, the Company agrees to indemnify and hold harmless the Underwriters, their Affiliates and selling agents and each person, if any, who controls any Underwriter within the meaning of
either Section&nbsp;15 of the 1933 Act or Section&nbsp;20 of the 1934 Act, from and against any and all loss, liability, claim, damage and expense (including, without limitation, any reasonable legal or other expenses reasonably incurred in
connection with defending, investigating or settling any such action or claim), as incurred, (i)&nbsp;arising out of the violation of any applicable laws or regulations of foreign jurisdictions where Reserved Securities have been offered,
(ii)&nbsp;arising out of any untrue statement or alleged untrue statement of a material fact contained in any other material prepared by or with the consent of the Company for distribution to Invitees in connection with the offering of the Reserved
Securities or caused by any omission or alleged omission to state therein a material fact required to be stated therein or necessary to make the statements therein not misleading, (iii)&nbsp;caused by the failure of any Invitee to pay for and accept
delivery of Reserved Securities which have been orally confirmed for purchase by any Invitee by 9:00 A.M. (New York City time) on the first business day after the date of the Agreement or (iv)&nbsp;related to, or arising out of or in connection
with, the offering of the Reserved Securities; provided, however, that this indemnity agreement shall not apply to any loss, liability, claim, damage or expense to the extent arising out of any untrue statement or omission or alleged untrue
statement or omission made in the Registration Statement (or any amendment thereto), including the Rule 430A Information, the General Disclosure Package, any preliminary prospectus, Issuer Free Writing Prospectus, Written <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Testing-the-Waters</FONT></FONT> Communication, Marketing Materials or the Prospectus (or any amendment or supplement thereto) in reliance upon and in conformity with the Underwriter
Information; provided further that no indemnification shall be available under this section for any loss, liability, claim, damage or expense which shall have been finally judicially determined by a court of competent jurisdiction to have been
caused primarily by the gross negligence or willful misconduct of the Representatives. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
7.&nbsp;&nbsp;&nbsp;&nbsp;<U>Contribution</U>. If the indemnification provided for in Section&nbsp;6 hereof is for any reason unavailable to or insufficient to hold harmless an indemnified party in respect of any losses, liabilities, claims, damages
or expenses referred to therein, then each indemnifying party shall contribute to the aggregate amount of such losses, liabilities, claims, damages and expenses incurred by such indemnified party, as incurred, (i)&nbsp;in such proportion as is
appropriate to reflect the relative benefits received by the Company, on the one hand, and the Underwriters, on the other hand, from the offering of the Securities pursuant to this Agreement or (ii)&nbsp;if the allocation provided by clause
(i)&nbsp;is not permitted by applicable law, in such proportion as is appropriate to reflect not only the relative benefits referred to in clause (i)&nbsp;above but also the relative fault of the Company, on the one hand, and of the Underwriters, on
the other hand, in connection with the statements or omissions, or in connection with any violation of the nature referred to in Section&nbsp;6(e) hereof, which resulted in such losses, liabilities, claims, damages or expenses, as well as any other
relevant equitable considerations. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The relative benefits received by the Company, on the one hand, and the Underwriters, on the other
hand, in connection with the offering of the Securities pursuant to this Agreement shall be deemed to be in the same respective proportions as the total net proceeds from the offering of the Securities pursuant to this Agreement (after deducting
underwriting discounts and commissions but before deducting expenses) received by the Company, on the one hand, and the total underwriting discount received by the Underwriters, on the other hand, in each case as set forth on the cover of the
Prospectus, bear to the aggregate initial public offering price of the Securities as set forth on the cover of the Prospectus. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">24 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The relative fault of the Company, on the one hand, and the Underwriters, on the other hand,
shall be determined by reference to, among other things, whether any such untrue or alleged untrue statement of a material fact or omission or alleged omission to state a material fact relates to information supplied by the Company or by the
Underwriters and the parties&#146; relative intent, knowledge, access to information and opportunity to correct or prevent such statement or omission or any violation of the nature referred to in Section&nbsp;6(e) hereof. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The Company and the Underwriters agree that it would not be just and equitable if contribution pursuant to this Section&nbsp;7 were determined
by pro rata allocation (even if the Underwriters were treated as one entity for such purpose) or by any other method of allocation which does not take account of the equitable considerations referred to above in this Section&nbsp;7. The aggregate
amount of losses, liabilities, claims, damages and expenses incurred by an indemnified party and referred to above in this Section&nbsp;7 shall be deemed to include any legal or other expenses reasonably incurred by such indemnified party in
investigating, preparing or defending against any litigation, or any investigation or proceeding by any governmental agency or body, commenced or threatened, or any claim whatsoever based upon any such untrue or alleged untrue statement or omission
or alleged omission. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the provisions of this Section&nbsp;7, no Underwriter shall be required to contribute any amount in
excess of the underwriting commissions received by such Underwriter in connection with the Shares underwritten by it and distributed to the public. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No person guilty of fraudulent misrepresentation (within the meaning of Section&nbsp;11(f) of the 1933 Act) shall be entitled to contribution
from any person who was not guilty of such fraudulent misrepresentation. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;7, each person, if any, who
controls an Underwriter within the meaning of Section&nbsp;15 of the 1933 Act or Section&nbsp;20 of the 1934 Act and each Underwriter&#146;s Affiliates and selling agents shall have the same rights to contribution as such Underwriter, and each
director of the Company, each officer of the Company who signed the Registration Statement, and each person, if any, who controls the Company within the meaning of Section&nbsp;15 of the 1933 Act or Section&nbsp;20 of the 1934 Act shall have the
same rights to contribution as the Company. The Underwriters&#146; respective obligations to contribute pursuant to this Section&nbsp;7 are several in proportion to the number of Initial Securities set forth opposite their respective names in
Schedule A hereto and not joint. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 8.&nbsp;&nbsp;&nbsp;&nbsp;<U>Representations, Warranties and Agreements to Survive</U>. All
representations, warranties and agreements contained in this Agreement or in certificates of officers of the Company or any of its subsidiaries submitted pursuant hereto, shall remain operative and in full force and effect regardless of (i)&nbsp;any
investigation made by or on behalf of any Underwriter or its Affiliates or selling agents, any person controlling any Underwriter, its officers or directors or any person controlling the Company and (ii)&nbsp;delivery of and payment for the
Securities. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 9.&nbsp;&nbsp;&nbsp;&nbsp;<U>Termination of Agreement</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Termination</I>. The Representatives may terminate this Agreement, by notice to the
Company, at any time at or prior to the Closing Time (i)&nbsp;if there has been, in the judgment of the Representatives, since the time of execution of this Agreement or since the respective dates as of which information is given in the Registration
Statement, the General Disclosure Package or the Prospectus, any material adverse change in the condition, financial or otherwise, or in the earnings, business affairs or business prospects of the Company and its subsidiaries considered as one
enterprise, whether or not arising in the ordinary course of business, or (ii)&nbsp;if there has occurred any material adverse change in the financial markets in the United States or the international financial markets, any outbreak of hostilities
or escalation </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">25 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
thereof or other calamity or crisis or any change or development involving a prospective change in national or international political, financial or economic conditions, in each case the effect
of which is such as to make it, in the judgment of the Representatives, impracticable or inadvisable to proceed with the completion of the offering or to enforce contracts for the sale of the Securities, or (iii)&nbsp;if trading in any securities of
the Company has been suspended or materially limited by the Commission or the Nasdaq Global Market, or (iv)&nbsp;if trading generally on the NYSE MKT or the New York Stock Exchange or in the Nasdaq Global Market has been suspended or materially
limited, or minimum or maximum prices for trading have been fixed, or maximum ranges for prices have been required, by any of said exchanges or by order of the Commission, FINRA or any other Governmental Entity, or (v)&nbsp;a material disruption has
occurred in commercial banking or securities settlement or clearance services in the United States or with respect to Clearstream or Euroclear systems in Europe, or (vi)&nbsp;if a banking moratorium has been declared by either Federal or New York
authorities. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;<I>Liabilities</I>. If this Agreement is terminated pursuant to this
Section, such termination shall be without liability of any party to any other party except as provided in Section&nbsp;4 hereof, and provided further that Sections 1, 6, 7, 8, 14, 15 16 and 17 shall survive such termination and remain in full force
and effect. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 10.&nbsp;&nbsp;&nbsp;&nbsp;<U>Default by One or More of the Underwriters</U>. If one or more of the Underwriters
shall fail at the Closing Time or a Date of Delivery to purchase the Securities which it or they are obligated to purchase under this Agreement (the &#147;Defaulted Securities&#148;), the Representatives shall have the right, within 24&nbsp;hours
thereafter, to make arrangements for one or more of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, or any other underwriters, to purchase all, but not less than all, of the Defaulted Securities in such amounts as may be
agreed upon and upon the terms herein set forth; if, however, the Representatives shall not have completed such arrangements within such <FONT STYLE="white-space:nowrap">24-hour</FONT> period, then: </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(i)&nbsp;&nbsp;&nbsp;&nbsp;if the number of Defaulted Securities does not exceed 10% of the number of Securities to be
purchased on such date, each of the <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters shall be obligated, severally and not jointly, to purchase the full amount thereof in the proportions that their respective underwriting
obligations hereunder bear to the underwriting obligations of all <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriters, or </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; margin-left:4%; text-indent:5%; font-size:10pt; font-family:Times New Roman">(ii)&nbsp;&nbsp;&nbsp;&nbsp;if the number of Defaulted Securities exceeds 10% of the number of Securities to be purchased on
such date, this Agreement or, with respect to any Date of Delivery which occurs after the Closing Time, the obligation of the Underwriters to purchase, and the Company to sell, the Option Securities to be purchased and sold on such Date of Delivery
shall terminate without liability on the part of any <FONT STYLE="white-space:nowrap">non-defaulting</FONT> Underwriter. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">No action taken
pursuant to this Section shall relieve any defaulting Underwriter from liability in respect of its default. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">In the event of any such
default which does not result in a termination of this Agreement or, in the case of a Date of Delivery which is after the Closing Time, which does not result in a termination of the obligation of the Underwriters to purchase and the Company to sell
the relevant Option Securities, as the case may be, either the (i)&nbsp;Representatives or (ii)&nbsp;the Company shall have the right to postpone Closing Time or the relevant Date of Delivery, as the case may be, for a period not exceeding seven
days in order to effect any required changes in the Registration Statement, the General Disclosure Package or the Prospectus or in any other documents or arrangements. As used herein, the term &#147;Underwriter&#148; includes any person substituted
for an Underwriter under this Section&nbsp;10. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">26 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 11.&nbsp;&nbsp;&nbsp;&nbsp;<U>Notices</U>. All notices and other communications
hereunder shall be in writing and shall be deemed to have been duly given if mailed or transmitted by any standard form of telecommunication. Notices to the Underwriters shall be directed to the Representatives at BMO Capital Markets Corp. at 3
Times Squre, New York, NY 10036, attention of Legal Department (facsimile: (212) 702-1205); the Representatives at Wells Fargo Securities, LLC at 375 Park Avenue, New York, New York 10152, attention of Equity Syndicate Department (facsimile: (212) <FONT
STYLE="white-space:nowrap">214-5198)</FONT> and the Representatives at UBS Securities LLC at 1285 Avenue of the Americas, New York, New York 10019, attention of Syndicate (facsimile: (212) <FONT STYLE="white-space:nowrap">713-3371).</FONT> Notices
to the Company shall be directed to it at 561 Eccles Avenue, South San Francisco, California 94080, attention of Chief Financial Officer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 12.&nbsp;&nbsp;&nbsp;&nbsp;<U>No Advisory or Fiduciary Relationship</U>. The Company acknowledges and agrees that (a)&nbsp;the
purchase and sale of the Securities pursuant to this Agreement, including the determination of the initial public offering price of the Securities and any related discounts and commissions, is an
<FONT STYLE="white-space:nowrap">arm&#146;s-length</FONT> commercial transaction between the Company, on the one hand, and the several Underwriters, on the other hand, (b)&nbsp;in connection with the offering of the Securities and the process
leading thereto, each Underwriter is and has been acting solely as a principal and is not the agent or fiduciary of the Company, any of its subsidiaries or their respective stockholders, creditors, employees or any other party, (c)&nbsp;no
Underwriter has assumed or will assume an advisory or fiduciary responsibility in favor of the Company with respect to the offering of the Securities or the process leading thereto (irrespective of whether such Underwriter has advised or is
currently advising the Company or any of its subsidiaries on other matters) and no Underwriter has any obligation to the Company with respect to the offering of the Securities except the obligations expressly set forth in this Agreement,
(d)&nbsp;the Underwriters and their respective affiliates may be engaged in a broad range of transactions that involve interests that differ from those of the Company and (e)&nbsp;the Underwriters have not provided any legal, accounting, regulatory
or tax advice with respect to the offering of the Securities and the Company has consulted its own respective legal, accounting, regulatory and tax advisors to the extent it deemed appropriate. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 13.&nbsp;&nbsp;&nbsp;&nbsp;<U>Recognition of the U.S. Special Resolution Regimes</U>. </P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that any Underwriter that is a Covered Entity becomes subject to a proceeding
under a U.S. Special Resolution Regime, the transfer from such Underwriter of this Agreement, and any interest and obligation in or under this Agreement, will be effective to the same extent as the transfer would be effective under the U.S. Special
Resolution Regime if this Agreement, and any such interest and obligation, were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;In the event that any Underwriter that is a Covered Entity or a BHC Act Affiliate of such
Underwriter becomes subject to a proceeding under a U.S. Special Resolution Regime, Default Rights under this Agreement that may be exercised against such Underwriter are permitted to be exercised to no greater extent than such Default Rights could
be exercised under the U.S. Special Resolution Regime if this Agreement were governed by the laws of the United States or a state of the United States. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For purposes of this Section&nbsp;13, a &#147;BHC Act Affiliate&#148; has the meaning assigned to the term &#147;affiliate&#148; in, and shall be interpreted
in accordance with, 12 U.S.C. &#167; 1841(k). &#147;Covered Entity&#148; means any of the following: (i)&nbsp;a &#147;covered entity&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 252.82(b); (ii) a
&#147;covered bank&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 47.3(b); or (iii)&nbsp;a &#147;covered FSI&#148; as that term is defined in, and interpreted in accordance with, 12 C.F.R. &#167; 382.2(b).
<B>&#147;</B>Default Right&#148; has the meaning assigned to that term in, and shall be interpreted in accordance with, 12 C.F.R. &#167;&#167; 252.81, 47.2 or 382.1, as applicable. &#147;U.S. Special Resolution Regime&#148; means each of (i) the
Federal Deposit Insurance Act and the regulations promulgated thereunder and (ii)&nbsp;Title II of the Dodd-Frank Wall Street Reform and Consumer Protection Act and the regulations promulgated thereunder.
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">27 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 14.&nbsp;&nbsp;&nbsp;&nbsp; <U>Parties</U>. This Agreement shall each inure to the
benefit of and be binding upon the Underwriters and the Company and their respective successors. Nothing expressed or mentioned in this Agreement is intended or shall be construed to give any person, firm or corporation, other than the Underwriters
and the Company and their respective successors and the controlling persons and officers and directors referred to in Sections&nbsp;6 and 7 and their heirs and legal representatives, any legal or equitable right, remedy or claim under or in respect
of this Agreement or any provision herein contained. This Agreement and all conditions and provisions hereof are intended to be for the sole and exclusive benefit of the Underwriters and the Company and their respective successors, and said
controlling persons and officers and directors and their heirs and legal representatives, and for the benefit of no other person, firm or corporation. No purchaser of Securities from any Underwriter shall be deemed to be a successor by reason merely
of such purchase. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 15.&nbsp;&nbsp;&nbsp;&nbsp;<U>Trial by Jury</U>. The Company (on its behalf and, to the extent permitted by
applicable law, on behalf of its stockholders and affiliates) and each of the Underwriters hereby irrevocably waives, to the fullest extent permitted by applicable law, any and all right to trial by jury in any legal proceeding arising out of or
relating to this Agreement or the transactions contemplated hereby. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 16.&nbsp;&nbsp;&nbsp;&nbsp;<U>GOVERNING LAW</U>. THIS
AGREEMENT AND ANY CLAIM, CONTROVERSY OR DISPUTE ARISING UNDER OR RELATED TO THIS AGREEMENT SHALL BE GOVERNED BY, AND CONSTRUED IN ACCORDANCE WITH THE LAWS OF, THE STATE OF NEW YORK WITHOUT REGARD TO ITS CHOICE OF LAW PROVISIONS. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 17.&nbsp;&nbsp;&nbsp;&nbsp;<U>Consent to Jurisdiction; Waiver of Immunity</U>. Any legal suit, action or proceeding arising out of or
based upon this Agreement or the transactions contemplated hereby (&#147;Related Proceedings&#148;) shall&nbsp;be instituted in (i)&nbsp;the federal courts of the United States of America located in the City and County of New York, Borough of
Manhattan or&nbsp;(ii) the courts of the State of New York located in the City and County of New York, Borough of Manhattan (collectively, the &#147;Specified Courts&#148;), and each party irrevocably submits to the exclusive jurisdiction (except
for proceedings instituted in regard to the enforcement of a judgment of any such court (a &#147;Related Judgment&#148;), as to which such jurisdiction is <FONT STYLE="white-space:nowrap">non-exclusive)</FONT> of such courts in any such suit, action
or proceeding. Service of any process, summons, notice or document by mail to such party&#146;s address set forth above shall be effective service of process for any suit, action or other proceeding brought in any such court. The parties irrevocably
and unconditionally waive any objection to the laying of venue of any suit, action or other proceeding in the Specified Courts and irrevocably and unconditionally waive and agree not to plead or claim in any such court that any such suit, action or
other proceeding brought in any such court has been brought in an inconvenient forum. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 18.&nbsp;&nbsp;&nbsp;&nbsp;<U>TIME</U>.
TIME SHALL BE OF THE ESSENCE OF THIS AGREEMENT. EXCEPT AS OTHERWISE SET FORTH HEREIN, SPECIFIED TIMES OF DAY REFER TO NEW YORK CITY TIME. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION 19.&nbsp;&nbsp;&nbsp;&nbsp;<U>Counterparts</U>. This Agreement may be executed in any number of counterparts, each of which shall be
deemed to be an original, but all such counterparts shall together constitute one and the same Agreement. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">SECTION
20.&nbsp;&nbsp;&nbsp;&nbsp;<U>Effect of Headings</U>. The Section headings herein are for convenience only and shall not affect the construction hereof. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">28 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the foregoing is in accordance with your understanding of our agreement, please sign and
return to the Company a counterpart hereof, whereupon this instrument, along with all counterparts, will become a binding agreement among the Underwriters and the Company in accordance with its terms. </P>
<P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P><DIV ALIGN="right">
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="4%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="95%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">Very&nbsp;truly&nbsp;yours,</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3">RAPT Therapeutics, Inc.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="bottom">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Title:</TD></TR>
</TABLE></DIV> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="7%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="92%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">CONFIRMED AND ACCEPTED,</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; margin-left:3.00em; font-size:10pt; font-family:Times New Roman">as of the date first above written:</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16" COLSPAN="3"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top" COLSPAN="3"> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BMO CAPITAL MARKETS CORP.</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">WELLS
FARGO SECURITIES, LLC</P> <P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman">UBS SECURITIES LLC</P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">BMO CAPITAL MARKETS CORP.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">WELLS FARGO SECURITIES, LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Authorized Signatory</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">UBS SECURITIES LLC</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">By</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">&nbsp;</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">Authorized Signatory</TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">For themselves and as Representatives of the other Underwriters named in Schedule A hereto. </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">29 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The initial public offering price per share for the Securities shall be $[&#9679;]. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The purchase price per share for the Securities to be paid by the several Underwriters shall be $[&#9679;], being an amount equal to the initial public
offering price set forth above less $[&#9679;] per share, subject to adjustment in accordance with Section&nbsp;2(b) for dividends or distributions declared by the Company and payable on the Initial Securities but not payable on the Option
Securities. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="68%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="83%"></TD>

<TD VALIGN="bottom" WIDTH="16%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP>Name of Underwriter</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">Number&nbsp;of<BR>Initial&nbsp;Securities</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">BMO Capital Markets Corp.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">UBS Securities LLC</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:1.00px solid #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:3.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="center">[&#9679;]</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="font-size:1px; ">
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-top:3.00px double #000000">&nbsp;</P></TD>
<TD>&nbsp;</TD></TR>
</TABLE>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sch A-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE <FONT STYLE="white-space:nowrap">B-1</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Pricing Terms </U></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1.&nbsp;&nbsp;&nbsp;&nbsp;The Company is selling [&#9679;] shares of Common Stock. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">2.&nbsp;&nbsp;&nbsp;&nbsp;The Company has granted an option to the Underwriters, severally and not jointly, to purchase up to an additional [&#9679;] shares
of Common Stock. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3.&nbsp;&nbsp;&nbsp;&nbsp;The initial public offering price per share for the Securities shall be $[&#9679;]. </P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE <FONT STYLE="white-space:nowrap">B-2</FONT> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>Free Writing Prospectuses </U></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">[SPECIFY EACH
ISSUER GENERAL USE FREE WRITING PROSPECTUS] </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sch B - 1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">SCHEDULE C </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><U>List of Persons and Entities Subject to <FONT STYLE="white-space:nowrap">Lock-up</FONT> </U></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Sch C - 1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit A </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF OPINIONS OF COMPANY&#146;S COUNSEL </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TO BE DELIVERED PURSUANT TO SECTION 5(b) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">A-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit B </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">FORM OF <FONT STYLE="white-space:nowrap">LOCK-UP</FONT> FROM DIRECTORS, OFFICERS OR OTHER STOCKHOLDERS PURSUANT TO SECTION&nbsp;5(I) </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[&#9679;], 2019 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">BMO Capital Markets Corp. </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wells Fargo Securities, LLC </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">UBS Securities LLC </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">as Representatives of the several </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Underwriters to be named in
the </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">within-mentioned Underwriting Agreement </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>c/o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;BMO Capital Markets Corp. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">3 Times Square, 25<SUP STYLE="font-size:85%; vertical-align:top">th</SUP> Floor </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10036 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>c/o&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;Wells Fargo Securities, LLC </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">375 Park Avenue </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10152 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>c/o &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;UBS Securities LLC </B> </P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">1285 Avenue of the Americas </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">New York, New York 10019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; margin-left:4%; font-size:10pt; font-family:Times New Roman">Re:&nbsp;&nbsp;&nbsp;&nbsp;<U>Proposed Public Offering by RAPT Therapeutics, Inc.</U> </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Sirs: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned, a stockholder [and
an officer and/or director] of RAPT Therapeutics, Inc., a Delaware corporation (the &#147;Company&#148;), understands that BMO Capital Markets Corp., Wells Fargo Securities, LLC and UBS Securities LLC (collectively, the &#147;Representatives&#148;)
propose to enter into an Underwriting Agreement (the &#147;Underwriting Agreement&#148;) with the Company providing for the public offering of shares of the Company&#146;s common stock, par value $0.0001 per share (the &#147;Common Stock&#148;)
(such offering, the &#147;Public Offering&#148;). In recognition of the benefit that the Public Offering will confer upon the undersigned as a stockholder [and an officer and/or director] of the Company, and for other good and valuable
consideration, the receipt and sufficiency of which are hereby acknowledged, the undersigned agrees with each underwriter to be named in the Underwriting Agreement that, during the period beginning on the date hereof and ending on the date that is
180 days from the date of the Underwriting Agreement (the <FONT STYLE="white-space:nowrap">&#147;Lock-Up</FONT> Period&#148;), the undersigned will not, without the prior written consent of the Representatives, (i)&nbsp;directly or indirectly,
offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right or warrant to purchase or otherwise transfer or dispose of any shares of the Company&#146;s Common Stock
or any securities convertible into or exercisable or exchangeable for Common Stock, whether now owned or hereafter acquired by the undersigned or with respect to which the undersigned has or hereafter acquires the power of disposition (collectively,
the <FONT STYLE="white-space:nowrap">&#147;Lock-Up</FONT> Securities&#148;), or exercise any right with respect to the registration of any of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities, or file, cause to be filed or cause to be
confidentially submitted any registration statement in connection therewith, under the Securities Act of 1933, as amended, or (ii)&nbsp;enter into any swap or any other agreement or any transaction that transfers, in whole or in part, directly or
</P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-1 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">
indirectly, the economic consequence of ownership of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities, whether any such swap or transaction is to be settled by delivery of Common
Stock or other securities, in cash or otherwise. If the undersigned is an officer or director of the Company, the undersigned further agrees that the foregoing provisions shall be equally applicable to any issuer-directed Common Stock the
undersigned may purchase in the Public Offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">If the undersigned is an officer or director of the Company, (1)&nbsp;the
Representatives agree that, at least three business days before the effective date of any release or waiver of the foregoing restrictions in connection with a transfer of shares of the Common Stock, the Representatives will notify the Company of the
impending release or waiver, and (2)&nbsp;the Company has agreed, or will agree, in the Underwriting Agreement to announce the impending release or waiver by press release through a major news service at least two business days before the effective
date of the release or waiver. Any release or waiver granted by the Representatives hereunder to any such officer or director shall only be effective two business days after the publication date of such press release. The provisions of this
paragraph will not apply if (i)&nbsp;the release or waiver is effected solely to permit a transfer not for consideration and (ii)&nbsp;the transferee has agreed in writing to be bound by the same terms described in this <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreement to the extent and for the duration that such terms remain in effect at the time of the transfer. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding the foregoing, and subject to the conditions below, the undersigned may transfer the
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities (or for (d)&nbsp;below, convert) without the prior written consent of the Representatives: </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(a) provided that (1)&nbsp;the Representatives receive a signed <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement for the balance of
the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period from each donee, trustee, distributee, or transferee, as the case may be, (2)&nbsp;any such transfer shall not involve a disposition for value, (3)&nbsp;such transfers are not required to be
reported with the Securities and Exchange Commission on Form 4 in accordance with Section&nbsp;16 of the Securities Exchange Act of 1934, as amended (the &#147;Exchange Act&#148;), and (4)&nbsp;the undersigned does not otherwise voluntarily effect
any public filing or report regarding such transfers during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(i)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as a <I>bona fide </I>gift or gifts; </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(ii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">by will or intestate succession upon the death of the undersigned, including to the transferee&#146;s nominee
or custodian; </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iii)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the immediate family of the undersigned or any trust, partnership or similar entity for the direct or
indirect benefit of the undersigned or the immediate family of the undersigned (for purposes of this <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement, &#147;immediate family&#148; shall mean any relationship by blood, marriage or adoption,
not more remote than first cousin) or if the undersigned is a trust, to any beneficiary of the undersigned (including such beneficiary&#146;s estate); </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(iv)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">as a distribution to limited partners or stockholders of the undersigned; or </P></TD></TR></TABLE>
<P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="4%">&nbsp;</TD>
<TD WIDTH="4%" VALIGN="top" ALIGN="left">(v)</TD>
<TD ALIGN="left" VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman; " ALIGN="left">to the undersigned&#146;s affiliates or to any investment fund or other entity controlled or managed by the
undersigned. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(b) to the Company upon exercise of any right in respect of any option granted under any incentive plan of
the Company described in the final prospectus relating to the Public Offering including the surrender of shares of Common Stock to the Company in &#147;net&#148; or &#147;cashless&#148; exercise of any option; provided that (1)&nbsp;the shares of
Common Stock received by the undersigned upon exercise continue to be subject to the restrictions on transfer set forth in this <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement, and (2)&nbsp;if required, any public report or filing under
Section&nbsp;16 of the Exchange Act shall clearly indicate in the footnotes thereto that the filing relates to the exercise of a stock option, that no shares were sold by the reporting person and that the shares received upon exercise of the stock
option are subject to a <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement with the underwriters; </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-2 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(c) to the Company in connection with the repurchase by the Company from the undersigned of
shares of Common Stock or other securities pursuant to a repurchase right arising upon the termination of the undersigned&#146;s employment with the Company; provided that such repurchase right is pursuant to contractual agreements with the Company;
provided further that any filing required by Section&nbsp;16 of the Exchange Act shall clearly indicate in the footnotes thereto that the such transfer is being made pursuant to the circumstances described in this clause (c)&nbsp;and provided
further that no other public announcement or filing shall be required or shall be voluntarily made during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period; </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(d) the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities which are shares of preferred stock of the Company into shares of Common
Stock of the Company, provided that any shares of Common Stock received upon such conversion remain subject to the terms of this <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement; or </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">(e) pursuant to an order of a court of competent jurisdiction or in connection with a qualified domestic order or divorce settlement; provided
that each transferee agrees in writing to be bound by the terms of this <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement prior to such transfer; and provided further, that any filing required by Section&nbsp;16 of the Exchange Act shall
clearly indicate in the footnotes thereto that the such transfer is being made pursuant to the circumstances described in this clause (e). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Furthermore, during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period, the undersigned may sell shares of Common Stock of the Company
purchased by the undersigned in the Public Offering or on the open market following the Public Offering if and only if (i)&nbsp;such sales are not required to be reported in any public report or filing with the Securities and Exchange Commission, or
otherwise and (ii)&nbsp;the undersigned does not otherwise voluntarily effect any public filing or report regarding such sales during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Nothing herein shall prevent the undersigned from establishing a <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan that complies
with Rule <FONT STYLE="white-space:nowrap">10b5-1</FONT> under the Exchange Act <FONT STYLE="white-space:nowrap">(&#147;10b5-1</FONT> trading plan&#148;) so long as each such plan does not permit sales of
<FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period; and provided that the establishment of a <FONT STYLE="white-space:nowrap">10b5-1</FONT> trading plan or the amendment of a <FONT
STYLE="white-space:nowrap">10b5-1</FONT> trading plan shall only be permitted if (i)&nbsp;the establishment of such plan is not required to be reported in any public report or filing with the SEC, or otherwise and (ii)&nbsp;the undersigned does not
otherwise voluntarily effect any public filing or report regarding the establishment of such plan during the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Period. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned also agrees and consents to the entry of stop transfer instructions with the Company&#146;s transfer agent and registrar
against the transfer of the <FONT STYLE="white-space:nowrap">Lock-Up</FONT> Securities except in compliance with the foregoing restrictions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The undersigned hereby agrees that, to the extent that the restrictions on transfer set forth in this
<FONT STYLE="white-space:nowrap">lock-up</FONT> agreement conflict with or are in any way inconsistent with any investor rights agreement, any market standoff agreement, stock option agreement, stock purchase agreement, or any other <FONT
STYLE="white-space:nowrap">lock-up</FONT> agreement related to the Common Stock to which the undersigned and the Company may be party, this <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement shall control. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">Notwithstanding anything to the contrary contained herein, this <FONT STYLE="white-space:nowrap">lock-up</FONT> agreement will automatically
terminate and the undersigned will be released from all of his, her or its obligations hereunder upon the earliest to occur, if any, of (i)&nbsp;the date the Company advises the Representatives in writing, that it has determined not to proceed with
the Public Offering, (ii)&nbsp;the date the Company files an application with the Securities and Exchange Commission to withdraw the registration statement related to the Public Offering, (iii)&nbsp;the date the Underwriting Agreement is terminated
prior to payment for and delivery of the </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-3 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">shares of Common Stock to be sold thereunder or (iv)&nbsp;October 31, 2019, in the event that the
Underwriting Agreement has not been executed by such date (provided, that the Company may by written notice to the undersigned prior to such date extend such date for a period of up to an additional six months). </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><I>[Signature page follows] </I></P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">B-4 </P>

</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>
<TD WIDTH="50%"></TD>
<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="49%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"><B>IF AN INDIVIDUAL:</B></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><B>IF AN ENTITY:</B></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.00em; font-size:10pt; font-family:Times New Roman">By:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:3.30em; font-size:10pt; font-family:Times New Roman"><I>(duly authorized signature)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><I>(please print complete name of entity)</I></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">
<P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.50em; font-size:10pt; font-family:Times New Roman">Name:<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:2.50em; font-size:10pt; font-family:Times New Roman">By:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:7.00em; font-size:10pt; font-family:Times New Roman"><I>(please print full name)</I></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman"><I>(duly authorized signature)</I></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:4.00em; font-size:10pt; font-family:Times New Roman">Name:
<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; text-indent:6.50em; font-size:10pt; font-family:Times New Roman"><I>(please print full name)</I></P></TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Address:</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">Address:</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"><U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></TD></TR>
</TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">[Signature Page to Lock-Up Agreement] </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit C </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:11pt; font-family:Times New Roman" ALIGN="center">FORM OF PRESS RELEASE </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">TO BE
ISSUED PURSUANT TO SECTION 3(j) </P>
 <p STYLE="margin-top:0pt;margin-bottom:0pt ; font-size:8pt">&nbsp;</P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">C-1 </P>

</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-10.24
<SEQUENCE>3
<FILENAME>d723949dex1024.htm
<DESCRIPTION>EX-10.24
<TEXT>
<HTML><HEAD>
<TITLE>EX-10.24</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">Exhibit 10.24 </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g723947g1016004818785.jpg" ALT="LOGO">
 </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;11, 2019 </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Wendye Robbins, M.D. </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">San Francisco, CA </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Dear Wendye: </P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">The Board of Directors (the &#147;Board&#148;) of
RAPT Therapeutics, Inc. (the &#147;Company&#148;) is pleased to welcome you as a member of the Board. We appreciate your willingness to accept this position, and we look forward to your valuable contributions. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with your services on the Board, we will pay you the following: </P> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Cash Retainer: Following your appointment to the Board, an annual cash retainer of $20,000, payable in quarterly
installments. The retainer will be subject to adjustment pursuant to the Company&#146;s director compensation policies in effect from time to time. </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt">Stock Options: Subject to approval of the Board and the terms and conditions of the Company&#146;s 2015 Stock
Plan (the &#147;Plan&#148;) and the applicable stock option agreement, you will be granted an option to purchase 32,000 of the company&#146;s Common Stock (after giving effect to the
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-6</FONT></FONT> reverse stock split effected as of July&nbsp;19, 2019) (the &#147;Initial Grant&#148;). Your Initial Grant will vest in equal monthly installments over the next
48 months subject to your continued service, as described in the applicable Stock Option Agreement. Subject to approval of the Board and your continued service on the Board, you will be granted annual grants starting at your second anniversary of
Board service. Annual grants will vest in equal monthly installments over 48 months subject to your continued service. The exercise price per share of the Initial Grant and the annual grants will be equal to the fair market value per share on the
date the option is granted. In addition, if the Company is subject to a Change of Control (as defined in the Plan), then the Company shall accelerate the vesting of your stock options such that 100% of your stock options shall become fully vested.
We will review our compensation policy for Board members in the event of an initial public offering. </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will review our compensation
policy for Board members in the event of an initial public offering. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We will also reimburse you for reasonable expenses that you incur in connection with
attendance at meetings of the Board, or committees of the Board, in accordance with the Company&#146;s generally applicable reimbursement policies. </P> <P STYLE="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g723947g1016004818965.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p Style='page-break-before:always'>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">In connection with your services to the Company, we expect that technical, business or financial information
of the Company (&#147;Confidential Information&#148;) will be disclosed to you. To the extent that Confidential Information is not publicly known or not otherwise previously known by you without an obligation of confidentiality, you agree not to use
(except in connection with your services to the Company) or disclose Confidential Information to any third party and to take necessary and reasonable steps to maintain the confidential nature of all Confidential Information. By signing this letter
agreement, you represent and warrant that you have no contractual commitments or other legal obligations to a third party that would prohibit you from performing your duties for the Company. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">As part of your overall responsibilities, the Company and the Company&#146;s stockholders reserve the right to remove any individual from the Board at any
time in accordance with the provisions of applicable law. You, of course, may also terminate your relationship with the Company at any time. When you cease to be a member of the Board (whether at our request or your election), you must return all
Confidential Information of the Company. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">On behalf of the full Board, we are excited about your joining our Board and look forward to working with you to
help make the Company truly great and prosperous. You may indicate your agreement with these terms and accept this offer by signing and dating this letter agreement and returning it to me. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If you have any questions, please do not hesitate to call me. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Very truly yours, </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="10%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="89%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Brian R. Wong</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Brian R. Wong, M.D., Ph.D.</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">Chief Executive Officer</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top">RAPT Therapeutics, Inc.</TD></TR>
</TABLE> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="40%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="100%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">I have read and accept this offer:</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Wendye Robbins</P></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Signature of Wendye Robbins, M.D.</TD></TR>
<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">Dated: October&nbsp;11, 2019</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-23.1
<SEQUENCE>4
<FILENAME>d723949dex231.htm
<DESCRIPTION>EX-23.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-23.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 23.1 </B></P>
<P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Consent of Independent Registered Public Accounting Firm </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">We consent to the reference to our firm under the caption &#147;Experts&#148; and to the use of our report dated May&nbsp;24, 2019 (except for the retroactive
effect of the <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">1-for-6</FONT></FONT> reverse stock split as described in Note&nbsp;2, as to which the date is July&nbsp;22, 2019) in Amendment No.&nbsp;3 to the Registration Statement
on Form <FONT STYLE="white-space:nowrap">S-1</FONT> (No. <FONT STYLE="white-space:nowrap">333-232572)</FONT> and related Prospectus of RAPT Therapeutics, Inc. for the registration of shares of its common stock.</P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right">/s/ Ernst &amp; Young LLP </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Redwood City,
California </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">October&nbsp;21, 2019 </P>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-24.2
<SEQUENCE>5
<FILENAME>d723949dex242.htm
<DESCRIPTION>EX-24.2
<TEXT>
<HTML><HEAD>
<TITLE>EX-24.2</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE">


<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="right"><B>Exhibit 24.2 </B></P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>POWER OF ATTORNEY </B></P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">KNOW ALL PERSONS BY
THESE PRESENTS, that each person whose signature appears below constitutes and appoints Brian Wong and Eric Hall, and each one of them, as his or her true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution,
for him or her and in their name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to the Registration Statement on Form S-1 of RAPT Therapeutics, Inc. (the &#147;Registration
Statement&#148;), and to sign any registration statement for the same offering covered by the Registration Statement that is to be effective on filing pursuant to Rule 462(b) under the Securities Act of 1933, as amended, and all post-effective
amendments thereto, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority
to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact
and agents or any of them, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof. </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt">


<TR>

<TD WIDTH="38%"></TD>

<TD VALIGN="bottom"></TD>
<TD WIDTH="44%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="16%"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Signature</B></P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Title</B></P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" NOWRAP ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman; " ALIGN="center"><B>Date</B></P></TD></TR>


<TR STYLE="font-size:1pt">
<TD HEIGHT="16"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD>
<TD HEIGHT="16" COLSPAN="2"></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE="margin-top:0pt; margin-bottom:0pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman" ALIGN="center">/s/ Wendy Robbins, M.D.</P>
<P STYLE="margin-top:0pt; margin-bottom:1pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Wendye Robbins, M.D.</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="top" ALIGN="center"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman" ALIGN="center">Director</P></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="top" NOWRAP ALIGN="center">October 15, 2019</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g723947g1016004818785.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723947g1016004818785.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  Q +T# 2(  A$! Q$!_\0
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MO>T;@_\ 36(GK]1_,>E,T*:.X^*"S0N'BDO971AW!+$&FD*YK?9_B5_>N/\
MO[%_C1]G^)7]ZX_[^Q?XUZK14\P^4\FB\!>)M<O%FUN[,:CJTLOF,!Z* 2/U
M%>FZ7IEMH^G0V-HFV*,<9ZL>Y/N:N44FVQI)$5U_QZ3?]<V_E7D7PM_Y&N?_
M *]'_P#0EKUVZ_X])O\ KFW\J\B^%O\ R-<__7H__H2TULQ/='L5%%%249.I
M:!:ZC)YI)BF/5E'!^HJ&Q\,6MI,LLCF9E.0",#\JW**Y)8'#RJ>T<%?^OD="
MQ590Y%+0H:OH]EK=BUI?1;XR<J0<,I]0?6N-7X560N-S:E,8<_<$8#?GG^E>
M@T5WPK3@K19YM;!T*\N:I&[*NG:=:Z591VEG$(X4Z#N3ZD]S4\L8FADB;(5U
M*G'O3Z*AMMW9TQBHKE6QS>@>"M.\.W[WEI-<O(\9C(E92,$@]@/2NDHHI7N,
M*Q/$/A;3O$J0B\\Q'B/RR1$!L'MR#Q6W3)(Q*FTLZ^ZL0?THNUL%D]SG_#_@
MO2_#MV]U:M-+,R[0TQ!VCOC '6NCK,C0K97,WG3%T,H4M(3C!(%.:YN_[/+?
M9SGRL[_,'IUK#V^EY+I?N:^QZ)FC165F:6X11YKC[.C$++LY)//Z4^YWQBU0
M?:/G<[E27+'Y3WS2]OI>P_9:VN0>(?#-AXD@BCO?,5HFRDD1 89ZCD'CI^59
M>E?#S2M(U."_@N+QI86RH=E(/&.<+6U#<F&2Y=C,(HU ,<K;G+GICD]>!]:6
MUNI5G"7!<B;D%HRH1O[F2.1CI]#3CB8Z)]?^&$Z#U9I45CQ"XFMF9%NC*2X5
MQ, N<G'&>GX5)B>2[N%;S'V%1\DQ0#Y1GCZU*Q%TGR[_ -=BG1LWKL:E%4U9
MH[Z&(NP1H6P&;.6R._<T',U_-%YC>6L2YV-C#9/IWQBM/:>6NWX7,^0M2()(
MV0YPP(.*YS0/!.G>'=0:]M)KEY&C,9$K*1@D'L!Z5J6T9\NXD,TS-'(ZKND)
M&!TXIMO(]R\,4LSH/LZ. K8,A/4YZ\<=/6I5?96W*=+?78TZ*IRP2",I!.^[
M<"5>0YQZ ]1FJDM[%8$"Z6XC+_=Q*9,_U%$ZZA\>B[] C2<OAU->BBBMS(**
M** "BBB@ HHHH **** *2_\ (.N?K+_,U(W_ "#3_P!<?Z445S1V^1L]_F8&
ML_ZVV_ZX+_6KND_ZBU_Z[/\ ^@445YM+_>W\OS1W3_W=?UW+%U_R%(O^V?\
M-JM7W_'NO_76/_T,445Z"^&I\SC>\ L?^/1?]YO_ $(USVM?\A27Z+_(445S
M8_\ W:/R_(WPG\>7S_,LW7_(M0_[W]35[0?^0:/]\T45.'_WF/\ @0ZO\!_X
MF3P?ZBZ_ZZ/6;JW_ " [7_=7^5%%:XG^ _1_F9T?XJ]2C%_R Y/^N@_D:M>'
8O]7/]1_6BBN##?QZ?I_F=E;^%/U_R/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g723947g1016004818965.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723947g1016004818965.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" "0 S$# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M%%%%;&84444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
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M_/2T_P"_'_UZ/^%F^)/^>EI_WX_^O7'T46079V'_  LWQ)_STM/^_'_UZ/\
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M% %:BIIK.ZMY'CFMIHW10SJZ$%0>A/M[TL5E=3RK%#;322,N\*D9)*^OT]Z
M(**5E96*L"K X((P0:?Y1^S^=D8W[,?AFDVEN"39'15BQLY;^\2VB*JS DLY
MP% !))^@!ISV6ZY2"RF6_9UROV='S],$ TP*M%226\\)D$L,B&-@LFY"-I/0
M'TZ5/_9=]]D>Z-K*((Y!&[E#\I(SS^'\Q0!4HJ]J6DW>F7$L<T,GEI(8UF,9
M".1Z$T?V:$L([J>\MX3,C20PON+2*"1G@$#D$#)H HT5.UE=);I<-;3+#(0$
MD,9VL3TP:)[*[MHTDN+6>)'.%:2,J"?QH @HJ\NFJ-.BO)KZWA$P<QQN'+-M
M.#T4@<^IJ,:;?EHU%E<[I,[!Y1RV.N/I0!5HJS'I][+,\,=G</*AVNBQ$E3Z
M$=J;%8W<YE$-K/(8?]8%C)V?7TH @HJX-,NY'*VT$MQB-9&,43':&&>>/_U]
MJA%I<FT-V+>4VP.#+L.P'Z]* (:*FN+.ZM AN;::'>,IYB%=WTS3[*QDOI)%
M1XXXXD,DLLAPL:CC)_$@8'))H K45HV^D&\U.*RL[RWG\Q2WFC<J(!G.[< 1
M_P#7%5(+2>XODLDC_P!(>3R@C'&&SC!]* (:*NW.FM"D4D$\5W%+(8E> -]\
M8^7! .>1CUS5B709[>[E@N+BWC2&!)Y9LEE0-@ <#).3C HN!E45K#0)A(ZS
M75O"@ECACD)9EE9UW)MP"<$<Y.*;#H-S+A&F@BG>62&&%V.Z5TX8 @8'/ )(
MR:+A8RZ**D2(O%+)D#R\9'KDXI-I;@DWL1T4JJSNJ*I9F(  ZDGM6@=(;^T8
M=/2\MWNGD\MU4L1$W?+8P<<],]*8&=15^/34GG98-0MI88XC++. X6-0<<Y7
M).2, #O4%[9O8SB)W1U9%D21#\KHPR",T 5Z*U(] O)([%LQ*;TOL5F.455#
M%FXX&TY'?'U%(-%=MDBW=NUHT!N/M/S!0@;8<C&[.[C&.<T7"QF45<DTRX74
M(;*,I,]QL,+(?ED#?=()[?7I@U8&B2R2PK;75M<1R.T9F0L%C91N;=D X"\Y
MQR* ,NBM3^Q7.)1=VYLS"9OM7S; H;:1C&[=N(&,=Z7^PI5=_/N[:&$,B1S.
M6*2EQN7;@9P1R20,=Z+A8RJ*DGADMKB2"9=LL3E'7T(.#4= !1110 4444 %
M%%% !1110 4444 %%%% !1110 444 $D #)/ % !14PM;@L%%O*6(R!L.2*1
M+:XD)"02L0<$!#P:CVD.Z*Y)=B*BIA:SFV-P(F\H-M+8Z&B"SNKE)'@MY94C
M&79$)"CWQTJE*,MF)Q:W1#14[V=U';QW#VTRPR?<D:,A6^AJ4:3J19 -/NR7
MSM'DMSCKVIB*=%*058JP(8'!!&"#24 %;WA:(->3RGJB #\3_P#6K!K<\,3B
M._DB)_UJ<?4?Y->?FJD\'4Y>WZZ_@=> LL3"_<ZJ1/,C="<;E(S]:Y>\TNXL
M\MCS(A_&HZ?4=JZJBO@X5'$^SA4<-CB**Z6\T:"XR\6(I/8?*?J*P;FTGM'V
MS(1Z,.0?QKJC4C+8ZX58S,YU'VH#U(-6JJ2./M.[LIQ5HD 9)KV<=3JRC1C:
M[Y?Q_JQY&75:,)8B;:24FV^EOZN+2,P7K4;2]EJ+K7HX'AV<[3Q+LNRW^?;^
MMCYW-^-:5*]+ +F?\SV^2Z_EZBL=S$^M1R= :?3)#P!7U-2$:='D6R5D?!X*
MI4K8Y5).\FVW\[W(Z***\X^L"BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ J]ID[V\TC1ZDU@S)MWA&8-R.#C\_PJC10!TQUNW=KR*VO&L?,DAE%RL'^L
M94VN2J_=W$[L#Z&J$NH6CSZX\49BCO% @0+C'[U6YQP. 3^E9%%%@N:VAWT=
MDM^K7?V62>%4CE\GS "'5CD8/8&I)+JWN=/EM)=2*2+=-/YPA8+."@'0<@C'
M&1CDUBT46"YT"ZC9'5M,U(W;JL'D+):^6Q*!  <'H1QD=^:<VL0'28DBD@BF
MCLVM71[=F=P2<[6!V@'.>1P?6N=HHL%S8U>[M;NW23SEN-0:3,DL4;1JR[>K
M!N-^>X_&K46LV$8ATYK=&L/LIMY;C:WF?/\ ,[ 9QP^"..BBN=HHL%SIK;Q!
M:VPL+EE>2[,D0OAMX9(LA2#W)^4GW04UM9AA)2.ZA:-;>Y6,V]N\95Y% YW$
MGG';@5S=%*P7-Z'4;233H[.:=XRU@UNTC(6"-Y_F*#CDC QQTS5D:MIWERVB
MR(T;6MM$LT\#%2T><@JIR <Y!]A7,44[!<M:E=->ZG<7+R)(TCY+HA0-VR >
M13?^8:/^NY_]!%5Z,G&,\>E3*-[>0U*URQ9/Y=[%(+MK1E.Y9U4DH>W YK:D
MU*P?SH?/"RW%IY,U[%;E%9_,##Y!S@J-I('/I7.T50KG07-_87EC+8->.@6*
MW1;EXF/FF,.#D#D??P,]EYQ1JFI6-\E^L5Q(H:[CGA#QG]XHCV$<=#GUXKGZ
M*+!<V]0U:&[?72)9'%Y<1R0[@>0K$\^G!I+"\MH-,>&ZO5G@:.3%BT!)60@A
M2KGA><$D'\#6+118+G2-J.E0:=-!;/\ ZT6^U?*?>"C*S[V)P>AP%&/I52^U
M2*ZCU@>;(YN[U9XMP/*@R<GT.&6L:BBP7-2752NA6EC (RRB82^9 K$;FXPQ
M&1QZ5;GU"POM<U"ZN)2RR1A;5IE=D4C:/F53G& <#IG&:P**+!<W]8UBWNK:
M_CM99!Y\ELR_*4!$<14YYX^;&!3]3U*RU1;I%O'M\W;W"EHV(F#(HYQT8%3U
M_O5SM%%@N=)'JEC-($NIU^Q>7 )(6B?>62,*6C9?NL.0,\&JQO[0G2[P3MNL
MDB1K-D/S['R2#]WD<G/?-8E%%@N= TEE=1R6(U-I!=WGVEIY8RH@4*V<Y/+'
M....!S6?I=U;QQ7MI=,\<-W$$\U5W&-E8,I([CC!QZUGT4!<V+>ZLM*M;I87
MBOYK@+'\T;HBQYW-W!R2%_(U'?Z@D^M1ZG:.8)I"DTF%.(I?XL>HR,_C6711
M8+G2-K]M:QPPQPPW.QY)2\$9ME1V4*"G&<@ \D=3QTIMQJ>F7:26L:O:12V4
M$)D8M(%>,@@$8SCJ,CV-<[12L%SJH-=M89&%I>FU9##&99;<R":&- N-O.T[
MLGZ$<C%5X-2TO[39W&^6!-/N)9(H-A8R(7WH W8YX.>WK7.T46"X9)))ZGDU
M8A_X\[OZ)_Z%5>C)QC/7K2G'F5O3\'<<96=_7\B:SG^RWUO<[=WDRK)M]<$'
M'Z5NWFJPRE-FJ2--]L,\5P8"IM4P?E]\DC@<<>]<Y15"N='+JEG+ ;2>[,TD
MML\4M\(".=ZN@(ZL!M(SC/S>U4[FYL'N() WGQ64,,21.A476"2^3_".3U[5
MD446"YU":_ILK6DLMO-#<)=33M(9#((V9 %;&!D!@/E[!?>H+C5DFNK=C?0R
M3&W:&[N)+8^5*N<JICQVP.0!SCZUSU%*P7-F_P!1BN;V.[M[HPR6:PQ6V(=N
MX+G+X'"X/(7T-71KEK%Y%L7C>%GF:XEMK;RE'F1F/Y5ZDC))SCT%<S13L%S?
M6^L$TS^Q_M1,30L&NO*;:)#(KCY>NW"XSZFG7%_IM];I8/=20P6SPF.8PEO,
M"Q[&^4<@GJ,_CBN>HHL%RUJ5T+[5+N[52BSS-(%/4 GBJM%% !1110 4444
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
M**** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ H
MHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BB
MB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
:**** "BBB@ HHHH **** "BBB@ HHHH _]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>g723949g00v03.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g00v03.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X4XI:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O<FUA=#YA<'!L:6-A
M=&EO;B]P;W-T<V-R:7!T/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIT:71L
M93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^4D%05"!4:&5R87!E=71I8W-?3&]G
M;U]O<'1I;VYS7W8S/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*
M(" @(" @(" @/"]D8SIT:71L93X*(" @(" @(" @/&1C.F1E<V-R:7!T:6]N
M/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL
M:2!X;6PZ;&%N9STB>"UR97!A:7(B/E)!4%0@5&AE<F%P975T:6-S7TQO9V]?
M4$U3+3$N97!S)B-X03M7960@36%Y(#(R(#(P,3D@,# Z,3$Z-34@1TU4*S U
M,S F(WA!.U-C<FEP="!V,BXT+C(L($EL;'5S=')A=&]R('8Q-BXP+C F(WA!
M.T=R87!H:6,@='EP93H@07)T=V]R:R8C>$$[)B-X03LJ*BI4:&4@9&]C=6UE
M;G0@:&%S('!A<W-E9"!P<F5F;&EG:'0N*BHJ)B-X03LF(WA!.RTM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM)B-X03L\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M06QT/@H@(" @(" @(" \+V1C.F1E<V-R:7!T:6]N/@H@(" @(" \+W)D9CI$
M97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70]
M(B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM<#I-
M971A9&%T841A=&4^,C Q.2TP-2TR,E0P,#HT,SHQ,RLP-3HS,#PO>&UP.DUE
M=&%D871A1&%T93X*(" @(" @(" @/'AM<#I-;V1I9GE$871E/C(P,3DM,#4M
M,C)4,# Z-#,Z,3,K,#4Z,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \
M>&UP.D-R96%T941A=&4^,C Q.2TP-2TR,E0P,#HT,SHQ,BLP-3HS,#PO>&UP
M.D-R96%T941A=&4^"B @(" @(" @(#QX;7 Z0W)E871O<E1O;VP^061O8F4@
M26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S*3PO>&UP.D-R96%T;W)4;V]L/@H@
M(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z06QT
M/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U
M<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V/"]X
M;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH96EG
M:'0^-C@\+WAM<$=);6<Z:&5I9VAT/@H@(" @(" @(" @(" @(" @(" \>&UP
M1TEM9SIF;W)M870^2E!%1SPO>&UP1TEM9SIF;W)M870^"B @(" @(" @(" @
M(" @(" @(#QX;7!'26UG.FEM86=E/B\Y:B\T04%14VM:2E)G04)!9T5!4T%"
M24%!1"\W44%S54=H=F1'.7IA1SEW241-=4U!0311:VQ.02LP04%!04%!0D%!
M4T%!04%!14$F(WA!.T%10DE!04%!05%!0B\K-$%$:T9K8C)*;$%'5$%!04%!
M068O8D%)44%"9U%%0D%514)G549"9VM'0E%92D-W9T="9V=,1$%O2T-W;TLF
M(WA!.T1"04U$07=-1$%W441!-%!%03A/1$)-5$9"451%>'=B1WAS8TAX.&9(
M>#AF2'@X9DAW14A"=V-.1$$P645"05E':%521E)O9DAX.&8F(WA!.TAX.&9(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9B\X04%%46=!4D%%04%W15(F(WA!.T%!25)!44U2068O14%A
M24%!04%(05%%0D%114%!04%!04%!04%!449!=TE'05%!2$-!:TM#=T5!06=)
M1$%114)!445!04%!04%!04$F(WA!.T%104-!=U%&0F=C24-1;TQ%04%#05%-
M1$%G44-"9V-$0D%)1T%N34)!9TU20D%!1DE227A15D5'13)%:6-9155-<$=H
M0GA7>%%I4$(F(WA!.U5T2&A->%II.$-2>6=V16Q1>E)4:W%+>5DS4$-.55%N
M:S9/>DYH9%5:2%1$,'5)24IO34I#:&=::$I21E)Q4S!6=$Y62T)R>30O4$4F
M(WA!.S%/5#!:6%=&;&%7,7AD6&PY5UHR:'!A;71S8E<U=EDS4C%D;F0T95AP
M-V9(,2MF,T]%:%EA2&E);4MI-'E.:F\K0VLU4U9L<&59;5HF(WA!.W%B;DHR
M96XU2VIP2U=M<#9I<'%Q=7-R839V;U)!04E#05%)1$)1545"45E%0T%-1&)1
M14%!:$5$0D-%4TU514954DYH26=:>&=:17DF(WA!.V]B2'=&34A2-%-.0T96
M2FEC=D5Z2D121&=H85-5>5=I63=,0T(S4%-.94I%9WAD56MW9TI#:&=:2FI:
M1D=I9&MD1E4S.'%/>G=Y9W F(WA!.S K4'IH2E-K=$U453504FQD65=6<&)8
M1C%E6#%2;%IM9&]A5W!R8D<Q=6(R4C%D;F0T95AP-V9(,2MF,T]%:%EA2&E)
M;4MI-'E.:F\F(WA!.RM$;$I75VPU:5IM<'5C;EHV9FMQ3VMP86%N<4MM<7$V
M>71R<2MV+V%!07=$05%!0T5135)!1#A!;5@U;V9M:'%L-7%L>&\R:EA$5W4F
M(WA!.VY7<D=+86%);%I*<$9.2"M-8FA!9&=",39N,C-':S!K4DAI;'53.%@R
M>#)X3U5Z:GAN:&A(8F)M5"MP-6]*6E)*-F]D:$E$>41G;FPF(WA!.UAX<FUF
M5'IV16)V<3ED+TMB.'@Y5VMV-'1%,75:<FTS=5!G<W)U53%K5U0Y;4YM3S=Q
M,U%%.41T;6@W47DT36-X145#6C9F:FLY-S<F(WA!.T\T.61N>%-N2TUP65EJ
M-GHY=R]N9F\V<W@X-RMD-#E.=6PP93!M5T\O9$)*2S4O659Q,%9A-V-J4W9Y
M>FU/,F4P2C1H=UDK9E4Y>C(F(WA!.W9:9EIN:7@X4U$Y2#0K>&=S,# P,&AK
M;6MA4U$Y6&-L:69P3V-83V-P1S5'>3E&1TEI2T%O2C4U93@R6"MM6$-*3DDP
M,6E30DI%>$PF(WA!.T92-'!8<%1W>F%D;F1R6DU%9TI(:7@Y,S9N6#9Z<S9'
M5TI)1E0O2$XV:6IQ-DLV14UJ04972%%G-V<U,V])27-02D5%1VDS:%$K6'(F
M(WA!.VIZ-RM94WIY0F16=E%!-T%#<#96*U=854=Q>7 O=T-0=GI%+S9U,3<Y
M-2]P:E%7>3<O2#,U:68Y6&$Y*S@O,'AO3%IA8CAW4'I#548F(WA!.VTQ93E!
M2%5L:4(K<DAH0SA24C)M9FY(-2MS6D9,6#1V23%)<D1C>&\T3E!&;$-Y9CA.
M9S11=D58<U U9F9M:G!N;7-',&QJ1FQQ.&$F(WA!.SAM=&DQ56M59%=I63=M
M;F14=5!F<FM*4G!M2E=Z9DES;EEQ=W8X,"]/-BM73D%)=&Y(-E=V=556:T\V
M0VYX>3 O=T%I=3-V5$I21G,F(WA!.UI':W8O2GIZ,C)V-E%D33%#679Q*VYQ
M4&IC,65A1&]R:VYQ>2]:8C9$,WAK2U=*=#9*:U=4<U9E5&9N8C5I.'DV5&4V
M56UJ,VLY<6LF(WA!.W-5<&U%0DE$14UT2S!'5&='16E8;68X06HW.'A0*W)T
M92]E9C9:3V=X<W4O>#DK66XO5C)V9G90.4UA0S)89C0K+TU4+W$W6'8S;BLF
M(WA!.VU.0F)+-D0X,%!Z071:95,V>D]70C-754I)3G8X;5)7>#11=D578BM7
M4'IS92]8.44K6GEB6F)I:V%A>%IK>%!'4V1M9&1W3B]W0G F(WA!.V1V1F%:
M17=:0V%5960W+SAY+TQ'<F96=C U9#-6;$]V<3).,FI616MF=E-O1$PS*R]V
M:$9&0G--9"]X.2M9;B]!1F1R,S=Z+T%%=S F(WA!.T575FHO;4HU*U$P9E=B
M=%0Q;U=)+U=-945,>$9C;C5G+VU#-#5*<D8T=SA1>$DO5FIW:&5)="\T*R]-
M5"]Q-UAV,VXK;4Y"8DQV.$$F(WA!.T@S-6EF.5AA.2LX+S!X;TQ:4TYO-51/
M,&(Q179):"M854Y8975B,TYM:FIG6GDK;4ET.#(P=6MY6C@P8U5"*SAN2VAF
M96DT<E=+4&0F(WA!.W%33C1K8D0U1"MU8U(R:#=26DUV<'AE:5!F.$%X9G,K
M2'IF6D]W=BM"+W Y4%4Y5%=B2C-F=T0O04ER-#=F,%5Z,%%43G)D9TEQ;5HF
M(WA!.W)M2# V9&52:T90>'IN.&1M63<W93<Q06I(1DEC;VE**U9*-2M:-&Q(
M;FY64%5R571'5G(O3#938V9W>DDW479X<%@K3FY#-T9R.'(F(WA!.T-V4#=Y
M;$]N-B]D5S%%;"]F42M"4'A$-4A.6&PP,%IE4F,S2G!X3&QS5U17;#%&9%%,
M3D989S-I2T=O>EA:35IG84QG5&=9;6DY;C@F(WA!.W9">&]69TAR>2MR>#EF
M1&E+9FAN;W9:.2]L-%@O3D@S4$1A>79';E@X-'!H;5DT>G-69&ER<U9D:7)'
M+TYV:TAY.35K<UIO<FTQ:FDF(WA!.W980DU.+T=G5U9(-T5S3C)7=E94*W9F
M0T130TQF371J95@K9S8U1F-W:W@S=6Y4,3(O;FIA:DMF63!O9F),=6)6>698
M5G1C4C-.=$8F(WA!.V-29C-C>4Q);&5V1FA59G)Y:'55.5$Q0S P-GAN=G)Y
M45)7='-H:VUK8F]&558O,FAI<C5C.'HV.7%V;E1Z53%W<4TX;'I)='9P.6\F
M(WA!.TXK15IA:V-9.3DV;C-*>31#9S!K,E9/,VTQ,WE4-7-$1F92,4A46F%3
M4C$K1C$W:C-34D0Y>'@U:&529E0K9V$U638U;SER<6QK,TLF(WA!.T,U44U"
M,U9U:DDS=7)B2$MI1S1&34U#=7A6,DMU>%8R2V]4571),'963&,R*V\R:U8S
M0W=)-%1)2'!8=W(P4'5-8E8X,&9M8C539S@F(WA!.W(K85I,1S%*3FQ01W1Z
M87%X<7EO-5IE2E K4S9-0C=:9$4R1W%1;W9:+WE6,6TT,5!Y3D-K-T8S,"M:
M-TU/86ML14-U;&$O>7))1BLF(WA!.U%Y=5$S6GA/>D\X:7EF4"]!4'IK1"]Y
M;59L+S)Z;W8K5#@R5W<U3F,K8E!V>4LO-5%29BM9<6(O04DQ>44K8DM02C9&
M:U=4<U9E3F8F(WA!.VU0.$%L5G%*,6E86&1#:$YX0F-S6DQU>E0K.%-2=G1/
M:2]T2W@S24<T4'0P>4TK<#1T3$]"*W)H3F5B<61.,E@T9F%73%!(-E!%:5HF
M(WA!.V57+U S34)843EB8551<G Y>5II84--47E&<2M&2U9Z9WAI;F158F9A
M1'%C448X56$Y-&5O9FQP*U=L-UI8<V5T-C-(-E5K5SEN6FTF(WA!.VA935)4
M,4I+8D-G-D1R6'=P;34W4#=0;$=82% T0C5F=&YT;4TT;D9I3F<X>BMG2G0K
M6FXU9E1E649J,4Q43U V5&=49SA414M*;W@F(WA!.U5G8VIS1U=U,6-V-U$P
M2GDK<5 Q9F4T;EDS87<P.7=N.4(K=R]Q94XS4&PO6&)767<S1VXS36-Q;6A6
M;VXO1&)F3V9L:&Y%,%%8<V\F(WA!.V%V1DE72E)).3<P9GE"-4<Q3S1T64@Q
M2T(W4S%2:7IP2T-K:FET44%P;U%$-#5:9S=(;FUY:55X=S1X.'DX.3)P,G)J
M9U-)2&EL-6,F(WA!.V<Y84%#9TMO;T)S04]G1V1E0E1X-4QS2W5X5C)+=7A6
M,DMP3C5P.#(V3#5A,#93.#%'9%992U1$8D%J,5I7-TMI.65V9F]-249O2G F
M(WA!.SAT45%8,G4V,G--2V,W,U5B:C162%1N2SE4.4%R;#-*<35V<FTP=&MT
M8E-',FHK>$)'<V%6.$5!569Q>6AU94IF;FHU-2MT6%$X<U<F(WA!.T5T8F$R
M65!Q3'%D;FU'-GA62%I/<"]Y=CE83$E"<FUE:5EF:U@U2#E/32MA8C90-#5!
M,&5M23-53#EL-79P,U9F879I345Z,%1!2FPF(WA!.RMD=FMB.4HV6B]I0WAJ
M<F8V96@K='%O,VMT>'54.#0K=BMR6'='34-S9W=N.&UF4%@V13%J.40S,&Q.
M3#%*=T5::E)9<F<W2R]S2"LF(WA!.WDS,$AT:W!"15,K:'-Q8DA9<3=&6%EQ
M-T950G%U=F%,<$U,5&%L97<R:4M/4CE6=W)%9C5++V%B-4%985<S>E8K6E!M
M,DQZ4C5O;#$F(WA!.T,S57):>%)R8C)N2559>&]395)(*U5Z<V-T:4M$5$DR
M6'1F-4TV2E!P6&ME,TTV;$IB*U8W=V]W;U%R:%54+V=K:D1F5&QC:G4R4D<F
M(WA!.WI/8VEY9E O05!Z:T0O>6U6;"\R>F]V*U0X,E=W-4YC*V)0=GE++S51
M4F8K67%B+T%),7E%*V)+4$HV1FM75'-6658U-#@Y4S981&,F(WA!.U<R;#A4
M95%O5$I/=S5+:E5R441O5#0Q>E%D;SES*TAK.$Q(.5A5.3,W6&4Y;61L1$Q5
M<VXP;G S=DM6+TUJ>G5*+U<O4S!P971A1EDF(WA!.WEN+T%C95 T6F<O;G,Q
M,WA&-FXK4CE,5F-!*S,W,W!N-65F;5E.96TO4FUP;VM/<#!*:&M46DIG;W%2
M42]:8T1F=T]B:E$Y;V5)94<F(WA!.U@Q9F4X>C)T,DXT03A42'9$<C5F<U10
M>CDU.71V3$9S:U530V963&A3,$5"*WEQ,7 V:C S<%AO3RM883-7:D-+1SAI
M-#-:6%IC=%8F(WA!.TMZ=$%C>BMG4$ER<CAY+T\Q>$XV<#%.-#DV<6M3;VE$
M,F]"=CE/84M7=GI%,WA06%$W1S!S4EA!1#<R52M59GIK=6MV-V94+T%$27DF
M(WA!.U!B,T%!6%5!;U)O,TQ&4C9G5VDX3G5O07 S.75Q-TUX>GHV9FI*=59L
M.#(Y;TY::3!F84AG5G<T>D=*=G5*=FXU9F,Y9WE463=&6'DF(WA!.U!C*UDO
M34EU2E%.575W03=52')Y*U X07):9%134U4V+U%V-7-F.$%,3G)0+U1Z9W-*
M;W4O478U<V8X04Q.<E O5'IJ65=I9V172&XF(WA!.R]4259F5E<Q3S!H;4I2
M5W5';E)73DXQ*TDP3S)%56<R:"],9FQV5B].5W(O049#>6MJ83=:5$EZ,T5N
M2#1624)/.5=A;&5I9VY%;6PF(WA!.T%T-S,K6#,U5C9:-590,3)A5#8W<D1+
M5BMS16-5:E9H.%-X2V$Y96A9-R],2S53='-%85)N-6PK9%DO2S-L.359;4@V
M574V>%=%97@F(WA!.V\Q4&EK25!A34=V>F]-66DP>4Y0;E1Y+T)P;"]R,$$Q
M>3DK<3)$>4=3.758-75Z3%AK=TA%33-**VQF<'EW=%%F43%V*V%F-6$R.$4F
M(WA!.V1V0G%S8V--2W)(1D=S53165E555E%05#9!1$LK171V148W9FUZ*UA4
M2U9B5C1Y<$9#1$9/45%F*V5E4$-6-&<K9G9/='0U96<X=U@F(WA!.T1E6')T
M8G)3<'HV<T%66%@P=5(S:6\T52]#96YT5$Q!,48W:BM52&YN+T5/:6953#)4
M;'$R;7%%:TQ(-'!996E3*S5(,E<Y.2LK5GDF(WA!.T9.:U1B1"\K8VE0*T]J
M;W8O1T=B+VE3-4M$1V)Z<E$O2C-M8EA92DHY2G-(=319;3E/4C!+0VI5<E0T
M:4]X>5).35%#57@O-598*UDF(WA!.T@O5FQM+S1+4"]M<DAI0V5%=2\U5E@K
M64@O5FQM+S1+4"]M<DAI0SA*5EE0>6PO34MA5&=U:T]N8W1*2D-G02MB3TUE
M24QW;&XS:W(F(WA!.SAI:&)8360Y-6UL:FY-6D1*<#!.5U%K8B]V6$E(268U
M23(Y.&=:<VA"-T%!04%!2T%B041)33-9<2MF+T%0;DE(+VQ-<DPO=&Y29C@F
M(WA!.VXU<W1H>6$U.#)F9FM6+WEG:2\X>%4S+T%"<FM*.#)5950P3$ES;EEQ
M.$YV43$T<S1L63AR:FQZ9G96=7!Z>3=X1'@X4C4S8C9":CDF(WA!.T96,%EJ
M<4=I6&1P5G=05FA(*S=&-V9-9',R5TQ54FXW,UI9.#A:95)A,$,T;71T9# K
M944P;&IU66U1*S1C6FPT<$540DAE:E9117,F(WA!.U5G95)I9G54=C@P8FEA
M8GIX<5%K3E)%630T>#1+23%)02LK=5I0845I8S!R8TAS4T%';&A85R]V66TX
M:V-9<35P-$1Q5#AH:SE&,EHF(WA!.VTQ2CE!.5!E95@T.7IJ.7,K,&UK-U!J
M*SEL-BMK0G9)+T1O4$TP141C5&U:;$I&07$X44]V8VXY6GHP2',W46I4679$
M0C1U<C10,B\F(WA!.S)Z3'1(56Y/66E'=T%(4%EE9E4O05!Q8GE68WI84&Q$
M4G U>GEL97IH-70S2D-!5E!Z>E8U>%5Y4$XW3%%437-%0V5F0U!U5')+;DPF
M(WA!.V9',3$O=E1,+W)T*W9,,F=V<VY+1SDR2W!8-6TX=3)(;4A28FI3<C%F
M,U4V+T))0E9O-4)U<VDK-FXK;45':T50;4,Y=$YC.&XK6GHF(WA!.T573G9Q
M5VUY:&]P5BMY=T<V=71E<75V-&)(3&5B5GE,-E X04LS;FY39&,X<B]P,356
M=#!T,$HQ1D=0.7<X67$Y93E+8G(T:C-Y;VHF(WA!.V1T0F906&YB>E1E*V)V
M33!L,G%-63)946%D86IC<DA7:4%!9G1/5%4K-7DP0VUO;7EZ0T0O;DAZ>D4X
M36)Y-FIA>%--;TQX14\S1FDF(WA!.TML86=53E!B23AB3&=8+SE#.6$Y+W="
M6%<Q+S1'5"MM4$=V03<O;UAR6'8K<G)A+SA$2B]42&I89V-F*V-E=&9P='%L
M<EAT.$UN.4TF(WA!.V5.94)G;6MA;G)0:S=Z471W14U6.7 X<E)83G5X,F11
M94UK8F5Z1'8Y27E2,T1%8D9M=C4S87A9-GI(-6,Q3WAF;F)85G1--DAU4&DF
M(WA!.U=Q="]L2V1J-S5'05I46E O=T$T.68X04M/-FXO=T%X62\U3DQG;6U(
M2C9R:T=B<U9D:7)S5F1I<G-69E O.$%Z:T0O04UP;%IF.$$F(WA!.V)/:2\U
M4'I:8D1K,7HU<RLO27(O04I14F8K67%B+VI8250U<V\X;F]74EI/>%8U9#5T
M.'581VTS,&QX1VAA=VU9=$<V:EI#>')W8G<F(WA!.W R>F<K,75Z6EE-:&M"
M*S=L.6YK.60R9')9-5E#2E!R2#1T:BMA6C)+9&54+TEC3CER1G9R17-*:'1R
M4U%3<G126EI&3E9O4$%.=50F(WA!.VY3.6EA6$IK:TIY+W5X.7)R*S!U,5!$
M>&Y'1&-P0W9C1DPX-69*;7!35"\T:3!U17IG;T4Q0TY&-4]V055754M/<3AD
M;3A+5CAA9&0F(WA!.V<W3S K5$YX-4]F9# K3'AN85AB978P*VPX4%0W1&5Y
M0F-G1#-F8EIQ=SA86FU9;&U*2D\U2C8U,459:4EO0V<K6%I-:W!Y37!%;5(F
M(WA!.S5K.# K.&YE5&16.'HV<$AA,FMB3&%Q=RMT,VA".4]*3RLO47-2.6QE
M+WEQ8W)Z-30T>%HU=5IO3D)057I%66HP.50S9G0X;C%"6C(F(WA!.VM&;EIW
M5VQU=D=#,FI32TIF0D552V\K-%IZ,&E38DPV4$-!:D522$EB2S)":RM.<G(O
M96U8+UAB.658=$)F6D]53C=S5F1I<D%V>F$F(WA!.SAG+S1K,&HV-UI2,3%M
M=U5M14%B>E)D5VDK9F109F)V:V]M;4UH8C4T:#%(54QA,75R2TME4TLR=2M+
M,V-!2D-V-F)C;#5$+T%#5WDF(WA!.S%Q=#9P*U)V:V(V>F-N>E!F>#%G=#)+
M86%J1%IP4G,P=GE4;W9V.$%,25104FY!9%AU1U9T:G-69&ER<U9E42]N;C5'
M*W-7-#@P5TLF(WA!.U9M9U99.5-24G4P63)36#5P.6QV86YH:S1(;W=M2&ER
M,U4W,CA6<S=L;UE79#1K4%)42G@U52MF15I9,79C+RMC978K560Q4"]M3$@F
M(WA!.R]*<&-R;3)1-5!68V=Z9&ER<U9D:7)S5F1I<C4O=T0K8V=F*U5Y<W8K
M,F1&+W=!;C5S=&AY834X,F9F:U8O>6=I+SA!359.+WAR:THF(WA!.S@R5654
M,$Q)<VY9<3!Y<7EL5T%:5'-19'=29TE",DM185%1,$A20DHV9W-,8U T*VUN
M6#=S>%)O348S=U)V,T)V+TXU87)I;#@P8T$F(WA!.T%!04M!8D%$37-">#-9
M<6Q&,S50.'%89'@Y675D2',U6GEE5%-.0D=762M,1VYX9E1L;WI406]%=4Q0
M431*1S51:50W9VU6<F%7=' F(WA!.T%T=F%W>#(X0V)*1D5O4D(X;%5!1$MY
M4U1:8VE%27A&4D9"5G=-;EEQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$F(WA!.S=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&
M6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1E=095ED2G-9<EI:-#!:6EI,:44F
M(WA!.T]W:VLS16MO1$-N2VTT3V%B=$A3631W-&=$6FY(<65S="MR<SE&<4IM
M5DAK26YO3V=8-C595W5N-DAE4U=I=$<W0T]P1'5X,FM8<'DF(WA!.UDU4%A9
M25EC17I!14AB<64X9#52<$TP<VUA26QV>C9$=5)N-EEU4"MR5F5F9$(O,59Z
M22]/4R\Q3$HO<V8K2V-F.'1(*V9$+T%'6"\F(WA!.T%"2U-Z6$TP;FQZ5UI3
M2DDS*W504D=.2%5C,"M(66M$-D1M<VYK2C R53=J,6XS.'AS-3A905HX63)0
M;RM(26]Q2W@P.35%439097@F(WA!.VAM04QT24]+,4Y+;6LU3D(X<WE)-$U:
M24AH6D(X9CA!:C=63$Q-0R]%9V9H+W=!9%<V<71M3F5J:'59<#5O1G-X=VIG
M17)K34I+5DDF(WA!.VDS-F1Z:V15269M04I#4FHT9DEC4C8O,%4V8WDX16U*
M:41X.6$W=DYV5$=T,C%T13!T3&E+1TI'1V]P3C9I<4-W0FDK1U4Q-60Y=3(F
M(WA!.TA41TIZ9UEH25)!4$AD+S5U,'5V-D5:>$QW:6-H:5-4-F%R-#AU:6QQ
M97)*9%AS=C%F55EB56%A9C-+4$MI971C1#=164UA.$%T52LF(WA!.UHY<W(Q
M3W)'5$EE2$I'2&@X<DE(1DQR.$LR.34X;65$5&U%0GA13750;G-F5$@Y9E9%
M-G1Q8TXY-51M=F)::49D57%&4'A+9E55374F(WA!.S-C6F9Q.59(3&]Z3U!7
M=G9'>E9P.$)X-FM1;#4O8VAR;3,P-#(X9W1D3W8P=5-P.4(Q.5I#2"]:4$IN
M;TXO2$M-;5!'66YG>#523' F(WA!.SE1,RMB8D-C*TEC53AF1#$K;FPX;EAI
M4TYQ,71&93(X,3=)=&=P;&IT,C0O=E$Y1V9D-#AC,%-C,%)K:DM:.$U8=SDY
M."M96$51354F(WA!.VI!:4DT*W9D6$QK57HP;7IS,6QA5T]X=4Q34D)11V0K
M6$E.5W1!2DI"=%1V;61P34U,<U%L06HK8V8X06IX8U156EHQ4FQ'43AH*W<F
M(WA!.TXK5C-:.4%S;61I>D=0-&E453%"4%A$,E=39%!#*S5D94MZ4W)V55EB
M94LX,6)6;UHV=D-R5SE&1$U+15(Q+UI)<#%Y=4=-6DTR5TTF(WA!.W0T*VYR
M-4TU5$U-94UX-2MR-S!.86%.<#<V,7%.=39/65E5='I%;G%Y8D9W+TPY<G9X
M1U599$AJ3V9*16<Q15)R8SEB=G$R-4Y635DF(WA!.V]30C-*;#!(4W9*1GEY
M1WHQ3V(P9U1(8C9E1VII<5189S=51SEF1$UI8W9$>6UU56-83#-%=$U9.&5-
M6'IL:RLX3$Y.,&4P=F)'0S@F(WA!.W8R83EU3&A&;%HS9'5#.'AY-&]G2591
M2S V6D1484]'6$=*-5!82U%V;6$S-VAY1$Q0<5I9-6U%4%1'2G(K,'%T-V\X
M<V5N5%%A8S@F(WA!.V=-:DDS;W9-.4-Q<T,V235,36Y.86IB3$TR:DUC6FII
M2C-R8FE0>$%035=W>&%K1UE/4W1R,V]F06MD85,T<'!T<%-7.#!I-',Q56<F
M(WA!.W1C<$HV:7)V,5IO-4]64&]Z1')&:C-N:6Q$>G4O;5)+,TIV2E!A1U--
M=DMQ*SA5>69.-C9L,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W4F(WA!.WA6,DMU
M>%9,.6,K<695-"]R6'%E;C8X4$@P<6-U9G%,=W)Y-V-U=5EE=31/06-D,7A2
M-60Y:6Y+,&Y&>$AH<2M%."]C-U@O<78V2FXF(WA!.RMT*W Y6"M$;C963V8R
M,7!4;'0Q>#$O0C1-=4\K2&)L>C5H1VHT=D9(1%A&-2LU34UZ2$=9.61F;W(Y
M1#9T>2MS96@Y868V>G@T97 F(WA!.S9N3DLK;E@T94YA9&,P*UAW=D)Y,WAC
M4$=B-5AD:FPU93DR95!X4$9X+U1F1'1Z<7%03EHO=5(O-UA(+T%%-5I$.34O
M="\X03!R6F4F(WA!.VHO868Y;6U56#%B.4YP6#%F<FXQ358U8V50<"MP,W K
M,WDK:DTR4$0T-"MR:CA0>358.3DO0GA:8UAG.4](:BLR=G553E,K<69P32LF
M(WA!.VPY62MV9E9P4%<K<6-+*VPK>GHU+W16*W@O5$MT5'=E3'1X94IW1RM'
M=5A3-S8O>E=Z0GAE2'9W.$A%2S1R-2M69$\Y16%:*V@O,&8F(WA!.V(O5F94
M.41G4%0U8V562V9T9C58:C<U9'!V03A/4$)81%@T=GHW,G)0-'9'94LW=$QB
M,SE$96QQ,T@Q+W$Q669R9F]C4%0Y6&MV.$$F(WA!.V0Q+V(K>GHW9E1M1FTX
M0W-V,6-0<#1Q<7(R-65F3&DO5S573'AB>"]4>&(Q9#-8;C5D>DDX,U1Q,&@Q
M9C O,'EN;R]89G)V,69F-FXF(WA!.S9(2#!U6BLQ-C-F;#1:<4Y:6&IJ:#A4
M:C1F-$](;&8Y3'ID;'!R.$QF9S1E3"M,:34Q-4MU;"]7+W)9.5@Y23A+2"]E
M<C9T-F8O2DPF(WA!.S1Q-5IP95!J,SA8+T%$=4-V.6IU,39J:#1D=D0O=T$S
M:78W545+*W1.*VAV<C,Q6#%'.6(P4%$Y2&Q5."]3*W-B,7)8-T\Q8WAE<#@F
M(WA!.T1X3T<Y*TAH-&90:#0O,&)/4C!(:3A(1E<Q.%8K5CA0-E4P,$@V:#E5
M:RMQ97!Z.5)V<EAR,3EB,7%$;#9L93E+93):*V<X4&=00F0F(WA!.S,V=4PV
M=4QZ8U178V9%3TMU5S%C<3AL,7 Y52]43V]E;C9N,6YH8BMV>7!W<%(K2$-M
M+VI7=5-X8TAJ>G$K2V\S,V1A<CE,2$IX948F(WA!.T,V-&)L6&8P=3%W*W)F
M<'!V="]79G%W<C Y4# O55 P.'$U3# K4#$T=40T5F8S;SE8:&8P94PT,U-4
M4F-E5"]!2T,K=F96*U(O=68F(WA!.U$K<E9R.%AP+U=F9BM88DY:2'(K6#A4
M:'9P=SA0=S0O,&)/9$PO8G5$:3@K3&DK4$0K;F1&4F,O<6,Q4#!N.5DU2GDU
M96XV,V5N0W8F(WA!.S=N:C0P*VY,-#-W2"LK-')(9'AF1"M';7%68U$O=2M(
M-#$X9C1K3&-E=C9:+U1(-E$O4CE2>C5F5G5(1W8K-W9Q+S=Y;FIM4&LT<2\F
M(WA!.V8K3#1F*UI69C!U1&5M-D98*S8X4&HO>G(K2$9S+R]:/"]X;7!'26UG
M.FEM86=E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z06QT/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA
M9&]B92YC;VTO>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F
M/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52
M968C(@H@(" @(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E
M+F-O;2]X87 O,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*(" @(" @(" @
M/'AM<$U-.DEN<W1A;F-E240^>&UP+FEI9#I!,S!#13,W049#-T)%.3$Q.3@Y
M1$$Y1D)",$%#-$8U,#PO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM
M<$U-.D1O8W5M96YT240^>&UP+F1I9#I!,S!#13,W049#-T)%.3$Q.3@Y1$$Y
M1D)",$%#-$8U,#PO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-
M.D]R:6=I;F%L1&]C=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!
M.#4Y,$0S,34P.$,X/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @
M(" @(#QX;7!-33I296YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD
M:71I;VY#;&%S<SX*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A
M;F-E240^>&UP+FEI9#HR.3@X045%.$5&-T)%.3$Q.3@Y1$$Y1D)",$%#-$8U
M,#PO<W12968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M
M96YT240^>&UP+F1I9#HR.3@X045%.$5&-T)%.3$Q.3@Y1$$Y1D)",$%#-$8U
M,#PO<W12968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I
M;F%L1&]C=6UE;G1)1#YU=6ED.C5$,C X.3(T.3-"1D1",3$Y,31!.#4Y,$0S
M,34P.$,X/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(" @
M(#QS=%)E9CIR96YD:71I;VY#;&%S<SYD969A=6QT/"]S=%)E9CIR96YD:71I
M;VY#;&%S<SX*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @
M(" @/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @
M(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*
M(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z
M86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX
M;7 N:6ED.D%$.$8Y13@R,48R,#8X,3$X,#@S03DQ,C0Q,T$V.3@X/"]S=$5V
M=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR
M,#$T+3 Q+3(S5#$Q.C,R.C0P+3 X.C P/"]S=$5V=#IW:&5N/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R
M871O<B!#4S4\+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @
M(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @
M(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N:6ED.D%%.$8Y13@R,48R,#8X,3$X
M,#@S03DQ,C0Q,T$V.3@X/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z=VAE;CXR,#$T+3 Q+3(S5#$Q.C,R.C4W+3 X.C P
M/"]S=$5V=#IW:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A
M<F5!9V5N=#Y!9&]B92!);&QU<W1R871O<B!#4S4\+W-T179T.G-O9G1W87)E
M06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T
M179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYC;VYV97)T960\+W-T179T
M.F%C=&EO;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G!A<F%M971E<G,^
M9G)O;2!A<'!L:6-A=&EO;B]P;W-T<V-R:7!T('1O(&%P<&QI8V%T:6]N+W9N
M9"YA9&]B92YI;&QU<W1R871O<CPO<W1%=G0Z<&%R86UE=&5R<SX*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F
M.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%
M=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.#DQ-#%&1#<Q,S0U130Q
M,4(R0S-#1#8P-39#-4$U0C4\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @
M(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,30M,#DM,C54,3<Z,C<Z,#0M,#<Z
M,# \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T
M=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+W-T
M179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC
M:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E
M9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS
M=&%N8V5)1#YX;7 N:6ED.CDP-S0S.6(S+3 P,C(M-#<Q,RUA,3,U+3$P,6(X
M9CDY,3=E9CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @(" @(" @
M/'-T179T.G=H96X^,C Q.2TP,RTR,50Q-SHU.#HR-"TP-SHP,#PO<W1%=G0Z
M=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T.G-O9G1W87)E06=E;G0^
M061O8F4@26QL=7-T<F%T;W(@0T,@,C,N," H36%C:6YT;W-H*3PO<W1%=G0Z
M<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T179T.F-H86YG
M960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R
M8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/F-O;G9E<G1E
M9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<&%R
M86UE=&5R<SYF<F]M(&%P<&QI8V%T:6]N+W!O<W1S8W)I<'0@=&\@87!P;&EC
M871I;VXO=FYD+F%D;V)E+FEL;'5S=')A=&]R/"]S=$5V=#IP87)A;65T97)S
M/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D
M9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @
M(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @
M(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HP8S(Y.3<V
M-"TP8S4V+60P-#<M.39D-"UA,C1C-6(U9C(R-#$\+W-T179T.FEN<W1A;F-E
M240^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,3DM,#4M,C%4
M,C,Z-#DK,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IS;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-#(#(P,34@
M*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @(" @(" @
M(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IA8W1I;VX^8V]N=F5R=&5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IP87)A;65T97)S/F9R;VT@87!P;&EC871I;VXO<&]S
M='-C<FEP="!T;R!A<'!L:6-A=&EO;B]V;F0N861O8F4N:6QL=7-T<F%T;W(\
M+W-T179T.G!A<F%M971E<G,^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@
M(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E
M(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%
M=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)
M1#YX;7 N:6ED.C(X.#A!144X148W0D4Y,3$Y.#E$03E&0D(P04,T1C4P/"]S
M=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE
M;CXR,#$Y+3 U+3(R5# P.C$R.C(T*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @
M(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU
M<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@
M(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N
M9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @
M/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#I!,S!#
M13,W049#-T)%.3$Q.3@Y1$$Y1D)",$%#-$8U,#PO<W1%=G0Z:6YS=&%N8V5)
M1#X*(" @(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C Q.2TP-2TR,E0P
M,#HT,SHQ,RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @
M/'-T179T.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7
M:6YD;W=S*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @
M(" @/'-T179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @
M(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @
M(" @/"]X;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*
M(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @
M(" @>&UL;G,Z:6QL=7-T<F%T;W(](FAT=' Z+R]N<RYA9&]B92YC;VTO:6QL
M=7-T<F%T;W(O,2XP+R(^"B @(" @(" @(#QI;&QU<W1R871O<CI3=&%R='5P
M4')O9FEL93Y0<FEN=#PO:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!44&<](FAT=' Z
M+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @(" @(" @(" @>&UL
M;G,Z<W1$:6T](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]$
M:6UE;G-I;VYS(R(*(" @(" @(" @(" @>&UL;G,Z>&UP1STB:'1T<#HO+VYS
M+F%D;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @(" @(" @/'AM<%109SI(87-6
M:7-I8FQE3W9E<G!R:6YT/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L94]V97)P
M<FEN=#X*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y
M/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3X*(" @(" @
M(" @/'AM<%109SI.4&%G97,^,3PO>&UP5%!G.DY086=E<SX*(" @(" @(" @
M/'AM<%109SI-87A086=E4VEZ92!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(#QS=$1I;3IW/C4T-"XU.#DX-#0\+W-T1&EM.G<^"B @
M(" @(" @(" @(#QS=$1I;3IH/C(V."XT-38P-34\+W-T1&EM.F@^"B @(" @
M(" @(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$:6TZ=6YI=#X*(" @(" @
M(" @/"]X;7!44&<Z36%X4&%G95-I>F4^"B @(" @(" @(#QX;7!44&<Z4&QA
M=&5.86UE<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D^0WEA;CPO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI
M/DUA9V5N=&$\+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y996QL
M;W<\+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:3Y";&%C:SPO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G
M.E!L871E3F%M97,^"B @(" @(" @(#QX;7!44&<Z4W=A=&-H1W)O=7!S/@H@
M(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QX
M;7!'.F=R;W5P3F%M93Y$969A=6QT(%-W871C:"!'<F]U<#PO>&UP1SIG<F]U
M<$YA;64^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P5'EP93XP/"]X
M;7!'.F=R;W5P5'EP93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O
M=7!S/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C
M<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H
M='1P.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0
M<F]D=6-E<CY!9&]B92!01$8@;&EB<F%R>2 Q-2XP,#PO<&1F.E!R;V1U8V5R
M/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z
M>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD
M/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_\  $0@ 30$F P$1  (1 0,1 ?_$ !X  0 " P$! 0$!
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MRB!B*)G*4Y#%$!*8 $! 0U9C3KK#K3[+BVGF7$.M.MJ*5MNMJ"VW$*&"E:%
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MOZUUJ::42I3;:E'O*D))..G4D9[NE8Y\T+:;[K^W?X*8U^[.OO/?]L[^(O\
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M,S9FZETH.7/'I+J$,Y"/<@D!A)T&X-R0H))&X@D#/4@8R0/=D9^VK?"5%)4
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M2(<CAHK7S[2 N-;W#+AH44I\[LNB%V1"CN*&Y4Y37(*MRDL2&E*W*SGR!O7
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M5AWKOO+D'FMR7$G/]0I0]-=,J<Y'>+:4(4 E)R<YZ_8:[XL!M]E+BEK225#
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M +GW=/&J&=)Y#>U)_:.9"?Y1XJ_V'O\ LJD\DJ!'":ZR2;LI%B*JH.#+@DZ
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M.ZJMVK[E-3NMC+^6 R@-G*B\+.LI"*4<>=C%C!<[#R)#06GN/123UP?%)_\
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M<QJ=3MMM-M"MDB'8^88UXU4T/"6RL*A:?#N&GIC4^0K*8C95MG'UU9W^KLK
MV;+1KSN.8V>@G9BC(5NR12YV4[7Y$I>G%W%R"2R GXE(Z0!!ZWY-G2!SY"T=
MJB-J^PQ;PRPY!D[WX-WM,@@S+)>[>ZJ+=K/- QB1 F-NLE6U*7V@U*:RP^TI
M5G:DL+^G+L_;7742F=K4JW7!D$1KI:Y;8?M]RBD][,N,M#@3DJ:<YC#F'6G$
MCB;&%CP9*4>'?Y%S_88^Z+JS'MYD\W'7R!<-G"4Y)(H)*0Z%W9(L *R3;<$$
MVJ).WP.!/K=1U>T)>N%,_2UMEZTXOWB)J=YRY^=HTGC7JRT/L/(NTYMIM=M9
MU5%:B;8J&-K2([2=FU03]+)SSJVUZ_AW^='TQPXMDFQ-IA>;GV.&&GKBTZTN
MWQ5N+3-<L#ZY&7U.[G%.K.[*2>F!GD)9GHU7<9\A[I:;9C6!QPN_H]SEIJ4F
M';*WC6[6M88^L75\8TM/1\21K77Z,@:2D#1<F[6;-7X\130NRU7V4;!QH.E=
M3W[4.A[1HIV9I74]PND^YR8VI#9+^[>8=CU1+4JXW>';TL6:6W,,Z6;?.D.L
M1Y1(*&K<N%J8\[\,O/\ 8K19]4W'4[<:_P!BAP(D%E^RBZ6A%MDW6PQTIAVZ
M3,4]<XRXPBQA+B,MNNQQD*<_FJ[C#;NLUUU*V'<8O)N8*(<2*R-@W;G26?K1
M[=1XJD=BZ%D=-1P90Y#,Q%J8H@+<12$FNBPN\-9%CLLBX7GC2[/?M-N>G.-7
MGRB%MN3'8;*Y*VUQ9!BJ0MY2U(5&)84D@LDME-=UW:UNS=;FS#MG#%$1JX36
MXJ%VS@TE:(R)+J6$J2^R'PI+02%!X!T$$.?3S6P\B)MZ?B")=TJ:NC9K*9"Q
M$\2D)VT7B1L(L+!D>E,GK)P]N,DZLS!F]C%E&;V#=JMD4TG+QJY8)F<NTU+T
MUDVSIOAS;I&E[IJ=AB?K+AQ);EW:_:JFW@P[QK?2T:5%>E:EG2+Y$C2H#JXT
MJU2%L-H;?DL/Q$*?D(7;&FE.7K6DUF^P+$Z[$TUK5A<:WVBP1;:)-MTM?GX[
M[;%DBLVJ0^Q+0EYBX,H=6I;3#K4A0:94GIC6<*Q97.5)BSY 5S?"V*=MPLHG
M.,@VBSPURM%<?1S%K1J,X1BV,G 2T=(-(DKJ0>N313=RG'G=.%7"C<RQA/K"
M^EX"M8+XI6N]7;49BV_BI-8@*MFIK]99<*)'TII1YJ!%G6BXPID>W)?F27U6
M]I]$-3[RWEL%T[JR=?I:=.(T%/MEOLO/F: C.RTSK':;G'DR'M0ZA:7+D1+C
M#E1GII9C1VA,<:5)2RTAM+H; 36&I8PBS9Q?4P;?EX:ZCBB*LZ;'\]>6.19I
MU;YB*6=^;^6'G!*9BT01!N*XMBB052I J8QQMAO0<!7%25IDZCXC^96N'T"^
MHB__ %0XA;A=']1W*WNR.T?VD[20J)':;Y)=+ *2L-AQ2E&<5JR6- ,7T631
M7G->L)5I5(_L'H[!@-66',0SR?,G)!$AUQ?-#?-(5L*R@!(S2]QZM"4P5!UV
M<MA6,CG"/921Y:WV:P2$G'NZ5?GJ\9)RLY*R$E(18NV;1P2->.EF22K5N=-
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"_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>g723949g02t00.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g02t00.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X5DH:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](EA-4"!#;W)E(#4N,2XR(CX*(#QR9&8Z4D1&('AM
M;&YS.G)D9CTB:'1T<#HO+W=W=RYW,RYO<F<O,3DY.2\P,B\R,BUR9&8M<WEN
M=&%X+6YS(R(^"B @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @
M('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ+R(*
M(" @('AM;&YS.GAM<#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+R(*
M(" @('AM;&YS.GAM<$=);6<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N
M,"]G+VEM9R\B"B @("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+VUM+R(*(" @('AM;&YS.G-T4F5F/2)H='1P.B\O;G,N861O
M8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @>&UL;G,Z
M<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C945V96YT(R(*(" @('AM;&YS.FEL;'5S=')A=&]R/2)H='1P.B\O;G,N
M861O8F4N8V]M+VEL;'5S=')A=&]R+S$N,"\B"B @("!X;6QN<SIX;7!44&<]
M(FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T+W!G+R(*(" @('AM;&YS
M.G-T1&EM/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1&EM
M96YS:6]N<R,B"B @("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+T9O;G0C(@H@(" @>&UL;G,Z>&UP1STB:'1T<#HO
M+VYS+F%D;V)E+F-O;2]X87 O,2XP+V<O(@H@(" @>&UL;G,Z<&1F/2)H='1P
M.B\O;G,N861O8F4N8V]M+W!D9B\Q+C,O(@H@(" @>&UL;G,Z17AT96YS:7-&
M;VYT4V5N<V4](FAT=' Z+R]W=W<N97AT96YS:7,N8V]M+VUE=&$O1F]N=%-E
M;G-E+R(*(" @9&,Z9F]R;6%T/2)A<'!L:6-A=&EO;B]P;W-T<V-R:7!T(@H@
M("!X;7 Z365T861A=&%$871E/2(R,#$Y+3 U+3(S5#$Y.C,V.C(V+3 W.C P
M(@H@("!X;7 Z36]D:69Y1&%T93TB,C Q.2TP-2TR,U0Q.3HS-CHR-BTP-SHP
M,"(*(" @>&UP.D-R96%T941A=&4](C(P,3DM,#4M,C-4,3DZ,S8Z,C4M,#<Z
M,# B"B @('AM<#I#<F5A=&]R5&]O;#TB061O8F4@26QL=7-T<F%T;W(@0U,V
M("A7:6YD;W=S*2(*(" @>&UP34TZ26YS=&%N8V5)1#TB>&UP+FEI9#I!,SA%
M-C Y-$,X-T1%.3$Q.# T14(W,#DU-#-!,C8Y,2(*(" @>&UP34TZ1&]C=6UE
M;G1)1#TB>&UP+F1I9#I!,SA%-C Y-$,X-T1%.3$Q.# T14(W,#DU-#-!,C8Y
M,2(*(" @>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$/2)U=6ED.C5$,C X.3(T
M.3-"1D1",3$Y,31!.#4Y,$0S,34P.$,X(@H@("!X;7!-33I296YD:71I;VY#
M;&%S<STB9&5F875L="(*(" @:6QL=7-T<F%T;W(Z4W1A<G1U<%!R;V9I;&4]
M(E!R:6YT(@H@("!X;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#TB1F%L<V4B
M"B @('AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/2)4<G5E(@H@("!X
M;7!44&<Z3E!A9V5S/2(Q(@H@("!P9&8Z4')O9'5C97(](D%D;V)E(%!$1B!L
M:6)R87)Y(#$U+C P(CX*(" @/&1C.G1I=&QE/@H@(" @/')D9CI!;'0^"B @
M(" @/')D9CIL:2!X;6PZ;&%N9STB>"UD969A=6QT(CY086=E(#DQ*W8R/"]R
M9&8Z;&D^"B @(" \+W)D9CI!;'0^"B @(#PO9&,Z=&ET;&4^"B @(#QD8SID
M97-C<FEP=&EO;CX*(" @(#QR9&8Z06QT/@H@(" @(#QR9&8Z;&D@>&UL.FQA
M;F<](G@M<F5P86ER(CY46%\Y,2YA:28C>$$[5&AU($UA>2 R,R R,#$Y(#$Y
M.C,V.C V($=-5"TP-S P)B-X03M38W)I<'0@=C(N-"XR+"!);&QU<W1R871O
M<B!V,38N,"XS)B-X03M'<F%P:&EC('1Y<&4Z($%R='=O<FLF(WA!.R8C>$$[
MXH"B(#0W($--64L@8FQA8VL@8VAA<F%C=&5R<R!C:&%N9V5D('1O(&=R87ES
M8V%L92XF(WA!.R8C>$$[5&AE(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N
M="!I;B!T:&4@9&]C=6UE;G0Z(%M497AT1F]N="!!<FEA;"U";VQD351=+"Q;
M5&5X=$9O;G0@07)I86Q-5%TL+%M497AT1F]N="!!<FEA;"U";VQD351=+"Q;
M5&5X=$9O;G0@07)I86Q-5%TF(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TF(WA!.SPO<F1F.FQI/@H@(" @/"]R9&8Z06QT/@H@(" \+V1C.F1E<V-R
M:7!T:6]N/@H@(" \>&UP.E1H=6UB;F%I;',^"B @(" \<F1F.D%L=#X*(" @
M(" \<F1F.FQI"B @(" @('AM<$=);6<Z=VED=&@](C(U-B(*(" @(" @>&UP
M1TEM9SIH96EG:'0](CDR(@H@(" @("!X;7!'26UG.F9O<FUA=#TB2E!%1R(*
M(" @(" @>&UP1TEM9SII;6%G93TB+SEJ+S1!05%3:UI*4F=!0D%G14%304))
M04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K;$Y!*S!!04%!04%"04%3
M04%!04%%028C>$$[05%"24%!04%!44%"+RLT041K1FMB,DIL04=404%!04%!
M9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G1T)G9TQ$06]+0W=O2R8C
M>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)15$5X=V)'>'-C2'@X9DAX
M.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F2'@X9B8C>$$[2'@X9DAX
M.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9DAX.&9(>#AF+SA!04519T%8045!07=%4B8C>$$[04%)4D%135)!9B]%06%)
M04%!04A!445"05%%04%!04%!04%!04%11D%W24=!44%(0T%K2T-W14%!9TE$
M05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"9V-)0U%O3$5!04-!44U$
M06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%614=%,D5I8UE%54UP1VA"
M>%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z4E1K<4MY63-00TY546YK
M-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3,%9T3E9+0G)Y-"]0128C
M>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B5S5V63-2,61N9#1E6' W
M9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM6B8C>$$[<6)N2C)E
M;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$0E%514)1645#04U$8E%%
M04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[;V)(=T9-2%(T4TY#1E9*
M:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G>&15:W=G2D-H9UI*:EI&
M1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT3515-5!2;&195U9P8EA&
M,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM
M2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F:W%/:W!A86YQ2VUQ<39Y
M=')Q*W8O84%!=T1!44%#15%-4D%$.$$Y531Q-T9867$W1EAZ3BM9;B]+8B8C
M>$$[-GHO>D5.*V]:=F1.+V1H-%1T5"]!0FEF=B]1>#-,,T%D:7)S5E)U:E=L
M<&0V<&(R.35.-D9T23%*2D]3<%19:T1K,W=R>4\Q5'-/*R8C>$$[47E3249H
M=3 X27IM0DDP1U-2*U-D1FYI868X051T=EIJ,59I*W%Y4$1026Y/4EEX5C0U
M1E)G=DEL:4(P1F-O.&51,C1B9&HO04-D:B8C>$$[279X04XK5WA0,D935'E:
M;S5I95(O34YQ;U)58FE/0EIU44IB:5!6-U4R0F]F141$-#AV-7!9:G,W2"]Q
M<V9S+U=X4G5023A34W1D:28C>$$[4E$P*U<K6D1Q>3%H43=&6%EQ.4$O2D@O
M04I43G8K65-8+VE36FAA-S90:3=R<T@K+U X0590-DAV96%H-T(R2W5X5C)+
M=D9V>G<O-28C>$$[4T=W+S5H0B]Y9&9/9#=8+T%,=V8Q9C!L-U0R82]U6F8Q
M=C!"-7IM<&5K6F,O;$111$1%63EB:45V<$E*:S52=E,T1SAQ3%9O+VA&5B8C
M>$$[5D]X4&-$<&U(5'=O97(K,3%!,2M7>F5-,64S4&PP-D@S;GDV3GDK4TY+
M9TEJ;#%U179)=D]&=UEW1U=O;U9$4V9&>D(K1W!55C<P,R8C>$$[>$]M:5 T
M:"M0>#5,2'1,2DQC67IT-R\Q9$]V3E(P>GEX;TXS<#=T4'%I5S$P3&U30EHR
M;&DY4&EJ4FA0,U9E6C5Q-W-'1&-F:#DX1R8C>$$[4$)!>#-L4G8Y6%0U+TIL
M;3%U5T4Y;UA(:$)Q:F98<GDR,D96938Y4$IU:'-Z4B\T:71X27!#9SA9+U1.
M5U9143-R5G K.'%D=6=/128C>$$[865(.#AF:C1O4&%/56(K1DPW8C8O=T)(
M>58Q.&QE6&MI5G!D9FAK9#0R:T%I84EC5T12<49)36AQ5S505&9T6#)Y6#5A
M04@Q:CA6-28C>$$[<T0R;&U*,GAN;C%V>CAV9#EY5V$S-5ET8E)23G K;U)8
M<U)M;&ID5EI+>$EK=G!X<WIC:%AN54=V140V37!Y-%)(-E1F4#<S2C R="8C
M>$$[;%!A8U1%,%!J=%HK4UEY*U1V3%IN:V%$6#148E)R2'A(2TYN9&IY5G%%
M=$=".&%B0VY1-6%D4$,Y<&EV>#=N1VHR:&UO6&I01G8S+R8C>$$[04QE;C)U
M;3AL*U@R=4I"0C5H9U-)=39W:50P>3%&;CE%8S)%:6EM-&%O2#)D-EEN5%%V
M85DO0G)V*U!U5U!A3V%H94DS,34O>F(W=B8C>$$[:#<P9S$W4V)F5$QM1TM#
M.6EV,&QH5U5Y=S!)5FE3<%$P6FA58V9(<%1-9DQJ15-+3G5W,'5C-5EK;4IJ
M4G)F-S!T>7!Y6#%F;F-0:R8C>$$[-W-69&ER<U99-60O;"\U3S%#-FUV8GI4
M56UU<#-:<%I3.&=,1W1+,$1!6F1(551!;T9W.&UG=WIK6E-I0U-O+SAQ=CAH
M+SA!5F]J+R8C>$$[04]$;"]W0V$X4#5R2C-S4#5-,"\X=T\O-59F-40O-G1%
M9CA!=V-V+T%$6&HK87ED-B]Y6G O-6=D+WEQ+W=!:"]W1%9O:B\T3U@O;28C
M>$$[=D@X,6LW,2]K>E0O04UW3R]W0U98*U$O*W)22"]W04A,+WI8:BMA>60V
M+WE:<"\U9V0O>7$O>4@O=T)7:5 X031/6"]!2G)X+TY:3R8C>$$[.68U33 O
M.$%-1'8K5E@K42]W1'$P4B\X2$PO>EAJ*V%Y9#8O>5IP+S5G9"]Y<2]Y2"\Q
M84DO.$%G-68K83AF>E=4=E@K5$Y0+TU$=B8C>$$[*U98*U$O.$%Q,%(O.$A,
M+T%-,30O;7-N978X04IM;B]!2F=D+W=!<78X:"\Y5VE0+V<U9BMA.&9Z5U1V
M6"M43E O341V*U98*U$O*R8C>$$[<E)(+T%-2$PO=T$Q-"]M<VYE=CAM868K
M645:<%!K=GEX;S$X=#-P;&=L=&-&5U%Y2WIK.%11:V9%>$AB27IZ5&M+2F)C
M3VIX67IC228C>$$[,%4Y>7!Y;EEQ-T9867%K,G-E52],,G1887HV<%IR8WEX
M4G%K8DUZ<E)E5$=N=W-V9DUF3G!C95$S25=83# K=GI945)J;'=G*S5!+R8C
M>$$[.'%Z.&IF.$%6<50O04E/6"]M=DMV-4]W9GIF=$QK9GEZ<78U-2M1+U4W
M+VQ79FMB+W$Q2B]W04A,+WI8:B]*,D0K8CEP6"M79%8O4"8C>$$[4'E(-FTO
M.$%L5VYK9B]Q,4HO=V-V+TYE4#AN65 U=C)L9C5:,5@X+S="*W!R+VQ79FMB
M+T%+=%-F.$A,+W=!,30O>61G+VTO858O;"8C>$$[;E9F>GHX:"MP,R]+<R])
M,R]6<50O9S5F*V$X9C5/=V9Z9G1++W=!<S9R*V5F:U Q3R\U5FXU1R\V=%-F
M.$A,+T%-,30O=T%N65 U=B8C>$$[,FQF-5HQ6#@X+TEF<60O>7)0>4XO=T)7
M<% X06<U9BMA.&8U3W=F>F9T2R]Y>G%V-34K42]5-R]!2E9N-4<O-G139CA(
M3"]Z6&HO2B8C>$$[,D0K8CEP6"M79%8O4%!Y2#9N9CAQ>CAJ9CE7<% K1&PO
M=T-A.&8U3W=F>F9T2R]Y>G%V-34K42]5-R]L5V9K8B]Q,4HO=T%(3"]Z6"8C
M>$$[:B]*,D0K8CEP6"M79%8O4%!Y2#9L<VXU82M2>$=X1VQ*54%K9DA,-&8V
M*U X;EE0-78R;&8U6C%8.#@O269Q6E1M839X,DMU>%8R2R8C>$$[<EEV<VXO
M5V(O:5)X5F1I<G-65U1Y<D9%6%DP-D%5,S-9,$A12'5C:D]80TQ30F%8='%6
M=VA93712555E;$8X2V)K54Q%8D-V,"M">"8C>$$[2&DU<TUG;$961W%+155/
M=$I4*WE#1%5#;2]8,RMJ2FU03FQ%9VM#*V%+9VU-9TY2>$DV:G8Q239F4FQC
M6E=Y:T%&5$I-6%EQ-T98628C>$$[<71B*SA4-F8Q67%U>%8R2W5X5C)+<6)%
M:5)Q9&5++W)/2U%H3&EA-'!S.4-01$-!,D%"0W1E,WDY2DLK>$$S=S!'>F=(
M8W545C=L9B8C>$$[='AQ=SEU=5!#9S1W<5-A+UIW,C=4,T%A2TY256MF1CDQ
M3GEF041R:4E%;6<Q>F=):7E24T@O>&XU948T=&\Q>G=M95 Q5D1!9VQA."8C
M>$$[9G,O8C=D94Y09DQF>753<G!W>G%S65!$939A9E@W37=I6DIK:VI90FM:
M1T1"9V1W4E$W-5)4;&E"2T5K,6ER8UE9-B\U5&10=4=3-"8C>$$[5W=9=3E1
M82LQ17166%919C)E27AO32]$1&IE86AV.$%V:'8P2$5D8V%#*T=/-5AG=F)S
M:C1Y<F4Y2V9Q3T%H9V-94FAL3'=V554K128C>$$[.2]B03!Y1DI0-6XX,%<K
M:E=J4W0X5%8T26<K,'IE07(P<#-/6D=$05IL,2MT,7-C36),>GE8.'I036I4
M8S1Z2$=L9&\V37<K:VLU<R8C>$$[4F]O53@W3'1R3F1I;6)E5&9015=U13)T
M>6=H=C!(2V<K>30W;&$O<7I",4]L-$YX>60S,F0R;4TO<$\P,E8U:4\R5WAF
M6E K<S,O128C>$$[:FER1%!.6&Y793%F-G9P-G,X:FMP1T5&6&-J<5(Q;V\Y
M<WES5T<Y>3-2:#-S3UAZ<C5Z:&M%-4UO441N>&182V-1858K26YB9DUN=R8C
M>$$[249N=WA:8F]0;7!T8W1J5G93;FE"3G=R2&MO-VAW1'14<FQ%<V9!9DIW
M<RM->%!K;D,R,%@Q;WIY:#5886\S86]'-3=%,3)'551X-R8C>$$[8F)*1V)A
M:4YN4VE5=VXP:%8Y=T9L<5%A9'EA:VMF33EV;W@T5'<Q,5EW-&5,939B4U,X
M.4I)-492:"]U,$E304)59G-N8RM!-UE-528C>$$[27=&8VEY>3-),T=Z1DYT
M3FY75S)O1'E-4DM-9"MO,S<K>'EV:71-45)S96E+>%I/>%8R2W)7+W9%*VXY
M5TMO5%9D4E-X="ME>&MB6B8C>$$[065M,U5N,D=!;6UV2E!H1'EJ5R]Z1S%/
M831:3$HO,V%M;G%T6&8S5E%104UP37DV:DQR6D4W26IY-RMA3W!7.3!K5W%5
M;717241/2R8C>$$[.&QR,S-*>&IK6EED9DE(,6-N<E55<V-S4U-X;FQ'-$1+
M=S=G-VI,,V-!,G-F*SAB+U98.5IX6D)+<FI69$]'<&I3>DUV,3EO=EA%1R8C
M>$$[.693<58U5G!4<7!Y5DYS4V]7,3=:,W%T3&%43$Y%<G1'6%$Q2$Y'2W-T
M9EDT=&=+-EI(.4HQ5&E'2S!8:TMR56IA=$XV65)Z5$EM="8C>$$[;4-E8TY$
M,6TK<S15<UE:8GDR;'0U3%,V4W9O5W%Q>&1*;E-.:W5,9T]Y<V91<%=-559J
M>4-Q1WI.1FQH14AI3E-V=5 T<2]S,D1R928C>$$[,$U5-5-"9TQJ5W="2'<K
M>C=E65(K;2M7-RLY;&<Q2%5J2F(S37I,9#-337-#:WE00UEJ1T954TUG:E)U
M04AQ1V=!<5A.5TTU86]21B8C>$$[4C,O2#10-TYN1V@R9$Q*3&EN-F0W4'ER
M-&)F,E=Y<4<Q:FEJ4D5"-&]!<3AI5TY"=#%/*UE&=3<U2E(U:S@P42M8-4Q5
M,TYR2DYB,R8C>$$[0WE&-4E3;DI'46]&2$)I=DQL>C9G-V)6-C5::GA'9DIN
M0TIK:4EF3DAL*UII<3-S84UO<697<D1T5VTS<4)A,%!7;E1V9T]+439+628C
M>$$[4U)*,7)24V=C86AB1D0P8C%O-E9P-#$Y>&ME0UAC>#14,TDK0U-.-4I&
M:EI8.49U16]59VQ(241C5S=G.%="*U)Y2D1#4UE$*S5F+R8C>$$[0494*W)!
M,%-E6&9M65IV<FQL>2]U*T0X9CEB:T]8.$TR,FHU1C5(='$K2U!D=6Q6=' Y
M;G$Y;EI7.6\Q;EHS:4%I-6MM95--<S-X8R8C>$$[4'1&,4Y64W!O3W!Y,E5Z
M06MM>4A&:&AJ;6A'365#375T,D\K=G5895AB5S8P-WIN8C)H6E=N=#4R:6-O
M87%305%A13!W6C5#5TEN>28C>$$[5&]S57-E<45E;TPR2#8S9F8X<TQF.&I)
M+W=#=6,S-'54*UEF;4AV4$1H+T\K=V]68G$X95,V:F%.;W5-1%!':$MT5FEZ
M-R]$9WA:6B8C>$$[4WDQ255/160S97EL:FE)06<S-FYM1C Q-2]I84))4%1*
M;&=-87)-6%9'5G5166-O>4=".7=C,VMA-%5N:VEH965A3E%S:D1A,C%V228C
M>$$[3'%";S)32C5#-U)!96@V,T9N3S,W;W%02'<S,T910C-954%T.&HR3C=P
M;FUY87IM035P8FMY9T@T5'I66%1F-E)K9%9/.&1X-7!M428C>$$[63<X;6(S
M.4-N1TAL33%32%)'-&UQ='5(2D9/=S<W*T=A.%IP.#1J:5!D9$]-4D%J:$IR
M>G$Q2TLW,4%636QM1'I*8F1W1'AO048Y="8C>$$[>E@S>6=:9%)Z-% Y:T<T
M=W<X:DEF22]F*U Q<518*W%2455I<S)9='12<$5(2W1"=E%,-%I41$YQ041,
M=WI)+S%G>FQI=S-82%$Y>"8C>$$[5$A3<FQH2TEP1D-'6F5154Y50C%P54%K
M0W119G=Z67I02G=91VI42$YD."ME661/=G(K1S,X=3-&-V)X<TDY4&U26D(V
M<DEP.5IJ4B8C>$$[6#)74VER,#5D<T%I,FMO3WHO33-Z15EP;'5F3$YX2F-X
M2C9W.4%4<6I2:TMW0RMP1EAN4G5M2&A2865E6%!/3W!A>'%J,E4R:#-';B8C
M>$$[<$9'>GDS13593'E5<79"87AR>4I,5D<O,F%(,D%)4T-Y6G8W>%!P+U9K
M57-3+TU!>2]5<"M&9CDU<$].4'!R*T=6>F-,5CAV9SAS."8C>$$[=2]O13-%
M:39W=C=K:5 P,W$T;U1+<78Y:B]I=&UB-DUP1F18531/0R]7=3%U1'DO1F)7
M,S9,;4TP<D5T2U=,8VQ"5E1X87%O2W%X228C>$$[,B]J<VUK-6\T=T)W;#9V
M-4QV=%)0;&EW0U=W=4%K45@Q0DMO-F1I1%5G9UEN2FM'=VA9.31$,$]I:$$T
M;SA5<5!U5$\T=G186&UY828C>$$[8GIE:6IH-GE$.6\K,E%N;GIG8EDW+WIG
M-6M-3TEN968K>$Q#+TY-9',O;E,S83DP;6$T:6%W:E@Q;V958FTO<7EK5S=B
M<D-14'1(;"8C>$$[.2]43FA%,DA(24A%:5!)44U79TY45&IP-V5T2U1A2W-I
M:7!)4'=I6FEF8G-+:D=:,C<R>D509VXQ=&13>D\V4&)35S1J<'AA46]E5B8C
M>$$[97<T<S)9,DA02V-I2E%L1W4K="]K4S5'5$=)9T530BMF-E%W<2\X07I,
M,7942')Q3VEY4GAL0W-%<$1+<E--5T-G2&5T4D@Y:C=69B8C>$$[05IL8TQI
M2$I84D58=FXW54Q3,3 K830P,'=V92]U941L>'AU0DLX9E=M-FXP=5%&2S!0
M6$=K;DEY2'EP<6PO<75J4EAL.48V1GEX8B8C>$$[;D-),VE!-&UG2$9M8VXW
M.$):>$YI,$8U,G-,<353>DU+*V]Y3S8K:GA5+S-T22M3.&UJ04MH:3-X2&]#
M2U9P4S=$24,R8T141TQ%-B8C>$$[5&,R-6MK5G!(149U.71*0DY*-E-V16]1
M<6MO;&-L*VQ/83E3=&542&IL,')"8D-3=G-,0V%*-3=3>313<D-I2F97>%IX
M2F-R>$5D,"8C>$$[63-::UI*0U5O<F,P5FUA<#1K35=:2&M4*T\U16EZ>GDK
M8EE70T<Q-'1&249K4FLY4&E1=T9#1$964U-U-4E*>D9N9#=T36EN;R]U6"8C
M>$$[+W="5357,'E38GI4-5=H,6DP35IQ<D$X-'!&1E-J9DQU1#-'6D=$3UE&
M,75U,%%Z4G U=&8K479-1FUK,'!J4U-#1E=K6C!*<GA1128C>$$[;C1303%A
M1'!M>4=R9UAN2F1K6F=E;$I&;TAL,U5F3E8W8E(R.7)+9$HY64QC,W=O:&IO
M2W8Q67%D:C16>4=F3TDK+W5B3D1O5&MQ9R8C>$$[94$X-4$Q5F9J*WEN,$AB
M44IB,C!6=6A*4T9&:E5S951%2TM#<%!5-UIP>3EC0E1C4W)U,4)Y<7<U9#9C
M:G1G;UAA8C)P9R]M=GEB8R8C>$$[>7E#-'-3>6Q#5VAK:G)Z:DHV<5%.*U!Y
M>DUX6F=/8F9'639S4&<P2'IJ16=T25I*63=C13!66DA7348O:%!W*SEF1$UG
M-6-F37-Y428C>$$[>F)Y-V]B-F%J5#-C>'5R*S5!13!R35=9<6EI:6<W+UI!
M-S=::E-Y0UDR-4],;FU224-U4V%25$DW8UEM*T972C1!:79&6#1G1VXR828C
M>$$[<W=*>6Y&449E+S=#=WI!:S)/6' K,&).5'I326=K0W59;#=R>%EM;W%!
M06%%1"MV9D1/5D=V>"M0>#=N1FDT:&8T.2\T+W1U,E9O,28C>$$[*W-C2%%4
M:S=U44MS=TMH5F]A,38Y0C<K3T=744559&U!9UEN8F1',DU13GIY6G=S<6=6
M:4)Q46]',V999D8S1E1L4FQV44]Z6D=14"8C>$$[4#9K:79D3"]!1$8O4V,W
M,D=P=WAA9DDX<G!'-%8S6&LS-W-$;D<Y048V:79B1'-N9$)*<#,U=G5)-%HY
M4G-H1U1796%-04]62V)O=B8C>$$[-V]5;R]2:'94,W@R6&1/4$IL=#5V='9R
M='8U9W50<D551$I(67EN:5AK1S=--T]!<&(W4W)U0C!0>G=';$1*1R]V12MN
M.5="2T0Q8B8C>$$[5%9V<F)H<TI&<55*-D=V54@R3T%I,G9*1&E$>6)7=GDW
M,5-#-&1R3TUM3FE326UQ0U!:5RMY=RMN2T1!=6YY-D]13WE8860U43%/9B8C
M>$$[549T2DE36F%K96ER2T=01F52,V-G1"]0,G=X9VI&<%IC5R].-B\U5S!1
M-EAP+S<P15AK.41C5DE)2$=O5E)X*TA92"LP-UIC03=N1B8C>$$[1&A#85 O
M94U0.&QF,6Y#,D)I;7572&TP*UEK=DY0;6E/;&TR5T8W95IN-').-FIL<%1%
M;RM,-%-O,EE:345->&1O1%1D2#AZ>#8T:R8C>$$[;'IE*W9P-G!C<DE':S5&
M=61Y.&M*-$MI0E=73FQ"25!S0FAT;4%B6D=&;V5/-5IA8DAW4&I407IT2V9-
M6&UJ>34U9'0T6G1C=D5T628C>$$[-6XT=T(Q85)I>41K5T-O<G129'9I26]$
M5&9C6D-E45(U="MN,'5436%G3'(U1#-K-T)F;R]M9GDY<D8Q3F)737I36$5!
M17I16$5%,28C>$$[=$IW-F5O<5A%8U1-07@V<E=L4EAQ35)-2%IC;6UY46E*
M4TAP2G$P,5)11D)O9'I89F)P:S-'44=T85ED4V=33GA726,K83@S445/:"8C
M>$$[46AU3$Q7;V,Y83 V.5)K;U,T4WII4C%34E!+5C$Y9F5::655<6Q%:U1G
M4D%N4#%+2UIJ22]W05I61D\U5W$Q-')79W0X555Y-&=R4"8C>$$[-6,Q2F19
M6%5"8U1E;4EP0DQA:#!%5'4U2E1I0E-N04]1,5(X6'=%;C1C:C1G<6QS2C5O
M,7),8E)Y<$U!2&QN:VM.2EI*5C1L=4MC9B8C>$$[55!W04EO2$)A2T0P1U%K
M8F%P1D]H+V-T+W%N.5=6=%5K4F=9=7A6:&5P95AF3G8V474R,#8T5U!4,V18
M:6=J=5AT9UDV2BLV5E5I8R8C>$$[4DU(5FUA445L<3 K57)24VYO;6=F;4A:
M-C-&3&0V=$AC-E8Y6FMM=4E89#-9>'5S<6]Q.&PR-#%5.%%1=E1B8F1*0S=S
M,FDK>68X028C>$$[5V(O:5)Y2U8R2W%.-49(3F)01DDO0DA&0S%A63=D54=(
M14M3<C9U,TU%8UA*0DAW9D5F:%!C9SDK;WEZ:6I)5GE99U1I8DET0S(T9"8C
M>$$[2'5#-V5U,TYG1G)X27%1>$)"2F]/6&9X0CA-1TE#>4(P+U,R-FE2-%%3
M2W8Y2$PX9#%D-DTY3GI$.$UF,E1887919U4S;TYQ:DI%*R8C>$$[<')I2VAD
M='=W6&,X>%-H:&I(17IU44MM9UE"44=$94EB-W9L;%=735I$:#9-65-L>$4X
M=G@P5%-#,VEG47!'=$%35UDY>7@V:VYU8R8C>$$[041-04)5=W!D:7)S5E=T
M+V5*.5 V<U9867$W1E=,*UEJ-7)J,5EY85!B:&]J845*27%11W-O.5%S2DAK
M6DA&4#-F<&=B1FEE5S)%528C>$$[:$DQ=F9Z85,Y8W@R;VYS;FMJ5T9:>&)2
M>4Q%1$-79'9486=D9WII;%-/<"M(:4]5=&MB=E%4+V5T+W%R*W,U0FM&2U5C
M;$E(9G)H6B8C>$$[:$-P0WEK:VYR5'AW:W1G2VMY151S1%AE:%5G9'9#=4AO
M:3-J6&Y32G!F4&UR<F-Z<G!Z5WDR5G=U<3-Q4T=+1%165D1+8DQI1U Q:R8C
M>$$[,TQ5:C1Q4#)W1T1D35-207E%>60V235:84]%8U X56E*06-Y9"\X064Q
M9G=36%).2$9R-6HP3V5Y,#=6=$QU5&9734U%36E/:4Q&5R8C>$$[85,X:%-.
M>6MN<$MK>$UK9VI+13AI4%1$.$%:1&-(<F9Y83E,2S1:22]W0U-J06EW2S1I
M3#139'5S<2MZ;65F;U!H.$HX2V(K27I*9"8C>$$[3F%396(T.5%B45IL<W)U
M3WIM6C0V6$5S=C%C535!.&9604Y/6%1B8RM)=VA"-4U2.'58;FTR1S9G=3<O
M048W5'!D3610,VEM8TAK3R8C>$$[3$U+96]I=6Y(:TLQ3F1T.71S:U=%4U(Q
M4D9P869M;F5W:FYQ=&A):&Q!;F$R6E%1=G=/2T]K97A)8F-D,7!G3DM/2C9(
M2$5246HS3B8C>$$[3S%4=C%Y3G-Y:71X0S106&EF,5E'<W$K0D1S5F1I<G-6
M5WAF6E X07).+WA)-'%O,VQN.6$T2S!R<$-+*W!':#0X-CEM4%=L2S=:0R8C
M>$$[8T]*='@U3T1P=CA!8S5D3S Y5F]T=$94<#EH9C99:DA(=54U<&YQ5VIP
M;6Y%1696670O.&A2+T1(=S0Y=UAX-2]W030O3E1I,&%W:"8C>$$[8WE7-DY$
M261U84\Q9DAO4U90,&I):D1%8FI:;$Q5>FM+;'5&-U$V9VEN,&)H2D14651*
M53$O,6]Y9W O<V-K4DQO54-51'I(>5 V-R8C>$$[*SE4:D=U1F=*1&)+=F1L
M16I(+V=35B]8:U)X.6%:2'=U;D8Y:30V66MR0G)Y4G)K9V=H1RM'3456-DE.
M=2\W5F-0:#-Z,U(T-4@P:B8C>$$[:"LO-2]Q<$=:63!/>%8R2W)7+W9%*VXY
M5TMR<U9D:7)S5F1I<7HO9')F-G$O<D]+<EA(9D9K0W-+;C5M;C!953)X=GIJ
M-7-T+TQN,28C>$$[27IW0V%/-VM:1$EZ1D)'14%,3G-K:$\S8D-!<&MX3%=0
M4#A!*UAM=#-&=$AF5TYZ33%M>G1(3VY+2V%-;&9J0TY"27)-:D)4>4%E:"8C
M>$$[-&I:='-%<U8X,C-"<EHT:51!."])2#=$86IP6&Y0.$%,+U1T5$9Z<$YH
M9'HV:&1G5S!L>%!).#!G:FI2<$%/8S!S>%93849G2U8V-R8C>$$[;&%9>'A!
M8G,X+V%'5$M"1U(Y239!040U0VU8-D(U,C O5TY59E,Q:&5'*U-%,TE5,%I$
M14A#16AH*S%Y8G!42D5/3TI+6#5J>6%,1B8C>$$[-6%B.4U7:VPW6G1-9T5%
M5&U.=61#5E!+<3=F1%0V8T5E87EQ;FXX9#$K56ML=D=V-DIN1G5O94-2=E5F
M;6=$=DMT87-#>DAI82\X028C>$$[06=S9'-N=3$K;$\O3%@U9V54=$I&='!D
M;$1E;$QX<$QK>7EX<4I#6E="1$5!,$LX43(O9W5W3F$T0T5X;4%Z-WDQ<C)N
M83EP=W8W1B8C>$$[6%=$;5EW2D%!95,P4%ET-#5!-TTW=$XS2#=L+SE5+W%W
M35-Q-&]D:7)S5F1I<3),-THO,6TO-&MC5EA9<3=&6%EQ-T9867$W1EA9<28C
M>$$[-T9867$W1E9R9C-I9E0K<D96,DMU>%8R2W5X5F%0-S%V.59F,6Y&6$9C
M571C359T6DIB4E-5.5)&9FE1>3AG1%%J=4LT<717>71L228C>$$[2WA)2T1I
M2TM"=%-L4'5W,G1Q8U=L,DU-<W-S5G9':VMX1%-U<4M#>%5C45-A9&AJ87%Q
M,G-3<UA61D1K54Q!04=G,W!81S%T93!+3R8C>$$[<%8Q1$ME<6M62#0T13)S
M3FYB-V9U:S)O4'-J;T159FEC55=T*V\R,4ME:VY%1&E">$9!4$1$83)S,#=3
M=% P,C%7,7-,94\Q=&Q*6B8C>$$[66]L0TM#>'%445EK<6E:4BLV9B]!1E0K
M<D%G<CA69&ER<U9D:7%!=4Q:5VU:<61C2TAN,2]Q2#5K86).9GI,<%-A:%II
M959R9EIE528C>$$[9'5J>3A+3$=1-T9K4D13:%!V5G%,3%I'-DA86&9Z4'5O
M-V4T=&9,>7!$2D<S34]&53%:;$M30DAK5F=1;&9H2C9N9D=G:F1'5T]R9B8C
M>$$[;4E:3&1,-U))659L;6AG3$5-4V95<GIK+V1U.4)'<3AM<E%B,#8Y6%I+
M4'5H-3%S8E,T93)T4#!R8TYE3VM%8VYO>#AB64M3:F9!628C>$$[+W1.<U-4
M565'1%I53' Q-2M9;D].<C-322M%,$4X:G%#=$EP56I,47!S=V%J=%)45W Y
M*RM(6E9K5W8V:'!5130Q>$PV5G)P;R]Q3B8C>$$[>$AA255J4UI"=S5C471'
M.5%K8U@S-F5/3DMV=4Y4+TU54TE,9E%96&I.;DA->G4Q1#E934A.-'%C>#!L
M*TA(6E8X,F\O;45S:U!$428C>$$[65=J945T3E)W4VMO=#%K<"]E0V\Y66Q+
M93-8975/>6]/-#%,.#!(;'1H1&]%8V%I8FQC9D9(4F]Q,$-B>4YX8GA92&)(
M6F0P,CAQ>B8C>$$[*V-R,CEK3W9A86UN,G=G57AO;D9G6E-14V$X;F)P6&)T
M9TY+1U@R8T-X=7A!;V%5>4M56&EL,DMU>%8R2V]3.&=%:G%32S!&355-3B8C
M>$$[,7E$>G1B-BMR-E5G=61+65%"-%A33&EP9C%&;6\Q56LK1&=J9&8R<VM+
M46=Z9F9M2$)P8T1284],>39A3FUF,794:69L-B]%2S13428C>$$[2T-)=#EH
M=CE'-3)64W-R+T%0339,5')N-GIO:U4Y-&E+,7%3>4M(6G!Y:%9W<F=#:V9X
M8F9X<&IS=39.:'9F>D)A935J:S!/,U=.4"8C>$$[4RMR>3AX4F<X;$AQ3V8W
M2V8U-S1.;%%-3W-F;6,P2F58>3-%:VER>4U96E<U9D5&;T0V=V]D-C!P,CDY
M:G-U-FI.9B]!2G)1:39T-"8C>$$[.4=J;BM&>F(S=C=S37).5&=/2'%"5S0Q
M<"M086AD:V)P>&,S2&YE4%=O-#0Y2VIK,#0S4W=/-%I34'%Z3E4S02M)34=6
M3FEP-VHS1R8C>$$[1%I+0FY0-6E#26Q,5U0Q9C-U>7@R<%@Q4G@T2T-:2RMH
M>#5&5W!Z<C%W-TMT:6LO339+,6M%,FYX>E11=TU9:7!I1%-Z<F-Q2TXP528C
M>$$[07=6;U%"-#EC9&Q2=6@S6&YY6%=H8C9T<$553VY--V-R;$-V=W%S5WA&
M2D=/.&\V169T9&1S0G!76$QA3'E(=VIR9U-M5T),<U9D:28C>$$[<G-69%%9
M<3A6,6UA,3 Y-W564$]S=VQI=EI5:G1O66)J-$=:,CE31E%R<6]0-W=6,S=%
M-5E08WA8=F5736I8;6]7,VYE87EF56]O-28C>$$[1E9R96-/:6U14'E+06M,
M=7)G8V1T+T$T+T)55E!*-C@Q-6574&Y+8V%96C-D,6=I=4MX=&1C<$5,175O
M-')W<4)'3G@K>G9U4&=Q+R8C>$$[4G16<TEV<D-4*V4U8FU7-6E%3F<U:G5!
M235I>7-S:D)Y5F)O1C0W5E@O5WA0=59"5T]P-DA&.68P<5AZ8S$Y6EA#>'HR
M,S%I1U9R9"8C>$$[0D1.>EI*:4=6:4IQ,%EI9V%V53E-4'=7,E-T*U8Y-THV
M3&9P54(T2FQU235L:&M74C)$1F=*0S!R-TM'-$IX;U%O1S5/4C1K,')4928C
M>$$[45!.9C%E>'0W9GI88U)2,C=Z=&-U15I8;44P-6PK2FQC9D92:4LO9&IX
M0D9+1C4K5W9M2S4Y9#(X=W5,:656,DTO0U1L-E1O5315.28C>$$[4VXR5%-N
M5#)X-&LP=F<O3#=Z8VPU6GI496%:2C1B3V1*;&E:2D)Y5E%Y37123'0V:75A
M*T9A1&)(:4-+96=52&AK5U1Q1$9867$W1B8C>$$[6%EQ-T9854=+<TDQ:GE*
M-6AU9&5V.54P-WI"2G V6'9!0T)69'5)5S--4C,U:CEU:G)3;$0X:&MG555H
M9CA"965M9VIJ9GIF34AJ5R8C>$$[64TV231,;5%F0E=S:"MW,V9W>'-D>4M+
M274O2DAN3V952G)H4$YK,$54>'AR2$-K8D)6:U)%4FXT*W!4-'%/,5!%-#)%
M,%5,8V9L<B8C>$$[-6AN:'1O1#5H9$EO<F4T:&11:FUR,T)L671V2E4W>4QY
M-59*0S!R43!W.%,P:2\X1"MB,6IV:TAM>31C,TYU<TYV27E(;$4V>DLU:R8C
M>$$[1DA'-6I8:'14<F=S3%-6>"]L=#4R<R]R16QN-7!K4'%E=$M,5VMK4TY.
M241W<31D:4%'-"M05$1X0D9&1S(O:U!Z52MK,T5%,G5',R8C>$$[=3=Q1T5K
M<#9K;VEU;S4P;6%537IR>4Y)*TYA5C,V-UE,0V%50BM79FUI4%8U.5%G.#!3
M;TQK47!C3'AK1'5K35IJ6&LT;$)*05EK928C>$$[*RM(:4-+5C5V>2LX-$YB
M;VM8;2LV:FU727$X;C=W:'!#46564%4R,C5$,G%01$)X0F%+2'0O>3(X-%%2
M=7%E8DI5858R:VUD161#>B8C>$$[35)V55-D+W=P='-4:#1G=%!226\R4TI&
M9'959%9!6C95-45$8S Y.&=Y6#1Q-T9867$W1EA9<7<V."\U5E0V8R]W0F(O
M4EA$-G<O,28C>$$[:FXV6"LY1R]/=&8R*W53,U)S<#(S+TMO=C,O,68Y155O
M4%<T96I3;DE5-F1U6&AJ=75Y4'-0.$%L6&XQ2V(V:BMJ=G%F<D0Q+U0Y3"8C
M>$$[:#8Q1S0X<69T8V$X9F)P=&<S6%I"4#A!.'%L.40T+S!2-E!A=F\P+W4P
M<%0O66-+9E)41'5U>4AM+S561C98-W8Y2%9R1B]V3'<Y6"8C>$$[:#9I.&8W
M=C0O5'(Y<G14<FIU=7I/.&EL,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+
M=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2R8C>$$[=B\O6B(O/@H@(" @/"]R
M9&8Z06QT/@H@(" \+WAM<#I4:'5M8FYA:6QS/@H@(" \>&UP34TZ1&5R:79E
M9$9R;VT*(" @('-T4F5F.FEN<W1A;F-E240](GAM<"YI:60Z03(X138P.31#
M.#=$13DQ,3@P-$5"-S Y-30S03(V.3$B"B @("!S=%)E9CID;V-U;65N=$E$
M/2)X;7 N9&ED.D$R.$4V,#DT0S@W1$4Y,3$X,#1%0C<P.34T,T$R-CDQ(@H@
M(" @<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/2)U=6ED.C5$,C X.3(T.3-"
M1D1",3$Y,31!.#4Y,$0S,34P.$,X(@H@(" @<W12968Z<F5N9&ET:6]N0VQA
M<W,](F1E9F%U;'0B+SX*(" @/'AM<$U-.DAI<W1O<GD^"B @(" \<F1F.E-E
M<3X*(" @(" \<F1F.FQI"B @(" @('-T179T.F%C=&EO;CTB<V%V960B"B @
M(" @('-T179T.FEN<W1A;F-E240](GAM<"YI:60Z8S5C8S%B-SDM8S-D82TT
M93=B+6$P93DM-#DS,#DS,S4U-34V(@H@(" @("!S=$5V=#IW:&5N/2(R,#$Y
M+3 U+3$U5#$V.C$Y.C0W+3 W.C P(@H@(" @("!S=$5V=#IS;V9T=V%R94%G
M96YT/2)!9&]B92!);&QU<W1R871O<B!#0R R,RXP("A-86-I;G1O<V@I(@H@
M(" @("!S=$5V=#IC:&%N9V5D/2(O(B\^"B @(" @/')D9CIL:0H@(" @("!S
M=$5V=#IA8W1I;VX](G-A=F5D(@H@(" @("!S=$5V=#II;G-T86YC94E$/2)X
M;7 N:6ED.D$S.$4V,#DT0S@W1$4Y,3$X,#1%0C<P.34T,T$R-CDQ(@H@(" @
M("!S=$5V=#IW:&5N/2(R,#$Y+3 U+3(S5#$Y.C,V.C(V+3 W.C P(@H@(" @
M("!S=$5V=#IS;V9T=V%R94%G96YT/2)!9&]B92!);&QU<W1R871O<B!#4S8@
M*%=I;F1O=W,I(@H@(" @("!S=$5V=#IC:&%N9V5D/2(O(B\^"B @(" \+W)D
M9CI397$^"B @(#PO>&UP34TZ2&ES=&]R>3X*(" @/'AM<$U-.DEN9W)E9&EE
M;G1S/@H@(" @/')D9CI"86<^"B @(" @/')D9CIL:0H@(" @("!S=%)E9CIF
M:6QE4&%T:#TB+U5S97)S+TAA8F5E8F%(+T1O=VYL;V%D<R]205!47U,Q+U!A
M9V4@.3%?1F]L9&5R+TQI;FMS+W-K:6X@=&AI8VME;FEN9RYP;F<B"B @(" @
M('-T4F5F.F1O8W5M96YT240](C B"B @(" @('-T4F5F.FEN<W1A;F-E240]
M(C B+SX*(" @(" \<F1F.FQI"B @(" @('-T4F5F.F9I;&50871H/2(O57-E
M<G,O2&%B965B84@O1&]W;FQO861S+U)!4%1?4S$O4&%G92 Y,5]&;VQD97(O
M3&EN:W,O2&EG:"!)9T4N<&YG(@H@(" @("!S=%)E9CID;V-U;65N=$E$/2(P
M(@H@(" @("!S=%)E9CII;G-T86YC94E$/2(P(B\^"B @(" @/')D9CIL:0H@
M(" @("!S=%)E9CIF:6QE4&%T:#TB+U5S97)S+TAA8F5E8F%(+T1O=VYL;V%D
M<R]205!47U,Q+U!A9V4@.3%?1F]L9&5R+TQI;FMS+V5O<VEN;W!H:6QI82YP
M;F<B"B @(" @('-T4F5F.F1O8W5M96YT240](C B"B @(" @('-T4F5F.FEN
M<W1A;F-E240](C B+SX*(" @(" \<F1F.FQI"B @(" @('-T4F5F.F9I;&50
M871H/2(O57-E<G,O2&%B965B84@O1&]W;FQO861S+U)!4%1?4S$O4&%G92 Y
M,5]&;VQD97(O3&EN:W,O0V5L;&=R;W5P:6YG+G1I9B(*(" @(" @<W12968Z
M9&]C=6UE;G1)1#TB861O8F4Z9&]C:60Z<&AO=&]S:&]P.C!D.3,W-C,Q+30W
M,F8M,34T-2TY8C(T+6(Y,V8P8C$T831E92(*(" @(" @<W12968Z:6YS=&%N
M8V5)1#TB>&UP+FEI9#IF93=B-F)A-BUA86-C+30Q-3<M.&$W.2UB.3)A8SDY
M-C-F.# B+SX*(" @(" \<F1F.FQI"B @(" @('-T4F5F.F9I;&50871H/2(O
M57-E<G,O2&%B965B84@O1&]W;FQO861S+U)!4%1?4S$O4&%G92 Y,5]&;VQD
M97(O3&EN:W,O8F%C:V=R;W5N9'-K:6Y?;F5W+G1I9B(*(" @(" @<W12968Z
M9&]C=6UE;G1)1#TB861O8F4Z9&]C:60Z<&AO=&]S:&]P.F9F9#1E9#,W+34P
M-64M,3$T."UB,F5D+3,V-#(U9#4V,C<V8B(*(" @(" @<W12968Z:6YS=&%N
M8V5)1#TB>&UP+FEI9#ID-64U93<X,2UA.&4P+30U-C8M868W."TS,S,W,#(S
M.&,Y934B+SX*(" @(#PO<F1F.D)A9SX*(" @/"]X;7!-33I);F=R961I96YT
M<SX*(" @/'AM<%109SI-87A086=E4VEZ90H@(" @<W1$:6TZ=STB-SDR+C P
M,# P,"(*(" @('-T1&EM.F@](C8Q,BXP,# P,# B"B @("!S=$1I;3IU;FET
M/2)0;VEN=',B+SX*(" @/'AM<%109SI&;VYT<SX*(" @(#QR9&8Z0F%G/@H@
M(" @(#QR9&8Z;&D*(" @(" @<W1&;G0Z9F]N=$YA;64](D%R:6%L350B"B @
M(" @('-T1FYT.F9O;G1&86UI;'D](D%R:6%L(@H@(" @("!S=$9N=#IF;VYT
M1F%C93TB4F5G=6QA<B(*(" @(" @<W1&;G0Z9F]N=%1Y<&4](D]P96X@5'EP
M92(*(" @(" @<W1&;G0Z=F5R<VEO;E-T<FEN9STB5F5R<VEO;B U+C(P(@H@
M(" @("!S=$9N=#IC;VUP;W-I=&4](D9A;'-E(@H@(" @("!S=$9N=#IF;VYT
M1FEL94YA;64](F%R:6%L+G1T9B(O/@H@(" @(#QR9&8Z;&D*(" @(" @<W1&
M;G0Z9F]N=$YA;64](D%R:6%L+4)O;&1-5"(*(" @(" @<W1&;G0Z9F]N=$9A
M;6EL>3TB07)I86PB"B @(" @('-T1FYT.F9O;G1&86-E/2)";VQD(@H@(" @
M("!S=$9N=#IF;VYT5'EP93TB3W!E;B!4>7!E(@H@(" @("!S=$9N=#IV97)S
M:6]N4W1R:6YG/2)697)S:6]N(#4N,C B"B @(" @('-T1FYT.F-O;7!O<VET
M93TB1F%L<V4B"B @(" @('-T1FYT.F9O;G1&:6QE3F%M93TB87)I86QB9"YT
M=&8B+SX*(" @(#PO<F1F.D)A9SX*(" @/"]X;7!44&<Z1F]N=',^"B @(#QX
M;7!44&<Z4&QA=&5.86UE<SX*(" @(#QR9&8Z4V5Q/@H@(" @(#QR9&8Z;&D^
M0WEA;CPO<F1F.FQI/@H@(" @(#QR9&8Z;&D^36%G96YT83PO<F1F.FQI/@H@
M(" @(#QR9&8Z;&D^665L;&]W/"]R9&8Z;&D^"B @(" @/')D9CIL:3Y";&%C
M:SPO<F1F.FQI/@H@(" @/"]R9&8Z4V5Q/@H@(" \+WAM<%109SI0;&%T94YA
M;65S/@H@(" \>&UP5%!G.E-W871C:$=R;W5P<SX*(" @(#QR9&8Z4V5Q/@H@
M(" @(#QR9&8Z;&D*(" @(" @>&UP1SIG<F]U<$YA;64](D1E9F%U;'0@4W=A
M=&-H($=R;W5P(@H@(" @("!X;7!'.F=R;W5P5'EP93TB,"(O/@H@(" @/"]R
M9&8Z4V5Q/@H@(" \+WAM<%109SI3=V%T8VA'<F]U<',^"B @(#Q%>'1E;G-I
M<T9O;G1396YS93IS;'5G/@H@(" @/')D9CI"86<^"B @(" @/')D9CIL:0H@
M(" @("!%>'1E;G-I<T9O;G1396YS93I&;VYT2VEN9#TB3W!E;E1Y<&4@+2!4
M5"(*(" @(" @17AT96YS:7-&;VYT4V5N<V4Z1F%M:6QY/2)!<FEA;"(*(" @
M(" @17AT96YS:7-&;VYT4V5N<V4Z3W5T;&EN949I;&53:7IE/2(P(@H@(" @
M("!%>'1E;G-I<T9O;G1396YS93I&;W5N9')Y/2)-;VYO='EP92!4>7!O9W)A
M<&AY(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I697)S:6]N/2(U+C(P(@H@
M(" @("!%>'1E;G-I<T9O;G1396YS93I+97)N:6YG0VAE8VMS=6T](C B"B @
M(" @($5X=&5N<VES1F]N=%-E;G-E.D9O;G1396YS95\Q+C)?0VAE8VMS=6T]
M(C,V,S8Q-SDW-S0B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D-H96-K<W5M
M/2(S-C,V,3<Y-S<T(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I0;W-T4V-R
M:7!T3F%M93TB07)I86PM0F]L9$U4(B\^"B @(" @/')D9CIL:0H@(" @("!%
M>'1E;G-I<T9O;G1396YS93I&;VYT2VEN9#TB3W!E;E1Y<&4@+2!45"(*(" @
M(" @17AT96YS:7-&;VYT4V5N<V4Z1F%M:6QY/2)!<FEA;"(*(" @(" @17AT
M96YS:7-&;VYT4V5N<V4Z3W5T;&EN949I;&53:7IE/2(P(@H@(" @("!%>'1E
M;G-I<T9O;G1396YS93I&;W5N9')Y/2)-;VYO='EP92!4>7!O9W)A<&AY(@H@
M(" @("!%>'1E;G-I<T9O;G1396YS93I697)S:6]N/2(U+C(P(@H@(" @("!%
M>'1E;G-I<T9O;G1396YS93I+97)N:6YG0VAE8VMS=6T](C B"B @(" @($5X
M=&5N<VES1F]N=%-E;G-E.D9O;G1396YS95\Q+C)?0VAE8VMS=6T](C(S-38S
M-#,T.38B"B @(" @($5X=&5N<VES1F]N=%-E;G-E.D-H96-K<W5M/2(R,S4V
M,S0S-#DV(@H@(" @("!%>'1E;G-I<T9O;G1396YS93I0;W-T4V-R:7!T3F%M
M93TB07)I86Q-5"(O/@H@(" @/"]R9&8Z0F%G/@H@(" \+T5X=&5N<VES1F]N
M=%-E;G-E.G-L=6<^"B @/"]R9&8Z1&5S8W)I<'1I;VX^"B \+W)D9CI21$8^
M"CPO>#IX;7!M971A/@H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,  0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_  !$( -@"8 ,!
M$0 "$0$#$0'_Q  ?  $  @(# 0$! 0          !08$!P,("0(!"@O_Q !@
M$  !! $# P$$ @H-" 8'!0D# 0($!08 !Q$($A,A%!4B,1=!%B,R455A=96T
MU0D8)#0U-EAQ@9>AL]8E,T)%4G.1T4-78I:QM28X<G2BP<5$>(6W\51C9822
ME-+A\/_$ !X! 0 !!0$! 0$            " 0,$!08'" D*_\0 8!$  @$"
M! 0"!@4&"@4(! T% 0(#!!$ !1(A!A,B,4%1!Q0R87&Q(T*!D:$5%A=B<M$(
M,U)65Y66P=7P)$/3U.$F-%-S@I*R\49CHK,E)S8W161T=7:#D[2UTD1FPL3_
MV@ , P$  A$#$0 _ /[^-,,-,,-,,-,,-,,-,,-,,-,,-,,1-_\ P%=?DFQ_
M0S:N0_QL7_6)_P"(8Q:[_F59_P#9:C_W3X_S==?=F/P)PTPPTPPTPPTPPTPP
MTPPTPPTPPTPPTPQ?9.U6Z$/#8^XTS;?/8FWLMPVQ<[DX?D(,-DN,7P!;'R<M
M<VD,XIE0(T'.<KR_:V\O]-8:YCE[51H5KZ-JU;EJ-:J U2V&HWIP_.%AN;IL
M-SMC=2<-<1PY2F?2Y!G461R%1'G4F55R93(7;0@3,6@%&Q=SH4+,=3=(N=L4
M+69C2X:88:88:88:88:88:88:88:88:88:88:88:88:88:88_P! 3HH_]3GI
M3_\ NY[+?_ESCFOB_BS_ .5'$?\ ]^9K_P#OI\?M[Z(__FJ]&O\ ^ N$?_X"
M@QV<US^/0\-,,-,,-,,-,,-,,-,,-,,-,,-,,?SS?LZ_\(],7_N6\']_MGKY
M/_A-_P ;P7_U?$'_ (LFQ^AW\!'_ )OZ3_\ KN#O_!Q/CP U\KX_0+#3##3#
M$M14%[E%K$H<9I;;(KRP<5D"FHJZ9;VLUX0%DF;$KJ\,B9)<*,$T@K0A>HP"
M*5R(,;G)?I:6JK9XZ6CIIZNIE+"*GI89)YY"JL[".&)7D<JBL[:5-E5F.P)Q
MB5^84&5TDU?F=;29=0TX4U%;7U,-)20!W6)#-45#QPQ!Y'2-2[J&=U079@#A
M+"F-D'B.B26RHOM/M490%21&]C:1TSSA5GD#[*T172?(UO@:,BE[48[BWRI
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MG_\ =SV6_P#RZQW7Q?Q9_P#*CB/_ ._,U_\ WT^/V]]$?_S5>C7_ / 7"/\
M_ 4&.SFN?QZ'AIAAIAAIAAIAAIAAIAAIAAIAAIAC^>;]G7_A'IB_]RW@_O\
M;/7R?_";_C>"_P#J^(/_ !9-C]#OX"/_ #?TG_\ 7<'?^#B?'@!KY7Q^@6&F
M&&F&/4#]CZI8.W6,;S=45WG.'[7SL;K0[.;.9KGT.XG8Y#W2SN(6?<SQQJ"H
MO+6398]@L"=XXX:XX2LR)/:NR,TQA>U>BBFCRBBXBXUJ<SR_)9*2)>'N'\QS
M5*B2DCSO,T,U1*J4L%3,\U)ED4FE%B8,*OKL@9E^7?X0E;/Q'F?!GHMHLBSC
MBB#,ZA^,N,LEX?FHX,RFX5R&9*>CIVDKZNAI8J7,L^J( TKU".C9:>5JE*(_
M<L>"8Y1;U]8^7;98!C6\>(=2/2'>;X;9 KHF6V8KT]AF&/UV?8711:2516YX
M=CF,V;:6->"OA9#!BQL:B =5#)919_H@RNDI>(_2#F&3951\09?Q?P#4\29,
ML*5\RU32U]+%FN74L=*]+4-'-F$CS31K%'51(E&JF!3-'+XTV?9C7\$^AK*.
M)^(,SX-SCT;>E^AX&XGDJ9LHI6H$I\GS"HX?SJOEKHJ^DCFI\F@@I*>IDJ)L
MNJ)9<TED%6RTTM/I<O3+M$S;E]0[9../:EO1ZS>T?6%[WR[VLF\+\>;:MI_>
M:W*X Z"3)7)A*;7-I/LFY5)33^\%25KG&X,R 908#PVHR,>C\<1CT@>L5VLY
M^:03BGYWK'Y*Y;5A_)PR7U?US<,'YEGQVB^D[B\\1BK'&[MQ6?3&>!V]#HH\
MGY*\'#,32FL]6]2_.'GKEJ_EP\5&M_)8%XC'ZM>+$WF73%M7%P?)XLGITAXG
M@,7H<H-\X748.TSOV@.]H</IIT/'1V<[()&$.#DEN;V"3@:5"W\T]HZUAG%%
M-5BAY.8<&9(F65J/PC'0Y4GHUI.)8^+Q-F>I>(UH*:2.D6:2K?+2M94-RGRP
M4XJY6G,Z,(S"(\+)O2?Q5+GN5RQ^D:;-L_E].>8<"S^CAJ7(.6_!#YQ6P39B
MU+3Y='GH?+:-/6(L_-9^3X$I!23(\J59FSLYV-P]^2[X9AC.S4CJ/W-PG!.D
M6)BVU&27FY&7.!09[@%:_,<P=75&4!S&^9$.&+4UPA6KJ3#A2FRW0&0!10!N
MYGPU0-6<2YA1\.MQ?G6797P%'19'65.;UY2ES3*X3F%?R:>M7,*D(RI!"%G-
M/EX?F<I8U118R/CK.!EG N3YGQG'Z-^&,\SWTO39KQ9EM#PUDXDK\@XAJAD^
M3BIK,JDR;+VF1Y:NI=J05V<O$814-4/,[]/]A<93#?V2?;C%TP@>VWN7?JMA
MK@ <T@[ACPYR2E(_'6YG7N?'O?=3GK$60][Y@%&L.R>^QC2G+P'"]%^3O3%E
M%%^35R?U;B>*/\E+F,6;+EY#$FD&8Q$I5<DG1K),BVY<Q,J.<>P\>YG^6?X-
M?$F:?EMN)?7> :J8<0/DD_#C9R##I7,CDM2%DH/6PHF$8587#":F5::2(#MM
M*QG=9VT/5%C/65:Y]CFWF;;Z[,4^R\O=JRL7V5=:S-WI0\LO]MQ96:1)@U]5
MME)L)EQ*A"%4/IFN&GEX.QO>246>'(>-J+TA3YI293F7$_#U/PX^>S2F:*:3
M/W%;4Y0*YF>*&#)VD>H>-5I_5QV8!@/(XLSX4'&'HMS3T,TF09EQ%DG G&E9
MQK#PE34ZTU320\(1-E.7\2ME*1Q3U%7Q/'30T44[M5K6D,=%XV-MW$Z4>GJO
MW4VIQ8NS,C$X"=7&-;25KX]%NA08_N-M=*B3'385_>9GE,[[+LA(V/ NXN<X
M$E933*^PF0E3RBBD'G9MP-PG%G>1T1X>:AB''E'D,.BESJEI<WR5TD,L554Y
MC6R_E"J(2*I3,\L$-/)%*\?M!"-3PYZ6/2'4<*<69LG&D>;U'Z(LSXNJA)7<
M+9AF'#?%,4L*P39?0Y+E4 RC+E,E10S9%GYJJV&IIX9P0CRHVC:"GZ>9^,;H
M9\G3'MPJ8/U/;6;$XU02L@W+/6?8Q;3\NK[:[NU%FT:7;Y+8UD:.XQGR053+
MB)!LF5?@%(KIG-TM/PE+1YUF8X+R>V7<:Y)PO1TLE5G#P^ISRU\4]34%<PCD
MGK)H54L2ZP">.*40:%:)^XS"M](D&:<+\/\ Z3^(Q^7/1=Q3QYF>80Y=PQ'5
M?E2D@RBHI**AU9'+%1Y93U4L@1%C>K-%-/3&KYC1U,-NSWILV6RNQR;"=N]F
M,/QFWVYZ\<.V!HSFSC.JYN;87D%5?V%K59YD%G<9(8"RK*J:V'9XY41[:MK7
M K:F++L/(6QSLTX.X<KYJW+LIX=R^BGR?TFY?PO3,V9YG",RRZJAJI9X,TJY
MIZMDUS0@1S4D"5$,.B&!));M+JN'_25QKE--EN><1<:9QFE)Q'Z!<Y](-=&F
M19#4G),ZRZKR^GI*K(<OI:/+$D$5-6%IJ7,ZR2CJ:D/4U<L--I2F[)[:[.[8
M;<[[])^9TFR^/8GE669?U+;=V<6-B^ZN&4[FXKMS.L\6M*?'=P\NM;Z7:M<*
MQH8F23HU2/)H=M83P8W$E1Z29"[#)^'\ERCB?@7,:;AVDH*ZNS#C'*)D2ASO
M+J?_ $+*)9Z&:"DS6NGJ9)QHFI8ZV1*<5L<\LJTB,M-)'YIQ+QEQ/Q'P'Z6<
MFKN-<QS;*LIRCT9\14LTF:<*9U6 YMQ'!39K2UF8\.Y/24$5)9Z:OERRGEJV
MRR:DIX'S*6*2NAGUMTT4L"@R/HOEV&US:G*,S!^R*U,G;>YG[B$@X%=T)WS(
M>,8GB5[DTF3CEA CPYV$S(I!/N)\"=+-=DG91$K[F#I^#::*EK/1W)+DHIZW
M,%]+<+Y142YL8\KJ:60O'1T%!4UCO22Q)'+ELD>DU$L4LC5!EK4BJ(ND])M;
M/F&6^FF&GXI-7E62R?P<ZR/B6BI^'%GSZAS"-89LTS?-Z#*XX\RIYY)J?.X)
M5=:.GJ((4H5@RJ6HHI]=[?[1;?Y-CG2BFXNT.5SB3MO^M*ZL=NH(=P\OJMNL
MHQ;?.76UBEVDD9_19988]A(W285S@V%V<'+;^<&/+N66]@"QENU.4Y#E5;1\
M"_E;A^NE,F5>D6IERB)<UKX,HK*+B9X8=61/FM-7S4F6@O%49;ETT=?52JCU
M GE65\=%Q!Q?Q!EF9>E@\.<8933K!Q!Z%:*FXBG?AW)ZOB/*\UX%AJ:H+Q='
MP_7913YCG;".>BSW.J6?*,O@>2*B-'3O31#IWUC].-K@NY5S/P/":6-A,':S
M;_<R_P#L&K\\JZG&*K+Y9\?B6>2XGN4>5F>W%A>W<3S)A=W.L35 [&O&.6YD
MEH@^?>D'A"?+<XJ)<KRVG3+8LCRK.:K\FQ9G!!105[M2)-64.<,^8Y3+4U,>
MO\GU,DS0+-$!(0]E]C]#?I'I<^X:HX,^SNMDSN?BKB'AG+QGM3D%55YG59/#
M'F,U+EF;<,I%DO$M-04,V@YW0T],E8U-4,T*M$6?;G['U4P=LL-WDZI+K.\-
MVOLZD4'9;9O,=P(=U.QL&XV7";>93*9&QZHN[8UE2X'6G#&8"O,%S<B(DIP0
MH\K-]Z*8(LFR[B'C:HS/+LEF@6+ASA[,,VCJ)*-<VKU%37.$I8*F=IJ?*X7"
M!8F4^M$.56[#D?X0=7/Q/G/!OHMHLASGBBEJWGXUXSR;AZ:B@S.3AS*'-#E4
M1ES"LHJ1*6NS^IC:4R5".#ERF(.Y"-V1M.G79BQZF=Z-P/L)=N1MENUMKC>^
M>S^4TV%YINE@N+FSK*0P\RFWFV6 Y/@>X^3019 .\K80*%AB89%LZZROZ$3&
M1V#[";A'AV7C+B/-?R:<XR;/LGH^)<@KJ?+LQSO+*%LSKECS"6IR?*ZW+,WK
M8Q5K4Q1I2ACEZ3PRU5,JZ!CS:D](O&E-Z,>"^'SG8X;XGX2XES+@7C#*JW.L
MEX5SW-4R+*I)LF@H.)^(<KS[AK+)WRYJ&JGDS!D7.I:6II<OS!V:1FKN4[<0
M]K-F?V1[;#'=HL'NBXUEVPV1MC8F?<;(%Q;%,LH+>Z'9%2TL8F0U(=M11Y>2
MI$R.&K,>MK&YAY2>^IZZO\&)7Y/'D?#OI?R:DR'+:AJ2OX8JQ'0MF]5ZE15U
M+/4"9A-,E53IDX62M$=9':EGEJ(ZUJJGBBT;+*>(Y>*>-?X-O%&8\7YY1)F>
M4<>Y:9,V3AS+QFN;93F%'1/2J:6FERZKDXE>2'+3-ETP.8TE-1395'E];4U&
MNZ=56';4;J[J];;[G:O'8.6;.;D]+4FLSV!;9:F2Y0/<S*\,PS+:[*0R,A-C
MI:IU+.;&IXE-14SZ[V9DDTB;8%/-)L.-\OR+/,\])!J,CI(J[A[.>"7AS2*>
MO]<K1G-?EV75\5:KU34C0&FDT4\=/34YAT!V:24M(='Z*\ZXMX3X4]"(HN*\
MQGRGC+AKTJ15.0U%)E!RS*VX8RG.L[RBIRIX\N3,5JQ6P&2MEK:^M6IYAB2.
M"G2.!:[F>W?31B]ANS[#TQ;='3:GK)PC8>@',R3=(PK7%<\2<Z\FY,QN>,2T
MLX*5\Q,80'L-=3>>![1!L_897O/%S'*>#:*7/3'P7E#?D3TA9=PO2B2KSHK-
M19F)#4RUBC,P)IHN7)ZD$Y45/JB+1S<I^=LLFXB])N:4_"7/]*'$<9XK]#6=
M\>Y@T&6\*HU)FN0F 4$&6$Y WJM+/ZS#^5.9SZFMY=1RZBEY\/JMFV9Z-MIO
MI2W"QN[V:QO+=MK;JNW-V@I[,X]VLSR[',4Q83%#4K,Q6_QO%]LH-6DR/(C9
MQFES?7]TODC@HI30Q9)\WA[T>Y$,[S6CJ>'J.OR>?CC.,AIYW&>9C7TE#1J"
MM.7H:JCHLECAYB.F9YA45-54[HM,]HV;6\:^F;BW\UN'<RH>,\QRCB6E]$_"
M_&-931GA')<HS+-LV8ZZL0YME^99KQ/-4F&2.7(LDHJ#+J+ID>OB+RQ1^%>4
M5HJ;)<BIP(9 5-Y;5H4D?Y]!09\B*-#?"W[<C!(A/A;\?=\*?+7S)70K35M7
M3KJ"P551"H;V@L4KH-6PZK+OL-_#'W5EE2U;EN7UCZ"]70TE2YC_ (LM/3QR
MMHW/1=SIW.UMSB#UBXSL-,,-,,?Z#&OU8Q_/?AIAAIAAIAAIAAIAAIAAIAAI
MAB(OV/+0W8QL<0A*BR8-C&JY[WOAF:UC6HBJYSG*B-:B*JJJ(B<ZN0D":(DV
M DC))V  87).,>K!:EJ54%F:GF"J 223&P  &Y).P W)Q_ </HMZPBC8472M
MU%$$1C2#(S9;<9[",>B.8]CFXXK7-<U4<UR*J*BHJ+PNOLW\Z^%_YQY%_6U!
M_M\?B3^B3TJ_T:<??V0X@_P_'W^TIZQ?Y*?4;_4IN/\ X<T_.OA?^<>1?UM0
M?[?#]$GI5_HTX^_L?Q!_A^'[2GK%_DI]1O\ 4IN/_AS3\Z^%_P"<>1?UM0?[
M?#]$GI5_HTX^_L?Q!_A^'[2GK%_DI]1O]2FX_P#AS3\Z^%_YQY%_6U!_M\/T
M2>E7^C3C[^Q_$'^'X?M*>L7^2GU&_P!2FX_^'-/SKX7_ )QY%_6U!_M\/T2>
ME7^C3C[^Q_$'^'X?M*>L7^2GU&_U*;C_ .'-/SKX7_G'D7];4'^WP_1)Z5?Z
M-./O['\0?X?A^TIZQ?Y*?4;_ %*;C_X<T_.OA?\ G'D7];4'^WP_1)Z5?Z-.
M/O['\0?X?A^TIZQ?Y*?4;_4IN/\ X<T_.OA?^<>1?UM0?[?#]$GI5_HTX^_L
M?Q!_A^'[2GK%_DI]1O\ 4IN/_AS3\Z^%_P"<>1?UM0?[?#]$GI5_HTX^_L?Q
M!_A^'[2GK%_DI]1O]2FX_P#AS3\Z^%_YQY%_6U!_M\/T2>E7^C3C[^Q_$'^'
MX?M*>L7^2GU&_P!2FX_^'-/SKX7_ )QY%_6U!_M\/T2>E7^C3C[^Q_$'^'XF
MB])O7.:E!C9NG'JG+CL60Z5&H2[4[JDI8\IZN5\D%6ZC6"&0Y7O5QA@:1RN<
MJN57+S:'$G" E,XSWAT3LNEIAF66B5E'93)SM94>1-L9;>C/TQO2)0/P#Z26
MH8G,L=$W#'$S4D<C7)D2F-$84<EB2ZH&-S<[G'*7I5Z[CP8]8?IXZK#5L2 2
MJB5Y=K=V"08M68PY!JV/$?2+'# *<(3DAC&V.\PAD<-7L:Y*#B+@]7:1<\X<
M$C.)6<9CEH=I "HD9A-<N 2 Y.H D7L3B;>C?TS/#'3OP)Z3'IXH&IHH&X:X
MG:&.F=E=J>.(T91(&=$=HE41ED5BI*@C&D=(_7#+6R=+Z;.J.4ZY]F6X61M+
MNF9;7V-[21/>2DHG+.]E>QCXWM7E\#V-<+M5J*DEXEX27EZ<^X>7E:N5IS/+
MAR]?M<NTW1JOU:;7\;XMR>C'TPR^L&7T?^DB0U?+]:,G"_$K^L\HAHO6-5$>
M=RF ,?,U:" 5L0,?=CTF=<UO&JX5MTX=4UG#I >RTL2QVHW4FQJB-\'[GJP2
M:,HH /M8_M41@A_ SX?A;Q1.).$8FD>//>'8VE;5*R9EEJ-*V_5(5F!=MSNQ
M)W.*S^C/TQU4=-#4\ ^DFIBHTY=)%/PQQ--'2Q]/T=,DE$RP)TKTQ!5Z5VV&
M,F;TL]>5E8,MK#I[ZKY]J.$M:.SF[7[LRK =<HR!6O9-/2ODLA*$I1+%:1 *
M,A&*/M>Y%BO$/!R(8DSOAM(R_,,:YCEBH7N#K*"8+KN =5KW -[XG-Z./314
M3BJJ.!?29/4K":=:B;AOBB6=:<JR& 2O1M((2CNIB#:-+,NFS$&N_M*>L7^2
MGU&_U*;C_P"'-7_SKX7_ )QY%_6U!_M\8/Z)/2K_ $:<??V/X@_P_#]I3UB_
MR4^HW^I3<?\ PYI^=?"_\X\B_K:@_P!OA^B3TJ_T:<??V/X@_P /P_:4]8O\
ME/J-_J4W'_PYI^=?"_\ ./(OZVH/]OA^B3TJ_P!&G'W]C^(/\/P_:4]8O\E/
MJ-_J4W'_ ,.:?G7PO_./(OZVH/\ ;X?HD]*O]&G'W]C^(/\ #\/VE/6+_)3Z
MC?ZE-Q_\.:?G7PO_ #CR+^MJ#_;X?HD]*O\ 1IQ]_8_B#_#\/VE/6+_)3ZC?
MZE-Q_P##FGYU\+_SCR+^MJ#_ &^'Z)/2K_1IQ]_8_B#_  _#]I3UB_R4^HW^
MI3<?_#FGYU\+_P X\B_K:@_V^'Z)/2K_ $:<??V/X@_P_#]I3UB_R4^HW^I3
M<?\ PYI^=?"_\X\B_K:@_P!OA^B3TJ_T:<??V/X@_P /P_:4]8O\E/J-_J4W
M'_PYI^=?"_\ ./(OZVH/]OA^B3TJ_P!&G'W]C^(/\/P_:4]8O\E/J-_J4W'_
M ,.:?G7PO_./(OZVH/\ ;X?HD]*O]&G'W]C^(/\ #\/VE/6+_)3ZC?ZE-Q_\
M.:?G7PO_ #CR+^MJ#_;X?HD]*O\ 1IQ]_8_B#_#\?V\='M1:X_TG=,U#?5D^
MENZ783:2JN*>UAR*^TJK2OP2BB3ZZQ@2QBE0IT*4(L:5%DB&>.<;Q%8Q['-3
MY*XGEBGXCS^>"2.:&;.<REBEB=9(I8WK)F22-T)5T=2&5E)5@002#C]@_1;1
MU>7^C3T?4%?2U%%747!7#%+64=7#)3U5+54^2T44]/4T\JI+!/#*K1RPRHLD
M<BLCJ&! [&ZT>.[PTPPTPPTPPTPPTPPTPPTPPTPPTPQX4_LS6T>ZNZEITZCV
MRVUSS<1]- W7?;LPC$;[*GU;)DC;AL1UBVC@3EA-E+'.D=TA!H90E0:N4;^/
MF?\ A#</Y]GDG"1R7)<US84J9V*DY;055:*<S-E/)$QIHI.69>5+R]=M?+?3
M?2;?=?\  PXPX2X5@](J\3\4</<.-72\*FB&>YSEV4FL%,G$0J#2BOJ(.>(#
M/ )C%JY?.BUVYBW\1OVH75=_)GW]_J@S_P#4&OFW\P..OYF\4?U#F?\ NN/N
M']+WHH_I-]'_ /;'A[_$</VH75=_)GW]_J@S_P#4&GY@<=?S-XH_J',_]UP_
M2]Z*/Z3?1_\ VQX>_P 1P_:A=5W\F??W^J#/_P!0:?F!QU_,WBC^H<S_ -UP
M_2]Z*/Z3?1__ &QX>_Q'&6O2CU>+";6+TY]1"UK)+IK*]=J=Q5A-F.&@72VQ
M%H_ V2X*()QT&A5&B,5_:G&KGYB\?F,0_FEQ9R0_,$7Y$S7EB0C27">K:0^G
M;5;5;:]L6OTK^B'GFI_2/Z.O63$(#4?G;PWSS"&UB$R^O\PQ!R7$>K0&ZK7W
MQ(P>FGK3K'0WUNQ'4S7OKX\N) =!VVW.B.@Q;!56?&AN!3C6-'FJJK+"%6#D
MJJJ9K^=78N#?2-"8S#PQQC$8E=(C%E.<1F-)?XU(RL T+)]=5L'^L#C&G])?
MH6J1,*GCWT8U J)(99Q/Q-PM*)Y:?^(DF$E:W,D@_P!2[ZFC^H5QP?M8.LKW
M0F/_ +7_ *DO<*2?;4I/HQW*]T),XX]K2M]R^Q>T\*J>?P^7A?N]1_,KTA^K
M^J?FMQ?ZKKYGJWY'S?U?F?\ 2<GD<O7^MIU>_%S]*'H:];_*'Z0?1KZ_RN1Z
M[^=/#'K?)[\GUGU[G<J^_+UZ/=C9VZVVW79O!)IRY/TY[ZPHE+AN$X2*FH=H
M]TH%),KL!I14-#86-;(A3@2KM((6^U3^&-<57+&CQ1J@DW6>9-Z3N('IVK>$
M>)HHZ?+\NRU:>ER+.HJ:2'*Z=::EEFA=)5>HY:C7+L"VZ*@VQS'"G$GH)X/C
MK4ROTC\!S2UV<YWG;UE?QAPK/6PU.?UKU]?3TU3'40/%0\]SRH.HA !))*W6
M==1.FOK5K[%+B!L3U-PK=(R0DM(FW&Y\:Q2&@F@2(DX-0R2D9 ,8% >7Q()C
M1HSL:B)J(^#O2/%-ZQ%PSQE%4:.7SX\ISE)N78+HYJP!]&D :=6FP M88Z.;
MTE>A6HIO4ZCCST8STAE,WJLW$W"TM-SBYD,O(>M:+FEV9S)IUZV+7N2<18.E
M#J[BRQSXO3EU#QIPC>T"F@VHW$#+&?N5WG')'1-,PW<JN\C7H_N55[N=6%X$
MX^202IPCQ6DH;4)%R3-5D#=]0<4P8-[P;XR9/2OZ(I8F@E])'HZD@=.6\,G%
MO#;Q,EK:&C:O*,EMM)!%MK8RK/I=ZR+MXRW/3]U(VY0M5@26>V&Y4]XF.5%<
MT;Y5*5PVN5$56M5$54153TU.;@GTA5)4U'"O%TY4$*9LFS>4J#W"EZ=K V%[
M=\6J7TH^ANB5EH_2%Z-:17(9UI>*N&8%<@6!815R!B 2 3<@8R3]-76I*=4N
ME;$=34EU"-HJ-Q]M]SS.IA,5JL'4J2H<M<-BL8K60_"UJL:J(G:G$WX-](S\
MC7PQQB_JH"TVO*<X;U=1:P@O >4!86$>D"P\L6X_25Z%8A5B+CST8Q"O8O7"
M/B;A9!6N006JPM:/66(9@6FUDACON<8+>E?K"8(H&=/'48T!Y8YYPMVLW':(
MT\*N44THTI$826)7O4<EZ*9BO=VO3N7FV.!_2" RCA3BT*T@E8#)LV :53=9
M6'J]C(#N'/4#N#B^?2IZ'BR.?2+Z."\<30(YXKX:+) ]M<*,:^ZQ-I75&"$:
MPN#88Y7]+W6253*3I^ZD2+(GCM)"OVPW*>I[,/<@K$RNI5\L\7>[QS']TAG<
M[M(G*\R/!/I".HGA7B\EI1.U\GS<ZIE]F9O]'WE7PD/6/ X@OI0]#:Z OI"]
M&JB.!J6,+Q3PR-%,]M5,EJ[I@:PU0K:-K"ZFPQG'Z<>MN3-'92=CNI^18AL&
M6PIY]N]T2S16@PBCLLARB5+CLL&   #)C7I(:$(AH1&#8U+K<(>DEY!,_#?&
MC3+*)UE;*LZ:19U4(LP<PEA*$55$@.L*H4&P Q93TC^A**%J:/CKT7QT[TYI
M&ITXDX52%J5G>1J9HEK AIVDDD<PE3&7=V*W8D\7[6KK4]MB67T$=37O&!,E
M6,&?]&^Y_ML*PG&]HFSHDKW/YX\R9(1#RI07L/(-]M*][_BU'\S?2-S(YOS9
MXRYL4CRQ2_DG.>9'+*VN66-^1J221^IW4AG;J8D[XE^DKT*\F6F_/ST8^KSP
MQ4\\'YS<+<F:G@3EP02Q>NZ)(88_HXHG4I&G2BA=L?+>FCK2;+AV#=A^IAL^
MND2I=?-;MMN<DN#+G2'RYLJ')2G\T:1,E%))E&"]A)$@CS&<\CW.6@X,](PD
MCF'#'&(EB>22*493G DBDE8O*\;\C4CR.2\C*0SL2S$DDXJ?27Z%C#-3GCWT
M9&"HCBAJ(#Q/PN89XH(UBABFB]=T2QPQ*L<2.K+'&JH@"@#$U$V&ZX(<'-X#
M-@^H@[=QJ^OJLRES]H<\L;.ZKJRYK\@C1#6D_'9$\+'6]362Y#XT@)I*00QC
ME?$<8!<F/A?TE1Q9E$.%N*V&;Q0P9A)+D69S3U$,-1%5)&TTM*\B@SP0NY5@
MSB)49C&65L*7CST'S3Y).W'_ *.HSPY45%7DT4'&.04U+15-31U&7RS)2T^9
M1T[L*.LJHHUEC=(C.\J(LP21*J[I1ZO'0F5KNG/J(=7"D/EC@.VIW%6$.41B
M"?)9%6C\#)#QH@WF:-".8B,5RM1$U@_F+Q^8Q">$N+#"',@B_(F:\L.18N$]
M6TAR-BP%[;7MC:CTK^B$3-4CTC^CH5#1B)IQQ;PV)FB5BRQ-+Z_K,:L2P0MI
M#$D"YQ)0.FOK4JC0)%9L3U-5LBJ$<%8>!MON?#-7 E.5TD, L>H&^&*0Y5<<
M<=PV%<JJ1'+J]%P=Z1X&B>'AGC*%H%9(6BRG.8VA5_;6(I #&K_6"$!O$'&-
M4>DKT*U:5$=5QYZ,:F.J:-ZJ.HXFX6F2I>(6B>H62M99FC  C:0,4 LI&.(/
M3'UFQG6SX^P74J!]\(P+QX=L]S!.N02"*4X;9S*9JV(CE52&',4S"$57O1SE
MYU%>"_2(AG*<+<8(:I66I*Y/G"FH5S=EG(@'-5B26$FH$[FYQ)_2=Z&9!2+)
MZ0/1G(*!D>A#\4<,.*)XUT1O2!JTBG9$ 5&AT%5&E2!MCX)TP=91233%V ZD
MBFLWQB612;8[EO)8$A$86&^:]U,KI;XA1C+&<=2* C&/$K'-:J4/!7I#)D8\
M+<7EIBAE8Y/FY,IB(:,R$T]W,; %"U]! *V(&)+Z4/0TBP(OI!]&JI3"1:95
MXIX8"TZS*4F6!17 1"5&99!&%#JQ5K@D8_"=+W6059"EZ?NI$BRIHK*4I-L-
MRGK)L0]WAGR%=2KYIHN]_BE$[CC[G=I$[EY'@GTAMJU<*\7MKD$SWR?-SJF7
MV96O3]4B^#F[#P."^E'T-IRPOI"]&JB*%J:+3Q5PR.73O;7!':N&B%[#5$MD
M:PNIL,98>FWK7CMF,C[%]3@&6,X%I8,#MSN@)LZSBE0\6QF-94-25.C'1# E
MG1\@)40@R->G.IKP=Z1T$BIPSQDJS2+-*%RG.5$LR,&260" !Y$8!ED:[*P!
M!!Q:?TD^A20PM)QWZ,':G@DI:=GXEX68P4TJ<N6FA+5A,4$D?1)"FF-TZ64C
M;$&7I'ZLS$(8W37U &,9[RE*7:/<$A"D(Y7O(1[Z%7/>]RJY[W*KG.555555
M76,W 7';,6;@_BEF8EF9LBS0LS$W))--<DG<D[D[G&:OI<]$R*J)Z2_1ZB(H
M557C#AU555%E55&8 *J@     "PQ\?M0NJ[^3/O[_5!G_P"H-4_,#CK^9O%'
M]0YG_NN)?I>]%'])OH__ +8\/?XCA^U"ZKOY,^_O]4&?_J#3\P..OYF\4?U#
MF?\ NN'Z7O11_2;Z/_[8\/?XCCC+TC]50!$.?IKWZ"$(WE,8NT>>C$(0VJ\A
M"/=0(U@V,17/>Y4:UJ*JJB)I^8''7\S>*/LR'-#_ /\ +@?2]Z)QN?2;Z/[#
M_P#S'A[_ !'']R>OTJQ^&>&F&&F&&F&&F&&F&&F&&F&&F&."5^]I'^X+_=NU
M4=Q\1\\4/8_ _+&#1?P)3?DJO_1 Z'N?B?G@.P^ ^6)75,5PTPPTPPTPPTPP
MTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPPTPP
MTPQ!8Q_%RC_)4']''J3^VW[3?,XBGL+^ROR&)W4<2PTPPTPPTPPTPPTPPTPP
MTPPTPPTPQ!&_C-6_D*[_ /,,?U7P/Q'R.*>(^!^8Q.ZIBN&F&&F&&F&&F&&F
M&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F&&F
M&(+*/XLY%^0K?_R^1J2>VO[2_,8B_L-^RWR.)W4<2PTPPTPPTPPTPPTPPTPP
MTPPTPQP2OWM(_P!P7^[=JH[CXCYXH>Q^!^6,&B_@2F_)5?\ H@=#W/Q/SP'8
M? ?+$KJF*X:88:88:88:88:88:88:88:88:88:88:88:88:88:88:88:88:8
M8:88:88:88:88:88:88:88:88@L8_BY1_DJ#^CCU)_;;]IOF<13V%_97Y#$[
MJ.)8:88:88:88:88:88:88:88:88:88@C?QFK?R%=_\ F&/ZKX'XCY'%/$?
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MRQ%T^KJ^E1=BS W MNRF^ICVV&YW/CB!?NGDX7=IF$:YS>6M$*+)=QSZ*Y&
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M^)M^%O#OMY]QBLS$5B_%VHXA7-;PB^K4^37_ %M7CA>[U:BISZ)SJ2@G?J(
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M "#>ZFGF-)K7-8Y'< &XB$@%]$5LBO)&,CFM[G/8BL7 J\MI*Q3S(E5R-I4
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M@ 51JA'HO#R.(XCU:[X=<?Q'19[40WR:=*6H:=S.[=#R*UQ:.9D?3I?N+@L
M!J %F]FX0K.%:=D7,H5JZ84T:4H33((W%B6FB5HV=F2VY!"FY,=R&6_X'3YA
M15PQ9%-LE6PCM))%*++0$P32M)">-"]K9(XZ(UK7]J,16IV\^FMCD%+6TU#
MN8U"5E=$9A/.&$A1Y69A&'90Q*1E4+6%[;;6.-#QOF.2U4\ZY;#R()#$:6!
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MIN)L$'++VGW%C9EB%%5SJWJCV>S6UK*O!;^QE91'LK^S;B.5+/0S*RX&8LR
M.OEN(^&X,KR_AZ.DS2J>NX7CKHLNSR2"&2C:@K93&>&LTAA<SK"M)HA#SQ:"
MB[MJD91>RSBP5<F912T25=-FLE/ZQ1PR2QU3R4Z-+^4X$J$0QRK.TDG*;1*\
MTD].(/5XXJA_32VZ?L%WMRA+K(ML*?<O. 2R$MLM=3FHTN!-D(ZLFYW3U]K#
MP:TR+W<V*MO;6];#%>RPFE0ZF$PT:J!YD.)X^%*"7+Z7.:B&D>S'**2JCF5"
MVSPT\B M%2DN^B(2 K$0KEF6^.QI/1[4>D#-8LUJ.&Z6HKX=ESO,:.6F C!
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MR>=J<(\U>]R48&D1RQEASG@5J3SH[WW@3)TH<J6O=!ZUF0YFHCJ2E!(@C4^
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M/U%_,KC+^:7$W]0YK_NN'TP;2_\ 6CMU_P!]L:_6>GZ2/1W_ #]X+_M3D?\
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M;G\<?SJV\T]G:V=C*<YTFPL)LV0YWW3CRI)3F<[GU[E(1RKS]>M 3<D^9O\
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MC"I#\O<U!O\ 5XTU%=+*=2WU7.G3:]P0"?>+=^POWQR#2")&+!K*0IL 6!+
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M<6:OF /(.HU:XZ*\0T:5$9(&,Z 54(G<-PV\2'HSN5Z."O+?B:J6I(V5=R0
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M&>*^)N(_1WZ6X\_X@SC.HZ;(^'9*=,TS&KKD@DDXAIUD>%:F601LZJH8H 6
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M74\:'@&%1T'9DE6QI&/PREG-(S[1$$UX">QQ/,C1."%58C2(5&KXWL-RD_\
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M$*IAN+-8VIEB8@6MTN-[V)&ZW[8J8'ZCHN6YV]TN :AI%W)OU(;"VP[-;&R
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MGN"+>P3)9S95=D62U<2?7RA83 KIH2#I["JO[.^FV53"KYEB7(<HM[6SJYA
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MHR*R]MR#(O:X-[@G%5G1B%LP+%0+BUPZNRMWV!"-WLPM8@8KV0=9^V5#$N+
M>,[EW]?C&/[@YCE\^AQNLD1<2PK:S<'+=MLYRRX?.R"N<:OI[["[F2*KI66^
M46U,@["FQ^P4-@"#(4SFPN@U,JK<GJ9U5U46!W(8;FR@]R,4-0@!-G("NS6
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MW!![C'QIBF&F&+A@V'S\VOXU3%AW)(+2!=;V%37>UK70R*155LB62)3BGG8
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MUJK\_5/OHGUIZ+Q^/4E['IM9;W[_ 'V[7O?S[8S(NZC?<6\!?_@1O\;7&V-
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M#F&.V,>CR&:2OOW M85C27?M,V%?U%O8!R*V'8/8#;I10U5-"T+F$)K0*5U
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M_*3%5^B%]1NNMM1M8J X%R=)(4;$; DVMBLF<M)%R!31PH!>.36SLO,OUEF
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M6Y(9@B'3:]L>E>B#T;UGI6XXRKA2F>2"EG$F89S7QQ\P95DM"G.KZI@3I+Z
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MJMM>_C$PRN[,6,9,,:@QFRAPTI((O<@!EWVO<V(\*#+Z8.H*RA;#9/CX=LL
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M4BN-6&@.M+];2PC8U3>:;.IH<625 1Y[0M(Q)#H+!R7M:K"*]QFI':-C7O\
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M^TJM+"?)3VB-):=ZN8QIAJXX#(P,+N8K",YY(]6N5>4^!'+J8-NQ"W!7MN/
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M.4?'8KE[.[N[E[>')VO:YC$>CD^2]_IRYO:O-3:VU^^U^W_$V^&)C2+$G<>
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M&*Q\_)\\/39-:3\;##DUU6:0UY;J+L'17ET7< RD:6A144:B!I*EC=K 1Z@
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M[*SV(N#IU7( Z0",6X9W5(55V,C)3[V+LP:E#N07E2.X8 ZF==BVQ8@X[_\
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M320@1IGC(VD! EB]FVM/:(L+FV^X\_&QN+[[XK7ZI*6I5=0T4^VBXN=+G2
M>ZZ;CR( QU1HH&?TE_E.=83F>>6%9F'4WE%'*QX]336.-7>WUIT[R;6#E$V/
M)P]EJ>=9Y+1TTY<@]MC =-3W$, 8,R; E9)("HCH-*P@@W:XD$HN.EK; [+W
M%M1!VQIDUKJ*R2,'JG!&E=+1\BZMIMJ!+!2&N 0"!L2#%8AG.X<JFAU&?9CN
M=C64LQ39VGV^VRQG;VK;C69X)?[$8399A?W5:#% M&&+N#<;B4^17$2YJB8
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MJJ*G///W7/R<OK3\/^/_  _#&,Q).XT@"P&_PL/\VM^.#DG\6LB_(-O]?/\
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M_#J\A]Y_=@FXMK^ 87YT.G_T[3;S/W#]^'5X6^\_N&/SZ1+7\ P?7Y_Y3/\
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MN:;B6%S6V4[&H+;>%Y<.DT\ <NE@N+[4"SE1V,&6L?$0W)LUP(UD!*VN&=4
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M(SW)I,S)G97)R*+F+\TP#"<I=>EM!Y157=/&L(,^$>9-?+M\^8$'5;V2!H0
M@*R+TZ=)70[+:VDJ;$$ 8N"."Q&DF^H'J8F[,K,;EKZM2*VJ^H$7!%SB9A]*
M6S<(K9#,9MI4Q<T+N#,L+7/-PKFSN,KDX8';R=-R*RM\IFSLD@6N$1HV-7./
MWTBQQVYJHT<%I4R_ )S*&:0BUQ;3HL$0 +JU[ +92&W#"S ]CBNB'OI:Y;42
M68DDKH-R6)(*])!N"/#'YC72]LQ1H$]1C\ZQ? GXFZOFW6=9UE\JF7;.\/9X
MG14MADF3W,JDQ[%KY))@8C5GAXZ.8THIE256N&AII3<%K7#7 55!UBS$@* 6
M8?6/5;QP581:RL;%;79FMH-U +,;!3V4=-_#&?AVQWN+=W<_>2ZDT=ADN=UF
M+XC5I34<FH2GPC$#7,RMC69I=O;/N,GLYMZ5+^\C,J(DZMH\3KA5 &T;#2#2
M7C2,7"H68W(-V:U[6 LH V!ON6-]\572)'D.[, HL+65;VO=C=B3N=K@*+;8
MV+,V[QZ?EM!G4NL:;*L8H<HQFBM?:9K'0*/,YV*V.2P4ACD,KY"6<W"<8,LB
M7$/*B>ZT'!/&%+GLE0#,%9 >EBK$6&Y74%-^^VINQWOOV&)$H6#$'4H8 ^0;
M26'>V^E?NVQ4=P]@MN]TSPY6:4UA,DPZFWQY9%/E678B:RQJ_?#)>8M?EQ&\
MHGY)BMN2OAOL<9R!UE12W@:XU>]SGJZJ2/'?20+D'=5:S+>S#4#I87-F%B+[
M'%'$<EM0;8$;$K=3;4ITL+J;"ZFX/EBG6O3+L-'L)L^XH600Y7+R6M90RLYR
M^NPU][N-36>.Y/(QC!ER:/AU'EV64]K>0IESB]'79)-]\7QQ3?:[BV/+F)I;
M  WTV-]*EK(0RZFTZBJD @,2HL-MAB)2&Y)4[WVU-INP(8JFK2K$$W*@-N=]
MSC-N>E39V\66^1CES7GL)-L>PF8WGVXF)S[$5_CV)8M>5D^PQ?*:B;,H;BBP
M3$(EECLDY**6:@@6):]UFQ\U]!-(/$&UK:D1@+%F! 92 078@C<:B+VP*0GZ
MK"][E692;JJD$JP-B%4$7L; VOC!S^JVK-DFTN!1]P]OL(W(P++<=RW;C#95
M[0QKT]?$J+?#KFFJ\.)9PK:77WFW>097C,(L*,456>=%MA@EK5-B%JFL+(VA
MF1U96:QM>X8$M8C9U5C?O8CQO@[1DHH(5T8,@N+V *D6O>Q0LONN#X8^\OQS
M8:=D^;;>W.7833;E;U4534Y!C,K,:A,QR>IJ($V%4>PX;;V1R& "OE3Q<P*3
MQ3!$*Z8DGQHYA3* CA6*1$D'2=*W-S=@/$^9P9HB64FS2"Q%Q<@ VLI/E?L,
M=7KK8G8PV<V>+81O;ML[-LAS2QA7>$7N;X=;75'[9E-IDEE"H<.DAN9C,OIK
M*RL*FI;$B8W<5M0T->"XKY+;J7>WUDE"AFB?2%!5@K $A0HNVPTD 7'4+W-C
ML!9*QZB%<:F8W#%20"2; &YU"]A[) MOWOVTI-G,.%0[B[<9K,ILNL=YIN>Y
M7N#322-A'R.ARI(^+2(C*H<QUDE#C^'MQC 1V82,>Z/65YSGCV$SMUCEVNCJ
M"HCT*A[V*]5[VM<M=[>_Q&+PT:71AJYA9G!MN&VM:][!;+]@Q^T/3!M/CM\W
M*8E'>V&3-GXM:.R')]P-Q,RN3S\)@YC68M(E6.6Y3=292U%?G^61 "D$($H+
M5K)(SI757L(S2%=-P%LPL$119RI:P51:Y1>WEMW-P6('5I8M=3=F9C==04DL
MQO8,1\#B3Q_IWVTQ?+WYQ245A%N_;LEM(<8V69A/Q>EMLRE$FY9;XU@]A>RL
M+Q>VR26>7)N;/'J"LFSS6-L0YW.N+59E&ED9=)-Q91[*@D(+*"P&HA1L 2>P
M\ABJB-6U ->['VB5!;VB%+:03XD"^Y\SCBN]I-H<EA;FP[2-6F%=9=19;N1*
MAY5:UEE39OBN*X2[';U]Q57,.UP+(*+%,<P:UK9=+-Q^9"B K<A$K#6)+"8#
MR#18G92J @$%69M0L00P+,P-P;FX\+ >4VNZWU,&??<,JJ ;AKJ0H6Q%B-CW
M-\4VRZ:-@)&/40)\:8"NE2+J)7Y(/=?<&MR#+';HRJPEY476>1<TC9/GD'.Y
M4"D;(H\@O;R!=.KJ0(814K:QD>0FF!-COL2NA"%Y=[$(5TIHN;%0+7/F<1*0
MV (;QZM;!FU6N&;5J8-87!)!L/(8N%ATV[5V&/"Q=N-2JBIB9F?<*M7%\HR[
M$+6DS&4&9%D76/9!BU[3W^.D-!L;&K?$H[*OKUJ+"=3^R>[)<B(2(FD!OJN=
M&@ZE5@4%B 0P(-B =P3< ]\2*Q%=.E@ VH:25(;M=2&!&Q(V(V)';%6%TN[
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M>_%I@'!VW_S]N+GIB>&F&&F&&F&&F&&F&&F&&F&&F&&F&/CQL_V4TPP\;/\
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M&-D=-44>.,A@.6',;:5O&I#+-$;ZE<QF\>O2>EF -P>DE&\@T$\PJ)!K:TC
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M*:':I$G"DN@L'0CQ.V/$<DCRRBVL0;T&V(0*A1I!5K6538B]A T)M[^K4+_
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@:88:88:88:88:88:88:88:88:88:88:88:88:88__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>10
<FILENAME>g723949g03z39.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g03z39.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $R EX# 1$
M A$! Q$!_\0 'P !  $$ P$! 0            @#! 8' @4)"@$+_\0 8A
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M!2G*R$X2K/>4"H C:D=2DJ R<)E(5S[NTA9!"P580E2B5)QW00DD'<? * )
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MP#S D7&%$1>V(C$I<>:S(E.OY!XG5B;M:O&:?NE:@I^(\ANB6.QW6)YIX?\
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M@\*^T#(.QZF4GMA%K;2P4X$HD=):&''%#*?9T]I&W4>MH'&U+6VE:"XV$EQ
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M=?<4J%2U+*E*.2I2EGT;E')./AJ5*4H2E*1@)2$CT[4C &:RB/CHR&#8C8D
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M &?!&%(CN)\:_-O]*77WJ,\F,VW1'N'>-9+7I^&$JPZW;W&]]\E 9"BVF 3
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MB3-Y)F#X-$58'/6?GVTA,/1$:8\L(=XD9:93'96AMUDN[%.\%:5!*G-V-P*
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MU,F,1:IB8L_2:E8"J[$I]H/3-3'.[=5#]U,F2VJ6EX59.PIPYJ/7,,FHB(M
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M#;L35YAU]9-@KX4=.E:;)DG6T1R__4N\L<T]3D^T3S4?[1ZJ'W*B1X5+$_\
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MNMH7Z/\ ^[6\@J>J'PF,_>\/[W:_PXI3X3&?O>'][M?X<4I\)C/WO#^]VO\
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M2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2H&^4_[)KY/#^7+JG]WCI.6F/M$O\
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M?*U6:8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I7D90_^>M[;_P!AZO\
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MJ0X#P20,X(#@1DX]!4">6.>*A>>CM$<8#)&0>&5\L^D)('//+-=MXK]^\/\
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MJBRNX8E9D5[XWZ/]K[B4XX^/]O7J.+WO[?IPY&8=>8D.-(6_%XO9W2,K:XR
MAW8?#B( 2KT@5ABXSHT.=;V)3S4*Y]F[?&0LAJ7V)U3T7C)^[X#JE.-Y]JHD
MUW\5TSH$$'6H^&N$_&"TV:-L-30%(OCKKDQ)-M-21L*^VI+\<J10RWH]D5UL
M<S:?7)9=6I2MUW;7;GUR7'H<=U<UA$:65MI4)++9);0\D]USADGAJ4"I'1)
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M#+:-Z3IMQ;:M*0M2=W/-T$QY,4Q&51IBW7)3"D!3;ZWL<5;B59"E+P"HGGD
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M<'8:%RE(QL;4A$E2PD@A(2-V>=;ED.TSD9W,OE@U,IF^01W1W^=)Y"Y2:XZ
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M '54Q/JNP"U2,3&GI3<\W9R<EV=,=?:NK92YV1^UN)V1X,=O=N95 "&UL/\
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M<6X98O3+#+C3AMPD1UMM2&5ALL<60%J$=U25M.N)#AO6CRC6VTZ;7:&HNH'
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MB1<1$ ERDK)R!#0@$=&QX[A9QYI3ZD,C"!BM.D$D/+0TRRVMQQ24)WO0 D@
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MOP1=H'(J<?$%E6)@BM@ 2AD\.[$-%H(B!HT]Z19VL5 9&W?9*V0%%20GVQ4
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M8I3%*8I3%*8I3%*8I3%*8I4#?*?]DU\GA_+EU3^[QTG+3'VB7^#;_6IJJ_\
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M<K*<#8X0JE;BF$Q[(3%X#NNK&F9]]V0LI3PFH_<=L!+.FE[?]ZVI/L][\8\
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M'_[O,BW*//BI_P )_?6#?6P,]G7_ (T_NJGOHXNM>GX81]\-_F\>;5_[U/\
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M693(] ?CZ@FL2U,(I$K4:Y *NYLQ!DDA$DS+5CE;5:%LV$D@EV()B?=X4:1
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;F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>g723949g08p42.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g08p42.jpg
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M9'>3F,'1)C9257)T=K6WU? S6)*7H4-F<X2%AH>RL__$ !T! 0 " @,! 0
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M3H86;DB%;&9C\MI(M\;JRU!RHYZ9YT=++4&'=N?N"PE\$\,\TS90+$)V2)4
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MOJZ081:DIE1I2 ]J95I*Y\=ZV1V)*V3*7Y ;RT[&*M#Y7J[NGZ\ \R/)#F\
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MJL42V1JC(+3RLP?">#FHP4\OZ,J]N&"IDK7Z%K0E0VK2?6DJ2!N )!VE)5@
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MC[KLA[:&]*>D//2'E+>=<6KK$F3(F/NRI;[LF0\K>Z^^XIQUQ6 ,K6LE1P
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M/TUB=_\ $'Q]Z?>I71KG2B!"T$9=()%W!]ZZ#7 IXQS4DP4H)VQ5:M6D16;
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MDM_MD=YR%,?2T^W^>RO:7$_G)UE\62[#DQI;! >BOLR62H!20ZPXEULE)X4
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M[R2%J;6E:?G)((SR,CZ*BM"7$*0KYJ@0<<'!^FJLO?9[\*+-FM70WV#I4L\
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MFGI_37[-_)!%?P?Y09$_"CT<#CX@U-_-VO\ 659'@5J0_P"^UC[X^?/]V?\
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M_56TC]K_ ,G^JNJ[_<;_ /K_ !;S4/<_6?SULCN/K'YZZF_T:_@_[=Y2OO\
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M5WP;_>Y-_P!(;Y^F5+^[KXC_ +M1OR1:_P!$K\WXN>3._P -\MX+_P!#V?\
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M"?WK3_\ 2;4'Z?3[87Q1_=Z+^1+1^A4_)!\B/WI^#_S=L_7+C[4+P)_>M/\
M])M0?I]/MA?%']WHOY$M'Z%3\D'R(_>GX/\ S=L_7+C[4+P)_>M/_P!)M0?I
M]/MA?%']WHOY$M'Z%3\D'R(_>GX/_-VS]<N/M0O G]ZT_P#TFU!^GT^V%\4?
MW>B_D2T?H5/R0?(C]Z?@_P#-VS]<N/M0O G]ZT__ $FU!^GT^V%\4?W>B_D2
MT?H5/R0?(C]Z?@_\W;/URX^U"\"?WK3_ /2;4'Z?3[87Q1_=Z+^1+1^A4_)!
M\B/WI^#_ ,W;/URX^U"\"?WK3_\ 2;4'Z?3[87Q1_=Z+^1+1^A4_)!\B/WI^
M#_S=L_7+C[4+P)_>M/\ ])M0?I]/MA?%']WHOY$M'Z%3\D'R(_>GX/\ S=L_
M7+C[4+P)_>M/_P!)M0?I]/MA?%']WHOY$M'Z%3\D'R(_>GX/_-VS]<N/M0O
MG]ZT_P#TFU!^GT^V%\4?W>B_D2T?H5=J#XB=W1.A+,<IX>@2F9&V47$_9J3*
M0.T^W\\J,I?8'D:D)C?%VQM;+R=.Z3M33FO5&WVH7@3[=+S_ /2;4'Z>*?;#
M>*7[O1?R):/T*LFX!XJ$[KY 3;E:@\@9SGF:G@/,J_.TI2VAR)FY$X\2UOW(
M=L5HGI45+/[6\Y&9^F@6)+HL +2U[+X>Z"L/AKI6W:3TZQTH,'JNNO+YD3IT
ME74ESI3G*G'GEG:C>I71CML1D$M,-A/G&K]6776=\EW^[NA<N7L0AM&0S$BM
M)VL18Z> AMI.2< ;W5NOJ'4=63NJ88:C,M1V$);:90EMM"=>B4I3K6M:UK_B
MUK.[5U:N;%*\HZ$%V4(7KIN(B>&.C)P<K"<VM*)8XE&=AS(ZE-J2XC3L=YQ'
MO;6AQ&]^Y"DKUI6N/NUJ@7VU7*RW6.F7;+O!EVVX15E01(A3F'(TEE2D%*TA
MQEQ:-R%)6G.Y"DJ (W+?/EVN?"N<!Y4>=;Y4>;#?2 5,R8KJ'F'0% I)0XA*
MMJ@4JQA0()%04/\ ' "U\%)^\]"N3(FJ6&FU!BRD@;R*<(LPA0(G(%;'5X<N
M<94(5L<T6/J+R$0_5I6E^]Q3GDL+P1M#9:%WU7K/4S=MT]>=,Z::OLZTNITS
M;K[;56B>];C"LT%<NYJMJC!;N-X5<GDQ26B%;EJ5Z!)\3[BK>JW6#3=C<F7B
MVWR]+M<6X(-\FVJ:+C$;F"5<I0CP1.2)2X=M$)I3^%C;M0$].Z^+M*O$.OP"
M%AMD*+7^?0.;LIB?=:4X^$&.QWXDQ#IJL%E"#2GXS6YQ*O\ TEPC'0W!EI<@
MMICZU=5> .EM61K/$FWC4,9BSZ,BZ':3&^Q]];MJA+:=CRD.72P7%5NNBG66
MS+FV?XN7-92F))2N*A+(V+%XMWZP/W*3&MMG>>N6I)&J%E[XW:0W/E)<;>84
MB#=H8F0 VZL1XMR\XF*XI4ADID*+ASY?'ZZY4NH4Y1 W].ZR3MA6PR=/P-3H
M4BXC6!9) 9?T[Y=AEAB.A<),V-/6V]M2GUR$;TVGN"O#2R+TYK[3"IMU,+Q$
MGZCN-Z?#L,2XK^IH34&<FV+\ET&6V6F4KBIE,2U(<*BZMY.$#K:=:W--YTE>
MQ&@>:T=%LT.VM=.1Y=]JR2G)<4SD^:ZKBW''%)?+#L<*0 &TMJRHXQ:/'.EV
M?5A3LK9PK=OH@Z@6M@++%,1[!!#.1U!39%B6'FMKLHIEA4&(4:2UKZ>^]"?C
MO,:82SP%_P#!+2]^%Z2;C?K6C4FD86C]0M6J1;V6;S%M:V%6NZS6I-ME(5?;
M>TR8D>X-A \DZY%=9<:#0:Y>T^)U]M/Q81#M,]5EU#)U%9W)[,QQRVOSDNB?
M C.,SF%"U3%N"0]$65GS+:'VW$.%PKERPU<98JK8:>_IR"+L@(O7YJQB8\>2
MQ$-#Y Z4]$VMAZ.B4AF0M;*W8SS6G4H4XRZC6T;](O5@@7O3UZTT\%Q+??+3
M<K/*5!#++S4>Z0WH4AV-N:<91(2T^I32G&74!P)*VUI!2>EVV[2K9=[;>FRF
M1+M=PA7)@2BXZTX]!DMRF4/;7$.J94MI*5I0ZA902$K0<*&-&N8 CE'KE"E3
M2S0FL2:/*@RH[T-)%YRA$A)03J6XY!=C+1*?#QD$=,Q6%.LN/IC*B+4VXWP5
MST%:;KI2QZ0D2KBBW6%_2DB(^R[&3-=7H^=;I]N$AQ<1QA29#UL83-#4=HN-
MK=#!CJ*%HY6#JRX0+_=-1,L0U3+LU?V9#3B'S&0G446;$FEE*9"'4J:;G.JB
ME;S@0M+9=#R0I*L>F<0 D[Z]?"EDN$]]*B<D2%<)PV!U>)%P#E9F$@I&$-C6
MB.ZR*?F)$17K ^/!3")">(B0Y<A+C7#2O"FT3]7N:ON%[U+,>2J>_;;6N=%9
MAV6=<K.Y8I,VUSHL%B_LN-6]Z2+;'<O+T.T2ILV9;8\:0\E;?),:^N,33J-/
M1+79([9$5J;/3$?<DW.+"N2;JQ%GQ7Y3MI<0N8VP9KJ+:W)N#$:-'FO/LME*
M_4Y[RF#02)TV[:+9=+!8( $-,.W"6,ED4@ZPW.:!C$;%"1##VHVB,UZ40F,2
M2I.5(<DD)K[FT^WD-&>'D31\V[W5R_ZBU1>+Q$M%LDW;4TF!(FIM-A;E-VFW
MI-NMUL9<# FRG9$R0R_<)\A];\R4\O;MU-2:PD:BC6^ BTV>Q6ZW2+A.9M]D
M9ELQC<+JJ.N?+(F3)KC?5\K';9C,.-0XC+2&HS#:<YCI/BS2MBI@"79KM/K[
M54MU+J(>5.![C4$%=U-[/M5MYH U+DR5M,LPX,JRR#[D& TW#:UMO2MJZ2GX
M/VEE6^39Y-]U5,L[>GM1Z7TW;)$NU%C1]IU64&[MV-U%G1)??4AMN-%D7UZ\
M+BPFT1491DGLY\7;\)C%Q9M5ACW)5XLU]O4YJ/<.KJ.X6$+%N7=$+N2V6FTJ
M<<>?:M35M3(DK4^OU8 F&MT 15[+;+3!E$7I]PB52&29ENQEQ([=/%OB1RH2
M&8C#S:Y$>0MR;M]^0EQ[25,)CHUMM7I=DT?;;#?=17^)(G.R]2Q]/1IK4EQA
M49EO3<!ZW0C%2U':=0MYEY2Y1==>"W0DLI90"@](NFHYMVM5FM$AJ*B/9';P
M]%<90ZE]U5ZEMS)0D*6\XA26W6TI8Z;;12@D.%U6%"):SXQU:O, 8$NZ=$LH
M6I,G$U$$:*@6!E:EV"&1@32P_P"[];!SGRS$4L1;&3"<V?L:J4X_$0V_IMU'
MG5A\![!9FK/#D:IUI?;7IQN[#3=HND^SLP+')O$:;#E7*'\36.U2W;DS'N,U
M$"5/ES#!5(6]'0AX(<1W.Z^*]WN3EQDLV+3-JG7E=O-ZN$"'<7)=T9MKT:0Q
M"D_&5TN$=N$X]#BJEL1&(WF@RAMY2F]R%806\7&ZS0+I7^=S)!T_<JU5J>U(
MM4\#61U>:J4T@0K=LCJIU(C2)AT"1F-$WW'VES3DN,B5*((F;6Z]U2Y> *+%
MH[5%FT7)>N]XU-8M/Z90]J&9:+#"LS>G)4R98]1,G3.E&'I5WM$V2U.=4ZVJ
M5=I+"9$B:B25N.<]#\6UW74=BN>IF6[?;K)=;Q>UMV>/<+K*N2[S'C1KI9G!
M?+^ZTQ;KC%87$;2VM,>WL.J99C*9"4(S YXM4BQ :+7"!<ZR*I-="UYJ)#CU
MIW4U(B0S-45CSC  N:KAPE,;6LD9JY0.1F,/.,NR5*2T\WV6[> &E;U:-)V2
M9<KLW;]*V6UV5N-&9L;@E)MKS4I5Q8EW.SW*Z62[3Y*%&?<[!<+9.DLNK;<?
M*PVZCA+?XMWZV7'4%TC0K>Y+OUSG7-;S[MT1T#-;6P(;L>#<84&Z6^*PI(BP
M;M$FQ67&TK0T 5H7-'0*0+Z-42U--29\0:8V/W)D"W([4YOZ:4A%F/@.2XLR
M.GWR(#3;OQ(SGJRIQ*/8O:7$>HZQTK UMIRXZ8NC\R-!N?D^N] 6RW+1Y*?%
MN#727(8DLC<]$;0YO87EM2PG:HI6GHVF[_+TO>H=\@-1GI4(20TW+2ZN.KS4
M.1"<ZB676'#M:D+4C:ZG#@25;D@I.(F>-!;!T,9?RY^S3="" PU J;\@6[6X
MQT-!DP!A*.IP2H_&;C:E.S]B(IQD(^9T@M('.S$[6KKET\,K7>=9P-8W&\7Z
M2+;,@W2'IUQ^WKL;-VMD1^'!FM*5;E7AAM@2')AMK%V:M3US"+D]"<E)*U<S
M!UQ/MNFI>G(5NM3!FQI<"3>&VIB+H[;YTAJ1+BN!,T6YU3I91&\Z];W)[<'=
M";DH8(2G*#/,>:V(C(,6#GM'.EY?P=2BAFI@"9&3J.PW&8U(G31[\E[X$9EF
M.S\1U7PV&FVD>UM"4ZYVYZ"T->YKUSO.B])W>Y2.F)%PN>G;//FO]%I##/6E
MRH;K[O28:;9;WN*V--H;3A"$@<3!U7JFV16X5MU+?[?#9W]&)!O-QB16NHXI
MUSIQV)+;2.HZM;B]J!N<6I:LJ42<0Z7Q>%TL[4#\B[76KRJ0Y*E 8M:<JZAS
M)24CX.S3T&Q5BPL.EHT;UCCYGM2L<VIU<+3#S[SKG6]=>%\775WTW>7]5:IL
M$C2BY$BT,6)=A,)JX2$](W1R+>K#>6G+BPQEF')PE4)"G%1 RZZZXOFM*ZZ?
MTK;[U;6K#8KLU?TLLW%VZ)NPE+B,JWB"B1;+M;7$0W7?E9+&2F4H($CJ-MMH
M3]L\:@;NXJZ$[I>SZ0)6980=9.%A\VOB;&0!*KLXO#WH2V9:0Z.=E*CA=%_N
M\/F3IDD>*B_%0VU-OPQAG5=OU1/U1JZ\)M%PDWFU6*[7&'*L]OO<VT*LDJY1
ML6YNYMI7"<?+-K%Q^)H4F5)?A6^/U$H;BO7$@6"78HECT];C<(;%MGW6!#D,
M7*9;(UP%S8A/_LQ<%:DR4,AR?Y(7*2S'8:E3'MA4J9,]-KI%,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4
MIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE8;T*] >9TRPWJS/+9"UP>N
M=*TSI"I,ES:T,1($-#BVFW)I"8]'@PVUN-MKDR&M..-H]RT]8UGJVSZ$TO>=
M6WYU;5KLD-4J0&@A3[ZRI+4:)&2M;:%RILIQF+&0MQ"%/O("UH3E0YS3>GKC
MJJ^6W3]I;2N=<Y"6&=Y4&FDA*G'I#ZD)6I+$9A#C[ZDH4I+3:BE*E82<B$E1
MYT4--B)34X48@0R@V:QOW,RX$^.W*B26M^FM[;?CNMNHWO6M^U6O76M_AG-6
MVXPKO;X-UMTAN7;[G#C3X,IHY:DPYC*)$9]L^U#K+B%I]N%#-<9-AR;?,E0)
MK*X\R%)?B2H[@PXQ)C.*9?:6/8IMQ"D*^D&L-KG3ZA:KK>: '(ID6/GR@Z;!
M&_,^&GZS%5):^4<TO?S/R:D[B$?9KUA3-HCO^UQ:=;ZS9-?:;U!JK5FCK9-#
MU[T:;:+PQZ0@?&<<OM^66%'K^6*?+SMH_8LDH9=PM0%<Y=-)WJSV'3^HYT8M
MVS4HFFVN\[CY%X-+ZR<#I=8$/1=Q_9#&YQO*4DATKI]1Y.#@V&Y$-#QI&P@Z
MW'<_,VK<TW-1'^-O2UHUJ*-AZF%R*];VMH:/EN--O/);9<:YU[IOP[M,2]:G
MF"%!FWJU6-E?I),JZ2DL]0A2DCR\&,)-RFK!*FX,.2MM#CH0TMI;2=ZUC<)%
MLL48R94:VS[HZGD ,0&%.[ 4I4>M*>Z,**G 2N5)92M2&RMQ$A:WK>M;UOUU
MO\=;U^.MZW^C>MYW,'/(Y!Y!'MKK51[S_I]0Z8FTJJ9%,_5/M1.H%_[C7H2%
M[;]\B/[5J^..E:<]T&:G]IE:;>^'O>VE^G3-':^TWKL:@.G9HE_8UJ&?INY?
M-&)T HWO,X4KJPI 63$E)^3D=-WID]-6.RZDTG>M*&T"\QC'-[L\2]0NYS%E
M[MK;N0.G*9*<2&#ZVMR"L +3E<>GU"B6"@UJQ$4Q"O1SS]>KK7YGHN6Q"<D[
M>D;4M.VXSDM0X.VM"7%J)F1K7P]-.//,M3:^TUI&\:/L5[FB-<-;W=VS61OT
MX5):BK>ZCY4I)0PN2J%;6U(#BE3[G!;V!M;KK2R:3O6H;;J*ZVR,7H>F+<W<
MKFOU92RX^EK8T DA3J&1)FK2HH2(D*4O<5I0A<A9W.NM5^;UI6MZWK6];UZ;
MUO\ '6];_P 6\4KKQX<6)[_EH[3'Q%>Y?PT:3[E?NJ]/T[Q2NSBE,4IBE,4I
MBE5I\G"AF55*_P VK8<T>,]1L<4)-&U^5 @%MTD/K1Z]/0R):<+%07GPD/Z(
MT]/(Q&_C&F]-N;>^&A7A?CS/N<C3UGT-8[;=+O<]?WMBU2H-F?B1+D=*VP"[
MZM<BS;C,M]OBN/6J+\5H<F38Z"Y=$)0HNE"3ZGX4Q(+5XN6J;I-@VZ#I*UNS
MV)5R9D280OTX_%VGT/Q8<>9,D(;GO^?6B/%>5L@**DAO<17NH]&["R"J_+XY
M4I2+)SZG=@&VM14$"L)A][G<.GD>=OJD.K+"5J)5X[$8(2HDHA%).H+?*/*D
M(C38OC.G-;>)35HT_H)BX3]*WO1NF?$J#J'XPM%HO-S=<T5%TU,T4ZIUPW"W
M*5/LUVCM3)$:1-CSEHN/EW5/H8E1_2;UIG1*Y]WU8Y$B7^V:DO>BI5G3#N%P
MML)M&IG[W&U,VEM"84P>4N5O><C,O,QG8J##ZS8:4\P]Y$V[7,L2M96P'WI<
MJS4GQ M(VDS12%B6]';J U:"02,\A;L=D 1(2$OJ8<]?FCC+A%3SPN ICC)>
MJM47&=J&X7B[NR9-]TI\&O4$'2LJWH7;D"[:JM O\ZU1W4K<8;L\Z8\EU32\
MF1=FES2XY;X:F=UBPV*'$M$.VVYMEJU7[QKM$J_,2U)FK-OL-Q-HC3W4*2AU
M=QC1VBVEQ/#5O6F,$(F2 Y*W7"]U,W+G"C]+E5#4)OO<2"ED_!L"#$#7(#?R
M91Q0E"$C_CO^B6(4SUDH=]/3?N],]%\1[CJFYZFT0J[Z8D:;$5'B_'BI:O$6
M\IN4,>&UT\K/<5;D)3#+KV$M1).7DN 8)5BNGZ,A6*#8]4"W7UF]&0?#IZ05
MVZ1;C"D'6L#KPTB829/3;Y<D,?)*2?=64\@ZW$E<;YV!Y[!9Z-?JYSRC1CU/
M0:9K4V!J(#&#BTB62.1=0M.0"'LCO,:6MYYUS>V][TE2LY_PV\1X\CPST59]
M&Q6M:ZPLFBM),7?38NC=CE1!&M%O@W%Z1/NL?RN^',VL.,A2W''%^G(2HUQ&
MM-&/-:WU-<-22%Z8T[<]3:@=M][5!<ND>07[A+E0VVHMO=+^V3'W.H<*4H0E
M/J R!7Q-$R1OD-92ALK<B@XSX[V<A,'QGWGG $=%K"-+"4]@!&B/MS6HS3SD
M9Z*J2>GD7-OHF.+^4:8A*MS\'QHOEPNMPU//A7/P7OTR3#8>==59VD:AM3:K
M5IIJS,1W6Y3<=MQ;#D<OW>9.67DR5J\NAJ3$QJ5X9VN' AV.))@^)EICLR76
MVT"XN*L]P6F?>W+BZ\VMA3JT)=0Z&K='BIZ982.LMSS_ !DDC6)79V*0APK3
M(Y6MDZ:[!4:BUUS4JL;;=KS#-A5*F-6^"X/BN7PA\\^S-,E&7UPA4A#\).GX
M#OP69'B@WI5"[AIAJXV2?IAR(JZ1[(YU["4.69IJ]*D26]21%PXZ]7S?-NM2
M[G<&GE1+<\EZ*-GQ6:E.,Z&<ORDP[X["N<6^(D" ]=$EJZ[D7)URVAIE=ED)
MDNIT[&\NAR/!AK;3(F-EM\Q*SW_L&ZC9"X^PLV$ZQRPG:[*,W1DBD\@OT:R!
MH$&G.I<CZ<(ZE0YQ>/L8;5.-.:"[-,RD07_9OSEOQB\2_L;OMRAWIN]79KP_
MFZBOD#[$T6\>&NKV+W:H<33+@6R%S1(C2[DR8%U,JZ*^*C<VY"8KNVNYK\.-
M%?'5J@R;:NV6]S5T6SVN9]D!EG6NG';5.DR+X@I=*8Q9?CP7?-0!'@I\_P"1
M6R9#9(M-SLY<Y!CM51MQK=DU2C(B*$-K#0@C\F"?HPBQ/Q51QK;<-UD?/GR(
MT5[27)7P-)1,DR'D_$SZ T9=M4/7+Q2TWJ.Z?'GV+7*VL6JZFV1;6\_%O.DK
M;>G8Y9@H1&<;A3);\>.X$KD=(!$E]]U)77D6IK?8VX&A+U9H'Q6;]!G.SX G
M/ST-2+;J";:VW@Y*4IY"Y,>,VZZCTL[R5,M-(.T4IXX1KH$3Q0[S)DRJX!J%
M=B?<D!!M@)MN"Q]()2X:+"+??ABRAU5L:$: #V9<:?-F;<C-268SCKJ/EGPS
MFV6SV[PLNVA&KH=2VO2&JI_BPFU0;Q.;7;X6E)TF,F]6]YV+ N%V5J%JV_$\
M-J2Q,E2M[*'FF%N.)]WUO%N5QF:\M^JEP!99VHK!$T J?*ML129<F_Q67U6V
M6VV_+B6\69<TW*2MEV,PP$NK:<=0A!SBJ^0O38X6U7(N?U9J?S\QRH\?>;#
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M47.$%+WN6VX"5;GW$-./17'&65(YFQZ@NVFY;D^RR4PYKD5Z)YKRL.0^RU(
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M$/\ EQ8_YA_Y2*S\5SW3#SR<[77$[E%2L.*&5'NHX/*C[2>359995C<TTK:
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M4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2JE>%'^!,U_&+\P_\
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M (Q"=*?_ +8EN_#^+\%GX;#;32.M+6I:BI1RHXR< =@ .  .PKT1*4H2$I&
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M5O6M;WF%*"05*(2E(*E*40 D 9))/  '))X J2$*<4E"$J6M:@A"$ J4M2B
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M_LZU_*L^YS^??_[2GY$?!/\ RNY_];/RP_77CS#O_%?]'8_[.GE6?<Y_/O\
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M%$3,YH0(*V LY#%Q'ITIL6!!0R)PV16PPM,(0&'SRI*3MJ&.ARI;S+"\@$D
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M5J<;44ISEP*(QZ3L2A('J65<G.0$\G:!FJ7W%H6A*'$A2L8;('/J&Y2U'YJ
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MK[/)=$ETBYY08DH-6ZJ'/2.)D8&I;+NHD^9'^'(<C)&'L9!PVP,C.#AAOD9
M.#[,@'W@5*,<LYP1EQ\X.,C+[G!P2,CVX)'N)JY.:];%,4IBE,4IBE,4IBE,
M4IBE5.\VN[W'QN\=;IU>B5>+:;&&?"P(C))B9)#!VS)2..>L!N/ >BRWQPY+
MVM?":EQ$KF/PTOR&X^W=YT7Q'U/<-(:2N-]M<)$V9'5':;2\EQ<>.)#R&E2Y
M*&E(<6RR%?-2XV"XIO<L(W5ZSX(Z#LWB3XC672=^NCMKMLUN:^\N,MEJ;-5#
MBN2$6^"Y(0ZRW)DE&=ZVG2EEMXMMJ<V"JK?9$]QMW5O'%5+L=7CBQ7#E5OG-
M2LT!F8S#LH2($UMB)*^:>D-O6 "S'C?6),-QF,^P6%KU!BO?%4_U[PBU_?-?
MVJZ3;["CLR(,Y#")L-EQB+-#K1=4A+;CCH#\7"0\6W-A0^QZ$JW%7=?A(^$&
ME?"'45AMVE;I,DQ+Q:GICUKN4AB5/MBX\A+"'2\RS'*H<\%?E@\T7$O1)?RS
MB-B6MK6>MU\XTQ2F*4Q2F*4Q2F*4Q2F*4Q2F*567L?)/%(66D>3?;.>\O;-\
MS&LFY?4[578$D@$A@?:X-FOR=QGGB4X6[IENO:<CSRD:;N)&!H3,5&:WS]KN
M6HW&TV"TSK@6I[A93;HSZTH=4]GJ(2G< VAP;B_A2&U)W*>.W<:\]U7ICPUC
M2E^(6KK'IU,O3T=,QW4=R@LN/Q&H6#'>6YTUKD/1E!"8 4V_);>Z3<(!TMI,
M"?9J]\Y'V'B)D%SNY0K <IW3NSE[*%^4)C2HD5T;N/3KO2R+\$M"@R%P3M<+
M1)<>5';>89DZEBY2V"D";#CVZCTY>=/OL"ZPU1A):06' XR\TX66FD.H#C#C
MB MM1&Y!(5@I4 4*2HQ\/O$W1/B/%G.Z0O;=T-L>")["HTR#*C"2X\J,ZN-/
MCQGBQ(2VLM/H0MI2D.-E8=;<;3L5SK=>B4Q2F*4Q2M:?0^[^8LN[=W'4,!QW
MG',>.%"22EZZ/4.HVBQAJK7>?P[VW=]5T'/!0>C .@R%$Z^(B\^DS3--V'F*
M,12Y.0Q!B[B&H^QHK+BW' ,)0IL))*]NW)R4%'!._ 5D8P.:TUNO[G0@-I0V
M3E2TK)"4HW;L C>%]DA&2G!SDG O#QBW6>_\BYA>;M57J/<+A0:E9K13I")+
M3]8/FP4$B6!N,S4IG,*&S9#T7Y>>A$^/IO3,UMN4V\A.LXE*'%I2K<E*E)"O
M\8 D \<<_1Q[JV6U*6VA2D[5*2E13_BD@$CGGCZ>??4EY"ITQ2F*54OQ(_O=
MY"?QM.__ .M3>7O]VOX!K\U4,=G?X=W\]6TRBKZ8I3%*8I3%*8I3%*8I3%*K
M=YD_\$+RK_BW=R_^&-HRZ/\ X0Q_#-?[::ID?X.__ N_["JG&I_^*M9_]GPW
M_NZ-E1[GZS^>K1V'U#\U9!F*S3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I
M3%*8I3%*8I3%*8I3%*8I3%*8I6M"Y5[@]<.UJ.-^T7ZIR0+THR6@U&BCO('F
M!\,=GCSLD$9$TDSU&K7ZX#HXZRL2ZV] $6M$$(5856QK J9'9A-;B2Z0<PT+
M* "I1:6D@$ @J""A)RG!!*<D>HYSFM-26PI/[+<0%DA*>J@@D$@A)6E:A@^G
M .!C P:O[0:.*YU5X%5$$;08C0ERGW2]TM9^ZV<I-G279DZ>6L=EGDBLU^1)
M><6AK<A$&"S\* +B01L:+#8U5J*U%1"1]"4A*0!V "0 /SGN23DUM(2$)"05
M'Z5**E$GN25$D_F'8 # KRK7QWD=\-0[)>>6<XN=B'18\(>>M='K-B-08<.5
M(FQ(D,H7%S)T:+%FRY4N.PP^AIB5)D2&D)=><6K*7'$@I2M:0>2$J4 <\'(!
MQVXK"FVU'<IM"E#L5)23QVY(SQ7?9YCS:.2MIF/SVCL%[_$W O95FI@6B5U@
MJ97&5#MLY$!,JR1%1W'(^XYAV8SME:VMH]BE)WC>O"1O5A'*1N.$GWI&>/P8
MK.Q&5'8G*OG':,J_SCCG\->Q5ZG5J.#@UBEUJOU"M#$NH&UZKAAU?!CTOO.2
M7TP1(F-$@1$O2'G9#NH\=O3CSKCJ];6M2MX4I2B5*45*/<J))/UD\UE*4I&$
M@) [!( 'XAQ5:O"C_ F:_C%^8?\ M;=LRZ1]U_BH_P#0-U3'^Y?QLC^G<JVN
M45?3%*8I3%*8I3%*8I7F&BC(,.6-R(Q.;'#C)Y1^&%%SS9B6R/BNRW8PD*+8
ME$RY-]#*FH L=%DSY\I;42(P](=;;5D#) XY(') '/O)X ]Y/ ]M8)P">> 3
MP"3Q[@.2?<!R?957/RR*+^])Y;?]4#R-_5SE_EE??(__ $AK_K51YE/WN1_T
M=W_JU6$E]K9XQ;Z7(Y//J'9'T.2WZP1G3.:3=/(LJEK@2:G+Y[+>3T1PEHC[
MZ_)%.5'939K:H'TIQC>Y6>.2/&+2"=8+T2\W-<>-Q-D>N)9CKM0N*GO*KC+)
M?ZRF!()C.2/+ED.;B<QP7Z^EH?P9O$ASPW;\48[]I9C)LHU5&LR9<QN_JLJ(
MWQ@W-:"(GE$2U0@)[$,31(+.U(*9Q$2OSPK\I*/4?$OQXKCW+/)>;)%<EID:
M;/JWBSW:Q5\C.2&C;F$!=@ T*:'.19LC;DE!<?,E1B'Q-R6Y#VG/?OV14!F.
MI;,5$.,PA:NFPTIAAML%1)"6D;4HR220$CDDGFOFQ=SDS2),]Z?.E.)2794G
MS,IYTA(2"M]W>MS:D!()6<   X JS_Y9%%_>D\MO^J!Y&_JYS'EE??(__2&O
M^M4/,I^]R/\ H[O_ %:L11+G Z!5AEM&"+<"A%=S=,BKW3K)0;3%^1(2ASGU
M.J6X:(L O3SL1<B%N>/8U.'NQ2,7XL*7'><I4DH44DI)'M2H+2<C/"DD@_@/
M!X/(JY*@M(4 H9]BDE*A]:5 $?BK+LC4J8I3%*8I3%*8I3%*8I3%*B/O/%ZC
MY$<AO?%[VHDW5K\'2+(R0\AN*5@.QIT0J+)CGWF9,=,P67'P",=$J-)B/.Q4
MLRXTB,XZRODK/=9-DN<.ZP^F9$)WJ(2ZDJ;6%)4VXVL I5M<;6M"BE25 *RE
M25 $=7UII*UZZTO>=)7DOIMMZBB.^Y%6EN2PMMYJ3&DL+6AQL/1I3#$AL.-N
M-*4V$NMK;*D'7C]E!X?4#Q]YQ<^EA3!ZPW#H=QZ'1R<TMN(Q"'U[D/6^@4,1
M'%P(;2?8^9^@I-F9$J1*4J4ZQ%A)BQXB]R^T:TUI.U4N(R_'8B1H2>JVTR5K
M4MZ0TV5N..+[A*0$MI2E(2"HJ*RH;?,O!CP.L/A$B\2K?=+A>;E>RTP_+FML
MQVV(4)Y]3,>/&8W *6MPN2'G'7"XI#0;0PE*@YMJSHM>ZTQ2F*4Q2M='7:#Y
M#!>N6.S&_.*W<CX7="E K_,A86C<<)$P?2;G8'*LWSU]%BY58)I448(20#U7
M/R#:);,J>0$F([C<6*7D;B%M%M($9*W4A965*6 4)&[>,+3@@9W#'LR/:*U'
M$.AQ2C)4AM12$ )02%J.-O*"2"<;3GOQ[JOQ5110%6:\$-V0A<3(D*,&E;86
MB"QY2S$84-F/,/$8(.&.#0YI:0VY.DQ14"$.8>?6U#BL1TMM)U%$%1( 2"20
MD9P![ADD\?2<UM)!"0"HJ( !40 3]) P,GZ !7LR)$>)'?ERWV8L6*R[(DR9
M#J&8\>.RA3CS[[SBDMM,M-I4XZZXI*&T)4I2M)UO>8K-:D3WVEMA88\IK97>
M9#IG/.64#C=FX24,2B TCUE77^EF>3 [H4TAQ[Z5STK:(+!6M):',&"U,;:L
M6Y#;9^ Q!WQ#'R *R%K4XET  AOIH#A2/>H)R%<X"N/8<Z!F*^64&_0A+:FB
M<Y7U%E 4>X"2H93[T\YY&+$<L\P6H([L@GR5DU&F6SB798_(C)VBCK>1IUI?
M-TD5?ZR6#BG8YVQ!W)06?-BD($^209C2Q"WDD]Z(,1&:EQ\ELLA2DN-]0!6W
M<G"BE0)& ><$$8X.,<9JY#_#@=VI4VYTR4A12<I"P1W(X)R#G!'?D5[?A#90
MERIO;+56YVB0 _Y2]W)B)^H\J+J7!E6=MQA_4:<Q&F,?$1O6_AR8[+J?T+;3
MO\,C)24J;2H8(8:R/=Q]%9CD*2X1R"\X0?P_35T<UZV*8I3%*8I3%*8I3%*8
MI3%*J]YAEA4GQ1\MA4<F/D%('C7VUR>-9F1G9\)M_E]H4PY+AH<5(C(>3O6V
ME/-H2YK?JC>]9F*^PN:AA#S2GFG62ZREQ"G6PI:2DN-@E: H<I*@,^RI3(DI
MJ 93D:0W%D-OI8DK9<1'?4VA06EEY20VXI!X6$*44G@XJP-3_P#%6L_^SX;_
M -W1L'N?K/YZ@.P^H?FK(,Q6:8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*
M8I3%*8I3%*8I3%*8I3%*8I3%*T^W7P;I]*M#W)(MZZU8ZYY=#K3R+9$C3.86
M5GBM0%63H_D?;(\&Q:IXV6*BW&=9NA5.OEB*")8,=N(0HU.G3*Q7VHG()DJ4
MD.;6PJ.4N8W+'444H93QGG;M0I0& 0DCC)SQZHR4'I[G%)?W(^:@]-(*WE<[
M>-Q4H ]\D'/I%;?FFD,--,M^[X;+:&D>Y:EJ]C:=(3[EKVI:U>FM>JUJ4I6_
MQ5O>][WG'UR%<F*4Q2F*54KPH_P)FOXQ?F'_ +6W;,OD?=?XJ/\ T#=41_N7
M\;(_IW*MKE%7TQ2F*4Q2F*4Q2F*4Q2F*53.;X"^,$[NVO(J30G%]#^OHM[C>
MC))-8?N33Z9C=K?KNGODEF-3T().>FTCWRB=DY$!V>X[(7YZOPMT6YJ<:M7:
MR;MYI,\CS#PA*N"5AP3E1-W3,CJ@/'_<E/#K*:+I*S[,UX_>*#&@SX<MW]*=
M._%RK,E7DHQN;=F4V656E%QV=9,/RY,5/>0B+B*V^B.E+8C?A%QNE"^S(Y+;
M.;@6[5T(#XN5@K3ZTIEV6X7,0*=%?:0T-C.-S2VXB-*FJ%05)F$M1_D8RD/R
M&U:[7K.X7&V6>_3K/%$Z[18<Q^WPRE3A?D--J6D)900X^4 %SH-D./;.D@A2
MP:Z%X;V>RW_5>E+1J6>JU:>N%WMT2\7(+0RF)#D/I;6I4IU*F(8=)# EO@LQ
MBYYAT%MM0J"OLO?*ORF\B#O41O<H:SM3KL")+$79RH#JGL;972*8SM,3]'&B
M1I/2QZI)!25Q7B@O8]*9TIQ!&,G7BW@MKC6VK9-[9U,T9$*(TVY'N)@-0.C+
M4[L5;OD&6&GLM;W>4*?9Z6'5D/(%?3OPH_"GPK\.H&EI.AG4V^[7&0ZS+L:;
MO)NWF;:F,74WH^=DRY,7$@-1P4NHBRO,$QVDF,Z:W$Y] 5\<TQ2F*4Q2F*4Q
M2F*4Q2F*4Q2JK$O$:D%",\F]U3RGC/$9LJ<['&^5_D",',.2WW)"V8 V#T!B
M$/A-*<VB+"ALLQ8C"6V([3;3:$:V!(4 !TX_''+#1/X3MYJ@QTDD]1_DYX?=
M Y]P"L ?0.U8T"\%N35<<D/6N@>3]?$IF%2*1@7RM\@1D!) Z5FG#4[42%T!
MEC4LN:)$"Y*1IOXLXE.ESI*W),AUQ>3*6HY4A@G@9+#1.   ,E/L  'N  J(
MBH2,!;X')P'W0.3D\!7M))/O/-6@HE-@<_JHNHC"]M.P1/SWP"MZM]COMIE?
M/D99-SZI:[:1+6 K\!Z8Y'A?/D)'R(YJ(-B_"A0XS#="U%:BHA(SCA"0E/
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MCYX96SK#I,D3!%Y72I4<BP*958P$&,XF'ZI#3=@JC$ND(6 H?)C/S2?40>.
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M9E\C[K_%1_Z!NJ(_W+^-D?T[E6URBKZ8I3%*8I3%*8I3%*8I3%*B?MG%>?\
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MV2>#V !)/8 59W\MSPS_ /O9>-O_ .=_-?ZRY3Y>1]X>_FE_]6KO,1_O[/\
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M(6VXIK3;K:E*FE04,I.1_P"/8>1^&LWQ6:8I3%*T:^+OVC'DIV'S,>XA<N9
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M'JD\PK5?\1?)D'3C=8L$?::/0RM*+,W*/8Y++4AVS+O=2M1XK(BJB*3"6!/
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M+$FT$-O1AOU4D.'*G+;U&;FD(49QQ+LIA+F3'?&,LN#<<#*%<GDX[=\ G'?
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M<^VNP3\HO'$+T;7(3/<N6".H;(BQ":&4NP ?:%EC<:',##&Q,N<S*<(%HQ"
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MJF2=R44R9"5EY#:$A*W M2P5DKVYVG"CA/<DX'YJNC1U)2RMQ2BI#90ELI0
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M0H4 24J "MI)! "L$[3[C@$X[\4"TD@!0R05 9Y('!('NY'-9=D:E3%*U?\
MGUPWN-LME%O?CD(5,M'2:+=?$CL$]F7&B.U[D/6'X)&+T5Q4I^/[D<O,#S$]
MGY-3I-*K.]J$UOW/;UNQ76TI4EX^E"DOMCWN(R-H_P \8'/''-:<IMQ2D*:'
MJ6E3"R#C"%X._P#Y!!/'//%1U)XIY-U/S$JL"FRNE@^%4RQ<'$<K76$SR?-@
MW!:7SV""Z+1K/!<[W2J:*>+&()=F:X8XS?[G(D3:N=J)+3(A F#/JLJCJ*@@
MNJ#I7NP%]52R4*3\DI1P".SB$X!"AGDPZ;R7P$E8;26@C;G:&DIPM*OE$I&<
M'.6U*R4E)P,)KN"\8?+7G'CS#K?.Q?:A-HLGAGV,'::\QT\Z["%]J:[+3"/,
MXE:#R;>L#2SK=)DVY(^538P:,\/7/45DO$IC[TJY3\=;Q4LME(D(*5=,9+?3
M4%[CMRH;L?.SSVX Q5T7T- (#@48ZPH;SPYU$E  W820G=@I X[FK-V+G?>B
M77._L6.B^0UHL-FL'8D<_O(7KC8OQWC\%.\3DAJ)3)W/)5JD!BECCW-;D!\&
MQ0!EF5;9:;H_<?HK"_BT!373:PIE(2EO<DMY>+H<RI6\#.-O.=V-OIVYJXI=
MZCF4NJ)4O:H.8:#1;PD;,X)W<8VY"CNW8J(>?<9\TJ_U;QSB37NJ5RIU*A>&
MP@&W7?FRM*JE9I/. 8SR"I5\'M>0%%I,*07L,,[$-R3?*NF60C!FUR50R+<X
M U#9L6Y&*'B-A*ER2<\*4I2R6E(^24KYN, .(3D'>.:K2W(#C7SPE*8^-OS4
MA*0'4K'52GD[LY0M6"-AXQ6]#.,KDJ8I5:?,?E=P[=XN]PY30);,2XW>A%0X
M#4F7N!%(3=[9E?0I<[W(3$AV-F,Z ER75I89CDG7)&],)<RZ.M+;S2UC*4J!
M/MQ]/X._X*ID(4XRXA)PI22![/P9^GM^&J6SN06;RWZQ1G;)XVW#QPY;2?&K
MM?$NB_?1-#A3K6YUD350(6@4J#2[*>V6J'.'0D^TA;)-2+&M$_D5!H4.6MU6
M]@.)8;5AY+RU/-.HV[_3L*BI2RI(PI8(24\G'<FM<ME]:<LJ:0EEQM>[;ZBO
M: E(2HY"-I.XX!XQ4.TOBWF?)\>N\%[=37HGD]UFO<A\+Z7/64A2XM1XQ2A4
M2H6OL\\PS)6\/&V0C9^D='FMCFG2B)J*_J+!>D)9]MJW(_5:"599;+DA0Q\Y
MQ1*DMX]I&$('<8SD]ZK2W(Z3I4GY9P-QTG/S6TC:IPGV9W*7QSV]M6P\%..=
ME\;;%V7C5VJ53'<M)S:[U3E9?FT@K)H(,@?@JKE^H$1-D4S88,Q@C6Q5S;C/
M1%P7G;48?CR_=I3.M>2XV\&W$J45C*%A8&X@'<E?IX_;%/\ R1Q5\9MQDN-J
M2D(.%H*,[02-JD8.".4[O=ZC6QK-2MNF*5I6\G?%GR2Z!T7SCM-"EV9FDWL;
MX]QG^60XW.HH_P DZ17*1*%],IH>Z6*N'[+0K9!A[E#J\;%RA45928F-+C2-
M/Q2@OD6'F4)C!>-R2Z0OU$LJ*AL44A0"DD\D')P.".QX]YEU:Y"D[MJ@T-GH
MP\D)(6D**2I*L< @CD_A&65KPJMO7^H>1#UX.7OE? +CU;Q_O87ENJW15D;S
M YORKDT@:B;<2,6P7"JJ!VFJ(K1V,#)0)<C8B<RU/4W,<EO1,A+:&MH0MU+;
MJ2O<O"2M:\^D$)5E)R,CVCCC R(Q<6[N*FVE.-*"-J<J"$(QZB"I.%)P<$=C
MS@YJU%,X^8D>5GF)8K55I3/->J\F\=Z>#,-RMCVSZ@8SL0Z\0!LP3-C&ALH;
M'LHMI^='6/E,KGL/#Y?QFOB,T%P!E@)5ZT..J([XSTMIP>.2D\<^W/>KTMGK
MR"I/H6AI(/OP' L#'(^<,GCO5*6_&J^\NY5\:F<IO DGR[SJ\AKWRVN\\KM
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M)+R5'Y5*LMD8/*4J0% \C!.,$9 !Q6UM6YG> &E)'R:DD.!60<*4E921P<@
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MU*0!W.  ,U4B7EP(4 -R0IL)]2E;G%I2,=OF)WJ/8<\]LS_5/,SBUTZ<!Y6
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M+#\6\RUE6=C824N!2 %[5]8@N$^O<"2$D84-I2,54F(A*2-[A5ELI6=I4CI
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MG#_STF'-1(4'A:7(^GMM?-2=;WN(B9*;:'3)("23O5M&"00G=D^P8R._O_\
M.HK*@!M3N.0,9Q@>T_@'L]OLK#VNIV2MTBRV_JW/IM3>#WS53"!*R6C76?:1
MIJV":I230W3#(O3+MEGG![>ADOX,J'^>],U&4I45B6P%02A85E.XD@I"< E0
M/?L >?;[*B%J"25H*<*V@ [BH$@)(QCOD?5SG%>+#\EZ&3.U6GC!UHE7JTSC
ML%-,?AB!10+]TK23IUR?*%#)L?5)OW5,AR'U"!5K%9#1$:U',5H4=%$!TN7(
MLJ 4HE.T8.[D@[DA2<  J&01RI( /!(((K'622D *W*)&TX!&U12K.2!P0>
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M=?AJ"HK,Q9%J-"G2["],@$:R@'][HWW?7,1UDC"D$$A(5N."HJV[>V<[N,D
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MQN*_-DN.DN+2,).!DD< D$@ E)()3D  [2,@#-%-H4=RADX /) (!) 4 0%
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;3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>g723949g09y11.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g09y11.jpg
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M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
M0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M_\  $0@!" )% P$1  (1 0,1 ?_$ !X  0 " P$! 0$!           '" 4&
M"00# 0(*_\0 2!   00# 0  ! $&"P8$!@$%!0(#! 8  0<($1(3%!4)%A@A
MEM87(C$X5EAW>)BWUR,R-5>7TS,WMK@D)31!4=C2)D)%58?_Q  = 0$! 0 "
M P$!             0(#" 0&!P4)_\0 1!$  @ $ @8(!0$'! $$ @,   $"
M P01(3$%!A)!46$'$W&!D:&Q\!0B8L'1X14R4E.2HO$((T+2%C-R@K(70R0T
MXO_:  P# 0 "$0,1 #\ _P!_& , 8 P!@# & , 8 P!@%#O2-AN]J]'^>?.
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M0Z/V6X\9%W3EM/J-6[WS7JUYHI"NW@O8CXZ3R"X ZL<B6D80J80=%C'$'F"
M90HJ3>C-L:;G_%V2MN%&L,^&[BK\0HKVPSOOX=WW.C.0T, 8 P!@# & , 8
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M2Y+6I,)#;"])WEI637/R]_J:3Q:>ZWG[_0M#D*, 8 P!@# & , 8 P!@# &
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MEXAR<HK)EV(F<-**R'&9S["C<6:NDES[W?W;<$H5@VF[]G=:_P#G>6KI1/\
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M9\,I:!HC>M[^VB'" ^#+(-)^.GWXK*]_#Y<GOP%EARR)-P48 P!@# & , 8
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M3OT7QWL/6.@<LW6U\PD<=K!0/9.A56T%+(#L5Z/5VRP3]5A3R(*KFMSJ94B
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MU/* B$P,2:+O,QF"$PH,(1)@^1LNIV;'<96SO>D:3K([[[]Y<\43;D P!@#
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MWFW&E_*XVM*2_>7:B/)]C/9Y'_FJ>9_[ .._Y>UW#S?:_4I87(!@# & , 8
MP!@# & , 8 P!@# .;1OW]($>R8?E_7+Y+X5ZS!J6_:OQ-])S1@W AS6#3(3
M[#<;==C+G-:>VN;]9P4ATZB0A"4CE_&JGI8CI^D:7J/^PXXJ:*MI]&Q5_7Q*
MI^(J9,N;#4PTO5.#X.!S8=J\W:<A152C22DOLM0_Z?)=9T,3NE)ZTRI=;!HN
MMTW+T5\+ Z%T=#/G28Z&.N^(4W]I35(CV$I'5PU<4% Y<3;J5TES[*=:1@#
M& , 8 P!@# & , 8!1WUSU'JE&M'&ZKRN\5ZIF>ASRP2-#/"G"$4J;W8Z# $
M:GR-4>V-C1:XI8R(0]N<"6H^8!///+#0C4T7J%)WNLOUY]^_(S$WA9VO^G)^
MV4PJ'M7^#VP=R,4J@P2I$);I][])U[H'H.XS3XF<GJ9SSW4JSPNJ':H53,L5
MP'4$%>AM7GN@(BV;_2*.-/$(2:VV'NSESRPY7QMX;\KF5%:_GB]V&%^Y\_3M
MCF#D& , 8!4OUW_P/@W][3SA_F(/RK)]GW1'FNW[,MID*, 8 P!@# & , 8
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M_E6%KNZ[MQU6S!R# & , J7Z[_X'P;^]IYP_S$'Y5D^S[HCS7;]F6TR%& ,
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MWY6[D<#&2=?)CJ(0?B&1%BW49H]S;T9M3_YSMO1Y8&']-:T$R@M]LW#&KEO
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MJENH6S#0I*53'D+:BZ=<2I.K9VO9V6^Q+J]KXFZ9"C & , 8 P!@# & , 8
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M=)2(ZY*WH,>%#8BKVY\6&HS#;?RI;1K5N^+\266?W9LX[C')1'0R761?.*;
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M5(U"G21LK>X1:)!(,?3FPY+/PD1&MN:;^JW\[*VW%Y:M@RYFTX P!@# & ,
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M;<TGVWS,.&\5[X8=N!=W.(V, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MB#\JR?9]T1YKM^S+:9"C & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M\2<[]V<;7TP^ 'Z [']<CWQ_B3G?NSC:^F'P _0'8_KD>^/\2<[]V<;7TP^
M'Z [']<CWQ_B3G?NSC:^F'P _0'8_KD>^/\ $G._=G&U],/@!^@.Q_7(]\?X
MDYW[LXVOIA\ 0]/\0=;;[K7P4#U![=>X3(YN8)6"X.>F'M6"%TAD[&8#@HS.
MV6I*ADH$J3,?<3693.I#:4J+QU_",N[2ME#>_#<3&_+WGY6L3#^@.Q_7(]\?
MXDYW[LY-KZ8? H_0'8_KD>^/\2<[]V<;7TP^ 'Z [']<CWQ_B3G?NSC:^F'P
M _0'8_KD>^/\2<[]V<;7TP^ 'Z [']<CWQ_B3G?NSC:^F'P _0'8_KD>^/\
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M4OUW_P #X-_>T\X?YB#\JR?9]T1YKM^S+:9"C & , 8 P!@# & , 8 P!@#
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M;[\T'?=CY'%1=,[8/*6R.0KGH^Z<PG]?JUM[C8$4SNM*Z5.'D;3W)\QSRHU
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ML?FL6[O98/#NNKY<O/@9_P I^E.P=F]!T;=_N])# +EY&$7=GEX@-/',D[Q
MZ]T2DV@[5'R=PF39#K**C&)D6WH!K8RODPXC6X4B+//V&Q))<U%Y-7]]XA;;
M5]Z\TSJMF#8P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@#
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M & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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M.A[-5C'7J@BN."?8_P"93@?F4X?98-A]=KL48D[<C+MVF1[.#I8PWK<*#!&
M9A><S"^ZF1XP6 EQM<N%_P#XC9=\\/F_N-V)>(+RQ:+!;*OTNC,S8W=N<^A:
M%!L_.RQL6S;JMQ)GB5E!7B+$NHI)L"2%1T6&JS@_X*;JM@<<EN22Z$I;4OZ6
M\[K_  6W_P!KY=WM\3>?.WC!CA5YK=XF6\;;9H;D=HH4AI%3;",M6.[]MM':
M[&8K+'XL3;K=9:)6AX$#K#*I3T 7 A;D&)KR7%+-W5K;[^5K!*SO?=;SO<O1
&F30P#__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>13
<FILENAME>g723949g10n01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g10n01.jpg
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M 0$! 0$! ?_  !$( *4"70,!$0 "$0$#$0'_Q  >  $  @,! 0$! 0
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M]J-J*< * =_F<DDYP1D#@2OQFI%BG=8:Z%OW.PRQ8D;?*H  QP<'K/E8O/\
MZM#NQ(#5_'ZH':["\CZ+XPPS!7LA  4(7WIW.Q%VJI1P0SRTU&'U47*)Z@VR
M?]4G%8\)R-,!!#4G4J"QT:5,9-K ^"UQ KR-J.489WC+'&5'3J"1P3PZJS.!
M4I'BK2#XA4EW0,O&PX49PQSD#D!CP,C5_/+J'1$<^HG/.$U0GW:RS_(%BU5F
MP]:EU[G-<@^.=X;H=GEB;RCGI,Q8)%K-2A[-7@*IPSV29;\H_*AP8/N9<3IJ
MTWL]K"H"K:PKRQ-R[QE=V!M&<^8YXQR<20U-C[52I3:3;N!?" 5-M;#;2222
M,>7XDXQ-BX+YT6GR4Z30:SS/CHV-2#W%Z%VJ[6NV= =&F*F-MUAO50GUH17!
M]/),6<N,L5.7J!.6:##2PKWLUQ8YW4&/+Y;IEI1R]GF6QJU55R&*JK!B2PV@
MAN>"0<#GK.U:EKG4)6-IK2QF9L%0Q92 NT[B"O!R 1_#/1K,DUQB(Q$8B,1&
M(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B<LO.R_=A%^0?B[S/FISO\<+?
M*?WDS:*WXXSN1C+^<ETUKG3H*8B=V:*]4VQPCZN25.;VZU,>8EK3%0Z]I&D[
M=,E9JN=Q5E6K"FT6%1NW9&*SNR<#^4Q:EK!;2B&W#+82*C6&)7;@YL\H R<^
MLK]S'S1ZE6A/CE9>L7NS6!BE@?M%7._U=P('@W*1)\;(U?+U:J7:./$!@<OH
M51KTAN.1GUAN#72):>X_J5/:VY/<N?3UL;A6H&XZ3PFR=OSV0S+DD[&/0')'
M0 =)4FH=5J9W+!?:O%&!N^: *JW &]1U*^7)ZD<R>"7VC=RH <EKKG!!8:XG
MN-<][=R&NTCJJ+8,M8/IO2*MRL#5[E9"=(K#5(L(JU7:LJ.$8P^RU]P1))31
M$R=(%Z@S:AI%8CP[25%CU6,U>TJ41G+*NX[@55L E3G@XSF6G5L@/B5 ,:UL
MK"OD,'<(%8E1M8%ER<$8R1TQ,^2\\.D@CY/BAOB-29\EHG:^6<;AUV#U4A*X
M_+UUR@V/I->NC_1'>=QK+"&CJY4; P8 ?T?R#OU2/ :'HF1B:)$?@TJ$"P6M
MX/AV69V 6?-LJ%=N[!)+##;MO7X3IU-@)K-2^-XB5@!\U^="X8MM! VJW&TG
M('H<R7O!?IO2.IT7M!CJ<KX[* \J/("DL"6R<<W"J86K7-P>,IPHW&%A=&A-
M:1IP6.+/C(<DC%9;EOQV5N[9;KU*(C5!.C45-G&-Q9>6(R<%NI&>)9IG=UL+
M^\+K5QG.T*Y 4' R%Z XYZR[.9IHC$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q
M$8B,1&(C$1B(Q$XS>:?2_(>I]BZ?8:WTSK GC?+.>4LRHGXUR^*7N=PRPN1S
M)^RV+R5X;='(-ZN%:- XT,T'2,L8 4Q4!Q"3&2_.=??;^AITI:M R(;'=AB[
MQ$%HX"K38GE4@\'()W'[)\_4/:MCE7<5HBG-7AMX9Y)-U;89@1R,$#:#CF;#
MS;SBL\[S@OWCQ#D)Z&,Z!9.+$Z <,R7*31*7STAXQU;IEJF %*$&29BWW,C*
M(FZOSV1(W,?9;,RB1\0/$[<D<?3 :9;CY-JV!@!N9G%S(H/( 51@,_V8!)G4
MU+'4/4#OW.FTGRJJ>"')''+,<D)UQDY $QM"\[^KLT6LBJ;S)OI]BE\Q\KNU
ME375>P,!9T.N<&\@+)1987W]4X[[4M(G#6XT.J1VP(G0]OZ2--DYJ(A*S23:
M9"[;GV /IZP$KR,VU!LX:SC!]XY.>2 .%'%U-FU55-Y*7V$O9@XJM9<9%?.0
M %X&. 2>6G4KDU_B]7Y7S3J4$>^(A=*Y_3;_  Q4EY$F2,BW&N#;%''R)#:&
MFY#\)HBB,Z\VTVAUQM2TH0E6DZQV)X;NA.2CLA(]=I(S_'$W(V]$?&-ZJV#Z
M;@#C^&9(&0DHQ$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$34+_ $*H]1I=
MEYY?0S-BIMP$R0=D!OR)L1DH*F)TB3#<DCI,.<RAU.M:VY%E,/)_\KB<DK,C
M!U.&4Y!X."/MR)%E5U*,,JPP1R,@_9@R&.G^'WCAV4I',])YG$LA"/1D<T6[
M]X;>'9(45F4]/A5LW# V 7"L$$61D/% JCD<C)!E5_5!#\(@E,G5B:BZL81\
M#=O]U2=V,$@D$C(X.,9'!R)6]%-ARZ9\NSJP\O. 0" <$DC.<'D8,V+\-/#_
M 'BY_P!P8/NW.K5GMZWOJE@]5=3IP.%6JU;OA^K?!J4+!CH<!J!I.@[R&$NR
MAS\A2W5<\:WZ?_RVJZ#W&)9EZ>I).>OUSO@U?0'OBSJ??4;0W7T QCI]4U.S
M^&/C/< D*OG>7Q'8(VUWJ[#I VR7, <@V+IQ!\IT.1#LX"QC+)''W.;)<<L(
M!HLBODV],Q9 M<6-'9:ZNHN4Y#]553E5((083*D%25'NG&1\<SC:>E@ 4X#,
MPP6!!<Y?S AL,?>&<'IC DF4OB/*.<GM66BT@/52Z*'5N8-.AM2HD./0J5))
MRZO6H@E$GZ3$A")!@DZPY&@M2W=REZDR'TH:2B#6.XPS%AN9^>NYL G/7G ]
M<<2:UHARJA3M5.,XV+G:,=.,GTDJ9"3C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1
MB(Q$8B,1&(C$1B(Q$@7LGC'P_OY*J&>LTI5G+4B.<B54E'L]QK$T/&LNQFSK
M#$FHV "ZZV2^C#/GIE*?UK45*6_@2MW3EM=]M085MM#8W#:K9QG'O ],F564
MUVE2ZY*YVD,RD9QGW2.N!/'7/%#QUJ4&EC*]R>LCQW/AW11-7@>A"5$CP>MQ
MX<3I+16/-G26K,Y<HL")'-2K.@Q+D,LZ0E]M*G-*&^YBQ-C$N5+?:A)3&/=V
MDG&W $"BI0H"* N\ <_KC#YYYW#KG,UJM^$/BM5*W=JB)XZ!=KW0P ^J6N =
M)V:UJEU41*5/"U@9-M)PS/K5=!D=I) P=9E!Q84FS%)"XL2=$BR&9-J;V96-
MAW(25("KR>"Q"@!F(X);)(X)Q(C34!645C#@*P.3Y0<A1DG !Y & #R)]FO"
MKQC9H9#FZ>7QUULI<1?0ITN1:;Q*NCUY!LHBA+;KI<FS/='9L :$CZ<**,6M
MJ6.%N/BX;K(^3(C.O:;]^_?R%*8"J%VGJNP+LP3R1MY/)YG?9Z0NS9P6#>\V
M[<. V_=OR!P#NZ<="9+7*N/<UXA6Y50Y958E0KDX\6L\H7#EDYC3QXZXVZ6)
M*=*S9\G3TYUIMQY"7DL_'K:D-(4M>U5O8]A#.VX@!03CH.@XQTDTK2L;47:,
MDXYZGJ>2>LDO(2<8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(
ME9.K^&_C5V^V;O'3^7#['9WQD *4(LG;97V[('%OKD#A5Q&U@^&%70="<6K4
M:%;(1F,RSO4=#>H^DM:NKU%U2[4<@9) PIP3U*E@2I/KMQ*7T]-C;G3+8P3E
MAD#H&"D!A]39FR$/&7A1,V0L<KG8M)PE=^>=(>)0YQL;(CW;E "-5>?'A7TX
MI%0$?KE:B- F(P9$"!-%;D0B<2:Q+E(>B+K ,!S@*Z8P#Y7.Y@<CG+<\YP>1
M@SIIJ.3L )97XR/,@VJ1@C&!QQCC@SR@O%G@5:2T@'SH? 2Q2^D<\:TV6L;O
MP4SKML=O/10>MR##N]LV:UONF),G>]SH;J]QQ<J##UJ/KINM/5S[R/T'O5KM
M0]/U5X Z?$0*:AC"8PKH.3[KMN<=?5N<]?@1)AJ55 46JUFDU0<V'JU.KX:J
MUH0T[)D-"P%>'1A <<T_,>DRWFX(Z)&C(=E2'Y+B6M+?>==4I:JV8LQ9CEF)
M8GXDG)/\3+% 4!5& H  ^  P!_*;!G)V,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1
M&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B)\]NM:^+U<;U\"T
MMK]5IU\"U_!\"%?G_LK5\Q'PIWZ;5\:/36_BUZHC;K2?F;4XVG36OB=WM:=?
M+3O7Q:VYZ[_V-;3K>_57IKT_/]F(S_EUGTQ$8B,1&(C$1B(Q$8B,1&(C$1B(
MQ$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(
MC$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8
MB,1&(C$1B(Q$8B</C?@GY$20W21DL)0;Q".='/VF<./%JM E=3)'0_EF$#6\
MN8&4L?.7$ILKL_';C!@=!E6NT"[)0[(JME6V!5-1.^D-32"A!=<*%X#'8 =.
M64 MCS>':I*[0589QEI\TZ:[#C"L"Y;DJ-^1> 3Y<^7?61N+'*G!Z397?"+N
MS-DNA4P(IO0(3]DJANX,E+%&2OR<##NS4#H,2NW)DF*>9831:56#5/#Q;CN:
M*F.$&1L=<<%,G2&>>TU$*,LOE8+@?H2:W4LN#^N[!CMY&.<F2]FMW,2%;S*6
MR?TP%B-@Y'ZBJ5 ;@\#I+,T@%V[@CW@CSJP]56;%'(0KB?1:7H$ (B72U)\8
M.IW*4=$766+9NLES[U<Z%H:=F3&T3!VG=OQ&ER7&TTL:[?:G"8()L1LD'#7(
MN"H.WW7/\?4RU1;5[*C/G<!6ZX!&5I=B0V-WO*/7D3H'F2:XQ$8B,1&(C$1B
M(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$3$'K !JPF:?LYL17 0UM+I$
MT>)0Q F TMUMA#LTD0>CPXK:WG6F4K?>;2IUQMO6]K6G6^@%C@ DGH ,D_P$
MX2 "20 .I)P!]I,P,GI/.H6C"IE^I435>#P+"?W)M(-C0, 53I8LX8V[/1H8
M')(4E< G-^1"F)WI4=]S6];SNQ^/*W)('E/)'4#CDCU G-Z<^9> "?,. >A/
M/ /H3-OC28\R.Q+B/LRHDIEJ3%E1G4/QY,=]"767V'FE*;>9>;4EQIUM2D.(
M4E:%;3O6\C)3[8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B?Q2M)U
MM2MZ2E.MJ4I6]:TG6M>N][WO\M:UK\][W^6M8B5 7YU>."(D0KNVD]U^5&OD
M]=F16C3H"$,H$R\0II:;/;BKTV,L+G.+FY39C;;K5E8#;>@[VB>,][H]FNR1
MM&1M&W(SEMO'VC>NX>F?J.,_M-77)QACNP< +NR3]1V-M/0X^L9V.K>7G%[9
M: 5.B$SHL\;2:9?CV&ND T>N&@$CJS!"LVF=+3J$&/::X;UL@S'=?<B.BJ.1
M):FZASP3I;C:>Q5+$ J,<A@=P/AX90.2/G:Q]K =0<2745L0H)!.>H(P1OR&
M/0'YM_7HI/PS8H0:#V" R5 EAAL7(4ZE@D(GQ24!]3#JV7DLS(3KT=Q3+S:V
MG=(<5MMU"VU^BT[UJD@@X((/P(P?Y&6@@C(((^(.1_E,GG)V,1&(C$1B)J=R
MN,"D#&"I$5;##$B<U 3&IM/LMU)H==8DR$OOBJL,*D&(*415H=GO1T0VGW(T
M=QY+TJ.AR2J6. 5'&?,P4?S8@9^J19@HR0Q]/*I8_P E!,C3\0=6_<;N_P"G
M_L7\&Y/PF^E5][7^*0\5?HV_=6?AC\0=6_<;N_Z?^Q?P;CPF^E5][7^*/%7Z
M-OW5GX8_$'5OW&[O^G_L7\&X\)OI5?>U_BCQ5^C;]U9^&/Q!U;]QN[_I_P"Q
M?P;CPF^E5][7^*/%7Z-OW5GX9HO2.@\YZE3R=)LE.\DH@DJX/=?DUSC/<:\9
M9<&D(I*.J&6&U%F7&^)^(VV_IM?H_&6\PO6T.;R2(Z,&#4Y&>ME9'/U%I%W1
MU*E;L''2NP'CZPLW=KO]49;;9;HO>--M(0VC6^ =D5O2$)TE.MJ53MJ5O6M:
MUZJWM6_V[WO?YY'PF^E5][7^*2\5?HV_=6?AG[_$'5OW&[O^G_L7\&X\)OI5
M?>U_BCQ5^C;]U9^&/Q!U;]QN[_I_[%_!N/";Z57WM?XH\5?HV_=6?AC\0=6_
M<;N_Z?\ L7\&X\)OI5?>U_BCQ5^C;]U9^&/Q!U;]QN[_ *?^Q?P;CPF^E5][
M7^*/%7Z-OW5GX8_$'5OW&[O^G_L7\&X\)OI5?>U_BCQ5^C;]U9^&39 F-D8,
M(@TU+8:G1(TQMB?#DCIS+<IE#Z&IH^:TQ,@RVTKTB3#ELLR8SVELOM-NH6C5
M1&"1\...1_ ^LM'//^L]>(C$1B(Q$8B,1&(E7N[_ -<7A1_F%O/_ &C^3.7U
M?HM3^Z3^_3*+?TNF_>O_ &+I:'*)?&(C$1B(Q$8B,1&(C$2J?"0_DT/Z%TZ3
MV<P/GTF5*=W2V8[XAY.W-DG%1I =@<C4T:);$^C#\,U\J8N1N*[IIQU,R0[_
M #U\DG9OR[Z/OGW\O^5#M+1:SNKJ-18>Z]5-O9MH+G7.VGN[,JT*#5:'LVOL
M[YF[3=J>'JGO-%@K>P:F^SU_Y0=;\E6I[M]U*NXNBU.G[>JI3_CMEM>M0A?9
M5%M6M?5,:-5K&UF;*[M!OH6H6IO5#34EK,_H6>01B(Q$8B,1&(C$1B(Q$8B,
M1&(C$1B) _DCRDUV;ELJD@"4$83U;.?6EEPA+*B6I::->:_<5C&K$!0\>JLL
MCH)[2)9PD>24"ON(EQ8[JD[3EM-@K?<<XVNO !QN4KG:>& SRIX/K*KD-B;0
M<'<K>H]U@V,CE<X]X D?"4'K_P!G;T2M.5^0UT#GYF11AW.)X)$FND@\*Y6*
MHD/#DD3 W6&/3)CCZ6ROQ*;B5/Z4T2?$Q[XG;@?>JBAFQ:SK$.?*XW%\\@[0
MPU !3/ZWS_FSC.T\Y;(S#2,-OF0[0I'EP&*F@X8>B@T>7'0-C'',]TOG5J\?
M[5X8\UC]0MYP4U29O*[575/PF*(6WS?BTQR&:% G(#Q02\Z7#-366U'96F8_
MRXJM+TC:MTLZVC4/L4'=XBG'F&^T<$YP>#CI]<M5#4U"[V(VE"/U3M3@A?0Y
M'QE]<RS3&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B8D^:@UH$:L91:FQ
M@ 22-$7$?!\3<$5#>G2UI^8MIOXDQV'%:^8XVCUUKXEH3ZJUT#) '4D ?QXG
M"< D] "3_#F0!S#R!YAY%R+YSV& ML"6(#1(]JK5ZKR1.YP2UA(,W;*=Q2!&
M,\U(!V 2],C.26)2(IJ$KY.]..;:M>IZ=KDJ<D[2ISRI^SX@_P C*DM2TL@#
M @#<&&,AA]I]"/YB:DGP0\9D-^S;HTQH,ZBYLD*\U9[&@$8CW=JTLSXI4?HE
M\$J.):NUJ36F_C;T#48??B;]PS$>CR]IN^ESY<' R"NW!!QP3M&?C.>S4]-I
M \V1N.#NW<$9Z#<VT>F<]9M%7\1>)U2S K=#"FB1T(@TX[)L%D+G&+"7/R.J
M/$;':8$^0[!.GEM]OZU :F2H_P IH7>2@Q,;V4,(P+BVHL92N0 <#A0-H79A
M5QT'S=9^U0<Y)ST45A@V"2,GDD@EM^2P/!/SCC[&(^$>*8^ )H=\&"X,,:.@
M^0_DE%A#Q\9F'"AQF>W7A#4>+$CH;8CL-)UI+;3+:&T)UK24ZUKTQ><NI/)-
M-))/K\TD[2,*P' \6W^XTLUE,MC$2NG'_)NA=JO?4.?U8=9X9?E918PO)-C&
M(@\G\HC.$O21CC,R2^VA! =(1J.4CCICD=3+[<?>_=-1$@M@8L!^K_OC_42Q
M>).,1&(C$1B)XFB0Y];;3,^$\X\Y/:9;:E,.+==%2-PR;3:$.;4MP=+UN+/0
MG6U0Y&ML2--NZVG&#\/A_GT_GZ1D?'X_Y=?Y>L]N(C$1B(Q$8B,1&(C$1B(Q
M$8B,1/C)D,Q(\B7(7\N/%9=D/N?"I7P,L-J<=7\*-*6KX4)4KX4)4K?IZ)UO
M?IK$2#^5>27)>SF)H"BD[6HS!#Q[ L?;N8].YP_+"28X28V3$[Z)3ZLV;BIB
M66N2Y"Q"YVXL2P Y,K3+!: Y(M>FRL L%P3C*O6_//!V,V.AZXS@_ RJNY+#
MA=V<9PR.F1P<C<!GWEZ?$2=LJEL8B5>[O_7%X4?YA;S_ -H_DSE]7Z+4_ND_
MOTRBW]+IOWK_ -BZ6ARB7QB)BC1T)6QSQ>Q&10$3&VVF04-$(@L<QMYQ+36G
MILYYB,UMUU:&V]+=3M;BDH3ZJ5K6T$@<DX'Q/$R+3K3[33[#K;S#S:'67FEI
M<:=:<3I;;K3B-[0XVXC>E(6G>TJ3O2D[WK>MXB?3$1B(Q$8B,1*I\*X7T3F'
M0NG6RW=/EW,/<I3KH@2Z\2=4A3A%<ULF3:FKW%AD8D57TQB.+^;%W&=<_P!X
MVVW&CM?SU\DGR2]]>X7?/OYWB[Q]_=1WG[,[S:BQ^S>SK+==8RFS7/JDU^OK
MU3'3Z77:>@G0U4Z#Q*#18_SB(E-*>O\ R@_*!W9[V=V^Z?8_8W=.GL+6]ATH
MFMUB5Z5 P73+0VDTCT*+K]+=:/:K+-7LM%J)Y69K;7M9G]"SR",1&(C$1B(Q
M$8B,1&(C$1B(Q$8B05VSR"IO"(XR1:Q%N,Z)B+18-M5$3$+/C@%-2%W8C9-$
MHH,U&&C]V 4AV0A3WPKE(TM*-;UO=E=36YVE1@J/,<9+9P!P<DX,KLM6O&X,
M<@GRC. N,D\C@9$DZE6\+?ZA6;Q7'7WP%M!#+"'=E1G84I0\M#:FQ=2H;Z4O
M19*6GDHD1W=:6R\E;:O7:?7(LI1F4]5)!QSR/KDE8.JL.C $9XX/U39\C)2M
M/6OZ^_$__P!U=:_T?LV75_HK_P#I3^XLJ?\ 24_:_P#Z#++93+8Q$8B,1&(C
M$1B(Q$8B,1&(FL72QOU"I6.T1JZ=MKX /.*M5JL1F9EA-JA,+?T/#Q'WXR)4
MZ1\'PL1]._.>5_NX[3\A33#G5&Y@,A<D#+=!GU/U?^S.,=JDX)P"<#DG'H!\
M?A,B +?7@88Y]-*!_K H>4^DFXR(9D9]0B-2]#RT1MZ0B*2AZ=]O.C)?>TQ)
M;=:^8OX/BV(P2,@X)&1T./4=.#Z<0#D X(R <'@C/H1\?C,MG)V,1&(C$1B)
MIMR(/.TF\.UV4[*+0*]96(N@D&'8R4<Y&$25QXL<(\\F*2+-2%1]LA)KC*)K
MRV8LC;;3^U9)1YEST++G)P,9^/H/K])%O=;'7!Z#)SCX>I^KUE1O "C+IW(C
M:YD)4$@1N4Y3$"7Q.Y<4(UX+H.#EQ*TZ-OU)HUBLS4<E-+G)5E:&S ;]AL!X
M<-*3GATY[=^J;<XP<@*,XL6P$Y/.49P., #(.T D#(E&E7:C$C!+'CPFK(&!
MQAE4GG)SC&2<$R]>9IIC$2N/C'_PAT;_ #'>2W^N%YRZ_P!Y/W-']I)55[K?
MO;?[C2QV4RV,1,;"#"!LDC-'"AL"88D(E%I<*#%BR2DIM'RT22+[#3;LV0AO
M_80])6ZXE'^SI6D_EB, >G7K]<R6(C$3$G3,.NB"!L@R5?A#(ZY4ED&".6<N
MXTC>M;2/K]:'%CQ:1OUU\$,6-F2W/SVVPK6M^G0,D 8R?B0H_B6( ^TD3A.
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M)..I.72* A/ESGJHP<=<'YNO'H, 8  Y]!TAS'-<8B5>[O\ UQ>%'^86\_\
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MS,F&ZGX7].M;:?::=0D70.,'(P<\'_\ 8_R^R2/1::%YW3:Q1:XB2@%4@8X
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M*.SZ*6[.[3_XKI;:-$;^T;J;>R_!&IT:VVA5GJ?=SO7W'[-[@=Y^[_;'=/\
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M:D1WXZW&ESK<UN'4*2,C##*D,"I!'J""1(.@L4J<@'!RIP05(8$'X@@&<J/
MBP$@M[Y>!(6?R +T7H/-[W.XG+O7D'4>C!K("HQ +#)SKKR0-3A)3EQ[40C%
MEB(RK7;XXV0J<!-S8!S34)W=J@"KG%09706!:2A5F!P$L+$.,@Y.%R.1D3%I
MB0R FTJR,:RURN"%P/-6%&P\\ %L=#@\3LYGSI]",1*T]:_K[\3_ /W5UK_1
M^S9=7^BO_P"E/[BRI_TE/VO_ .@RRV4RV,1&(C$1B(Q$8B:G=:4"Z  D5JQJ
M/(%RGHTAU5;MULI!7YD1Y+[/R;#23=>L$9O;B-?/9CDVF93?Q,2FWF5*;W)6
M*'<,9^M58?R8$?Y2+*'&TYQ]3,I_FI!_SE(KKX[\^%]YX948!KM4>NVRM]DG
M6$8GR6\CEMDI59AT5P&ZX^YU9<IG<!98@I"8K["'O<JU(2]I#6D:5N<U6L17
ME6K /@T\9W9_4]<"9VI065@&S#!\CQKN<!<?KRWW/.24WEVR^ZFY=%[.:@:G
M_>_I_3>C^GTWWOM?I^NBV^U:#^OOY'N]A_8[(>D;W_N?90O;YWL9\;MO&<;4
M1.N.NQ5ST]<X].IEZ5JF=N[G&=SN_3/3>S8Z^F,^O022\A)QB(Q$8B,1&(C$
M1B)07RKZ3X<C.F47G_EOS^E&H[-4G7ZA7"^4-N]B(1%DZP'*UZ*U% GIXB9(
M;:@$WDSFHP@W'CZ:U[R2+6VQJH34%&?3LP\VQE5MIQC(;J ?4<<C^,RWOIPZ
MI>JG"[T9UW#.<$=#CT.#P?KQ+T!B(TP'%%@KS<@.4&P2(E]EI;#3XV=%:DP7
MFF76VG&6W(KK2T-.--+;2K2%MH5K:=9B""0>H)!^T=9I!! (Z$ C[#TF2SD[
M&(E<?&/_ (0Z-_F.\EO]<+SEU_O)^YH_M)*JO=;][;_<:6.RF6QB) O*_)'F
M/8[GT2B4N86>.\R(K'GOJ MR##E[:G2AC\L/(VZYN5$9(0WHJU26H4A2OENM
M1W(SB7MI!7#$@9X^/K]G_P#W$GK$G&(C$1B(Q$8B,1&(C$1B(Q$8B:Y<:\FW
M5&TU1<I4%%GKARO+FH9U(5#2:&2AJI26-N,Z?5'U)V]IG;K6G-HTC;B-*^+7
M0<$'X$'^1D6&Y67IN4C/PR,31Z[Q+GX,?%CSA*;84C'X5K^\UM5L[8]6@>%!
M5R$<AEIWS98N;% UD"&9<&NQG%P!C*);DN0]-DRIFQR>#M&-NU>!M))P0.#R
MQ/.>3]DB*U QC<<YRW)S@#.>HX ''H)BAOCWSP2 F5N%JQH%R6@<5E*K*4<D
MBX-0;@IH4 3,4]N1!B\_>'1)]0TAS;HXJAXL^],(S)LJ0-K%MQVYYSY1SNSN
MR.GGR0WQ'' @5(!MYQQZ_1]W_MQE?@>9N%;YE5*M)K\X7'FJ(5P9=QL2?-(2
MI<J7OI%F#7*[D2:G%_!-*6"S@H9F5+6VGY,ER6B&W&C25L:B78Y!Z$J<?] *
MJ!\  2 /AB2"*N".H##)/TR&8GXDL ?])(&1DHQ$H/Y:F_!\C?\ GO/?+YFD
MB9TBHVRUT:W= L\*E /I\<M7PUGJ&[&S:0)9Y9O<P5.EU>?'?K5@@"WG)/N9
M(K49.J@:D*[Z?<<,H95&XY(8JV,$<<C<.03Z9F6\Z8LJZC:/*Q5G8*,94,N=
MP)SP2I&"!]4NW5WZW*K-=DTUT.]4) (0_57J\J(H [6WA\=P&Z#5 _\  J#N
M#%15#%0O_";A;8W&_P!S\&9FR"0V=P)W9ZYSSG/KGK-*XVC;C;@;<=,8XQ]6
M.DSN<G8Q$J]W?^N+PH_S"WG_ +1_)G+ZOT6I_=)_?IE%OZ73?O7_ +%TM#E$
MOF"LR+,X *HIL@%$M"H;F@<FS0R!  S/_+Y2RL(5/&$9,/7^U\QJ&0B/*_+X
M7D_GZ]&,C=G;ZXP#_#((_P IPYP=N,^F<XS]>.9S$ZS0OM".M7*S\B+E>7C>
M46VH?3IUM%UA&J)&W\EF?[YD9,L<CI7WA258;%Z@*L#@U2=_4/:I'[4M-J.B
M6JX#%%.<$C=T^.,=?JZ?7,SK>X9"5&Y2,A3L'KG&=V>,=?\ *6]CC_,O4AC<
MJV^,BHNGFMR4Q^>=41(5'^-/SDL+<Z>XVA[;?Q::4XVM"5_#M2%)UM.V=/\
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M /P_?W;T6CLU>@UM.IU%=6@?0U'24%7]AU@:BKQ7LM51[MQK5;<L!:-_\O\
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M/BBO33"*56K&H[7X(LQ$@1SAY$=JA%1VB@!M\F4D21WT-$JLKYK+$,/-X:6
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MC29/OYL::6$-M#D[CZCJ?2^XO4F1&;TSM+BEHFB;R1O1,#.7. ?J& >9%VV
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M*AA_%6!4_809P@,"#G!^#%3_  92&'V@B0)^$WE7[R>1_P"LGR^_GEEOCO\
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MO1DLZ9<V#<6'VM"OIBU0OD*WA<Y=CG.68YYYR3SSS_/GX\S<@PBCIA5&..,
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M=Z?H:O-D[1Y?4XS_ )2NF[ 8,K[O$?(P,YS\,_\ OTZR_/XBRO\ ^6WR5_\
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M<G65=9$M#5&R*=MR9WP...?%IG;TG<:,QISVT&)N1(W$@LQHVWWOE?,5ZMW
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M@;I?G-XPU#J_@C6KUQFTPNT3JO=1_1NY]-G+)5L(.C2-D*\9.VF>%)UW4PM
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MT--6A0MNJQU9KJ6*H1Z!]RJ2?11DGX=9@U-C!PH%F3PJ4W*'<'U*;&8 >K9
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MT+JKT1:PZ[%SM!KK;&3D\LA/7ZYG;2TL[6%6WMU866KG P/=<#^0EK088?7
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ML20"8Z)9!O2-+6Q#ASX9M->-I((!VYWYP&;!?80/+T/03.VIL4;2H\3P]YY
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MAV*;.@!&IG5^J5#FK1(C)&QI<[481NT_4W&HT=QU_43Y"?A^9\6K*D%C$,2
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M"9$",XV\6W&WQ+-N-N-[8QSQC.,>9N/K/QG?"KSGPTSG=G:N<\'/3KE5.?B
M?21?S_PG\;N?@3E;1S:N7$18+"-LTR'?Z_6;-%9*!ADD.)D1![H*.,9E0Q\\
MFP\75!=/EU%BCYXN5?GR'5S?4W.0=[*0"HVDC@XSSG/.!QG P-H&!*UTU*@K
ML# D-APK<@8'I\/7J<G).3)N?Y/RV3(:ER>:T&1*8(2B[,E^GUYV0T5G6@/>
M)I-IYP<IQLA,NE> 6^5,0K4A^SA!!YUQ94;#E,U^(_TWZ8]X] I4#KT"DKCZ
M)(Z&6E$/)13Z\J#SN#9Z==P#9Z[@#U F/K?$>-4Y\)*J7)^<5>56B)4O7I-?
MI5<#2 10X&CUPR0$/#QT=P=+*5Z'" SWXBFG)06%"%O*5!AQF&C66-G<[MN
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MI<82M-#-<F%9V'&X8?(PV6R"I(.2Q.0>I/KF6HM+9947K@Y3:05PN"& (P%
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78Y9CP"2 ,D@#+$X&.LFC*Y9&(C$3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>14
<FILENAME>g723949g11r70.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g11r70.jpg
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M 0 # 0$! 0             ! @,$!08'_\0 1!$  @(! P$%!@,&! 0%! ,
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M52L4O8-;6%<20U8(R$M8;?Q"(;,=:-22+Z5R,VD?$C/N#;&5<@"N-I;H0S*
MZWQ:GK7K)Q:I<K*NTKO#-C)*G<%ZV%)*FN0& ) ,U7V)UP[JU-U3=8%OV%7=
MFN=/?2E%:8B6-=5&2TTJ+E7-Q2;-8@;-8UEBFWV8/M[\HS<ZF%7YJ/Q6X^$(
M@KD*$<<P$3NFFQOATZHR=[G.0[V&2QW8W$#]T!:VL2#N)M35S%]0Z9L[,'[K
M ,8V*<=$Y#0)_>)-AA1X IA?$VGF>NN\QTR#0(_I%VO.[E#H$MMS86K8^Z:N
MP=K?6(EDDZ_!RTQ9%V7-=F+7;$1CDI"4.NER,RH5Q#9#K3^/#G :92-YSXQC
M+!%?:_C>@2 NVP%NBQH38ZEKV#!D.0*79-R>%+(!+;MI9JL*">/.8>P?:458
ME%.<T]IN_;E:NW35+=4 "XN9I]3Q#4:MV F M(5DS9I8=(<M % EAOCQ*IMP
MR;])%1S)3)*Y,>1I&\7>9%Q[,HPFPS6S"Q6T'@_&N.3Z2#JU.WN\;9-^(YA1
M5:4&C=G@CT%\\2<Z!Z[8C>NR:30W-.["US';8TZ1NW45HMTC3BVKK4(V2C(J
M6]5#UJ=F3JR8@B49+BF9-Q:I2)3ZYS$>MX85ZN73'$C-WB.<>08W"AAM8@D4
M2 &''-=#+8M2,C*NQE#H<F,DJ=R@@'@$T>1P>:]) -U]3.]=:=<Z-6T*@6K=
M5)ST:$[37JFKE:_KK@UO#W"7"F7<VVVQ4=)(;:K .:Z%  R4@B2F)*,0Q!8<
M<+EP;X\.-]+WC,N-_:=F\[SX3C!VA5L>\=UUP >?(UR9<B:C8JMD7N-^Q=HY
MWD%K:O(4!?)(X\YW;W]I!58'2^L=[TC55BNE V+KZ<V,1,S]ZUKJV/K0%<(P
M!,5-9]WL@K5EV*S)MF@ATZKHE")18+KL<62VZQERJZ1CD?$SJKJX0 *[EB18
M;PJ=J$5XFJKY'$-JP,:950LKH7LLB  <;;8BVO\ =%GB8>[?:?Z_@;!K. JF
MMIRU$;'TOKO>H+$_?]7ZME"*GLM*W8*#I\?L&TQ#-_O HS!+TM78"0PP,MM(
MS$J4_EY ]ET3$.6<+LR/CX1W%IU+%5.Q?0GYU7,AM8H*!4+%\:9!XD4T_0+N
M8!F]0#UXOF9?=_VE^L]*;+N=$.HUAGHG4D?0)'=5G9M5 @C*,C8XXLA""0-)
MG[&%:MER47#FC3%J$I81WP$%Y'F.$DYR/B,>C?(BL& .0L,8VN=VSJ2P4J@)
MX4L1?RDY-6F-F7:6&,*<C J-N^B*4G<Y -D*./C*6MO5ILZ(ZD-NTPG9-B%H
MT1UJ=#.HJ%'UBLZ]/0BK[IUN[/VJMR9\U#9.<K5KE4^LE)QDPNV1+7EMU@T%
MI2FN:# AQ(P1=WLVIR,26][&]!A1K<!P![OF09D<[C+D4NP7VG3XT 53QD2R
M#8O:QZD'</(RY*G]H]&V6Q:]03H/9$'K;874-,]+T?M,R=I)$2UML*6G8R*C
MV:V-,JM)<#*I@WGG["N.""CG_4@82<2$O#F;:,J'_:H73$,Q0!K[L@6=Q%6+
MZ=3QZS4:L$K^S<(V4X=]K6\$@"@=U$CJ0)]J5]I?JVZ[DA-<BU"8#I=OVQ8-
M(4G:#MMH16)[8M?3((RT9K<.P/;#@*G/G1,C&5BWR,+Z&3.0(V4/&MF)<;-H
MW7&7W#<N,963:_"'T>MA90066^.:NI*ZI&<*%.ULAQJ]KRXOJM[@I((#$<_"
MQ/2;G'.J.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(G@;U4]7&TZ7U4]5>ND]8MG
MT)&:RH6KIK2-!KVAZAME-\M]DUZ]-RT$4\1KZPS8Z"IYJ*;0H^:#8Q\=>\A]
MD4)>&/4PX$;!@?V=<I=G&1CD9-JJ] ^\!T]!Y>IGF9<[KJ,Z'.V((J'&HQJ^
MYF6R#X&/)KSOGCI-D"_M(9?5=#TW![:U-+3.^)3ISAM^;IK EDHVLVJ96U97
M'E.AA;%L$*Y+WB:,!D#(W5D1EZQLI9?$>\A33>%X^R!VR'&X&,9CBQFG?<>O
M)0&E%@'(?">LV]K*+C#H3D.(9<@!5=HZ'AB+8T2$'/D);BOM *]-[/JU!UQJ
MBY; K\YIO6_4/.[)'F:O7JQ1]*WY\I)ERL(LX>/+O%5<-L8\NLPHDG.R33IK
M8(OF19/?,Z4JC,[JI&1\02F);(G[H(%4W-,2!T]9?VH%PJ(S HF4N"H5<;_O
M&S?'FH!)YKH9\Z'U^,V6H26W;?T\[AUUH)W6%RV]3]Q27RM8H:P4^ELJ,>1.
M0]:FCI.BV&R1^,&4R%L&<?,F,J9$+2]A*5FTM,$7+C?+O5&Q\J0S>A(IE4^\
M1T](75 KO;%D3&49UR':5*KZT;4G]T,!<@E2^U$H,]5-JSDYK*?K4[KO0[W4
MC#U8>\ZZN;]QU<T6S'N+^*4R>F@JC<0#C(T><I=G2'+Q&)0-U>"&\O99NVB8
M,@#@A\O<EMKKM>KZ,!N4BZ9;!J576*5<E&4KB[X#<C;DX'52:86+4T1?SI8?
MM#K3FM;I BNGBYT_9-4Z3I3JSU1'76?HTC%W/6C3Z(E-EFVX"T=H!R!/*9F)
M:F%RK5E/A@C0Q?1S3X ;Y=(-V,G*K(V<8'*AK5^M"QS8X#"UL^@,'5-60#$R
MLN YDW%#N7I9IN*ZE2;(%=98E9ZQYBH=%6C>H/<5 L1.QMHPVJJY 4&NE5,B
M;V7L39+( 52>@W095%9@ +ZI[%M'#DCA"*Q!EK E FID%R*50Z<-J<F+&XV(
M7)8@TBI>Z^+.WW20*)Z<&Y89RNGQY<B-N?8 HVVS/0%4=HW=19X'6CQ*EZB>
MK_?5;HFC9^.TUM+2]Y)ZX-,Z9O&MY,;7UG*V?2+,#8)*2@M>7 HDJF3$=;\#
M@Q ]C"EJZ9#3(Q Q,I$#MN&O:8M/B+Y <B9%]FR9%<;QL9:HNH\0*]2*-CR/
M25RY\@7&1C?&WM"(R':=ZD,2%;W3NJKL4?/SEP0G7*5+ZVV[97=!WF/V1I7:
MP>HKMJPBW:];9C)J3'B3P+&;LDJ?#I$=1TQDP.5)V,PUM,8MMUM8CS*ARG\S
MIJ?&.]4KD3O%?:_(%B@FW<6L< #F7&IM7/=,'QY.[9"R=2 0=V[:%HV3?]97
MT#]IM4K)KNHV^#T]<;%9K1U-R?2A\CU2W:\L>/O-!JZ[0(3!7@.P-T>QU.3&
M>BV![*S,@QC7K7S7GL1X"RGK'1L&93D4!<(S[BK#P%MIM:W!ASX2+XJ4&L5E
M5@C$G,<.U61CO W6"#M*D>=U].9GV?M$X3[LI&Q&:6OPVW0NII72&+HQJ:J1
M<S*;M4*-*,1PET:DDU--7S#$YD2;80^T +@<AORW6LBDE1[(=X'>)W9P]_WI
M# #'=>[6[=?&VKD^U#:3W;;QF[CN[6SDX-!KVU7-WY?*8N3^TLJ=9K.UC;OI
MV]4R\:RV]KG0K6NIJQ41!UGVGLF$5-146):TSWR7$UL48:1D";=*SC47FN@J
MG/ WEU$?B1HV8XPN165\;Y=X5J5$-$U6XDF@ %NR!'M:@/NQLK)D3%L)6R[B
MP+O;0'.Z^G,MS6'6$/NG2>Z+_0:">YLC2YMIK-CUAFV4B82Y;H*#'G0$0EZB
M)UZDS]=F(\X0R.GV)<84G#9HKB1R!E85F^G[O)C5F\&2B'VL/"31M2-P8$41
M7I+IG[S'D95._'N#):D[@+X8'80000;KRFA_23UU;Z:U]I*O["UIN+J&W;U(
MPEOVA4L*L&B:S!,4^LDU\.2/B'(1FLAUBG)8*ES (ZUJ/MZI6,<C4"X9FX1E
MKISZ;%NR,CX\6/"5QMQE)W&^M[B6N@2OAKGR,YL&IR[,8=,F7)E!=><8&T;0
M2*V[5Y- @M8/J)M3#?:,5F7L5>E<Z:V.%T\W'<KF@JEU(/GU!=5F=D8FC*R*
MI=/9FEW6.I$G9(\R%C[J7&X!]6VE)XH&?/2/B=(0".\0Y5Q]ZV&FW!*W>]6T
ML%HE0;]+XO;VM;![M^Z;)W0R^':7O;[M[@I:P&KZ"14_[3%H6:0P#TS[9G:N
M5U)6[I+B+7$V+7"4V#>$$5,BP%=AX66LT7(XBK)\)PZ19YCX/!0""%H*-+>"
M,;;L-'8_QD##"N<@AN,9JR2 >5OH+)^%B1[9S_@Y"O?'!N!3G("0  2#1/F:
M 'R(FV_3+U$"]1M3NTRNDSFNK1K+:UTTSL&F3TA$3+\%>:*J.S,"A3D$01%S
M<;D>6 ='DQ,H9?6MY#27&6FR7\,V+N64;@X?&N16 (M6NN#R#P>#-\67O58[
M2I1VQLI(-,M7R+!Z]1- M"=?^QH8*5(WM0+S9]>R/6-L7I[!WT,O7<;7ZJ89
M?"X#7-<?I\01&VB2K\6RD.,F+J[#X2.6]EEXJ9/:<QGJRZ5"?V3*'&!,O=>,
MEAM!<[B"M^84'GX3FQZEA?>(Q4ZC)B&4;:7]H0@(%&AP-U?B9L-+]?436>HZ
ML:$MFI;#7!+KLXG4U3MIM[UH_.RM@;"=)!L+NIP;(3L",U[-.L^1%7(^/:&<
M]0%DH,1\U@56(TI;$V5<BG:F]EVO0'\.\KL+@=5N^O4"YJ=2!E7&48;W**=R
M62!=[-VX*?XJ] 0#Q,7H#[1FE;]NDK"Q.OY" J$<)L \BV&[#UG(V&M Z[?)
M;D2]EZHCK(O8NO6)9H-]V"6=#27K,Y:2]@9"G7F)RZ1L2@E@6.P!0KTQ<"MF
M3;L>KYIN)&+5+E:@I"^*VW(2NW^-+WI?-6)7E6^TXJ.W(NQPM9J4[KZ5NFFM
MS[$T':I&SZXM1%EQK&NR$F4NQU"O3D[,Z\GVQ$#V:)@;K%Y'EX@8Q67U.CK"
M=LVC;'3%@P7)C3*H5UV[S7A8@!Q?A)4\'\95=6N0$!2NY';$Q*'=L!/*@DJ:
MY 8<BY3]#^T,LFNJ'&;/W!.7K8Z8'H7Z<-TV^I1<#KV&BI6T;2V@#K^2M<7(
MQ\7'3")\@F6:=.@LY'JS4:'CX4"Q(/*SG5M('8IC"I>IS8U8EB0$0N%JZJAP
M?>L\\3--450/D+/6FPY&4!0"7;;N% '<2>1TH"A<VCD/M%JO1HSJ,(W9IW8F
MH9OIYK%!NAU6DY.E6B6M]>VG(J@Z(B'*JU@/A K!(S^18:4B#I3TL,48AQV7
M)'&.=%P&D9CB[O(F09690P# *4Y:]R@T!R#7/ITFQU2KWO>(V,XU5J)4E@YV
MK6TD63P1?'KUJW.F#J[K_4A,;&IKM3?H>Q-6XJIEGK.+G2-B1#T)=@C3:Y,0
M5UU],S5=ET+^&R ,R$T\T9!R8WHS&\^<PZYGFP'"$;=N5]VT[60VI (*N PZ
M@@UR#+X<XREUV[73;N6U84PM2&4D>1!'4$<B;?<PF\<1'$1Q$<1'$1Q$<1'$
M1Q$<1'$1Q$<1*!W)T_P6YKCH>Y2\]+1!>A=F8V;!B1K0;@TY(XA3X7X;*J*;
M6ZT%Y)ZWO&&IM_S4(QX_#G..:X\IQKE4 'O4V&_(6#8_"99,0R-B8DCNGWBO
M,T11^AGRZF.G2I]3VMF]>VF3E:^_$VJM7VH6F%8BC)*K7:H&Y.@9IF-G@)2#
MEQT9<)!D8F7CR@9&,.-%6EEUQHEAARG"^\ &U*LINBK"B+'(^8-B,V(9DVDD
M4RLI%&F4V#1X/Q!ZB41&=!<"FL4")LVU+59I^D]3E!ZGW[$W6*+519.PZ[P6
MW"4L"JU."B8&NTO#1;N5# L/22"7BGT2'@?;8'U.J-L510&POAJV:@_5BS$D
MM\^.@KB9C3"E#.S%<JYKVHME;I=JJ %H_.^;\IW-D=$&;=M?86RJ'U!;BTB'
MNSY#SO"KZT)K\>N\OZY'9 KLE W J)?MVMYAR(8:B)F3I\F([+!([/I2ZX^X
M]":G:B(V+'D[O=W;/?AW\D%00KB^0&!J2^G#.[+D?'WFWO E#=LH"C6Y30HE
M2#,)G[/:GA[JG-GUS9EMKE4M^U0MUW/68];H$FB=V PR,F26SL.:K4AL&)JU
MH)!%D+16!)I3,@=ZE\,V-4^CR)]J8XPA12RXSC5[84IZ> $(646%-<?'SK[*
MHR%P[!6<9"E*1NXNF(+@-7B /)Z5,X?T'4@^F;'I;EXM2 ]D=7JNL&1,0+$>
MICK8JQUNR?*02<CY:77?45H<?U#Z527DD/*\[QX;SA[4VY&VKX-/[..O*T1N
M/^;GY23IE*LNYO%G[_RX:P=ORX^<L[5O32-JO;N_=C1E^GI>J]0$TS;+#J^6
MAJXN$B+@J*BX23G0)]D!NQDLR$9%H$Q#%F*C!FWWE^4^1X'T9OFWX\2% &Q#
M:'!-E;) *^[P3UJY=,6Q\K!B1E.XJ0*#4 2#6[H.!="4EK'H#3K%H.I@=2&[
MY+3%3KFS*UK+3#IL!%5BI@;2$DA)5JRR4'%1\UM(6O8E2GZ8!>RI(6N%)&*&
M0L@=+N=7U6^V.'$,C%"^2B2VSI0)(0FO$5HF9II@E*,N3NU5U3'8I0_6R "X
M7]T,37QDFB.A*BQ<?TNQF;M<71>EW56V-35]QC,='G6:&VY3(BDS$I)FC#X=
MC)B*!B&S(E^)PTAHYU2W$+2VVG%3J6)S':MYLF/(?,*<;%@*\P;YN6&F4#"-
MS?L4?&.G(=0I)]"*XJ5'K/[,6K:[5 X7N>Y3XM8TOM'0L%'?)>M:T"'1=EQ;
M4<Z85\KUN+.FKE'N-I,.M4Z=)EV!UD9); V&WE$Z/K"]_LU!;(F5CN=B60W7
MB) 7T H#R\JS32!"#WC-6-\8\*#PL!R=H!+<<DDDRWA^A^E1@.@$8FI:T-].
MG3W?M P5>FUB1T3?X"\4V#J!Z[:?'A/FQ;KX< RAQ^&'4EC!Q3J!7LM,M9S]
MI8G+P%[[*F4D<E"C%AM!(!Y/GZ?'C3V=0,7);NL38@IX#!E .X@<7M\NEF>?
M/39T?=0I6[NF56U*%N"M:BZ<J?OBI$0.X-JZ5V!6(RK;&H96O*WK_5INJ082
MSV<=8$@\7.6Z\P<.4W#1T1 A- )BQAS.K-J,0QY@C8V?,V)KQID1BR-O9W#D
MJ.> JD\DD]3.7#@R]YBWKD"8ER+61\;* R[ J%*9N.K, :%<>>^O39T(073?
M;(29B]JVZW5BCUZ:J^MZ9+5;7,(W7HN<*\UTBRV>L5:*L^P)J.!QF&AI2PR&
M,Q\8\4SZ9YQY+K7-FU)S*04569@SL"YL@= K,54'J0!R?.=.+3#$P(=F"@A%
M*H*!]6"AF(' )/0S[[<Z#:1MTGJF*E;Q:HE?52OIU79TQXL0XFL?X.<F-)U_
M$#ZD=>7_ )@=&2W,_$,O>2VI60O*5VSR,>J;'W%*I[CO=MWXN^!!OY>51DTR
MY._MF'?]U=5X>Z((KYT+N9_=_2 [LW9[NY-=[MV'H78<WKE>H;S+T>.J$X)<
M]=YDBI8< J,M\)+,Q%DBRSB_@MPAG!9B-9?RTC+J6F/*C'J-B=V^-,J!]ZAM
MPVMP+M2+!KE38,G)@WOWB9&Q.5V,5"G<O4<,#1'D1TN8>M] ^J:3*0I%-FK)
M"0U>Z2;1TBQ<&I0!R,56UV5JU2ER,.=&;?*MK\LA\DC.$,Q;[YA+N F4Y;:;
MEM2[ [@"6SKG)Z<JI4*!Z4?GQ(&F12I4L N%L '7AC98GJ3?R$D6L>C:HZPM
M_3W<(VW6.2+Z>= &=/T (</&('GX$Q<$M<],*880ZU+HS!,82T$IH//GN]V_
M9':'U!=<JE0!ER]Z>3P>>!\.99,"H<1#$]UC.(=.0=O)^/A'3CK.ANSH_D=H
M;H^_RD[YV)I38:=+.:,293HBFS4>_43+7)VF3R<!;(662\443)(R(^(Y'F11
M\7$R@)B'!R!RYQZC9C[IL29$[SO?$6!W;0HY4CR'QL$@^51DP%\G>+E?&W=]
MWX0I!4DD^\#Z\'J" 1Y@TO-?9=ZSR+K:+HNS+S1(FA:!F>G UC$)0;@9.T6P
MS4C8YV8CS+A6)9BE7V<FYF6(E[A5@ CG!#,1\8W$LCLY3<:U[<LBL6RC,.76
MF   .U@64 "E8UQYW,SHTI KLH3&<716M2;)&Y3M8GJRT9]MB?9JPFPM>:_U
M67N^YMT6G:<J>E3H";HVK[R&3!U",9A0K;2_G2KS3^K=C&Q3+8LA;*<^PXX\
M.%(#A#2 :"5$UA1F<8UW-D;)89UY8V5;:1O2^=K?+I#:0,BX^\;8J+C*E4:P
MO 92P)1J\U^8%S*6S[-FA2EZ,ME*V;=-=15IKNJZQL6O@0% M1MI T]$1]<J
M9D-<;E6)JS4::+K<8'!6B2KIB,6,-E*SAO4J=><A=6P0*R*Y4N4-NNW>22"%
M8!@";4'IY<26TB%MRLR[@@<4K;AC  HL"5)  8CKYR86OH'HEJV?9MGO76T@
M'6;J(Z<^HEV($$B,QP4YTX5ERKURMBJ<'41F%GA7//EW7%J-9=3A(3K3?MR!
MJF"!-JFL.7#9)LC*UD_,>7E).E0N7W-9S8LU<5>(4J_(^?GZ3[170=2(FE:P
MI+5XM3H>K^K975S&F."Q&"I*U*G+5.?*AR4CX:17_/M93'J!THD?*%'SYWC4
MYE4'5,6R-M6\F#N".>!2C</CX?E)&F4*J[F\.?O_ "Y:R=O3W;/S^,PNMOL^
MJCJS;(]XK&R[4Q0(S8EIVI"ZE^5]=H%"MML<*++$+V"W5\;!E:;%RAI$M 50
MF;2S'')%<=.,0PM#\OJF?'M9%W%%0ON?W5K]S=L#$"BU>O D)I51]P<[=[.$
MVIPS$FMU;]H)L"^OG/0;G+.J.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(E T?I_
M@J-OW>F_PIZ6-G=[1&KXB;@BF@TQ,(UJV$DH2,=BG6FTF.N2;,DX\=@MQQ*'
M6T8'PA&58SJV4MBQ8J &(N0?,[R";^53)<07+ER@DG*$!'%#8*%>?/G*7ZBN
MAZ WKLP7;T)L>P:LO;^NGM2V:3B*G0;F-/T-R7)FQFQ0;Y7IQJL6Z(D#CEPM
MV@5"S,>T2IC&7FFV4MZ8M2<2=V4#KO[P LZTU =58;E('*FP9GETPR/W@8H^
MW82%5K6[Z,#1!Z,.ER>U7I*H=6V=8=BXEIN:8LG3[4.G21J\O@!<>14*D1).
MID2C A@RGYB99DR&)53>!Q5]U.C#L*7VQ5L[,BI0&W*V4,+O<U<<^0KB77 J
MN7LG=C7$5-5M6^>G4WSY2D:/]GA%5VME:RM_4)O#8NC -9WO4=&TY)2<#6ZY
M6:9L ;(4BF=-JD/%';%FZ^#X&*3*W+!Z*DM""HL)!30SH^C:LD[UQ8DREU=L
M@!8EEY%!B0@/[P6MW0S-=*%&PY<CXPC(N,D!0K=0=H!<@< M=>4Z56^SE@X?
M7.T]<V+=%SMD?L+3F=%Q)>*;K.IJI]'QV['>FJ-7B$6J[$8:#;E+=8W2CI1D
M(=!3.<I\?).K)='&-5V9.](W.VYO3Q$[5'DJBA(&D 1T.1F#X^[]U%I?7P@;
MF-"R>LMB;Z+*/8;4=9I*U6?*9+HSF>BPV.&1%LMKH\Y)#R!MJ9)6(\XU9TX8
M\AA&4.1:$KRXH1Q2<8YF-0RJ%"KQJ!J+Y]X"@O7W?S^,T.G4DDL><'L]<>Z3
M>[Y_E,87T4QL_P!+.O\ IIN&V+I.&:F,I<KK';8$55J[<:9+ZP,9<UF?'QL?
M%KKQ:ZG%BB0*U28)A<W'(((DS5S!2I1N?::SMF7&HW[@Z6Q5@_O\DV-Q-\<#
MR%<2IT]X5PMD8E"I1Z4,I0C90JN*KXB8_'1&1.QE)7L_J$VWM6X5+J:UUU./
MVBSK@QH\B?UH&7'P=+KE(B0@ZE1*82.4IV3%K,>.<=(*=.(,=4H=H5[31;9B
MQHK87P[19X?JQ8DLS>EG@1[/87?E=V7*F:VKJ@H*% "JI\]H',P>ROL]*;L)
M.RRF]CVF"FK_ -1])ZFQ#,P=6L,/"76BUINK1L*?59^.,A+?4R </%EQ$^RZ
MER2R*3E:FPTL.V35,NSP*0N%L/5@2K&R0005;RL>5^LA]*K[_&P+95S72D!E
M7:!1!#+YD&^9\J7]GA4*@NM//;3O%B+K_5JOK"=.DXFG@/RVP#*6/3I:%(%K
ML+#0X%9-0,B1&"AXJ/\ A:^P(6$AMMH2;5EMU8U6\'L_!8TF[<#XB26'2R3?
M4PNE52#O8UF[_D+98KM(- "N2>G!Z<2NNH[HOE8?6FP)34,)?-F;%M/6-&=6
MT2JL7JD:XO&M;:N+!@RIG7Q]Q@I6F6CX"%'(QFG7%4:-90)248S.A'C1GCOA
MU +H,A5$73G =RLZN+NG"D,+)]Y;VD U5RF73D(YQAG=LXSBF5&5JJT)!4U_
M"U!@2+Z2L-+= 5SVI2NH WJ'>V)1K1L?J'U]O#6,Y<);5MUVI7[-K"K#1,3=
MKC'58*:U(0F=-.GPW*",$1!A58G,$D8-ML-YNV35*C8NZV,$POB<*'7&0Y)*
MK>W)QP=UV2+L\RN/3,ZY>]W*7RID0L49P44 ,P6T-FP5'%<<3T2TKTZ#:CUQ
M<Z0=>IJ\RU_D[#+62U'P-2JZ6GIZ/3&)CZ[5Z=#0U>@(&)%1C,9%M#$Y:?>*
M6LMQIUI@?ER9=[JVT*%H!06/3GEF)))\S.G'BV(REBQ:R6I5ZBN%4!0!Y<2N
M=/\ 1'3=.V'IXL43<[-+D=.NF[;IF 'D1HIMFP1%ME0)4J7F,C#H6S)"N@(:
M';"RT*IMQ>7$*5C&>7?4LZYE*@#-D&0\G@CR'PE<>G7&<1#,>ZQMC%UR&())
M^/'E*^A?LYZE#6.O1WWP[,.Z?:=N-W?E1Z;R1J@FG0NRE3)ED%6JUL0#=WD:
M7%V*0+FHZDF3"XW!RTNGOGYR3ZFQU;$$]VG>MC[ILWBW%*H^$G:&(%%@+KI7
M%5&E4$#>_=KD[U<7AVA[)ZUNVACN"WP9+A.A"D!QU7CD7>U+;JW6K)];(SBA
M8CQDW&3)L)+M-?Q@?"4UEM5A(2@EOM*9P.SE3^<Y7WK[4UL=J^+3#3>?NBO%
M\^.G26&G4!1N/ASG/Y>\23M^7B^<O31>AH/1*]S+A)R5F\[HWM?=\S&)5H-K
M$/-WYF#8.@XWTC;?F10.(-E0CI7F%KR^[YSBL81VSR93E[NP!W>)<0KS"V;/
MQ-S3'C&/O*)/>9&R&_(M5@?#CCS^<U+B/LW( "7C@I'>VTIS4K/4#)]3,MID
MR/I+5:F-H/V8JT1#BI\>O(MPE8C3'1<&U9$R[%S#P#<@ML,]\HAW<ZLD&L2!
M^Z&$9+;<$VA3Q>VSY-5BZZ3 :07SD<IWIS''X=I?=N'-;MH/.VZ- GF?*%^S
M5JL'LJ+O8NXKNY$U_J4+ZG(2I/5?7OB5<9<R3+FXZRW9JNM7NU1N42QX-?5(
MSZ%P 13Z<HDRLL%CCK&*%>[6SA&$MN?W10!"WM4\"Z'-#I TBA@W>-0RG*!2
M^\UV"U;CP2!SP/CS,I6?LY*:%N>O;>O>T+7M%RFKV$JL@V6JZ\CK6:SLB(EH
M"8C]C;5KU:C-@[,BXV&G9,*"!L,LE "'6<.*)99RPY!U;=V<:HJ;MFZBQ4;"
M""B$[$)(!-#F2-*O>#(SL^W=M!5 WC!!#.JAW LT">.+NI^=2_9S5?5#,C"#
M;>ND]2A-=7[6=!JQ=5UM$/5.$V &9''2$[:*_58VR;#GH6-,>C*](V8_*(\!
MT@=0S_G>-#)JSDY.-0Q97=@S^(K1H*6*H"19 ')C'I5QV [%0K(@*H-H8$62
M%#,0#0+'I(_._9=ZUG:+(T1_9=Y8"DNF_373:X<T% 9*;KVF-CQFR(BQ(2L3
M+.9F8D8QN.DF5)]"V$XM8K2'\)7BRZUU8,$6QFR9N2:O(A0K\@#8^,J=&A4K
MO;G%CPW0]W&VX'YD\'R^$N+</0KK+>%BW_.7:?M&6.H'6NN==S4?%+C@\UA6
MKK 3:JK9ZZ:Z&4Y\9%GG!#UM2+1<>[Z!L=X5T9\AIS/'J7QC$%"_LG=P39W;
MQ3*1Z58X]9IDTR9#E+%OVJHI KP[#:LO'6^>;$GG3ATV.:%7=).7V1+[,LMV
M>@TFR1E0H5"AHF-KH+H4>! U37T!!1 "R\ONFSAB\$.RLCE)>4C+\W#U,N7O
M=H"! MT-SN22>I9V)-=!Z"6Q8NZW6Q<M7.U5  %  * /B?4S:#F,VCB(XB.(
MCB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB.(CB(XB5_MB:DZWJS9=BA2LA3,!
MK^Y342;AIA_(DG%UR2. *PP4T^,]D<IAIW#1#+S#G@\#S3C>5(S9 "Z ]"R@
M_(D RKDA'(ZA6(^8!(GCET);_P!U;GE=#RE\ZF^J&PRMOC6YNS4^3Z/JG7=,
M2;[,%)2AT6G<\9K**&9@W,!JQ&38$X/F1-P(",^MTM#:_0U./'C&4+AP *:5
MAG)R#D 'N]Y-^H(Z3S]-DR9#B+9L[%A;*< &,\&QWFP"O0@]?69_:'7=LZL=
M<&5Q5P@!^D'6&V-<]+VU8!QBN*DI39FQZ_9SY78;4H0$NRQ\+JZSDT^KVAL>
M09C4NX4G +RRB2V832HVFY4]^^-LR'F@B%0$J]I+KN8>?X2SZEQJ+!_8(ZX'
M'%EW!)<=32$JK?I<P'6#U"]3FK=\[7;M6W]K]-NJ88.G/]/5ZKN@(/:?3S/^
M;"AOVIW>%P&K=KNT:<]8UEQ+D7& BKAXII$D$*]W8+EIP8L+XDVXTS.=W>JV
M4IE'/'=+:J>*(-\DT?01GRY4RON?)B0;>Z9<8?"W OO6 +#FP0 * L=03N'1
M-[[&LW7C5=4NW:"G-5SGV>M5WNJ,J8<834I;8TSN3Y;=NU:L)$?FT$04C7%H
M'A@R)A48Y&.#'.1_Q%:RLX-B0:5LFTAQJSBMKW!!CO:PO;8/7B[L74W7(QU(
M3<"ATJY*6MI8Y"-P/6B.G-5.$_:"UHWJ8G.G&"UM*2QM6V+$:SL,L_L/6-?M
M3,K*1H4BY9H/4]CLL7>;1K^+1(C)D+1""DK<1A]V,BY'PL()CV5NY&8O0*%U
M&QV6@2-I<*55S7 /'2R(]I4YCB"DE6"D[D!\K8(2&91?4 DFP 9)JKUH'WW:
M$M6*'T];7N&IJ]N65T'8-Y03U7-A8G8D#G+$^4_2FY;-R^[Z"D?#'RNP,@MP
MX[V<K;:?1Y?F0VGVH&;+C5SC&48SNLH>GBK;O(Z)=RRZC>Y5<60H'.,Y!MH,
M.O%[MH/!:NOE(1#?:,5B7L5>E<Z:V.%T\7'<KF@JCU(/GU!=5F=CXFC*R*I=
M/9FUW6.I$G9(\R&C[J7&X!]6A*3Q0,^>D>QTC $=XG>KC[UL--N"UN]ZMI8+
M1*@W\_.@U:V#W;]TV0XAF\.TO>WW0=P4MP&KYU(W*?::0<+%[JMTEH?8@VN-
M-;+MVD%WM=CH;(5UW17KU%4N*H59BC9P.4:1.#R[-G)M,PS'5N!APY1DLXB2
M"]&[8:,DXU&5-^1%R;*:UQE2Q8FJ-41M')-4.9!U@ R-W;;$<X]UKXL@;:%
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M1'$1Q$<1'$2NMP?O2[1_U=7;^S4GQ$L7B(XB.(G&?IG]6>(D$U9^]CKG\W_
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MB(XB:Y=4%SW!1==A3.EJNJU61RR,B2@S,;)S)@4)BOV(]@@&*AX6Q'F/R-I
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MX17!NJ%VGM_4'6K/63;D[K_9-WAVCG=X/:SB(V^UV-@F,#ZNUD_H<94:6PO
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M>5CB(XB.(C..^.W$2-0M4B8..-B1DD% R!TO(%,R9"Y##A$Z81(RN,Y(\7Y
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M]O=.%<U/9@) P]I=E:@D@>'5G +/2VUN+2JH/'B8A0#;, "1D.V-O.;LOMG
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MEKQCOR[=C=KH@R>PY,^,W6;0[=?B:K\]&V8J31X\06BI;=&/M[LASM.NQX'
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M6*_L0"15G.<=\XQ\:K]9QW[YSC'=SP_^EC'OSSETO9NU>Z[2*@* ASZ'+84
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MQ\<8:("[*DC,+=:CAB!!WBU([=VFWS7F!6E9QWSA3[S;?MVRK'?')5D) +J
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M\+D-\IIY;TP>ESU#VOKO8<>A':&NVX]1EU Q]]D*7D3&I7<V5R.,=F@ U@$
M*(OS_>\SZ_T\Y9J>G'03?^8TUK47\_\ B5.@P<8_]G @3.$_3'[GMS :_7J;
M&MU=CI>HRLO_ *"Y2OA5?"+)ZT?H/UJ1^W]-VG9&MS<>/KW./7Q)\?Z2J2+\
M+(NMFCN#+0%YLQ%Q'GI2ZI3?Q%S G=./.2ZC\DO=.V.T1EQL^N>E8,.\HJ-I
M%V%0D@_ 6/*1]:YOJ?Y2'Z8Z6=/UW5].KMFT_$$R<5!A!R(^Q0X&\R^#D-^,
MQ14F^?9Q9'QE+>R@QT\H\MOPDR9#\@Z2^Y;6]K=H:G/E<ZS* 78H<)[I0"31
M4*J&J]?4\".AXX]*^/7X_.7!&:%T=#/^JB--ZJBB?;L1&:\J4>_C.,]\9\X2
M):<]L^^/Q>V??';G&VMU^0;<FOUF1:JFU.;@?"L@^^DFS]\_K$WKC)UTI-FC
M@Z<,+3<2*1FS:VDF781+);8-3#2;)(Z8G'IF6\(PD9WQO9[NYRA.$\HF1TQ9
ML7?:D]\Z,P[T=VP0W612A?)9YMGW7S9@GKZGS'].+OY_SELX]L8Q^CF4B.(C
MB)$9"HLR%FC+3F8FQ3(D,J/'"$)8;C'1#B@3#FRAE#+6]DMV,C\.N><A:6Q6
MT,Y:\3N7+*[*CXP,=.ZN3L\?A! IK^)YKH>1P"'D1Z^?G])(#HV/DV4CR8 <
MBRE:7$M'"LE-8=2E2<.);?0XE*\)4O&%8QXL84K'?LK/>H)!L&CZC@Q.TTTT
MPTVPPVVRRRVAIEEI"6VFFFTX0VVVVC&$(;0C&$H0G&$I3C"4XQC&,<1/IQ$<
M1'$1Q$<1'$3SAW?<.F/&Z1[E*]6>Q-17ETF*T5-P^LRX14%+2.O99=LS'W-T
MW5EV6$Q5R=PB@SUB-G(BLUERSBQ!Q\3,&&(?Z\:YN[VC N11>4%[L!P%M:=;
MW!.  2=I/(''*[8>\W',R.:QD)5$H;\7@;IO )) %@<$\^CW.2=4^3[#)3#P
MQ+39 Y#3C!##S:767F7D9;=:=:7A2'&W$*4AQM:5)6E64JQG&<XXB8(&H52,
M?BRHVLP$>3!QJX>%("AX\5^(B'%I<<BHQU@=#@$<ZM"%N BJ:&6M"%*:RI*<
MXBAZ"+\O*:Z;7HTK69N3N]8ZBIG3;^Q;M019:+DW-.-5:5,81 5J5;@R+_K2
MSS2K<?18(A,#$CS2P"IP$=Y<>@=P]2JM8-C][J3Y5T_GZRPYH5= ].OK\?OK
M)E]T6R/X4V[<?Q?*_37_ ' ?FY-'U_,?Z3^O'QE?I./NBV1_"FW;_5CIL_F_
M^0#_ &_LSQ1]?T_TQ.?NBV1_"FW;_5?ILS_[@.*;U_,?Z8D&C:=L"0O]HJ3?
M6->2LP4!63<UZ. Z9R+U%2)Y$TY*DV6&3HI:X^#*C':H[7GUBL.$OO2RGE+8
M4 K,"[(OI?IZGSHUY<?TJ37 ->O/-?TDX^Z+9/\ "FW;C]57Z:_]_3__ -_)
MH^I^/3\O#_21'W1;(_A3[M_JOTUX_9H#W_GY-'S)_+_2(GP*U'M%(I&0^J7<
MV3,,.^DP56.F_ V2? KR,$9;T#AWR/-\/F^7G#G@\7@SXNW((-'GR^'Y\#C]
M1UB86HZVVC-56N2YG5ELZ2-DH.+-..J\%TVGUDLTD)ETM^OFJT(ZLJ&<)4XJ
M-?<=<<=#RRMQ:EY5G(7Z_I]?W>GI_>2:\A5?._K9,D7W1;(_A3;M_JOTV?W
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(1Q$<1'$3_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>15
<FILENAME>g723949g14k32.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g14k32.jpg
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M 0$! 0$! 0$! 0'_P  1" #> 94# 1$  A$! Q$!_\0 '@   @(# 0$! 0
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MJZNHN-Q7U=-3.O4] >&C3^]N-H*DL\\9]4%K60$Z^0X!,P8.%54]2!*6M4D
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M*6'[#?32[G]/_9Z=M_H*)6WS#[5 @?YE$_\ ^6#Y]ML:(XS>789.1_\ 3O\
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M_P S'7(&W[;?P>?)\[>?.WKR?T'5'?VGI'_@83;_ )5C'E<:E(G]5SMM6_\
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MX!_VK_\ +O\ H?2,8IO[0...3MITG,A'EB==!% ^_G^#GW;_ +OC[>?/K'^
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M6$LK23N($I MM)Z?/ -G],7J<4&*J5Y(PRM\LK[2NTC+WOH=B590-U"\MMO
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MSY]=_P +?CAC[P3LFUX,].F_?TQY@YS,LLG-5+>997)+#<G?DQW \;;>P\D
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M24ZZ8:DDK/.!D.@E(20-H$?L[SUG&Q2R>-QZ5(PZ26[<BI.Z%6$,)42=H_\
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M>Z@QUCZ6\O6V]C;&Q9!C81VV_/3TQL$Q $SV(X(P-^V&!8[_ *;?5N3[^?\
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M=(R4=/VCFW]4?.\[8YG35N:DJ%# \FV4 LS>=@2>(/G[>NNW86%E/B($6O\
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MA!LA2$JF8N ")@6VB<)/OM)<=9U$+81S%@20$A((*3U)!!CY],//6_\ 9/\
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MDJ]:Q5RF NFM!2AC3Y:^++4YYFL)2D$2NZQF5RA8CE'VXYMG[^>TN9Y/4O\
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MMW\L'<KR]%(0'T)6IPA0)BP ((!(MOM:>IQ9:">]%L8:U.D%.Z%D#RKM['9
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M6"+=5%EK;GO;%)2)!UR4*2@$*(OJ2!K*2DCL+QOB<<#OT5=Q#QJTQ7YR[D]
M]P_^ITY^:Q5>TQ4Y8M][PYBVS6A+S^IU#E2T'W6>2MPKE+BJWQ8G4%RI+/\
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M /$*7,KHWJUT6;6TDZ2"E(<=2C4(\/A"BH]XB=\<M<)E%TAF=;1ZCCO5M3X
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M)T@^ID$8;.U5'1I4EI"%D3!^=I'2\6 OTQ._PIH7 2]RU6LZCRX;ZK6;_O\
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M7$!H)N>ZL  =VV82H3&5*^H56,ZC<V(WBVWGZ7C"J/LY*A>VK>2!;?RMY=;
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MA-QK$>\<ORM<!BQ*I;7LM=JJ:J:H96NF20G62HC<#>XF+V_KQ7W$54IS5K;
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MY'-'<K1L[ %9I -R3[ >Y/C]O8^?2CK32VE:B=&DE8!DE(%Q.X3&Y%["+7P
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M$D4$'R G1&B)C9)98V90WOZ.<2(X/X>I6ZS*J3*??%EM3(HTI]X:6NY*M02
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M ,3FINO>.UKJ2+23YNI7S-RY%B(Z-7+1W[%&BE:O;G45.Z8809$='CB382,
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MO/R#ZM[)Z,973-)38(24CI;4J\_V3;ZP%-%5\89G[QRBTT^M*PV1.@)2E.T
M7*9N"+^>*OYF$NEE8SSEN<W?8['F_P#A&V^^['V'] 3OXS5.<Q>N#N3O^/R^
M<XZX]GG##&44S1?2E.AIJ)$7U3U,_6!<GL,!5K1<^9P.4JK'(DM:.K;@/!FF
MCD2RL3NFY&X59/*'8,0-_?TT FWT\C;;_*D1U[WN;8S+B/+V$-,A0-P@W L;
M7L=CVBWE;&II6AJC1^5J6ZMF2:]CIF^1DEB1(K%8 <J=P#@KJ_MY8E0!QV8
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M:PN+;1]FD:)!*%*@*!62 93)LE4   D@G%'_ (D-8:MT+JK3=3'5<MCL=J?
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M5RS*KCF3R!W4-4H'1=PBRC,DGS/51@ZK&;C?#2CR!KE.5E?_ !5I[4MJ1I=
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MHF6ZY_5I<+8YB5&0(7\P?+O:UV5F6NYDR@4]8Z]34Z0IE)65:4"^EM-Q&HP
M(/08*-8: GP@@BTYG,CE\@^1FOYZ/%S5:6/@$B5H5KT8)*[K9(VE9I)''U#?
MF#X](T%?0/H6S6O .'40HW*P9 !GH(GM)M-\-5TV?4*6#0KJ$KU#F$+4E9;
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MCPV>JPD\A;JZCC,;AG4()(94A[\;R1^.?D=39NWEF:/,Y>2C+%/:U.MS+*Y
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M%8A:BJK*BX DD(T:=P.^H_AT.,H0&'%%(DN:=0(-B+V-AN;8'OQ"W1F26/\
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M27)59NGMNO,\5K15*KD8L1E8_I^>FK4)'BDQ]A4>')5Y>W(P^7FA,A[U=S7
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MHDG3L?O_  /3;";_  ]JTNM/$MJ&H!8\4FX%C!'UQCUCI2#6^.DR=!H&R=>
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M+-A)I8Y;<1"[\HXP$>:'?_WVOQ* ?6!MR-Q\/<4TM8REJI4E"H@RH6'U!'>
M=^O3%1YYPY44;Q=1JO\ "J^DCM)L#&PG?:=\,7X2>I<NDOB)Z2WM<PV,+A*.
MO<$F8NV)!^%U([%M*<60N//YK5:%J:&[8G+E(8J[S$[)N#^84 J*.I+,K<Y*
MUH OJA.K2D7,D62/.+8K_C9.:5?!W$F7T[3BJBHR>K;;0C4I;L-ZG&6P+J4\
MTE;*4B2HKTFYQ?'J]TH^*#,_%_JO3VGM(9:SB=8:^DS&GM;3XW,IIC&::R-F
M*[4S-G4U""6I7KZ>I,L5I(Y_GHK5+Y*K7DO258)8FXU2N9<TM-0A*DM0XV%)
MY@=3*2DMDA1*C=-H*3JF+XBO"7M&X3RSV;Y6:Q^@5^J<F315F5\UCW^IJF6U
M-.4J*)TA3CE:X"I)6CDK0\77%AH.+#SZ"0ZD&B_BZZ.0287.=4\(M#Y9-*YF
M;)P:L7!3WHL[5PMN_6H7;4U2V7QEB.S5@<WLI%6XDNS>A!I7:-#;H2HAS[1&
MH190!3(,@:@=0O!W!P)XVS6@J\]]DO&5135-!PRXY4H>]_8;9_5JJU#!HW*I
MME;K3*5MI34(*%J 9I5. C2!C^Z68GJ5B]#ZPU[J+3>5T=@=)"E\U1UA':P5
MG4%B1YHOE</4EJ<KEJI8:M7 MI6KO9O)!!9:9+$<>16J*2I3:@4BUQ-^UOWB
MYWZ!]Q;5\,9CG>2\/9?64N<YCG/.+3V4.4^8-Y:A(0LNUKS500PTZVEQP\DN
M.!JG+CC006U+L3UCU=KB]TZZ/RZ,TAGLRFJ-("]?DQ&'R&4&*#T\/)!!.V.K
MS1P/,MB7MF0H'$+]L, =M6W9)4!',\0*C\.^_G?N.N*[X'R/AZFXDXR1G6<9
M=0')\X]VIVZVMIJ3WL)?K$K4T*EUM3B6U-(U: J-:=42)0_1SH=K#66JLE%G
MX<WIO%TA7R.J/G:=ZO=:O(6L5*J8R6)9;5ZX(W>FDD#HBQO9$<K)%#,Z2H,(
M49"EN&PD&X[D;"3?Z [XL+C;CW),DRFE<RYRAS2KJ"[3926'F'& XD!MYU54
ME90U3L:DA\I<25%26]2 I:VWSK9=4:HU)I'1^F])YO2^&QL,^$T7%EJ=[%V;
M,4:0OD\K--9B1QM%%!8N<#+)!71)9]YYG4[(T(2M:EI420I>D@B?V1;?K$VG
MTG%>9&<JRO+,YSK,\XH,VKJI;==G:Z-ZGJVFE**Q2TB$-K4DRXMQMB0A+KBB
MAN&T @=ZY8/+:*Z9Y?IQI7":@L5LE8H9'J'KZWA,E%BKD]::O+2QN/MO *L=
M&*ZM;\_OF/F!762Q-;M,JM)#KR7%+2D@%+384-0G<Q,[$[>9M%T^&LQIL[SV
MGXES.OR]IRG:J*;A_(6:VF<JF&UH<2]45#0<+G/6SS/!H"M/C*6T-- \M+];
M)Z=RBYFO8KM/6[RQ//1I7X4$B]MV>ID(;%.4JOF,S0/L0-P?'IAQ3PRWQAE5
M3PB^8H\U:*GG8G29YFQ.DP4VD]=ML3'.\Q-9]G!"$R!"E)@)@BX/E%O0&,:T
M_6+4V6RBXK5:0ZHTZ]=I4NSVI,1:Q&3A)L54I_PX<=\Q7,T*+(U^)BHFDKQ[
MUV9?7!U5^B?Q#E/&--E63/.N</4]2DYBX4D)6PXI.B  ?&E"5I00H  D= 0/
M;J:&G8*RZ&U-^/<$K)!&DZY,1<B1)@WN"N+.+SV8M/E<K;DACDL/.7E>17^L
M0_4R<MY"RUH8R[M*ZJ/I)VV]=_<)>SWAC@3)Z>ER&F;YKS:$UZUI0I1"PCFJ
M)TV(B+F8\HQ$JOB1ZH<6U3!2@93*3$=S:3;SZ_<Y-!ICJ]^NHO+:G=AP7FK-
M&-P.XZJS$*%W WV(('C8>C]8VAJG5[LVE)(ORTA-H\@)F]_3$"SH5"UJ>J H
M3)(43^!F?OL9OBTVIM;TXM08;3S6&J4X8*T%8P.8PDI1'#@J>2?S<S)[*=R#
MZY/XLHJO,>*ZIJM2IND34)#*C(!3H;N ?"09)MVQ:_#684M)PA1JI"VY5EE9
M>;\,@\QP08DFP$2+S<8J?UDT?5R&<L6VJS9V=;HEGAKVYZM[O6D*XG,TYH^?
M?1Y#"UZ$D*[1[DC?U&7LI=RS/J1FGU+8KUI8=-X"4@JFP(Z[VOO.+&RG.59K
MPO6)&AJHRYGWA*2 )).@  "T$6M^!PS;5_(382]T_3(8/3N4S#U+%VOE4MUE
ML8NW!4MM%7N&NP';L">LR?1("GC=O'JUZ?ABGR5]QUI>I=0RN>R2M)3?TWV]
M<5&NOSCB$)%289I74K.Y);;7J6 8L"D$=KWWMLXKY;3%9L9:J8V""O!'%2NX
MB^ERA?<*6GWG>$.ME=B6ADXGCN0Q\[1CB"@_4[;=2XTY4)JC #<_M7WO/W'M
M@[E&8^^U2Z)IQ%/3TN[CA\.E%KD[7_#:\XJ1\3NJNGVI<7IZ.QE,-B<[IVYE
M:E[\7E@AB$%NQ6F^;2I%$]JU%5EKV%[O;2%9=MI/J7U?WLF]GW$U7PRWF>7M
M*:HJANK>9IUH/,1HJWT.ZIN-;H4I*=]*@1..4_;Q[7>#.'^,:G+',SXH?K6'
M,N9J/U?3M.9*I3N74CJ?=7.?J6$H4$5)*0$U(=3)@'",Q&B,O%IO'Y^?-4JV
M1Q\(GTMJ]<G6TWBXL?E89C6-R]F;$,<Y$=HF(0PL8S],H\@$(_2YXUF=915S
M"F$LI<<2XXDPI2%A&D:HDD*4JQN$GUQ-\ES;ARKX<H,XI'*POYHXUEZFZE#3
M:@AYHOE<(>49U-  :1UO:,!V2AGH8@#5=['9N%K(GR&7/4#I]:?(<(HU6U'9
MER\0KU]VV0211RA Q= OU&#<09'7Y@H\MY(($B"=QN !';SCRQ<F0YCE>598
MW0.-JYCBDK!,:M*HVG5TVF?G@C^)^M5B^'70-S CY/':<U!6R]7&T+$3W8US
M*LAGQ24A/7G@GFNO+;L59C6:-207W! O@M?$3=:\R^?V3<E1VU1$B\ ;^>,<
M6TO#SM<FJ80"$E)\(3 @)[0")GY#?"QT#J+&=/,&=>:[N6:.E-1U;5/)86U&
MM+4O4.6W3>O1Q.FJ3%9,;0JSCNWM2WX/EH!(8:Z3SN(O5@T;RZ1#XK%@NK?=
M4(/[!TZ8VZSVZ>9Q",YR]G.W6WJ!.E#3*&=($C4WJ!-MOBWB?+%P?@XQVF=4
M]*\UDL)I2;2U3&9[,Y33.G9<[=S<V>H2SQ-E@TE_&TK=2W6DK&6H\*S5; CF
M$/%!N1U7EB<ZYZ&5Z2II:P;1X1]+R.WF,)9=FCV0%EAYI1;0\WJ !%Y$6T_+
M;>!??%F=0]2JFG\%4BTUC$LY"REFMW!&M.SB9R2R-?LW6B@A68;;32'BKG?R
M#ZIO/N%\\IZ"I]T(4=1@I"IWG?KT$P#?J!&+]X?XOX8KJRE17JY1TB4DI D#
M8I(L#.Q-S;"ALZ%$N!MZDDEN4=80W"(WI8;)YW%VGM 23T+>0L8N'$N[\FE>
M:.T*G,JAE\@^EN%N%LRRU259G5-OA7B@G5$D*()5-Q,;2>D8=\2<5Y?55!S%
M#6AA*>4G1"(2B4),)CH!V^F$JFEM/:CQ6K;76'5%#X?H]'34;L6JL'/65<V]
MNW8AQE5],7*R0_B-U*]A'K5.=C\UI()&C3N+<"&6&:-264A*2J3(%U:8.T=(
M^8O;%+YDZS752W*?5H>\<*5^T2;S.UAVZBV%-U%UAHW1N+NY30]9NKU[)5X*
M^G,]JC'U8,)BX(X]JTXH3WKMBU:XAYNVT$$*'8$UTYJ?9>I27!H$D:H3T,@^
MAVOZ1WPU>'N=(O69@HG5?XC??^_KBR?0KHSE=:Z._P!IVM^HFI\]A(,;AVIQ
MN7K+7GM"**?%:=IVYNS1I592T.Z[Q+7@!B#)MZ4K7D7+MI[]2;]?OZW^9VHT
M^] :;@Q$ FPZ]1>.@^\8<O32'1>5UHEC2F,UIF,SB+OR>/74%RC:ITF!*M?C
MH0 ))\L=I^<\C1JP5]M]AZB^6UV2YE6K:HJ9::EIU2%J(D%Q"]*U WF52>X!
MO.)C54-?P[EO-K*ULLOLI<2VE1E+:T:D@B=PFW2(ZXLKU)U$,-CJ>..2M9&S
M7AD>W<M21]V:[,Q>=.,2I&D43CC$B+]*[[[G;U=.3M5+-.I-1U*"WO9.F(O?
M<#'/.8T[&<9TW44Z;-%2'+3*U+U DVM$_/I?%'=1:BLWK5DM,2KGV'WV/G8_
MI_U]_'GT4-YD_P!0W'29-COUB-\6=EV7<IELZ1*0.GJ+])O,3?"MR4DI[C,$
M="3[-N=OW&VWCV_R_J3D #;H(_O/R_KWQ+*-HA*>@ZW^^W[\*S45NLL; D^X
M18U\.S/N%1![DD^/&^W^+;UX"Y)N=OET[?F.F)?2#EMH4;#2F)];"W?IUC';
M/I$KKTKZ:K(I21>G^C%=&]U<:<QP93O]U.X/[CU\D^/O\8/'O^>7$O\ INOP
M(?4%//*&RG7%#T*R1A-_$EJ#4&"71IP52A:%HZA6VUXSA8C$,)\N4[*L3S[L
M_/?;^5=M_/KHO]$MLK7QZ1'A3PO,@]3Q#L01V^F+$]GI4#FP31O5<^X3R74M
MEN/?8G58Z[QVTGH<4SRW537]0NGX5@90-P>U)>4[@_9F5-_\F'[^NUD4SRDP
MDI"B+&)OY_VB/WVW3I<)05Y35,M_M.N/MJ2@']HIW(FT6/D!; /=ZVZXG=<?
M9QV)QO<(7YFS):FB);;8(G</G8C8$;G<>?!],*I=53'QJ0=]D"T=P(G^NV'2
M@PRHJ0V >\").QV[_3&:*E-JQC/F-05XI2@#08^K# K@;$MNT>[G<^229/;?
MP/23=0^\ %04$=$"=ND?@/[<**75+0"FH0E"O$$D'P@W O)^7A&]Q?!+BM'8
MQ(N,6I=0!!MR2OEYX7^C?P(U>-0-_*@>/N!^BR4)0XA*TREV09F#%KB?.(\M
MC@=5(<  ==2\%SL#J3$1>T3/I;RQ+3:4Q-6I+9J/D<E"HDEM16[*RWXI'(#V
MZ\DBGOE0.[:I[L9H%9HU,I4$1GV1AU'/ID*0M"2X-!L2@%0M$$'K(OZ8*Y/F
MJLNTLH60TZI*7.;+@T$A*P%*NCPSI*?A5?%5NH&A>,=S*THDDC1NZT=169UK
MEMN]"O!=T?</(#NT9W  /M"TO,_];/(5[X/#,P >A*=M_0?*,6I1NJY:*AA<
M,E,I"O$2!<ID]1TZ].LA+T?Q*A8,T"2S*L;[J(2TICV.P=5V8*I!;;8E5._C
MQMLI IEK#DEVVLR=!\-O";"Q3-C,$^>";;M#6HU.I)<7U)@2( ^L;?OM@RQ&
M;EB99$L35)@5+JK2PN#ONQ 4^S'R_P!Y&^J0,=O0EYEA]4J92LR2=201_P"+
M! \_.8WPS53*:4X  MAX: A<+2(,^$$D(($7 !M;R9%+5JRU[%>[-9FK+ 7<
MR<GAB(W),/<)$1*A5)B"[<0-O'K9MMNG:<2EEH(*%Z@&T_S;D6 F+ _/I.'U
M)2M)"2DJ;<2I*@I*U"8)5I,;I)).DVN;;X)L)D?R:UB/>2M(!*-R&)4[\0P\
M,/L/!&W@^A[-<EKPZ4EKS )[WM/W3OY8)55.EX*!CF%,!40 2))':?[+;XR9
M3K7TXT=JJAI%FR.K]=Y(UXVP5%_E<;A&DA2U'!D+2A)K62DJ[-)6ADC2N\PB
M(FD3B!>9<44=%5&B:25/@-G3?1J=2EP!7]( W2D@3WDX:4/!'$^?T-3F[3M+
MDW#U&BH K*A"'W\P<;=4PX[3(.OE,,O)4V%N)E805^&9Q4S7_P >NH-&ZPR&
M+M=-=.4ZU'*VJ"UFO9Y,B%K.T91YEM201.6VW>6K, "5(()'J.#C/.%/.(9:
MI(9)0K[,ZC<7DN1J !BQF9CM)W?9?04&698_6\1U;IS*D#B%MT].\PZZM*%(
M=3II@I#("B"C4E6H@AQ)2=31Q_Q>:/ZL8['XNE1DT3J5K"O4JY*W'=HY)^T/
MR*>56O42O9FD#)%#=BB5P0J3F0A/1S+^+\NJ4\O,$O-5*5 1(0A1L-27$$#?
MHH :8N3N(K/9KG_#-*[FU+5,Y[1NME7\696TZR@2?MF%A6H!"@HK0I7B"A$C
M!SA.I%RN(Z6:A8S)8DBE<J8RA5_"D'<DC8@_T._Z>I07QIEHDI%[WCO$[^9V
MGUQ$VWF7U?S5FT)@#RM$&TGH9PXX)*F2JQSJZ2K(NXVWW0'R#R&S;C^OCV]+
MLA#R0X3-RD1-O[>Y(PH>8PN!*1:#_/!_KC;]^(.U$8I94L[,Z>8'"CC(C;\7
M!\-X\C;[?<#TH2?$F 3T)N"DFQ[CUZ?2";*DN-H4U8$_:)),I4GI%^G7M\\9
MJTLU(1-%+-O%Q83Q22+/"=R=E=65F7]5)(;V8$'RD@+9.MM:DF_PG;\]/+Y8
M:U5*Q7!2'4"]@DP$KB(/D9%_N[XS92Z\L(GGH17)/YFDBAC$TL) )>7PJ2N=
M]R$'+W))V'JR>'N-$LZ:?-WR'+!M21I3$ )VML),1?UQ6O$60I90KW5!2 J_
M^Z1$^&%3'0#M]!AEXSXJ.N6"P,&BZ/53J+B]+)36A6QZ9F]&:E$1]M:5"^7?
M)TJ<,)$,5:G<BKP0@111I& OJPJ>ERW,1[VRU2K6HR)0G4I5CJ*?@65'=2A,
MFYWQ2]5P;P2BL57UO#.6/5ZG.<M]=*G2MTF2XXQ'N[BRH:E+<:4I2I45$WQ$
M:"ZFG0N<K9[3FHLAA<Q6D[L61HV;5&_&T@*R[6H9(W(D5W24,_&96*2*ZN5.
MM?2*=3I=0@@#:U^W>(B8]<2=RFR?.:-=%6TU/44KJ="Z>L0A^E6E)!2%LNI4
M@Z2)1X90I(4"" 18S4?Q:9?6$56OK+J#DLU5K_FUZF3N2-1CL*I43-3K\*SV
M!&65+#PM.JNZK)LS QEVE;9U?9#;H)(MYF=X]#AIE/ _"N2J6YD]!EF7ONRE
MUZG;2E\MD@EL/N!;J6M0!+25I;*@DZ92,;$/QG:]BBQF'TCU'U;!4H004J>.
MQQMQT:M2L@AB@B5D2,Q1QJHCV?PH'[>HP_4.,.$!N4E1@%.H1-OSZGTPS[-N
M!JY^KJ<QX?RJJJ*AYUYZJ>8"G7GEJ*ENJ<,R5J))5%R2=]G#I;XI^J-.2:[;
MU#JN:UD9*[W[.T3O:^6@2")I?[PLC&.%5C3E_*HV\>G;=6RMM.M D=-(Z[BQ
M'SW,^<8 YG[*>$ZI*6:?*<N:9IDN(IVE!82US5EQ>A.D@!:U%1C<[@P,%>2^
M*G45S(TLA/J#5,5W&Q6HZ-H0N]BF+R0I=6$QV"Z"PL$23  EPB@G8>%DU%,)
M! "3&H:2=C:;F-^_I@93>R7+J>DJ&$97EJV*A3+E0S("'_=RM3!4DHA1;+BR
MBUBHG$/G_B<S6<P][#YO7F:MT+L:+/1RL.6%:P$D2>*.8I6>,\9HXI%WDXAD
M#$^-_3IBHI$J"PE,B8,'?:W3;N1O] U5[-J"A>2_1Y+1T3[4EMYE#84)"DJ*
M5)-I2H@P-B4V!Q6G,96CF.Y(;$)J.6+2068CP4^X,3NDJ; >W'D/T_4_3/,E
M*5))!4$D+"B%#R"K0#OMZXC.=TSU&SRFZ9Q3B/ 51(4H;D3>_P"8PO)-7:)T
MQW1/)!?F',PN4[TY+>1"54?5Y V8G93L?OZ+(JVT  W4; W)4>G-5;7!-@K:
M]KXKQ>29WFK@T(4PPV07YD:TK^&#!@ITKF_4=9!5^H]:ZAU?;$59),?B1L(H
M595E==B%=V3^7<>X V 'MOOZ0J'*M]*T-I9"%I((0VE"R"(*0I(W@F"/+Y2*
M@R;+LM2$D*+ZB$DK6IQ*5']HE5M,^EKS@QT5E)\#/#)P9B"O-]^1 Y'W8G<[
M^-_/IJ$KTI;986='\J%'5ZB\D=3Z][8!\243=0@H2\V0=](@[;S'W_7RM(+&
ME>H->K^+6[=#)5T2&+*4Y LBHG+@LT9W+(K2$AE')C]!( 'J&\1\+T^?D*32
M.-K:(T.MN<LR )*M-U02;D](\L0#*<V=X7JJAL,NNTZU %2SS$%)"2HH"C"1
MO8=?6QGI31FE\5G<7F\CK2_ECB&YQ5FCD99(MBA@D!9 RL6Y%9-T5U#+LR^H
MBQ[/UBI2Y5K#QIR%TP"B%(5L2L_M2F(WN,2&L]HM/3Y=5IH*6I2[4-A#^DDH
MTS(\(@ :MKFQ[8$]1Z4U1'E<_/I^3'YK'P)>RNG\UDI6N7,<+MI;&1I7*LLR
M-9*/)8EI M+%"$\+^8T8<9AP_F1#I;"GE<I:0V%050@@(2K]E2C8*FVH'IAE
MPUQ@2U3BIJ6Z9#]4TVH+;N4+=2E4S_1)^OG>OW5SJ#J73G3NQ1JOI:_FELTI
M(9\GCXJE*)EL!7D$%!(I);,B.]2K6Y=N:>RBS_E[GTI[/:G+<YSEO(LWY#CF
M4K!J*.J2E!I4M$:@JH6"'XF#_.O%XP$]K@S>@X-SW/<FSZGX><=<6Q3A3"JM
M5:ESPTQ:T_R:JQ\LTJ((Y2G0X1I21BIHT?U'P)FUCJF2]KJY>C7)Y33F*6E@
MJ=C"VZO8&.PF2MQW+,\M=ZZM=K224,8[RE)'=50GMGA7/,E>JJJHX8K:6OR_
M2SEZ*2D4PANGJJ=AM+CONJWF@TT'&UM*.E/.<5S0222/EEQ[E>9L4F6-<:Y)
MQ-P]G#BW:ZH75N5E?3UM/4%]0936.C07N:I);:9#@2T VL)!"2UOA]ZP] M1
M9K46?ZE]*-,X_'Z2A3$X*CJ/(8?4^-L9EGJB04(,;>D?O5X6$"S+BYHXG>0L
M3)$Q%->V].<YCDE&YD[%/25S.>$9DE35(*A-,BEK$DJ#+BUI2\H)<028@"1.
M.C/T::3(Z/B=W]8O52F3PY3U.3MEFJ99<J%5%"7W'%U3;2@]3%?(53MMEI6M
M2]?@ -CO]C'P=]8=0_[5JTN1TQ^ T?F7T[B)PNEN--A')(<*:' VF[[%AW.3
M$!FB4*%'(M%F69T^=*9S)Y7NP*I"1$GR4#(,F.MA!Q]**W+6G\H8S!A#:J@-
MITKN"D 3):^!5A$@ B9DS@4U.VB[F63":-6[6QR6(>-W(*88KE0O'%86M#-'
M)P$,3,(?HK=I=^U'MN5D/ZP:IJXO,@I"R H^1WZC^_Y8%H:I*S+7%?\ OG22
MDDR"9))T^4 QO-AC4Z@= ^C^=S[YW56FJ.HX<IBJT>-R=B.U9M*U(M'%3J-!
M(.Q.!(S*H6,$MR/N0768*36*#E.I00I"9U*D\PSJ(\KCY=\1?(Z^LR]]RF?"
M.9SEJ3]D("%D!-NMA)M)L+1@ET]E+>!R&-EP->[@K^'QDF(CF2&I&C4/%>JZ
M12B22"Q6@[D8G7BRB9V))<GT/;=S"E"M!4IN""E .LI5Y@B (\A;K@]7^ZK4
M*NI:"OA3&D 2HVA($6(L?7RP>:8IZ=_'C:S6-;+,DT]VR]CE-=M6HX^^D<EF
M)@9VGF18^W$P;@O'CMZ;+S2J#:F$,.*"MPL!1.X-SM@<,HHGWTU@2ZVL1I*7
M%($#KI3ZS:V#6UUEESU[\#QOSF?QU_QF*-ZM;@Q&*QB+VY4L_,1P0595XDUS
M&_<1U1MR=O4+H<DSNFJ0Z:FH6V5J4$.O+<2 9( 2I4" 0+#U[XM1VJX:=R8T
MKM.CF); U) 2Z5)2E/B< U*N#,F/+MR<^*6KK-M8Z>P%0PYK3@CR5RAIZO9/
M&?M3"L[Y&Y=LVVN6!2*K1BQCHZF:99( LS<KCR!M=>XIK,-)IVZ<P&P&B7@#
M!4I,'^:-_N.*9S3,TTJ4F@1I>15!I&I 6#3@IB1U5,^(B\@ 6&)'5FF<OTUT
MQI'1?3O!Q29L6!ELYJG*I#8L8:PU>(,D5RQ3G6K#4L":Q+!7A DA6 !2\K*1
M])FU%E#^8/UR%.,TRU(82DP86=*2?YQO\_NP9S'*\RS]&74&4+0W4UB$N/*6
MG4D%L<Q0"39,@6^^^.A?PK:ERG4?3US0/4FYE\M'8CQ[8'6%2.'!4K<]."\U
MVM2INR+)"DAW2&&HTDB;RV?E_I8!EYO3YY4K#33B69\,$@Q)_:!W/YGH>_@]
M6<-42'*MYM50 -1 MY^&-A<C?> 3US2_%Y\+/23J!J7IM6JWJ>;T?E/X=U;K
M6O4:7"5;"5ULY&T;/F5X:TRI'/7JPV)6"EXI'1>7J].&O9NVFC:K:&G8U+90
MZLC2I94M"5DDQ.HF2HS))N3,GD+C#VK9LGB!S*J_,E)8]\<::2I/AY275)2D
M#4+!, >&/.^)+5^?QFN<#CM8Z6R*9W3>H**9/#Y6IW.S<I3O*8I42>.*93PX
MJZR(K+(KA@-O2ZV7*=Q;#OQ-K"8C;3TV@1^%M\6+PG74[@+B76E\U3:@8O=$
MB2>M_P 1WQ5[-4Y8U>5!*'/(\2?&V_['V_<;#;W(V]. T@I*C\COZ6 \[?AW
MN>E=<<#*)26U1("1/I_4>@': %/E<L\*S12K("6 18P3)(?(XHOL6+<?YO&V
MY]]O6N@?*._XS,SB:45*R&@M0\7J8Z3(_)DXTL-IN2W8.2RHYV%7>K58\HZB
M^_)M_#3/OYVW"D';SY*1W/:_T_/EC:IJX2&VE?"(Z3V@&>XN9OTMOVLZ:KPZ
M>Z%0[[KHS2R^??Z<)2'G]_'KY(\??XP>/?\ /+B;_3=?@>"2 3N0"?4[X3/Q
M$ZEGT_%I-8=-7M1?.G/<Q3@6;Y3Y<8?;NEB"@G^8;AM[]EM_8>NB?T37BTOC
MT#]M/"\CJ=)XAB+'O?%F^SJQS=04\G3[A_(Z9O[[\6HC:+?/%(-2=6&C$E>7
M0%FBT@9%>Y6+"/<@!S&D?D+^A<#?8;GUVBE]U2?LY2HFTD]+C:]OI8XN2A<2
MX(+M<H;*"@D(,190"U&!Y#[L!.)Q^C,S;&5U5D96D7BZ)(OR=>LP)(58H_H4
M  ;%BI\?U]#WG''W-#JPD@[G:;?F^"+S#:D_9A),6U;]Q<F)WC[CMAF8^_TF
MB9HH<E7=3]/(22R [$>"8M]O?VW\;?OZ<L!I.E .I2!ID"4G<>?U],"7J8))
M)4G5^TD/04^5B!]?WC$U\QTR= R9"1(R2?RZ^1D4\?\ OK"0GM[\MCO[>GH3
MJ((2"1$3'7_*[GMM]X:)>13F"A*RN!*E$Z?3Q><_+Z2 R_3Z.)%J9NO$>/@3
M23)(7&^P(GV*L?'OMM[GW'IT"_I(4G4B#/PQIB_38"U[?CC'\L0F$ K("8('
MQ6'6?D.X\\ ^H\5A$,F7TYEJ.3IR?F9+&1V*[6:CM_/=I1=S>>-SREM50
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MRE*0HD:F@4D0=Q)21/S&^_4 EP^L</-W(;%?*PJWT"2&,RJ#OY+'FLFVWNQ
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M2E6H&RIM&_KAF]<),&=(87/UZV!Q*37G@RVH+6&KVWP 2#\3ASXL3AX$:L]
M5!"T49M6;<$R31R1+')S5^D%1.Y1DF7YGD7O.6UU2XCWW-,O):J*A*P"M3ZT
MJ&H*W(B"0)O@I[!:7*<\S;.^%>.:=CB&FIZEZHR>FKQS$((.EJG<YD0E@E+S
M"@%A#[:%0/BQ3+7FK+60J80P:KZ=9\X[4(O1WM<XFP]K#2U(HX[+U*<"8VME
M*UJ%H+%F&K#E<@O<K/*>['$ZPWV,^VW+/9;29N[6Y!FV=YCG#]#HJD9DZU2"
ME8:'.66#4H2FJ4_\:FVO&2HK)*@3/OT@/T=>+/;*WDN69-GF2Y3D_#] IEMC
M-<LH*ZMJ:WF,A%515+S%144VBD0I*RXZVE3X"A:58!.I_1W4>I-1],-.:<P^
M$U#!G\Q=R^0ZC083!Z4IX;&T9'EOT<=1AK#55691 F.PLE1;%3*P6I#:1IH4
ME>]>&?:NG/LSXSXCS5-/34G$C:#EM*BLK'UTG*3RF4NM5*BRE1:)+BF?&5]2
M).*'XC]A=1PC0\!<-9)FU;G.<9%4OKSS,JYC+5O53=2[SBV:JDU5B$M*TH13
MJ*:4-@%0YJ41;#IMHC0NCJ-?3&@*>2NTLG5>7*YW4$N0&7L9>HZ.^)DJ7XH!
M2C2.+YAC%#VK$3[H60^H;5/T5<7>64K>+FH.)ND"9\B93-MO48N1::Z@;8HW
MF70E+"4E'A$F.D@$7^L[=V?K72&G15QQRZ6).W$$BOT+$5/*TX%19A([R!J>
M4B@0"N(K;1V>(B5+? =DE%.43J@A-,]KV"K:=M]YZ8A+#->TO0M7NJ=4'GSM
MT!C4!WN+"=K8#<!C]98TQY7160S$5*YM-\QD\=8JWA1[@CCG3"6.XEE5/D34
M9SRW)*A0#Z6%.ZVH(0H)00% $DGTMZ8-LT=.VL.N+14.%(^T:!T1T'CTDD$D
MS$7'GAQ0Y+6&'Q6HZW\926\[F*"4<-D,Y1@J)B[=BLQM7UK_ "Q,T=19!&BR
MNI9B716X>GE*[#ZFO 5EM9DW38=9'Y-_5"O>83I+X*6-:!) @K)A(BVYF)_L
MPOL9%>Q6ELG:M:BQFL]7XJ>O-^%X2/)08VH58*^:EN.*=G(1Q'E)-'55H%D9
MEY[*2&S356FJ*M++B?%9('6/(1:?3[L.:G,Z-JD24-+92$C[5?P'[S:\CT\\
M#VK.IMB' QXO6>2K:DQ.<83+2QT'R&2Q]D.">Q/%(\LM>-@#'!:9N)!)<GQZ
M HS]MEXL/)4M16I,H TBYW,3:0#Y[=<*,Y0_FM%[_3/H#(W:)4'"+21'A([2
M9B?3&GIGHYD-93XQ*.M9-#SW\A'^#988>CE-33X^9&^>J)!9K]W'P6*_%)LD
M)ZK0$"11)LN\GHJCQH8:?0EQXAS97PJ.D#X=Y2>L7WPQ?RZGHVC5UM*M"&TF
M HI!)2)Y@\1&D2!:\I%L%>O^A.E^E6&X/G,_F<AJ2S7PT.;REW%P(N4LPO9J
M5,/1N<(,IF+35YY375;%B0UV+0/NH+;B7A_,ZFE6*/+GZA2DA:BA((7I))M/
MEN?GUCW#G&_#]#F+3CM<TRMLJ;0E2P%I"TZ;]-C<#?OOBI^(S4/1K5]G7V7S
MNHLYD,?#/5QGX@)4IXB<Q&JAD23N 6FY/7>G!7IP02#BL!'CU0#W$>>Y?F*L
MM;HW<N>;407:A Y?A\TA9CY?2<=)T>1Y-Q5EB*Y54U6-J&K2TYX_%T@K G\?
M7%>/CBMZ?S&D^F/6*E#_  GF=?YJ##9^\O U(LKBX9Y\!GS@IX)(?FK)MK0L
MO7J5I;$L%::Q8(+1/V+[!>/LQJJ"J9SAY12TE3"5K2IM"BWX I"G$)&DZ24G
M?2;FQQ\^OTF_9%EN79Q^N,JIXI:)'O=2_3U+-1"U#F+;4*:H=6EQ"I24+2DI
M,@B1&'_\.OQE=/J/2/":8S^&U1G=.:,TC#%%KO"XO4><ERF2_$K:W*V52?"4
M,;C[+Q)<M5Z]7(R) M9HP/J3>>YPWEM.X]7UF?933^].E=/3J>U/+1U_DPI
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M1[>WI1#0!)49F(D"(O\ AVWO]512N $I>"E_M>&WE,B;7W^<QB0BT=J> =[
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M*.,B#%8K46.O9"1 /KE9*<,SK&(VYE0A'DCUNTYH<94X""'6U$V(*0H$Q?\
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M5R..2)1NP+JI!\;%B :E=X<S5EPI92HRN)B!HV/6+V^>Q@SBQ,GKLN )KR/
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M$V^Z_P Q]UXX_5../D*=6H:OA4HD=;=1V^6)58(14$B\>6VP8#R3M_+MMO\
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M@/:V-N*Q?_@+AO\ U/C97'_%RB"K.%$C;^)Y<(^0I ,1T_0'I+9.\FE&4_\
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M(.&?]3850^\W_)N*1Z&,8_\ R9>A_P#\2%__ 'BU9_\ [[U[_"&]L'^^X?\
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>SS>GRGD!YMY?.#FCE!!TAKE@ZM:T;\P1$[&?/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>16
<FILENAME>g723949g17g41.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g17g41.jpg
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M 1$  A$! Q$!_\0 'P !  ,!  ,! 0$!          <("08$!0H# 0(+_\0
M11   00# 0  !0$%!0,*!00#! (#!08  0<("1$2$Q05%ADA5M<7(GB8MS$V
M-Q@C)"8R.$%7=Y<E6)6UU"<S0G%166'_Q  = 0$  @(# 0$
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M)D3&Z)H;0,,/JO?I&Q&/N[KNHO<G]'_Q/\OZE?.Q-3PL-=BVW)%/R_$XX\P
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MXR0"),TZWMQQN4>!%^W]/R?4K^[J"&811SM(=>5@:TMML02=]P?W74TT)E?
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M;;IV'L%JI]7CPT*H\\PHB&'"BIF<DPS6Q7C776FWWQ?P<-JH<HYGLD,\4>
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M")A$PB81,(F$3")A$PB81,(F$3")A%_-ITK_ +6M;_\ '^.M;_\ #Y?^/_\
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M*Y?7"IA%GQ[KI_/[C8O)T=?YMF$#+[C+UYC4]5A;%1YH"X\JO=9LU?L)Q\@
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M<@B*)V7T%WL:<&".FZW)Q+$FGG0=C@A 8YZKM20\!'S+H)I$@*980-34%&I
M@[/>'-2J.S5_"O:5'/J#ZZHJ,J2IF955-/IA=#)1P35K)W2]Y@J6255.]D[I
M*1IIXF/C,/+9R/;'QWP_1=ML7'O8?-3:.S2Z.C(U*@HW:?0UNNX54.IU=-ID
MU*R%U%54,T-!6QRT<<.HRLK*B2.9M2)YM:_-7P_^2<(W2;H''V.L]-BPQ#;5
M&TSL?53^82-EW&E &KW6Y>3BXRS1HZ3BD1CUEK>BVTZ8?VPR0RWM';.%N$]
MX+T^HTOAVB[M2U-0:F>6=SJBLJ);-8UTM1*Y[[,8T,CCC+8F#(M8'R2.=YMV
M@=HW%_:AK%+KO&>IBNK:*D%%1P4T4='I]%3YND>RGI*=D;,I97NDFGE$D\IP
M:^0QPPQQW^SL*Z2F$3")A$PB81,(F$3")A$PB81,(JK>I_.UM] QG--T/LLE
MPJX\OZ F_P!?O4'2X&X3+)?[-SU9?CQ4390: 0SX^?,8E6D.NB2X"G8N4"+"
M?6C4T,HB+\HQ(U[<2TN<T6N#Y==QMZ'<6*AFB,H9C(8W,=D'!K7&]B//IL=_
M4;&X4%<9\8>B>7=CD>LS_N2U=#3;Y>O']/KLGPWFD.KH$=5HLJ)@(!ZP!DE2
M59B8H<PA8(=:; #&)+D2VQ-&2D@01+)41OC$8IVLQ!P(D><"X@DVZ$FPN3<D
M #H HF4\K),S4N=D6Y@QL&0:+ 7&X 'I[SYE:/945M,(F$5%_>'^[OF'_'1Y
M+_U1C\LTWM3?LT_X95:I]F']I@_$"O1E964PB81,(N*Z*+T(VF38W*IBIP%_
M=;$U79>\P<I9*J&ZF0$6<J6A(6:KTF<V[%I.8&2+,A*9.=&)<4ZRRX.[LS .
M&8<6[W#2 X[;6)! WMY'9:OS+3@6AVUBX$M&^]P""=K^8W7R(>C_ &9W'LG<
M^D</[1Y^\S7:]U%/1^1"W;?G"[VGH,0!6E6K0<E4H]%WGK%$J+.<5,Q#[.Y$
M&$=DFYU;90S1#A'L,O!.E4G"<.NP:C5]X=2TM<0:B$4<CJCE7I@T1-=D,^4"
M9"YTC2'-%\&?$.C_  C.,]9[=JKLVK.%M+9H;=>UCAZ,,HZ_X^I8],[X&:O/
M.ZK?3NBD%-WN>)M&V*.CD!BG>8^=/U/F/X=!?9>FT6[<X[5!TKI='BN?]2,H
M<_Y>[[1*E R])<J#;\<1/V7]FH><D56+0RIY-9LR"IDQ^8FH) D:G:P:<?'S
MZ'AR71'Z:)7&"IH8JL5<1:8:D3#-].(WDO8QY#078N(:7[Y-=V#6?@P4W$':
M[3]I+>+)J:C^-M+XAK-$.F3&J-?I9I'-IZ?4S51LCI:B:EB>\\ATT#'210$C
MERQ?6'S@7HH5+A1>L3-1L/06DG_M#,42"E:U5#%KDS7(W<3"3<W8Y0%+$.J/
M&,T5,F[(D&2RFML,/M#,^5/P+CRPX,VL'$.<-A>Y  .][;=%]?,S#1S"TOWN
M6@M:=S:P))&UK[]5W&:K9,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3")A$PB81,(F$5&/B#_\%:'_ (H?*'^O]!RU2?.N_4S?AN56K^:;^NA_
M$:KSY55I,(F$3"+E+S.SM9J,]/UBFRG0I^+!65%TJ%DH.(E;&4E:$IC@9.RR
M$5!!OK2I3FGI.0$&UIM6E.Z5M.M[- +@'.# 3NX@D >MF@D_8%JXEK20TO(Z
M-%@3[A<@?O*PJ]!^S>*=EZ%*\:ZY\/YZX=Q@(.Q5B#9NMH\Z60NJGO0Y,LY'
M@V5^XFPXT@,ZE)*X8&8W*KE&M1S0:YCZ!-]:BX_X.CXE'"+.**=NNF5L1HFP
M5[8W5-@X4AJ^[BB[V6[=W,_,S^2QYOR:] E['>TF7@8]H[^"JUW"3:=U4-2=
M4Z69A0A^!U'XL[Z=4^+P_P 1J^YF'D_WUEW7Y99Z<M\3^A+CKSEU[FWF'HS?
M-2Z#QBS315=NG"(<V>D(2M5]4I::8W(=-B3 ]WQ^.U9=DV0"/F8V8FSS#@BW
MF]#.>:<;]BDO$_:(>+6\3QTE'-5:?45U*^GJWUU,[38Z>!L.GRL!AQECI8RU
M[W1]VE>]S63-:UI]U[+_ (4M)P'V-_Q=R\$3ZAJ=)1:S1Z770U-%'I58S6YZ
MVK=4:Q!)_?&=/-7RM?%#'**ZGBCC?+2O<^4?63RZVVV[4X&PW?F<_P BL)1!
M[)5'LLW5+#+Q[(I;K I3TI2YB=@'FY%A"#6&QI%UYEIU+92&GTK;U[B]K6NL
MQXD&WB#7-!^QP!V^I?)+'.<V[F.C._A<03^]I(W^M?MTWGD%U2A7&@6!'VP+
MC5++5'I%ED=R1B6+-#&0I,C%.D-N:&D163%/BO)UK:'VFE;^>D_+.-U73X]6
MTO4M*FDDBAU/3ZS3Y9878RQQUM/)3/?$[RD8V4N8?)P!7-\/:Q-P[Q!H7$-/
M!!4U.@ZQIFM4]/4MSIYI]+K8*Z*&=HW=#+) UDH!!+'. *QGY5\%8&L$2!MR
M]&W5@L:PUV9K#W+H"LP*FW:G."V2$D9W5VBKVP28/-QT7(#@!##CB.!.LE&R
MXIK@[7EG93V5R=F^I:MJ<^KQZM-7TGQ=!%'2R4L,=*9V3OEF::B4OJ)#%&UK
M6D,@;S0'R\V[/H+X0/PA(NVK1>'M"H^&I.'Z72=0^.:J>HKH=0JIJ\4LU)'3
MTSV4E.V.BB943/D>\&2KD,!=#3BGM+JMQW@HW+H&2AK)?K9VHD^65)CSW48G
MG[DO%#J#%%_1X_=.I=2 U&Z<&6;K1())?Y19&]E;9^TTU[*]S"\O9%'"76SY
M8<"\C8.>2XEQ LT$G8 !?,36OP;')+).V.XB$I#A$TFY;&T -8TNNX@ 7<;E
M3[K6DZTE.M:UK6M:UK7RUK6OX:UK6OX:UK7\-:U_LS1;K^X1,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3"+$_UW<+5%>A;^!&]*^*-7PF$U3[,1YRX?'7'C8GW
M:57'G/V0L3\:0[(;?=<638-*>7^):'IH%/TI&TE/(0-!B:3'1N]K>64MD/B/
MM"XM[OY-BN/G<1*X"2L;[.T40=&/"/9-C?W_ ,JX5G?A^STW.QG453-O]H6Q
M0Q]32.OV'S@3GAP*71[!MQ%":%$$U*B/[;1NQ.+TO8CS4.E.T_D;^<54 ,+-
MIV^U\P_._3VMS;^3]JFI22'W=4.]GY]F%NOL["_O^Q:)Y45I9_\ Q&;YP_GO
M%8";[D78I*+5?X@:G\S@[WOGD9UB\$QLL+!U:]V+\J.8!Y['*)=LUFD964 @
MX9$,)+'?GDB1T6=:I&R/D(CQ!P.3RW/!MQ=S6[W=Y  $FY V)56K?&R,&0FV
M8Q8'8A[K&S7'R9YN)( M<^06/75)>5JW/Z/%R??G.BVFI^+:O-^3[G1^E6"1
M@[5Z3<]1RT38X7EDFB92_P!'LM,BTTWF[;!FI67=I$7LB1CQQR);[/(, <]Q
M$.#75!$[7, +8>2"TO%O UWB>2+#(['HJ#R6L:TRAY%.TP.:\XNFYQ#@PW\;
MF^%N]R6C<;N6FWMZS=R>O7F^MRG*J>'QMCVEY#?C^H#=.=*M1\PJ\UTDF/>Y
MINF,M@"M3;\I&-G?MF7MP0 :1V,G9VQ!J5,V+&5PD=S.[U'R>%A[#M\\C^C8
MVQ&^U]M[E29<H@6-Y?>*>SP\Y$YM_0QZ7N/:Z6/N6I^4E=3")A$PB81>A:JU
M8'L!5L8KD"S:C@VX\VRM1$>W8#(]GZ/M E3*!TR) ;7VF_MC.DK91]M'THU]
M"?E*9YS"VG,TI@:XO; 9'F%KS>[FQWP#C<W<&W-SONJ3=-TYE=)J;*"B9J4T
M38)M0;2P-KI8&VQADJQ&)WQ-Q;C&Z0L&(L-@O?9$KJ81,(F$3")A$PB81,(F
M$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81?/U<^B5\GOGI:1\O][L9?0^4
M\N]:DW%VX]T1-W/M78C^>S<O5.9\@XE^JBMN4CSN=%.RL9:86FABL'0S=<C"
MYQD2=FE\JUCN5")HAB]\ :&Q6;'&'@.?+);9TUP""[H;D"X XISQS)N1*2Z-
MD^64MW22%I(;''?=L5KAP:.@%W6*B2OWD=H4:F5KK5JE?*5@Z_\ #O%[!;7N
MNVP^(C'^D<OZ-+]JBY#I;]F=E:P':;A#\I5T0$:Q1+$5(3NPR6XO]8)87N6_
MI.C:)Q'5F,<MH)P>P1G"UG8M+\#8W )WL%JUWZ+9'& R4N;A(XV+V.,@+[DM
M!<&9BXW-KB]EQMCZG<#>05\B_=<OT/!U#RAZ@N?E"Q+Z5:J])W?J],]2/U3D
M<B%)BS0!?2;2!S5BGQU8C)9VP.257FGY5L Q,D0>O8,:)'81L)=41-G& <&Q
MN@O("+'!I>7$D6 <+$[66A>[EMS>X 03F A[KO>V;%AZ^,AF.-R;M-][W6E?
MM^Z]^*J/(*Y/\5@1N<$]S\='SO6==2#:G!K2]UGG1TE$:Y/JH;*2RU9-NPOY
M>K?]"&-?J6A_H3^)NI2MBR>1(<^7. S#;'!UCGEZ;VQ]RMU3I<6 QC#F0$OS
MWRS;<88^NU\O?9:SY05],(F$3")A%E+T7X2_'>B]YM/;7^F]0JBK7/&7(N"I
MY$$!(1MT/*_4"IN%L\G%S#H0[DHIV43'N1!+K!;RTC2+(J61FO(6]C>@-X\;
MQSWVM=(W5!K?Q4X1&E.JME[P)C.+3=W[T!4]VM?F>'G<GY)?2;OA-\7N[)'=
ME/Q5I0A=H+N%OX0-=.*T</.IS1&D%'_\L*OXO/<>^Y6Y'RG=N]?WPK1>?/(D
M3YS?A&*SW3T9<JI6JHBG5[G?1[]!3]#A8@9H(>-W'0D938%T<J(%!;$C'$G;
M:'&=?;VPY]:5(]FEJ#->\4+7%V1>QK@\G>]R7NZWWV7S+% (K6DE<UK<0Q[P
M6@>5@&CH.BMQE=3IA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBS
MM^)"CKBN54K?/QNW&41%W-5VH3S>Z0UV5^I;I%J16=0>P'&9EVL-]"55G+ZQ
M7W$S+M924EG_ *%^?O5NDPS=D8@['Y,S?-Y9-O>^V6&6%]LK>=E4J^9@W'F%
MF1YG*^<QQ.-K;XYVRMO;W77*_#5E>XV"O]"GNDQ7;(*@E5W@L71(KO(A49:D
MWFL<M%KG:9*M1,K\YP#GTO88R ,KZY'?RE955BG&])+DY!.MJP1 L##&792E
MQBL6XE^4>1&Q?8F_H+#R6M&9"'EXD#;1!HEN'9M9C(0#N&$@8^IR/FM/,I*Z
MO!.C(V30AN2CP9!MI6UMH.$'+0VO>OIVI"2&W$H5M/\ #:DZUO>OX?/Y8N1T
M-DL#U%U^6H2&TD!.HF,TF*>61%IT +I,:0YI>G'P-?:^0;R]..:6Z/\ ;6K3
MB];5OZU?/-SON=^N_7ZUBPVV&W3;I]2I5[P_W=\P_P".CR7_ *HQ^6*;VIOV
M:?\ #*KU/LP_M,'X@5Z,K*RF$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81
M,(F$3")A$PB81,(F$3")A$PB81,(F$7*@46D14IJ;BZ;58V:TLAW4N!7H@.4
MTX6AQLIS1XX;9>EDH>=00O[OU/(=<2YM6EJUO8O<18N<1Z$DC;IM>RQBT&X:
M ?6PNOT:I5-8A3ZTQ4JRS791X@B3@&H&*;A9%\M:'"GCXI F@3'B7&VW"'"&
M'%O+0A3BE*3K>F3K@Y.N.AN;CZCU6,6V(Q;8]186/UCHO(*JM7.:A1S:W F,
M5M\8JNLE0\>0U DA-Z9#(A6W1UHBWQ&DI:&=!TPXPVG2&E(3K6LQD1>Q.^QW
M.]^M_6_O6;#;8;=-AM]7I]BIM\0?_@K0_P#%#Y0_U_H.6:3YUWZF;\-RK5?S
M3?UT/XC5>?*JM)A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,
M(F$3")A$PB8147]P@=39"X'>J+3^D=,IO*^XP?0NL<PY',IB;];X&!@IUZJN
MQHJSXM-KC:W?MUJ>F*2HS[5C8%::?9VP,X6'9IBSY5KG,8Z2,L8^078TDC*^
MQQ);<!WE]MC6J0^T3FM>]K) ][(S9S@ ;6%QD ZQ+;[^GISGA\/J,I=_4/4K
M)SKJW'.4]:OE5M7+^7]FE]DW6*L&XB55U>T;KJI6:W28:WSY<.Y&UE)^QQEQ
M1;X(PH#XK6MJDL#86->R1\;7->^,>$BXP;>PR+1>[K>>^ZQ3!Y=,\LDC9(X.
M8R0W<#8YG&YQ#C:POY>EEH7E16DPB8147]X?[N^8?\='DO\ U1C\LTWM3?LT
M_P"&56J?9A_:8/Q KT965E,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%1CX@_P#P5H?^*'RA_K_0<M4G
MSKOU,WX;E5J_FF_KH?Q&J\^55:3")A$PB81,(F$3")A$PB81,(F$3")A$PB8
M1,(F$3")A$PB81,(F$3")A$PBSUEOB*\,YQZ$]!<0[M>*3R?7)Y#F8]-D9J2
MDE'W8*[<WA;O,F.BM /,!Z@SYEF+;2RZO[[.VWE_2M2DZM"DD?%%)$US^8'Y
M  6;B\M Z[WM=535QLEECE<UF!9B23=P<P./[B;*S?%_27"_1(]@*XETRM]'
M'JCT:/8G:\Z2ZF)>ET&N1C97Y(PVTJ,1'&J9^C2];T,Y]6]?+7SADAEBMS&%
MF5[7\[6O_K"FCFBEORWM?C:]O*_3]]BIOR-2)A$PBHO[P_W=\P_XZ/)?^J,?
MEFF]J;]FG_#*K5/LP_M,'X@5Z,K*RF$3")A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PBHQ\0?_@K0_P#%#Y0_
MU_H.6J3YUWZF;\-RJU?S3?UT/XC5>?*JM)A$PB81,(F$3")A$PB81,(F$3")
MA$PB81,(F$3")A$PB81,(F$3")A$PB815P@/+_-(KKW<.Q3$9'W&<[C(\_D)
M2/M4! 2P-:WSZC1]%#'K[I4>Z8VQ*!1S)\BDAYSYF[_YKZ&DH1J8SO,<<8):
M(PX M)!.3BXWW\KV'N4(@8)))" XR%I(< 0,6AHMMYVN?>IO@:E5:JDE%7K-
M?K:#5-*,1 PT=#I+4QIS3"B4QXP^GU,Z==TUMW2]MZ<<TCY:6KYQ%SG>TXNM
MZDG_ %J4-:WV6AM_0 ?ZET&864PBJ7WGV;R?SQ;P:==8R]RQ3=4 Z!<Y:HU\
M.7@^7\[E+>-18^]7\HN8BR@Z^59GW@6TU\&QS*6HZ4/=B6P 72=3Q4\DS2YI
M:/$6M#B07O#<RUM@;G'?>PZ"]R%!+4,B.+@X^$.<6BX8PNQ#G;BPO?I<V!-K
M!<7[OW\Z[Y@WK^.M^Z/)6];U_P"/_P"J,?FU-[4W[-/^&5K4^S#^TP?B!7HR
MLK*81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F
M$3")A$PB81,(F$58N\>N>0>=9F(@N@.VPF0D*W*7F714:G*VI%*YU!RT1!3/
M1;LJ,;6J"IT;+SD: _([022Z\Z[^("0@0M;,T4$DH);C8.#1DX-R>02&-OU=
M8$V_[PH99XXB [*^)<<6EV+ 0"]UNC02!?\ <-C:,/B /,D\/Y\0.ZV^._Z<
M\FO,/LK2XT\R[WV@+:=:<1O:'&W$*2M"T[VE2=Z4G>];UO)*3YUWZF;\-RCJ
M_FF_KH?Q&J]F55:3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$P
MB81,(F$3")A$PB81,(F$3"+,SV#XUZMW3H5QF^<V&@QM9[;P2N>=NJKN!E@$
MG*C7:[U(GH"+E10HB!F ;1,EQ<U8(%5?FY&K!,F:AY/4PZT@T7=RGJ(XF-#V
MO+HY72LQL0XF/#%UR"T AIN XVN+*G/3OD>XL+0V6,129$W:&ORR: #<D$BQ
ML.AOU4Y]5\'^8^UVTF\=*IMLGK$437SE/"]D[37(P<^K1H$3 2$=7:QT&&KL
M2?'"1@:FC8N*#*68VN2==<D2""G8V54T;<6.:!N/FXR;.))!+F$D$D[$^[HI
M)*6&1V3PXG;_ '20 %HL" '  CW ;[]2;\O^[?\ )?\ *G3O\RGI;^KN9[W/
M])GW,/\ 9K7N<'\Y]]+^=/W;_DO^5.G?YE/2W]7<=[G^DS[F'^S3N<'\Y]]+
M^=0[QWX:7*P6>F:[!%WV7=+[%?SN:;CO2'H)O4;Q\DT95!B#?TOI49I<B %H
ME!;DAH^44I2?S9,Q?TJ3))6/.'++1\FW.\,6\GZ1W8=B?2P] %''1L\?,S/R
MCL+32;1W\(/B&]NO^M3%^[?\E_RIT[_,IZ6_J[D?>Y_I,^YA_LU)W.#^<^^E
M_.G[M_R7_*G3O\RGI;^KN.]S_29]S#_9IW.#^<^^E_.N)Z7\-C@!7..@"\U@
M.BQW12:3:QZ!(&^DO1:PP+J]!'MU4TM!_4C@5#"SJ@'WTFA&"*:0O1(I#.UL
MKV962YMS+"S)N0$,.[;C(;,!Z7Z$+5]'%@[#F9XNQO-+;*QQOXO6R\JA?#9\
M[#T:ECWRO=&.O#%3KK-S-$])>C4BF6MJ'#18BADA=4##2.1+I,>92((*-IM:
M=,#L-?0TDZKER=BYF.1Q^1A]F^W6._3U1M'%BW+F98C*TTMLK;V\7JNL_=O^
M2_Y4Z=_F4]+?U=S7O<_TF?<P_P!FMNYP?SGWTOYT_=O^2_Y4Z=_F4]+?U=QW
MN?Z3/N8?[-.YP?SGWTOYU#O6_AI<L-D..JY-%WV*CP>Q0)W86Y#TAZ"6N7X\
MW6;@U/1$=N3Z5(K;D7[,_4"6G(M<9*:8$(2S)LCJ*')DCK'VDS+2>6>7:&+:
M3)MB;,&V.76X]U[*-]&R\>&=N8.9>:3YNSKVN_KECTWZJ8OW;_DO^5.G?YE/
M2W]7<C[W/])GW,/]FI.YP?SGWTOYT_=O^2_Y4Z=_F4]+?U=QWN?Z3/N8?[-.
MYP?SGWTOYT_=O^2_Y4Z=_F4]+?U=QWN?Z3/N8?[-.YP?SGWTOYU#HWPTN6:]
M 34D3%WU7 5\=K ,- I](>@OU=GL+5UMK]FEW74]*3-;CB:6]4@V&W9EV+22
M*0H>,8+4443)WQ_* NWF\QUSR8K<O%N(]BU\LO*_OZ*/N;.:3X^5RQ8<Z2_,
MR=<^U>V./GU\E,7[M_R7_*G3O\RGI;^KN1][G^DS[F'^S4G<X/YS[Z7\Z?NW
M_)?\J=._S*>EOZNX[W/])GW,/]FG<X/YS[Z7\Z?NW_)?\J=._P RGI;^KN.]
MS_29]S#_ &:=S@_G/OI?SJ'>)?#2Y8!6[,UVN+OLU8W>G]-+K),9Z0]!-LC<
MQ*N4L_S.-?U$]*BF%'1M.7%"'+(8?D%DM.*D#SRMN$N225CR1RRT#!E[PQ>W
MB,SNP]77]WILHXZ-ECS,[YOM::3V,C@/:ZAM@?\ 6>JF+]V_Y+_E3IW^93TM
M_5W(^]S_ $F?<P_V:D[G!_.??2_G3]V_Y+_E3IW^93TM_5W'>Y_I,^YA_LT[
MG!_.??2_G49=H^&KQ8[D?2@N,PO08?K15)LC'-I62](^AW(^.NSL42BMFFHE
M>G2D8L4>5V,Z^D^..$VVE6GQ7V_J;5O'62<QG,+#'D,P(8MVWW&S >GH0M)*
M./!_+S#\3@3-+8.ML3XO([^?U%=Q!?#=\P-P<,W.UGI3\VW%1R)E]KTGZ2TT
M]*I#93(.MZ9ZRRSIMPO3RT::::;TG>OH;0GY)UJ:N:YLYEKFWR,/3R_W-;"C
MAL+\R]A?Y:7KY_IKVO[M_P E_P J=._S*>EOZNYCO<_TF?<P_P!FL]S@_G/O
MI?SI^[?\E_RIT[_,IZ6_J[CO<_TF?<P_V:=S@_G/OI?SJ'>C_#2Y65>>($<Z
MB[['T<"\39';0C/2'H)94U2'*)9QX0*,4?THTQLIF]NUDYU407%%[$&?2\4Z
M'L@1^1E8_&3,MRQ'+/)BV=D+WLRWLW&]PHWT;,H\,\<CS+S27+<2!;Q?2L=K
M;#[#,7[M_P E_P J=._S*>EOZNY'WN?Z3/N8?[-2=S@_G/OI?SI^[?\ )?\
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MQ3#9![<:;LY@]I4>AAH<DK=\;F!A-OE&"1MO)I<YHOL-[M/2^UM_(:,D:\O
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MYJFI=,]P!!CR#F^!@=<-MNX-R.Y/5Q']2AIJ9L+&D@B3$M=XWEMBZ^S2[$;
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MC%R0]_5?MA%QO0:!5NHT^:H=U"-D:O86A694..GI^LFOMAGBR8^F)RK2D+/
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M]Z-<VE.]ZUO^*OGWW3>$>&=)Q-#HM#&]OLS21=YJ!TZ5%49IQT!VD&^Z^?\
MB3MA[3^+>8W7>-]>J8);B2BIJPZ7ISP?)^G:4VBH7BVPRIS8$^IO5/>][WO>
M][WO>][WO>_GO>]_QWO>]_QWO>_]N\[&O-E_,(OOD\!_]RCRY_Z)T+_[&-GQ
MKQG_ (6<0_YVK/QG+]J.Q3_%'V=?Z(Z+_L<:MYG65Z@F$3")A$PB81,(F$3"
M)A$PB81,(F$3")A$PB81,(F$3")A%_E:T-(6XXM+;;:5+<<6K2$(0C6U*6M2
MMZ2E*4ZVI2E;UK6M;WO>M:P 20 +D[ #<DGH %@D-!<XAK6@ESB0  !<DD[
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M,A(W/6ULU.I>F_0W;5O;ZOV?H]Y%>7M>XF;M4J[7FE;W\]_B5IDABO@IWO\
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M_;(5\_\ $G95\+3B_F-XC@U_5(9+YT4O&O#$6G;]<=,IN((=/9?H<*9MQ8=
M J\_N@OB'?\ D C_ -U>+_U$SF_XS>"/]^_^;=7_ / +HW]R]VY_Y#_]).$?
M_/D_=!?$._\ (!'_ +J\7_J)C^,W@C_?O_FW5_\ P"?W+W;G_D/_ -).$?\
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MY=K?O,>3'; <R%U@V0N8(^OM/,8MT'+;XA]'HM.[R8O%CERY6Y7C#7%_2V+
M\W]IW,=X2-LNJGVW^7Y6"ZJ7;:9R:H3_ "*,Z%S2ZN\7A=5&OQ=Q7"<>Z=SB
M1DA*]*[BZ8NPUB;L-%G(]BSD1@,@/7&BQY)F9@H+Z8VS@QACGN$F#V\PY$MO
M(QX%Q=UG .!MZV(L2I70D/+FL:69M=RQ9H=:-S";&S<FDM(#MMNMP+1+,>0.
MIR=N1([ISE;BK!$\@%J<)S>U<;8K?"A:):#Y@BNJLO2>47/IL(Q7ME-VB +X
MH4R%)6@N3AD1M9BQ(RP/[BHC#?:R+3)DYXDO+F+ V9(UAOT=S!<"QNXW:-#
M\F^.(/+Q##&!&&DFQ+HW/%NHY9W<2-A8JSOKKB-_Z^V_JD!@%*7YH]<\R1LV
M3&CO^MO7Z9386DC?-_>OD*6?"G(-._\ V8YM#;I&])<3D%/(V,@NO\] _87\
M,;B7?U?O4T\;Y <?_LSLZV\3V@-_K\_)1U<?*9T7U!FST+E5(=HD/=?,%L"J
M44W5H-H@SGPW9*Y?9<.-+:%BV9D"'MU$(V84X,5.1\ @,<E\N,#'W(R<&/%[
MW9%D[<C<VSY98">MKM?ZV)]ZT= 0^[6-+0Z XBPN69AY -AT<WWD#W"\ 5_Q
M'V$>CVBI2P,Y(6='%^B<YFK5*63B$;5^IV&XVBL2JY45FB\N@>FV$.><AY*V
MR<KV:Y)GZM/F* !3;W9F9L:975,9<UPL!S&/#0)28PUI%CF\L%@0T"-N) _1
M #5$*>3%S3<GEO:271V>7.:;C%@>;VR)D?<$V\5R1,'4_)DUNS70RC<U8&II
M'3JI=*E#<W>X_'.Q1 _$%<YG99OFG5ZQ+<AL(\B4AJ"GQ)YJ#G&H529>LRVI
M 5 [\;)VXMR><@QS7%_,(-Y<P,V.$@(%R"+B^Q!4DD!R<6, ;FUS0SE@@B,M
M)Q>TQF^P(-C;V2//Q:YY?ZD%:>)6Z\\]YU87:-T;A\S9XBONPS4''0<#Y,Z/
MPZUDU8*Q;^3<74+U:ZO8AHE;K!9\75TFPS+TF#%"*.FCM*&O>,FRXDWN29XY
M&Y$>;FM<+^1.^Q*P(7Y1N>QAQ=&7 6M8021NQ!\FN<TV)Z#;<!25X>JA#@%L
MO+LW&VNG5M2_/_GVRQ1BI2+F> \NLMB?K%CCY16MH/+FWIMJK34N$\5'V1KF
MD!-A&EAOBN:TJ7>RVQ:X_*R@BQ$KVMR!&UK6R L,<R+;+>F:?$Z]VM^2B(-P
M8F$XN'UWL2"00P%7[RJK281,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A%7+LR4[ZUY&WO6M[3VF[[3O>
MM;VG>_-'>$[VG?\ X;VE2D_/7\?EO>O]F]Y-'\W4?JV?C1J&3YRG_6/_  9%
M8<@8<MEP8MADH=W6DNL$-(?9<UK>E:TXTXE2%ZTK6E:TI.]:WK6_]NM9"IEX
MX49&QJ7$QT>#'I=VE3J0A&!4N*3K>DJ<TPVWI>TZWO2=J^>]:WO6O]N+D]3=
M+ =!9>=A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A$PB81,(F$3")A
5$PB81,(F$3")A$PB81,(F$3"+__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>17
<FILENAME>g723949g19v15.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g19v15.jpg
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M$0$#$0'_Q  ?  $  00# 0$!            !P0%!@@#"0H" 0O_Q !E$
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M&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]#
M,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X
M^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW
M'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]
M# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&
M&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,
MCW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^
M1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'
MT&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]#
M ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&
MX^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&&X^1]# ,CW'T&.<!5UIW]1
M^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U
M'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_
M4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW
M]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G
M?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:
M=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  U
MIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #
M6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z
M-:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H
M UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@
M #6G?U'Z  -:=_4?H  UIW]1^@ #6G?U'Z  -:=_4?H  UIW]1^@<MPL<M $
MF1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'
M+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+
MA8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]
M!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+
M<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y:
M&1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'
M+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+
MA8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]
M!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+
M<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y:
M&1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'
M+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+
MA8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]
M!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+
M<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y: &1;E]!!<+'+0 R+<OH(+A8Y:
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M7+,M0 +D7+,M0 +D7+,M0 <^X^1]#  W'R/H8 &X^1]#  W'R/H8 &X^1]#
M W'R/H8 &X^1]#  W'R/H8 &X^1]#  W'R/H8 &X^1]#  W'R/H8 &X^1]#
M W'R/H8 &X^1]#  W'R/H8 &X^1]#  W'R/H8 &X^1]#  W'R/H8 &X^1]#
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M8 &X^1]#  W'R/H8 &X^1]#  W'R/H8 &X^1]#  W'R/H8 &X^1]# !S@
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M_P"$6H>,L7_OJQ%_UFQ_U3@^U_ [_!1P;_V)PU_M,4;)#7!T@
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M?-/K] </'+N :CYI]?H#AXY=P#4?-/K] </'+N :CYI]?H#AXY=P#4?-/K]
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M#PST  N'AGH !</#/0 "X>&>@ %P\,]  +AX9Z  7#PST  N'AGH !</#/0
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MN!K7SE?&/TAL6O!-_$3Z \7(_P"J)/D\K[@:U\Y7QC](;%KP3?Q$^@/%R/\
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M\,]  +AX9Z  7#PST  N'AGH !</#/0 "X>&>@ %P\,]  +AX9Z  7#PST
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M'+N !P\<NX '#QR[@ J;A8Y:  7"QRT  N%CEH !<+'+0 "X6.6@ %PL<M
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M+'+0 "X6.6@ %PL<M  +A8Y:  7"QRT  N%CEH !<+'+0 "X6.6@ %PL<M
M+A8Y:  7"QRT  N%CEH !<+'+0 "X6.6@ %PL<M  +A8Y:  7"QRT !4W(>6
M9Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@
M7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>6
M9Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@ 7(>69Z@
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M.7< #AXY=P .'CEW  X>.7< #AXY=P .'CEW  X>.7< #AXY=P 55R'EF>H
M%R'EF>H %R'EF>H %R'EF>H %R'EF>H %R'EF>H %R'EF>H %R'EF>H %R'E
MF>H %R'EF>H %R'EF>H %R'EF>H %R'EF>H %R'EF>H %R'EF>H %R'EF>H
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MG"MG'VELWU>K;_P*':C<?D[SM6^LAW7,&\[$/YHXG^R@\X5LX^TMF^KU;?\
M@4.U&X_)WG:M]9#NN8-YV(?S1Q/]E!YPK9Q]I;-]7JV_\"AVHW'Y.\[5OK(=
MUS!O.Q#^:.)_LH/.%;./M+9OJ]6W_@4.U&X_)WG:M]9#NN8-YV(?S1Q/]E"2
M[']K2Q.W*L7&@*$<JLAJ]KIF96"EEJRSNO:&4QTW)=$;+.=$L57T^S25<B4Y
MN"-)%"GF3)IS)IG!!%!)GQ2K*QH+*KCHERD,<76\4<G&)<621/&A3A(5L'7#
M29H0I7*1%D7?Y2SS6'L?8:Q/8/555(G=D&(1V"XTZGM:M9PTOMQE/H.QAQDN
M))YYMLR0:E9JY"R2HRV7N0\LSU&%&YA<AY9GJ !<AY9GJ !<AY9GJ !<AY9G
MJ !<AY9GJ !<AY9GJ !<AY9GJ !<AY9GJ !<AY9GJ !<AY9GJ !<AY9GJ !<
MAY9GJ !<AY9GJ !<AY9GJ !<AY9GJ !<AY9GJ !<AY9GJ !<AY9GJ !<AY9G
MJ "MN'AGH !</#/0 "X>&>@ %P\,]  +AX9Z  7#PST  N'AGH !</#/0 "X
M>&>@ %P\,]  +AX9Z  7#PST  N'AGH !</#/0 "X>&>@ %P\,]  +AX9Z
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M/0 "X>&>@ -'9L!^<H0E['\QUV_X]LV&(V<OWF*_M.W_ +4X.:'_  Q-G_\
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MGD669G[YG[Y^^8^^%A%^?B$!$.%A%^?B  X6$7Y^( #A81?GX@ .%A%^?B
MX6$7Y^( #A81?GX@ .%A%^?B  X6$7Y^( #A81?GX@ .%A%^?B  X6$7Y^(
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M%A%^?B  X6$7Y^( #A81?GX@ .%A%^?B  X6$7Y^( #A81?GX@ .%A%^?B
MX6$7Y^( #A81?GX@ .%A%^?B  X6$7Y^( #A81?GX@ .%A%^?B  X6$7Y^(
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MZ_W1U/\ /BS[P;"Q\9<5>?Y_U@;9GX/K?(VP\'7^Z.I_GQ9]X-A8^,N*O/\
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M\98^>^NCH?L>>#+X'_N:O[,#R3M(_6KVO_K#UQZ2'==QE^,L?/?70]CSP9?
M_P#<U?V8'DG:1^M7M?\ UAZX])#NNXR_&6/GOKH>QYX,O@?^YJ_LP/).TC]:
MO:_^L/7'I(=UW&7XRQ\]]=#V//!E\#_W-7]F!Y)VD?K5[7_UAZX])#NNXR_&
M6/GOKH>QYX,O@?\ N:O[,#R3M(_6KVO_ *P]<>DAW7<9?C+'SWUT/8\\&7P/
M_<U?V8'DG:1^M7M?_6'KCTD.Z[C+\98^>^NA['G@R^!_[FK^S \D[2/UJ]K_
M .L/7'I(=UW&7XRQ\]]=#V//!E\#_P!S5_9@>2=I'ZU>U_\ 6'KCTD.Z[C+\
M98^>^NA['G@R^!_[FK^S \D[2/UJ]K_ZP]<>DAW7<9?C+'SWUT/8\\&7P/\
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M/\C+_P#RH?\ U98PV(?W%L/ZC_WH%Y7_ +<8_I'_ (%"4]J_^9O;/_L9>?\
MV.$>O,<?P-WO]B#_ -M;&J8!_A+PW_:>-_JS'G6I_P#D%D_T0V_[G)'Q#M?W
M4LO^?F?ZAP?4-G]B:_JT?X2%W%@*@    V,L$8*:J)!:2V5"V-JR:[,C%33
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MDYQM,"6FH16;$ZM"9"783KJ;9HYC[\B:FGDQU-&U/VB5HNE66*4@GA?ET;Y
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M_P"LNRI_A&UX>W^ ?]Z:?Z#7^KLQ\JOU97[_ *)_/-_V_#X]3H[B/'@
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M)<6G=KU4<N.=='CPZ\V)!Q#=:5!BQ8T:(I"DJC,1V6F30AI!%#PU\;B
M   .X/\ Y.-_WQ^J=_ZR[*G^$;7A[?X!_P!Z:?Z#7^KLQ\JOU97[_HG\\W_;
M\/CU.CN(\>                                        ""-H#_ +-4
MS_KNT?[BZC@/ZHC]ZV%_[>4O^@N1NF!_W0L?^CRO\Z*(.'!1M@
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MJ=_ZR[*G^$;7A[?X!_WII_H-?ZNS'RJ_5E?O^B?SS?\ ;\/CU.CN(\>
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M-M#7HE"0J&=99SX"A*,U".(H=T<,6\X>)#O_ ,W=_&7\>\65E@KA&GP9,-.
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M.;\N7]GAZU;U3'^SDMI_:R@_WB'<$Q/X?YH7K8>RZX.><WY<O[/#UJWJF/\
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M^U+(E=\C/T:#IP\Y@
M                                "(-H*TA?8Y81;+:TU-R-X<[,K+Z[
MKUO:7"9.DH');25,N3ZF0+)J8R42TJN<A@D3XY!E-AE1Q12S*,B,5&D;1UML
MSR):TI,R][,R+,4W5FVTXX19FA"E$1]X\BSR&76=U*HK2S^A:Q5II*-55E'4
MS4JE&GBCC3I%#ZR(72<FD1S3.9%)D3%44J5%,,XXH(83C.\9B51:5*3S5&70
M>0F2>I*5<Y)'TEF,Q$HF
M                          &MUE=MSO:!;UM261+61M0-E@3W9(U,KLEG
M*IB]^EVBV8MM=KIKI*G1&GD1MRQ;&A2$D*&&8E@ACG;YIF8K+;)#3+F9F;I.
M&9>\6A9I++^?+,44.&MUYO(B)HVR(_?/6@E'G_-GD-D11%8
M
M   :L;<O\R_:Q_\ XY6S_P##VH!7C?MAC^M1_B(4)/[7?_JE_P"$Q*-A'_<?
M8U_LIL[_ ,(,XIN?LCG]-7^(Q4;_ &-O^@G_  D)6$@G
M                                                  &@.S7_ #UO
M5(/]<-F#_P#SNP"Z>_:\3^B]_G*%JS^V)?\ 29_R4C?X6HN@
M
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MD+E49F)V%(50
M
M   ! &U/8ZY;0.SQ:W8NSO*&GG2T:D%M-HGISD*%2!MGJILB9"I5)TIDHFRH
M2DF44$D[YWBW?Q"JPX33K;AEF2%9F1=\Q2?;-UIQLCR-:<B,^\0F]I1Q-S4V
M-\<<,R-"WHT<<R$C*&9$E32Y$4<)'[)0Q' <1$?LD1^S[(IGRF9_QBH7(1%_
M$+@("(
M
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M+R+6(J8AR3^O%O*[),N-R*U+41!-1HSQ3C9D.--+WB&M#I(
M
M                                             TKM"V)J,M#K"V>L
M7"L:G0++:JFV=:G>4B.0U1)F=3LY*XU=.IFPYZ:.;'(J".,X7HU44V9+AW>
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MIVI0J$ZA.T0ZXRZ;IK7K-#Q)-!$19#4YC]3$HIKIZH*?6VM5@XR'W9[<-FR
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MB
M
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M-U_8U+7$SV:3D)7-)Y+CBD-H6AK;.=EXTX=B
M
M                                                '%/DP*9$Y/-(
MSE3Y4R3,(CW&<$V X(R(R]DC.&(]QE_%_&(D9D9&7?(R,OYRY1*I)+2I"OP5
M)-)^]R*+(^HQ'ED5E%&V(6;TM930"16BHVCD2E QI'!=/=%<E,K<%CG.AGKE
M1Q3U,42M<HB**:9F4$4,LOX,)"[GSI%E,?G2E)5(D*);JDI)"3,DI0624\A>
MU27>_G&)H:.OPW3P:.J;<;KZ]I3,9MUU3SB6U.N.F2G5YJ7[=Q7*KERR+WA
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M7]BR]KED-DAAQN
%   __]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>18
<FILENAME>g723949g20q57.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g20q57.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" #A 9@# 1$  A$! Q$!_\0
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MHTIYZ3:*\=KS#:%.F@Y,<F3">1-N)S?Q\&3-^/YOKHTOX_?\?O\ 5:4^GO\
M:OV_]KU]?;O^C^C)*.3 ?&_K.$Z&YI'[]W_^E:__ +N__P#)EWH?]?\ ]/\
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M<R/:"!\>G\]_&]?O,@KRSX0@81+NVD_'B0&J?(9;D\RZG%)6&)T R_7J//I
M:12FS'01UK.1UB@)&C0;%!)3G(L>+(<7-AZ?YZ%NP H)/+X="!Q&V#'EI"H[
M(8@@?,>M6/EB/CY5QOD=+QVONV>AQWN<_P#RK.#HFRH4NZ3!6HD6W2W21RDW
M\!7EIY_!D3[Y&B6<U5H%<G$J2F'+A6T1"*R"M<-QI%=,0X9YEP:EZ%O7MWOC
MH!D)]^N'08D!M[4D:8>X;'<[ZU8WMM:WLD,![1MNR-$K_> .P>CW,;/\L.4Q
M#%($M.6G_K9<#]0,/F:)?*F_S^17^<D^F2"-\$VJKB"]6&2J_"AS(4X_"%P9
M0>;(LC$QT$%,3(CT+-,?;[5##3*W,%PFD*DACLZ(!)V./R0#'UDVH!/N8J=A
MAQTI;; @$#0^3KKOX!F:C^4'%I0U9)FPV'Y/O5X?$K[O->GQ[N9=ML$T3K,B
MM<^D4UJ]6D6=&5JSDQ9JN5TH'F#JO9YS,Y46N&GH//1L!UH?!.^:<1Q(!Y/R
MXJ02 0Q!!91K;#<O536]GY UQ?D=[(TO'D00"00"- GZ&:(6\JH['CB$\@1-
M8"JC6.]5FDBQ=MNLBFUZ*BT]JA<>A6*QV]ZH%I8 /#^\W:2GRU*5*A0T/#EL
M[>;W*R2T;M:HL?:C,2J\B>-9LT%Y $G7$>[]Y$W:K%@ [8+VW$=OPV6XG0^O
MZ9K(3S#EEU'*Y$I-+M'06[S1^>TN/S+KK5[Y=;[+>*[:+;J"[U%VB5Q\#*I=
M6I5EL_01RJ24*A*\R(F"8-AF6 8.=D<?0#<F"<&=N=?%U565=\.1V&9E"'D
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MKB.-5HK'^<Z1U!@7=[H2A][K(<!4@Q%H"[-ZH!EB[.W(7HBAUTUO]('IQU6
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M!( TP_SV>I6:U<XNE2Z]47"]3O4SKA^AZG5B8#(\BM#1V_TQGVD91&3<V(R
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M%T#OK9Z[[GJ%P:S!;GQ3E-MKER/]#!62@U8T*O%JCP(EHM,(B(BRF3-CB"X
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M5(,S"IQL;U,?%%M*9M^4W%[:J[**L=S41R=BI/(ZDWX(Z:TS*I/%R[:9N/L
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M5JQI=BQ6M6'J<3^Z?[#,OQMWDO)^&\K1^'/R=N&,HOY?\,_A?\0YV=EY/EO
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M=:G*$XAM@ $@ !"G2C6RI)[;LG_UD;]A),72I3^ILCZTQSFM&A5>YA^<$R9
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M]=-='E,FVBJC):ZPO?4HQ,JIKKE:BI+"$MK]+C4W]1@?UO\  'XIQ?%^#O\
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M2X[8>(V7;;C8]>>KV9E*UVV8N\7*1+%Q[,?*%_.QDH*K2SH+O6!45LP_9_\
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MS6D[<:;GQ78BW6]+UM.UMI=VI&E:VG:M:]=>GKG@TV&FZJX $U6)8 ?@E&#
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MMRIEZNWE[#[YTT;S6O\ D4!HXL1Y-TT57ETVP&*1&BU7@YHAPH_S]P1R"NT
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MU6H((KX-H @K^YV?GL3+=>HX85WWRJD=K\1^@>3LOL4KCN_'XG6Z'/L8E%7
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M0E4NE>:G&Z@'/_L\W_*;:QP8U/&AZ;$DF!,F4+%O$O25:&M,USZK+2$29K4
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MK2)0>D^&'D!0>L]QZ7:/-GK]Q =!#5N-75;%<TW9@B!18Q*D5Z>)MW.+M1X
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M%S''I.U28@%B6_\ (XK6I#[J6_:UI"=5WUBJUD!) X]GY]RJWT_F2I<V5AR
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MCACDD,#<&M1NG$L4.6* H;/:2>3BH V,NEUH!@>R"1O0ZG!E5DH%#$.$]V@
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M4H,'J9$Z;M;4EIR=,-0Y#KC++-JY:J1_38HGI&L<QR#4A@I<\-,&Y$L %U\
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M*[&D:$?=)2U,UWY M704KR?U;"6!W85">W2CBNAO1V=GYT)930:CLMR 05H
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M-ZA<H%I4APO9=]D KWL*0  /DL=;ZF-$^7_DI=_%SI';!=NXS2+_ ,Z[;?\
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M31.<;,RV1T1J&U*+&2;\DD7)R$,I=GDR$F1.GRENRY;[LAUQQ5!.R3UV2>@
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5(C$1B(Q$8B,1&(C$1B(Q$8B,1/_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>19
<FILENAME>g723949g20u48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g20u48.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X66(:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM
M<#I#<F5A=&5$871E/C(P,3DM,3 M,354,#(Z,S@Z,S,K,#4Z,S \+WAM<#I#
M<F5A=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL
M;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @
M(" @(" @/'AM<#I-;V1I9GE$871E/C(P,3DM,3 M,354,#(Z,S@Z,S0K,#4Z
M,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T
M93XR,#$Y+3$P+3$U5# R.C,X.C,T*S U.C,P/"]X;7 Z365T861A=&%$871E
M/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V
M/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH
M96EG:'0^,3(X/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%
M05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!
M04)!05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!
M04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#
M=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(
M>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&8O.$%!15%G06=!14%!=T52)B-X03M!04E205%-4D%F
M+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%
M04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!
M0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC6455
M37!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#
M3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT
M+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ
M8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!
M341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C13
M3D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG
M6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E7
M5G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A9
M84AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+
M;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03E-86HU:SAU-EIC4E<R;S9P
M85=6)B-X03MX3U%)66)I94M*,THV8U9D;$HK:D95=U5K,6%O2VYD0U!#;4MT
M-'$W1EA9<6=.5S%E4%1L=#$Y0U<W=4QU6#!,83%G.5 Q2&-),')5)B-X03M-
M<GA)07%2<U-3=RLO0T%T<%1D+VU$-65T4%-38UA36$UK:TU*=&9Q,'AK5U=F
M9V933D8T=$EI>7%Z4F]Z3E1O1&IW;W1O9FU2-5!0)B-X03MO96YE4WDO5U-2
M8F5N83-4*W%Y<4=:62M-4C5&069J02MZ,&%M4$-6<TEY,S@R869.0F]C>7<S
M05A8=U!Q:$U:05%M17I5;%DP0R]#)B-X03MP<%-V3'%+:F9';'1X.#$R4S9R
M9C99.71C3&-71G,Q,C5#;W=K:5=N.3)Q3WHQ2DY&1$M+.7$T,'1P8W8U;&58
M>'!53W!Y<$Y&0DYD)B-X03MR6D)F,U5R2WAJ17)33C9-:W$X23!.6$EA<3!)
M27)T:#16=%A8>C-P=G S:W-L<&11=S)S3C=C2DDT:$EN5%1P4%-U9E-#>7,Q
M5F9O)B-X03M(0S%W8TLR9S=B.#!.075*25E9-$QH<FTV9#1B5T9$8GDK<DMN
M;VYG:VM5>G<Q<&-!+V)O2TYY24EW.$LX5$U-:6PR2W5X5C)+=7A6)B-X03LR
M2W5X5FI7<F5F=$HP>39V3&%A,G4S;'-U0FM#>'%O6D=H;FY:-"]695!K<5(R
M:VA9:G(P6&MC26EG;%9J.#@V25)Q1%1E=$)$<#=Q)B-X03MJ>7-N<4-8;F-Y
M5V%T17-*;&M91V5&:S-52'93:')J4S)O=BM:4&LQ160S=EI&.4MP:U)R5S9$
M<7%L;%II:&DU8U9:1U9M<%%%54\K)B-X03M00U9S26TK.#,R5FY.96E3,758
M=$Y/-4,K=C0Q4F]9;E=!6$)29T@Y5W9P<W4T5&I59U9R:E,R9TY6+TUA=S!K
M;VUO-EIE,G,P:7EU)B-X03MS37!S,%ER0TEY4VAA-$-312MQ07%X<WI%9VEM
M,D525S!B3#4R,%I0,#5W17-O,$-*6G(T;V]O95%C.$DK4EAK>2MK=V%T2TAB
M>&]+)B-X03M7,$Y9+VU2-5=U67<X<S=7:$Q/=$I!<VE!2BLR6G)D<#1/3$A:
M5#9M-4)!,T9-4$-6=%A(-6=E56EH9C8V=T-O.&IH<F4T57%%5C-))B-X03MC
M1TU&5TMW=7EQ9#)#:V=(0G=L8E59=GI*.'!U,#1A-6MJ4T-14D=2;TIU2E!P
M<DEX,E%L4DAZ06LU9V-$.7%L4E8T4W1P.7!M<%=M)B-X03MP,D5&+UIS>C)T
M=W9/1C-J94ES<#9.=VM61V]E;TY.>'5.<T-55&ER<U9E6&5B3E(X,WAE9C$P
M4%-O=%!84V(Y=%!U9%5U0G!U<%-8)B-X03M2:6MN351).3%A0S1T>5-T<W=R
M8T-.46A!,T%,67%Z5%=T64=G;E(Y4'-B1TYK=C5:3$LQ6&U,93-H34YN3F-X
M:'5+4T95271U4'=R)B-X03LX23,W54MQ4E1F;61*0F1Y,FLR:GDK=D)C=%IY
M;4XR9%!7='))86AD;$=-86QK141$-G4Q05I8,DEJ2'A9<6TR:BMD8F4X14EU
M-V%3)B-X03LQ93AK55=9:6IU3&Q"2$Q&2$Q$.6%L4T525S!R3$UO36)V,2MY
M>EEQ>51&54IQ96Q75W!24GA887520S1L:&5+5U-#4DA#;&534U)-)B-X03MJ
M<65,:V)(;V%9,G%6<#5%.'%P4$)/=&M1.7,X57-#*W1.-F%Y=T)"2$E)*V9$
M;4)%;TQ5<5%+16Y$6E)45FHU0CAP,D4Y=$YA,E)2)B-X03LW27-B4E103S92
M;# Y3GEK8E--9S5R.7)B-'5P,W@T:71)-R]!03-O:# K>C U-U53,E=N-U=S
M17)027%J,&YH-'1Z3&,Q.4M2;&\Q)B-X03M25$<Q<%I"-58P0S-L;FMH=$%V
M,6E!,G)X8VY-46=A;DM/3TET-F-A;6=Q1556>'1A47)E42]+8GAE;%!P-C-3
M9D@O=E9*3&-T5U)))B-X03LT,F)L33=T>4-1;W%T5W%G9D149DAI2S!V=&9*
M4&QU,6=U24ER85%W,TU-,71+:VQX8U-G4EA,8W Q5#%*1SE0,4<S8FA3<#-X
M=&%2)B-X03ME;RM89$<Q2&EB>3,Y57AX1T-.=6)Q5E%U:VYW;%=5:&<X2TU'
M2'A#;7AX=$Y*:F=6,DMU>%8R2W5X5C)+=7A69RMU-F@U2W5R=654)B-X03M6
M-T<U*W%Y>D=X8E5W>G)&2E!A>'IQ64571U@Q>65-<SA:+V0X6'%6,S)'4T9S
M5%,K>C%,.'0U-S$W5S-K6C=J5G!K;5I75S@T=DYB)B-X03MU8C1+<DU/15IJ
M95%Y=$=#2T9V:4AX8G4V-TUA,3%F>7HQ:3-397@Q2C=&2F96*W-3<F)8-W10
M0WIY>GIE;B]D;6ES,&I/4GE29C(Q)B-X03MO1F]284YM439J<78U85A/;S-$
M,WIY4UA$=7E814Q2,WAH9&=R,F)3;45,-DPX46I21V)I855P>3992TMD;#9W
M9FPV.6<Y-41&2G%-)B-X03MD*WEA93AJ4UA%,'-N,7E/0V%N3S1F;#A%4U)Y
M5C565&HX3D<R>#-4<VQE:V$W-4,Q23-D='!79U1Y,U=R5W%I-G0W9')8,4IR
M8VAY)B-X03MZ3S984$)(6&PK.#5U<VQ75V]/,4-154%H3DQ(>3DK6&9M93EK
M,45A8C8Q>79P,U!+5G!!<DQE>$-:6D)'2#1566QQ9VI:=WAP53%))B-X03MS
M:$Y!;W)5+WEZ.'-88T5P:&AA2%548E,R='9Q16MS.7<X87I)>45K4U-(;E%3
M1VY)-V1Q66E25VM39GDX.&]&4W8Q1G5,3GEC979C)B-X03MF1V5)5G5F-WHT
M=5E58S8O8F]/5F%93TER4V4R5FYB5U9N0EI7<65N8E<P85%W4C%*-'AX<495
M5EEK;6=(9D%L5WA6,DMV1G9Z4# R)B-X03M32#AZ3DMV3$DV6DAQ52\Q2G)6
M.5%&:F-Z=3980E9O-&LQ0SEG:VA504M9>&%W:W1)5#A336572W98=$I.,BMN
M=U18,$,R,F]4>'AY)B-X03M8,$-.>E9*>D=O9%9B8T5+4E1B1E5845EQ9TYA
M+W="-#0O.$%M2W10*V]Q4$9563@X0U-*1SAI<DI,6# P66=&<61E25!7;4MR
M=5,X)B-X03MG=%)Y24I#.39#;%0K3TMT-'$W1EA9<3=&6%EQ-T9867$W1EA9
M<3=&6%EQ-T9867$W1E=%,VIF;&YD,VQX.6)M-'5*1VQU3V-T,41B)B-X03MX
M4VE34S-A9C=345)0-G1U.&9Q:6@U-V-Q<TMM,%5J-UAY9C5,,4-&3#(P-5A-
M36A,4C--1CEC=7)/<6E&<$9D2G%C>7%C2&-(:U)S)B-X03M4:GA&85%D<"M5
M=FLU3$9R3SAT;74T:$Y*2D%';75&155B=7I*16=%<&]&5BM*<#EQ;%<S=SA2
M4G=P<69),VQN,30W:&)6,'5)9W=3)B-X03M66C=H5V\P<VLW2WA746-L85=:
M,EI7,E!F;TU&;$Y+1F@U271B4%)B1%0T-6=S=&QE9EAJ3VMF0EAD,V8Q5C1C
M:5%R4E-T1W9X17%+)B-X03MD86)T<E-)8GE.-5E,=WE*879"3$)$2&)25%<X
M.7A"24EO5DM)=D]+4D=.15!%:VUP1D%E9WAS<E-+,')18F)48GDW=4E44DHP
M=#1))B-X03M)1EAI<TYV87@X231H=6$P6FYA=G94=%5P2V%44$%R<U9D:7)S
M5F1I<GI0>F]L<&)E97)+66594#!F<58T8D]#0S-.<G$X>45M4U0V)B-X03MT
M1DLR;C-L<&%K4$E*4W$S0TY8-'5Q0V=696IX4C-%9&]K8E,K=&-+9U5Z=6]!
M6G=+8VEQ,$%Q9#9$1EAN*VXK8B]Z26YT3$]38E%U)B-X03M-<WDR=C%H1$).
M2'=986%L.5!S>$I!;75883!7=CEY>3AM-3$T-'%N9&YF-CEE85=:3E5H4TM1
M,SEM4D8V57-$47!).79+27%U6$4U)B-X03MJ85%O,'$X5DI(,E%18U9B.'HS
M=DAZ4C5F<VA(3$PV,S%L<$9H:SE*;'!'3T)R5D]T1R]A1T$T:$PQ6'9(-U5E
M35EN:'$K3'(S5BMT)B-X03M:2DIP82MA27)&=$%K860W47EI8W1%45%(231L
M0R]":C%026YL+T(X1TXK2B]&>2M#*TY++T1R,#@O:GE46# Y35$W,F1X84XT
M47!+)B-X03MV-#(S2F9X=W!59DQO=$I,=E9(:&MU6&%+-C1/3&=3;T%F4U%I
M9V1Q=#A*55995BMI;4%1-&0O-3(O-E P23A4:3(O;3=F<"]3:716)B-X03LQ
M0W<K<7IP*VLP=$A61TI:6DDK46]#86M%33,S8C15,U-(,$)B;6)38F5E,3%9
M6'E-1W!/-BMQ:E5C:EDQ4CEQ53-B27=J2TEQ4G58)B-X03MY4UIX;'9(-F9M
M<6%O*W)1,C9..65T;TMY;T,W:C!!5C9L43!H=4)5:G X3TTK2W93;4YD53-Y
M5$94;&$U2#DP:5 X039Z;&8Q2S)+)B-X03MQ2'$V="]Y>E<O.$%Y4&8O04MO
M-'%S,"LY=G)I939I=7)),F]G6E)(3'DU<$M$5W!5,%4W53=J26=M>EDR6D5#
M:%)2,E-9=7A6,DMU)B-X03MX5FA9.#4V.&YN5W<X=3-';G=X3&54,V)/>&QR
M3$A:45)Y+U8U9T9,2R\Q:#1G97%S;39L1%1M5E9,5&15+TMZ6$QI93-S,VIV
M>&1Y)B-X03ML8G$S6DQH-U=347EY<U)):G(V0DAR4TTS>$-N3C%0,FY3<7%D
M95)R3S!S.4)E,7,T23=A,6AV.5131T-&46MA2TY2=4M+<7%!05!L)B-X03MI
M<68T<3=&6%EQ-T9867%L375P83)V;5-$5# P=W1P3'=V2DQQ;G%,4EA(4F5(
M6#(Y-C$O6D]415)W,V4O8S!M8R]%165(,#$Y5CEE)B-X03LV:T8U:#%F>E!:
M,V]I,#9W5V$P2U)..6)+4U156FY:6E(V8V)),S=U4#DY+VQC4%1(>'E,4T1C
M;%=V96503D=I-E)*<4UM9TID=U%Y)B-X03M1=VU4,35,6C5$3&%P3#9I=T=#
M6FM$6$0O5C%1=51Z<%A&5V-9<3=&6&I8-6IP670K8TAL.3<V,4YW1D=M<%I3
M3$<P;G!3;3EM:TQ-)B-X03M9.5%S1$=T63!02U-#6F%G8E8K1FQ8<W5+=7A6
M3#ED9$5S560R0W%T>F%%<U110697;RLU>%9H9FLS>75.46UK,5<O:T0S1FIQ
M1C%()B-X03M"2D=Z9D9%0G@K0C0R4VYX3515,3(V57ES-#1K9S-::CA+='1H
M<4II36\Q=WAL.&)R:V57,W5:3S-L2WI0;5,S,7=44V5R0D%90D=Z)B-X03MY
M3U-#4V$X,F-M;GA(86U*>$1J-'5T56M:-65(-&8X041D<'900DQ)4G=U2DE+
M9&9415IR+W=!1VHU63!P6G!M;BM9-V4T=E=U=%)I)B-X03MU25I::3EQ<GA%
M<VMD4'-K<3!9+T$U1TE)=7IB3V-O:T-H5S(O;C5O-U96=3(P=397,5):8F]W
M=4EK8VQ63&Q444=M.4LK*T4S5WI')B-X03M.6'9Y4S-Y;F(V=F(V2&%7=#E:
M5SEQ559L94=*,TE58WI10D=$+W,O-5IW4DUI4%9Z6EI"04=O6'<Y3%-B.'@W
M4%)O3DET,VPP:')S)B-X03M.9$IT83A9;D(T3V%S=U)Y4C=5=U1Z4W@W>$9P
M>#971V,X37E!0G9V,VA0+T%+<D%.,3!U-6HO-'AY>' O=T%2;4=483-5<V=F
M,VMD)B-X03LO1V9$;F1.+WEB6GAI<31(5&$O.&8S,"]8=C0T<6QF;$]F4C5F
M34AM4#9I8G(V>7-S075X8S$T:FEJ26YP.&U:+W=";&EE5D]W-UI')B-X03M/
M8U1*:B].+U-Z;'!$:D%Y9C9P*VAL3U-93WA6,DMU>%9H,FDR.6AP4&U1-F1E
M5%<P*W,S:SDW97=U=&Q+6B]Q.7AC5'EX23$U56]0)B-X03M4:E!$:65W;T\R
M2V]I5S0O3'DS,6)53$-7,G,T<C574UA5*U9R>%5M-V174C5P9E0Y3G95:U9F
M:5IV=$%6,T=+;UA19&,P9E1F2V0K)B-X03LQ;F,R:5!B6$]R4U<Q=4A12CA.
M-V-.1T%I;&9H3E(P.&-)0VQH2CAS96%93$=F5V)F>E-K3W1837!U8FI366)L
M631P2#E59S%L.615)B-X03M0=T-U-#=C8WIF1WAN,&ME;G9D1V1&<4%0144O
M6&0X3C=%,S<K5F1'9"M2-SEB2%)N=$Y9,75+.74T2D%8=4IP,5DP:VEJ:TLX
M,F1U)B-X03M14C5#;V%V.4UX<W-H2U9G54AA85A&3$AJ15I3-'!D-T1B8GDW
M<C)Q5V-7<5,K9FIB,T8W17,W=TQ+,%E1<W9.15!'6E%/2G%$.$\R)B-X03M8
M:E!!8F-!+TAW8T-86BMA4G9X<&9C4'9:3C5*=C=V5&(S57),6&9-54]P34DW
M831J;6%646ET3C9O9%5,2&1F9U4Y=7942TUS;VXV)B-X03M25&YA8D9K9T1X
M>30W.'%P;'8V8S!7=% P:&)6.%!7:B]R-UI65&MP5$PU:FY(;4M'2T\U,#0V
M05E#.#EY,#9E<TIH5VEG8S953E8O)B-X03M:.&0K;4Y+;%!M8GI:-7-T3&4O
M=4Y#:3 R+V5'-5=,5#=/4S1I:F5E1C195#9P;&$T:E)/17=N5&E6<3%"4VQ+
M<S!Q5E1E92]Z1T9W)B-X03LS<#9:<&=T9EA203,Q<3%D>$-Y35I*041E4G$S
M<'560S%+;#96251N*S=A5FY.:'(Y9SEJ8DYF6&QT1&5T16AU6696:5AJ2U8K
M3DM,)B-X03M*2T)2<6EG9'9M975.2VIB8E5D4'5M-#(Q>D9/=T9323-6>E1B
M9C139C5H:7)Y1#AX9$1V.5$O3GI1<C!I>FAJ<W!D37!/5'%,>F5G)B-X03M,
M,'5%;&$S=%1A>&5T3%99,6UM,V1&2W-T5U5Q=EIG4U-246EH;T-A8C=6<4U6
M67)R*VYE9#5D6&UM,&TK0V%E-E<S<'=-54A#4EDW)B-X03MX6$LP54AI2C5,
M4U8V=#A327DW+T%'1U91.#AF;3)Z,$535&AB<3=I=6)5>E<P:'$Q>DM*24%Z
M451E<'=G:F5937EQ>4=I;6Q%-D--)B-X03MI44YT>7IG05I!13!%-#AL0U@O
M1%9O6E8T4TU:6&1+:'5*95HR235$63!R4W5'2DYB;VM!0V$S0V0T5TQS5F1I
M<G-69&ER<U9D:7)S)B-X03M69&EQ;DAB,CA4>5-2>$EK:W!R2S9Q05=)-W-2
M,7A657A6,DMU>%8R2W-'6F9,97 O;5AB87!A,S4O4V5N<2MM>DEB861O6D1(
M2$TX)B-X03ML<VPP,4Q8,6Q-=V-H2WE!27<K>GIO<6UT>')8:T<R,6I55W5*
M3$M(5DY0844V<&-34G%S:U)M15AO=$Q-5D=X0FEO>&%M=R]L,E91)B-X03MM
M;%A6<F0K4618=6)76DQI,FUL,7 T<&]M1&\V;3AU849756M%9DQ&5U@T<6=D
M3R\S<S%4+VU+6"]Q1FAX5E$X<"\X04M+-DXO=T%W)B-X03M.="]Y6EA&5DMW
M+S53+U=0*UE3=R]W0THS3TMP,6ER<U9D:7)S5F1I<G-6955E93=M,W90>D8P
M+U1B:GEA=7-78DQA450V>$XU96)5)B-X03LP55-Z3C9K6G9:2G):25DT,%E.
M>4-39V-M2D915DMR,4<P=#=/,71O-U-Z:6IG='):5FAI=#165D5J4E9!5D92
M84)11G!11'1I<71I)B-X03MQ4RMC8G(V<#5E;G5U1'EE:$IB>6-)<6QZ>'5)
M>E)A16(T44Q22U9#,%8U95-*9$1S1VE2;S!K9VIK-%-61$%U9UDX9U-A1W S
M.3A3)B-X03M+3DEJ2W=#;4=":S=&549B4C9Y=# U=5HT2'1D=4-P139V,#-&
M4S=!8C<Y.&E,<W!.36$Q+U%F4&0S<6UP>C94<6-D:F)3,C9P<'%.)B-X03M0
M2313-5=.9UHR:CE,:6]B;#98<#AM6"]!2&)4;6]82DE197$V1BMA4V580S)M
M83EX,7$S=%(V5G%O=&YH;&U&=WIS:E183G,W<V9Q)B-X03LU15-U4W9*9T=9
M0W!X5FQ(;$Y034-E5SE/6'I#-GEA,S9+;2]:94)(<6YC:7-A;VQ2,%!&865'
M2W!T:7)S5F1I<G-69&ER<U9D:7)S)B-X03M696,V0G!(;6HO;%EK.3-Q3VAM
M>C!723-4,F1X1DUR44<T:W5,9TQ/3%IR,E9);6QT;59N:VIT;&QA4U(V:TM8
M1$MS:C%(5F9);&AQ)B-X03M6+V98-7-O3#-41G1P3E0Q0U9),6%"8F=T1F)T
M3$]2.% R4TXR*T930V%+831Q9TY&=C=(55!Y.3%7.7-,:4LW<S=I5%=P24QM
M0C%K)B-X03MJ:U$S;'I2:V135EEE-'A6;5=+;TA4=CDW3E4O-6EL+S9H66-6
M55!+9B]+2S9.+WI!,C,O04-:6$962W<O=T-5=C%J+T%*:$Q$+VED)B-X03MZ
M:7%D67$W1EA9<3=&6%EQ-T98:VYM32MC,B]->$5S-#E53VYP9C),971$3&9R
M86DQ271H3%=&679Q8W$Q36DO,S9K8VY:-#(T26-6)B-X03ME=$)60DI!04Q'
M<D5D>E-M+W="07A6038Q<%HQ2S%H:%=:;T=H=7)7-D1R>3,K<EA#5$9#059Q
M2$-&9#ET-C!.3599;#5G.'8S96IE)B-X03M2-S)+,W5Q>F,T2DI85D955'DX
M;TDU2C5Y47IM4U)K36I-<$<U,W(Q34UG;%AP-71U17<T:'@S=RM83FU7:V\V
M859:231)9%E)9W=))B-X03MO86A"6&)*=%-+>%8R2W!:6F%:<6M'<%A&>E!Q
M<W1Z85-C9E%S,FII54I294Q69%9Q,51V='@K;DI%:75405)015-4=#-D>4(X
M>2M8)B-X03MD5S%+2S545&17;3!X<G%'4TIP16%2:D9)-G%O;6I8:TM&5E1J
M>%5R.6]V6&U"5TQ.1&YY.35U="],<'-B2%AI3E-33E9G=DHT>$YX)B-X03MB
M-GE:5S5'6#%79CEY9E)Q,51T>38T<6Y/9U$V>D)O,7)&<E9W;#%Q<4I3-VYI
M04--.51U=$9J-V8U27A634U69&ER<U9D:7)S5F1I)B-X03MR<U9D:7)Y+WDW
M6C9V4#A!;3%F86ID,G1T85<X360S0D-I4G-Z3E=A;DQO,T=6;UDT6FYL.5)6
M-%-Q9VI,<WIH5FQM=F59+TQ':S9J)B-X03M.8V%T8F5M8D-+,W5B:E98:%9K
M:&IL865'1FI)2W5+3S!I04%6+V5%+UHU:TMO1%%D4W-D5"],<E4Y47-*;'5,
M2S9F5UIB961+.%A2)B-X03MR>35O4E=M2W-Z>%9!-F0O=EIQ;B]-578O54Q$
M:7%H-50O-5)84G8K64<R+S5-<FEQ;%EF.'!F<D@O34I99CA!13=N1E4V>%8R
M2W5X)B-X03M6,DMU>%8R2W9-:T=P6'8U;F%L07%Y>6DS=4QE5TY',796<D]&
M24E9;T=K84]Z:&=E>6Q91UI3.%)M,W%V2E9$5EI6-F)I<G-663$U)B-X03MS
M=F)$579+,G!*6EAC5G=)<&QT8FAO6%=8,#5O-3!74TXK2BM&,%!65'5-0E-'
M43(X8VMD=D9(2DHV<VE)<79+44%7249#,4(P<FI%)B-X03M%1&9D4V)+<&A1
M-T95='1D2G593F%V9%)E+VUM9W5L4EDW1FEF4VA+2T%39W%2.%9+;F)+-#0V
M:UI79"MN8S-4>6=W:D=G3T<Y*W Y)B-X03LV57(U36U(;D,W.'=(55 S1G=9
M1U=X5TDQ5C19=VAK.59P1RM.9W9$-%9646I/=D5L>3)73DM13"M86&Y3>G9T
M36MS+TY6>F17:TUU)B-X03MN='%%3C-09&=T.55:5W5P12]F4SAJ9&-757A/
M9E15361M25=I<C!F1EA9<3=&6%EQ-T9867$W1EA9<3=&6&Y':#9(<E5(;DE3
M6$5D)B-X03MW3$EA=G%&.41P6E-T;F%X5'=Y>'!F>#-253@U<#5'9FQ!2F%+
M2GEF5$)1=&ER3$YF=79,=6A),VU$54Q.04DS55A/;WAW3$I,14-P)B-X03MJ
M4C(T9WI-4&DY4#1!>"M,<'@U14MV4')8.#-V>2](;%A68DTV:DPY6FYM,55X
M4B]5<C-F,3=Q9#0Y+U)O3U-U3W94=FER268K5C1F)B-X03ML:E=N-E=K<61W
M4'%..3(O-319<6AB3#@V4'DS:G5B.3,Q3U5,3D]R>&XV;&9B<4E):W(O04A(
M.'E%67%H.4(O3W8X04Q7=SAV-E1A)B-X03M897%Y43-%9'1B=TY',6YE+W="
M-G-10E%%43!*<7 V67%T<R]Z:B],=5!Z2G%D,BMP4VDS;G1R4T]+5#9L92]%
M,%14;'A4,$LW96]U)B-X03M+<'(O04UR=B],3"]!2W5S=B]31&9F.$%61$96
M<B]N9BM7,T)V5#%75&Y1.$]6:F8P<C)R4T1&56LX=B]!2BME6$QI*S%'4%=B
M;$QE)B-X03LP9VQ+,D4P1G)F33!Q8VE!5U@P;G!S060K4%AP:7%E+SAR=B]!
M0WDO-G5S=B]31&9F.55-5E-,4R]W039F2WDK6G17;'9D9E=84C-7)B-X03M)
M5TYU;&QF*W!%=T<Y5CE$8FQ7<E9R6&%N:&ER2CE*+TXS.'9T5W8W87<P+U5P
M2G)Q-UE*8G Y579%1$TS5#0S:%9".'EC5EEV<71T)B-X03MC<BMA06MJ<V(R
M2TXW>4MT-4A(-6=A1E(V9'5425=T6E)93W,O2# R0E955&AY;#5F6GA6-GAI
M<G-665(U:W9F3$AK*S!M5S=&>DMM)B-X03MS,S!M<#-+27%38U9T=VLQ>DE1
M>&I(<$I(0TMQ3U1M=G=Q,DMS=%148F1(:6-03U1$2DQ-9V$T;EE&<'EX8T]P
M8V@Q2$TX16%Q<'1X)B-X03M!;TM+=')P,75O:$%E9CA!8U%.8DI795DQ4BM&
M4SE8*T]4.3)+4TY6>'91+T4Q5E8Q>%EW,TA,,4=L6&M9:694;6QI+W58.5)A
M96UY)B-X03LP<3,R-F9B2'=T5F1S5E=3,CA%0FMU9C,W<UI235574U9W6#E-
M46A6:C5&46Y(9FA4:'DK36IL5G-64W923E-I:#%I*SAV5%-8370Y)B-X03MB
M*W!Q0U0S2$9L:W1R,C1K:U521EAC:%E'4&]G3T9.1BM%8V0X5E1"=$=T1VEE
M27E84$8W8C9M>$8S8VAV4T%)-4)H2GE76#1V-S1()B-X03LQ4#A!2S)'2V]M
M4S)J:T1":31$3VMP-'E/=GA2;%-!3TQ#:2]!3U,Y1S-Q1%4Q5F)K=#0U2DEP
M1TQH;UA-:4):2%93>%)O-D]Q:T(Q)B-X03MO-2M&<6ET1W!Y04E666Y*<7-.
M:G)C:TYU;"]086%(1S%T9F]T,41C2G=V:$AC;39M.5,V830O,%I)4T%(5#%#
M2%!P<7DT<7EX-V1()B-X03M-:$IC1U9"1S%(8T%!5C-7:$A&=FE0>$Q1.5!!
M67%O=G!T=3=U>&5C1C4P=51X=4HQ2$].5E9104A!161%2$M-9D%X<5-P3$=Q
M<4MX)B-X03M6,DMU>%8R2W-3=&9,,VY"+TYK5W(V:'$O3%0W864U34=N47E/
M:UIT<&M:26ML4E922E=J2TDT6C9M<G-0,D9,2V]M.#@X85IB>EA2)B-X03MK
M<V(R5S P.6M75R]H="]8:D1Y3SA01T]/379C3S1D4W!226DR-&%N0F<R2W(O
M258Y0F8K6%1E44-265HW+U4S:D4X571V2E$V:F-F)B-X03MB:6U73U)$-TUO
M3TMP-C!%5%A#6$)8.3E':E)O,51S<VA5<TMD3GEI-'%Q67%G9%8P4%,Y5F%Y
M82]G.5DV9&1*9E=:-4]V0S1I1$MJ)B-X03LO058U541N6G%J,GA62%EQ-T98
M14%G9SE$='1S9G=X5DQ.2SAT-E!P5C-E,VQJ0S!D>'%,*W)D=5I*2#5T5FUR
M4FU)1S=T,#AC5E)L)B-X03LY65=L+V%V85AK46UT-4MC-#)R43A31TA3;F-9
M<7=84G9,+S5E,TAN1%A,0S(P,FPU0VQU8FMT-G9":6]+:W!6:4)X-4M/9W(R
M<C%X)B-X03M6;G1T8G=7,79&8E%)231)55=/2TUD1E)"4E%0:T)I<7!I<E%6
M45=)1D-X<3-U854O54U68GA60C9L;S)K86]K86%N63(Y.&M,1C1L)B-X03MU
M66MM0TU15DQ+2$153D-2=&EQ37A64G9B;C9R87E82'!034EH>4UC9DAK44]T
M3V))=7<S-C1Q:VDK9B]!0W-,;39S-VDY:G1R-GEB)B-X03MJ9%=B=6IZ4FXP
M,FQQ>7=T3%%C23-9*T%6:C!&8U96-W9Z;#5C=#E);C%96#!-,6AB=D=K:SAC
M:UEJ<DY+2550<4]Y4CAF55!(;'DT)B-X03LQ0D9A9S1Q9TY&.#0K4712175S
M859C5SAK.7E28C-&>D1&5V%6;T<T3$574E,P;D0Q3U-G16IG=V1F9UI72W%:
M1'I2<&ML=#E:=&QM)B-X03MU;V<Q,'-N<%).>E0V:DU93&LK;2]&,CE/56-A
M27!:=C)18U9B5'IB-5IE57A2-FQ"3$E'2VQ9,T0P0W-Y334T,2M"6&ID1V8W
M25I7)B-X03M5;FM#35959%@X-F%"<%=L>6%L8WEU,$544TI+:5)U6D5A1T(W
M<51M:$-L3TYV1S!N>#!Q=$M63$M#<6@T+TUF:T\T,4)9-#4W4U,O)B-X03MU
M3'1B9"\S64UG=E!3:U9%;5!'<V-N0T-20C9L1'1W-C=9<7E41EA9<3=&6%EQ
M-T9867$W1EA9<6AT4'-)3$-"-$E3>%(U<#=G.&I5)B-X03LX-VU:-3,V06)C
M-414,GA60S-8*TEZ<FQK3%IB56%%16M.*S=U+S%O>6-327A'9U%X.$%A8W%S
M1#DS>$MP;FER2%!.,%AN:#!0*T9P)B-X03M)23=G,C=Q1&5/<3(T;%IL0W1X
M5T=7575%-494>30Q;T-R5G%Q<DDX5F1I<G-64W91,3AY0UA5>G)2=&EJ6&MH
M,&]7<DUA5UA&4D5*)B-X03M!>4E22G-3*S=#<#).2T1&53!X5FE/;&%,-7)T
M=DYZ6&LP:5!O8G!D8WA*8WE08V5O,'<K<F9#27A'.&-C45!%16=R>DEB;556
M,E9:)B-X03MD:7)S5F1I<G-69&ER<U97>7AP3$<X8FEQ3T-R1'!515505$97
M3VXX=69*:#%454Y53VXO04]N86\S3R]M.6%F.31W9VUT<3AE9D9F)B-X03LS
M5C%+=G=G9F%R,4%)5E@V4BM8+T%*3C!E>'5R1%1T3&ET-T\Y=49V3'%!1C)6
M-6MK17%K.&UB-%9D45%G*T5D2U5X5G)69GDY.&\V)B-X03MT.61854Q*<#1D
M4C1M.71F<D9W='9),&%X2VI'0EI&:35+='1'07=7=G<O4$954F,K5'1!;G14
M86U/94M%>5A->"MR,V0Q8G-8=EI4)B-X03M.8U9E1U=.>7-K:D9I=&%E07A6
M05,O;&8U1&UD5VTP;$I!;'ET-4=J>51.1W-Y4WE42U91=55#<DIC4VM)0GA(
M3G1T>FEQ>50X<V9+)B-X03LP96=W-D1P='8K:G1-4S1A95<S:5HR17%Z479B
M6$5C:%II+S<R,VQD3U%A<6UJ1&-9<6E9+W=!=E!+8U=O1R]H<WI(8U!F:E9:
M:4I:)B-X03M716PR=G)C6%I86FA25W5864)A0W101$974C1Q-T9867$W1EA9
M<3=&6%EQ-T9867$W1E5.<5@Q,%=5-U=)1%AI>'5B9%A.1DUG43A!)B-X03LR
M-#(U,'A6:4UT,RMA:V5O5W-A,DYV8U=,;7@K<U1+.%-323!G8S-P64TY1VEI
M4$5+1DA-:F]7,T]+;VTO:B]-4T54,T9R4$9D33@P)B-X03LX9&A93$1%:7AO
M-W592F)Y6C5Q=D=N1TU-2556=VI..$QV4F=Q;#EL3BMA-V%3.3%E,C-#*T@V
M3DES26US>3=#4%5P5'%)56QV5%5Z)B-X03M72' X43!P<#)93E4T<7!R3BMC
M3G1$<&QU3&5'*W5)-5EO.5=U-5=T;S1N:F9P2D552TY3358K<U9I56LX4D5T
M3U1"5DY,4U@X>$QN)B-X03M2=$TK=E%W5T]P>4Y45E!Q-5(K0E<Y:$)-4$PQ
M13E.<E0Q,DA+<F9:2#)S5E(S;&E4>F4Y=F%(6#0T5757:G5'=C!J-DDT;59B
M55)&)B-X03M3>6Q7:$1S*S502VY18EEQ>41&6%EQ-T961S@K=696,BMP*VXY
M67%V1#%U6$-N26-Q.&0O<S%P-S56;30K2#!6>&5F3'HU95102'<X)B-X03M8
M<G9H.'5A6"MA<D<Y=G9,.3E"64Y+;"M9;4YM,$5Z,C<K<T%E2'AO,&4Q97A.
M4$A,9S%L-7,Y>"M9:F$T*V<V9G%&>71X67DS,7=S)B-X03M8<3)S=$QD66QA
M>CE2-6DX>C@S;D%0<45R4VQ0:5)U33EM3S=,,R]X:W5H-G)B44QC:E9V<FAM
M=#5I8F1G8E=A-DHT5WIY17!6249/)B-X03LP;C)34C=:2%IK:TYR2"MC:TYT
M6E),-FIV14EL=5!887A:5TE:=S,W=T9P0VYP*VYY2G$U8FQ4>'<W23-6<$Y2
M+TY'3%1,0S)U67I")B-X03MQ9#%03DA#>5-78W,W;&)A5U-.6E9-4U<T:C5O
M0WI)=V)J=%-U-61L,U$Y,V1F;7):=G P3GA08W,Y-4PV56I23'!M-W1B0U99
M-"M3)B-X03MI:%=22E$U9F)I1C1K;DA:9#!24&$O;3%C>6-*2G!O655#>5,K
M9S%I;V528F](:$,S.31)+W$K+W@P2EE%2%DP>#)89#)K469M,T<Y)B-X03MI
M;# X=V=T,&@K=$Q+8D=4,4=7-59854]/56A4-G)U5THU.'=D*VU*<&0Q8E)5
M+TY%,BMO5&%Q:WE82E<P:G1L:FMS,F-O<S5A-6%.)B-X03M.<F1836)(:GI(
M9T-44W5*<&0P3$I"*V-$,E5-8WI3>5,S14XP3'8P,W-O=E-K36-I=T)75&<O
M,B]48FMR-V(Q<C)D;#-43%=03'9N)B-X03MA93DQ5S@P-U4U8EHU<FU+4%0T
M9E5D:U-+='-Z5$97;4U81F94:TA!4FAJ5G$X<6=905%T1F)E42]M571Z;S!E
M;&AR9E140D-M<7AZ)B-X03MY=U1Z4GE,27=M26UK3',U6D="53$O6C9#=$UD
M:S=O9GEH<&XU:S)6>$<R<7I837-25&AC4GEZ,CAW*WAC=4=J2DQS1U9Z0W1E
M.515)B-X03M%055*<$%T3F14=&9/:RMG5U5--%HY5BMT25I:=$UM14EJ9T%)
M-7EE;SA0<714<6=O<&%M,T5523)3;&DV5"M9:39!-E)81GA(<7%8)B-X03MZ
M>F\W5'A3;&\Q<U=8+V1J3VYP4UA8,EEY4&A"<E%5,F)#3C!495=8-6HO;S-2
M6C=E-FM/<7A1=3)P;V9Q;VIA5U-71#DP>4%,1WEP)B-X03M(-G9&;#,R*S%V
M=3=*,U%/:U=(-6YY871B,S)P0UE#1S!L5C=A4S=H:F=E8WI33$AZ1G-R<5-T
M=DE#0TEX5F=+,'=M:V)O6%%D3"].)B-X03MQ>74Y3V4T:VUM:%IO23E15V4U
M:&Q#4FDT:V%5,%EV>2]D1F%L5'HV54Y">'A*0S=V56-G>61I<G-69&ER<U9D
M:7)S5F1I<G-69&ER)B-X03MS5F1I<G-656)Z-C4Y6&(V;C9F,6EQ.%!7-6-+
M8VAY<G@S*WI7;G9L5V)J-&926$8U.'90;#5-.&9$>&5U*TAY-7!4-7,P,U8Y
M4F=S)B-X03M)3DYN83)P9'$Y,TMR>6]"0TE:4'1E:DQB4TU054MB2S0K-%IC
M1W-S4'9D3R].,C-S:S K,75*3#90:&-X1S=-;'1#-$-L;S172G V)B-X03MP
M3%)Q<G%22GE$13AY8VQS:F1B66%D*V)Y,BMN3&1857I"2C=B-C5#6'1+:49:
M-5!6<DMV-S%Q4E)X12]'4S-)9S$S1T]Y-W%S:V8U)B-X03MY1U=W9U-2,6EA
M4TPV-V0O-VHK4WAV2$=:=FA+,%EP25A#8U(R,S56<FIS=39V1F,K9G15.&YY
M>5<Y=S Y-4IC,T9U:SEK8F%.,V=G)B-X03MT,W0Q:VIE5&=G16PS2#9H6E1Y
M0W0X2&)"=&$W;T<X:2]/57=#4T):9G)-371Y:U-R2EEG4$4V42MI>FAV9S1Q
M-E-%5D)C5G!89FQH)B-X03LR6&10=DUC=C5I2G)6=DQO.$Q385=)24=U3&14
M84-S;G)6;55'6G5F27AB9%%V=EA!2U-B65IP;FY8>C!.6&ES9%)V,SE:6C1R
M85=&)B-X03M5<V%'-48U2$9,1E5,>4MI1B]I0R](6#1H.$<K4V]-8DMB=W@O
M;DQ/,%-8=V5/1VM2;4U%;&MR,5,T5C5#<D-H2EI!448R6&I135=.)B-X03MC
M1WED,%AQ9'8K87%E84QY3%18;"]19'IC4DY(9$TY;3-P4DUQ0U@P-#51>B]$
M>$Y"4VY5,%EM=4\Q3'5L;'9Q=C5N87I:6$-A5DUB)B-X03MG2DYC,G1Z4'ET
M66948S(X2E1G5E97;W)V2GAP4G=A8RMH1TY"9# W,5IF>E!J;E8Y3#53=T=3
M0E9H;&%Z5FQJ5S-J-74U2W1Y1%1.)B-X03M*-F=6<3=$9U%/;T9*,U-I*W8X
M03@S8D=*6G)G>4,Q6F)A3U=10W<Y5EIP6FMJ:U=.4GI6<7,Y23)A9T,O8DA,
M8TA:1S9V0F$O;3AT)B-X03MW56%A6E)C4S)J4WI!,D1X>&\P0VDW-'$T3$%R
M24)W0W)X*S!D-F=L,EAD3DYF2#5K9G!/-5135VPK;SE)<$9&:3-W*VY$=TU3
M>6Q7)B-X03M,*W(V=G%E<#A02#=/*T%5;F1+-W$O.$%Z5'-,2RMU-S1U<T5C
M57,S<D)B2&I%63=A66M)<7-Z<VAM35)J-4%T<V563S4R4G5I66@K)B-X03MA
M-S-Z4D]:;S=&:'AJ=4-D3SE65DXR;$=D47),-F=T969,:E9396DQ,TDR6&13
M,#(O=T1Z36DQ5%(W8E8U;&EB54I74S5T,E<P4$99)B-X03MM.60S:$U83GEN
M;WAE:U,T1D=K+S%-3WDW<F17:B].,C5U.59T-$),1%E-8F=A9$Q%.6M'25HV
M4D%M<V-K86E,;V%L*V1#9'%G27!D)B-X03LQ43(S-75,8U!(0DPX13$Q8THY
M8FQE,6)H0TDT;S=E67@P22]:9&EK87(X935&2V=U>3=O93A4.#5:,75O>6I*
M1&-1=39M,VMS;&5.)B-X03MP:U)K:&E,0E=$475Z;S!J3V%Q2W(X5S=/>3=P
M>F,S;FUO83ED5SEJ2GAK:4YO1$A/<GE10S%A2G55;D=.5V(Q1VU-9T1!:C=0
M>$5G)B-X03M5=V)*4TQ2=DQV-6QT2D9"<48S95%1;4]733-8,6M/62MD;S9U
M>DHY661P1#E99$1'95<S16XT2S!"2D-+2UIE56HU=W-R>E-.4#%P)B-X03M*
M>&1(-GEB;5=7-49W2C104U$K;U55<TDO4FM%55DS3F541W9X1V].2T=F-49K
M-T9867$W1EA9<3=&6%EQ;S-K='A&8G,Y=$(Y66U")B-X03M8:D1Y0U9Q=T(K
M23=B1&9+<S U4FIC63A5=38V*S%N:FI%>7%2-%(S.#!P.#).-6<Y0W=I,%)M
M4V5A-U9,:#$T<49H.4=2:5=D-&)P)B-X03M52$Y62$PP>C1D.'5$5U=(86@U
M<B]-:E,Y2FPK=3(P8GI1>%1Q8G5+,&UO5$-8:DUP;$HY1E!S0U5&;W=R:'%+
M;WE60D9L9$XU>2]-)B-X03MM93-V1FDP6G)+5U V=TE787IU2DAB:$576# K
M3%!(5E@R1$YT2BMY3S).0F)+6BMA3E$X-S)R-FUD3DTP:TE&<SEI64Q13WEC
M-#=J)B-X03MM9T1,2C9L6EDT9S50,E9B=#%W0VML0TIR+VYD3DIV>F-7,F]T
M8VQ9:D9C45=K4F%'-#5(,5E5:EI1,&M8,E%S;VEK,DI*-D1$45)A)B-X03M%
M3W1F;55,,F%-:39A3D9(;W1(63!J930U34DT+VEI-4-'5TU+.&IK,5$W5DA4
M1V=U-DXQ5'ID-2MS.5-D9C!D0TY-839&=6QW8E,V)B-X03MD;S0S=5I956M)
M4U0Y-SA%4W1X541L>E5$<4MI9W1L5F9Z:C5V:W-,0S9S=%!7-"MT-F-L,F5&
M<F-325IN:&UK3DA6*TMH6&II6# R)B-X03M02G5E>'AO3&%#=E!/=C5J5R]R
M:&1%.6-W>GEW2TER1S=*9%DP4'!Z3"LX0VQ*;DA(6FE51R]X5D9445=Y:DYB
M.#%E94E.475'<SE))B-X03MN:G0T24-9<E9R5G)L<$AA5T)E8E-14TY'>$-T
M2GAJ5U)4=%9V64%"4U5*-68X,V5F6DIB3F13,#4T+S!P9GE14E(S34Q1=$1'
M<7AZ)B-X03MG1"LW<5!14V9C,5!)1'-#0U-!;TI5,#@U9FU/9W5(+T%%5S W
M1E9E1T9T4'4P54UB9$=K:E9G4U%)<$]7-V-V5C9*5&)'9W1L6D(U)B-X03LR
M+TUH4%=U3')3>$9A.#1H5V5Z;E%P-G-$17-L2$)+<$Q'4&=.6%ET>'%$45DP
M1G-O;51Z;#4R:W,Y2S%#>7128U$S54XK3&A)<D<U)B-X03MK5#%R955R0E96
M8WE21UAG1D%:=F@U16UT3FUG=&\W>DPU<C@V5T]U>3)/;6%36F))46@Q=D=T
M3&UD1FM013!,44XX9&%L94MR=#EQ)B-X03MP,T=!04I*4VLK8E!Z3W1.3V=M
M:S!Q4SEU1FE94TML;DE+;&\W5U)'9$%Y;FU';&MJ4$%G8D4X9FAP:&])<W!S
M9DY8;FQ03F-7;7EA)B-X03M),S9-3GE91W4P9VMD1$=:0W=L.6(Q3TM"65A3
M=%502G=W,C=#:%,R5BMK*UIV3S$Q951P8V%723193&$T;F]B865)=D]G55(R
M<5-3)B-X03M0>$HU368S9T)6>#EK0VA/2D%4855W*V5F>D5K4T5T;VIW<356
M6EI:3E!U>54U4V-3-6E35C-O135.445N-% K3$9O84-,3%DX.69M)B-X03M2
M=T9F3$QT3#E:14IP8GI"0VA.3FEZ,30X9FDY56EG*WIX+V%X;TQ:4G,S;41Z
M>D0U9G-.45,R:W5,=#=U-U<V='A9>6AJ0T9M34@W)B-X03MG;%I%56-6<'E.
M5S)"8F9C549T3&]04#-N-5ER4#8U<&--9#EE4EA%:U=N+T%&8317579(1D\P
M84AL2V5*6G)C2&-F14=O=C)38U!#)B-X03M&<V]Y4'IB-3A84DPW54@P;5IR
M=C9X8G!B5V8Q2U5S:T121&Y*-E%K5FYR240X2'%64W4U27=51G-O4U1Z.34O
M1C1B8V%+;VUA2V%A)B-X03M#,&$P=65B<D=65W9-4'A!4FY)3S-X8U)3;G%,
M:#11=&Q5;#@X9FU$2&132TY&33%O<V,U:FY85#<Q4S54;7-$1D-X6F9664HX
M1D-1)B-X03M#86M9,$9S<6UR*V-F>D5S-7!5='1&*W-)4DDP3'):,TQ"46PQ
M2D-!+T-2:7I'2TY804%&961D;%AD04,R5V8R33 P,6QB>E12;4MA)B-X03M3
M3DAK:5EC4W)-;TI5:7!P42LK45I+,DMU>%8R2W5X5E)V2F)I2S-:-V%$-GA-
M0W9'2&M%<E9G1#A2,C)'*U9:<'EJ1S1X-'!D,3$Y)B-X03MR4$A'2FQ5:G=J
M=C5P8C5Q9E=K,&]$4FEY,S!L>&)X:&M#:VE.-6Q746MT2$]&05%M<D=.<61A
M6F-'<W-/;#AX969P>F1A9$XU95A5)B-X03M)24IH07)83G4T4V(P,TQR2U=0
M0T]11T\S8C1X1V<Y4C K140W57%#3$QD>C4Q+TU+3S!L=4DY2&%:66YI4E9J
M,"LW5U=94T-:;F1))B-X03LS:T12:%!34D1Y0BLQ>3,R571"8DMJ865B+WI)
M:6I74UA3-7(P05=56"LX33!*67E24U!C3U59;W=94VA9,F%V069B0S<P>&],
M6E1$)B-X03MZ2C5X.#AA9G)&-V)71VE09#)516M)=#59-U,T;$QO,%A*-G5R
M;VA04&%Q-TM/=%<K2$%!1DI3,C$X>B]!2G!"27)6.5!K:VY25FUA)B-X03LX
M;'-P06MH:W1M:U=&=VI$<$UY>&MQ1DLX87-4>4Y$45=Y<E@S;DAZ2'%C349V
M2&\P1CEB6"MN='%"<W!,5U<T05-1,TPR=G%%4#9F)B-X03M30T5&4TMS>DAJ
M4VUZ4S)G3E0X>&9M:TQ'3U!4<D(W43)K9$=J=$Y/:U9'64Y&2#9#<$XV,W=X
M<7I-2%0T5T$R-DA'9W1L3FHU=#@O)B-X03MZ5TTX-C902F)4,G0R5E=*<E-5
M:5=,,$IZ=S1H,UIX-G%2:C%52V<X=6=W549S;VI6=DTS;F1,3%-P3$MW6C-N
M;FTK=$]T;F-!=$A$)B-X03MD26M9.4II-S(T;6=,3V95<65W;V-A0V)3>E0O
M0414-3=U9%DP-F4Y.'9S-GEY4E%I5G)#5TYR84]7-&QJ;6)K>G,P9D]*161J
M>5I2)B-X03M10VTY8TY"1FPV9&M'4VYC5S%V8W=08C--4U1W4VIJ2D9);V1'
M53EM5G%G:D985SET8C(P0U<Y=$5K1451-'AX4G%%4E9(6E979T%X)B-X03M6
M57A6,DMU>%8R2W5X5C)+=7A646MS8D=3-FEV2DQE2C=U04US1G=Y2UI%1&EJ
M0DA)-4Q59&%9<7(T<7--14)N5V-X<5HQ56]S=$)Z)B-X03M#35%754XQ;U-O
M2DAT:7$O1EA9<3=&6%EQ-T9867$O+S)1/3T\+WAM<$=);6<Z:6UA9V4^"B @
M(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^
M"B @(" @(" @(#PO>&UP.E1H=6UB;F%I;',^"B @(" @(#PO<F1F.D1E<V-R
M:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@
M(" @(" @(" @("!X;6QN<SIP9&8](FAT=' Z+R]N<RYA9&]B92YC;VTO<&1F
M+S$N,R\B/@H@(" @(" @(" \<&1F.E!R;V1U8V5R/DUI8W)O<V]F=,*N(%!O
M=V5R4&]I;G3"KB R,#$P/"]P9&8Z4')O9'5C97(^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB
M(@H@(" @(" @(" @("!X;6QN<SID8STB:'1T<#HO+W!U<FPN;W)G+V1C+V5L
M96UE;G1S+S$N,2\B/@H@(" @(" @(" \9&,Z8W)E871O<CX*(" @(" @(" @
M(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^3&%U<F5N(%!O
M<F-A<CPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @
M(#PO9&,Z8W)E871O<CX*(" @(" @(" @/&1C.G1I=&QE/@H@(" @(" @(" @
M(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB
M>"UD969A=6QT(CY487)G971I;F<@($-R:71I8V%L($EM;75N92 @1')I=F5R
M<R!O9B!#86YC97(@(&%N9"!);F9L86UM871I;VX\+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.G1I=&QE/@H@(" @(" @
M(" \9&,Z9&5S8W)I<'1I;VX^"B @(" @(" @(" @(#QR9&8Z06QT/@H@(" @
M(" @(" @(" @(" \<F1F.FQI('AM;#IL86YG/2)X+7)E<&%I<B(^1FEL92!.
M86UE.B @(" @(" @(" @(" @(&<R,'4T."YA:28C>$$[57-E<FYA;64Z(" @
M(" @(" @(" @("!R<C4P-3 W,28C>$$[3&]C86P@5&EM93H@(" @(" @(" @
M(" @,34M3V-T+3(P,3D@,#(Z,S@Z,C<F(WA!.T535"!4:6UE.B @(" @(" @
M(" @(" @,30M3V-T+3(P,3D@,3<Z,#@Z,C<F(WA!.U-C<FEP="!697)S:6]N
M.B @(" @(" @(#(N-28C>$$[26QL=7-T<F%T;W(@5F5R<VEO;CH@(" @,38N
M,"XP)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @($)A<B!#:&%R="8C>$$[
M)B-X03OB@*(@,C0@8FQA8VL@=&5X="!C:&%R86-T97)S(&-H86YG960@=&\@
M;W9E<G!R:6YT+B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P
M<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R8C>$$[5VEN9V1I;F=S+5)E
M9W5L87(F(WA!.T%R:6%L350F(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM)B-X03L\+W)D9CIL:3X*
M(" @(" @(" @(" @/"]R9&8Z06QT/@H@(" @(" @(" \+V1C.F1E<V-R:7!T
M:6]N/@H@(" @(" @(" \9&,Z9F]R;6%T/F%P<&QI8V%T:6]N+W!O<W1S8W)I
M<'0\+V1C.F9O<FUA=#X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @
M(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM
M;&YS.GAM<%109STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W0O<&<O
M(@H@(" @(" @(" @("!X;6QN<SIS=$1I;3TB:'1T<#HO+VYS+F%D;V)E+F-O
M;2]X87 O,2XP+W-4>7!E+T1I;65N<VEO;G,C(@H@(" @(" @(" @("!X;6QN
M<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4>7!E+T9O
M;G0C(@H@(" @(" @(" @("!X;6QN<SIX;7!'/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O9R\B/@H@(" @(" @(" \>&UP5%!G.DUA>%!A9V53:7IE
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T1&EM
M.G<^-S(P+C P,# P,#PO<W1$:6TZ=SX*(" @(" @(" @(" @/'-T1&EM.F@^
M-# U+C P,# P,#PO<W1$:6TZ:#X*(" @(" @(" @(" @/'-T1&EM.G5N:70^
M4&]I;G1S/"]S=$1I;3IU;FET/@H@(" @(" @(" \+WAM<%109SI-87A086=E
M4VEZ93X*(" @(" @(" @/'AM<%109SI.4&%G97,^,3PO>&UP5%!G.DY086=E
M<SX*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE5')A;G-P87)E;F-Y/D9A
M;'-E/"]X;7!44&<Z2&%S5FES:6)L951R86YS<&%R96YC>3X*(" @(" @(" @
M/'AM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/E1R=64\+WAM<%109SI(87-6
M:7-I8FQE3W9E<G!R:6YT/@H@(" @(" @(" \>&UP5%!G.D9O;G1S/@H@(" @
M(" @(" @(" \<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$9N
M=#IF;VYT3F%M93Y7:6YG9&EN9W,M4F5G=6QA<CPO<W1&;G0Z9F]N=$YA;64^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%M:6QY/E=I;F=D:6YG
M<SPO<W1&;G0Z9F]N=$9A;6EL>3X*(" @(" @(" @(" @(" @(" @/'-T1FYT
M.F9O;G1&86-E/E)E9W5L87(\+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=%1Y<&4^3W!E;B!4>7!E/"]S=$9N=#IF;VYT
M5'EP93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^
M5F5R<VEO;B U+C P/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N=#IC;VUP;W-I
M=&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1FEL94YA;64^=VEN
M9V1I;F<N='1F/"]S=$9N=#IF;VYT1FEL94YA;64^"B @(" @(" @(" @(" @
M(#PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1.
M86UE/D%R:6%L350\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @(" @(" @
M(" \<W1&;G0Z9F]N=$9A;6EL>3Y!<FEA;#PO<W1&;G0Z9F]N=$9A;6EL>3X*
M(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86-E/E)E9W5L87(\+W-T
M1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=%1Y
M<&4^3W!E;B!4>7!E/"]S=$9N=#IF;VYT5'EP93X*(" @(" @(" @(" @(" @
M(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^5F5R<VEO;B U+C(P/"]S=$9N=#IV
M97)S:6]N4W1R:6YG/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z8V]M<&]S
M:71E/D9A;'-E/"]S=$9N=#IC;VUP;W-I=&4^"B @(" @(" @(" @(" @(" @
M(#QS=$9N=#IF;VYT1FEL94YA;64^87)I86PN='1F/"]S=$9N=#IF;VYT1FEL
M94YA;64^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \
M+W)D9CI"86<^"B @(" @(" @(#PO>&UP5%!G.D9O;G1S/@H@(" @(" @(" \
M>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @
M(" @(" @(" @(" \<F1F.FQI/D-Y86X\+W)D9CIL:3X*(" @(" @(" @(" @
M(" @/')D9CIL:3Y-86=E;G1A/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR
M9&8Z;&D^665L;&]W/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^
M0FQA8VL\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @
M(" \+WAM<%109SI0;&%T94YA;65S/@H@(" @(" @(" \>&UP5%!G.E-W871C
M:$=R;W5P<SX*(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @
M(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @
M(" @(" @(" \>&UP1SIG<F]U<$YA;64^1&5F875L="!3=V%T8V@@1W)O=7 \
M+WAM<$<Z9W)O=7!.86UE/@H@(" @(" @(" @(" @(" @(" \>&UP1SIG<F]U
M<%1Y<&4^,#PO>&UP1SIG<F]U<%1Y<&4^"B @(" @(" @(" @(" @(#PO<F1F
M.FQI/@H@(" @(" @(" @(" \+W)D9CI397$^"B @(" @(" @(#PO>&UP5%!G
M.E-W871C:$=R;W5P<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(" @
M(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @('AM
M;&YS.GAM<$U-/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O;6TO(@H@
M(" @(" @(" @("!X;6QN<SIS=%)E9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+W-4>7!E+U)E<V]U<F-E4F5F(R(*(" @(" @(" @(" @>&UL;G,Z
M<W1%=G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]297-O
M=7)C945V96YT(R(^"B @(" @(" @(#QX;7!-33I$97)I=F5D1G)O;2!R9&8Z
M<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(#QS=%)E9CII;G-T
M86YC94E$/GAM<"YI:60Z-S0P-S8U0S=#-D5%13DQ,4)!-C%&1#4Y,$-#.#9!
M.3D\+W-T4F5F.FEN<W1A;F-E240^"B @(" @(" @(" @(#QS=%)E9CID;V-U
M;65N=$E$/GAM<"YD:60Z-S0P-S8U0S=#-D5%13DQ,4)!-C%&1#4Y,$-#.#9!
M.3D\+W-T4F5F.F1O8W5M96YT240^"B @(" @(" @(" @(#QS=%)E9CIO<FEG
M:6YA;$1O8W5M96YT240^>&UP+F1I9#HW0C)!-S@Y.4%!145%.3$Q0D$V,49$
M-3DP0T,X-D$Y.3PO<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/@H@(" @(" @
M(" @(" \<W12968Z<F5N9&ET:6]N0VQA<W,^9&5F875L=#PO<W12968Z<F5N
M9&ET:6]N0VQA<W,^"B @(" @(" @(#PO>&UP34TZ1&5R:79E9$9R;VT^"B @
M(" @(" @(#QX;7!-33I$;V-U;65N=$E$/GAM<"YD:60Z-S4P-S8U0S=#-D5%
M13DQ,4)!-C%&1#4Y,$-#.#9!.3D\+WAM<$U-.D1O8W5M96YT240^"B @(" @
M(" @(#QX;7!-33I);G-T86YC94E$/GAM<"YI:60Z-S4P-S8U0S=#-D5%13DQ
M,4)!-C%&1#4Y,$-#.#9!.3D\+WAM<$U-.DEN<W1A;F-E240^"B @(" @(" @
M(#QX;7!-33I/<FEG:6YA;$1O8W5M96YT240^>&UP+F1I9#HW0C)!-S@Y.4%!
M145%.3$Q0D$V,49$-3DP0T,X-D$Y.3PO>&UP34TZ3W)I9VEN86Q$;V-U;65N
M=$E$/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*(" @(" @(" @(" @/')D
M9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E5'EP93TB
M4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z86-T:6]N/G-A
M=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @(" @(" @(#QS=$5V=#II
M;G-T86YC94E$/GAM<"YI:60Z-T(R03<X.3E!045%13DQ,4)!-C%&1#4Y,$-#
M.#9!.3D\+W-T179T.FEN<W1A;F-E240^"B @(" @(" @(" @(" @(" @(#QS
M=$5V=#IW:&5N/C(P,3DM,3 M,354,#(Z,S@Z,C K,#4Z,S \+W-T179T.G=H
M96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS;V9T=V%R94%G96YT/D%D
M;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+W-T179T.G-O9G1W87)E
M06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IC:&%N9V5D/B\\+W-T
M179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO<F1F.FQI/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N
M:6ED.C<U,#<V-4,W0S9%144Y,3%"038Q1D0U.3!#0S@V03DY/"]S=$5V=#II
M;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#$Y
M+3$P+3$U5# R.C,X.C,T*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O
M<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q
M/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @(" @(" @(#QX;7!-33I2
M96YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD:71I;VY#;&%S<SX*
M(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @(#PO<F1F.E)$1CX*/"]X.GAM
M<&UE=&$^"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB
M=R(_/O_; $,  0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! ?_  !$( 2L"4P,!$0 "$0$#$0'_Q  >  $  @(" P$
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MB X8#'0;5V0(DBI5\S8M\8329M]E_EDGC <@Z>H8(A=@H*@F^68*H !))8T
M  3_ $LT)L[A%+&R.!2J68DF@  "22>/;WH<R+^JMW&.P],"[3/P[>ORI*7V
ME'',.6?)DG@+6 V?+X$W9DWJ&=FJY?#>-I*%]F6V[#!)1UJQWW::H[YTSXAB
MR; VX;4;=57N16X^7/%\UWF>#*<N/>5V'<Z[;LC:Q7D]KXYKCVGY;$ZOMC-!
M$(I6LHD80S$R4QDMD6G)#D9KT9\4BD-&0D8K&8_(RQ*7%]LNB;M5=!B,CP-G
MJ^6R5</D&&K&N(J6R.P.X*J8U#.>++'<R@*.P[EB:X )DNV4,%QHI&TL7<D*
M.:"C:"=QY/:@/?M,DZ[W&U[ 4M7]PLP;B-)S8.L]6!.'J)3Z8_8$GP4HW:%F
MZ3= R*^I#7>X8VBV;)&1.[(GHU;:N\()US8_"R/CO=M-756*!''H:/(]#8DX
MLGBXUR56X77>B"0>>+%C@UR.95M'L=V=LTW=)/K_ %I2!V%4=8LTK$A%Y[84
MM%6O/9%7BV6TA^DLH]$RT?@[<T\379P?,D5*J&T=6IE[H*&D$?;W.'"@Q>*^
M4-E17#*BE%#=N[ O7\557869B,V9SE\),97&S)3.P=F2P>RD*#7EOOWX$F&V
M>Q9N#]?(E:0.O"B=F6<YK&*UY3\Z^1&SFUE6F2$BQL.E7DBHN)6C6S\B0E2N
MB6V&8R/&'26=M$M=LYX\0;*R%QL3>7R+R-B G<OONH!?F1+OE*XE<(=[[%7&
MW!WN0 K>VVSNKL 3, E/<1PWZ+K=N8E%1[P\C$PC]W!3KYVT:!IKM+1L&F,1
M+OFJ&[U)2)2E0T(=*IMO>47$YV]G7"GIQ8:?_J? 9C6XC<*Y7:65AZ>9:/?U
ME6U%:8YU46%!*D]FW!64D<^5K!_"<.0=@>S5%O(I(>R=74OFH9%,8Q!3T]I:
MQIH;)5L2FAEI&XS()7&IS7\7T?Q%W)"0D*2(!C&[\/L12?;CG:">R>\C%AR6
M,+Y/$"LP7*B@.%%L%97:F"@FB*-58@Y<V+:<R8]A8*6QLQV%B I9646I) L'
M@D<2:NV5SR#K]0LPM6*@0\ED(,K7P<2%D#YZ-"NW<YLF(0'50B]'-W;YNW9:
MR?9_G9LV74VV:ZZ83VQMG',\&,9<JHQ(4AR2 "?(C/P#QSMJ7SY#BQ,Z@%@4
M !) \[JG)'/&ZY#3N_.R]1SNGPW8BMJ3S"+GLD;4(B44Q8DV.&HS-SX<V6C6
MQN-3:OXSJ1 E=@+QBZ>B2WR1&VVKUPU60T]"FGA8<BY#A?+NQH<A&1% *@@&
MBKM1&X'D<]OG*>+F1L8RIBVY'&,-C9B58@D6&46#5<'CUXG1@^]"I:FXW(F$
M"UE5\658MQ5S4E'Q4GMN^E;RL;-EL"S)"Y1ZEG6+0<4/C[60SR8DTM1,=;N5
M&S?+Q^N-8O!TU.07VXD3&^3(P^[O16V@#[S$DA5')_"S*C57C5MEY7?(B8U/
MWMCE;)KRJ  6;T]+) E[XMF3[1P)M-- :4MW&M-Y$C&=WZL>;E]TM=WS8,N4
MU3(NAS9?.Z#5X]1:N'B2>KI5FRV6RT1YFVV=M[;XW5=>EUQ?R%UVL]YU+NVC
M=6ZN=M[;^5\U^/Z"=]R),<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$3UK*IMT
M55U=O0DBGNJKMY;;>E-/7.^^WIUQMMMZ==<Y\M<9VSY>6,9S^'$2G-"]MD+S
ML^]HRE Y+!(%4\2JN51N3SP42B\@G :?*67\R5[10P@T+1R+>U!$]XYJ<9LC
M9)CNN8>,6;5ZP0UZ,N#PTQ'<K-D9U*J0P4ILI=P)#-Y^:) / )HSGQ:CQ'R+
ML9514<,P*E@V[G:>0/+Q=$CFNTC^#=O[.,H4;:,PJV)Q[KWV4F@B%UJ5'S N
M_L^-YFZ)-:II'/X\ZC3*.8&6-]/9([L )]T\B;J2@D'*YO&7ZC6[Z=!XB*['
M+A4LX*@(VVO$"&]UI?<CS!6/'$JN=SX;LBC%F8*A#'>NZ]A<57FJJ!XL=^9Q
MW'<JQ4PQ"]4:SAZG5$5<2U2N93M,3&MIKB65EXIXE;[2,ZQK:.;0MC/\.$_H
M*A[$A<1-FO)_>15SH%R^SK8Q;V\<X_$K:-E[/$&.[O=L]:K=Q7K(^T/1R[%\
M$9/#O<=]!_#.2MM;0_I=[06OTEZIE-HA7<>=2R=R4+$8PQ="63T_(2#<6(9N
MCI=@ #HNG[O=)LWV(FB8\:VRJIIKN[>()>K&=\<YE5G.U068W0')X!)_0 F=
M+,J#<S!1P+)H630_4FI7S;O'U"U#/Y!GL35N18PHD(?+:R9INX1=KLE"2"F!
M^GJ(K#5AJ*Q)$T@T4#J#T5GVC_9JDHKKK]FSV!X3V1?W?2Z_"[XKO?%3/[3@
MJ_%2AQW_ !-_A0)OM7-U)"GG8VB*P%10W/;9@T:%3IG]2AKUZ>9J)2<1JS;D
M%3@3XF[C<@ ;,'C-\\/-]=P[)F[:N7;U%%RCOO1<.5RP7&[%33 *?*2:H^QO
MBCS<LV7&@!9U 86O/<=[%=Q7-]JYF?PJ<PVQX\VEL!DX.8Q=Z[+,64@CA%L6
M#O'8(L]!%T6I!FHJU<Y'F!KX>XV14WTU<M5M,;9]/GRK*R':ZE6X-,*/(L<'
MW!EE97&Y6#"R+!L6"0>1[$$2GK"^^QMTF)^_ZSU_3^]:5W-)+7B,QN673 8\
MM"6PIZH)EVL+%0R-ED@L4$R!L]CK:6F7Q'<L09.W+./X8M]55]_"PXPGC-DW
MNJOMQJIV*W*[BQ%L1SM %"K-S 9<N0N<*)L1BF[(S NRFFVA5-*#QN/?N!4Y
M!KMI.=851XL+19L1V0OPS*XU'Z8L4NO%AL/=UYH[4L:82Z7HA'ZSFN(RU;M2
M8@Z  O'\W9'HOH%&MUS>WP)&G7=E)R@X<04G*@W%M_W%5;%.?52?+36>(;.V
MW&!C(S92RC&YK;LO>S&N4 Y! \UKVOC+H39_9(%/MH#>M4Q!8>8ALBEL5MFE
MWTO-0!J0C.67SX18#23A&9"'''K=\F^C)3<B]%2A%N1:--&A$>LUS1DPE=V)
MVL,%9,@4-373(5/F JF% BQZ<RROF#%<B+RI97Q[BO'\+;@*/-CDAN>U2N</
M[0]RY-UJ%]JT:KZT/($YK->W'41Q:%C@9DI%1XEP=)#T"+^O2,89G=1K-Q\;
M9Z[W%9=83T</$4=MEM-FPZ89C@WY@V_P]VQ"MDT#08,1?ROY3%<VI.$9]F$K
ML\3;O<-0%D65*@U\Z^<L!</;V.5OUB ]@PD<*28O8E?C9?5-;;[:,I!)WYF#
MJS]%@0QKE746.C47;$9)."N?<1 QX&7=Z_(<IM&KK+'IR^8XB0H1BN1^X4!M
MMCW+-2J/4D=A9&V3.%PC* 6+H&QIV+$KNH^P Y8^@!EBJQEB\]K:O9TZ9HCW
M4T@\3ECE@W4W608KR,"P,+,T%5,:J*HME'FR*:BFNN^^FFNVV,;9SCF+KM=U
M[[69;]Z)$U1MR(W;<JM7M8!E(:TOCN9<T0D-C5W776C[*CIU:D1#")=8=F!)
M,23K&?R:#*[O7 ^!FP8UP77C:KENM\IRU;:.DMW.$]=5-=.E\6GQL$=\VXJC
M$JJ%1O4-ZL":OVG,F749%+HF':&=0&9PQV,5YI2!=>\F.ONY-/R7KQ578>>'
MQ-2@;3'H_3 TJ,MEGWVD36?,BD<![-$]7,K5:/!1)1FY#CME" =MJ9RR:MMU
M-4<WT^09<F)0<AQ]R!Z<$$^UV.">_$T748SB3,Q"!^P)OS<^45][L>P["Y*3
MWL'1X^LV%R.[7@B56E5$&XJ<XD8Y6/E'SETJP;BQCQ%=3! TJ_0<#]0C/58M
M]0;N&/PL.VZR.E/"RE_#\-MX[KM-CYD>@];[5S<OXN/8,F]=A[-8HD^@]S?%
M#F^*G"U[*4%O6JEP8MZ!?=FD3R"5F&TA8Z"TI#JYPSS&E/6IJZ3E'R]M&N(U
MNWP=V<[Z(:C\J[ZZY>#EW^'X;;ZO;1NO\W_U_P#EV^<>-BV>)XB[+K=8J_;_
M .W_ ,>_RAKV4H!Y -;41N"O]:Z^NZ1=>8N9*.9@Q\EW6T;_ &?,.WBR&H4R
MFJHGJX&%L,GC;"B>[A%)-33;+P<N_9X;;]N[;1)*][%=Q\Q<>-BV[_$79NV[
MK%!O8GT/XR*K([O45$*"MJ^8A,HS9(VIQ:JA( &/HCB#F1N6GR(Y&7ORFB[T
M&YD^^R.!#MZ*43>-E,O6"3Y+3RVT3396RX\3*4.0\$BQ7J11H[?4 _C4S?4X
MUQ9,JL'&,<@&C=<*;%B_2Q^%S/9)VOZXPT'$)#+;E@0$;.@^Y^+*O#J'N& 2
M&V$WIYHU2QN\^S[!;/LOSRS=$2R4SKH[>([;8QF@P96+!<;$J=IX['T'XGV[
MRYSXE"ELB@,+%GN/4_\ U'JW;YSL9YV=Z\UBQCQ.>W+7D8'RT.VD,4>$9,.^
M/)@3QV/9-C$?5066U,C5ERC#.KP=ERAALXP]VWPS357T+@S.2%QNQ4[6 4V#
MSP1Z'@]X;/A3:6R( PM38\PL"Q[CD=I.O,IK'$1Q$<1'$1Q$<1..[<?$:.G7
ML.'7QFZSCXS1/"SMQ[*>RGL-4L[:85<+>GVT4\[ZXW4VUUSMKY^>$37Z4EWB
M:V"YV,UK5/5'K_$=]\["0/8>7V%;%LD6GGZM%96$I3<!7,!(*ZY].1@"S[<1
M;^7N*ELJ;;,TDGCYGO?I^%?[#^7,R]>K2OR7N'T;O.J(&'>L&1%T+MZB+/;V
M=1DS6#&M(^7"(;2 7#K(A4X&$ODIDHF8B9P"VP.)H,;#,$1SY@U00/0_J*/]
MQ7Y_E+2\2(XB.(CB(XB.(CB(XB.(CB)K-JB=%^G1"Y*FL6H[ODL<*W19UK5'
M.ZEJ>96V!ET7MB1NIOK%B:T%&FGL8F\:D!8R >-I:U"C2+1L/+L"BS1SOE'L
M=1J!CR(^-2,:8\B.ZXRK(-NX;B 4( (*W7((L3C1CISD1TRL#D=\;(C9 P<[
MMIV@D,I)!W4#5@GTZ0X;O-W8/5?M->-*GV<6B+[L@,)5]7T6.V#/*@ 69B+M
MJ<F4OAL77EAL_+6T4C)@)/G,(8/\QE>8[(H"6K;ZOA*5&/9GP8L@W,,1#.P1
M<A3=XBJS;0%W$%-U;MO)[2"<N[#FRXV"KXMHBEVQAZ\-F5;)8*"&*@[2W8"Y
M%I.K)K8TT(VFRJ*:B:UM#Q$^M5EQ^&2*$EQ1Q**5U6[6+S.XI=!7C'0E"A<F
ME K1^JK+!H<MNV'CB\A9LUR2&%;[U11C+J7329D9@P(W-D)7&&NF(4U2DCFA
MZRA1G)<8V"/JL+A2I!VJ@5LC*1:@D7R >+-7,C[(4S94FMKMC(8[6DBED:44
M\/"P'T;:"-D6=U J7M&R)/:4( .B&K4+*) VBS0/JZ"_+676WQ'Q"^FNY$:D
MK&'(BI@#.%/_ %: WSC.5$5'-65&XGFNVX^ADYL3MDSE4)'_ $CD5QD&-W+J
M":!(%<7[#U$Z_L2SE'94M>%C5-5%MC0('P_^S-0DB,MJJ<UY*+/GMCM@K^#U
MK&83,@(*9RI2*KQX^\V(,0;D0D:D2 D.]>O'[K72<6W",2/DQDG58<@"NKJB
M(2&<LI*KN!'!-T+( D9@V;Q'QH]#2Y<9W(R,[-15%5E#-MH]A6XT+D\65'BD
M!DWAU24=74S>Q&KS9R-RUC H,<DKR$I2SKW(*_CJY>.QP>\*"P+0\[8BRA55
MCJ. )9U4*+M$-<;<R0AQJP74,Z@KO8*&K,KFB2 30)J[/I<U<%#I6",52PP1
M2Q6\146!R!= FN/6;%.<DZY03KE6%M9ZNNX8)F$LZ^SI6]>Q1U ^O! !DX@!
M,=D+3D S?6,V$(>BU1LH DAQ(<248;9<"WC,B-7V0<I+;]69\?CABJY5\+$"
M-S 6,2 ^9"#:G@B^]@\SEPH_@E06Q-XN4V5!-'*Y'E853#L:[&Q/VV2:\7!!
MZ0[05Y8_96H9/!G+D[<$3K$]+B4@L)C*7;A"%S&IZ,B:SF+L]P*X16-2AFTU
M DW[)XS*[#'S=-V1(-Q.3"R8<@;C&SA0$*CS+DRMR;NP3N HB_1D.T#'F5LN
M,KSD5"Q+@GRLF-;456UJHG@T>\C=(8S8D/ZYQ"/V,/D -RQ+S7$(C$P>:D)I
M$:E6F)M:IHG,7N'+S*TBC\ W C7R:SMR\8ZH(CB"VQ!FZ\J:ED;,Q0@V%W,H
MI6?:-[+\F:SZ7=R^G#KB4."*+;0W+*FX[%;YA:![_,W*/6B(JN2S&>.^Q?3V
M^@78H7(Y(/AUS]2*\MA)S8\90).?NVDP"U:O)9:-I+I&,!&YP9:YAJU"&63G
M5T@B"3;MFW2A=53P=1C.$@%L>=T\AKS@XWYV[B:.,<@^_)YG"$MXV#(,NXA7
MP*_G /D(=.QH@$.>"/04)WL<JKMK<TGZI16SY3*JVD76RE$+1FMH.(:"F ^3
MW]/42,# QS160L%H3*)/ *XUE3N7&@N"20V22QHY;K:+NVKG2"^#&,[(JNN;
M+L5-S*1B3SEN"&4,^T*#5A3Z<2P3/D;"KED;#CWLY4,&RO:@<^5BB;MQ'8L#
MQQ(IMBG+UK"H>]?7?4'8UUAK%0AG9"LIG&:U=;Z&)7,;* )7- 4!D,&;@VDD
M;'0:,\'18.BFZ=B9 :-ZLL)HO%^:)DQ9,FFS6F,H6PNK..%5#X;VQO;1VECZ
M@"YF^/*F/4X:;('"YD94/+,X\1*45NL;@HY()-2R%]V!)^XT*']>*VHKL#&&
M4YG=<.[#L6W:GD=212"U]#)['9S(W[1><(BR$EDY1"-I H^" CGN5'9/9Z^>
M#6S+9;;'&BZ=O%?+A;:K[4QY!D9G9"H'EO:HNRQKMP">)ME<ZA?"3'E&YDW/
MDQMC545E9CYJ+$U0 '<]P!<FKQ#(1)+&ZE6'#(F#DTB.&I/2N$!<.:E'<EV9
M,+UK0H9?"] NBA1!0.%9$#"[]GC506T8+DME44VFZVF>D8)G1F*@!<O+$!;\
M)P ;XY-"O4FIIJE+X&50Q);%PMW0RH217/ !-CM5S*(1TUIV&36.V(\?VS9,
MPARKUQ"RERW7:=LHP]X19*CGQ&-!YQ*C ,65<L5U6N2R(W)-!%131J[0PHIZ
MZMJ,C*4 QHK?>&/&F/=Z@$JH)%CM=>\E=/C5@]Y'9;VG)D?)1(JP&8@&N+JY
MKFIWIO/H13KGLK5T<ED;[B0JZ;YF(N/3AT?&-;%K#:WY[[U&N 1?VFH6$63%
M=]);%W39@EKI/3#";($=$GV[I/K?4*SC"Y4X&Q8E)4 ['\-?WMCDLC<,+^X"
MM<3DQ:=UQ>,BL-0N3(0&L;T\1OW9!JE<<KZ;CN]3-R%<3/[Q()%)OF-2R&*2
M8*R*N(E.@!*+R^-NUT_^&!) "+-VKUD1&NM5FBV<I;-7>$M7H]=T/<M72WY[
MKL9EW*VTUN0AE/S!'<'_ 'YGZ"-O56IEW"]K JP^1![$3->5EHXB.(CB(XB.
M(CB(XB.(CB(XB.(CB(XB.(CB)2J.U](2O:?N2X)!S0J*6%1?7*) 94X%/$@I
M1\Q2[ ,Y"W#DE4DV)-[']) )5*M&CA19A@D.^7JCAZWRIT%@,.GH@LF7,Q4'
MD?X-7ZBZ-'UHUVG,$8Y\Y((5\.)0Q'!/[RP#ZU8NNUB5-A3*P9O4W27JD]J>
MT(U8/7NS*&?7&=/0&4"*T 1GK#LD\3/@+.?C&\+FVECD8K'VT18PTR;(JM3S
MIR7;"$Q3["?0VQ7U&<9$*94R^& RERV?^%DO<NS<2Q( X%$W1P4,V/3X"F16
MQ/C.0E6"!<)O<'H*P<J-H4D\V0*G1NHO/]>L1WH%BKK14LLA=!F.L9CI7\GS
M4RU0GNP[BT_O<5M70;M FS%C79!5%Q&5)!]M<S-K]"2CNVZR:N)W+XPU>]-@
MQ@[=X\3Q!A">'L^]9<=]NW:;NH(;P3I=CESD(W;3L.,YB^_?]T>3T)W;N*EW
M>^L),6)UGD4/"1<G,W9:Q^O6[J."!#HZ[? QO8>K"TE54&,T'*RXX?'6)0F8
M4RCLW:"6;UX[V3:-UE-.;3,$S!B0M)EY)H6<+@<\<DD >Y( YG1JE+X2JKN.
M_$=H%V!D4GCVJ[^5S'5:Y)+=S[]FJL'>J S73NKH4'E.\>7V%%B^LZNIS(HJ
MP,9:99OB.@]2)K%@Z"ZKG1FH"W=-\(;L<YMO'V;$H;D:AV*[N0-J4Q%V.=U'
M\:]9&P_:<K;31P(H:N"=V2U!JB:JQ^'RE2^M@^:]=WW7J=V/45L2=F2Z!TC3
MOTR'U^;F,]JJ;0PW(3$@BTJ@8]!251D9.$S =+!YX+0#(F(4J+DCX6F/8J\V
MS;<HRJF1 ?M63);,%1U8 *RN?*2M'R@W36 ;F&$-B.)G1S>EQ)2H6?&RDD@J
M/,H:QS56M,14M3X:FR:G4B,+H1S,/:N;2[)N&D4SEEG$::J]D+7V0 :[#57
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M^=V[A/151NMIG7?719!RU<HKM'K-RFB[8O4'#-X@@Z062TH05)!%$=P9<$,
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M<!2%Q#(V[])!844##2PU\T221]?7K^,N?7UE5U;48:3:JY]"[+AK]=XU8RV
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M,XS^.,XSC\,XS^K..(C.<8QG.<XQC&,YSG.?+&,8_'.<YS^&,8Q^?/$3J=9
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M[[SZ5T[+J,_3]#GU>$8-5GTF#+J<(.X8<^3&K9,=]_*Y/) KUYDM?>RBV_\
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M_1;N&K1UJOHBFS=M$]/Q/V@:GHNK^)-1FZ'X)TQPXEU&73*%T^;6@OXV7#M
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M-<>6,>>=U%-M$DM=U=]--IQ8LN?+CPX<;Y<V5UQXL6-2^3([D*J(B@LS,2
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M,W65,L=&6B^NB6BV=]44M=?G7[1O@O5?&G3]#IM)JM+I<FAU@U0.HTZYO$(
M QLS*Q&$T?$1=I<[;:EH_:OV)?M2T/[*^L]<ZKU#IFOZK@ZET;[!CT^AU.DP
M.NI758=1AR%=5FQ;RIQL R[MJ/D'E+J18KISUML>I^OL%A!VUK"B9D)M(<NP
M0-E7"P5KE])BY)'XR<GKV0%]-5T'::RV%BJF-EU%<I821RFGIZ7X4Z+D^'?A
M_IO1\^3'GRZ/3^'DR8E\/$7+NY.% !L3ST%-\#F>*_:-\4:?XT^-.N?$^ETV
M71XNK:LZI=/F9'RIOQ8T9<SXG?&[JR&CC<BJ!OF[39BELM,XP-MH>^TU_-F7
MUR-*J[?A^'N[Q,] D]L_JSE-!'^/777/XX]!/$\_G[_A\OKYD^OCNVOAKCS3
M-U(=VQ_ZO>+3&*:[_A^;W]9C,\I^?YO/XZOI_/Y;\0;]*^O7_P ?SFM3Q,+;
M[1UC3<+.11V/K]^XL9J.>G:NF1\P3<CLQB2/%69 >2@H/1H+RLU0<J.<DG>4
MW#9NE[7I6W52^?\ [2>K==Z)T+#J_A[$^36G58\;@81J!X60$?X5G>QY"V#1
M ;:317[)^P[X8^$?B[XR?I'QIGPXNC_\MS9QXO4!TKQ=7BUNCQICQ:XD'"!I
M\N7+DI@V38,0)5BK9GX<-TWG,>OK@_8D5LJUCN\Z/M,21<S!VI'4>V:",MA_
MPY=)XFYPBVW6<;I*ZZ;H*;+;^A3.<;XUZ_V?=4ZQUGX9TNNZZAP]1;-J,67
MVE72/C7$RA"Z*!9<&[] ..*O\S]L70?ACX:^.^H=*^$,V//T+'I.F9],V'J#
M=2PJ^JT&'49ACU+9,FX#+D*T#P%6RQMC?S%IN&WGDU5UK@]-?X>^T=$R7T?F
M_P#0@4AERJO\7]H35SG/\'&V/QY[6?+K^7]^/?C\OPN>C[\H)IOZ'36Q1O\
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M)^>K7\WGCS_#\//\?Q_-^'Y_X_\ 1G^+B)^^K&<YQC.//'Y\>?XX_7Q$U/\
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M<$7%(&(@4O;\0AEYV3#X+:H@4 !QP*)B%B0L$ ET&%"A*8X9#BX-BQ?&VC=
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M[$*J_J,"XB0/XEOZ&5J_Y3K#_M8A'$2]_$1Q$J%WZ_0T[%_LT,_[;?B0>Q_
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M$U[,THRW=R%P^CLC(35(>[,/W&^(ZXTU%Q\6Z=)8=OO <]N;]/4 C^DVE]5
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M-/WLV=PB2-)_-ZB<;&X(/KP M%([-0"R$F+/@Y=)PCZ^O[?KS,:\2/N5U3M
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M_5G'YL_CQ$TI(>#'#X5(K&D-1]@[>#Y.P:B6U=A[1D,AMT+$[9HCM$>[9AK
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M&NFFN-==<?FQKC'EC&/Y,8_#GX\];-6?;WH)-.RTZ[/20/.8Q$FMR=/:+I&
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MP]0R3=IB.2\#)U-=V:,C:**_*3#[M-,ZKZ>UNOJKMC?73.FR+;V_H/\ ]C+
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M\!:X4V[5!5RNI^_NZ@;>VB@GLJKOZ=#.V^WITUVV].NNVV?+RUQG/ECB/-]
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MCZ^N)^5QX3EGMZ!@[.T?$)\2![V-0J6.-9^4C'>VW4Z\=W)I$6B4F( DG(U
MAI#UIK\UP-T78HO=0F4=56J:^-DL)'I]'_>>-/>$Y:+>A*\:79XA7B0/^Q+>
MLH\VLLK#.]=NI5\\M?2.MDY,_C:+P8T?ZQ563?*6&:.6"#K W*7NM=%?4GA
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M1 $(*6&RT]39BP@H0VXTJZ432##3,P'Q 44E,9C$E)L8S)B)F/([H?3L-4$
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M&B#5@S1>"UM&J&-$?^?YS"I;X6'0^706G:YVH9C#8W0 F0 :?7J6;V72\LA
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M(E/5)]8>'*3&>,(E$TF:HX-U3J0QX:G<WOFI/KBJKMA5-L>)O9L,[$QOL'=
M9W&Y!0W:'L.G6S!["U9_O5QJ)IC(9'X:2AQB%O09R/[*CG#%1TXU<X@>OX_V
M$?7US+&L?%-[O'.NM^=T 4%Z[B:)Z6J5-&KRJ"< +$WOBVSWW-4K:_84O"IN
M)FP:%5(K%=+;V#UA&#E;V3O,WT=<J&"T:;EQZ;69 _IW_'^WZ3L#7B_7[4O8
M&S1W8:)5M5=3160]F%(55<PI3L##)U;%64K I].8!.*,[<:FIIUINBPK)90G
M5R9I%2+5G((<V?D1F#A4_%W+,RB^_P OS_I_3\))/AZ>)9VR[*7%2D7N.DWV
M*W[$4=)+:92R+=/^X%"QZ@)0*81:3 *YD-M7\@[KGL,#ET6D+Y /9]<X@C=>
M31_.&T0=@)0#((I,A+Q/)[-)V-\9^0-)*;"M^DGA]Q.M:A%!S1$-]/L#L+%S
M]P6;8^%&#E#?0X[ 1JIH8 ,ZXR[", TK;#%FV#YK5XCW^OKZ_+*[D\0WQ%NN
M$QD'765Q[IW8-[R-GX?)>G)( BMRQ*L0S?N?VB-=7CL.L842LZ32>1/*\.A?
MK8J?1XO&T9*.7^0\@ EQ_P 6:)4FB![_ %Z?U]/GS5PJP,W14'B/0"MK3E,/
MD17MITAF%GVTPK<3)8]6K?L!U3L>JH$O8$%BDKDTP-QAE/ZRO2/18\V?2$CN
M]^ZB)*[N/DIN,KI/K]?7UZWQMGXDQQ$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<
M1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1
MQ$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1'$1Q$<1(BN^BJP[%P76MK
M>CRDGAVDOKZ=ZBDBYD'MB45=. %C0DC\\"_&D,ZB)?& I3=GEU\(AJTRQ(MW
M3!PX;*H[R+;'Z1]:[:L@S;4]@*YJ>GWW78B5,Z2R7C='+SJI8L@M>C%<#19U
MF,1Q#YW*3AE9-!HFG(M'F!TEU+#&[9HDB>V0=*NN$H;VBU-P-=VA<O8:I^U%
MB:8E4N;_ %V\:1WJ%2M9?ILV.);"T0&]$UAE2/"<LHV6^SRF# E]@N9^>B1G
M77AG]/ZJMD!<$+@<K8EX7,YO8]=0@A;ELG*6JZPK*2+HSN;UC1YJ:/ZI@<DD
MB<@/X<D(W$F&6.QPQN'T&[DWNRR10$LVI1M9*WLV[*;Q]3-QLZG>4@WE7U<Q
MA+2M'\O9SMT ^A8?XC^RBDH8-2/U;89DQIJGEGH_U9;J-]DF1CV,Z9T5VC+0
M.468.G J=UDC*&$$LJI[6LNE+*CH.<-F#.;1=K.ZHE41DB\4ES84+U/QM\0=
M!WRXP:_RTT(CV3M!$@"3^$CT4D8&-11G6,O@<5C]1-J!)1FJ;LNJK EBTHV+
M'3WW:7 Q@D_!:6U''1J52LF1VL#)\J3=RN4*$";G$A+ZO$2S51]3Z.HBR[:M
M6IXR5ALAN[6$[V&&'S*8JU\0?U[#@=>QDV'K1Z=<P.*GF\(B\8B[\S%X^((&
M \="M2B[O#!'.$2IF?!SZ$.#))^8KNS)/'3%DR&W"E3ROLKV1D="D)_*IJ0L
M4Z:?T(6M9S3[Y A-RI"2KA'D+7 J$W2B^XS;S]/$22[,\,[IY;MJR&W)M7\F
M<EYR?@<LLZ&!;8M:+TY;\JJ],2A7TDMZE8W,A56V49BS8"!:,W<NBI3+UB""
ML3&I)F*8(-T3T,O#&Z<,K27M7>OI.4<*6)-[@:5J?MFUI!0@>VK*8'QD]LL'
M0)F9/:@$3"4LY5)]29-E#TM<.9$;(-$&Q$F\=K(G<=>O#FZI]8)P&L*J8E-]
M9!#H47K2L4IW<ENVF IJMS[\82,P*F8Q9$VE "KXL2<A J;H;#QPOUC@XH/A
M740/:L4D4)B=K]#8W:_8.\I7*$1,AZ^=PNKXR@.U=8.C,ECIN0&:U.EG%3S2
M*EXWE!RBJXA\_L2$S774N (:,V4#?B'J^XU^U41)FLKI1UNMRT!5R3Z!+FK#
M"I4(@-.:2N7#=&Z?66XGU^4OKD6+.,Q2WV4M,D\D:N5F2F3Z:OT>0Y*!=$Q^
MJ*[?*=4 ZYR!WW=G?;>=EPKIJ(HJ/]=*"BXA5^NO&X>5DR5E7-,)0J\9M&Z,
MHL*:L(1'FXL7L18C(E50$EDKN2E)84(1+@<1'$1Q$<1'$1Q$<1'$1Q$<1,#C
M]H5Y*I&7B$<F $U)P&'V30,>^37(C,#'R0Q_EVWU_+2^(0719K^K^ NIIIG\
M<\\AT;X_^"_B'KG4OAKHGQ-T?JG7^CC5GJG2-'J\>;7:$:#5X]!K#J<"^;']
MFUN7'ILU_<S.J'DST/4?A/XEZ1TO1=:ZGT3J.AZ3U$Z<:'J&IT[X]+JCJ].^
MKTPPY6\K^-IL;Y\=?>QJ6' F><]?//2B%^V9VSKBQZM!0M[UV<1.Z+<UJ^)8
ME$0LIU(H[_R<SB?;%)&[$SX:-*?DP-^/PD,8,/RB+-3/X-UO<ZL28'3(6&7=
MCQ[VID ;S*M"T)'WKY)[3EROJ$=%7P=N1RB[E>Q2,]M3 '[I' ]9G0KL0E 4
MK$9WS-H"Y/0 [7,2=BZI@]I."SJ76#'FI@+&A,7<HRDU,#LCV=INH\(@^TA>
M(C<*_5L(N&KSX]#AW[#B5@&#M>1DK:AHL6\H4#U+5SVE_&V;_%9;4HI"*][V
M6]H')8F_*%LUWF"S[O;68@?"#<+?/BHS?L-&*/M<:=KFT!DTAKV15Y+9HB&9
M05W'1<P>3E9R*CS!D#: 3+IPL6V&I#5R:S?1.ZZ5R6##GPFR(0Z%6"NJWNLK
MMY))) XNZE6U* *5)KQ1C<%'W+:,U!:W%N *HGFJ[3N)3WAK5@SJQ_$!,XE"
M4\OK6B9,PWJ^VQ\HKL\SBY&4F6LFAF8"M)QTC;M$P>X^-F!PAV6#&UI4*W(
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M<6KJ42B=#VU;05TG#6/S\IC5)I)5\"D'*L?8!G2![-\ZA:1@]N'HZ?!C2@&
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M1:/N@#FTVM6/8_)12&@(H@>8,B%<N!A(;E<0Y11*M'S95QJ@NWQGCRH$=6+
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M]S*77\-F->?G:F56K_KG>P^(]:.O\G"P ;6_62PHC+=+9$RY\0.6&!J](SI
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MG%J#CAD_M-7K$D7'[NUM8X6#-(JY02KB07@48E?&^(N[E;.X;]WG_AV4!ML
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MS]UF)-&[L$%)G<ACBWDMO*(ST<@<@A2WW:[#NJBID[FP!%8W13$*BG9*8S2
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MYDRT#!QPML7,%-4]294F@R;()/R1'5)+5^^=:*NG>J:>'"JF--?*"S&K)-
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M$6._F_E)?=Q2+OS;*3/HV >R0:/>"1T@=AQSDVP%$/\ S\8R*K-]W[4>^_\
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MRN5'RR^^5-MM_/U9SGDEW8 ,S,!V!8D#\ 3Q^4@(BDE552>Y"@$_B0.9W;8
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MRPY;R@ $[CP:-?PWEH3N8RF;*%#J^IRQ9C9<H1M!R>K! E 0Q: -:9GJU7V
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MXD%?:IGEP+)R[/1ETBG[Q_1LCHKI\IXAZ5-M*/B\/(,;,IO8=RV5VN P/:^
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MVX%25ZII"2U?:=GS'[P=)9%+-#UUL^%GX^OO.D9E7\'CM>9D+Z;H2#06592
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MV<F69J*O=B2ZF1)VGQ6O-]GSAR6!:MR^&&([M]Z@26VUZ5-E W'PU(PC/AV
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..B.(CB(XB.(CB(XB?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>20
<FILENAME>g723949g26g87.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g26g87.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X5TF:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM
M<#I#<F5A=&5$871E/C(P,3DM,#<M,#-4,3$Z,S$Z,S4K,#4Z,S \+WAM<#I#
M<F5A=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL
M;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @
M(" @(" @/'AM<#I-;V1I9GE$871E/C(P,3DM,#<M,#-4,3$Z,S$Z,S8K,#4Z
M,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T
M93XR,#$Y+3 W+3 S5#$Q.C,Q.C,V*S U.C,P/"]X;7 Z365T861A=&%$871E
M/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V
M/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH
M96EG:'0^,3,V/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%
M05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!
M04)!05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!
M04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#
M=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(
M>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&8O.$%!15%G06E!14%!=T52)B-X03M!04E205%-4D%F
M+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%
M04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!
M0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC6455
M37!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#
M3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT
M+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ
M8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!
M341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C13
M3D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG
M6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E7
M5G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A9
M84AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+
M;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X03E5-'$W1EAK,VU1*V-5,6Y5
M63E/)B-X03M'=$YP5'I+,7=512].3TAQ1"]2;59N3'!)-W%F,UA(:6]O>3%R
M:WA417!J-6$O-5=&*VY0.4TY9C9X.590,6HV,S9N,4=V,64Q.4QH)B-X03MX
M*T0Q4%<Y9FYW*TQX-UEM;$9S,3AU86AE86AP9G(S<7AP9$IC6%9V2TEE6' Q
M=')M4T-Q.'0Y+U1R:U-K2FYG4S=&6%EQ-T9867$W)B-X03M&6%EQ-T9867$W
M1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1E5,66%R<&5O<3=A9F51
M6&EX3G=K84-22E%R941C0V%(1VQ2)B-X03M72W5X5D,S*W$V6' P87EA:&51
M5V-B;FEJ,T5I4DM7.$%827%C85948EAD1%<Y:G-',4<R5RML0VU+,4TP66Q9
M34MQ5E-V23%(5&)$)B-X03M3<%IE9FU&-4IS-W<R9'AR3G-L=T1X6E$S24MF
M0FU51E8K:S0X2E)95#(S=4QE-6A393-L4V%#46-O-5DR1$EW.%%W<41G4W%9
M<3=&)B-X03M5;3AP9CAC<68O=&\V<"\S56)J0U5"3V-#6%EQ-T9867$W1EA9
M<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ;%56)B-X03MN
M-6=8>DI09'9E>'1O:G=+:U9J=R]E2DMP,V)L.2LO,%4R<FQH365'<3E444E:
M4$5*=C!6>3@P>'511&)39WAE=4-J1#!.=FHR*W@X)B-X03M20R]&,#-Y='9E
M4'HK4G9-,2]P3C1,<E%8=&)M835H:U<P=' W2DEL:70T2EER6D56:DMR3$58
M+T%(;DUQ5S5B9$US<TU+6D@U<S!()B-X03MZ=DYP3VE184TX<TYZ6E=%<5AA
M5U9W3&%,-GEQ44-*848T*U,X;&9J6%E$<C%W06A*=&EV;DMB>F9O:C-6:2MO
M6#-P4W9C;E)1=#1Y)B-X03MZ:TUB8U)/6#5C<&@O94M)<6QH5W9%1&9#2TM#
M>FIZ<F\K='DV>%HV<G K;%$V-&M6<DYA3G Y>$EK86\P>F\S<D0Q0T9.555Q
M92M2)B-X03M"6D9I5VPK4W9.9C%28D]85$<U6$U7:W%U;WIY44$R<E=%:E!.
M.%!.<%!S+T-V16)J2D5H1DHQ<F8U;"M2=$\X=%AK9FQY-W,O<F%2)B-X03LO
M=T-I,F%137-43E5B8T%Q3#!W0TIT94E046)7,'1B4T)B93!H:G0T1DI+>%)+
M15%&:5=A:7%!3C)*2GE$2E9X5C)+<$XU4R\T-54O)B-X03LO8E(Q5"]U;S-'
M16]#8S1%=7A6,DMU>%8R2W5X5C)+=7A6,DMU>%8R2W5X5C)+;U(Y44LV;D99
M1S)L2FQ2-59U0C9F<#A9*TEA=G@X)B-X03LK<G%0<S1Q:"]-5G1B6$9H16QX
M16MY0S=T0T9K54U.-VU.5'-A+W-S4FA#<&HV8V9P*VM&06IP>#1J655P4V=P
M9U9,9DQ-2U(V3D1W)B-X03MR.%)D;4I*66LX:4]P2C=$0U92365O1CE3;'-F
M<3!Q;49%:TTU.5 P>7-H64Q3:FPY>6IF<S1&4F5+=7A65$9Z8FU9=T-61$]O
M<3!1)B-X03M98W=/=38Y92M2-&AD6'5Y-$I69&)+;5-9<U1M+TTO>70Y5E<T
M<VIC-FIY9&M72S-G:U8R-%)T2S=,-C1H5FQ227E346-L=VQ&<#!F)B-X03M-
M;6=P85=D,U!F=U<P3V]2<DQ:;31K4TEY27=5:FE(27(Y=&9V=U5M,FXX>BM7
M:W0P=5@Q87E7,VM::VIM3GA%15IK,UE":3%#5G)V)B-X03MJ4E<Q1%@O3E9N
M;S@X1G%B5S5V-WED2&Q7,7-O,6MK15563V-J0FU10E%7038W.7-115=L:2]M
M6F]$,TM*1D1D4S)J3&%V2G%#26AT)B-X03LT>&5M:U!Q2&XV9W%W-&XT3FIH
M-%9T9TAN95A2>C4W,6QD45A3<$=4-G-%1W%Y6&=C03(V2#DP3%I754QV,$\Y
M9"LK4TA*:65B,GI+)B-X03LR8G-69&EQ5&55=BM/5E O04YT2%90.$%U;S-'
M16]#8S1%=7A6,DMU>%8R2W5X5C)+=7A6,DMO4S4Q2TM#.70W4F\U5VMU82MM
M>4Q6)B-X03M.=717-U5X5EIR<VQX1F\Q-TYB>DY"4$1$2DQ(26=2:4=24W<R
M9%A7;3-H:$-O>4Y74TY66GI)>6=!=3%/5$5$<65)5590<TU#;TA2)B-X03M$
M8W9B4W9C6$PS1&973&E.4S1J6&ES53=X<4(V84HK>6]R6$-68FTO-#<Q;B]W
M07=T,2]Y8W0X5E5V36PQ0F)A8VMS>FA%1GIB1W O)B-X03MY2C!D=BM&46Y-
M8E4V<4=#4$9--UA8>F)S1T-75UA$2&UM9TE)0D)Q1#!/6D13;'9L>&<R:E<U
M0G%0:C-(+T=2<T%K2D-W8D-:4DE.)B-X03M&9D0O04UD-C@O-6AB6"]K-6-:
M2D-0=TLW1E5J:3AN-EI&-7%M.'I,3$UB*V1"1SA26E!204-,2'-V2&PP469T
M6FI$4U)'6'A.*TPW)B-X03M/-7IP9&]43VY'0VAW1#4X-S<O,$HQ3$=*66YJ
M2DE$<59*1D-2554W9VHW>&U3-$QZ,D0X<$AT-#)E,S%:64PS;%-/4TLP4T]&
M67IB)B-X03MV8E K-%(Q57E/:VQ78T5B9V):4&E9,&U0;5 X=&].6#!Z4SE0
M:G9F<3A7;#)5=&I%>E)#57-*16E26"LR;$-O:"MM=F)!2DI)63$U)B-X03MV
M+TQ46$=U-S%T1FI7-%165VY-<#1W<$A#<WI156HT>4]P6&HY6#5E;VQ4*WIX
M2%A#2DE)6G(U;3AQ6'5Q6'-';V%8<7(V4'%-350R)B-X03MZ6$-2:6)N0S=R
M258T<WDP26%-8C5%1DI#439F*U9L>F)W<F%Y87%G<TI5<V\W-C%I='IY;"]2
M-VU337)+,'!+8S).5RM%*S)3-&M5)B-X03MX+WI0-6PX>"M7.54Q2S P92MM
M:V<P,'<K<612=G)E675*63%K2$-'84PV=S%/9%!H:TYC24%+:W94=DQ7=')R
M;6E7*W!I2#!05SE2)B-X03M7:#5#44LP56I234$V,$1$:VAO4C%'44EP:T=.
M86PK6DXS63-D-5IV;WAA-70U-#1)1BMS;U9B,49L:TAQ=6E/26XY2T1M14A,
M66ET)B-X03M-26EI,5A34'I.<V11=D96<D]31W=K:&%71S9"37)L-#1B96%2
M1$-I1FA28G1A144Q;V1H:5EQ0VTS:W%E3S0P3C4T:51(3&8V:S9&)B-X03ML
M2VYI,F]4:U969T=(>4EW1E%N=4),<U9D:7)S5F1I<G-69&ER<U915FAE,V1X
M8S-S53!%8U-7<V]I4C!L85%V5TY*2VQ41VY(85%D)B-X03MZ:7%L9D5F<&Y4
M0C-0<B\X44=.:FMM;79-,#A54&PO54=K8FE(9VMJ6#-A4E-I:C=Z;$=P,4UC
M341/6$E.;41$3$Q-4FIZ2UEX4WAZ)B-X03M22DQ',TM/4E$V34\V<TMG-6)#
M66M"26-I,7EI66MG.'=L6&QQ-TTY<F-J,'!)=VPS8SA427!8:TAM9#EQ:G-7
M2VMD:4UX.4QQ5&PT)B-X03MR:DM.1W1W4EDV1G8Q1T59-G%1;%DV9#=C,S$W
M+T9.<B]D+U9487IG0W U-U!&>E!3;3=&04XK;&-42$XT=TE-9D-R;#%V=C5F
M<%5()B-X03M&-%)'+VE8.$M69&522'-O=S9H:#EA=$YI2SEB;4U(.$1M4UE#
M6$U7,$-22$I-1U%-:%-P545%5E4P27)T<U(P>$ES56].1S!Q.'$R)B-X03LP
M9'9O:TM2:SA36&%J1W10:DDR*S=+3DYP65E)8T5,-%<S4&YL;&QX4S5U=#%V
M9CA4,W!::RMR9E992TM0=%5,>3AD-F5)9C=X:UDT)B-X03LX;WI'4DDX36I9
M9G O2&MY;%!(-%E!2')V;6TR6E1J=7A64T8S8DYD3F%#44<U4D)),&9C2WAO
M1"M'5FI.07I-3#E11C$U37IJ;'<X)B-X03M696YK=FMC<$=Z:%,U545H1G!Y
M3D(P1F%B-5EW65AD9FUX;S%P83-&>&5A9&8R=W0W;$Q.,&Q7,U9J339.2GA"
M.69J.$-R.%94=%5:)B-X03M,:%)X2C%Q9FY4>3EP5G19>C9P8TY::E5)>DYB
M<3!B>4AI;U%V>4U):U9E4'%,53%P-S1+5S!.3BM:2&MU1S).>$IQ2$=-339U
M4%)N)B-X03M,;UEU4%!N1TDK84%E;W4W04$Q1DUE17)A='(O04IL=F)(56)F
M4SE,,# V<'%-,$UL,#!0<D-"56AI6E9,1C)6-FQM8T%#;4E#:W!&)B-X03M$
M*V%1;F8V>&(V65@P:4Y,1C=U.$TT5U=,.4E-63 O8VQ0:31/2TXX94AH5S!O
M.#,K83=E1'IJ9#(P=C9!=#5T3CE!5SEX<6QR4%!C)B-X03MN;D=S=DI:279S
M0E,R=S8Y.$E'>4-8<#ET8E<Y=$%L=F)22D)"1T]-8U5A:$5594-Q=$%-9WE3
M1G9Y.3AP3DAC>'1:>4UL,TPY66Y")B-X03MU8FLQ;7%36D)75#174$DQ2S!Q
M3G5M2&E+2U(Q:#58,$-W,4$V:%HR87<S4FI%4$Y3,T5)1E)+2VA00E-6:5%%
M9U9.0EA',#!P955V)B-X03LK3U90+W="=$A64"LV:F-9;$%4;D%L,DMU>%8R
M2W5X5D18;7!75FTX2UA-;VIE-%EP0T-#951!5DE&064R2W1A=$=S;6PS87-+
M<5E8)B-X03LV16IO<%!567$Q<$534F%884EG;V]I43=K;F-I<#-0=6-3<44P
M83EG;C%(5TDT>6536$MK,49.:$1(2'0T+T9'8WAC1W)J;&Q+22]G)B-X03M.
M92\S9D9Y375N34EX:V8T9W0Q3S%%;78V5$XV:G%5.6)I<6MC9&QQ9'%F=&1$
M:'EA551Y4GE%>75(3'521%5'341#:%5K4C5I5E<P)B-X03M(56510G!B5$56
M.%)'4T1M45EG-T9P0DDU2F=Q<7%H5D%#9U5!1W=!1TE&8D)"3G!B;T4P36QN
M3#9B<3E,<3=R>$E.2S-5:$A42D96)B-X03LX,R](97,O*UE7-B\U3U<K2W4Q
M=4LW;',T,7194DY)2C1*0W!92CA-57%Y;F,O-FQ-47%/1&9!1V-C3G%S0V5N
M:G9G5DQF3%5K8VUJ)B-X03M11TYG-$)C17%19"M:.$U*5E5H+S0W,34O=T%W
M='(O>6-U3592*T)867%H,3 K>5<Y83E71E)D=4],5&9T155!<"M'56I4-'AK
M.%-V)B-X03M797)A8S!Z1&=V,#EY27DU<5DS4#5&,#)84W8P8W0U95%H<#4W
M;5<V:6Q55%-09$8O5D5L54M-0TI#=39D4&9F1&%+83%R>4)O;7)7)B-X03M.
M;%I3=E!"8C9F87E75G5S3'%#27!6:E4Q3'$Y4T)#=$1I2DQ42'9.;C586&UO
M6&QZ3G!&,'-!,4IP;3%#4U=2;&(Y*UEE4T)5:F18)B-X03MJ2&]!:%1X4$PY
M<VIB2D-30T=595IV2G5N95E(:&QN=4QM>G591F%.8FUY:T55:&ID;%EX<U-R
M5EAK9T]20G!*0U8R6#5885!B*VM()B-X03MV8G571D5T:VUT87A*0DU,2FDP
M2'%+<UE9.%-A;6I#<#8T94IA4VDX5'E.6EAI,F%E8DY5,#5$2SA!<UE,=5@P
M63-J:SE.,4Q-:VI2)B-X03M+2#)Q6$$X1&@S-VM044Y-,#(Q,#)X:7-R54U)
M27$X9E5D<$A*6FEZ37IU5UEK<WA*<6-G5U-*>%8R2W!.-5,O-#55+R]B4C%4
M+W5O)B-X03LS1T5O0V,T175X5C)+=7A62S=7,6AJ.'A8<VEG:&UT<F1J.%1%
M5F538FMA13 S-$PY,D96=70S=')B6&UK97,T471D1V=09UE*238O)B-X03M)
M3DEU66UO,6M-2FE*2#9Z42](-#5T*TA45'E#4FHO0TQ25W-*22MK,VEX=G=9
M=W5!.4LP*T4Q,G%-='I1;$M":D4X2E!8=6$X56A')B-X03M12D9G9$=T1FIL
M:C!I>E-35#%(5T90:G!X<4MB8E9045E.4&IL0T%J23A22%AV5&UM2E1-9TM"
M-DEF4C=Y,&UV.5A31V5/5C%U;$Q+)B-X03MJ2WA(*VI1<G5!9C5L27DX=&%R
M95=L.4QQ9&QC471%24QF;C9I=GDU;FU+2&I48G!I<79Q3FM,-GAM=$=L949*
M,$UB=D9W-6-71D=!)B-X03LU<30S2'1G5EAJ5FMJ5E=C>4UO04QT5&MX039N
M:49&5#=$1E9S3G9B=V=I1TI)9WAQ=U)1=%0T;6U+<51A8EI.9DIF;4E'-U)3
M:5,Q)B-X03M.47)#:$9+,#-P:7%*>%9X04E)27%$<U%C5E=1=U%1<'=H:E=*
M2S$T;T%O<CAH:7%M;&A9<&1.9'!B4DQD3TM08T)&16I$=TPP-4A&)B-X03M6
M9D961SAV3$]Y=&YU8GEE3S)T;S9E<%!--GAO=%118VU99T1C,'A68EDV:G K
M;U<T=4Q#-6EU-V-K<4IO2%=22VIQ3U-%:F)&5E$S)B-X03M.=4QG5WAL5#9Y
M>4=264]1-6Q!47!C3#$T9VM#=4MT>E11=U)03DTV>%%X<5=K:V-H5E912VMK
M;EE!67%V>%949W5,961784-62E92)B-X03LR:F-O=UE",$I6,4Y/-G-+161S
M5E9-5F1I<GE#;FMH=%8Q*UA6;V13,'$R=3=Y-'1,;356,VUS<"]2=6I)-#5)
M:D=)=39K;$0R2F]C)B-X03MS,UDW4%@X<EI/>%8R2W-B.'4V<' Y;G!K-C--
M>7AT.60Q:6%H<68S8T=O5$Y),G=0,E%W3T5H051B.4\V5#9V<&9754UN3TM0
M:4LO)B-X03MA=48U4D1P*S)"=&I35F@X>&%+26UM*W1P-F%25%A$3G94,')D
M+U1L8G K>3(S-G-A5E5K,65W.5)R9$QH1G505E<R6&MR34)-.%AR)B-X03M)
M=3%++W4O:38O5&I3<&)P6&UV5#5.2&=V8BLY:#E34S)7-VLY2TXP5EDR65)N
M-%-:1'1*.%!81VQ5-TQ58D)F3FPK;C$W;3AI>%%E)B-X03MI4CA);59:6D1(
M5VTS0T]-=#E*>D5X-E5X>7EY8U)01C V0W549E!/2EEX0W9P-G4Q5'I&<'AM
M,'EE0FIC47AT2&534TE554Q"8W!*)B-X03MB=W5F55I0='E353(V9#9:;# T
M-DYV=%HP=64Q=4QA3SA32U8O<D5(3FM:=W)W3%=B-%)W<G=89G)J4UAA8G$K
M;7@R545,6'-C>GAP)B-X03MB2UI%4FM"1C!E1G8X2DQK8R]N.3).2W)Y83EP
M16%S>C-+9TM,:&TR3W=S,C1Z.78R1#$O1$=L5U U;#!&3'!,4C<V2F)M4F\P
M:FA,)B-X03MF17I41&Q(>$AF:TUA5E)V=DY/;5<Y:$YD=WE,8RMJ1$YC;4Y4
M>$II=&XT4W-#=W X3&)E+V)';%)A8799.#%H;&M73S5-<5=Z=S%*)B-X03M+
M>G9%2FA(54-H*T$Q<C!X<%5P,%!89$9I,"M39#<U;E8R;FY$>7E3>2]U0F10
M1$=W-6QU239,:5%R<$Y1.'5V-7=T55=3,V)556EU)B-X03MO5S)(<6E24D,Y
M0V%61DEW*R]4<4UH-&MB-&)&.7I:-$TK2&EO.%!F5S-Z4DXO-6]S;W)/3S1S
M,FEU95ET6DM/-WA,-DXU3#9-56Y))B-X03M2>618-U4X8VY46&%)2&U,4T%#
M2DQL1F17;5-29FE)1#)Y.'!X56=6-$1';%<R+VUJ>2]C;TAT-S9/6E,P0T%O
M4S-X6%1C659.0G-7)B-X03M)-F1U*TY,87=E8F9,<&YL='AE;UIO56UK;%-J
M9D-L<U-S<F10,E-$."LR3DMI5C$S4U=M.49B;%1*>FEI-&=(-V,V97!'3VXW
M4V(T)B-X03LP<5=E9&1*,5A68E14-U14*T%P9C(X.3%,2T]585)117DQ6D]C
M5$]$26E$:7)6,RMN149"63)02G9M>3%U3F-U,'9R;64T=6)I,VQI)B-X03M&
M=DXY5E-65S0O6$=H:$5V<&\U:2]D;UI4,5=T96A%<D-+4VE/,3@X-F<Y-&QH
M8U102G W>#)C-G!C97!)1DUK.7<P0FXY83,U4$=')B-X03MT-#5717=B63EE
M:$]Y-V]V579++VYQ*W1'<W14*W0S,TE7:5-Z5SDS2$9B=F)O24)/;C%D;E1N
M2U<Y5GEX2V1&;WA"2S1,0S!S=&1#)B-X03LO3DM.+U5U<&)I93(U<70Y85(S
M6'!Y>G%(6G$R.'I816YP<4%&56ME:WA5+UIR=5=W=3=/9DIE;%AE;&56.5!S
M<GIA.%)$2F1!<TA))B-X03ML;61P6D%70DE9:&Y.5#-Y2D\V46YE0DQS5F53
M,W5K9FU266%J8DQ(<F<O46LY,3EB:S%E>F=T25EL4C%9>5,S2TMI8VEA:&I5
M<VID)B-X03M4=4UN65DP6')745I*2&0K95!+=&\Y-&LQ*W9/=VMJ:74Q4DI*
M0VMK=E!I;$56=51F=6YQ1G)3;3E-3D9&<3EH-7 P0R]W0E%/;C)D)B-X03LT
M<S$P27A.=U5.>$M&565Q=5)W66A:54I!3E)55GAP3G%F;$PO:FQ4+W=$8E(Q
M5"]!3'%.>&E50D]C0UA9<71L1'1'-GAT=VM)25)Y)B-X03M/44)P<V%B5G!K
M6D%K1W1I;4I&-SAK<SAR4E1295@W15-Y*W)Y:%(P3DMC5F11=U1Q83AA,')L
M1VMW>7A9>$=5=4UJ<GDO4U<W55I9)B-X03MZ;GA22$0U27%(5'I(<4TQ-F)I
M5U)P:U=-=W0V9G!Q<4UZ3'@T;W(W8S(V<V5U6DQ1<5A7;U=&;S!A,U9Z1F)T
M35-S2WEU<49Y3V]8)B-X03MK4E@V35986&1W3&$R;&Y+3DE);$QL130X:4)U
M86-I;R](1EA7;'@Y6G1O<FHP,FE%<6AH1R](:T%E;&5*66109D954%DS=#%C
M6$XU)B-X03M&3D%K4S)S;VE6,&M,;&E55U-P0E)+9D1)3S4S>%9*9&4X>F%F
M665B3D8P,EI:1&-82$PP>7%G<BLO4'!,56MJ.7!D.7-X<W5R:$-9)B-X03MG
M8G54;EE/>CAM6$9,3$=U1TA0-$,Q9GHT3EI0;&4Y+U)*55A(02MR>30P.41I
M9E8K,2]K-&14-&Y$*S<K<&IO5&@X5#DY.4@T-VLS)B-X03LP<UAW,'DP1V]%
M1R\Y1U V,E)3;G)C0C9L3T\S,G$Y371X8UA#3TPV<3,Y-U)N-$]/6$(Y1FUV
M9#!9.35!.'-P;VQR9DUT>3EX.5IU)B-X03M:5DEC530K:$Q*1G1U9G15<FU0
M<$Y*-$XW,V)M9&]D;TA5;5!P-&5&56XX<V%C9E!L;G)F2U@V-&)E9'50265N
M5TY9-$)T4W8R6FTW)B-X03LY8VPK56HT=FDW.%@W2UE$=$1)34)W8F-"*V9/
M,B]0-3AW1%)94#!'<71D9EA,9FU(-%4T."]G*S-19C,S<"\W5T]Q.%AH+V1F
M5F9L)B-X03MY*TLY;FI4.%HX9C9+."MD:G4K2V5'-6$R,#,V>F5B4$1$-FQW
M1F]D,5AK.4MF3$QE3&AH8W5G,V-B9S1P.$UE<#)3:GE.<E9L<3)G)B-X03M*
M4&%C=455:GA.>DA%.&=E93-8<S1Y1T154GEX-&\X;3-784]E;FYW5'$V=%5T
M3EHP=5AZ6F97361Y:EAA,C!#;45(-'558GI--"\R)B-X03M):U@W.&M-.$1,
M9T(Y5$=7;'EI2&E'2C1$,51Z3%A(67(K6D]P>E=0;#9.26)L8D]7.74W83)7
M-F%:<EI55G!!-VMZ<E5X9WAX<T-W)B-X03LV1$I245=#6#$O<D9X975M;F%W
M='1P-GE7='0V;'1F,S)P24AU;61P;E<T85=%=C9C1G535C0P5W9W,&(T.&MX
M5$A49GI",6UW,%E&)B-X03MX0S<R,$EL3FYC;39L=6Y&>$5S-E1T37I/231K
M93134#DW44=J9D=+57=C2V)8,G8U<6%Y+TTS0S)C36-):VM34C0U4CEB:FIF
M:39W)B-X03MR1$IC0TYO>$A)5V)K-B]:*WE$55!#='%.="M9=FU+=S!U1TYO
M-$I*;T8Y0S=G;CED-3=C<4DQ1C-C>79*=$9*2DHX24Y0:#,U8DA()B-X03MH
M5S Q5#AX.5)U3E1S24Q63%9R82MV<$E995%K17(R;W50<3AC:6=S3W9P>7-Z
M2T<T+T1Y5E%E5U!#='91<V=Y9&ER>&Y69DEM=&%0)B-X03MO:W5T,SAL=61-
M=$I4950K5795=419<71!07%U2&%S;&8X;FA8+THR>7=3654Y;7ET;7A$6"]Y
M+R]3;#EE6'-.*TQ7835E,6QI+V-I)B-X03M263-T:VYJ66MC,#4K;W0P,VA1
M*T]316M5<S!B.'1,4%1B,5I"9E135V-53%)W44E89VQ6-4EB94=2+W)%5'$K
M-C)I,$,P<%4W;D5Y)B-X03M7:S$X;'=P1&]J=V]72U(S*W!)<&1M:V-H9%%N
M035/-5IM4&E73E1G2VA08T-52'%T-617;'5K='9!:S=.3$9%5FMK35%(<7E,
M1T15)B-X03M*2E=H8G=X<V16<$9U9V1'43%!645%<5-P,SA#2T5F4FEQ:EDR
M5G9:5WE7,75'14U905)89#5#04)1049Y>&]01$973C9,<FUI6&9N)B-X03MN
M5G)#,71Z2&915S9I855X;V],4E-S2E1Y0G%E6'%X+T]N<TUX<V5R:D]:>&DW
M:34R8G,O2FIW>'EM=4=83'97*V58.#%R9F%(*V=9)B-X03LQ:T)U2E!8-65N
M.7(P>G@O=D-V*S9V5B\R-EI$5FY.=#18>#5E6&4R9&YJ4VM3.&,P9'5(;C4Y
M,W=4;GI33E-0;#8O1VUK0SDY22MK)B-X03M7<%0O04-V=&)F6G)L*V9J-$1W
M9E8P8UA3*T@T9SA4-D]Q,WEM3E5(;'EW1W%%1RLY4#A!949E3DM64$0W3S,R
M2UE.4'@X030O<51Q)B-X03LO0SA1*T8Y2%)+4$HP4&TQ3F$Q<S9Z3VMT<C9W
M15-O14(U.$5)4'=Q<"]U94$O='EJ5$1/2DAX1#9E;DIY=&),4VU%9D)"12\T
M=68V)B-X03M3:F193VUF-&TP:C$W57DS2C4K;DU,6C51=3-W9G964FQ8:3(K
M-V9$,3)Z3$]+2DYK0W<T16,P-&IH0DE"-EAS;4]V0S!/:UA+6&1Y)B-X03LY
M<&%U:%-A94U+5T--2TXY<%I",#ES;4=T1C)Z0G)E2FQK37%S:6M3<T%'645F
M84E!5590>4="574X=6MM,FYO3&M2*W9.5#8Q.5AR)B-X03MZ.58O5C0K:#(Y
M5&PY<D-686Q%9BM*3%ET2&1E=#9-<&IK1'@O5GA'3T%K0EAN>BLP52]:-C1Q
M-WI-,7EU;GA'045T.6%T=6MA>4=O)B-X03MM56]+3DQB:F512TLX=F\W:$-P
M:$E63FUX=55$<5EZ-C!:545%8V9I6&I6:#E&5&M3061K9VM'=VLS:UHY3V9Y
M+T<Q:&)I,FDY4U1M)B-X03MO:D566'(Y<6=!<G115G=2>'AH=$5!935N:WI4
M>4<U17E0;6)1,FXV3G!-6&YR54QY3W=K:G9F<3!-<EA::W%H37I3<7@T*V]F
M=&E))B-X03M$-T<S2'0S<6IP8UEN>&=E<C1T.#ED;&QJ1TEN,$1P42]T6E)L
M-VE*4C5R.'=X*U@Y1FPQ2C!756\X555C8VMG:%5T3$ES9GA315!X)B-X03M#
M.'523D]G=V=79VQ!868U-S!I5U-/,W9B<7I7-VY90S%3=VYK=F\U1DI)<4I2
M1$5T5DMN;4)8:4XR24=(:%<Q.% U:654-6]$4$9F)B-X03M--B]#46EW6$)L
M6E=5=4A73# O55I/2TU3>7)153-/1&A+,G)(>G@U5D1Y<"MK16(P55-6,E9:
M1U5R2C9F2&DT57$U+V9X,4-K:V-H)B-X03M81VET<DHO4'9L5T<W:W,S=3-A
M-&EC>$]K9'9C4U5C4TY&=T)33F=736MB2T%/<$<R4$-6=$].3S%'>C%'>FEV
M8DM55%<P=TI2=T-/)B-X03MH2VM%34%145%145)52$%L15EQ-T98:F5L;E)0
M34YV85='<2M:9%5I:#%'=V4W=5DU=%%T;6E1<$US9F].>6A8-&I8;'8T6EED
M;4A.)B-X03LW2FQB3C)+=7A62G9+6"](2VXO-V%/<68Y,4<T=VQ!5&Y!;&HO
M;E=54C9B8FMX6%5V*VQ10VQO;UIH5U)253$Y:CA0*U9436)685-/)B-X03ME
M26I):U5B,CAM+T)Q1&E.9T$W5G5M*W%4*VAP=#-0-E Q;C!O6D@K<B\W.#1O
M5'<V3CER<#!Y-TI0:&E4,T)H:6AX>D5387-G2D@K)B-X03M8;6]#*SAR,C!G
M<V8P9C9F-W(P+S4K0W%05BMY;C(K=CAC<3 R;T]74$52=S=U4G)T24U'5&=%
M=5!B;BM#5F)4=C!B+T%)<C%!=U<X)B-X03M-9'E923%K:U)R9C%#5FMC>49L
M4GI+3UA.3C)896TO8DQH:6E$64%T>#5:<&U00U-4161,,E)U<B]O>C$W2#8W
M-B]Q*V\S,50P4')0)B-X03LY-7=.82MH=#EJ;#ER=%@S>5EA,%)Q;G!F;S8U
M.6%/4U=(,#)-:V-,8TA:86)H5S52,#(O>6AG5G)39E,O4G1V-DUC:TU*44=/
M3UHO)B-X03M5:T-N<'EB;$I88B]!0VII5E,W>2]+-S9N<DMM8U-M3S5#>7%*
M635+4#9352M&25E3;G=C5C-:='=F;FMI0TM9>&U#4T%E4VIR5#8T)B-X03M0
M3E=H3&%2=W1P-3EF-C W<U$T*T1E9T$X4',K+U=N6$I2-&5%,WHV3D]1-65/
M4$-"=V1E.44K8W!.46HX<C9M,6A%:S%X.5AC8TI')B-X03LT:F=6;S4K65=P
M07=9>$5Y2$9Y6EIZ35%*9TQL,%13,6$U83%H839263=K;W!N4D1Y5EA)2$E+
M5%-O0C9:13%E>EI'-D8X,&LX;3(R)B-X03MS=S)L.2MK-W%/-40S,3!B8C P
M-&-617IH<2].=U-",CA4,FYK35180TMA9%!$24%E36<W-V4U,#EL<78K3TQ/
M-T8Y5%1V<54V+U5U)B-X03M!-F@T9S-X935:5W(O:S W-&E594-Q,S<Q3T]F
M:6E81C9+-65A+WIP1'$X,FIX<'!6>$AB6% Q=3 O95-R>D906%%$8C)F:69K
M2UDT)B-X03MJ14@Q0W=N55)Y1TY9>4)+>'I4<VEB,%-!>6EB:E%/5DI8;%1R
M>')7;&4S3#9C<F)T-E-0>5!&<7-F;'DS6%4U;S5R;FQ)43!A.%%&)B-X03M-
M:&]$-&XV0FQM57A*.5!*<# X8V=H*SA)379*47-T3#%'4'HU<4XK,318<W!,
M3S-#,F@U+T-3.&=7;GAC9FA+3V5N-UAB17EJ=T%6)B-X03MU<UE:4$5*2CE&
M8VU3-5<S<&)R,FA287A"8E)36$TQ<3%R8U(S8TUT=C9F25-25C1617%3;U%#
M83!+.6-)2VQ*9%DX:E,S85-8<6%N)B-X03MD6$]T>%<X,$9J8S-,>$I';VUI
M94UQ>5%1<6Y%;5%&:44U9D-..$E+2U=1+VQP<%5A478Y9'9"9E)W:3%.-FIX
M<DEB8C!H1CE8<#9F)B-X03M%249866AE9F9L6&9(:5=L=R],4%)&95)O<G$W
M:C5,16M!1'AN,%5G;5=E2D8U4G-:1E)O,4-I8FYX6#1245DX4S!P<"M6;FPP
M869.)B-X03M:=$QC>F5T8TID1V59=WEU2DDK9%!H:VEA3F=F5V-K3VIB=%AW
M>#1L<&MU:F%26390<&QV<'1H2#9D<F)+5FI8-6MS>%!U>D5K-45L)B-X03M+
M37A6,DMP3B]G;GE:+S%99$\O-E))4"MA34YL1D)/8T-867$W1E5M.'!F.&-Q
M9B]!3&%/<68X0612=4U*4452*VQ:9C W*VDO4VHT)B-X03LK:C8O<2MQ961+
M.&%E;G=P5W8X06QD3CAO.&5(:65(9G)Q-CAM,W=:8TA(6'!U;4XO;6Y:9E=T
M2W-V.$%C;75M:&)L0GE9<T]836AF)B-X03LR5"MX6&PY1U4V>E-Y>6=#2G%N
M3S=.,7505'E*;DAI<TUV=FQL87EU1FE$3DM9,T5A>'-%8W1X3D%R;EI46&]4
M,'I.1')#9&MH+TQV)B-X03LV.2]H1WA.-TA.2$M6*T9B:5%3355!05)G84-I
M;%)51$HU66=3;T=W,#9B2D]C05IX-%ID>F5L5V5Q>"MC.5=U<#=I-&MS2C1)
M;'0T)B-X03MP23%72E-J3E968V9Y,7%02&MA.4U-<$%X07)D14U5>&ML27EU
M2C5$=5@K861+=G(V.3!A5S)E-U9,3S9-,"\Q5C1K2$5)44]F<7-T)B-X03MD
M>G@R<CA*8C)W634X24\S3D]B0UIM2C1I3T4S=#%42'I"6DYF84IF5V%R27I8
M14QX:%E70T]3=W!S>D92.35Y34I58F)-=4U4:5EN)B-X03MQ<SAT5T(P+U%B
M1WA+>6\Q=D5S6E=D;&51161A<W!:9FQ1.4U:>31I4VI$:D5)0TDV26)14$PX
M5VUA:G%T,FQN8C(U,4-94S@T6%HR)B-X03M)0V=564UI0F9I-5!S97)96C5$
M24%%.&U/4%1W9U-9:6I,;6U5*VTR<SDS1&1Y0U0Q-V8K-DMY>4EO<C%Q:7-&
M3F4Y4FM'-7953$=/)B-X03LK<S5B4U8S4TM:4VMH:F)I,T4W158Y>&EQ=$5N
M<'AO;DEV=T%8:WAQ>&]+5DHX8U953$A4-V%Y4C!T*UE74FUK65!*2DPX5'-7
M66HQ)B-X03M'86Q766LP>%9C8D-W3C)T-&)A23-I:6DS2E)F54%)<%%05&PP
M>%9Q*W-,82MH5T<T1&Q&9%I"=VMK:5!*1%945TYL3W@S*V5+<3-P)B-X03MR
M-F9P;7!3;D4Q2DI)<%1C;F9&5DMY<V)3>6@Y0S%J15564S-!5G!5.65U2W54
M5#="3'!R=$QA2F)T>%(W9TEO:UEE0F-$:V-65CA6)B-X03MD:7)S5F1I<G-6
M9&ER<U9D:7)S5F1I<G-69&ER<U938GEL+WAY<"\K,FIQ;B]D4G5-2E%'2R]5
M2F8K5G@O5V97:30O5B]5.4AM;G%C)B-X03MF43E0-T9E6#)V8G!V,'I$+TLU
M9D8X4R\S9C=(4"]0-F)W4$%R.2]Z=GEV,W-M.#,V1&5A,5E15S%R33!,4EA%
M53=S<WI15E=.=59/)B-X03M3<$QV-&)B1V@W6FXT.&Y#8G Q5V]W94E!3$DS
M=EI02%)*15I(54]J9W%Y<TMG9S=%14A+,CE4=&)3,'1)4D1A=W@R.$DS16-3
M:$9()B-X03LP2T%-5E9C5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<D)B8RMC)B-X03MX
M-30Q07A,33EU0E V83-,4TQ91T@P-V(V<G=)1$QZ-2MT>31$;#0Y<VQT4T]Q
M23AT3C4R5%1P:$9A-F1X3CEQ1$@Q2G Q8FLQ.4U7)B-X03MO0D-F:#5%.%0S
M1D1I855):CE'95HO,' K;&8P6F\O-E(Y4#!F<EAR,TA0:#16.41$>&UQ=EIH
M-%5E3&IO8UA+,%HV=FYV.$$U6F1,)B-X03LO=T-K:30O-F\U2%IM-S%F4&8X
M07EY-E@O=T)*1G@O,5)X,E8S<2ME+W=$;&PP=B]!2U-,:B]Q:FIS<G96.#DO
M.'-U;"]W1%-28V8Y)B-X03M58V1L470Y<79N:3!K=$5A># V43-C-'0Q2U0S
M0D-K;WHX;B]!2$]Y+T)41V=Q2SE8>C,O04US=6PO.$%34F-F.55C9&QD-G9N
M=CA!)B-X03LU6F1,+W=#:VDT+S9O-#=+-S%F4&8O3$QP9CA!,&M82"]62$A:
M6&5R-3<O-5ID3"]!3VMI-"\V;S0W2S<Q9E!F+TQ,<&8O4U)C9CA!)B-X03M6
M2$A:6&5R-3<O-5ID3"\V4TQJ+T%+;S0W2VAD4#%8>GAE>'I/;&IP,%EH;FQT
M>4I*-V=%;49Y:%IF,THK13!Q36%#;W(Q9E!F+TQ,)B-X03MP9CA!,&M82"]6
M2$A:6&5R-3<O-5ID3"]!3VMI-"\V;S0W2S<Q9E!F+TQ,<&8O4U)C9CA!5DA(
M6EAE<C4W+S5:9$PO-E-,:B]!2V\T)B-X03LW2S<Q9E!F+T%#>398+S!K6$@O
M5DA(6E9'8E9F3CEN8U=1=DQ+>&$S=6)M3S-K83-M;60P16A.6&\P4VEG03AC
M9&Q:2F=3-T9867$W)B-X03M&6%EQ-T9867$W1EA9<3=&6%EQ<#-4>7@R,'-K
M4V5P2VE-,&%F>DU"540V5&ER1E!Y,3$W5CE:,#(U;3%'9C8Q-F)W*VYC*VUS
M9GAY)B-X03M7,&-K.$Y%0VHY>DTW2C0W8C<U2U%10WDO27!D:7)S5F1I<G-6
M658K6E!M2%=.2$]L;E0W:W=2>E!*.5E335)M85AJ=T-X>&5R1DUH)B-X03MC
M.'EE3WA0:FMO:$):<FM5=7A6,DMU>%8R2V]$6'!,*U!2<GE3=VQ31S=J:5HT
M<%I%.5)6-&EP*T=O<6%!,#DX259G9FQF>FHU;79V)B-X03M.1VM75C%C*W!"
M9%=D=DQ08BML1W9*6DY05S1A-C5+;UE6=40V97@T.7%:26=5>$)E;#5":S=&
M6%EQ-T9867%W9GI:<G9M5%0Y83%')B-X03M#,G4T-#=B.414,V1K;G!!*VQ-
M:W--66QK66E1='@Y4FI3;D=N54AR:V=!9W Q-4@Q3S<Q4'DU0F188W)Z>FU3
M6D=U2#E-<DIW;%I1)B-X03LX8E)*0VI2:T0T5T-#;W=&46XR0DQS5F1I<G-6
M9&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5EDQ<G9M
M;E=,)B-X03M06#1T1C!R4T8Q3S5E>F$K671D3&)54EI"159(2TYW5%9H,T=%
M0D)+:G S-6TK5DQQ>7-R:64T83!L=D56:D,V4T]):3!J43A:6D56)B-X03MO
M,"]E259"66EU2&A+,FUM;F5B9DPK<%17<TYL9&5T3&5*3$Q!9VIL56Q)2#E/
M471Y56-/3#=F1E-V8D)3,FTK0DQS5F1I<G-69&ER)B-X03MS5F1I<G-69&ER
M<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER
M<U9D:7)'=&,X<F%V9"M9271B,')6)B-X03LQ,#(T4S!A>6-.8DQC,5)P0DM3
M3U5I04=Q:G-C24M+63-C+VMY:G<R.79$<D1I,W0T-&Q22C1F5TMY2DM:<$AJ
M26MJ0V5Q-T5S2T4K)B-X03LK4S0P8TMA*U-02VPS66593F0Q>3AT5%IM+VU+
M,DYQ,&E33DA%>D=75G%X:W%"2DME449D<5E#56=-,'E+6%EQ-T9867$W1EA9
M<3=&)B-X03M867$W1EA9<3=&6%EQ-T9867$W1EA9<2\O.6L]/"]X;7!'26UG
M.FEM86=E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @
M/"]R9&8Z06QT/@H@(" @(" @(" \+WAM<#I4:'5M8FYA:6QS/@H@(" @(" \
M+W)D9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z
M86)O=70](B(*(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O
M8F4N8V]M+W!D9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!9&]B
M92!01$8@;&EB<F%R>2 Q,"XP,3PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D
M9CI$97-C<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O<FUA=#YA<'!L:6-A
M=&EO;B]P;W-T<V-R:7!T/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIC<F5A
M=&]R/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D
M9CIL:3Y*87-O;B!"<F%D96X\+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z
M4V5Q/@H@(" @(" @(" \+V1C.F-R96%T;W(^"B @(" @(" @(#QD8SIT:71L
M93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^<W0U,SPO<F1F.FQI/@H@(" @(" @
M(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z=&ET;&4^"B @(" @(" @
M(#QD8SID97-C<FEP=&EO;CX*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @
M(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M<F5P86ER(CY&:6QE($YA
M;64Z(" @(" @(" @(" @(" @<W0U,RYA:28C>$$[57-E<FYA;64Z(" @(" @
M(" @(" @("!R<C(V-S@Y-"8C>$$[3&]C86P@5&EM93H@(" @(" @(" @(" @
M,CDM2G5N+3(P,3D@,#4Z,3@Z,S4F(WA!.T535"!4:6UE.B @(" @(" @(" @
M(" @,C@M2G5N+3(P,3D@,3DZ-#@Z,S4F(WA!.U-C<FEP="!697)S:6]N.B @
M(" @(" @(#(N-28C>$$[26QL=7-T<F%T;W(@5F5R<VEO;CH@(" @,38N,"XP
M)B-X03M'<F%P:&EC('1Y<&4Z(" @(" @(" @($%R='=O<FLF(WA!.R8C>$$[
MXH"B(#DV(&AA:7)L:6YE(')U;&5S(&-H86YG960@=&\@,"XR-2XF(WA!.R8C
M>$$[5&AE(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C
M=6UE;G0Z)B-X03LF(WA!.T%R:6%L350M271A;&EC)B-X03M!<FEA;$U4+4)O
M;&0F(WA!.R8C>$$[+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM)B-X03M&:6QE($YA;64Z(" @(" @(" @(" @(" @
M9S(V9S@W+F%I)B-X03M5<V5R;F%M93H@(" @(" @(" @(" @(')R-3 Q.#4P
M)B-X03M,;V-A;"!4:6UE.B @(" @(" @(" @(" P,RU*=6PM,C Q.2 Q,3HS
M,3HR-28C>$$[15-4(%1I;64Z(" @(" @(" @(" @(" P,RU*=6PM,C Q.2 P
M,CHP,3HR-28C>$$[4V-R:7!T(%9E<G-I;VXZ(" @(" @(" @,BXU)B-X03M)
M;&QU<W1R871O<B!697)S:6]N.B @(" Q-BXP+C F(WA!.T=R87!H:6,@='EP
M93H@(" @(" @(" @07)T=V]R:R8C>$$[)B-X03OB@*(@.38@:&%I<FQI;F4@
M<G5L97,@8VAA;F=E9"!T;R P+C(U+B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG
M(&9O;G1S(&%R92!P<F5S96YT(&EN('1H92!D;V-U;65N=#HF(WA!.R8C>$$[
M07)I86Q-5"U";VQD)B-X03M!<FEA;$U4+4ET86QI8R8C>$$[)B-X03LM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF
M(WA!.SPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @
M(#PO9&,Z9&5S8W)I<'1I;VX^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@
M(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @
M("!X;6QN<SIX;7!44&<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]T
M+W!G+R(*(" @(" @(" @(" @>&UL;G,Z<W1$:6T](FAT=' Z+R]N<RYA9&]B
M92YC;VTO>&%P+S$N,"]S5'EP92]$:6UE;G-I;VYS(R(*(" @(" @(" @(" @
M>&UL;G,Z<W1&;G0](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP
M92]&;VYT(R(*(" @(" @(" @(" @>&UL;G,Z>&UP1STB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+V<O(CX*(" @(" @(" @/'AM<%109SI.4&%G97,^
M,3PO>&UP5%!G.DY086=E<SX*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE
M5')A;G-P87)E;F-Y/D9A;'-E/"]X;7!44&<Z2&%S5FES:6)L951R86YS<&%R
M96YC>3X*(" @(" @(" @/'AM<%109SI(87-6:7-I8FQE3W9E<G!R:6YT/D9A
M;'-E/"]X;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#X*(" @(" @(" @/'AM
M<%109SI-87A086=E4VEZ92!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @
M(" @(" @(" @(#QS=$1I;3IW/C<R,"XP,# P,# \+W-T1&EM.G<^"B @(" @
M(" @(" @(#QS=$1I;3IH/C0P-2XP,# P,# \+W-T1&EM.F@^"B @(" @(" @
M(" @(#QS=$1I;3IU;FET/E!O:6YT<SPO<W1$:6TZ=6YI=#X*(" @(" @(" @
M/"]X;7!44&<Z36%X4&%G95-I>F4^"B @(" @(" @(#QX;7!44&<Z1F]N=',^
M"B @(" @(" @(" @(#QR9&8Z0F%G/@H@(" @(" @(" @(" @(" \<F1F.FQI
M(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @
M/'-T1FYT.F9O;G1.86UE/D%R:6%L350M271A;&EC/"]S=$9N=#IF;VYT3F%M
M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^07)I86P@
M350\+W-T1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N
M=#IF;VYT1F%C93Y)=&%L:6,\+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=%1Y<&4^5'EP92 Q/"]S=$9N=#IF;VYT5'EP
M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^,# Q
M+C P,SPO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @
M/'-T1FYT.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @
M(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/F%R:6E?-BY01D([
M(&%R:6E?-BY01DT\+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N
M=$YA;64^07)I86Q-5"U";VQD/"]S=$9N=#IF;VYT3F%M93X*(" @(" @(" @
M(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^07)I86P@350\+W-T1FYT.F9O
M;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT1F%C93Y"
M;VQD/"]S=$9N=#IF;VYT1F%C93X*(" @(" @(" @(" @(" @(" @/'-T1FYT
M.F9O;G14>7!E/E1Y<&4@,3PO<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @
M(" @(" @(#QS=$9N=#IV97)S:6]N4W1R:6YG/C P,2XP,#,\+W-T1FYT.G9E
M<G-I;VY3=')I;F<^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IC;VUP;W-I
M=&4^1F%L<V4\+W-T1FYT.F-O;7!O<VET93X*(" @(" @(" @(" @(" @(" @
M/'-T1FYT.F9O;G1&:6QE3F%M93YA<FEA8E]!+E!&0CL@87)I86)?02Y01DT\
M+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.D)A9SX*(" @(" @(" @/"]X;7!44&<Z1F]N
M=',^"B @(" @(" @(#QX;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @(" @
M/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0WEA;CPO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI/DUA9V5N=&$\+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:3Y996QL;W<\+W)D9CIL:3X*(" @(" @(" @
M(" @(" @/')D9CIL:3Y";&%C:SPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI397$^"B @(" @(" @(#PO>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @
M(#QX;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" @(" @(" \<F1F.E-E<3X*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P3F%M93Y$969A=6QT
M(%-W871C:"!'<F]U<#PO>&UP1SIG<F]U<$YA;64^"B @(" @(" @(" @(" @
M(" @(#QX;7!'.F=R;W5P5'EP93XP/"]X;7!'.F=R;W5P5'EP93X*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @
M(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z>&UP34T](FAT=' Z+R]N<RYA9&]B92YC;VTO
M>&%P+S$N,"]M;2\B"B @(" @(" @(" @('AM;&YS.G-T4F5F/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V52968C(@H@(" @
M(" @(" @("!X;6QN<SIS=$5V=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O
M,2XP+W-4>7!E+U)E<V]U<F-E179E;G0C(CX*(" @(" @(" @/'AM<$U-.D1O
M8W5M96YT240^>&UP+F1I9#HY-$)%.#,V-#4W.41%.3$Q.#(W-D1%,#A%1#4V
M13%&-CPO>&UP34TZ1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.DEN<W1A
M;F-E240^>&UP+FEI9#HY-$)%.#,V-#4W.41%.3$Q.#(W-D1%,#A%1#4V13%&
M-CPO>&UP34TZ26YS=&%N8V5)1#X*(" @(" @(" @/'AM<$U-.D]R:6=I;F%L
M1&]C=6UE;G1)1#YX;7 N9&ED.D5".#5&,#4Q1D(Y.44Y,3$Y,3=&0D0V131&
M,48X14$Q/"]X;7!-33I/<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(#QX
M;7!-33I296YD:71I;VY#;&%S<SYD969A=6QT/"]X;7!-33I296YD:71I;VY#
M;&%S<SX*(" @(" @(" @/'AM<$U-.D1E<FEV961&<F]M(')D9CIP87)S951Y
M<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @/'-T4F5F.FEN<W1A;F-E240^
M>&UP+FEI9#HY,T)%.#,V-#4W.41%.3$Q.#(W-D1%,#A%1#4V13%&-CPO<W12
M968Z:6YS=&%N8V5)1#X*(" @(" @(" @(" @/'-T4F5F.F1O8W5M96YT240^
M>&UP+F1I9#HY,T)%.#,V-#4W.41%.3$Q.#(W-D1%,#A%1#4V13%&-CPO<W12
M968Z9&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.F]R:6=I;F%L1&]C
M=6UE;G1)1#YX;7 N9&ED.D5".#5&,#4Q1D(Y.44Y,3$Y,3=&0D0V131&,48X
M14$Q/"]S=%)E9CIO<FEG:6YA;$1O8W5M96YT240^"B @(" @(" @(" @(#QS
M=%)E9CIR96YD:71I;VY#;&%S<SYD969A=6QT/"]S=%)E9CIR96YD:71I;VY#
M;&%S<SX*(" @(" @(" @/"]X;7!-33I$97)I=F5D1G)O;3X*(" @(" @(" @
M/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N
M:6ED.D5".#5&,#4Q1D(Y.44Y,3$Y,3=&0D0V131&,48X14$Q/"]S=$5V=#II
M;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#$Y
M+3 V+3(Y5# U.C V.C,S*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O
M<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HY-$)%.#,V-#4W
M.41%.3$Q.#(W-D1%,#A%1#4V13%&-CPO<W1%=G0Z:6YS=&%N8V5)1#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C Q.2TP-RTP,U0Q,3HS,3HS
M-BLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S
M*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X
M;7!-33I(:7-T;W)Y/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @/"]R
M9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @( H\
M/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ U0&8 P$1  (1 0,1 ?_$ !X
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M(K>7G%UR5.*4XI3BE9_]OOUA?#P_>0MW\CMB\M6_W5U^Q']1*JW'WMK^V/\
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MM9*ADJ9:0I+"B5J(4SC.&\OJ4[E.7,Y5R:4DI!DD_FB>3G_YTP_VJ&, //@
M?G0/_P#&&K(<AJ:H UY_CMV)_P#1J'_XC(\F?[F#_P"Y_P A4:_>2?\ T?\
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M%ZFCR!SVI5KUOX?Z'T#J73_5DO5O4.FZ5K%Q:?(=+0W;3B2VOHE6^.I-VHG
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M2T@46ZB0=>"=6P[AHX^TT?;0;;-)Q)CUF0D$Y;W4YVA? ]J+)(9$DWL=UU)
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MB3<LA%,'I+HYD>^'8F#V%EBD-%X6\P.3'I$ELG?1I"M:"4S Q.J,JLQ=OLA
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MO/C#TS9]8MT*]AKCZ@^KV.E1WB06'R1NKSM)&[EK]9U@5KI>XRP-(%5BL;'
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ML-//R]&HP<Z/MQF&KH(=SD"P9'2RKK"@OW:1+<@!U@W5NB/STZW46VGP7)H
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MKX0K("A=!JU7O$,NFXFMB3A)T,X)V";A'(0!L1^4W-;MTQ)]<66DQ3R (-$
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M,CH^OT/\BNSI"V4._P!QW]/VJM5.G/VZPT6L.ULVOEU,^;M\LW$S\<%3%IL
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M*)8K<EB3@!I6QC.T<*!P?'/U-;*<X^KU9;^)/$;)8;Z\W*'VS.5R@1W97KC
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MS;GD8]6,>X\5"2W>4]M]H1EW>G&69#G[6[ P<\9_ U:/D-357^_?X_\ 7O\
M]GW1_P DJ?)5^ZE_7'_NU1-][%^J3_9:L!R*I:QC\0WH5(=D=_Z7N0VS@ZBB
M_*'THW'OU-Z:5%OUJD;JV^JQ+);L,9@MHQFLJ@4QF&!EL.F)D<G.H8R&[X=\
M1_@U/\0->37(^H(M+6VTFVL?EGTU[LN8;NXD[G=6]MPH;YP#;VSCMD[CN]/U
M?\$?\35K\'ND9^E9^CKC7WO.H+W5Q>Q:W'IRQBZT^PMQ 8'TN]+%/R<7[G=
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M?I[DA+2YEG^H5@V3L1<FI]^3&Q$UEN!"XVX"Q($VNK(-WJ[@PV7+;_  &&
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MZ1M'.7DV'8!C /I[L)W>1Y/IQ^_/&#5G>19(0L>X;R0<D98QRC;X/A?5G_\
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MHF<21Z@"VQH@E+KYF"&?2NH?A]/H?3-EKC:E#<,PMS<6JP[%C%\ R=B?O/\
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M#J6N6"A^70Y3B1W([B%MK+$ =H;=Y!&,9&.0*@##OL,-RBKG8^W*LY(W;=O
M(YS@^U6SY7J>JRRS.SU]E:S:!=6'$T.&HEJU^3;<6ZH-86JW6375@3/-0+LF
MF:S'Q355DA#!LC8D7WU#K#&>9<RM,PV=DKO]997V[6_RAQC.,9.X?A]341#=
MT-M](5ESD?YF0YQ] %/XU9KD-2U539UG+![!::<9HNRYF,K %[$F[! 4.P3-
M=">ND=71(;U3(0C@:T)>")Q)N-K4F+0WEPW+2,XSF=%!BD]: L5P"P!]).>/
M]OK4#DB6,[7(4-DA21Z@,<_NY^E6KY!4]5<WM(7AO86@R:OIW8FP8J@[%DK]
M8YJJ':R% 'CI+36[-;MQ0[5SV-490J:8F[E &D--QWTW$04X0S*/F#O (GB"
ME)=TB(64( V_.1)&^?2C#&%(\YS[8YJ&4MOBQ&[!'+DKMQ@QR)CU,#G+ _3'
MO[5:/D%357#L/'[*FAJ%'T#7N+FB'V+1;U+E+ML#6T"#4JTQDV[&MM2ZL.%%
MR@P[S8KK6,#LNIQ@E:,*QGDT)0;R[[<HZ#TD_:4C/'T/FHY QVA5SAE8\@?9
M8$CG\!Q5A07B2 0R#0\QYCXH[Q8"GVBE DNLH6^&HEC.6",C.J4SE]G.6G<H
M]QO.4*QR$^3@Y'L?&?QJ0?P_#Z5[7%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2
MG%*<4IQ2G%*<4IQ2G%*<4K/_ +??K"^'A^\A;OY';%Y:M_NKK]B/ZB55N/O;
M7]L?Z;UH!RK5JJT=BMCWS6R*$94[?JVM!VFXPM,,:V)3[19'E/S9B4*EP":[
M?:BV('"@-DE'#G"O,$*]A+DM%I5C+G3^L>O^E>@(-$GZIO'M(^H.H-.Z<TXH
MT?\ ZW468+-<=S':L;5$::]NR=EM%M+ LZ*W8NG.DM?ZMEU.+0K=;AM(TB\U
MF\#AS_Y6S4$QQ;/MW4[,L=M /5,Y(& C$6-!2:@(-$F\*3(H%'3($ C/!!/F
MI91@MX,,@L]\05U_#BQQGSC7F&5(:<+)6A3R^X'\/'MGG_7 S_ ?JKKH_'S[
MXK+WQ1=<=;KM2]52^^]I,ZYDZ_<X^(I Q%TJU2;GHF[7S6,+LXOV;''FO2:Z
MK3V53:7P'&&(3"52,LV6#CV<=(ZQ^&FB?$7\FIK,NJQ+I OFMSI<UO"2UZD!
M<3=^SN]V6LXA&%"$9<'<2NWUGX7?''JKX,?EUNF+;I^Y/49TI;T:]:WMR%&D
MO?=@VOR>IZ:4.W4[@S=PS!ML14)M;??+0U;H%/TSK.LZKL6+=KB'I\,)2;/B
M6CIY,_7,"I<BY5$S$#BQ<FV:,XA]LT =D5]"TK91A&<<['HNC6W3VDZ?H=F9
MVM=+MH[. W3*]P8X1M7O,D<2-)_W%8T&?"BNC=5=37W6?4>L]5:FEI'?Z]?S
MZE=I8I)%9K-<MN9;:.::XE2$?Y!)/*P'EV/-4)\8%K=#O4>1SIVG VU#5D0O
M9+[E6AK=,5G7&:U9&YVP08$R#(XCELNK##EK#%#YF82&+-*%="%R;(A>F_#Z
M#IV?72G4<T<5L+61K47$[6UM)>"2+:D\RO&!^:,K1H[JCN "2VU'^:O\0FH_
M$O3>AHKCX7VMY<ZLVKVT>J-IEA'JFJV^D-;W1DDL;*2"Y,A:[6TBGD@@FN(8
M79HT5.[/#:OI0UM=GJUIU&\*I%TG:/V\:NTUN)@8FK#A+<GY=R))+KD$,%$0
M<W+02XR8L48"$"T)/GR32@0G4N"L\)U/'I,6O:E'H4IFTI9P+1][2KCM1F58
MY7+/)#'/W8X)&9B\*HV]\[CW;X6W/6%YT!TS<]?6_P KU;+8R-J\)@BMI PN
M[A;*2YMH%2*VO)].%I/>V\<<2PW<DT?9AV]I/C=Y])UCL#URN.N;-3[M<W"U
MC2=8"U\]$L6>-N,8T4Y7Y<9V=,#B4@LD+6%+8,^2A<6>6VV/EY3;S..G-<O>
MG=4AU.Q:$2HKQ.ERK/!+#* )(Y%1D?!PKJ4=&#HIS@$&;XB] Z%\2NE[KI?J
M!;SY.>:"ZAGT^:."]L[RU9F@N;>2:*>#<H:2)UF@FC>*612F2K+[?232]5T%
MUVI>MZI4;K36H[YAT\!L)V)?M4A:9);9$],'.P9A<2H<HO\ N(S 7QFFXP01
MK(K:T*4YKU#K=[U#JD^IWS0F:4(BI;JR010QC;'%&KEGP!EB79F+,Q+<X&WP
M]Z#T/X;]+V72W3ZW?R5K)/<23W\L<][=W=T_<GN;F2&.&$NYVHJPPPQ)%'&B
MH-I)EO>=-JVPM47*EW76,CN2KV( 6/F-<1!=? E;$.N3!6C,?(6>UTB'CS(=
M]#4ZP>Y:X4T)<9@F()7,- CO4=.OKO3;VWOK&Y-I=VSEX;A1GML593E=D@=7
M1FC=&1D=6*NI0FN=ZBT#1^J=%U#I_7].CU71]3A$%[82EE6=!(DJ%9(Y(989
M89HXYX)X98IH)HXYH9$E1&$(=$]+QFA.O54UV-IN5TS/1X\<1? )>8J5@(N5
M_=KT(S:KN-,5.\7MLJ-E)(=P*-1*GQ)X84:R&S7XR+8CT+N:[K6H:]?-?:E>
M&\FV"*-M@B6*!&8QQ)$D<4: ;F8[%]3LSLS,S$\3T/T/TS\/]$70>EM(31[
MW$EY/$)IKJ6YO9DC2:ZGNKFXNKB>1DBBB4RRGMQ11Q1I'$B(+2VYIM^K6$=Z
MJ_?(Y,/("DTWTP:\6D4H5P<F!6W9C(^O.M2C#C@;S4T:-&.M.K;,=2RI?.*B
M=XI(Y(Y&ADC=7CE1F1XG1@R2(R>M61@&5E]2D CD5VFYMX+NVN+6ZMXKNVN8
M9;>XM9XXYH+F"9&CE@FBE!BEBEC9HY(Y 4=&*L"I(JM'376.-0:SDZ5^0T?2
M2T7&VS[HH;FO71;(U8[3/24.1[E#L$[EPF JZZ_77LS61G&&@!@(Q14:$TXB
M_JFIWNJW"W%_?W%_*L21+)<22R,B(!Z%[OV5+EGPO!9F9O4Q)X3IGI?I_I.Q
MDT[IS0M-T"REN9;J6VTVUM[6.:XEP#/*( .Y+VTCB#R%F6...)"(XT46ND&C
M'P#6(XMN/D'A"6@3W1<'-!&.,K0,6X%EX?!C8SV4/+%R0Q@A*,M9>:POUIXP
M8R,\CW'C(_7SBNQ'\.#4,Z7U=<=7LV8.P['%O(%ALUFM[;#5)&JKT?.W"QR=
MFGW,$#STO\H)TZ3=;!$6TTH)AM"5$$JSE7))'5\83:0JK]HMD* H\@>PYJ.-
M&3.7W9)/V0O)))]S]:G'D=24XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI6?_;[]
M87P\/WD+=_([8O+5O]U=?L1_42JMQ][:_MC_ $WK0#E6K5?GC\:[8%MKFP=%
MPD'+$  ?:5EF'66B#T(>*=G01G<+98-'8PEU@%EIQY+6"_1^:T2UZ4^7RS_B
M'ONGX]1Z:M-?Z*Z>ZOC2RO[FT.O/K'_D7EG@BG^6CT[4[&(&<00F5Y$DD/:C
M4.%7;7VO_A5^&!ZWT3JS4H>L^J>E)K35;"QD3IPZ*BWL7RDEQ&;IM3TG496,
M+2R"-8GBC =R5+'-;D:+F#K#I'3E@E'EDR<YJO7LQ(D.NO/./G2=2B#2WG'B
M''B'5ND/N+6Z^ZZ\XI65NN+7E2L_1_3]R;W0=$O#&L)N](TVY,2/+(D1GLH9
M3&LD\DL[JF_:KS2R2L #)([DL?DKK#3(]$ZMZHT:&62>'2.HM;TR*>98EFFC
ML-3N;5)95@CB@6218@[K#%%$&)$<:)A1E-XUJ-RKU1IS&K'ZNU%_E =^ZT2)
M-+%M:Y#)U531EUYRUN-%9AFK%G.;1B$7^:\NNNS>/HK12T>N_#ENEEOM0_ZE
M$9_\M'\B;E96M0093=;Q&"O>*=OL&0>!*$/<*Y^3?\1\?Q<DT3IT?"MKX$:E
M<'7AI$EO%JQ&RV_)1A:9DD^1$WS?SZP'EC:&<&W$N-0>MF+?CK]IC%_<K3MV
MQK2G?=+E/S#*K2YOZ&'\]40JM_\ =Q0V7_7E2J]_V"I[W50W_9N1N=+UCY#\
MJZC^2^X-.^<N/DN[OW_+=UNSGN?G,;,;>[^<VX[GKW5[7T8.H1TGTV.K#">I
MAHNG#73!V>V=4^5C^</_ );_ ,KO[V[NFU_\J9=_RWYCMUT>UM65W<50D*-;
M#[2'79=DP.9&JMHEZJ_,1DC'&Q1\/)F0Q Q)<2:&>^DD%QSV7'$LNYQ[C+><
M4(Y#&P90I(P1N4-@@Y!&?<5V)T$B[6+ '.=IQD'C!Q75UBOLU:" @6).>F6H
M]+Z425GF3K#.E>^4^5G)\Q(N/&FJ;4_EEA3[BLLBML#H\FV48QJQW$G &?91
M@?N%; 8 &2<>Y.3^\U][F*S3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*
M4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3
MBE.*4XI3BE.*5ZF#P5&KC4F"*D6QTEN 8(9R:V*M>6T$K%POWTCK<QEM+RF\
M-J7C*<*RK'EQCW]O&:9]O?SBJ%=OOUA?#P_>0MW\CMB\M6_W5U^Q']1*JW'W
MMK^V/]-ZT Y5JU6"7C0[A-U5/=>L"Z=#O:)@B:(S9)V8V%'Q""8>3AWQ:I%L
MT.SU?UV$E;^9!)$J1(X;&RT@.*)]1:VO0.A_A[TSUNNI2Z\EK-+IZ1);QO::
M?<3QI,)&>=GOK:Y*VZL@79$$!?<7<>D'YU^._P#B&^)/P0EZ8M.A8[F.VZAE
MNIM0NFO==M[*>:S>WCBT^"/1M1TX?E!XYFD[MP\Y$)18;=_SA7;76+ZBM;:]
M)77SZDLFCU-]=5E'G2).LJ>@0'%5^1?>0AY\^&RK,<8\ZA#KA SBW$)4K.,=
M%N+:&SN)[2W>*2WM9I;:"2!52!X8':*)X43T)$R*IC5?2J$!> *]]TW4;O6-
M.L-6U"WN;2_U2RM=1O;6]D:6\MKN]@CN;FWNY7 >2YAFE>.>1P&>579ADFND
MDX2%FDLIF(B+EDCY6IA,G'B'I84YA.',LX*:=PWES"$87E'IRK"4X5Y^G'E$
M"1X)'ZCBKN ?(S7O###AL,BB,,BBCMH9'&&:0PPPTWC"4-,LM)2VTVA.,)0A
M"4I3C&,8QC',4KS<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2
MG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<
M4IQ2G%*<4IQ2OS?T9<9CM!2[B&^$OM7)^+'O.C7-U!V%W]WKL%29X=^"/$]_
M,DYK*'IH5>*@FWF%00K6$E@+2\X\YGF'SV&7!$ L8W7CT=TL.0?^XL2#SG/F
MN*7[Y&_^<;R56/A^T%/!]]@&W \9_&K%]N[3W5_M#=0_?U+H-M$;V+NOY'%-
M[5MSJK41^32^"B(O2,T1O%7:<JJR9)]<2J<4U,-M1R$N#+46F&!;;M3X>7F%
M>YZ%]/K7.WGGU<<^W-2SFX[MOE(A^=;M^MN3L?&[T<<<\9YX_&K9_?'B9_L!
MZE_QVV)_2_D&VR_2S_RU_NJ;=>?H[?\ F2?V5XG;CXEK^$8?Z^=1GL-.H?;P
M[O+8+F&WFL^;;R,+U;GT.MY_%#B?):,_BG.,\R!9C.)K@9!!PBC(/D'#<@^X
M\&M6%T^W?#:MM8.NYF;:Z_99<QG#+[,.1[&O+]\>)G^P'J7_ !VV)_2_F-ME
M^EG_ ):_W5MNO/T=O_,D_LI]\>)G^P'J7_';8G]+^-ME^EG_ ):_W4W7GZ.W
M_F2?V4^^/$S_ & ]2_X[;$_I?QMLOTL_\M?[J;KS]';_ ,R3^RGWQXF?[ >I
M?\=MB?TOXVV7Z6?^6O\ =3=>?H[?^9)_93[X\3/]@/4O^.VQ/Z7\;;+]+/\
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M_P".VQ/Z7\;;+]+/_+7^ZFZ\_1V_\R3^RGWQXF?[ >I?\=MB?TOXVV7Z6?\
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M!*DY:6E"V (V,C@F5D&''FE+:&$#%';<>((?<;:9:0IQQ:4ISG&0"2  22<
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M=B=JVOK%TEE-D6P/>VI^Q^WF.UUUCS7@YV=U+HHG,I#9E#,)^0JN[7'M456
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MB*)EJ^5%GBJDS)MV3+AGXY;X*(,@Y48$,8>F,'!</*==W:YGERDDC,K[0R\
M'!R. , CZXSX^E:+;PQX9(U5ER5/.1D$'DG.,<8\ $@51WPI02=\7/L5WZOC
M5;'VCN2:B-;X@JI7W82 J5<I4- MEMQ[QLQ-24D1:%1]9)EB#R,/8+@$/86Z
MDOVQK-]^:6*U7=LC!?+')8L21G  &W+ ?@:KV8[C2W+8WR87"C 4*,8&22<D
M FMI^<=5^G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*
..<4IQ2G%*<4IQ2G%*_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>21
<FILENAME>g723949g26k67.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g26k67.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" %, E(# 1$
M A$! Q$!_\0 '@ !  (" @,!              8'!0@$"0$" PK_Q !.$  !
M! ,   (' @D)!P($!@,$ @,%!@ !!P@3$1(4%5.2T1:3&2$U4E17TM/6"1<B
M(U5SE,74)#%!5G&5LS(X=(>TMA@E)C-#431%8?_$ !T! 0$  @,! 0$
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M^(OYE?7%%DN" \QSXB_F5]<462X(#S'/B+^97UQ19+@@/,<^(OYE?7%%DN"
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M# & , 8 P!@&S/C%_P#<ETW_ .+KO_V?7LXY7]N'S_[,&LV<@& , 8 P!@#
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M9V1LC($92^BF;$CF"/8JP<4].QOJJ</C0ABDD*\L2&(E#7V1G(YR5VJVW'%
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MJ.CK"6@!XI PI$F(6^A>W(Y.M$FXV\'@JU63Q2;6""=/3;UV;#1_.8@P!@#
M/W$9TYL# & , 8 P!@# & , 8 P!@# & , 8 P#K4_E6_P#VK?\ S)I__P!-
M.9L6;^Y^U_@PCP\_PS\T6=@<0P!@# & , 8 P!@# & , 8 P!@# & , 8 P!
M@# & , 8 P!@# -F?&+_ .Y+IO\ \77?_L^O9QRO[</G_P!F#6;.0# & , 8
M P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ?M._G+I']NM_P""D_\
M19U7=Q_:SFUX<^3Z#^<ND?VZW_@I/_18[N/[6->'/D^@_G+I']NM_P""D_\
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M!@# & , 8 P!@# +=YG^3;3_ ']?_P XS7G_ */W?@NQ^*]&3O-<@P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# ,C+?E C_JW_P"%O!7B
M_%^ICL$& , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , UGSL
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MKK>]>G?HUZ=^C7_'T:_'OT?\, \X P!@# & , 8 P!@# & , 8!D9;\H$?\
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MURD340 %'#E)/G8>.D;] P,W-#MBM,$$I-C1Y45L[V!J[]E<-F?3;FD$J^O
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M.=I@A:4<=G=JDRH9\,#:ACBE.-01/5BH[B>9VIYT8 P!@# & , 8 P!@# &
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MMWGM 2'#V]Z<N'0Q>@!V%HGU14*<AML=*L>@@4;:>&5J/4HQ[V5?GRKY4\L
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M_&0HKE70["Q,1'!*"H#BQ.[UVEFT$R$XSV>FUF6H5:Y+:&^?\4FS$U,0FNS
MW4=6)H"8BV#ZFU5.@UI%>BW &'H7)TK7%46RE:UO?#TV P;WB?[Y8JI;[G79
MKGL,QS;@_.>GF KILC,1/0+!-]9[E0CR8XY=I&,AJ':H/E8=AA6QG9&8%:FH
MYYB>*'9)U)M55IFW3=<GR_V"5VKO?>:M=S>,#NL76QO]@#J0=UJ]2ID/+IKY
MG$ NK*AHVNW[IE4I3UE<EEGAQI4A:7%[J@)[B8*;F0=F.Q*'&FRM*O.FQ5NI
MOQV N:,[!TR1\*TKTYYFAP_30V[7$AJE;'4-TTJ4@K[*TJ*.)DX*]6&G1\I.
MC@BE*KN^A&1D/;3MU22LJ&A"9!,HM:E'3*^N''\T!3@OB+Z=(!BT%B6L3/5V
M>@6F$EZRYRBF#],!@:]S^J7-T8GVWK#?#$OQ^[C#2,C<!KT]#&UN1BX^.@VY
MU<B>%E15K14I=>Z.^[?6FST8]^_/WM*$9[;T"7<'\4![=;LEJK'A3I<S5X+<
M%&N04!9;SUFX<PG[;&E$7)N/BPE,!:L5C6U;@@C( 94$3<@X4-,VG+55*;'$
MU_\ 5/\ QY9EVT]^_(MPOI7>+!<^;U"S6 JD+@/$;0(QX\O7+DV6P0MKX_U.
MPN5Z[U7F?5NA0@# DC #&P;DF9&-3HLS F-0CTA6E2DEC17T6,+IB\,J^U3>
M0V X'VJ]=3M3U5FF(@4WE%//KW;E!1[X[9/:-7:3JP L!YQ+VXZ%W"42PW?<
M>YLU]^O]#Y\6@[3'K*.Q:25<W=X4_P [0:8.VRU<<UV/J ;U;LE\>L/CKL35
MEEJVIJ405Q&K3!%, ))&EM+/A1=CM!M19/I8CXG2H^,V)IQ;ZL[FEL5(+JYM
MU!L1.]C[=4;\]R*8N-,-D[.5X>7XWHNJ0N+ HP_9#NZ!3L>N!<LQ0LLELWC(
M4%0R9222_J=O,<Q-ZL'L;8\AC14K1W:R:S<-+^>?^1K^OKE_YHS>9F.F*;<K
ME"2?C:E K:1%'JC-RU0N'!(P,9F,'L#[8,>ZN9?:L<2R8_Y<B!IJ-) :86TY
ME1/PU8;N/G<#8>8[!V6L]!>XM+7>HK/E^G<ZK(O67Z2B+&K$'=N7],OA 3U<
M<LA,25,&3_-$5"H%'R"6-.W"/;D1YN3CV6IG&BIK4V-TKDTOS[O!69_B9[IN
ML*E(RS4NPBU23\1:;79:!6*Q/'KB>1=$W4J[<#^=V+J%>ERN::CA3MW<F@2]
MDM#4TZ"+%*$%WI\NZJOJJ84K58JMV;\:<Z#W[]W%V>)NU;4+X>K/$/MF R,G
MUF=9;<0<Q'RX>_"-WF;":."6L0Q0+[C0KZA"-L$-[2CUO));TI&,.+7A_P!D
M"IH+L_>9(5)%:M%"KU;ANN^'[B$;7B:";,*0!U+A'%KC,S[\GNW D.E5V;Z0
MZ36H]M# ZV(]8$V_)-$LN@Y-+*MSBQRB:IYTOZ@KKK/7.H2]=LL859(N,N-6
MH?BHKSW1X*'*A9<D+E_B7X+2A7QQ&)S8D.F?K4JK=E;8<<;<D14%1ZHX%3L:
MLL:;*ITRK"WT+A3B;Z]=N%RKKW%*76[%$0DIU*]+ILIT&4A&I(6,:B^=W&[.
M*B85<@)&JGK4;4V8F(8.*(!%9..?;&D2A@Q7\4DZNF%]*[^-Q#3_ (KTKIQD
M&Y1HGJ5 K#L<5XO^KR_2)6N+G8*Y%PWBWZS H9@PCK6.U$4&!';;E;'IB8E)
M0.&FZN#&SD:TTL\[*)*]T?Z53"GTJ_;SQ!)*+XH>J6>U\VL5D& JO.[T_P 2
MB=QT-"0-PCH.P]9Y?3K,Y1K^<-=PNDT/HOVOMK;==?*H9E)<IRX$R5?29*F%
M1QPI)YWNM^Q^%,+[Z8[P0&B=[[.GCJ+;6Y2BUVN<I\.?AKZ4[3T4TV1;LI5^
M"GG+)7_>Y%F05!0K,;7TL0S@S1LF.<4T42:0,&Z#(J)NFUN+RO?3W<5JC>56
MN!<T-WCI,E?.<%$7.B"P=]\2_6N(&\G<KVDVR!@.9A]:: EVYW[0*/<GI1?/
M8>R3:"X/W4W#VV+8BO9FV6#[!-57W.Z&M?%*G^,]Y,SE=8Z9>JWW>RU6B.5:
M$E)T;PC5G=DF($R=(8C^B7?Q)1DPM\%N;BQS%Q(U98*K[25B):/,.W(NG"OM
ML#DE1>$3X40+,I?6;%'<@[3:NB3L ](\4G^NQ!]O]Q2$?$'0_/!R94&P3-=B
M2I(UMQF*VQJ<#@G5+.=$)>B11%%,!,1J])?JI=X@A_AW[#TZU]2NO.NB:)=3
M&<QYWT:*>F:W3JI/-N6Z9N$4<A$/3NAW[0]8+;@ 2Z^/:50]N#])Z)1N1'>"
M,38DDJI4OIMI=CBO#:#=#, 9&6_*!'_5O_PMX*\7XOU,=@@P#K#ANP]C(B;H
M#0YNDTH&E4WQ0=1<:?I9=BW,SE$\2G7*O%QKVR;.%L.+G H%!5F=84L]T]]Y
MV&?B$.Z;:SHKFZNK2QSA0(F;T7H-<Z7TGJ$ */8+CTJ]>'SDL"XU U<J5H%6
MOW)8OI1L= G7*ZTNOOMOR(FH2)C)JR0D3(W&8C)HUB9D-LP$A:*GAK/QH]MW
M^@7!4NW]NN\S <WDIRH\LG&V>\2,G>9J/HUJ)EA^13/.XN*A3(*F]-M%-K=@
M0U?2R^BQR+<;(!-5(E^- KHTUYD%*0XI5PNOVUW;J(%:1/6+LS?)BUR-BA^H
M R'B YH]7X2'#E-Q(04CX%3NE;)YJLN16>'&6"2WL6';-!=;(2;*2A0CLS+D
MNCY432V*D5]VR)7M[?:0]^%YG)WQ*=KK-.I<V+<>:W:5ZYQ./ZU#[CZD2Q$<
MZDW^@\9K* G60K4098Z3+!]4D(\ J2-C9[<O5'W69 A)I0<)%"F\*4=+V_JN
M?1/P8)A9^O>("O2MIYS'S<#<K'7>NP%=3*0$!3(3H4_2YSC*NC$B4REW>^UZ
MFV&T0,]KUCT:L#)3E"'D'@X8V=#V<X2A='2ZCNOI5.E[_P 9Y VPXKT,7I7-
M:3:%34?+R\U6@Y&4<#B"ZPIXQH@F)DRTU:3D963A1MS4;)"H&>DI1AMX9YD6
M6DF6T%NX-4;!J;!]1\0UNM54$#Z!28*$Z)VKQ1\K!&3S=R2D:I!\/O'1HFNS
M8YC]L98F+')!T)4?)^WB(A=#2;);,5H\%UR0RHJ.[#5>.-4"J;5XQNNL\G'Z
M/!$Q9$I2>'<_Z3T"(B*9!_9AJQV8JP-K:ME@NO2:R9&0%I;@4CUBO\[%MMRC
MB7RGC797;D3&DVD.%,6UMV94K7SIO+2G&A\Y'L-FYE<+:?"L03\@NS>+](E@
MLS$@>-44.>(KPI49$T<EF6CFU4ZK@7PZW6>/V\(L@&L#H'EH=A!3SMHFE7_P
M](W^"%J$=G[2Q?3^3Q?2^?V YGN/->:(N[%(;=?CX*X<9OO1IM$I!@6CW8Y;
M03*]'^['FGQ8QL5P)PZ&?2\4P[**E:;&Z5>RA:8^%>:1&I[Q*]B:K4A$1T^"
M7>*"QXB2K656J!7'-24-Q[J<WSZMW2P+O_2:=4*G5SA81YVUQD7-R]D/E7'%
MUQN'CA-M$M55W/5I?]R3\VJ^!/\ &WW_ (,L+XA^V3L;-=%"F:9%5>J'^%7V
MBE:J11S\^/W.'Y>7<17K,[86R(Y$5]N2WJJ^)'N/,%,-^^/>P?H%QJJY;7K*
MM<F_7:#@7OME^D>*WSH<W<.:NQMDC^\0\3QB3KAK4O'N\SGYN(#$;F ["F1E
MI>,#@''>B#2(L>&@N2;;B/<WL; \L25;JW;<:U5;_2XJ5Z6=.9E@O$IVPSH<
MF4FO14?01>Z]%XS[-9CN55RN#1M(^U  ]@383>P:Z>5;"G:ZS=RH9/*MAE4(
MY],/&D-L!W&0:JHL:T3JJ[=E*4W8J^_ A9_AA[#T.\RTO6>J%H1:-T.E7X&-
M:K5<%BGXZPDS01\_2KG2+Y>JU;.=R908>JEN3<A[F(RT4].LFZ,9U'2)+%9T
M]IWU][05*9XG^FC]*KB8XP>8H-XOW?J'#$/U"O0M<0GDE'ZS/C$5H\GH3_39
M^<B)_FHL);Y.4H$?1CW)&03"& :^S[TO=54PONKC6]K92GG^0<7_ /$/W:MP
M5*<L-FHDJ?USEO#KD#.?8HJ'A.5R?3^I4'G=@-+&3:7UV&N04;?FI@),H=&O
M+EXCT2$B-$2:F(M1/92C:I7&BV>\ 7[X9W)_[7^*L.RVZ/NTG%>("(C%3D6"
MF+$4V-X=N"Z2&N*:D)(2.D@MJ4Q-LA$-B/3:9 QH&,]I5'"XQ4^FB:^G;XO#
M<#:_,0, 8 P!@# -9\[ # & , 8 P!@# & , 8 P!@# & , 8 P"W>9_DVT_
MW]?_ ,XS7G_H_=^"['XKT9B.M\5Y?W6K[I_5:A'6V#21HP1LM10AT8<E"FTG
M1$M'/ARD47Y:U-+>!,8V^PI8Q&GAW'&E>:[0]F=!=JK#_+=/Z.DZ0LJC[R7#
M,<R7-D34G"IMGM$F.7/D3-5N%Q2ID#BA;@CUH&X7ZWL7V\[6_#W2W\[['Z:M
M6A=(.7W$Z*2I,ZSVNSN)1.SVVQ6J7/L=LDZR4<,%HD3%+F*&;*U)L,,:@?#_
M  F<#\.I$C(<JH@T+-RK&Q#[#(2$I/SSH.W$.[ 9DIHPUX !;C;+CX<;[&.6
MXP.Z6V^ZPTXCJ>RWP^[)=C8YT[0&BH+-:K1!W<VV3IT^UVN*5K*+NH9]IF38
MI,IQ*%QRY/=P3'!!%,4<4$+7HOB!\9?B-\3I=FLW:_M#-MU@L<SO[/HRS6:R
M:.T=!:-5P*TS++89,B"TVB&&*.&7/M7?S),,R9!)BEP3(X8KNM%2JMWAB:[=
M*S7[?7S%-J+@K1"QL_#%*:5Z[2B8R6&+"?4TO^DWMUA6T*_I)]&_QY[.M,#\
MO(Z5R3E)U3 H)O,N>F46*>;)C*652ZV14XTAI3RVB *X[&KAPWFUD/K;='#;
M<0I]Y25:VXO:K5XU=<Z@]X(3FMQBI,R"B*K-1#JI+G,LMN#!4,0US.SV*L&5
M UI\)&B8VHVD>SQPL8ZAR-!-7)N1[>D%N.O+UGGQ6/FF#(3_ #ZA6L*8C;32
M*A9(ZPDA&3X$_6H:8"G#(QAD6-*F!9$(EB3)CQAAQPGS6WW1&&&6F%-MM(2F
M5>8#PE#!$C.:/A546/F(.3 B*$L2*: D:S#L!!RX8-9VUH4B"C1Y..#D!V@E
M1XK<B$,^A&BV&W+?C?X@P&^)\9W7X^I;Y)S'=5B9-<U%5G="JNZ_&3+J-MN2
MT?#;BO=H4FXA2D+/&&;*6A6TJ=WK>]8J\WQ8.+3R^06,^Z5NF1%:*=J*G:+<
M6(ZHZ#B6?:2I20/J:I)<.-"S3+$B;,/3D/&F2+,;*R!R9A@4\]U+QUNJW??C
MS!EX_DO*HF :JD7S/GT;5F)D>QL5N/IE<#@&;"&\T0)/-0X\:W'-S(I###X\
MH@;1S#S+3K3Z5MH5I5XU=<,01^BU*K<?1(!25O?FK=U&Y3-HE[!9U5\"Q7BS
MLUQC3J1HVOQ<'&N)KU&J($>*%$Q+>QH*NH)+]H+V8:0=^RY7;E?F\+VP28"O
M<YM\"%+"U>KR\#9XV2F!EEUD#R92/OX*7IT@D.0CVWO_ -6 %:U8&31T/RK;
MRV)=IW>W&]*M75?'+H#GV&I4:8 GOM76:G*1DO"AQ=G^T,+#G 2==@GCY$".
MGO>0SHYL+#D2,H>&)(>:#'O'GE,MLK*(6LF[J5KLI^ 86"HG)C*Y$;K=*Y\]
M4S(9U<&B(K->]Q/P%D8BBB-1K(H.@MQ<Z-&0CY"&$>S2+4=%K>2ZD,7;:KS=
M08WJ'(H+IL(9%.EJKI4A(1!\K)1\#49E-B:A63AP8:W0UNK]A@K7 -M2)*FH
MR:CB= F:%DHI^/D@A2VB=-_^<LGO!@*KX;N15ZEP-*F:=7.@B5^=L=J#D;]5
M:C.&-V>V3IECGIH 1N #@X!TF3.<T*%6XF'C8L!@&-CA!@@1FD-9YT\&P7#)
MP,'-Z%U,PT3+:!46L'4G'!GZ#6?&FPIRA=%,N^SJ-AY*1B2U,^ILF-/- >VL
M4I]IR X;%/J0S:FAJO71VE2D7.*;8A(QIM4U" 1L5"RZD-C)3N4B(N&B(V+D
M-Z]K  BHT,1UH<$5MI5Y@XI5"HQK9[1E,J9;4H)80)-LJNP[[<B!;2Q9"UA'
MH=#6DP2S'@A&V$8C3C,T6&*3)()>':6A5Y^U@#Z2](I=@K*:7/5"KS=.0*$$
MBIR\!$R590'&>3[M$3 F"/1:18_V=CV)C0NFA/(9\A#?EH]6U:O3=<P820Y%
MR>7B(>ORO,.>2<!7CRI6 A)"E5LV(@Y0XIXXV2AXTF-="C#RS2'S"C F6"""
MGGB'7%O.+6I5YOB#)$<[Y^7; [Z51:<3>8X;0<?<R*Q"/6P$-+3K"10[$X"J
M8%&2R^\SIA@Q#6FGG6])]1Q>MRKPK=D#D,4:DBQY,2-3JL/%FQ49!&1K%>B6
MH\N$A4/-PT.2&V(D=^*B6R2$1D>ZVL0!#[R166DNKTJU>;!2POAFJS?7!.NR
M5BG9N4BK/,7&&C3XBBM+"FYB&GJ^ALVW1U1"O]@@:]$V:<$J=<G[5(14"T8.
MVTP^U#5]N)NM=2GG5^F'C_D%[$UBMFR.Y<RO09<MM4.O<H3$@/R.UUY^1)@%
M[-='63M4&3,2Y$.KS?3&/RLBZ%MAPXE3N-0<AJ$A6!Y(1B(BV1)D@TN8%: $
M;'E2I)/J2),DRAK39Q!Z-:0:\4EUPI/]%]3FOQ8J"/U/F_.Z$E2:-0J72TK9
M4.M-3JT'74K86]HA;"M0X(>E,J?UI]3>_2A3VM.;3M>O6RU;Q;!-,@,C+?E
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M_/N]R<!,M 6+J,?=HKC T[+A6"@==HT5*^(&HVJF6ZJL6&[=+ZY:PKE+R,K
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M_4QV"# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & :SYV &
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MC]U@5>[@N@]['_'U]RQ^ZP*O=P70>]C_ (^ON6/W6!5[N"Z#WL?\?7W+'[K
MJ]W!=#5;.P(, 8 P!@# & , 8 P!@# & , 8 P!@# +=YG^3;3_?U_\ SC->
M?^C]WX+L?BO1D[S7(, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# &
M , 8 P#(RWY0(_ZM_P#A;P5XOQ?J8[!!@# & , 8 P!@# & , 8 P!@# & ,
M 8 P!@# & , 8 P!@# -9\[ # & , 8 P!@# & , 8 P!@# & , 8 P"W>9_
MDVT_W]?_ ,XS7G_H_=^"['XKT9.\UR# & , 8 P!@# & , 8 P!@# & , 8
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MD;"Y0, 8 P!@# & , 8!;O,_R;:?[^O_ .<9KS_T?N_!=C\5Z,G>:Y!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & 9&6_*!'_ %;_ /"W
M@KQ?B_4QV"# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & :S
MYV & =-4)X'.C5CF_/KT'3U6/J]*[)8K=:^+6>^-2?/NC4X^^RI<:D< RQ$4
M6OVB*A2(^?ACVE!#>UMEIG@I*26V/O"CO\719WUKO\_]O?OWP)-U#PR]DLTK
MWVJ@<A@IZ3[IU:J]"J'B/D[14QICD$&$JJNZ@S@7"EW5N0HK<&>#7V::H^.D
M&Y9W_;6A4O,NG#C=BU1W>=_^.)/'A5T]O\;C(]!X3X@R">[4. YBW/U[HWB9
MY[W"*Z#]MJ?' *KL9(T5Z9B=P9TD/.ZL$<NN.O.-O@AQI(B3%A'OEHC@9.WU
M=US<+V;*5],"^_=U/>!&KWX5>RF[[/&UKF8X@SWBZKOB#@)B&E^6,N='H#<8
MV"]18R/M+4O$B2U=DU.V8:-Z1 :I9<DA2=CF*>4X\:]:W>6>]9T\6J#_ %GA
M[I<;H>$WE5GYMSBZA6.+L=0E[QT6W7-N(G[#S^P2<2F;&C0FCO9N8U*I4*M$
M2#D?N6(J]<:F8L Y]\A$T^Z<^*&AK2_.[##RN'^O?NOXU&Y!X6^JQ4MX>J=8
M^-U6H?S'W&Z3]_[N/8JK,/=DA)P6Q NP@L8&IVY'-W9N;'^U#%W'"&#$ 4TV
MHOUF0]RCJO-MJE[>>&&%:<-C\^_#@\3</P9<EG.,<$KU-ME:CJS;FY^_R,Z*
M Y#E+(;E>@6B2K[Y<C"/%"'.:K)D0VQZQ3SH0J68]>F%"[':L*HM_P#E@VIS
M(# & , 8 P!@# & 6[S/\FVG^_K_ /G&:\_]'[OP78_%>C-%/']XY)/PL#UB
MG4*&B9GI5PCR9M)-@02_"UJN,E.1[4@\ (2$_)2$F<R:Q&L^UM"#>[2R#4D)
M\@4C\-^+GQ3G]@H+#H[1-FL]ITWI*3,M*CM:CCLUAL<$;DPSHI,N.5'/G3YL
M,V"1#WD,N#N9D<U1K5EQ_4W\-W\/UD^+\W2VG.T=NMEA[*Z$M,JP.5HV*5+M
MVE=*3)4-ICLT%IG2I\NRV:R6>9(F6J/N(YTWYJ3*D.4^\G2]<?!/_*8WOJW5
M87D/;(JMN.7-U\*IVZN /P[PLZ@=XH:)G(]1A89(<JEA04>8"T&0)(K&:*:,
M'+65'^+^&'QOTKV@T_9>SO:>SV)Q:3BCE:/TC8I45FBEVI013(+/:I+F3)<<
MN?J.7)FRE+CESG!#,AF03'')_4?CW_"EV=['=C[?VU[!6S2D$.@H)=HTSH72
MEHEVV"=H^*;+DS;;H^TJ3)GRI]C<Q3[3(M$4^5.LT,V.3'(F289-I[<[GT6+
MI-AY=79$,PA_JEUDZ1%%#['2+%G1?.KWTA\Z44^\TM(*HJ@R(*-C(?>T<8'M
M;:1O/>:^GTJU][4OR? Y&]]\Y/)Q%BDJ1T'GO02JN+$FR\75NC4-YX$.:-8"
MCRY XNQ"Q44*6MY2@R9,X1DY;2A0EOF+;86H\FO)] 2\3I7.C[@;ST&^TPV_
M1S*R)"DBVB$(MH+#30Y#KQ==:.7+CMM#EB/NJ>#1II@L5YSU6R65+4>-'3.@
M*ULOBEX!68G4T[UB@RX#=ZI_.Y!R NE3D]0UCNLWN$C&II:)MMF,'$4Q*2DJ
MLEU#PL- SQK8Y'NLEI+5>6_![ 2*>[OR>%=ND4Q?J;.7"B5VRV2<H$-;*Z9=
MF1:K&.2DL.JO)DO>(Y(["6DOI*892(HD91:F4/(4HD[KG1TOIF"--^)GE4C2
M +O5K)"W5A^U\AILO#U*QUZ=EZM-=CO56H4&/9& )-]$6Y&2=H;)DQR%H)V-
M&22 VB26-,J:KV[[_!-_@%FPO2N=62RS5,KM^ID];ZWYWVAJT-:(23L4%[,^
MV*3[WA0CGY*-]G*=:&(]L&9\@AUMAWU'5I3N4>0)M@# & , 8 P!@# & , 8
M P!@# & , 8 P!@$1[3T2%Y+3+MT>P(>>BJE$+E'QA]I20<_IM@<"-'4O^K0
M1)2#XH##COH:;=)0MW>FTJWKBGSH;/)F3HZN&7"XFEB\DM[=%DJWW'6Z:TI9
M]":,M^E;2HHI-BDQSHH(*:\R*JAERH&[E%-FQ02X6_I3B3BN3.B]O^5+[MJV
M:EG*U05U79?I544Q\DAW4=Z_H\E%A]XJ,U)>3^+W@H587M/]=[G\C_9,\Q_/
MK5WFMW<GNZ_VZ15I_P#.M=;?2E?T[#Y[7QA[1_.]^[+HUV/O/_X5*FI]U7^E
M6KO7,[[5_P#=<#EZ_P!7<:O_ !G>-S6_0W4:#4NA5_3R(BW0@<R*P3ZOM(>R
M$>@D KU-J;V5'EH?!)VTI;6WQW-M+6WM*M^GDS89\J7.@_IF0J)5Q5<4]\+J
MGO3/H;1.DK/IC1MBTI9=92+;9Y<^"&+^N!Q+ZY4=+M>5&HI<=&X=:%ZK:HW2
M<SXG$A,7&T0?)NA6[E//)>Q0MPZ;!.U+V)HBF'%1EY.K56.L8ENMT-2)*/E
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M(<Z:D*O )D)Y-@K3QD@RP*)$@QQ+3$2\\.*PQLXDU2FQ+"F#;SW@WWS # &
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MDDZSX?>V2T-Q^J4#=;9J5=X_(\[MD3'7$OFL@)9BX&%A@IM5L@JA-6:6I@K
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M_OZ__G&:\_\ 1^[\%V/Q7HR=YKD& , 8 P!@# & , 8 P!@# & , 8 P!@#
M& , 8 P!@# & , 8!D9;\H$?]6__  MX*\7XOU,=@@P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@&L^=@!@# & , 8 P!@# & , 8 P!@#
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M?^C]WX+L?BO1DY\MSX:_E5],UR#RW/AK^57TP!Y;GPU_*KZ8 \MSX:_E5],
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M?N?M8%7F^+'O.1_3BOOW/VL"KS?%CWG(_IQ7W[G[6!5YOBQ[SD?TXK[]S]K
MJ\WQ8]YR/Z<5]^Y^U@5>;XL>\Y'].*^_<_:P*O-\6/><C^G%??N?M8%7F^+'
MO.1_3BOOW/VL"KS?%CWG(_IQ7W[G[6!5YOBQ[SD?TXK[]S]K J\WQ8]YR/Z<
M5]^Y^U@5>;XL>\Y'].*^_<_:P*O-\6/><C^G%??N?M8%7F^+'O.1_3BOOW/V
ML"KS?%CWG(_IQ7W[G[6!5YOBQ[SD?TXK[]S]K J\WQ8]YR/Z<5]^Y^U@5>;X
ML>\Y'].*^_<_:P*O-\6/><C^G%??N?M8%7F^+'O.1_3BOOW/VL"KS?%CWG(_
MIQ7W[G[6!5YOBS5G.P(, 8 P!@# & , 8 P!@# & , 8 P!@# +=YG^3;3_?
MU_\ SC->?^C]WX+L?BO1D[S7(, 8 P!@# & , 8 P!@# & , 8 P!@# & ,
M8 P!@# & , 8 P#(RWY0(_ZM_P#A;P5XOQ?J8[!!@# & , 8 P!@# & , 8
MP!@# & , 8 P!@# & , 8 P!@# -9\[ # & , 8 P!@# & , 8 P!@# & ,
M8 P"W>9_DVT_W]?_ ,XS7G_H_=^"['XKT9.\UR# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8 P!@# & , R,M^4"/^K?\ X6\%>+\7ZF.P08 P!@#
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M (6\%>+\7ZF.P08 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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MH_E6^K_:S1KG.J%NE;+_ !U]"YW5AU'>9Z?4U9]R6P=R6F_Z/M6ZS['O?_\
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MD'[MXB>9^':NAS_0I S3LJ\^-!5^%&;/L$Z^*EM9>H\-XD,9+ :'F=EFG&!
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M ]1?YJOEW], >HO\U7R[^F 6]@V!@# & , 8 P!@# & , 8 P"D^R^(OC/
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M , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8
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M\98.J22X<>N<YE+E:8B%:8TI $'8S3:EMILWXU>_=3':*NKVY*[)=:D>H'B
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M08='(;T\,XR^TK:TZ=86AUM6VW%H<3I;>U)WM#J5H7KT_P!%S2TJ]"M;U@!
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MX;*[:A-77TPNNOJE[N]#M4S R& , 8 P!@# & , 8 P!@# & , 8 P!@# &
M, 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P
M!@# *NZGQ/DO;8@:#ZSSZKWR-!><(CF[!&,E$Q;[R4)?>BI%/ER,6Z0AM""'
M(\L91#:$-O;6A.DZZ73?9S07:2SP6;3NBK%I23*B<<F&UR89D4F.))112)MT
MV3%$DE&Y4<#C22BJDD>I[*]M^UO8BUS;=V2[0Z4T#:;1!#+M,6C[3'*E6J7
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MQ,5'[WL",CP=[<*>WL,(8;>WCEM.&N[VRVC^L+<8964O_P!1"V6E.[6IM&]
M"(F*,#;CBXR/*CV=L;9!("&?#:V+M*AMMBNMJ8;V/M*=L;2C7E;2G;?J[UK
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M#Z^PA:0VWH,73;(JP64>SL^HT$[II+@;:?4]"!7$L,)6.G6FEZ9:TI&]-H]
M'&:A(9@06/9B(QD %Y) 0+0 K8@;Z%+6AX49#6F1WD+<<6EQE"%I4XM6E:VI
M6]@?3W7&>T!E^[@/:XYA8T>5[(/[0",ZC3;@X;WE^8*PXVE*%M,*0VM"=)4G
M>M:U@'/P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & , 8 P!@# & ,
48 P!@# & , 8 P!@# & , 8!_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>22
<FILENAME>g723949g26v56.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g26v56.jpg
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M 0$! 0$! 0'_P  1" #> ET# 1$  A$! Q$!_\0 '@ !  (" P$! 0
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M<J_%;U <QK$E!W2F\%M72J\S/] E;525=ROVJ"$QN5@N8G<]KX8!:7)&O/\
M0+A6I6^H;) @X,=T)PEW(LAF12[!E:0(V$"MV:[O OO.? [%(3Q)YK!O#B-@
MBX98F=<N67M&V^(38,>*[F!89  (..AJOEWVF-MH$MV(CXF!A_+WS%H+$=S6
M:'::*I?".1=0LGU9GH.0H0C]E"C7:B+NK/"SD+-RLRXS-3IJ&V%01<C;QE2(
M_$P6[9<>#2N@W A^,Y[W! &0 ?&L"XD# OX>L7"#8?XL2/P04Y'=[O()/).>
M*R.0^D<Z=5:.79;AQ6B+F;-P'G'DMRR)J'49.=CS*)T#J]!YGJK7V6-I,3N!
MN$;OH,3)CGPH<Y7I=3$L**\UN(><?CZI&6"K*V%E>&0M& =RH[[D&XY4[",$
MAAQ[ZEZVX4L8URT:2H%?/=9T3:YV@!AO!R,@\^ZKL>.O:KKU&5[?3>CU&LU.
M[<0Z</0I;5+LDI:*O-"2]'J=]AI2.D)JOUB4:>3&VMF/D!B8IM/Q8*R6%Z:)
MT.-K31J@B9&9ED3<-RA6!#%2" S#Q7(Y\#6Q%(SF5755:-PIVDLIRJL""0I\
M&P>/$9^%:M/%:_\ EU8/&MWR$FICR%FI?[@G3+K$V[H?6.$&\,F;%%PLXF-*
M9Y]6*R9UD%8OPJC(=F596,F7C6]2_P#R<3]N],L E[("$#M44JD<HE +#(W,
M>S/QQY>'-:4+3F$RDRD]D[!GDC[,G!_B*N\?#/F.:B5KMWEO4ZRFQWOJ5H/@
M:7X(\C[VXU5.M$,V.?F^V7^?B&+)*'3W'3(]^>TVVV%NND!E5ZFQD:%\@/FC
M"BWD3[*W=MJ(H+73Q=Y,@"- < "0''GD$%B3G XJ EG RSMA;5)>Z_),C$9)
M,9YQY>RN.,YS6T.-\P+C)7?J)RZERB XAR_IW4>-R=EN?7]U/H!-OY70WKI,
M3S-9.JKT*_5BW!WPT! 3IUF$KC!-Z<CGHL9V.S3]77:@W2&5T20!(]R;7?:!
MG<#N'O(V[N[G/-;G;MN<XC$:.\>6DVN61=Q.-N,? $G:"V/*H&J/TD'1+ U/
MUE_D523T,V]^,U(YR4J<Z75^?2R_)QB\DP,Q82;]RVKW<6"K0_/Y=]$S%5$P
M.]:/A=5I+#)[9>[&M$&")&V[)F?A&8=CMR!M<KD[AD%NY@[O"JENW.5V+OW0
MJG+JA[;=@G<@; VGD#O9&,9K.NA^>EZY&/'1M[YC0CK=;Z+:0N:B<]Z?]<J[
M>/(6J]@A>3KY"%,L0 A KLFFY4ZT;;+CV;!!#_6^'EHGXJKNEE16U63)1WVJ
MRE]Z;2L+1E^T(R?O64<X/<(/>XFURR<.B996V;7W!I5<)V><>>X'PR.\",BM
MF@NR=C#;-TPDS;#.RTBJ<6,DGW:??Z'6ZE#JF-.^WII3B$N*;]G:TI5O>M:5
M;E??%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%
M*8I3%*8I3%*8I5-/.#I5UYWS3GP5(M+O/B.I]\X_QRQ=,'%C"C.;U#H%C^76
M"V1VYP4Z"#E$CLHA(N2F@R8^-D)H8U;7OF&%IV+9%=WW#=LBDD5,GOL@R%."
M"1YD#D@5KW+LB+M;9OD2,OQW%8X+#/ /D"<@$^%50["?>N;A0/':?YH]%O!<
MUYE^.?,K"6IRE*[3R&H=1A)9V;J<W<QH-V,GMV+;*++6B9FEC&PHVM1SRYAA
MA*T7Q[6/:-;HN+>9P.]V<C(>&"DY&/9;#<GD8JB3<@$:W#L3<0H3W>TC5QRI
M8#!SXC*Y XYJ*[OVOR%@)^_^--0Z_P!%ZB;5O+?E?-:=;XL_FM:[!T"GV[@L
M_P!5N_,4=(,J0_-86Q<^FHT<^0LDE! R1<*R[5UNM2AXC&K%CB(69HT3=;R.
MRD.T:,LH17V;MY##P )&2&\ :@\DH+0K([[9T12"@D=6B+LF\KL!4\Y(R0,9
MS6P3QNZET[H'A;RCI@LG5^A=8EJ)#[E9"WEOT6NRUJCY?Y#:FYD^)@CM!$1Q
M(4L(X?%0'RV9E@4DQXHD9(LJ8U)HT6YD3!1 QQM[Y"XRN 2,Y&#@G(S@\BMJ
M)W:W1P0[E1RW<!;.#G XQSX#!(X\:POZ28F^5'Q>Z%V'G'6NC\OM?)Z\5,Q;
M-'/KXL19"9::K<;IJW"S5;FRCQXQCXA<6B+.AG&7CBU$NEI4TAF5GM:=8WC1
MUD.#N!)7 )[N" ,^>0?Q5&[W"%Y$D=&C4D;2 "3CVL@YQY8(\35QN=4PJ@50
M"L&WF\=&(">-=7;.BGPTG:S]&&/%I9/,@(&MQCC(*7=!A)9B!UMALLH>6^ZE
M;R]=VWL6"JF<=U 0HP/($L>?$\^-;"+L4+N9_'O.06/SD #CRXK.,C4J\^Q'
M>_(U?>9L&,Z3W:"?F?I!+=P^AV*SS'(D^)R:A6;F&3)<PL$:3#2'2F+A)4M,
MS&U1G3L/N=EW(P>MRS\B&:AOE1%%V0S'$<6JR,%$GK&YEP'!!";0Q!/C@ Y&
M*XOM9>U(#R@FZ:-2QC[ *K<H1C?NVY"^&3C!J?NL?2'=4"<[C6Z#4:'[N,Y'
MY66WD_2HZ0Z#(10\MXU?#C39$@9:.60U%NQ_N2"B]QU!F[; 0-ICV*?9YK:2
M29%BI+1/L9=F^V0*Z80'$WAC;(649\W525[RCRJQ[QQV@55^US,CC>0#%XYW
M(JM\R%@K#:QKGPOF3U>FSL[#6"%%N'4+1!>"5(JT-(WW0'( >@^1$?U!;]B>
M-'YT'8JU%_#U?4E:7$C6)^>E6XF#KL5";]"#<&WC8#!VHK73,0F9"D79G&-^
M">]A>0 ,LQ/ED7#J<$;G86ZJ-V$W2!N<[<@'&6\<G &*OAXT]NF>V5F^JM58
MBZI=N4=:NG&+N#79PBRU,VS4K46^1,5*<-BH.0-@Y(&:CWDM242#(Q<CJ0AC
M6ED1RWWM::,1E-K%EDC612PVMALC##) ((/@2",$>-;,,AD#[@ T<C1M@Y4L
MN#E3P<'(\>0<@\BK&935U,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE,4J&NJ>._">X%01O8.1\_Z2;65.;@B[A6(N;*C6GG$/$!L$&C
MN.[C2G6FG2XMU;D<6XVVLD5U2$[U8DLL>>SD9,^.UB,_D_75;PQ28,D:.1X%
ME!Q\.?+X>%?EF\=>#7.WU:_6OD'.Y^YTEB-%JMCDZI$%2<(+"D;+@QA'UB[_
M +&@3%*-@6'4NLPAJE&12!"5;=V6:559%D<*V=RAC@YX.?G'!]_G1HHF96:-
M2RXVDJ,C!R,?,>1[CX5VXO%>2A2(<N)SNICRD?9;U<0CVH<1!0MJZ:.4)T*P
M,O:1[:)6XC'&,6 O6_>R39+R2%+TO>8[23!&]L%54C/!5,% ?@N!CW5GLTX.
MT9#,P^#/G>?G;)S\]8*7XC>,)Y5:-.X-RTPJGQ]5B*P^53X@A<+$4APAZI0X
M6W1EZ1$0+Y+A$?%JTL!HE+!&QU/BC.,S[>8 @2N Q8MWCR6]HGXGS-0,$)()
MB0E=H'=' 7V0/@/(>%9^%QOE4;86;8!S^JB64:R6ZX,3C$0*W),VF^Q@<-=)
M]LI*-.IE+/% !1\T7K?O3A!6&7E*0VG6H=HY&"[8PJXR<84Y4?,"21[C4Q&@
M.0JYW,V<<[F&&/XQP?@![JCTGQ#\7S':\^5P;E[SM4@X:MUM:ZE%[W"PE=/<
ME*\ !KW&M,(@3WR"85U.OB(I91>@'AT%DI=GZQ-S]E?O$D]X\DC!_*/'WX&?
M 5'L(3C[$G=  [HX Y 'S>7N\JRJ,\?.(0UL-O<7RVE 7"1MLI?#;"/!AMR+
M]SFX.2K<S9E/:1Z:F9>"F9>-DS4)2\>/)G_%*=66^M<3+*5VEVV[0N,G&T$$
M+\P(! K(BB#%@B[BQ8G SN(P6^<C@GXGWUC\!XH>--5BK9!5OA?,(.'O1$43
M;HV+J$0&'.J@I=N?@V#6&1D(^ AIMI$M%1C6FHZ.D-**#%9>6M:LF>9BI:5R
M5SM)8DC(P<9\R."?&L""%0P$: -@L !@X.1GYCR!X9Y\ZEZ%I]6KDI:9N!@(
MN(E[O+#3MOD@!&AS+',AQ$? BR<N^VG2S3!X6*C8QI][:EH""&8UO2&DZU66
M8A022%&%!/ !).![N235@506( !8@L0/$@8!/O. !\PJ ZIX4>)%%F/K!3O'
M7DM:F]QLW#[E(>FQ(1NXJR0YU?GH_P!^RPE?PLO"24A%GL^OLDA&$,.:VAQ6
MMVM<SL,-+(1D'!8XR""#^(@$?$ U4MO IRL48.",A0#@C!&<>8)!]]2$=P+B
MDG'DQ,AR^E&1IE"K7+2@2(()P8CG5-/>E*K2W6E-[2NNU^1(?-BHS>OAPR'7
M'6D)4K>\B)9 <AV!W%\@G.]AAFS]\1P34NRC^\7E0AX'L+R%^8>0K@G>-W 9
M._RW4Y+C?.9#H<]&'P\W;CJG#ES$K'RL,NN2C,@^^*XDIR3KKBZ](%/(66;
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MKT+H\)?^<UVKT&"^1[Y]<(BV_.RKC\:)M<JA^)4 (5'?*R6G$O.FM ^NR!6
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MY"528A(NX)*U.5B+F;1=F*M#2LO(*E'I*!L)I=9#@!XZ8D]F.V,J*RNO+JC
MAN[D,?'^,0J[B ,8( ).0->2X[-V5D. I93N7O8V^7\4$MC).>"2 ,$SIQ/L
M877JF_,%1&JA9HBZ=!YW9JB3,"2[L;;.9VZ:IUC9C)0=D-,Y$N&0CTC%2C0
M;A,42,\6" 5\0(Q5)&8V SN!5'#8(RKJ&&1Y'!Y&?'S-61R"1<XVD,Z%2<X9
M&*G!\QD9!QR/*IGRNK*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8
MI3%*8I3%*8I3%*8I3%*8I58;_P"(G'.HV6R6:]LW.PKLD3.1WR(R_6K=8KAE
MD@HBM3-CIT(B22-5;&5#P,6PW(0^QF@BF")4 467DY4XZY;B1 H7:-I!SL7)
M"DD*QQRN2>#X^!X  I:"-R2VXYSQO; ) !91GNM@#D?.!DDF(+;PWFO)>H^#
MJ:K7V'IYGR.Z[LN\SVFYSH$P[?/'#RKOES<F+D:TN;,;LMQ*<L$D#HEJ+4>V
M)L<%AD %H>U97DCNMQX[*+NCA!MEA5<*.!A>!YX^<U6T:1R6P4<]K*2QY8EX
M9F8EO'EN3Y>'' J_N:E;5,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IB
ME,4IBE,4IBE==,2H<%$RDW([*U'P\<;*';"CY"6-T''C.ED[$BXH4V4DBM,L
MK]P!&AEGF.^P.&,^0XVTO(&2 /$G R0/'XG@?.>*P3@$GP R< GP^ Y/S#FJ
MYU/R\XQ='N-CPAEQ61W867(H"">?W$=LI4 E7SL<XS<.H!A<2\V^U)DC%F1H
M#;"Y$PYF'6S).VM!(O:9V_8B _>7S\,#.>?+PR>/'BJEGC;L\%OLN=G=;R\<
M\>7GY>?AS5G<IJZF*4Q2F*4Q2F*4Q2JZ^1G;I'B\!!/00//S;!:)(F,BU],Z
M.SSJK _##H==+*>!@K?<)Y[WKXHH<+4J?,%FF$CB$%1:RPW2+8HQ(3DL ,9V
M)O;GYRJCYV88\<'FJI9#&!@*2>!O;8H^)(#,?@ I)^%<;E=N\ECY:(8ZKSWC
M)U0L 3A\?T3BO49Z?!CVEQ[DA'+EZO=J55BBHN5TED6/FJO8+$ZX2:(Z3"!Q
MFR9(7+K#@]F\F1XK(@&><<%6;D>)#!?@2>*(TI(WI'M(R&C<L/#/(95X/D5)
M\?#'-63RFK:8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%
M*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*J]WO
M\KGA/^L?<?\ ="\HLOB^U7/T2?S\-42_;;;Z5_YB:K0Y15],4IBE,4IBE,4I
MBE,4IBE,4IBE,4IBE,4IBE,4IBE,4J!)^@]VD)N4-@?((.O0I1K[\9!KY#6Y
MA<4$XO:F 52A,XP0?L=&]-[*>9:<>]/;4A.]^F6AX@ #%D^9[1AGXX XJHI*
M22)<#R'9J<?#)/-=1]S7R,_=- _^!]4_I#F=\/R'_$;^RL;)OE_^&O\ ;3[F
MOD9^Z:!_\#ZI_2'&^'Y#_B-_939-\O\ \-?[:^;O,/(A]IQE[R6C7F7FUM.M
M.\,J3C3K3B=H<;<;78-I6VM.]I6A6MI4G>];UO6]ZQOB^1_XC?V4V2_+?\-?
M[:X*..]U;6,XWY#5]MP-PET1Q' :6A8KICJWRW1EIG-*8<*>=<>)6UM*GW7%
MN.[4M:M[SVD7R)_.OY>'Y*QV<ORPX\/L2<5V7W-?(S]TT#_X'U3^D.8WP_(?
M\1O[*SLF^7_X:_VT^YKY&?NF@?\ P/JG](<;X?D/^(W]E-DWR_\ PU_MJ>XP
MMI.FX4F9"E)^-CH]<OIK8HYBU/-;:3)OQ3+SBX]B2?')='1O6V-;2XTPXYIE
M6]5'WXP"3CW?-GSQ5H/ED$@#/O\ GQY9KM\Q6:8I3%*8I58_,$Y=:\=NN7V)
M"B%W"G<\M9-3E)&IBW$N.,D@4!$C1<04,2T45+(]R&T(8G<*^;H!V>0N+%?V
MBZW&9HU.=K.NX!MH.#YGRQXY\<9QS5-QQ%(P W*C;25#8SQP"#X_D]_%81X:
M2O43X2WB=(,\@WV8K=7#K(7>..\3Y!N+!0)*-OATX#B[K@,F TAD)J13,:1\
MK]S&LQ6O<DE>D[D("I3LN<[NRDEDR<CEC* 0?=CQYS4;<OAMYE.,8[6../ Y
MX41\$>_/AQBK:6F"<L]=F*\U/3]85,!.@[GJL6-'V*,;?]$NOP\@4%(- ';:
M]MIHU(JR1-N;(#<',;8(:UP<$' ./(^!^?!&?F_+Q5[#<",E<^:\$?,>:TV
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M=!QD?&2 @+K^S5R5HTJKQQ(X[;[D>=9TJK8D@D4B?UN(;,UED04RH'!*EAN
M!)(S[E[Q^(7DCPYJN8L(G*$!@IP20 #[\MW1\"W&?'BJ>_1V]2ZAU"&Z:3>K
MJ1:Z_!EUF,JHUDZ#QCH5^!*T;=-2TI83N+RLS%1\9.P3-*3'BS1:#";-%7<^
M)$#KA,2.C8NT1"FU-I.XMA9$7&%P ) #D'=G ]DJ#R#6O:.[A]S;@" N6C9@
M<MDGLR0 1MQDYW!B.[@#9'FG6Y3%*8I59?-7\SCRQ_5K[E_-C9\NM_NB#Z:+
M]M:IN/N>?Z&7]AJFCG7Y/J)_ VL?R(#E;^VWX3?K-6)["_@K^H5F61J5,4IB
ME,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4K%;S<(?GU-L]XGW=M0U4@Y*=D-I
MWKWKC$<*X3L8=.__ $A9:D)%#93ZK?*>99;2I;B4[5ACM!/N&:CWQ_I\Q5.=
M"'6MK3=]OLG)=(Z#]F]*:MEP=3($16_:_$S6(WY94PTZ]$(!@ADHU[.M8J*
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M'\XWJO\ D3X!_MUY+98?M2?22_LPU6/MK_1Q?M35-F5U93%*8I3%*K]Y6$S
MGC=VHBOW<7G$PUSVP[ NYTF=!B5UW8:DJ-(L$6*=)5MM3>UC*LP 9)=;]_\
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M@K^H5F61J5,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE41\US^P7"-KG"^
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MH,CY&%/@=H\5)X 'Z_.MCE>C9*(APXZ7L)]JD1]/Z)GY0.' ./VZ2\\UM\2
MCHF)9^&9<;#;^$CQ]+:';<>TX2MYYS4)!.0-H]P)./RDFML @8)W'WD 9_(
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M+L0$\WQHZFP]L)*ER3Y>+K-EY67/>X*,,2/(V4J4C4-2FS23XK>%2O# +LP
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M5?3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*K?9/,'Q=I\_,5:T]XYE
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MH/\ ZPA_O5RO_89Z8?\ ]M^KO_4]U_=J>Z)T"D]/K0=QY[:(:XU60=+8!GX
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M%NT%9ZE8+&Q)<SAHN-6$=3X-##D>_"RI*A6$2"G&0(V6;)87I*3I25!=9>6
MF<G#F,J@12&"X<D^T?'(]WB1SY ?,""0,Y=@RDY0 8VC&,'\F?QGYS2'B_\
MTJOFE_D)\>O]2=S9D^X;?Z67_G6NGW;/]#'^LU;B0B?'^3Z)=X"5 BM6\>K2
M4U<$'$R@4.Q#66*;@[!)^KA;%?!F"X&0"%L$L"V--IB9@'9QNAY!&U^%7FG>
MAR_ZTZJT?4+/3QU)!T_?:IU*EW-?VNF1:9KNGQZ3K5_E[B+1K74KC2+RUM]9
MU&U2#55T[4[0W=UV-XI;U>VO/2/:=-:#J5G<WGUEDU>UL-%:WBM)[V2^TJ[;
M4--M>[#)J-Q90ZA;SRZ;9W#2V#7EE<"W@[2V8+E[URXX_/5CWEJJ3TO"P=FF
M*V8B=&6(!"QWP4)9B4R#1>XM*1M.LBDMF/[?2@8UUIOV8\]UCL<O4WHRFUC0
M-_4'3DNIZ9I.O:IH5RNK0/;VFE67JNE:].M['<&P581)%;SI<S&8)!=21IML
MKR2'A8]$ZWCT[50FD:REE?:AI-CJD!T^59KF_N>WO])B-L\/K;-*4>6)H(Q&
M6EMT=LW-LLF4#6GGS1(KP=CIS9EQV,:"Z-+PB";3OU&A1"Q5M$:=F]^TD.)&
M?9V5]J1@&E^NFFLY^#J#HU)[:2VUOIE+GJ7L+JTD@U+2EGZ@.8-,MKFV:.82
M:KRMMI\$T1GY6"TC;(CCKB9=(ZD>*9)M,UMH-$[6"X26ROVBTCB6^FAF5XBE
MAP9[R6-Q%P9;AQR[U&#-2\<8^)L+J'*"S"23Z:[,$/6L=R.CGXLIZP-0$:01
M,K8JJXHX=V<'B()R)^6F":E&!F'PT/M=!BZ<]"-EIVLR(_1\6EWTJZ-J,TO4
M,#V5E-87$FM1Z/833:FT73S:?=Q/J\.FZ0^G>I7-N-0B@BEMDFC[8^L^D^YO
M--5EZB>_M8SJ5E&FD2+<W4=W$FFOJ-U%'8K)K"W<$JZ?+>:@M[ZU!.;.262.
M=HW^HM=X&&U)0#HM9#9)^:<^(1/3&]+LV[D)7[?*@,FR\FX59C9E,C!G/2.W
MS)5PC326BM;:3EL&B^A^W2]T>6#0;:.?ZX=&3)J^I'=KQZGM]&ZEU&SBNM2O
MWGUZZU,7NE7<EZ9;K4&F"".<;!F$NI>D6=K748Y=5G>+U3J2)M.LN-*&A3:C
MHMG<O!96BQ:5!8&UO[=+<1P6:Q[R\1W&LLHL=RN;(7>Z() G&LIEJ>_9(YO:
MSG=Q$NX-*A&EN_V263N2"V\[(&;>*DF]LG),*$+9?>[#TE9>C[593U=TC;Z1
M=W,:ZCTU+KEDI>ZD^MNHO!J-M=7,GV>YG-]:F22]N3+<7R&*[%S<6]Q%-)P_
M4%SU=81CI[J&;4+>!FL]:CTNY(6!/7;)9;.>"%/L4$0M;C8EM!LAM6WVY@AF
MA>-)/SOU=3IBE,4IBE,4IBE5>[W^5SPG_6/N/^Z%Y19?%]JN?HD_GX:HE^VV
MWTK_ ,Q-5H<HJ^F*4Q2JX>3/E!0/%.I5*Y=$AKU-QERZ'6^:Q@]"KB;)(L3E
MG0<X$6>,X?'):C6D1S^G/AWB90LA8X43&2)CZ&,NA@>=F5"H*H7.\[1@8\\'
MGGSP/>15,TRP*K.&(9@@VC)RWAGD<<?/Y $U8_*:NIBE,4IBE,4IBE,4IBE,
M4IBE,4IBE>(SS>_.^\D?\L-X_EHG/S>])7^/_5_^O]1_I#5^WOH/_@@]&W^Q
MVA_T&*JFN"D+6I29(QI*M^NFT-Q^T(U_>3MT)QS>O_;6K?[^<);:KI\,$44O
M3&C7DB+M:YN+GJ))ICD]^1;37;:W#'PQ#!$O [N<D]KO- U:YNIKB'K?J;3H
M97+)96=GT:]K;+@#LX7U#I.^O&08SFXNYY,D]_& .GB7!9!E]<7/F$M-%$)>
M4ED#7LONN*?=]/>1B-J0I3NU-K1K;2D[_K:E:UO.Z=7P:MT]>6$75GH]T73;
MJYTG3VLDDO>H6[33[2VCL+7)M>J942:**V2.>&4I<QN,W$:,XSYKZ.KKIWK#
M3=6GZ ]+W4^M:?8]0:O'J<L&G]&KV.L7][-JU^ +[H&"22WFGOI)K6X@62QF
MB8"TFDCC.W(6D*;;2A;JWU:]?5US325J]=[WKVM,MM-Z]-;TG7LMI^S6O7U5
MZ[WYO=S17%Q)-#:6]A$^W;:6KW4D$6U%4]F][<W=T=[*9&[6XDP[L$VQA47V
M:PMI[.TAMKG4+O59H]^^_OX[".[N-TCNIE33++3K%>S5EA3L+.',<:&3M)3)
M*_KX^B8_,=YG_P!O=&_V]L&?>'H)_@UT;_2M7_K2ZK\COJM?X<NI_P#0.F_Z
M@T^MDF>P5\V4Q2O(G]/3^>+0_P!76G?SB=7SZ8]#G^*]Y_KRZ_H.FU^8/U:/
M\*FB?[!Z5_7W4U:2\]8KY%IBE,4KTO?U/5_<WRQ_Q[B7^K]7SP3TV?;.F_P-
M6_:TZOT ^H<^U>DWZ3H[]GJBO2%GA5??%,4JE/G78[O1^.DWZI1UNDHRHCV0
MRXHJ79HCC)(T#)UF2A$'/2LS0;Z),/A'R(I,.(\-%"QLRT#-2,A\O!)97LVH
M5I K%06P%W1&7D,#C =,<#D\G&0/&M>Y++'N4,0N=VV01\$8\2K \XQG !Y)
MQFHY\"Y2RLV/O=+NOUR3;H%[F-BE4VSR!J7D%H@>X1=IU'R(D]3N;<_!ABB&
MZ^\)(@R*Y>7+;CHXI38$5J))F)W6TB)EV[3O VQ-%RI&1AG?.,\$8')')SB%
ML6W2JV[<-A.Z19.&#8(*H@&<<YR? \#&=CF:=;=,4IBE5E\U?S./+']6ON7\
MV-GRZW^Z(/IHOVUJFX^YY_H9?V&J:.=?D^HG\#:Q_(@.5O[;?A-^LU8GL+^"
MOZA699&I4Q2F*4Q2M2WTM7ASV7RJXQ&[X?;;2JS5N2CD37(=6PJ,HO3(-R48
M=9*+AS#QZXS;*@>M,U&2Y*&'"XM$E'D.DE#P*!?/O2#TWJ6OZ:ATNXN.W@=.
MUT[UADM;Z(R AFB9Q"+BW8]JDC %HPZ$LPB ^T/J+O3ET+Z'>O+K_M!T71QI
M.JVMTUAUL=&BN^H>D]06SD1XH+V"WEU1]&UNV4V%W90F18;QK6YB2*&34FFO
M%XK<9LO!.&4;FUUZ/:^K7.)BV';7<[7/R\\X7-O#L))CZ_N8?>=BJE"H9:B:
MY$L(&;;CQ&S"F-RILB0_VG0=-GTG2K6RN;VXU"YC0&XN;B:28M*0-R0]JQ,=
MO$ (X8QM 10S#M'=C\^^F'KK2?2/Z0NH>JM Z6T?HW0KV[D31]!T;3K+3D@T
M^.61HKG4A8QHEYK5^SO>:I>R-*SW,[00R"SM[6*.P^<Q7F-<"2E8R&#=D)B1
M B@&->T^=)&#@ALZ^W?JZ24XTRWKTUO?JM>M?9O,$A1EB />2 /TU)59CA59
MCXX4$G'OP*J_T;S.X51X"S2,);@.DSM?B3I!NN<_V9:=$OBLK<2/(3]> F(.
MO">TG^S9.7*9'!82\ZI#[K:1G*GGCC4LS!5&!O?,<668*,RL.S +$ <DDG:H
M+$ R6,DXSDX)*1E9)L $G["K=IG .<A0H[SE5!844)\RI_OH Y=MY;?:[QW;
M>V3*O2[[RR!9Z)(LJ4B1CK3T?H=_Y=(@5$?>DC/5^KP>WYO:R6I6>^$2J,7Y
MSU;Z4^GNC;IK+53$)DB222:77.E=)LXVD!*Q22Z]U!I<JR[=CE! XV2H59\U
MZ9T7Z*[SK?3QJD74>D:3;-<RVZ6-SIG6>J:M*L03=<);=-=*ZU"ULSEXD=KN
M)W>*4-$F *F>+\V+.%'!0',_%1TB-C!F@(>%A^BU^0 $&83IM@,1GC]4ZG'#
M--IUI*6V'-M)UK?L[W]GKYR?JD-&N24T3I^]U^7PCBT2:]ZB,C\]Q9.D=&ZE
MMP3CQ,^WXUZ0OU/VBVBAM9])=IID8Y=Y.F;K30BXSNV=7:KTC*1\.S5O^[XX
M[)'D%Y[6?>OJEXB4R$0[O\!RW="L;>V4[_ZS[4]4.<N*]G7V[0G25*]/37HK
M>M;ROI8]+FJ$#0?0?KA#^S)K%W#HT2@^<@ZB?INY7&>5]6W<'N@X!'T<>@'2
MP?KSZ9=5O&3VET;I[3Y=Y]T;Z;JW4B#/ADL5'CDBH"C=?2L3O?;.JTE/T[G)
M=?%<< YH%S"0A8QGX<+3(M%-Z3J3!79]E_$JDBYN1DE)2Z9O3.Q6XM@3KJ]0
M_5#W'4MZEQTIK=K ;6-[C3M'DZ3^M]M;E(MAT;6M=NGTFZU(R$]K!+>2SJQG
M[2-(8[=AWZY3ZDZPZ!TP:68=9ZABU"54N>II>J[>^NI.TFWRZ];=-"VN5TL0
MB,6T=C;6RDI!W^V>[:6>6.8</6\T9Y"TGRAZ,>.XAUR0[^S;NH4X=Y._;5MN
MK<V?F>1AL*=3[>MMU(5OTUZ^B$>WK.?77ND86$GI!Z.]+RR)@R7/66@:OU3H
MT3*<G,?1<FO=-11[N0_J<*$=XA1D#H<G47701H?1SK_HIZ>MY%94MO1]/H_2
MFM2H1@;M4ZICL.L)I AVD-JTKD\=]@IJV?/^E^.XH+%:YW:>85T,;>D#U6'>
M@JBX*KT2GV&ZPI$22,K6M)3M.H]O:?32=ZUZ:UGI'3OI-]$]ZJ6'3_6'1]NR
MD*NDI?Z?H]Y&QQW?K/=&RO(V\ 0;52#A2 >*\CZBZ3])+SR:GU)HW56HRR9:
M35KR*_UA)1DG<VJJ;R&0')(/K+ \D9\:F0F3C0QD&F2 (H;JV6VRR2V&!G'"
M%:0.A#[KB6EK?6I*&4I7M3JE:2C2M[UK/09[^QM8$NKF\M+>VD:-$N)[B&*!
MWF(6%4FD=8V:5B%C4,2Y("@DUTF*UNIY6@AMKB:=5=FABADDE58@6D9HT4N%
MC4%G)&$ ); %<[-NM>F*4Q2F*4Q2F*4Q2F*4Q2M7_%_^E5\TO\A/CU_J3N;L
MGW#;_2R_\ZTT^[9_H8_UFK16;Q?K]E=L<F];K4-8K69?53DIHUXD F(OD(]7
M2H5FND$JAQ68V)&J[ AP["#WUU"%4:^0A#C6_G?7?0'HVNR:W?R=1]0P:UU%
M<]7-JU^+J6>SFT[J[2I=%N-*BT6:=M-MXK'3H- BMKJ&);V4]-:6;J:9%>.O
M9-*]+.I:6NEVJ:-I$VF:-#TZ-/M# D5Q%>].Z@FJ17[ZG'$+Z:2[O9=6DGMY
M)&MHUUJ^6WCB)1AV,SX\!'2\W,Q-MDJ^5.JM6B-!1P>_<,6<RC2*Q@GFG12@
MDC%T4/2GQ'V#'19*1;&) *4.<QOZIZ%[6[U+5-4T[J*^T:XU9NH>W]5LK<]E
M%KUUTG>O#:R1R6\]L(+GI*V!FMYH;I[:^O8X)[.X,-W%JV/I+GM[*PL;S1K7
M48=/&D=D9[F8&2328.H+999T=)H9S+#U#.>SFCD@6:UM6EBN(1+;R1T_XSV"
M,G:L'7YD4RJLR52D[3)R\CIJ:)W5>J6OI+0X(&J[(E,K5JV2,:T:%:XY9;RV
M")!A.@7?FO29O05K-AJW3]MHVIP7/3\5]TY?=07VI7H35)_\'O2#U%US'#:V
M@T2]N(G(ZBO+&.ZM>H;)KF1XIKR)1:R?7#LT?I4TZ[T_5Y]2L98=7DM=:M-(
MM;*V+6,0UCI#1^EFDN+@ZI;0NJG1K:Z:"?1[I88UDBMI"9U]4SF$\9X**<A7
M2K(?**@&X2.CT.Q,.&.J"K-%OM%@0S!0V&F"Y0<7H,I(GSBT)?D# HYM(P@P
M^F\[9I7H)TG3FTII]<O+\Z,FE65DKZ=IEM"=)T'I+J_I+1[6ZM[6&.&XOH;?
MK*_O;S52JRWES:V4:PVT$(0=?O\ TJ:A>+?I%I=O:#4GO[JY9+R^FE&H:MU#
MT[U#J,\$L\C/#:R3=-VEM;V )CMH9[IC+-+(7KAN>+T3IB-;#N<]'D1TA%EH
MD0V&A)-+,=2^;4QP<4X,@5]O1@W-(LX@8Q4C!%/FOIDX*2^#C' ]5_0%IO96
M*6W4^KV<UE>:?<K>VL4=O?K%9=+]#],/#;W=M-!+&+F'H6PNIH+EKW29Y;J9
M;_2;[U:P>VO7TLWG:733Z'IUS%<VUY";6>1YK0R76N=4:XLLMO/'-&Q@EZJN
M[>*: 6VH0Q01FTU"U[>[6><:'3FZ+#&08\@N0$>LEIGQ%.BLBNB-VBP2%B>C
MW%,*VDO09DF4TR4I+3BQM,MK;UMKVE>L=(],ITEI=SI,-X][;2:YU!K%LTEO
M%!);IU!K-[KDMFYB.VX%M=:A<1Q7!6-V@$2,@,>YN@]0ZVW4%]!J$ELMM-'I
M>D:;,$F>5)FTC3;;2X[E1( 83/!:0O)$"ZK+VC!COP,TSM%<%3%*8I3%*8I3
M%*J]WO\ *YX3_K'W'_="\HLOB^U7/T2?S\-42_;;;Z5_YB:K0Y15]87T&]0_
M-JI(W&>9D"(N+6"V0U%LL$&J4><-'L^Z:)*#95I+Y3:G/:(1[+>EJ3I:M:0J
M2J6(4>)]_P !FL$X&:I;UOS9Y3]S2[/#T'J=U+"KYTF#48)YNL2UCD(I'S*/
MAPY^ LOSF,6<:*PPX1'-%E;96XVB/DO>; )OC@;>O?1<L 6/(4'@D@C!P#YX
M'Q'C54D@$;G:SD*2%4D%B.0 0<Y./+YL'PJEMF\P/&%7&:A;K5!=DXS>BS^3
M7*VT24[!?3I^O4X?K%.:O["1U]&C9V5C2*PB:CM%[K$<20@Y Y 48:XMD?86
M&;M&53'(OV1%<1KM9MC;.=A4'.#[1QX@GQK6:2(1*[!XV^QLR&1]RKVBALC=
MG&,@\9^ /%993O.#ADEV#DI'*N,]HM?&K359FTE=N*Z=?E"5JPQ)$T&+7R:%
M/VLZ-E-+,BF 2T34J _[^70L:),:B3=KPUO((Y.TDC616"]EL7+ XY# #'!S
MP#X>(R*DLJ-)'V<;O$RENVWOM4@D8*L?>,<XY/AP:V#5GR[YC:[%"5F-B[FW
M(3\H#$!.&1<0T*@D\AL9E9+C4^^ZAE+CB=N*;9=6E&M[2VO?HG>H864$DK@<
M^?\ 96V'!.,']']M6FRJI4Q2F*5C-RN=2YW5YJ[7NQPU1J-<#5(3MCL$@-%P
M\4&E:&O?F'%N-L-:<>=:'93M7O'R7F1V$./NMMJDJL[!5!9CP !DG\519E12
MS$*HY))P!^.N56;-7;G7X:V5*<BK+6;%&B3$#/P9PTG$3$4<TE\.0CCQ''1B
MQ"65I<:>9<4A2=_9OU]=9AE*DJP*L#@@C!!]Q%95@P#*0RD9!!R"/>#7>;WZ
M?;O[-:^W>]_M9BLU_*5)6E*T*2I"DZ4E2=Z4E25:]4J2K7KK:=ZWK>MZWZ;U
M]NL4K^L4IBE,4KQ&>;WYWWDC_EAO'\M$Y^;WI*_Q_P"K_P#7^H_TAJ_;WT'_
M ,$'HV_V.T/^@Q55K.D5ZG7%$!# 0XV$*P*AUQ3SB&&TMI6ZK6M*6K2=:UM6
M]:UK][6M:UZ:UK6<MJ^O:UK\UO<:WJE]JL]K:QV=O+?W,MR\-K$6,<,;2LQ5
M S,Y\V=F=RSL6/7^GNE.F>DK>[M.F-!TK0+6^OI]2O+?2;*"QBN;^X"B6ZE2
M!$5Y65$C!(PD4:11A8T51RLXFNP5Z]/HF/S'>9_]O=&_V]L&??'H)_@UT;_2
MM7_K2ZK\@OJM?X<NI_\ 0.F_Z@T^MDF>P5\V4Q2O(G]/3^>+0_U=:=_.)U?/
MICT.?XKWG^O+K^@Z;7Y@_5H_PJ:)_L'I7]?=35I+SUBOD6F*4Q2O2]_4]7]S
M?+'_ ![B7^K]7SP3TV?;.F_P-6_:TZOT ^H<^U>DWZ3H[]GJBO2%GA5??%,4
MJ!_)N7FHKA'4458:JRENDJ588ZLU^X)KQ,389 J.>:>B=Q%K.C:]/DO@K*^$
M@ILP>&EBM, 2[S,:02XFV$ RINW;0REBN<@9\<J"1\XY'B.:KF)$;XVEBIP&
MP03[L' /P!X)X/%4T^C%9L0%0Z;$N\_CZ'20I>"57M.<OY5R.U3UB67;AK)+
M3M4Y2V%%/ $5T&@%1TO(Q$8\N9+M4-%))@(.+?WL7NTLAW;F(.>_)(H'=( :
M3GAB^0"1C:3R36O9@A7&T*N1CN(C$][)81X![NSG YR!P!6T/-*MRF*57?R&
M\D:MXYP\)*6"LW"XE3B+?(,P=)'@'I4:M\]ILS?[W9R?K)8*W'JCJW5X,LE0
M8QY$U*GD1T7#QAQ1GHU=#"TQ(#*N-HRV<$NP55&U6.2Q')  &22*JEF6( E6
M;.XX7&<(I=CR1X*#\2< #)K&_,:7C)/PJ\E9$,X=P*R>.'5!X%];B6$RI5IY
MU-!5P,/3^VU.FS9TB #&!IU\28:8,(PTLAYMM6(2$GB+D*%FCW$^6'&<_-@U
MB<;H)@O.Z&0#X[D('Y20*F7G,]![YCSZ2U,Q6XXBE5AT<_4B'L)]O4*%K;C)
M7OO<.HUO6];6AQ2=;UO7K]F\J=UW,=RX+''(]]6H#L7@^ROE\!7UD>M\IA_:
M^;=-Y[%^Q_;?,;I6PO9_]KXF2:]/^_TR.]/OE_E#^VLX(\1BL%D/*CQMC-[2
M3W/EKBM?9M %T@Y5?KK]K2(LPQ>U?^KI.U?M>F8WK_WC\0CL/Q$*0?Q&G'WR
M?,9$!_(6S74_?=^/B_\ \%>BIC>_[7ZO4CH-D]O[/7^M[@:K(Z7_ /IWO61[
M5/<_YJ3R\?XN./GK./BOOX93^HG^VOY^^EI!/]Q*+WFRI_ZKD-P;J?NE:W_:
MJ][*5J,;2E7[2G%(U_?WK,=JWE#(?F:#_G,/TXK.%^4'YN<8/N),6/TU#O;O
M,ZT\ZI>K)5/'+L1C^YB/CW3+[5G:K7A1BM/[4ZXL(R6FEE/.--"!LNQ@0NW2
M=+=.TZVP";CM)7X6-H3X[Y@CKQY!8YMQ8_$J  3DD8,6*(-QS*..ZFY#SYEG
MB( \O9/) XK.Q^B^6UWB(R0IO#N><Z:E(X*09,ZUT20E2V4G#-$(255J9 MG
MA.LI<UIT0Z4'.;7K;)8H9"'&4Z5W=:E&"ECI?K4Q'<DN+VWL[#/_ /).GK=Z
M@/EV>FS'W@5N6T-H^'NKSU>/^,D5O+<W8'_=A86UJY'F&OXA[B:QB0XIY?WC
MVDW#REBJ.$[Z[<B>34%D-"/:U^$@>?DRP[*UK6O5*'/F6]Z^Q?L>W]NNJWEM
MZ3-0RMKJ71O3$9X+'3]9ZPN0/#=%*U[T9;12'@@S65XB'@QRC)//VTW1=IWK
MBTZDUMO':MUIG3D&?';(AM.IYW0>![*ZMG8?QTKI0/H^N?%G-R_0>C]-Z3,H
M5[:C[1(Q$NI;N]^JG$N62*LLB.K>_3:=BR3"D;UI25>UK2M<$?1OU/?,6UST
MO==S@_\ Z;I^VZ5Z5M0,Y*B2PZ?GU;;GP+:LTHSS(U<K_AEH5JH73/1YTLA'
MA-K5QU!U!/D# ;L[S5XM.#?!=.6/QQ& 2*FG7B;Q=R#(K\A%VF8!?%>$TF7O
M]V-;&0\WMOWH4<N=3#!O,[WIQA3$8A+3B&]Z1[*-)S4OO0-Z/]7L[JTU\=6=
M1M=P2P2774'776&K3)VJ,O:P0W6M/8031%NTA>.R C=5(7"A:V+7TK=6Z=<0
M7&D?X/Z*MO*DJ6^C]*=.:?$Q1@VR1X-,6ZDCD VR*]R2ZE@3SFLKYMX^<DY5
M"BPU7IT.XL9QUY4Y,Q\=*V,MUYS;FUE3#X>B%);U[+;##/N1AVT)2RRC>U;5
MS'17H>]'G0>G0V.B].6%Q/')+/+K6KVMIJ>O7<\SEVENM5GM_6'V\)''&8H8
MD4".)26+<=U-Z1>K^J[R2ZU+6;N&)D2*/3=.GN+'2;>*--@2#3X9NQ7=RTCL
M'DD9B7=A@"9TI2A.DI3I*4ZTE*4ZUI*=:UZ:UK6O36M:U]FM:^S6L]- "@*H
M"J      !X  < #R KI))))))).23R23XDGS)K]S-8IBE,4K'IZI52TL_#V>
MLU^QL>S['N)V&CI=KV=_]7W<@,0CV?WO3TSAM7Z<Z>Z@C['7M!T;6XL;>RU?
M2['4H]ISD;+R"9<<GC&.37):?K.KZ0_:Z5JNI:9)G/::??75D^??OMI8FS\<
MU6+JGA9R+HD.+&00CG-G!Y9F3<<J37NHPM"6GV7AWJZX^B%;<4V0M0YPPK!0
MSGKKVGAW'QG?!?2#]2YZ-^M=,M[#2;9^AY(=1BOW?IR/L[&X58YHI(9-%>5=
M*1V29S#=P6\5Q ^1ND@>:"3UCI#TZ]:=,WLUWJ$R]4I+9O:JFLOONH6+1O'*
MFIK&U^RJT:B6WEFDAF7R258Y4S\3E_4JD**)1>W21T?'CLCAPO4JG!W ;W0[
M:6FQ]S=>W2;&AKV$)1ITD^1=1K7K_7%;WO?<;;H'T@=.6\%MTEZ5;Z[L[.&*
M&UTKK_IW2NI;<1PHL<<!U71?\%=;6/8JH))[R]D0#.';)/6YNK>DM9FEFZ@Z
M"M(+FYEDDGONDM8U#1)=TKEVD%AJ7U^TLON8L4BMK5&/&5 &/O\ 6WO->^RQ
M<HKEU&1^$N2YE=F13E-ZU^%OZL7T2!;0Y]GM:98M9VU>ND)4M7V[M_PC]+VC
M<:UZ.]#ZI@7E[[H/JJ*WNR@]H_6'J^VT=%<#)$<745T6X12S<U7]9O1YJ0SI
MG6&IZ%,W"VO5>@R36X8^ ^NW3LNHL5\B\FCVX'M,%' BRF>:E&LMQN=3G*=?
M*;]47U#.&G5V5L+_ ,2P4L(P6<C:C'3CM<)9);=2RHE\H A#+N]GLO:;'=\_
MZ8^JDZ3USJ;J?IW5NF>L.F/\')C ]U=Z)J.LR]O%<-:W-OJMCTW9:M)HD\<Z
M.(FGEN+.9(Y";R*4)#)V_7/03U!I>AZ%K.GZWT[KGUZC$JP6^IV>FQ]E)$)X
M)M/NM:N=/35(GB9"XBCAN8VD0"V=-TBS"'Y&\*,=TQOJE.CB%?9H>>EFJV1K
M?KZ>BF+!J,=2KU^SV5(TKU^ST]<]+MO3=Z)+F3L3Z0>F;*;Y'6-0CT.8'W&'
M6182 YXP5!SQC-=)F]&'I!A3M!TAKES'\IIUD^J1D>\2:;ZTA&.<AB,<YQ61
M2G8N40T*[8I#HU+:A&7&6ER+5CBC!_>D*]AAI&PR2%NN.;]=I;:2M>TI6OT]
MA"U)YJ_])GH\TS2Y-:O.M^EH]+B:*-[V/7-/N8>TF8+%&GJL\S2R.3E4C5VV
MAGQL5F'&6G1/6%]?)IEMTQKKW[K(ZVKZ9=PR;(AND=NWBC5%48RSE1N*KG<R
M@YX!( 2H0<E&&BR$?("L&@FA$-$B&!E-(?&*%(94MI\<AEQ#K+S:E-N-K2M"
MMI5K>=OL[RTU"UMKZQN;>\LKVWANK2[M94GM[JVN(UE@N+>:-FCEAFB99(Y$
M9D=&#*2"#77;FVN+.>:UNX)K:YMII+>XMYXWBF@GA<QRPRQN%>.2-U9'1@&5
M@00"#7,S9JFL;#N-2D;#)5("S0)MIAAVRI:N"RP)$W&C.^Z]A\Z+:?48,UOW
M['JMYE"4_$#^UO7OV?;X.UZFZ=O=:ONG+/7=(NNH-+A2XU'1+?4;2;5;&"39
MLEN[".5KF",]K#WI8E [:'..VCW<I/HFLVNFVNLW.E:C!I%](T5EJ<UE<1V%
MU*F[=';W;QB"5QV<G=1R3V<F,]F^WD3MGK5788)LMA@ZZ,2[M@8B=E@(E@A]
M*-N;98=/(';==TWK:]MMJ4O2-;5O7IK>\YT*S>R"WS G]5<465?:(7YR!^NM
M9' )N&L'TH_F?)P$O&3D:[PSQ_;;D(@\62!<<9$>;=0@L)UYA:VEZVAQ*7-J
M0O6TJUK>O3-V4$65N""#VLG!&#^FM.,AKV<J01V,?(((\3[JMKOLMR:O<]4C
M(F&#T3/B1= 9V'HM<[%#7FNU*SS9,K&V\Y.G8(>4-D"84V"KIJ$ML;:=-2-(
M):^>#Z3NI8NK=6Z=NM/TRV]8UBWT_HZ$VHN7U;3X.K-%Z<UW59]1L>I+L!]*
MBO[J]GTNZTG1;I$CB,<ET(+Q8_9/\!]#?I[3M9@O+Z?LM.FN^I)!/V*Z?>2]
M/ZEK.DV$5G=:+;G;J$EI;VT=_!J&IP%G?>D!DMR^*6/R'OL%#'F$UFK!2T//
M=17)1RB)25&5 <S A9!R$#/:>C-NV>:3-(98E-C;C1G!2%(ACF])WOKFM^FC
MK#2-+O+J;0NG[74-,UCK]KZR:>_U" Z/T+9Z7>/I5K=QRV/::]JBZFL,5^83
M86\D$K+IMV@4GF=+]&G3NHWUM!%JNKSV=]I_2*VMR(K6SE&I=57-];+?SV[I
M=A-)L#8L\EIVHNI5EC#7UNV0)DO-FO\ $=!YS7:\;3V8.[%2P16IJNS4C+!.
MP,*?/FO#F VR(#4@X45L$9IR.4H(A2S'736]I#3Z=U9KO6&F]8]$Z+HMWTU%
MI/5-QJ-I<#5-$U2]U&UDTC2[W6;F6&YM>HM-MF2[M[9+2".2Q+6LQ:YDDND(
MMAT?I_2NG+WIOJ?4]2M];?4-!AL[B+U'4[&ULYTU&_MM-@22"XT:]F#6\T[7
M$KK= 3Q 0HENP,QP]_R8KWN(54?5++*%SL/6Y@($=Z#8<2U98WJ$J.R0\9*,
M#M. B\JFEG?UU7IHZ/T+HE:GFV^M2^G;1NRTMK/IW7;^YU?3-$U.UM(9-)A<
M1ZY9=?7\,<TMSJ$,,;VMOZ/=4>Z[[=V[LO5Q.[2HG-Q^BO4NTOA<ZQI5I#I]
M]JEC/<2)J$B%]*NND[222)(+.25UN)NK[!;?N#[GN3,8E",WR1Y.03H#A+-)
MMRSFA2YE<0M^KLE)JX5'@.A$3RBG; F,TI->LL6E,2DY<BN16\/[K0PSYK=:
M^GG2)+1YH^ENI&NXX+G4VTUI= BN%T"TZ3T?K2?5S/)K(L,KHVN6 73ENVO6
MO6EA,:P0RW23;T4:BERL3Z[HJP/-#8B\6/5I(3J]QU!J7346G")---U@ZEI5
MV3>&W%L+4)*',LL=NW9F>0,0NI72Q@0\H"F&;M053+E@72P+3-UF+/.?3MB%
M<*,B(QI8X:77YY4&I_XI;0ZM+8<7K?N?3'IS].]4ZW9Z9?VBZ6G4%IT[<ZC:
M2W-GK^K:%87EW*IBTMY[G3K!&AMA)-K#:4TOK#QP-OAD9=2W]'%X-:T'2[B]
MM)S?OI$^L0V<Z0W.D6&JW=M;QGM+]88+R[99)RD6G"_"=DKR B15KI(GO$["
MU^)E+[7)$Q^7K]ON;JH.K[J;4)4J/$5F4G3R ;%=9PN8UO5C;3&/QCR')!QI
M8_RX?:-D+XG3_2[JVE:-IVH=7Z)?74VHZ-U+U1(=*T#_  <32NG.D]-T*_U>
M\FL]:ZIU:YU,$:T@L);"57O&C:+U*'89FW[ST>6%_J5Y:=.ZG;01V>I:)H2+
MJ&K_ %Y>_P!:Z@O=6M-.MHKC3-!T^&Q.=+8W:7<96V5Q)ZS)N$8Y 7D]7RRH
M*/51[\Q(RIRQSQ%1#3BX8/YC6XQJ6<4V1OYC'N.VF.=4]')>TRR+*H7_ &8(
M.(;?:^GK1KFXTFR;I3K"&]U"Z:&\MSIB.=,MO7=$L(]1=DF/KMD\FOV4C26:
MR=G%!J"N/6;>&WNJKCT4:E!#J%R-?Z<DM;2!9;>87KJ+Z8VNJW3V:AHAZM<J
MFCW,82Y,>]YK-E^P32306:SW>O*J8I3%*CGKG38'C7-K?T^S#21T-3XE<D1'
M0S([\O*D./,A1L1%-&% A*D9>3*#C0MFG!!()*:688*,EU]N<:&1U08!8XR?
M >9)QDX R> 34'<1HSD$A1G \3[@/ 9)XY('OJJ$QU:,[':_"ZT@0LS6#8OR
MZ[-1+/5[ J+=F*W<.?>-GEQ3K1#EDP<C+0QS8\O#DN 2,7)&!2,:\&:RXGW^
MVF[PAC2Y4D',$3!AG!5Y8&4C(!\#R" 0<BJ"XD>V8 KB>52IQD,D,ZL#@D>(
MX()!&#5]<U:VJKAY9_D(N'^,UG_:B'RR+[8OX_V347]D_B_6*TT2<8#, OQL
MDQHD(G3>GV-N.M:7IIU#R/PV5MNI]EUM"OP5I]?9]-^J=[UO<!QR*I(SP:B"
M3\<N*S5@9L\O0HV3F&(Q40A\XN6*'4 IY3^FW0'I!8#SB'''/=$.C+(;0XMM
M#ND;TG5HGE5=JN0,YXP#GY\9_3BJC!$S;V0%@,9.3Q\V<'\8S6807+Z#6-@?
M5^M P[<6K2HY@!PL<0/TVI6M,!H(T*A/M+4KV-,^QM2M[VGUWO>0+LV=Q)SX
MD^)_'XU-41<!5"@> ' 'XO"K%\5_*[S/^'%:_E87*I/8;YJL3VA^/]1K>5FE
M5U,4KHK22^'6;$8*ZIDD6"ER1WD>FEM/L1Y#K+J-[UO7M-N)2M/KK>O76OLS
MB.H)YK70=;N;>1HI[?2-2GAE7VHYHK.:2.1<Y&Y'56''B*Y#2(HY]5TR&5!)
M%-J%E%*C>R\<ES&CH?@RD@_ UYI^F=CZCV*BV+FO2[Q.VVCVL5D.>K\D^UH0
M]D4T:2$VI8[+!#3PDB$&<*^P\T\.6,P^TM*VT[U^,MG]4AZ<+&ZM[N'TBZXT
MMO*DJ)<"RN8'*'.R:WGM)(9XG]F2*5&1U)5@0:_2>Y]"WHNN[>:VEZ-TM8YX
MVC9H3=02J&&-T<T5PDD4B^*.C*RL 0<BJ6*\>@Q"WC*[T3H%;<32VZ3&-QDB
M PS%QS"DJ']R@4 -6T)6C1#Z6UCF%'.E23LA\P*>)W[)IGU<OI1M(+&"_P!%
MZ7U,P:U]<KV=DU>WN+ZQ;<TNF*WUSGCM@7=S#.(IHH$$,"V;0Q;&\TOOJ5NA
M+B:ZEL]3UZP$NE^HVL*OI\T-K=+@1WY'J43SD*JB2(R1R3.9)6N1+)N7^ON$
M2I&V6I3LO4) +=-*J1X:IAM"#_C6GV"#G/>MDL[TIHA6DM%#FFZ6T.I<JYIE
M*<Y"Y^KM](;P72VG2O3%M<2=0)J=I-++JUREMI,;1N-%EA6\MFN'<Q[9KZ.:
MUC>.254TZ-F61-2#ZE'HY);=KC7]>GA31WL;B)$T^%IM0<.IU..0V\PA"!\Q
MVKQW#JZ1EKQU4JUP^0]<[#Q+F]4Y72.JW0>JTT!V.AF"SQR7F!GSBI!;27%B
M?@#MD&/(#%1I+ 0FF QTH88;3KQ_J;ZJ#TS=1:[J.LP=77G3T-],LD6C:&1#
MI=A''#'"D-K'<BYGY6(2322SN\MP\LIV[]B^CZ%Z"O1KHNDV6F2]/6^L26D3
M))J6J9DO[MWD>5I)V@,$7!<I&D<2+'"L<8SMW'TNTHPF0IM2/->608=68$PL
MAS>MN/DDQ0CS[SF]:UK:W75K6K>M:U[2M_9K/U_Z5N9[WICIR\NI6GNKO0='
MN;F9\;YIY]/MY9I7P -TDCL[8 &2>*_.S788K;7-9MX$6*"WU74888U]F.**
M[F2-%SGNHBA1\!639SU<53%*\1GF]^=]Y(_Y8;Q_+1.?F]Z2O\?^K_\ 7^H_
MTAJ_;WT'_P $'HV_V.T/^@Q55K.D5ZG3%*8I7KT^B8_,=YG_ -O=&_V]L&??
M'H)_@UT;_2M7_K2ZK\@OJM?X<NI_] Z;_J#3ZV29[!7S93%*\B?T]/YXM#_5
MUIW\XG5\^F/0Y_BO>?Z\NOZ#IM?F#]6C_"IHG^P>E?U]U-6DO/6*^1:8I3%*
M]+W]3U?W-\L?\>XE_J_5\\$]-GVSIO\  U;]K3J_0#ZAS[5Z3?I.COV>J*](
M6>%5]\4Q2M:?TG7.V>D\FHT,GQ;M'D_*CWG94,!6+;*597.C-PI[2KI)LQT7
M-LV0%+2U1NZ_)Q!D>:Z4CWON5(2ZG<LWV2,>V$(V\DJ&WC/LCD$'SR"#\:T[
MQ-Z*.Q,Q#9 #%=O![QP#N'E@C%8_]%YRRZ\MI_48^[4J2I1DE,5A\ &3\;N7
M\'?T .Q/I:!W8.<E))ZPJ,T^EMR?M4'!R47M_2&&R=2I/P^;UU=D*MNP&R1,
M\O/'.UQ]CS[E)!_%SBS1D$FY2I)7 ,21\<^:</CWD C\=;3,TJW:8I5?/(+Q
MPJ'D7#0L59K#<JH_!IM@3$W1C8,*7(KM_J$O0[U5RE6*OV:/^4VBK39@)1(T
M>-.QI+84I 3$3)!LE:MBF:$DA5;.TX<$C*,&4]UE.0P]^#X$$55+$LH )9<;
MAE<9(=2K#D'@J3X8(."#D5"7E5X;\OZ'S+J-HJ7,!Y;N,?RF5!YD8',2()9=
MDJ-7=1SZN;;*F18+X LZ.BX,OXU R7(]][WD@&]M)[&5D9]L4DC+$9%9R "1
MEN\PRI.<$^_YJC)$NUW1 9>S(7RR0.ZOB!C( \J[:G^!?C,/3*J!9.2@GS@U
M?B6IDR0G+#N2?E?@F522RB(V:&&4]\:I_6_A4-C)]-)'0EK2-:JX4G'(R<$@
M$GGC.1[OA4Q&A RH!P,^/CCGS_\ KRKG$?1[>&Y?K\5PV!)]?Q_$3MR>]?\
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M;N;;G.-QQXFNS^\I\4?T$<__ (J7_P ?*_6)OE&K8]7A^36GWE/BC^@CG_\
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MDRN]FD5""$=GVY4$+P&![N>,$>[PXJ)@CPVQ1&S @NBKNPQRWB".]YY!]_B
M:YP7BGX\LTSEM$EN246W0G&JU$U3G[ETK$'9I.%B8@>/90A)\E'NN..GO18,
ME+_@I9DY8=N2*864VTXC';R[G82,ID)9]K%02<^0/QP/<./"L]A%M13&K",
M)N ) 'AR1^,^\\^-?WV+QEY-WNU\WLO5J\'<@N9C7@:,IT_&0<U39KZ]@PH)
M[]@B)B)D%E$1?R$,F%="* V*4IYQ_P"*2IM#:.:2)76,[=^W+ D,-I)&""/'
M)SD'\5)(4E9&<!@@8;2 5.[&<@CRP,5E#W!N(D7&L]">Y#S5R]4N-!AZC;E4
MFN?6&LQ<6.X)$Q\'*ZCM&1@D0*\^+$,B.M(BQGR& -#M$/(7CM9=K)VC[6.6
M7<<,3XDC/.?/W^=9[*+<K]FFY1A6VC*@> !QQCR]WE70,^+GC:/$7& 'X-R-
MB$Z%\'J[Q+'/ZPS'VE$?+;GX]J9%;C4LFLQ\\I4X PZC;(4RMR5&0T>XLA6>
MWFRI[63*9VG>V5R-IQSQD<'WCBL=C#AAV4>']H;1AL'//'///SU(L_SF@6MJ
M+9L]*JUA9A(Z;B(9J:@HV2;BHJRP;]9L,='I,&>T&%.5TDB"EAF-(9D(E]Z/
M*0Z*XMK< [KG:S#)!.">2IW GYFY'QYJ91&QN53@$#(' 8;2!\Z\'X<5C$[P
M7B-GBIB"L7(^<3</8(NIPDW&RE-@#0Y2(H23$T>/,9( 6AX6G:D3_JLVK7I
M;,)5%?"J><VJ0EE!!$C@@L00Q&"_M$<\;L#/O\ZB8HV!#1J00H(*@Y"9V@_@
MY./=GBN#(>./C]+,T$:3XERDX;EB6D<V&*H-8>'HC;! YC+-587&;:@QVS1!
M#T#QZ&&4GB"G:;^+&9>0$THWXD<;_;[Q[WEWN>>#CFAAB.S,:'L_8RH[GA[/
M''@/#W5\E>-7CRN:M5C7P[DZY^\M65BYS2Z!6%2EI8N83D?;AYXY49LB4'M
M;S[%@8+<=9F$DE*D$$+*(4X[:7"KVLF%V[1N;"[.5P,\;?+'AY4[&+)/9IEM
MP8[1EMPPV>.=WGGQR??7V:\<N ,6@V[,\4Y6W;Y'1R3[,FAUG4X6F4KS]3E4
MOR7RWXM:):L%$0$LC;OLR<0\X ?H@=6V\=M+MV]H^W[W<V."&'&?)@"/<>13
ML8MV_LTW??;1GD;3SCS7CYN*XB?&3QU15)&BIX=RGZG2P-?C9.M;HE;5#GA5
M,B1+JS!02H[;+R:V7+RI4"I:=N1!,B:0 L=XEY:\]M-N#=K)N!)!WMD%@ V#
MGS &??CFL=C#M*]DFTXRNT8.TDKQCR)./=FN\UPGBFH;==3R3FZ8!5'5S)4(
MBEUY$5OG2C52*Z-N/3'Z%W4UR"E'+@-M?*UF*42H;;RE+WCM9,[NT?.[?G<<
M[_#=G/M8XSXXXK/91XQV:XV[,;1C9G.W'WN><>%2KK6M:UK6O36M>FM:_:UK
M\6LKJROW%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*K5:^"NWSK4[:+1*QA?.)
M2"Y<,92%Q 1Y%BEN?R/3C=,39AH6]#UM_5X"^+BV7#_GK8A$>1J*C79-BQ7+
M*%C"J#O!?O9(VA]GA@\MW3SQCQY.,4M%ND8L1L(CRN <E2_B3Y<\CG/AQSGY
M6+Q?JDE&B0-?L-EK=<U5;MSJ0@7Y$RU!?<TZ*BFMVVG5UVRF'FU49UFBPXT!
ML EZ,JX94N-$PC39(7RT)B"254G<KY\#O7=M8XX;VB3QEC@DGG(P@\!F VLA
M&=PV-MW*N[.WV1CR S@>&/SI'C1%=5+L35NMTP]7+M%1T3=J_'Q\:#N:9K1E
MU)IK@4II#I$.]"HN>D2*VVBE3;M8K;V]QR$S@\X28H!M497)4DGC<%#9'GG;
MX>6X_#!H@^=S$A@ P QG!;;SY8W<^_ \.0>L-\7FY<Z8FIKH4L;.WAZ3%Z<:
MQ Q 0EPKLI'\PAGH4*/1MSZM/?)>25N,W)C$G+]W+VXAH5DR3AGZYGML  (
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=3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>23
<FILENAME>g723949g27t37.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g27t37.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X6"[:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z>&UP/2)H='1P.B\O;G,N861O8F4N
M8V]M+WAA<"\Q+C O(@H@(" @(" @(" @("!X;6QN<SIX;7!'26UG/2)H='1P
M.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O9R]I;6<O(CX*(" @(" @(" @/'AM
M<#I#<F5A=&5$871E/C(P,3DM,#8M,CE4,#8Z,C$Z-#8K,#4Z,S \+WAM<#I#
M<F5A=&5$871E/@H@(" @(" @(" \>&UP.D-R96%T;W)4;V]L/D%D;V)E($EL
M;'5S=')A=&]R($-3-B H5VEN9&]W<RD\+WAM<#I#<F5A=&]R5&]O;#X*(" @
M(" @(" @/'AM<#I-;V1I9GE$871E/C(P,3DM,#8M,CE4,#8Z,C$Z-#<K,#4Z
M,S \+WAM<#I-;V1I9GE$871E/@H@(" @(" @(" \>&UP.DUE=&%D871A1&%T
M93XR,#$Y+3 V+3(Y5# V.C(Q.C0W*S U.C,P/"]X;7 Z365T861A=&%$871E
M/@H@(" @(" @(" \>&UP.E1H=6UB;F%I;',^"B @(" @(" @(" @(#QR9&8Z
M06QT/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E
M<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z=VED=&@^,C4V
M/"]X;7!'26UG.G=I9'1H/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIH
M96EG:'0^,3$R/"]X;7!'26UG.FAE:6=H=#X*(" @(" @(" @(" @(" @(" @
M/'AM<$=);6<Z9F]R;6%T/DI014<\+WAM<$=);6<Z9F]R;6%T/@H@(" @(" @
M(" @(" @(" @(" \>&UP1TEM9SII;6%G93XO.6HO-$%!45-K6DI29T%"06=%
M05-!0DE!040O-U%!<U5':'9D1SEZ84<Y=TE$375-04$T46ML3D$K,$%!04%!
M04)!05-!04%!045!)B-X03M!44))04%!04%104(O*S1!1&M&:V(R2FQ!1U1!
M04%!04%F+V)!25%!0F=114)!545"9U5&0F=K1T)164I#=V='0F=G3$1!;TM#
M=V]+)B-X03M$0D%-1$%W341!=U%$031014$X3T1"351&0E%417AW8D=X<V-(
M>#AF2'@X9DAX.&9(=T5(0G=C3D1!,%E%0D%91VA54D92;V9(>#AF)B-X03M(
M>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX
M.&9(>#AF2'@X9DAX.&8O.$%!15%G06-!14%!=T52)B-X03M!04E205%-4D%F
M+T5!84E!04%!2$%114)!445!04%!04%!04%!05%&07=)1T%104A#06M+0W=%
M04%G241!445"05%%04%!04%!04%!)B-X03M!44%#07=11D)G8TE#46],14%!
M0T%1341!9U%#0F=C1$)!24=!;DU"06=-4D)!049)4DEX459%1T4R16EC6455
M37!':$)X5WA1:5!")B-X03M5=$AH37A::3A#4GEG=D5L47I25&MQ2WE9,U!#
M3E51;FLV3WI.:&156DA41#!U24E*;TU*0VAG6FA*4D92<5,P5G1.5DM"<GDT
M+U!%)B-X03LQ3U0P6EA71FQA5S%X9%AL.5=:,FAP86UT<V)7-799,U(Q9&YD
M-&58<#=F2#$K9C-/16A984AI26U+:31Y3FIO*T-K-5-6;'!E66U:)B-X03MQ
M8FY*,F5N-4MJ<$M7;7 V:7!Q<75S<F$V=F]204%)0T%1241"455%0E%914-!
M341B445!06A%1$)#15--545&55).:$EG6GAG6D5Y)B-X03MO8DAW1DU(4C13
M3D-&5DII8W9%>DI$4D1G:&%357E7:5DW3$-",U!33F5*16=X9%5K=V=*0VAG
M6DIJ6D9':61K9$95,SAQ3WIW>6=P)B-X03LP*U!Z:$I3:W1-5%4U4%)L9%E7
M5G!B6$8Q95@Q4FQ:;61O85=P<F)',75B,E(Q9&YD-&58<#=F2#$K9C-/16A9
M84AI26U+:31Y3FIO)B-X03LK1&Q*5U=L-6E:;7!U8VY:-F9K<4]K<&%A;G%+
M;7%Q-GET<G$K=B]A04%W1$%104-%44U2040X04(O6$QV+V8X;B]"3B]83VDT
M4C-0)B-X03MN6&EZ-WHX,V983'8O9CA!2B]W5&8Q>#12,TPT<RLX+TYM5VI8
M+VM:9$=S;3%+4U(Y4VHY5G(Q4#E,2F8T8FXP,4)35DEZ=C9'=S1F)B-X03LV
M,C=C8U=C8VY%835F1'DO83=80FTP+VAJ:DHT.3<K<BML6%=V-79D-S!2<#)P
M+VPS4').=TQT6'1.3DYN0V).,FMV6D%T>GA";45Q)B-X03MO,W%/951%9D-Y
M<E)F9FQG;$1+23=C-SAM95!0<&IK3C))8TER9690<F8T<EI3;#%(.'8T9%)D
M,3EA-7-6<U8T4DLY,').9$<T-VQN)B-X03M1<3,Q9C=2<55"-D)U:%)$25(U
M,S5C<2]79S4Y34HX>5DX4&9,;F9V-W9H-S%A83,O3$=392MK5%AR-D=)5$UB
M2TIF5TE-4F=$069&)B-X03M#>#)N2E5C;2MY4'!+4$8R.4DO2'A39GEH2B]E
M5$%V8FYY<BMR,V]+52M1-'11=6)A2%4W>31S6D5T1&(S>G1+:GAS8FA"9$1G
M<V9X)B-X03M(,&5256QA1'!2:E1*05I+=6AE+S-B9F$Q1U=N16E"3U)J-F0Y
M.796-G5N8VI6;2],4&IQ='%B>39P2#91,'951$IC.#5&2V=Y2#!X)B-X03M(
M>$1Q,5(X44%B86Y$-U=1<DQS84AM3FTT6DY*-F\X575L1S5B.2]4.&531V=B
M.'9P-V$R5V95-W4Q;D9S6'58:D4S*SE)9W1W13-%)B-X03MW2T=8,6E31D<K
M,S)E2DUI36=*;T$O9R]S831Z,'A!=6-G83,U.#9J-RMV1B]9:G122#574C9F
M3$19-G)D5%A+,C%W67)L:F-Q-UA()B-X03M.6'1W5DU9:G!4:VI(654Y.7A'
M27I8=4(Y:F)K;'!"06E--5A2,SE84' P<GDO1F]+06528E17-S)Y=F(R-6YS
M23%I348R<W)32&TT)B-X03M+>4E'9RM"=E0Y65!Y<%)J1G1S,41)*TE99V=#
M+W=!9FHT=&-:865/47AL2U)J=%)U+V9Y-W(O,E!M:6\W9CA!2S)6<F-3-C=F
M44EK)B-X03M5:3-01#%M6C5F57)'>6MW34-!;%%4>%=V=VYI1'E'4B]E+WI2
M*U!I>B]W43$K.&U.=E O04EN.5A48FUP4E<S-5I3=U)35&593"LR)B-X03MN
M84%'4T9%;&15;$535DA)>#<O=D]F5%DO=T-4,TXU9C5O45!Y:$9N2DU'=E!U
M.3-E>'IZ0F-A5$A.1DAO;'I03$%V<3@U<%AF;3,W)B-X03LU,6IR55)J94I5
M9EIF,G%(<&PK3THO:41G86Y,145$1UI6=G9:-WI89#!O+T9+=G)D,2]V-E0O
M9VHO6$Q/161Z:F5,4'90>F5K+VM8)B-X03M.3DHU:G9X2DEZ9U=:;T=*4"LW
M53AC=V1E04EJ,W4Y-T)M5&ML6C9085IW3T%R+TUN+T5H;7)E;U@T<2M53'4W
M=7AD>F9V<% W>'8R)B-X03MJ-&XS>F]9>$90;G583%!J3S4U<5 Q>3<O=T(O
M>68X04).+UA$=VIU665,4'90>E1(44Y0,6)7.51J,#8Q=5-K,&EY3T=K855I
M:V%')B-X03M2=&\Q:V-M:3=!2V-H:VQ'07-H=C P8VUA9D1'5R]V2V1A;#5&
M,2]4;W!8=617=%%9;U5N-&EA9C1K9#!24W)M35(P-51)3UA,:G8Q)B-X03LK
M1G%5>'IX;'E"8W9,;TTP05-::C5N>3AQ-FIY*S%V52])4&UJ5&]:<&)I.6E)
M:&IN:TE34UDX:&)&9E5#<U5#:S!E=EAS46%-0TU9)B-X03LV:45U451L-U!Z
M=T)*;'E"4$TY4&=Q-F@K5W9N83!-4WA44C-J>74P9G!W>G-J<7EU<69%='=)
M1'A,3W1'1E)U3C9%5D5D5&I0:VY*)B-X03LR8G%9.&IX930O<G!,-R]Y6C4S
M,#9%5#9H0DQA,C-+2EAN95I75E!78FEH8F=Z34YX=G1T.4EY8V,R33AM;65I
M,4U"8W)!,C8Y+WA6)B-X03M*9DI(;E)B<4]#1E1C:6%D<E='84]C2VI42D=:
M5U0Y-EDR46A63WIQ=31P,7A'9DA6<&QO9%-#04XW3F,K=%@Q<C=60S0X<65B
M8EA4)B-X03M(,4\W<F(R670P=6]N96136EDU2%9&.4Y56FE4*SA"4&=/=$MI
M<$=70DY$;7AL<&121TA(3&%.6#E83D=8;FM8>DYA,U=N>%!F=TY$)B-X03MQ
M5'A245A35'E&1FMN3$-*6D4T*W-V27AK5C15.2MU4FIN9U%D=51::S!/94)I
M1$QA4D%U>GI03'HK>#%R-4,X-#-D>F)W5W-Q5&97)B-X03ME5%)33&-!3#9+
M:4IV5UE-439Q5G5%64M6-3 O6GA/;WAG8B]!2$Q(46%M4D%"=2\V6%1B9C=2
M-2M34C9V638W<$8R3%A51V5'9&M7)B-X03M65D5O97%0=7)64FU'*U=W35I#
M=S1M94]B1DQH;5-$-S!$.6-U+SA!9CAN+T%!5&8Q>69#3S5P.%=F969M-S8U
M9"\W+T%*4"M#8BMU)B-X03M00T\U9D9N,VXU<5=383-9<3=&6%EQ;2]L9EAK
M,$Q5:F9T6G!E=C9B4DI(2WA644I+3$ED='I7275G*V1D-E5.5UA(>&ER<'ET
M2G%F)B-X03M";GA6>&9J.59H:TU8;GIY-#%R3DAD95<T2&Y-155517A%3&MV
M16E2,5ET0T=53W%M=D4W8D)E2G$K569L-3-T3#AF3GIX,FQI25!&)B-X03MI
M1C!/-W!8;"M/;F5P;CAW<E)D6&XQ0S,P<')&<FE'4TM8-FQC3$),5C4P;C5I
M55%S,RLV*TQC<3%Q855&1D(O3$AH;VTO9B]!1W-F)B-X03LU5&IX.%EH=S)$
M>4YD465F1#5F87(S9C5J841,8U)Y=RM5-T=*4G9/<G)"25I'.5-.:5-Z5RLQ
M55(Q,B]M-61134$P,&=0<5 T*TM:)B-X03LY<#1Y8CA+4#)E6#E(,R].6'1V
M>E P2S%M:&QT=DMT=$%5;&%75# U23$U9W))<7%F,T=W6#%J,#,R<# R=TA3
M>5!/4B](>%IW-U=X)B-X03MX3GAX069,>B]O*V%75"MF-"]R<TXY66%A=6XS
M82]P2#$U-$I/16MV,2]K62MB;VE-9G$U649A,39D<VU.4'123CAV<R]7,%,W
M4TA%)B-X03M*4FIW;C%84C4X6'<O:%9)9GI!,'E+>6MG6%%)4%A/;DQP,$YW
M2%%.1S-'5EI:,2]D5D13*W169T-+.7EC0C U=C9U='-H,FQ!4G)W)B-X03MX
M9D1W,S-C-U!,<F)$37DS575X5C)+=7A6-E@K4D@O2U(S+R]!1$)N+VLV;5E'
M=BMK93DS+W,O+T%(:W9C.7-N<'=&4E@T:R\T:TTQ)B-X03M4,5,O1EAY5F5F
M-S%Z+SA!1U)V*TI(3VEJ>40U,6PK<RLX<5=383%30S1U3&54,4E*6&AK;WDX
M-#)+;FEW2W-+:G-184A!441Z6E)M)B-X03M9;7=A5DHY4S%'-&MM;&YU<'!:
M8FQ65S1D-4=:<$959W%(2DY704M,4W9G34%I0C!43$Q-:VMK;2MF;7)Z*UE.
M975),FIN,4LV;6ID)B-X03M3:G!*4$EW2W-E5$M15S-"27%2:U)J:4]G8DIA
M;DM24FQ)+T5T438W<F--:E-W-FAC>'EU>E-/-E132WAD>7!::5%D>7A286XR
M2&AH)B-X03M/3THV0D$Q1U%'>$M8>DLK9GI*-6EU2V5V<6PS3%)K8V,U-5<K
M2TTX:V)D=7%N8V5'05EO:F]%>3%753@U4RM:8E!M9GI+5U9J<3$V)B-X03M7
M4GI+:F972F%H>7!5=5!I,EEQ>$9F030K1D1U0R]M.'8X*UAZ2VY*<C)U>7=.
M8GEA:F1007EO:E).3DE52WAM<4M63%5O<#-(:&@X)B-X03M/4&-%2%4U4TM-
M<%8W>75U9DUF;4<V.4PV,7%L,U V1&E72#%:-5@T4TPY;#$U365,1'-29T=/
M235!3$Q5-5I68W!'="M:86<X=V$Y)B-X03MB:TYB-FQD47-&-$%X>GE+95!&
M5C0W3C T>&]0:V\X351J:65G5T]P>6IL2UAZ2T=U-S(Y=DI23&0S16QZ2T9#
M0U-6,F1G<3E&<7A*)B-X03MO36M)9V-M13AK<&TU16LK86IK;41S5F964#A!
M:')Y-2]W0E=Q>B\V4C1V*V%C-3=X2F0U9E)007@O>E(X;F8T83AU9CE7<7HO
M=T-K)B-X03ME3"]M;DAX2F0U6'=-9CA!3DAY9"]H<GDU+S%A<E X0392-'8K
M86-F16PS;&9!>"]Z4CAN9C1A.'5F.$%6<7,O*VME3"]M;DAX2F0U)B-X03M8
M=TUF.#!F2F%F3&9L,R]Q,3)F+T%#26DO=T-A8V9%;#-L9D%X+WI2.&QH.'0K
M6'8K<EAA9CAI278K86-F16PS;&9!>"]W03!F2F%F)B-X03M,;FPW+W$Q,FXO
M26E,+VUN2'A*9#58=TUF.#!F2EEF3'9L+R]!2W1L<"]Y26HO-7!X.%-8955E
M0FHO;6HU3%0U9#AV+T%05G-T4#A!)B-X03MK4D@O04TP-"M*3'9+*T)J+VUJ
M-4Q4-64P1"]Q,E=N+T%#26HO=T-A8V9%;#-L9D%X+WI2.&QP.'9A0B\Q8DQ4
M+VM22"]W03 T*TI,)B-X03MV2RM":B]M:C5,1#5F,$@O04MT='(O>4EJ+S5P
M>#A36&56.$1(+TY(>5=(44Y"+S9T='(O04UI62]W1&UN1#1K=3AR-$=0.$%M
M:C5,)B-X03M4;T=H9CE7-C$O-45X+SA!3D]$>$ID-5AW368X,&9*861",$PO
M<3-7=B]);5 O;6Y(>$ID-5AW368X,&9*34Y#,#-4<E<U:V4Q=%E9)B-X03M(
M6D]*84M.54I&46%6541"2U)037-O631X-4%"3TIQ.$)15BM*4#A!:5%Y3%EV
M>%9J4G-,2&MF.4=I-B]Y3"]42F-266-%935C3E!S)B-X03M0*U=A3"]G1B]P
M:GA&94-08W9';C)(+TQ.1B]W0R\P>#1I=D)(=5A$5#=$+T%*6F]V*T%8*VU0
M158T23EY.61/,"\X035:678K05@K)B-X03MM4$56-$DY>3AA9' O=T1Y>7<O
M.&DQ+W!J>$9E0U!C=D=M-F0O=T%S<U X07E,6"MM4$56-$DY>31A8G S+TQ,
M1"]Y3%@K;5!%93EE)B-X03M#4&-V6%1.3B]W0U=32"]K5W8X051(:5!E=D)(
M=5AJ5$Y.+S5:268K4F%F,'=C4C<P.$5E-65.3# S+VQK:"\U1G O5$1X2'98
M9VHS)B-X03M.+V]V5% X06QK:"\U1G O5$AI4&5V0DAU9"MI.4TO-5I)9BM2
M868P>#1J,W)W4C=M;3!N4VU5<3%N07ES2TUP:5%G9SEJ=&IX2'92)B-X03LT
M8V4T2W,P>GAK54%)3U):;V1R-E%F<VHX8TY+<V)5<%(K>78T-#!Q;3)R5$0Y
M:&9X+W)J4T9&.6%N2#=#9FHO049X<$MX9&-L.5)1)B-X03LV2T5*05EI=&%9
M,'%A;D%Q,#1O5TA&54LX-VAI2T-G3DU65RMV2C1$0W)8<78T1$%R6$XO1$-R
M5E<X359A*TQ&55AP9CDX+RMR+TA!)B-X03MQ4&UR=T9/=DI0=35$1DLO1E5I
M4#)Z.#A+1WAG5F5-2W)X9U9E=4MR>&EQ.%EQ=D=+<C%X4W9'2W)X:7)E2W5X
M5C)+<48R=S1H92]8)B-X03M&5T@K82]*,$AM0V%+5U<U84%W47I1>#A%56YL
M358K3&MF:49/4%)30V9';%%:03!X25-,+T%(;59B95-)96)R=W,S3&I)4DM3
M;UEX)B-X03MK1&5F=#9:2"MY4#!Y=&%40RLX<EA5=7%T95$V;DI"8GEV23EZ
M84%-5FPY4S-304)I2D9(=SA/4S=B5C)P9W1A63AF>7EM1G8V2C%5)B-X03M/
M;D5X*VDQ=%=%24]F<#A5.5=O84UZ4TU'3$AC9SEJ53A33T9M:%4W2TMK.4(T
M;D%Y5G!L,514.60P94PY2E1Z5S$W2DQ(3EIY2F(K)B-X03MM;U,S95)E1$Q%
M<W5Z24]R;D%R251K5E=(1E5R,6$U=3=3,75B:3-S;G9(:&AE5T]*1T%-:VDO
M6FE!05IQ=#0X8VIX2&EQ='$U+V]:)B-X03MC231B=F9U63=P,VY(6$QY+W=$
M45!L93EG=#)K6DDU-4%Y16]%9#!:;&MJ4E9,8T97;D]G3&)T-#)5=W1#:GHU
M-6E014AY;&5";6=E)B-X03M925=C35=4;CA!57A":CEL83=B8VAT,'%E2'I7
M,%AB*V(Y8V4S=C5:=DLY-TA*85-2<D)#=%=A9$<U3DEY:V]G<6E2:S!&951%
M2T15)B-X03MJ0E,R;F9L-U5,>E4Y3U<V=3=".4]L2G Y6&LU,7!11W8W>$EN
M-FUM-FIC8E9&1&=+46U2:3)/0E8K;"\S>B\V=CAC5E(X,S)"=E0T)B-X03MK
M+S1K355R.%9322]B4'IW;V)'0E5I.#8V;'(R;6%19%$P:U)V.5A.8G%/4D-X
M.4TW8VQO4CEK.69B-5IH-C=*:VA$:6@P-75Z-TMW)B-X03M98W589WDS=GER
M=B]!1W904"M6=65A=C5B8B]K5S,O3F5A8BM68S-L.&YQ4#E$;6TO<&90.6IF
M+T%#=#-Z6"],82\X04ET=BMA.&8U)B-X03M6>F58>5@O435P=C98>B]9<E=N
M-7$K8S=U-FET8F5/,65E9'A(17!4:4-Z1V=(2FY!2#!N2E(W5'I%,$LS635/
M=TY,0TIK5$MH-2]S)B-X03M40V9Z=BM:.$1)<F%9:BMQ=DM*-%E(;5)L-6A+
M<3AB=7!(26=B2'5015I99&)Q4C K>'@T.6QA0U@X6C(W-58U.5%P>&9M2BM9
M>C-3)B-X03LR:'-O67)H;&1K:FUI845K4FMQ,5!59$MK37!7;E=U,UA)+WEH
M<4QQ:&9U6FYS8E)#4$9X16IY3C@O8U!W3C!092]M=#4V<TQU5S!V)B-X03M,
M93-G=5E4>&QI949G=U O04%F,UI'9F%794IO,$0W;7I&,D1P2GA%;VU2:690
M.$%9<&8X<FTX,R]W071R+WE+8B]M=DDO>7)M.'9K)B-X03MZ+S!/-F(K;#@O
M,DQK+T]N>F5'0EI,4FQ"1E8Y3FA5949E95 X<35F2E0W3V%F.$%P9E Y:C)B
M43E:<SE:,'$S,4LP87-.=V]B:C-6)B-X03MU:DDS=7 R3V1":'EJ2D532%8T
M>E4V95=(25E3-6A(6F$P3WA6:E!M<GI4639295%W5%AL=F)U.$QZ=6LP3GA+
M>&I4.7!41'-0<#8Y)B-X03MS24-#56=L+TUR431V53EB5F)*0T96;W=B4R]"
M;RLV<U)48TU.>%1*8TM,5G)F>GIP9'I&-G-7;S),;V]L85)V<70X2T-#27I3
M9&5N)B-X03MW2U-++V%O44MN1VLR<VPX.&%.2$DP8W5P5T5C:G1X:%-3,G95
M3S5!;S1A;F0Q+S1B=TY';'1K6C!V5W8S9&9Q4%@Y-SA%,U1B-U W)B-X03MZ
M-35','%C96PV-G5O5S!H*V]I,%)Y6G=Q5&5O5C1M;D-R158U,#8Y<V)1,7)N
M+TM1*UAF*UEI-"]W0V]36$5+539/0E9H>%9*+TY+)B-X03LV861(,4)B.#-$
M44=X;6%E0S,K,#!.0GE+8W9G-3EH53550U!&07,X5F-U;E U5S)59D1U:%8O
M1C548S9D*UA02S5L;&HQ,D(T-%%*)B-X03MR6FAB06]Q.&PT8TAR.&$O5G0Q
M,U!C-T)I=59U,#=)-U-$*U@V,T8S8U=:,6%/831S6D=L8T,Q;TEP1TU28C%%
M<6MB+T%"54UR34%+)B-X03MF1S-+=4$R;W!"87)"*U@Y,TI.9'I1-GE)-V5/
M3T-79$IB3E0O;V-C54%65C5(-&ES:7,T3D-$,D<T0TQ86DUV2UAM2'E(<$=S
M,FE7)B-X03M!,657-'5%1G)%3'(V=3!A<F-Y4FIQ1U@Y<4U(-&9%-TA%9W%#
M.4,P=GI6<#)Q6&8Q4S-I:T1N-GA2>5E75"]2;D5B-WAY3V%%=#A*)B-X03MP
M=G9K2UI)<&13='10:FQU3&AU2TMV.$%%1$-):VUG>&Y-4D9N:S)K;FU/*U%3
M3$9(6GA%:&M366MY14$Q2$I!1'@O-$Q*5D5D8F%H)B-X03M,2DQC04%E9DY6
M6%4W,C!L4TQ5;V=Q>45,2&-2;FMH63EI84M19EEJ-F-E04AC2D=59S%-5F98
M;V@V:&I51V]/-$]18FQW=TLQ8TYB)B-X03MR8E-T8VQ28G%J1UEV.6YG0CA8
M2W9A;4-:1D<K5%!'2D=1-&9Q=F(S=FY0541:;2]U1%I";'-Z23,Q8U Y;U(Q
M4$=V,%IX:S8T:G<X)B-X03MN,4Q$>#A!-"]Q<F8S=%=&;DQE,W1V6G<O=T(W
M8U-,16QE;%A)07(W8C1)>$UI04]Q8W5146E:2&M"8DTT=GDR,38Q,4,R=4Y,
M=C1()B-X03MB,4=K<W)R:DHX46I,4$A)=D)*55!.1D1,4FHQ.$%4;6-.1$U3
M0FEF9'HK0C9U;&PR>&EL06I*13AT>'0Q-6IM1'-D=C=A4G5L5S-N)B-X03M'
M,C%63$5A=WEI4EI84V5/,T9Y-2]W0DEJ-7-X;%91,WAS2&1G-V-11%AE;WEE
M25I22W5,-TPV*V9Z3%1N;G!P62M,9S56='AC4#A!)B-X03M#93=Y,D%O6'-P
M,V5I*V1*2DE,=E5.6G-22V)386%&<%9-;$E*>E=E;D,S9%%F,VYZ,RM(0DQ&
M;$Y'56\O5#EH-3E04#E43$AQ9$U!)B-X03M9=WAZ<FE!3F)B:FQZ:T\W.6)T
M4B],9GI,9F%I8FI78BM"8C(T:F%6>DA'>D%#24MO6#DR:5)Q9FPT5C,S=S5.
M1FM-<FU26B](455U)B-X03M(=&I"0T99-&YH0G)N,RLX:W-,,3=28G)29%9N
M,'DV94]3941J>F5)<U503D$T;U=#;F\S:&U$;7A(2$EX4$U/-C!U<&IM>&EC
M8F\Y)B-X03LO=T%K0FQ493EG+TDV4%9X6C9G-VUM:W,T14MT5W!N2#)Y;F%N
M1VY,-E!F3C<R44HP9C5V-EAK4&%9-"M+24@Y-2MJ>B]1.5)Z9%!,)B-X03M/
M>%9"6#)H-DIF>4=3+S K,G4U0V=J3'IW>'E.=T(U0F%U1#A03&5M1S%1<#AN
M9553;U4V2' U561!8E=';F@O3#=9,E55<R]W6#54)B-X03LK<W)C1%-R64US
M8GAE;4EW26EK;$]D65(K-DIB:4MK<EA'>71+-F574$Q56D)J,&UY47)4:59T
M-&A4:G@T,&]V8C Q<#AH-%DR=$II)B-X03MC0U9H>%9)=&$X=EA/;V%Z<%=O
M4C9H3&%X-F1)>GE7>4MP179*4W8R:G5U>$E0:5!!-S11549/1&=666-64F-9
M2'!R.&AI;&1167$V)B-X03MG>%8Q0FER<41&5G-G2'!T.&HK<D971FU7,6LX
M,#)Y6'-S8U9R87!*8T@Q5T-R>FDY2EDY>E%F875A+TU$3&]!.$I).7II6EI$
M>$EG)B-X03LX='HX<4$K.5-V2DPW.4HV<'%';BMA-T].4DI'9G%S;'E(:6=T
M*T5A;&Y$;5))>C9O,D-O2V=K8S9S3TYO<6=$175.27E%-7EJ:VIZ)B-X03M'
M,3AH=#AT+TPT.7AH;U-W1WEU.4TQ5%9R83AU8GE2;&HT,UIU2%EK1F53<DI4
M,'IZ:EEI3DYL24Y/;5%N9&=G8W9*='=G8TIH2U%*)B-X03M*+VY8.2],:V1H
M<T=T1W5';G-9;F,Q66]J369D,%9Z+T%-4WER24MK435/0U)L044Y46U!>41A
M>#-Z,V$S5CEP4S9F1&8R,FYX,T1F)B-X03MV,W5:4%1,<71$=U0V9G1F,C5J
M87946F,P3T=(>&,W<R]8-F93-5!%>F8U=DPY2F5E9CA!2W5V*S$O<&8O22\K
M>DY8+T%#1FXO1B]Q)B-X03MD.2]O>3!F9CES9C%T+SA!2W5F*S$O<&8O22\K
M>D@K47,O-'8Y4V8Y1U=J-R]T:BMT9D@K6&MK6DIJ.'AA66A)2VMR8T565FA2
M:'-/)B-X03MH0F]C4#AH86HX6"MP:69B2%)(;CDX9C%R9CA!;%<T+S9M2%-V
M*U(O.6U$*U%S+S1V.51,+U)L;RLO-UDO<F(O04]68D0O<5ED2B\V)B-X03M3
M4#=-9C5#>B]I+S%,+V]Y,&9F.7-F,71J.'1"+W="5$9P4"]!16MF,EDO>49N
M+T8O<5@O045:85!V.$%T:BMT=B]L5UDO-FU04V8K)B-X03MK:BMZ2"M1<R]W
M0TPO578K:DQ2.2]W0G-F,7%K2#57=$Y-:U-E661+9#-92T539FLU<65I<4)U
M8U0R2&Y(4#A!5"MP23ES3DED:'5F)B-X03MF2#EB,GI33DMT3DHP>3,P-C!8
M:F(R>4)%.%0S3$@S63=N3GII>$-%4D5C9SAX<4TX<W-Z3UA-;WI,1VPR2W5X
M5C)+=7A6-2\K8FUI)B-X03M#8E1O3EAJ2#=Y,5E25&YX:FM0=R]W1$%V*W9#
M149G1VAA1$1Q8U5R>5AI,FA35TM*3UE5:&I,>3A85G1U4%)68C9"=FMK2G%F
M>3 Q)B-X03LW-GA(07,Y<7I3:$-H1'E5;S1K66)M361O5"M'0S P;"MN*U9,
M;2MS,79)6C0O4D%I33E1,TIF5W5'9T%886I5-#AJ=4U.;W!.2B]Y)B-X03LU
M=4E'64<Y5UE)4E57-D-2,E5+4S5J475P8W%X:E=N:30K:U=M;4YY:6)39%IC
M45-C<&)'-$EJ;'!X<5EN;T1X-U9P,'=O55!/;&I$)B-X03M"<D@Q=3)(1WHQ
M3TYB,C-8*U53,35R+W-81$1/4C=1=V5(;$DV2&0Y13=&,5AJ86-8>FHV5#A0
M,DI+.71C>'A*3$I%-E)304Y(27EK)B-X03M+=TI:459*,D\V35!O3UEH:5$W
M451I5%%/-"](-E=:<'!V-68V:F-P83(O,74R=4=D>$=S36-Z;5)04G)'5FE+
M>G5A=4)V6&-63D8R)B-X03LT-6]H:&UA1F<O<S=T*W8T2%142$YQ.&-E23A*
M2&U2='9V=F-2>2]T4%5(<G5N95),0SEH:C V.'5B<V-,;$QY2S16-#)I;5=/
M:TE0)B-X03LW<4IV-WIQ4&)F,VIN>#19:V-*2C4S9E$Y3V<V='5L>F%V2D5M
M8UEX*VUQ;S),,R]!26HP4VY7-TMW3W S5#9%<W1X<$M%1TM8:3=!)B-X03M$
M:4=98VU61%)35#EO9%!V>6I,1U!%940V6$PP,E-F05!&;UI0:"MS<&9A6%4Y
M<&11,U5$8UIO2%=33G9";$Y2;&-*1TI"2$U/4FMX)B-X03MI8U1'6$EI;G)M
M<E%1-G195VUU4C(S,74Q:VI6-VDP6FEG94YV-WE.;D)8:EAB-'5N2E9R=%A/
M-#!E;T5O:5$R-&@X:2M39'%A27AK)B-X03M9:V-29U1T+T](-#-#8F%6<&8U
M6C-.<S97-%,S3D]%,6Y08U125%$W2T-P:F513D=31D-S5BLP3G1X;5)/5U5(
M9'<X5TQ4155.=DMY)B-X03M#4&AE,S954'%D=#5213-O-D1#3&Y61TMP.5IH
M:VQL:F="3E)5.'EH669S4BM+<E=G45522U%&>35F96E74$=:5FI&>3<W3E(O
M2%%E)B-X03LW=49(3VY7=C%7,6IH<%1I04M6<E-M=U=V<TYS>'EB3G5W:D52
M04$V27-:1FMG=&,P8416=$]K=%IA0B]T47ED,&-D1"]83&-/57=L)B-X03M9
M8V)6-E=/84)I9F@W,VM.,V%Z,FQZ2F)4<G=M:5EQ-BLT>F5X:TI#=SA.;'AY
M:$EX;'I#23!N4TPS5F)P<F%Z45!+<V)Y:TAW4F$P)B-X03LK6D]W.7IK8VU1
M449L;G Y4$Q,3&AJ>G$P,S!V>3%R,7!D5W0K<T5B=D1.1S97-6U21V%O16DP
M3F%5;V9';RMG-5103D%G:3-.=V%()B-X03M.0U%N43)),G1/:DYQ;%E8,4QY
M.6(S:VI31S)35#%95T13=DHV;U1K4DE45&E6<7I(=E4Q<FQ.4B]H;5(Q-G5C
M6EI.:E!&1U)U=6-E)B-X03MD,S4O96AR,D<K=' U8C@V4$9P>5=K37E42D)0
M14-Z5'E%2T-%5C8X3V8R869:+WEA1$I224ER:74O3'5A.&M:>$IN-%EH=V<S
M56@Q)B-X03M0=39D,S9%3G)F;&TK=G(V-W5T4'1R84=+2E8U5VM%9S):0S!4
M:%%Y43%)94IQ+T1V,G)K<U=C4D%"2B](>F%D5&]:-4I'54)%061!)B-X03MF
M9V5G-W8Q5W@W561*,414;D5D-T8V56I&9T4U27@K03A4<W!/,65H-SES>5E:
M0DQK-C=.<#4T:E5X4T96;59G>6MQ>6UO23))27E4)B-X03M31%0R9GE.-6]8
M5SE-0U1S4#!H8D%,8T1U=R]::TAZ-RLK85A5-$]#5S-)=F%D;38S>#1B+U=/
M9C8R4UIJ3WED:7)S5F1I<G-664XK)B-X03M:.71R,F]7.7)P,FTR8W,X1E1.
M8W9'2VEO,E)A+V54.4=%24QZ>B]"6&UV+T%+=&,O=T1W3U-T1DYF-$PX,68Y
M5WEF+T%)2$<Q<#,K)B-X03M$4$Y0+U9S;B]W0T)X=&%A+W=!1RMA9BMR6E O
M04U$:F$P=G1F2FYM1U<Y=#=A87IK9T4W:&5B9T-I,4A*<58S-&<Q3TYR5'9.
M6&QN)B-X03MZ5G%/=%135RML5&EY9T,R,6MT0E%146II;F8Y<C=8,#5Y*W)W
M-7-U47DT5%A2-W9S>E8V8D)G:D1J:F9-*S@O:6LR,'I54'I(<V)7)B-X03M'
M>D=G<DIB47AP0U S8DDO<$EO2$AK<F='<#5.5F=F:5DY='-S:$Q54D9C1S-U
M+T@T3&HU;V%'8VI,>&1Y8C4Y9FPW:'17=TAV43$K)B-X03LO=T-93CEC4GI8
M1V@X;&I::C9233=+>71#64-R.'!I>"M!;C1Q.'9E9T%%2GAZ>4YM2#,Y,60O
M-U=Z1DQ246E13790*W(S,R]!1&4O)B-X03MP>3AU84QU=&,O3E=F:G@P=S(T
M5TXT<5%#4D%E9$M-9C-P*TYE4'=T-VY,2EI.568T4U!D9C8R;4=(<S90.&0W
M,W98-G53>38Q6#AY)B-X03MB9WEG-DA&16MQ0D=J:6E:5D-H46]P*S@X1D@S
M6D=:,45R.498-4UO63E"1W8S=#$S;CEI43-N;&)Z9')/='9D,V5N3F).97IC
M<#-!)B-X03M):E1M9FEB-&U9,$A8<FQ%=$IM>51S>')I3&Y1-U,P=4A&=WAM
M2F-),C=Y.7,P2S!G=&]L=$EL06=H:453268U5F]"6$]N:$%2:4EJ)B-X03MK
M2&<X;5%Z:UI(;51A;'%0:S=18G)I>C(T5VI+07%M:6=&:%=I;6]&9F),0DEJ
M:U=M5T]-=5E"5$14.48P,U0Q071O47!58U99,5EG)B-X03ME04HV1#)'06TR
M44%!;TIE9G1N-31Q,DU#;U!7=%AG,&Y4<$QU6&-J84M0=3=N;W8Y8W1W-&I/
M5D)X=%9Q63191U(O0F51,W0U8UAL)B-X03LQ3&181&,U<&U,3S,Y4%E:=EE2
M15)194=Y-5I:2D=5=5I23V@K;3)P=W!09'19,GI(;&,S0TU665)X;C%44VXW
M5E5(2%DO1E1A=5)Y)B-X03LO5'-,3%IP831W1$QH:C%0=3,O4G0U<VIA=W1M
M,#AZ=#5O6EHW6C5!679716AC26945F]6.5)#2V].<3E2;4YX;38T3V9K-U$T
M;SA&)B-X03LK3G5,-C,U8F)J;W1V=$]L,"M15S R=E0X;TQU4&Y(-G%X,$5O
M:EEY:%1+>DMW.59V:4-N<'941TTK3&-22$PX9$5:8TIX;FA/5U<P)B-X03MH
M,7)N5R\Q95HW,6%84S=3.&E(4'I+8F8V,4QW=DQE-'5O-VM55D]3<WIO.&%V
M=6](5'=(8D%*:V9W6%AL5$M70TUX+V966C-":TIF)B-X03MP1G)6,&5*,U5.
M-79J2'%P2#9J;54P<%-4-%0K.7(X1E R<69A-V1#*THO=&8T*U-"<'=4+V8X
M04]U=G8O<&10,'-B,7E.;S=X5DXO)B-X03LK:V%X;R]R.'561$E/5$Q8:RLT
M66UU*UI/23)/5D]T,5%Q5F-82'1Z+T)+04%,14MO<51S04]P3U=U34)B,EAY
M2C571VDV8C9S-B\W)B-X03MK3&]"<#8Y55@Y;4UF3'8W-7!D5FXT-6)C9SEN
M,EIO=D%H6BMU6% Y5$IS>%A:=7A6,DMU>%8R2W-:.#57*W-Y4%IN4SE&<SE6
M-6,Q)B-X03MV6'4P:5EP16]"5D4Y4C1T,UDK-#AC25%71U-7=C5J:4],:C5*
M,%IM-&MS<&ET;$-/0U%O6"]3:E55,S=D861T-6)D-DXP5$-N;7AB)B-X03LY
M2611.&]A8W-.,V-Q=D]',FIK2F=5<UI$2S9Y=6E.=RMY>FYR=%$Q4$8R-S%5
M>EHK92]1:4LK5#E(339+1T-T1D%G4U1I,5%V1V0O)B-X03LR;%-M+W=#=C1(
M8G989&UL=#5E,%DR.&(S1VLR561Z2D=V,6Q5:&I+.&ET1U=V2&-D4FMB4W58
M>35O360Q8EA596YW4C-&<'DK<E-2)B-X03MX<6A4:TM';D5!63)Q4$]"5FAX
M5EEC5E=(0W$P-$972$956'!F.3@O*W(O2$959D]"=T9F-6LO-&M-57(X5E-)
M+V)0>G=O8D="5D\T)B-X03MS8DLW0VDV=#1R9TI89TI55C96-C U035/37I(
M:V%A.&U'12]Q06PW>&%K3D$P3"]!2W0Q<B]Y2FHO-7!Y6&I4+VY(-718-5!$
M+TUJ)B-X03LO<%%V2&PO468K<F)A+SA!26E0+T%*<'@X868X-"].4#501"]!
M1$DO-E5,>#5F,$@O<3(R=B]):5 O;6Y(>' O>FHX,2]*-&8U:V8Y)B-X03M+
M1G<X=F%"+S%B3%0O:U)(+W=!,#0K3E K8V9M=C501"]-:B]!2U5,>#5D.'8O
M.$%6<W10*U)%9B].3U!J5"]N2#5R*U1W+WI)+S95)B-X03M,,3AU95AV*W)8
M868X:4EV*V%C9D=N+T]0>E@X;F@O;5(O,&]81'DU-64O-G1D<"]Y26DO-7!W
M94Y0.$%N2#5R*U1W+WI)+S952W-0)B-X03ML+U%9<$9L:3 R,5-20T=2,6=J
M1$MW,T)"0S=(135:;G%F;6U/:WA!,DE2=C-"34UR8V@R2W5X5C)+=7A6,DMU
M>%9J,VU8>FQP=6A')B-X03M/3S1357I3>E%W;U=J;&IG4')/068Y25I04G%Q
M8VTT.'$W65%,45-X-"]M;VAT3DUN1VY!3F9P8T\O2UIL:FHY1FEQ;%I$1E-2
M9F=*)B-X03MK6E(K-T$S-FEP-%57=C%4.# W2%,T8F%E.# K8W=Z,C%T8W59
M9FI+:352,C0Q6E5J2E5O3W)G:T=O1S)):7!+1&XO3U130F5814YV)B-X03MP
M.7A.1F%S16UC=D5J;&A)169G:%DX=FA02F0Y-DAO0EA$=TQX374P3%=R9E=T
M3&DQ2S-I;&AH;4Q"56Y52DE#:D9'<6],56]Y:UI%)B-X03MH25)P3DXX0W-/
M,6XX=S1R0R]G=#1B0U-E3V5)4T)P9E5T<%%F5T520F=M:5=3:#5F03-2;2M(
M,WE1:6DQ2RLO35=',W9,:3)3>%IJ)B-X03MB,V=T1F56>D5*5C1Y079&.$1C
M>C9S16M956133V\V0C16=&)E+VU,1EEZ6%-8;6Y43$A(4$IA,E5K6DQ#85-)
M>4)G96%2:&8W<V)O)B-X03M8*S!+-S%W.$LR;T@X,#E(3FQ,3W1N8VPT5DQ3
M<5%I;W T;W<K3FU(=VQP5E=O6#-P5&9"=W)B271",74P,79364Y4=$5K4T-F
M;'=3)B-X03M52TA(0GEH<49,1'%V:F=)<&)4=E,O-S4O=T16+VIG4VHU+W-$
M+U=4+VE1>%-V>%9):CES+U!#:'-91EAJ0W$X6498<FEQ.%EQ=D=+)B-X03MR
M>&EQ.6-5<GAI<3A9<3-I<G-69&ER<U9D:7)S5F1I<4<Q1S)E-G-B;3%36C=D
M-31N:5<T:DI$>&PQ2V@Q24E)6F$Q1TMS3$=G+VU8)B-X03M(3$1+3EET,S1/
M8FE71FYC27IY8VI*14MX3S-P9W9X5W1A0VQ&0E@T<%=%8F]+8E%F>FI%:&MH
M.'=79DYQ06@P6&E&0DIO1D9T5'8Q)B-X03LV-&)#2TMB-D1P+S5G45@X1#8Q
M<61T9#)9:F-816-3<7!,;$5#1F%1;V1M1$4O14]V5'-!85-,6D9"8C(Y=$%L
M=F)22D1"14]-8U5A)B-X03MH1592,$-Q2T%$27%U3TMR1&EQ=S1Q<T]&5G!W
M2W-/2V]V4R\W-2\Y6"M/2V\K879!549F:50O:5%X4W9X5DEJ.7,O4$-H<UE&
M6&I#)B-X03MQ.%E&6')I<3A9<79'2W)X:7$Y8U5R>&EQ.%EQ,VER<U9D:7)2
M>%9+1S@P84E,*U=W93=%5GA&2W1U,W%Q.%5:;F166EE5;&16:F51)B-X03MQ
M-%!"5TQE,E-P9U-H27904&Q/67I#4%<W32]6,C1Y:WIX<4)S<'%#>$%:9FI!
M-41A=3-81%-#5G(K9&9,4W558E8W9$A74C1:1F%6)B-X03M62U!(>C5#44=N
M1"LV86AA9U!B=&AP:EID8RMB3D9G83)$-F=H5S=%<&=L46PT>4E0-S!T26=:
M14-6,TQ%66%9,E5-4$\O;'0S:U).)B-X03M9=#)E2FM2=TI2+W5Z:GA99GI,
M*SA8-&@X4'8Q=SA)4F-N86PU=3!J5&QH93=V945D>$=:;UI65C5),FI7;G@X
M-'=Y9TAK2U9/.61S)B-X03M.0FIX4U<S6&UR5&)A>70W,F$U9$Q7-DY)2E!4
M;%!,67179U5K3'A5;FM24VTK1V=X-'!D-GAF3FUI>4I'-C9T8C!M8FA&5V1&
M3$]+)B-X03M654%K2&M/47%V6&9(:$-$2V9M;TXU>C!$,5)(*VUB8FM63#$Y
M9$].06%B=%AI4&Q81'=H2$90>E90.$%%5F<P8SAK96]2>7)B23!S)B-X03LO
M<'E#46]I5D1%<6A*,DMK665%341/9F55=5!N<E$O<D%T-4Y13G9-45=+,T-3
M=U5',S)J2W%"9G1#;&5T8TY256Y*,V]G*UIT34UO)B-X03MI+U-K2'%S4T9J
M.61/4DE*0D%(2W5X0G<X35=(2&LX,4=B>F)P,%!R*W!D4T)B6E=E-&8P-5-I
M0DAA33%C2U9R>FI9059Q86)9.$U5)B-X03MI5U1V9&(K8DY-=4QG5SA.-%=L
M85(T;"M'44M8:F]'06-Q1D\U04)R43ES94=+;5=19%-N=6TV:3EV9$LP:D5X
M=#A,,3=!.2]O>4TX)B-X03M923):67,U171Z<WE75W!18U0K,&TO='E'67)S
M;"M+<$5F=&XU-%5.:D%Q.%E66&I!<3EC5EAJ1E8T>%9E3598<FEL94U66&I&
M5SA6)B-X03MD:7)S5F%B1D1'-WIY2#55=7188E8U-TAN<413>%A$5&5R34%:
M65)33G5!8THX23ES;4-X25-Z+T%*5E8U2CE3571:4U-24W)%=C%D)B-X03LW
M:61O,4U.47),.&9+=D4X9'IS0E%51F%M,DI#<&-F;'8U3FU.>5I.3W(Y8FPK
M<UA&2G Q-5-58V-T<$)4*SEF66)B-&)9;VDX.&XV)B-X03M$9#)S1G)C,GIY
M,CEQ<VE123 P+W=R2TM-=&5D4TMF6G(Y;CEM;4<R2UA84#5C*U9*25IO,7,R
M:6%A,U<P37EY>7,T:6I+;$%/8D]V)B-X03MW*VUV561Q2&%U1D9L1G8U5C!2
M-%E96F)54W!B>%-7.79Z3$5X=WDW36E'=G=J:4])<'9X,G=S8DMJ8V55=$5N
M=%EB4V5"-6)7,FQ7)B-X03ME,6AA4UAJ17ER>%5*4F=1;TA296U&:EI1;SAI
M958P5TY6<U132C)K:B]E>D=J4'@U159F+VET8U5'56M/,S5E*U4O<7$R=C90
M4#%D)B-X03M76C%4,5HK<CAE5R]/=$0V83=E,D=G>#0U2S!8;$A23&-Y1S-T
M;6E%>4Y$36EY4V-8:EE05D-#>$90,VA/,E-O351+4T=8>4PU86IG)B-X03MJ
M9VIS;5-/1GI*1GAL;D1+-V-A:TU(-69S1'9J45%:>55X-4DP2T\U:G5)8F53
M2U-/9&)K,&MK6E=K4FEW3$LU8V)-,6%I:#=6<%59)B-X03MA1$AX2DQP4$IM
M9WI82#%I-'1$4$Y6=#-:*TI6-6UN-$9!46I+2&)O5BME3D)E3U,V,CAO84QA
M>5)08C(W>'1%=V-F=DI(<GAO47 Y)B-X03M1=G-'4E=(=5!N:E%16GE,24Y0
M<VYU<FQ9>4-%1S=N=U592GIO2GA9:DM637!L5E)%<6EI<4=1069*:'1M1S=7
M;%1&2U)M3BM2*T4Y)B-X03MF1$-H8TDS+T%*5#DR0E8T4B\U5#DR1E8T4B\U
M5#DR0E9W5G9!-'%V0W0T2$96-%4K1TMR=T0T67!8<41I<319<79'2W0T<3=&
M6%EQ)B-X03LO=T0O,E$]/3PO>&UP1TEM9SII;6%G93X*(" @(" @(" @(" @
M(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @
M/"]X;7 Z5&AU;6)N86EL<SX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^"B @
M(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @(" @
M('AM;&YS.G!D9CTB:'1T<#HO+VYS+F%D;V)E+F-O;2]P9&8O,2XS+R(^"B @
M(" @(" @(#QP9&8Z4')O9'5C97(^36EC<F]S;V9TPJX@4&]W97)0;VEN=,*N
M(#(P,3 \+W!D9CI0<F]D=6-E<CX*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^
M"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @
M(" @('AM;&YS.F1C/2)H='1P.B\O<'5R;"YO<F<O9&,O96QE;65N=',O,2XQ
M+R(^"B @(" @(" @(#QD8SIC<F5A=&]R/@H@(" @(" @(" @(" \<F1F.E-E
M<3X*(" @(" @(" @(" @(" @/')D9CIL:3Y*87-O;B!"<F%D96X\+W)D9CIL
M:3X*(" @(" @(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+V1C.F-R96%T
M;W(^"B @(" @(" @(#QD8SIT:71L93X*(" @(" @(" @(" @/')D9CI!;'0^
M"B @(" @(" @(" @(" @(#QR9&8Z;&D@>&UL.FQA;F<](G@M9&5F875L="(^
M5&%R9V5T:6YG("!#<FET:6-A;"!);6UU;F4@($1R:79E<G,@;V8@0V%N8V5R
M("!A;F0@26YF;&%M;6%T:6]N/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F
M.D%L=#X*(" @(" @(" @/"]D8SIT:71L93X*(" @(" @(" @/&1C.F1E<V-R
M:7!T:6]N/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @(" @(" @(" @(" @
M/')D9CIL:2!X;6PZ;&%N9STB>"UR97!A:7(B/D9I;&4@3F%M93H@(" @(" @
M(" @(" @("!G,C=T,S<N86DF(WA!.U5S97)N86UE.B @(" @(" @(" @(" @
M<G(Q-3$Q.#$F(WA!.TQO8V%L(%1I;64Z(" @(" @(" @(" @(#(Y+4IU;BTR
M,#$Y(# V.C(Q.C,U)B-X03M%4U0@5&EM93H@(" @(" @(" @(" @(#(X+4IU
M;BTR,#$Y(#(P.C4Q.C,U)B-X03M38W)I<'0@5F5R<VEO;CH@(" @(" @(" R
M+C4F(WA!.TEL;'5S=')A=&]R(%9E<G-I;VXZ(" @(#$V+C N,"8C>$$[1W)A
M<&AI8R!T>7!E.B @(" @(" @("!!<G1W;W)K)B-X03LF(WA!.RHJ*E1H92!P
M<F5F;&EG:'0@8VAE8VL@:7,@8V]M<&QE=&4N(%!L96%S92!E;G-U<F4@;6%N
M=6%L(&-H96-K<R!A<F4@8V]M<&QE=&5D('!E<B!P<F]C97-S+BHJ*B8C>$$[
M)B-X03M4:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P<F5S96YT(&EN('1H92!D
M;V-U;65N=#HF(WA!.R8C>$$[07)I86Q-5"U";VQD)B-X03M!<FEA;$U4)B-X
M03M!<FEA;$U4+4ET86QI8R8C>$$[)B-X03LM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF(WA!.SPO<F1F.FQI/@H@
M(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z9&5S8W)I<'1I
M;VX^"B @(" @(" @(#QD8SIF;W)M870^87!P;&EC871I;VXO<&]S='-C<FEP
M=#PO9&,Z9F]R;6%T/@H@(" @(" \+W)D9CI$97-C<FEP=&EO;CX*(" @(" @
M/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*(" @(" @(" @(" @>&UL
M;G,Z>&UP5%!G/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O="]P9R\B
M"B @(" @(" @(" @('AM;&YS.G-T1&EM/2)H='1P.B\O;G,N861O8F4N8V]M
M+WAA<"\Q+C O<U1Y<&4O1&EM96YS:6]N<R,B"B @(" @(" @(" @('AM;&YS
M.G-T1FYT/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O1F]N
M=",B"B @(" @(" @(" @('AM;&YS.GAM<$<](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]G+R(^"B @(" @(" @(#QX;7!44&<Z36%X4&%G95-I>F4@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" \<W1$:6TZ
M=SXU.34N,C<U,SDQ/"]S=$1I;3IW/@H@(" @(" @(" @(" \<W1$:6TZ:#XX
M-#$N.#DP-C(U/"]S=$1I;3IH/@H@(" @(" @(" @(" \<W1$:6TZ=6YI=#Y0
M;VEN=',\+W-T1&EM.G5N:70^"B @(" @(" @(#PO>&UP5%!G.DUA>%!A9V53
M:7IE/@H@(" @(" @(" \>&UP5%!G.DY086=E<SXQ/"]X;7!44&<Z3E!A9V5S
M/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^5')U
M93PO>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^"B @(" @(" @(#QX
M;7!44&<Z2&%S5FES:6)L94]V97)P<FEN=#Y&86QS93PO>&UP5%!G.DAA<U9I
M<VEB;&5/=F5R<')I;G0^"B @(" @(" @(#QX;7!44&<Z1F]N=',^"B @(" @
M(" @(" @(#QR9&8Z0F%G/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T1FYT
M.F9O;G1.86UE/D%R:6%L350M271A;&EC/"]S=$9N=#IF;VYT3F%M93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86UI;'D^07)I86P@350\+W-T
M1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT
M1F%C93Y)=&%L:6,\+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @(" @
M(" \<W1&;G0Z9F]N=%1Y<&4^5'EP92 Q/"]S=$9N=#IF;VYT5'EP93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^,# Q+C P,SPO
M<W1&;G0Z=F5R<VEO;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT
M.F-O;7!O<VET93Y&86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @
M(" @(" @(" \<W1&;G0Z9F]N=$9I;&5.86UE/F%R:6E?7U\N4$9".R!A<FEI
M7U]?+E!&33PO<W1&;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @(" @(" @(" \
M+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E
M/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT3F%M
M93Y!<FEA;$U4+4)O;&0\+W-T1FYT.F9O;G1.86UE/@H@(" @(" @(" @(" @
M(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y!<FEA;"!-5#PO<W1&;G0Z9F]N=$9A
M;6EL>3X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&86-E/D)O;&0\
M+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N
M=%1Y<&4^5'EP92 Q/"]S=$9N=#IF;VYT5'EP93X*(" @(" @(" @(" @(" @
M(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^,# Q+C P,SPO<W1&;G0Z=F5R<VEO
M;E-T<FEN9SX*(" @(" @(" @(" @(" @(" @/'-T1FYT.F-O;7!O<VET93Y&
M86QS93PO<W1&;G0Z8V]M<&]S:71E/@H@(" @(" @(" @(" @(" @(" \<W1&
M;G0Z9F]N=$9I;&5.86UE/F%R:6%B7U\N4$9".R!A<FEA8E]?+E!&33PO<W1&
M;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^
M"B @(" @(" @(" @(" @(" @(#QS=$9N=#IF;VYT3F%M93Y!<FEA;$U4/"]S
M=$9N=#IF;VYT3F%M93X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&
M86UI;'D^07)I86P\+W-T1FYT.F9O;G1&86UI;'D^"B @(" @(" @(" @(" @
M(" @(#QS=$9N=#IF;VYT1F%C93Y296=U;&%R/"]S=$9N=#IF;VYT1F%C93X*
M(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G14>7!E/D]P96X@5'EP93PO
M<W1&;G0Z9F]N=%1Y<&4^"B @(" @(" @(" @(" @(" @(#QS=$9N=#IV97)S
M:6]N4W1R:6YG/E9E<G-I;VX@-2XR,#PO<W1&;G0Z=F5R<VEO;E-T<FEN9SX*
M(" @(" @(" @(" @(" @(" @/'-T1FYT.F-O;7!O<VET93Y&86QS93PO<W1&
M;G0Z8V]M<&]S:71E/@H@(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9I
M;&5.86UE/F%R:6%L+G1T9CPO<W1&;G0Z9F]N=$9I;&5.86UE/@H@(" @(" @
M(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @/"]R9&8Z0F%G/@H@(" @
M(" @(" \+WAM<%109SI&;VYT<SX*(" @(" @(" @/'AM<%109SI0;&%T94YA
M;65S/@H@(" @(" @(" @(" \<F1F.E-E<3X*(" @(" @(" @(" @(" @/')D
M9CIL:3Y#>6%N/"]R9&8Z;&D^"B @(" @(" @(" @(" @(#QR9&8Z;&D^36%G
M96YT83PO<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI/EEE;&QO=SPO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI/D)L86-K/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X;7!44&<Z4&QA
M=&5.86UE<SX*(" @(" @(" @/'AM<%109SI3=V%T8VA'<F]U<',^"B @(" @
M(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP
M87)S951Y<&4](E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'AM<$<Z
M9W)O=7!.86UE/D1E9F%U;'0@4W=A=&-H($=R;W5P/"]X;7!'.F=R;W5P3F%M
M93X*(" @(" @(" @(" @(" @(" @/'AM<$<Z9W)O=7!4>7!E/C \+WAM<$<Z
M9W)O=7!4>7!E/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @
M(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<%109SI3=V%T8VA'<F]U<',^
M"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T
M:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7!-33TB:'1T
M<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM+R(*(" @(" @(" @(" @>&UL
M;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]S5'EP92]2
M97-O=7)C95)E9B,B"B @(" @(" @(" @('AM;&YS.G-T179T/2)H='1P.B\O
M;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O4F5S;W5R8V5%=F5N=",B/@H@
M(" @(" @(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S
M;W5R8V4B/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED
M.C)%1C4R,3%#,#(Y044Y,3$Y-4$Y0C,W13 X,3(S,#4T/"]S=%)E9CII;G-T
M86YC94E$/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED
M.C)%1C4R,3%#,#(Y044Y,3$Y-4$Y0C,W13 X,3(S,#4T/"]S=%)E9CID;V-U
M;65N=$E$/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$
M/GAM<"YD:60Z,D1&-3(Q,4,P,CE!13DQ,3DU03E",S=%,#@Q,C,P-30\+W-T
M4F5F.F]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.G)E
M;F1I=&EO;D-L87-S/F1E9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@
M(" @(" @(" \+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ
M1&]C=6UE;G1)1#YX;7 N9&ED.C)&1C4R,3%#,#(Y044Y,3$Y-4$Y0C,W13 X
M,3(S,#4T/"]X;7!-33I$;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ26YS
M=&%N8V5)1#YX;7 N:6ED.C)&1C4R,3%#,#(Y044Y,3$Y-4$Y0C,W13 X,3(S
M,#4T/"]X;7!-33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN
M86Q$;V-U;65N=$E$/GAM<"YD:60Z,D1&-3(Q,4,P,CE!13DQ,3DU03E",S=%
M,#@Q,C,P-30\+WAM<$U-.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @
M/'AM<$U-.DAI<W1O<GD^"B @(" @(" @(" @(#QR9&8Z4V5Q/@H@(" @(" @
M(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4](E)E<V]U<F-E(CX*(" @
M(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS879E9#PO<W1%=G0Z86-T
M:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z:6YS=&%N8V5)1#YX;7 N
M:6ED.C)$1C4R,3%#,#(Y044Y,3$Y-4$Y0C,W13 X,3(S,#4T/"]S=$5V=#II
M;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z=VAE;CXR,#$Y
M+3 V+3(Y5# V.C(Q.C(W*S U.C,P/"]S=$5V=#IW:&5N/@H@(" @(" @(" @
M(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!9&]B92!);&QU<W1R871O
M<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R94%G96YT/@H@(" @(" @
M(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S=$5V=#IC:&%N9V5D/@H@
M(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @(" @(" @(" @/')D9CIL
M:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @
M(#QS=$5V=#IA8W1I;VX^<V%V960\+W-T179T.F%C=&EO;CX*(" @(" @(" @
M(" @(" @(" @/'-T179T.FEN<W1A;F-E240^>&UP+FEI9#HR1D8U,C$Q0S R
M.4%%.3$Q.35!.4(S-T4P.#$R,S U-#PO<W1%=G0Z:6YS=&%N8V5)1#X*(" @
M(" @(" @(" @(" @(" @/'-T179T.G=H96X^,C Q.2TP-BTR.50P-CHR,3HT
M-RLP-3HS,#PO<W1%=G0Z=VAE;CX*(" @(" @(" @(" @(" @(" @/'-T179T
M.G-O9G1W87)E06=E;G0^061O8F4@26QL=7-T<F%T;W(@0U,V("A7:6YD;W=S
M*3PO<W1%=G0Z<V]F='=A<F5!9V5N=#X*(" @(" @(" @(" @(" @(" @/'-T
M179T.F-H86YG960^+SPO<W1%=G0Z8VAA;F=E9#X*(" @(" @(" @(" @(" @
M/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @(" @(" @/"]X
M;7!-33I(:7-T;W)Y/@H@(" @(" @(" \>&UP34TZ4F5N9&ET:6]N0VQA<W,^
M9&5F875L=#PO>&UP34TZ4F5N9&ET:6]N0VQA<W,^"B @(" @(#PO<F1F.D1E
M<V-R:7!T:6]N/@H@(" \+W)D9CI21$8^"CPO>#IX;7!M971A/@H@(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @
M(" @(" @(" @(" @(" @"CP_>'!A8VME="!E;F0](G<B/S[_VP!#  $! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0'_VP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $(
M ET# 1$  A$! Q$!_\0 'P   @$$ P$!              0#!08'" $""0H+
M_\0 ;Q    8"  $&!P<,"PD*#0,% 0(#! 4&  <($1(3,8&Q%!48(3)QP0D6
M05>7U=87&2(V45AA<G66M-$C)"5"5I.5H=+3UU)35%5CD9*4HC0X0T1%8G-W
M@N(F)S,U9&9XA[6VM]3P1G1V@X:SQ>'_Q  = 0$  @(# 0$
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M6;A=F\WOO)J[:K*MG35SM"_(.&SA YDET%T%9PJJ*R*I3)JI*%*=,Y3$.4#
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M6=.PQ%SO8[FZI>"G U%SLU>8T8I1BE&*5M?P)?[]#A8_Z^=8?_-L7G6]8_\
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M449&>1R%$$'C@@^(YQ62/!!__ -E*MN']RG[:/!!_P#P#8IN']RG[:/!!_\
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M_P!;/GUK^'5W^NW\67W-8_F:[^?\>V"U]V6/YM<_&4]I=T,_ZV?/K7\.KO\
M7<N+/[FL/S-=_2#'M@M?=EC^;7/QE/:7=#/^MGSZU_#J[?7=.+7[FL/S,=_/
M^/;!:^[+'\VN?C*>TNZ&?];/GUK^'5W^N\<6W]SJ_P#,QW](,>V"U]V6/YM<
M_&4'\B_H:'$>NSY]9_AU=_KO?%O_ '.KOS+>?2''M@M?=EC^;7/QE2/Y%_0T
M.7KL^?6?X=7?Z[]Q<_W.K1__ ++>>RPX]L%K[LL?S:Y^,H/Y&'0T.7KL^?&?
MX=7?Z\#Q=?W.K/S+>?2+'M@M?=EC^;7/QE2/Y&'0V. .K/GQG^'5W#W87B\
M>7FZL_,IY](L>V"U_P!EC^;7/Q=/:8]#?;JSY\9_AM=P]V)XO@\X%U7^93WZ
M18]L%K_LL?S:Y^+I[3'H;[=6?/C/\-KN'NQO%^7J)JGS_P#J2]^D>/; Z_\
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M!3P;HQ.NL;E% 5.4X_9]7)UE>CM,N:J9UNNT1U:JCVPV=F\E;_=+=L4MUPQ
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MH$1<:<>W,MW"3"O<EVT"")0E@Q529:9$7<DPF8I=CH5*<>2&0'I,=E'?K6Z
MD)5R,Z]RGK)!NNE(,?4JKJ;<NVD7%$&VKA7 MK%TE7 1YCK=O8BK,E1B09LE
MT]6TU'/6*<;V%F.#V<6A)69HUG9SQDI+3*</$W!:HZPEG$=N>BV6YPK:7+:K
MP2,87! \&SCF-2BY6>=V%K+-YJ*7,T**1NUR- RE1GI-MF-RMKVGTL,3S LK
MZFM06V7<(Z)'=UR#+4])C-LMP&7Y+DM#Z)#"RCO:\\A],4%$V+"OMK>@;HVM
M%39=F1>-4Q&Y&BK[;++-=AFTV(RI%G6)[LA^[RHD!FW.Q'(,ML.G>-/G[%[%
MOGD9)-'#"1CG3AB_8NT5&[MD]:+';NFCINJ4JJ#ANNFHBLBH4JB2A#$.4#%$
M,Z"ZTXRXXR\A;3K2UM.MN)*%MN-J*5H6E0!2M"@4J20"""",BO8F'V93#,F,
MZW(CR&FWX[[*TN,O,O(#C3K3B"4.-N-J2M"TDI4E04DD$4KE*RT8I1BE&*48
MI62=0;5MVD=ET[:E&>^!66F3+>58B83^#/40 R$C$2!$S$.M%S4:L[BI- IR
MF68O%TRG(<Q3EY>PWN=IR\6^]VUSJYEOD(?;R3L=2.]=CN@$%3,AI2V'D@@J
M;<4 0<$=:UAI2T:XTS>=*7UCK[9>H;D1_ 3UK"SA<:9'*@H(E0I*&I<5P@A#
M[+:B% $'[>M$;GJ/$%J>F;;I2_/A;;%)NE&1U"*/(.70,9M-5^2Y@ !9"%DT
MG+!P(%!-QT)';85&CANJI^C>F=0P-4V.WWVW*S'G,A9;)!<C/I[R1%=Q_E8[
MR5M+(&U6T+1E"DJ/X=Z\T7=^CW5EZTC>V\3;1*4TE]*5)9G1%@.PKC&W9)CS
M8JVI#8)*F]Y9<VNMN)3EW.>KJ%&*48I1BE&*48I4#ENFZ04;J\[HU2\T_,,)
M3"7E 1 #!YP >3D'[H"(?#BE8F=V?3+5=PV>[!I35PS6<H.T'%V@D%FJ[)S9
MV+Q%RDK(%.@LT>4FYM'*:A2'0=5&SH*E*K 2I&F3#IY)4?\ =/8D]G8I)\BD
M]HK&2V3Q4G(X>$.&-V?'_-5G]4]AJ$M@TJNNDV3V#2U'*[E%FBW3N\$9=9XY
MD(N);M4D2R(J*.5Y6<A8Q% A155D)B+9$(9S(-$UA#N#E*L>/O3RP3V=@)\@
M)\52%HY!:>SPA\0QS[2!Y2*1+9]#.&Z3I/9=#5:KMV[U%RG?Z\=!9H\CXF7:
M.DEBR8IJ-G45/P4FW7(84EH^:B7J1C-I)FHLV.<BA>>6-ISP)X<O$4D>4$>(
MU.]!Y+3QXCOAQX ]O80?(1VUPM/:'3*J=?9%&2(D5P=8ZE^KZ94B,VMF>NS*
M&-) !"M65*N+MP8W("+6I69PJ)4H&5.UCJW/S%_LGQXQXOYR?VAVBHZQ'YZ/
MVA\9[>Q*OV3V&NPR.C17\&&_T[PGPCP3P?W\P?3^%>,/%/@W1>,.?X1XU_<S
MH>;TGC#]I<WPG]BQM<'':KAX]I\O9V<?)4[T?GI_:';CM[>'EI0DKH%<J9TM
MCTA4BQ6YT3)[ @#E5*[;5EXU,F8LD(*%<L[I373<2B(+-K965TQ,E/19W<['
M1CO%\,X[T_SL^+^:K]D]AJ.L1^>C]H?$>WL4G]H=HJ%62X?$T%7*VR:.FV2;
MN'JSA385?(@DT:1\K+NG2BII(")MFT5!3DFX7,8$D8^&E7JABMHYVHBVNGAL
M7Q/+8>9(^+QDCSD#QTZQO\]'[0\63V]@)\Q[*[JCH0BJK=6_4]-PBY7:*H'O
MD(19-XV?RL4Y:J)&D .1PWE(.:C5T#%!5*0AY1F<I7$>[31C8OGL5\7>GL![
M.P@^0@\C4[T?GI[/"'/ECGV@CS53N=P_+&132V%353KF131(G?X(YE3N7%9:
M-R)%+(B90[AU=::U1*3E%5Q;*RBF!E9Z+*[G#H]RKA_-/(9^+^:KY#V&F]'Y
MZ?VAX\?'_.3^T.T53SK<.W0^%!L:D^#>"@]%S]4.!Z &GB\9;PL5O&?1@V\4
ME&3Z?G=%XO 7O.\& 5<G#N<;5Y[-ASSQV=O#RU'6(_/1V^$.S/;V<?)43A'A
M]35636O]/241.X(L12_PB9TE&KFR,G1%2FD0,F=L\IMO:."F !1<U6R(*@56
M#DRM0#OYBCX_ /Q'Q <PI/RCM%3O1^>G]H?&.WM!^0]AJ#P+0"RZ;9.]U-1=
M9=NU103OL,=95RZ?Q,6V;I)ED!.HNXE)^"C4$2E%19_-1+-,IG$BS36?E?S5
M>7:>/,]G8#RQP![*;T?GI[/"'Q#M[2!YQVUCK4>W>&.\;BN>L*#;FC_9^M$H
MF5<0;B327)-URQUF%L41=*:Y2<.(^UUE>+LL>!I.+76-'N543O&[9!W%.WUE
MMO(;2XI.$+) /802"A0YI/ \"./B)P0*(?;6M;:5#>C!([4D A23[I.%#B.1
MY\P3MWF"LM:3\8?VP\&7_MI:]_\ IEN/-F/X,G_[,O\ [QJM21RC?^_1_P!T
M[6Y9^OL]HYK5F'@'R_94"GP=OLQ4#P5>;ZZ@/U=OL'%5J _HCV=X8I4 ]0^H
M>[%*[M4^D.8.3EY"\O\ . ?<'[N*?WYX^NK'6J5W/LYI:$KGT5"1KIHYS1?%
MY!\)FQ5=&+,^,>3GEYJ:J"?0 '-_8.7]\.=!>T_K!?2+%U(WJXMZ*:L*K?(T
M9W$@B1=RY)4F[=W9WIVH<91U(&/R/\ZNWMW;3B=&/V5>GDKU.Y=A+9U+W5CJ
MK<$,@V_N7.U65(=5UO/\KCQ5I5Q*\/\ ?-B[)W-::_3*-8&9-!:D@HDUIUPT
MLEQE73&W;X=W"-TO>I&P1T;K_9$7!3,2_A9"0@YZ-4LSVFJ28QK- [PGI;+R
M$(:25*'Y5PJVK*4\0T$%U(22M&1QP0=H5C)X5TAQM2EN* 0?R:!Q *C@NDAM
M6X * ((X$;L9KH\L_%.RGKZM'Q^QWD6S8W<:]!(59$.CIA81F36\Y&S<YK=^
MV&\@JLSDYV/\8[+M1IA2VQ4IJYPBU@&L8VL83G9GO<G=[K)*P0E8[WQ X0D#
M;AP$G(EW*L;B,*P,#ECO2"4>%X\=^<Y!1RJP;;Y3-OUQM.J6E/<*D)*5G;$%
MKTE=HC=_+7&5DZ_2UJU#75:3UU"SL=5EF\Q;(^*G9"OTAT<B,PVFW3.WQ-:9
MGL.I2M"D]7D*05[E<$@%6XIPLI*CA.4@J\6.]*C53UBDJ!WX(<"<)&3P3@*R
MG('$@$A.>/NL8RT_L7$JPFU'K4FRWWBRYR#S9<*I0HIQ6H>C1?$9KTD$CJIT
MSJQ)*Z.9OA_&\KNV<!)6^<50!891&!V"$%&*T"62,'JQE.$'>=Q465YZP$X3
MAW;S"0#C&4Y-7)=SPW<%'<, @)#J<;>'?9;*CWNXX[% "KVTN3:,UN*7N5X;
M[$8P\[4-AQU6BY^O!#P2,5#<0&P5:@:4:I0B:U?GE]:/Z,M&-YIRQF9:'564
M?,GLI%R?B^CNP-!*=A(4@D@Y))91NP<\1U@7G P#CQ$9EO>5[E;N(6 " !@.
MJVYX @E!3C."1S&0:ET!2-UQ&U-TS6VX6*8/+M5=:O%;)6[E,6>$5GF;_8J2
MT+4VTU2*RC&Q-8AGT/')-00.J4C6.E9?QQ-V&9D,/*:*&@V2=BE\"@).T[.*
ML*.5*()_<,  5+:7 M97@$A'$+RG/?9"<A(P!@<NPG)))PH2:X\%FED;)1,@
MG(-:7-/()ZO U-%%Y:-5U"?UU8&B8+,CM_"-P[+E*YM_6R3LAF"U6K[N.<BV
MC'B[13)MB9!W#&X C*N"7%!:3S_R: 6U_P X]HS6/,CCPX[20>]&5(!21Y7%
M$+3XL#'+.49:P\898Q$T.[OIX0ZVP0K,R&OG"EI>V!O":S-1HJ?AY/5;"74K
MZTZYV45M(VZIZO@G8M!8V.W,(AG6+)8Y"8_CV9[S<-_>@97N((<QNQLR$J<(
MYI222D"I['#.#NP=O'.$;1@ISC)7Q4E(X8)  *JFR9<353BMF1HI6NMQTCL7
M8-EH3FGTT;,V)!RW$G=Y>XA:VS>#L=PCY>PPD[ O:K,5B-M(!0I-Q)0E-=S-
M?G)%02RHMGO580@+W$ Y#* D#)"2 00H*QA8P5X(  .I"P<@;EE)2,\"ZHG(
MXG)!&TIW=Z<XR,UO5J9>TRNM*1(7:.EHNV.:Y&GGV<ZJP7F"2((%(NM(J1E?
MJK+PIX)0>*D3J]:41%?HG->A')%HQKJ.!(6H((*<\,9QCXLE7+EX1\IYUL("
MBE)/ X&<D9S\?!/_ &1Y!RK(?@WX/YO^[E*M@_%\H^VCP;\'\W_=Q3!^+Y1]
MM8MLY.9+NB_Y-#^=NGZL5D P@^0_'2U8^V.#_*K'](3Q6,<QY1]=;*R\W&03
M-5]*/$6C9$HG.HL<I  H!RCUC_-UCBL]:TR/$@O-JOFVKJ;-W@D>=5)[-MB(
M1U78J)>94CVT2Z\?7FBB7G,HBO*)K%* CT0@&2D%:@E(*E$X"4@DDGA@ <2<
M^(<:A:D-(4XZM#2$C<I;B@E*4^,J)X) \9. *P?8]Y[$>S-?<^_[A_K8P<HZ
M>NX9]MJ =N7!5H>2C2M) T96[3X.9)5^1<"QTM%.>D2 JSM=F*S1SR;=FNRT
ME2;9-4E:<)48SR1S!RG(2#RQGB//QKK;^L-),.!#NI;,E25'<E-QAJ([U0VJ
MVN+VD9Y=ZKS9K),!OC9ZQ172JU7V(P1(*CISJF\5VZ.6Z1>01/XD:OD+$L/W
M4VT,NH'F Q"B(!FI(A3(O_K,23'XXR\RXV#Y"M(!\Q-<K N]GNG_ ,FW6WS\
M#)$27'DD?K!EQ93\>X CQBLVZ_WC2K\=5DS>'CYIJH*#^%E$58^58N2@ G;N
MV#I-%RW7)RASTEDDU2_"0,UJY$@CF//XOEJM[2$#5UH(" @,PVY!#S@/[3D,
M5C7R\_H-8&3^'L]N*AOQ^;TU)BI7R\_H-3$]$.WO'%5/@#R_;4I.OL]H8K+4
MN*4QBE:N<7_#G'\2NFIFHIIMD;G#"I8=?2JW,3\#LC1N<"QR[@>04HNP-Q/$
MR/.$R*/3-I,R*R\8V .@=).BF=<::DVX);3<XV9EFD+PGJIS:3AE:_<L3$9C
MOYRE.Y#Y2I;#>/9>@OI4E=$VO(%[4IU=@G[+7J>$WN5U]I?<23*;:&0N9;'=
MLV+@!;G5O0PXVW+>)^3>2C7\-(R$1*LW$?*13UU&R3!VF9%TQ?L5U&KQFY1.
M '2<-G"2B*R9@ Q%"&*8 $!S\\WV'HS[T:0VME^.ZXP^RX"EQIYI9;<;6D\4
MK0M*DJ!X@@BOVKB2XT^+&G0GVI4.9'9EQ)+*PXS(C2&TO,/M+3E*VG6EI<;6
M"0I"@1P-)9BK8HQ2C%*,4HQ2LWQ^^;Q7]1US5%0G+33F\/>]AW27EJW;Y>')
M9R7JOZU@6\1)Q49X$11. )K]RX;NG3U\#D+(Z0(T8@U45D.QM:FN46PQ+' D
MS8"8]SNUQ??ASWXXF"YQ+/%3'>89ZL%,46I:T+6XYO[K6D(;V$N]'D:"L5PU
M=<M67B!:KRY,L.G++#B7.SPYJK6JPW'4UP<F19<KKU)5<#J%IMQIIE@M&VM.
M*>?+J4QZK7-]*5]GKQJ-8!Z-"UCO;7'2FFS(C+?5M@MC0JDT8OBI869JY]4
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MAE'4N^*V2,=0R3<'3Q4$4S'.)$^:43F$.4>H7":]<[A.N,@(#]PF29KX;&U
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M_P#LR_\ O&JU)'*-_P"_1_W3M;EGZ^SVCFM68> ?+]E0*?!V^S%0/!5YOKJ
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M[2!X3CSJT-H'C4H5\F7%IQ#2G$EN*=NZIG+>K,1- T.'7$2^+*LQ65%JJLB
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M\ ^7[*%/@[?9BH'@J\WUU ?J[?8.*K4!_1'L[PQ2H!ZA]0]V*5<=3_W:Y_\
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MJ4M:CS4I1)43\9))->W---L--,,H2VRRVAIIM PEMMM(0A"1XDI2 D#Q "M
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M.KN'N..YA#E^JMK'^(M7S/D^UOU+[_V/]F?^&J/;TZ#SCUFZNSP_REF\?_\
MGU*'N-FYQ$ ^JOK#S_Y"U_,V/:WZE]_['^Q/_#5'MZM!_ W5W])9OQ]=P]QI
MW./F^JQK#^(M?S-D>UOU-[_V+]FX?A:>WJT'\#=7?TEF_'UW#W&7=(^;ZK.K
M_P"(M?S-D^UNU+[_ -C_ &)_X:GMZM!_ W5W])9OQ]2![C%NH1 /JLZN\_\
MD+9\RX]K?J7W_L?[$_\ #5/MZM!? W5_[=F_B%=_K+^ZOC:U=_J]L^9LCVM^
MIO?^Q?LW#\+4>WJT'\#=7?TEF_'UW^LM[K^-O5O\1;/F7)]K=J7W_L?[$_\
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M[^]'_P [:A_X5H^O9\*G\!=^?FK0/[3\>V.T-[VZI_J%J_C5/:2=*_O[T?\
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ME./3&+18VY4?4O2Y'><"X=FES&MEMZ/T1F^$T3'%0RF/"4BXS9=^5G>[^U:
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M.3,J"2A)5S*03Y2./_EXJQJP%''+-6#EJK7J[[E=?YQG?+]K(&SIY7)NNEN
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MU*96\5*B-QA"P^I]#I$>K2>:BG(W;$EJ.3DXIE-14G(QKF3,A.N&"@QS%>2
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ME2&C)=2VN0[MXAB*T5R9"N2&&G%G 237SJ7VZSFQ[M:[]95_"9ZX6"5L4JH
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MV72,X7?+R*SO65>I87*=CRV;EW&+XU%GF-'6H,,-:>67BJ,VVEQ+'=4AY_J
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M:W&NCRP+NKL-O3TA;DZ-I-QMN0SJ5%KMCMVA33<&'#!FS;[I]UZ4PAR).O\
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M4HQ2C%*,4HQ2C%*X'J'U#W8I22A"<[G<TO.,7FF-S0YQBARB!1'DY1* F,(
M/F#G#]T<4I8Q" 8H@4H"0G,*(% .:01#E*7D#S%'FE^Q#D#[$OF\P8I2YBAS
MS&Y YP@4HFY Y1 .40 1ZQ !,80#J 1'DZQQ2ES  #R        !R
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M0>8\OH--$ZNWV!BJGPQY/MIDGHAV]XXJI\/SCT4V'6'K#OQ5*8#K#UAWXI3
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M\V14!%9S"R;*4026Y@'Z)59BNNFFIS1 W1F,!N:(#R<@\N24J3X0*?*"/KJ
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M5X6;G9QBDX9^&2=6@HR%D7C>2!"19,%8N0R@LE(!2X%X\+>DI)/C*=F0 <<
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M&\>FNW?ZQ;NSOF@ BF\UXZDMA3JE;592A'>A9XG<L[24\-J=A).,+(P?%L2
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MF'JC^3E9FQ621E[!.2;UTL<Z\A,2CYX8A4D 6!N@@DG92U+.5')P ,   #@
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M61 LF]7+#$.Z44!-J+9R]70!FBY1,L"J<;R >*21C@G)YG X9SV<!Q^45L"
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M28U_8Y:8J57I3=VGK-?FP#67K,+4(I2K3LJM87[.3=SKZ6&<"5\';9]V,@#
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MQ3E"8\RD$6PP4%$0MO;(-GB<C&M#$B#P#ITZ=K$M[, *.,)!X#)V )''Q9
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M:,7'O3%!5HQ?RR:0@$BN V* HI*\*V@C! V\2.../$ 8'G[:P]W%I#B(:%1
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MQ^#_ ">*R5)XJE/\6O\ _4W']7BE,>*I3_%K_P#U-Q_5XI4A(N3 //'/NO\
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9H#Z(>S%*EQ2C%*,4HQ2C%*,4HQ2C%*__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>24
<FILENAME>g723949g27z46.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g27z46.jpg
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MM<'4)C(Y1V>%DK;'1&)E<X>X*#-%2&2"IL;_Q  > 0$  @,! 0$! 0
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M)7/+(9*^(H2<5TCPDA*LAX21>R3P@8CEYSPPQK%K*4,*BI.?BJ-KD<!-A>W
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M#/:+2RM6I"8RZWVTM!PV(E-PMM!J+QBB+,T2/(YHLZYOB0K2>"E?P>NSR6T
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MC$QEE!C8.HH<FQBO+7@HGC@QQN,/+BL]FB.)! :1F;]ED@2. 4( -8$QQ5'
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M8F;3#S$O"=?)(]Y"D(]$_P!7_!_OJMSR?K_U0CTJN$>B?ZO^#_?2*W/)^O\
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M"<W 5K/<VQX( 4"C :^=C1\5V\3#MIC[@FR9D.K*BTE;BDIPIQ!*@I*1Y+D
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MLF@6%Q"!:GGVV;NLL<L'D-OVBZ.:"EM>I)17$>1!QJ,MEIT@Y/WDWY6,SNS
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ML;^ )#K'=K.S1W-[!I&!9EWM?M#XF"76OAX2AWS9INNKLB:T!W(TLTDG[E\
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M0I"%(1^>#G=_56[7_P#FPW][V)5_*'LB?]^73;_**1_[>I$?T@U'?[U>B?\
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MR>DL#V#!Z[I='$//^["RN-\@AY.;)Z2P/8,'KNET<0\_[L+*XWR"'DYLGI+
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M18.P'F#8^ZFSG_V+7_%4,>SW@Y7[7T6"[?\ UH1O_P"E=5GLC6Q?^U!>5_\
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M*I9]I1%6V:2F.*F&6-OT]3JA*560DZG(.I?DY^69FY5Y.Y;$PVEQM5OS585
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M$?#CT<9!BF9$=YCYW=R%XS08!V_#-U/.";452L<*E0'$M)=25'"5%0*$I2H
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MS3LO*)52I=<Q529N8EY<HD5)=>0%7C<(S26F)0._O;0@D]A2Y\9)Y%S-=/\
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M%BROCZYRN-EC25I,WSQN:0F4USM&DL&O-N@DZ>R#72/+LQKL .Y&IYMC,<Y
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MER3/,R+3@0MMC\@=7PZ)L8:SF,;;0H$'&%!*U*-PE#>$>#B!!*L1L,E)S4
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MV?NW^&*@K4%I(3<5FA[N&?\ J<33V<F@(%CHAIAOX:+]I1V^H?Y"=,>FO_\
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M)(1I?'),H2,Z$$@$-KIW#AA@O$J4HH1X8(6+N'&"4J%RIPJ%E)!&$C,"]QE
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M>QK;_ I^ .AGP;I7]&'3&?=RUP?SCZ6^UYGK1S]7]PGM]W&'3MO\3F[^!3\
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M3*I*GRC\J3-2DO.M;)URHL+4-C,MA6)I%EXDY@!1BBW9[^$-_L\1;Z]@XO\
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MMNR'S;Q;A*0I2BH V4M:!8!.9& GR9>??*#/R9D3_*XLW->J>_0S84YV[KR
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M*O$N4U;-AO4X;V]MCV1,HR:I4H6Z@,D"R:X[()*RQ2V@I(4D)MX"7"576[C
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M\OT/S?\ 7X]<>PU]D*_5TNT6^[_K4U3_ %[7_4F5ZVT:S]#$VO4WMULJ?/\
MU>.6]V+6NE>+#HU)&ZB1_;#01E?SU"*Q+L-_9!\?OTRT6_4_IIZK_5O^Q,;U
ML)UJ:$@ &IO>SJAP_P"31SG>Q2UW+(PZ,R.\?\XJ!PC_  AYHNH_8>>R )WQ
M[O3;3;M6M:_\M'5M_NQO;]28?UZE[JFA/OH][.J'U:,CL4]=UA_:Q);A_P X
MJ!]HQ=D^Q!\^L;XWOIYI^RV-OZ9^K_U+6_LO_8K UIZ$B_\ 91[-1/\ \.J'
MU:,I[%/7:+?VL26ZW^Z*@<%O?&/;'L0W/CNKWOI]I[5^W_UG:P_K_NNJX:UM
M!P .ZKV[WMJ/U:*CV*.N^Y_M8DMY_P"<>C_VC&_78[.Q9[CUMOYLVMR6AS7'
MV/7 UGR%-"<FC$FR?)UDKWII.73CKJZX"B1?"RSRGD9D.HH\XLN8V*Z8YED_
M#Z?ZS*34:$[2]'9IU]ZHKV,ZZ9:8E@S)!(+K:2^VV5+F2 T0@* 9+P405)O]
MMU ]C+I9HYIVQI5K$I<I)R= :$Y191%1I]1,Y6BK!+3#B9*8F$MMTQ(5-H+I
M0HSG::VL8:=P_H[K\_1_06%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"%(0
MI"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I"%(0I",?E
MD68IS%9-"I0%XSC,PC[S%I$VV)+"NX,4@;B6EW"L8WKBGB>%MY9"'A(10Q:'
M?.^C+HK88*8Y2HI4%)-E)(4#OL0;@YY;^&,*2%)*5"Z5 I(W7!%B,L]W!$<2
M#CUIR5Q':,#D<*$>8EN=4 C9#,<XO:R,@):8A$X(U%I+W<[%L9C9&H-%!FXR
M/$-1(3@S#/PRJ3_F0YK3#KB2VH*L6KX#8>#=2E'R9W4I1-[[[;LH@6D*"TE-
MPY;&+G.R0D'?E8)%K6S%]^<8F\\2-&/[Q('=T8I@LE+KL7E?&4-N[?;]?2_&
M-Q=BA;4E+=:-T[$U])Q[1:-,;(X"OL:/&>@6Y)-Z2<+YK74D'W0  4^#?"=F
MV5INHJ.%91C3X2B00H6)RM&"PV22<7A6Q#&L)58!(Q("@DY  @BQ&\&)HD,)
MC$J+AQKZV6,)@$G3F42SP+.#Q:9&E'W^+)GV1!)&1,QP890^ V"<$RF_^/;$
M>"^%BAKH5A2ABL?'&%6XW%PJV?G2#<9Y?'$RE)PW'B'$G>+&Q3?+S*(L<L_B
MC'ICI[74_>VR1RV/W=7AG3CZ;<79V>P?!\(ML.(;58L?!VUR#%5\!GD#BCYV
MUT5+DV:[M9ER&<YQ;R\I<6D$)-@;W%@?&0IL[QY4*4/UW&8!@I"5$$BY%K9G
M\U06-Q\BD@_JL<KB,:%XWZ9":96QC0_))KF\59X5)QO*&4Y^,HRP2N>S=I;;
M+*/>9 5Q9/LV;N7AC>J*>O9ZL$04JWMK2*#G;.72<6:5%8R3DI02DG=Y0A(L
M<LMUR;QV2 "+9* 2<SN"E* W\*U>GS1"S'Q&7&W2GL=YE >,<9Y'MV4,##%2
M]F,)-W+;XKZW.F=V]?9;E"(<<&!)7E=XD&N(G%GV:RG,28N)C4Z8.*+K87[M
MX #<I;22K 19NUL\ 4K,"P65!*?! (L16&2',9(PXEJ &,&Z[@Y8BE.1-RD
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MZIM%<"/5M]6&$<*N>OK0\U$7_%-E>^?</QU3:*X$>K;ZL,(X5<]?6AYJ(O\
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+>8/ +?G=8W,?_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>25
<FILENAME>g723949g36g08.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g36g08.jpg
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M 0$! ?_  !$( -("80,!$0 "$0$#$0'_Q  >  $  @,! 0$! 0
M!P@%!@D$ P$""O_$ $P0  $$ P ! P(# P8, @8+  0" P4&  $'"!(3%!$5
M"18A%Q@B(S%7EI?6)"4G-#4X6'=XM;;5,C,F-D%"4589-T-'86)CD9C7V/_$
M !P! 0 " P$! 0             " P$$!@<%"/_$ $<1  (! P,"! (%" H!
M @8#  $" P $$042(08Q!Q,B0111,E)A<8$5(T)RD9*QT@@6)#-38G.AHM&R
M@K,7)31#D]-CP?'_V@ , P$  A$#$0 _ /\ ?QBE,4IBE,4IBE,4IBE,4KF;
M^)OY"='\>Z1P*2Y]U3]C0M_\AJMSZ^7Y//XGIKT#1I:O6<V8DAJA)1$R_+$1
MBXX:2;"B!D2IVQ/@C._X2IM>Y91)*\H>/S-L+.J;BF7!&!N!&,YQD\#.36G>
M2O$L15_+W2JC/M#X4AB3M(.<8SQS6D<%\PZA4>==X[7TSS>FO)OG_*H:H+F
M?W6G>&2=:E+1*2<;7A(-M^$KS]TE[G(C:A 8]#BPXPIIA^1*CF#-$;G+;LSQ
M1I;"!W+8_/\ F[@ "<^IMH7OGW]LXJ,=PJI)(]SYR(%S^9\O:22!C@;BW;'M
M[U,,?^(SS"-%Z8UUSF';.#VKF?*'NWO4;IE5AF++;N9MFHB]3=.U7[+.19YK
M4P^)"R,/)2429%R97MF^V*#*EQ]1M'.SRWCE5Y/+W(QPKXSAL@$#&2" <@<=
MP#8+M/7O22-DC,NU@,L@]UP2._&"1@_MK#$><B>A^/??NA0-$[-Q17/N-S'1
MZ]TDVJ\QZA73 %Q)Q04A3I*M]"GN:V:W0OL,FR7/;+:8$UI! FCO2(X2^-+X
M;9+$A:.3?($9-SHPY (8%0ZJ>0' /8XK'Q.^*5@LD92,N&(1QC!P5(8H6&,E
M"P/SXYKR%?B'5RGBP],;Y?W?MM^AO&GG7D-:I.ET^AQC)=(L4"DZ8M4H*3>P
M8J D!%,++D:U'O'?4V2%BZON<99*($"T+9;?%&IF>)0S-](' 4>DD]^YQP,G
M%8^*"X79)(XA24E5495ARQ]0 (^J,]\#/.-SF_Q".9K"XXSRWG'8.XW/MG+F
M^TUSG7-Z[!NVJ YG[B!'[-<MS]DA(:%91+?(KP[#$K(N2%@$=C@MO)=%((B+
M1_SF]XXEC?RR[D[2_P EP"3Q@]A@')J1NDQ'L1Y6D3S B ;@GNS9( Y]/<Y8
M8%8HO\2;CA4-X^2-#H78NGRODI^U$"A4^GUF!1;HRT\B:B_SA3[G%6&TP;=>
MF0"9/;)!.RS(0,6/D)DN6:A4B2!>19R9E#M&@AV%F8G:5D)VLI4'(XS['VQG
MBL&\CQ$561S-O"JJC<&CQN5@2,')^>."<X[P3U3\1:1F O&6V<>A>C0VY;RT
MEO'_ +OQ>1I59-ZLB=KM>-*E>::CSRSHP&:)D78=X&9BK)&BZ8+;5(S46TQ*
MM!6I: &99"A_,"6*0,PCPQ&'SP2 ,Y!4_8#QFM[O/DE PS.8I8]H+Y4'*=\
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M;I 3C<%).W!Q[C@'@<57J#XN-VK\56S= J,3T 7AG,DP'2NJMVBD6"J4:?\
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M4P\D=Q#1"FG$L.N(VZVV]M&]-..-Z4C;B$+]*E(TM&UIUM.E)^OUU%MQ5@A
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M#J;79YZSF>+OD9Y"KF[!*VJR0\M7$2_&9:$KU#^S1$1#2"2;*[*.E[GE$O#
M@Q[:I+9BBC>,LV2VXC:)HHL *"#B0$ODDC"X[=SGC6EE=)%5>%*@Y\F63)+$
M8)0A5  '?GG/ '-ZLUJV:J!0_+F LMG[<!;( :B4WC\9?;%^=B[$N4:D*MRW
MIO3.3WV9L,2F CORJJ-L?+9J3BQ!9*SIEJR8#(K* .23%,[#P%5C*G<TA0;<
M8PTB)(@!R=V0X!.!AACGO5"S@F3<-JQ[CN)[A'=&)R %P4)')R"#D=J@#H_E
MY1.T>$_4;4Y&2]:D;M7N]TJ(KT>!-7] )%'M%FHP:[-:*7!R55K1<T$!%6-T
M>5E6(\ 6:1H69F(P9,V58L#1W"+D':8V))"YW*KG:&(+8R1P,G'8$XJIIUD@
M<X*DB10,%L;25&2H(7(P>2,9[G&:Z?9IUN4Q2F*4Q2F*4Q2OD^PR2R\,2RT0
M.0TXR^P^VAUE]EU.T.M/-.:4AQIQ"E(<;6E2%IWM*M;UO>LBRJZLCJKHZE65
M@&5E88964Y#*P)!!!!!P:DCO$Z21NT<D;*\<B,4='0AE=&4AE96 964@@@$$
M$5S@_$MC>Y ^-\3'^/ T;&@!WBI,W$&/:@ 3&8!,F.FLLPK,NEJ-8%;O&ZYL
MUL'39VM:%]/^*=3&M^;>),/74>@V4/APBPWJ7T:W4=J+&*X2P$,N%M1>;;9(
MQ-Y?G!,3;,;/S?G"O<_ VZ\)INK]4N?&R1[G3)M)F?3Y]0.K7%G)JYN(-SW[
M:9OOI)VM?.%J\I:V\S=YG]H^%(G@?QMIG8JWP^X^47.JC<^Y4"JUIV4F$^\V
M(';FQ CIL?;$.6)$346W/H)+:BSQI&OM%N$O1P;;)&]K^FG1^G]06?36H=;:
M38:CU-I5C9M-<#<(X[]4CEN5VV\D<%S MT'D6&5);4.7:*,*YS\&3Q*UKHW4
MNN=&\+.H]8T7H7J#5M32TLSL,TVD---!8R;[R*:\LKIM/,4+74$MOJ#1+&ES
M,SQC;:S.XKRBF*5#/<.#\_\ (.L1U2Z&*:_&1,Z+9(]V,=$%D!I>/'*1'/M&
M$@FK;:$-?'DUAH2D.4?CA8Z<8E*\1*PLE9'*\3%D[D8.<X(/?L1[9&>XSD8.
M"*Y(UE #>Q!&,9R.WL??!Q[X&<C(,=R_AIPJ9G.KV JNNME]DK(M0MC J(=@
M$*#"5#$#,U8?4.K\L%MR<,B=7)Q:V9(FP$_>RBGY*)K)$%,7$H"#=GRR67.>
MYSG//J[XP<C QV+9B8(R7)'TUVG&.!Q]'CT]NXY.<DDA<3KSF@5WEE&K'/:F
MPX/7:G%,1,8DCV%%NLM;6MPL]\<<5!DF<0X\;)R+C.BI*0()/-<>,)?><J=B
M[%F[L<FK%4(H4=AP*W7(U*F*4Q2J-<NX/Q^K>;?D1TFO\^KT5>)'FO()DJPB
MCNZ+W+WZ>Z^FZR8[2WEB!'VC\H5Y<T6&,.^>Z"X^^M3TA)+,^[=:]K%WH]EI
M-Q?S2Z=;2,(;9M@51"J"%6=5$DB1!V$22.Z1C 15VKCA=+\.^B=(ZNU?K/3>
MG;"TZFU:(_'ZK'YQEF:Z=GNY4A>5K6VGNWC5[N>V@AFNFW-<22&20M>7/A5W
M5,4IBE,4K$S\Y'5F"FK)+K*;B:_$R4Y*. QLE,FHCHD-X\U8<1#"'R\J4D8=
MW8\;% FR1SND"@B$E.M,KR 6( [D@#) Y/ Y. /O)P/>L$A02>P!)P"3@?8
M2?P&:Y?^)D5#QGDKT+7RX"PSQ,CUN1=M)-"\LH>\DAR]]<E!XZ6M'40 ^02#
M42(6+#I_+:6E&#QP;U>:W'H)7O=G),*]PH$8V[H"O"XR%3\X,GGGMGGFM2'
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MAU]H5WJ6HZ9%I\UIJ#68>U\[X.[40Q3;X!.TDBO%YGES)YLJ@[&# N43T?\
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M5MUT1;75Q^7+<7$>YK5O@WN;:%I[FVBF+9>>VB21Y \<<3>5(L<KL #ZY?\
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M0?(F#I#W[1>EL65FQJ/F) ^OH=NJEKNAL;!$.*%#,M2GB?NSF]O-I0:<Q'M
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MKHG2^%$<P@.>N/*A9-P.;&,CBFYK[<U4K43(O$1DI8B0E.2C1D#\$'3$<8I
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MQ(HU+[(8HH5CC6R&?*KJJ8I3%*X_?B%=(K,1UZC\^M=ILD+7YZE1!,]$P07
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MO^+$RNXS9VAOIOWO>2AU/*'HCI<]3#K Z5%_6$($^.\VXQN$'PHF^&\WX4W
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MQ4J8I3%*8I3%*8I5'_,G@W2NO,4J3Y5)D1\W#/24;-MM7&<K&B8B12PH1]*
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M+X^RHN7"9D(\G8Y+;)+&WQ"&7?9(9:?:]7H=;0XE2=:Q!!(/<$@_>.#6P""
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M;T6Z0W+Y)@R#Z+,6N^5746(XS*Q !E6O'4:U L'&N+ EM%6>#Y?(6';XL"5
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M"6I9HD@9(TG2]5*28D@"A9",DJ^EUU,;(11(1HZ'74:?VEQ>E861UQM8C;N
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MVB(Q!AX<BH:Q#@PP.KCY*JA90Q(0E07!.0^[<>W?80%YQ\LDU2/-8OAF4;G
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MEANVF./4ZHO<9$3TQ&GEAV+#/.X8(_O A4*<$MM)<>H?1QV.1 R-YA10I(X
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)IBE,4IBE?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>26
<FILENAME>g723949g36g59.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g36g59.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@
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M#M!V,?8+VR0?TF(E[*C!JU:'>6]%PDE64I6:9^O)#SD5&"YDT%V:=HAD<SK
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MG&3WGXE,#N'P">H(+\2Q/YN9_N<9/>?B4P.X? )Z@@OQ+$_FYG^YQD]Y^)3
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MN9%UKUQ0(6Q*Z6EZC"1^E6K*MJ).F< 9I(W':EIC=FL)E1_'MG$JV)&I8=%
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M]4YTHBHY*V%T,;Z?.L?._<L?JF+D(N/U(&W(J9Y,,[=!!5=C6.,FXGCI87,
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MY:]R,9)+BR^V'KRI:DUK ; 0L.[$=CN8&H--@J2-*MCR"U_+)^1'664<.ZW
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M,(F$4ET$'2"S5TBDY;.4E$'#==,BR"Z"Q!351624 R:J2J9C$43.4Q#D,)3
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M.$R#R.5GX1,(F$3")A$PB81,(F$3")A$PB81,(F$3"+4?:'WXO$S_%SRE_\
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M")A$PB81,(F$3")A$PB81,(OPHHFB05%5"))EZ/*.H8I"%Z1  Z3&$"ATB(
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MF^(^M4\ZG_;E_P N5K.EW=]"R/.I_P!N7_+F<'N/P*BOT!R#[0.7_*&85K7
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M5;JZ_P!FHZV":1D+X8YZ2>KCGBD>R1KXV21M<YKVN:"' G?GZ"O"S[)_'?\
M4_0_]1YP_2:C\/+_ #W?6O;>C4_X"+]&WZEW#K33&H],L9.,U'K*AZRCIIVB
M^EV-$JL+56DF];HBW0=OV\*S9I.W"* BBDLN4ZA$A$A3 7V96^223!D>YY&P
M+B3CW95C(XX\B-C6 [D- &??A=EY!33")A$PB81,(F$6G^;"UU4G5V^ 9@<S
M[_(+)Y#W>95B=?9XAF5A5PB^+:)(T5#NWA/K(I'.'Q HB'</?F.?]O[#^P6>
M7]O['^Q77<S.(-)-^U*28.5H]<M0.$RBGYP$%CI ?R/5)O(\H">4)0,( (]
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M]'_-&4/^R\XD9_T0L9S_ .-KQW^]3_W.%D_[277_ %6D6,;E3-%$!"NJ>_\
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MIO'^IT7UK^&YKV4 Z0JA/TC<?ZJRH_9Q<5 _Y"\.G.?^?W(<AGN*?[ENP?\
M:F\?ZG1?6I#S:LP!T_--/](W'^JLK/V<O%8_Z"<.=O\ G"Y=Q/=\RL;]BS87
M8_X5WD9V_P #HN_'>OQ].&SD#V5)(?;_ '2./]4_DRIWV='%8&?X!\.?^XW/
MR 5C?L6+ XX_A7>A_P#ZE$N.V#F+.3[%PS=U), 7:O&I3?.)P8A/3&B[0QS)
MC%AYSR"K"<">60#&* "8 Z<Y5Z^S9XHO5FNUEEX'L$$%WME?;)IHKC<3+%%7
MTLM+))'K:6F2-DQ<P/!;J R"-EOVS[&.Q6RY6^YQ\47>66W5U)71QR4E&&2/
MI)XZAC'EI#@QSHPUQ:0[!.#G"[?X;;S6421H,V\$TI M1/!*+*"*DI66P>6M
M'@)A\I5Y6">4LW+TJ'/6Q53 &[2ME!7Z=]AUTS_;6@'1/Q%5:KC:X)JG@ZIG
M>-=7:H09*JQZGG4^:V#54T+ 7.-MZZ%K8X;9&'>(^R0Z-/M?5#I LU/_ 'E7
MR1Q<1P1-]2GKY-+(+GI:,-BKW8AJG$ -K>JE)?)6N+?65B\2?MDG*)@,10H&
MZ2^T/:&?O!?E,'(RM'?E"+9I2EZ:@)S>,Q;E()"]Q*-8UG5+V77J6Y+P[82[
M.NT:VV#TF,%I2T5W"EDGGKR>A(6&3A$)N7<NDXY".>;5(V1TA$0;G2=3RW7U
M;<C+FC?UNQN 2<X [1JU;F-C!>3[0TL#M/6.W :3MZN^3D@#&3L,+RFY ;+W
M12N*>@]6I6795[I5&B];7ZY[YU&QL^U-<[$MDER$CH:&T>WW+#FDHIU7M802
MDK".W;Z:/-6ZY0NNX!!N55:516W8XXW3ROPQKG%[6Q2%L;V@1$F7JS@@O=@\
ML-:7N/8M)[Y&PL8"YS&Z7.DC#G-<>M $8>,C# ,')U..D;DD+9F"W;NO7^ZM
MXWNK62+)KBQ\_>/6IY_6]UITPM9SQ.XZ!J*"DE6LTYLK,U*>5I&8:OV4$E7%
MQ]>EE0FE%TE$VJ=3HXW11M<"7-I97A[7#&8W/(VQZP.,9)&V,*YLDC9)7-(T
MFJA86.:<XD$8.^?5QJS@#GG*[.Y=\Q-NZ?V_O*IU':6F*#$Z>XV5'?-<K.Q*
MNI+S^U[$I8KE'2FOX9\%SK9VZ4XC$1$8FI',)29:RLC%^@ID2<.S973P1R1Q
MN<R1QDF=$7,=@,&EI#R-+LXR3S P#E3GGDCDD#7QM$<+90UPR7DEXT Z@=\#
MD"<X[UQRZ<\-V1UZO4LSD]9U%'6VUN/>LV/%"R5YV[W7MN/W(QU^YF['!SWS
MHCG[!]'FN\DK5$HJF2D4=I3)<\\10_E@23:6,M:,/=K9*\SM/W.,QZ\ C20<
MZ1JRX'UA@K!J9-3CEK=$D3.I<W[H\2!A+@=0Q@.):-)]DY[EQAUS3W]-[%W?
MJV8O52K:LQ6N5;'3\A0*G5KY7&SG3\-/2L&[;7JK;A/<:Y<HF$A'*EKB=BZ_
M@T1L!B-X96*7&.:.Y"GB#8Y UQ =!U@>XM.)" <M,>DM)(TECSMN<C)6/2)2
M^1A(;D3:"T-</4!QN'Z@X8]8/:-\@8P%Z+\&YZ=L_#[C=8+->VNR9^6T_2'T
MK;6X=*SMVXA6JAHR77-,3JTA9:V0Q*W:9=W(>GS-CB926?L8EX]7BF6I4@-J
M)@&Z )' -^;/,;##3S:,8 ( )&YVJ<DP1$NUDQM)=W[=NYR1R))R2"3C.%M7
ME"N3")A$PB81,(O ODI68RQ\T[@TL.[HUE'U2Y:]V%6C+0NZ7".K[I,RO%&@
M.PE+##Q2VNV,[1JPZ2EZ=&1<JFFS4WHO.;)^;\(=Q*2?4A=BG;B,[M>QV\?K
MMQ,_8$ZL/=LXD;]5I9J.PYLPS.<R<G,<-I!H<3"TY< 6Y:,%H!V,A+L#<^^F
M<M=)>8=7XP;VI/(&>V1&QNOYRKTJ\<KMRZW.YNTM$S%_MG(R*J!8B@6AJ6F2
M*5*AJM(PDTWE+2W=6L7+(];<L( ZJ#YLWW'31.B#"7ASFP1O&D$-;$79<TZO
M6)!&&^KOG)Y+4$,C92X!I#73/82X@N=+C#3AITAI&Y];.QPN<1.I>05HY9/=
MC;/I%$9:F@8NUPFHGU+VJ]CYW7KBV5<T7;-AOZ@EK) ;?LRYKH-J^A/N[O&,
MZ745U4(V(D))22>2D3)$V ,87:R6F34P$/TNRU@=K]5C=S@-)<[F0, 2#)#,
M7O:W0-09I>06ZFX+RW1N]WLYUC2WD,YS];BG2R:_WMS)K"=HNEQ*SMFE5@GM
M@6)Q:;.Y],T]#.12>3+E)%9PBV%3S#-,Q !NV(FB7I @#F)G:HH#I:W:39HT
MCV^Y9A;IDG&7.]9F[CD_>V]JWNS66PM:[AQ"X^7VRS%PM5'?R5AGG7IDJ^2O
MNQXM-RY\TFCYPK"(MS"-:AYM),OFVC-!+I+Y7D>48QAN;/*T!H< !L/48?UE
MI*I=!$XESFDD\SK>/U!P"\U>0@\+-1;!L.E7>B+V_L9HR.:-9YEM*_C$HN[5
M$(.(]<[=YL#SZB;(\@B+E,Z!P4\T<"D.40 ;&3S$CUQC4,^HSYO^ZM>1L#7%
MG5NSC8ZWXW&W-RZNXE2G#FZQG'?2TMHV\KWF<UOK2)E[5]TR\-(-U/&US$RD
MG)DCH^]MO16CMRFX.DT9L6Z3?SI4D6Z*)"D+9/-,)IL.;I$LH T,)P'N':WY
MNTJN$0%L3#&[46L!.M^,EHR?:\EZV0'##C?6)V%LL)0I%G-5Z6CIR(=GV'LY
MZ1K*1+Q%^P<'9O[DZ8NRH.VZ2IFSQLX:+@44G""J)SIFUS42N!!<,$$'U&#8
M['<-S\%N"GB:00TY!!'KO.XW&Q=CXK:/*5<F$3")A$PB81,(F$3")A$PB81,
M(F$7@5\I[K:C:KY6\>N8*FKWFT5:W6+C<=DT",E&T %A0TJ\I1*G;7K]6*F_
M/A7'E[BG%A04C7";NL51H@N9!DU=J9]9X%O4U9:+AP8:_P"U\ERDZJV5KXC.
MVG%6R4UM-IZZ$M-0R(MIBU^145+W#+BT+\A]/G 5%:.+[!TY,L XAI>$Z=M5
MQ588JMM#-<3:YJ=EBN8D-'6MF;;IJELMT;+%I=;;; PD1,D7ISPJY0S/+[3_
M -V5WJE[JF D;#*0U4:2%I3L[FS1\**;21L""J-?@4VD>2:!_"H%$KE1=W$R
M!S>:2(B*WB^*N'XN&KG]JVW%MQF9#'+4N93FG;3OERYD)!GF+GF+1*=V@-D9
MS)./M?1)TBU72EPM_"N3AJ7ANBGKJFDML4]R;<9+A#2:8IZYCF4-$V* 5?7T
M; 1(Y\M+.3I:&%^WF>:7U%,(F$3")A$PB81,(M/\V%KJI.KM\ S YGW^063R
M'N\RK$Z^SQ#,K"KA%PW8G]B\G_Y.?_X#X1=6V/\ KY,_X6D/_FEL_#?&'^5/
M$?\ Z]>/]OG7ZMX;_P 0V7_TBV?['"N)+=?:'=GD9.9\?Z35Z2'EX'Z5\=;K
M[0[LYLOMG^W:5T(>7@?I7R5^L_Q\0SGR^P?[=A6W%[ _MV!?&<?7#M[\Y,O;
M^5]:Z<//Q/T+XJOO_OOY<TIN7@/I6XSGX>87QEOK]@9SYN7@/I6VSV1X_25\
MU;K-\![QSGR<S[V_2%NQ<O!OT+YJW6'P'N-FD_F?R1_2"V8^WP\U\9?W=GCF
M@_EX'Z6K99R\?(+YRWU/_0#.?+S\7?2MUGM#Q^@KYI^HW]X?N#-*?L\/-7+Y
MRGN[?#-&3D?'^BU7Q\F^_P UAYSW^T?#Z ME8)_K#V=P9JR_*\/)6LY>/D%@
M+?4[0S0/,^\_2MR/FWW>2^6IU&^/CFB_GX>96TSGX>86*?J[? <T7\O _2U6
MJ!_JCV=X9KNYCW.^A%CG^J/9WAE#N7Q_HE7Q\F^_S6,?J[? <UW^R?#Z0K&<
M_#S"QS]7;X#E*M6;"SDI6IF+L$([48RT.]0?L':8%$47+=0JA!,0X&352-T"
M19!4IT7")E$5B'24.0V_:;Q<N'KM;+Y9ZN2ANEIK(*^@JX2 ^"JII&RQ/ .6
MN;J;A\;PZ.5A='(US'.::+C;:*\6VLM5RIXZN@N%++25=/*,LE@G86/:>UIP
M<L>TA['AKV.:]H(]W>-^Y(W8E5C))L)4 =%,V>QP*F.,---2I>LHD1.8ZAD$
M171=QBRASJ.(=XP57/Z9Z6BC_;CH=Z3[9TM<#6[BBCZN"XL H.(K8QV3;+U3
MQL])B:"2_P!%J ]E70/<27TD\0>1/'.QG\O^D?@:MZ/>*:VQ5.N6C<?2[/7/
M;@5ULE>[J)"0 WKX2U]/5,: &U,3RP&)\;G=H[KL&BJG4VUGW^OKQG4&$DV9
ML'VQ6,/(,0FY3SB+-C#MI9J\4=3,@1-0J#*,;K2#E%%8Q$CI(JB3ZK&)'.TQ
M:BXC)#21L.TX[!WG9>!F+ S,FD $ %V.9(V&>T]PW*UIE^9'$2H6.IZJDY/5
M<3I>T:<'<]4O!'U9+J^1(UV66 ) Q4&U9'9J2K2=1?6=X[0( 0[B(DG<@BT=
M1[MTA<*>=P<\!YD;)U;FX.L99G).>T>J!VY &<JAL\+2&$L#"PR!^1H/K 8
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M_N%M,Z2>C\:<\9\-[#_K>C[OY5?./J/9H^5T4:QC[?Q<M^'X9IR=#72QG/\
M<YXQQC_J"X_/_H%LLZ2^C[/^6?#?+_K>C^;_ $JQCZBV>(= 46RC[?=&.!__
M *^W--W0OTM'ET<<9';_ *@N/>/]!\RM_NE]'W_;3AK_ -XHOWRB;4&T?)'_
M + K/[O]ZG/X?[S*7="G2Z2/_IMQIR=_T>N7:/Y!8_NE]'O_ &UX9_\ >:']
M\HFT[M,2_P!@-H]O1_O4Y_\ \Y2[H3Z7O_PUXU[?^CMR[B/Q=7,Z3>CL8!XV
MX9&#O_OS0]_\LL<^F]J"'LH%HZ_Q4Y_+_P 7*'="/2_I/_TTXU__ .=N7?\
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MB+XF2QMQ4M:TM<7DZH\9=NXD8(#QISV+GO!=(<-D#)'1O=FF+B' -QA^0&C
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M09[0\?H*94KE<.H/@'=A%5/W]GCED?;X>:KD[/'R5B?6#M[AS ]OQ/FLGV/
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+3")A$PB81,(O_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>27
<FILENAME>g723949g36k80.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g36k80.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1" $/ ET# 1$
M A$! Q$!_\0 '@   @$% 0$!              ,$ @4&!P@!"0K_Q !T$
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MM<U@)UY,ZPVU5ZY1I3P5*N!',5IB)BFKU]"1;)I V%P@F[4B5R(-RHMW%F+
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MC> VD,KBUP&=S9<MKF,ZZFYU(:6"W)N1EES2-SL)-7NFAS7'(TQ%UP \7')
M TU#C?E:8VRX]>(JMZ[0V-:H+5UM)8=$;XOE?K]8JUI@%82T:,VK7]7K2L])
M/;Q.!+UF;3EWMNF(UHT@G$''L0CT)I;O#B4<W[4A=)NVF1N66%KBYS2"V6-T
MEFC(+.%@T$DW-S;4 .V9A'F=NR##*]K6M(L8I&LN27FX-[D:6 M<GE'8U2XM
MN(FV&H=-CW&GT[';N(=74">PU(:)L,,I75M)3.S32;FA:ZWW=4H6U04M'@S-
M&/-E*M9Z&/&O2I1)I)8S*CJ>!N=_MF5L.\R7+3?>!EL[XFDM(Z<FAN-;(R>4
MY6^UW=(8BZP(R[LOOE9*ZS@1PSV(ZKZ5\.W$5NG;W$-P^.;C>*=7J]<.'+=3
MZP:[C8>4:1=KNNO]V*:_=R58\.N1S)3RR$$RLK+PEE8E8*JL[E#I-E0G#V"%
M30QQPS!K7%S9HK.)!(:^+/8\G@,Q:;%MSE-_<F(Y)'RQYG  Q29F@&Q<R0-N
M.5Q/$<;#,-;YAKFR47B!VWQ/\3335#VZ1DK2MZ:9;P.T%>(6[5>H:OKS>B:T
MLUJA!TDQ6>UR_-;#&FF4EF;N,10<.IH_A+DA$U05R-?#'3P&3*0Z*2\>Z:YS
MSG>&G>$79E-NO@+!5<V1\TV3,"U\5G;US6M&1A<-V-'7%^(XG7I64'X^MX>4
MN]S(5G7:4)1H'BX\GZW*'K["T5:4X=*_-R56F)YL&XUKM=&=K?0Z2=JA&6KJ
M:2":S<(\B;)(1H.I-:O:D66'E.N]U/=PS$.$S@' >UY&Y1?*XR.O8@MO8*34
M27D.5MFB?*#:X,0-B[VS,0ZVH#&VN+.Z3)M_$[N_5;^1V);4*%;;@;@QKNU6
M:,(VV)7:+7E+UN^J5MGX]K2]_GXN0A=?QEC7FK1;$(R,M,M"P;PB$I QRIV2
M1L$4C0UN=K>V71F^0O=DA<XV=E!#GEMFMOE!=P)U1TLC#F=E+MQGTS-:,TC1
MJ,S@0P.N3:Y T(NK^MQJ;>:RR^M0O.@I)1+B H^IOHJ&5;EQT@E$6S4DUM%X
M@XK1-GK-S7:*?Q"%/\%2VB2)57FXU9P+)_WQF->U8R,^2;^Y=)N,PWMVR!E[
MY.80<W,OH>(LIW[[Y,T9]L#-Z =W8L+N&<\L$9>>1<B^NBKU[N?849\&'M;;
M;2XGG;VF^XATHF\M9&0DVS \AN^\5J+LD"\DWCYX6$JT<\0E*XDX>+I,8F+8
M-^Z,W0 ,/C8:Z.,MRM]J);8 Z1M<6D"VKB+'PD]*-D=VK(_-=UY;.%R!RW .
M%[\EO$=0"W/;X6Z4#C)X0X%#:=G=:RDJ'N:NQ&NS"FSB(Y"@:SJ:*<W99/O[
MB0O5A?OG2CXDE8%/!89)%%*-CTWBTK)R>-I:^FJ#NVAXDB)=Q)SO=R0-,@ %
MK-U-]3H +N!;/",QRY9 &= RM;J>EQ\)-AT &Y//_##M^&9[%W1>]-WW</$G
MKRKU-G5#T5QMR#V9N;=.Q$=AD1LV\J[KJT7&OQ.O*'6V$FUJC1Q&M*/ VB.*
M60BX 464,+_-/&2R)LC(X7EV;-D+(HV9-(B\-)>]Q&8ZN+>!/%8XGC,]S'/E
M8&VRYP^21V8 R!CG -:+VT#01P%K7WK<)O;3'C)U#8$;=<%86^<-V^+-5=&2
MC!A#1U-FZU#:>6:1MA;0DA($M5P=V.:E D9-[(.VL2B9K"5U-%)L_E9S$P1F
MFE!:V[9H@Z4$G,'.?J+@96AHT XZD] &60R">(YG$.AD+8^ ;E$=@;$YG$DW
M)-AH!P).G?@R=G6"U3KN.M5MGKO:;EH6A[8MLJ3<MHV;!Q=J?6^U5^<CK95+
M.R!#5&R'#UNKW56J#MA6"UN,;1(00/*T,U*Y*U@: 6M#0V5T;1NVL):&M<"U
MS>>S7BX$W-[ZV443RXD$EQ=&R1QSE[0XD@@M(LQQMS6V%A:W)N<>N?PC7$#3
M[I:M<FUQ3I.QU&=LVBWDBE!69"+D.)&\7#8:?#2P8-QL"JYZA:=<TR+M%I;
MN=X9U9&*#*8C.[*@%FT<3FM?G=E<&R@9FW$+6LWU].<U[LK?%P/%4-7(QSF!
MK;@F/4.MO7.=N0->:6 .=\X:C@LNU%Q);=K?%MO'3\^[BT:/([EV>]8[ NZD
MV[KTY;*AHG4TVTTE0U/'QT-:][1&?V1(NI9M.,',$618P4<XF1DI!&)(8W01
M2"^81QC*W*'!KI'@ROTY?0S2VIN2!8*[)7MJ9&&UL[R'.O8N;%&=VW7D^Z>2
M01:]A>ZUVAQJ;;V-H/><U<)6OQ>T],U+3?$%4FVNX1LP@EN]7Y-9Q#Q-WJ>X
M]NUK85)MH1*E29EDCU&P2L9*S"4G554U$E6=C31,EB#0XLD=)$[.;GF\XM='
M$YCFWS'B!86=Q5>V9'Q2%Q:'QMCE;D L;/%P'-DD#V.MEUL2";A?=@/_ -O;
MG%KDT\.8/8'5A$\GHAT]8X1.3]?1VX1/)S]':&$3@YP]H=>$4HG/T=H81-PB
M,(C"(PB,(C"(PB,(C"(PB,(C"(PB,(C"(PB,(J3^B/1UAA%!/^R_C=N$40_-
MT]@X11#^D/1U!A%"/S=/8.$493U=/9A1TGQ#TE1C\_1VCA4/-?\ ./I"C'](
M>CJ#"J>:WR^E1AYQ]H]>%511YA]@]6$48_HCT=8811C\W3V#A%%/S]':.%/0
M/&?0%"/Z(]'6&%D//'B]:BJ>KI[,*1SG>3T+7&Q]9TK:\ 6L7N(6EHE"5CYQ
MEX',3E=E(R:B5C+1LO#6"LR4//PLFR4,?O#^*DV;HA%54N^]Z54(:['NC.9A
ML;$&X#@0>(+7 M(/400H>QLC<KQ<7!T):00;@@M(((ZP0B@:YIFJZTVI]#A2
MP< V=R<EX.9])RSUY*34@YE9B6E9F;>R4U-2TI(NG#Q_*2\B]D':Z@F7<GY"
M\A[W2.S/-S8#@   +      <   I8QL;0U@L!<\2223<DDDDDG4DDD])67J>
MKI[,HK)!^;I[!PB2/,/L'JPJ=+_$/0D81G#R_@$D_I#T=085'\X^3T!9[>/U
MM4?M:8_S9,([W/S0L!#G#VAUX4#B/&/2GX6=&%B?Q\GXE-)S=/8&$',/C]2K
MPKLYH\OI*<3T0Z>L<*RJPB<3T0Z>L<(JL(G$]$.GK'"*(ZC8Y\LQ</6#)XO&
M.1>1J[IJ@X6CW@H*MA=L5%4SG:.1;+KMQ70,FJ*"RJ0F[VH<HS<B]B1?0^'Q
M]:BP-K@&VH\'BZE$<56KOHJ2A7U;@7D--.G#Z8B74/'.(R6>NW .G3N28+-S
MM7SIRZ(5RX<.DE55ERE64.90 ,#,X$$$@C@;FX\1Z/(F5MB,HL3<BPL2>)/6
M2DN:'1I%*-2D*94WZ4*Q<14,F]KL.Z)$Q;IN5HZC8PB[,Y6#!RU*5LNS:@DW
M6;E!%1,R8 7)#WB]G.%]39QU/6==50M:7"[6FS=+@&USK;JNIZ5.J(2BTV%6
MK@32[F.>K2X0<8$HL\B6CEA%.U7_ (+X6HYC&+MTRCUSJBJS:.7#9L=-%90A
MF9UK9G6U%KFVNIT\)U/6H>UH(.47XWL+Z</HZ%+;5:L-O!RMJY MRM6LFQ:E
M0B(](K9E,K@[F&: )MR@BUEG12N9)NGW*+YP +.B*J !L9G>^=T'B>(X'R='
M4I+1D&@X <!TVO\ 2B+IE/A6T8PAJI6HEC#/EI*(9QD%%L&D5(.4UD'#^-;M
M6J2+%ZX1<N$5G34B2ZJ3A9-0YB*G PO<;DN<218DDFXZC<ZA4:T:Z#0$C0:'
MK'A4I&GU)NYAWB%7KJ#NNC)&K[I&$C$W,&:9%0TP:'7(V*K&#*BLJ,D+(R O
MA54%UWT3FY69VHS.L[G:G6W"_7Y56PTT&E[:<+\;>/I5[:1D:R7?.V4>Q:.Y
M59)U*.FK1!NXDG*+=)JDX?K))D4>+I-446R:K@RBA$$DT2F!,A2A6YT%^'#P
M=.GE4V^_CX5; I=./)34N>IUH\M8XXT3890T%%FD9Z*.F5 \9,O1:BYE(\R)
M2HF9/E5VQDBE3%,2  9;,ZP&9UFF[1<V!ZQU'Q*,HN387(L387(ZCUA7,:_
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MEFIE$UC-E7$>S;K*-S+(HJF1.<4Q423.)>Z(40%[G:.<XCC8DGTE T#@ /$
M%D0QD:N_;2JT>Q6E&"#EJQDE6B"C]DV?"B9ZW:/#IBX;H/#-6QG2**A$W MT
M!5*<44^YK<VM?0\1T&W#Z+K([@SQ>I1HBM5R 6E7,# 0D(XG'QI.;<1$4QC5
MIB2/R]W(2JK-!$\@^/W1NZ=NS++F[H>50>4<DN<;7)-M!<DV'4+\%,8 !( !
M)N;"U]!QZTY6KUI=TJ^6KL$L]7E(^;7=JQ+!1TM-1*!6L5+JN#MQ54E(UL0C
M>/?G.+MF@0J395-,H%!F=PN;6(M<\#Q'B/2.E0QH-[@'4'4#B+V/C'04X*Q6
MCJBX/7H,S@9M.R"N:)8&6&Q(M"L$9X51;B<9I)B4&:<IW7AQ&H W*N"( 3&8
M\+FUK6N>%[V\5];=:D@9QH.OATV(OX[:76 6C16L;7!*5=:L1D' 2%SJ5XL4
M95HV)@&]NEJ98V%KB&]J\"CRGF(U6<BV#J4;*F(K)HMS,73@[!T\;.+ME>TY
MLQ)#7-:7$NRAPRG+<Z&Q('5>XUL0=$QPRY0!F:XAH S%K@X7L-1<"_7P6YLQ
MK(GAS![ ZL(GD]$.GK'")R?KZ.W")Y.?H[0PB<'.'M#KPBE$Y^CM#")N$1A$
M81&$1A$81&$1A$81&$1A$81&$1A$81&$1A%2?T1Z.L,(H)_V7\;MPBB'YNGL
M'"+0?$C:MSTK3EVLO#_K^(V=M2,C3+5NHS4N:):NS\SAVD0A4S3;N.1$SQ"M
MDDH1:=%(S!K+MG:K=-?+"V-TC1*\L83JX"_D\%_?6-N-ECE=(V-QB8'O Y+2
M;>7PVXVTOPN%\+.$_BP^%ELNO[3+U_APA]Z"OLZWI3]KV%:X>ESL)96H1K64
MI"52D[M45*Y&5GO2#=K$-X%FV:*++D #K]_'.3GIZ$/:#,8K,;9K07 @W(=F
MRNOFZ[FZXN">N+"1");O==SW $'0%N7,W+:W"P73AN)+X83S<O 1JT.?D_UT
M:K^=L<P;G#_A3_J'\BS;ZOO_ /M6='NQX?\ ?2#\2/PP/+Y^ K5P>;]M"JC_
M /5K&YP_X4_ZA_(HWM=8_P"S,L3KRVZ'ZZ2;B0^%^Y1Y> S5_+_"?5OSLXW.
M'_"G_4/Y%!EK; =K,TOKO&Z_XTH>(_X7OE'EX#=8<O+^V?5OSL8W.'_"G_4/
MY%&\K?@S/YC?SJ./$;\+QR#R\"&L.3D_;-J_YV,;G#_A3_J'\BG>UGP9O\UG
MYDHW$;\+IR#R\".L>3^$VK_G7QN</^%/^H?TU&\K?@S/YC?SI)N(OX7(0\_
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MM7_.OC<X?\*?]0_D4;RM^#,_F-_.F!Q&?"Y<@?V">LN;]LVK_G6QN</^%/\
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M1TM"3JM5>W-HM+I%DW#<D7(03%5PR>L',AWXYTBBD0AC*%DL(UN"+7N#<$7
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M"SDY9LR?PZ9I%I).&*"R4>NV4:'2=&24*]9F*#@EFNRDGP$>4C3CX5CD87M
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M3J(T.F$>$B_GJRM65?:WBQK^J-D:V@)^"&;;RM_<WIPQ5;S6QP/"%\7IQG@
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M&$1A$81&$1A$81&$1A$81&$7=_!U1N3Q[L)ZCZ0C78,3E_8@*+F8=$ P>L?
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M)+0O;.Q%-A-:ZOP3$L.PZJGMW0HI:JCIIY2P98:J 22QN>0SVF6.,$V!J'@
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M'Q'@_FRB_07OE39_E'/?.\A[QCOQVN^5.T?GO$_W2=[V ?$>#^;*+]!'E5:
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M?J-5L=]PR\/<G:*9=I'3.N7MMUY'P452K ZJL4M)UZ.JQ 3J[5BX4;F-WNL
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M+N_BT:Q%_6W]+-W#MO&+Q\CKX:;KW7$O08R,?55S-4EP^!&2RYH"&:L:V\0
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M:>[<'W!)SAK=+-UZ.^\U%M(PB,(C"+D+:GT_ZK]H"'X0S67',/C]2PR<YO\
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MZG8YS]W9QSM))S$FUC;JS8_)TMB#P/PSQ_6).N<OA'@_@GC%1HIX9_:%^_\
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MS@K2^K(7&=MSA@9VK-L[(T,U.^,4Z 3\8\C"*'>&;*F<G9)NBJ&$R"8NS)"
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M1)5S^U4S<IYS1(X/D UW3)#P!7UB3  \P<P%Y YQ\P<@<X^<>GSY^E    '
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M?J6&3G-_KH<LVD7K6.:.Y!\L1LR8-%WKQPH/(FW:M4CKN%E! !$"))$.<P@
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MC"(PB,(C"(PB[?X6J=X)%RMV=)<BTLH,1%&,'G"/:*E._6(/)YR.GY$T.?E
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M-%P+<38A=CHI)-TDD$$TT4$4R)(HI$*FDDDF4")IID* %(F0A0*0A0 I2@
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MPB,(N0MJ?3_JOV@(?A#-9<<P^/U+#)SF_P!=#EL _/T=HY#^<?)Z HZ!XSZ
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M*&TL4K7X@E<K\A>K2DI&QJ:ZA%3OG+):5%BA+1KEY?=R2-WA.:^:V9X+W",
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M..]WV-OQ#V$?-6PG[=.XGLFOBSLY?9MO/RJHNP/@^ Y>6Y<'?JY/T]TN/_\
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M(RGP_#J7$*JH?@6.]M-[<K7T%/3PX:RB?45CG2QR3.J*)U31QTK'R/J&RL=
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M)UEMWAVRC9JO:DO#RN/%WQW"\I"KQ,@PCTG41)REQ3%Q#6O:7EL+BVQ  F+
MW7I(,C X6T!!!.MH,P:,S@0V\C;\=8@\G0=;6.(\5CQ%[5#<9I9U)*+@M8NI
MZZO[92ZO%P<)=8-[77*E\KU_GHE5Q=E6;6-;/84-<SK6Y1"3)XYA2JQK^,4L
M#*5C%7LFFL=9+- <22TYAD+ >1<FQSC*;B^H-B"K&>X: R[M!8.%N4'$<JUK
MC(<PXC0Z@B^\[WMV<K5K9T>HZXE-AVE.EO-A3\7'3\+!#'5II)HPZ#2*=39D
M6LW:IR1%^A7XA96'B5PB'RDU8X IX_P[$R,.:7N>&-S!@):XW<1>YMP:!J3J
M=19IUME$A;R6L+S8N(! L-!I?BXF]APTU(TOI'9/%I*1-!O%D@Z7(0<3(1?$
M)6=1WY](0\F66V9I"E;.L3TLU3P 7$3 OC:JNCVN/UW<B,NV@ )+QL&,O&)N
MLK*<%[07AQ!A,C "+,E<QNCNDC>-!%A:_$V*PF<M:\AI%Q*&.T(SQ->[4= .
M1Q!Z;"]KA96PXH9U.194.7U/)LMM3<K0XRJU,]L@E(J:1OM,V+>F4K,6=H@N
MVKA8:OZBV&XLK%"-G3M'D.S8P*MC\;,EC5W L7A_M8#RYV5UQE<QE@#SKF1E
MM1H;FUBK[TYVM+.6<H:W,+',U[KD@<FP8^^AX:9KA:]V%QGVQ"A[:?ZVU,X5
MMVK=-[2V!:U[98XAO TBPZYFMK4E[$NVT>HN]N)"7#5T@NP+"K1[:>KJZ3P\
ME!N%$VYKLIFYXP^06?)&UH:"2\2"-UP38-Y+Q>]['2Q1U0[)(6,Y3(Y'',19
MKF%[;'WW*8>%KCI"[_BUWSF,CG,FR3CI)PP9KR$>B[!^BP?*MTU';))\"#8'
MJ;5P91!-V#9N#DI 6!!+N^]EU#Q-C<=!X7\*V1>PN+&VHO>QZK]-NM78.8/8
M'5A2GD]$.GK'")R?KZ.W")Y.?H[0PB<'.'M#KPBE$Y^CM#")N$1A$81&$1A$
M81&$1A$81&$1A$81&$1A$81&$1A%2?T1Z.L,(H)_V7\;MPBB'YNGL'"*(?TA
MZ.H,(H1^;I[!PBC*>KI[,*.D^(>DJ,?GZ.T<*AYK_G'TA1C^D/1U!A5/-;Y?
M2HP\X^T>O"JHH\P^P>K"*,?T1Z.L,(HQ^;I[!PBBGY^CM'"GH'C/H"A']$>C
MK#"R'GCQ>M15/5T]F%(YSO)Z%$'G'VCUX5DD_/T=HX1(4]73V81(/S=/8.$2
M1YA]@]6%3I?XAZ$C",X>7\ DG](>CJ#"H_G'R>@+/;Q^MJC]K3'^;)A'>Y^:
M%@(<X>T.O"@<1XQZ4_"SHPL3^/D_$II.;I[ P@YA\?J5>%=G-'E])3B>B'3U
MCA656$3B>B'3UCA%5A$XGHAT]8X1581:/1X:]/ ,P5Q6W\BPF(BW01(25M5L
MDZ_ 1-\>ED;@SI\&\FUHVFA./DTEU5ZRWBW3$$D6T2O'LD4FQ,N_ETLZQ!:;
MAK07%G,+B!=V7_>O?B;E8MS'KH2"'-L7.( >;N#03R;^"UN L%L:AZ]K6O6<
MNWKY)99Q8)?QY/S%AGYNTV"<E2QL=#(.Y2=L3^2E'8M(>)BXIDB=UX.S8,&S
M=LBD0@]U1SW/M>V@L  &@"Y.@  %R23UDJ6L#'$"^HN227$G07))).@ \0"O
M-LJ%>OM;EJE:F!I&"F444GK9-X^CG!3MG*+UD[8R48Y9R<7)1S]LUD(R4C7C
M21C9!JV?,7*#I!)4AKG,<'--G#@; ^#4$$$$:$$$$<5$H#@ >!OUCJX$:@CB
M"-0>"UH/#CJ]1B5MX/;DY4;$_M2]S;;#O;38+R<E*^WJ<DY>WMK84;2Y;O*N
MR85\8Q24&+:QD9$(L&30\-$J,LF_DO?DVL!DR-+  <P 81E'*)=<"Y)))U-Z
M&%@9P-[YB[,X.+B TDN!!YN@%[  6 L%L!IK&C,5]<J,8%!DEJ>-<Q&O6+5P
M\0C*TQ=0:-8$C.,3<%8JK-Z\D:&8NG:#ARPCW<@W9JHDD'H+T,CSGNZ^\-WD
MVNXWOJ>/'6PTO;J"-8T6L+9&$,'0T6RZ#APT'4+VXE83/\->J;#/.;0HSM\%
M/N[#.6E:5I>R]C41X$U9H*JURPN$5J=:8,[9O-1E*K@R4>V%*/=R+)695:FE
MY"1>NKMGD: .00&AMG1L>+-<YPOF:;D%QL>-C;@L9B8239P))-VO>W4@ \UP
MXAHN.!(OQ)*S9IJ#7C+6<SJ%I "C0;'"VB#GHH96:</YAI=BR/E8ZE+&[D5[
M+(S=A6EY-Y+6)[+KSSV1>KR+B2.^.+C*F1Y>)";O:6D&PL,MLH#0,H:+"S0
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MFI^=V!<)B;M"KP;+*24XY>/)95<B!TI,TA<UV;5K@]M@ &N :!86L  QH#>
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M?=ZE6!1'F#"LT6 !_K5-*'(  /\ X\^%95 '+Y@PA-M2G%#D  '_ ,>?"*L
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M_;U7Z"J'8=.+SS')ZO\ 8^4]RRPPNN.H@_S8?U%7ODP7X;_V]7^@O1V722@
M&FN0>0/\&RP^H/J,,=RJ_P#@?YL/ZBQG:C AH:[_ +:L_;KT-I40H !IWD'S
M_P"#)D?7]B/R1A.('A3_ .;!^HJ':W9\<<0_[2M_;+P-MZ])Z=@Y.7F_2J;'
MFY^:-'ZN7[C8EJ.UN''VZ#]58SMELV..)?\ 9U_[5>DW%K@!\]C]7UHG?R7C
MN+B7P;_.I_U5'?GLU\9?]G7_ +5-#<FM^4/U1^L/\#SWY+QW%Q+X-_G4_P"J
MG?GLU\9?]G7_ +5/)N?6@#Y[)ZOK//\ Y*QW%Q+X-_G4_P"JG?GLU\9?]G7_
M +5,^.G6?RE_[&G_ ,E8[BXE\&_SJ?\ 53OSV:^,O^SK_P!JCXZ=9_*7_L:?
M_)6.XN)?!O\ .I_U4[\]FOC+_LZ_]JCXZ=9_*7_L:?\ R5CN+B7P;_.I_P!5
M._/9KXR_[.O_ &J/CIUG\I?^QI_\E8[BXE\&_P ZG_53OSV:^,O^SK_VJ/CI
MUG\I?^QI_P#)6.XN)?!O\ZG_ %4[\]FOC+_LZ_\ :H^.G6?RE_[&G_R5CN+B
M7P;_ #J?]5._/9KXR_[.O_:K/H:9C+!'-Y:'=D>Q[L#B@X(15,#=[4,DH4R2
MY$EDCD4(8ADU4R'*(><H>;-":&6GD=%,PLD9;,TD&UP"-6D@@@@@@D+GZ.LI
MJ^GCJZ.5L]/*"62-#FWRN+7 M>UKVN:X$%KVM<"-0KIF);*,(C"(PB,(C"(P
MB,(C"(PBI/Z(]'6&$4$_[+^-VX11#\W3V#A%$/Z0]'4&$4(_-T]@X11E/5T]
MF%'2?$/25&/S]':.%0\U_P X^D*,?TAZ.H,*IYK?+Z5&'G'VCUX55%'F'V#U
M811C^B/1UAA%&/S=/8.$44_/T=HX4] \9] 4(_HCT=8860\\>+UJ*IZNGLPI
M'.=Y/0H@\X^T>O"LDGY^CM'")"GJZ>S")!^;I[!PB2/,/L'JPJ=+_$/0D81G
M#R_@$D_I#T=085'\X^3T!9[>/UM4?M:8_P V3".]S\T+1VQK<.O]>WV^A'A+
M#2*7:K<$4+KP$),:U!/YD(\7H-W8LP>"R\&%UX(Z\'[YWWP=;N.]FLQN=[&7
MMG<UM[7MF(%[:7M?A<*A=D:Y]KY&/=;A?*TFU_#9<5ZP^$#J-E+,&OL) 1C=
MI&ZQ=1,II:WS/$+%R<]M1:>:P.NGA:K0(28BMF(NH(Z+BI)Q$DH;PQL8'A!.
MF17;?1N!:&.)),EQ*T0D".Q<_E/(++'G7' Z+ *L/OG#1;)8Q.,P)DO9G):"
M'C*;MMTA;--QN:=@4[#Y</I.#5@IJ_(J(0E2V19U8ZK:^FX"#GK+;DT:%'J5
M+Q0[LL42PMG9'4;%*K@@UG98_+R8^U9#;( ;AG%T;;N>TN#6W?RKAIRVU(XM
M"RBJC:"'W%B_FM>ZS6$!Q=R1EL7:W%AT$\3E,CQ@Z2B:C*W=\]O2,%7K%/UF
MT&'5.S!D*B_K$/%6&:7MD5Y*^,:Y'-:_.PLRF]EV[1-ZRDV_@(.7!7""%132
MN<& ,NYH<WVR.S@26C*<UG$N!%@3J#?356=4Q!H?=]@\AWM;[MR#,<PRW:,I
M!N;7!%E?(_BITO(6\U+:SDZ=Z2ZH:Z/.*4FY(4DEY=02MD:5<UZ7@TZF$LZA
M$B/D&X2X]TF\C2"8JTFP3<0:>4-S$-MESVSMSY<V7-DOFM?3AT'J*MVQ%GR7
M=?,&YLKLF8C,!FM:Y%CQZ1UA89N3BU@Z!IW6&Y*1&PEMKFU[I6:O7I&YV";U
MK7VT79XNPRC*U2<B-*MDTWBS(P1#MB$K"JCQK(-WJ)N\BGWZ\5.Y\DD3B6NC
M:YS@UHD==I +0 ]HOK[[2RK)4!L<<K '-D<&@N<6"Q#CF)RN(')][TI$=QHZ
MRA:C 3^S9&*BY*9K=ANRQ-5H["W!48VCURV>2$I;'MN9:UK2K&'BI-1!&==3
M$!$H1CE0S=-9Z7P==R-+(7.# 2&N:SEY(W%[FY@T-+W:VO8 GR:@5-2S("^P
M+FE_M>>5H8U^4N+@P6 -KDM !/'I4R[<:&LZEL2$HS9O,S# EDV37K]<205K
M:UFGJ:NU/:=IVE.+F0K#J#NLU%-J\VB96NPDP218+29E"@Z<QKN/ RF>YA=<
M Y8RQMVESMY(V-MQFNT$F^8BVG1<%6=4QM<&BY&9X>ZS@&[N)TAL<MG&PL0#
M<7Z;$+)&7&-HEY%NI%K-6U=V27J4+'5@-9[%)=[&[O</*6"F+U:EK5A.RV*,
MLL'!SLO&2\7&.(L\=!3+M=V@C&NCIQVM->UFVLXEV=F0!A =F?FRM+20""0;
MD=:L*F(B]W7NT!N1^<YP7-RLRYB" 2" 18'70J"'&AITLHD<)H'U1DZMK*8K
M<G!PE^F[9,3NS;E?:/$UI6BLJ,9ZR>A/41[$$9DDGMC3GBR,/-UF!49,EY=V
MM+:V7E!T@<"6!H$;6/+LY?8BSP;VRY;$.-S:AJ8]=>26LL0'EV:1SV!I;EN-
M6D6U-[@AMA>SEX\-(C,K)J>5[6G,M62VSI2\O:1<FL=%EAM@O=9OZJ^C%*]X
MS:V%I;(N3AG39TDW$DN@A%-R.W+K^HV[4EM[C-O!&&YVW-V!X<#>Q:6D$&_"
MY-K(*J+_ 'LHCSE^5UA9YC(X<<P(L;:VL#K;HFD;>J5]0K+BOM;B"-L:V=Y&
M+2]"N<$W0)4GT='2Q)5Y+P;-E$J+N9- 8$'SA$EI:I/7]94EF,>]<(:\L;F!
MP=ENW(#9[2>5J+ $WX<JW--@ZUPLS96ORVS<K-:['#FVO>X%N.E^<+EMP"N?
MK9Q@)U2N<2LHXH!W,YH:808U^ 3LI2!L:-D!=,8Z6*^\1G/703F82UI3C--C
M8%(:#@?'YE'23TC1#.RFS=KC/82MN79>80 2+7Y6A;8\FY-NA8G5&43<BYB(
MRC-SP= ;V-N4' Z&P&8Z%;J)Q#ZP++RD">3F#2$26>25,RJEIDV$C+U6.&4L
MU;KK^/AG*-FLL,T(X%>"@_#9-RX82S)@V=/X.;:QV/<R6!L+&WNF@@$V:7 D
M90>@G2UB; @DZ5A)U.@(.A.K1F<!8:D \!K>X&H-K&]XJM01K5TN]>6Y%S&)
MW9Q/12>OKL]EZVRURTITE=9&PL(^#=JQ4=!1-_J,JL]7$&[QG-M"QIWKLQFI
M<[8)+"P:;Y;$/;8EY=E )(O<M</!8WLM9TC+G4BU[@M=<90";Z:6!'CN+*^[
M8W(IJZ3I/=UP9:MV [IS8;*+UZV9UR)8S]+BGKLO@D)*MW:S&#M,U?'B;QY%
M(IU&@6UZ5P;P4RC>L3,S#K8C0-Z23F\(Z0&]/*<T=*M*[*[A<'B>H#*.H]!)
MMIHTGH69P>S81;6CO9=F<,*[$PT3,3EI0(^"85J32(3<OW\7.A')*J)V2$CD
MR(V&&:HN%V4TF[C&HON]H+.!:<V4:DD!O1FOH+> G@>D:Z+7+KW<=!Q/38#K
MMT@<1UZ+4=@XJZ/79]G'S$#>XR$\DKW:['+R%"O360J#>B.]?FDG,]7S5<SI
MK72P=];3KJT'<$C6:+06)0=/CND6&40.(N"TG,UK0'-L[,'6L<ULUVVR\2?!
M:]"\#C>UB2;'2V7P<+.O?P+)YSB-U=5Y:9AK ]LT6YAV4N][XYHUR%O+MX"R
MP50FS5PZ4&H>PFCK%9(:/[B)3=&D?"S.H8))DU=N4+1Q/+18 W(X.;IF%Q?7
M2X!X\.!L2%5[A:VO$]!UMH;::ZD#3CT*U2/%'J2*C'LH_=VU$L,UL[^T1Y-?
M79U,4Z/J#I!E.R%NB6D$N]K[%%RZ; T=/T4T91JJI*1IW<2RD7[.^Z?X-<MC
MF;9V87 :2=3XN' ZD XG.%CY;Z'3QZ?1U]%UEE:W1KVVVY[28.5>.)IHI9T4
M3KPDRRB99>DS*%>N"$'-O&*,5+K5N<<)1LDDS=*'%<'"C,'39D]7;W:QS1<C
MCE/$7%P2+CHN-1=8#P/B/W+3\#Q84]=:T>6,5.51O$67:,?%=YK5YG%EJMJ>
MQJ5*P6N>.VJ"#*((]L1$HZ)C&;J77?/Y!C"LU7<X1\Q:Y=V=+:W#>EHU<+@#
ME7.G&X'#Q+ K[-\4>HX%!\I,O+;'.HEK:Y"Q1"VOKN>:JT51HZGS=KF+-%H0
M*SJ&AXB"OE3G#R;LA63V-FFJL:L\5,*(78QVO WRV((L;Y@+&^NH(\BQ.!+C
MY.KJ_P#C@IM@WW6H[6MWV'$1L[(EU]-,8*QUV6@K'6K QD7@UIZ#=:%D(-2<
M%PI7;9#6&/;-XARO)-'[)!!,'*YDT<K <WC'DXVXK YISVZQ<<#X.NW$=:A3
M?$?K&$@7UBE5;8RCX56>2M15:'<1=TLM71B7LXO<&I(8RD DTCIV'E6H/>Y6
MFH>01EH!*4CBKN4K,8=.'3;7C< BWT'R\5C+200.)M;4:Z]'7U>-1W7$/J]+
MRI,,C.'0JDZO5GKQ"HVAPQ?VAG:D*0ZK<(\0B5&\M.(6M=*'-'-E!<'Y5)-$
MJD(W<2:5HVD6\)!\FFO]>(ZK6DC<6VL+D7%W-&A:3>U[@66($XEZ@]G_  !@
M5+R?3CZX[7FY'Q\PD4G\E*;GB)^!/7"UIT];3%9=Z=DB+)22[!J^\+< F[0,
MS8%FMA:QA<!KSKNT%K:;H@WOJ#O.CJ3R<2NJW35!RB\M N7KB'2BH1:C7!K8
MIEO8824LD-*Q4&ZA4)%W#/H.#FGY)0$"-$O%;MFX41D029JV'-=Y/2M5\$EB
M+-TO<YVV&5S003>P() MQU4BS;JH]>K=8O"\PT4I%D@9NVI3A49U5<U:A:>_
MNBTC'13&"?.7:WBED==6/?&B79$N^)H)NI(J<8MEOP\/!:Y@>]SV <MKPVUV
MVS.>& $DCB38$7%[7L-5CMIWA!QNKMI['@HY_(+ZK939YNMV5G,TA\C+Q-<C
M[4C&2?CB&4?1:3^#F8643?EBGQ",)-!8$%5BJMB9FGD7Z@>.GA\BPB!QEBC)
M WKF!KFVD!#G[NXRN =9P<+9AJ+7Z5A;;>[]U2++:6[+6EIEF4I7JS5(/7>S
MG]I:3UMM<BWA8.&F9E_0:Z-<17E'\>9R_1C9PK*'\9R[AN5&-,FO:_)Z..EC
M?4V&NFGW].G7JNIQOFL+I6-(<^1TL 9ECC;F<YK1*[>$-:ZPNR[LK0>5<8U;
M^)(T7!4&QPT#76T1=:F[LYY?8MP=T*OQTHU-'HFH"UD3JMBA8ZY"[=/&:[>R
MO*\T;+QK@B2KXR3\L=9KK:@"Q -R;#P"X!%]3>]K6Z=;:XH<[Y6.?(712;O)
M#$)I"TW]NW>\C<Z.P%C&'DYA<-Y.;84+LQO+_&8M)1#J)9ZTF6$:[%L92POW
MZ#S6='V,NNC'P39ZHN\;!<#PZ4=#*3AY%:-(XCUW!I!)JEMM=J\D6RY;]/N0
M[H\=M+WMIQLN(GIBWM4-<'NJ&O<+^UAI;42TX!=(6V!W6?,\,RAUG 923BT+
MO*KV.Z0=*AHZQ*OI-2Y,Y55]!RT8-9E:=&U"87C9I!XQ)WA21BKK#/F;D5BM
M1(Z;(]].Z=$0)(D!<&B]SFX@BQ;;0Z<;.!_^; GT,L<,DSW1AK=R6!LC'[UD
MSIF!S"UQOE? ]KA:^A/ 74]7>.LT9)2&4L!PEDD9E8\<$5+F=_I%?D=8/$2I
M%8B)W2]V73AHMJ7E7F.47T6F[CBF=@SLX7UZM2='9> _WC95%#4E@DW?()8
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MF9B1D%Y$I!;E:QH:]CP #;,PN(N22XWS&]R3:P%@%7(-;EQN"-2.#K VTL.
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MV*'K<?LWQ7*L)ZT-?&\_K&J+V>4AG,D\UJ6A-C+K,)2$=I05\M,Y7WS9N$W
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MV3;-R>;E[A,O()U!  [M54_=*K*"'*HJ<ZAOT1ASSN:5\\LDTAN^1Q<X^$]
MZ@!H!P   T"^B*2EAHJ:"DIVY(:>-L4;>)LT<7'I<XW<]QU<XEQU*N.8UL(P
MB,(C"(PB,(C"(PB,(J3^B/1UAA%!/^R_C=N$40_-T]@X11#^D/1U!A%"/S=/
M8.$493U=/9A1TGQ#TE1C\_1VCA4/-?\ ./I"C'](>CJ#"J>:WR^E1AYQ]H]>
M%511YA]@]6$48_HCT=8811C\W3V#A%%/S]':.%/0/&?0%"/Z(]'6&%D//'B]
M:BJ>KI[,*1SG>3T*(/./M'KPK))^?H[1PB0IZNGLPB0?FZ>P<(DCS#[!ZL*G
M2_Q#T)&$9P\OX!)/Z0]'4&%1_./D] 6>WC];5'[6F/\ -DPCO<_-"UZH@BY2
M5;.44G#=PDH@N@NF15%=%4ADU45DE ,15)4AC$43.4Q#D,)3 ("(81O.'E]!
M6J6'#SH.+KT]48S2>IXZK6ETT?66N,=>U-I!SSR/5%>.=2\6A$ILI!Q'+F%6
M.6=(JG8*#W;0R)O/F3?3%P<99"YM\KB]Q(OQL2;B_3U]*JZ&)HRMBC#7:N:&
M-L;6M<6L;='5T*_#IK42DC39H^K==FE]>,V\=090:77!?TE@S,)V;&J._%W?
MZ\S9G$3M&T4=HBU4$3H$3.(F&-[)9PWC[/)+QF=9Y/$N%[./C5VQ1D,.[9=F
MC#E')U]SIIX+<%1&Z4TW#'G3Q.I]:QA[1,1=BLAF-'K+49^?@Y5*>A9J8[S&
M$\92L/.HI3<6_=]]=1\PF64:*I/@[_DF64VO)(<H+1=[C9I%B!KH"-"!H1IP
M4;J)O-C8,SVEUF@7(-P3IQ!U'4=4R<TEIFUH(M[1J76=C;MYN<LB*$[1:O+(
M)V&SB)[).E1?1:Z?C>PJ#WV<D1*+N55 JK]9=0A3 ;+*W5LDC38"[7N&C>:-
M#P;T#@.A6,4;K9HV.L2X7:T\IW..HXGI/3TI*VAM'.)60G'&F]5N)J68N8N4
MEG&OJFO(R$8]KZ]2>QSUZK$G<.6+VJN7%:>-%5#H.J^NM#N$U(Y0[<6]E  $
ML@ -P,[K Y@ZX%[ Y@'?. /%-S%<G=QW.A.1MS=I:>CI:2T]8-CHE_$O5U]N
MU_<+U],/IFG4V6I-&KBQ*^A4J3'6 \0:POJ^TCX!E->-9I""C6#A:6GI5FRC
MT56D.QC$W;P%V]=NS&  '.#GNY69Y;?*'7<187)T:"3J2;!5?$W-O#<EK<K!
MIE:"1F+=+W-@-20!P N;SK-H?1UULA;G<M,ZIMMP(+$26NS:[J$]9"C& 0(T
M2SLK#NI0HQX)I@QY'0>" 0G>.]]R7D-FE:W*V61K=>2U[@W7CH#;7I5G11.=
MF='&YVG*<QI=IPU(OIT=2OOQ5ZO5:BP5UQ0U&0,+=%@S/4*^9J$9L"23F;['
M @,<*0,;O,)(RMN: 4$+))))OIE-ZZ(54(WDE[[Q][M-\SKW8+--[\6C1IZ!
MH+*=VRULC+6<+91:SS=XX<''5WOCJ;K64WPA<.D\XI8+ZGHC*O4I_8I1"C1E
M+I[2BV"2LE9CZDY?6JM>3ZC.9>1\/$1242\,*#IF:,CP%99!FW03R-J9FA]I
M'W>&@O+G9P&N+K-=>XN2;]=SUK&ZGA('M; &YCE#6Y22W+=PMJ0 +'HL.H+:
M?Q1:I\J8.\?%G0/+2LQ:,)7+8%/KP62 AFS<[-M%0TV$?XRC(]JT56:-F;)R
MBW;M5EVZ*9$5E2'Q[R3*69WY'&[FYCE)XW(O8F^NO2 >A7$<=VOR,SAH =E&
M8"W &UP$V-U'JB+:%81FL=>1S)/R1 C-C2JVT:D+K]^I*T("-V\:FB4*3**K
M251 "!Y-/U5'D-X$X.90:OED(),CR==2]U^78/UO[H:.]\-#<*1'&!8,8!R=
M UMN0;LTM[DZM]Z=1964_#UH11TS>J:4U.H\C[!(6MBZ/KRIF<,[/+/&LA*6
M!LL:)%1&8D9!BQ?O9$ABNG+UBQ=K*G<,VRB5Q/-EMO9+%K6GENU:!8 Z\!<Z
M>$]95=S#>^ZCN'%U\C><;$GAQ) /C /$!9^E2Z:6(L$ 6IUD(*UNII]:84(&
M+")LKRR"H:PNY^.!IX',NIXZJIII>11<JRAE%!?'7$YA&N9UP<SKML&FYNT#
M@ >(MT6X="A[6BXRMLZ]Q86<3?-<=-[ZWX]*M$KJ;5L[:6MYFM;T.7NC)1DL
MTMLG4H%_9&RT8')&+HS3I@K(IKQH"8(Y8K@%6)3G!H=$#G V1DI:S+G<!K=H
M+K:G70::]*UW1W=FR@G2QL+Z#KXZ+(&]0JC5G6XQM6*\WC:<X;.:C'H0L:DQ
MJSEG'NX=HO7&B;8K>$6:Q,@_BVZL8FU.C'/GC)(Q6SE9(X2:&[C=U\QN277-
M]3TZV.O2A9KHT6%LMK #2V@Z-+CQ*S+Z=U(^E)*>?:OUZ]G)H9 9>7>4RNNI
M*3&6CU8B6%\]<1RCAT,K%++1LGWY0_C!@JHT=]^0.9,<F=X  >ZPM89C86-Q
M87TL=1U'5:[H[DD-&O@&MQ8_2F6;5>LK@5XG:]=T>S%?2PSKXL_5(*7*^FAA
MF-;-+/0?L%P=R1JY%QD =ZX[XX/"1S&).H9@T;MTY;(]MLKW-L+"SB+"Y-A8
M\+DGQDGBH,=^+0?'8^#T:*BUZHUE?V\2UO>MZ'=6M?373@6UMJ%=L;>$*Z3;
M(N"1",S'O$XTKA)FT27*S*B"J;5L13NBH) 6\<A8#9[FDG7*7"_CMQ57Q%P
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MR6GO\1_SIG[QCMJ#^)_A?^5.Y&(_!_\ -@_51Y+3W^(_YTS]XQVU!_$_PO\
MRIW(Q'X/_FP?JKK72%&\G856>D$R!,38=R0 ,106<8DH/>T0.F8Y.[=*D\)7
M[@Y@[@K4ANY42.&=3QNN[8F%/&3N8=3Q&>4C4D$ V8#E;IQ+CP(7J^Q6!'#:
J-U=4- K*W0"[7;FF:[DL#FES<TKAO7V/#=--G,<MYYP:[NC"(PB,(O_9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>28
<FILENAME>g723949g37k35.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g37k35.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
M !$( /T!;P,!$0 "$0$#$0'_Q  >  $!  (" P$!            " 8'!0D!
M P0""O_$ $00  $$ P$   ,#"04&!0('  0" P4&  $'"!$2$PD4%18A(C55
M>)6VU1<T05&U&",D,5C7,C-6EI<G-CAB<7*!D;?_Q  < 0$! 0$! 0$! 0
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MZ?3.E^=NE7OI72#J@U&-3)AFKE!"G*L,2^''U=RO-P3388\B6&7EM/A"Y0%
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M/:):R3>@;).N?<C+<(F[1[#SDN1_3.'3NV5%)7\\",2B)L'VQV8R"_=)4*+
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M96YJ#^X$1L=*1(;=BKOX])Q#TJRUJ9TSC<0R$#M"HW=YUQDAV45SMHWR":-
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M]PVVMBTCY.S8LJID95ODE=P)'@ 2=M4&)!(#;9[DU"IO&UBR*6 XHA:!/4D
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MW='G;9C7/>GP!/1+V1R*Y6(#M-*]35RLT@(:$?F:C)=0Z,%8*B!;02)ED2N
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M7HZ1 @2 @-N:2/HM]G9#C3.EK3UXAA1F)U"F\>5.,>7J^-D!]3H"UF<SME8
M# PIT;U\?ZK!B/6\AQ*AYS?^GVR8, NW!K+RR,8C'#!IV:O/-K.,<>@H1E$2
MV#3;+-23+[H[Y)B2B!FPDMA.,K?2^\.VY!T10"N5<AOH%=:'G;*!_651G8][
M&4%=2RFSY4I,W+DY2,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(
MC$3J/^U!JE6ZM3WAHOJWGF.M7"Z??9F\T/NDP]JM0M7[14"N;0?02FH<>9D:
M[?JS*&L&<H--@BOOLT<\S'Z040*XOOT3-C:SCRE<K*%;$.2V)NT*<T"C ?:
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MG+Y^F'W"?-I+%UR^];Y+*ER$K&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B)#
MG&_5/,KMV$WA]X\_:H74^GR/5V8KJ=&Z-+66 G;%6JM$V.-9D:E?*]%DQ)$Q
M7BIL+:XY)C;DN0R^\[IMO>NKM,#KC&5<VY$"7C9 " S$&F1C=$#KX3F&/.C9
M.S;%M=SDIU<D$A01W6 JQ8XOF<]^'?:#_P#K'QM_\:]M_P"Z^>7H_P##J?\
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MZHE,?(345 Q+T>']&91M03+4"PZVI_YW]N/O:4O:=(UJ;OIWV6N8;$"#G'R
M2;Z>V55<J[N<9W,6_6XNA7\)L;Z/MS]H>5_X/UO^N9C\V\L_QQ_VFOM?W?\
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MJ^N;H#4'-%DL6H9UHP81+CH92?<F)!VEX5PC%EPC3N-UY07HV2Q&2U[UBJ_
MSQ<K':!E;(<F+*<R&OLR%L$  ;:/=H]?OF!<-[+V"+\:]SK/5;+)U*Q5C[/N
MCV[S)SX14,;SJ<XR)5_PDSI217Q#?RCZ'^4@@K=L"GENLUT"7C(\&,4,MYT?
M>3'C.?$R ,&U3+F;G>,EWL\-J5ZI'4@FYYC=^QR![4KIU;$O&TH%]:OUFNMU
M\"P*FW^M=6]"+A_<=RK7H7I=%'\M\5\=7[FU3JGY)CUDBQWGE8,S9M6021K$
MD5(09S\>2M=?$-CXH@F5)(.'+^Z1S0LT3%>F5L*/VV74([-NW4KTM$,.1?4@
MGC[YMWR?;L,KKV6/"RA=M6R\W8-CCI=<]#Q/'0_5/I1SU7=8=GK G/K#6>M<
M&K'*>135YAX*JWN@7*+KATSK^R1KFMIO/3UW_4E.MMW:#LP*:%)) '=(BQP=
M*<)@P]@K=F7#8\K/D"$E66P/M-ZICV=WNE3NYXLPV7+VQ&_:0^,(K, &#5?V
M>PL^XWWE8 'R\:*^UYY<]VF$\O<N#TO<K<>L= CH!32E)<:L[/"NC'U<AO:-
MZ5\XUA$C"$Z2I.U;:TG2D_'YM2T#]FV9ST7&I/\ T]HN[^%RNL3>N)/%LA _
MZNS<K_&IUM\4ZEU?H/<8SW+$P!)W8NK<!]@F\_K[@BCT'/\ G_AW(Z76!!(Y
MOYMG)/Z7'74C<<QI*Y!XM3&DMDDN)1V9$1<?U4FL>/+@WGI^FR9&)-=.YLY\
M/NJ<N-W9^W MWQ9BHZ_HTQJ./'OAC0Z_>9NSD7L;KD3R7M=TF_0UFOE5"\IT
MZ_6@ZJW.C]AZCSCLMQN\!51Y6"2SS*H4CET/(L3<PW,<TNDK,S?.VX#\H-"/
M!C$O/2R:?&<F-1B"$YV10RMCQOC52:/VC,Y! IU"J^ZN.!-IG<)D8Y"P[)6.
MU@[H[,!8[BJ@H\JQ.TB^D^.)].=U70/5%9AO4L<)"T'KWE@>HW2R=FC>ALD5
MGI<+:G[O2A_3U5X\+7ZK^4<U718]%^E*HFD4*8%EZRNT[^HY,E>G!BW8&.$D
MMCS[D7&4Y0KL;L#DW&E:]@;>PHUQ4\&7)MR@9O5?" Q?>*8&QVJIM6R/6VA5
M-B_&;;YU[+MXM#\PVZT=0O%9H43[>NG'>P7CHW0><WBFGUA'/9F9AXMON%,A
M*[4+WSX*9($'!O!C )3\E&R#!QJQH]I6IOIUWYE"*6.F7)C1$=6#;@+[)F9E
M8CDKSP1QS*+G.W$2S!1G9'9V1E(VD@=HH 9;_6H??4XRK=U[;WNW<GIU=]$]
M%JM4ZW[V]J\];N%+?A&9U7&*93EVBBPM??G8&6""9 BD?"O'$19)48LUN0;T
MLH=E2?6Q8\2.S84+)I=.Y5KKM&8JQ-$'KU -&JG@R/D90,K!7U&=-RU?9JH*
M@6"/N-6+GIK?HWTBGU^;29#L[T9/UKV.%P^-X]<+_!H1;?/8 @C#$PCC,;R^
M1NDG8K;5OK]"8[DY;8VK,R[B8TS\-CM)&<'#A[#=V=AM.<IR*A[N4GIVAR!0
M%/=[((6JSR>G@RY>V*[^\,W9A&8=[&*_9[;LCO=INJ^.DU?$=<G.KW_QI,]/
M]!6FQ=Z(^T.-&Z;YEDUUUF"XP+4ICIM:J.XRMBU\6QU1H.N_AHXI4C,OCW)5
MBDB7DR<C77"8_9QC&NH"8@,0THV9ANO)N"%K).T\WP!:UX T<AR[8"V0E_K!
MW8B5I*W 4 -R\<<GO63R1Q_2YG\>?U(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$8
MB,1&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(GSE"BG#/!FC#F"$MJ9(%*9;(&(97K
MX+:>8=2MIUM>OS*0M*DJU^;>MZQ$]#45%L""@,QH#((*FE!!-!CMB!J8W\S"
MA1T-Z9'4RK])K;2$;;W^='PWGMGK9L]?;%#RA^*C"63AR8X @>3UM,DP^&.Z
MS(:VC3>]'-.-J07K;>M-[T^ES6T:TG_PZUK%D5R>.GL^Z*'EUZS],QD<.@%L
M>/"81&-[9C4,B,-(CV5-Z94T"E#:="-J9UIK:&--IVWK3>]?+K6L\L\\]>OM
M^^*'''3I[/NGEJ.CV?NWT0 VON6W]A_2%8;^Z;)^;[SL;Y4:^ALCYU?7VU\F
MW?F5]3YOCOXK/GUZQ0\NG2>IB'B17I D:+CAR)925RI# 0S3TFI*%-I5(.MM
M)6:I+:E-IV2IS>D*4G6_EWO6>V>.3QTYZ?=Y3RASP.>O'7[YY7$Q3B&VUQD>
MMMD=8;*%A#*0T(YK25BMIVWM+8ZTI3I;"=::5K6M;3O6M8L^9BAY"?I49&J2
M2A4>"I)C;+1:5",;24T.GY!VR=;;^#[;"/T&4.Z4EI/Z*-)U^;/+/GTZ3VAY
M=>L_+D1%/'"2CL9'NR8#3C ,BX$,LX)A[6TNLB%J;V0,TZG>TN-LN(0O6]Z5
MK>MY[9JK-'J/ Q7CXSZG1AWULN/,,O.#.;='6ZTAQ8[NT[1MQE2T[4TYM"E(
MVM&TJ^56T_'X;WK/+BIZ&8V.'VQL< )C8J7D#;9%8:V,DE?U"$L;0VG;*7W/
MTWM-_+IU?Z2]*W^?%GSZ]8H>73I/G'@H01F0'%AXH9B6<?>E6!X\1EF3>*1M
MLEV0;;92@UPAO>T/K)2XIU&]I<VK6_AGMGCD\=.>GW>4\H<\#GKQU^_SGA$!
M!-B.1Z(6)0 \&W'O!(C@TB.@,I4AD%P;3.F5AM(4I#8RD;90E2DI1K6]ZQ9Z
MV;ZW<4/(?#RZ?"%0$$N+;A%0L2J%9TTEJ(5'!JBVDL.I>8TV!MG8B-,O)2ZU
MI+6M-NI2XCX+UK>+-W9OSOGXQ0JJ%>5<3ZDQT>AQ#J  T.MD/E-NI%82X@HE
M/R$DH7I&E)((3O:7WD[TXZG\SBE:_-GEGSBAY#SGKW$Q:I),RJ-CU2Z!MAHE
M=AC[DD!J5M:A4G;;^])&VO>U[8T[IK:M[5M/Q_/GMFJLUUKP^$4+NA?2_'XS
M\ZAHA);Y^HJ-T<2^,229H$719!(;2V R'R--?6=?%8<<9&=<6IQAI:VVE)0I
M6MK/2S7/%^?7X^,4/(><Y+/)[&(C$1B(Q$8B,1&(C$1B(Q$8B,1&(C$1B(Q$
&8B,1/__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>29
<FILENAME>g723949g40n70.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g40n70.jpg
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MMK<C,C8X07:#L[74)%56A"4Y87.X)B=1<2AU@?_$ !X! 0 " 04! 0
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MSHK#G]UF_P"N#U7?UE-Z?XH6GG-=E?Q8V<_Y#@_\/IX^)=*_Y4NDK]?]L?\
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MA_3_ /\ V]L?X)['YP+I._$C&O3AO\6H8^__ '+OY=-B/1M-_M#'XUGZS?\
M7!ZKOZRF]/\ %"T\W_97\6-G/^0X/_#Z>/G_ $K_ )4NDK]?]L?]Q8C&M?-^
MC@$.(1_4Y\56%>#"O!G&?%5\:<^#/A\&<?%X<9_<S\>/BX@._P!,=:MCW77)
M+I,Z?[\,Z6^F2L7'?&QMNZ[L)@'2;@RJN#Z;,I$4(5J34C8;ZX1C&+'.7->)
M/E8LC+<?#$2)A+GE/FM#25TO:3&:*9M#M!44N#T&&5TB5.JZ4[^95+5M-EU)
M6A4/*_ )D$L2V%VNS:6[,X_BV U'1CL5C5/T=='V'8KMGCNU&!5U71X3BRF@
MD85,PB71U.&*^.N9-6/=\YIKSWJ9;E9>25*LV;.3WV/C5UKV_;(-BV?,UX]:
MNLV[=*U&K>LM21I%2A'1M+J]M$'W89_:&)U=J:73[T&:-:)V<LSY&'B*])1*
MER1VDD;:XC3X93-(P]:X4VRM+M'63\0Q)EJ7DO5U%--DAY&'9)]3:2'289=/
M+:[Y@I55F;O6]"&SN);4XG)KMHIF!/B72QBW1M@V'[/;+I,PR562,)P[$Z6N
M:77;2"=088K5K29U.M1B-4N65NG<3)LR1@-8Z,]=" R+W3[LSL:LVOIZZV9^
M6MG:N\W2@UUZ:@L**4*UX:"V0\B-YUDF8A*C'B!.7( K:Q).5DD[E8QK65&U
M5=,FFCJJ1J&HIL:V36^'XCO%FTF/36:7*GS)U ,V[64\NKDI+59P.63/EBTP
M[+0=%.!4M(N,X5C"X]A^)[#=+L_+M#LY[GF4N+='U'*EU-30R*+:!Q+-3,JY
M-1@];/J)KT17>5F'5#7IUQFV= -&@5R^0*AN.QF]L4/6/3YMB?73= &@Z0^$
MWM+HXED&S;F+H3*>>@,ZZQ2#TIVL-#'QB&&$+[8Y+5 U--MG5O/HWJ<+D2L-
MK,0QK#4GRJV9.JUG8.M9,,XTQI)<O=3DI&0**@S%F$DC+D#Z#%.A3")%!C4G
M"]JJZLVFP79[8?:6?0UF"2*+!YE)ME-P:E2C3%$Q:IJ?==%.Q>7/>:V'+3O3
MJDL'>M-:3C&]^B[6>KJ!U!6&G[=N=NM'37LZ@ZAO@:P:S@50&6M-I=L+!0M5
M34>ZGY4JOQ)(&3'@-D!<$BYAC,I]'8Y\!Y6?!]JZ_$*W!9%5AE+34^/8?68G
M1S9.(/4SI5/3B29<NIE-2256<RS@7*3'07RCK(XC;MLNB? -G<%VWKL+VHQ;
M$\1Z/]H<%V7QJDKMG9.&4=5B.(M7RZBJPRL3&*V9,HI4RAF))6?32I[!=XXW
M4^0YYS<YS'PF'$(<0C971G\EG63_ %=JI_\ EETQ\V'%_P#Q'9;_ )Y4_P"V
MMH8Y[LA^+O2I^HF&_P#Y.Z.HUJYOT<"AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$
M(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(O RPGPL<G##'# F(:9B
MQS$483FP(Y:/!G1R<)@FQ%?::GLPR46*0BM2DNHCSHT>6RE#[+;B<4R1)FM+
M:;)E36E%FE-,EH[2RZ&6YEE@2A:6S(Q6Q9&*FX)$:JGKJVDEU$JEK*JFE5:R
MTJI=/439,NI23.2HDI4)+=5G+*J)4N?+68&$N=+2:H#HK#)?V5-G]NP4_9'O
MOG/!V5:<$?=A8>W8LTX:@--L6)?G'M&#LP.TV*E%_*><) UM$%V0N*A+6,']
MG8?DW?N"CW>Y6GR>Y9&3W.DPS4D9<F7<K-)F+*MD682X4,;QK_?'M#OO=/\
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MON09D]RSEMN^I7[(*C>FG#VJ0]0V +Q=;10[/:".P=H"MA,"\4 44@0!533
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ME,Q[Y2,UQ?A'+<)VN:JV1VNQ:=LOL$U;A-3LU+H9@V(V<59:8E4XC+JPTL4
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MQT8;*O@3X=+Q<8C*Z/\ 9:=*&%S0&7$&ERJ-YZ480YWJ'E+*E)=YK(BL14;
MJ_5]JNFS]@[!Z3-%UBF#<1U3+#/Z?M&+@MIE%(@5C*.R0)+TC"BL^'"5V=IW
MR3SZ<.^(G"E)K15&S&(U245%M)B]153,V60F-8P'.66TXWS3%"_@T9QF(N!I
M<VC)C>']*.S>%3L<QSHSV/P[":?=[VNG[#['&2N]J)5(EMW(=WO4SY4D[M6R
MLXS6%R,=U*OJAWJ-)F=3=*VDKJ'$3VA$TL.Z;=/QA>#3["9+(*(0)@X,0B><
MC+;D(!CGI993#S#N(?DWV5+SXE[WL'F2Y6);18M239J&:DI\>Q1IFZ4Y3.:7
M+G.\N2&N-],"R[AAFNIMH=F6Z1-LJ>IJ]F>CC9'%Z6DG+33JF1L!LLE.*MT$
MQ:.5/J*.3*J*UI95Q1T[3:HHZ-NLKH3[:Y9ZJ]LD;6)U_P!)FG3Y&CE/,-NC
M>]CU.*57[#Y>1%36B2S=?&M,V9<F)*8:K?CJ..NQWT-0%J:7A,5QV<PU*:96
M[28I)2LE[ZE;WP8G,W\C*K;^6),^833A64F?;<@,I+BXBV KTD;33\2IL$Z,
M]EJV?@]1[CQ27X/-F:8T-=G>4,/J#5T,A4Q!IDN8BT%_=C.CJL@E2!C<FU=0
MT$''LD[IBTK!"2=E2M.HGSNF'5L-#.TH2&G)=$FM2:TU('61A+J?''3VHSOC
M(?1CPKC2$M9UI\$><U.F/XL\Y:!<4*)M!B+$X>]\M8A6H*S)!MHZ%AJ/A"^@
MF8GMS*HTKYW1[LG)I)FT$S943IW1WLY)"[1R55IF"S5F8<KR,00,,TB<LMKJ
MZ^-+F!<FQ'ZKLUZ_6M/21J%RNZO,6D!>RS72_JIV+7RU'?[-=(SN6Z\I<U-2
M=_TEE#$38@-K.'R;\9C.',Z?-LYOZ*F.TN)B?B$NGG4<H[0XD&GRZP9J1A>?
MU/=(_N%F9&G'26&.D;ADZ2O<.-8EX,MF#0;.U6(T6,U2]'6S;2J&IPA]WBTM
MRM 3-&&-_P"(3:<395$OX2I>6AS1$]PW=LN@GY56N&D>G,#8(443-E"Y?3MJ
M%3[,4Z'@'Q+RLQZ^\UXLX.3@3VO%<RK#,E&',(<PI"=RI<)H*V2M12XMCDZ2
M[3468N.8H 6DS7DS1UIX/4FRW0Z<5-KBQCC6*;7[08+6S,.Q39'82CK94NFG
M3*>;L+LL72764LFMI7)2A=;3J6HDSELQ.68,P#7 QGWS]D^Y1TU?BZZG^K7-
M1[WZ?XQQ[UYB7M$;?X0\0\F]@/F)LS]GP]\_9/N4=-7XNNI_JUQ[WZ?XQQ[U
MYB7M$/"'B'DWL!\Q-F?L^'OG[)]RCIJ_%UU/]6N/>_3_ !CCWKS$O:(>$/$/
M)O8#YB;,_9\/?/V3[E'35^+KJ?ZM<>]^G^,<>]>8E[1#PAXAY-[ ?,39G[/C
MH-]BQWN;N?7;H^MS-?:0!QR+>S<N%*?IC7U2L4;L>H;]/1YOL ,)#*0/++BI
MCR^S2&^U079,)[QX\AU"N%=(F#R:78_%IZUN+3F0X?:758K75,ALV)T:'/)G
M3GEO8-F7,IRN%86908^W_<X[9UF+=,NQ^'S<$V0HY=0-H<U1A>R>!X97R]UL
MMC<X;BNHZ.54R,[2PDW=S%WDEIDE[RYC*>?'6;_K@]5W]93>G^*%IYS797\6
M-G/^0X/_  ^GCXATK_E2Z2OU_P!L?]Q8C&M?-^C@$.(0XA#B$.(0XA#B$.(0
MXA#B$.(1LKHS^2SK)_J[53_\LNF/FPXO_P"([+?\\J?]M;0QSW9#\7>E3]1,
M-_\ R=T=1K5S?HX%#B$.(0XA#B$.(0XA$IZ,/B*INS3MIL$U T#6MIZ^/FR+
MC;[S< 0'MH@B2FK9C-/2741849Y]3<=EU]>&\I::<<RE&=NQB3-J<)Q2GD(9
MDZ?AU;)DH" 7FS:::DM 6(4%G8"[$ 7U($<CV/K:7#-K=EL1KIHD46'[1X)6
MUD\J[B32TF)TL^HFE):O,<2Y4MW*RT=VM959B >D-5ZIM-67KPL5V)!M.:?U
MNHEU;C8FVJM7ME,2+O'VC1[_ %NFV?8$>66N9*2^0G$1D[Q@%4"*C2#Y5V2*
M0UY&- X)4[.XK(V.D4DN;BF*5X39J8V&U$^@*TC8?5T<^JIZ(K+I):JBI,2T
MZIG9EDRPLPG,S_></Z1ME,1Z9J[%ZBEV5V6P U'2?3R]IL-H,?1\7E[28-CF
M'X5B.-RYE3BU0[SIU13SKT6&49EO75+3*8+DER<*Z73^F>B_:EDW48W_ $'=
M;-9UF8@ ]8:LB;&8B;>.7=YZLNT2W/;#UE6Q\6I@X'C7.Q.S8DAEUV%7D"$D
M2:'XL75[0R<5VJPZ1A,K!:S"6J*^4\W$,0>A+89)I *@5E,*&OGNU3.?_NL@
M(P(#SS-*(59MHZ.J[97HGVDK]K:O;7!=K5P[9^JDT6SNS<O:!)6U-9C#/AS8
M-BDS'=G,/D2L+HI-\6KVG2YB,\F@%*M14AI4O9O3/5'T@ZHZA-Q6(GLO9EH=
MWK<[1=9>[V1L3+B-96G7A@I#TW>X!49[H1QT=L,L^S87*D.>!'2]8UW*1-BU
MN#/A)V#%-GMI\1P3"Y"4%!3C!Z6GI%PDNUC7T];*EMBE&\N89$R2]%*4R/=,
MP3I,N?7*4:>Z/'T/9/I&Z+]FMN=J<0J=H-H,1;;'%L1Q:;M@E-++C9W$<"JJ
MF5LIC,BIIO=\BLD8[5,E>V%R&HZVJPW IJS9=!)GR1SP5L76E-Z?Z+0:$?>P
M2V)O@]>]T=O#/3CHW7VO)0(;I>L'XS+@@78X?@)7B[$08PRU!FF7!F)$F$_
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MQ8C\247[7/\ Z4/O*=G?+O&O4]#[7#X"O4WK!;$^9-:_7?'ABQ'XDHOVN?\
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M.^7>->IZ'VN'P%>IO6"V)\R:U^N^/#%B/Q)1?M<_^E#[RG9WR[QKU/0^UP^
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M2OV%\2\!9(6;H)2-E+V+D#Y_0EY=S1:FQC'9DURCQ<@W6ZSY\NM]W>^?C?>
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M3BI65$@1$*<4E"5/OMI4M24XSE6<8Y<)F("KF)X +<GT "\5+Y02S90.)+6
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M+"!"T$S0J %42@V:4SE\S9@;-<W!"999%B"IO9A>Y!%@Q)9C-RVFA MERD7
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M+39@47.:8;>9<S'N )MQ/ :QG5@LJ66-AEEB_G;*H[R0+\!Q.D:DP-A%ZQU
M;5GUBP,PJ_=_L@>H]<V8@Q@=*'%Q:NB^J)(5U<V2S(:COIMXD##>[$['(-%&
M6!N'D+D.QGL^4-*6XN5IG=>((/NDZV[>H6.MQ;7LO&#,1,?*=&J9:MP-QN%N
M/-J!PUOI'B[>3VT-_4D>Y<5S(E4ZY-\ZWII@4V'=<JPH?T'V64N' 6U#7%F2
M@EJ-V"5E15!!Y)!3L.6IR/'1&:G*$E,<OC4TMV&NMZH6/FNH'#L@6+34U\6H
MF*#II:F;3Y&)X]L2ITV;GV9M^[@*F=+*C3-#ZX-5CJ,9C#X++%FWTY<R%#%,
MI4J'A<& R*UO;]BMP0[D=EX7L2C2ENK@J8:?QS9:HI8<)C RM3I*RYC?74W=
M5UOJC\#%Y4QG8 FQEJ1-T%C,O86TT "LU@=5=#PBU=2,;7=NL^T]%T$!59^Z
M-Y4,, W'?K;*3+K6IM9/0284$<,X,35QU6;$.2:GZVUS66H3YFQ8<MUAR+$M
MRSLJ9690DURV[EN3+5>+N+$@>;@'<WL.J+FPB)H5B\M0-Y,4"8QX(FH!-^WC
MD0<6U-A<Q"FT!5?@:I^R5QS+S1+8(*=2X.O29)V/.M*X8WIYU%[W^8$F.I[4
MY,E;9]T,D"_ \7M%Y=..1,9*+EXY="<]);12&S :+K-?>WMV;NP-_P P+?01
M5[9*N_C#*%YZ2I>[U/'\)<C_ (K\3&Q^V-?AX75GT@[(E.F9MP,W+9%>=5./
M%9H0&(C=.6R7I0RKU]V5D(#9*$X;10S+@P4$C,UJ-DC.D1H V-#QRV.YGIIE
M"*= +D[Z7J3Q-@;"YL!P&IOD=1OI+ZYBS#4FP&Z?0#@+D7-A<GB=!;538PRW
MUD1>JY5@FM;+(.=?=-M +<(ZX-+OK%Q.[YIYY6OG:CYAR<1>*379$JF3EY,M
MUUK2XV:77.Q#2Z"?S*58J6+BU*RE"NEA*89@;VRLW6&E]X1I^=&)@RA@,IO4
MJP>]VN9BMEM:]U!*\;;L$W_-CK/5(V8R+#C-SFW/R]K.R<.35@5YK.'GT9Q3
M(OF$>/2F%7?!V:.@OB8>2E><%"$MWQ5XT1[.KET'/7_BU)X^:PY 1JQVZWU/
M&VGFT X>>YYDQE?(B8<0AQ"*QG^!S/YT7^VYRI\9?E_=$]A](_<8H^6B(<0A
MQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0AQ"'$(<0B\ /XVB?\?\F>Y1^'R_R,
M73C\G\Q'SO[Z_ESW/_2QL7^^!CG@]TO?E9Z4/\Q-M?\ <N)QZN='?Y/]A?U.
MV9_@E#$3\^=QS&'$(<0AQ"'$(Z$_8\O].=C_ .Y$/^\@OG>3[A/\?MLOU13^
M,4,=6ONJ_P 4MF_UA;^'54=5^>HD=%(C?9NUZ9J,0++7"44\>P'8M7K .O5\
MW;+1:;)-C3)L8'7*U7(!,R6GJ@CB!!_$:&J/ &P)I(@_$@1)$EJR(SDA;:#,
M22%  M<DD@ :@<>) &IBK.J %KZFP !8DV)L H).@)X: $G01@XCJ<U&9#!3
M,<L;AY,;5%:2="&JI9 -HK^SS+29$*K6FM&1L$S7I+D1V-/3+(Q&A[PV; )Q
M9<@?.BR7;&4X)%AHAF7#*04'%@02#P/ WN".(BHFH0""=7W=BI!#GL((!'/4
M<"#P,2.;V-5:]>J+KDI,?9M6QX5O(52&W"DO,3(M%BB)EC7(FMMJBPE16#8Y
M3*)3C:I>75ICX6IIS":A&*LX'53*&-^&:]M.V]C%BP#*I.K7('F6U_-I<=\9
MSRL6BLC?O!#[U;_+H?*GQE^7]T2.!]'\Q',[JNBB3'5%HD'9-5[%W57W=([T
M)KH>NBXL80;+0KII"-!L\U!O8.N!CT47%GD!OC9-29C;IMO# YUE<F1%UDFX
ME3"'26=Y+&9P3IEF=71'.NAX6TX\]--/X26"CS!DFG*A U#2;,;L@TN1QOKP
MXQ%8JJ;ZI%KT0.K\.9J^)=>K'94_4&NMO6:=LU>N=;N=*-Z9(0[?BK7N=@LP
M[9!5JO #7XW83D$/)G"A6+&,SY=P;<F6PFDG/ED('9 $S/OE\7,NFA52Q6YL
M3E/;CM,4R@+IFG.45R7RKN&T:S:]8,P4/I<"X[)G?ZH]G-584')FM55K8L7<
M&WM5GR\+6>W=J*L;>K)?DFS6M] Z]./;#,>=V)X9P\W(OKD"CY>SF21/YGCF
ME8Q*7-<!RIEHX!>6ELW8TUQE%K&W4N]N"ZQDWK9=2@;.Z$A'?-D[5E*<QOI?
MK=7F;B,3;ZOMY%]8:VNT>L!:I )D=Y5[8NPUZ-W+M"M K1J794K7X <1UE3[
M0%V5K<3=HXPL>(G[.]8D49V"NO%8,Z<K$S%MS+#NMRUMV57>2T)5T#DAV!1R
MMP+"V:^8$ 6BN^F%$:V6YF!FW<QP"CE "JD.F:Q-VODME()-X];+UI;(*%9(
MS6 VN&G*MJ+6]_*2ZCI/J+ZB*OLBV[  S["U4J=<]2AAD37U91$@L,C;S>1!
M0F1>*^550X[0,DE\LA +N2+NZB\R5*9 IMF978YC?BJD 6\?40,]KV0 @(K7
M$N;-#E@396064:>,P-[^*+&-R[<B'M71*9UH-6S2@>U5&LVRX27":J7:Z;7L
MH$VBUUHX8F)A2JHZH.R1JMJGI4,*AH<DJ]#E"B4=B7&P#J3+ +,*L573,K'5
M5(&H;6S*-0=+@C2,YZ\N[$H"H9M<I4:$@GLTN"="->$0STG!F\V+;-WH JQ5
M7IVMJ*-%U#7+%-/+P=(@6+'BZ[7KH*Q2I)&K5.^H)UB "ANI@N6)FIN710R,
MS88THA><39%8JTQ<V<BV@-LJ,1Q9+,3QMFRWZNE)0U=EN);9<@-]2 <S@'4*
MUU ';ES6LVN"6QRQ[3"=:)@?L07K6Q1;D#Z;=9G[!9)55# H8@-0R"QF#T-U
MJ=7C.U-A[",UI1T"VJR*CR*4@4V1*!0L;EERH9 *EAE,UP%N3<MV'0A$0&QZ
MM\][ F*&[B><P0YA*0DV T70F^A=V(N-;9>) B)!S#FIBUL$BM7WWI-V98-%
M;?56!L:],;=T/L\K5@XX^Y86IPVS0S\38E(C1ILP00*"M?G28HP5=FRC;<5J
M''N3G )=9R"8ESER34!)%M5(RMI< N 0-!?6HNI(R-)<H]NMGE,; WT8',MC
M8D(2">-K#(E]1NY*)JG4HB)>-<%[E%Z::;LPRE6E][;GN%KG%!T]P3&-US7-
ML7(UH#=&B66">V+M:3<*QV+)\A%K(B")E1TP)2.[G*P7>L@_"2I:KJ.!=0'-
MSXBJ,HRBYN(&:ZH@S*6W:L?P<R8S$@VN$;J#35V)!-]!:,L<ZI=WWVEWS86J
M16JZ\)U1H+7>W+* V"+M1\C;[%?M6KVPY5P9T%:JM$IX8$ =@0T6,B%M[AHQ
M(E15"PT8>Y->C<RT94<N2\UD!4@ *KY,Q!4EB2#H"M@.)O:+;YV5G0* DM7(
M:YN63/E# K8 6ZQ!N;Z",4.];.W)1&[.T.B2#;>K@M"41I@;IYZBMGD=JVJQ
M:UJ>SCU?KNSM<1)M!U(ID?<!P.NIND*X2I1)/G4\T$KDJ$3DR)"67,P&<M9C
M-E)D =D!9'LSZJ2<I7307:XB#/>[95)R!;J)4UR[%%>P=1E3Q@!F#:ZFPL3T
M6M$&PVNF3(52LTW7ITW!A9@V1ROP2Y:NMR7HKTUQH$:SD;@TD=F5$B>=6)T,
M83<9F3195F(Z,EZ92 P+#,!Q%R ?E&MO18D<".,:DW(T.4GMM<CY#I>W"_ \
M0>$<^:@H^-^QV%KG&L9HK>-.HW=M2LVJPE'YQTC8]0[6V19(>3I7/DW)C=H@
M@Y-:L_C(2P1!G2\%UC$24MCFI8 U07* K[M"H%@!,10;#S7N.1 /'6-,+K3L
MUR6E[U@6.I,MW(N?/:S<P2.!CI(%*,FPXDU'0XTP7&0"C#;N/ ZVS/BM2VD.
MXQ\6'$(=2E>,?N*QGFD(L2.6D:H&X!YZQ<^(0XA#B$.(0XA%9$_S9GWFO_FL
M\JWYO^(1(X'T?S$8C:ZA4[V#F5B[U>NW*M$<(20KUJ"C;"#G8:7AQK$P26C2
MX$G#;B4N-^687XBTI6GP*QC/+JS*;J2I' J2#WC6*E0P*L P/$$ @^D'2*2E
M4"BZV!MUG7=+JE#KC3[LIL!3:\(K 9$I_",/R4C L2%"Q)?PVCR[_D?+/>(G
M+BU93CDLS,;LS,>;$D]YUB%55%E55')0 .X:1^T42CM#!@1JFU5L,$.HM 80
MBO"$#!%F;+2#S=B&0$P\1(!U!R7*,H+Q6FB"2TF013(Q,><>4S-<G,UR+$W-
MR+6L3VBVEN%M(95L!E6P-P+"P-[W [#?6_&^L7,G7P!J4%FF0@@M,KA+)FO2
MR8V%/E 3&84L;DJ%?E,NNBR61Q">/S.@K8E9A39<7ROD)+S:X!(O8D7%C8VN
M+@V/,7 -N8![(D@&UP#8W%Q>QL1<<C8D7Y$CMC%K3J?5EX.!;/==:T&WV2N)
MPW7K!:*?7CYL$C$CM>$!RI4=+G#48E8Q*2B&^RG$G&'\8P[C"^2'=00KLH/$
M!B ?2 ;&(*(Q!958KXI*@D>@D7'R10%M(Z8/(J#9S4>L3+>OH\2'0VRM"JI!
MNDQ(&&,08E21+%.IKD6%B+%[)'$8ALQLQ8V64(RPUE$B9,&:SN,^K69AFO>^
M;77B>-^)B#+0Y;HAR^+=0<MN&6XTMYHN,S56KR%WA[+GZWH<W8PYE$8??Y=0
MK\FZP8[;*X[;$2TO#UG([34=QUAI#,Y"6V776D82VZXE49W"E [!#Q7,<I]*
MWM]$3D3-GRKG&F;*,W_JM?Z8\1FH=4A+>7V$#UGK\+L \B4@U>A--KH^X%L3
M?%S+R2LD0<R9G9E90VJ3F5-=S(RVWY;*_)H\47<J$+L5'!2Q*BW(7L.Z 1 Q
M8(H8\6"@,?2;7,8#H+IKU=T^4^J@:G5*C[J@=&K=&/;(ATVO KC=XE<&0AS4
MNRE1L7!"<J5F S)<CRR$QI#J4>!2_)(5BTR:\PDLS6+,P4L2JYB38 Z"U[<(
MK+E)+ "JMPJJ6R@,P4 #,0+GA&13^GK016OB*F3T?J A5:^1(& -:FZUIDH
M%+%I"I94F)#O!5CAT\I*4J02F0X[,B>\M;DIQU:E9R$V:"6$R8&-@2'8$@<
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MXOO76$II"L5MP#KL%<2&J0&V[,!VQU!:[UA"%B[))*0A%8I]DPU; VQ+=.D
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M88CY=ERA]Y/QC<S"D^<6W6/ TQEGPK&:['->Q$QYH(TL[Y22/E46Y1"RD46
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M;$VL+G;FC;)'7X]LP0''340=9W-NA2CSZF/-YVPQZX"L!UD.A"U/KC5YX_'
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MI.SR/0/=TOV>6N.8[Q$0[/(] ]W2_9XN.8[Q"'9Y'H'NZ7[/%QS'>(0[/(]
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M\A+M>PCSCZ6T9>P4N!DS*CK5CPHB+CLI\#;2$IQS9BN[," O!1<:(HRH/D4
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M(P0_#K5WK0"Q&A)R9%?&AY@061;)&&U!(OE#.,P.093W M?,;#*RL+CB+J2
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MU%3.82K"2WK V6S(\I[G,NY#XK\5V,](S'[5@IE$9,%<7.9B;[Y<U[-;>!^
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MO=B_]MX;&O?.)Q]"AQ"'$(<0AQ".R/V&?^5K=']%@_\ OJ"YV3^YF_&K'O\
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MIN-XGPA#=O\ !,/-4_T2/PB-^FXWB?"$-V_P3#S5/]$C\(C?IN-XGPA#=O\
M!,/-4_T2/PB-^FXWB?"$-V_P3#S5/]$C\(C?IN-XGPA#=O\ !,/-4_T2/PB-
M^FXWB?"$-V_P3#S5/]$C\(C?IN-XGPA#=O\ !,/-4_T2/PB-^FXWB?"$-V_P
M3#S5/]$C\(C?IN-XGPA#=O\ !,/-4_T2/PB-^FXWB?"$-V_P3#S5/]$C\(C?
MIN-XGPA#=O\ !,/-4_T2/PB-^FXWB?"$-V_P3#S5/]$C\(C?IN-XGPA#=O\
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MK<.X6A$P8T!F&5#R[*W"6&H6P0D%22XRNB(]AEL;I8.G$*<JZW N.&60UV<
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M:+1B3FQ(5[!B%V(L$)!_'2-',PJWAJP.'YIIBLK%2Q[K)EU\A"COX=RP-B5
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M LRFQ';XL2/J[6E^A;,OFY=JD*@JX6RHT?70FOT/)F170%/HI.XGV7WBQZ/
M(ESA\_>C,N9E0N#$%#X@H9$S-<;F$9E'=2BH@;*K,Q+6N2P4<!H  H[=3<^:
M+*C!V=B+LJJ M[ *6/$\22Q/#30:\3AP74&[J1:K>)U_=Z.'UE?-R/;>+')P
MB?/V4"8/%!1R^4,0+EQ9M0*1+7/@DH<&VD'X<^K!K#)9B@2904,+8L7EL 65
MBZR\@%^H; A6)%F&46.47#$:D D14(ZE@K *SY[VZPN066UK$,;V:X*@VL2
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GZ)#*7,.-^-XN5.95C]NA2,^''@^/]JK/_P#WX^06)XF)"@<!'__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>30
<FILENAME>g723949g40x04.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g40x04.jpg
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M(B,Q-SA!<G>7MK@D-5>TUB4S0E%689370]59<=C_Q  = 0$  @(# 0$
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M89W5VS_IL#G5"KQ;U;9ECH2:BJXU\#6:+/'70W8BP6*$@UDD-*.3O2(0L/\
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MG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*@IWXI('95"U%KR<=LM:MEYWN
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M21-YHW,;KN0]5.0:W;E2NWIQ2G%*<4K^8SC.<XQG&<ISX9QC/Z<9\,9\,_\
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MGINZ=\ $LQ["LQ&X8=!A6+]#@'[3RPF#D@9Z]20 J_DU8UUVV"3(2V9]>%E
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M)F\V0\4@1:^$-$G8CFOY$=]BN(FD>S$$1<$1*=PMQL*.GEDED220INS'M"J
M2649#9Z]*'.D"L#*5*F<YW(WF2*-D0/M 8$LQP!GH5_!S6=M7<7LT()[5MH^
M\%4;#C!>U HAHUR"!E!M95_5/6:@[(U[L")571+EABST74P].E%S,^8-L;-G
M0%=CO1H4!F-BMO"0@*#9F B3KEVDG=&3=G:05&,#!!7/OKEIY1O8,=V)AR\#
MR!(%=6"XSG=ZG(.<8Z5Y;CV=VZ&#6VH#.SEHQKBFV/L<0I6_%$Z*^:N!W6W4
M_5FWJ3K\A9W:\X L4!K9-SN*Y J+"21/0@+-4<?<8&OL*+!&2K&$;V$(:+S
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M2W6I6&G1PMJ'M/LB*;V>$RM+['<$\H,$"#F%2\8>./[Z_P!,/_6=R_PRN_\
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M82+M*L5AD*+@E47<,\@8!Y@^U9)'7?T+L"<^;<,^0 1AGRN6;:?[\>HV'S]
M0,KU"@@$8&#V;KL&G[QN<]:]=Q+39[?#OQ8T %D@)F!+8@ITS+ZBL6K&Q#=&
M]N,%QYSG8E2(1:R9AC"<:S+D:US-@#D_*6L9%C ?:%*A2<@C^^>T;=@;J3]I
MZ@=<KY\>M<HTA902VXL!@YP(^1NWE>@_OO0G .25]*F%H!^T/ZTC)N1HU8[!
M!NFUQ$@[88\.(8*P0FU[L'"39<8= %C6,/@X(U49L8-@C4Q/0P/BL0O0;37E
MV[SM  VH<#. 2BDCJ2>^>Y)SW.:GBSL&22<L,GN<,P'N]/<,5V?D=24XI3BE
M.*56YV6_6 ?#K_L=F?V:#^:@XQ^^IX2?1QG^IHJ])>&G[W[X1?\ &\,?Z37%
M61\V_7FVG%*X[N3>VN-#P*<2V.92'BWJ^5S78)?@TKS&K&^MMJ7+]1YK$4,+
MCM/SS))><LP(C7F7A3CK+3GS_$'$VD<,1:?-J]P+=-3U2TTFU/E.;F\8JKOE
MEV6\*JTEQ-U6*,9.25!^QX-X#XDX\N-9MN&[(WDNA:#J7$5^/,,66FQAFBAV
MH_-O+J1X[>RMAAYY7P,*CLO8N?05\=3BE5R_%,_HIR/[U-2_YR@\U)XV?X#R
M?Z[T']90UZ/^"M]]B'_9;BS]33U8US;=><*<4KGUPVOK77TN) N]WK=5FSXR
MID*,<*1Q[LJ*EU3*GV$OK3ZC:74*;4I/CY58\,^'CCQ^-XE\0^!N#;FWL^*^
M*]#X?NKN W-K!JVH06<EQ;B1HC-$LS*702*R%ESAA@^E?2:)P?Q3Q)#-<:!H
M&J:O!;RB&>73[26Y2&4H)!'(8U.UBC!@#C(.16[#Y\,K A%!TEF:/)1(T^!,
MCKPXQ+AS&42(LEE>/T+9?8<0ZVO'Z%(4G./Y>?4V=Y:ZA:6M_93QW5E?6T%Y
M:7,+!X;BUN8EFMYXG'1XYHG21&'1E8$=ZZ&XMY[2XGM+J)X+FUFEM[B"12LD
M,\+M'+%(IZJ\<BLC*>H8$5Z^6:AIQ2G%*A5V1%Q.S6JK71]7IE7(E1]NPJA=
MX0HD*J!D":KX]F8>9"D]BU2PTV2;#P+&)GCYA"L68.E]]$H,_ L@\<;"683R
M75G\H:,LA(+ @G R$8, <$'#*??D'!@E'-0JG4K( V"%(( )P64C(!!'E(Z]
M,'J-_*Z\N8KJQ"UGJZJZ\5<PFLZS6ZS2]Z-NW;7RI06$*877KTJJ8$(+QLQ8
MDB#B>#C1!K!'VL^**^61TC%8!U,^^1GVEV+-%Y7P2?,N[./?@G..A.>M9%6$
M.Q%7<% 59/,O3'1MN/0=,= <=,#%5\=)VNP<_L\0 [#TYU]T[7=0ZGC_ #2G
M4KK<4ULNJ6C9%HO3EHCZHNV+990YA-GFUNGG+A80%@L-,LU<0!8AAZW<H]I6
M[;N>2(<I)+(TDGQFF#[E0+MYBX!&W+!00&#9ZE=M5;?FF;#1QQB-/BK$5VEV
M;=L;)'F*JS%258>@;-7.\ZZK]0!W9W=,: OEB#;$TI*AT.%3]MVZK68;L,(5
MNMH&:?U['O)BPR=<0@[K59H9\@^FAURT%+DLDNXO#H9FKAXI2)*5:BMA*@*2
M>;=&K+L(5>8^P#>3YG \[*%QMR0QP:K27!C8AH_*%D8$-EB(TW$[,=%)\H);
MXV.F#FN<&_B+64",+@YG7YE6Y:B7V?F\:[:VPPJO"J?J;3E/WC8K($ON:!AP
M\1(5&_5<8!KTFH@T2;5)GCR!H8*@I.2\Q:*2#S3RV";7Y9R6DD:,*4WX&&0D
MG<?+@@$G:,#=$9'+^V*7W+OZ!4C60L&V=<AE &T=2?09KINN>]0G9>Z*[00>
MO);6MKG;C&M*EM"19F<$R.R0&CZ_O\J&GT'Y'C(RO)I)QR%#LJ+9.D2K(*F#
MU@8T-R,2=P>V*1ER_G50[)CH$:0Q AL]6W#JNT8!SG/2LUN T@7;A68HK$]2
MXC$I!7'0;3@'=G<,8P0:V,?^L6MOW*M>?MSV?S@_<:_Z3)^BCK(?=+?B(_TD
ME35Y6J>G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4KD5BTE1K
M;L:%LNR1)9<J,KX,# %OS930)M-?L\JW#9TP;%=88,OQSCL,BQ%-)(CHI .'
M*1(;!0?'F(D$C*A08 )))QUZC:0">W3(R,'!(S@D5@45F#'K@ 8].AR"1ZX.
M",]B,]\5MUMH52O$1,2S!FIV6WH<B*0C29H@X.DP'G'X<D38@TD>>$28ZWI&
M&Y PE$>PU*EL97EB7);=Q5F7XIQ_.#](.0?RBN2H;H1G^8_D(ZC\AK5B^C=4
M' D&MD:; 6!%LPH@P3$E%!L$<-@US%00$@L#9T1,2O2JMYJ\6KL?TP9L.X]
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MQY!.5(*H,CAZITMJ'8)\@T- J$#2\E,N(ZAKBX*\Y=G+8A8]_*&(VD &[9@
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M2P7LFG<]_8FO(D>5([KV?EB=4D=.:&V,5Q4"_BF?T4Y']ZFI?\Y0>:P\;/\
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M3@;L&F:MK];I=RM;-B#UVV26[LU;3+0]$-09,:(ZZ^4]+&3E(X94,RS&1E=
MBMY6SEI&+*,$J-NT9[_-6*!WEC?DO"(U96+LIW C 0!6;(#>;<<8QT[FK,N4
MJMTXI3BE.*5"H?\ K%K;]RK7G[<]G\LG[C7_ $F3]%'4 ^Z6_$1_I)*FKRM4
M].*53O5>@_84;V1MVR$;LD44.2+6PM#V34)(TM?Y\>Q.2UQAZ@%PKAVM8>\L
MEIHN@Y!*C6$1_.(0[*1!F0\E(5@2H<#\%LX/3UVD'Y^A%5N2^XG>5[G>N"W7
MYF!'TY!'NZX-9H0#W>4[66WK\GX@^W5B 6HJ?;QTQBM=8%V29?B=IO4&V4]Q
MG&G%1UN5ZJ!*I87AC,!!:''/9G37%07XV&K1D@Y0;V>'>9&4KNEZ*%4JV.9G
MJ2P[XZ5&$E,S1^TR[0BD'$.=Y+;E_O?HH4XQGK6G:YV;W;I?;N!I>R62_;0H
M\:]2ADTI<J33X6"FMWISF&KJ\:IM,JPN+F*%4V3CO0/;1\D&DAI2),E;T=RJ
M[!FR$5!_!7=@?[Q8]?IK-3(KA"[/UP2P7)7/?RJ!V]P%7/\ ,:M4XI3BE.*4
MXI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3B
ME<8N]LV\'V?JVO4W7(>RZYL;Y=&Q;C,L#X\A4FHL-QV$N$.;'OL.Y4XE#B,R
M7EX*.*R+:P-<Q\QY(JQE'+.0XQL7&0W7KUS_ /\ ._7M4;&0.@504.=[$X*]
M.F!C_OM77)\&&4@S!I".U+@$8DB#.B/)\[,J'+97'DQW4_\ B:>9<6VXG^M"
MLX_KY&"001T(Z@_.*D/7H>QJN41TTC!"VOM-6OM]L*TZ/IA*K677G6&P,:M@
MD)0S6Q>$>I (Q<X0")LN[4:FE 8MV**E2?*['"#XA0A*9A*PNX;C(:18$65@
MRO,-YZN-K,%)**S9/7T+=,55$ 4I&9F,:X*Q-M[(05&[ 8JI Z?-5DO*=6JY
M'OS4H_?&E=I::*%) .'LND6"H+-16$RWP[Q@>]&B%40UNQT3?ETM3$Q4)4B.
MF8AE494AC#N7421.8I$D SL8-CMG![9],]L^E1RH)(WC)QO4KGW9'?\ )5;L
MKX;.P_HX1< [-U72[=9$;JJY8!5=8&A^H:O0=[Z?UOJ*Y8H-0:N34X;;O/K(
M5L-4Z606(+6PR:8GCD1W<SG[GMB;AE)&5>6P9G!D9HI'D7>VW&WSE.@R% .?
M05?9'VG#HK-S 0J$1JDB(AVKG(;R!N^"Q.1ZUF3?PR%G7[E3GMHPXNGB$'=I
M.E#F:M*>O@*[[QT[7=/EY9PTL\T$-5VM1 Q&Q"($4.,($)QO Z=-:C"VI,S$
M7N-K;"9!RPQW>4I%(9  ,9!.0IR2,#.#GIR;3.Y=^(SS"HQY@TB!#DYP0N-P
M&,Y/?H*6'X?&V+#%L%S>W#08NZKV4VY"N95N@'WJ"Q2MO:.HNAR4*N \W%DR
MW8:^$US7K6,GD2ST"<<?)BYL)L8Y'D-<B[C!"B-^4O+*@N-^^.1I02=N-I+L
MI &<8.<T-JYRV].8Q<,=IV[7C6,X&[.X! 1DXSGH*RO<300^G4;1%B&;*V[D
M?1=W=*:&.U\NZ*3K"=!!;NUI6XA4G340,,2#2HZ6YRYJ9B,?,F8\E+6/2PC/
M%O*6:4%(\M%<,7V^?)1C@-GMZ=NU+F,!8B&?RRVZ[=QV=)%&=O;-6H<HU=IQ
M2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*K<[+?K /AU_V.S/[-!_-0<8_?4\)/HXS
M_4T5>DO#3][]\(O^-X8_TFN*LCYM^O-M:??Z!4-HU S0[Z%9L-2L#<5DP&?D
MS8C4UN%.BDXR5R!TF'-;]*="BR,98DM94IK"%Y4VI:%9([(P=#AAV/3ITQZ]
M.U8LJNI5AD'N.OOSZ55#VZZ'=2:L-T++ Z6 P95D[4: HAQ_)BV2G2%0M-U;
M@V "ZN;8).40BD1:V)&&?2=PE2LM.MJSE7,C#;WKN]Y;6EV\=O+L>YM+>=D
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M&(K@CP2ZF?&PM65RE;RX@O(&:>#G6=S$L\$*13Q/)&4$D#\DA9H]V^,E6 <
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MEPU'2+U5JY3K,-<)!*L4K)82U(?5(?3(JSC.(:),F5A]R4S.A(?%EO6RIV;
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MZ^ D,2TR/3Q&1!:D,K9RM3KB%X2G.NI.5D<HR$>O,"J<_-M9OYZ]%)S.O,"
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MZ#U1JFV[!O-$JK0.T[3(H+7HJD@4FK.$&R1@DW)RQ/FR8L%3:S3T%"!K$1O
M@<!$>3(ZOAX\.-Y9)%16;*H,*, 8& /3OV]?4D]R:S6)$9F5<,_QCUZ]2?\
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MOM.Q)@WH6D0K^4"($]/<17J)1<;AO>$KZA8W#?D)E('7W@U*;D-356YV6_6
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M%CHD'92(V.F-E]Q+T4&1<4\AIK+*4.*=;R7;N&\L%]2H!('S D _GK%MVT[
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MSG',2""01@CH0>A!'<$5(K*RAE(96 *LI!5@>H((Z$$=01T-?/BN:K<[+?K
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MFID6/+19K,;LM>%$7"&"6T1=ARPW]T!"!*<)"54I(#D%N9D]2/3"@$],GN)
MFX2%<0%QF,'?*"0R$ '9R\=1Z9RQ(!KI^W2U<G]V$&MEJMSE5(_##F3KRYKY
MNQHM^0Q#9!YVP/5Y%,\ME9F)BORG<9 ^6:PQAU3'EPC/AI"4$>/FGA-NX>&[
MA=^W;D<1WF-V[R_GZ5Z@MB#\$;5"^<'QSC+;<YP>"=.SC'7\W6H<-SJHQ48
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M]"#3++\H]I7IP]UJ:\[PMO"W54W%A;-R^85$:2KF1LDY.#@#.0N>H.17)FF
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MN@5^S6$9*E02Y\)6(!:;'ERVWIBL2Y/JS&>4IRRWDVJN J@E5.54N%#E00"
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M>&R/%C83"?X+,2#!CL18S2?X+;+2$8_1CF!)8EF.2Q))/<DG))^DUF % 4#
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MP1@D7%:@CA\-A&,(8BPH;#,:.RC&$MLMH0G&,)QS DDDDY))))[DGJ2?IK,
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$4K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>31
<FILENAME>g723949g41e02.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g41e02.jpg
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M(" @(" @(" @(" @(" @(" @(" */#]X<&%C:V5T(&5N9#TB=R(_/O_; $,
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! ?_; $,! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! ?_
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MK7&<96K.,XS<POAQG'AYK*T1?0U6U%_1D_J_\JZ.HL09_P :60UG_6B@=?\
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M*F51#CE-G0IZ&E$AU<.0S)2VI17DE9M*625&6LB.XS+60^U>LO:>RSL=BTM
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M4FMY^"\?DE2C-D76[&=-9]C/7L/VGH4FPYE6M'8&KS(\&D=(]FI] .5.<2U
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M[MM'_G$P:4YMAR0^BG\F]9ZE4KOU+%KO*FL5_'1=OYB7%$62%4K&72J-6W7
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M,-FRAM:N?^;H<4' !P < ' !P < .R>OS_6ENG_X5HG_ * ZPYRUC/ZNQ?\
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MFH5.H4=+K*U+<BU*G,0Y3L6:V:$Z!;T2<Q)B&2EHD-$]@5CCOH;UYS.&C#@
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MPLG26XM?WLD>-]46R=5CEVRPB"M5KU-VB?'5/J9UP0L+*3<@W;P@^[1:"I^
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MI^<G?_LIKWY_X\\\SV!&^T'?R@>A'1_>%4ON[%_5P]Q!U3\Y._\ V4U[\_\
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M==7JM1JBHZ:!&<2PJ?,>EJ92X=40;B6C=-!+-"342<1I3?<5']Q!U3\Y._\
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M?(/8?<?@)+:7>7B/(Q\+%/[QF_>7>"V%W%X >T^\_$1W)$!P < ' !P < '
M!P < +",^ K+_9"?\Q1RI^LGX^ GJ/O+P,5[EA < ' !P < ' !P < ' !P
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M 6$9\!67^R$_YBCE3]9/Q\!/4?>7@8KW+" X . #@ X . #@ X . #@ X .
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M?JV/^_\ &D[./R#5F>XN8>:@7TL1^K8_[_QI.SC\@U9GN+F'FH%]+$?JV/\
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M/R$JNO/6?5U=FKK$3YJ!?2Q'ZMC_ +_R=)V<?D(U9GN+F'FH%]+$?JV/^_\
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M *W[^WRR/6+X^!@-6\^P!P < ' !P < ' !P < ' !P < ' !P < ' !P <
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M;;@XK= 5$>&R&U>4#:AL:%%'5;#;:DQP5_'UO,7Q,W6<Y%MM-.98?B6T]W>
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M5&_6&?\ $3P)+:7>7B/V9^F2_P!9?_Q5< >T^\_$8W @. #@ X . #@ X .
M#@!Z2G_RX;__ %OW]OED>L7Q\# :MY]@#@ X . #@ X <Z=0NU3&NVM; *XZ
M_$.;,N[]79(PZF3O)4</%U.QVPBX"J8I;;Q@Y-[BC!X/ECB X9LE*LIK+@L)
M*C/@&K:GMK:>SI=6HU/N]1'V%FH;,M-EM\O7QQEY\A4-@LT.L5(S0CY,20J1
ME+^2"ME0\RI#T0D*S%JTI@>3C$6 "T3>I5B?TQYV_7I=.B[#E:9#[';I90[
M<4()FJZ,*^32AKA480G1HLDFTD?$S*&O6%2H$&+-BOE([Z0#7%<W_L<\_FAC
M3T60;/[KJ^L:U=[7K4S0K.,#$M3']M64H?U)9)(HU$EQ85//A:>4*P0@DX],
MAS4#3$,+,D&@#,+;CWQD-*@@AZ3=AHUPVO23)FMT4D8'7&WU!ZI3=8!30^*Z
M4Q0:Y>ZY8B#MRMC\V,)K1@&K+)L3#FQXS@!T%J/:PK8TFR.HM5:DR)9!PQ5*
M9")"UV83KI,89$ V4X,:D+*MMW;+J;J,?F1XR(U;M57@N,-3$ONR@#=W !P
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M8+$I^;W-50@T +S-E>)Y3,S!%QHL94J1V;>'Y"F\O.X;1A:U80GP+[]H"T<
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MZ5&_6&?\1/ DMI=Y>(_9GZ9+_67_ /%5P![3[S\1C<" X . #@ X . #@ X
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M\>O6%_P(\2.58 &G@4@JT+F+9 (=GJ:UHF*8EEV+M6,#*Z(MD*+9J-9!)*S
M+ <B5D%*JXIR"LB4FEK&1$@X@#,6/8\$S J+($,+G,>, 26I-O2-G6?;8A8
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M@ X . #@ X . #@ X . %A(_ %;_ -YC[XURI>LKX> D]A=WXF*]RP@. #@
MX . 'J2\RMUUE#K2WF,-Y>:2XA3K.'<94UEUO&<J;PXE*LM^/C'CX3G*?#C&
M>1>5YE>5Y77EUE?LOROZA4E),U))234F[$DC(S3B]7$6TK[CNOVW:A[>2+!P
M < ,\5\*#?U^']X;Y![#[C\!);2[R\1Y&/A8I_>,W[R[P6PNXO #VGWGXB.Y
M(@. #@ X . #@ X . #@!81GP%9?[(3_ )BCE3]9/Q\!/4?>7@8KW+" X .
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ML6QS0,Q-6"J;M/"AD@:P,J\6 )&S+-;YRF%QQC<QQX@:F2,RY$C^GB/EEED
MY;:Z&'GAI.$4V. DDR&I-M:EEW")J]3%ZM$?:8!D([;MCVLE?3).Y6<.Y%8(
MIQ'<KP.6_(+HC"!6)\=8X WM?>G]=PN96_CKAW%9>Y],1ZLX]7\%QX,]INV[
M+L\,F3AX,C7#PJR1ME3P!<(S*"2X\".[)'GF)\J/(&@%EU_JPY5PNT(MGN,2
MTGMIVPO;"I8;6%5D:+?*TVL4] T8%=L%@?S '1JTPY#5+,R)JV74,3)4J2TZ
M0E &MI?2@#?D].1:-:IH\_H4;3*^3(Q!;:8NS*U3 BX X2?'9(>""Y"+K=.
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M2FB6M=#:X0456FV7(\?1DXC+B%%1$G%H>>L34]#$B*E^.V-<84^T[,2[AAD
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M  < '>Q'Y4OU6_P< ,^02G)@CW$R%86YY7XZO C^EXCR<)\/]'P>]CWO>\'
MGJ+O/\!@=[$?E2_5;_!P(#O8C\J7ZK?X. #O8C\J7ZK?X. #O8C\J7ZK?X.
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MLJ:EB$TZT_!F078CTC+CB&F$[K^VZX!>INSM;#;=!U^1V%1Q]])I:6-I$VV
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M_P ,/[SC@26P^[\2$;P(#@ X . #@ X . #@ X . #@ X . #@ X . #@ X
M. #@!\T7>D/9 ZD].&:K- ";;5K%H ;OL*Y-<R%N%)U'N"L[0'&1TMIG"'[I
M2I(.?! 27F&T$J]9[ (E.Y<8!YA6O*\_C=\;^SKO[ 'A%Z=M[F+I3Y=I$UV0
M#K-MZ@9I<;FQ5L'K>8.VG1]J@@GFA3*'20-D8'EI]K#/[ *6RPRKMDG*($(4
M@ZZX^3:F\BZ]MVK;=<9'=>?QN >%=Z>=[0L#RKXF'.$T2Q:3L5?U]?[C5K18
MSZ]:JO<8M68NSPM)%E)-) QK6,/ZIB;(D60M%N >1)G/U&*2??R,ROV[;[S(
MKMMW4=^6OF /TW9%(WAKN[/:TKYJP[ VGOO9L+7$2S0F44<?/U'JVBXS!LDH
M8D"JVF'JQ.M%C[/,46N7<++%A%B<IM,LM.HR,K]5Q%?=D9]0"8!])MW'4S9P
M8E!ITTO;ND@_J$&AB3A\:$MMKNNZKE,J R1,&QY+-* )OE4!#2"H<1,V"!BO
MN"HF8;4=J+RO+L41_ B(OP 8UCT'OXU<(F7(HWN*!OC0&SL.A[!3Z[5R%7UN
M2U:\=E&Q<*D*OUPVMB+4RX_,ZSVY5<?!QA#0J=#S$B@N+R(LSN,O'679V7$8
M"-V#K>PZAT3IX-4IU5K/4A VI98VM8\527E68EMRT6ZNV=*T0V$32\ #4-AN
M[(/J4PJ,.DTZ,4)2848>L@Q&TSRN*^[L+M[=@"_%^E(@+JN[*G2A()N#8JET
M]5'7<B=*93/[NT\S";5WM+\E4[&?BOQESX;_ (SBWR#CDU.6Y#BG.22O5O/9
M??\ A^' !H><V^7V-4M" G:66.#>KK<^PR%P&&YV-L5L?<(&Y#[YLYKZ=6AY
MH!'K6+3#J4&^2S'F=90@VE^:1(HFRCX0F2U$9G?ZI%<9:NHMO[V@+#5^EO=X
M>D)"($!LV.C: +:>KSURN%7N=,/R216C.S8M5J6=<1QL&K2X%->*#?YS(1QP
M799 -F77B ]@Z0(KT[SO.[49;>T\^J[5N 7>G=/>Y5;41?[*V_F _M/3-U4[
M:[F L-O4(HVO]SU,[WSBJUBN5B(41.N%=\@%UZ-)%Y$N(6DCF5&EQ&(Q%=\%
M%ONSU[]8#?\ :ZMLRD;G.[>US4A.Q!NP->TZC7"K2K5'J)P23UV;NI:JV().
M)#IHDB-(1=@'!EB'R90V7"4/#3QB2>7I\5N"N,KCU:]1[?@ T]L'6/4[<EUJ
M<9\TY!4I0ME5VP?S?DZO670!"YV>,1 U$O=[;0;#;BNKQ%8C#11^328P&PV6
MPA>_9H%YF0.AB!&DMY'NR+,SSV$ KH+I;V%%U)?:W/&5G%PLNLNE6JP).2+,
MC*2VF*_78]@;?)^29<;CCS0^?+"2,>-V[JDS&D1W7<YQ;$5Y=AJXF8"QD]#;
M1)UG8NH&ZM06!UJNG4?<A6]RA'!*Q \;P&[*P#F5P$Q"CFA.Q*NN_0J5*,.3
ML!T4 %+0.ER'R,4+ K>6H\KM7==PRZ]VL-?P>EG9E@&H;LM>3$7 ;Z;:N\,L
MVP@=M'%:UK+J H&R;C %0 -(K(UBGBJQ5RC%.8.MNG9[Q@@-?$5Z.^ZHA.(N
MKM.^[K,CS,^N[L ?39IIIAM#++;;+324H;::0EMMM"<>!*$(1C"4)3C&,)2G
M&,8QCP8QX.4 >S@ X . #@ X . $D7_3W?[.+]T8X$GM^!>!"-X$!P T);-7
ME;3MUZR/K98J1+0EXU?/DM/X[S9*VFS5R>TMB)E'@6RV-'SG,OY=QA,A++64
M9[3QDVOU7=>*_@ YM;T3N.T *H/N="U;.?U!T\&M*B*_:#TX]2=OFK ;U-+.
MDR,<9 C$*U4Y8?4$%@2T3:G$XA:TO+)A"$"O)2<F\LSUG?JU&6H^8#8NK*9;
M-4'K[<QVHPM+!;1NFI@$#45))P5PJI$@I?K]MVF3;KH3%:CEIL<G$?,#Q:$Q
MWZY2@\J>=;+2GX42#N/5??<1ZSZ^N[/QU@-92^F39-OJ=:T?8X@4'0=</;^>
M$["AG<$9UKC;2H>V-:4N.U6$0H\P5+"UG;Q2=;UD)J8_?=?ALA'2T(J[)&S>
M6WK/#\+KC/OV ,^QZ0W;LWL+;8Z_4JC;]>4O4(FF V[:LP)N-PUIN:D;G.RY
MA6(%;6!J-@FZXKU=K[\H?).1V2I<D6"P%0XL:8,RNN+K,S/5LO*Z[O[;P'1.
MHZ9:F+/MO8]\!P*Z5V=8:VZ.J3)2-8705<J--'5>%WN4BL-C7S1:=W^0DLC,
MR8405-&P<S),EN9GE3ZBRZ_C^^(#>_D\?QEK[!GQW%(4XKLD>,XIK.%-J6KQ
M?"I3:DI4C*LYRC.,93X,XQR 'L0A#:$MMI2A"$I0A"$X2A"$XPE*4I3C&$I3
MC&,)3C&,8QC&,8\' "4E?!PO_G?\=/ GJ+O/P(1O @. #@!7[8BP.56RMU)^
M/%M3E?,HK,F6TV_$CV!0Z2D,_*8=_P!$]'9(YC./-.?Z-QM*D+_HYSRCF/ O
M1W$O K 9["7<>&^_5=?=M&--*4J'+3"4A$TXSY1%N$2D(E&TLHZEI5]52$NX
M#41ZC(C(]0^3O2W7-R=4E]K%[ZCVB,FM=/GEL $.-!\B/.K8TPM)GJ)%1_DT
M6)(D5F(@:Q-["-'9PZ+KS"F75O&LR-# 3)G.MNS",T0[R02DFG2/&J_&HM23
M-LL-]Q$5Y(U:U7^+V/BUZV%2B5&U275Q+,:1J,U(8T'EM5<>6YIGVL*$*7#1
MH4KPH0G$S%2:5&J3I/L%SH1[B' !P < ,B)^E1OUAG_$3P)+:7>7B/V9^F2_
MUE__ !5< >T^\_$8W @. &E]O:DF;CA(J1JX."-:SH3T>V50;5:T2*VM:W4Y
M1%DV*U0[%$$ANPQEMYD+7(5A[97E,&TCE(0C$D=W?WG^&T!RONSI2+V&(9UY
MK6L2!--N&G*YIURS0]OW .D>)%9L0G#VSJS,D$I.QVZB#-()4J0Q-=*V(BX3
MJ=\D>:KS,C,D?6>V^_9\=1]7;PU@+"4Z?K%/V@'G#-1ZJJ3X7>(+:"=]UF6W
M#N92EAF(V9E7*0WH4FT2[9:8#+U!LS2C#=*EU:9+.1U,3NPK3<WZMO5==VW[
M=EVKJ 3&Q-#F'+4=MFO*;!K,,06J4J,)H) 32+9L%1NSPB^Y+#'L4"<$R&LD
MJI*DTVH$)9NO%8JRVS,-F1$:[M&DQ?F>V_;>=W[^>L[K@Z9U6/N(G6]'&;"G
MX)W>!6 \6T3L24S52##,-I$M3T]#3"",E"\=G*(H8800DH=FH9:2_A":G^[@
M%^X . $E%^#RG_##^\XX$EL/N_$A&\" X . #@ X . #@ X . #@ X . #@
MX . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X . #@ X .
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MQ/F&-6? N0>=EB]*R/59]GQ@3EQ/F&-6? N0>=EB]*R/59]GQ@3EQ/F&-6?
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MU-;C>109,O+TI#C<1<A.$K4 ?M@VIK"I+DMVK8]#K+D*5Y#,;L%PKP9<2;V
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MM:Q/HXJ^18-EUEJ2KB71MANM3LL:N YQFK7'%ZCU]F):9[;M?FP),QE!$=*
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M8?<?@)+:7>7B/(Q\+%/[QF_>7>"V%W%X >T^\_$1W)$!P < ' !P < ' !P
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MV/H6/9\!>>9[S&?((2TP1R\.XPISROQ\]FUGP^(\G"?>RWX,>#'_ )8QX?\
M;X>!-YW%K/:?7W# [SF_'8^A8]GP(O/,]YAWG-^.Q]"Q[/@+SS/>8=YS?CL?
M0L>SX"\\SWF'><WX['T+'L^ O/,]YAWG-^.Q]"Q[/@+SS/>8=YS?CL?0L>SX
M"\\SWF'><WX['T+'L^ O/,]YAWG-^.Q]"Q[/@+SS/>8=YS?CL?0L>SX"\\SW
MF/?%)3%28Z<O8SA3[6,X[)G'O9<3C/OX;\./>_\ +W^!)&=Y:SVEUC]ED9B9
M4E*7<82F0\G&.R9SX,8<5C&/#EO.<^]_MSGP_P#GP!F=YZSVGUC'[SF_'8^A
M8]GP(O/,]YAWG-^.Q]"Q[/@+SS/>8=YS?CL?0L>SX"\\SWF'><WX['T+'L^
MO/,]YAWG-^.Q]"Q[/@+SS/>8=YS?CL?0L>SX"\\SWF'><WX['T+'L^ O/,]Y
MAWG-^.Q]"Q[/@+SS/>8=YS?CL?0L>SX"\\SWF,M$M^0.)8>7X^$XB93_ $&T
M^#.9&,9_[B4^'_\ WP\";S,CO._5^)"%X%0X . #@ X . #@ X . #@ X .
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MZA,J>HI#-.:8;9;ID91&;3!J))ON/K29+>\H=<4V>!HB0M#IKZ!YECI@X .
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M9IZJ4:GQ<6K)</>KQ6]H:HVG/*.S( KRFOTDD0TK5A0M^? =L3;%A,OSP$;
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MN'9C2-M-/,$P4ZK+>6O2/LI0VV:HC9,I=)*$I)3,=)H/2R,7V&YT(]R#@ X
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M3YAC5GP+D'G;8O2;OT4;V/&!.7$^88U9\"Y!YVV+TF[]%&]CQ@3EQ/F&-6?
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M-$GK@H5V*UO/,1VW7VP":D7X$V\"C1EX(3#1,*-?@12=>:( ._PY(V,F'(1
MU"DHCR(HM]+488T3*R5*[>$.E08\^9$ ,X#>*5:9<V!6+A5K'.',0Y1"$!L
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MCSB!E \.2Y2V67Y45QQ2FHF/*> &'L3?E:UP8,BYU<N!^-3ZL.O&QCU;B I
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MC_SSC@!SDSU0:]=CZ.?6.M<=6]WI+ &,\.%]O4WH4P0#FMWK#1IUH5F+<+
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M8CQWWW4I::<4D \Y&Q-?PP@FRR[U3HM</R&(H*P2+.$8"&I4E2TQHPDJ[.3
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M>G77E^I]HW'8KK&,,Q[Z4I)0&]9"U'(VF2D-6.XB*K+&UT$ TX83;>B,);C
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MSE.<^^G.4YRG.<>#PXSG']6<\ /+@ X . #@ X . #@ X . #@ X . #@ X
M. #@ X . #@ X . #@ X . #@ X . #@ X . #@!8;3\-R/U87_E4+E4>J7Q
M\3%E^L?P\"%>Y85#@ X . #@ X . #@ X . %A(_ %;_ -YC[XURI>LKX> D
M]A=WXF*]RP@. #@ X . #@ X . #@!GBOA0;^OP_O#?(/8?<?@)+:7>7B/(Q
M\+%/[QF_>7>"V%W%X >T^\_$1W)$!P < ' !P < ' !P < ' !P < ' !P <
< ' !P < ' !P < ' !P < ' !P < ' !P __V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>32
<FILENAME>g723949g41j36.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g41j36.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L
M0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@!I0%9 P$1  (1 0,1 ?_$ !X
M 0 !! ,! 0             '!08("0,$"@$"_\0 8Q   00" 0(# P0+!PT,
M"0,%! (#!08!!P ($1(3% D5(1DB,=,6%T%155=8E):7U1@C,CAAD=8D-#8W
M8G%V=X&AM;;P)28S-3E"0U-U>+&S"E)R=)*RP<311+?B5(*%M,+_Q  = 0$
M  <! 0               0(#! 4&!P@)_\0 9A$  0,# @,# PH.#0@(!00#
M 0(#!  %$1(A!A,Q(D%1!Q1A%1<C,E-5<8&1T0@6&$)4DI.4E:&QT]3P)#,T
M-5)B9')UEK3!TB4V0W.SM=7Q)D5T=H*$LN$W.&.BPD16=[:#AJ/_V@ , P$
M A$#$0 _ /?QQ2G%*<4IQ2G%*<4IQ2K$V>QL<G7MP8U 958_9[L$<BC'7A$@
M[4!;&IO_ '/>L3<2.7)+BT._$I(0SY&4?\&VK/PY,C1K3S HHR-03C5COQG
MS\-2KUZ%<LI"\'259TY[LXR<?!6CS'4-[6575>OH^Q;NC;[9"-9XVIF=^QS8
MWV$?8_DI(GHL2'NWW][X\Q6%>1]CF O!WSZ_Q?-YDN5!Y'/TR-&O1C*-6>O3
M.,?'GT5C>;.Y_(U1]>C7G"]..G7&<_%CTUMRT5N4"UQ\QK>Z[ H%IZ@--PE=
M'Z@XW7S4XU7:W:)<(LG#D>B;C0"\19^(\UX!*T*?PRPKSVVU>%.;%ULI(6E*
MDM.$\HJQD@$#?!(R,[U?-.!0*%+2IUL#FA&<!7HR <;;53D=9_2VO7M3VQ]N
MFGM:XO-T^UW5;B2[("0DM<_ZKRJ#024 SD5YM()BWB3D"@LMCNN.E(;3XN/-
MW]:D<M6M"=:D[9"?'KO\6:><,Z4KYB="E:4JSL5>'PU'P/M).A>1B;A-B=2^
MN%QU%6PBPN.E28Q']5%9#'7 QY48S(6]ETG'EI?J(LXSV4AS+F&G&UJG\SDY
M2.2O*NG3\>_9_P#%BI/.XV%'G(PGKN?Q#&5?^'-3=3NI30M_U*9O:J;6ITEJ
M&,:/=EKZ]*(B8.$]UY;3(,SJYE,>1!F"Y>'RX#+#AF^$H-21U),&R[24RZE?
M*4A0<.,)QDG/3&,Y^$9%54NM+1S$K26QG*LX QUSG&,>!Q5DZ5ZV>E3J(LAM
M.TUNRHW6U@#D%N5T?,I$3)0@G]=F14?88V()FPQ$]EE%0S9XXS2D.ON-MK2O
M,SD9]H!3C:DI/?L1\9!./CQ4K<AATE+;B5*'=N#MU(! R/2,BNF3UT])(E\$
MU>[O"IJV$=LPW3H]0&9FS)O.R(Z3&A3*R\&'$OJ%=9ERQXSWB5EF'<-=P,U(
MK=PI.(^;/Z=?+5HT!S5MC01G.<^&^.N-\5#SEC4$<U.HJT!(R3KSC& /';X:
MBSVF/4OLKI/Z8RMLZH375VYN^5"MM8M$6],1?H)QP]!GB#8.CEY?_J9KRG?4
M>%OYW="N^.T\-E#[P;7G3I4=C@Y'3N-23'EL,EQ&-6I(W&1@]>\5B@9[1_:R
M/9LQ?4 /%5;'5!);69T#BKKB'U5U&V$; ("(C<PGO1).77M>A.S#87O/'E23
M[?B<6,WG"ZXB-^>%K*N2&^;JSOHT#!SCN6<=-Q\-4#+7YH'<)YQ<Y6,;:]9V
MQ_,&<>-<.N.NO?\ L+V?>O\ J-/V'T]ZPV78MWE4:2G]F0]NCM=$U\61GA$P
M\;'U@.V2[=I.: &6"Z\C$>M(QJGWQU9:2N*XS2)2F@AU: UK 04E>=MSDI&G
MN\<D5!$EU<5+NMI"R[I)6"$D;[ #4=7AW;&MEV]NKCINZ9G(8;>6VZQK\^P,
MK)AX@_WE*3AP;;JAUR#<#7P):91&8(0L?WFZ"W'Y(;=8P3EUIQ";-IAY[/+;
M4H#J1@ 'PR2!GT9S5XZ^RSCF.)23T!R21XX )QZ<8K]2'5OTU16N:1MP[<]'
M9UGL>QAU&F7;$GEZ F;,:B16U">M89=3''L^Z)-)[,M@',6Z 4S)Y$>96C ,
M/%:FPVK6@:E)QN!MOZ>HQC.<[9J)?9"4K+B0A9PE6=B?#/Q'KX5;L?UQ=)LG
MJB:WB+O&G)U17[431Y"YFJE(R.<MP@@Q[M>B1Y*-$DI^44 8.<.- A22S EJ
M+$\\=IUQ$3&?"PWRE:RG4$['LG(R<' &01N1OMUJ7SEC07.8G0%:=6X&KP&1
MDGOV!VWZ5>6B^J'I_P"I:.EI/1FTZSL-F!<8;FQ8IPP.8A_5>9@1Z3@)D2,G
M013,LOI"-)CFA#%CD(&?=6.\E$KK+K) =049Z9P0<=<$$@XR,[[5,V\T\"6U
MA0'7&01\((!'R58-9Z\NCVY;23IBL=0.OYC8[LHN$#@A3B\"2<TAQ3'NB&LC
MH3=6FI1U].1QH^)FC2RR?ZG%:>?SAO,YBR$HYA:4$8SG;('B4YU >)(&!UJ5
M,EA2^6EU!7G&,]3X ]"?0"37:V3UR=)>GYJZUO96\Z;4[%KPN !MT!(*E'9N
M,,M$;[X@Q6(H&-*/EWS8K&9#+<(/(J%$QE\S [>,JQ!$9]P)4AM2@O)21C!T
MG!W)VWVWQGNHN2PV5!;B4E. H'.02,C8#)R-]LU<#/5WTU$5O5=P'W#4B*MN
MVQHJ&KYYAXUV+M5J<-:C?L=:+;#4W%S+<@\D-^.F\QA0Q#9#1#32Q"L,PY#V
M7$\M66AJ6.]*>N<=XQOD9VWJ;GLX0KF)PX=*#W*.<8]!SM@X/R&K@V%O?6U,
MM@VI2[[6X7<5II-GM]*JLLB2?>*C("*FSB+ <W'!%Y&@8_,')/&D/*:4ZS'&
MM")?(1AK,$-+4GF:%%M*DI41CJ2!@9.Y.1CX1FHK=0E6C4 XI)4E)ZD '?X!
M@Y^"L<-#=8%6CNFS5.TNIO>^C"9?8URGZ5&7_6ZK/'ZML,\U8YT2)B89^T0D
M3*!$!QD7EB9*F H\!D\$][!60TMOKJNQU%Y:&6G,(2%%*M)6!@$DX)!R3L!O
MC&U46GTAE"WG6\K44A2<A!()P 2!W#?/?FI3!ZW^E"0U%([X8W?4&M21=F+I
MC]SD/>T4$1:PAV#'X")!E(T.7G9/TA+1; T)'2"RQ?-(%\YD<A;4AC/AP-<M
M6LIU:1@]G?<D$@#;&Y&]3B2P6^;S$Z K3J.1VO  C).^=ATWZ5<6H>K+IRWU
M6+/;]1;;JUV@Z6*Z=;7(]PX23K@+(Q)>3IFORP4?8  G1PS'!"R(M YOI"D!
MN/K'>2B5QAYI24N-J25;)SC!/@% D$[C(SMD9J+;[+H4IMQ*@G=6,Y WW((!
M'0XVWQM469]I!T-).J$=GJ6UQ@F](PY7NY<EZ93:I,J(0N:.]V^AJB'#PR$-
M*M1$*EYA*#6LK">9(<G\TD]KV%?9Z]/#.V_:V/UN:E\[C92.<CM=-SXD;G&W
M3OQ^,5(6U.LGI@TC8IRI;7W/4*/9JY60KA*P4RZ>F317I(\:, -"%&!(=EWB
MS"V6V(V(P=*.-X>)2%Z84EYF5$=YP!2&U*25:01C&0,G.^VW><#T[BIER&6R
M4K<2E21J(/7!QC [^O09/R5')_M)>A:,B:?-F=2^N41]ZP\JO*:)E2B\MCFK
MCWGIV,%BWY.I#MF-.L9(MHD(QW9>5AS+;+BTSB'))4.2OL]>GAG8YPK;^#FI
M#,C ))>1A73J3UQN ,IW'UP%3%NCJDZ?.GBN0%KW)M>JTB#M6?\ >N2603*$
MV1M+(Y#A4#%0(LK+3 +#!8;Q,A'@D!"MF!K)(:P6/EVFVPZZ2EMM2BGVW=IZ
M[$G !V. 3DX..AJHX\TT IQ:4@].\GX ,DCT@8KK?NL.G+.EW.HAO;U0(TLR
M0*&3L 0L@R'".-DQ(9B.D&A1GI*/DO>AP8;T::"P<*Z2SZH=E*\*XY#W,Y7+
M5S.NDX!QC.1DX(QOD&G/:Y?-YB>7TU]P.<8/@<[8-6[2.MWI.V1M)>EJ+O:B
MV;9F%%M,5J-,+7F0)CQW2S@8>8<#;@)N1"&8)?+C8B4./';$,4\,C A/E3*C
M/H1S%-*"/$XVSL"1G(![B0!T\14$R6%KY:74E?\ !'?CJ >A(\ 2:QWZ8?:2
M:VZD^IS>&AXPNLQ<?2RX..TV<.=*GS6W?0B7$_8M@92['A@QD9 C0\)Z2,<;
MP6T@@HAZ0.44T)'57HBV66W3DE6>8-@&]TA ZY).3O\ B'?19EH>>=:&D!)
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M 1N<$[>V'7Z['7.)$E+LEUU@>Q",I+B@"E*EX.!N!DXT]1];X8K&XJD4\?\
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M>AK"HI,4/$$1C1PI@$5$*/GD5"D)0I#2P0'"ZK!0=(6HH3VA@]ZLYSG!R95
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M7:^:HV]!1O2CL9ZTV"3/$MDY*Q<*9JG;1D<2_F,8ODU8'#BK7:/1M29\,L@
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ME5RTP1"PV<8$#G9AU> I*=QA<B_$MHBDO-A9<9<J<U8;+0P$%06K;<D# R?
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MG%*\]OMSO[,>AW_"3<O_ ,^G.=8\E?[LN/\ K+9_ZIM>4OHI?WKX;_U'$O\
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M@H*YWB,:>ASMR;RJ>35WRBQ[0RU<6( MIN*742&'7D2&[@F&% *:<;6A39B
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MY'6/)9Y(WO)U<)TQ=TC3&I-O5!:CQX[[>@N2F93CJG'GED[LA*4 '.LG4G2
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M4D9\YD;X!%2=[EAOP3&?F OU7,ORV_<T?:I^:M5Y[_NSOW1?ST]RPWX)C/S
M7ZKCEM^YH^U3\U.>_P"[._=%_/3W+#?@F,_,!?JN.6W[FC[5/S4Y[_NSOW1?
MST]RPWX)C/S 7ZKCEM^YH^U3\U.>_P"[._=%_/3W+#?@F,_,!?JN.6W[FC[5
M/S4Y[_NSOW1?ST]RPWX)C/S 7ZKCEM^YH^U3\U.>_P"[._=%_/3W+#?@F,_,
M!?JN.6W[FC[5/S4Y[_NSOW1?ST]RPWX)C/S 7ZKCEM^YH^U3\U.>_P"[._=%
M_/3W+#?@F,_,!?JN.6W[FC[5/S4Y[_NSOW1?ST]RPWX)C/S 7ZKCEM^YH^U3
M\U.>_P"[._=%_/3W+#?@F,_,!?JN.6W[FC[5/S4Y[_NSOW1?SU'VU(J,8U_9
M7F(X!EU H^4.M!CMN(SD\3&<I6AO"DYSC.<9[9Q\,YQ]&>6D]"!$>(0D$)&X
M2 ?;I]%92RNNJN<1*G7% K7D%:B#[$YU!.*PSYJM=/K+70?]@F?^VY'_ ,H3
MFS6K]R#_ %B_[JYOQ+^^7_EVORKK)R3J2HZCU.Z9/P\FTSEPA4QV!LHR#FIC
MU5_).2_/7@CU_P!DV$X9P.QZ;T659=?]1V8K-2^9.EPN7CS5B&_S-6=?G:I:
M=.C2-/+\USG4K5KZ)T[VTFTF/9+5>>>%BYS[Q"$?EZ2SZDM6IPN%W6>9S_50
M (Y:.7R2=2^9A%!A(:2L4S$5^&%<.EYV3 AXH)KXNER,F4T$"*WW^'C?)?::
M1W^'B7CORN^\W&9>D/*"&6&G'G5GHAMI!6M1]"4I)/P58PH<BX3(D"(VIZ7.
MDL0XK*?;.R9+J&&&D_QG'5I0GTD5D9U Z-KNNI*I.:QF9B[5R?-LE')/*2*4
M4K:%"L+E=MD1'HC A6UQDC@B!GJPVM#QK\3.C-N/%.LK>7KG#U]DW%N6+HRS
M"DQVXTY+:-24>I<^,),1YPNK6>:WID1Y1&E"76%$)2% #H?'_!%NX>D6I7#,
MR9>K=.?N5C=?=#3KIXGL-P-ONT2.F*RVE462'($^UI(6^Y$G-I4MU:%+59\Y
MTZ;9@,QZ"X.%-=/MD50W6("\4:S/PETFW7F(JL6IJOV.274I<QX8EIL>RXBT
MX=%+:6XAT0I#-XQQ':)',T/O-AN(]/"I$&?%2_"8"2]*B&1&:$ME 4DE4;FG
M"D$ A:2<1.\GG%< L)=A0WUO7:)8EH@7NQW-<&\SE+1%MEU3;[C)-HEO*:=2
ME%R$4:VG4%06RZE'3M^@MJ4:-)E)^O!^3'3(==G!82SU6T2]8GY'S_=L/;(2
MLS<O+U>0D5#/M@C3H0"R2&EB-846A3&)X=_M4YU#4>0O4ZRN2PM^++BLRH[>
MGF/1'Y3#+,IML*27%1UN:$D+5A!"JI7?@/BBQQG)4^WLZ(\QFWSFH5SM=SEV
MR?(U^;P[M"MDV7+M<B1RUI8;GLQRZXE3*<O)4V.>T=/FTZ=!S$_-P\)Z2M%Q
MP-L"B;Q1[#/4XR6+P!'#W"MP%BDI^KNDGJ2!X9N."\B04D K+!JDL9EB\0VJ
M8^S'8>?URD..1%NP9\>/-0TCF.*AR9$9J/*"&_9/8'%ZF_9$:D=JI[IP!Q19
MX4N?-B0>5;GH[%U9BWNQW"?9WI;PCQFKQ;8%QDS[6MV01'Q-CL\N01'>Y;Y#
M=5J5Z6=VP4WFNS5:A8J78$FY&8'/OVO1V:O&U\N."D9.XG+M.(^H1JWY>*]U
MGV,J-$GD2(;D&[(H(;RJ@UQ78WV/.&)3SK2EL-,J;M]Q493LE#JVFH;8B\R8
M[I9=YK<9+BF"VL/ALI.+V5Y,.-(,XVZ9;8<66VS,D3&W[]P^VBUQH#L=F1)O
M+ZKH(]GC*7+B^:OW)V,U/3(95!7(#B<T)[I^VJS;8^F)@(\F3E:R[=8^2!M=
M2/J!%,'46@FVYO0DX]3&*X(X"6P9+DSK(8A3"PR7&B_"RJX3Q!:C$<FF0XAI
MF4(+C3D26W,3-5H*8GF"V$S525AQ"D,I84M:%:T@HRH6*^ >*476/9Q CNR9
M=M7>8\EBZVE^T.6=LO!V[>KK,Y=F1;FE,/(>EN3D,M.H++BDO80:ZGI\O%?=
M(<N-5.-C9#7>P[K5I.FW2@2<9)"TF)R659&Y@:5F8N7JT20MER5'BG\2LJ.@
MD.#<5(,N):MSQ%!D!(A2T(=;N-NA2FIL&X-.MJG.Z$QBRIIEUF4ZD*#2G4EI
MI12M\!M0)OD^3^]P%.*O%J??C2.'N(;U:Y-FO5@E1I+5EB%YRY)F-2IL69:X
MBU(7*;BK$J4V'&82O.$*".B]TU[C'@7K"_68YL9JGB[!;C<W&DJLYU&*A1K!
MBVQE1;L2[/)P(T26T2>>!$D-1RVS13<L&1LDP)43Q+9E/ICIDN%1F+MY=\RG
M"*B>A]4?S-V88PBM2%/)*6VW'DEP%"T:D.M*7;K\G'&#<%5P7;(Z6DVAKB!$
M;U8LIN;]C=AMSQ=HMH3<3=)4%N*ZER1(8B.(CD/-/:'8TI#-.BM [5FJT):8
M^O@K$DX<^Q0T._:*H%<I^O1>"LR$]7J&;-CW.>B!DA&+R?$P18[S0I+PRWFA
MGUMU7>(+4S)7%<D+"VWFXSSR8LM<*/)=T<N/(GH85"CO*UH'+>?0I)4D+"2I
M(-O%X#XIF6UJZ1[>RIJ3#?N,.(NYVIF\3[?%YOG$^WV%Z:W>I\-H,/'SB) >
M;6EMQ;16AMQ2,3=Q_P!K>R_^Q%_Z;C>7EQ_<;_P(_P!HBL+8_P!]8G\YS_8.
MU[->F3^+;T]_XC]3_P"H4!SR)=OWUN?](3?[2Y7ULX5_S8X<_H&S_P"[X]3A
MS'UGJUE^TXTP/M/1T^QEI&72(F0C/.4GOZ=TH9U(1>>R5?$(S+!:.^,XPME.
M<XSC';F6L-T<LEZM=V;U:K?.CR5)2<%QI#@Y[7P/,EQI7H6:M9L1,Z'+AKQB
M3'<:!/UJU)["_A0O2H>E/?5X>R^W,_NKHMT]*RSRUVNDP[NK;BR0OQG,6#7;
MZJRIR0SWS_5LG&!1DT]\>^<R>,YPG.<I3GO*#:V[3Q;=FX^##F.INL%:/VM<
M6YH$M'*Z>QMK=<83_JCN>IQ_#TI4NTQ%.?MS*3$?!]LEV*2RK5_&4$I6?Y];
M!.:76:IQ2G%*<4IQ2G%*<4IQ2G%*X22&A1WB7UI:9':6\ZXM6$H0VVG*E*4K
M.<82E.,9SG.<XQC'QSG&. ,[#<G8 =]*\WNDGC.N_KKV9U&/>,[7D#*9U5IO
M+F%."8U[3)!S$E80N^,HRU;[#DR68>[-DL(?.CW<Y:0E/.F\8?\ 1SAZP\$M
M$(F%*>(>)=.RO5*:V!"@N]"%089 <0<H43'=3OFM:LW^4;A<+ZO=K)MULR=A
M&94>>^CQYSVX4,$ +23BO1W' L1H(H Z$MLBL-LMH3CLE*6TX3C&,8^C'PYS
M*MEKN\4KPI:G_K&Y?XP[-_\ 9<]@6/\ <"/YP_V35?(OC3]_I/\ X_[3(J5>
M9BM3J\:#4LWFUQU82?B,S(,2SWK<C9,PU[KAI"7RGT^"!?'Y^ ,CXSYZ/+R[
MYO9?@\M5G<)?F,1R5R^;RU-#1JT9YKS;/MM*L:>9J]J<XQMG(S%AM)O=UC6P
M/^;><(E+YQ:YVCS:&_+(Y?,:U:PQH]N-.K5OC2;.Y>5AZROLU#T/IV0CJ-M$
M7:ENV!B)@Y&[O4>QU6K05'+L$6'--0$>)-U.SE6Z7AXZ0$3+ONR5=CU27J(\
M96,,*,YJ<6??KRV[.M:K5#M_.?;@B=&ERWYR([JV3(<6Q,BHALO.-J+*0U)=
M#6EQ0W"#U2Y6/@7A!^/9.)V>*;M?Q$A2+VNR7*U6N#9'9\5F:B!'9FVFYN7:
M9#CR&DS%KDV^.9/,CMGV,O"CITI59B$V\;0[2;>GJIL/4%/UU(B-,0<?9A-G
MJN"<8F0)<=#X4L(]"1D?GP28L:&?[TRHB0!4(6BMZMRV7[.B?%;@"7;;Q-N3
M:RI]R*NU^9?M+C*BE;*DONN;M+<6WRL);7K0;0<%VN9!XN?L5T>OB[5Q#PC9
M^'I#*$0H]S:XF-X'[,8F-I<9EM+@QH^TEJ,R_P"<DN2&"T\(@5K>ZI:O#ON-
MQ2-;R04/<_+-C75P\E(3;M=#$2TV8IV36_,LN!)5$(/;PI.'EK2.I+RLP+E"
M)@CGC-R:6]"RAT!YIMA,A:\E #02RH+P\6SC8 J! U$\.WD)O:_,E$<.268E
MYP]'4J')D356YEH(2\5R5+F(4P#$2^D$:R0V0LWI8NG;;U7!R;)5=@AP>6AX
M&5B(*R5:S6:N3EA=\B"A[75:Y-2ECJTE+D]@P0Y^,CGWC\ICO!@_.!N6,;B.
MSREZ&I:DA3+TAIY^-*BQ9+$89D/1)<EAJ-*;93VW%QW7$I;RYGE]JLU</)[Q
M=;&"])MC;BFY<.!*AP;E:[G<K=.N"^7 AW6UVZ;*N-KDRW/8F&9\:.M;Y$?
MD'E5Q6;I]VO4Q$&2->!/;3/ 54]FK6FI70Z"M$HMQJ-KEECJC.39U:FSWFG1
MQ(Z<' ((+;=#:2HMEYAN:+Q#:9:RAJ0XV3'<EMJE1)D)N1%: +DF*Y,88;E,
M-@A2W&%.)2@A9.A25&G<^ >*K4T'9%O8?2)S%KD(M=TM-Z?@W24I:(UNN<>T
M3IK]MFOK0IMJ/.;CN..I6R@%Y#C:>.U:#VC4!A"I*#C9%LJRBTM:*E;:A>28
MVY')?6'4IH.FSLZ5"6,O I218F59$+)=%*9';=>%(;:C%O\ :YBEH;?=;*8R
MYH,R),@I=AME(<EL+FL,(?C(*TZWFE+0D*2I1"5))A=. ^)[0VT[)@QI*7+D
MU9E)M-VM%\=C7A\++-IFLV:=.>A7%WE.!J)*0TZZIMQ#:5K:<2CK7;1^Q]?1
M+TW8XJ)S&A2K4#,OP%NJ%N76IY]LAUF"M@]4G9DFK2[R!"O* GVH]]UP4IAM
M*B!26FIH-\MMQ=2Q&=>YBVC(93(AS(8DQTE(4_$5+CL)E,I*T9<CEQ("DJ/9
M6E2J5[X)XBX?BKF7*+$\W9E(@3%P+O:+LJVSW$NK1!NK=JG3';7,6EETH8GH
MCK46G4)!<:=0B)>9>M4J.MM?VN[/_P"Z#?Z0#Y9W#]QO_P T?^M-96R?OK#_
M )Z_]DY6$G-3KJ=9:Z#_ +!,_P#;<C_Y0G-FM7[D'^L7_=7-^)?WR_\ +M?E
M76S78NC+=6^G77=EDY.H8JL?9=BRT591K(*7&W!JSB:\;@A*D.PA<Q(R1F86
M<]6 5%Q[\!F%DFK,F%?8PTO7K;?8<KB.XQFFIGG;D6W-.Q5QEH=AF*NXF0N6
MI1Y+;2.?'T.(=<3(Y[1BE]*M0Z#Q#P1=K;Y.^'KE*DVD6IBZ<12XER;N+3L>
M[HN;'#J(#5J;;"IDB2\84[FQWHL=RW^924W,0EMZ3%73U=*OK2]E[)L#S2Y>
MC5:PSFO(E\ PX::V4H/W94&C?2M90*%#G2"K0^022$VK,$V*T_ZDEEM>5XBA
M2KG 1;8Z2&9TN,Q<74N(;4S; OFS"C6<J<>;;$5*4I61SRHITI41J_D^O-KX
M;OCO$=P6E4NQVN?.X>AN,//M3>)"T(UH0_RDE+3$-^0;HXXZZRD^8):0LN.H
M2J583?=4N.N;=1+]%UW72XFQUC:>NI;6M8+C#\W:(DQ8RR!YRP_(-HE+!3RR
M5QLC(*#C6)> BE21:4X8RG%/V"7#N4.?;W9-Q#T:5:KDS<Y276_,7FENQEX4
M&R6H\Q*0ZVWK=4S(=#:"2JMHA<=VJ[\.W>QWV+;^'C$N-LXHX=E<-VQV,^;U
M#E-1;DSV%R$B7<+.ZZ8TB068J)=OBF2Z &R)D=V%JRVV^EJ*LE V)L65WQJD
M^G7"DZVL&M[C[G1<4.SYFX\+@JM39R;.%>#89Q!AV$E,LLL[WY@17A?PPM]V
MB1)NF-<+=;FK#=FYL.=<X]RA<[S(B.BS8D2YK#"%A:CSUQT\D(;Y&L93N"^(
M.%[M=[,7;C8.(>(I7'7"S]GO%EX;N'#EX\S]5TKN#W&&8-JLTZ:^TMEM/F#-
MQ<$LO/\ GW).'+#LT[J/6LOOF++OQFPU;7V1!QDM!P<+9(>=JM7KFV1;O:3Y
MZ3G0(V)7;\^Y,04*FL25@"<6>;)NRHB/*8<OHK%WN;-@>1 1;A:;:^ZR^^_&
M>8ERI-H5"B(8:8<=>$,<[GOF4U'<'+0VEI9RH8.Y3N$^&Y?'<1V_O<0?35Q'
M!BRX,*'<HDZUVRW<6,WNZ/SY,Z/&B*NQ\R\QABV2;@RHR'Y*Y3*=+:Z_<]JZ
M;%HF_JO6[5K9;-]$KGVO(RA:MML3)^@A=H5:SJ$V!>KA7Q[6;95P<>ZZH;,O
M/UPL\:0**FFSU1;9-O#M-Y7<.'Y<F)<@JWKD^J+L^ZPW6M;UKE1==N@0Y"HC
M<7GN)&KDQY*6U-H0R6PZ4W]YXIX.:L7'UKMMTX;+=]:MOTO1;%PO=HDKS>#Q
M3:KH6K_?+Q;V[J]<E08ZU<KSNX6UU]I]UR:A\Q4NVN1LC3=IWMU*W.4F*^MJ
M[2,G(:GG=A0-XE=>J>?MT><XY;JO68\NQ$J<KK+^(!B2@).+CY1##TE&>-D9
MQF[3;;S$L/#4)IF0#":;;NS%ND06;B F&X@"'*E.(C) D%/G"FI#3KC1*6G,
M*6#BW>(^#[IQSY2;Q*F0%(O4B5(X4G<00+W*X?*UWB._JNUKMD=ZXN%5N0L0
M$2($F+'DI0N3&RAHID<K9%$V #]A,),*DH[]S!9*'>K71-7$UV)H9D;NAG83
M%A'I4/&QCKU *=]U1DF3$ *GG8R15/SD2S,)D@,XU-MG6]?GK[(;<^FB+/@1
M)]U3)=GH<LJK<J.J:\ZZ!<$#G.M)><$<.MB.P\IDMN5L;G$=CO[ LL*89,?U
MLKE8;[=;%PPY;HEB>C<9HXA;N*++#C15+L#JO-(LER'',]<:29\Z&B8),<]*
M7EJ+J?6.IX<BW&2XLST^=5$/%2K]=G(IN4E[^49$5_W3#G#>^@Z])3 Q8<?+
M3 48V6H8N4(8 '=PE$[+4^[72[O)AH96QQ%PJ\ZR)+#I:9MZ$.R.:\VKD+D-
M,J0MQEE;I1K0TE3BADTI4NQ\*<,\*PW+N],:F>3_ ,J4.+*7;IL5,F7?W'H=
MO\TAOM^>LV^3,;=:CRYC,8/%MV4XW';6$IB]C<5#1N^MW%R;?S6XWIH8UP29
MF,EE9:M2.F(W72XI(?H_5+9^S1],?ZUMA4?G"\R/J/0>(K&5-FG^HDB&&$^<
MN<3FY)1S6NU$^F=%Q#NO7H"O,D\S05!S;EZ>9V*U5'%]C'&MONYG.>IT?R:H
MX<<>\WEG3=!Y,7N'3%#/)YI1ZMK$?G);,?<R>9R,NU*,)U"4-3>K;RW=*%49
M/7>M*I6)&NEZ0#M&V/LCH=;3 1[E(N)M2DZTN(L"P1#6R;#:XAZOH..&S'&)
M99P1BG^'9X-U@F%<)C5QN<N4U(1?%Q;3YM/D^<."=#1+;D\Z.'%(*8\1Y,@M
MH5S4$G3M$/R@V,IX8O:+S8;1*X>X;M5LD6YW@AFY\5>J%BMP@1U6.\O6F3;3
M%N!8:>2Y<+M#<MP??;\V>"&P[J/W+GQ:YLRNV,>),9GLG&,8QWFXW/;&,=L8
MQC[F,8[8Q\,<WVX_N)[X$?[1%<)L9S=HAVW4Z=A@?M+O0=P]%>S3ID_BV]/?
M^(_4_P#J% <\B7;]];G_ $A-_M+E?6SA7_-CAS^@;/\ [OCU.',?6>J-MN59
MJX4"QPCK>',D1Y&6\9QWSYB6\Y3G'\O?'W/C_>XJ(V(/IK2W[+2T.ZGZI>J_
MI?DW<C@6MZ.Z@*,$O/EI4^8^W5MB.-(5V3E3DLF 2RVUCOA@-Y>4]L9PCI7$
MO^6>".#^(1VW[7YQPE<EXR08>9-J!. ?W$I:E$]5+ ![SK5N'F5]O-NZ-R^7
M>(PZ A[#4K &VSX2!CN&<5OMYS6MDIQ2G%*<4IQ2G%*<4IQ2G%*U<^UBZ@I7
M4O3DK6=%,RUMCJ-ET:CI;;#F4%@1LVWY=TLG=O.'V!H>NNOB>\&<I7&24Q%&
M>+&&\YQOGD]M<:5>7;Q<Q_D;AB*Y?+B2 4N&+VH44 ]E3DB4$E+1R'D-.M]2
M*P/$,IUJ&B%%/[-NCH@Q@#ND.[//;;A+31.5CVBE(5TWJ\O9V]/L5IG3E>:'
M#PRM$4&&(XXWA#[C++6,N$O=L=L$&OJ=,*5C/SB'G59_A<U6\723>[I/NTQ6
MJ1/DNR'-R0C6KL-(SORV6PAEH=S:$CNK+Q8K4&+'ALC#49I#2?%6D=I:N[6M
M65K/>HFMBG,;5>G%*\*6I_ZQN7^,.S?_ &7/8%C_ ' C^</]DU7R+XT_?Z3_
M ./^TR*E7F8K4ZRDZ3M:66_[(9)JGNN2D:^!-O%5O,D.'8BX^2K,[&8E(D$W
MT[4J&#(D@BR;813IX6#QBW LQZ2C!M6XMN<:WVU29?-:;D+92B3RE+CH<;DL
M.\IY:-2FEK;2M316@-KY:D!?,TH5T_R4\-W*_P#$:'+5YK)D0&9JW;<9+;-P
M=CR+;.C^<Q&'N6B4RQ(<9:DI9=5(9Y[;JF.0''6X M]8)IECDZP=)0LJ?#N-
M"R!->D42\4U(>0TX;'LRC*$B'/19*W8TTF/<*C7#12,QQQX?DEO9^'*3-C-2
MFVGVFW@5MID-EETMZB$.*:42MM+J0'$)<"7 A:>8AM>4#0KO;';-<9-L?DPI
M4B&I+4ARWR$RXJ)'+0IZ.B2A(:?7%=4J,\Y'4[&4^TYYN^^SH=7F43L'7]\O
M8V](K>8^D=C2T)%@WZ"L>O;%;VLS04(!!S$O2BH*"LL5(1]A;CVI%$984P1D
M6<04,DYT1+)*=-3;KA @*L3MB5?+:R^ZY;WX]QC0SR''W'V69R'Y$9UMV,7"
MV78_/0ZA*%\M*RI%=A=O]@OU];XYC<<-\%<12X<5B^P;AP]<;LGSUB"Q!F3+
M*[ @W&*_'N*8Z9 C7 07HK[KK8?6T$.BIV7J-UM(3NT;!'/RSZ9+872E-P;!
M4 Q#R5L#TO#ST;=9]P*,65"P9,P<L>5'CR9!#B_>Z48\;K!:6:4;ANY-Q[7'
M<2RGEVWBQA\ID*>:B+O;T=V%'#CH2^^EE 4RIU+1 Y.=@I&JZN7E%X<D3>)Y
M\=<MSSGB#R538*'8#<.3=F>#(<^->K@IF*7(,%R8^IN4W'<D)4?.P!E3;P;X
MR-CZ;H"]V6>N[&&V',;$V;K[859K@53MT*TQ$UK:?V<'PUD.L,. */.+$?\
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M0002",549>=CNM/L.N,/L.(>9>96IMUEUM06VZTX@I6VXVM(6A:"%(4 I)!
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MU).RB*H_*U6=.*4XI3BE.*4XI3BE.*4XI4=;:_M=V?\ ]T&_T@'RSN'[C?\
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MHPMYM#[4UAE2PEQ]*(SQ:03@N<H!"EA/524JU8SI"E8295_0L20A9;NMG<6
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MK&U?>((S<S"+5;FW;M>7EYY35MMX#SX<(Z(>4&XY(W =*A[4UA[[.7 M[BF
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M=2[C4=.MW"UE@/+DJC>>/%U;C?G.E;+ 4HJ2AMC'+.@$ *=#BLC4DIZ"R?;
MW.L]'G3OKS3&G3'*U>-FVR/DTG1;J19&(J>N3(V>(/&=8[."/D6;%6$'[X0V
M4'B69[N(;>;Y+Y%_)C9;UQ-.O5T@,SX=M@267&Y2 \U(EWAA^$6W0L$.@PUS
MEK.2I+A97V5%*JEXUXEEP;:Q$BOKCOR7VE(+2M);:B+0\5)QNGV5+*4]Q3K'
M3(K%;5?6?UD]7-+B=6Z/C:_K1IH9B.O6V'/+L%M(DLBC^\A*;#+_ *FAD?O^
M7$&'I=*2P\T\#*Q9C.$N2WKR4>2OR=3WY'$41_BF>2Y+M/#K;:X<$0B\Z(CU
MWFXR^#RBA;<?*"XVM#L9]E1(FA<3<3<21VTVU;=JC@)9EW%:DOOJ>T)+Z(;&
M<)/;RE3N#I4"EQ*\"L@:#[.*LZZ9F+GL,ZV6V\G-+/F+684Y/WV0,>RWZA]@
MXU:W$DO=\I5AG+3CK79)3I"D>/GBOZ(SRV<57:Q76QLR+A8N&+;$+<'AG@.(
MW";B-(6GE>8VYDH$V4V3K092UH;47%1VV$J*#US@+@^U0ID>86V)MR?<U/W*
M^.%Y3JE A1=?7GDM*Z$-!)(*0X5XU5N-Z=ZO!UX.,$B <C--@AX2HEE*#E=F
MF\869C&.Z2\]\Y(QW^#V5X^]VPWD:><E&"^ZN4XI46&K,X:9AYC*"?.T_6R>
M]](.SNL;]]WQ4D-\Y"0TG#KNS.[0[:AAH][>4]@]Z<5FACZ,?WL?^'/6(Z#X
M!^2N<5]Y&E.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*
M4XI3BE.*4XI3BE.*4XI4.[7_ .+L?[?=7SB_E9_<)_F__E6T<.?MI_7ZY-83
M"(0Y;YU*V:H1CW6%V9&1A5K7GOG'AF.Z?C'9_P#T..^?N?#[G/&-A./*'>-^
M%1^P+=^XACB\=M/[\JQ^]OO>,D9&XVKK,W]XH6UR_;G_ -M_>OVA_<F>DCW;
MI6GGK Z"^J;JFVEZJH055KVOHC&,QV#"9/!LA)$(Q@N0>$#AGAVVV&^P@C7K
M/'V20^O/]4I0U];O(AQMPMP5PR9$B+=KA?)Z4MNK8:BHB1X;)RU';>=EI=4M
MQ?LSZ^1I_:6TCV$K<\P<:V2ZWRX);:?B1H$<E20XIXO.O.9UN*0ADI2E(&A"
M>9GVZE>V"4[1O9-]$^V>C&J;/B-@W&.FXN_2E?FXZNQ\04$W 3$8(<!*GX/(
MD'O79F@EQ [C7NX10_N5I6'G</90W?>4/C:%QM)MTF-:GK>[!9?CK=>DH>5)
M9<6AQE!;0R@-\A?.4#S'-7/(P-.32X=LC]D:D-.RTR4/K;<2E+2D!I:4J2LA
M2EJ*M8T ]E..6.N=MO?.<UL=:?/:7CQ=MZ@O9U:FV=E+G3Y?]V6]W8T6<^MB
MN62VP,564ZRKUDSA;3#X4G)R\L$B/*7EF1:+-0I'[QXL7\/*6I;B/VU#:=![
MPDE6LI^  '/=MXU82^T[%0O]I6X=8.R5* &A*OA.< ]:L^YF:CTM[0?IUC'>
MA=G4LQ8;19-9Z<W?KO8M2I5:NL45 @LSLG/ZKHD2,1*BPPLQ[M##MWD93@Q2
MF72,#AI"F2%N1'3YR7  E;C:T*44G)( 6H[9(R=/]^\JBAN4T/-N62HH;=0M
M*0H8W)0D;CN 5TSMOTIG0+J72^_'^O:_]2E$HNP=K$=5>V*5>WMD1$5-R5,U
M[7XV)9KD-'/3;3Q-3@XY&9X,&0C'8U6&8$9I!7^]P-0D92W&O-DLK6AOD(4G
M02 I9)R=L:B003XZO34(J&W?.5NI2M9?<2K6 2E Q@;] -\8Z8]%8^]7VE]%
M;2T=[.?1G2ML8XC4EKWG=JIKN^^_INQDPTN9'2+WJ\FR^&99IJ&MJG<DQ;+<
M>N.;9?!CFH]3;/DU6''4.2W'T#6EI*E)P!D ^C;=/><^G-4GVVG&XK3"SRU.
MK"59)P<$]^^RN[N[JK'3+O2W;[]H'T_5/< $E7]\:6Z==Y:/WD'C+P)#UPKT
MJ\PW;8F0'PTVMJUPQ 4\T?&Y;';E'CEQF/=R(\E^#S:6HKJFR"TX\VXWWC20
M.R1_%.1@[XZ[YJ9EU3LEI*\AUMIUMSQU#':!_C#<$=_3;%7;1M&:4V9U.:$U
M5T5:V A=4=$NWCK]NSJBPTV3)VJX-&$2;FE(:\K:Q-[&<-+(P#:239 P",A$
M",#.)CP8Y,Y*IQQ#+KDE>I<EL(;9[DIZ<PIZ(QU3@9U;]2<12VVMYI$=.$1W
M"MQ[KE77EA75>>BM]A^/T!\Q=92M=/6E[.'3/6?-0]MO0\HS;X&#Q78J< GI
MH)8D0@PR12(B-;-5!KSDTXAY9+T4Z8YXFVED*999:;V_AOCGB/A1IV/9Y;+4
M9][SA^.]#BOH==T(;U*<6UYRD:$)3I;?0D;D *)-8BY6.VW527)C*U.H1RT.
M(>=;4E.2<!*5\L]I1.5()[LXK&/I3]EO*](&SI"UT?84U,5>78;2? SJ8XGR
MB1G<Y'-&,"#CU(4D=P@9YI0SBB$+84Z]C(K?>/&_',SC*#']5K=;VIMO2\&I
MT%+[*W([J!K8>;=>D!0YB$.H4E: VKF!" '5"EDLC%F>=\UD251Y&@KCR%-N
M!+B#V5H6E#9!*2I"@0K5V<J[(K+K<*LMAS:E.3#*DBJ[N5U/CFD9PM'=4:GO
MCQ$8S_!QWQ\WQ<^:'EK4$1>(5\V]L!,=9YO#B==\;]D1VK:D$:I/@,CLZJ]
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M].:ZO,R;'$'^4<!]W]M/^3/:C]RC[(W]F^$=:SRII82(EC"ELI5X4_#YN/\
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M:1(;4"D-NEI9&K2DUG;=9I4.3VXL<IBRFV) G+;3%0ZM)*&WR%DZ",$E.H;
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M5RE$*("AOOU._A6V#[496/#X66_FIRA/9GP^%&?I0GMC'9*N^>Z<?#/W<<X
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M $<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*Q
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M/.MMY)6IM"DH .HC%<5DVZ4A5P>9BR5P8,QR,[*0PZN,PKFJ0TAZ0$EIM:\
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M%UVU6Y1':9B-(;7<Y+9WPI]3K4)"QA24"6D'M5Z?X"M:2'[JZD%048\;/<
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MCDG2GT=2? ?.?D\+=^0&1@#4H_(/#/>?BK355?:';#W]<2&;1+B/Q2)0D5J
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M .ULUJG'G^8_&?\ W4XB_P!T3*TH_P#H^7]A/4Y_A3K'_1-RYU?RT_OC8_\
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MCO\ 56/YXL?_ /F27_WG@_\ ];AUZ29_^#*?Z%E_[YDUF-LVCC['HUAIA)&
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MG+;#0;C,>Q-:EP#:^G_?)_43LJ3H4S ZUUAM4JD6&Q[(B<0<M<0'*K3"J\?
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M%79YRO,+L);DS;S*2VLE.I+A4YJ;4M>[A4"UN6T@)QGVJ@K)&K:I7&7E)=0
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MT>8A<^VMA39IJ7ZZ7L%O#F F&XCKL%E#F!_.*M/ISBK=;)4E?L>2J6A>X&Z
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M+6(W3++'US9=IUVS$[$A-AC3+A#&JJU=Z_2Z$K:WKJXB4L+P8L')SE=DAXP
MF5(-L(X>+M(0E<=;B$,+YP"FTKR@HQNLI*E<O!PG<@*!)QL35J2M2'TH6M]
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M F)"(E)N+BIL.&)/)B)$T<62:%=>0G+!SCTXIJ&,Y_7PJZ9Z_56LQ0$S.2)
M0$B*X<-G$1-%&8 8$P>8>7&!QQ$G'@1H:DD2QIX@PL0VI.9-T3.<8XP?U^?I
M4<@?K_=UJCYV_K?!,F)FTB>=$MR"RNPLEEEU<5)@PT@)&DX"R-,R0LK*Q(#L
M5#O'27J9>(;2(K,K'^I8/Z_KZ.M,C??IUJUYO>];AM83.U<1,X?!0ML<JA (
MXN&)EQYC8#6ORBTQY^12&<BG..'/1I3;$JAEAT)8B9''IN1"23I[\9_%GK^H
MIG;/Z]<57X_;=8D-AV/72<O,'U]FH)3)NY9S&S$I<(ZPS0D1%J:6X\Z0'#5]
MR0*?<;;$4@I#+#SC[!"&X8V!\<_%C%,[D>&/Q[U]5NG5Z5X2JW!81Z!4DHGT
MLED!L5->(MB/.D<!9 8)(K89LR&"\2@XX $]X,9_ )>&6D^'XQXX_+34/'\1
M\,_DJ[:U;J]<!C2Z[(8/:CCO=IV%"F@OBF9"#DFFWA9 80I""HR1CY,%_+/I
MSXT\*0"=?#*8><@1CK40<]*CNQ;E'J\TN'EJA8V5&J*&J[N'87S;-(#V:K4Y
MAA@%<F@N+!E;%<80&)F95L:->0XZ28\ T[&YDIM/I'X_ GP]'=4N<=Q]'3?H
M/BZ]_P#[5T6M[1;A*A%5B>0[#FQX%X_?XC*:<]+WJ4UY%/$9]X8S+B'3L)*G
MH?BTNK9K@:I0EEHIX:,>:?2/1UWVSMM^IIJSW'T]-M\>/Y,U4M?[KK>P9":C
M@0S@78<J,%SEUT"1_?Y4RRA,1LFB&*/<KUA$<JL@],5^<2$=$#%Q"C? _(>F
M8@1C!\?_ &^?J-C40<_KZ?Q? <8JH36U8R#M+E)*B)1=I,.@&:M%MY&[VZ-F
M<+R?.1)"W4M) J6 II^W((R@N'!C&"LCO^_:^U),;9^'/HQW?'MCTFF=\=^V
M/3GYN_T;U=%<O-4MJC45Z89D<Q[(I3^<,%C(=CSEEM@2X#A@X[<I!R+@![<=
M.QBBX<]8)B SGE"OX;$$=: @[U:S.YZ$;(U:,BY Z7?MT\S QBP(>44RC)=;
ML=HC9HA1 HZE5B8CJO*)AK&&@N)E7&G'@2GX\*4- 8/]_P"OIWZ=:9'R^C]=
MO3\QKFMFW*=4F[&V4607)UN+DY$B-'"-0@MZ)B$3ID0%,$#-03\XU$NLR+L.
MB25)#@.H.?%;$[O88)QZ?^5"H#([P,X_'5Z6"5,AXU9D?"2%A-42$(-%QJA6
MGG7#C&1/4/DFO#BB1X*7E'213BU+8!'?6..65Y C\*';NS42Q&^(:9>C<CUV
M=1&NFUR(G)9;T.L.!F;;;):DUX+]XD7G)H4^PQ*6DRL.DJ/S&S,#+CND@'$N
M@3:?3\'7<8SX5#5Z#X'IL<XW_7P\:[*-UAFCN>Y:?:Y&6S:YZL!0!0X4%+EH
MKE>:LLC,.#3982HX-X!X9F/$D<#2CITA&C'!1N'C'8]CT]V<]1\&WIIJ\!WX
MQTZ=>O\ SJZ"=F5Y- D=CQV#)2OQ<&-9"O*'<%(]S/0P%C=,;28EE#R1H"0:
MDG,,K<3GP.B)7DMMQI$,;X_7\51R,9Z_K\QJWA-U0!MDDZPS&R6#0;H'3Q'G
M5!MBRK;H-H)DK (YDC.41,*70K_%&^H2T0HZHR&&6E-.CN+CIVSZ,_D_+D5#
M4-_0<?EW^+!^2JDO=6M$"),78G$H<);&8'S V3$D9EZ**G6"0(CW1[UD(TF$
M!.EQ98(-^+)C 3CQS'!0R76H:3X?C'CC\M1U#KG]>O2JS';+HTO.#UR+L(I\
MJ8E:@DBLFN@GY9C1Y<EH"82-F'.)#C"PS3A1#WB0&#0E&-,>L&PZP<9ID=,U
M0YG=%!A_.3F1-DB&+%"UE0T3#RACCQTO<HRB//Q[GI6QI@"!LDL-'60J'(/3
M#FXS%$)]]/!QA+!_7X,_%Z,TR/D_7^_?%7%/; JE;DFH:5DE,RC[(KS8Z09!
MX="I%TL:(8.E&1'(J)(FS 2P81B5-"=ES&'18Y!+R%(Q#'Z_K^/PJ.?U_7\7
MC7,#;$25&C[Q'P\M((DZP#9@8$% STT6F1C&9(6+'2Z2.%D]WSVQDJ>,8#2]
MGQO%-#I6\F.-\>G%0SMGX_347D;\C0TRR"JG.X*JB;(9>$#&0A0E:A:HY"(F
M9AL]$BEB;:9;G6WDB1J5G(S#V, I@:8BDQI<=/X\8Z[Y[OUVZ;]]0U>CIG._
M3&-_3U^'T5=!>U!FS;U'!5FP$E43%?R:X>@*O &CSA$JP],,G3I0+8]:A$0Y
MY<G.E);8>"$(*AFI5G(2S88Z>G]>[X:CGKMTQ_?\W7^ZKQIUH"NM5@+;&L$C
M@6&+$E1&2_(R^@<MO#K?=P1\D,AM2<X6P6$22$8PILH,A\9YIU<#MM40<C-7
M+Q2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4J!ISIYID^=,2!<C8FGIQ
MNXX.0,5'MLN$6]!+"3<H7&N9656PY:S!US+JEM#,6N=]:T>ZZ(X''4?R?BQ\
MPS\%2Z1^4=W?GT>FJ9^YEH6"I8EI\P7WG)$R;:@HBFAR(BC[K'7T\5<^-5V[
M#*AOS<6&RVS,RA_D1S+;"5+*::,1'4=O1\/ACQ_)32-QW'T;^/7X?&NT%T[5
MD,6&B\V2UDP=;E%SE=AGW8+ \5+F6R)NDN:DEF#:D3,RDU&/J4P<80P$+-2X
MX+;"<Q>8MJ._3?K32-NNW2KNVEJ:'VN")&S<O+@ CAS@+P034(:"8U.B,B.E
M/QU@B)J.S+1J&/'!RV!/61*R3LC*QDMS.(!13T_7Y*$9QO\ K^O0]U4)[0M8
M> BPL3-C9=A)*>FHH]IZ*R4)-3=QKE[9D\(=B7 WG(6QU:)*C1B!G0G&4/"R
M@TBT]G&(ZCDGQ^;'Y#32,?\ +Q!\/15P,:KBOL234I*8FIEA=Y%V ;)'XB$F
MGS(VP1MC9%?9#BA8Q,4],"H 6(R VYB'4H=)&"NQG(9WSZ,?_;I_)^/Y*CC;
M'IS^/-6=$=.U:KS,9F!LUNCY2&:@$1LVZ_"2<BVNO2-X,%?)]Z098T@Z\#?I
MF">R:.]AN*&BDBX'+"]4['5Z!\&_H]/H%0T@>/P]_?\ /1/3E4,5!VFKF[0Z
M ^D-+IKA,1[Q7D/7!6LD.*6B&0+XW84QT]WPB)1F6PEUM#8>,A9:CG.WZG5^
M7\5-(QC?N_$,5(D;5/<-H-D8R7-;9LT@Y-S\<0P"0.6[&56M5 !D9[ S18*!
MV(8(]2DONY>)<-;=2IAX= <,_K\>?[ZCC_E\0']U6<5I(8Z8M\R=>;@6];9&
M+E? ^/3G%P!=:F@+!36X(]55S*,1E0EHT<V(A##389XMP\R7!DS922)+9Z;#
M;X>_8]]0T^D_B\<CNK\M:)@VB?5YLEF<=DC0#[CXLP6$W9^*O$GL*+1+X3"8
MR *!8)F58:'@51278(YV)*R0EL8@=GT#YML?KG--/I/I].^1GX/R;5V*MJ@>
M@&Q#D%9YMU+0E>J(S,B)7W6QZ56$6*1!KN5A0\>28XIZ3>PY.R)!DSW88<]5
MEY^7<E1.>X=Y[^IQZ?140,=_@.[H,_/4BFU< ^UP%O>=)Q(UV%LT&$PC+/I'
M!;456BCW"$J94_E]I=7!0*IE]EM*'RL/-O94RIF'H_7O^>H^G]>[YJC_ %OH
M^G:Q%DP8-M+P4C"1M:2RY#5:,?9@8G!Z! B9*O0$-*S1&6I!;!$E/'29SZ!Q
MWLNI.<D"SXDY_4_WDU  #]1_<!5%J'3O4J2]7B8.1.%)K,S!28#XL'1HETL6
MOUFX5(2+FG(.IQ;DRV_$7FP>KD3EN2V37VBQ#0\I>;?B5$Y](QW[;YR-_1\'
MHJ 2!^H]/S]>M?BS].U8MMBFK'*V"R*)F/?J?+0BN..@CV&I/5 V/"EBH F=
M;B!A'ER,9$9D\QHDJX^2L8AM;;+(*(&/G[CGQH4@G/Z],5>]@II]XHQ=7D[C
M8(U4H>0X7-P#,,!)O1*9U\YB!=03&'QZP'(Q(\#+*P$AR7CT$X?RUZXA&8 X
M.?RU'&1C)^'OJBL::C4'119%FGRF DTW,G%I$JL=&3Q&O)@R<I)!8D/7(YN,
M]Q'$">$>O^Z!3&(2%'+9<9'+0<S_ '_CZ_KZ34-/I/=X=W3N_7 KNRNIH\YX
ML^.L=BK\R3:9>TMS,7F%=+#>GJTQ596.'9E8>1!5'O1XPY;."!7BAY484M)*
MV65".L[8[NGX\TT^!WR3GX:KT#5 @:]+4QY?KJHR.Q68>'>880W%54>K0\+B
M"R^TE+T@TK+)Q>2S<K+[2*A<N*8%8[,[Y[^OQU$=X[NGQ8%6= Z*JM??J9@T
MK97Y"IU";JK<D1(#)/F2ITAXHFX3! P ZG+<.3*6I\*1"P$*PY<K&O(*\D"Y
M#B5$^'7/P>CX.G7/04Q^3'_O\/7?TGQJDU/IWJU3D6Y5B;GCC48'\UQ\>L@I
M*>'K%BJ>3#<0]>CEFR)<?9"RY&1,<(--E&6"''\#X4'D5$_J>\@[9)\*@$@>
M/ZY']]0CJ]EB*ZB'=2Q1<XS7]3Q\S.A,&F1!@$B7+5BIQ#SZ1V*\#+!&NYGB
M9$QUZP2<>X:X;Z&*C!2AQ@(GVN>]6WR'X?14![;'AOW> 'A\O6II%Z;Z8 7*
M&1IQL:2;,#38)8,)2!I.,*&V/!;1\E4TW5,3,T&Y9*[%L9'L!\IC$0.D;ODU
M*)%,-1/ZGPQX]_7;OJ.D=VW_ #S\?=5>NNDH&]6H.U2TW.MO /58D2/:;@"A
M R*I,/3(RXPB5A)"2A4RSK_D6!,.< N58&"0XZVEIY), 2!CX?'O&/&A3D@Y
MZ8_$:K,922V*-+T 6X6*/"9C1JK7YV,3$A6:MPX59AH9O()^(UP1V4P^,;)M
M2C\>I\8B0\MA"$A"J0SOG J(&V,^C\6/_>K3QH.(S# 03MLLJ@!X.8J4BTP#
M38Y$Y3)TJ--DJU(,Q=5"'0R^1'O95+ LB3RT34XIV3<*,9*$:C^//Q_K^N*A
MI'XL?%G.-OD^"K]E*(V9*3T['6*P5^9GF*HPX=%.1V<"HJ)<L6(T@4^.,&*&
MDDS1H<P*>V2T0)E'I/0EMH+2S^OPX^:HX].#_P _GJKT^K TNN@5N.?+*&!4
M<^HL]0^2RS)21+EI$MY 0P0+&29 XI](D>$''AH<2( &*&RPPW G.] ,#%7-
3Q4:<4IQ2G%*<4IQ2G%*<4K__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>33
<FILENAME>g723949g45v24.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g45v24.jpg
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M 0$! 0'_P  1" %W 60# 1$  A$! Q$!_\0 'P !  (# 0$! 0$!
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M?*&,D<C[QMWGE4%V6=R;W#[P]R:U<J[[9^*-+VZ"=K5[3E%<1C8?,<?OJ [
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M((W**S)Z%W;'(L>JS^/(UA8^(ODJ)0ZL2^] [*K?K&V[U!H^FA]1W]JZEV_
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M;$D*K&[;)$YBDKTK$Y )W$D<%@!V(!UOO%7%G)/#O(_$65K>.]>?/Q)]..+
M<<:*.EF(Q17.%[:1WW(X%WIE5:?-W=C8X#$L@9;3"S62WA:#^PL4\G5CNDBR
M,77UY>]Q=-Y8X0@<$BG>Z[4+YU<B/&R*%;]7B[4:K'F$V]GL#:KP>]GO7&!X
M>S&[U.8^G1P@'PMRWE,%PA9U&]YLV/(F0.Q\<?(W&?$^B_3Z8:NMG?J5G#:<
MLZ..]FT3AH:"P(%!?F+;0OBN%JJR,JMER>8C-("L:HP;T/(+)(X%1K5=^2&
MXU1%8C$C".%C.Z1F4KZD0T*^KG==;20*)YJY?<EAKW8<L=EUE6YDS04V'[AK
MC5ZHN !30LW6P\'<M5M5>VC_ $?&%!#J+"B&",D]?CM20$B<V=T:ICQ,%3(!
M-%H@J\T2?-C) _\ E!_*]3RJ6?'(%A92S?0>7( 3_P#,1^>J[\B< ;#<V/U&
M$@JRLK8:32\&<H\&[.P@;7U<O)'$'#>$NLYI:RSF6*'[>IY R 5/?GQ2L^(:
M.Q#(D]%E8LRRJHP^=VU94D4<G;)(X*D?)1K'Y:B:)F.5QMW&-XV/;<D:D'\G
M'/YZA-N8Y!Y?[51.YF;B2]WF][C.Z[MX[A['B^J'%/MV\)8+D?$!\?Y!KK"<
M2I_38N*LK#I"R+ @6HB/UUT;8DM%F(GZD)2.<P[PJQ02Q!^P\QT8LW'-[S7S
MZ0!J.GD@$NPNTL\<NP5?EJZ[!=UPB@]ZLG7W]S&(Y([DQ.Z[D[!<.\H4='9]
MH=3P304>RQ=GD-SRGN'\G2[@EU3B+*.+224V)J'OK KBU""CL[#1W$="AU>'
M,=)2!DA,"/(A(R#(2K;E1-FWEAP"Q[@=J%]ZU=*K2^<ZHX!@\L!E(9V+7]T\
MTO:R*-FB1JR'=5PGO.3N6<K2X&K*J:NQ[-.\OB837#"RC9W'ZSD<'B&GPHAA
M@K/CK73OK; FOAB1LJBTYCQF_P"S+ZQ02*D;%C9&1COM]V5"Y;OW[\_CJ^:-
MGD4**'V>=-WLK.$"_P C^[479XW7;W>_3TSXG;3RW@INWN_N@N3;W489U'EN
M.6P=N'(.";F\]HOFDK];G+O0_IB":3(R6>8^*OSL1U@+9VE?7]7G:BY9,T;>
M:!L"M;/<JON([J0+M6IN3[ G5HW,V*!%(OE,=^Y:"5$R4#V8$U14D4!=7J**
MLWG+']O'!/;&;Q%W"9O*:6/D^\YZWW'''M_?:RKQ)W+N]G"XLR/Z2C2:#7<B
M5\T,UQJ"Y!'Y7"'H?1(9?7=9-67_ *II99O,B+ J(E=P%+;%];7W5/91]YA1
MX!U0>8(XXMD@5MYD=5.X*7:D6N0S#NW[*\CDBI>Y O-9_4O R\7<7<Y<!<&T
M?&.YQ8^IXP[8\_I^>\M:5UWD0Z7B^"EU>,Y"+XUXST5)6+<_U /DR ;FVI*I
MEA9UB!1%ML4+MEWO'+(9%;:\Q6(@AK>U=-[@FJNP":!O5SE@8]BR1QA&7='$
M&D4VM)3*Y5"!=[:) LCWAW"8'F##<:<6:K1<1\W69.%^IER1S)IJ$VBK]7RK
M)QOL\3RS5U>V/K\BD=1I")[#>T+]&7CF$5<%A/;O#8HU<1\5[-&[NHDB&[#2
M-396,.K1DJ"W(X0UNY[>YU8%<)&Q23T9;R,*M]K+(-U+P>7%[>.]:W2IXRY1
MX]WV:YLM>*]QJLGQOWR=Y>ROLEGZ*6WV,F.YD"L*##\MY/)JK#=:%43/<Q8J
M)AEZM'HS[*E /^U(BZM+HRM&'52^/C@,32[HZ+1LW9;^O%K1(U4(Z,)#&S!,
MC(8@"VVR6%=1W-?2S1-:^7:<5<C<M:SE#EZOXBVE)B>5.[#L%.IL=JLU-4ZZ
MVR?"&VJH^2^4]7B9T?8YNG-K3F@+%I8 KN3-XN&PMJT$64.-Q72-43S%+)!E
M6RFU#2*=B*W9C?/IXMCR3>J,CR&1]C!7EQR%(HD1-ZG*]Q=@41=*+&KNT.-T
M@G?1R=O%S]B/C;OM9X:S0^F^S?'3V6LHN4^:S[*I::C4B(MJRDN:0DB!7.F@
M!/!<OB.5G6.6'V9%OU":1J]PI2( _@2#^8.LE5/VB1B/28HE!^2&E)'Y6/X:
MMMU!J;3IIITTTZ::=--.FFG333IIITTTZ::=--.FFG333IIITTTZ::=--.FF
MG333IIITTTZ::=--.FFG333IIITTTZ::=--.FFG333IIITTTZ::CKE/BC#<T
MXXW \C5EA<92RG&GL*RNTVHRCSD&<Y4$+LLC<T5J16%,?(/95,ISJRU#EE#L
MA"A97PNO1VC8,A 8=B55J_)@1?P:L>VK'C61=K@E3W 9EOZ$J0:/N.QUO%;6
MU]-7 5%2$+6U54$+6UE<#!&*%7UX,$8H008T+60CBBC11P#P1,;'#%&R-C6M
M:B)83?)Y)Y)/OJ\"N!P!P /;7V]--.FFG333IIITTTZ::=--.FFG333IIITT
MTZ::=--.FFG333IIITTTZ::=--.FFG333IIITTTZ::=--.FFG333IIITTTZ:
M:=--.FFG333IIITTTZ::=--.FFG333IIITTTZ::=--.FFG333IIITTTZ::=-
M-.FFG333IIITTTZ::=--.FFG333IIITTTZ::=--.FFG333IIITTTZ::=--.F
MFG333IIITTTZ::=--<_^[KZD7 ?99L\SA>6J7DVSN=7F/ZLK)</GL_< 1UGZ
MJ?3_ !ESV^LS\T1GW5=.[XHAIXOA=$_Y_=SHV=SX5_1]USQ?B9.;TN;IT<6+
MD_99!F3SQ.9/*26T$6+."FV0"RP-V-M43BY&9%C,JNLA++N&P*15US;+\:KG
MBOK@=G^]V62PU+E^=HKC9Z:AR=3+88S'0 1V>BM1*<"0Z:#D4F:$-A1D3B98
M1B)8X4>^."5Z)&[?YGZ&_%>#B96;-D]%,6)C3Y4HCR\LN8\>)I7"!L!07*H0
MH+*":!8#G4*]2@9E4)*"S!02J59-<U(37X ZZS;78YSCO&ZWD#8V/Z/D<-F;
M[8ZFW^T./_2\YF:HJZO+'["K%-LS?L:P(HG[2N#+.)^+X1!2"'QQ/\GUL-13
MG.Z#@;893M[W&6Y%K-!DNZJV%HN [ZHK[XX'?VY?&VWY=C C?!5/?G)XL!QO
MMK@U->S/MKC: G-V#AM1.%3$M5HB^.W?Z<U_,ZGSIJFM$O\ DS$9?;\?\<7M
MW]CL^4DUCL)3?IUL3^NIAZD>\U"I8!@$559^EU94!7_G@ZO^]^3X:_[LAKXF
MM-;WTTTZ::@/FWN7XG[?R,C5[XK;66HWOZ\_%X3B[BGE+FSD72!95E7)J[FM
MX_X>QVXU[L[EVWE&W1:6>G@H*8F\HP3[* ^[J136E7_BOYZ^WC7N1X0Y>'X^
MGX[Y"J=#)REF.0=AAZ[[6VJ;NVHN)M3F\/RA(5G[RNK;RALN.]IKL[D=K0:*
MOJ;_ #.FLFT5Q6"68Q@H[52"+L=J_CR/W@:DO4:NGQX5?87:6ZC6FDR^4$_1
M<WH]03^L;'05V8I%*"S%5<&U]0EM:AK=:2P'%SF7JON]!I[6GH*ZQLQ6J:V3
MIIITTTZ::=--09R#S<'B;>US-?GC-5K \^3?5N<KR)A3+C[<*8M@D,TM;,+$
MLRPK"DS)248]S4?%\CFQ+LL7IDV3&D[/'#C-)Y9F=E])W!22E@T+'<J#\USJ
M\I^KW@VW/HKX^MGO^'?C42<==Y5#R#Q3L^1!L!J8;[&%:,&7C<!766JN3*#T
M;'%3Q%@4TDK+*5Z0P3$B#1QN15>KD3SUF=5Z)_1F1'']K3(QI%C89:1TGKO>
MNP226T1!##?S7MVU%&6D4%4]1)&V_<?6NQ]C6HTXY[XN2-7Q9:<F;_MEL.#5
MJ[*QB?F^3N1Y!K4JE!1'Q6X<=)QW;F2D&,;/\52M:R='PIZ$2P2(0DIZ%!+D
MQ8V#U YIE0,K+BB,[B 2K*<I@-IL66L@ [>:%Y21%W3((N_=MPX^H ]N1QSV
M'.MSN._# 5.IX;S,>!Y.NX.<*R2RR&KH<R789*%$B5PK+6Q6. T5ATGHR"6.
MMF?%#/ 4=")!*CDMA\.9<L69(9<>,X,OE9,;2 /&:NS9 ^Z;[UWYX.J,0%B9
M/6)!=@4%%U=\_C[:L9BN6 -KFYK\>MDK)AIIAB:FQ*="8,3%&KU&*:\..: A
M'(D;X7C?)&]516KX_.KS,&3$F2(.DR. PE6P"I[%0-P8>_WN!SJ5(7D("]C[
M\=OFK_/5([_ZE65H^4.0N,'X,9+?CBG_ %:U&LMF=3W]LQ@3[ E<UGR<'(E\
M+",UJM*K[6:69S_#0T2.5S.CQO"B9&)!D_TCM:=_+$:X@D5#0/JD&4K<WP1$
M1QR1JUTV+*UV8F*D$5NKO1Y''^/>L?1?4<T5P!D;&7MHU(X^VO"\]GY!M?*7
M":>*3#$US)2,-7>@D\,\4[2IVP1-\3(JK"/,0W-?P7CK]I Z[CF3%A\YXVQ=
MI(HFK^U$ VI'\@;%P#SR 1!PP!'KKN ?=17'\=3Z-W8&9ZK]^8L!4\8Z:T&L
MBLAEHN0F:>?1LKQY9DADM'9'/5]285)&D, DCRYG>72,1Z,]7:,=!$\@3IV7
M]N ($CC',01N+ 'FR%PM\L !0OCFKI&\D S4A/L#N_C0'X5=ZADOZA%N)Q7L
M>3UX2KR6Y:+.J/G@.7JNT.LBKP\<68 DNJQIXM.:#"1'*T,C[@THF2(111F2
M?=MV;>$53,Q<5^I&-9]_FS/@N@@V $TCY"^<O>F5@IK@Z;CY/FA;/'HOY^6
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M-(OVW(V8UL&"A,>&>.0<?:(Z!.LS^K9L$43P8"J,C(AQ4?,8)N>4TI\B%Y)
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MR7+\V]4(**%"^0R:-8:UY,49;QQ!I9Y(V1O>GQN\\[U<]2ZC%@F?I\6'' &
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M;_\ ^#$US/6_^\1?^C_^F^N*W:]_Q,=N_P#^/3B3_P#7_/\ 7K_B3_5WK_\
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M)PL6?*DJRD$3RE5]V?8#L042SM2J 2Q !.HI9X8%WS2QQ+V!D=4!/P-Q%D\
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MTQ-KC<X:'54%G&R0A(73'!"3P#WTDI+2;*9&HPA[H63K\C_;KHND'J6;TSJ
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MPSW13(2UDKW,8_RJ=9T4F+*@,TK1M+N\V(?=0CX / ;X]K'%<&!D"V!6T=N
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MC >2-/+ORLS(_P -5?XZVD.!^AV4%AX11".ZNT@(X%#CJ)!X^OT'>M7_ /\
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ME4 5NQWL'\=2CD4Y-*XETUINN/4SNKXMNZ7.\8;?=QRP;'0""6L(:A:YYTB
MW4<]7#*>U'R$2P"1PM29%57]12R=*;JR)BS/D09,!^WX>.28T+(7WPJ*",LB
MJ;%6"QJ]=$\12%74;F %$]SR!S1L\'\Z'?7\/UU1Q=SQ1=P7./ I&3Y%SN"=
M6T?)^$TQ F>T5)4D6%CHSW4]E"!7J^"BN(_/L<_[F))ACV+]N,0L)Z6W4,7*
MZ=TCJJ2PSRQ[X,X',FB(F1QCPJY9XS.Z>6&C 96?>M[*..'DW!Y(T&U')E;U
M;%526HL#7IL?34:<;\^O[P.;+CA/BONCN-)59.RO-!<%:?.TV2!VV96UG,!
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MC#O1SE<YR.BC:[RY55?/E5\]<)F3ODY>3D2*$>::21T  "L[DE0   %)H
M:I^5?3M7TKZ:W/K&TTZ::=--.FFG333IIITTTZ::=--5 ^H1_P !/>W_ -)'
M<;_V?V'6[\-?ZQ^'_P#C?2O[?!K!ZG_HWJ'^XY?]GDUS@^B17A&_3+[:21YU
M@N R.8XT]7.<Z1LW.O)SV*L;D1K6M:U&*K7+_OHJ_N5$3I_'P(\7=69E;:?L
M)W$':0.G88[]C1UB^%372,0;@!61?:Q_E<]#GY_?J^TEGK@=L^:8V(JE'1XO
MZ4OHV9Q,KD]26D*_U]F)^8V*O]E\)^?'7--M6$GRRU@;=JDF^Y[#F^Q')UUC
MAC"P"EO3V'/X'_E7X:XK]Q_'VDP?*.@TV-FMLS;6^@:>7>OIOUEMZ.9(_P">
MO8Z)DD@JQL>L?NOF-%5%1$<B>/4ND]5P!TS$AEGQ5;TAHGFC$@)-D%"X8?N%
M&^3K3QQR?K*B=C[ (Q8GG@4IN^WO0]M6([3N-\?G<Q>"\H9>CNF6U@5=2A$1
M1_=B/FGE+A62.5OGYWJ]KEB1%5%1K5;Y]5ZU77LR>>OL+O8Y(A'F!P>"*3=R
M*XK@:F0B._,A9 5[.AC(^O( ]^>YYY^LU\K<=9;68C8UM-7@3Y=,C8F&?>"1
MD.%&$9*YM;7@(B/^X:GF1BHSV14;ZIZ^$ZU/3\V;%GC:8.'=@6#!@VYJNU(!
MN^:/N/PU)) #'YE*5<;^.:L7W%\@$]J^HK7-OL9Y^BX\Y"W\VBKS!<FVJ.S^
M1SXPTL9$SZ>/S6%*.W]T;YW-]GJK?941R>5:WQUV?7NGGK'3<9XTV,A2[1OU
MB$J6917JH "^P)/MVUJN48H X)Y"M6YOC:*%COV[?4WJ6^'OJ?<CT6AT-?9'
M!Z">WVJTM3D[ECX2 (8B'-=$'-'^V6)(%B2.5SD1SGKY3\(U-9D^"L.;!@D#
M 2*HMXV4,-PH"0^Q[4#[\=CJ3S)@VPQ.U\A=AN@+-<6>*)-$<:[-/Y9J-9AQ
M+J.:NI[BR ;)$ *=$LL4J-<DD#6(CWIY<BM:Y45KO".:B?RO MT>?%S'B/F-
M&C4TA7T^U'<>.W<_OUMAD!8 -OJ()(;N+OVX(XOZ]O>M<=NX3M]O]9N+K?5"
MF-L+$=)G6,DQ4I(<\#5;,,R)SO5\4\+G,5[$3PBHOGSX\=_TK-BAV1%HDVJ%
M%D < *".?>OP[\>VM7D8)>0.&N^] FB2#5^W?4/]M-5OZ G7[.K#EK+RM"_I
MT.JECGA9:QMF>Z=R1M\S),K1VO8GLYZ^7*C?ROG8]5R,)D#Y#1;65?O.JK:<
M@DD^]C;_ (.L@IY!VAK(4>]GU7Q\?R';VUD^9KF][2='4\_Z%WZGI:\:;15M
M"HB1L@N3QUE?!;%IY=.R5OHYH_GW8QOLGCPJK=CRXG6,)\!828IQY'G1C@WP
M-L@W << _0_%ZPSYL;[Q&QOMZ6(/8_%'MS\'YUB<-WF?_264-MPYW+U=!4UX
MMM%<YA^+@<^6)XHWO&PPDEY7GU1$<]J-3V?Y:G\IUA_]E#X8=\K"R5GF8 F#
MS59D4WSL07N%\6!?(]M2@(ZU+PQ5N_!%"^QHT0/RN[]]7?[(=7VIU.7WO"E#
M^HU*UUP> =<>C19SSF,6L<T9\3/"D1QB(GQRM\^WA[4:Y?*Z+Q!C=<E?#ZAN
MWE=K&*J=*);U*>=K#@< BJKMJ2%8VA(1T9EH4&!)NK  /?GCN?;OSK0N)</G
MN#[;346>L9+-*78IMF6&ECC//_0VM<DT;2U\.FA=#(]K8/#E7PBN55_/6RS<
MJ?J>,F3D%H6GB\MULQ+:!8@:- &H>&+#DGM>K%88_ HR(2?+OUCFQ:]Q8(H5
MV-U7;>>;/J>\/\3Z6NI+K&W1$1[G04Z9PCW() 3Q%.7,QKG)$YKD<[XFJY[&
M)^[U\^>N7P_"[]0\X1]1B\Z%0Z(98=TI.ZPB[@S[-OJV[B ;- C4RYN3."'Q
M9D2$!M[02A"":^]M"\59Y[?3C4EZWO/[3+KLKUO,BW-<)6$UME2Q49\T0-V5
M<3S.&;4P"-:DY91<ROD487V*(8R61OEC7N;+T'H'7\KQ!T_!PUERC]H4[X@K
MQ(L1!<RM>V-$%;W<JJ@BR"1K$RLQ5Q9Y 5-(5[&M[<!?C<?C]WT\C?*?>/S'
MR+C/\*A]-8T'%4,TRQY*O(DBB.@<0^:*&RG]WSR"-]D5U='*T.5Z(XIA*LA^
M+ZR\/^!>C='GBZG+B03=7""\BBT<#U3''5J&_O\ KF7>/_#$8+!N7GZA/-&(
M;V1_M!>[G_:/?;_LCC^M?%5-Z[266."-YII$BBB5GDED94CC11;.[L0JJH!)
M9B !R3K! +$!022:  LDGL !R3JQU'PWO./>2NQ[26I ]=5\W\]XT('X&2S%
MB5U'M^.'K(L[?$+I"V:>*26"#Y7,BB9$LR/FEC9XEXB\?P^(\'Q7TGH<;_8<
M#I.4N5U&4%#FF7&S T6+$P#1X_ZDAII0&G#$*D<:[Y<R2!\#(Z493MDRLZ%/
M+H@QA9L?NW9B?,%A>!7WB20/2A]8?69;.<9< D;0\)*C&=Z7;KHM#9?%*Z,;
M*5I&P,T!90\<"N04<-)/=$8^25S7-8QZ^$7PC]&L,[YW4# K;Y_#W58X4! +
M3,<;RE4[B-UT!Z@!WL:Z3Q4R)B83.0J1]8PC(Y!VA%\TLQH?= LD 'CVYU&8
M??3]*/A*TB(XIWM6"=R/;CQ;RVQM):E#15!4TWZH-=-M@AB8 )W%.FD;5Q2J
MQD/QLA5KD:G1KX9\7YF]LF-JA9F@CG96.X68RGK95]@3=@_0:L;Q#T=%"Q9L
M*@<'8LBV.UD;!WX_ <ZT*H^H)V#<!;BPW?"G,UM=0VEFDY?'<B%UN6E&'C?
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MO7-=9 ^W>&G!Y;J ##WL3X7)%GD@\_EKTGXC 8&H!(T'&2UFLD@T[KRTAO\
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MPV7Y^8GDQ*43<'21PI.TAT)0*"=I4$$L:LPL154M<AR?8#N:XY%<UWYKVUZ
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MFFG333IIITTTZ::=--.FFG3350/J$?\  3WM_P#21W&_]G]AUN_#7^L?A_\
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MV&DK1EE2R_7+%JQ$)-8_+#\$(C8D'^&-D_NY5?U@-XEQXABXN+BS'!^SB*5
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MPR3JQ(H$D*A8\ <][')]]>9;NCXMU_$/*%YC#18Z[^GQ5LQJR]3X[%*DA'&
M-+A7V7[AD/F%51%<YWX1OMY7KY=\8=/DQ\^21R3^OE+$76[S2;7D\$]J-]O:
MAK](.G]6ZGU/P_AM"D8C$4.Q=I+",QIM4\]PI )^;][&JM76;,,&$TQ_V#3+
M"O\ N0A!D5)(%1\:K&5 [T1K9&*U&>6H[SY\]:(Y\@A2(<U=$]^?;CX[?RU7
MJ_2'SL7$S,H[)AMC*KZ5J/MQ?<V;)'<]S>IO[8LC;;;G?%U&+CE2U'BC-(I8
MED=(:&"Q"BHU=&]CFHJJKE3]Z2-8K%;^[RWT3P)-+]O5G)"^0W>Z%RQ?A7O]
M:L5\^?\ C?P_A=6Q4PF=2RJ)?;D(K(!9!X.^OCM^?KE[$NXBZXNFY"L#:A:@
M%@U8,37F2S,&4BI$?"U]=$WXA0TDC>WW8GN[V57(KU\KU[+UWIB=8QXHUDN<
MJ%C)[[SPH-\GU?A8X]]>0]&Z''T*:<1DT2U+8 L77 H<T/8?3OKIMR+QEQ5W
MIXRLVEC>2TUR=7C5\0LYKD$EA#>V58U7X55&32*L?A?#E14=Y:GX7B\?J/4O
M",XZ;G1++CNUNZ*0;/<\$]^/H1VOOKH YR"!)2\5P.17%?7_ !SJMG W;CSG
MP9S)8;VXR(ZY2#.VE)E#<Y,+/%!7LB?*/]ZZ0F*=CI)?9_R.C<C6N3]BHWQU
MOL_J_3<_&3%QF"J /2QLVS;C=U?J)JKH&K]]8[X?ESLZEBAJC=CA0._T/R01
M^6KY:[N-_J'@>UQ7(@U78 Z"GL*2Y&K#4(N) E';\@4C?:2!"T@<Y948BJOL
MQ&IY\)UH,?P\$RQF1B0>6HE8%1L'?E3[]O8UQ\:DO8 UCDU0/)]^WR._'[N^
MM1[,_IX</]M,5YS'QT(>:3O1(CHV'MC^.K#(<D_Q0QM1KVD-6;UF7U7\-5?"
M*B]8/7>NSY4HP1&J>65C-'EJOGM]T\&KX[5WUG"5!'0HDKV[$>_8=^3\?D-=
M%CQBYZBJA+LO*O5)X(I5C5P[6JCE5WJ[]O[41$:]$7ROG\JB]<\@8LQ5/4.&
M(XY/:N!_ @>Q.HO-]Q=GVVGW'';\#^(OXULH=MF2@CZ$]1Q"2JZ<%I:/]GS2
M2#+"]6^J+^Y5?[?Q_=>K)%FBDAE%D;U8 @5Z6NN:/Y7^';6*3ZB?DD_O-C7B
M_P#J@Y?7\.=Y?:T5I(AGY2IYK'O<R7)&]L94%=LN.K"R0ES'JKXXX4!^3T]7
MHU[_ ,^51>O<.EYJYWA'Q*20BIT',#-PH4-@9@+&[ JB;( ^G!US75XV?K?A
MA .9.J0*HKN6R\, ?7N/K[:[:Y?G[C3N!S\6=J-77LN[F!1C<C*I0,UD:K7Q
MPC#%%10,DAA="D[_ +>3YOA_^K1\C6M?\F8V5!!D,T3),(BVR5&5O2";8=B0
MWS3 ][K7O&3T7J6/C')C02PJMO2[M@('#]@"*YNAQ^(U"O,G9UC.Y#5#UIE<
MX@[CC-0T&;L3;2PL,\/"]K"&#RUZ'QB-G*)=[G$H+,7-$)!$Z1L$ L:=KTKQ
MGXC\,84R=*ZQD=+Q>J9?VK.3#@Q4S)BJ;(V.8\#Y:QQQV(HHYXXD:21PA=W8
M\?G])@ZDPF:%99881M\UG\H.WKD41A@E[R;.TD@"Z &O]PG89Q_Q-HI+BYR5
M&E55 5\E%:U2##%E:A[UCE':/"QCQ(XGLC04HM$5TKO9'(J_(V+(\0]1ZSMD
MR>M]8ZA-)(=Z]1SLK,VQW8-9$DB@ ?LH1M':M8&-@RXTS#[%B1)MH/ B+R0.
M+4!K[WV'R>^K+\;\EY@1XU3R8*[/'T4\*4#R OLIPV(US'RCGQ*XDETT<KXB
M841[)&+[O:]/W=2Y>#/0;"E60,MN%?=N->X/ Y'?V]A\;)!7^>[=Z^.?R_O^
M*]M6.K=AG+W2A8RVIP L3=1S_IZ7Q,8G]0V#9?O(2@(73I.5&Z5L<D4GJDDC
MG.]H_P!J>=>89XL?[7#.6RD(ORJ9HU Y4T"!W-@]JL?6JLBL(V3:AYL@USR#
M?'([?'MS[<Z?J9C8G()P3PLNST%10\I;B>YVU?4(TF"BX8RA-&1K7'!0H_[R
MLN]07B\Q!7E0O^YK+71N8V5 I(7]]X!>7.?/ZI-CQM)TR!4QYFX,G4<E)EA"
M6/O0P+DY&Y;*R10>[C6CZV@=L3IH*UFR&7))'W<'&9'DLCD">9\?&(H%DFDY
ML<54[AOJ#<F]N.9T_$XFWRW-A6F%<+1ZI1)&RB51-C7D'":.-)1VO^?/J2#"
M,!'+%"0;'*XEOVRQ2>H>$O!F'XKZA#+-#+CX>(LDF;5JPD"[<>%3RH<S$2$,
M/5'%*"+UJ^K9(Z?&8[CGEDX4'U#9QN)]]NVUX/<BM4WW7?)RERAF1>W3M*K]
MYB,7HI);'2(19CKIRB[=J36U.&?5N0;-Y4$F><62R89^J7L:1N?)4"DR44O;
M8_@_HWA7[1XK_2!U'I^=/C.\/3X(X-N%'%&Q^R1Q8KJ9^H9\D4:,L3*R0'S#
M4@3[0NH?J&7GE,/I\;QJ5]6T^H @;RS]HXE-[G)%CDD7MU_?;9VZYWC>_KM+
MR-I<G1Z.(Z-("MP)95^<!KS1F1J>--:A"16?P2N)BE*J7E.BF^%LSXX9)(G\
M=XE\6]5\<-)AQ1Y6%X=,9ECQ,&17R\TQMZ?Z3EC;9'SM=<&]E@'=*\:RZV/3
MNGPX?K;9+DC[[RJ1#$I]\=B/5)[7W([4";ZY@2!<5\H6,'<: (W,<@<0P@8G
M29&] 'ICU.10V?9#0&QB%@W0[VI)*Y4DKS@A9&MD'F:J\K#"N1TZ*/HL<4!P
M,ECF+E "=@/3ZN"RMNV@#B[KW!&5OVB8L:W51)[@D#CFC?\ #Z5JSMY9\2]D
M'"X-MQ+$%_5?,4()&,%T]N496V1M@*AZ-/?-/%"& +(8YDZ-= U#B?B8J+[]
M:&&'-\1=0;%ZD-D.'(PE$"[95V$A"OXN%)KC8;XO4P6*"'=&RG> 6VDFK[<
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MK')T!W]7\.:0*G@!FQ]K8CJ2T"6RA%:ZPI1U9'7E5S_OA9(48]'-E1J-Y/\
MI*+IR8V?T]UW;E$\&YJ:-"5K:6H'DL" &(/KNJ&RD5E!1AS7'(]_SK\1??\
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MPWDR9\H[!C01>9/*QK9%%%&"9&W6; J@2?2"PQ1&\#%I#Y<?.]G- *MDDWV
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M%(6S,82D<%HFF02 7Q>PG:30OD\ ZXH]@O*/=1WET/<]:\G7FBQXV'J<Y54
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MVAS>H)UAF-XGGM[+$Z#B/DYX="5<.>,0(==T)@P YMD0X$WT; 1]Z#'80?)
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MS]RC6=2KC0])ZROVN-6Q?-*2E'!8H_I-W8[D&R!ZE'UK.R<[+ZIBJ<G(WRP
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M^%_Y=;3-CPYX)!:GSJ8'TGT^_<$]P37>N*YO3IV!D3R_J%+RA@%7OW!(-?\
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MPHB@I2"8T:C")JH&6=B-\(U&2R0.D:C41/5$<B)X3Q_'5ZSS*"JS2JI[A9'
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M333IIITTTZ::=--.FFG333IIITTTZ::=--.FFG333IIITTU4#ZA'_ 3WM_\
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M0=/PND=/$:1^-^D-&@ *_:,%=U?)_I$T#[@#ZCG4#^(NHR!M_AW-8MW):?\
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M?)[2>_S\L\Q$KZY7D3.DN&1*"QWV6(8VJMZAV9;4[6_VEH_75IAB(5=O"B@
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M/0XG29P,&S'MD.OS;JIWE-.&'05ED4Q8R$,A%0FF=;57&=@G* R645FICM+
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M!7+%F38%&\,HW$$$@#TD,#=$&[K4?V7>BTKD_A^HQ&&WNTSN[P?<4[0X*DR
M_P#BK0<G<*;OB3*F9RY@NM#29W,Q9^/2;:*\EM[AE5;%Q9]<]<G_ *I2QW=P
MQZC<LRJ5:+:Q;T%)%<@B@6-TM4+'-@4:M.1^L155F#++:@>L/&R+7+!15M=F
MCQ1[7*2]V>.L\KC=;A./N8>3@MEBC.0&!XO&"1FYS-UIBUEB[33:^]R=0%>!
MVL1M8[)@6MGJB2JRP<!3%BCH0^SR&#,K-&FUMGJ;N:OT[0Q(JN: %BR-7^>M
M*521]R[J51:@<'=N*@&[%62:- ZUDWOCXJ5%FRF3Y:Y&KH>%LMW V5QAL3'8
M5E-Q=M,YI-/F;JUFMKBEF'/MP<K:#@YV.":_*/:T8>ME2$Z4.OV:3]IHT_6&
M(!WHEU8*0*!X!(.[[M<WVNW[0G[(=QY8D)5; 1@2";([@=N_TUM_('=QQ!QX
MT>4Z?2Z(4G(\9;=A>,S\^E9^@\Q\BU'&'&<C!PYD/*,V&CM"9:6O!#*+-K*"
M^)@C?.(.(9:L$CW0 HNOJ-<QH7?GMZ0!?/!(]C>KFGC7N2>$/ OAV"I];8G@
M59 /X:QK>\# 1UFA2TQO*5'N\_O<OQI_A#9YFK=R1=Z_;4:Z?(@Y\:MT5CD[
M$.[S<%E>I<.UL%145E'?$:(VG_1SFQ5^SM8IHRI4OY@;T!5.UB>-PIJ%;;)(
MJ[T\]0#:N&#!=FT;RS#<H !(Y%F]P HV11U\P7>3QW8BV0H>,Y7DWE?RG)PO
M%Q,_)@#\BV?(0> J.3K>LK@R;^'-_H]'CK>.VLMB=IP<;]N-(2#?G FTI=J^
MSOP2R;"GF>9N.P*7*"Z%V6%!0I;Z<&J?:$-@*^X/Y>S:-Y?;O( NJ"\[B0M<
MW1!.>A[I,M:4E,;E>/N7-EI[30:[*G<<4.2 @V64O\$HJ:^OV<VBOZ'%YMU2
MMA5N%G.V#1=-!;5AF/GT(1D1*T,+ D%HP %8.6.U@_W2M L;YOTVI!#41J[S
M@0"$<DEAM"C<I7[P:R%'T]7(Y%C6!XT[DXN7.7L-48YCF\;[#@;<<ANANZ<B
MKUU;L<=RO0\<V5+91R%/B#=3%S7]5: LB)8ZS!282QF$:Q\]SP^7&Q;[ZS*G
M!M2K1EP1\WP0?@]M427>ZA?N-&S<BB&5PA!_ V"/D:V+E7NAR?$1VH2_PO*M
MKE\ '3V/(_(6>R@<^)P@%TQA$!=F=;7E-;7\0-?+#9W:8*EV$E&#*QUJP6?V
M@;:D+2!::,%K"(6]35WJ@0O/ WE;]KU5YE0FU<A0"[ #:H//-D$_7:&JQ>L+
MH^\+CG,ZS79LS*<H%57'G(F4XOY#Y K\D//@<3J=N+CB<S'<6TES!9& F_UW
MG(C"<]37;J#[V,O1PU%;.$<75<=V52&2W1G12QW,J[MU"J!&T_>(OVO5#.JE
M@5>E8(S #:I8 B^;H[AV!J^:&M%Y)[PV"7V+HN-LGK[&JM>YO"<!V_)UCE8B
M.-#K.7=PY3DG.4EG#>Q7K+B@D'NJ>+1G9Z#'KI*@ZG!N;2TA8!-<L'I8NR@B
M%I F[UU5H2*JB.=H.ZB"0!SJUI^5"JU&58RY'H)W4P!N['/-;;% D\:L1R?S
M31\96V0S']-;/>;?=-ORLSAL!5UMEHC:;)PUTVIT1$E[<YV@K**@6YHQ33K2
M\#6>QO*BKK83[*P'%?$D9<,;556K9B0 6O:. 39HUQV!)H#4KR!"JTS,UTJT
M30[GD@ "P+)[D :C:G[M\AKLED-7Q[QOS1R&NS?R,ZOSV=Q M=?587%FV-X^
MUINE7:7V4HL[)%I0I!:NBM+R#5W#%>ZOS\\@-I$!>8&5F5WC3;LLEK!\Q0ZU
MM#$^DV2!0^>1=@G5E5E5VW;J 6B C;6)W$ <^Q-GX[ZP\?>UQ9:09XK%Y?E3
MD:"YXNS7,ULS#XV*SL\=QWK+&[J:BYO\X=;U>HLC'669T8A><P]+L-,))3$K
M-3M817/-K]F<6&9$IVC&YJ#.H!(#5M IA18J#??OJGVA#6U7>T$AV@$JC$@$
MBPQY4\*&/';MK6)^]43+[3GNCW7&^\'I.,N9^..&\)/F,Z-=W.YT'(G'^.TM
M)715\.DEGDM;JZTCDID^SK0HLX?G2K:82PFMQZZHQ]RQ%76WC>1MQ("A'<$_
M=[ +SW.ZZXJZ?: &D#(P"R*BD"RQ95(%7=DGC@<$7S8&QU?=?1BD;&.YJMW;
MZ>?E?*\;8GANMP5?6\FAZ*]X&PG,A>+*=)N+#.71]-07-SK-+K;*WQV<S0BD
M9LQ\TM%#=:"A@)"T5"[&=I"Q*4)6CW?=!%D!0H#%NX[T*B86UAB=ZHL86G!,
M0DVGU;3Q;%K50..:LSEG>8<E><;77*5G#?X;.Y4?6S[(;>4I.>N<?_0LMC%K
M$NP7*5$^&I2K-);95!5K3VM>R*RI+&RKRABIHC&P<(*8MMV[38;=6VC];'!H
M@\$ ZD#J4+FU W;MPHKMO=?X5W%@CD&M1=5]V.5/J;2UL.,><\ZL.;H==F*R
MWXW((MN0J+3WU=F:*;(!Y^RO4CL3+NXIABL]K)<KHZ,6T'N-#4U-)"=9"7F
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MK  B'AQ'51@=1?YVW%?+-%$>+8@&R*.36Q0$BSBE3,5$4$,^\,06A^Z0"/\
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M W4:YOL*]P95X1X%K^TG*:?8;7;B:/,Y+M=X(XRT$XV8+%2*D[8LYR<MSJ'
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M+'WM+G%Q5KG\9J,S5UE+H-+)*_0M/%!KY%EA1MRQ-9+$EG#%=RE1L]&VT)W
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M1D#<$1J"?81A1S\WMUD.9>TK1\CZKDC64G(-96LWE_P7<&XZ[I+PK*:6IX?
MW %CB=W^@:F@L[G,:Q^P&LW#BD#1!V>=K5L0KVO>37RTCR BHI2]@E 8$;@9
M-M,MJ0&7;7U!-$'G1X"S.P8#<T9VD&B(P1M:B#1)!X]P+!%C7S<.=H5WQ&WD
M5M=H.,PA^0N04W_]/X7C&7 9#+2.P.#Q+Z*ASP.FLXT%9_1*64UG,0AUN=9%
MV%BQ3IR)9:R3K)LL2$HNVV?>S>IFLD@?UJKL *'&K4@,>_:4 =MU!2H7TJM
) G^K=^Y-Z__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>34
<FILENAME>g723949g53j78.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g53j78.jpg
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M @$# P('  0! @,%!@<( !$2$Q0)%2$B%C$C%S)!)$)1&&$E,T1B<8'!_\0
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M5B+PYRJ[6 4'@ON]A]3G^VK  C1;$6 T&>,D0F-LL$\3D?')&Y/='-<G^_\
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M/,#\S'KV6-;KXKIXUA721MBB)KK^H,$CB8W[?L)AM ["8?Z7I&1$.^/^\_\
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MNOQ[M(J_WM/<KO;#')'"W2LT,$=3+)NCB+Q@_-4Z@,K,'& <D9 !UFE-MD8
MA48'(+ A@!@G/&&SSXYU'?Q8YSSR;>LS_3,D[HA]N0#65V/HJ\NH/QP(GW3W
MVBMJR9&'&@CQO#@=\F-C8][(F*Z<AJ+QOX:=B[];1=-]8?"OK&X*:=Y9[A5U
M,\U-21PRCOSO3* :H232Q"-E)1,2*G+',C52R"G[E-54Z(N(^T$ / /J#GG<
M25&W^$D'@9Q='C\=P?D;WVE)S>3*?PKW7)F=)=& .GM[N<:0Q[:\:/\ [E5%
M8C557*O\^O9]@M7P\Z,FJ;C;NAZGI^25]\]P:Q3X1?#2&<HQ@A0#<[#:JC).
MH"3YJ< -4K*%'"]T>?' S@DX&.>?8:1G<O-+%<XDJLWS^$+IV^T IY5935=E
M$VL!B"@^Y);NPC5[1$*>K818$5)YY'?\:*B*J375OQ3Z<Z8LE'>HJB.ZT]QE
M$5&U%*CQR>L)))O&1B+=N=>&P#QI."BEF=T(*&-2Q!'/]/\ WZC50_;O(#>>
M2XN1Z)TG'W&=Y'44%ISWH>."-(,S=9KK]Q,:Z$A6_&1D5C5/(IZTRRC2(2UK
M70->Q2V^_"_C#?NH>J[/#5=*U4S/TU6V^MN-OHF:2":1ITJK3<&*>N2D+PE'
M!!5)%.X;=2=!#3T\C+4ME)5>,\?4 >?MGV^_U&IJ?IY;WE7/<5L>9U?0:VTA
MA5+C/9AIB26"BO&_&)_$KFNDD'=/(T9DT#&M8A,CE:WV7W]//@?\0BZ=64_4
M+R6YI*J*JM]#+')^/5R4P_>0HAM_$:2JP>VH\L-HY.M+E31YIS$02P82,/R@
M!CLX]L+Y]L^#YU:=A09:[)40DP_XDD8+'.&5/9T'VN=*V-W_ .YK7HCO?^47
MW3_QZ],].4LE'9+=3RKMD2 ,RD8*]QFDVD>Q < CZZAYCNE<CQGC!R./II6>
MIO2>CT:-'HT:\Y7(R*1[D^361O<J?_*-:JJG_P#:)[>L@9('U..?OHTR_%^F
M9#:\C"Z+5U,.%R\EIO8R0;"00.&MFS.[TV=O#RI8_K&8VQMZ<^U=*JHYZ&HZ
M55E<Y5D[G;*FWW%K=(WS-0$I&!AW/O%5205,2J#EB5CF1,?52!QC6JN'7<.!
MZO/'Y20?[@ZC#5?J6^+W0C-_D./;X+<]%R9S*"GH(12Q1];>EE?MPRY<Z>)L
M%_6#&?)3SJU9HH889'*OM[+ZE)^D+[00TM9=+?44-#4')J)$)[2!=[&9!EH2
M1PHD"Y)'MK19X7;8DJLWT4Y^W'L?Y''WT_&(\?:EMI!T/K$\G0>GDLC)(,N2
M)2\_F)%8Y4J\I2/>M: ($V1XRE-@68Q$=-*[W?[>HRIN3;334*_*T:E@HC],
MLN0 7FD'K)? ;;G"^!GSI4<?^_72#ZU8<KW\H<(OCG#Y#09&_L!'6=;049 &
M:T55%^*:.#9V4#6SFBK(\$EE?*]!R&/@E]I(E1N(Z>9!%)-6K2O(N^,/(YEV
M,>'*J<QJQ&06P2/4,@Z,D'P?&<\?R\_^_P"U GZN7C*?HZ?*]WY#Q/<\$M\1
M9B64^ACJ8:X/-[8 N(O(ZT&8-48+),<S]MM_@U@Y0R1_D_)LBIZZ[T;71W^A
MK^E+O<8JV::+O6N>1BTD;Q@[H0S#+;<!T]18!C@#&H^96BD6IC0C!Q,HP-RG
M'@^/;DXQG&=,9XR;?6>7(170.<\7YETCM^(JALWY&>/&O!!$M!=< ]&S=,QH
M:.'FM*7<HGYI$HL4C@C&RLD5&D-]UXI:6CC:R=5W6\6B>AG*T=SHYIC%-3,,
M0Q3%?2HC ]'.&!P"=NLN#GO4D,,BNOJ4G!+'R<^,CC(_U74M:;R97B)[(='^
MFAC<YIJF=R.+CQE[$P69%1BM9)-7$CN:QZ*OW-<YKD7^O^O2DO2%KNJ;H_B!
M/402*>):J-RZ^^[,BDY'D$??P=:"HF49-'M9? XP!GC:><Y^W\_IIP+C]5[R
MCNAXZ/D'C1#FRGJD,+*G(:.]8V=?BC?@$E5$&UWP^#?B]6M^+47W1$]O2,7P
MZZ0IV[MRZF6H0Y)#5-/"QP!ZBRR%^#D^<\Z/FZEORTQQSGACS_+VQS]?Y:0S
MO#?]3/\ 4!/C9Y*=,V7#^5O(_)DKX[)V>LIAY&_/\:NRE(0/,UL\3UC^RS7Z
M6?ZD3W14];5-_P#AKTS3&&RVQ+Q<%(:.H]959%/I<U3C^ CE8^2#[\ZT6&MF
M;,DS11GRO 8^.!MQQ],X(_UNT\6_ SQP\3,%48OG>#ICCP"ZVWL=KH*T2RUE
MWH:J9"0;XNS*9.1"<(4BDAN'E:HDCE6)_P#/OZY3?^J;QU'4":X5!$:;A!20
M?@TL"-G*I%'M0E@<.S E_)T_B@CA&$7D_F8\LQQC+,>2=3,]5W2VCT:-'HT:
M/1HU!S8='U&<[0!TB'#0&\WL:-F!K]Q=;6BRU/6SC69!MC8V$%HV.8<,N63Z
M*V0F1'&_2^2!B(J,]<FN'524=ZAZA:BS9JJDFL]NO%5.E);X:R"K<M\]4$.*
M*DKP3\G5U $;E&5@C8!>K%F%H]Z[U82/&!E\$  *,C<P_B5<XSSIX8*7-Z"^
M'ZOK]93:A<R#(;DJ"KM0S,CF"%B>Z2\&5K_:UT$\/M -:%>T0+5>^N@CG>TE
MEGI*ND >]7J^6J4PPM/##2U<7[OM\6UF:196DW54NPX:H9410#VXESG215O^
MW%'*=V 1M)=S[  #C[ >??6DXQ#07VIM>L:&RR:]+W%1"!5YVOGHGVV-P41#
MK(#/32ARR69]I9/0:ZU,Y$BPQGQ!UPP\4-1^06M9;YT]=*OYBEO=DKKC74Z-
M3TU'74,]3'08[Z*B1R-4L'5DFG)]!(C]*A 3K)%-&,/',BJ<$.C* W@^0 #D
MD8_U\Z;;S\;L!^.@7>?=9R9O/:8"UWX=4XA)BLW"J>ZF,%_Y9:B$CXNLXU]X
M?J<U\[5A8_U$_%&EO57T=<X[$\BURJLF(F96>)3F5&V$.8V3(D5<LRY !/&E
M:+M_,)W=NWZ,,@G],'5<9?&,QV+5Y;>>.6CP^>=:4;[>WCL;EHT5&15AOGOA
M+F*"-3(0%>QIE66S\KZU69&QN@:]&^</W)9^M*FSV.AJ:"SPWFVO-6V><=L6
M7J6R0EJJ:&D;MNE-<:;NRS-  KNB,S##'4N9I:=)92,]M@ X(_$1_2H.W'"@
MX']#YXV/C52>4/:*#I]/B>9\TH>=]!"O^>WW7MB<MCFS?IGE'-U&'R(,,J[9
M4>U\]+:?&MHB;-8"9C(VQD(MW^&'PUZFZ>N-XJ1>J6JME30_N(FJIVEC>**J
M,S5%N965I4C60I3-4AX<#".1N!:UM9#-VML91TVN&4^EPP_3/CALD?H=6H>/
M/B#P[QMHP1,-BJ/_ "A:NM"O]R4 R?1:$P&!&2&RDERF2 ,(G=+.@0,L<$7V
M(Q?L5B/]=WL?2UHL5'!2T].D[Q,93654<,M5).Q):8R"-0K>HA>VJ[5]/US%
MO*[^6./I[8]AQC/\];/J7E?POD6D$PVIW%;-T*QA2>NP%,_]UUAD2JJ(Y*P7
MYJ+\D171_G2"_:U/>+Y^FG5?773'15#-<.H;G'1P0+ND"1S5,B#SF2*FCE>)
M3[/($3_RUO#335#*D2;BWCD#.//)(TD-KYBXS&\RTO19<9OCR: 7\B/(1TT,
M%_8(Y$1LL:S%I7CAPN<Q322#&*+"KI%B>K?@O,[/^TC\+;]',MMO3FXI.M/#
M:JNFFH:VH+X"S1K4I'&*89WR3-(!&G+#+(K/I[-<*=.Y) W;P3O!!7C@CR.<
M\#=C)\<9(1G&O,34=AS-'M@^-6M-FKYCY18C[AK;S\> J8,HE@,E=# 2-$0,
M2R,H<N0,E8E6 F1JM<L#U%^T/5]+WZFM%T^&W4TE'5QI5TMUMLU'7Q5EK<D-
M=*.*)@9:6$JXF#2)-&R@&+$D1=:GLK5,)EBJJ<$$HRR-V]LN PC)/\3*01@8
M^_!PG^Z>;]SSWHN,YYA^;3:1-;('$_3GEE-' D-D6&-D%!6 FW-C]<J*V9\;
M8FQHBN1'HGJSS_&J@NU-<3T';I.J*NCAC>EAWM1"YU#Q=QZ2A$L1EFF@/HE'
M;50X(5G'.D!:Y8W"U;+3C(W;V7TJ3C>3G&WWXYQCCG4F.1=#V>_%OP=5E7T1
M5:SZ8+L4>Q'I39YFN9()##<#AV+2A$=%/)[CK!)#*QS)??\ A;%\->M.J^K8
MKB.J>AZ[HZIM[P*@J:N"IBJFE4N\052E3!- AB=UFA",LRE')5E"-;3P4[J*
M>I2I4CED#8!&/&0,@G/W^VN=+SMXY^HSR3@M;BJ^JT6WX]13[[.ZRPYE>0&"
MDB6^RVG4;?MFNI1(:^[HL_:T5^VBLZFU)L*S,WV9F*^QX-S623>O.A[_ -+/
M=EGNKQK>:N:B-/5UE.13Q+%34MNAML,H[BI/OB1H9"B_,=W9O0H0(*LAF?"T
MXQ&0P=58+M7#,7.2I.<G@,2"<X(SJ._Z?V)XQO\ HW-"CKW99:^YC?T>L"L,
M)3&V\Z4=<]T9I!T]0/.;24S9GPQW%H\:05L,R?D?!DCGIT;X@U]QM]IK_P "
MFJJ:Y1/2.M5((PL\V"FP.0LTF,E$#!L^VHZAB5IT&661&W*!_$@R,'CTCZDD
M9'OKH"[%^IQXV9?JH?C/A=I4[KN.K#97UHH!+H>?9N[NOB-2UVYZ,YK<QG33
MUE?*-6.LI;>91W#1!*;,+!-YVH^C^H)J*>ZRVJNBMM&%EJ)Y(6C=X@1N:GBD
M DJ./+1H\:CUNRH"1-]Z$.(^ZG<8[53DDGGW ('@XR1D\+DD SJY5@@N8\\R
MF%!5KVT%6R(PACY94.N#)9;&^LEEG1)Y76=T8?8/DG3[GN)5TJK(KE6N54WS
M%1--SB1R5#$%E0>F-20 "40*O  XX &E?/GSQ_/ \_S\G[ZU_:^4T?<N3[WD
M>D,/KJ7?9P[/&V-6L"6->A36N@.#_)BF@6<0F.$AC)8U;)]:L56?+YM7MEPJ
M+57TEQI2HJ*.=)XMP)4LASM8 @E6&58 C()UJZAT9#G#J5./.&&./O\ 3[ZY
M"^P>!/EIX+]^S'D+RO7YG,=#YS,('F>@65[79?EWD3SII3!K7';N>RL!8<]T
MD"J?(0/06;U@U4?SCS!95M] OKL$_4MOZOA@+VQY*AW:.ZT43,\T<3+N%33J
MJ.7I4D)?N*O=I<$R+VQOTR@@:FW*9EV, (@?=@?&"1AB.#@X;VQKL2P-T7L>
M?XO2W5?&&?I\CG;ZRK'CD1,"+N:@.R(!<,?%$7$HLQ#H'0EP1$1NC5LT4<C7
M,;QFLBBAJZF&)M\451-%$Y96WHDC*C[E])W*H;*\'/!(YT^'@9\Z5L(PXS5:
M/!".UR_)S88F1-5WLB>ZHQK45?9$3W7^?9$3_P >F^!G..?K[ZSKV]&C1Z-&
MCT:-'HT:Q#SA*P(JQ/GC%"!'E**(E7VCA'@8Z261Z_ROQ8QKG+[(J_Q_"*OI
M"IJ8*.GGJZF58:>FBDGGE<X2.*)2[NQ^BJ"3^FL@%B !DDX ^I.FC=VV@6":
M;_&=XC'#(37K_C,RI:Q2N8R!P2QSR+&LWV-D:TU!'LB]WRM8J*WU4_\ K2EV
M1.MGZ@8547=H2+<-M6C*6B(83-V.[C*BI$+*I!=5.0%E@+?QQC!PV6Y&//'O
MC[>_&E;C\Y'!AZVAOJ\4B.8%6V%89#$6,YI"K)(,3#*DD,Z)\OC(CVN:Y??^
M/4ATU;)*+IZ@M]?$AD%/_B(7"R*#*2[1-Y5]N[:Q(PV#QC6DC R,R$@9])R<
M\>^?_<:3EAPGD90AD(W.<:!*0-/$V6OS]8 K))6.1LB?BC1-^;7*CD>K5<U?
M[-]E_GTE5]%]+5,4RGIVQK-+%)&M0+1;S,AD0KN5VIR<\_76RU$ZX ED ^@=
MA[Y\@YTB(,3@KCG)U;H,Q0U^GS0_[-8EY@&&LO:>_'<T>HN**TCABL C"WJ%
M95Q\3_@^65S'+*D9$/JM06CIJIZ=FAK[);TN-B7Y&<TM)3TU=3UT!C6CK**H
MAB22E>L(IJNFGA*JID"\]J1 L7F$BMW)"DHR"[%P4_C#;F.=N"&!.[ 'U&D>
MNYZ?C:R&@Z7<Y&+_ ((ZLR[TM#,1G;6N^OZ5LD*K;2"2$PT9R.L*^W"_$0E9
M$BF_'7V5E1]57FP4[4/6E13T-2F(H+S\H)K/40X BG8Q5(JZ>H9"IGBJ87A[
MP?9-VB,;=B.9]U,K,N >WG#AO?R-NTGQ@Y'WU$37\C\8:"YK[/EW/<CU;JNK
MN9/RQ*EAP^2NYS%^UP#Z"D,%S =/7HCCR_8>)GX\<OWDS3R(Q]-O-SL-YN%#
M-T=;[=UCU#8)JF[SU-/%%2TLU48'5+:M0L119*K\KIATCBW-(^X\N42: .:@
MO!%,.VNY@['DYR3G@9/)&/L=/7K=;WH[D>OH\Q:Y_#F75)/2XVQRM6/3%XHR
M *2".MI()Y)VMFFD:T*(R9C9:698YA?9T;5;P4_M,?%6*AK9;STK9;!::Z\P
M6*WUT4CQW*Q2PUD<-PHC;YI9OG:A:=98!.?EEHIBLR+,O;Q-'IVC8(M/5M),
ML)G=0N49-H:,A@H"[O\ *0<CCZZBCXB<KW!'%@NO]CV.GU-X9LM*&[16]O;D
M:6K"I;5U4 ZV,<?\S3)K$0U)R)(HE'18(G?-ONY=_B-TMU17=.VWXP6WKCJV
MTVH]RIOM!17>Z2I0FGJ.U;KG0T\55MV38"U\31M$&:.7M[>YK%NJ*/NM0344
M#S$A8';"H< AT<GPQQN5AXY7W&%1+RO";?R:YAT<Z:C..RUR4?N"=%/7MG,I
M/Q)OP+NP*-<V*1P1;HH7ND=\F-5'M7W3V]1G[/O5U?U3UVU!U)5U=YFZCDJY
M6FN*=]KI#'3,%26!4["%XN66-57DD G).;Q24\,#/2@*8, JK#"DG\Z>6.T\
M9)SQK:^2'D+S'"?Y7@6751L:QN=++"?FGBZ)D=#9C&L)A-,HUL&Q/"6$N%LQ
MSXG0Q-BD5R?%'>D/C!\+^L['UNE@Z4LG:LL%(MXZ8%-:>U/"7,C34+3"G'SO
M;J=XI4D:5UBECB&5B0#:@N<4M%(:@[IF]$SL^Y64#"OLSZ6  );(!(SC.=--
MM_U2_ 7F^!R/-.2=:?MMCS/+9_/2U6$RUU;,@K$!"K3!+RV<#7@#22S1M,>0
MV>6&8]DL37.FF?\ 'VYU[^S_ /$KK[X?6BDZ/I8K'U?9:2U+!#75U+;I9*"L
MH:1;M;)T(FD:":G,4LBA,BHI8MS##;JS17FAH:MY*IA)3REMV%=P"&)C=",*
M&4^"6_*2.1XAB#^JOAJ+M6 L<;XT[KN?3=5=?XAS>HK+D'+0);7KVHXD^ ZJ
MMW.*A<Y71DQ)!'!!\E^QJ^_R8?!;]EGKCX;QU/4/Q&N5IMT$0:"GHZ5/WI4P
M3.V6K&J$,$81D&U8TC1U*[MS9P,7&^TEP?MTZ222_F$A(2-E'\"C& <\Y).1
M_74L-5^L)><1M>OC]0\4-EG.B5 0,\&0BVHAM839UPI2SJ^W6A8L0,P\X\K2
M00S&S+$L:)&]?FWTQ;/@U+-75=ZMW5%'7VF[PTD@Q3.DU.U(DRR!8>ZP,DW<
M"E79".VAY!QJ$DN(C]#P.K)GZ$'//+8&0..0#Y/TU%_NOZJOFQ1X+ S>57A5
MRS.^+_E5D+RO)#"U&W?NA,+H@B@BJFTMF%M J=;99DT:ZK&LIXWCQV S_C"<
M(3$-&=-6KI_J6[5MLLEWNE-=K,_<:*Y6Y:9IVII>:RW>HBJCIJA%$L082*"L
MA.TC+B25XD1WB!C=,NRR ]O)*[6!7). 6XQP<#G5-'B>3Y1\ZD[5K?'O'=DV
M/$+13,5E-/E60VFS>*^20@3GFJL:V,>[%E%'G9^XVP$(0ME##_ZB5/=6)W:6
M\6JH^6MW6$U%\U;-M31UM8CJM8,;)*EJ7+0F563$1?<<88 'DQ>R50\U$KO$
MV59 5#>D\*I;GR3QG@_48&G8\4N?8[JVS$YIT26PSNHZ%I3JZPMV0Q..IMI(
M5+% RZ@)GA:D54<Q!RI)BF*"V.0C[4D8KEM-ZN,]!9_WQ0)#4TE+2I4K"SLT
M4U&5#.(7PQ&]#N50I#'"[<<:9Q+WI%AE+HS[L\X9),9()P3QC!/\^/;KUN?)
MKQN\*N5\,Q'7^\#V;[ 3/<^H]/:6DNMOM 0#720$:F\EKY+$V"ABD"DC,O2O
MD&(^085T[W^_MY2%HO/4]QNU7:K+(JJU1<)J6FA[,-)"TF[MH'V L PVQKZW
MPS*A .+#O2%(Q+(HX2,,QR6;:!R1GD^68X )R2,ZFE47E-?U .@I+2OMJ.R#
MBL:^WKRX2JXP&>-)HBQRX7O@E'?$J2-E:]6_'^??U6F1T<QNCI(K;&1U975@
M<%61@&#9XP1G/&-+:JCLD\9M]VOMC_)/0 =4VH.B%K./YR:Y315V4Q9L3/VM
M>7TM:2VKI=A#<Q2D7>B8^/3"&1@/=9BP1(U+_"M\I;7;9;"K4=.L;O<ZA(TA
ME-6A_%6OD;,LE,8B%BB<=J1"Z]MLG2),;.5;#,-I (W <^EE!! ;/N.<X&=)
MSME=J_V3+ ]0ZYUS7XW%]0X]ILUD;?'5>0V#@Z/=T99>@L-=EIHG=!M,Y0B6
M"C5)I560684V\M67!($:)BD[6^?Y*AMT%164]=2U%535+STR+4TKH(4IIT84
MB33M&#-'&Y1"T,1B#[AM@Y'+<,K#( R<@_3G!Y"D>P!SCF=/".W[;KFYZ&$5
ME:BHY]F!*&"BLQBR3K9;PO\ /?:4UP>V1],?8! LJBC&4C'!U1)\E6ZPLR!9
MB/55N=!!0K3K%+)+(P;O.X5$9AC_ +,..ZD0\+)*=TO+A(P0H4X\?3_< _VU
M)(S0T5>_ZC;BM'F^QD/T2&0(1]KW?%D?T(]9ODKOX]OA_P#SZC%CD895&*X)
MW!3MP.2<^/[Z-;CUIHT>C1H]&C41=G;=2WVVZ;RQL V5K*"AK-)D9XA_W#_J
M'5S,>TH4@V14'K5'MV05UB$B_?\ BF#S_%8Y55.>]84-[O\ 1WNR4-93T9>U
MR2TD)C$DM9,.8UE=R%2G,JK#.HY*28/!Y=4SI$\<K*S*&VL<@8)'('Z#G./'
M&B3OFFJ*<XX7-6&Q?3A0$WX\5//0/RKD1S"A[64GZQ))1I&NB="&^61K8UE5
M/J5%]4:^?%*^=,V*IO<?3U=U'26J".IOJ1TG[KJ;) H(J!,LI2&IE@D5T:.F
M+LL<9E(VL#IQ#1PS2]IIE@S^1B=ZOD^D KD@[<>1Y/GC6RXAY78CLEI99QHT
M^;T]<2\=:D^<:52T:B.20:6"5Z.1[7-5C7>SGHONB>R>G/P[^._2_7MPCLQA
MJ;)>:J%JJ@HZXH8[A3J1N-)51LT,LJAE9X W=56!VXYT5=LGI4[OIDBW;=Z^
M0?\ R0^H#[^#^FGXU6B.IYJ:OJ@QBK&Y.6"-Y\ZB@"BCQN)-(G(_C^[!HY/H
MA;[OFF^#$147UUZXW!Z62DI8(U>JKI)$A,I*P1]J-II'F<> $1MJCU,V%&2<
M:8(H.2V<*,G;Y\XXSQJ,7;7ZPC3Y27.Z2LSO[C:YG)[.UHGHXT>FU>B%!J5;
M/-_Q3W++4;_\%]D?."R8TE6HQ6^J)?36U-VMD7S,--MEI5O,EN)!:*HK:>"V
M02NX_$E-3WYHE.6B2)Y>%'+F)HU5B5)X8QB0^DD#UX 'EEPH/CC4A*3DN'I:
MQ*UU2ETCV.:69H)7W!I[I/E]LALQ:N;,^3Y.^2JQ$]E]D3V3U;X>E['%N+6^
M&ID<YDFK!\S)*WUD,NX,?_Z^,#V&F_=D&<.R@^RG _MC^?UTIJ7'Y7.-8RAS
MM-4-B^21_M]<*,L?S:K7_!T4;7-^;55K_BJ?)JJCO=/4G2VVWT._Y*AI*3N-
MO?Y:GBAW-C&YNVJY.."?.-:L[O\ F9F_4DZKF\R*3HU3H1Q^47G.P8-2#*1=
M!;76CY[]GN/R(QX#PX'2(1+#:QS+]GX[%=&4&UZI_P R+Z\B?&/]G>AZJZVB
MZIH^H8K)172.(7JVU4[_ "HN,$@,=THJ9598ZNK@_P /6.H'>$,,C$,@S8*&
M]S0TAI&C#JH.R5>) HPPB9O>/@D#SR<<#4L>*\\LF>/=!@^@6N9T-O:9PD;2
MW.,8L=&<?:I+,385SGHCGDI-/^0XIS4?*8U2'?V=Z]'=*=%VRR]"T/1DLO[X
MM:6V2@EDJ?Q164U0'W[]P]08.<$C/@\'4-/4/+4M4$;'+!L+Z<$8^GUQSJIK
MNWZ:W';GN7CGSJRV'4MQ9[#3:R\VB6FPL1(H>>T6;/(=$\6N6*!XZW*"Q1(2
MY4DE:QB)[K_-F^%WP_Z:^%\%QOG2MEI*6:E6"F@JIH8JB2"2>0#9"95+)NCR
MK%.0A.>#I.JJ)*Q3%-(Q1ARH)R<#CGVY&><\_P!-5S]H\/IO"0CI8H'81\\Z
M[K+7)+DTF(_?>A<[T#G**^>%['QDUTL;%K[0P:5CZ\Z&3YJUI+%?ZXLO4-#U
MJ;9+/T]%-)1/'.E:T$+16^L@\K'(061BQ[D<9&UT8< H1JO2T[TB2;*AO6"@
MC)/XBX.!]#M7TY/@DD^<ZE=^E!XJ>.57XH>378KK.YBVMNX:S14A8=RP%(A
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M3E!^9@I.%]SCR0/L//G&JLK3KWEOV>IU&M%UH>5J*&]$@$P.(2,;1Q12/?+
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MVEKA+)15$AW.K5';A:*5MV7V!\ '&FMSMT5!*&IW#P5&7C8$9].%88 &,'/
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M3U5QS0 VFN5455+0>-"5545455F^:JJ*J*O\HOK@K%2S% 0I8E0>2%)X!/U
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MSQ'M+RQ!]CXY\8)]_;_1J9M8#P,K$="[!V>ZN.K;S/9H\*O+NT>;)-IF!/\
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M&U@XTK(SWL:Z1J^WQ7V/\(.GNEFN]=<)*:)[Q%2-'2P.6:G:ED([TBP$]II
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M=3(&O_X6N^S^R)[\@NW1E18>ITZSHX#<:2DEEJYZ&,HD\8,13%,K'8%3.\@
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M9!!*GD[?KS[#6]R^.K,LTN4>8VRM+)T;[6\MB7FVUBZ%'-@:03(JJV&!CE;
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+CT:-'HT:/1HU_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>35
<FILENAME>g723949g64u12.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g64u12.jpg
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MF-4D,C=1)6$*,S9"4E>7N-<F)T14@:'_Q  = 0$  @,! 0$!
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M?K,SWX>*D"H+GU5\?/&F<H<HV5'U)'EEU&VQK?7[/9WHT%Z55&\H%*K<()'
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MS#&"1C.,$\9[X],^>*P54YR <XSD#G';/KCRS6*C^;\[B0I:-BJ%2XR.GQ=
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M3XK5HMG@VT\(DO)GF4W#R1+:!8!)-T3\</Q(?%[R(@>:-!]&K%1ZIT-I@/\
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M4/?>-D#GBI \A\HA]Y=.>>:[GDGF8O-,Y9B !EF/"HJ@!5486.-0%10J( H
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M(H"=TTEBL<0:9HT;FA^"CXM^1-/[Y9>S6JH6KG7-8FH7*@RGYH ,@2+?9F[
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MDZ1&DI#<@3)I.=.)-).*4Z:\X0K4S2DN2[$R !R>=P'8'/I@8QC%9$,0" (
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MH)66PT'4KO0^GK@W)U3K\W$LMSKNI].N)^(XM<J+,'T3X%5\PAN5FN:QQR9
M*YS/TS OWSM]J8 AU]1D]!C, AT@")KG&:G#-AU"&I4W$URO2[/B-3Z@::X,
MMGGQD4QQ7KKL:VCRS>%I<!:3W&,LS.UR\DVI7$I:YEN8I)IHS^B>D?9?%8:6
MMEKNPV$SK<W?3\$PGBU:[\-(_?.L-22&U/4=P(HTABT>"VT_I+3+18M*M-(O
M+6PL;I+OLLLC,M#CM-#CCM-LL,,MH:999:1I#3332-)0VTVA*4-MH2E"$)TE
M.M:UK6>8))))))))))R23R22>22>YK["B)&BQQJJ(BJB(BA41% 5555 "JH
M"J     ,4?89)9>&)9:('(:<8?8?;0ZR^RZC;;K+S3FE(=:=0I2'&UI4A:%;
M2K6];WK,5M5 ;+XN?AG+Z47'V?EGBH%TT8<>?DJD:W1(B62&?(QL>-+RM#08
M(.L21EIF)"0:?!*8D)&6!&^1\D]E#UI9KS8"KSE,D!AN(R 20&^@ G&> /HJ
MJ8;/><I!O[E?A![@9*Y]2!DCDD>9J]D#7X&JPX%>K$)$5R BATB1<' QH</#
MQHJ-[V@8",CV1P@QT[WO:61V&VT[WO>DZ]=Y6)+$EB23R23DGZR>35D * %
M '  & /J X%9?,5FM'Z7T:H\BY_<.GWV3^STVBP$C9;'))'(,<&C(QA3[^V
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M0,966WT'77D+G>&3P4V!,AF)P/)9K1^)25\GY.X_X<P/K[OB_,W:NMVSV?\
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MM&5"!7)4Y"J!PB X(^(#<&PO8[MQYXJ!8Y%D#%RR@,,%B3R[$<'@\%<GN-H
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MC@MY71]NQ0N!SA57)P > 3GD%LDY&[;V )TB1TW;VW9;(^(M@9..2!V!"\
M[<]R:LED-35\UWD1QV/I5X[WU.>\&O,AVL?GR^W2V](J_EN'7:O-QR)H]XJ^
MI@@%NF0=:<BF6Y1ILYK;=9K;;3)SPP,8XMGKQ2%EB07-ONVHJHT!)!P/AR<
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M9#;$^Z_R+#Q1CR$ 20G9&Y5!K4=4#2);8VJ9_+#;N122G(9]I48W9)QXA/\
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M\NP51@$\D]NV!].!6DCB-"Y#,!CA!N8Y(' \^_\ *OGYZ39^<]7E[PY;K/\
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M'CGFN.YB+2HDMR(F=O$CCB+*6)PX5\9 )!R,$?6*^CRJ-13%7K;,%'NQ,&S
M0[4-%OL."OQL4W'#HCH]X9Y2W1W0P],CN,.J4XRMO;:U;4G>]\AL[FR<G)R1
MYG/)^VNNN-JXX&!@'R&.*S^8K-,4IBE,4J..Q?\ 2+J?^'%X_AF4S>/\I'^^
MOWA6DGY.3]QONFH3\#/ZE'BC_E^Y3_!D1DES^<3_ ,5_O&H[;\W@_A)]T5;/
M(*GIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE?$[^+5>KQ>/.'J81MI>M-9I,
MO!4V@CPDFN4@*XH6K5LZ7KD8D-UX8*SC3YY2[2"GVRK,ZZXT4A"&PVV_U1[+
MQI:])VONH@6Y8SOJN=@G,WC2A&N,_$8_=_#\$M\'A=N=]?R?_"I_VM;VN:G^
M.??WTOP[!.DORQL!8>XV?C)IN,Q^\?C$W'OZI\O[X3N'AFWKZ@OPW*C>*+X0
M^/E7Z-74U.V1U4DG"X#<6U"E QDA:I^3K7W6-:9'4-.DU@R'+GM%LHDG)A\U
MV6UN3<+WO\_]:OIK]4ZRVDF-K$W*^&T1!A,H@B%T82OPF'WL3^%L^3V;?#^#
M;7]#/8DG4\?LKZ,3K%;I>H!I;^]+?!Q?"V-[='21?"7Y87GXH-A[U[Q_:?'W
M^\?+^)5X,\O7U2F*4Q2JZF^4O*(^>9JY0':D6 D28D XEKQB\ER2Y"-KYD5'
MS<I&H&Y(]J2BHLV=@QC)0!1 #+LS$Z41_P"(A[>F$#D;LQXX!/C0\$@D _*<
M$@'@\\'TJ(S(#MQ)GDX\&;D# )'R?(!(R1QR/45$?8/, I%M5PGQ=J".W^1A
M00I,K$DK.A^<\2CY%&MCV3O%DVPV16-CH4HEGG[#>KY,K'W'(CXM\L-][>.W
M^'Q9V\*+R/=Y"/*)?TOW_F#.<D9J.2X^+PH5\2; R.R1@_I2GNN.^W&X]N*S
MW!/$@'GUJ([=V:VE=W\FYT-0LKU.QAM#Q=-CG]+VNF\=J>O?&\\IXNGGV-ZC
MD:FYO;QA<S(.).6"QB6<NOAQJ(H0>$7NW]Z1N[M_@. !QFLQ0;&\21O%F(Y<
M]E'ZL:]E7ZN3Y]ZL]<8:QSL/]#5KB51I3ZIA[[V'"PL\]],WIS3P?T$\,4#[
M"-J0I3WQ?,W\6M-JUI2_6%2 <LNX>F2/\1S4S D85MI]< _X'BHLY!QVW<KV
M\$5V"=NE<(F;Q8W8&5J5-BM*GK_;YF\31VI.$C!)!+;<]8)5P0/3GT[0SS0R
MM+2PC>;R2*_^["D!%R&8\(H0<$X[ 9^FM(XVCX\0LN6."JCEF+$Y'/<FI]R*
MI:8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3
M%*YK^0SX)?EGRJ=.,BGZIS<2F/6245,+2'0YK\W$3ICUI5$W6IIKB5ULF!E]
M.70*VQ!,:Z.8'#Q;*#UV6Y%D0.,'<Y8+Q\X;<8&5;/.1\)4@Y&3^C4E/RZ'C
M"A<]_A.[)R0P"_"0?B!R#V'GT/F)=4= 2<['QY-B4%$ERH47$$1J"YK8XCA0
MX4:5*'1T0E^0]J&12#Y(*/TMU#A)C _O>34 R0"<9(!)SQDXR< GCZ 3]%6B
M< D#. 3@8YX[#/'/UXJBY7GW60I2$C2*%(H5/N<IW'IU8!EF/A]'YFOIQQ33
M#<4L-9%?!:77@(=<DU-6>Q_$V-'QT0\U+JLBU8@G<./$SP?T'V?7R><XVJ.Y
MSQ5<W(! *=]F/B'Z2;R>WER "06([ <UYZWY%5_ODUXGSD97;' $2/9['*-,
M$14Q*P*(U?B[VJ3#0[>0HA%/:G]Q]DC$2-6=E43@4H/.B"BR<?"/S#IH3$)@
M2#B,#N <^-&/FD[L9!PV,$8[=J+*)3"0",R$^9&/!<\L!M!PPR,YSGOC-7ZR
MK5FF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2OFDKO:'JGT'R/AE_BDU/Q$
M?'\FNX;?X?%\#K71X"!4J]2GMF8:S69\SY56E.OOTX%&:$8 LALPP: '*:-'
M;[!0%(3[DUQ\C'B0RE"?A'!4#C;V&>X P2,&N.LF'F'OBV_RTGR0C5@/B/(8
MDYW=SC&#G-?2#6G_ *JN0!/W=-@^HA8I_P"_I&;#3.?*"PY]W2&UZ-")DO=]
M;H9K7QL:>^)'[*=9R&X8C&W!/'?'/;/GCM777L.<\#GUX[_;6:S%9K4;[?*A
MR^F67H5^G0ZS3*?$&3MCGC_FV+&Q8+>W'WU-C-/E$.;_ $:'##'(--)<:$#'
M?*>:97LJL[!%&68X ]3]O%:LRHI=CA5&2?0?9S5;XOSL\9Y2A7OH>[I-Q,5S
M:5JT';X*Q\]Z#7+]'R]\^#=!CQ>>3-8"NDN_>4$L.5/[1"'-S3>WEC+VD([8
MTQMI@RKM!+[BI#(5(3YYWABHV_I9(QY^51"YA*LVX@(5!!1PV7^8 A7<=V?A
MP#GRK]2GG3XT1/-:OU1Z[2Y<!<;)8:= PL50K[+] >M5.;D7[I F<WCJV3>8
MJ0I@L3(FVI$I B-0H0Z"BW4LF1ZRPMIB[)M *J&)+J$VM\T[\[3NX"X//\Z&
MYA"!]Q(9BH 1RVY?G#9C<"N"6R. *D^WW*K]$\=;?>Z3-!V*HV_CUGL5;G %
M+V)*0\K3SS 3&=.H:?;^5AU&UL$-,DCN>]@EEE]MQI,:JR3*K##+(H(/D0PS
M6[,K0LRD%6C8@CL05-1SX&?U*/%'_+]RG^#(C-[G\XG_ (K_ 'C6EM^;P?PD
M^Z*MGD%3TQ2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*5SQ[?VGH?<NBS/B5XI3BX:
M<B?A'\C?(@)O1<3P6 .TK3M1J1&MZ&F.X6 73S,: R]M-,9V[)GJ'D1W'H2U
M'&D:"><9!_(Q'O*?UF](AYG]+L..]621Y',$!P1CQI?*(']%?64CM^KW//:1
M*;X$^-]#K5=JM;B>G1L969%BP1Z8WO\ WB!2JWH 5'F7=R/K/1X2%8N,NVZ4
M]+ST=%@%&D'&N*]J2%HW@W<Y+-N7+J4;Y*(Y0G.PDH25X&%)(X'I3W.W(0%"
MWAL)$R\AVR $>(OQ863!/QJ >3SR:M96:Y'U*# KT41/%@1R7TCD6:TV>ZSC
MFB"GRW-GV>Y2\]995272'$,+DY8Q8PJ6 AE-!C#,-5R2Q).,GT4*/L50 /L%
M60 H &<#U8L?M9B2?M-9[,5FF*56'L_F-X[<'D&JY>.A@F7\U6F8CE=)$/OW
M4YDMQ&UBA@T*I#RUA:69Z;2,5)"1\:I6E;<.;0AQ:9H[>:495#M'=VPJ#_F;
M ^P9/T5#)<11<,_Q>2+EG/U*N3_/ KEGT"]>6';^M1[$=$=:XU9K[4Y2#I58
M99?I-LJ7/[0IK4D\\04R:W"RNM1XDA/SQ"'7HN9B@WV_I7(>*'$_F9UEUC^$
M=:?A(V-G9V4@U:"YDM>F>FK26>YZ.U+I*6=6GGN)F$$5Y87<4"SZSJ]PMO>6
M5W H"Z?-I]I:VW[>Z;Z<]C%S[%;FYNKE?Q?- D^MZW<)%!U+9=0I$5CAAC!F
M>VO+=Y6ATW3H3-;W-O,23>1W=Q//V(X;PSFOCY08ZA<RJ4=58QO?W"94,01*
MRM@L13:%2L_9++((3,VF;.?TK9$W,*V6\TEIIMH05D<-C^EBS7,\<4EV(UN#
M%'XT<4C2PQ2;09(X)&B@9X4?<(W:"%G4!VB1F*C\3>%!"SI;%S"';PWD0)+(
MF3M>5%DE59&7!=1+(JL2JNP 8S%F:S3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I
M3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*H)Y%=+8JODSX^4Q?/.'V8B
MZ'5X06P7E=#7T*(2;<V(V6*K+D_<X*S1"8>'^<JO)@ZK<=V^S&_9V'((J)4W
M-VH4W0RMOE7;GA=VP_#D;L*5.3P<LNT#/.>*TK[9HEV1G?CEBN[E@#C+ C Y
M&%;<>/AQS?K>M;UO6]:WK>MZWK>O76];_3>MZW^F];U^_65:LUB-5VOZ<^74
M%#Z=^2,=^348%ISY876TPSGO^#W?)$IWO48OU]P&M[T+MK6]YG)]3Y^?KW_G
MY^M8P/0>7EZ=OY>7I4-=.!"CKOXOBQX@H(VN[V=[0X8[0S&GBO&_R+))=TTR
MA#>G""7G2'U^WW.ONN.N;4XM2M[H<K-GGY,?]6*M'&&AQQ\H?^E+4^Y'4E,4
MIBE,4IBE,4IBE,4IBE,4IBE,4K"V*> K,+(3DEMW8H#.E_",W\QAI+SB!P8V
M/'UM*BI*3->'CXT-&_D,/)'&:]7'4ZWR]:U>TT'2[S5KXR&WLXPWA0)XMS<S
M2.D%K96<.0;B^O[J6&RL;93ON;N>&"/+R**O:;I]QJM];:?;;!+<N5\25MD$
M$2*TMQ=7,F"(;6TMTEN;J=AM@MXI97PJ$UXJNBP(@PEVEYAR>)^<V09$TU])
M&N&D.E-PHCS337U@T(P\U$M2+J$D220_KWTH=)4VB/0$UA=)M6U^6)]7G\:Z
MO(K<1^[V+7<\MS'I=O)&D?O,.E0RQZ='>R*)KX6WODP62=D7?5FTXW\ZZ2DB
MZ?%X<%M),7\:Z6")(7OID=G\"2_D1[QK96,=J9_=XRR1!CG\[%<ZOG^\I;'T
M#G2N[] @O.[P0(>J4MT"Q@\?D>0<+D^EI:C)64-3SY;Y4P=.3O0QV&MP#;,C
M&LFS5G;2S).1RRB"1^K"JMX2FVN@&" R!Y0G( W=@ GGWX7MFN7,63Q'%S;'
M!9MACB+]_FYSEF\N0"3Z9KNO19)$S2:=+MO*)1*U6O22"%QJ(9;Z#H@0I+RX
M=M;B(I3NG=+5&H<<0#M6Q4K5IK2M\QAAF';#$8SG&#Z^?U^==)3E5/?*@YQC
MN/3R^JMJS6MJB?NMAEJKR'H%@@>9&=EG8VO$NPG+P112W;I,..-#Q<.\T8V\
M,@!9SS#\H4M@C8,8P6:V,2Z.AAR2(!I%!?PP3R_ZH\SQYX[#S/%:2$JC$)XA
M X0?I'R'_P!?HKBO#\L[I?\ F<GV:W<-[T3Y)0OE9XK>2G:P+=5J;5!.C57E
M<W,CL<L\?H"-O<X@ZO\ )JPHS<</:2HF>L1<@B2?<*E9G49'= R1JXC66(0F
M":&(JS-L9P/CE)08+MC)7(&,=AD\X)*Z;VCE\8302RA@JAPA/P1#><J@\FP3
MG/<X&4K/'>\\ZNG.?+(SA/2;%%%^4_G7U:3XO"!09O5:U3_)BE057YL=+5ER
M=:CVSMGTUM^U@B2Y1,");ED$(<4.>T@TD3J\ E0$06L8E.0A,+EGP=OHWPY'
M.T#Z:".566?PG(,UTYC&-X69 J$C(&<KR,Y&ZI_JGB!TNO> G):':.W=DXS;
M.2\'NRKA5.6V"H,0\])38<A9GJ[<'9>KVK4DFNI<77OD@I$,93;LGH<HIIP0
MEN$SH;J1ECCD625=K.&R,$+N7!7&[YW//;L<U,('%JBF22-HXFW*A7#9!.&R
MI[=N/I[U;KP,_J4>*/\ E^Y3_!D1D%S^<3_Q7^\:GMOS>#^$GW15L\@J>F*4
MQ2F*4Q2F*4Q2F*4Q2F*4Q2F*5SX[KV_H?8.BROB1XGRZ8VZ M#:\@>^L,Z.@
M?':L2.E>L/#.:5H:9[98A$OM5R ;>UNMH]\S*+$4*Z1%VHXUC03SC*G\E$>#
M*P\SZ1K^D?/L,YYJR2,[F"$X;_>R=Q$I\AZR$?-'8=S5K.(<0YYX]<ZAN9<S
MB%1D!%;>*,,,>V=/V:?.4EV9M=KF'$I)G+-.E:V7*29/[2U[;&&:%CQ@PQX9
M)'E<NYR3]@ '95'DH\A_WJ>.-8D"*.!Y]R2>[$^9)Y)J5UNM-;;2XXVWMYSX
MF=+6E&W7=H6YIMO2MZVMSV-N+]B?57L0M7IZ)WO4#R1QE [HAD?PXP[*IDD*
MLP1 2-SE49MJY;:K'&%.)51V#%59@B[W*J2$3(7<V!\*[F5=QP,L!G)%8"V7
M&I4*!.M-XM%>IM9C&_ED;#:9F.@(0!O]?19DI*DB CIWZ;]NW7T>[>O37KO)
M%5F(55+,>P4$D_4!S6C,J@LQ"J.Y)  ^TU1HKSV&Z041">'G%.B^4<BV\Z&N
M]@#_ ,F? XPIE>VB4G]@O H@4LX&K^FV+386SK-9;<2(_MU3.G+(M=G-Q(D
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M^?Z%0:II>[1>*?6]-^NU[G[-"P^D:U^_:]R)HWM]/[?7T],V",WS58_4"?\
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MP M?3*%4^G4[Q;[;<:5<XEB<KLRCJ/@I#JDXPA2TM$_;KISN4E0]K4VO^AD
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M5TJ=5%Q8ZE:P7=G($8-&7@G1XRT;A7B8+OCD57C*N%(P?C&+XW#<FAU>*H]
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M2VD#/I\^A=*C81=ZG+J%WU)U/#$XPT:7.DZ>FD:8)?BVKILEO?-'XMM+J5U
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M,>:;4#2*'T"4YU*-1-FZSV_FLM!QTS S%B89Y&YTX,,^'6B3 @WC[ ?00TO
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M'AJ+<')2%X&('SA(,.LA(YR<@D'!(S46XK<=_$8W' #RI. 3V*$E&C4>> "
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GIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>36
<FILENAME>g723949g65i17.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g65i17.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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M8[;X2)08<R FP96)5,)!*0OGN:2"0<?3$$XY)\)P0>P)[3FHA)7D$M\MCRE
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MJ6?3BECFV(^(KUO 3FC1IN*/+A1[*X3@:!/;!F(,HYWULU+*4EH'<HKW A)
M[\* P"4GD,X)YY(R#BJ!]:@\H;$I;VJ&\$_2RDJR0"#D\B/6Y=M=&V]2G4U1
M*[I\I>:I2JC&.4.7>]RW=6J-I6FB4%).U!A]6KLAT)=6EUTG KQ"5,N4@@6L
M2($Z+E^)#]$XS(62TTHK"2I6%!+:=Z$J5R)4KFGF,CO>2>1Y\Z%YY(05)2G*
M=RU;5J2G)P 2#RY9)YGL\52*W5U4Z^T=<]=TRS1S\N9>"O@390NKW8M'  G
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ML)\/F=F0U#B53U6V<@-$$["H!!AI3%;!E3FXH!"0K:G?DJ)QG!VIP#[.U()
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M\.(DV5V@T:DQWY<$,,CO)8?;:RB&UV-X5E:E7.K4Y':4LY5Q74YP <!+1 Y
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MX\64@#VN6.=4ZLU@#OL!.WSQ[-Q5_8HYJ8/H []92WW.F?D>0Y'C'X1613T
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M$UEG;G1?JW65D.L&#.S:C2:9U#UW2M@N!Z?0[3%,UP\3N V5L >S5FHTNHY
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M6\ECN)Z7AC<7,N=L2#!8.$9<.F/D%T\*IZ,BATV_0)=E&'+R.-,/RH=[!"B
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M_%GO[''$;^V(_&3^VG59/W._^2<^#5_0[S=Q<.G(#NE@Q>C)/0P-B%KGPBS
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M C<T=HN2W7%SP,"8IQ:I'$*U$ZIC56J(H=3&U'?HX?-G4\&+O<&@ZK3R&FK
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M2<Q:E1W7V%.(?:R-07.X0^&W:Q'5(S!WIDI):WS[U;;9%:=*2%-MOH?GJXB
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M2@H>:RWU.1$9;()^FIE-;FW"EUCA(M.F]-P+&K5=MNTJZ7>!JF<_!BSV[<Y
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M,+:4MF4VZTM:%<:;T^DQ[=%E*:?8BM7)F0WM4 ^B?NP$'(*"@'SV0H$!2""
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M*N'(Q8ME[)ND+#*Y#4E68PNYVP^,@O\ BLHPF5"AQY2&N_'0\F.ZZTN-3BE
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MU?;YZ+LZDKM%J6@80JVP5) YX2J*T4C)Y]A';7CC4:%M:AOS;A)<;O5T0X2
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M;P0EK(XA3D5CJTAJQ$:U35Z8U"F'?7XT6R2E6:XB/=Y4WZSCVQXQN'/?E_\
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MQW%.(?BOOMRE+E\=TK0I+S189V9$GI+;D!BV+LTR7IE.GY6FY4"[7]ZXWR5
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M3BE>XOR4G_)^].G^YKM^-"[\\F](W[\[W]\A_P"70Z^POD:OX$=!_P#*7?\
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M.=O%.5)"#D+2A(40,[@5;CC.$@ D#F3CL&>6;M4WU6RJ3"M+XE($D@Q;ZK8
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MR3L!)",MMOSEMH:1&AMJ4XM@8-C-M#QD=3CBVH<=O+KCLA;SSGK G/L#L_\
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M]U*<MSJG1;.\<GB E?$676W2]#?M(5,6$S'LXPUTVB"P38T&*XC#:K.$MI9
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M6PEWH<2!!66L-C+E39+S" /'XG3WTP($*)AF*U:M16HJ.!G'(9P    ,DG
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M[.8Z,$'H;RLNC2T97:K/>VG=(Z9TFP8^G[/$MX6 '76TJ<DOA.,=8F/J=ER
M",@.O*2DDE*1DUY1UCTA:VZ0)29FKM17"[J;45,1WEI:@Q"K(5U2W1D,0(BE
M X4MB,A:P '%*Q4BP==#UR,N*(AICI><R_*D+6Y(G3Y*L8PY+(SY"W9D^8[W
M<9=E2WG7G,X[5+SSD7;7#L 56^*4XI3BE0KW[]5CT%?MRZ@_Q 6KF0U]0D_R
M6O[U-0.?5H_LN_W9J:G,>IZI)\X+K (U93DKS(+7A)$X8F^#(D^:"Q,-Z>0E
M>;Q&GY3_ )O$CO.^#&8>D.]SN,M..*2C,C++DAYJ.RG>Z^XVRTC*4[G'5!"$
M[E%*4[E* RHA(SDD#G6--F1K=#EW"8YP8D&,_,E/;%N<*-&:6^^YPVDK=7L:
M0I6QM"UJQA"5*(!UW^R\>3S^$#_-9NG^[KG-O,UUMZ2_G&T_+ZZ*^BAZ#/5Q
M_P!-ZN^8:>R\>3S^$#_-9NG^[KCS-=;>DOYQM/R^GT4/09ZN/^F]7?,-/9>/
M)Y_"!_FLW3_=UQYFNMO27\XVGY?3Z*'H,]7'_3>KOF&GLO'D\_A _P UFZ?[
MNN/,UUMZ2_G&T_+Z?10]!GJX_P"F]7?,-/9>/)Y_"!_FLW3_ '=<>9KK;TE_
M.-I^7T^BAZ#/5Q_TWJ[YAI[+QY//X0/\UFZ?[NN/,UUMZ2_G&T_+Z?10]!GJ
MX_Z;U=\PT]EX\GG\('^:S=/]W7'F:ZV])?SC:?E]/HH>@SU<?]-ZN^8:>R\>
M3S^$#_-9NG^[KCS-=;>DOYQM/R^GT4/09ZN/^F]7?,-/9>/)Y_"!_FLW3_=U
MQYFNMO27\XVGY?3Z*'H,]7'_ $WJ[YAI[+QY//X0/\UFZ?[NN/,UUMZ2_G&T
M_+Z?10]!GJX_Z;U=\PT]EX\GG\('^:S=/]W7'F:ZV])?SC:?E]/HH>@SU<?]
M-ZN^8:>R\>3S^$#_ #6;I_NZX\S76WI+^<;3\OI]%#T&>KC_ *;U=\PT]EX\
MGG\('^:S=/\ =UQYFNMO27\XVGY?3Z*'H,]7'_3>KOF&GLO'D\_A _S6;I_N
MZX\S76WI+^<;3\OI]%#T&>KC_IO5WS#3V7CR>?P@?YK-T_W=<>9KK;TE_.-I
M^7T^BAZ#/5Q_TWJ[YAI[+QY//X0/\UFZ?[NN/,UUMZ2_G&T_+Z?10]!GJX_Z
M;U=\PT]EX\GG\('^:S=/]W7'F:ZV])?SC:?E]/HH>@SU<?\ 3>KOF&GLO'D\
M_A _S6;I_NZX\S76WI+^<;3\OI]%#T&>KC_IO5WS#4X]4;6H6[]?5S:6L#WJ
MFHEL9FR*^<]&& WG[(XI."S%^C3X\47B^"2&S8W=F0(ZG/!\9K"V'&G5\2N-
MNF6F:_;[@SU>9&* \SQ&G=A<;0ZCZ8RMQI66W$*[Q:@,X.""!W#IK4MEU?8X
M&H].S>Z%FN:'G(,SJ\J)QT,2'HCIZO-8C2F]LAAUO#K#95LW)!0I*CD/F%6]
MIQ2G%*<4IQ2HW[0ZN.GS3-I72]DW_P!3EE1 AE%#?4M<R_9!G^+YH_YV"KI.
M#^B^"Y^A8E>,CN_HC:.\GMY):M(:BO47KMLM_68W$6UQ>MP6?IC>-Z=DB2TY
MRW#GLVG/(G!KKG4_2UT?Z-NALVI+_P!SKD([,HQNY=YEX8?W<)?&@VZ2QW^Q
M7>\7>G'?)&1G'?LA_1[[[O\ (/9GS-YLO,ZUEZ3_ )PM7RZN._1"]$'JN_,.
MI?F:GLA_1[[[O\@]F?,WCS.M9>D_YPM7RZGT0O1!ZKOS#J7YFI[(?T>^^[_(
M/9GS-X\SK67I/^<+5\NI]$+T0>J[\PZE^9J>R']'OON_R#V9\S>/,ZUEZ3_G
M"U?+J?1"]$'JN_,.I?F:GLA_1[[[O\@]F?,WCS.M9>D_YPM7RZGT0O1!ZKOS
M#J7YFI[(?T>^^[_(/9GS-X\SK67I/^<+5\NI]$+T0>J[\PZE^9J>R']'OON_
MR#V9\S>/,ZUEZ3_G"U?+J?1"]$'JN_,.I?F:GLA_1[[[O\@]F?,WCS.M9>D_
MYPM7RZGT0O1!ZKOS#J7YFI[(?T>^^[_(/9GS-X\SK67I/^<+5\NI]$+T0>J[
M\PZE^9J>R']'OON_R#V9\S>/,ZUEZ3_G"U?+J?1"]$'JN_,.I?F:GLA_1[[[
MO\@]F?,WCS.M9>D_YPM7RZGT0O1!ZKOS#J7YFI[(?T>^^[_(/9GS-X\SK67I
M/^<+5\NI]$+T0>J[\PZE^9J>R']'OON_R#V9\S>/,ZUEZ3_G"U?+J?1"]$'J
MN_,.I?F:GLA_1[[[O\@]F?,WCS.M9>D_YPM7RZGT0O1!ZKOS#J7YFI[(?T>^
M^[_(/9GS-X\SK67I/^<+5\NI]$+T0>J[\PZE^9J>R']'OON_R#V9\S>/,ZUE
MZ3_G"U?+J?1"]$'JN_,.I?F:GLA_1[[[O\@]F?,WCS.M9>D_YPM7RZGT0O1!
MZKOS#J7YFK)>JNJ_06[;*_4-8WSU2V*.)E''A_J8N(?N"X4B'$DRO.SU?%PE
M>'((1&_!3)S(7XO>;:4A#BD:R[:2U!8XR9ETM_58RGDL)<ZU"?RZM*UI1LCR
M7G!E+:SN*=HQ@D$@'DNE>E;06M;DNT:9OO=.XMQ'9RX_<R\0]L5EQEIQWBS[
M?%9.UR0RG8'"X=^4H*4J*9$\XY78=.*4XI3BE0PI?U?O4#^]>Z9_QC=2/,A7
MUJU]^>_59K'3]=._>6?UGJF?S'K(IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4
MIQ2G%*<4KC<::=3E#K;;J<^UE+B$K3G]G"L9QG_JXI5&>J]:DKR[(KP1]S.,
M8RX\*@N+SC'N8[RV,Y[,?L\KD^,_AJF!XA^ 5V(H()!__P (.+B=F>]CS:!%
M8[%?JYQX32>S.?U<X]OE,D]IS5< =@Q54QC&/:QC&,?Z,>UQ2OWBE.*4XI3B
ME.*5"O?OU6/05^W+J#_$!:N9#7U"3_):_O4U Y]6C^R[_=FIJ<QZGK$^^O\
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M//I*RF2K#$/8M3'>O&#(;;;<5"1,:+2U.)5M=+,MK<IMLJX"U1E)<+;?$3)
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MJ9"4N6Z:BY3+:Y&85%_[/=,=*PX.+7Y$ZG=@>:3X%E$5:[![%.V=.N0^SQ;
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M'9A;[F>U6<N##:M\.-!94M341AMAM3I2IPH:2$I*RE*$E1 YE*$C/8!6HO\
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M6VU@=T6):8EMLC%L?9BW>9H.^SM/RE/M12C5\C6+T.>ZS*>6VW%NSFE+.;=
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M*<4IQ2G%*<4IQ2G%*XU+SC.<>UQ497C( [#7 N0I&>SL3G_K_P!G^W_;P.9
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M$ J5LPDD)/+F .WGC!Y8S0':WULR#]V(J-V.//EU^Q8A11[%5:K<L4_4 +8
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EE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI7_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>37
<FILENAME>g723949g65p26.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g65p26.jpg
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M 0$! 0$! 0$!_\  $0@ [@)= P$1  (1 0,1 ?_$ !\  0 " P # 0$!
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M&/=ME+,0SELX*94;2,\@5E:RR.XWL2'C9QNQAB' W184%4"GD/ALD8! S77
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MQ[ABECUNMS1RHL^-%E,V/=3N"&93D@D^'$#D$,#N" ]P/7GL>*P6VA3&U2
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M_P X'V E$YP<Y%J6HM8QKLSFUA0UHC42_P!3F1Z3@M$AADD)^N4SY-?--H/
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MS@!(&U2#,6(.%%0T9 0N5K;;+4-H6D5D9)%'G3ON*DILP70(Q  522H')!Y
M/?.<0D;'ROG& RA@V0K;E!)R0 <X (X)'NQF+/QFED;N-W9>J'8Q>VN12KE1
M42I(>3>+33:Z:"#;9"C-@8YM1.N!S,*3)8KKL<6F36*K/F04(BEFS<+(P4[4
M&%R-V&.U6()7.<<D=R,X9@#VVFC4L-SG+8.,J"Q4$ CC/ /I[E^7.[\]K%9Y
MR=LPF=T-=KZ'==P+<<W8IE2&V.8(KX(131TZ/6JT, 16 \*"$C-2B;0C:7BC
M\SXLQN-\B.@8NS. 0FU%RHVAB,L2QY)/)SVSVQQW)R4!"07RQ\QR5!P %'
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M6;EL40^%K\6S1A0B '-N2&1\DC679Z11HT5D38RF-FYC1%0A%B<LP,:R^+E
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M?TQOL&K-*-<]=L]<Z'J.8%O'PA;\&B5S-OU@Y.IC0ZVMV@6(J.H06OPA#(Z
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MP>.*CP8LYV+G)/WR0Q/WR ?G&:B6B> G"Z@?Z(<,Q970&^B-M1I(:S Z&*%
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MFU<O%A+$:M6@%MMU0.CJ_,/7J&),1*)#;FJ2INSE8_RL*6F.W&;FDGH0Z7=
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M8I3%*8I3%*U\O:JV )U@*:.#!9:Z%98.ICILMJ/+L1B"$*628-$,.*TN;,C
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MZ/=:7-\%VMYKF3J/4NH;>:Q1\-<P6<,%ZXVB(SIOA-U>70?)**6FK[3:.('
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M7C)!-0CW)P6!P1$2/#(/G+AQGTV!5/;(W<X&*C+EG2?-%OFO&@Y&J=<MDFA
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MT!P=.Y=?:9$BTVU5I*9XJ<X9LXU17:I<)F97$F8"W7=RM1G[X91$)?*&+H%
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MZ0\^_I"=Z[U;V$],:O!$G7>M]8>T6:-A*?\ "CJ._&F+-G):WT#27TW1H%#
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MW#J]C=]0R=(:5^I6GPW:60;3[C2'ZEMTN"YU:ZTU;RSNU/ZGZ3>F:":=KO\
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M\UW0#X;SS<.2V]#CI9FZW%7OXR?;B6.93F99 22-T@;S'Y&;XWO[GCFD;PL
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M@N-92S-*%&V.-5R0D:[5R<98\DEC@<DGM41Q+&6;<[LV 7=MS8&2 .  !D\
M"K%Y35M4SL_G'R8$?Z/50P&_WRQ<YNM+YTL73A=>7]L+K<8%W)N@J62LEIK@
M4BY4(O.KFW<9A,D''#"=?* XDLB<A21S6PMM(RJQ*(K*SY8GRJI098*K$;BZ
M[< D@@\ @U0;A 6 #,595\NWS,P8X4E@#MV-NR0 01R>*U/RQ[MR*W>#?>#
MSH53C;Z;X@=)MM+#%[ '$V0R&O7'3I.K.1Z_-G-%%R"T>?&1%C-QW'7I*]QV
MM..Z]N90Q2+<Q*4;R7"*Q ) *2 -R..,')K&>1&MI2&7S0.5!(!(:,D<'GG/
M:KN5C]C5>_>,3_,(^:Q[GYS^>M@=A\P_-6<R*FF*5IY+H5 #3GQAB\4\42B[
M0F4/)68+!G1E.-H>;2_$E36GV=K:<;=1IQM.U-K0O7JE2=[5B64<%E!]Q(%4
MX\?[/]'C7^I]V*>/]HXH)ZB7L6G.U30=B;BRYYE<XA(=5'=+SDB71RB[I!TA
MJE;^HMF5+5/U]8^STV)OA/AQ>-O\/;]*W8QC ]W.<8QNYQVXJB(VH>4Q&,/G
MZ9@XY[^O&/?MXSWYJ[H2R5VRL/2:X>"GXT=W3$B0$*02K##^T)<TR\[!??;:
M=VVI*]-K4E?L4E7I[=ZWFO6P"#V(/S'-9K%33%*J-YT_DP]#_P"TTW^G%=SS
MA]%I]87K/[OTQ_Q7HM=S_0^_78Z:^Y:Y_4&IU\_&?C=7Z0UJ]W_87;__ (7/
M_P"J9><MZ!_9WT5_&WIS^N+.N/\ 5G[%>IOXOZS_ %=<UM&<2KD%,4KZ;.%_
MM)<>_1;S_P#HF)S]W?9%]:CV9?\ A]T;_P .Z=7Y3>T']GO6_P#&_J7^N;VI
M4SL.N(5\I_TSOY7HW]#M+_UY<,\/?1$?L^@_B]IW^]:C7ZM?07_6@NOXY:U_
MN&C5R/>9<=VG:)<B/K6O3:64Q5:5_P!:OF(S^_77ZWXNTZ_QZWO[\Z9LKVVM
M5=9](T[4B[ J][+JT;1 #!1!IVJ6"%2>29$D;/9@.*]/:GIE[?R1/:]1:QHJ
MQH5>+3(.GY8YB3D22G6-"U:4.H\H$,D,>/C(S>:M?7,@)-LBUG)NBVXSOPV/
M@P?3X;ND/J1M>AGP=.*1'TXE&UZ7[$[WK7XZ=*[#@TC7I.A[WJB'H30FZ274
MK9KF]^&Z]O\ A-H9[".9(#U0+MK:.749+:25(C#XSX+$PN4Z>NNH^DX?:AIG
M05Q[5^J%]H+:/?"RTO\ 4SI0Q_ []+35I[>2Z7H4Z>EY-;:/#>PP2W"W'P:(
MLJCX1&LN?98=:5M2YDF1K:?32'DQ$IUOUUOW:W'BL+]VO3>OO5M/IO?JGU]-
MZZ^O+^UNHEC@T73-.<2!S/9RZP\K*%8&)AJ&K7\/AL6#$K"LNY%Q(%+J_;VF
MZ5?V,[RW74NMZS&T31BUU*#IR*"-RZ,)T;2.G]*N3*H1HU#W#P;)7+0LXC>/
MI/\ 1.?ER\J_>?I']75GSLSV%?7+T7][:O\ U5=UT5]%G]8SJO\ ?G3?_$>E
MU]?6>^:_'^H]ZY^U3T[]'MT_HV2S=TW_ #C8?OVU_IXZ^%U1^QGJ+^ M7_J^
MXK^=#GN.OPDIBE,4IBE?9#]!_P#D.POTK]!_V)GESVM?LN?^#K+\TM?JI]"!
M]9^/^,VM_FLJZ_YUE7J2F*5''8]6S?(NJ:H0,79[SOG%XU2ZV<8C2@EAMFZR
M4^SH,Q%F*1$DBRQCY. 0CRE)C/1)#S;ZDM*5O6<>WQ$WDA=Z[B."%W#)&/4#
M)%8ONV/M +;6V@]BV#@'MP3QWKG1]'Z.M([HEU1!$]?F4&1S6NR[59^Z>/50
MX39P_:'S;VCE*I&JY1J&^>IR!;;DTF.W%L06L$(0=L39)?UK)UO;NBNQ>8P^
M]MHBE:53& ,,V6;#9['@L-V1Q6I:A@S?5"NT9,L2QL),\JN%7<N._!"X&&.<
M#J]FC6[50O(SL72N<] XI5>=$N<39W0K..%O<]/A3Y:ZVL2W::Q&NQX<8'V0
M"$Y]4*#1)YZP%;><@VA,VT;J53@A7B!R+#)[$,:.DC/O 12=X("J=K;005)=
MG< !1C"[F)XXHF=T:,(5RQ V$$EAN7<<Y 0*N220><#&35#1_P!(9WPS68JH
M\'D D[;!]=OP(^1JMI?K%*K!WB/DSV1?.+8/1T2))-7F YX]1*U)L,8W6XOP
MKBZ4^R;3XF/!G[1M(@W_ %A"[E*AEW,PDACWJ=API\;(7#?%^-SQK"YE*_\
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MSBNJ>WOHNR)CM[O35D!P&U_J+0NF48\;=MEJ%[)U"^?41:#(P&."2!7++#V
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MKJX[W;VC;XL.CZNFF5(]%Z;EGB=-KVW4H5HQ+85Z;ZQU;VM=)V5]-HNB/?\
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MU^O8W_1A=]0?3?:1U?K'5ZOR_3NG&3I/HM0>?"?1=)N3J&K1*204ZBUO6(9
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MYY'>21LO([.S,<EGRZWZ^FSA?[27'OT6\_\ Z)B<_=WV1?6H]F7_ (?=&_\
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M!4Y:ZGYE:UK6O$/G.M:UK6M:\J8NM:UK[M:UK7$O36M:_6UG:@CMAP+A@!P
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M*U:U6O32E:1I6]:^[6]_=]V8'X*><W'/_=C_ $ZS'PD<8@_#)_97N?'\]_\
MFKQ"_C!V;_AK&+7[*X_%C_3I_E/N@_#)_97,7HWT9GEST:_W2_SKQXXCIETM
M!RT2A\67TUV-"D'",@B]%CN/5GXJV6')"FVUN?CJ0G6U??ZY/^2>^Y_!%^E5
M)AN"2<P\DGN_K]ZM,_N3/E?_ )1?'G_O^D_\,X_R/WW/X(O[:CP+CWP_A?\
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MJ,/@,QXC"I4Z3)F2-M-)V_*D/R'/<ZZM:I)+')))]Y.3QP.3\G%0  ,  #W
M8'X!68R*FF*4Q2F*4Q2F*4Q2F*4Q2HCZ'PGE75;%3K7?*K]>':')1(KLM!NQ
M"&?8V?KEK:''AX,N-&V\$S::A5K*S7;=$. 6C]>$%VQR2$%B0BQ)9(PRHV W
M?A3^U9<@D$J=K,N5(."1G%8-&CE689*\KR1ZAN0" 1E5.&R,@'%2YE=9TQ2F
M*4Q2F*4Q2F*4Q2F*5#-D\?>1V[I8SL%@JS\[H@<+#KD(^BS6Z"WNO0"$LK'!
M3@@X]$KQ4/LC.ERY(TH)F0YKSRE369&M)TFP2R*AC#80G=C"]\8R"1D' X(.
M1Z568D+B0KYP-H.6[=\8S@C)S@BLQRKC/,^) YU<Y?58U5#DB#)2=&9G%2;L
MB5%#BZZ/2N<;GDI^H0BO PM?!C$RDC00$2-#!XD(;"C16XDD>4@NVX@8'8<9
M)/8 <DDD]R22<FI2-(QA%V@G/J?D[DD\   =@  , 5)V85G3%*8I3%*8I3%*
M8I3%*T#HO*^<=< 2:OTNEUZZ Y4:7$7".CF9:F6)R&T3-0)GHF<,=D(::2Y(
M'28LA6FV_P"^_B)],D=XSE&93P<@X[=OG^_6+(KC#J&'RCW]_F^]6%J7"^34
M.\63H]0I(L#<;;&7#-%8+I#3*XS[L"1.9&"'9C@0 DO*%"YI[Z@'#-V">-'S
MC>Y\R%&?:R:61U5&8E5[#CY<9.,MC) W$X!(& :A8T5BX7#-P3SV[G S@9."
M< 9(&<X%2SE=9TQ2F*4Q2F*4Q2F*4Q2M4O-'JO2:D>HMV$-':M98*AY@6Z_+
MB?,1]N-O-K8G#Y$0B.FQ)+3$P>2&RXA$;.CQYT"5&F1V7T9*S(P93AAR#_\
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MZ\].:(UF%T-@=$DD(;$]5BK\D=)S%HBC+N3]*=SA>Q$2R*5.[#CS8PVPY'.
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M(=81*,8<AA@]LJQ( (&[RP;IB2%5/CQ@,6;&UI6C).4&#E?E !SDXP<[2/I
MRSLVE5\O2AQ=9 [0Q%D(&>@#0U^);Z]Y"="XI4G^7\^%T&/$Z1 ISM/08O\
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ME:G)K9^'MX427:CL3;I(HR24/C%6(W1(V  "244[0XSAL@)Y'>++JH6Y:-B
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M('179#\: A3#3>TPH[\N4\Q%UO3#+LF0XVVE;SFU"2>Y)YSR?7W_ #\4  [
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MUM+K<"<ZRJ5#0[I2M.)CNMI7K>]*UO6]XR0" 3@]QG@_.*8!.<#([''(KRQ
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M#CY:R,"$YRW/R^^,1>[[$#Y,_@KV.0^''+.(FZ-8*(3MT&=1H74QC,;X]6@
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9)]Y-3UE564Q2F*4Q2F*4Q2F*4Q2F*5__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>38
<FILENAME>g723949g70e01.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g70e01.jpg
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MU_ F,U*7T>'Q)3EB=YBV9Z<9)S0U0T1&@H>2Q__$ !P!  $% 0$!
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MH]IJD%I8:\S*978=M@ZJK6FE4VL.)&G6+X8+,TIP 70XX !YS@XQX]N#B?\
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MLC :K3#F R/+#T59+J:S1V-CU]8:/:=:XVM7(N\Y/63P4F$:ERZ^B.ZVC%9
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MW2GFI6)T,<>&[EF)Y!*1LD!9P=HR5>WQ+*61Z\C&1)$"[1QNQ'(&PRR*/E9
M,A@!YZ6#X#@N-\BN+954:D45MJ7JYKW=4V88! MHY;S"Z#3[#8SL!-.H@@68
MR!E,_)LEF2[T)I5,3Y550VE#/A2@-N!>N3^N+$3U&@T[1]*:2M+-$Y^+E>Y2
MDN3">94B;;&0D,(D[S-'.S1["AZK(X]M5=A,DD[YX(_9$' W<Y )RQ(SP1]#
MU5"=-KG@8Z60$"YAN%5 !7,#*K/1N TDF83M*XS9<F9(<20A$16?I "3<*#9
MJ:E2V2[1H9:';6U8L2M+'8BGWH(0S(C*L<<9/:7=N<PE<'/S#ROB3#L$="J?
MLU1U9#A78 LH+JI9P. & Y'3<LH4:!+DV%=?CFUL!(JTQK$!(-C;M+(<,K(=
M6 MFL5L0S9Q3$F2@Q>R!%:?U4N+$-Z!J$$52:!*[R6:5N%):MKMJA=3&.ZTJ
MD]Q2)A(%[B!RN#MP1FLD*=Z18I#(D3[%=D".P'/SHK,N<GCYFXXSD9ZGO3;4
MG.<EM(&)XC4V5[D<D!VU--1UEG;W5S("![FUE164]=83IEC,\BC %&V>]VY'
MC8JO0-)6A/>B,BLI"DPNL<FU_P!FY1RKJAV,3NQPN<?,!E;RA //V^G@_;V^
M^/RZO\W3+F#!:1<AYG+K3?E?&")#%()S%YU3X3J#%AQAB#'([0.CC9'S$3P]
MA6]4NOTBF!57,8^0AC!81OJ'4[FL,)[<JV[(C2 R,$5&BC)"#,485F53@MR6
M8$CCA9J^V-0JKCYL\?\ J.?YY^XY\=5HH-5,BU OY.&X52R<FO P[F9%'2!.
M9T^%5 +86$H3),>+):.-# 6;UE ,C1,>QPFO1&\4=6C;<1SPQ33Y;!@BBDFD
M7'R\QQ*[X''..."2!G%UI^GW]7N+0TVK+<LR_P#3CA"DG !.-S+S[?7.-H)(
MS7S,-7)UR%:T3V#5!N&YSE5&@DC?U&8]=MVN:Y'(USFM9LG4BJGU(<JRJ65X
M6&20RA0&"[1D,&(*L"#D, 0,>#U5N2K,C JZ$HZGRK #*L">",XQS]NH7L3M
M93L;U15+-D-0HD8KI37Q>MSI*$V48@%4_2Q@7])%[KW(BHF\5=-^H.5[@6#&
MW=C:2Z@'\);./O\ ;Z],DP(<-SW2%Q[D9\'\Q@<$\><=6*PG',"L^7VQK@!I
MI>J&:ZBU5576,PD$EA00*U(QTAABH4MM @V RRY$RTCPRQ"=((9R(]48E7*O
MJ*UZUTZ" 2IHT=.V;2C<!+,4<Q2@*Q4JIVC##</F(P!S[!H.BT;?Z-6CJ_J&
MSJ?J;6(J,LDZU+.O:9?J7-.-2I5C>-[NGZ<]-[4]NY 5@L;UJ3!W[<9JR+IC
MS7L1G6)SB"1)(V!)L_J8TCDW(T+FJJ.78CD8J>%5$XUMB"2(%) 4:'._Z[!G
M."?L#D?7ZGKR"M9BJ7)"J+/!(SHBV(XHYP'W#<8PS;"N<G&0,?3H]D%1,HK&
M542I$22^"1B//72AS8*O*-IT[$H.XB;->C7]"ITE:]KOJ8J<"5+4%VM#8ABD
MC2=68+-&8I,H[QEF5N1NV%E(X*E?<$=-G6PL:HSL8HG.P@Y168[N/&!@^..?
M;HG#$<82R%C/>(P^R%[TZ&O=WQJ\@G.1$(X2HUCD8Y>V\K'/5$\+RTZED7=M
M:/#$ \[?9L>RMX^I\<=1P;MCX'+\*?ODG_?[C[^.I0P;$!WF3T=)\WC8PXKY
M4B;:Y <D./%C AS;$<II8L8Q&!CQ8H996!'(E25,B1HYE:C%JI;<'[1[A6&G
M)/! \L5?XO&'Q^TKG!+;G )&1C')P>M/I.@'4]2TW34NU=,FMK([6M6E,-6/
MMUK-LNSPI/((F2MVT(C+F:5!@*=XE.YRNJQG$,YQO Y_S6KD55+12;V-63@Q
M;9EE(K3V%@PEO'!91C1S5$JF ,L:$25%ER9/88AC,6IUC0:">K:,\5]M2H5+
M\MS3Y9$$$K"K!&#'\.K!3#*UQ)96()[L$9&1@]5K&2-9Z^Z($_)(T>[M2 L"
M"I90Q\'(*@^/OBI[AJ:0@@M7=S^AC7>-D151%5=D1$V^IR[(B+U+LB<:\\(K
M-M7";FV_@&78X0\< $>0.2<<<]4SLK2N$X!?"Y^RJ#GZ<_GQUT/PK$,BON4&
MXKH>7G?A^.9)$U&O*2OIF7L>HR<0;?'H]K.("2RTIQQ,=O(SY)0")".XCYEL
MV/'J*\D_+'U?3J:^=/DTK0TU6*6:'0K=J 5[^J+>AJ);JK;E5:MFG6&GM8DC
MFL+8@MF 4X+/?LF"UCJ?\F\TEB?M;1E4(,:-EL;E+# \Y(!/S#ST=T@AXN[3
M;#JK5#5B%I=0Y'E$05/EB75]*%CM5(DW47(DL<:P(&0Y$RH*^M@3#2P0XLWO
MQ5'Z%[+ )YY7IS4I]*]0>I&TS4]7H2/Z9U)Q7TJNC6+NO:>P?1EEO7I:L,=B
MQ7O:G3JQUI97>.8X<".2(OD4M2JB6"&:NTZQ/\0LA1H)&RVTHK?M,JI&0!P/
MFSCHMRO<PF(:0:\?:;4;'!9?BE3C65XY74T" Y:3(!6]2:DK\@;]H;$0*^2:
MI((0;.5%-(^72NT1B'&)A-?Z3]2KZ4T*]WFU*Y:U"Q/J4]"Y.EBN]^Y)%+?
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MAS&/(_ZFN1$<KFOZV-\JG2U$:J-1-I7K2)'&DZ2PB95EBW[6$D8)VOD$E3O
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M[R]^=(BRAT<*#WK$C/F,N6?J0>8/3K"L:UDU/JM(I$M<%TV#/'5'G3(DVU2
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M68*QD$44F(S)M+[0 R,=I9?E<!\ G.P)D!B1ORR\EYC=R<LGL<A;^2HI9BE
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MI\@_GT52-U-/K?K-X)]16#;.U4%%-E6#%V3PHV93;'B,$Y7( RPH\098PF@
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MY]^C<>&1[-UW0;5:5W0TC1]/2BHQ2JU48YZ.Z=U^EJ?4JJBHWBJEF"R*%(#
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M2HDY#R3'$T@GQVD4'2H[6OFM1O1O2>&62PD,6^NED1S3 1RSP9VM(SABFX$
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M\1_/^O/69Y]_.3_7KYLB*J_?[;\=!."/;'^XZ77LU\H_]%'EC_=ZT7_AOC7
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M75PY6X23XL4TL "LBD5\@<>2<0W^$*YK.OCU@2V(*U,VC5@;;%%*E>1GB+!
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MSNE91DL0O(=N>,$ <#!XY )\^IZ7JT.N:AJ,NK=[2K2HM736)W0D!PYV[5C
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MLOUJY?&[G;[K]7A%5=MD\+U(LNH4[BQ"_-A H\DEN/I[D]-+GW3'TP?)^_\
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MV_'Q[[\1-&5>0;.TP8AT)+$/C#9)_"?8A>/?'4);N88,7W*H4Y+LXP-I!/\
MI92""#@CZX/6*HJ;*Y/UM]D7[_Q7\4V79/SWX:I(W@>1@9X^_CG/\1R,CWZ>
M5(VDJ5$@X# *V /;GGWY^G1F)&E%($0F$5YMG ;NJ*]K2.9U,7=$5J$8YJ[?
M3UHYJKX7B%S$@=VV *NYGQ\V<'@8P<#VQSG./)P=2KW9I*R5Q*TLNT0)W&CS
M'O=-P?)7:K!BWRG\^,!9R;&;/%;1:6T0*SFAC'5L.0*8U$FA880GO"KE:;H>
MWK"_8C7+Y:ONL-#4*VH5([$"S+'N9=\L3Q<CV^8 \XX]B/I[67J3TYJ7IG4F
MTK5?AQ<6&&>05;,5I$2==Z RQ':'VXW(<,#P0#QTEPH7K9@HGJHD)7[N?(L#
MI'C":)CGN4I>ESNIR(J,&QCS%>K6#8\CFHI3S+"O="M+C VH #]\<@>XX/G(
M'VZJZ-%;UV.JEBK35T9I;.H3=BM$J@DLTH5SX& H4M[ $D#H[(I2,;4+#L:^
MQD6K'O2) *=9%>1DDD=(UBTX ,CE>C.^SI>0: >TBD3RB<I+/J%N6E%5G$O<
M2")I56..PT@R#&^X\#_5N"^_4VH:;'IM?3K4>K:;>-Z"69X*,D[VM.>*=H3!
MJ$4M>(0S-M#QA7D#*PYST3D1VQ2GC2NMDP$A&+T/84"=MI$*B$:_9SNOM-8K
M>IG3U_7X;U&6*DM&=ZDR;98#LD"E7 8 GAE^4\%<'\QGST%&U>1#N:1)6=9!
M(W@8SD8X/S<?SY^I12;]*-V;M]^S6K]Z>51-U54^]5<OG;?;P@_*KC[_ .>
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MX958RE5+C#@RBXK D9$W(K/*#8Z''BA," 2:T<681A),=#9/UK-3AT18R_\
M^:6;J2:;%)7CLH\E>"6:0]MZ]II$:"O91E$,B]M9 P4!G77>EM.H:O-+6MZC
M#I4D:-/)J-N0)3CJ0QM_RJQ;HY)+DT@1EE$HC2,,NUI& ZZ,VFDV*EUMBY?J
M%G.6_:;4W%+[+]!<4RZBH9]M(R:WSJRP<F)R,<J:;*</81T1?M7/R$DJIN)
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MHFS\;KNNP^GM0CU+5JRBI7EA6*0__HHX9*RRO;M6FP*K-$;=5PK9>6XB?A+
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MS8<>"!X(P/8^,>\=B(1/$I*/A%PT?"L#XQG^!)'1-[NC?Q[?@OW*GE/[4_\
M#SPT';DD'QGW_P Y]S_#H-_E+#V9C@?3&?K[_3^/'22Y=W*J)LB^=OVIOP*3
MDD_4D]"-R<_E_0=8\<Z;T.(7_$?W?T'2Z''!X/Y?[CI<\_3W_P#/7LU\H_\
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M;.$8F#:B@ @,TY?$9X'RA"2&W>,CJN&INN?,'*Q2CI<ER;![5MA]BXII9)F
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MM>^[E3W_ "^[QLO]^R\-QA/OQ_,YZZ#P?O\ W'7LW\H_]%'EC_=ZT7_AOC7
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M/<;!K#;:TUMYE=?=SDD9!3919U=:/Y/*CN"E6^K675V==Z6VB2'#EHKN;B5
M)SRI'&,#(XZ:W!QC;C@@$G]_/7K><I']%/ED_=[T7_AQC?$)\G\S_7HT>!^0
M_IU6'XO=/?Y!\-?FXI<6')-?66FH8U>.(,A)"O?E6.J96-$PCT1L9#.(1&*@
M1->5RM:Q7(9I\U:O;CGN2PP5H5FEEDG8)$!'!(ZJ['CYW"Q@?ZF8* 2<'HW9
M&T,QR,!1EN""<#Z@<]>8Q'U?R+'+>_9C[H\7)I$:NM0:C5S::LRVJ@S($6@S
M"%),9)]L2UMS&9#OFQ;?U!7"M9L-CJBZL.]YY-Z=J6*=*:S*TM-7M57TRW%)
M+0NS+"+VE3")=D92$(/ANXC*H,(!,BKU<UYS8O)7[AC,^R,VF8EHH%.9=S/N
M);"J@R?!(P!QU.5/?08?+"(F T=1/R>?F=;&@T-IW\GR>V9$IY='&*/&70'4
M\J+"LIMF<LT# S26ES( P,](Y5=CIZ,LGZ136U5YA!'1FDL6(62O3[\[PS1Q
MB2,B<2R0A0JRH8A!A0Z+@GWM*.IP?HZM:CIXIQZ%?9)-*VV(6U=+=(K3U!;,
M=DBS%38F0S+1/:$G(!7)%:]8K^CI*+2>JA?)[^_A882;D\\=I+DI"RV9F=G;
M2X#:QS8GHXPJIM?#F5QH:0S7#K&TKI4H'IB)ZC^CTW(->U;69GFBIU]9HRZ9
M3L50D<E33Z%2,J7C+02E[?Q2PO&W_P"F2#N*'R6\%]06FD45',$\FZ*5K*MF
M15[:HJ1X*CMD 9&T\@<XXZK?2P9%O8# %'_IR/ZV!<T;B]2JBB#NPC6D,CE"
M)SAN8U[V[HJ=2<:J]>:!97E"R,\CNSX';#L^9"., 8+8XP!]NJ6-&<J(P<*#
M@<Y*@8!/OG'/OT_].+6JQ*RN<@DRJYEK2TL[[/QK.M6T]1D4EXHT0D6.]%BA
M?%$IY39LIBC&\0T1G65BI4ZG\9;CJUJ_<B6:Q"[3Q,56*!,2M\Q!'[; 7!_$
M/!]QZ!Z"U33?3]C6M<MST#J%/0[]?T_!=I_K#N:W?18*T_:/$*5%$KM:D!CB
M9DR 3U'LR<Z8XACJ4L@ZNZSD=U$<K7^_E$1&,%TC$QOTA8NS41/>ZV3-*9))
M.8X8P8W<Y$>5[8VL1\H.W8!PN% X'6%ELR6"\CL\AF=LNWS.[$E<%CY(!*X\
M#R/;H-E7,.*K&29T6!-=U=M)!PQI;HRMZ7O$CT:?T[E1&/5KN@GZJHY';2QN
M%$BQ@<LO?&,C (=<X!^4'YO&#U*CZE5@1A+<AK69))$7NRI!8F0[9) N[MR.
MK *7VDJ1C.1TYI6IF=3LI%G-SEEOD.9MDU4UF39)/E9!>,D4J@=4&]?;$EG<
MZO6-&],A7N:%D4(V-[3.ETDB&Y(&=NWOD!+HH7)P5+?(%'@G<2 3@_GU!8N2
M6:^I5[A%H:I7:M<-D]Z8Q$$; \V]DW E.XI$B!LH00.K79I\0[F@S[-HNH.:
MYS3:BYY78_9XSC%_ENG6#3VX,&ZL1R[:QPRE;3KCL"_O.RP<W(CTQ;A!O5D6
M0 HA2$EC2&O-=A,,-EG$:U+7G80Q9I0%X)<L0-Q/./ICH#0ZVF^DZEL^GZXJ
M3ZI6(U.:>,23URLQE*U+LMFPXW*G<:8I [,6C5/+F"=3M(LQTO.*=JXQU=DV
M7ULF]@47J0ID 3'E5IF6F15IA DPJBSB3I<BIL8P3PKF1%.R#(<*-((RPU_1
MM1TG]6&Q-1D;4XQ<EBK64FGJQ%'$<<T299&9DY4C"E7&<J5Z7I_U/I'J"UK5
MNVFKR-\'!/3MM :U;4)K\T<D4W<=0C(M433E%"NIFJDJ$8$QC24UK<!L#5X
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M3QM//U'GCSD=-*2  ]ML9P0005&,Y/\ _+Y]\]3[R\Z>Z.9MJKBN.<P>K_\
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MJOR]4+D8MCC]*H66T$^QLLS@9&8N9L6(^+"QJE.CX>/CBRW3&_,#3Y8)9YQ
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ME1&IPFP'C/5S^F+UOZ;]1WZ/JS1ZDVDQP:-!7MUY:RUM*K-0C6O0J:16#_\
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M>C?%BVLY4Q&55NKKZP@#/-QL!(UIB%1;%/'M8$V&^,:/:UTHUXVL!F#V4?\
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MIGTDAJZ%9B77?5^J59(KFN^E]-J)B?3*QHU]DY5"\TP2Y:O&58HS5,L([M[
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M,\1Y&&S[9]N>KBI69$%DSR5*IE^%^* =1N.#* %QW6A4[VA_U  ?A/6R7"D
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M59\L>O,PMC-F1Y18,]EO11GQA$CMKCE 22L!//D#///_ ,CIP ]U8_D<?_\
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M[@%C"EK.,1*#L*#L ';D8?)^H/)..FK%* IR^X+7)S(Q&\2$SD_-@Y3 ^A'
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%A=+K_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>39
<FILENAME>g723949g70u81.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g70u81.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[4$L4&AO=&]S:&]P(#,N,  X0DE-! 0
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M '(
M                                 0         !     @   !T!  #_
M____                     $1)3E4B -@)- SH$] C)0P
M                        4@    $          P ! !8    "  (    "
M  (  @ "  (  @ "  (  @ "  (            -       !
M                                                         0
M               "                       /
M
M
M
M
M
M
M
M                                                     0
M                                                  #8"0  4TU4
M2@     0 ,@)2 !0 "  50!N &D =@!E '( <P!A &P ( !0 '( :0!N '0
M:0!N &< ( !0 $, 3  @ #8 (  H '8 -@ N #, +@ P "D   !);G!U=$)I
M;@!!=71O %)%4T1,3 !5;FER97-$3$P 2%!$;V-525-520!4<G5E $534%))
M5%-U<'!O<G1E9 !4<G5E $9A<W1297, .&)P< !297-O;'5T:6]N #8P,&1P
M:0!0<FEN=%%U86QI='E'<F]U< !044=R;W5P7S$X $1R>51I;64 , !3871U
M<F%T:6]N #  0FQA8VM);FM3<')E860 9&5F875L= !(4$-O;&]R4VUA<G0
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M86Q'<F%Y<P!.;T-M9 !(4$-O;&]R4VUA<G1?1W)A<&AI8W-?2&%L9G1O;F4
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M $9A;'-E %1E>'1!<T)L86-K $9A;'-E $%L=&5R;F%T94QE='1E<DAE860
M1F%L<V4 2%!3;6%R=$AU8@!);F5T7U-)1%\R-C-?0DE$7S4Q-%](241?,C8U
M $]U='!U=$)I;@!!=71O %-(3W5T<'5T0FEN $%U=&\ 4TA0=6YC:&EN9P!.
M;VYE %-(1F]L9&EN9P!.;VYE $A01&]C4')O<%)E<V]U<F-E1&%T80!H<&-H
M;#$Y,"YC86( 2%!,<&E396QE8W1I;VX 3F]N90!*4$5'16YA8FQE $%U=&\
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M2D]"04-#5%]*3T)!0TY47T=23U503D%-10!(4$)O<FY/;D1A=&4 2%!"3T0
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M<G-T2&%L9E)O=&%T90!44E5% %!A<&5R4VEZ941E9F%U;'1&;W),;V-A;&4
M175R;W!E86X
M
M
M
M
M
M
M                                                  #H$P  2550
M2"0  0!XG.W9RTKC4!@'\']:$$L'1G I0A<J,QL9H5X[*+&M%YQ%K((+=>$E
MV,IH2ENA2UV(^ I]A)F7Z-('F*VXF(7BSMW,9L;OE,2&V)@NU&K[_X63<YIS
M2:#T.R>G-[U *FTL#$"#(R2I_@D(N\J:'+NU<^BAG<J_P41)#A,%^(F@$HUW
M _]=5/\NWQ[-TSQY4+L8UG$(2Y*)S6>X/[TO_/Z).E=<DF&7G3FA6JT^Y/OA
M!IUL$;O/[J.:XYF@^WKGIU# A*7FR PR&,676AK'2- MJ.U\A8XC65U9.,"6
MY#GL8+K5#T5M0$/CM;,W+*DX]%'R?KO"759U3COGNKO>3:W_52(B(G(T6@H[
M\TA!#JZ!B8A:3^U]J'BM2\G"-DS$8" K9?666JR5\G(MB16,M?IAB:AC_99T
M]\&__J\$LG]1__IKU>:)>O7_I]H#R6>MDE7,6OEALVRBOK?RDLF[WQ*T_^+0
M$(W!'B.)*6Q(]"Y(S-Z3\Q8.)'+/(8?O$M>+4E>/\AM-1OP8/LDY+OFLC%/"
MY]H=O*V'990R3/_'I%?%MZS.ILMOERC2Z@>@-V+1T).IS%IJ95Y?3>K&8E_B
MY]Q9_"9]\NMJHG<YL?2H0ZYR>3KT)WT^>#OYHZ=\81BS"WHZ8S08FHB(B(B(
MB(BH*?> HGBN
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M      $  0                                           #A"24T$
M.@     !&P   !     !       +<')I;G1/=71P=70    %     %!S=%-B
M;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /<')I;G13:7AT
M965N0FET8F]O;      +<')I;G1E<DYA;65415A4    ' !< %P ,0 W #(
M+@ Q #D +@ S #( +@ Q #  ,0!< $P 2P!# $T 5P!4 %  4@!. #, .
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P   S$    ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<   ([    "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 \     !  (#P     $  CA"24T$)@
M#@  /UJJJT"'QQP_@   .$))300-       $    >#A"24T$&0      !
M !XX0DE- _,       D           $ .$))32<0       *  $
M CA"24T#]0      2  O9F8  0!L9F8 !@       0 O9F8  0"AF9H !@
M     0 R     0!:    !@       0 U     0 M    !@       3A"24T#
M^       <   _____________________________P/H     /__________
M__________________\#Z     #_____________________________ ^@
M    _____________________________P/H   X0DE-! @      !     !
M   "0    D      .$))300>       $     #A"24T$&@     #-0    8
M            !'0   FU          $                          0
M           )M0  !'0                      0
M       0     0       &YU;&P    "    !F)O=6YD<T]B:F,    !
M    4F-T,0    0     5&]P(&QO;F<          $QE9G1L;VYG
M  !"=&]M;&]N9P  !'0     4F=H=&QO;F<   FU    !G-L:6-E<U9L3',
M   !3V)J8P    $       5S;&EC90   !(    '<VQI8V5)1&QO;F<
M    !V=R;W5P241L;VYG          9O<FEG:6YE;G5M    #$53;&EC94]R
M:6=I;@    UA=71O1V5N97)A=&5D     %1Y<&5E;G5M    "D53;&EC951Y
M<&4     26UG(     9B;W5N9'-/8FIC     0       %)C=#$    $
M %1O<"!L;VYG          !,969T;&]N9P          0G1O;6QO;F<   1T
M     %)G:'1L;VYG   )M0    -U<FQ415A4     0       &YU;&Q415A4
M     0       $US9V5415A4     0      !F%L=%1A9U1%6%0    !
M   .8V5L;%1E>'1)<TA434QB;V]L 0    AC96QL5&5X=%1%6%0    !
M   ):&]R>D%L:6=N96YU;0    ]%4VQI8V5(;W)Z06QI9VX    '9&5F875L
M=     EV97)T06QI9VYE;G5M    #T53;&EC959E<G1!;&EG;@    =D969A
M=6QT    "V)G0V]L;W)4>7!E96YU;0   !%%4VQI8V5"1T-O;&]R5'EP90
M  !.;VYE    "71O<$]U='-E=&QO;F<         "FQE9G1/=71S971L;VYG
M          QB;W1T;VU/=71S971L;VYG          MR:6=H=$]U='-E=&QO
M;F<      #A"24T$*       #     (_\        #A"24T$%       !
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M3=^R8OM_1,]AEN@T@^H/_!/TG]=5L[)Z;C/#,JII<]I )8""V"'-G]WZ%?\
MUZG_ $B2G.8^S^CUY][W&U@#BS5H(?3L:7/]_P"EVNL>_P!1B-#VUV?Y0M;Z
MC;6UO<PQ7Z#_ -.]VX^Y^UGIL_D?I/\ 3>I9JZET9UU==+ZW6W$-;M&I,.<P
M<?R4?$OQ,VIUM+06[G,=N;$G\[_/W)*<CU6,>:SU>P&3M#V/G]W8-6[]GIO]
MO^D_\$(T'[+=>SJ;W44^VTM:=PAK7!FYS_:_W^]ZV!C8XVQ4P;=&^T:?U4[:
M*6 AM;6AQEP  D^:5J<)M]+;'"WJM@EKF;'M<PL+VAC&N]S?TS/;;_I/9_@_
MTR<OK;62.KVL88J87,.CP&.>=SO>_P#GO\)_Z*6V<;&))-3)<9)VC4S,_P#1
M4;QBTTOMM8WTV^YYV@@"6_I'?U-N_P#L)6IS,'J%%#B<G/\ 7W-&UFUP(=)]
M1S6N;ZGNW5-K_M_\77>=U?IS:VV&\;';@T@$R6G8[Z(0&=5Z(XASBRNS0 /9
M#]?S>-WM?]+_ (NW_1IW]1Z17C5Y1#10ZM]S'A@B)8VQK3_I+'O9[/\ "I*3
MNZKT]MCZG7 /K,.$'F0S;Q[G[G-]B+C95&57ZM#MS>#V(,!VUP/T7>Y.[&QG
MDN=4QQ,DDM!F1M/_ $5*NJNII;6T,!)<0/$\H*?_T,;J'^,+ZZ5=0RJ:NIEM
M=5]M;&^ACF&L>]C!+J-WT6JO_P".-]>/_+4_]L8__O.L;JO_ "KG?^&K_P#S
M[8JS*WV.#& N<9,#P')U^BDIW1]?/K<#(SV ZP?LN+W^E_VF_.2_Y^?6\ C[
M>V# (^RXNL1'_:;^2LBK"ON_FAZA_D!SA\WM;L:G?T_,KGU*G, U+BUX;'&[
M=LV[4E.LSZ^_7&NYU[.H[;7@-<X48^H''^ 1?_'&^O'_ ):G_MC'_P#>=<_Z
M+CHQS7G]T'4_ .#=RM-Q,>RFW+K;D'"H(9;:0QH#W;0RMKGN;ZMN]W\Q7^E]
M+].@2!NI]&_Q9_6KZP];ZKF8_5<PY556.VRMIKJKAQ?LF:*JG?169]>?KM]:
MNE_6K-Z?T_/-&)2*377Z-+XWU,L?[[J;+/IG]]2_Q0#&'6L[T76.=]D;N%C6
M@?SGYNQSE@_XRO\ Q<=2_JX__GFM%3'_ ,<?Z\?^6I_]A\?_ -YU%_\ C"^N
MCW!S^I!SF_1)QL8D:M?I^K_OUUN_L+GVL<Z2(#1RXZ *_3T+J-X::Z+7;_H'
M8&[OZC;7UV/_ ++4E-]OU]^M[2"W/8"(B,7%$0=S?^TWYKE*O_&']=*QMKZD
M&-)DAN/C 2>^F.J-_P!6>MXS2_(P[ZV-B7&HGD;OS7*E9BNI>&V[J^[A8PL=
MM_.>UK_I[4E.[_XX_P!>/_+4_P#L/C_^\Z[SZO?63K>9_B]ZGUC)RO4ZAC-R
MC3?LK;M])FZK]&RMM+MKOWJUY;D].KQ16[(M?4V\;Z6NK!L]/7;;;CBSU:?5
M]OH^KL]:O])7[%Z#]5@T?XJNMAIW-#<[:XB)'I\[?S4 0=M5/*?^./\ 7C_R
MU/\ VQC_ /O.F?\ XQ?KJ]I8_J>YCA#FG'QB"#R"/LZYSLK%&%D7O%=37/M.
MHJK:;'_VFL^A_:14[!^OWUO)DY[2?$XV+X^I_P!QO](=Z?\ \<'ZY;=G[1&V
M"-OV;&B'?3;'V;\_\]4Z?JQUV_2G"NL=J0UK)) C=[=V[\Y"LZ%U:M[V.Q;M
MU8FP>F3M_P W<DIU?_''^O'_ ):G_MC'_P#>=6>E_P",+ZYW]3PZ+NIE]5V1
M378WT,<2U]C&/;N;0'?1<N>PNGVY'K/ J^S4MW79=SBRJH'CU'-]_KO_ ,%C
M5,NR+?\  5V(_3'X;>NX3**B^L9E#:KG%S'$"U@%KJ-]K6O?]+9O>AQ"R!J1
MNI__T>&ZFUSNKYK6B2<J_P#\^V*[T7"Q[<K;>)IK8ZVU[A+&M9[GY.3_ -UZ
M?]'^D?=9Z=5=5SUH]-Z=CY'4^J9%[18&Y-S6,?\ 1#G66N]1_P#Q;/H(/6^B
M7]/Z5?8PN?6ZW'%P<"US&.]9]3?=[GU66M9[_P#BTE(K/K7EUW/_ &96*V .
M;39>W>]K!_A&XC3]AQK-K=^]E5CZ_P#2KI,&G_&#G]#=UM]E+L(CUJL)S-MG
MIL'](Q:2STV-M9OL]]GZU2__ (6E<!6VMVCCM!!W;A(,^SVEN[;]+Z5BZ[ZN
M9/U@SK,9G3\RXV68S<;TX<PV^@0VYC[(LQ+*,>J[TZ\C^<I_1_X;^<2DC,CI
M/4J6VY-8;0]H#\*6L:VX_P SZ&5M9D8M&5^8]_K_ ,Y]G]3_  JY;J&1EYAK
M]6&U4 MHQ*QLJI#C+V8],_G?X6S])?<_^?MM3UO;B=3R&9%+G-<+\8TR-PW!
MU>/NV[OZ+:VJ_P!/_@ET_2^@648S<K,K;;38-ME+Z]U;; /5:SU'?1L;7]-#
MA%\77IX>26U_B<_Y=Z@#_P!Q6_\ GQ8_^,=F_P"O/4A,#;CS\/1K71_XL*Z*
M_K5U48_\QZ$5ZSH+1^=^<WW>S^0K/7<>C)^L_5<:H WY#Z*[A+0XC[/3Z=>Z
MWV>ELWO]WL10\1T=V%A>KG9E9=7C@"IK7ACW6'5M&-[7N]:S_#Y7_:3'_3?I
M;O3I55WU@ZUNMNQ\AV,;'!SQC#:XZPQCKX?D6MW?Z>]7OK5TFKIE>)54XM8;
MLEKZGZNKL;Z'TW#\W8=E?_$V+#K=6QKB07?O02V6RUS7.<[Z'IV5M^BSU/TO
M\XDI]"NZ-]=^D=$HZQ9UI^2Y\6Y6!DS9Z;G ^P?:3=ZSZMSOM%+*J?TG_%+)
MKZO3E8V9956QF;C,]<!Q]:FFS=Z3;,)F5ZSJW76V5M_2665XMW_6;:K_ $3J
M#[\S/ZOU^BUV/GX]C,@5U6BZFG*+65YSFN]9E>+]G;Z-%K'5?H-]GIV[%Q>-
M.-FVXN._UJK!=BEP$>K4-Q:_TW;MF_T*K4" 11V4AR ]]KKG/=:^TE]CWDN>
M7'5[WN?[WN?]/>O2/JI_^2?K7]7._P#/:Q\+ZO-Q,)_[28RQF2W=O+#["T.]
M;T+W#W>@[]S\];7U4AO^*SJY)W ',<XC@@-!.G]5%3YQ73Z8#[);I.X@B!^^
MT%;F=U.KIE(Z>S# M-;7/QK7DLK+PU[79==/H?:,S8[U'T6V6,IW_K'J?T=;
MO4.C8^=/4+!ZEH=7Z9-C> ?48UU$N=]FMW;?W/\ KBX3,=D.S<I^4'')=?:;
M_4EK_4+W>IZC?I-LW_324]!T*WZS_6?JC<$]5MQL=VQV3<US:ZZFC]!CLKHI
M./7OLN>S'QZ*O\+:M+ZR9?5NB]3/3>O7_M.ICAD4YK :LAN_3U*74.8W>V-K
M\6WUJO\ B_98N6P:_4O?72ZT.%)+KVU&TTBL^ZV^JOU&MH^BSU_\#]-:?UHQ
MZ:,7"I?7D5]0HW.NMO:]K,BF\NLQLBAEUCWUOQ]GV:UFW_KGL24P^LMCLFZ@
M[V_9[,>NZBM@#6-=8/5?<::X;Z^1['WY'\[_ #G^B]*O,Z.".L]/GOEX\?\
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M_6OZN=_Y[24\Y]6_K UF,,/+8;6,9Z;=@E[6#_2-'Z1[?H;;JF^S^;N1>O\
M0*NI7?M#!RFW9>239=JUS'M=_-6.]/\ 28^4S^9S*[*_YS]*N2J?Z;VOV-LV
M_FO!+?\ HECO\QZOU]8<-2RUA\:K0[\,VK*M_P#9E)3V_P!6,; ^KM>1CV/;
MD9-S&Y-]QQW.#JZFO)P\:BZ[%NIVN=ZC,NWV66_X*GT*[;<WZQX>9]8>I4Y.
M;U!M..VLBISV%U=-9_3>@VRIOZQ:WVL^T[?T_P#P2P!UL[=OK7@'EKJ*GS/C
M^L4_]2H#J^T:7WGP#::6?=OOO;_T$E/5XU_3^BXK<8.'VFM@#JJ#O<"6R_\
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M))3Q>/\ 57ZJOV^MT38'UE[7,LN<"6AQ<SZ3/]&_TK/\+_UQ5A]2/JF2QQZ
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MV3A"24T$(0      50    $!    #P!! &0 ;P!B &4 ( !0 &@ ;P!T &\
M<P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ', : !O '  ( !#
M %, -@    $ .$))300B      %*34T *@    @ " $2  ,    !  $   $:
M  4    !    ;@$;  4    !    =@$H  ,    !  (   $Q  (    >
M?@$R  (    4    G $[  (    .    L(=I  0    !    P    .P /.'P
M   G$  \X?   "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q
M.3HQ,#HQ-2 P,SHT,SHQ,@!,875R96X@4&]R8V%R      .@ 0 #     ?__
M  "@ @ $     0  ";6@ P $     0  !'0         !@$#  ,    !  8
M  $:  4    !   !.@$;  4    !   !0@$H  ,    !  (   (!  0    !
M   !2@("  0    !              !(     0   $@    !.$))30/]
M   (          #_X0%,34T *@    @ " $2  ,    !      $:  4    !
M    ;@$;  4    !    =@$H  ,    !  (   $Q  (    >    ?@$R  (
M   4    G $[  (    .    L(=I  0    !    P    .P   /      0
M \     !061O8F4@4&AO=&]S:&]P($-3-B H5VEN9&]W<RD ,C Q.3HQ,#HQ
M-2 P,SHT,SHQ,@!,875R96X@4&]R8V%R      .@ 0 #     ?__  "@ @ $
M     0  ";6@ P $     0  !'0         !@$#  ,    !  8   $:  4
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M 0$! 0$! 0$! 0$! ?_  !$( 1("5@,!$0 "$0$#$0'_Q  ?   ! P0# 0
M            !P@)!08*"P$#! +_Q !A$   !@$# P(# @8-!P@' @\! @,$
M!08'  @1$A,A"105(C$*018:(S)16!<8&3,Y0G9XEIBWU=8D-U)987&U)5-B
M@9&7MM,F)R@X0Z'P-#9&<G<U1U1CDK'1DZ:GP>'_Q  = 0$  P$  P$!
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M^I>+IMT1P+4,452YW&BTI;+</>;38LO2F/YQ]5[).)NZC9ZW'4"H.[-%RL/
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MB!SQDC</CUA$2T6ZPGDA2G,5W=7ND8WFX1K6JJX=2[J5GX"+ATI4UJDY]@A
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MY+*>P(>1225CRF=!#Z?*@ME'4 @,C%2>@<*Q*D^C <\=87/B9MH8W1()5E#
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M% AJN.$U]DGS:)UERAN\HXRO..F5NG:&XNM;DZW^%]9%$+! H2J!FKIY$G<
M*:3T6JBR*2X"19 516;JI.$TE27QML=7VAMK!MK=#7-'Y2KKO1EW%=P(W+U%
M^8^<CQQWL_S]C;<BG8E,QV&[8I@-JY,71)UJ1A*H1TJ=K+VIO XB)"5*$AI"
M#A:R1]%7*/L4<P8F<.BD@GDVO'$7C2]+Y\3X:&((YS;SX\C$<"W)8D$MRM$F
MN35\SE3!D3+?>,R#%M VXE'5J2E4$ 6&! '(HFK$O39Y8=S6,<68"P-?MGMX
MKK.D4VHT*S9(-EO \K 1Q86,0CW<_P#!(7($C97;$#HBH5HQCW4@8A@ J!C
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M22)9!5D"QV3=P=,X%QPL@7,KMLWXMJD@D;@Z/7A!/(4@<5<TS![PLJE]F2V
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M),_.5$+PE23U44A"0+*FBQ!]KH^[/>S=C[VK[K=^TZ773;NK]W=N\B+XG/\
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M\TA!1D7")0#Z1DIJ:L<=$LV"C(7#Q-Z^;,E)^[OO=257NP"[L:10U5S5DFP
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MD+BV@9^PR,E"1\VFZ8Q:A&+=DV191<>U;2^;*!JB&_Z>=1CX'[,%L@.SCPV
M :Z]3R29FF'&?NMK?>86.0$FLAVXSXQ?BHDU=@>7%1%7Y)7]CS:I5KI.8RB-
MN<%>MZ]1Z]PR5RFL'-[73<_V*O8EK6058>SUY( A: PG(_&A+E,+5U)2/>-D
MFJTJWACMM/W\Y4.<Q73$=U0R[6Q*V0K8/5J+;1N^=7,S>W"&*C"&U()R;CCM
M,I7&'IAP$!V6=OE5[:4.HI4HE4VY,\]7RNW79>IF3<:F$HYB[Y6L"1\B6+KH
M88K#M]D"6DG,YB.)F?V4DL=S5FFI"G.'7X/QL<Z6;1D2!:'?NS'&K+J!CQ<
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MNBN(1C5WJR"Q6[4X&8HFH="%R5I=Y6N,I5^\VD< W^(KT8FC)1 [8 P+8_\
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M->**L K$4&O:?6C1KZ&>3# DJ""5K</,7R+^HZ1KWJ' (['MT8  B(X<MP
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M(@'/ #^D Y'CG](_ITB<=!/ITEXZ>CCI#\S_ $?I^;_T?I_LTB %*'/!2AR
M /  '( '  /Z0 / <_0/&D0Z2AT\%+\H<%\!\H> X+^@.  . _0&D3J7:M72
M"C5RV0<-E0$JK9=%-9!4!-U""B*A3)G 3?,(&*(";S]=(@JU;+MS-%VR"S0Z
M8)':JHIJ-SI   "9D3E%,R8   !!*)0  #CQI?GYQ7EY3M*4I0X*4I0_04
M/IQ] _V  ?[@TB)AC#$54Q,SLS.MC(._PJR'D3)3]W-*,G;UM.9-M#RVV-E'
MN&K!B+>%)*/3DCV9P672:I()NG;U9,5S7=R]77A54%>B#:+^=2J($NO-F<WZ
MNVX_E?2*3[-I[A1W[5O[I5$K=5SV$O<*H$,)B(J+=/<.B0PB8J9C"0IA$0*
MB.J2T[P*4.>"@'5Y-P !SXX\_I\  >?N#C2)YT&;-L@#9LT;-VQ2F(#=!!))
M "',8YR DF4J8%.8YS&*!>#&,81 1,(BB<HM&C9%-NW:MV[=(@I)((HII(I)
MB/(III)E*0A!'R)"E HCYXTB=X@!@X$ $!^H"'(#_P!0Z1.ART:O4NR\;-W:
M/613M.44UTNXF8#IJ=M4IR]:9@ Q#<=13 !BB ASI$'+1H]2[+QJW=H@<B@)
M.44UTNXF8#)J=M4IR]:9@ Q#<=13  E$!TNND1-7&(:H[R_^S4Z-(N+3^QJ&
M+!CEU62U<&O%MJ5S([%@HP,[&93F$4P3=_$?;$;% H,N^!7 7WMW?=\;=^_Y
MWMV]?2I78-^_F]NVO*KW7TZW\XI;EJV>(F;NVZ#I PD,9%RBFNB8R9RJ)F,F
MJ4Q!$BA2G((EY*<I3%X$ '5):=W <@/ <AR #P'( /'( /W<\!SQ]> TB=#A
MHU=H*-739NY;+?OS=PBFL@K\P'_*)*%,F?YP WS%'Y@ WU !TB"[1JY;F9N6
MS=PT.0J9VJZ*:K<Z91 2D,@H4R1B%$I1*42B "4. \!I$[RE*0I2E*!2E "E
M*4  I2@' %* <    <  > #P&D1/ZQC6NT^UY"MD$>0:J9-DX6P6:#%9N:O?
MA1$1", O:(YD#0KAG-3\-'P+&P*>]49/OP=BGJ3)M)*2KV3L7+*JG]P$ ^=$
MW1^0))'I9\JJH4*6(_?()'E8 6_6R  >:X' -VH.JRTX I0#I   OTZ0  #C
M]' >-(B?_L:5T^3T\M.CR#VSLJ2>@P*#I= T/6(-[,EG;$K LDVJ2K:3MCUG
M7T[&^<.G1G32J5YJT38IMGGOK;SLV< ;MQ]2:H7ST'-<>9E=@W[^2=NT>@%V
M:XZGB^?(2^W#9NZ2.@Z;HN452&341<))K)*)FXZDSIJ%,0Y#<!U%, E'@.0\
M!JLM$?R[A2%S02I1EIL]P8T^NS\?8)RA0+N$9U;(RD-+0\]!Q5\*\@9":>P4
M5,PC-\6*@YF ;RA3NF$]\5C%Q9%T3(<>XJJ[B" QO<E@@E>0+()%D-75:(N4
M= ] E@H-E15/1! ;@F@0#0(OH;!(BS:SEYP!2E#I* %*'T    #_ *@\:1.L
M4$1X 44A H<% 4R#P'(CP'CP'(B/ ?>(Z1/LA")AP0A2 (\B!"@4!']/  'G
M2)T-F;-D50C-HV:$55.NJ1L@D@51=3@5%E"I%(!U5! .M0P"<W =0CI=]8JN
MD[3HHJI'0423404(9-1$Y"G243. @<ATS )#$. B!BF 2F 1 0$!TB?+=NW:
M(IMFJ"+9NB4")(-TB(HI$#Z%323*4A"ASX*4H!_LTB=H  <\  <B(CP !R(_
M41X^HC]X_4=(@( 8! P (#X$!#D!_P!X#X'2(< (@(@ B'/ \!R'/UX'ZASP
M'/'UXTB' <]7 =7''5P'/'//'/UXY\\?3G2)UKH(.45&[E%)P@L04UD%TR*H
MJIF#@Q%$U ,0Y#!X$IBB A]0TB?1$DTRID(F0A$B@1(I"%*5,@ !0(F4  "%
M H 4"E      #@ TB=2[1JZ3%%RV;N$14(J*2Z*:J8JIJ%535$BA3%%1-4I5
M"'XZBJ%*<H@8 '2(>T:^Z%[[9O[T4?;B[[*?NA;@;K[ N.GN]GK^?M=?1U?-
MT\^=(G=T$X$.DO CU"'2' FYYY$..!'GSR/GGS]=(G3[-I[@[OVK?W:B(-E'
M782]PHW*;K*@=;I[AD0.(F!(QA(!AZ@+SYTB=X%* B(% !'CD0  $> X#D0^
MO > Y^@> TB @!@$I@ P#X$! ! 0_0(#X'2)SI$\R;-HDHX62:MDUG9TU'2J
M:"1%'*B10*D=P<I0,L=,H 5,R@F,0H !1 -(G)6C4BZKDC9N1RX[7?<%13*N
MMV"B1'NJ@4%%.R0QBI=9C=LIA*3@!$-(@#1J#HST&S<'ID0;F=@BF#HS<INL
M$#..GNBB!_G!(3] &^8"\^=(G=TEX$.DO CU"' <";GJY$/O'J\\_7GS]=(G
M45LV(X4=E;H%=+)D15<E23!PJDD)C))*+ 7N'33$YQ(0QA*03&$H )AY1.X
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M,/)A%-C(V/AHV/AXEFWCXN*8M(V-CVB146K&/8H)M6;-LB0 (DW;-TDT44B
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MIB'=+&O+&!VV1$,\2CI92/;-K01K-+2+*0&,(J@277>-E$$')SMR\>1P<>D
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MS[&47=2T09F*<LZB(&6=+R$#77L/#N#)>R*V0RU)4Y 059MB#(Z45?)7B8$
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M#]H/$FX%L;CAEKKLZ%#TVFO*ITZ<,@;"RT<9\+!2%=&LJUU1?J'\[%^<N#U
M*_/VG:=DF#K$',6.;=S&*%&D- 1CZ9E72;',>/Y!Z=M'1R#EXN1FP:NGSHR2
M)P;LVSARL)$45#EC2D+G0D@"GY)H<XW Y/SXDZD$X6 !)W8^ "3QD0G@<\#F
M4;<+MZW!9'S=C?+6*\R8\J,;C*JRS"MT[(F,)6_QD;>+"X?-9S(3 (R[5-()
M]:J*M:K&+/TGYH6.6L'PTS=2P/3FG%EQ)C?&^-F+L"S*X0E15)RC&MWB-$6:
MOI(RXLKY$=,BJ$!I70N QNW'B7G;X1UH$UU,M;TRJ;F2D;8X6)RZ[:HF&RWM
M>L5E2C3%)L599*Y$N2\H%B3F9)VXDQGY-92PPC@K&+(V@I!BW K\H%?KM6<;
M92<8/1;.X,#X%K:0/(<'D\WTZ"-*N1<0&0\VU#:5(\378)YL\@\>$CKU,AFN
M:=,-(AI$-(AI$-(AI$P^O5M^TB;A?3MWT91VHT#;SAF_U>A0>-I5C:+A+W=I
M//E;MCZN7%XDZ0A91K'D39.YI9HU%%$IC-T4S*B943"*)&O^.1;N/U1]N7](
M,F?WYI$/QR+=Q^J/MR_I!DS^_-(A^.1;N/U1]N7](,F?WYI$/QR+=Q^J/MR_
MI!DS^_-(A^.1;N/U1]N7](,F?WYI$/QR+=Q^J/MR_I!DS^_-(A^.1;N/U1]N
M7](,F?WYI$/QR+=Q^J/MR_I!DS^_-(A^.1;N/U1]N7](,F?WYI$/QR+=Q^J/
MMR_I!DS^_-(A^.1;N/U1]N7](,F?WYI$/QR+=Q^J/MR_I!DS^_-(A^.1;N/U
M1]N7](,F?WYI$/QR+=Q^J/MR_I!DS^_-(A^.1;N/U1]N7](,F?WYI$9(;[1/
MD<\XJNIM=I:N/5[LID57 JF;<VFP2>X*SPVM22/C_P"/]D[$UJ$;(-:/(&JH
MRX]\8/M?D==/WK+71-^W9WNP=YMK;6[UV\75UYSG^[8[ZOMW;^[WMW>Z]U[?
M/GFCX;YJ/;_'(MW'ZH^W+^D&3/[\US3HA^.1;N/U1]N7](,F?WYI$/QR+=Q^
MJ/MR_I!DS^_-(A^.1;N/U1]N7](,F?WYI$/QR+=Q^J/MR_I!DS^_-(A^.1;N
M/U1]N7](,F?WYI$/QR+=Q^J/MR_I!DS^_-(DZ'H7>N-FCU7<N9SQUE#"^+\7
MQ^*<<P%UBY"A25K?/)1Y+V8()9F_)89!XB1LDB/?3,W*145?!C"3QI$R7=(A
MI$PWO4Q^TYYMV([XL^;3:IM<Q7?H'#TO48V.M]AN]MBI>9+9,<T^[K*O8Z-8
M*LVYFKJS+,4RH*B"B#5)4P@HH< 1&&?CE.YC]3/!?]/;_P#^3I$/QRG<Q^IG
M@O\ I[?_ /R=(A^.4[F/U,\%_P!/;_\ ^3I$/QRG<Q^IG@O^GM__ /)TB'XY
M3N8_4SP7_3V__P#DZ1#\<IW,?J9X+_I[?_\ R=(A^.4[F/U,\%_T]O\ _P"3
MI$/QRG<Q^IG@O^GM_P#_ "=(A^.4[F/U,\%_T]O_ /Y.D3T?CEFXW]2O"?\
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M6^R5Z8OD90MB?O2)IL251J=H+0$S&,Z< MU 5/I1,/W[3LF)O61W&CT*&_\
M0_ /DH<AQ^P;0_T%,(_0WT\>//&D2  43?Q4E1Y #%Y#Z@/  /'2'U$Z7T\"
M!O\ :&D0[1OKVU>GCK$>/XG F ?S0#\PAQY\@/'(> $-(G/9'P I+ /W^!_3
MTC]2 '@X&+Y$ \<<\@.D0[)O'*2WW?Q1^_CCC@H_<HD/GCGD0#R)=(AV1^HI
MJ](>>?\ 8)3'#^)]Y"F'R ?3GP7D=(G'8/\ >DKX\#XXX'@0#P)0'D3E-X'S
MQP'U^J)R*)N/WI;Z\#X'\[P !Y('U%1/_;Y^GDHBB?/:-QR*:OC[^/'T$_\
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M\>D. Z?],! .1\_0/(:1.>P;[TU>/'GC_2_-YX*;CP=(1^_@W( /)=(G HF
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MI1#@ 'D43>!_YT.> ^<0_-^O: X ;ZAR!@\@ "B $X^7L'\#TF_*@'SA\O\
MH\?G ;QS]_U\<BB';_0@8 \<?E0\#P'W\??W4#?]7U^8>E$!*'@>R;I#R'Y8
M/H'S#P/'^@0WT#_;YXX%$.CZAV#\_FB/=#\XOR&$?E_T@-X'[AXYX#D40Z X
MX! WG_\ ; (<#^GY>/JHC^C\W@?SAZ40X+X'L'Z0 3?OWW?G>!Z?] IP^_GG
MD Y\"B'0//[R;J^G[Z'_ .(/ =/WGZN/T!X'D ZA1#M\_1 __P#5 ? \ 7GY
M?N%1+_L_Z7RHATAQSV#=(<&-^6#@0\G#Z%_T"GX^H_?QR' HAT?Q10-U?3]^
M#]/0 ?F^?R@#]_\ L^@<Z1 "\>00/^D/RP?0?)/XOD ZTN!^@B'GZ_*B'2'U
M%$_'U-^6^H?G_7I_YLIR_?QSSQR' HAT?=V3^/'E4!#J'Y0'\WC\\!$0^_GC
MG[](G/1R(?D#B/W?E>1$1 !+QR7[BJ)?[^.? "(%1..D"^>P8..?_C?0 #J-
M_%Y_>RG#G_;S]P *)F,_8W0 NZG>"7H$AOVOU2YY/U?FY&:%-X /],H\>? >
M/(<#I$V#ND0TB:F7[1%_#+[W?Y58L_L"Q1I$A9TB&D0TB&D0TB&D0TB&D0TB
M&D0TB&D0TB&D0TB&D0TB&D0TB&D0TB2:^C'_  K.P/\ G-XT_P",IZ1-P7I$
MCK]7;^"W]0C^9_G[^S>P:1-.GI$-(AI$-(AI$-(AI$-(AI$-(AI$-(AI$-(A
MI$-(AI$-(AI$-(AI$-(F;-]C#_SF>H%_(7;E_P ?S+I$BA^TZ@'[LCN-Y*F(
M_@?@+@3J 4>!P91  .!5(''(<B(AR'C\X! -(D /!1'][1\\C^_% "]7/''*
MW ]/=3'YO("F8! 2D4TB'R\<]I$? &X[I0\<]?'A;GGI(8HA^=\X!QUB32)S
MP'' D0$? C^6('/DI>.>^'U%,PB(<\ 8IOH8H@B< 4OC\FA_O%<OWCR B K>
M..X0! >0_)" AX5'2(<% 1-VT1#Z]/> .0_?.! %NH."D,3QY$Q@#\\2#I$.
MD/IVT.0Y >%R^1$!* ^%N/ @)_ \>0Y'H$O")R8"B/YB'D>D [Q ^HB("(]\
M>GCND^\?WLP&'@BO*(?+SSVT>.>>.Z7_ /'Z?"O4(=)1)^GDW'/<Z!TB<  ?
M3H0Y_-Y!8@_,'@3@(K '')1,'D"^0X^0VD0 I?N30\^ Y<%\?[?*W'GNICY'
M@.T8!\%5TB'R^![:/CSQW@'CCYAX %N3")2&* ?7DP  ]8ETB'2 CQT(!R E
MY!<HAU!\HF'\MQY, F > *//RAT=(Z1.>"B40Z$0Y#Q^6*(AR(\ '*_W=XGD
M>! $S"/YJP"B<<%XY[2/WFX[X#X_.X'E7GGI*)./!OG\?E.CA$.D.0#H0^G'
M/>)YX^01'A7CR8!.' <#X']Z'C2)R)2C_P##1Y'SY7*4  W/C]_-]!5(/GS\
M@@(?*H&D3@0* "/;1^X> 6 >2_G\>%N0X*02^!ZA$P!T]9BZ1 2A].A 1
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M)RN3?W;%2%;NP#DIB-M8U8,[72*=S$"65<://4>;DZQ981:%L,6NBFZBWI5
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M='  8>2J$-R!#]L?S1'CYO\ 2X\>=2<;"^G%]+/1BOD/4?ISTB=?84 1 0
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M\!T_FGX$! 2]?E,.1X+U\^#<CSQU#TZ1/M-)9PHDBBFBJJJ?LIII)',HH<X
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MDPDXX'2)YE\.9!!$SEE$14V@F1-<QJW-P,^J5)4YRD,9E%2#I^ <G#E,S0%
M)VC]'1P842P)*)E(=X9A+1RT6\2Z#J-I)@Y9KEZCE 0,DX0(KTE$./S.!)U
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M +:['[-U&B[;[7U+:JWSZGM?(=)ER:S*[ZS4]QNUKOD"M.34:@9]M+MVLY'
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M@(Z1+8=42D@=4J,[:F9^Z!6[=Q!0TB8S< (*CEPJUL+,R(\=9DVZ;58YP H
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M&,LD0.M>3K+0I"F9F0*!U9.&,HJFF03.XCH9E/'L 4GHK&PQ%+:A44OD9V)
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M]+Y]/?Z'GI&@S.R; E85E6DYCN-AG;507("Y%XDFW=^X4<LCQ@+ "7P\#*=
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M3'P3 N5;6J]A9JZ>U8"8%&?Q>*:Q=?AZ[%N.M!,ZS]^Z57*"BB:0D6.=$5C
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MRC,I/2)"JD]/RX^7OTB3Y7]=O <A>H&/VY[(Y&1JF+XUK6*2OD7/EU2EC1$
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MLXY^R-*,JXB>V-?@;+VIJAE.),N@Q'2Y4^O:WMSLCX?THTWPXF'+GU#'O-0
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M8DE)F'LRRCRK/XMS&R,C&C&EA9EDX%G)1Z[UT=F[DF:ON%/5?B_X(^"_M?\
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MA%9T!E *97J,(&2/X?/WZ2)??AL[B,7,VN5L=M7K"DS$LG&S57[9RA .%DS
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M\,S;BSXYR@[KT]4+$!$2 _0=5JO-)CJ JSIN)PEV+]-R[*X(15PFJY54 5.
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M3;D-X0('9(8 YTB9&GV02-2A]X^]6.1*H"+?!-5]J93J 3,5<C,UF)^DP 8
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M2P?0[0]7DXOX<K'*,'8OH.*1(1'#URZ2:)+J=PC% 6K4!*0HI-Q<+NA3 2E
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MR B '$#B/ E*(@*@!^<;C\T!#G[M(G  8Y!*!1#I$."<"(B<1(0PAP'YPB
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MA+PX*JCQ$=H02*B6JR^$>SEOB!9 7XM$/@8M#-RM"O??-O<C* L JG:_#?>
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MZ@043.')#(EZ9RR/-9-M%9EK!+-I^2K6*\48W^--BG*5['8VH$#2H-JH*B*
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MH-BIE2*=0KR47,DS$B+Z8F%73Q=Y^7=)]3MNV[Q#(MB(OW=21,KAZ;VZ3>3
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M[7(?(&0I8%0>5VO2SH\BLLY,LM;KJ@XAH5!LHD[ $7+=_*K2X]Q9906\.]
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M-F@0B+5!)(H%TB6II$S8OL8O^='?[_(';S_XBRYI$BB^T[\E]9'<:</K^!^
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M.HLFNG5<@SJM,MC!PX*9 S:0BY,"-E':XB9$S^#5;*@DHFHBL;E%;2))_?\
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M:: F.8$$6&-8JJMDTB@<4P ""84BID.8P))]*(PZ[Y/R=D^36G,C9 O-_F'
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MEG90BB9^X<-F6XSE(Q5 %-,W75P$1/Y4$Z1A*4.2]1Q'@43L1]/F9,N KO\
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M\\"'' B!A$.-(@.TW=5R!OVM6X3@W!S@&%\C@//(^"D"ME WWCX "E 1#D>
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M@(B &4CFYC 7D2$ZOE1*M^Y373D?_9<]6\0!-,0$?3YERB97I_*E$H7LX$3
MWA,P&.82^3$*(\ CW[XGT/I2W(2%$-KWJX H \G WI\2XD$.0\$,%[Y 0+Y$
MQB\?<!?THGR'I3W3N])MK/JW=GK .Z7T_9?K$GT$_9&[  #]1 G=_07J^I@1
M_/W\OZ3Y=^E3=$VYU&>U3U<G+DH+"1NML!E&Z:P\E[!/<A=%A1Y#K%4XMU@
M>D"D\")D1M-H],??B$FH%,V#;[C0Q?E24L^V7*A9-8>H_P"540BJ69HV 2=
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M5VMUEL+Z[M!& 6C7"#6 !-8J\P<R*9%$,E=<2Y=VH&;?C9!C7O3;,*#-O50
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M*!5:L%HS<5@R>Y5ODPX@XB-7D!H!'K"A5-H[4>L6$L%FFFI6TF5!5.F3)D3
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MNN,)C[M"5X(#=6!-VWE;6;^L3&V;0*\ZK^(HK%]YLF'Y;#=%M6+ZW8H&.@+
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%(:1/_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>40
<FILENAME>g723949g72t68.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g72t68.jpg
M_]C_X  02D9)1@ ! 0$#P /   #_[2,B4&AO=&]S:&]P(#,N,  X0DE-! 0
M     &D< 5H  QLE1QP!6@ #&R5'' (   (  !P"4  (<G(U,#DQ-C<< @4
M0$UI8W)O<V]F="!0;W=E<E!O:6YT("T@4D%05%]3,5]#;VUB:6YE9$9I9W5R
M97-?-2XR,RXR,#$Y7T1-1U]V,BX .$))300E       0XR_!([KS0:S)C1.9
M]5JL@CA"24T$.@      Y0   !     !       +<')I;G1/=71P=70    %
M     %!S=%-B;V]L 0    !);G1E96YU;0    !);G1E     $-L<FT    /
M<')I;G13:7AT965N0FET8F]O;      +<')I;G1E<DYA;65415A4     0
M    #W!R:6YT4')O;V93971U<$]B:F,    , %  <@!O &\ 9@ @ %, 90!T
M '4 <       "G!R;V]F4V5T=7     !     $)L=&YE;G5M    #&)U:6QT
M:6Y0<F]O9@    EP<F]O9D--64L .$))300[      (M    $     $
M !)P<FEN=$]U='!U=$]P=&EO;G,    7     $-P=&YB;V]L      !#;&)R
M8F]O;       4F=S36)O;VP      $-R;D-B;V]L      !#;G1#8F]O;
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M(%5N=$8C4')C0%D            08W)O<%=H96Y0<FEN=&EN9V)O;VP
M#F-R;W!296-T0F]T=&]M;&]N9P         ,8W)O<%)E8W1,969T;&]N9P
M       -8W)O<%)E8W12:6=H=&QO;F<         "V-R;W!296-T5&]P;&]N
M9P      .$))30/M       0 \     !  $#P     $  3A"24T$)@
M#@             _@   .$))30/R       *  #_______\  #A"24T$#0
M    !    !XX0DE-!!D       0    >.$))30/S       )           !
M #A"24TG$       "@ !          $X0DE- _4      $@ +V9F  $ ;&9F
M  8       $ +V9F  $ H9F:  8       $ ,@    $ 6@    8       $
M-0    $ +0    8       $X0DE- _@      '   /__________________
M__________\#Z     #_____________________________ ^@     ____
M_________________________P/H     /__________________________
M__\#Z   .$))300(       0     0   D    )      #A"24T$'@
M!      X0DE-!!H      S4    &              .G   $J          !
M                          $             !*@   .G
M          $                         $     $       !N=6QL
M @    9B;W5N9'-/8FIC     0       %)C=#$    $     %1O<"!L;VYG
M          !,969T;&]N9P          0G1O;6QO;F<   .G     %)G:'1L
M;VYG   $J     9S;&EC97-6;$QS     4]B:F,    !       %<VQI8V4
M   2    !W-L:6-E241L;VYG          =G<F]U<$E$;&]N9P         &
M;W)I9VEN96YU;0    Q%4VQI8V5/<FEG:6X    -875T;T=E;F5R871E9
M  !4>7!E96YU;0    I%4VQI8V54>7!E     $EM9R     &8F]U;F1S3V)J
M8P    $       !28W0Q    !     !4;W @;&]N9P          3&5F=&QO
M;F<          $)T;VUL;VYG   #IP    !29VAT;&]N9P  !*@    #=7)L
M5$585     $       !N=6QL5$585     $       !-<V=E5$585     $
M      9A;'1486=415A4     0      #F-E;&Q497AT27-(5$U,8F]O; $
M   (8V5L;%1E>'1415A4     0      "6AO<GI!;&EG;F5N=6T    /15-L
M:6-E2&]R>D%L:6=N    !V1E9F%U;'0    )=F5R=$%L:6=N96YU;0    ]%
M4VQI8V5697)T06QI9VX    '9&5F875L=     MB9T-O;&]R5'EP965N=6T
M   115-L:6-E0D=#;VQO<E1Y<&4     3F]N90    ET;W!/=71S971L;VYG
M          IL969T3W5T<V5T;&]N9P         ,8F]T=&]M3W5T<V5T;&]N
M9P         +<FEG:'1/=71S971L;VYG       X0DE-!"@       P    "
M/_         X0DE-!!$       $! #A"24T$%       !     8X0DE-! P
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MQ $_   !!0$! 0$! 0         #  $"! 4&!P@)"@L!  $% 0$! 0$!
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M&][J_9M]O^%9Z=G_ %M8>)?AMZ??;UGJ#'74@WNJPW;YID4T7!EC7V?IGO\
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M &@ ;P!T &\ <P!H &\ <    !, 00!D &\ 8@!E "  4 !H &\ = !O ',
M: !O '  ( !# %, -@    $ .$))300B      %&34T *@    @ " $2  ,
M   !  $   $:  4    !    ;@$;  4    !    =@$H  ,    !  (   $Q
M  (    >    ?@$R  (    4    G $[  (    )    L(=I  0    !
MO    .@ ,0=\   G$  Q!WP  "<0061O8F4@4&AO=&]S:&]P($-3-B H5VEN
M9&]W<RD ,C Q.3HP-SHP,R Q,3HQ-#HQ,0!R<C4P.3$V-P       Z !  ,
M   !__\  * "  0    !   $J* #  0    !   #IP         & 0,  P
M  $ !@   1H !0    $   $V 1L !0    $   $^ 2@  P    $  @   @$
M!     $   %& @( !     $              $@    !    2     $X0DE-
M _T       @          /_A 4A-30 J    "  ( 1(  P    $      1H
M!0    $   !N 1L !0    $   !V 2@  P    $  @   3$  @   !X   !^
M 3(  @   !0   "< 3L  @    D   "PAVD !     $   "\    Z    \
M   !   #P     %!9&]B92!0:&]T;W-H;W @0U,V("A7:6YD;W=S*0 R,#$Y
M.C W.C S(#$Q.C$T.C$Q ')R-3 Y,38W       #H $  P    '__P  H (
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M+_0A[%F*IE$F+:&#(AQ[@T7=9WU"%093LAB-,+BKV&T17WHDIMI]:DM+5'>
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MB7R>!]1"(SDRJ+S#F6#2]D?GAA%84/D,B(I6H)CE5 MX4I*Q \@T.W228IB
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M6NKKG!D)2'X%PU)>9D*2&UI=0B1&D37&7D=8A*@EQM0"DI6!Q)!%A,(S"FW
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MDU)6TA3[0Y[-NE:!N>7,U\Y+LS!CW6YQ[8^J5;6+A,9M\E8 7(@M27$1'U
M *>82VXH   J.PIUZMUKZ-*4:4HTI1I2N'<]J]OZW"\<IRG/'MRGMS[_ )<Z
M4J+MI[S/+^HR23GP:D4R#G.545&6HQ^XQD,['\>L/DH;$U9=75]+59MK!MCP
M+ 4YL.WI'55I$C %+X52JHX/#E8U\1#J.QQ+*5 C[N=/FQ6ZT=L$45GFDX%D
M.?;8W'<Z7'EJA6Q)6-MD&C( CFNBM<]JC8BV5]J*R?N;KJ#Z%!"Q^7BQZZKI
MVDNCX[32QZ4E:#YN7#^2KRMQZK7A9(36#D_.SER[!G*HB*J!F&-'&J\>Z"$Q
MO[$1/;5:K%=$2*"%?RQQP" &33U[F,")HAH^%-L4(J(SAO<J3@\\,1>&^[G)
M]+%*<6E*0Z?ADF_ GL@KISFM]O9)5;6S'K[#'^L8YG+RI5557DBKRQBE95R%
M9%1:QV_K'KIPF\*J?42,5B>Z$"J>ZI[H82I^1&?K(I7=%EB+!C3'/8P1HH)'
M>Y[$8C"B:]'*]'*SMX=^NCU8J>Z.5/?2E-:1?UBY%7K#(6S<M3;A=\JC2+%J
M$;+IG#&^1&5T,#E12KP=6KPBN4H6,<A%*SYA[JPB2@ J!PA&C&&XMI-:AD:0
M3FJK8M7ZM'_?W1;&,1/RX<GLI6/3P9UA454B7=R5&>M@E\%:!E?'>PL89&_I
M#MDVS55KD^KUP2>W*L8Y>UJE==935,:_MV)$CG.V+42D/*8:;/;Y?F $(2=.
M<<S^Y8? T:558C/JX16<J4L6:<3L><C!+_;4[%<]_8X;74ENO<%O<GD(KF(Q
M6\.X$\KT:G9W-4I'KE>S.\K$O'C?CN&RV\<=W>29E\4BK^?"MAC1/\R\?GI2
MG6:-'D,49P".Q?NPS&E:O^=KT<B_^S2E);\;I'+W,K@Q7I]B0%)7%3^;R0'Q
MW\?S=W"_FFN, \P*YR1R)I"I*IQ(TM8=I:0$%<70$&CX\X;O!:2QH]ZVT6>9
MSB]OE*]IFN(YRN1S>[3 \!] *9/B?E-+*Q+\//CL*N6U/=K)564!57]CY,:<
MHT1?VL@\M_)KOMI@> ^2F3XGY30DJZ%QZBBC2&K^=;9B*3\ON.QBU8V\_E_"
M'>_*>WMI@> ^04R?$_*:;=%<@!/RSU=;;17.R(:JU:P\U&<8YC[50A:IM@!B
M\IW^Y>U6N:[N]U1&!X#Y*X!/B?E/T\U.H-Y1'=XQV5>A?[P4P@2$_F6.=1F:
MO\RC1=,#P'R"N<GQ/RFE9$&J(J(Q47A45.U47G[<*GWY_+]NF!X#Y!3)\3\I
MI$MVQO68XPP^7/O'I'X1J(TXZ*[/R[Z5Y;X1&3A.%[E:O/MPK \!\@ID^)^4
MTN=C/[EO_P#%/_MI@> ^04R?$_*:KYE6(W^VN06>Z.U=9(M8-M(6?NGM/7^%
MC,Q1&M:?-,' 8L>'6;GP0,1TN.I8U;N)!"E7<.!?"I+Z#,DA8"%D C9"S]J.
MY*OW'@?M/O<BHB"D\2>_=:>?%YQX*_I=^^]3%B66X[G6.UF5XI: N*&W"XT*
M:!I1KW!*2-+B2XL@89E?95TP,BOM:J>"-8U5C&E5UC%C38QP#C(*20H8([OI
MW$;@\B-QM68(4 0<@_3_ (CF#L:[F(U^2R%X&KP4D7W1[_,ULJ=+]G,Y[/$]
M8?TN]W*]CT7AJ)SQ7-+3QL>BM>QKVN145KD1S51?NBHO*+SS^S2E)A*&D(YS
MWU-=WNY[B-B 81>?O^D8QI/=?=>'>Z^_WTI73^'X35[@'M(R_=$%<6BB:O"I
M[1BRR1OS_54*M1??MY]]*4BVM;/9+H CO[ GEM^4',C54@+?2U-G)1Z^.OC2
M7+Y C_X6UZ.7N:]$1S'*5"^]PK_!;##=]PR:N0/;63,I\\\<*77K)VBS2170
M\ODS2^ML1MBX1:0,:W)D2DCO."JQ"\AQ&-2X.-\C>5<3?QQE/WZ=T[Y^V'$C
MTJ!/*HU[<*_B[*^]5L?D.%?@D=]6!]==C]R4@9#%Y5KJZV"9[F\<M7LGQJQB
M=WY(AG(GM]2\JJ1U)7*W?B5$E5-U%Y<C>[T*3FHJMY]UJ2V"(B+]*N7Z45.5
M7CWTI1^)*1O"'L!0E5$7ML6&K7>ZJU/IGCC._63A>4]O;GCE.5*QZ^3&FY!:
M'C2(\D8:RJC,> S3)Y'2+,YV\L<X?LQT7E6_4JKP_P!FLTI3DTI58 QXV1=7
MUF8D<4@6VFP-)'"\H4>L6UW0SZZE2%$][5\9OE^V4!RN:K7H,Z<*J/7CJ*0F
M5KIXE*5"T:8C!)(R6WKU<Y*EXR-E=596L*&" HCD:](6M<#HEC(2M2#J37TU
M;B4DIZV/I6P0FV>+!'$CK]5R $JR.)O(W%6?UVZO-Z-*4:4HTI1I2C2E&E*.
M-*51#=CC$^OWI(RD? Q[F[3=1FS=D55X0AZ86"[K8Z!?LCG]N-Y,\355R\>5
M6M3ARK91VHKX^(MEP>;)4@G^<D577M(95W*0ZCU]A8[_  2KNJ]^JU6*0Y:^
M*]J2N3AA85M%5W8B_I%?62AHI.>6)XXDA>WM5KNU55S7(U'*5]ER"H&1P63&
MRI#?98T 9K&0U?=/K!!'(*-.4X57M:U/S5-*4@PIUD2ZMVP:EPTD1JJ8Y+66
M*$B=_KX:&0,9UC)Y(R"UJ--%BN7P\/>J\(Q]/IS_ $4I96!<26N29<-C,5%Y
M#4PQA56K]QEDV+K%[_;E/( <)WYHB:4I+QRBJWTU0:5&6?('!BL<2T,>S>,T
M<:"(HOF$B=X%0C7^PB<I[=SE5%TI2G8HP-KCA&HQG=)GPFHB :JM+5RI:L9W
M_I%^JO&_Q@X<J,[W(HQOX4I?TI2)C;E6@J4<Y'*&"&.YR%>;ET5OIG<E(C7E
M<CA*CGO1'.=RJ^ZZ4I*==0(N23Q+),<CZFM1(T,9;![2AFV_>U(L(9Y(RJTX
MU,\C&C0;0\N;PY=*5TVLVVE&I"1J@,08[D?;)N98AE8IX%A$0L:%"*=Y2*V0
MYB!D2(I%:]W(T5.YJE)45^01<\N$<"IL7'Q+'%4@S2ZMRLAW&5?0T1&6C7.1
M9J<=YQ-^K]9$YX4IW?.3B7B92VL=J<=Q0CCV _R_597R),MWW_.(Q?NJIQ[Z
M4K5AU[[OY]B6X&%0\#SK+L6@2<.?)GPJ>RMZ%AIOSJ>-#R8B+$>XWIVB8A"#
M5?&UK47A-?.SV972#KG1^M-*0]+:LU!IZ)*TNN3)CVBZ2H#+\@76:UUSK<=U
M"5N!M"&^-0*N%(3G K]B>QOTCI?4.F;_ ";[I^T7>0Q?4L,O7&!'EN-,^U\5
MSJFUO-K4E'&M2^$$#B43S-4-%U"[Z!1S1;N[AC:\A#/1F5W+4<4SW$*1426G
M+R$<Y[W+[N<JJONNOQY]>_I@_;,UM_**Y_.*_1?ULNCO]A.F/Q-!_P!C79^^
M*WY_QP[C?TMNO^]Z?7OZ8/VS-;?RBN?SBGULNCO]A.F/Q-!_V-2;%R[JJG5E
M1;P]X[R3#OK$%/4('>FC),FVYTK%2I%7LRI9R686W-8Z7!?';)A-EC=+$%J.
M5O?X^I/9#R[?;;G&Z3[H_%O$UJV6T-=*-H7)EW)T0#[7-PQ?S+\O:3<X*I,-
M3(D1DR$%]ML9QU5ZR]$$>7-A/:)M[3]NBN39O'H6X)98A-^5@S%R56<1O)5F
M#+#,A+I9?+*@RM9*<X4'*^K$EY=4(,^W%B75?EL#%+N++SH]<X.3V4.V=!!*
M/,M@ <TT'%[%R67E= ;&@A<^4T1HJE@CZH]DE(NL^R)UKK=JYVS4$33$^-*U
M:[$\EO4YJZR(L9QV3<6F>J=8LMR>$Q+AAI:CA:GPEY@NRNV+H9:@1;F=-:6<
MA3;3(O<1^/IYJ1U]MB+@-/OH0Q"<=*VW+G";\F*!)+CQ0EDK;="/F3FG5.^9
M5UW[I^7V@[J+93(-A7[GPKC'GQ*1GDNI$O(8602J&N%3B5IK1UE/B>@ 4!Y/
MC#)CD+BO5OLBDR[?$:Z0=3S!=(\^5#GV_7\6X6<QK4D+NK\B]P[R]:8+=L;4
MAVX*G3(WD;3C3K_ V\RI?*=/=#Y8EON:1L4?R%V*Q(BR])/1+B'IRN&"VS;)
M-L:N$I<U?$W$$6,]Y2XAQMGC<:<2EJ7VY&_^&28'K=S,OCMLX:V%794.=NLZ
MJRA)(/#(:#;8_:RZZ4@9<61%DB9)<:-("0$D8B-[=::^])?3MIQV(BY=)&K"
MU<(IF6^;;]9+NUNGQ0\[&6[#N-LN,N$_U4EAZ.^A#Q=COM+:>0VX.&MA:]%=
M%MX1(5"T9I\+B/\ DTN-+TTBWS(K_5-OI;D0YT*/):XV7FGFE*:"'FG$N-*6
MDYI(?U"[Z$<%Y-W=PWNCD4H'.RRY<X15$4"D&JR^6O4)C"5R>ZC(]O/#E1=%
M]>_I@_;,UM_**Y_.*VGULNCO]A.F/Q-!_P!C79^^*WY_QP[C?TMNO^]Z?7OZ
M8/VS-;?RBN?SBGULNCO]A.F/Q-!_V-;\=DK[)K39W:VWMXY[N=9X#B<Z;9NM
M6RK.PDRJ6$8\R:M@R+WRI#WN*=RRS*XCG*I'?=?LMT43YMTZ,>CZY7*7(G7"
M?HW3<R;-ENK?DRY4BTQ77Y$AYPJ6Z\\ZI2W'%J*EJ45*.37S@Z08D:!KK6$*
M%'9B0XFI+S'BQHZ$ML1V&9[Z&F6FTA*6VVT)2E"$@)2 $C84SLMIL@V]R*SW
M3VOQZXE$MSCF;G;5!BHL+<!@A# _*\4/&(:JI-U($, A#DRI4.GSR!&#092>
M'+#091COHB2% (7MSX5[]G]RK&<H/RI)R.]*NF$%)*D[Y]\GXWG'@K\B@,'&
MQ$DX-N/A.>N-DN,9#!GUL^KJP"0K'5]A%EPYUZ&SK+*!/9&M*VXJ9J$K;JBL
MXL6RH[2+*@3XL:8PX6X*24D@C!'KY[@@C8@C<$;$;BL@0H @[?3QW!'+'RU*
M".1R(K51R+[HJ*BHO^94]EUQ7-<Z4HTI2),Y?>THN[V'&MYJM[N%5PFPH;5[
M4(U7-1+!_/(BL1>WE1O4:N4K.LJZ!<5T^IM8<>PK+2%*KK&!+$P\6= G )&F
M0Y(7HK#1Y,<I F$]%80;W,<BHJIH"001L1N#YQ2H3V#L)]=07>T]_,D3,DV7
MN&X2LV:5YIU[A*PPV.V>4R#E7S3Y%KADBNK;RT5/'*S2BRV.-5="*C971DA8
MY.#BVY!7)8QW85D@?%(K!&P*3S1MD]XQV3WYVV)\0:GGC459UQPGVX3C]G&E
M*:$"GJ;*5>R9E76RN^W<,)#10'>UL>NKHA48YXE\:^J!(1[6+^NBJY>[GA2E
M3\/5S?XE9\1$7N1L*ULX8D7M[/8$>6,''")]*B5JJB*J*NE*K7LS6R[C=CJ=
MRH%S9#:'<;$MNX)R,KY:&K\#VVQ><8+WR(3C.8'(<PR(;D842^;S=SE(CEUU
M'3Y\HO>L9W,>VT*U-GB!]SMEG@NJ&![W$N?+"AOVLD<S7HVL1Y'I3HQM0V)T
MY=M0OIP1B3?=3W:.A9Y ]9;+-;"".;80<FK00@V(G/2;-CRV<<"4<)\0J+W+
M[E=ZV0(GT\)] 0>Z*[CZNUO;J\YI0TI1I2C2E&E*-*4:4J-IN[.#5^Z%7L]+
MN8\?.KC&_P 4P*LYXD99-<21:@B!BI*DAD6-A-'CV3310ZJ-.)&KL<MIMDL$
M#8CI:E54ZXGFQZVZ/-S(H$4^"]7^V=5+EO*@ 1:7=BJRC:&P;+D(PI01#RLU
MK/.1H3,:T7+QO5!M=9C[A]'QHZSZT%+G^J:KR-BPOXCR/_4!;W/=[^KK^FOY
M7N>QAUS'<*@ZV+ZF0SW_ "G6'> GT^W^U+/OS^7"UJL4BVU! ]112)WJ;5S+
M@8S?,Y+I87)+K[""U4@D<RO$OFDAY=&AC>J)V\*U7:4IYA"&.-H@"&$3$X:,
M3&C8U/V-8Q$:G_,FE*1WIX\D OO_  RDDH[]?MYKIT56)]O&CE2T(J<JUSD:
MO"/1JJ-2EM?LO^9=*4@4+VAKCH5WC;&LKH7)%5B-$*XGH+W(T?#&@\?:O'8C
M>.QSF(URJ4D7&007EIRUZ2+5\>X"B_+1D/'594:97*QTYK/EJ$19B<"D38_#
MNU[GHC>URE+*OR"4GT!@5(E3GND.)93../=JQ@.BQ $]_9Z3IS/;^+<B\Z4I
M'H:4$F"5+&7.M/%974;Q29W=#[(]S/"C'0X+8L(C58QB^&4&02/SX%(JCTI2
MF.-%@Y!$#%!$C"-1SD:(+/"Y$ASX'\6$;6A03?7KY'(B/[W#1/I[N%*[[Y%0
M%>1&!>HKNF7]._L:Q"V (SB,7N;R9K#N\+>5[R*UG:[GM52DERM'N"%%:O=+
MP^0J.Y]E2NN8J.;Q^:I\T:O/W1%]_;C2E/+2E:8_B7?^,[;[_P! R?\ :"TU
M\O/9V_\ 3W1G^2"_],SZ_<WL5_\ HGJ3_*)/^C8=:V]?AJOU%1I2I<Q3.::D
MJMMH<P<YQL2W<F9S:*  GL?3'C8&)@XCG'8I9W=C5AW (@1(CHR^=?(]!^E:
M=U;:[5;M"Q9*99=TWTDR-67#JFD*0JUNLZ10E,<EU)<E<5CFY:6&T %@]:>-
M7!TR[V"=.EZI?95'"+SHMK3\3C<6E29R'-1*4IX!M01'Q=(V'$E:R0[[GV4\
M<P8YOWBC05$C(X5M^):[<;&;*9>QX4*P';X1BU1G,"A;8PI,D*2K^E9E8JE$
M,YT:PH85;$,1CZYSI7IUBZ8].):MC]\BW'V]@ZVL4Z3=V8D68BY:3L%LU;"M
M G17WVQ(O%K3J)NW!+I4Q,L\2#'<<0N$HR.DW3HZO"ES6K9(A^U<K3%UBLV]
MV0_&5"O]VFZ?DW Q7VFEEJW3C9E3"4)#T>XR)3R4J3) 9;TS=/#I%? QJ9*L
M9T.7CN8XU<Y'281CN&LK(%_88S=4R56&TEI'IK U==XZ61=3R$J+&XK+9]6X
MY&U=>9--*Z0]+O0HEADR)LR+)LFJ+#=+[:=)V73";?"O,RQ72UBW:8M<]FV3
M'85ULSCMUF+7;9ER@W!4%3RQ!B.#:,Z1O;<E^ZL-1H[S%SLEUA6R??KE?%2Y
M%NCW2#/\LODZ(N;&1)@7)#<",A$V+"E1!+#:3+DHJ#LG9B0$JH>*S+JU]-#+
M\WMK>("K#,GFE&(P=54"EV)(<&)$4 7&DSR2)\KSR%BPA^,2^1Z@3IID6Z)I
MV7=;EY/&=]LKG<H[=O:E3'9#CB$6ZV(D3%Q8D:/U3:G7Y:WICY=>+$5' V>_
M6HWESRM^[LP(G6O(\BAPGG):V(Z&4)4J7-6S&2_(>>ZQ8;:CI;CM=6V'7U<2
MPU==<K;T:4KTN=.[FOV&V<5CFN3]S3#&\M5')W,H(+'MY3E.6N:K7)]VN147
MA45-?=WH9_P1]&7^0FE?]"PZ^5_28<](FN,;_P#*J^_Z2D5,FO2ZZ/59LIPC
M),7S/*]T]JZQMG.E2:U-Q=KBEA1*C=*+%J(:+>4992A@46ZM7"<")57<TH:S
M+H,./B>82(T0>-Y/ATB5!0"%G ^T7S*/,?%![QS![2>\&,I*25HYGWR?C8[Q
MX*'C]MR/($2KA5O@FX6/0\IQ'L=72WR(Y?3 ET%M5V<$Y(EK1WM<B0+2EOZ:
M<(]==4EF&-85D^.:),C".)6IBI)22",$?(1W$'D01N"-B*S2H* (Y'U$>8CF
M".\'<4ZEJ"CY]);VL9/NC7G!.:B^WYV4::947CW1#)^Q%;[<8US0@+X7\7/K
MI+$3V9)KS!*Y?^5(CS/$G*_FV%[<_JKI2D9TNW3(!N/4B,L2H,U?E]@A?:?.
M#[\3XM<'N_M;^JDA7,1?='(YKD4I9^=#'SZJOMXJHJ)PM<:6WW_/R5GKA<?M
M57I[*B_;E44K2[UU_$&M>F'J/KJW:_ J&\R1^V]%#S:\RB5<#K[JED7EC<T%
M,"IK)-<])^..+=$@7<P\GT:Y5=PF5ST<0CO >E'IEN&B+Y'L%KM4.6I,5F=+
MD7#RC@Q(4M*68R6%M$>YMY<>4IQ/&I* V"VHJ_8?0%[&:S=*NDIVKM0:@N5N
M;7<95JMD.SB'UB5PFF5NRY[DMJ0%)+K_  M16T,+ZM"G5/X=0$[8MB-U8N]^
MSVW>[$2JD48L[Q>MOW4\DB')6R)0U;+AI)1@O5!!+&8<:7X0>KCH*2@1(5!M
M]BTU>V]26"TWUIA<9%TA,R_)W#Q*94XGMM\>$\:4K"@ASA3UB.%?".+ _,^N
M=+.Z)UAJ/23TMJ<Y8+K*MOEC*>!$I#"\-/\ 5\;G4K<:*%.L%:RPX5M%:B@J
M,M:WE=4I#QWZJIA_;B7,M)S51S7(HYMG,E!7N;[+^A*/[<HGV[G<=RJ4MJO"
M<Z4JM72@JV&UUGE[N%?N'NIO#G3"(Y7H6!=;DY*.B(CE1%<S\.PJA@E]T\3&
M(WAJ-:G4M%>ZV9V<3GVUO-_N25$YXF9-XF^2'.!D>1HCA/[@)&<"O1>E$>3Z
MFC6GD+!I?1]D4CXDF%IFUFX)QDA*O;-V8I8'^,4LD<1-66UVVO.J-*4:4HTI
M1I2C2E&E*:<_!,.M,KILYL<;J9F78]'-%I<A/%8^SK@'#/C.8 Z^_(X]M;QX
MKWH\D,%S<BB/ .WL6R5*J?\ $9K)4WHSWKN*YCG6FW]7CN[-80:+Y8\S:7,L
M>W&]0)S45S'"CXT?E[>%1BOY7M5VK$4_JAL9QQDM_P 8DH_UJ@D_ .'O0 X/
M,6R%Y]7#5S*BSBW5367,%Z%A6U?"LX9&JCFDBSXPI4=Z.3V<CQ%8Y%3V5%Y3
MVU7(P2/#:IQON.1K"R-.*QQN/]B3*R:J]J.[60K.'*([ZE1$X&%_*\HY$Y5O
M+D1-*4HRI\*"-"S9<:(Q5X:Z0<8>YW]PSR.;WO7[(QO+G+[(WE>-*4TYUPXM
MQ1'KJV;+5[[&N88XDK8R^JA+.]C6#!22,=\L8Y70X\ACFIW</5K>'T^GT_)2
MEI(U]+3F381JQB_[S5@25(:G_G"Q#XG(OYHE2)S?;@B_FI272T5:V3=,D1W3
MB1[ESA%LG$F*BR($":\@62!- %7'DE<Y8K'-<_N[RJ]'#&I2M?M1M<-S6JB
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M)62@ ) !XB2 !G<<Z2-O.K/J)P/%<>VWP^' =5X7$J<.KX+\-)8V@3 1:Z!
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MI9O%N>DS)5A+J)KC"2W96FT]6EB,X,@/')XG5;^&!W5U*_= W1];YC;,:-=
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M.?D+VDRS\;'C5M)"D9 P<A(YCP:>%$) AR):I*L85/X4J8EF80%L 0F21!:
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M5;$3+E9YL=BVCR7"XJ6X,AAQ=P=ER4->2M-.<*.)$/\ X#SC_ S*_P"CMO\
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MN]%[U,4N-Y9N5?W])EHLD;D-5EN02)L4LF)4SI\-]1%LSD9$M1V,>,./'JF
M>^*L@"B6,QR#_!70!TBZXN/2A#M5YU-<;A"N[5S3<H=ZN"WD=<Q%D2&?(&9*
MR&):92$)#,-#9+!>3U?5H['L>L[':8^GW9$:!'8=C+CF.Y$8X3PN.(0L/+0,
MJ;+1)XG5'"PD\7&KM;D<^V]OH60/W7VG6%"W$#$C1,DQV=(=!QC=O'Z]'>GQ
M_)C#&9*S(ZT3C-PO.1QSS: Y75UF&UQB7.JG?0]*@1P+SP[\)'-!/>/%)/OD
M]_,8->)*2<\2??=XY!8\#SW'<>[D<BL#!M_MJKB96X[8Y?38IN)D]C:E%M?F
M%M5T>XL*6&RE5[ZJ7BTJ;Z]\N.Z"X02P$G5MJ 3;*AGVE-)A3Y&G>O=FCW)%
MG>NUL;NKH26K<J=&$UT*3QH*(Q<#RN-)XD)",D<AS ["QI74\JR.ZDCZ<OCV
MGV"L/WMNU35VIDMKZMP.3TLF*CJW.PX2[PH7@*()%:D.NR=U+.ZFTJZ%^?.H
MBBI)&U,#%AVKH$T4>MKTM#0XU6CPS+,%Z>:.T=)822()(S)",KB1&N_#73Q/
MZ6&.E%$:S2=4M0'6X*M),6)R<B*^$,1O*U);AD-R)3=Q4XF6)(6M"%LI4!&4
MR#Z+H]K3J]/E<ENVJ=2IP7)<P,EQ!4MP- J='&VVID)+?5D)*@HY*PK%Q]MM
M@\<W%WRW,E[O1K[*+>CVBV$KKZAN,HN9>(0<MO19[DN54\?$ SVXA)HXKY52
M^'3S:>?7Q"%-* U9$V2<W[ TI*NS]SD"[IC(ND+2ND8MS4PQ'2XF[OMW*;=$
M"4VCK5LEUQE2&DNEA!XE-(3UBBKK^H8D.+H/2YC+DE%UU5K>>VAR5)5'-OBM
M:;MEN<3!4Z8K;_&Q/0N2&!(>2$MNN*;9:2F]V.8- PBM#2X/'H<<I8_L"F@X
MQ35M6!$X1$CPL;!CT<*\)[N49%7G^;E>]$J425$J)[R<GY37G8 &P  \ ,?F
MIE;Q8.3=#"9&W64!5*?)[&L!,E8W9-BVRMJI+<@:D5EK628,9SWU"-<^08[.
MQ7,3ZW->G2^D'0UHZ2-)W31M]>GQ[7=C",EVV/,,34^0SHUP:ZEV1&ELIXGH
MK:7.*.OB;*TI*5$+3V;2&JKAHO4$'4EJ:B/3K>)(9;G-NNQ5"5$?AN=8AEZ.
MZ<-OK4CA>1A823Q)!2:F?V/K8L2)ZVPWFA*O[9>.V#?\ZEIL5LQ,;Q[\E>SA
M/=>$U^:/L'>B3]>==?C6S?\ QZO;/LH>D#]:]*?^0NG]LU%>XG1ELECV3[-8
MQC.5YG-G;C[E+C%L*?<T!)$'&Z["<QR^YF1HXL<B%C3D_#<2& \MAHPG35\D
M4SW#1-%>/88=%D&7I^)&NVMEKN]X,)TN7.SJZN(S;;C<9+B FPIPX!"0A*E<
M24ES)0K;':]-^R%UI=;=K&XS;?IM#>F]-"ZQPQ#N*.MN$F_62R0VGBY=7.)C
MBNKCKC:.!Q09'"Z@!69P3X;NQO\ A+N9_P UUC?]4M;W[!WHD_7G77XULW_Q
M^NJ?91:__6O2G_D+I_;-<_V-W8W_  DW-_ZZQO\ JEI]@[T2?KSKK\:V;_X_
M3[*'I _6O2G_ )"Z?VS1_8W=C?\ "3<W_KK&_P"J6GV#O1)^O.NOQK9O_C]/
MLH>D#]:]*?\ D+I_;-']C=V-_P )-S?^NL;_ *I:?8.]$GZ\ZZ_&MF_^/T^R
MAZ0/UKTI_P"0NG]LT?V-W8W_  DW-_ZZQO\ JEI]@[T2?KSKK\:V;_X_3[*'
MI _6O2G_ )"Z?VS1_8W=C?\ "3<W_KK&_P"J6GV#O1)^O.NOQK9O_C]/LH>D
M#]:]*?\ D+I_;-.NCZ#-H,?B$AP[_< @BR'R7.D6U ]Z$>((E1%'C(F]O:%J
MHBM5>5=[\*B)V.T>Q$Z-++&7%BW36"VW'U2"7[E:E+XUMM-D HLC8X>%I.!@
MG)._(#3W#V0^M;D\E]^WZ;2M#26@&H5Q">%*UK!(5=5G.7#WXQC;QNUK]3UX
M-1I2N$<UW/:J.X547A47A4^Z+Q]E3\T^^E*H%TY6/X2ZI>O3;F)$ES 2-RMJ
M-XZN'$8QK49N=M'1TU[)>>02/#$U^3;>6ZO5QD*4JD1K3%8]$L.[LQE=_"XV
M3X\#A(^0+%0-;.R$^*T+'H4VE/YT'PJ\'BOIO\=(BTX5^[(34L)JM7W14ES
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MKK1[R/&QK!GA^@Y<J]O:Q'5#U1[U<BKW(CN&]C%*^UNQRN1U421;*K5_3A1
M5OO[<K92.P!F<^S_ $"3BL_,7/MI2D7'H=M-I:UMA8K$$&*.*Z'5^1A56(GI
M#,D6DEYIA>X@7*A(C8!4Y^HI'?6JE9\BNA5DVA?#CC#Y;8PY)OK>>0A:>U1J
MRI+WJ>2Y3()&NE/.O/")]?8YK\__  _W4IT:4IK55C!KJUPY,@0W,M+T 0L[
M"G,@;J>Q@X\:&A"&(@_'^B"-YTY1#,0W>FE*3SR+69D-<Z'#;6C+4V[/5VC#
MF.\8I=*]KPU\8S!,3DCD;Z^5%DHKE<D5PQE:]]/S_P!5*[KJFCCKTESI!;*3
M'G5$ALBS3U 1.!;02]T>!':*'&+PU6C.".PS55KC%(UJJJE.\C$<(C$X1'#>
MWA4]OJ:J>Z?94]_=-*5&DV7'/5;>KZJ*67%N,5.\<0C$1OJZ\\%2-!RA& (R
M81!HK6_0J(B<IQI2I/TI7G0^.=TN;_[OWFS&Y6WL4N6[?4,6#MW/Q8-M @DH
M<[SG-:^EQ^Y9!LYL*/+;EUA<T&-OF@<0E>:OB^O4$ WJ![.WO--AQ*QA9RH'
M!W2$DJ&0"=@"<=^=MP*U=Q9<<+:DCB2,)(R!A2E8!WP#Q<03G(P<'E6T#H#V
M-W4V+Z9]M=M-V,DGES[&L<"*U8"T#>1*D,VWO;*KQ8<N4R=%DBQ:GEUM%Y*]
MS8C%@.%7G+#8$KZ<EQ+K[CB-DJ4"-L9P "<'EQ$$GOWJ]'0IMEM"_?)!SOG&
M22!G]R"!X;;5=)%R**ONVLMA^WU-<>ID-:B_DQRV4<[^W_EPF*[[]J+RD'T^
MG_&IJ/GP0^UA!LJW];DAXJR(R(W[O?,KG38H6<>_,DH%X^[47E$?[J5VU4R+
M+]>2+)CR1^L7AX##,SVB1>?J&YR+PJ>Z<\II2O+1\6/XD^*;ZP<_Z,MO,2R*
M*+&MT:BHN-QY62Q*NHR"ZPZWE5UQ0EQQU>XA<<%=_I 6TR[C>2;3Q9SJYL7L
M)K<08I;*)"U Y22$!.2 H=D\62,XW[MJTTV6ET*CH2?A .,G;B0K!'#CEG&"
M?DQN8PZ).@[J-K:8KG93"PFSZI>F;?LFT-?#OW26QPCI=N@1,EO9=4Z0"D3)
MH^61J-J@4UK"K"2Y$P03#B1292)+7$.R5!EYKK.R!GW^4@$]V,G/,C;:N(\9
MT)]]PEYIW@P>60V.(\.P)!QL3MDD]U3=\&_HEW^V[ZB<_P!P]QZJ/B6"8K1Y
MUM?D%0Z]KK,N6Y= R-E%-KH\>EL)3/1XS;4L^06XD/"U\@0 52RPRY9H^$^2
MTXTE"#Q*)0X#PD<(*<_;#F01L,CN/GS@QG4.*6OLH 6@C([2L@;!.!L01GTX
M S6O[K-Z>NC787J5WQVBB[F;MP7U3*.9ACJ7%<<RS&,,R*_C/OK?&<SDR;ZA
MO[&JIHLJMKH!:&'*LXHIZR)Q;.;5%@6-IAV0ZRAS@;.<A620I03@ IP"D$G.
MR_#PJL^U&:=<1Q.#D4X2% *(*B%$D' &,  \]ZB;).CW<O:"3E&>UN1XW?-V
M1VHZ?>HB]\,:[C2!QMWK+'SXW21(X0O<6522[ 3[N8:?5A2%&-)AE\JL$F8?
M0Z$H((ZQ;K0R1OU8())/Q@=AC.>[?-1]0MHE05DMH:=5S [9!2.1Y'F21MG'
M/%;:NEGXEN]'6),K=HMZL>QV1)K-\^F_,:;+<-I)U/'# J-Y\8L9]!>0DDV4
M9Y'"@)/IY8GQ#$#6V0939;T&8=%^*VP.L:4K=IT%*E#.[9QPG SS /AD>-7V
M)2Y "'$C/&TH%(.-G$Y!W., 9'+->ES%9L&30T[(DV++<.JKT)Z=P4<C_2"[
M^^.)SO [N[E<'A/&O+>$XUJ:VM-O=_;J%NWMEFFV\^<>LC9=22*I;&,Q"E@'
M<\9XDM N>-IV1Y8 %+'4@TD":\*D'W][>MZPTXQJ_3%[TS(?<BM7JWO0C):2
M%KCK6 II\(4I(<#3J4+4V5)ZQ(*.)/%D7K9.7;+A$GH0EQ45Y#O5J) 6$GM(
MR,E/$DD!6#PD@X.,5JZ^&QT[1J*;D6_5EDXI(X$O+-OJ*NC!<",\4&;#%9Y!
M/E$-PHY#0>&%"\?:%ODDF.Y_B:W\L^QBZ-1!D7/7K]P+W"]=]-6Z(VR6DJ1&
MELHDW!YQ2U<76ECJV&$ I;RXI;JU!*4^A:^OO6ML69+'!V8L]]U2PHA3C2U(
M92D 8X0O*U$[X& ,FMOY9T=:\\\!PECLBFDLD"(P@7#&)[_(TJ/0;F<-5>[O
M1O">[D3WU^RJ\OJKVV<0=CU&[R'.-D@6/;1=/^&*AV,*B2._<W)Y@G->0ZHJ
MAO*TI&/<]5[AN5ST5KW]1MWNNL]3/9)$:T:;@8[@OK+U-7@]Q*)3/$!ML#WU
MZ+>08_1CH6.< SM2ZYNV!S4UY/I2U-*4/,[;I24G!Y*PKF O8]25MCU#[HFC
M"?!%CNVVV%&)*H\BK0<NUM\_O)O>V"^.,CR1W5;B-(A$5&B<]O/:Y:5N_5'2
M)JA_8B!IC2MN!SE27)$[4EP?00.66W(B\=X([L8ZB]V+) 1N.NN%Q>QW%*&8
M#*5>?M!P#/+!Q6JK!^N_*MI=U\RP,./4USAMMOGN/86]F1)<G(#MR7.[+TTV
M$\)J^.0E?6K C>E.TOK4B*@Y45"C\7Y=B>R1E:>UQ<M-JT]$DV)S6=YCRIPD
MR/;58E7F0SY2RE.8O!'06N",65K>;9*0^VIT%OU_4^F6-0Q;9/8?D1'[;I'3
M=J9C/(;ZGK+18XC$E3@PA:/*IK<J0#Q#JP^GB0I25 [57W?57<A'Z'!]F\$
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ML,JPQ)N;U^X.3U>,U8Y,+)I=C2U@,BQ>3Y[^(_Y)6Y%'NK"A6>ZS;\LR2<A
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M?21<U<)0WJ"'!#@/-JTZ5L:W LY(!;D2Y0( &,$8R*ZO)94\SIV$C/6/QE$
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MV2Y=D=9B=#C];+MKFSR4WR"+75D 3C2YLAUJD7MC@$U7/(WN:J\(U7*YO=6
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M(;6HUJHU$U6)))))))R2=S\O]>]60   !@#8 ;  <@!2;<P:$[W6.3X\V%)
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M<OI^BN'_ ()9\,'Y% U,N[&(PK3:[<LLQKI]S-V[S*,.P571BA21C5F)H(:
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MTN84\. DF?(CQ -25($!QC2611M5IWE;'<TJWU*"6X"CLE)4HD;D86@G;O\
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M"G!$Q&M8U83WL@R$:U'.<^,:%PU$8&"Y>$12E&':09ZN9'-R<?\ '12L)'F
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ML(9D4<F%85UE'*D:=$*TL.PKI\4-A5S@GBR@1ID=[!\@E)!22".1!((^2N"
MH8(!'@1D?(:JA*Z)[G:5\FYZ,-W\AV#D.,28_:>_;)W&Z>KB0\BF,%V WLQU
MEA2SB<,D66WUY1%$-?HA&[49JQY1Q[2$!WNX]D.C_P#(!VL#8!84/#&Y,/4\
M&2RLM\^Q[YHG[T[I_ 4GT&NB-UFYMLU(!2=:FSEEM%&\S8@=]-O'6.X_3[;$
M5W8.59VT"&[+]M/5O5JBB9I2.@1FJY9&0^,:D5U"'/[W<XS]R7A#O=RR>%S\
M$Y\V]<=<I&SZ. <NL1E;9\YP.)'X0P.]57GQ7+L5SJAK\IPK)*++<:M@-DU=
M_C=K!NJ:P [[%AV5<>1#D,_)5$9W:Y%:[AR*FJZDJ22E0*5#F"""/4:G!"AE
M)!!Y$'(IPZXKFD4M)&0A)$ AZN215<]\%S& *]RJKGR()&$@G(_E4>=\?U2M
M7ADAB\.1^FE(T^XO(1?EK(@+&4\32OGUPC/;717/4:S9]4XCCJOL_P!)%A2Y
M<B>89$8*/'$<P5*6:-:WTSTKY7JWJ523C$?W3"2W^Y'SF*UA R%1$:@'B"D<
M+!QPA" 0Q,4I:TI6!,K(,]6/DQVO,)%0,ECG@E@[OOZ>8!PY(%7\U"5G/Y\I
MI2L'TMS"5SH<P5B'GGTEI^B.UJ)PC0V44//"?K<2X4PQ'<HZ2U%Y12OH=[&8
M]@;$1ZB0Y6M1D]K&1R/?RC6 GB>6 =[U1>P+)'J>..\#%5$TI6=/G@KHKY)D
M>_A6L$$2(X\DY7(,$:.Q5:CS'*K1#:JM;W.Y>YC$<YJE)\"J[F2)5L($F?8M
M8DP;FH:. #'.<"N"A&\/CQN]RN>YC5E2'FE.8SRM$)2CY*L9>ZJFR:Y$XXC=
MWJZ[V7E&^AD*Y(XT_N*\L%5Y7ZT5$TI7'S&SA(OS.N\XF\_PRF0DI.U%1/(6
MN>B3A*O/\3$^9N3CW)[HFE*48=C"L&N?#DB/V<(1K7<%"Y??L.%W:4!$_,9F
M,>W\VII2J!;A.?U4]4U+LQ$<LG8[I9L\;W-WL*->ZOS7>\K1W.T>UAGIP.97
MX1&:S<O,8/,F,^Q)AM98@&_O:ZTCW%DN$>Z/!2&_W+?)Q?F*O>)//'$:K*]V
M="/\6R4K7^Z<YH3YPGWZAX\(/A5IMZ]F*?>_':7&[R]R&E@5.78UE!Q4DQ!Q
M;R/0VT6PEX]?5DEDBKMZFZB -7&980Y+ZYTAMK5K%MH4*6&K5FI-O;RHQ>BN
M,CR"QBU-%C]7/NKFUG%:&'6U57%+-L)\LSN&BC1(@2G,]?9@V.7WX]^0"HA(
M&22  .\G8#UFN"0 23@#<D\@*TV=1V^4W>RAP'\.GJLQHI.?S-V=MH <)>'<
MZ'2XV&=45?XPZ0]T+&CROJ VMG5EA?6,G*L"L:R^=Q79#BV*K*Q])4B^RT$*
M6#V3P!"NUV,JQGAD-A096"!@+&.840-JHNN=8$X[22HK1V>T.';M,J*2XC!.
M2G?XHSO4_P#0[TX;J[(9EG%M:VE56;6991?/:W%<7=D%%A5QF>8Y";+S7>'[
M0Y'*LY6R=+AE'-%@X\<;9_,<B*TEG>U\ ]=##J*2\AT)P#QI."I7"5\*4A("
MG$@=85$%><83G"=LU+':6V3DCA(R GB"2I1*B4MDGJPD83C.];*]5*M4:4HT
MI1I2C2E&E*-*4:4HTI1I2C2E&E*-*4:4HTI1I2C2E&E*@*]V/@8]A^[;>GZ-
MAVT>[.Z KNQD;EDQ5E],+EUL>9+9D.1(LV%97Y($NQG'J8TZR/ J#2&K'KS0
M1OK#R!PE2.M*EH1PC@XL#A&.RGN3D;;#/GJ,M@)7U?"A:\]O&3Q'[8]ZL9R
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M,8-9Y-MO=4QL[M(N5A?69S,MLJW$C0(M]F670L]@7PL@RL ZR$E!D8C5-_C
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>=@C!S<S5>IZ-*4:4HTI1I2C2E&E*-*4:4HTI7__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>41
<FILENAME>g723949g74x93.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g74x93.jpg
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M 0 # 0$! 0           0(#!08$" <)_\0 51$  @$" @4'!P8("@D$ P
M  $" Q$$(042,4%1!A-A<8&1\!0BDJ&QP=$5,E/2T^$'%A="55:R\1@C-#94
M<G.3I=0()#,U4F)TM+4W=7:S8Y66_]H # ,!  (1 Q$ /P#W\8 P!@# & ,
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MZO[;,CGU'S# & , 8 P!@# & , 8 P!@# & , 8 P"OWK/\ N5O3'^;]<O\
M)S),[707^^]#?^ZZ/_[NB>6Y<_S)Y8?_ !;E!_XG%G@:XXZ4ZYXXYZ[[[ZUQ
MQQQK?77?76]:YYYYUK>^NNM[UK6M:WO>]ZUK7VY^HS_+%)R:BDVVTDEFVWDD
MEQ;+!+>2/5C=)1=QYD]"(((\=**K+4Q8Z222?&OMZ[44[C?/'''.M;WUUUO7
M.M?N[W]F=4M.Z#>2TSHEMY)+26";?4E6NSUDN0/+J,7*7(SE7&,4W*3Y/:72
M26;;;PEDDMK(_A50VQ9+XN+KJL+$GQ./_+V>'0J%264O@FE5EFZ6R[0$,?N!
MOS'#==!/ZU-'[ZR"R7/V]I=\\_5B,?@<)&G/%XW"86%6_-3Q.)HT(U;)-\W*
MK."G9--ZK>33V,ZG1O)_3VF:N(H:(T+I;2E;"6\KHZ.T=C,;5PVM*4(^44\-
M1J3HWG"<5SBC>4916<6ED9#1-WQ$Q'H]*Z;M6,'Y<00$Q0'(:\EP4Q)RKI9)
MLV&1X82$-GIH@Y<+H((,AJ#ERLLLDDFGUVIQSO-+2>C:].K5H:0P-:E0BYUZ
MM'%X>I3HP2<G.K4A4E"G!)-N4W&*2;;LF<V+Y+\IL!B,)A,=R>TY@L5CZL:&
M!PV+T3C\/7QM><E"%'"4JU"%3$5IRE&,:=&,YRE**46VD]S_ *D+UE_BO^B/
M_P!E+*_X9SY_EW0?Z:T1_P#L\%]N=C^3_EW^I7*S_P#G=+_Y,AMG#I>1DB\-
M'Q62/Y>U<%6CF*LP9-U)&[L$D[<&VJX-!KV31<!T&#Y8JBHUY4'I,G:COE'A
MLMUQ]\L10C16(E7HQH24)1KRJPC1<:KBJ355R4&JCG%4VI6FY14;N2OYVGH[
M2%;&3T=1P.,JZ0A.O3G@:>&K3QD)X6-2>)A+#1@ZT98>-*K*O%P3I1IU'445
M"5OJA5?SRR3/Y=KJ$RZ?2#;95YH%"XV9E)GZ1#?'*SK\,!LGSWZ9'I1/E5?Y
M'RD]J<:[[UOKG[9B,5A<'3YW%XG#X6EK*/.XFM3H4]9WM'7JRC&[L[*]\GP.
M31NBM*:9Q'DFB-&X_2F+U)5/)M'8/$8W$<W&RE4YG#4ZM34BVE*6KJIM7>:/
MY=0:;<RW\@]0^4\SK\2T'_)?4?+:EOXOU]FN17Y<VT_&/Q+>]ZUIC]']3O[=
M?8E^[CRG#<QY5Y10\FU.<\HYVGS'-_\ 'SVMS>I_S:VKTF?DO2:Q_P E/1V.
M^5.>\G^3?)*_E_/_ $/DG-^4<[_^/F]?H/[S:O9]6I?4?L:#S" 'NFR;SD)-
M8T:BI?IFMUWRDZY&G63!YMLKTGWRFOI':7?7'>N>][YW]DP^*PN,I\[A,3A\
M52UG'G<-6I5Z>LK7CKTI3CK*ZNKW5\S6DM$Z5T-B%A-+Z,TAHK%."J+#:2P>
M(P-=TY7U:BHXFG2J.$K-*2CJMIV>1T*^#Y_=YU9_D_9G\GLBSRG+_P#FOCO[
M7!_]W1/ZU_H^_P#JAH7_ */3/_B\4>R[/ST?Z'# & , 8 P!@# & , 8 P!@
M# & , 8 P!@# & , 8!RUN;X<)RV9=ZJE#>_EHQQZ6,U$50&\5XN2XA.ZN@D
MD@J"RKA.P16Y(7:[D:<R@A5LA%_R3.HU$Y Y:2A4-PFJ-)VMT7\;.CW;#^IW
MX<ADS*"TBXOUXSX)>N!'IS3+F!NE>^6HZ0VM(/P!RZU8".G<]&I6>SBD3M#;
M9)M'(76-9 NX$4_+G#I0+]&ZWW^_KWFO6IYI/>9/#WM,H/NJP7LL:.;L]2PB
M6P4Y,:C,QJ3AZ>:L (XTXB\W=+3;EP5BG4SG7)E9&+3R:G2ILG"VN^D4.06;
MCV+U_?EP.LV#(P!@# & , 8!I9N./23_ +=(+->$^DTN-<J]JZ[^WCG[N_MU
MPCWS]F_^[^N__P 9T.D-%5\7B76IU*,8N,(VFYJ5XJS^;"2]9WF!TG0PN'C1
MJ0K.2E)WA&#C:3NOG5(OU&)_)A+]\,?](X_FV?#\@XKZ7#^E4^R/L^6\+]'B
M/0I_:C\F$OWPQ_TCC^;8^0<5]+A_2J?9#Y;POT>(]"G]J/R82_?#'_2./YMC
MY!Q7TN']*I]D/EO"_1XCT*?VH_)A+]\,?](X_FV/D'%?2X?TJGV0^6\+]'B/
M0I_:C\F$OWPQ_P!(X_FV/D'%?2X?TJGV0^6\+]'B/0I_:C\F$OWPQ_TCC^;8
M^0<5]+A_2J?9#Y;POT>(]"G]J/R82_?#'_2./YMCY!Q7TN']*I]D/EO"_1XC
MT*?VI(#%#MJR:-E-\]=H-T4N]\;WOG?2?'/.]\[WKG>^=[U^Y]NM;^S_ -^M
M9Z;#TW1H4:4FG*G2IPDU>S<8I.U[.UUE=)VW(\[B*BJUZU6*:C4J3G%.UTI2
M;5[-J]GG9M7WL^K.8X1@# & , 8 P!@# & , 8 P!@# & , 8!7[UG_<K>F/
M\WZY?Y.9)G:Z"_WWH;_W71__ '=$\MRY_F3RP_\ BW*#_P 3BSP4"?\ K49_
M_<&7_P#TIY^H*G^SJ?U)?LL_RVP_\HH?VU+]N)WSNZG0]I^\;<&Q#VY(X;8[
M67/),VJ6*12QTIH@I'@S$J]C]?DWI>-PD_+OP]HJ]$BV!I+M\IOOELBZZ0<)
MZ_E^C=(U<#R8P$\1R;HXC!O#PHO'U\1A'AGSM24(5L53C3K8FEA]>2C4G*F]
M3*[5TS]4<I.3^'TY^%#3U' ?A*QFCM+T\?4QL= 8' Z8CI&'D>&I8BKA=%5Z
MM?":,Q6/YJG*I0HT\0G4DWJPGJS1%D2L$1Z$[^*988&2L_-HF<K461:228J2
M$1N*<L[B%-5G$E_(8D\<9'Y8N/53+MA XBFG()"X;.G/;#3HCK[:^$GHE<B<
M)5HRTO4PORG"5'#JC/G];1U5I4?*JE*E*E04TX.I.+=*DFEKVB='H_2N'Y62
M_#?I;"8RGR.P^DWR8JT\9I%XK#O *EI^A"4\;\F4,5B:6*QTZ,E7A0I54L7B
MY0G-T]>J5^FMHQ2K_+MB5 IZ=Y])6)/[&K"60K<5XLU2.TOJ!+&WA>7#)78H
M.-/$Y/+$2+6/;91ECSVW8M>G3]YO>T$N>UP^"KXW3>$T@M#/0^$PN$QM#$\^
M\$JVD?*E2C3P\Z&$JUH\S0<'6UJTK.3481R;?E-):;P&A.1.E^3[Y;?CCI?2
MNE]"X_1OD*TR\)R<^2YXBIB,?1Q^EL/@ZBQN/C4AA>;P=).%.&O4GG&V,(V/
M86OAQQ(QJ>3/193VI/!O934H.:(]CDJ/KYTDP[>Z??4],DW*RKA-KM7:'"ZJ
MBO*>E.^NM[CA,+^-]:GY-A^;_%O#3U.9IZFN])XJ+GJZMM;52CK6O9)7LC@K
M:8TNOP/X#$?*FD?*'^$?2=%U_+L3SSHQY-:+G&DZO.Z[IJ<I34'+54FY)7;9
MF/AP6^2$V]S6S*+Q'I]8D=OXA-;)(#%B]BE@;*@YP<'0YF;)NW+<"!2DX%.2
M$U@K!D<D!!5-N9+NQ;-N/UCE=@(5,!Y9*MB-7"5M%QP^#A-4\)"K+2F&ISQ$
MJ4(Q=6JZ-5T8*I*5*E!-TZ<9RE,^C\#_ "@K4-/_ "/3P6 =72^$Y4UM):9K
M498C2^(PU/DOI+$T='T\36G..%PJQN&6,K2PU.GB<75<88BO.C3C2-,\W$VL
MF\R7G2T+LZ&U'<,IL2N)?V^FLV'5H/LVL(V&EC K7[6<FG8T&R="9,6#RO84
MP6'(FD4>]-=NU&BR:7T:7A*CIG1FD<1@\1C]'T,)C*"AAL-/&3P>-K5,/*GB
MWAJ49U91J4:=2ASE.G-TVUK:JDF^NY'5H8WD7RFY.:.TWH[0'*#&Z6T1I!U=
M):2HZ&HZ9T+@\/CJ5?15/2>(J4</3J4,97H8YX>O7I1Q$8M0UW":C+7IJ;3"
ME8WY3G4*L</*[5EGEVPJLG-JQ_K\=<OP;"P95#OJX_*W;;@@J1 B.'T#%6,(
M5Y<D0H/A0$9=@W#-=;X-"X;#Z2K:<PV(P=2A@:&F\+C<-@:JYJ,*LL)0Q%JM
M",G#4JU''%3P=1.,*M3^,IQJJ27?\M-)Z0Y-X/D-I/1NE\/C]-X_D3I;0>E-
M.X1^5SK8:EI7&X!U,)CJD%5=;"4(U=&4-+T)*=;#X:^&Q$\-*$I:)Z,;@2OC
M.AGM;3PK<4"@-N6-&9//YN,>QF=1B>3D&$D Z ,8@\>GTQ4!<Q^+.I(,),9A
M(DC!]4UT[:QQRUY8N_IT0ZL.46E(XS"T\!BL5@,'6HX;#3C6PU;"X:K4I3Q4
ML1&-)SQ2JUXT9PGAZ3ITU3U958RUEU?+".$K_@ZY+U-#:4K\H=%Z*T_I?!XW
M2VDJ-7!Z4P6D])8;#XJCHJGH^I4Q2P^BYX7!3QE&M3TABXU\5+$:\,+.'-SS
M7P?/[O.K/\G[,_D]D6<?+_\ FOCO[7!_]W1/H_T??_5#0O\ T>F?_%XH]EV?
MGH_T.& , 8 P!@# & , 8 P!@# & , 8 P!@# & , TZQ"4E#U_.B\,8."LP
M%0Z3DHH+:!F<B=$I*Q"/G()@VCY&85Z/.N'A1)JW1#/I_!V9-13EDYF$907[
M-,@.8/ENV_24G] #:ZM:P/3D'DI.%R&T=U9ZC\X^5 ,3F]?1*01**S9U3<I\
MPVG)3D5)Q&06%!&[A*T)G-G7#.1L>DPY_GIV1'O%C3M;=V-Y=:?N[SK?@R,
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M1JY8+N0I\>W)L.W8]\D@_&ON6[GA-\,?MV[\<\X78OFZ#M!9'@8-RP!@# &
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MY44%3\V79[3K_@R, 8 P#QXB/BW6\\_]I (4+WYY:\157;CP7\GG\P?GY.'
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M=XY:(+#DFI+5O?8N_P")Z!L'&, 8 P!@# & , 8 P!@# & , 8 P!@# & ,
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MA8UB2F.2U*-2WU5&S]?K\5K)Z]C$[IYF5=OH4AHK+R$8)H+B8^VB6ENM-I0
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M"ZMJ!5W)&U5N[([1$NSG,UX'#DE?579Q:V96OELVVWVME9'HBP<8P"I'OO\
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M A-(^Q^PEK3,)*78]4X*:ZT:,ZTW8/D$M:+%-:XUH@[^<!O6 , 8 P!@# &
M, 8 P!@# & , 8!Y^/A\CNIK[QOL_,Y7YYFNXN;]#"8H$B-,"XZ:X)PBQ:?<
MC;(B4R?^:ZN7.$P"-K2Z-3^11*QK #*"9C4@5Q))E(@\CEKL::5DTN&=^*=U
MDW;-99)[>A%TKTZ^(>XD'I#]!"<D'"4GU6-:)X/]>:'8M[VE$94K-S$6</\
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M:DFG;,YK4!\/OKS9Y-\F>J/AJ1()7WH./^=*ID%L4XL:(-*]]N1*214=.IE
M[/)EG1'L7;'XV?.EJ6N!QTLO!S+M&&%$U*R?=C HTY7;4G=7>>^+V7RW<5;-
M;,[%XIO\3^KXWXTX]MPZG;RN"N0.I1Q<4-K\7 &%G^?7=>C#3JT!MP16R+!@
M'X$8K8L"=1R3@ACTP=V2<#W@@83!/D"_0RHMO5NDWLO>SX6LGM\9EUJ-LXQ<
M=8QRQ3E3V-21"0\OU=US:^H7J<!VK4BZ9L7975?S">1;2)MFW0-#-,).^6T,
M?M-/TF+_ .I9-Q&K.UT^E;/78EK!!@# & , 8 P!@# & , 8 P!@# & , 8
MP!@# & , 8!#WH:;R^LJ O*R*]CFYA/J^IZS)O!XER/)%^I3+XG"S9Z-1SD4
M'ZX+D]FS3!D,T/%=\$GNW7TS'KERJEO1A;4<5?A*-FAWTCZ!GA6-QJ,S!R*F
MK-8H(\>^L: ?7(@?G,0D)FZ'#Z^]+5M5"1ERF#CCBCJE<_7S H!>6E,5EDF$
M= PX;EL2]Z=NC+VO9LLCT%X,# *D>^_[AKV)_FQ7I_)I)<%6U=:]I;?!!@#
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M>6S:5C]*?]I=\,3_ "*]Z_R=TW@J^;+L]ITQP9& , 8 P!@# & , 8 P!@#
M.4GQMJ3JJZ?AB^NMVC"A$P5JFEK'N2N7)'ZI)[#K-@D'D+R+2X&]8N6CMH1'
M=KNFRR>ENF108]?ARS5\*?O&2XU!M3C;_B2[&\S3/ABMV_C\Q)?AAR!HU'"Z
MYCS_ - >1)'RT09[L_S+9<J=&9 ().&J";<I95$6=)7\+G;]QTF7D<>.5_-7
MC7M<Z1=;"7G>=V/KMM[;-]YV.P9& , 8 P!@# & , 8 P!@# & , 8 P!@#
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M( \4#/\ O@EVG'P1!L>E0R/2\5)M=&WN1<W]'=?_ . L._V9"?S'!!^CNO\
M_ 6'?[,A/YC@'\',$K=FW<.W4+A3=JU15<N7"T;!\)(-T$^E5EE>^F6N>$TD
M^>N^^M[UKGGG>]_N:P"M/G[5"3&4W>(K>EA3&.")A'I60L93\ER>&61)[1B
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MJJRCERY=/'BSA\0?OG:R[TB2?N7) D_<.7[]RY>.%EU(79DC-X P!@# & ,
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M<(2DX*+JR<G&*>(U*LX.%/)Q4::U><=N<DVM6R4I2WJ-&+T)SF90N-W]^<=
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M7IN)%(R#L\\SC[B>*&FX9!AW.OVOLZNGB;NK;5>W#HS5^GCNS/0AE,# & ,
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MV_\ >$?]%Q_Z<<W3^CAZ,?@.<J?23]*7Q/WPGPG]NN...-;_ '=ZXYUS]O\
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MO2"C9CIGI@.&MF@J?FRV?F[DO8=J,&!@# & , 8 P!@# & , 8 P!@# & ,
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M73M5,>C%VB/"2H9?=XW>LC63>:O2;N6]R2)W4H(7"2<M+&#PQ/9^29V8^0T
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M0BA.'JCK:]"3VQXIR,*OQ1%RYYC!EYR*5*)K!VW+-\[1<]LTU'&V_":RFEN
M<G+)V[DO8D869?";\Y3CTLKZH+6+ZL:6"M88&S.P 7TQ9@BN>3T>>#'S)BWA
MS0GRV9QI584WX<1YDY;CM-.UF#1)HQVFW2#7=K96LUL6_IM?UDA>Q?AS4A[=
MD$+DEKS;T+%7\%#D@8E"F[SFU7"7;,H]1?KK%PT?=Z&/R/"R//"9/;5-_P!-
MON-7#A=NV9IM@4G'9OZ$_:F;?9/ANI+2\KQ3R%();>(^M(<-A8L7)(W=$X"6
MNZ0@O*/(CLY9+<CU(#W3K2.MED2RCMD\Z^4IRU049C^F@FLT];*^>Y;^AY#S
M#X;J3R;4\^IRNI;>,AC%C$BQ0Z3LVZ)Q.Y<P7,QYI&77$6DQ(BF0B7*3!FFN
MU6C_ $/>H$]_B6G6W23;MN*Y-V;MET)>Q$2^3?A;>?/&]GN[9K&?^FY-(W<7
M*1+L=;/H:?6-$^1I=X,>N7'Y8,/.12Y)-44WY9O'B+G;/GM91OQPXZX73!R;
M5G:W0DO8D8B=?";\XV#Z37]2FK%]6,[ <3Z/6,H  >F+,"UWR<C3@4Y8LFT/
M9D^6[&/+*"&W+D"P=-F&FZB[-FFT:=)H)!K.VKE;/<M_3:_5F2+[&^'52/MX
MY"9!:\V]!Q5[ Q18.(0IJ\9K5HMVU,.VKURJ9$1]WH:1?IK->.$2735-]]/O
M35===N@T3;@I..RW<G[4S9[%\*4[9WEF*>19!)[L9US#141$!Y6 N2;"+>4:
MPU1LJ/V5L]$AW(S'UW35+1AN26<,'O/"&N6:/T([;,36=];?F]BMGT/(JC$/
M@>>$(;'BS-B+NU[8;XWV?#^AGE^V8T])0MU^$,@R3"&W0 -A)>)CJ+9BFMN*
MK.GT:>.U5ER0I]O:7*0KG)[^RRMUVM:_38XI^/\ X,GQ.O*_Q>8_:@>Z)<:\
M7P::R5^UM*:WKN7R*?TB_;&.PM22Z"JD$3IB7J)/QPLZ[>Q$3"61QFYFD>>I
MNF8AGT.24X.%M7SLMBMGQOXX'LIP<)&P2M18"Q+ GX]UWSNQV<,5.@E6R2C#
MF50UB3!IS!NMOKY_)4Q%U8U&R:>_M0^@A4?[:?3K[?\ ;L".$?+%3$:NBE73
MP+U/AT;?S>1NR1)X4#NSTXM,3/A5J3%ZF ),-)/YWJU+%<OV::O;$>M*7*@M
M)LX9#7+0"#8=\/*KA-@2:?3*0RN6NEC"!&MV8*5637'55IH'+3,=*19_%+'3
M6 D7K:WY;'"+:O4JZ@CJ.+;9\P!!Z2/D3 M_O]7P)B:>,/,["'#8"SK!JVB@
M;@=R''(R6:<+B50U51*DPKX86U)/QD>6"5K!(@""&6A!$J'>@&$H&O&LMX[.
M]A=^.NY,5:UC#:CC'Y/@C DP"=')+)G'XU)Y3,C#^03$^1E$F,%)--#4@DI8
M@8/EB!)VY)EW:GSG/7"6TT>4TN!#?L 8 P!@# & , 8 P!@# & <MO6I*B:Y
MN0#Q.?9OJ;S](+49/#S^'5@.&3^!*"(E'WBK^12 I,Z O!*B ?0&)%W.WL?E
ME4#"_<?E<B8\N2(F6F6PTMFQ.V_A=Y97S[4R\4C\]T_.85"(#9,+'VN"KLQ&
M)+$U[64=6/(1TKB#E)V#ENY1+URT@7DZ*Z??U1M4CT]?M73\8]47%/WC)82[
M6PU4?Y#\X"B3(N/JP.U(#[1(7,U<)D9#O[MB$G,8?+F%4>S'2#H<W(P>#E14
M4=)+1 (7A$,+A@+ E%(^Z'!=^JW8(;Y#\X5^0K4I#JL#@W]0.90[KIR@2D*_
M<<5F Q$(9XXY>&'*9-LB$;- D>9&N"+.'AF3$3$4 8]BT;(B&N>C../TQ^"%
M/N<_,UZPF7&N_NZ^_KC?A?VCO?/WOL^]]W>]?;]W[?L^W]W[/MP5;'U>]%M,
M$& , 8 P!@# & ?.[;(O6CIFX217;NVZS9=!PEI=NLBNGTDJDNCUO7*R*G'?
M7"J76]:4XWUQO>M;P#COY%^%O(/A[U_)4/*%FQ$;,S%A2R>&H$YCMC1V@;3#
M'GNGPN"2^.2RU[TDL#/0YEON(0*YJW*L3@R*LHRWLZ%74J =:/#4I:SSX6OO
M]U^WO1I/PD/8-)^C;T^))"X96DWI^TX%Z* OIS!Y[TQV[:,/R('@A<< 6:GB
MGUK +<T&MTX0^G'B444; CQATV:OY2L,'"RBXJ.S-7R\<+>$=QL&!@# & ,
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M[,XX2>"; (C"JBW2#!<>FVX((KJKM44M!K7332S2LU&*L[K>DMUSJI@R, 8
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M38:*%CF2/#=FP'#V:2+1DR:()\(-FK9%)!!'CA-)/CCG7.@,C@# & , 8!\
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M-3VL/CB$4#LCPMZX%OG'4\<2E!^8'"'<3;.3HOCQUON+:8(, 8 P!@# & ,
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>42
<FILENAME>g723949g75n05.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g75n05.jpg
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M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\
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MLB0G0T9W@H63E):BU"A$1V;"U45C9&5H@X27MV>&DJ;%_]H # ,!  (1 Q$
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M-$31$T1-$31$T1-$31$T1-$31$T1-$6&LC_39E^+B_\ K+C7W=5_P%3[:?\
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MD](RY\-NW^D%*/7(K],31$T1-$31$T1-$31$T1-$31$T11QL?T^E_P 8.O\
M2FUU&B?Q:A]K;YE^>:Q_C^E_;ZGG6MK9I&LKAES>CE^T-4)#)+/<Y=\-1TF^
M2(M(5[&.-XNNMJ?!PYE@,I%QDDC(+RKXC#R[>8=&2=.P<KMRJAL+'7.%E!@L
MTTFO(V%SIDG>;;<E*"*Q;BBH9DN>6XH[6 R'=:5&,;LS;323".FX6O2#I=C;
M9BN$431<2S,5%8L;4Y2,JG'HFCP7(4SGNEB+WN8&$2T.)!,R"8D3,1PWF5HK
ML6Y##4RTOV\9EE&K%W!Q6YJ#O^/*$I(';620P'CLKC%;?':B2B/0P5N=#EK;
M:7[4BR8/'+]D8.EPL910MX4WC#1PNZ/HRUSHL'NZV*VYT";[>U3]W79"=KYM
M\._)>+ZH^RT>8ELQ6.I5J"F(&!>6J*L.'&Z[9PRE[,^C8-F5*'D#3!A?O4 5
M0:G;H];M5%(Y:U)O5KM<<$-:"2#:'C8!*L;(=XOV[?..)L"3>$R;>[EB3(5%
MS]*V+)%OK<A=%J=5)-999OB-M5DY!"Q&FGA C9>8C9]2)AA;G2E4#KE*#=&W
MU]<E=H;1IO>'FH'M<P!@(:"=KYRX6NIVH;N-M[O*!\*(Y6KRV40L+JI'I@-Y
MCVE[Q-#JI.HD5#1@,172.BJ4P^;[(] ]*A@$.2P=#5#.DPG#$XI&6_.5A'<0
MS:%WI>'L0K5N4BDQN>!0A4$@*?IPN02]90+P;I'U+U / ^H>NBR4B>ATBY\%
MFW^DI\)I)(EZ$4TTB<B/2F0I"\C\H])0 .1^R/&BUIG-:^-ED:RMV3-Y68;.
MU;R&3"[HLAXA0E7J1%I*O8WQJSK\?3:S&**@92-C5F;L\H[(R%NWEUUF[IR5
MPJW25 MFOU6T6-/4Z)K^!<XF3Q*RAE-KB;;:MG_=+#QJ9<BFQ":9MU5CYLL>
MSN2=1-(J5N9E*\AR7VJ[DEBUY2WJM%UD6'=;D$QP=%<%1F.KT=(^#BL8RG.^
M[@H'L-Z&0:M#4#)+K<.AF"=F9NH#D;;Y&[>K!5X&*@+7(,6D^ACB[%JS:?/+
M4)&0,\1>6RQS+"QM8MVH9%LJLW0.6P:#27-Z(L #L-0U 22!;$,40> $*B[B
M?^L7Q4_[Y=KO^@PKHE/PM%^UU?,];PSD(H42*%*<A@X,0Y0,4P?:$I@$!#^T
M-%HJ ODVG^Z= EY5OV_X!XG[?82Z.O\ A! 7KZ.GIZNGX>KCGCTYXT6S)]JY
MG^,;_P#ZM6-E&NY-L?B(1<%BR^,,7.%MF *3]N&J1ENEF,&AFUZ)659AYI3W
M?2EWTJ>/ [^982K)K%I20$CU'RS19&=G"1Z?E5F.:-&)>W'\_L)(!/1C,B\1
M-I$JSYC>#EW$.&,ZQUVG*W=LIXQW'PFWJGY%>U9:(A99&ZQ]=F8:Y7"H57NB
M9Y78>5EG<C%5A!)*57C6#%HV[JZRRT)T+'O80"UKJ1JN:#.4@M:3O.TY!5#%
MVZ2RQF;<3T5+/C[<S4\I/96M6D[_  4_Q;,XUGT(A>3@;#$/HZKP$1(U*7?M
ME8.1BIPS^7BC.&+]&:>%*Y1,1](%CW='T18)'6#@X;B))#MLY<-JKNW"^;K\
MEXULN?[#F2AF@X/YM\!6<8SM+@*S5)IY3K%:X>N6W(.2VG,U7F<3(L"M9-O!
MQB# U<A$'KLRDF^?O!;,K]OR>OFBJVDUXIACKX"7 DN (!(:W;/';P"PVCNU
MNU7M>#74/N\KVX9[=LO8XQSDS'E<PU&M,:Q+*^RR,%+OZ9E&N0"!VRU:?N2!
M!I6"VRJMB(4JZC<0(LV$LG0M(>#2Z/"UQ8XO.(P)$M)O;.!92$J4KNHS?DO<
MW#5S.L=BNFXBRR[I%#&-QG3K5+2CX:?5IT\;:%;"U62-6(<TFV7($8DSLLHO
M.2!%+$T;1<>W,6(]%393)IXB]DNZQ %R);_2MMME;-42@;L,GSC;:1D>V^R8
MFDY.NE_V[9H@HY@W4C8;-,7*S,#1+- 2BZ2DPVAK-8ZE)Q7D',@HQ:(S\4BJ
M+B12!54I=18.E:V2YK6U&':6$ D$6$@&9C9QM)'!>3+CEC)^XF7&00'$%#O3
M'$>.F"3!DFM(6>E1A395LB\F5$7SYH:T2:5;BB%=FCTBUY^H1+S*RW;+%4:U
MC*8^G<W&[@'>"([!)[5L#QM]+I'_ +M)_H":^'K7^%I_:_\ XBNIY.?Q?2/M
MP_V LCZ^6NB31$T1-$31$T1-$31$T1-$31$T1-$31$T18:R/]-F7XN+_ .LN
M-?=U7_ 5/MI_V&+C^47\:H_<X_O*BUC>(QEN.QSM\7IZMI8TZ5SM9H3#+2R/
MU^RVK=?MCCM7ZU/.D>\1A!TE.:!5R@ J-WSZ-[8&65234^FOCZ,S%4F)%,%\
M;R/!'>86"]GV7\&53=1E# >$+W6[1B?)U/KF5\=MH!Z*[*MWJL0[2G9%JG2J
MFBL>0G86"AKN'2F" -VLB8JAE.XFFN<[J]9CS2;4>TA[7%KIS+29:=UB2,]R
M]\+>MWF3:)N;R=!YY@Z$PP;EC<#6:/5VN*JC8"6Z*Q7,RKQBSNTQ+D,Y:LE6
M"+>M-35MM'2R)&BT[(R<LZ=$:(.[SH6T6NIL+"2]M,N.,]4NCP0/'<G/)4B2
ME\A9DW(^'+E1M?5*8IDO =_O8U^.J\!*L:^J\I>,;%=8=BZEDG#UXSMR<HA$
MBX?*JNX%O&HNHE1-VY<G,5H:REI+<,X:C1F;C$0W+(C/BLSXGW<42C4O*=EW
M!WVLTIDWW69[QG4WAX,D6@\CZ;9U48UFJC6XDWG9-&.)W'LL_3.^D#\K/':Z
MP\Z+&^BXN8*32?G3'&^TSO/D"L^TVZ@;EMX>U%NVE8V]839XERIF>DIJ(+*U
MFV9&A+&UHZ$@XC9)!$DB]IK4LD]B/-M#*1CP[AXV O=%0Q2 ZE1JYM?C:P[P
MTC%F-^1NIJY8Q-B[(4AC>S7\B,=-8RO<-;*)96\L2NRT?843*(-XA*7(=%PY
MB9T52MY2MBL+*=!)NBZ;+]E,H%A8][<0;<.:0YL2"-\<-^Q1KW\M&I:UMI,5
MLW Q]ZNVXIS BF!CE/:G?6!A O)@/_P@'D#?9YT62@3B?<_P53;_ $5\\0A!
M!#%6)@1121 VZ;;R)@23(GU<7E#CGH .>.1XY^3G1*!)<^3/SJI_LJ?>BUU^
M>?.&;L,91M6[+,+S,-.K>7\3VZDU[:I$RD@8)%#^#K**6V3DHTJ28MUV>5KA
M(V2&8&660*NR\N"XE:B591N]<[=W>OHLIO:*+,!+'!W2_P#YEH/]40>!XK;0
M&]3;U#XGQ%EN^Y"AJ+ YDK:<[5R2H2#HRCILSCU;##B>,8O ![7'T@2+D@4!
M("NTU"$ZN@W26IT-0O>QK22PP<A;8;D9YK!N8MPN+=P4W5L"U#+53A,9VVMQ
MM^S??W5I9587.+910_L3&59<2SF+>^\.5A062G%D@1<0./DI-T8/-S\/R5V4
MWTP:A8XO:2UC0)ZVUQB;-V;W1N*N/PR)FN/-GF-(.#EX9Z[KC_([>3BHV19N
MW<(D^RYD)U$I2+-NLHO'E>QX$<QY72:7FFG"[?N)?'HHTH'IG$@W#;D1/4;,
M=ZO[?RV;CLYW&K"@B*WS,9T>Z*1!5Y B)0'N=/7R    //H   >FBKHY/34Q
M-L62LW<ZV;I>'ADY1)!%,YMMZ0&.FD0AS -7CC" F*4!$!$ $0$?40 1]0T5
MJ1/MEM_^$/I6.$[1N:P>.TVU7',$#>JGF7(6-<06O%+?'$#7X6GA?JM).XB0
MIUL:+K6YZK5W$.1H[4LDC(ISQ#F=@TC.HK5)ZR?7;Y+=JF*3^E#6%I8USVOQ
M$DX3<$97FQ$1Q6,IG>'8[[>\T TW,-]O<9C;(EKQM0*4RP+)Y0);5Z0N$:_M
MV0+(I5IPZ498)Y-ZW8P51>U^2BX=NFJZ=+/S@=1Z^OKL6040T,^==)B:'.=T
MF&,5X:)&0BY!G<KG/N7W$YL:['XK&TW%82G]Q]<SVGDAY*TEM: J\KB1.OI.
M)JO0-F\NZ/W7;2>&M,9%V+11O/QCJ:+*HL !4J]%3IFL7#&*9IEHF)QS8D3P
MGL.^5>.7,G9$QW;(:@9&WJ47$R,30*P+*1K&.:O<LRY9N+@CPEFM,UC=U V5
MA2*JFY:H(P$-6XB25E%%GP^WDA: U(]>SUXJ&-:YI>V@7RXV<XAC ,@'2,1W
MD]D+%T3NMW%7/ &'I"FVBK_-.L>])QMGD+M,T%>)A[-5VS>\$1MLQ0)/R<I6
MGQVT?#S4I -E8>41=QCB,*,8+M=HD5NAIA]20["VB*F$.N"8L'9$; >.14A?
M>;/^+\VU? ]NS$ED=GG[&.4WV,,@R-"J-<L^.\E8ZC(MZ\(\BZU'M:S/U55A
M/MI6/2DXE:03?,?9[MR^:BJHX+&!3=3-0,P]&]H>W$XAS7'B20[?%MHW*R6.
MZ;)MQVZX+C(%XT@MS>3\N1VW^TE&*C'QZ=<*!.O4\X6IS7'#=:-\M%52JS4Z
M1F+8[5A[PPO2B)032$K=$QM5\B:36=(+FX<.H)SS,6G+,W6S9#^61_"I_KAJ
MK_ =_5=YBL%/^$9_7;_M!2CUR*_34T1-$31$T1-$31$T1-$31$T1-$4<;']/
MI?\ &#K_ $IM=1HG\6H?:V^9?GFL?X_I?V^IYU!JX;<,E0&5K;F3;;E:%QO.
M9(1BC9.HEYI:MWQU<9J#9^S8JV-V\=/5N<J]D2C@*SDW,4_4:SA$T%GS4'2:
MJ[C8]?7]H6%M1I8&56EP;X+FG"X YC(@B<I$C>K&=;-\AV""S?:+GG%&>W#Y
MJQW\R5+)+>D!%U/&.,W3T%Y6H4*E-;#YU%&027?+.99[932#F7,QES DNW=D
MD"L*[06 ,(IL.+#BNYVPN,1;L^28]9QK4*MCB"Q4QB&JU-@:;'T1",=(I*).
M:\PADH+RKPH%*"WFF"8D=F$.5S*JG.(F.(B6$O<7%TF2[%F<YE0^QELLGZ"K
MM90?Y63LL5M9M68'M93<U=9O)S5,R- /H.NUAZ^-8')&[RFI2!T@E"MED9&/
M:LV24='=D5A+*ZLUQJD-(-5K0;V#@02>PP+=MUF+<9MV4S0MC:XU"UDQOF+#
MUO:VG'N0@AC3A&K5<R;:TU.<B4Y*'5EJO;(D#,I2/+)M!,=)N?N&;B\:NRI2
MJ8,0(Q,>(<V8[",Q(/!2430+P0ZJ3<7'245%$TP !5X#K,03<G HFYZ>HPFX
MXY$1]=%CD[S';L6",CX27ON;MNF7T[&E%HX'>93=KP)XL[M2S!D>D%J"9$I$
MK]N6)]D'#SYS'92/G2_Q8H-1^?Z*[*F%E1L3T@:)W09[Y6?]%C4,K9MPR;6\
MJ7#,&VS+$)CF5R6$8XR;0+W2E;QCJV3\0S"-C[@R1C9^M3E6L?LXI&LLK%OE
M6D\*2#B0;@Z2,LJ6<56E@949BP^ YIPN O()@R-UEXJGL[3ESY@M&X>]K9BR
M1FV@.,4V*<CH)"EU^GXS7*X4+3,>02;R86B&Y)%S[9<RSZ1?/G\RU92:B2#H
MCHSPCJW@"FW UCL0!.(EV]UA.[L7A@MN^Y@L=1,=6C<^V/BB@25=7+(46C2]
M'S/>8"JJH'AJC;[XTO;V,9QRR;5FSLDE6Z]'R=E9(.&[L[?VDZ.!2:E+K.%+
MKN!\(AS 3F0V)G.)-C==>1]FCR^P.["%3R"VBS;F+IBNVMG!ZTJ["G%QLG2"
M*,%TBSC<9PTO[GG$CE,\4#'SY0,@Z\L/?(VL&FD</\&U[3?/%BOE:,7D4[-%
MKK /S$EOX4O\([WC2\O\P$<)>Z/LL_>[PY$"]^\?MKS_ $=KH#V9[+]E]?7_
M !OS_'\7T63I/G/11_PG23/]'#$>65Z/F-+?PFAW">\"?EQP2&&O=7V8;O=X
M,@#=_>#VQY[H[?0/LWV9[-ZNK^->>X_B^FR.SR3\:=)\YZ*/^$Z29_HX8CRR
ML+V#9BPM,7N"82=[?1TCE[,U<S?2+)!1"2$QBRYT^)K#2LOVI7CYVUGU6,E6
MP=.043C4WD=(.HTI6JPDD"%<5H-,ALX*9IN!-G DSEE,\<I5VT_$NXM_D*GW
M',V?(F7@: VE21E&Q'3YW&T)>)628C'$G<H*/KQ:#SY(]$QWC"L,4F$"A+BC
M(=!BM_++%!?3PN:RF071=[L4 ?4V$'CG"H4%M";-=IETVM35X=.6UQ-DPRMQ
MAXGV:X8#?;O.W1H)(E:2>%<IQ"TL@Q>MSR"1)ELV<$$[$KSA I=6FLVJ&Y8;
M'^B(-^(5@6+:CG[(T#B2O9"SICQE#81OV-+S4X/'&'WU:C;(]QM*,EV2MU/)
M7^:4 %HI!XU9Q541KT1'23PLFJA)),F3! K"M3:7EM-TO:YI+GXB,6ZP[Y)L
M(VRL88@INX&9S3O=?X;R[4Z$PD=P*T#,1=VQRZO2,<Y)CVFKHW2GG96VK UL
M::+T6;EC.)S<!(I,(LRK5 [14'96>ZF&4 ]CG'HP06NPVQ&QL;=EU6]RU.P_
MMYV6M=MY;%,.KO,1;M3"*)6RTED'(&=(NUQMRC)R+29ME -+O,ES45*2PD,D
MDSBY-R@0XLDC%!Z^GT**1?5K=) PCP\H;3B"+[,-IS.><J:NW+% 82PECK&J
MRQ7DO 0"2UJD@/W!F+K-KKSUUF3+<=2OM6U2<L](<XF."2R9!.;H =%@J/QO
M<[83U1N:+-'<(4S<;?2Z1_[M)_H":^'K7^%I_:__ (BNKY.?Q?2/MP_V LCZ
M^6NB31$T1-$31$T1-$31$T1-$31$T1-$31$T18:R/]-F7XN+_P"LN-?=U7_
M5/MI_P!ABX_E%_&J/W./[RHH;V'!J]KW(T'.<_9$'L#B['MJK='HGL@W5&72
M[/&R%CO*TT>0,FL=S56B5;;Q98E,R!#KO/:!NZ+</IKX@J8:3J8!!<X%SIM
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M0!ZQ-U<&*! *)A#N%#15Z5HM),9V]?DR7$V="IF$BE<$IBH@H(#*  F,)CE
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M;"7RVU.SM(*/H5=;/NJF++0,R=9_9IF3C%"DFDH!0&3!^@J5 Z[<R3A4HO\
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M?\V<E/\ M.L/UJ>X?L%/Y[^R(_L7D;_\O3YO7BL_\E6U;_QGD3_;FG3\Y/\
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M4;=DO']5MEC%(M>K%CN5<@[#/&76%N@$-"R<DUDI05ERF02!BV7%18HIDY.
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MYOC'(S4<?6M)_'M**_>_9H1^^>YUY_SIJ3\U-0+;D&-H80 0;EX'U#Z'[/\
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MO(,%VRQ2..M-V@X<>4$H'7;+%,JCK,\N  #H'9N.6<6[/2LE-S:>(N9BQ<1
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MAW'1B'32 XE6X(D;@H*)<B!R& 6QCJ*@)51*(@D!5!4[IA3Z$I\?9ZF/+"L
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M#B2./D]=B]9U"JF.*B@HD.B"7F@0.5=!<Q0,F'F')!3*/0)P$O0M\\'K. %
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MMX^^V$9]B[DG ]PW<*FFJGTB<PF$R:"AE5%#"W$YU2G[_<'L&.8"E,94 *B
M^CKGP#A(F2=HVY>O!3<P0?' /F/D'>5S &GP+ H8%CE6<=/41-!X=4YCB4P
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M5&6B*U87]K@V2P+JE23C[!)UJGOI),[8$%5%7%;BS)KJ*MRI*D2*Y6*5JO\
M%J^H^SI^3\;^TL+KDN7OO.UY]S,_&M%7I#V'GT3/--^$&F_D+6RE#LX_H:Q7
M_=Q2_P!GHS70ZL_DK5?WOT/\6I+\:YP?\H7+G\,>4_Y:TY3/UN+E%HC\'>X9
M=L^>_%.:Y,V)4[9]&1.ZV-)5+A5Z<6KNLWH&@)*/4DI=T6-8C+J-H&)JN304
M%1SQ(9LEI#D!EQ6<% V]M_C[PMYTC_,UOO1_5'10_P $]WG"T*;EOKF6S/\
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M2(NAWN6UURNU)J'2Z>@ZP?I/MJIH[=*;3T?1*ND10?4J4FO)8($OI/$2;"\
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M63=R@2[A<CUV[7<I 5\ +MT"*E:LEPZVJ*0 0B9O.3R::X'_  D<\]6:5?\
M\.SL.W/)/WB?/K:W(.!>/F]U# X?PV>?#BLB$\2C: (G,K:<N" I]L@)8.LI
M1( <B4W<,8RGPBHH'1U='0?I#@.=93SG<F9RUD.W5FDR?_#\JD^P3Y\R0?\
M$$[A\WNH1QV5EW!XEVS\!4#WIR[TJ)%1. 80LX&%,INK[*IDP/P(@!RI ( 8
M?LB(C1_.9R9<(_PD!F#[F:3LM]3W'NLH/L$N?2+?,$#^'NHOU_H78;Q,=G_6
M<Y+1E\A#$3)V_F*6H"% @%^(HE5*;K,":7)A-P84^3 ;J-J@YR>30,SK,_\
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M6!:](0X $Q.0'5O?,&VRWDNLM1L@<!<QE8;MFW=V9B?W@['43Q'E\O?\Q_\
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MQ3]#JS^2M5_>_0_Q:DOQKG!_R@\N?PQY3_EK3EFSYCN<_P#*YR#_ /E?@O\
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M1]AY]$SS3?A!IOY"ULI1;./Z&L5_W<4O]GHS70ZL_DK5?WOT/\6I+\:YP?\
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M5 [E=^,MRUJGLVU3$DI9< 969V^HW.RJS^ K-)RSV@&J"D"5!2]0[F0L;9I
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MRLT38GDP>B4S,!1B2 Z*F+AXH@4SAB8JJ:BIE7:O,4M'-/I:A?C($MF\3?\
M;/EDE4?4=6Z*E&"\$B1(X[8R\W956KT KD:\"&F/8\HF9%!+R/0FBT44!-JX
M5CFO><I1;A-LB[B%D_,'79.DUU6Z"/)@VFUNFI0&R13)$B9).<_5=E^"QG16
M4ZS6FKX3Q-[QM!OLSOEE.^VZ<]NCU@M)2CC_ 'V<(W0K"IN(P\!&NU(VR@E
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M[A%K;;]([?K)C+#N4NJU4VVV#,,;"PMGAVCJ&7RW!T]U=(1W'H046X@:=&N
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MJ51%0.H50$3 <PG$YMP/.BMPL=!(BX#H;N@AW&=^<KYG1A]3&X%SOZSAV&!
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M-,ZKE4K1BBZ?.3))IJ',BU;+KB5,XE3'I-Q+6EQ#6B23 '$VVV\:AS@T%SC
M%R57S+H$$A3K)$,HKV" 90A1.L)1.") $0$RHD*8_;#D_2 FXX 1U"F?B7TZ
MJ28IE4433,L?M) <Y2BJITF/VTP,("<_00Y^@O)NDIC<<%$0(J/ V6!M$>YE
M8"4:RD<SF+'7W+QL<110F:A/R=6LL>H8Y2=*\/8(:4BW?IT X9JBF<Z70H:2
M"TP1!AI[G .:>]I!':H!#K@S!(/:TD$=Q!"Z$K;75[*2H(R:2UA4KQ;6FP22
M<J$4KYI#V461(^(B,><AGX=@$2NQ=#_*]CL_/-,)C%%IPSQB8\2C$W%AF\8M
MN4Q,Y9[)E6W?,KTO&[F%865>PN):Q(3#R&@JC2+MD&Q/H^O!'>WI4E>H->LL
MTG#PQYB'0D999@G'-GDQ$,#N0?RL>V<V:QSP2(@0"7.:P NF!+RT28) F8!.
M0*ASVL@&9,P&M<\D"),-#C D28B2!F0K@B;G6)ZK1ET@I=";K4U6FUPAI&'3
M<R9I>MO&"4FSE(MBQ17D9%-VR705:HLVBSIP99)!% [A0B1H+7!Q:1!#BTS:
M' P02;"#G=2'-(#@9!&(1>1O %SW*MM7[5X@FNBH8I5&S=V*+E%9D\00=I]U
M 7C!XF@]8JF+R!V[UNW<)'(HDLD15-0A:^OJ<E;U]1FNI4L>L4BAU6YBJ+"W
M(<54Q*HN!S)B@0W5P98%"'3[91$X'(8G'440 HL8/BNNHL=''453(*1U$1*"
MR93$,=(5"]9 4( B8@G(('*!@#J*(&#D/713;+<L,LLTXLD,B2.*FJ.0ANT2
M+,\HR7PMF9I#Q[&2D9^)BIMW;G=!0IZ%:F)"K6)M#6E2>+7)@T.^/&2CI) Q
M]9#2>&"IU,)F#TE.20 2,./%B <V6QB$B0L?2L+S3Z^(9CHZD09 .+#A@D&#
M,&+%9B*SBCG[9%&YU.V*W055,Q^R4XIF5Z0,)NV50!3%3CI X"41Z@XUC5Y&
M\;U\%G$@0R@JM@(14J!CBJD!"KF,4A43&$W *F.<A2IB('$QRE .3  H^-3(
MW\._<J=8W=:J->GK78W:,77JQ#2EAGI-8BJB,=#0K%>2E'ZI&Z:RYTF;%LNX
M4(BDJJ8B8@FF<XE*,@%Q#0)+B !O), >-02&@N)@-!).X 23XE8;;*^(7B^'
MVK:TM5G6?(US,XD;$CI@7-OB&51&]/)-)#V<"L0P:U?M2#EW8"1*""[IA%*'
M+,2+%@XMT;_GAP_P1 J7'5)=A SN<5K3M.0)5>D9\[ZW\*)IY]8!N(G*W5O>
M-@S,+(KL(!C'K2KQVS;QJ""SI5\HLF#8C=!)1=97N]0E,5-))10W2)AZ2&$
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M2<6.1DW=0"059UFM-7JTN:/33#(_2&EI#2^8< X@@C&^F3$U'N'59  ='6,
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M#6'""'.\%A M"M5YL<RC+-(6+DIV@HP[B,M<'),(M6MM IB=FMR;EW<( B6
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L_3NM&Z*@@ FXUBJ.#ZCW#)SW$;#!)()XG;Q62DTMITVFQ#&@C<0!;NR7_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>43
<FILENAME>g723949g84h44.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g84h44.jpg
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M(" @(" @(" @(" @(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L
M0P ! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M_\  $0@! 0'D P$1  (1 0,1 ?_$ !X  0 " @,! 0$            '" 4&
M P0) @$*_\0 71   00" 0,"! (%!P0)#1$ ! (#!08!!P ($1(3% D5(3$6
M(A<8(T%1)#)887&3U25"0U(F,S0X=X&#D;$9-51B9'*AH[;!T=/P-C=35V-G
M@I*6EZ6RM;?"Q>'_Q  = 0$  @,! 0$!             0(#! 4&!P@)_\0
M6!$  0,# @0#!0,'!@L%!@4% 0(#$0 $!1(A!A,Q02)180<4,G&!%9'P%B-"
M4J&QP1<D,V)RT4-355:"DJ/2T^'Q"#1CLK,E-414HM1&97.#DW2$A8;"_]H
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M(L%I+LC;<? V*+JM4M2M7NA#Q*G3Y)@*Z5MF3DV30T"&2K(K8CY(YS(^XUQ
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MI3BE>.>_-J6&;V9MLNO1*[))U.IS=2U]73)=Z/#E[(3-T$Q1CYCC3P\1 ]X
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MW-=V_P >S?+N[[#^Z)M&;5NZNFTK1:,6RRH-NVUL+A];UPM$M+44)U*4\0E
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MGG5/X#"E@K!)*'(?<\ULLON#((>5AL=2R74-.<>WXH-T\IMB]<2Z)4&G6MR
M>J5]P8)"MXF>@KJW/#5Q9-AY^W0XVJ!S&W04H*A(U)W*8$>$[^76MJO+FGZ@
MQ%7:_3UEB%@RE@@:^-%N>]S@>*G9STU883&GE.8%!4E!)QY&6TI]%+[GKO8R
M[UWN)W;9*2X\VD;(UEOF!:S,)!&P5 G?<B2*YMOAW[QY35NP'(&HPO04C;??
MJ)._8?N@NVT72&YM>WB[U*UV.X1-3UG(Q^->6=B*<A0C8^7:OT)<AQ28%B83
M88Z3B_6AY8.4?C3!VRXIQI["W\-Z/VFSFPH7%TIVR++@6T@A*4O-OA;3@ A2
M5:DB 3.G8[;UW6',CPRK1:VS=K?\Y2T9$ ^_EE;"[5^QU'8VR^8M83H\9A?7
M<3'LF<TC0-8P$C-:Y9M49:(Z(!1"X(=(09'LU81E+\@]*&K0Z"#!QL?&86]Z
M[GMT C83EI/Y-:YSSUDT@O.O%L0TW"CK/9(Z>7;N:YEGA3D;E3+*$H>4HK<*
MA"0I9E1/G,S).P^5=765UT%M:B6NVTRE 1,H-7SBCT-X;:DB R!#B@2AIJ,+
M5B0CSB&2?36DC&4DMO8(8:4IM3N:RXA=?2V[;O/DE4.-N$:D1L)3'A"OE!'2
MF1P:L:X6;@-E:DDI4W\.W6#_ '=-HKI8TST_5"/K5=V!LI34_$!Q9*F9*WP-
M?602T1-$X,7&)''>6(^789MM/O5$H>&(]N^\^VUC&.L>(KK>3;("5:?$XD3
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M$G=!Y;2$JNM)!0E#FI2=95VJ,M(]/]7;W53J9*SNO[2VQ1S+_7[/2/Q9-UB
MG:A:+-6HZ%KS*AVZ&#)B56SAIL3:)W%B]Z(GO#9BDBELZ=CE4E]*UM6;S[:>
M8Q[LN\4RT4$H442D,%Y*5%"Y44[F-X->CS2KC\GW19.9*UMG<DXQ<(R LQ<W
MEM>LHO'#<*)&1]V]]!79PRBTA1"5F--6B9JW3C:['#U1G>3[]CK!\>&&#',
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MK=8B2X\5EL5R*;RWA0:$NCMF+0E:NY65/I\,JQA/G1;K3>)=E>H/3.H]%+!
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M2P/-SLX^RTR?AE&<X:?)5C"5PD6ZB%E2-2B%!*B"J29@2>D] >@V/E6SSW@
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MLFHR#'K'8=_/]T^M7LTMJP#2FL*AJ^,L-DM051CG &)ZVEBF3IZ7C2CLX(6
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M7&?ZK_\ QJ?J!=&_]'^C?W<K_B?'Y4\0?Y4N?]G_ +E/Y+/9]_FKC/\ 5?\
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MJMIU,=IIU3AMF4V<@)'4)N2=') M-"CW&82BC>J:@.QP[<4A>Q/1E9!@N:D
MBVD@8=R Q]/]EGN;%]QQC\<K'N6-OF,?<VKN!=U\-!J]Q;13;8Q&IP-7=N&
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M[^*56W8VL;)8.H70FTX<\ 2"US7MNPUO%=+,:D)02\1E:;A&1 VF' C61)B
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MRW"SS"C\W\7F[=()\Q:P#OI/2H^W_8Q?[7GL[XPP9/5WA[V@6UV@&/T;3/\
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M##PK_HDM)>:]88E#1 [O@M/J,/MMO-*[MNH2M*DX4KN<4IQ2JV;-HETG-_\
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M#BJKF18S&&W/ESWC2E8;D$K:*24I(T-(6B% R)5*2=M]Y.^[D:E(*X(#;H4
MI0.MU:%R"(V$* WVV@;;9A/3=>SNG6C].,G8:I$0$)=(R-MEEI(J*U)6'4-3
ML1UGA'08,.L-5Z+V#<B8RJ1VQ06A?PP1B3N\J 4_[P.&<CG)#RG@#)22E*O$
M XH:3OJDI3*B@S(A((ZFK!E7)2S*0 H!2D^$EM*BH0 F I4)"QT,J,]JT[/2
M[M>CWJ*GZ%,4_9%8K6[B=[04/N&SS$38/Q+<M/[ UGL8'%AK>N["#%-OS<Y
M7J#DF*_(/$24K=Q3Q W'0)$J><VI)"@I!4WRB6P"(2XA:#"EB=@4D2! 3!ZU
M7DK2H%)2L)<Y@#A(,J;4A8E*#&Y"@8.Y5(Z&K6Z+UV=JC5-1H<F: ?)0H\F_
M(.1#+P\((;.3<G82HBOL$820S7()^57"UYM]MEY$+'@)<''7C+#>%U8<<4H
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M$.%/\P39.  :7@17Z%R_M)RUA9\'/<;V.,]H[><X;1E/M#*(=PW%^-0,GD;
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MW'6%[F4OM8Y^XLFS>BY7/H-?&:<4IQ2G%*<4IQ2G%*@RJ_[X;<__  ;:+_\
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M?5:Y #)-D,3CUBDRZX(Q#QN9>1G%"TWO!U:0J2E0DPA$&#JG4I1Z1 DR8 J
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MF->Q/_86-O;)MQ[(YY:TW',;QZ$V&(;6EL:1=7MRVJ_>"E>%I-M:VP6=1+X
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M,YR\::I\M]:EN//.+6I6>-=WMY?NE^]N7[ITSXWW5N* )F$ZB=*?)*82!L
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M$QJR1,@5<W$_A/.)D4DJ9Q[M*UQR7I)@R.I"DD@B1$A7Q>$C3UVV%3S6NA(
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M&CHY,C&R3A8DTY'@D3+1Y @[K=><YOXAN2HRE)\1W)W3L?(C<=HJQ:;,>'H
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M>RX(^ ::MF6:B#" >I6-SOYD_LW](J5J2A4&8"9) ^@D;CR[@'?H:S;?Q/\
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MWN#-O[/5,R!'VIQ7A[;[QCF\R1YD0343;-ZO>I*&N%!:AR>F:"AS9.7C+-'
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M$'UIGH\!:_W!U)]84?V_F]NH&PRW;_[1A3?G_P IY]_W]^3^4"OT\/P^O_\
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M0(^D1-=V+FV5J,(EK9"W^I#1\58CB(R-/C(6(=*?=MLM5LR*;);J[%E-RT)
MNQ2U"OKF1O3RAC=6HE 2H@ H5N!)$G]$*B$D[$SY5B4_LG2$KE(DA2=B=B )
MW*9U*'8?.M;A>K&^SU<AU"TFL%DMJIK%@M];O!4S"$.SLMI&,?>K [FOD#3.
M!SML'1ED"(,AEPA=2GH\4YT[&'HZ2PD$^(QXM*5)@[!PPKQR-D @P9U Q4!]
M92/"D_#J4%$B5%L2F4;_ !F1M&DB9KJQG6786J95YN9J%:B;7-1L%$YJU\V
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M+*V]?/5Z*%'KFJWC4R\U/!-D&RL9"849).C&3$^[B0-9DQ,(D :6Y/QR=U]
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MMJRNSCD14X^4C8IUR+?+A34644 0#J*=0*P0#^JH@1\^PZU8$%(4.A2%>H!
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ME_<%J _9$5E3,">I"3]Z03^V9]9KL9^OTS]L\M5J@*WZ:>#ETW_31L=0=AB
MA@DB9&<30[]%13'H1]<O<"!Z>%)&&Q@.$M<4AFR5G"1\,N2L*R37#U.@Z?\
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MAXIF0L!)49EU+[9@$82T(0EE3V<8SVSI7N1LL>E)O+EICF? E9)6OU0VF5J
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M/L9$.?\ *Y9J&,=E4#R"XV2S@ _ SCGM#%('?\'7$)5.XZB!V,@S^#42#/\
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M]DFSY&+=>8<B5.I5*W2L)6H%.N6GDZ3VT6CCZ5)_KE2$@=HG:8-8WPH:0@_
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M6)&0::]UE)03H&1W'"C&A>3[NL=5($%(ZJ/Q1'1)[D#;O/E4"X0>@5T*H@3
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'IQ2G%*__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>44
<FILENAME>g723949g84x74.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g84x74.jpg
M_]C_X  02D9)1@ ! 0(!>@%Z  #_X4<,:'1T<#HO+VYS+F%D;V)E+F-O;2]X
M87 O,2XP+P \/WAP86-K970@8F5G:6X](N^[OR(@:60](E<U33!-<$-E:&E(
M>G)E4WI.5&-Z:V,Y9"(_/CQX.GAM<&UE=&$@>&UL;G,Z>#TB861O8F4Z;G,Z
M;65T82\B('@Z>&UP=&L](D%D;V)E(%A-4"!#;W)E(#4N,RUC,#$Q(#8V+C$T
M-38V,2P@,C Q,B\P,B\P-BTQ-#HU-CHR-R @(" @(" @(CX*(" @/')D9CI2
M1$8@>&UL;G,Z<F1F/2)H='1P.B\O=W=W+G<S+F]R9R\Q.3DY+S R+S(R+7)D
M9BUS>6YT87@M;G,C(CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O
M=70](B(*(" @(" @(" @(" @>&UL;G,Z9&,](FAT=' Z+R]P=7)L+F]R9R]D
M8R]E;&5M96YT<R\Q+C$O(CX*(" @(" @(" @/&1C.F9O<FUA=#YA<'!L:6-A
M=&EO;B]P;W-T<V-R:7!T/"]D8SIF;W)M870^"B @(" @(" @(#QD8SIT:71L
M93X*(" @(" @(" @(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z
M;&D@>&UL.FQA;F<](G@M9&5F875L="(^9S@T>#<T/"]R9&8Z;&D^"B @(" @
M(" @(" @(#PO<F1F.D%L=#X*(" @(" @(" @/"]D8SIT:71L93X*(" @(" @
M(" @/&1C.F1E<V-R:7!T:6]N/@H@(" @(" @(" @(" \<F1F.D%L=#X*(" @
M(" @(" @(" @(" @/')D9CIL:2!X;6PZ;&%N9STB>"UR97!A:7(B/E5N=&ET
M;&5D+34F(WA!.U1U92!-87D@,C$@,C Q.2 R,SHT-3HU,"!'350K,#4S,"8C
M>$$[4V-R:7!T('8R+C0N,BP@26QL=7-T<F%T;W(@=C$V+C N,"8C>$$[1W)A
M<&AI8R!T>7!E.B!!<G1W;W)K)B-X03LF(WA!.^* HB Q-2!H86ER;&EN92!R
M=6QE<R!C:&%N9V5D('1O(# N,C4N)B-X03LF(WA!.^* HB R($--64L@8FQA
M8VL@;V)J96-T<R!C:&%N9V5D('1O(&=R87ES8V%L92XF(WA!.R8C>$$[5&AE
M(&9O;&QO=VEN9R!F;VYT<R!A<F4@<')E<V5N="!I;B!T:&4@9&]C=6UE;G0Z
M(%M497AT1F]N="!!<FEA;"Q";VQD728C>$$[)B-X03LM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+28C>$$[9S@T>#<T+F%I)B-X03M7960@36%Y(#(R(#(P,3D@,3 Z
M,C8Z,#(@1TU4+3 W,# F(WA!.U-C<FEP="!V,BXT+C(L($EL;'5S=')A=&]R
M('8Q-BXP+C F(WA!.T=R87!H:6,@='EP93H@07)T=V]R:R8C>$$[)B-X03LJ
M*BI4:&4@9&]C=6UE;G0@:&%S('!A<W-E9"!P<F5F;&EG:'0N*BHJ)B-X03LF
M(WA!.U1H92!F;VQL;W=I;F<@9F]N=',@87)E('!R97-E;G0@:6X@=&AE(&1O
M8W5M96YT.B!;5&5X=$9O;G0@07)I86PM0F]L9$U4728C>$$[)B-X03LM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+28C>$$[9S@T>#<T+F%I)B-X03M&<FD@36%Y(#(T
M(#(P,3D@,#@Z-3,Z-#<@1TU4*S U,S F(WA!.U-C<FEP="!V,BXT+C(L($EL
M;'5S=')A=&]R('8Q-BXP+C F(WA!.T=R87!H:6,@='EP93H@07)T=V]R:R8C
M>$$[)B-X03OB@*(@,34@:&%I<FQI;F4@<G5L97,@8VAA;F=E9"!T;R P+C(U
M+B8C>$$[)B-X03M4:&4@9F]L;&]W:6YG(&9O;G1S(&%R92!P<F5S96YT(&EN
M('1H92!D;V-U;65N=#H@6U1E>'1&;VYT($%R:6%L+4)O;&1-5%TF(WA!.R8C
M>$$[+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TM
M+2TM+2TM+2TM+2TM+2TM+2TM+2TM+2TF(WA!.SPO<F1F.FQI/@H@(" @(" @
M(" @(" \+W)D9CI!;'0^"B @(" @(" @(#PO9&,Z9&5S8W)I<'1I;VX^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SIX;7 ](FAT=' Z+R]N
M<RYA9&]B92YC;VTO>&%P+S$N,"\B"B @(" @(" @(" @('AM;&YS.GAM<$=)
M;6<](FAT=' Z+R]N<RYA9&]B92YC;VTO>&%P+S$N,"]G+VEM9R\B/@H@(" @
M(" @(" \>&UP.DUE=&%D871A1&%T93XR,#$Y+3 U+3(T5# X.C4T.C U*S U
M.C,P/"]X;7 Z365T861A=&%$871E/@H@(" @(" @(" \>&UP.DUO9&EF>41A
M=&4^,C Q.2TP-2TR-%0P.#HU-#HP-2LP-3HS,#PO>&UP.DUO9&EF>41A=&4^
M"B @(" @(" @(#QX;7 Z0W)E871E1&%T93XR,#$Y+3 U+3(T5# X.C4T.C U
M*S U.C,P/"]X;7 Z0W)E871E1&%T93X*(" @(" @(" @/'AM<#I#<F5A=&]R
M5&]O;#Y!9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]X;7 Z0W)E
M871O<E1O;VP^"B @(" @(" @(#QX;7 Z5&AU;6)N86EL<SX*(" @(" @(" @
M(" @/')D9CI!;'0^"B @(" @(" @(" @(" @(#QR9&8Z;&D@<F1F.G!A<G-E
M5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \>&UP1TEM9SIW
M:61T:#XR-38\+WAM<$=);6<Z=VED=&@^"B @(" @(" @(" @(" @(" @(#QX
M;7!'26UG.FAE:6=H=#XY,CPO>&UP1TEM9SIH96EG:'0^"B @(" @(" @(" @
M(" @(" @(#QX;7!'26UG.F9O<FUA=#Y*4$5'/"]X;7!'26UG.F9O<FUA=#X*
M(" @(" @(" @(" @(" @(" @/'AM<$=);6<Z:6UA9V4^+SEJ+S1!05%3:UI*
M4F=!0D%G14%304))04%$+S=107-51VAV9$<Y>F%'.7=)1$UU34%!-%%K;$Y!
M*S!!04%!04%"04%304%!04%%028C>$$[05%"24%!04%!44%"+RLT041K1FMB
M,DIL04=404%!04%!9B]B04E104)G445"055%0F=51D)G:T="45E*0W=G1T)G
M9TQ$06]+0W=O2R8C>$$[1$)!341!=TU$07=11$$T4$5!.$]$0DU41D)15$5X
M=V)'>'-C2'@X9DAX.&9(>#AF2'=%2$)W8TY$03!914)!64=H55)&4F]F2'@X
M9B8C>$$[2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X9DAX.&9(>#AF2'@X
M9DAX.&9(>#AF2'@X9DAX.&9(>#AF+SA!04519T%8045!07=%4B8C>$$[04%)
M4D%135)!9B]%06%)04%!04A!445"05%%04%!04%!04%!04%11D%W24=!44%(
M0T%K2T-W14%!9TE$05%%0D%114%!04%!04%!028C>$$[05%!0T%W449"9V-)
M0U%O3$5!04-!44U$06=10T)G8T1"04E'06Y-0D%G35)"04%&25))>%%614=%
M,D5I8UE%54UP1VA">%=X46E00B8C>$$[571(:$UX6FDX0U)Y9W9%;%%Z4E1K
M<4MY63-00TY546YK-D]Z3FAD55I(5$0P=4E)2F]-2D-H9UIH2E)&4G%3,%9T
M3E9+0G)Y-"]0128C>$$[,4]4,%I85T9L85<Q>&18;#E76C)H<&%M='-B5S5V
M63-2,61N9#1E6' W9D@Q*V8S3T5H66%(:4EM2VDT>4YJ;RM#:S535FQP95EM
M6B8C>$$[<6)N2C)E;C5+:G!+5VUP-FEP<7%U<W)A-G9O4D%!24-!44E$0E%5
M14)1645#04U$8E%%04%H141"0T53355%1E523FA)9UIX9UI%>28C>$$[;V)(
M=T9-2%(T4TY#1E9*:6-V17I*1%)$9VAA4U5Y5VE9-TQ#0C-04TYE2D5G>&15
M:W=G2D-H9UI*:EI&1VED:V1&53,X<4]Z=WEG<"8C>$$[,"M0>FA*4VMT3515
M-5!2;&195U9P8EA&,658,5)L6FUD;V%7<')B1S%U8C)2,61N9#1E6' W9D@Q
M*V8S3T5H66%(:4EM2VDT>4YJ;R8C>$$[*T1L2E=7;#5I6FUP=6-N6C9F:W%/
M:W!A86YQ2VUQ<39Y=')Q*W8O84%!=T1!44%#15%-4D%$.$$Y1FI#:&--5EAJ
M1E9W>%9E=4MR>"8C>$$[9U9E35981$96-'A694U5;T,X.'@V2%DS4#%A.'99
M-$IG1DQ">E%+2$E6951F6D9A.7HP,S9:3T]/4C-!87 U-%).13!U4&UB>3AK
M=B8C>$$[<$YQ3G5'-D4K;W9%2&99=CEK2#14<U1J-&-U-69(:#-H93-M2'DK
M;T)B53=106QG0UHT>'5G<7<K,2MY1'9J-&-U-'%C.% U=RMA4"8C>$$[5FQ:
M47EK37)#<7-.=U%E-'E$83-I<G-69&ER<U9D:7)S5F1I<G-69&ER<U9D:7)S
M5EEW;FY3-6U3.&$Q,%<X=5!Q;"]*66-K04M.-B8C>$$[8DUJ4V=I<F-A;U)S
M<'!T56IE:'!&<%I(*UE/=GE2,EI4>35/-WI2<S%W=$IL0TUS=D19=$9U4%0T
M=C0O14(T-&5&8EHQ:U5U>%8R2R8C>$$[=7A625)H475'2W)X:7$T67%V6$96
M-'=+=D=+<FAI<3A9<79'2UAN+T%*<C%R>7IB82]D>&%N<# X;G!,0DI.3DA0
M27%31EAI2VXP9R8C>$$[5E)M5&U09C9..'I-54I'26]U<3%78D9'6C1W9'$V
M;G9(4DQ,4S4O3&%:-4QB.41826IE6C),1U5S1#9%0FU::%-5-V=B8U(Q,G!8
M<"8C>$$[:WE-=D\R:4UT36)(0V5F,T,K.6-I9FPQ<6UQ=W=X5VPV=G=R3$IB
M33!A4DU8:4-O>G9*2T-#:3 R1&1E;4XU26IM13%P.&MW2VPS,28C>$$[,#5E
M+V]Y3V8X=S=$5')U5%1L<TI04G1*4'%I37)G.%=1<VE",6]39UEP.$IB<4XX
M<$=N2D8R-6@Q,%EN:')K82](9#5*+S5:.'=1-B8C>$$[-W!A,S!C5%<U-7-K
M:T0O85%J8U8V9%9)8C9C<7E9*T4P-4]N>FI*2&EQ:S%Y='5D:7)S5E4W;35T
M-U<S:W5B;5)9<F5&4SAS<FUI<28C>$$[<6EP2DIX5D-A4G(R:C9X0S@R;5A3
M6%5C8F-*0VA.5DY+,$E.0TU*0W--:R]-1'I7=6UW4V9O2U)D4F535EIB37=8
M2G!'1G%J:&=T3B8C>$$[;41+=W)5,#)!1%9"-%%I,E=E6#E8=C<K0D)F,E)S
M8G8V=&(S17-23F%'8TY694HS6&DP6C)/*T%H2V)91E%U;W)P6FE1-FE)5$-R
M,28C>$$[5#9X>#1H*TI',U!A=D5N1E=+-FYQ;6YW-C-"6F%F<'5M,U9O.71,
M3$QD3SA-4TI+;V(P,#4P669%=U5D0V0V.7-+<$9F87AR>4<U1B8C>$$[='!'
M:W,S<#(U=&@O;W!54TUI;5I74')B+W9#>2MW1F0X3D)'-TI02V-M;C-E:E=P
M,74R,#9(5TI'6EI926AB;7 U:TIX0VPK<3 R<B8C>$$[9TM1>4@Y0S90+WEW
M5R\X07E+5"MM0EAF;UA2+RM70S,O=T-24V8P>%8S-D8P9CA!-5E,9B]K56XY
M3596-V$P=&):1U,R:%-&1U!*;"8C>$$[:E5+0S%!2S!(<TU65F-64T5954U'
M=&13+TY73E!49E1B95IJ2W=-,'9!55-Q<4-%:FQ46599:F5U4S)9-W5L,5@X
M,4AU561D36IG9R8C>$$[17%+,&%E:SE9-C%**TM3=&%D9'@Y2%A(6D\V4&<Q
M:CAY5%E4>E-A4&)F5VMA1#!995A(;7)Q,W$O=T,W5W!W8FHQ4%-V,$-G=38S
M4R8C>$$[8C<X>F8P>D5.47-O9C!E>E5N0RMN4E9:,$)+37-N3#115TEQ1'0T
M;F9#85AD1"]79GIB-'-6=#1Y6#5R=CE86&<T04E++T5E55IB-"8C>$$[45<K
M2VTU1T]Y-W,Q,$M45DI.2G1M,5=-4F%I130S4V=G9W5H2VQH>#)O.4]1*V52
M2U5X1T)6-'A694U5<UHQ=E103G1Z9%AC3FDY<R8C>$$[3$,U945H<F<K<%--
M245L:3E*;S-8-'HX5F$Y=F9,-%-G04PU=4AM>#5:16E.8TIR;CEO<6M&<&YL
M-WHU<'5K5W1P85AT<7-K26TY5"8C>$$[:T%W<3A3:4QG9E0R0U!Y-V9E3G-N
M3$IJ36E30S%9.$=E14%!4G1F,V)D1F0Y1S@K>6%"3D)*<451,5IV5$UC<U1,
M1D=O5U5K;W!30B8C>$$[6$%-65AE=EAB8D)X-"M,;'0K4$Y0:%IZ:DE*2$@Y
M;E S9'EI,FEF;54P.&MH,5,S54=60D=63W=H0DEB:W!I-',S13E70B]$2&IX
M.28C>$$[>41I,49N,41N.6YY6D8U9&<X>'=X6$@V8W5)2C5N;#5196=V14MN
M16)(6F$U5FM-9C182W=$24%E36<W.44R>71V9&ER<U911W9S<28C>$$[-D9Q
M3$U1<6DQ;7%X-D0Y,F5U14MX2#AL2%$K4TDQ0FE,3%!,>5=).4LP<'E(:FAN
M>EEX-4UK4&Y,>75,2F(P-FQ#3%8R:U)*2VXT;28C>$$[:%%Y4%%5<6%+2R]D
M-&I"4E1A=%E814YZ<3 Y>D$S3T=A>7,U26YO4E98931+;6AO96AX4VUE0E5(
M3&5**VQ)8DIR85)Y63)N4S8T028C>$$[>$E2.$9/6%IQ369O4'9I<4UX5C)+
M=$]I3TM/;UE!:&=#2VEQ;6]0,$56>%9V1EA9<3=&6%EQ-T95:$=&0T$Q2S=U
M24PS4TEO;31P9"8C>$$[6&)25&EG4$I"851Y9V)J8C0T,4\R2T4P1TM6=WA6
M0EA.,5!(<D]N,C9.4T=D2GI+=$)U67=N2&5L9'52>%9->&=694U66$1&5C1X
M5B8C>$$[94U5<GAI<319<3-I<5AA0F0S1C-9>7DS1#@S5SAV65%A069"1&1Y
M>%)J641O:4%:4$E!1'0S1#=M:E1Z36]K;BMD3#=*14IJ:T<Y,B8C>$$[2W5X
M5C)+;V)6051P;#)"17,U.4=3:TQR>E9Z>$Y&2VXW45!H:7)&+WEO;FUU=DM5
M9#-063(Y:$Y.3DIY:G19171K64MA2S-&3FHT5B8C>$$[>55U84DX:W=J.&<K
M5TDW4#9N2&)Y2F%I5#%L:5=E64):3T1X8VPK4#14=VQ+-V5!.$)G=&%21VIA
M6' K;6%N8U=L:D%S1456;EIO<28C>$$[<4YY16%D45=05FI11&,W-&Q+8VM6
M0D(W*T<S-G-#<$I,<%9U3EET;T).9&E*-V4T9#$K=#-7-TDX254O,VY93V-+
M<#!Q:%9#:71!2R8C>$$[0W!*3S-I5'5C0W0T<3=&6%EQ-T9867$W1EA9<6M)
M=V]11W$R;&A,2EHS3C!R33EL3C8Q=5%Z2T)*=UID=W9866YR;$=F57AX4G58
M3"8C>$$[:S)9<TUS:&]+;C9:=%(O;68V6F@O=T%R64\X+TIY9C50>2M4=C Y
M6D1U9G50.4U(.'-93S@O2E X;EIF2D-4,W5I5#9J839H2TA.>B8C>$$[6FE2
M64-'8TQ344%.>55B3C R<F<O;&Y",VXU2B]K,TPU9DY'9C1M,#AE4#-(*VU$
M*U=T4#-N-4HO:S-,-69.,RM+.4U(.#,S2"MM1"8C>$$[*U<Y4#-N-4HO:WI.
M-69.=B]&*VQJ=3,S2"MM4B]L>E0Y-2M3+W=!;#5V3#5U+WAN<$DO;2LT+S!W
M9GDY<'4X+TI0.$%*5V)U2'ID+R8C>$$[:F92>#%,+SA#9C994#5F,#-E9FMN
M*U-C,V-0;3<O2&5I:G4O+T%N*VU$+U)"<'4X+TI0.&M:*S1F3G8O04(O;UDO
M;B]!3T)0.4UF.28C>$$[14=L-WHX;"]K:E S1#5U+S570F]F+T9N+T%N*VU0
M.$%O9S!V969K;BM332]C4&UH3DTX,F56.4YT,V=T0DMS8GEY5$U'-75E8WIL
M,B8C>$$[,V%V9'-L3#)J,#!U6E!Y83AF665706]!8WEE9F9U:2\K5F=A2"]X
M6B]W04-F-EI(+U)"<&4X+TIS+VMJ4#-$-74O-5=";V8O04):+R8C>$$[=THO
M<&HO;V<P=F5F:W8X04I'9G5(>E)E:&5:-UA68FEE2TTP-$=S5F1I5G W-6PV
M2'1,2'%425$O:"LW=F-F5F%+945!>39P,VUW8R8C>$$[3DPO34UI>&%$<4UJ
M.'5+,C!X4$93-2MW96EG16Y#1EER*U1+,GEE4S!7,TQ'35A-,4,V1TXK;RLP
M=D]102]*<TTK8D=02F%.02]-;B8C>$$[.4-P84YQ<698;S4U2$XP2E=P2D9*
M1$EV0G%X8VPT>6-75V@R-68U27AS2C-4-WDU8F%P8EA4=V%P8W!D,VMD:%I,
M3$UI:V-M5G!W>"8C>$$[2EEN;%9Q+T919DQ!5D-B6&1H0F1C9E9A56-144)&
M3DQ#1%AX16)*6#9C0U=0>6559$9854QA>59::&)V6C-+1F98;39#4T@O04-U
M;B8C>$$[-W=M;E$K1TM+5#9Y,'DQ<R]W0S1-=$%V04Q*4$Y+;T$V55=2,D$V
M9'-5;W)&6%EQ-T9867$W1EA9<3=&56A'1D-",6HO961F.6-F<28C>$$[3V%N
M=&XK-D@Y8CE"8R]S-RLX4'4O56MJ6GI"9#1&2G-R3$U+5%I!<V=P=&M#>D-K
M,E9L:T9.<V=7455M>7-S=W!.:T-Z0VTR45I"628C>$$[8T-1='=*9&ER<U9D
M:7%D*U5B4SEU3F%I3G-3;VHK2U8K=UA.>#)&:GE3,4%-3U$U*S<Y<G)U,5IW
M1T5I6%AL-S-Q,F5G=DE*3C5Z=28C>$$[,7102V5R,TQ+6$56<DME061O-B]#
M4CEP0T=(,%E2>E%5<"]+<E1M,"]W06]X5WA94'AM;$E:5G5%6&,Y;'59-%I0
M.$%H85E:8S%(2B8C>$$[3%@O3TQ40EDR.7=T:DE:6C)M5G)C>7AQ>4-)2U5,
M13E/6F5M+U1I+UAJ:G=R8DI03#)R439R9'9F>$DX83-&:%EY.$A6,7 V:&YE
M9R8C>$$[3'%N269&.6]B64-Q96M60D(W*T<S-G-#56MF4D0K;#1I2357<WA#
M-&$V3C=D97%R<W<K0E(V;C)4>$)0.6TU=%4V5E%Q:%)79T9"528C>$$[:VYB
M>$HS3T)6<W,X34MH<'!&:E5M9UIY1D9F1&9&5TTS=7)7<W0O04ET6'59,2MT
M4$9)<7)'155#3GI685)(:W90:4)Y2B]J;71Y828C>$$[;45P>$9Z:G=Z23)"
M;VUU4C(U9FIZ8S9'0U59;F%*=4XX>'1U;E=K-FY:6%9R1C96,%HS97105C1*
M2V%%.5552BM#-6TT33!C<T)/4"8C>$$[22]">&-U230U1THU:$@U83%O6%9.
M5'1T3G,R=3=K3UEL2W%F5%)N87)-1D=Y9SEZ9TIP:$]9:4Q+2W=S,UEQ.'9V
M9&4X.5=6-61-=28C>$$[:F988D)*;45244%396MP8FIX0W4W4'E53'9X1D-4
M:S9$1E!T175D879.36MK,6%W4S!V:VMD56=$0C!93#EH<6=N-U=6>FA'5WA&
M:"8C>$$[;$=22$Q:9#5C1W!4-E9&2G)6<$A"9FMT-FMA055!1$AJ<T=F=#<U
M039F1B].:CAG>D=A9F5F;6UG=&)B+V939F--:BM7>"]Z62])3"8C>$$[-# O
M-7@K84-L=$QS-C-B3$A&14Y,.4-2<FMM3E,S<6AL16%Q,TMU-%EN-U!B,S)0
M-6)&+TYJ.&=V:GHO04IX*V%9:7AS+SA!9D-F."8C>$$[0TU(-6)&+TYJ.&=N
M>#4O>FHX,7<P*W@O-5HT+RM"1T0X<FDO;7@K450T*U0K8V9M=4=N5T@O3%!(
M+W=)>"]+-'8U<V9K1CAF2B]/4"8C>$$[>EA$5$Y/+S5:;W8K04=0-5A&+TUJ
M.&=V-6I*+T]0>DQ9,')44"M75TPO9T8O<&<O2UEV-6MF:T4O;4UN.#98>DQ(
M;'1D8R]X66QQ,B8C>$$[;#)H,$QN25AU0D=N4#!V455X;7!F;%@Q<7(Y:CE7
M2#AP9R]M>"M14BM9>2]Z<&9-<VQ':F%4+WEX=R\X078X051"*U5W+WI)+TE*
M+R8C>$$[35I0-3!V;5=P3D<P>C R.4]Z9SE3:#1C:T9+.7$P2%1(.'!H+VU2
M*U%8.'AK+VY3*UI32'EP839R9'1C:EAT1W1,45)X=T-";VA',R8C>$$[3U%Q
M,W(Q0W,O2&DQ0GA/13940C!J2#5"9GI'6')+6'I,25 P3G!0+T%#>'<O=T1!
M3"]40BM5=R]Z22])3"M9>69Z<&9-<$HU<W-B-B8C>$$[,7-5;#!(5$Q3965S
M9VQ76D8R2&]U54EQ>40K.$-J<FA':G<O>DDO24MD5&PO;E,K6E1$>7IP>C(R
M;E)81GI!3&953'%/3C<R2F%C528C>$$[;#1$:W$X86=!2$A$<&]9:65!5GA'
M,%I-.#AG2$5E4V(U93%*6C5N=F)E>3AU-FQD6$M&-$ER855Y26]Q4W9%9VEN
M2E K2D1#1DQ'=B8C>$$[>6-V6DQV>5A(2S=S.4QI5D8U33=55F%504UJ4TY4
M-F--=6%).&U73G%':FE-4TYC,C1J8W5!-61/2DM":DE+,3,T+T9Y.$XX:6Q3
M="8C>$$[2&IF5W)P-&U$4G1:,FI)>6M&4W!K=4-#0T\R1E5X=TLW1EA9<7-L
M9VAM54Q.1W-I9S%#=4%W<C0W-'%K3V]P86988DU2-E1)-E<Q=R8C>$$[>E-U
M:T-L4W9O>7!595!X3TU+<'9:,CEK55,T:G1&9V,Q;T=J5DA8=#(V6496-35K
M:&EA5G=X5F5O4D=K8G<R5D%Z2#9":7)&+TY&>"8C>$$[1&-79D\P;C%#,'4S
M;'0P17%26#9+03!Y269G54EN42M'+U1%9W-*9VMB1VEM.6YF861B:C T;'9J
M>E!784<K:S,V9F%L5G%$-F-,3B8C>$$[3DU#<$--2T9W>%9E35981$96-C1Q
M=D="5C1X5F--5EAJ1E8T>%-L<5=+:GI02F9C2'%B2DEH2GEF:"]E<WA7;&5&
M96@V5GI(15 S,R8C>$$[1B]2+U,U6GDO=4)$8C8W*WHU<'5->4A%8GA62G9,
M5FEB46%M1$A*2#8Q+U!+4%5,;FM'<#A3.'ED:C=B6FDV84A$>&8Q:35U<WDX
M9B8C>$$[0G5.;T%*>FU5-%-1*V4W0U,O.$%+,3=A>'AY5$\O<&-9-&5F33A:
M54\S<"]&,G=H0E0T0V=!2&)X,R]89U,W1E5"<B]!3F,O465O9B8C>$$[53-7
M3S8K<GDK:DDO4&ER8T12:G=$4'0Q,D9C259I=C5-;59V2DU5:W,U=4AK=4IM
M-6MU96A#,'))1E!B,W=Z-7-9.&UN+TM(45AT628C>$$[8E$S=#4Y6'0R:V%&
M3U50=VU52T<S.4]P,FEJ-B]W079U8V5*3DHW-68P:3,P:3EM<TQA4U(T3&5Y
M<S0T=E9B:W=61VY59$%00W5!;"8C>$$[53EW2F1I<G-69&EQ2'5R4#$U8F54
M,7!)+W$W."M-8F-69F%L2$AC6E1L=SAC;VUY3T4S=#$Y-V)J>3A)26](:4AY
M.7E)>35Q9&ER2"8C>$$[=&$X<C,R;S-.>DQ&<6HR.%9W25(V6$8R0T="=S1+
M56Q106MJ=W=C3%9,1EI/-3-42%(Y375R2#8P,7AD;3=E-FUA8F--<7!Y2#)%
M5B8C>$$[;FMO;S=B-&=-;W=Q+TY-34Q.25)H475'2W)X:7$T67%V6$96-'=+
M=D=+<FAI<3A9<79'2U=/87I9-C=*<35M,&Y6571I,%E4-G9,2B8C>$$[>553
M0E=9:U%L6%@W4$%N=C%Z07IW>4=D=VQ8;&8V2%HV8DQI1T]S:TPS-6=D4&8X
M,'-A,R]-8V=3+W!U>45A2D4O34=.449C1&MZ9B8C>$$[=6EP53!02#-Y9W@Q
M4%!J:C W=C%/5THV3&PT8RMV9BMV-6]O-F(K6GI#54A68E)A;6M25E8V8FIC
M;44Y9'$P>69H-G(K8U!X.$=R>"8C>$$[=$-+.45V>"]N26Y7-U1Z3B]H1#!O
M.5%J<SE7:F5.;G9:<%%Q0D9L0E!+4EDP-G)T5&HW16Y-+T%*0TE%.7HK4&,V
M>E5Y9UIK=S)J*R8C>$$[4$US9',Y3R].>3!G844V+W X;VEL.4U.2W=D-GDQ
M-$)M84MT5#9I;%%46' R,GDO6G@Y,&$R;69N0S!B06%V6F]Y>$%Q=U--.#5+
M0R8C>$$[;TE-1S,W5T1:3S9P<71J*V)).653>C%7=U--1TUX8VM647%R15)+
M5S523BLS.%A8.$YS9&PS6F9:,U5+=S(P16PT:SDP.%-.>35*>28C>$$[;'%T
M9E5!54M#1S1K+T-T36EL5#$R>G-B+U-P.4YV6GIB=V%G<'13-G5S8FMY:6Y&
M0S%2>5!954]%2U5(;W5H,G9L9E)*3%=W4S1V628C>$$[-#-E9%EF,TEL6FY.
M4W-A<4QE265W,GA*=$%&35EK."]E8VPP*S-L2&PV45AC:GIR4$<P3G=6:E9&
M2'!(-%9*-C@K6"MP=#EO665%3"8C>$$[8DED2S%$5C5N6%5B:E-,;%=U<DLQ
M1&]$06A%:2MO-VIG.'=:865Q3FTS=T95>2]35C4O,6%R<B]!24LQ+W=#<2M"
M2VTR<S-);E-!-B8C>$$[5&0X,U9N6&4Q<%)#;TY4-B]W1&QJ1%-Q;C93=E K
M<E9D9CA!0E=V+T%&6'=+-SE*6&XO5G%U=BM#=&8K<2M+<6-M<S--8GA),FLS
M9"8C>$$[6FU+2E$R<$91<E!V*R\R,E$T8595+U-6-2\Q87)R+V=R6"]Q=F=6
M,S93=E K<E9D9CA&82]W1%9F1E9/9E=B;49!-S949#!,26=O8B8C>$$[56US
M:D)",&XX5W<P<7 K:W)Z+W$Q6%@O04%6<B]W0E8X0W4O4U8U+S%A<G(O9W)8
M+W%V:7%!1T9#-%EQ=D=+<FAI<3EC5EAJ07$X628C>$$[<75'2W)X:7$X67!E
M8F5D6F1(;#AX6$U5.7!D>5A34E%);C%A54M*1V%34%E,=V-L+W="-&\R<61H
M=&UJ,7!G8W!"17(R-4AN>3AN<"8C>$$[*WI9-4)H0D5O.$YN;4]7>#@K5W@W
M=F5G2#!N4S=+,VYL;G,W-DM/,CE+,F%)>E%%9R]6:F,W<5DO9V-G:7!897!)
M<C%R46-566=K:28C>$$[5S%$;4\V*S5Y0FYY5$E!;$$X5FYL3"MD=SDK-"]9
M>78X=F13<TM4-EAA>7E.16MC5C%B<$\V4$E"34-:0CA.1W%'-C%(46<Y.'HK
M>B8C>$$[<W-D-$$W8WAF;GID5C)T:&YT:VM"9&M'9V$R-4EV.$%-=3!S3')Y
M:F-W,W=C=TY*04$P8G!(>%IP5E9785-136E)0S-X37<R1V)74"8C>$$[3C!H
M950R.$AL0SAV-V%W:VHQ2S-&.5!'-W,X:U!',U=D:TU246U(-T%8:'5#3FU(
M65I:=7A4=3 P2'E&<65R<G!!=616=&)I5G)H528C>$$[.6-W4GA'53!J8U5(
M5BMA.&5M-4901$):4VQJ-C<U3W1T33%/,65,541,9C-B>&A#.7,K.&-S3"]!
M0E,X2V=B8F]1>2]4=FI24F%+,"8C>$$[1%%F>2]W0F(Q2T14<F5B5F]R>39$
M;CDW-D)644E/6BM-2S%!>79T465X<&E35C)E:'AF;#%P2V$S6C9W.7IC4S-.
M:TEE0T]Y1D=A0R8C>$$[2#!66G9H<C!!8G)S,5-/<'E017EP;&524S=&6%EQ
M:UAM+U0O041*95=-23AV,V=T3'=31EI3-6]H:&Q2;S)B64UE8UI93VYU34E1
M5R8C>$$[25<K:B]N67,S<E,V<%IS,TE-6758=U5#2W!&4%,W:79T6&9*5T5B
M<V\X;5=F;E,Q4S=J.'DS54XP;%DO<4Q28G5"42MP>F)I=&1Y2R8C>$$[9E1K
M5%A2260U,S!Z>EAF,FQO;FQY*T9J4$9-6DQH:3-%=6EO,T90<W-.,V]..%)3
M;&HP2&LO.$%-;4MX0F9Z2DQ,9FUZ;7 X645A,R8C>$$[5$905%-H4G53.$1*
M.&97=$M5<&MR0TM+6BM6=$<X+S)M='10<FUQ2F0V8UDU,45+<T0X8E1C;VIX
M.4Y/:58S-61W2V)90U%K5WI,228C>$$[<%E6-6\P=CAY2F1D:W4O3'0O1$):
M:3-666]P,G%N<41M2$)I36)F16%Q5F%U,5!F2D%H0G109DLX6&UE3WIN6'I&
M3D1.9"MU>&=E0R8C>$$[9U0P94LX9&=Q8C%R,7)G3DM%-'=*4T5954QH:7$X
M67%U1TMR,7A694U#<GAI<319<79'2W)X:6Q).5%U=DY9,6-15U9J02MN9D-F
M<B8C>$$[8VQ#=T]X2C0K;V@X4C R.38P>D1Y>7IC9%)I3TAV.$%W6%E966%F
M=S=L23AF9"M!;%9N<4@U:W!B<GHP,DLT6FAY6C5V5%(K9D)!5B8C>$$[2WAY
M0E%V4&M!,UAJ43 W2$AH:S%)2#!G*RMV,2]G3UAK>&%);F%:2'5V>C=X,U8X
M5UEW4FAK:6UL:59B;F=!>#1G1E-W2$E$9'%B<28C>$$[3R]B3FI%8VE2=39E
M4C-)0CE+<7EQ>6Q704MK54E/-$E/5%E/-$Q7=$)8>' X=C99<3<P-#9G.%)5
M5F]A94IQ9G9)>%9A65E4,6I8<B8C>$$[6&]/<#<O:&EQ-$EG3E%O0CA14&PO
M45EQ,VER<U9D:7)S5F1I<G-69&ER<U9D:7)S5F1I<G-69&ER<U91,RLT-R]I
M=CA-5F-0<4@K4B8C>$$[*T=+="]W0V<O=T-2*T=+="]W0V@O=T-2*T=+="]W
M0VEF-4]+="\V3B]K-'$S+V\O*U1I<F8W:C)X5C,W<C)X5G8T4&)&5R]H>%9V
M1B8C>$$[6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W1EA9<3=&6%EQ-T9867$W
M1EA9<3=&6%EQ-T98+S)1/3T\+WAM<$=);6<Z:6UA9V4^"B @(" @(" @(" @
M(" @(#PO<F1F.FQI/@H@(" @(" @(" @(" \+W)D9CI!;'0^"B @(" @(" @
M(#PO>&UP.E1H=6UB;F%I;',^"B @(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@
M(" @(" \<F1F.D1E<V-R:7!T:6]N(')D9CIA8F]U=#TB(@H@(" @(" @(" @
M("!X;6QN<SIX;7!-33TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+VUM
M+R(*(" @(" @(" @(" @>&UL;G,Z<W12968](FAT=' Z+R]N<RYA9&]B92YC
M;VTO>&%P+S$N,"]S5'EP92]297-O=7)C95)E9B,B"B @(" @(" @(" @('AM
M;&YS.G-T179T/2)H='1P.B\O;G,N861O8F4N8V]M+WAA<"\Q+C O<U1Y<&4O
M4F5S;W5R8V5%=F5N=",B/@H@(" @(" @(" \>&UP34TZ26YS=&%N8V5)1#YX
M;7 N:6ED.C!&04(V,CE#0T$W1$4Y,3%!-T4P1C9%0D)&-3 W.3,S/"]X;7!-
M33I);G-T86YC94E$/@H@(" @(" @(" \>&UP34TZ1&]C=6UE;G1)1#YX;7 N
M9&ED.C!&04(V,CE#0T$W1$4Y,3%!-T4P1C9%0D)&-3 W.3,S/"]X;7!-33I$
M;V-U;65N=$E$/@H@(" @(" @(" \>&UP34TZ3W)I9VEN86Q$;V-U;65N=$E$
M/G5U:60Z-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+WAM<$U-
M.D]R:6=I;F%L1&]C=6UE;G1)1#X*(" @(" @(" @/'AM<$U-.E)E;F1I=&EO
M;D-L87-S/F1E9F%U;'0\+WAM<$U-.E)E;F1I=&EO;D-L87-S/@H@(" @(" @
M(" \>&UP34TZ1&5R:79E9$9R;VT@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B
M/@H@(" @(" @(" @(" \<W12968Z:6YS=&%N8V5)1#YX;7 N:6ED.C!%04(V
M,CE#0T$W1$4Y,3%!-T4P1C9%0D)&-3 W.3,S/"]S=%)E9CII;G-T86YC94E$
M/@H@(" @(" @(" @(" \<W12968Z9&]C=6UE;G1)1#YX;7 N9&ED.C!%04(V
M,CE#0T$W1$4Y,3%!-T4P1C9%0D)&-3 W.3,S/"]S=%)E9CID;V-U;65N=$E$
M/@H@(" @(" @(" @(" \<W12968Z;W)I9VEN86Q$;V-U;65N=$E$/G5U:60Z
M-40R,#@Y,C0Y,T)&1$(Q,3DQ-$$X-3DP1#,Q-3 X0S@\+W-T4F5F.F]R:6=I
M;F%L1&]C=6UE;G1)1#X*(" @(" @(" @(" @/'-T4F5F.G)E;F1I=&EO;D-L
M87-S/F1E9F%U;'0\+W-T4F5F.G)E;F1I=&EO;D-L87-S/@H@(" @(" @(" \
M+WAM<$U-.D1E<FEV961&<F]M/@H@(" @(" @(" \>&UP34TZ2&ES=&]R>3X*
M(" @(" @(" @(" @/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D@
M<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z86-T:6]N/G-A=F5D/"]S=$5V=#IA8W1I;VX^"B @(" @(" @(" @
M(" @(" @(#QS=$5V=#II;G-T86YC94E$/GAM<"YI:60Z.38S,$$X.#=%13="
M13DQ,3@V,#-!,S)!,#9$-#<S,4(\+W-T179T.FEN<W1A;F-E240^"B @(" @
M(" @(" @(" @(" @(#QS=$5V=#IW:&5N/C(P,3DM,#4M,C%4,C,Z-#8Z,#8K
M,#4Z,S \+W-T179T.G=H96X^"B @(" @(" @(" @(" @(" @(#QS=$5V=#IS
M;V9T=V%R94%G96YT/D%D;V)E($EL;'5S=')A=&]R($-3-B H5VEN9&]W<RD\
M+W-T179T.G-O9G1W87)E06=E;G0^"B @(" @(" @(" @(" @(" @(#QS=$5V
M=#IC:&%N9V5D/B\\+W-T179T.F-H86YG960^"B @(" @(" @(" @(" @(#PO
M<F1F.FQI/@H@(" @(" @(" @(" @(" \<F1F.FQI(')D9CIP87)S951Y<&4]
M(E)E<V]U<F-E(CX*(" @(" @(" @(" @(" @(" @/'-T179T.F%C=&EO;CYS
M879E9#PO<W1%=G0Z86-T:6]N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z
M:6YS=&%N8V5)1#YX;7 N:6ED.C!&04(V,CE#0T$W1$4Y,3%!-T4P1C9%0D)&
M-3 W.3,S/"]S=$5V=#II;G-T86YC94E$/@H@(" @(" @(" @(" @(" @(" \
M<W1%=G0Z=VAE;CXR,#$Y+3 U+3(T5# X.C4T.C U*S U.C,P/"]S=$5V=#IW
M:&5N/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z<V]F='=A<F5!9V5N=#Y!
M9&]B92!);&QU<W1R871O<B!#4S8@*%=I;F1O=W,I/"]S=$5V=#IS;V9T=V%R
M94%G96YT/@H@(" @(" @(" @(" @(" @(" \<W1%=G0Z8VAA;F=E9#XO/"]S
M=$5V=#IC:&%N9V5D/@H@(" @(" @(" @(" @(" \+W)D9CIL:3X*(" @(" @
M(" @(" @/"]R9&8Z4V5Q/@H@(" @(" @(" \+WAM<$U-.DAI<W1O<GD^"B @
M(" @(#PO<F1F.D1E<V-R:7!T:6]N/@H@(" @(" \<F1F.D1E<V-R:7!T:6]N
M(')D9CIA8F]U=#TB(@H@(" @(" @(" @("!X;6QN<SII;&QU<W1R871O<CTB
M:'1T<#HO+VYS+F%D;V)E+F-O;2]I;&QU<W1R871O<B\Q+C O(CX*(" @(" @
M(" @/&EL;'5S=')A=&]R.E-T87)T=7!0<F]F:6QE/E!R:6YT/"]I;&QU<W1R
M871O<CI3=&%R='5P4')O9FEL93X*(" @(" @/"]R9&8Z1&5S8W)I<'1I;VX^
M"B @(" @(#QR9&8Z1&5S8W)I<'1I;VX@<F1F.F%B;W5T/2(B"B @(" @(" @
M(" @('AM;&YS.GAM<%109STB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP
M+W0O<&<O(@H@(" @(" @(" @("!X;6QN<SIS=$1I;3TB:'1T<#HO+VYS+F%D
M;V)E+F-O;2]X87 O,2XP+W-4>7!E+T1I;65N<VEO;G,C(@H@(" @(" @(" @
M("!X;6QN<SIS=$9N=#TB:'1T<#HO+VYS+F%D;V)E+F-O;2]X87 O,2XP+W-4
M>7!E+T9O;G0C(@H@(" @(" @(" @("!X;6QN<SIX;7!'/2)H='1P.B\O;G,N
M861O8F4N8V]M+WAA<"\Q+C O9R\B/@H@(" @(" @(" \>&UP5%!G.DAA<U9I
M<VEB;&5/=F5R<')I;G0^1F%L<V4\+WAM<%109SI(87-6:7-I8FQE3W9E<G!R
M:6YT/@H@(" @(" @(" \>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^
M5')U93PO>&UP5%!G.DAA<U9I<VEB;&54<F%N<W!A<F5N8WD^"B @(" @(" @
M(#QX;7!44&<Z3E!A9V5S/C$\+WAM<%109SI.4&%G97,^"B @(" @(" @(#QX
M;7!44&<Z36%X4&%G95-I>F4@<F1F.G!A<G-E5'EP93TB4F5S;W5R8V4B/@H@
M(" @(" @(" @(" \<W1$:6TZ=SXU,2XP,# P,# \+W-T1&EM.G<^"B @(" @
M(" @(" @(#QS=$1I;3IH/C8V+C P,# P,#PO<W1$:6TZ:#X*(" @(" @(" @
M(" @/'-T1&EM.G5N:70^4&EC87,\+W-T1&EM.G5N:70^"B @(" @(" @(#PO
M>&UP5%!G.DUA>%!A9V53:7IE/@H@(" @(" @(" \>&UP5%!G.D9O;G1S/@H@
M(" @(" @(" @(" \<F1F.D)A9SX*(" @(" @(" @(" @(" @/')D9CIL:2!R
M9&8Z<&%R<V54>7!E/2)297-O=7)C92(^"B @(" @(" @(" @(" @(" @(#QS
M=$9N=#IF;VYT3F%M93Y!<FEA;"U";VQD350\+W-T1FYT.F9O;G1.86UE/@H@
M(" @(" @(" @(" @(" @(" \<W1&;G0Z9F]N=$9A;6EL>3Y!<FEA;#PO<W1&
M;G0Z9F]N=$9A;6EL>3X*(" @(" @(" @(" @(" @(" @/'-T1FYT.F9O;G1&
M86-E/D)O;&0\+W-T1FYT.F9O;G1&86-E/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z9F]N=%1Y<&4^3W!E;B!4>7!E/"]S=$9N=#IF;VYT5'EP93X*(" @
M(" @(" @(" @(" @(" @/'-T1FYT.G9E<G-I;VY3=')I;F<^5F5R<VEO;B U
M+C(P/"]S=$9N=#IV97)S:6]N4W1R:6YG/@H@(" @(" @(" @(" @(" @(" \
M<W1&;G0Z8V]M<&]S:71E/D9A;'-E/"]S=$9N=#IC;VUP;W-I=&4^"B @(" @
M(" @(" @(" @(" @(#QS=$9N=#IF;VYT1FEL94YA;64^87)I86QB9"YT=&8\
M+W-T1FYT.F9O;G1&:6QE3F%M93X*(" @(" @(" @(" @(" @/"]R9&8Z;&D^
M"B @(" @(" @(" @(#PO<F1F.D)A9SX*(" @(" @(" @/"]X;7!44&<Z1F]N
M=',^"B @(" @(" @(#QX;7!44&<Z4&QA=&5.86UE<SX*(" @(" @(" @(" @
M/')D9CI397$^"B @(" @(" @(" @(" @(#QR9&8Z;&D^0WEA;CPO<F1F.FQI
M/@H@(" @(" @(" @(" @(" \<F1F.FQI/DUA9V5N=&$\+W)D9CIL:3X*(" @
M(" @(" @(" @(" @/')D9CIL:3Y996QL;W<\+W)D9CIL:3X*(" @(" @(" @
M(" @(" @/')D9CIL:3Y";&%C:SPO<F1F.FQI/@H@(" @(" @(" @(" \+W)D
M9CI397$^"B @(" @(" @(#PO>&UP5%!G.E!L871E3F%M97,^"B @(" @(" @
M(#QX;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" @(" @(" \<F1F.E-E<3X*
M(" @(" @(" @(" @(" @/')D9CIL:2!R9&8Z<&%R<V54>7!E/2)297-O=7)C
M92(^"B @(" @(" @(" @(" @(" @(#QX;7!'.F=R;W5P3F%M93Y$969A=6QT
M(%-W871C:"!'<F]U<#PO>&UP1SIG<F]U<$YA;64^"B @(" @(" @(" @(" @
M(" @(#QX;7!'.F=R;W5P5'EP93XP/"]X;7!'.F=R;W5P5'EP93X*(" @(" @
M(" @(" @(" @/"]R9&8Z;&D^"B @(" @(" @(" @(#PO<F1F.E-E<3X*(" @
M(" @(" @/"]X;7!44&<Z4W=A=&-H1W)O=7!S/@H@(" @(" \+W)D9CI$97-C
M<FEP=&EO;CX*(" @(" @/')D9CI$97-C<FEP=&EO;B!R9&8Z86)O=70](B(*
M(" @(" @(" @(" @>&UL;G,Z<&1F/2)H='1P.B\O;G,N861O8F4N8V]M+W!D
M9B\Q+C,O(CX*(" @(" @(" @/'!D9CI0<F]D=6-E<CY!9&]B92!01$8@;&EB
M<F%R>2 Q,"XP,3PO<&1F.E!R;V1U8V5R/@H@(" @(" \+W)D9CI$97-C<FEP
M=&EO;CX*(" @/"]R9&8Z4D1&/@H\+W@Z>&UP;65T83X*(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @"B @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" *(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @( H@(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @(" @(" @"B @(" @(" @(" @(" @(" @
M(" @(" @(" @( H\/WAP86-K970@96YD/2)W(C\^_]L 0P ! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$!_]L 0P$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!_\  $0@ T0): P$1
M  (1 0,1 ?_$ !X  0 " @,! 0$            #" 0'!08) @$*_\0 9Q
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MY9H4H+J <5@M=6/<Z)SF@F*1TG7=Y+M30XX]P.ZWWE5Y(QK)0''$D;8_@@
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MS)&9*M&;I1&^F;JJ(1EH^V-/>. =)!P-CN<8'I.!XKDSPVFEV<[N.:0T9(U
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M-?E)^%CIZTGDDJQ"/Y5BSE[&I#,C24NG QKA=-Y+GBHXIG\D6/1<&8LBBZ=
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M8U97"3"&4GV4<V\CB/-;-A*2G*D8D )<2&C4'RB9S3EW=+@T $#'=&<9ZY)
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M$.$\#^Y?AWH/\26W]F4"NSMDAU;"O >@.JV3P>W_ '_,A[0N/\G^[CC#J?\
M*:]?MJL9P?PD3OPOP[T_B2V>]_)E@GV?LOPA_P"4.\^S]]L_]S^$,RR=HG:
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M1*9VV 0$0$!72 0$/0(" GZ0$!] @/5A%3#C6[:%W[SV,9TW #\@=>"0163
M# '&#1I1$HB;H, & 0$0Z0Z0$.L,TS?<J7_1/_K7K-#]UJO]*S^J8KI)N$%A
M$$5T51*'2()J$.(!]T0*8>@/?F9:5-A$PB81,(F$3")A$PB81,(F$3")A$PB
M81,(F$3")A%3?"SIA%.'4'N#NPBU-LO_ )J0_P#5D_\ VCKF?+.VW_W6\4>J
MT_\ CMK7O?9C_AW8_5<?_"J]5N/U=OP'/YV'J_V_[07[!C\?9\ZP%^HW]O\
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M335=742G#(:>!ADD><9)PUIPUH+GNPU@+B ?>KB]I*,U[5XPI2)N/)"J+'?
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MKF./&V=U5_?<_P#3).;)V$OMBL\EMB:3J%!VUJ'8NJY2M:ZV4V!I4(6 A:G
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M:Q?K8,@[ZFOLM=_\)>NN?[[S?JJ8[:^/.@GMN, ?WMB'RO\ >"_ T#&*"/\
M>[#B/7Z)>Q![?X5'[N5GZF?LL._DEZ)Z?WXF&V_^8?2I_OV\??A%M_-T/ZR^
M_J^10^@:]$]'\+V/]:CW9$_4R=E)_P#@[WUS_?F;Q_U%$=M_'I/_ +3;3_\
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M,.\Z@O\ CK_?ZIZ^R-=^R#[2 ,^56G!_Z*A_77T'#&FG#]E M_N?X>L =?\
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M_P#K^/L-.P_^+^(_YP5/T:?9(=J/X99OS1#^LGU ]>_>,/TBG_Z_C[#3L/\
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M-PS.2.BY@WCR1=PSA,SH2*Q;J0?KL#E,U6>NE$C+J>/>W2][?O7.;UST)'4
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M&?5;=<*.[6^ANMNJ&5=ON='2W"AJH\\NIHZR!E32U$>H-=HF@D9(W4T'2X9
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M&PRZ)2\1S,#7R,?&\L>-GZV$ 2,9J9JM*PK%:BG .XNO0<:Z ADP<L(E@S<
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M<[R4@F*Z94B)1,PNRB9ETY)JI&ETN0QSP&G)#!)H)& XM=W3OX$^^,D+-5.
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M>H>6M-'L#2\ZTC&%CIL$,%YVLA6DM8FC^)39EL4:;S3,I,9EQXPY6S)44E?
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M3?DJJ9FS%NG5ANL]\ $:W9P,.=L/23N22 W.%=3PNBU:M.7:!W22,,&,^:T
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7A$PB81,(F$3")A$PB81,(F$3")A%_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>45
<FILENAME>g723949g86n48.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g86n48.jpg
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M@<A80;I!:1G]L?*7+!$9I4B!QO/)^  )8_CA02!ZGBHIY1#$\I&=HX&<9).
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M)@?3G<Z*:_254ZO^2K-UKD%.AE@MDF6*,MYL!"S%VMUK%AAPIB8("<&=BD2
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MF*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2F*4Q2LT_BG?\ (;E?_5=YR_\
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MGRFMYR-OED B=E( WB.S$O//WI"Q)SCUP/0"N.G\+DR(I!SL,EX8@1_],84
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M+8]0/O'Q>AK9O./KD*8I3%*8I6:7PT?^%^W_ /N-^J/_ "%3RY>?W7_)P?\
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MF%;2K276'7&][UO6E?;K>8(()!!!'F",$?O!K(((R#D'R(Y%9R_#1_X7[?\
M^XWZH_\ (5/+=Y_=?\G!_P JIV?]Z_SD_P#QK2W*=7*8I3%*8I3%*8I3%*8I
M3%*YFY72I\[J\U=KU8H>I5*N!*D)RQ3QS$;$Q@B5H:TZ462M#2-NO.M#CM:W
MMXDIYD4=MTAYIM=BUM;F^N(K2S@EN;F=PD,$*-))(QR<*J@DX +,?)5!9B%!
M(X_5M6TS0M.N]7UF_M=,TRPB,]Y?7LR6]M;Q A=TDLA"C<[*B+RTDC)'&K.Z
MJ<#?=/J*1FNY>?.\>+):"[+9X/@OI$:NDU@?\TZC2T&44.SFO5Y+>RWIBIUJ
M1-LR8.2"TM38PA9<>7'/:9*[IH/3T<6NV^C=5QS:7;RSQ-.MPWN^]3%,UN@G
MSM$=S<(EOWHWQEF575QE?'NNO:-/=^S37>L_9)=6?5>HV=H\=C)IT?ZR]WE%
MY91:C,]AM[KW6F:?/+J L[B$$JD4LL,L#;);H_"F] ^G/0O$[=9?2L<6\=$W
M+472[L?5 J87<(A<<V_)I5#Q<9#113$#(;2&S-1D6,,8LEX!U3Y\28[N;VC:
M+T_HFK6L&@R*$EM>Y=VB7+W2VLH<B,]V22613,GC,4DC,NT.-J2(*X3]&OK;
MVA]<=(ZIJ'M @E>:VU;W?2=7GTR'29=4M6@62X!M;:WM+:6.RF(B2[M[:..4
MR/ Q>:VE:M1\\]KZ,IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4JA<
MAR[Q7WKL73(*&GS(OMM2EV1>M0?+.M]4XM:SCW8R.*3(6N"H-KI2+BT_&EQS
M"[<H&90K[J8S4XD@1X5FT)+F*-"1F,C[,O&DB@9/"LRMMYSX<CXX\JJF.WE=
MP"1(#]H$D>-B2!RRJR[LC'BP?+&>#5L.9\FYUQRONUGFU6 J\24>[+27R'33
MY2;F'V!Q7IJQS\L5(3UDFGA1!!'9B>DI&2<%$$&65M@9AMN!Y'D.78L0,#R
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M&4L"_D1Y8('J:#=CN2QM#+(V_N'" E2RJH*,"&"D)Y@^>1GC U'YHS%C\YH
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M>/)1*N'K,FG[HM@'*.@EC[<HR3(NR3:-WJ$Y&&\2'CRJ" Q&Y)0.CF.3?$V
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M)4M:DI0E.U*4K>DI2E.OM4I2M_9K2=:UO>][W]FM?U[S#,%!9B%5069F( 4
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M@Q2+'NK[RF^,E02Y#^%,,%PQQP2Q   )/[LFJXND*!]L@#'" IXG\)8E1G&
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MP/,G YQ5*+QZY] P4UW$B'ZU)O2+R_3$7::HH*GD#><X'E_J[D_&N?W2)$_
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M-KF@RGC DJ/(M=VACY MHT-U)$>$*(VTSIG>I-QPK;8OQE^D3^DCU![(>M-
MZ:Z=Z9L-1L;G2K;6=3O-<]\[E_'<7UW:M8:0UC/!%:RPI9DR7EPFH?:W$:^X
MJD.;GZ5]C?L6TKVB=,:OK>M:Y<V5W!J$^FV-OI/N_;M7AM;:X%WJ*W<4LDZ2
MM<@);0M9_9PLPNBTN(( \#%_$IFN>]@DN/F^-!HAWTIV :RC]? [E^80KJ-(
MQVI^,@FJP:Z*#2(UQ;(U7BS7G9./'20.6O>](WOZXT;3NG+'3[2?3-!BZ>75
M;2UU2XL+#3[#3G%Q=P+*_O\ %;0PB2_3/;N9'#.70@MQ7SOJ%YKMU=W,5[JQ
MUDV%S<6,-W>7EY>*8;:9HU%I)-)(4LVQO@12%",, 9J]7TWQA?\ ZI\-_P#_
M ,[TO_BLY7_R_P#^\_\ PU2_\P_^S_\ S59WSPWZ[;'M?ZKBO.I)6WH;\C_I
M^'Z0.P@?2)/\P?FG_2&ZXXIY3FX;\'_"?L1I&I+ZW[5;&^R&7W?P]CO>N[N[
M/PQMV?QSG\,5-%[QXN_V?3;VM_XYW;_X8Q^.:LCD-34Q2F*4Q2F*4Q2F*5FG
M\4[_ )#<K_ZKO.7_ +VSENS_ &C_ .!-_L-4[[]BO^-%_NK2S*E7*8I3%*8I
M3%*8I3%*8I3%*8I3%*8I3%*8I3%*8I3%*I][:\H#^P>/B\WW;WZ3*0MLC;E!
M3/X>J7CU24?'2\0L*7BTF +("* FS4H>8*;("+2,4C1#2'PRN@>T?H9>O^GT
MT?\ 6#:;-;WT.HVUQVC/$9H8;B#MSP"2(O&\5S)AE</'($<!E#1O[%[$?:Q)
M['NL)>I/U.FMVM]I-SHM_9>\"SN!;7%S9W@GM+HPW"QS17%C 2DD31SQ&2)C
M&[1S1=+Y"\W">4^(P7(Q[.5<"@I*7G)>>?#_  P<J6FR=/DMQD7LH[<=&C--
ML#LLK,(<?=;?.=4ATM;+5SH'I"/H?INUT%+U]0>*:XN9[IH^RLD]R^]Q##W)
M>U"@"HJF1RQ#2,0SE1QGM?\ :3-[5^M[_JZ32XM'BFMK.QL[!)O>9(K2QC,<
M;75UVH!<7,K-)([B&-45D@4,L(=K.9W.O,*8I3%*8I5#O7_J:Z<"G*; U2JP
M<FS8(TJ6DI2S#R)(!+#!GT;D-'( /C=(,:1K3YS[SI*6F30=)%_VBE*^1?TE
M/T@>J/8]JO3&D=/=/Z3?QZS97&HWU_KL-]/:3PPW/NSZ99)9W=B$ND4":[EE
MDN!'%=6@%OXRQ^AO8I[(M"]HMAK>HZQJ^H6CZ;=0V=K::5+:Q7$<DD'?6]N6
MN;>ZS"S?9V\<:1%Y(+@F7P@"K7NCG?-8[@/F^SUGFD'1R>D^L?*,M9(D<!MH
MEMN;F7SWX$S>T(VT.$LUX=P!AH41+J5JT(VK^I/N?LMZ*Z%LM!77M!Z$TKI.
M?KGIJSU'7-.ALTCG1-5T^*[FT>YRJ]N"U:ZD@>SA2WMED5B+=&X'E'7W4W5-
MSJGZIU7JJ_U^+I;79[/2KR2Y9X6:PO'MXM1@ 9@TDZVZ2I<2/-,4(!F89)D'
MI;7,_ ]JB;!SBE3%IM'0A)EE#]KL*MPU:KH)L6\=%0?T<6T2\2:^Z'K;\B0<
M8$.,W\PEY!CC3OQ]UU'T+^A_K^G:ST1TOJ74&O\ 6=OJD2R]1:RQTS0M$M;J
MPENM.TGW73XYY9KJ:2U!FO9KNZM8+=-]Q*MTZ2?1W2K]5?I%:3>:;U/KUCI&
MD]-36,ACT?31[]JNIW$%Y';WFH=^[:)(H(TG(CMH[>">65ML*- KII'SRX,=
M!HM1O P!$6S:Z_%SK<<6K2WPM2(K9&QU.Z0VE]+2E[2T2EMM)+6D/I0A+FDZ
M^XNB^I8NLNDNG.JX+2>PBZAT:PU9+*X.Z6U]]MTF,#2!4$RQLQ6.=419XPDR
MHJN%'R]U+HDG3?4&LZ!+<17<FCZE=Z>US",1SFUF>+NA"S&,N%!>(LS1/NC9
MB4)/99V:N#IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4K-+X:/\ POV__P!QOU1_
MY"IY<O/[K_DX/^54[/\ O7^<G_XUI;E.KE,4IBE,4IBE,4IBE,4IBE,4K/[I
M_P 2[S#R3TC%>7[;)VU-Z-D:]"RL_'0 I5&JDW:F02(**L<PY+CRC3Y0\I&/
M$$Q,%+1L8@YO\5."4P<D3NFG]!=0:GH4G4%M';>YHD\L<+S,MY<Q6Y=9I((A
M$T956CD 62:*20H>VC@H6\1ZB_2"]GG2_7UM[.]3N-4&L2W%C:7-]!912:-I
MEWJ20R6=M?W374=PK21W-N\DEK9W5O;"9?>9H3'.(M <Z77MU,4IBE,4IBE,
M4IBE,4IBE,4IBE9K5%[UZSZRF'+"BW+Y:U.V)PM+S;B^?JI#;9RX-,&G6OH%
MS*F-1FAT ?;/J/VI,M_LOQ'/AKIN7])./](K4GUE>HV]G\>KZT]PLL;-T<W2
MB)=MI(TH >Z/J9A%@(%LR=8:\)&I#M^^U]2ZTGL5?V-V2Z:=&'5SZ?IBPE'1
M>I!K[/;C4#?DGWA;$2&Z[IN/_+A;8-EXQ;5[O!O6$9Z,ZN]3+'RF%&:C!9.P
MTR8)2S.24+N,>&TK9_UH.T %DM.-JU(1CHVF#&F0_ED?/;):Y;V0_I$6'ML]
MH<G2^M^SW2X([&WO]9Z8U*<1:M>Z6;"6 'WSWJTVVES-&Z,+VQ>W$5S'%;=N
M7NI,G'^T/V.W?LQZ/37-,ZPOI7NYK33=<L8C)I]K?BZCE(]W[%SNN(8G5Q[M
M=)*9(7>??'VVC?)>H\ZZ.;SOO/6H68<W1J3[,]&AGQK$DZ&7 3Y?1X]ABQ!C
M)4WIYR15)Q "R15[,$_#6UKTD?['$==_3>Z)ZXNI- ]HNEZFYZ3Z5T/3;:\L
M8KZ2VN-'U>XUEX8M:MH R"5[U[_3K1KBW8W5M[DC,!#XUY;]%SJ?I>"/5^C;
M^Q7]?Z]JU_/;W4EJD\.I:=#IPDDTR>0ABBVJVM[<+%*O8G%TRJ3)E6TN5ZPZ
MS??,DA8^85V4$Z#3+!6:K<)8<9NU$:A"(8MXBWQ[#T;MK99T@$,-)L/QYB8E
ML]TQ+JDJ:*%J'](CVB=7^P>]UKH+1=0M^LNE]8T'I_J7488(^H)AI,VEW,DW
M4MG#)8F,W%U>6L,%_#+9W(TY+M[D2,ICG@M#V.]'=.^U:VTOJS4[.;IO7--U
M75]%LY)6TB,W\=]"D6B7,B76\0P6T\LMK)'<P&]:W6 J&#PRV]\M6SIUUX]"
M3W602!+0^;(LLDF1J(<Z7AF74:CI8R+:8%:$>(^U]I&VQ!FRQAV#VVMH*2XY
M])?H_P#477G5/LTTK5_:+:36^ORW5]''/=6*:9=ZEID4BBRU&YL(X;>.VDFS
M+$G;MH$N((8;M(RMP)'\6]KFC=)Z#UMJ&G=&W$<VDQP6KR10W37MO97SH3=6
M4%V\DSS)%B-VWS2M#++);,^Z$JMB<]JKS.F*4Q2F*4Q2F*5FOV+U[U*C>C):
MF5V+HR^4\UO?E#G?0@IB(G2[U9I'U19;! #SE3GP[&##0(M":"@S%1<A6)]R
MRK)EQOQ&(VR(O5R.W1H0S%M[K.R$$;0(%4X88R=V2,@C''!JI).ZR[1M[:-
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MOH3$6=8SA/5\VW6I:P-*&.E4ZJZ^AH@G*\5*-+VB">B41:P=-BKCT,?[NGZ
ML^@8M7Z*Z2Z;]I&D:1UU?Z!I&DP7=[KFD6VK)-K%GI\%K>:C ^HVTDW<N9(W
M,EPX6>ZC8FY#&1UKR*?JW]6]3]0ZWT7J6H=*6NKZCJ$MO;:7J4^GM%IUS=RS
MVUG*EG.L6R!'4)"NZ*!UQ!@*IK1]CW3XD&99&&]4^=AQQVFV&&&.KT9IEAEI
M&FVF66FYA*&VFT)2AMM"4H0A.DIUK6M:SN\5A)!%'!!:&&&&-(H88H>W%%%&
MH2...-%")&B *B* JJ J@  5UJ2]BE=Y9;I9))':22224.\CN2SN[LQ9G9B6
M9F)+$DDDFOU_7?XJ_=?Y[_BU2/YSDGNUQ\B7\C?2M/>;?Y\7YU^M/UW^*OW7
M^>_XM4C^<X]VN/D2_D;Z4]YM_GQ?G7ZU,7,NU\@[2%*2/(NG43IH$&4P%,F4
M6T0]H&BS"FEOC"GO0Y9;8C[[*%NLM/*0MQM"EIUM.M[R-XY(R!(C(3R RD9'
MX9J1)(Y,F-U<#@E2#C]^*D[-*WIBE,4IBE,4IBE,4IBE0KZ(Z_K@_'+EU),%
M^9C*\B"!AZ^J1_"&9BPVRS0U.K8!DMH.15&1[\_8(U$C(-QQ[H0.R"6@BW&T
M#N20Q]V14S@'))QG"JI9B!D9. <#(R:CED[4;/C<1@ 9QDL0H!.#@9(R<'BN
M"Y-ZBJEGI$K-=<E:#Q^TU?I_2N062,E;]')K9EMYA8R(*6*J$_91JH9-P\B)
MJ.FA?J(8"0!8DT!G"I>8V\]O)"0P$8>12B2 [#N"NN0&"E@".1YX.,BM(YE*
MDR%8V#O&07&"R'!VDXR/X9'^M4L^'5VOC5<C/9J;#UOF4$J:^()Z;L$.F9OM
M5BU2T!)GU=4;-QNCI5C9T1():=4#)"_-"+TVYL=YS2%?98NXY#[MB-SBTA!P
MK'!&[(.!P1ZCSJO:21CWG,B#-W,1EE&0=N",GD'T/E6BGZC?/7]O'&?XH4C^
M>94[,ORI/R-]*M]Z+YL?YU^M5S]$_$(X#Q2%CA*[>*ETKHEN!GU42KU&>#L@
M!9M?_"-R*[)+UQZ2%KH8@TRU(,MR3P9$VR$>)$;<(8>6QGLRA&D*,JIM#%@5
M^\2!@'&>1SCRXSYUH]Q$I50RNS[MH4@CPXSDC..#QGS]*ST$^+'W1OY/UM Y
M05I+A"B/IP+<&IUI:=?2ML;7;2TCK87]NWG'$$Z);^ZA+8Z];=5%6G??X+_(
M_P#NK_F%^*_W 11^YRC<UF4O[>6!H46Q0^X]:];^4TO?X[(?6BLJ^[OY:],E
M.:^\E1NMJ2I"@G?U"G^!'_\ OR_U_&O+"^*OZ&';E?JJSRV0>+>2[&J>@["P
MQ$)^9]K@^F1+0RZ<QMK_ %&MDD_4-N?8ZX0^C[6=J=Y__I_D>/\ 6I+YW\7"
M0C;&\;Z K=3KW,FPGW)"P4J*L[\O7GF1MJ9+>CGI6?>G RBTH%6("**8-HI)
M+;I6AE#/[HC2.J(,LQP!^-8]YV9:3 0#G:#D?CYG/_\ /XZMB^EO.Q@PQ;7=
M^.Z:*89(:T]TNELNZ;?;2ZC3K+LTEUIS25:^^TXE+C:OM0M.E:WK,]F7Y<GY
M&^E3]Z+YD?YU^M?O^HWSU_;QQG^*%(_GF.S+\J3\C?2G>B^;'^=?K3]1OGK^
MWCC/\4*1_/,=F7Y4GY&^E.]%\V/\Z_6GZC?/7]O'&?XH4C^>8[,ORI/R-]*=
MZ+YL?YU^M45Z1YT^&OU;T/$>FK?T[F1/0XTZ ES@A.VTT6HV::JS0;%?E[)!
MZE5K,+CF(V,94R(<!'2;4>PW,@R*5E:([?8=9]3:;HDN@6L@6Q=)HD=K8M<V
M\5P6::*";@*KF20@LCO&78Q.F%V^-Z_[#/9IU+UU:^T+5+*>378)K*ZFACU
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MO _X/<\_R[COS_.E_J/]:=B#Y,7]-/I3]*?EW]MO _X/<\_R[COS_.E_J/\
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ML5*B>@\\F%3E6FG),<4MZ-E84Y@Z$E38*;BI6$G0HV;A9B&FHT^*E8J6CPI
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M71_E#<@[TD'GUZDJP+4;V?3$14FJ8#JTQ*/Z1'FNAH+9%?<;G-O*%#;1_8R
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MQ)MN%<[Z73G=3'.NB1IA@9D)9M"FB;!;EH<IIMJ5V^U8MY%C<EG9,J5#*H<
MG'WT;AU(SD9'.#Z5!<1F1  JOAE8JQ*D@9^XXY1AY@X/&1ZU2B#\*]AND?QT
M+OS56Z/7Z0_ZU?'IO0KK(=>*I5>ZU7JC'<=II]RM-<"+Z4?3Y*$D) JT2X#+
MT.0[&JBU$JAXXEJP;F-3)VMR%NP-R*(PQC)[C;5/@# _=!.><^9JN+:1@G=P
MX7OX5V+E1(%$:EB/&5P?$?+C&<9KBQO#7IAZ\>69Z<BN9%D\,C/%C,A> IZ%
MW;G8_C+0 W8X$N<G.=35\DR9)]R877!*M>:%3I^"*?3<0)B94PUK;WF'9, 7
M'<]YPI!VYD_9M@.% 'KN5V!^[@5I[M-NA)"$QBWRX*[B(\;QN*E^>0,%58?>
MR:YG?PM[6YSPN*(I'(W;J5Y3[C1W)=PAMQXCT'8^N,6CDEX)DU0FR7S:C3'I
M2)B;>]IR7J;!.X6%0V K24Y]]7=G?)M$T38&<=I8]KKC/DS@$KY,>3S6#9ML
MQL3<895)X_:LX,;D_%5R WFN<#BMT8A@H:)BQCG/G'#QP3!COS%._-*:&:;(
M<^:K6E.??>2M7S%:TI?V_>WK[=YQA\S7)#R&?/%>CBLTQ2J_^J>+F>A_//5^
M,1TT/7I2]U=V.B)@UAPF/#F0S!)B(W*,,I6\]$/R4<*-+MLMNO*C7BM-,O.?
M=:7+!)VI4D(R%;) \\'@X_'!X_&HIH^[$\><%EP#YC/F,_AQ@_A5:!^#]K]#
M]8A+OZ>H?-N=TZF\+ZUQC\H4*^2-_,Z&?VQBLQ=VFCCS:?5F("FAPM:2U6X
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M4>;:)V:C$0RCRM&QD3:J91*M1@(9A]LIZ3:$;K#[)Y!AR26VT,ONN%O/N*U
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M\0^!+@8MV.4FOJ3"#WO>XV8$C9LN1+X$5>ZFXX+@8^T0<@D\Y.>>:I>ZR*K
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MGX>( )VSOW$*3D8WE5.W\.2<$\$>N00"2$EPX"[06 P0=F6&XDG!X'D,$9Y
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M(C3+!!5.DXJ.&8*H&W-41"&T-C5QAMII*-S/(6+9QEMV !@'.X,!C[P)^_\
M?^+5J(8PH7;D!=OF<D8 (//W2!ROW?PKNY+A?*98"/C#:@-L&-*LY+#(LC-1
M^WF[M)-3%SBY-Z/DA7YFNVZ3'%-L]7EW3JY/O! [E8HO0(FF=1*X)(;D[1Y
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HIBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4IBE,4K_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>46
<FILENAME>g723949g93u91.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g93u91.jpg
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MZT76,F:N1;+A'1;9*(=Q6]"DM)@2W"L-Q9JEM)$62LMN!##Y;=44+ 2=JL7
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M/7IL7&9<?+7XB(3FZ8&06N2A^0G#?)&%\S*MW5(QUV=Q\>/NX^OG&Z[*K1*
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M[R,>&(7G/P+<3G_)I+;4IMU7P+PWV)6YKV) *N2M14O[U93M"A@$#J02KOU
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ML5D)WPG"2U$N&G,]@Z/-WFT#N-NW3.5,#<.:VZYA9Y#B0AL-N[0"L<M*4G<
MD+2I)'A&,8!'5;VG/(;B)T9;K+<C"9!D*<DJ4$KW\H%3@0 GF+VD86A1!P05
M).[U$G#Y1^R; /M#5%M=E7+Q:Z<8Y(2<1.SM="0<M5:'400R"UAE\=W(BU9P
MS(XSYLMQA;2$:=>X*6RE20=RV \&R"E8V+R=H[@J&TDXW#P[1T&Z%+: I'12
M@K!<[X/7KW';N?6.@[UU)TW8W;3K>K3!DFW*R)4?WSRD/#/961X[N%? -A*6
MD83W<,LN)\9EGPVWUN/)6XK?([G,9;45!1VX4H8ZD="2!V)QDI^].1Z*TRP
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MQS5<D+A08R5+K<2398NISD:U(D8DR@G8HN>FR#X0^6TX2A(5M6C>-P)"\YW
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MY'A0PRWV<"1N6>Y*X+6MQ)2%&"^:L,Y=2EY2L9:TTE"W$!*0-H4%+ZD*PGJ
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MSKLF0YEQ9.#6\WGBCPQ1HS5=CT^[<DO:DL^@6HL>98Y#UTBR=+W6SS;BS?\
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M-0X%SE6V/?8<BW2)G(;2FZ71^:S*BR%1WFPX&EI:DI4VE1;);25=QI-1<5=
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MG'E+VHYQFNU3V/L/T53Y:7B:_&'SD]*1T)"1 A$C+3$N:-&Q<9'AMJ?+/D9
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M1@X4TZVKKZ@:M9OL;N%MON3-UN<&\ZUGQ@#'?UO>Y5\;:6#N\4)?D]OD)W
MLRX<E!'4)W$*&DNZ=4["IH-CHI]T%73UK;+IE>F(*"5/#X<+<=N%=B;5-A.G
M5:)65YL3) @&8'?+;R^AI#KI*B.(>2W&<A:X;27?$.8^\XK:%.;SA:>KCCA*
M%YPD^($D]0:]!KO<6Q)AQ$EME4F(M+#+"0V@QHY9:Z)!;CH\G#B$I25HVI*4
MI!"0!KQLG8>T^HV]4YNPZ<IU3+K4!$4>,:J(8S8=R9AFV0XJ4DI85YF*/8$
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M>3W_ &NL=^,';?\ ;[C_ $D:U_'CGY';?X.GQ8N!GR$9_/VJ?YY1[TQY/?\
M:ZQWXP=M_P!ON/\ 21K7\>.?D=M_@Z?%BX&?(1G\_:I_GE'O3'D]_P!KK'?C
M!VW_ &^X_P!)&M?QXY^1VW^#I\6+@9\A&?S]JG^>4>],>3W_ &NL=^,';?\
M;[C_ $D:U_'CGY';?X.GQ8N!GR$9_/VJ?YY1[TQY/?\ :ZQWXP=M_P!ON/\
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MW/.&/OO27G9$AQ3S[[BWGG5G<MQUQ16M:B>ZE*))/K-=WP($.U08=LMT9J'
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MIPI4E"5%)%:FS?91</Y5Q%HU/;=5Z G>5NP"K5UF,."B<R&2]$>EQGI2HCS
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MTA_(:?%_X3?)=?Y]U%_-:/S<O5!])#7\2Z%_9CCXV/'OY<-_\+Z0_D-/B_\
M";Y+K_/NHOYK1^;EZH/I(:_B70O[,<?&QX]_+AO_ (7TA_(:?%_X3?)=?Y]U
M%_-:/S<O5!])#7\2Z%_9CCXV/'OY<-_\+Z0_D-/B_P#";Y+K_/NHOYK1^;EZ
MH/I(:_B70O[,<?&QX]_+AO\ X7TA_(:?%_X3?)=?Y]U%_-:/S<O5!])#7\2Z
M%_9CCXV/'OY<-_\ "^D/Y#3XO_";Y+K_ #[J+^:T?FY>J#Z2&OXET+^S''QL
M>/?RX;_X7TA_(:?%_P"$WR77^?=1?S6C\W+U0?20U_$NA?V8X^-CQ[^7#?\
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M!@MATQI\HC3O)2 RM*0CF-[BD%12"'%HZ%14KJ$@X).#GKBLT=2CS4J.[8X
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MNN-NN*2M6,BM:@$J6H@# !42 /4 3@"H"4C)"4@GJ2 !D^LXI(>HM3Q\38H
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MP&''QV RL.(89;:9PPYV)QA/)4E964J"BX58(/514?63W)S0%.W(P$@=,=
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MI45&X#9DJ$I'G<L!.X( S@9 '7MFJH"BM'16$R%XZ+P$F,>V_)"=Q.#V)/3
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M5PE-//./.RFXZEOH1*<=675R'T(4N.TPM6[W/5E="5\G_/SOU]B*G%2,@H?
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M9=5C*5.9+PYX_B*3G*<K\3O9QG.,Y[.0)\Y,OR],R4)V\N>6"0\)?,(VE?E
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M*\&J\]/N^FG\5<]C[#]%>X^/'W<?7Q6$=Q[1]-/XJR^_N^LTI\A@1AXHEU#
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M?BHRGO\ <[R.]W>WM[O?3V_IXXI6-/<PS^S>/X-S^7<4KW&L,XSC/IO'P?\
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M.9\WZ?\ *O4W7*L]GHW&/_6\_DW%.9\WZ?\ *H_7+/['8_"\_DW%.9\WZ?\
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M&T';-FN<J+?I2E@20]*D;2W:56&>'KDZZC,Y+0H]OD51\;(VL:)#S4*SAMC
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M<=#CV@"LD=3^V=NT&W%+ILR7'T:I:N5>K032X#7NP;'63\2\ZA-AVCKZSV>
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MG!MRE)3C!;Q%;R03US(0D[AV..I]O7N :J%$*R3O_P!87@$#IB.M6$G&1G
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M=M7(K?CK: ,%A\F!L[S4N\\#)LYC9HE$F0MHE_!;G)+CQ""5N82<H)4K 4D
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M:7L-F%NOE$)<(?><793KBD[5.+4GIX2HD=.@Z9QT';V#U55M" LJ"$A6#U
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M9.1UR<>GT^NKB7K77;@,/&.4.G.1M?I\KKV"CW*U#N PU"G18<&;I46(L/+
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M*;0E*L(P'&65*2 49)DA/0+42DE*1W5C)ST!JB5J41E7F/.)220K \G*NI2
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M=47/3DW0NE;]8-*7ZYP-/7>8[J./='/)7&X=R=;G6B^6UMR'/>BASR?E*;+
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MJ+)0/IX;2E&$(0E*$(PE*4IQA*4I3V82E*<=F$I3C&,8QC&,8QCLQSWR
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MFAW2!QWW&&UI:6\PRZI.5M(4F I0Z!1 [X!(J< ]P#[JBD:O6IUF3%FZ[!S
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M/_\ :SJN;R&O_$D>_P#/)??_ ..JO,'%W_VM'_W7"_\ [Y%;A]AS_P!D"O\
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MD'J/134QIW=Q^A7?G_T?W?N\4(._.#C(^JHTQQN,XSD9W][^Y]WBK*&00/\
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M6A"AO=LU+?[-;[U:;5=Y]OMNHH[$6^0HDAQF/=(\9:W&&9C:" \ALNO!(/\
M[MY]HY;>=0LHNMJ#K&/E(G7M0@:;&3<_)6F6!K\<Q'#2%AF,M>DI<IMA*4NF
M$I''9RYGX&QAAA64MCCLM(6RT6NS,O,6F!%M[,B4]-?:B,H90[+D;><^M*
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MK8AQM*2B(SR6$H:2  AB.WU0PTE&JDZBOLVW?!$N[3Y-L-Q>NYA/R776#<Y
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ML@=D=MUK"'+.2DM@*+;NTI"B2$IV@G&W"U))6/ODI!(!S5&XJG24I<:W!12
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M.^X+&3A/:HYJ]B5$)PXA1&TG*2&RL=<=B >V"DX'B[BW]A;NW!=-+W^2UXQ
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M7PME^)!=5%.@5 I)I P./EL@!94[L4X6TX"=W@"2I9';'C&U&<GKXJOO=)*
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MLO(3$[+0$.1YU&1Y%A=I]>K;EC4(V+(*5&K( ?A$5".@4X4 +"6RKP)#F=P
M "CW.-RE8[]^M67+<6.J6PLE"E.!/C64$%.<D@8P,X S[,@U+8GE%]HWL2Q"
MQ^K-&Z^<MVYZ3U!VF2I-9N#,K.[:I1ALBU9#RK!?)]I8\V<:IZ6ATC)C6_ 0
MN)9C"S9HN6A$1"2"5N*VMJ: 4I. VK VC"1V P#W]>>F"I;B@H!#:=SB75%*
M3DK2<Y.5'N>X[>K'7,E</*'[AL,M9INL5#5VL)2T]05+ZG3)"BP]J26-MRF
M28J)@;%FN-C!<C[";,'R]CBS@3&337<,#K#C<O ORF*V D%2UA+2F0%E/^S5
MCIX4IZC "2,8'K/6BI;A)*4H02ZEXE 5GF)!Z]5$8)))&.OLJ<G?**[0,EJ=
M)U#5FB]7,5[>=8ZD+/"Z_JEGC8G:6VJE(IE(>7OWI"Z2DJ["#E9*<:K%9E*U
M$L.R1Q0[31F0R0PBH 4%+<7N:+(*U))0A0P0G"0,_.H*/3KZ<C+62DI0V@)<
M2Z0@* 6M)R"O*B2/F!'?UXQ@BY=3E]O&L+WJ>6B:B/7=A=11_4U-&QP$RS-#
M7R0@)VNO1,823/E@LU%(5@-=: *CC9E)38RUSRV4.L/9$LI2M*P590UR0"1C
M;D')Z9W=!USCYJQ*>4I"D$)PMWG$@'.[!&!UQMZGIC/SUKGS+6*CBE'%*.*4
M<4HXI1Q2CBE'%*.*4<4HXI1Q2L]],V@+7U-;EJ.I:HEQA4T5YW89OP<O#5BI
M@+;<G["7C\ZC*0A5X:!8=<93(2Y,=%H=0\<UGF%]Y+#2G%>CHD?TE'LD>WT^
MH9/HK*PRI]Q+:?3W/H2D=U'V?3@>FOMQUMKVJ:GHM3UO1XUN(JE-A@H.%!1W
M5+2,(CL624[A*,E2!Y"GCY,UQ/C'2!)1C^5//N*SQ=:U.+4M9RI1))^?Z@.P
M'H%<E"$M\M"!A*0D ?-G])/<GTFK\Y6LI['V'Z*]Q\>/NX^OBL([CVCZ:?Q5
ME]_=]9KW'QX^[CZ^*I6-8[2>IHEVO/1NOZT$[5+C9=@UQ;$>A&8>Z7!$HBRV
M(+X>QJ1ET3,BDE?9E&,/I\%MKS<7P<A=<.[*U'<D(5\Z4XV@^S Q50A QA(Z
M**AT[*5G)]IR?ZZ6;HO4<LX \?185]Z*E[Y.@/8P4R\/)[1**.V&_P"*.2TX
MZU<#2WBYT)Y3@)I.&'EC>(**ID'G!G"SU" >QZ-C".X^]'0'N!4<M!QX1T*B
M/:LY5_:)R?75XQ]&J,3)0,O'0( <G5ZF_1J^8RA>'HJHDOPI3\"+G*\X2 Z1
M7(-U2%84OO1HW8O&$JPJI6H@@J)"E;R/6KKXC\_4_P!9JVT#&!YHVCY@<=/_
M ,H_JK#X_2]K@S;&Q=M6^)BK=,W6T4FRQ0Y\>2RU *HU/K%=B!#VTR;L;:O,
M9BNKM4&[+Q>$UZ4/6[%L-&MKD2,ID+Y;;:24A"5).#WWK4HD=,IR%;3@^(#!
MZ=*H&D[UK(!*E)/;MM2D 'KXL$;AGL3T]9NY73II(BS.W![74&[856T2_-&+
MR<H<*\B20\NFXQ<7DST3$6@J1%:)DYV+!#DYC*B6Y8DUDPQM^O.=V[=YQMV>
MCJ@C&TG&2G'8$X'3'85/+1G.T9W!7_S YW =@K/<CJ?3FJK%:)U!"$GE1NOZ
M\RN3>O[QS#HSA@#_ +JCL*1L8?T8:Z1'-@W$BO0[\[',BMQYCXF75#8<)+4_
M!=<. 5GILQZ_N>=G4=<IW'!SGKW[4"$#LD==V?5X\;NG;!P,CMTJ4@>G+2-9
M!DHZ&UW","RQ%1(/R0N0DBGL4&<&LU("0?)FF'C0]3GQ&)6OP8I+,-%%I6L,
M!K#SV')+SJB"5GINQVQXQM4< 8)4DX43U/I- VV.@0,>'_\ *=R?<#U ["KB
MLNF=7W3%@39Z;$RRK1*5F=G'W?.F"S9JF(9:JTJDT0@<L.0@VF&V@"P7AGVV
ML*;RM2''$KA+KB=NU1&T* QZ KSA\X/I!J2A*LY2#NP3\Y3V/N]%5"_:IU]M
M!N(3>:V--/0!!9,&>DN1BIB(<D!\"22(V;A3(Z7#&DQ4H'E QS6Q)-AIEHY@
MA#+6$0AQ:,[3C/<8!!QVR""#CT=.E%)2K&X9QV]8ST/4=>OI]=6O/=-6A[0+
M7@IK5U5(!K%;$IL1'C!N1<>FFA.8>$ILB!%/!!SE0'>[SS57G&)&!2ZZ0[B/
M[Y)"G;!]U)40XK*E;B>YW'NH$]E?[PP>W7I4<MLX&Q.  D#&!M'9)QW3_NG(
M^:KAG=(ZHM(LZ%.T>&,:L=FB;K*.H22$=FWP-=B*C#6:/D@"!9&%G(RL0<7!
M!R<*5'EL1@OFB'<-/$)>A+KB2"%GHDH'I&TDJ*2#D$$DD@YZU)0@YRD=3N/K
MW !(4#W!"0 ",'%4L[IPT?(5>O4Y[7,$S 50J7.KS$?D^)/C#+$MYVS$LSL6
M8'.K>M+I#[UJ<?DG56=YU;T]F0<5E7)#SH4I6\Y4 %9P00/-&""/#CP]/#Z,
M5'+1@#:,#./1C/?J.O7T]>OIJI*Z?M+KD!95&N*T*6' T>LC) $7&@LP.M++
M%W'7\:F+CW1HSP:=9(6,DJ\K(>7HO(B117&P5NC..<[C&]1R5*Z]3E:2E9R>
MOB22#UZ^X4Y:,YVCLD=L=$'<@8[>$]4^KT5,QFAM/15Z<V1'Z_@!;DY)RDZF
M60R_EH6P3@SH<Y9(Z(6^J%B[-."$$C35DCHX6<EF"S&I \E!A.'8+KA3L*U%
M. ,>L#!"2>Y2"!A).!CH*N&V\%>T;MQ(/J)P"0.P)!()QDY.3U-7-":PH%<:
MH;$'58N-9UA E5B@-C-N)35:^:#'1I<5%=YQ7ABO@1$:*M+GB*RT&SC"L9QG
M.8+BU;\J)WD*7_O$9()]Y)J6TI!3@#P)PG_='08'NZ51+=H73]_L@]PN%#A9
MVPM#Q8;YQ7GC;4N%!GOR<(#98\4IB,M0$-($D&Q(-E#E18XDA]X-EE;SF52E
MYQ"=J5D)ZG'3H2,$I.,I)'0E)&:A;:%.94D$Y3[P.H!]8!Z@'(!JH1VE=61E
MQ?O@%+B1+:5:G;P],,^=)7ZWD567I1=C:%\YR /+'5:=EX>0,'%:=D!SG5FY
M?(PV\@77"G85';MVXZ>;N"MN>^ H @>L5=3:!E02-V[=G_>(VD^K.TD>^J*'
MTUZ+ L[-Q$UM ,V(2U%7B-.QD];4);I U^1E;#7HYPQ<7792;/**,GR8,*/5
M/$$D.S/GRWG,JDONE.TK)3MVD=.J1V"CC*@/1DG&!C%$LMC!"!G.X?,H]21Z
M 222<8SGK2BNEW09\0-"/:UAF8\*>LUDCD1Y4Q%$Q4I<E-*MJ8>1C)(.1AXJ
MR9'8S-U^,*$@)+P6O.XQWPT]@/.@YWG)"0<X.0GHG((()&>A/4>NA8:( V#
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@'%*.*4<4HXI1Q2CBE'%*.*4<4HXI1Q2CBE'%*.*5_]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>47
<FILENAME>g723949g98a14.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g98a14.jpg
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M 0$! 0$!_\  $0@ R )8 P$1  (1 0,1 ?_$ !X  0 !!0$! 0$
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MR!+^(HLL<:LTBO1Q9-P51SAL8VRJ%+:?(X'2%9/,OUEB"Z4'%40=C:-_AWD
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M&,C'!/GA2--XBX2.&93,W ;X7N86'&1SUSSY@>6<ZVB="M= T6L:N-=0%U+
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MW%S@ 2YQ<<-S@9/7&3R<DYY)71G-*VJ/*?\ 98LF3AEZ1F/'>?Q'CH]9(?\
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MN&"'*=6M59,F5C-:2)9 =>+KN.P7JP1FTYB186M6P35EC-%)X)"[]3W C(C
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MDF5^XG ?[  2%H#I@YG'#MKCG)R7O)<T$-=@1LV@$E@'4EPRL&$6OJNI6O\
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M@8;@Q2P[&?8B+*);#N.57AH>X-.6AQ#3P> >.02#QY@X/DK3"XL:7<.+07
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M+TN56&=M3+:OP>&E=^;O!G6S<%]'\%[=3]!:EL43&7'X)N/)4P]$)Q[,^_\
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MT/9_X;T.9:2#D$CZVG!QY_F6'8QSC\+IE>6?1_-VP0VOJD<:UW9:?/I.G[D
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M(Q$@;)M.JB]P>880\.8[>!)G+"",@R%I!Q@C'()Z'E5&TP8W8)IMFUS=N6
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MT9?D9#A^]QD-\\K$396L+2,>$#Q<N.&8.".ISGDGV+)NG"NW*F??_6]UU[L
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M.(E7AD4=*EOA)1842T4CFLGC+@PM+@"7]&@D>(9( (' )R!DD#."-M0TNIY
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MX SV@M$KQN99;A.ELE9A&1LC<'1P-:86/$[\EVW ;W;/OCPXG/.X@GC(PT#
M"TR-(DF>1+(QT49&W=D^-_@9M QQM! YP<NX.5NGHTH[)/IO&"+8/L\91.X7
M2QR:;:ZALFF1*!]X+',/1M>U$-MH.#NLBE4R,09" C$\='BF/9I<\='@0GVQ
MD+55$&4XVD!K1N#F.W[0!O<8R6[G8R0#QYYZG?3@B(9W ESSM+7MVY<7;&B0
M!VUN< D 'J .@[B'P(@R''@PF4,18S:&F6FTX2E*$XQA.,8QC&,=F.5U84SA
M$X1.$3A$X1.$3A$X1.$3A$X1:AW9LX1JBH"S9P-,.C[/L+6&K508,AJ,ZB1M
MN_UW6\2>ZZ[E/]2#9-F:GS6VE8D.Q8[K<?.'E(SC9&PR.(!P0U[^?\AI?CXX
MPM<CQ&T$C(+F,X_RW!F?AG*\X.F"G:JIN[M"2]?V#<4L&<K/4KKBN5FWR*$R
M,&&>F EKSIUL-H-/UZO1S1ERR537=($B(.#$<3ZBJ#[,5$)LTN2IJY,Z1T4V
M\1Y:Z%Q+=_(F#Y0 "<#!>XDXSXB <*I UC7Q%ADPYLK0UVW@PEL1)(;DY#6@
M#('&XC<L]^TG"'#433JA.L1MSC Y=WL!:X&L=0,@=0A</-,AG5M0.GRYTD](
M*RJ>0M-JC9+D9#,H9035>#1'C=@B-.PHRT=YN?MR&M#1W/C)W$9,S7-P'!K3
M@=7@G@%3JP2(\,#L;B7'O2&CPYXB<TY+=QR3T:0!DKL#I3E3IW3=I.83#*KT
M^5KJMOR@JH]PBH'N.P6U^HC,[!,V"]8A=F<.0'+<7F6)^$N.^6RS-<>CLUYP
M!-* <@/< ?#SS_D ,_YH ]BWP9[F/(QEH./$/Q;R78]FXDXZ\K96R9(R!0+D
M4-2K!#$!JV7.DY%4($!=C;@ H;I>5@-.%/1R+,YQF$MME,1Y#K^5YC]N4NJQ
MF#,ES0,9) &X9;D\<Y\N5-^-KB20 "26\.P.>,>:X*F/;/UM/T9$M.Q#YVP8
M@5(V7U?.NFQ8MDMUFV-M""BP!*T=CL8&7L3J(*\U"0&.S#<AJIBY!*]Q:^.L
MV+<U:PQXDVL ;EP$@:S :QG!<#RTR$9R,>(X9DC:JIWM[O<]Q.&DLW.!<7OY
M:T_2#!Y')VC+L [ECP>3NI_[6FKM[1"ZN%U./T3=4;>I9=!L]L/6(M4_SCND
M['M>Q1]AJ-<&UVQ>SI%*]WUHG:!OKG2"/>?H1XSDJFK_ !L/7.YN?Q.Z<^]>
MIG"@G")PBU!O.LZUMFNB8C;-CB52EKECGIAV=8!E8CP9C<I*!JLES'^AS+CD
MQQMMEJ3A:)#RFV?5N97Z"NK:QT?9M=6273]_94R6Z:HIJF1E+4&FE=)2R=[$
M.]:UQ#=WK  $CH1U78M+:HNVC[M'>[*^&.X105%/')40MJ&,94QF*1PB>=A>
M&G+"X.:#U:X<+@+2'1-T/]0^FM=7:Q5RL;>N,JDU.69V$"O$@?>JJ;.5P8;,
M5X7>]4&*O9ZG%1-G+DX 12\/U"U(D+:S(6M]SCM"]G6FNSJDKZ'3457#3W&I
MCJZEM75OJW=]%"(&]V][0YK=@R6Y/B)(P, <AJ_76H=;U%%4Z@GIZB>WP24T
M$D%+%2[HY)C,>\9$!$YX<<-<UC/" #DY)O9?[*W3$?TLT.VF T5':IBL[0UE
MT_=257?5^R@N5WOJ.Z[BG,IQ^"DPMQ"9#O>]*<7A*D]Z73R[/7\?0X^7YE@;
M_P!GS(J[F7E=&OV374$GM_!4GIH9Z5#Z&\9S^+IB'6.K*"4(83V*4ZP*J\.6
M_G.$LBVLX4V3=];A\<_H^O\ &J7Y'= U+]'8OV4]TU[&8_"7:M#"=9[)J+><
M=G;D2+TOL$5NR8E&$Y7C*=)P%Y3Z"64+?5EE).?)WX\@_GX'GY_->9V\.H_I
M'HO5%7M25J1M>F:]-)'NV$C:]<;%HQ/4[CR:\RN&; ;C+5#;J&\>]5V$J2)"
M@<H")DQ7*Y&.L)BX:\7U)^HPOW:7J*X]I5+K2@M<5V?'<:.S366:IGDCL%-;
MK=,STMES@B:ZIEI9# 7PM /ADVLQ*Z\W_P"T!T3V0NI.R.Z:,O5UJ+)46^S7
MC4-)=*6"BHJC5SKE=Z*3T.2BEGJ(J*EFA?7&&1SFMD^\">9DD#?9&I:VZ0;E
MZI6H>M3;I%Q[LS'<J7VBVWML>L4KX<M,7O<NRXCN,]N/11[.MO/X?H9QGLS[
M0J)SYC__ #CY +<*>E[8<9*<USKHZO04=6,*;:[>EFYMJ1G':G^J]D]+]W(+
M1G'9^GB?ZQ6/QP[VY]+A8!QY ^_/V$+[^0[JA&?^HNMVUEO1^#\I>A]'6+TO
MW>T?DZKNG_6=O[7J/9>W\?1]#\.PL?#X+76V:9UTC]>V)2][ZCO$!MH?Z8/6
MG3+LK7NV2&/>T#"<U^^1.JZX!Q+L=64RRF<:U()FA6"0]"8"I:2$/S3M@BU%
M-V<:ECTI]UCJ!T=M^YPL;JJ.Z[A>+<:CT1]$YM2'>BB?O>Z()@[T.\!<O0.R
MV2PQ:\L$FI?N:+(U]>:XWD4S[:&_<JN$)JFU;33D>DF'N^\&!-W9;XPU:-Z3
M:SU2W"OV%VE[F;UI2W'XB6R5NUF1VN^8DI)6)HE^3HD5V-7JI5WAI9HDFW>U
M52YJ+DI@U3GNAT7(27\O_4Y4?:31_KR;VALUA&]QT_\ <INK)+M([PB]>G>@
MBZ/>6>M1^D]SC=FG,F<,QZ'VZUW9]7#2LF@Y=*3Q@7O[HR:7%L$>2;2*05CK
M8UK7GBJ[CO22W$^SJ]=;?FO[(,?V<];/519([GXOAJ_CI^U8(2I7QI@D-9:'
MK&P(S.<?@E,B_3GV_B1)2K]+GTVOGW/U#\_VE4GNAOIQ<9<D7AC:^RXR$9<F
M-;JZENHK;%>5CL_A5NUG8^UK#3X;#GXY=C0P<.!V9RG$9*,^CPF3]7P 'R"P
M2*K[+'IOFJE17>@3111M[TG9J7^GG6Q3,G&>S+LB:I8:<Y*RK':MYYU4A:^U
M2UJ7G.>$\1]I_&?Z=/S+S'ZX/M).B\'U!Z>A5ZBP>H< 1,0Y&TMFZ\V,V[79
M=552KY!@UFL*$R)@FQSPQ)D):94@>3 L+<#Q 7O9Y)$FJ# ?J9-$]J.=67^U
MT51<ZV8VR"2:IN[73B@HYI(^^%%<J6&GC'==PTM@EE.72O:0UHD\OU;^K5U!
MV'7B30=J9=)J"U6NDU!=)*86B,4D=WO%#0F.BBKK75RU]0(JPUT@DJZ2G!9'
M2LEWRRR4WN%LWJ!UAI$;K9VVKLS0_8YL54J9[@IMILWKR$Z,RL;">2'&S7FY
M\IAQK P%C#]H.Y;F8 !2RAA;,'=#1F)OHT3&L;2,$09O&&,A'=AH<YQW!H;C
M>7$<9<[D9]*?7,J RK<]S_32)VR=V1WAGQ+N+0UNTNWYV;0>2 W@@;WY!;4X
M1.$3A$X1.$3A$X1.$3A$X1<;\*NG"*RU:HU2DBD@Z96*]4@N),J=@160PX"+
MQ-GNYD3IGL N-%B^U3)"E/RI'JO6R'E9<=6M><YY)SG/.7.+C@#+B2< 8 R?
M8%@-#1AH#1R<  #GD\#VGDK*<=V/ECRY%6!T'N'R5='PX\?//"RJJ._P^N.$
M57A%7QW8^6/+A%5;_7X?7A%)1W>/TQPH_3_!^U24?#CQ\\\+ ]<^[]"E(_9_
MD_3A0^D?POD5*1\6/'RSPHJMPLCJ/>/FJR/AQX^>>%(^O\1]BJH[_#ZXX4G]
M/C]A57A37"^Q^I?852ZT]/Z1%:^MY'6MCK!INTG8E2,3&)AHDZ)<AGP\YJ X
MB4!U^I06+:BL*0H8,:N13!CT90>)Z'E=ZUK=[?VE:=TQ3VBX366MH:H5]7';
MZB1DE3,:<Q55-*V,A]):2::.OGC<8(&W*;TC#Z9FWZ$TQV5Z:O/85K77M9J2
MRTVJ;9=:%UHM\UYHH9(*&D;6,GMU=3OJ&F&XZC:*^:T4D\8JZI]DHS19AKIM
MW?2/BQX^6>>J+YX/J? ?8N$^G;J:V)M#J;ZC]66C7MOKU+I4P.N@E"M2+"DC
M(\:''BR(MEER8+*H4B^QEL7FGQR>(KK@54UMOUW8QC/E6D-;7B^:UUE8JZT7
M"CMMLEIS:9Y[?44XA8R)K'LK9)(FF)]U:6W2W-G[MSJ8R-:'8;GZ%[2^RO36
MD^RGLPU;:=266Y7V^05C=0TM'>:.L-7)+-)+'+:X8:B03Q:=E;)8+U+2F5@K
MFP/=LS)CMJVV!=3JEEL[04U9'@ 0D78KU<'RBIX[(@0WI+ <..ALOR99(D\V
MB'$:;:5VO/(4OT6\+4GTFXU9H*"LK6TU36.I*:>H;24<+YZNJ?%&Y[:>GAC:
M]\DTS@(XVAI\3@3@9(\*LUM;>+M:;4^NH;6RXU]-1R7*YU,5);[?'43LBDK:
MVIG?'%#34S'.FF>YX\#"&Y<0#RQT&[\V%U!Z4<M6T*J7KML'VVT#')TH#.#@
M[$,2;GJ@RJZ_(C,Q)C(%Q,RFE&8STB3#)5QY1'U3\M"5="[+=5W?5NFG5]\H
M*BCN$-PKH'2/I9:>EJX14R]U)1N>QL<C:4]Y;IVL<]\<]&\S;72 'U_]4'V>
M:;[.-=-M&E+M17*SU-GM-4VGAN-/75]LJS0TXJ(KDR.5\T+[BTPWRD?*R.*:
MDND;:7?'"XC+.MK<]RT1TXWN^:^!&#-R:AH&!)8P')-PZJN:EQ4ZY6##467$
M@!ZV,8FS\3"S>!;I5 L?+SE$[T<W>TK4=QTMH^ZW6TTM14W%L8AIGPTSZF.A
M,@/>W&KVL>R*GHX6R2]Y.!"Z<0Q/XDP>,["M$V77_:;8+!J*OHJ*RNF?5UT-
M57Q4$UW; 6B"R6XOEAFJ*VYU4D%.8:-WI;:,U=3#AU/D;QTU>2FR]74.]G*N
M:I1RRUT<0-U6P"YX<F#,Y;]25@K@E&8\WV-!!J0H7+=:2DD+7#(L^DQ*;5GL
M>GKG->;':[I4T53;:FMHX9JFAJX):>>EJ"W;/$8IVMD[L2M?W,CF@30F.5N6
MO!72=9V"ETOJK45@H+K0WR@M=RJ*>@NUNJZ>MI:^BW%]).)Z1\D'?.IWQBKA
M8\FFJQ/3/P^)P&U$?%CQ\L\YE=:^B/P?F%)1W^'UQPI*9CNQ\L>7"+[PB<(G
M")PB<(G")PB<(G")PB<(M7[AT[0M[T6=KC90T@4JL\D ,NQQ-@/U8DR4JYN#
M8@4^">K!(2;'2AQD;"G,/09\=>'&$X4K*,J3F<<CHG![" X CD!PPX$$$$$'
M()\E"2-DK2QXRTD'@D'(.00001@CR*TGIOH8Z<]"W,??M;UVX0K*)A6B ,?L
M&U=GW0>/9NTU@E;'806WVXV'C3; 1CM3RL]F"B;-F85*??6^M:U;9*F:5I8\
MMVG;G#&-)V^KDM:#@>0SPM4=-%$X/8' C<!E[W#Q<NX<XCD@$GJ2N<>M^+M:
MS[2UE6W:E3S&L8D"_D0E87U9;@T99-G$QU/'6,\5FB-0Z\G'FV]8#PI=R"MR
MQF1,]@^ZU(&,&B81M&VF+&L><NWDL!=W$<@8"X@#,CPWQDC/A!X&#@%:Z@2.
M>QN&%GB(!GDB<\AH))[MA/@ ./$00>1G"[FZ>)HHEHS4Y$&T,8#$*+7IHMD-
M?;!M(6W ECVI$5$+8=LC0[-<&,,N(]$V>B12TO/:J=':D86VFM+D2O!SD.(.
M6AAZ^;&Y:WW#CV*Q%CNV8QC:",/+QCZGNY</K/)\UN3FM;$X1<"6;_52-)?X
M G5'_E$='W"D/4=_";\GKOOA13A$X16.QEIX02^1&5@Y<)C*V$M@:Y(K44M*
M2Z\AIQQAZVV&K THC(4J0_B2:CN*9;6F,W(D9;861:UT S9A>I:#5;=2CU)-
MTJF5"HSHIPA3B2"4L!6A8Z:1$R:=:K3'4+7+CO-QU$G1A%>$>L<'--J0I1%N
M;A$X1.$7EWOG0G11<NM_4^Q-I5BL3MJ"*9;IQ!Z9/L,=HD>KA33^=>O6,+!E
M- STD>/)R40O><.4B5#:A0B>)<,; C1NPT6JK_;K<^U4=PDAHGQU,0C#(G.B
MCK',=4M@F=&981,6 N[M[=KB][-CWO<[SJ]]DW9_J/44.J[SIVFK;W%46RK?
M4NGJXXJJILS)X[7-74<50RDK7T<=0^-AJ()!)&V"&<2Q4\$<?<]MZ?="W[UO
MW[TCJ*Z^O[?7?>W6U,L?KO2^+UOO@+,]9V]N>WT^WM_7SKR]%RM/*^S_ .B-
MM2G!'2KHNH259RI4[7NNJYK8CE><]N7/>5!A5N?ZWM_'UOM/K,9_'"NW\>%G
M)/4D^_GZE^?S&]&Q_P#U(;ZDJEA/XLQZ=UG=8%7%,*_9RW7@V\HM<5A/[+3X
MAYG&/T?593^CPF3]7X@?F%I?J*Z)K/8M'[-JE!ZM^H2KRCU5G"XL#9^UXMJU
M[/\ :E--J#VXW::L;O<,(7;RL7+FA[7%FMIEX4^@K%]I$S^<TU<J6SWVV7.M
MIS54M'4B66$!KG$;'L;(QKR&ND@>YL\;7%H,D;1N;G<.A]IVF;KK/0.J-+V2
MXMM-TO-M=2TE:]TL<0=WT,TE-420-?+'2U\,<E!521QRO9354KA%+M$;N&OL
MH>@[9%+TE:V[OU-7>LCK!<I\R)KSIXV<+C"XONXF;#3#-J-_=J:9@EC3L+#<
M!FK% K:Q8UB22E$Y+D6.$[%KO4MLU%+;/N=3RL-#%5LGJIHVQR5'I%0)8H@U
MKGN,=.T.+2\@[YY0&AH#G^==@O9CJCLWI=4_KDN%-*+[5V>:AM-'42U--;_N
M=;#1U=6Y[XXHVU5R>Z)LC(6N @M](Y\I>XQ0^IOYCVE9?XV*S=3%R4O_ -(9
MMW65U;&0\K/Z\OU1>ZFJ?C&>Y3;%?9:SC]'*/1_#G05] Y/U?B'SQE56.@/H
MD0\W*(=*6A;0095AQHO?-9U;89QMQ/XX=2=O0ZPF,.]OXY<]M]-6?Q4K.?QX
M3)]N/=PM^4_4^K->H0U0=:T"CMMIPAMNGTVNUI#:,8[,)0@*.A)2G&/PPE.,
M8QC\.SA87*74[TE=,^Z-Q]-U[VMH_7-^MS>RIM;=.V6N0B,TA7A>G]OV\:#,
M^L1ZHX)@6,$,)PQYEJ=%CN-/LM-)BSR#$KDZ.\7*@IYZ6DJ3%!49[QG=0O()
M;L+HI)(WR4[RWPF2!\;R ,NX&.L7G1NFM07"@NEWMC:NNMNWT67TFM@:6MD$
MS(JJ"EJ8:>X0,E'>,@KXJF%CBXMC&YV>T2M:KAU,)!P $,H&NI?'(*BH)%(]
M]/H>B]"3+8>Q%=3ZMOT7&,-KQZM'9G]%/9QH)&<$C/!P2,CV'"[,0#C(!QTR
M!Q[E>^864X1.$3A$X1.$3A$X1.$3A$X1<;\*NG"*OCNQ\L>7"*1CNQ\L>7"W
MCH/</DJZ/AQX^>>%E54=_A]<<(JO"*OCNQ\L>7"*JW^OP^O"*2CN\?ICA1^G
M^#]JDH^''CYYX6!ZY]WZ%*1^S_)^G"A](_A?(J4CXL>/EGA15;A9'4>\?-5D
M?#CQ\\\*1]?XC[%51W^'UQPI/Z?'["JO"FN3+_\ VZ?3?_>BZ@?_ (_5O//;
MO_=*T;_Q=U?_ +ZP+V?3O]PKM0_XY]G/_NVK5V*CXL>/EGGH2\5/J? ?8N1]
M'?VU/6U_OUT__P")V!SSS3/]O7:7_I.DO^CL:]HU]_<A[!_] [1/^FM2NRF_
MU^'UYZ&O%#ZK?C\UR3T%?VK5#_X3;D_QV[&YY[V6?VCVO_3M1_\ 2:\+V?\
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MJ&>V6S7]?=Z*C9401"BLUQT]0T@J*6)^(XO1;Y3_ '2=1QELKY(&2Q,+WY'
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@$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A$X1.$3A%__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>48
<FILENAME>g723949g99b72.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g723949g99b72.jpg
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M!7\$J05*^H8P.H%1Y$.@1\M= .H 9!#?A!@=0;X\Y^.OJ!NKN@:["&#@6L0
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M2.M&BQ_NV)%P2=I3NR&^RD3:Q(F^.'XMV8;QB;)E_%4F+2_7,8.4_+Y>-1T
M <S5SI3UQJT<G1C)T^B/2!J<(GYJ&37G0-1R=&GE1C'73KYP<G8MU^](JP=+
M[&W 7W!NK4^V\ZUEOZ[K&H[;7B^N0]H"M2X&RYNTHCT$S'LUCL*W9@W\'\5;
M4B"N&ROVZ1A3*O!OTZ)$C$<4B:^^TBD.0<:-&XP!UU_'TK1&[F21'T=P(05!
M'IZ]CDGII^+K51<HJZG%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%
M*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2HZ[::;VQMXMUO<U)<I.MRNOMTDKB<V
M+!%5&PD*:"?TWM6I9GP:Q=6986PNDBMG&5YR&N!.>B1C#Y9IEO(_,EC1!)'&
M)N8NL-&%"$L QYB-C4NXP 3G(Z8\:SSQR2&'EMH*R%BX"DJ.6ZY ;8Y) Z'K
MGPK8VEM:;IH,L^_M;LG8-]1B4: T&A&]9:QU^BMOQG9*YDJ._KX&(?)J(MNQ
MV7&B:WVHV(B5QDH6\]E4)'B?'+A$6,Y(=WSZO2)QCXJG&DBYUS-+G&,HBX_8
M SGX_5M4N5'O3>'#6VP)CJQV.V7\0]X[9UV(MND]>U0K3)U?I5OG@PK3L^R[
M4#D9-B8A16TV!Q R'"5/RI4-AMG.$8O:U7$9$\*:XT<K*Y# LN3L$/=]6Y-4
MK<MEP8)GTR2*&C5"N%8@>E(#G WVZUT0#$5%Q HLL<2#K*#8)%8@RRS&+BU3
M8K4E0XK'CR);#!*#EW,:<RQ*DLM2FG4-R'D)2XK(1@D9!P2,CH<>(Z;'PVK4
M#D X(R,X/4?$?CKZ7.*YKUILV&-ARR)&7&@#X$9^;.G37VHL.%#BM+?DRY<E
M]:&8\:.RA;S[[RT-,M(6XXM*$YS@!G8;D[ #QI6+2=BZ^AD:^'F7JFQ2ULCP
MY=6%R;.$8(V6(07Y($JOPG9R9)F/.7]"&\.:DMR5_194O/S<EH?!.EL+D,=)
MPN.N3C;'CFHZUV&I<G! R-\],;[Y\,=:^D!ME6M7O3-7LM?LF A22$->X3(X
MQ[H-0_+[6(*>[Y,CW>4B^9/M,"7Z4MCS)]5I/CCG!5EQJ!&1D9!&1ZQGJ/CK
MD,K9TD'!P<$'!]1QT/Q5)?23\0=D/MJ=IOO,(<T7/I0_FT'U8JF#T9/GYOK&
MJU.9JOIQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*
M<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*YP:Q^$.$[3WY6=.!-8OQPIH_8:84
MN#]["R"H*YPFMUG@ ==*B#79,YF;1M,.V.VR&C34NA3[O4@)<;)5*62SL>T*
M1&0ON%#!=) *GE G42/OI-*[8<*Q4^%9$N@\JQA-B2I;4"0WW0@:<=-,9+;Y
M4LH(\3T?YCK73BE.*4XI4G:[^N5VB_0UU1_;793FA_>T'SEQ_*&J$]\3_D0_
M\VJQYGJ^G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<
M4IQ2G%*<4IQ2G%*<4IQ2H,^$,V36->Z;JT>UB9I&!<-H5T6Q+3NR7U[#")M4
M$6+:+<@_M"+%GI&LD&J"\""!WH;JC]I*@X$"0+*Y@&!VJT1GD;20"J,?<^:2
M&(39/'TLD^ R=QD'-=.$C74-F<#/,,0& 7W<9QG3@#&[$=#N'3ON._V8,64
M_4JD$8$4.B[%!R:;M-G:4L57KQ,L0T?2]M^0()>HNX0OQ;7(L52?EG%M^U/I
MR26\/?=E+BWY(4Y8Y9T.J/0"5P2T>Y#1G5A6VZ=,&N+>XYQ(TJ $5P5?60&)
M 638:9!IW!)Z]=C7U$]I]1ZGVGN&H;'O?5W55#KIRM>P2Q^W*Y&O9#8%ZP5+
M'_PB4C$ :L 7)YC+*NSI[^9+S;;Y!^88:>FRPW'(>1(V19W<AL@QG3I7 &AL
MG(&<?\-NAYY\:/(KM"BJ1TD&HNV2=2X&">O_ !R=\6TP^Q*89E17FI,:2TV_
M'D,.(>8?8>1AQIYEUO*FW6G6U)6VXA2D+0K"DYRG.,\S5IKR\4K1/9O5D;<^
MA=JZZ>#OV&6?I%E: @FC4H&R6M#06<Y6(<Z2P3$Q),!P[B J1 -RLU^5Y4I,
ML/0DNIY9"_+E1\XPRY.,X&1G&Q\,]-_554R<R)TQG*M@9QDX. =QMG'4X]>U
M018>N.Y$[9ZVVRKT"V0[C5=;]9J'8M@3;1IH_JFI4V@3K++VS7RE0,POPAC;
MTU%/SOBA9*#.LD(R>E@)>"E:BUN8Y,U++'RY59UP6F8(%D#LS!>60P.@ID=X
M.!@ [-J%9C#)KA(1@RI"K/JC**J9U@J>\&W[I3.3@Y&FOYZ<]7=_42LW\/.R
M4ZQGUZ8ZVZAB7 "UJN^$+5>=-E-AS=@;6'!Y2KG6Y8N]0+2-"PI]U%0[=+C.
MD)<\.)G#1C^>;B:)F0[3CF32:3K72D@70A/=8%2"2%.D8 R0:6\,JA@<PGEP
MQZAH;+1E];@'4N&##!89.22 16_?@^QA<+KO>0BP629<3@SM[V6@%[80'B1,
MZR$HNPI;,PY,%@88\(.DDWT+F/PA$"&.C./*:AQF&$MMIJNR"\9 T@V\!"@D
MZ04&!DY)QTR=SXU=; A'!)8B:8%B "3S#N0  ,_$ *O+F6M%.*4XI3BE.*4X
MI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*5\PU+F0 Y:>.@+*$(0R?+@
MC&U>1PC,C177HL!"_#/D7+?0B.E7AGRJ<QGPSX<P\4N;FSX9Q&[LK1N(7EK8
MW=S:6"-I>]N8+>26"T1L'2US*J0JV#@N#@UJL88+B]L[>YN%M+:>ZMX;BZ8:
MEMH)9D26X9<C4L,;-(1D9"XR*@GIYV-W)N:[WH#L()"2&##7"#9&"$?#IKQE
M).+#;J\CU%KR\J3%?FR&FIJG";/NI_+KSJ%J]/Y _HT>6WRF^4_M5VMX1VSX
M5:CAG"[%[Q+ZTX5-PT<&XHM_;VR< G+NW,:>WENIHX[HO?Q?U=*9))%9M'T5
MY;/)AV'[#\ [/<1[-<0G:^OKI;9K:XOX[T\3L3:33MQ>+2JA%BFC@B=[<+:2
M>>1A$0J-70GGV;7S73BE.*4XI3BE.*4XI3BE.*4XI3BE<<>JFS3(SL,]K&5<
MM!6NMKVWN' ^YKTCM\1MFX&;1C9MBS! [B-NQJ1;2$#% +5R=9T#E0+-6=8F
M 8@H:G@FY3783(#%K"2JW+CRO-C**!H&3&!J7.H-C.59P2 #BNO@<B71JC8<
MR0!N6X<DZS@.3I.-)&<;A2!TKL=SKZ["G%*<4IQ2I.UW]<KM%^AKJC^VNRG-
M#^]H/G+C^4-4)[XG_(A_YM5CS/5].*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE
M.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE0-\(%LE^AT74@67>R^JZ
M7L?<HVJ;)V;7:6B]V6FTP?1[U<\R*V(=K%R9A'#-EJ];KT*PN5HNH#@J\0CQ
M4RFV)4?5:H&9SI#LD99$+:59BRKN<KL%+'&1G&.E9;IRJQC445Y-+N%U,JA6
M;NC#8)*@9TG&<C>M8=#-AUPCMG>&N]:;<N6]]5QZEK[8\38>Q=?L4Z]1=A68
M]?@UTK1PVQKG6;EW1D:!JE@AER -^;!R6DCO>,EM'D8G<H1'&[HL3ZG30CZE
MT *58#6^G<L" <'&<5&V<&21$=I$THX=TTMJ8L&!.A-70'."=^M1SNNC-.;.
MW[LC4M9[8E-<T*X[M"[0V=2X?5F;7*6F^M127:*OT6G[,%M;(V+$DRXD53Y=
MQR;+J)4'.%4=Q0U4Z,2T1MW(DD: .ZQE$8S MI)$)9D.A,#H-M0(+>&,\J=^
M1XUG*JT@9U$)5=6.<%5QK?)^7200OC7=G6L*KC==4$=2'W)-+@4JJPJA)><=
M>=D5>*"@, 'W7GT-ONN.BD1'%N/-H=6I65.(2O.4XZQ]6MM6S:FU?E9.?^-=
MD@ 50OHA0%^0 8_X5FO(U*G%*<4IQ2HKZ2?B#LA]M3M-]YA#FFY]*'\V@^K%
M40>C)\_-]8U6IS-5].*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4XI3BE.*4
MXI3BE.*4XI7^8QC'CX8QCQSXY\,>'CG_ -<_^N?FQ\_& ,X&,[GXSZS3/_#:
MO]XI3BE.*4XI3BE.*4XI3BE.*4XI7QS]A 5,,1L=I.!ZU7@\9<TN>/DX08,+
MAMYQAR61*$7XT&#&1E6,+?DOM-)SG'F7CQQSD L0J@L3L  22?4 -S7!(4$L
M0 -R2< ?*3L*X,]6C&LBO<RE7ZMNZD.!-G;+W0#U[JZH]H;=?KII>;4!.Z"3
MNRBVI)3CM#'@[%#D7YH8T DN#:HC<27J:Y,@FY;B^SG#BW93S%*)&7=H%19-
M1C&@28UDCNYU $E.]N*ZR$H;A67ED.\BJBS,[1E1(=9C/< (U8T[*).[G.3W
M^SGP^?/S8Q\^<Y_Z<ZNNTJ<G.VO7S(,=8QNP,6<,8O9_6H>52*M=;ZLQ<:M%
MD3;".$Q*57#TTG!$Q(K\B788,:17$-(\Z2RL+1YK>1+D@KI(4.=3*N%;H3J(
M&^>G7XJJY\6 0VH%B@TJS99>H&D'('KZ?'7@)=ONNPIRZLR]AXS)H!N+7+!"
MA5.\$R$DU+L9JGI@U(>-K4N;L%46UUJQUPH]08]FC!S=?.#2ST*6((-1^1;R
MG3A/3&I260#& V6)8!.Z0PUZ<@@C8BN#/$-7>] X("L3G)78!<MAE8'3D @@
MXP:RBK=C-*W>[Q==U.^CSMKGUN#;1\:# -+%$0Q$!7[7$R.LZQB*L0++JEKK
M-I=KL,R]8HM:/B3\H4R)GQICD6AD5=;*0NHKG;(()4Y&<@:@5U$8+ @'(Q4E
MEC9M*MEBH88!Q@@,-\8Z$'&<X(.,&M=:[^N5VB_0UU1_;793EC^]H/G+C^4-
M03WQ/^1#_P VJQYGJ^G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%*<4IQ2G%
M*<4IQ2G%*^?,+"AZT-SR8^"XXGSH1,F1HRUH\<I\Z$O.(4I/FQG'FQC./'&<
M>/CCG.">@-<9 ZD5ZGQEKG_X@"?_ +K _P#[^,'U']1ID>L?K%80.WEI8O;R
MFOA6W-9DKV$8S),4V!>JQ+M N/CT_,[/!,$W"<1#?K,Y=R]&1Z.'V,N^3#[6
M5[I.%<3AM(K^7AU]%8S$"&\DM9TM92>G+G9!$VK!TX8ZL'3G!QT-MVK[+WG&
M+GL[:=H^!77'[-6:[X+;\6L9N*VRIIYAGX?'.UU$(]2\S7$.7K37IUKG9C$A
MB4RB1%?9DL.X\S;[#B'F7,8SE.<H<;4I"\8SC./%*LX\<9Q_7CF"N_KS<4IQ
M2G%*<4J.^XEDOM.$Z6M=?=V8SK>M[NK9W>Z].AYM@O\ ^#D2!LQ <V@(+@DS
M16DO;"CTMC9, ! EF)=*<+,)8<&.%4YT6X5C(IT:S$PBYA 762N=R0 VC5H)
M.-7QXK/<%E$9&O0)5,IC!+:0#C8 DKKTZL#./BS6*=9-D67;&]-\7FI3MP$.
MN)VO:YD55S;U3L-,BQ=JQU60==86HPEO"5^TQM?IK$&EOF4SQV!JKJ^6D"'7
M'Y)A2I3((XHE81B8,^KEL&/+[I4R%21JU%L>.G&:XA<O)(RF0Q%4QS 5 ??4
M(PP#:=.DGPU9QXU'-MU%7+92>ZVTJ.2[BL4ZH[DW%&L.N:=V7#4.K;.FP#SJ
M>P92OUAT#('5\8(FN7&.-#GWWY-T0$991)BI,LO,7K(RM;(WF^IHX\,82[("
M/N0)SDD]TDCT<_%6=D5EN'4W&E9'#*LP57(/W8A2,  ZL ^ECPSFNN>I%UES
M5.LG*4N>[37->TQ=2<*8Q@FY655P:H"LCC"48Q/6*S%5,QA",8D9<\$IQ\V,
M,FK6^K&K6VK'35DYQ\6:WIIT)I]'2NG/73@8S^BMA<A4J<4IQ2G%*BOI)^(.
MR'VU.TWWF$.:;GTH?S:#ZL51!Z,GS\WUC5:G,U7TXI3BE.*4XI3BE.*4XI3B
ME.*4XI3BE.*4XI3BE.*4XI3BE.*4XI6E=O=CM%:#6 ;W/M2G:V7:DDUUU-K*
MM#,F$!<P$E50<.8SZV(&2H[$G./^'F8QX_[^.61PRRYY:,^G&=(SC.<9^7!J
MN2:*+',=4SG&HXSCKCY,UIG_ .T5Z-?G2:?^;YORJC?N\L\TN?@)/V35?G=M
M\/'^T*L0<1@EQ\ L,E,SAI2'%(CYL=6%QYD&:PB3$E,+Q\RV9##K;K2L?,I"
MTY_Z\SG;8]16@$$ C<'<'XC7N<4IQ2G%*<4IQ2G%*<4IQ2G%*^>5$BCHZ8'-
MC!YD2095'GBRL.,0'3HZ_#*F)D*6V]&DLJSC'F:>:6C/ACQ3GPYR"0002".A
M!P1\A%<$ C! (/@=Q7&OJ#%LA[?XNWS:]N]H4SL+=XD>9"=8>ME%ZWY" YFQ
M*P"R(OXZOC-YCQ>!\&%"@O2G&RY*T);$FWIP:9.D2NPN"!$5U1YTQ$@S3/-D
MZ&.5),1.22<' &XW K!!J,H;$F-4@!$42PX&I1A@!*!L!O@EMCL:[29QC.,X
MSCQQGYLXS\^,XS_7C..==785SYV5T1B7NI'ZE!N50%,'MH[0O\8H7U$/L9>B
M1-F0QL-*M6D,6T/*HFPJ0D9'DT[8$!Z1%A3,-NRZ?+3&BMLZTNM#!BK$A$3
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M>P,SII1<L!G+2*,C/ADXS@=:SW<TT4#R>;S/RU=PEJY>60HC,(U B.[XPN<
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M$28/3,04_I5E##](%:L%ZWUWKOO)KMG7]"I=%9*]4-ZNE&J=5@=9;).1-O\
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M+7C_ &U[9</[%<!FX[Q.+G0V[0V\5O;VT#SW$T[E8H8N9HC09+2.S.JI&KL
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M1C:)6R(QL@45XEPWL'V+X/QV\[3<+[+\#L.T%_S3=\6M>'6T-[*;ABURW-1
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MHJ30+;6K68=)"<I:3-:JIXQ&;8-O004J+*F,$"P5+C9:%HMF E4%I%#%1]S
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M+%E(")AIE4P<2B_SF!-CX<C3(_\ MH[KC?TN67,4I,6(Y#BW@!PC'!" $=/
M['X]JA!+$!)F2,9GF(RZC.78CQ\1O7\]^.P^@+'U)V\&KV\M/'C$YFI1X0H-
MLREE"4Q^/L"JR9#,6#!-ORI#S$>.^^\VRTM;3+#SJTI0VM25K%*)T)CD &K<
MHP^\;XOCKBZEB,#@21DG3L'4_?K\?Q58/RHNL_YQ.B_^)Z/_ #<H'_&_]U^4
M'_$__3_WO_AS/R9O@I/7[FW3U]*T<Z'X6/U>Z+U]76GRHNL_YQ.B_F<PSG_S
M<H'_ !L^'@U^4'_$SXX\&_\ >^?'S?/QR9O@I/7[FW3U]*<Z'X6/U>Z+U]76
MI [W]A=!6/K%<Q%>WCI\\5=NNCU-# VRZ64(.)'[VUF2GJ;A033\E:8(Z-)(
M2\I:SB-"CORGO(PTXXG1;12B928Y -,FY1L;QN!X>O;Y=JSW,L1A8"2,G5'L
M'4GW1#Z_5O\ )5?Y[1=9\>;Q[$Z+QY7$LJ\=N4#Z+R_)Y&E?^(/F<7ZC?E;S
M])7G1X8SYL>.?DS?!2>OW-NGKZ5HYT/PL?[:^VHZW!V+Z_N]O^HEBC;QU#,!
M5NG=HHYXM"V339@\/*+@=5)#PR4N.9<8A33"X[[0F))<;D$G67&H;;RT*3B]
M8Y$M;HF*78PO@1N6*KS22J@9;'Q ]1ZZIUQR75JJRQ98R)EI45%9^6JZW9@J
M#)W+$ #<["HDUO\ "+73L]V%LM=:[$$.GNL9 5V31GR@;0]D"N21#K3"VK&<
MV53428!FS1WO;XL2,?GPXLQE0>&U)PMN:OT9Y.O+/;]N>TMWV>^QJ2U46]U=
MV%V+R6>5X;5T5DO8(XHDMV>-PX>.21$<<@ERRRGZP\L_]&&Y\E'8?A_; =M(
M>*2^>6/#N,6!X;'9PQW-_'*RR<+N9+F:2[CBFC,12:&"66$^=@1!7MUVQ7CQ
MCK$!UIKG2G>L1NZEU@9/$1*"+%]>"N (T0X,E1&"TZL!"ER?CRVR,I*GWBT-
M_",84F=A>6O#WP^)B[R6W+9B"7)E&2<] Q"^'J\*^3(5Y05$N>8J# 0"+8;=
M2H+>/K'6MLRNSVG[1VFZ<W:P[9U&%=AZ*[/P+EG.Q*FR.K5A.%NO6!0HL](-
MJP$G'$CYDD2)*/MD'VV9#329"XCZ\0$,@AN%$<AS) 5[C9( ER1MOC(R1M1I
M8_.82708CF!RZ[$F/ .^Q/@#O\57?GM%UGQY_'L3HO'IN(:<\=N4#'D==]/T
MVU^-@^BXYZK7D0KP4OU6_+C/G3XYN3-\%)OT^YMX=?"M/.A^%C_;7VUR;VIV
M/9KD;X2P]H/=.KHFPCNUM'RZ5/C;#HV"9D QH72H6V3:$H@7]C-%HC44P,84
M/]KDM$8LR&-3FPQXC&/$?*2O:M.Q=ZW8^&X?CJP*(!;1<R[6$WP\[-I&RL&N
MA:F0Q*%,G4P S\JO9?D0'D_F\IW!8_*3/:1=DWNKCSMKV<P\.:Z'#I/ZM7B4
MT;HT=@U^(!.Y98,Z1=LMF;@C</P<';*40T.1?[4=@M:,65FYS6*FN_[.H@V]
M*JBQPE37QCBRS48FC&33I)(I9YELR_&5XJ]0=[J6OQGR0CMW-V8E;MO;\16]
M_K"8<//%+=XN)M8"*'>ZC=$F %SSQ"URHN&0'.81"3YO_213R46W;R!/)7<\
M%?AAX/;MQE> 745SP).,&YNACA\L4DEKJ-EYH;E+%VLUD(TXN3=*-VVM[IU:
M=IM;.F=H=017&IX@D6!-;9US[++(BVXC<+.9B[#A^"Q)1$B>U1\(<<?SEQ49
M^-EY.4>V0LX30(9-\@'0^=^OAX9KYZ,D&<F:/XP9%]OR5B_6OL+H(-M?N[.+
M[QT^*A'>R88J$F$METN#%,"\=>]("\DA4B4:::(0,$Q\\=F9$6]'Q/A2X?J>
MT1GFT3EBE,=L!'(2(2" C$@\V0X.WJ(/R$&JHI8A)<DR1@&8$$NH!'*C&1OZ
MP1\H(JH+5V=ZUKK-F:1V%T:MWW"51Z:=LT)3GG>'R$LH\F#^5>9U6<);3X>*
M\YQA.,YY0(9LC[E)U_ ;V5>9H<'[K'T_#7VU/723L7U\KO3SK*#L&]M-@C0/
M1.KX!H08V?21A0/.C5$6S(AE!\TXQ+'RV'FW&GH\MIEYIUM;:T)4E6,77,,I
MN)B(I"#(Y!",01J.X.-_T53;31"WA!EC!$: @NH(.D;$9V_351J[1=9T>IY^
MQ.BT^BG"W?-MR@)])"O-Y5N>-@QY$J\JO!2O#&?*KPS\V>4<F;X*3?I]S;V5
M?SH?A8]NOW1?;6![5[,];Y.L=E1(W8'2,B6Y0+<VW%8VO0W9#CDBODVX[:&6
MSRG%K?<QEME*4Y4ZO&4(PI6/#DXX9>8GW*3TU^\;P(SX5"2:+EO]UC]!OOU]
M1^.M;=2NQ_7@%U2ZT!SF^=,!BX/KOI:":%%=HT<<2#S86MZ[%FQ"D&6<9DCY
M423&DQY4>6TR['?COLNH0XTXE,YX93/,1%(09I2"$8@C6VX.-_T5"WEB$$(,
ML8(AC!!=01W!U&=OTU@?<_L/H U4](L!]Y:>+/">WG4^PE61NS*7.=&  ^ZZ
MQ/+'"#<4VZN&'%P8LJ:1)R<-PH42-(DR7VF67%IE;12@RYCD&;><#*,,DQG
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MXYTOPLG[;>VG)B^"C_87V4^3?UW_ +!=+_\ $];_ )6T?_B_^]_$7_$__/\
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M6^LFXJ88%U32^8+(;H11KN\C1!%\36ZJEJ_6E!DS)E%UW1:7,(QV8I"54JD
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MV>P3FA@&N"21TV2?2XID>($0WB!*<\EE#KRFHD..](<PTVXYE#:O(A2O#&8
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MG-NS1D_^(3+-E3A)N4$3[U@0&U-D*P!;5C;%=9YO.%D'A&%BA"L,O#S=;_?
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M:Y729>!8;9%(.UJN2Q0!I]NT6)28PYAEXZ8?:<(R<<[(\SM'C2<8TC .% )
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M5QT(W!('Q$9J6]<?!W7=9C2HK;1P4+IFI-4;OU@9*Z+V9LW65IV<_>=D5FS
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MU,)2(U53J:,*VIV*@8:0*0,$E@Y]6,U%[EX]*F(<QF8!5D+#2JAB<K&6R<@
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MJM3+(/9-5V41DK&D&;D3MQ"-@BT8PJFS D!$&3V+0QYEB6)<QPAQ(TCK(S:
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MCM7FNFKPX*"MO5JI$SK*Q&5.#VI*=372C44=C)HA4R:=)=D=F=O6.Z0N3WF
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M4+\W35'ZIC_W./LM[3?WYQ+]YD]M/M.>2S\0NS/\,@]E/D.]0OS=-4?JF/\
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2QMTK;7*ZLIQ2G%*<4IQ2O__9

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
